{"generated":"2026-08-28T16:42:09Z","content_changed":"2026-08-28T15:15:36Z","count":8463,"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","note":"Auteurs (minstens twee artikelen) en sprekers, afgeleid uit de inhoud; titels van hun artikelen staan in articles.json; dutch_institution = affiliatie bij een Nederlands instituut voor zover bekend (title).","people":[{"id":"scott-d-solomon","type":"person","url":"https://hartvaat.nl/mensen/scott-d-solomon/","name":"Scott D Solomon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":140,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/06/26/finerenone-verlaagt-hart-en-vaatrisico-via-vroege-daling-van-uacr-en-systolische/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/05/11/finearts-hf-subanalyse-virale-luchtweginfecties-triggeren-hartfalen-verslechteri/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2026/05/09/meta-analyse-decision-digit-hf-dig-digitalisglycosiden-reduceren-verslechterende/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/05/10/hf-revert-antisense-mirna-remmer-cdr132l-mist-primair-eindpunt-na-infarct-met-ve/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hf-verslechtering-bij-attr-cm-attr-act-subanalyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hartfalenverslechtering-bij-attr-cardiomyopathie-attr-act-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/dosisrespons-van-sacubitril-valsartan-bij-hfref/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-uitgebreide-fda-labeling-jama-cardiology-implicaties/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/07/antisense-tegen-microrna-132-bij-hartfalen-fase-1b-resultaten/","published":"2021-01-07"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deepak-l-bhatt","type":"person","url":"https://hartvaat.nl/mensen/deepak-l-bhatt/","name":"Deepak L Bhatt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":139,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pcsk9-remmers-verlagen-events-bij-ascvd-zonder-eerder-infarct-of-beroerte-real-w/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/02/27/nieuwe-aldosteronsynthase-remmers-bij-hypertensie-bayesiaanse-meta-analyse/","published":"2026-03-08"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/04/15/inflammatie-en-cholesterol-als-cv-voorspellers-onder-statinetherapie-lancet-anal/","published":"2023-04-15"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/02/baxdrostat-aldosteronsynthaseremmer-bij-resistente-hypertensie-nejm-fase-2/","published":"2023-02-02"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/10/21/icosapent-ethyl-en-coronaire-atheroscleroseprogressie-bij-verhoogde-triglyceride/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2020/10/13/dapt-na-pci-met-des-netwerkmeta-analyse-van-duur-en-intensiteit/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/06/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-acs-trials-jama-cardiology/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/05/12/management-van-stabiel-coronairlijden-bij-diabetes-type-2-aha-scientific-stateme/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/11/01/themis-en-themis-pci-editorial-perspectief/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/sham-gecontroleerde-rct-s-van-renale-denervatie-meta-analyse/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/10/endoscopische-versus-open-veneoogst-bij-cabg-nejm-regroup/","published":"2019-01-10"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-j-v-mcmurray","type":"person","url":"https://hartvaat.nl/mensen/john-j-v-mcmurray/","name":"John J V McMurray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":136,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/18/2025-acc-scientific-statement-obesitasmanagement-bij-hartfalen/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/08/01/candesartan-dosering-bij-mannen-versus-vrouwen-met-chronisch-hartfalen/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/05/15/implanteerbare-hemodynamische-monitoring-bij-hartfalen-meta-analyse-over-ef-spec/","published":"2023-05-15"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-uitgebreide-fda-labeling-jama-cardiology-implicaties/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"}],"videos":[{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/nieuwe-data-in-praktijk-mcmurray/","title":"Wat betekent nieuwe data voor de praktijk? — John JV McMurray"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-gabriel-steg","type":"person","url":"https://hartvaat.nl/mensen/philippe-gabriel-steg/","name":"Philippe Gabriel Steg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":120,"articles":[{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/11/01/themis-en-themis-pci-editorial-perspectief/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/10/31/laesiecomplexiteit-en-uitkomsten-van-verlengde-dapt-na-pci/","published":"2017-10-31"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/07/01/1-jaarsmortaliteit-bivalirudine-versus-heparine-in-de-ambulance-bij-stemi-matrix/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregg-w-stone","type":"person","url":"https://hartvaat.nl/mensen/gregg-w-stone/","name":"Gregg W Stone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":107,"articles":[{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2024/03/02/intravasculaire-beeldvorming-bij-des-implantatie-lancet-netwerk-meta-analyse/","published":"2024-03-02"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/10/13/dapt-na-pci-met-des-netwerkmeta-analyse-van-duur-en-intensiteit/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/09/01/routine-revascularisatie-versus-medicamenteus-bij-stabiel-coronairlijden-meta-an/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/11/13/ultradunne-versus-dikkere-drug-eluting-stents-systematische-review/","published":"2018-11-13"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/20/bloedingen-voor-coronairangiografie-bij-nste-acs/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-s-sabatine","type":"person","url":"https://hartvaat.nl/mensen/marc-s-sabatine/","name":"Marc S Sabatine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":105,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/10/12/baseline-ldl-en-klinische-uitkomsten-van-ezetimibe-plus-statine-improve-it/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/08/11/veiligheid-van-aspirinestaken-met-p2y12-achtergrond-na-pci-meta-analyse/","published":"2020-08-11"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2020/01/28/morfine-en-cv-uitkomsten-bij-nste-acs-jacc-analyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/29/langetermijn-werkzaamheid-en-veiligheid-van-evolocumab-bij-hypercholesterolemie/","published":"2019-10-29"},{"url":"https://hartvaat.nl/2019/10/15/triglyceridenverlaging-en-cv-risicoreductie-over-therapeutische-klassen-meta-ana/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2019/09/01/persisterende-arteriele-wandinflammatie-bij-verhoogd-lp-a-ondanks-lage-ldl/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/09/01/verdere-ldl-verlaging-bij-reeds-zeer-lage-niveaus-jama-cardiology-meta-analyse/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"},{"url":"https://hartvaat.nl/2016/09/27/ldl-c-verlaging-en-cardiovasculaire-risicoreductie-jama-systematische-review-en-/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javed-butler","type":"person","url":"https://hartvaat.nl/mensen/javed-butler/","name":"Javed Butler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":104,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/05/05/apture-shunt-verlaagt-hartfalen-heropnames-bij-patienten-met-hfpef-hfmref-alt-fl/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/04/07/confident-hfpef-machine-learning-voorspelt-sterfte-en-opname-beter-dan-bestaande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/04/21/jacc-beschouwing-placebo-in-trials-met-incretine-therapie-bij-hartfalen-wetensch/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2026/03/03/tien-jaar-real-world-sacubitril-valsartan-mortaliteitsreductie-bevestigd-maar-sl/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/16/farmacologische-behandeling-van-hfref-geactualiseerde-systematische-review/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/12/01/hfpef-fenotypen-in-device-en-chirurgische-trials-karakterisatie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/cardiale-akoestische-biomarkers-bij-hartfalenmonitoring-systematische-review/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/dosisrespons-van-sacubitril-valsartan-bij-hfref/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/04/27/2021-acc-aha-kerngegevenselementen-voor-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/09/15/empagliflozine-bij-hartfalen-diuretische-en-cardiorenale-effecten/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/06/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-acs-trials-jama-cardiology/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/01/raas-blokkade-bij-hfpef-systematische-review-en-meta-analyse/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/08/canagliflozine-en-cardiovasculaire-biomarkers-bij-oudere-diabetespatienten/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-faiez-zannad","type":"person","url":"https://hartvaat.nl/mensen/prof-faiez-zannad/","name":"Prof. Faiez Zannad","title":"Hoogleraar cardiologie, Université de Lorraine, Nancy, Frankrijk","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":90,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/06/26/finerenone-verlaagt-hart-en-vaatrisico-via-vroege-daling-van-uacr-en-systolische/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/05/05/sterftecijfers-in-controle-armen-van-hartfalen-rcts-dalen-niet-ondanks-betere-ac/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/16/farmacologische-behandeling-van-hfref-geactualiseerde-systematische-review/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/08/05/sglt2-remmer-met-en-zonder-mra-bij-hartfalen-gecombineerde-analyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/04/19/therapeutische-doelen-voor-hf-via-proteomics-en-mendeliaanse-randomisatie/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"},{"url":"https://hartvaat.nl/2020/07/07/baroreflexactivatietherapie-bij-hfref-beat-hf/","published":"2020-07-07"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/masterclass-globalising-hf-zannad-van-spall/","title":"Masterclass — Hartfalen-evidence wereldwijd inclusiever maken"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"renato-d-lopes","type":"person","url":"https://hartvaat.nl/mensen/renato-d-lopes/","name":"Renato D Lopes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":92,"articles":[{"url":"https://hartvaat.nl/2026/03/17/answer-hf-sacubitril-valsartan-versus-enalapril-bij-chagas-hf-primaire-resultate/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/11/19/screening-op-niet-gediagnosticeerd-af-voor-cva-preventie-gerandomiseerde-trial/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2021/01/19/stoppen-versus-doorgaan-met-ace-remmers-arb-s-bij-gehospitaliseerde-patienten-ja/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/14/verlaagde-dosis-doac-bij-af-werkzaamheid-en-veiligheid-meta-analyse/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-en-evidence-based-prescriptie-bij-hoog-cv-risico-jama-card/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/10/02/periprocedurele-uitkomsten-van-doac-versus-warfarine-bij-niet-valvulair-af/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-l-claggett","type":"person","url":"https://hartvaat.nl/mensen/brian-l-claggett/","name":"Brian L Claggett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":90,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/11/finearts-hf-subanalyse-virale-luchtweginfecties-triggeren-hartfalen-verslechteri/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2026/05/12/massieve-lvh-bij-pediatrische-hcm-vroeger-diagnose-vaker-sarcomere-variant-driev/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2026/05/09/meta-analyse-decision-digit-hf-dig-digitalisglycosiden-reduceren-verslechterende/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/28/lp-a-verhoogt-risico-op-veneuze-trombo-embolie-bij-premenopauzale-vrouwen-en-hor/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-uitgebreide-fda-labeling-jama-cardiology-implicaties/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"},{"url":"https://hartvaat.nl/2020/05/01/langetermijnvoordeel-van-intensieve-bloeddrukcontrole-op-resterende-levensduur-s/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/12/01/number-needed-to-treat-met-arni-voor-preventie-van-cv-dood-of-hf-hospitalisatie/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/04/10/geen-verband-tussen-hartfalen-en-kankerincidentie/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/19/sacubitril-valsartan-en-30-daagse-heropname-na-hartfalenhospitalisatie/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/02/01/regionale-hartdisfunctie-en-prognose-na-myocardinfarct-met-lv-disfunctie-of-hart/","published":"2016-02-01"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akshay-s-desai","type":"person","url":"https://hartvaat.nl/mensen/akshay-s-desai/","name":"Akshay S Desai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":87,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/05/09/meta-analyse-decision-digit-hf-dig-digitalisglycosiden-reduceren-verslechterende/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/ai-voorspelt-hartfalen-op-basis-van-12-afleidingen-ecg-in-grote-cohortanalyse/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/kardia-2-zilebesiran-als-toevoeging-bij-ongecontroleerde-hypertensie-rct/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/20/zilebesiran-rna-interferentietherapie-voor-hypertensie-nejm/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/12/01/number-needed-to-treat-met-arni-voor-preventie-van-cv-dood-of-hf-hospitalisatie/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/06/01/maatschappelijk-werker-palliatieve-zorg-bij-hoogrisico-hf-swap-hf-pilot/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/19/sacubitril-valsartan-en-30-daagse-heropname-na-hartfalenhospitalisatie/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/06/11/ixmyelocel-t-bij-ischemisch-hartfalen-lancet-dubbelblinde-gerandomiseerde-trial/","published":"2016-06-11"},{"url":"https://hartvaat.nl/2016/04/21/aliskiren-enalapril-of-de-combinatie-bij-hartfalen-nejm-atmosphere-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/03/19/serca2a-gentherapie-bij-hartfalen-de-cupid-2-trial/","published":"2016-03-19"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-roxana-mehran","type":"person","url":"https://hartvaat.nl/mensen/prof-roxana-mehran/","name":"Prof. Roxana Mehran","title":"Icahn School of Medicine at Mount Sinai, New York, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":81,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/08/01/seksegerelateerde-uitkomsten-bij-hoog-bloedingsrisico-na-pci-leaders-free/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/06/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-acs-trials-jama-cardiology/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/07/orbusneich-combo-stent-japan-usa-harmonee-gerandomiseerde-multicenter-trial/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/12/20/bloedingen-voor-coronairangiografie-bij-nste-acs/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/02/16/ticagrelor-versus-clopidogrel-bij-troponine-negatieve-laagrisico-acs-met-ad-hoc-/","published":"2016-02-16"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/expert-acc26-overzicht-mehran/","title":"Expertinterview: ACC.26 overzicht met Roxana Mehran"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pardeep-s-jhund","type":"person","url":"https://hartvaat.nl/mensen/pardeep-s-jhund/","name":"Pardeep S Jhund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":83,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/kwaliteit-van-hartfalenzorg-bij-aziatische-patienten-in-de-vs/","published":"2026-04-08"},{"url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/05/15/implanteerbare-hemodynamische-monitoring-bij-hartfalen-meta-analyse-over-ef-spec/","published":"2023-05-15"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/12/01/hartfalen-en-atriumflutter-systematische-review/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/10/01/associatie-is-geen-causaliteit-behandeleffecten-bij-hartfalen-en-observationele-/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"muthiah-vaduganathan","type":"person","url":"https://hartvaat.nl/mensen/muthiah-vaduganathan/","name":"Muthiah Vaduganathan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":79,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/06/26/finerenone-verlaagt-hart-en-vaatrisico-via-vroege-daling-van-uacr-en-systolische/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/05/19/sglt2-remmers-bij-oudere-patienten-opgenomen-voor-hfref-24-sterfte-en-16-heropna/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-uitgebreide-fda-labeling-jama-cardiology-implicaties/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"},{"url":"https://hartvaat.nl/2020/06/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-acs-trials-jama-cardiology/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/01/langetermijnvoordeel-van-intensieve-bloeddrukcontrole-op-resterende-levensduur-s/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/05/21/vroegtijdig-staken-van-ticagrelor-bij-secundaire-cv-preventie-jacc-review/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/02/07/doodsoorzaken-bij-hartfalen-met-behouden-ejectiefractie/","published":"2017-02-07"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/04/12/protonpompremmers-verminderen-gastro-intestinale-events-ongeacht-aspirinedosis-b/","published":"2016-04-12"}],"videos":[{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/nieuwe-data-in-praktijk-vaduganathan/","title":"Wat betekent nieuwe data voor de praktijk? — Muthiah Vaduganathan"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-p-giugliano","type":"person","url":"https://hartvaat.nl/mensen/robert-p-giugliano/","name":"Robert P Giugliano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":81,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/10/12/baseline-ldl-en-klinische-uitkomsten-van-ezetimibe-plus-statine-improve-it/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/03/09/halve-versus-volle-dosis-edoxaban-bij-af-gerandomiseerde-vergelijking/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/28/morfine-en-cv-uitkomsten-bij-nste-acs-jacc-analyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/10/29/langetermijn-werkzaamheid-en-veiligheid-van-evolocumab-bij-hypercholesterolemie/","published":"2019-10-29"},{"url":"https://hartvaat.nl/2019/10/15/triglyceridenverlaging-en-cv-risicoreductie-over-therapeutische-klassen-meta-ana/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2019/09/01/simvastatine-ezetimibe-versus-simvastatine-na-acs-bij-75-plussers-jama-cardiolog/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/05/14/verlaagde-dosis-doac-bij-af-werkzaamheid-en-veiligheid-meta-analyse/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/05/14/edoxaban-bij-aziatische-af-patienten-concentraties-en-anti-xa-activiteit/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/30/endogene-factor-xa-activiteit-en-edoxaban-farmacodynamische-marker-en-klinische-/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/01/verdere-ldl-verlaging-bij-reeds-zeer-lage-niveaus-jama-cardiology-meta-analyse/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/doac-s-bij-af-met-kleplijden-jacc-review/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/nieuwe-risicovoorspellingsscore-bij-af-voor-netto-klinisch-resultaat-engage-af-t/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/12/21/ezetimibe-bij-post-cabg-patienten-met-acs-improve-it-subanalyse/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/09/27/ldl-c-verlaging-en-cardiovasculaire-risicoreductie-jama-systematische-review-en-/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/07/05/nierfunctie-en-uitkomsten-met-edoxaban-in-de-engage-af-timi-48-trial/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piotr-ponikowski","type":"person","url":"https://hartvaat.nl/mensen/piotr-ponikowski/","name":"Piotr Ponikowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":79,"articles":[{"url":"https://hartvaat.nl/2026/06/26/machine-learning-voorspelt-diureticumrespons-bij-acuut-hartfalen-drc-ahf/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/05/26/adipokineprofiel-bij-acuut-hartfalen-voorspelt-natriuretische-respons-en-mortali/","published":"2026-05-30"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/12/01/gelijktijdige-griep-en-rsv-vaccinatie-bij-hoogrisico-hartfalenpatienten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/02/01/transveneuze-frenische-zenuwstimulatie-bij-centraal-slaapapneu-en-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/12/01/vericiguat-en-nt-probnp-bij-hfref-victoria-subanalyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/04/01/lv-longitudinale-systolische-functieparameters-als-voorspellers-bij-hfpef/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/08/01/ijzercarboxymaltose-en-plasmavolumestatus-bij-hf-fair-hf-substudie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"},{"url":"https://hartvaat.nl/2016/03/19/serca2a-gentherapie-bij-hartfalen-de-cupid-2-trial/","published":"2016-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-d-anker","type":"person","url":"https://hartvaat.nl/mensen/stefan-d-anker/","name":"Stefan D Anker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":79,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/12/01/sglt2-remmers-en-cardiale-remodellering-meta-analyse-van-mri-trials/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/lv-dimensies-en-cv-uitkomsten-bij-systolisch-hf-warcef/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/08/01/ijzercarboxymaltose-en-plasmavolumestatus-bij-hf-fair-hf-substudie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2017/11/01/raas-blokkade-bij-hfpef-systematische-review-en-meta-analyse/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/06/07/dagelijkse-telemonitoring-van-icd-s-gepoolde-analyse-van-drie-gerandomiseerde-tr/","published":"2017-06-07"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carolyn-s-p-lam","type":"person","url":"https://hartvaat.nl/mensen/carolyn-s-p-lam/","name":"Carolyn S P Lam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":78,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/05/ai-echocardiografie-door-niet-specialisten-kosteneffectiviteitsanalyse-uit-singa/","published":"2026-04-08"},{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/01/sekseverschillen-in-effectiviteit-van-hartfalenmedicatie-meta-analyse/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2018/06/12/sglt2-remmers-en-cardiovasculaire-events-de-cvd-real-2-real-world-studie/","published":"2018-06-12"},{"url":"https://hartvaat.nl/2018/04/01/eenmalig-intraveneus-ijzer-bij-hartfalen-in-zuidoost-azie-practice-asia-hf-pilot/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerasimos-s-filippatos","type":"person","url":"https://hartvaat.nl/mensen/gerasimos-s-filippatos/","name":"Gerasimos S Filippatos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":78,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/08/01/ijzercarboxymaltose-en-plasmavolumestatus-bij-hf-fair-hf-substudie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjiv-j-shah","type":"person","url":"https://hartvaat.nl/mensen/sanjiv-j-shah/","name":"Sanjiv J Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":75,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/humain-hfpef-nieuwe-metabole-accelerator-bij-obesitas-hfpef-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/03/01/kaliumnitraat-bij-hfpef-gerandomiseerde-trial/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/01/amethyst-verinurad-plus-allopurinol-bij-hfpef-negatieve-trial/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/11/16/sacubitril-valsartan-versus-standaardtherapie-op-nt-probnp-en-inspanningscapacit/","published":"2021-11-16"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/10/20/praliciguat-en-piek-vo2-bij-hfpef-jama-capacity-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/06/01/variatie-in-uitkomsten-tussen-complexe-hfpef-fenotypen/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"},{"url":"https://hartvaat.nl/2019/06/04/neladenoson-bialanaat-en-inspanningscapaciteit-bij-hfpef-jama-panache/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"},{"url":"https://hartvaat.nl/2018/04/10/geen-verband-tussen-hartfalen-en-kankerincidentie/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/02/07/doodsoorzaken-bij-hartfalen-met-behouden-ejectiefractie/","published":"2017-02-07"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stuart-j-pocock","type":"person","url":"https://hartvaat.nl/mensen/stuart-j-pocock/","name":"Stuart J Pocock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":74,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2020/04/07/yoga-gebaseerde-hartrevalidatie-na-acuut-mi-gerandomiseerde-trial/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/09/29/langetermijnmortaliteit-na-bloeddruk-en-lipidenverlaging-bij-hypertensie-ascot-l/","published":"2018-09-29"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/04/01/polymeervrije-biolimus-stent-bij-hoog-bloedingsrisico-met-acs-leaders-free-subst/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/20/bloedingen-voor-coronairangiografie-bij-nste-acs/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eugene-braunwald","type":"person","url":"https://hartvaat.nl/mensen/eugene-braunwald/","name":"Eugene Braunwald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":73,"articles":[{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/10/12/baseline-ldl-en-klinische-uitkomsten-van-ezetimibe-plus-statine-improve-it/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/03/09/halve-versus-volle-dosis-edoxaban-bij-af-gerandomiseerde-vergelijking/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/09/01/arni-naar-hf-voorgeschiedenis-en-raas-antagonistgebruik/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/02/01/arni-initiatie-na-acuut-gedecompenseerd-hf-pioneer-hf-open-label-extensie/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/09/01/simvastatine-ezetimibe-versus-simvastatine-na-acs-bij-75-plussers-jama-cardiolog/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/05/14/edoxaban-bij-aziatische-af-patienten-concentraties-en-anti-xa-activiteit/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/07/angiotensine-neprilysineremming-bij-acuut-gedecompenseerd-hf-nejm-pioneer-hf/","published":"2019-02-07"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2018/10/30/endogene-factor-xa-activiteit-en-edoxaban-farmacodynamische-marker-en-klinische-/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/07/10/fatale-of-irreversibele-bloedingen-en-ischemische-events-met-rivaroxaban-bij-acs/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/nieuwe-risicovoorspellingsscore-bij-af-voor-netto-klinisch-resultaat-engage-af-t/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/12/21/ezetimibe-bij-post-cabg-patienten-met-acs-improve-it-subanalyse/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/09/27/ldl-c-verlaging-en-cardiovasculaire-risicoreductie-jama-systematische-review-en-/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/07/05/nierfunctie-en-uitkomsten-met-edoxaban-in-de-engage-af-timi-48-trial/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/03/15/plaatjesremming-met-ticagrelor-60-mg-versus-90-mg-in-de-pegasus-timi-54-trial/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/03/08/acute-ledischemie-en-vorapaxar-bij-perifeer-arterieel-vaatlijden-tra-2p-timi-50-/","published":"2016-03-08"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-w-j-c-serruys","type":"person","url":"https://hartvaat.nl/mensen/patrick-w-j-c-serruys/","name":"Patrick W J C Serruys","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":73,"articles":[{"url":"https://hartvaat.nl/2026/02/25/hemodynamische-en-bloedviscositeitsprofielen-van-culprit-versus-non-culprit-coro/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/24/invloed-van-coronaire-ziekte-patronen-op-klinische-uitkomsten-pullback-pressure-/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/01/01/ffr-versus-ifr-bij-coronaire-revascularisatie-vijfjaars-follow-up/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/04/25/kwaliteit-van-leven-na-chirurgie-of-des-bij-drienvaten-of-hoofdstamlijden/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"subodh-verma","type":"person","url":"https://hartvaat.nl/mensen/subodh-verma/","name":"Subodh Verma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":70,"articles":[{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/02/01/cagrisema-verlaagt-bloeddruk-bij-overgewicht-obesitas-redefine-1/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2025/05/03/solbinsiran-langwerkend-sirna-tegen-angptl3-duurzaamheid-en-effectiviteit/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2025/05/03/semaglutide-en-loopafstand-bij-perifeer-vaatlijden-en-diabetes/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/04/01/sglt2-remmers-bij-hfref-of-hfpef-meta-analyse/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2021/12/01/sglt2-remmers-en-cardiale-remodellering-meta-analyse-van-mri-trials/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/12/01/eerste-en-recidiverende-cv-events-met-liraglutide-bij-diabetes-type-2-leader/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/06/04/microvasculaire-ziekte-en-cv-events-bij-diabetes-type-2/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2018/01/23/empagliflozine-bij-diabetes-type-2-met-perifeer-vaatlijden-empa-reg-outcome/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/19/chirurgische-versus-percutane-revascularisatie-bij-diabetes-met-acs/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"},{"url":"https://hartvaat.nl/2017/01/17/dapt-versus-aspirine-monotherapie-bij-diabetes-met-multivatenlijden-na-cabg-free/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-v-kober","type":"person","url":"https://hartvaat.nl/mensen/lars-v-kober/","name":"Lars V Køber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":68,"articles":[{"url":"https://hartvaat.nl/2026/10/01/voorgebruik-van-opioiden-verhoogt-sterfte-en-ziekenhuisopnames-na-tavi-deens-coh/","published":"2026-08-21"},{"url":"https://hartvaat.nl/2026/01/20/af-screening-naar-genetisch-risico-loop-subanalyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/04/22/thoracentese-bij-acuut-hartfalen-gerandomiseerde-trial/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"},{"url":"https://hartvaat.nl/2016/04/21/aliskiren-enalapril-of-de-combinatie-bij-hartfalen-nejm-atmosphere-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/02/01/regionale-hartdisfunctie-en-prognose-na-myocardinfarct-met-lv-disfunctie-of-hart/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikhail-n-kosiborod","type":"person","url":"https://hartvaat.nl/mensen/mikhail-n-kosiborod/","name":"Mikhail N Kosiborod","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":67,"articles":[{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/04/27/empagliflozine-en-pulmonalisdruk-bij-hf-embrace-hf/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/05/12/management-van-stabiel-coronairlijden-bij-diabetes-type-2-aha-scientific-stateme/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/02/05/glycemische-controle-en-cardiale-auto-immuniteit-bij-diabetes-type-1-en-langeter/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/06/12/sglt2-remmers-en-cardiovasculaire-events-de-cvd-real-2-real-world-studie/","published":"2018-06-12"},{"url":"https://hartvaat.nl/2017/07/18/sglt2-remmers-en-lager-risico-op-hartfalen-en-sterfte-versus-andere-glucoseverla/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2016/12/06/comorbiditeiten-bij-hartfalen-hypertensie-obesitas-diabetes-hyperlipidemie-en-me/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-windecker","type":"person","url":"https://hartvaat.nl/mensen/stephan-windecker/","name":"Stephan Windecker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":67,"articles":[{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/07/adenosine-en-ticagrelorspiegels-bij-patienten-met-en-zonder-ticagrelor-dyspneu/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2018/04/07/statines-en-niet-statine-ldl-verlagers-en-cardiovasculaire-uitkomsten-meta-analy/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"},{"url":"https://hartvaat.nl/2016/08/16/intracoronair-abciximab-bij-diabetespatienten-met-primaire-pci-1-jaarsresultaten/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-b-granger","type":"person","url":"https://hartvaat.nl/mensen/christopher-b-granger/","name":"Christopher B Granger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":66,"articles":[{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/01/01/dialysaat-kalium-3-0-mmol-l-met-natriumzirconiumcyclosilicaat-bij-dialyse/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2023/07/13/traverse-testosteronsubstitutie-cardiovasculair-veilig-bij-hypogonadisme/","published":"2023-07-13"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/06/01/continue-cardiale-monitoring-versus-standaardzorg-bij-cryptogeen-cva-jama/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/01/19/stoppen-versus-doorgaan-met-ace-remmers-arb-s-bij-gehospitaliseerde-patienten-ja/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/11/01/invloed-van-acs-trials-buiten-de-primaire-hypothese-systematische-review/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/27/albiglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-harmony-ou/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/04/12/infarctgrootte-en-uitkomsten-na-primaire-pci-patientanalyse-uit-10-trials/","published":"2016-04-12"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milton-packer","type":"person","url":"https://hartvaat.nl/mensen/milton-packer/","name":"Milton Packer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":63,"articles":[{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/07/29/summit-bmi-centrale-adipositas-en-gewichtsverlies-beinvloeden-tirzepatide-effect/","published":"2025-07-29"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/05/13/summit-tirzepatide-en-ckd-interactie-bij-hfpef-met-obesitas/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/12/01/number-needed-to-treat-met-arni-voor-preventie-van-cv-dood-of-hf-hospitalisatie/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/19/sacubitril-valsartan-en-30-daagse-heropname-na-hartfalenhospitalisatie/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bela-merkely","type":"person","url":"https://hartvaat.nl/mensen/bela-merkely/","name":"Béla Merkely","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":62,"articles":[{"url":"https://hartvaat.nl/2026/05/21/eplerenon-halveert-recidief-ventriculaire-tachycardie-versus-spironolacton-bij-h/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/11/08/closed-loop-stimulatie-en-cardiopulmonale-variabelen-bij-chronisch-hf-met-chrono/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/02/01/katheterablatie-bij-af-met-hartfalen-nejm-castle-af/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/01/klinische-presentatie-bij-eerste-hartfalenhospitalisatie-voorspelt-geen-heropnam/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaun-g-goodman","type":"person","url":"https://hartvaat.nl/mensen/shaun-g-goodman/","name":"Shaun G Goodman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":62,"articles":[{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/01/interventies-voor-statinevoorschrijving-bij-primaire-cv-preventie-meta-analyse/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/01/17/dapt-versus-aspirine-monotherapie-bij-diabetes-met-multivatenlijden-na-cabg-free/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-valgimigli","type":"person","url":"https://hartvaat.nl/mensen/marco-valgimigli/","name":"Marco Valgimigli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":61,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2020/12/22/fentanyl-versus-morfine-op-ticagrelor-plaatjesremming-bij-stemi/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/05/26/subcutaan-selatogrel-remt-plaatjesaggregatie-bij-acuut-mi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2020/01/01/weglaten-van-aspirine-bij-gecombineerde-antitrombotische-therapie-voor-af-acs-he/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/07/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-veiligheid-en-werk/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/08/07/adenosine-en-ticagrelorspiegels-bij-patienten-met-en-zonder-ticagrelor-dyspneu/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-c-petrie","type":"person","url":"https://hartvaat.nl/mensen/mark-c-petrie/","name":"Mark C Petrie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":59,"articles":[{"url":"https://hartvaat.nl/2026/04/21/jacc-beschouwing-placebo-in-trials-met-incretine-therapie-bij-hartfalen-wetensch/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2026/05/09/subcut-hf-ii-subcutane-furosemide-thuis-verlaagt-opnameduur-met-5-5-dagen-na-har/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/03/25/meta-analyse-glp-1-agonisten-voorkomen-hartfalen-in-type-2-diabetes-sterkste-eff/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-versus-tirzepatide-bij-patienten-met-obesitas-en-hfpef/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/05/15/implanteerbare-hemodynamische-monitoring-bij-hartfalen-meta-analyse-over-ef-spec/","published":"2023-05-15"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/12/01/hartfalen-en-atriumflutter-systematische-review/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/10/01/associatie-is-geen-causaliteit-behandeleffecten-bij-hartfalen-en-observationele-/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/12/15/infarctgrootte-en-linkerkamerremodellering-na-preventieve-pci/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sabina-a-murphy","type":"person","url":"https://hartvaat.nl/mensen/sabina-a-murphy/","name":"Sabina A Murphy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":58,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/03/09/halve-versus-volle-dosis-edoxaban-bij-af-gerandomiseerde-vergelijking/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/08/11/veiligheid-van-aspirinestaken-met-p2y12-achtergrond-na-pci-meta-analyse/","published":"2020-08-11"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/01/verdere-ldl-verlaging-bij-reeds-zeer-lage-niveaus-jama-cardiology-meta-analyse/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/10/fatale-of-irreversibele-bloedingen-en-ischemische-events-met-rivaroxaban-bij-acs/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/12/21/ezetimibe-bij-post-cabg-patienten-met-acs-improve-it-subanalyse/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/07/05/nierfunctie-en-uitkomsten-met-edoxaban-in-de-engage-af-timi-48-trial/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/03/08/acute-ledischemie-en-vorapaxar-bij-perifeer-arterieel-vaatlijden-tra-2p-timi-50-/","published":"2016-03-08"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harvey-d-white","type":"person","url":"https://hartvaat.nl/mensen/harvey-d-white/","name":"Harvey D White","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":56,"articles":[{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/07/10/intracoronaire-trombolyse-bij-stemi-meta-analyse/","published":"2024-07-10"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adriaan-a-voors","type":"person","url":"https://hartvaat.nl/mensen/adriaan-a-voors/","name":"Adriaan A Voors","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":54,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/28/atriumfibrilleren-en-hartfalen-versterken-elkaar-en-verhogen-sterfte-aanzienlijk/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/16/farmacologische-behandeling-van-hfref-geactualiseerde-systematische-review/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/01/amethyst-verinurad-plus-allopurinol-bij-hfpef-negatieve-trial/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/08/01/candesartan-dosering-bij-mannen-versus-vrouwen-met-chronisch-hartfalen/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/06/04/neladenoson-bialanaat-en-inspanningscapaciteit-bij-hfpef-jama-panache/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/03/19/serca2a-gentherapie-bij-hartfalen-de-cupid-2-trial/","published":"2016-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bertram-pitt","type":"person","url":"https://hartvaat.nl/mensen/bertram-pitt/","name":"Bertram Pitt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":53,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/12/01/supar-en-uitkomsten-bij-hfpef-topcat-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/01/kbp-5074-en-bloeddruk-bij-gevorderde-ckd-block-ckd/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/07/01/mra-bij-hypertensie-met-gevorderde-ckd-block-ckd-trial/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-w-mahaffey","type":"person","url":"https://hartvaat.nl/mensen/kenneth-w-mahaffey/","name":"Kenneth W Mahaffey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":53,"articles":[{"url":"https://hartvaat.nl/2026/02/23/semaglutide-vermindert-infectierisico-bij-diabetes-en-chronische-nierziekte/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-bohm","type":"person","url":"https://hartvaat.nl/mensen/michael-bohm/","name":"Michael Böhm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":53,"articles":[{"url":"https://hartvaat.nl/2026/03/04/leeftijd-en-geslacht-beinvloeden-verband-tussen-ambulante-bloeddruk-en-cardiovas/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2025/07/14/hartfrequentieverlagende-middelen-en-uitkomsten-bij-hypertensie-cvd-meta-analyse/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/08/01/empagliflozine-vermindert-nierletselmarkers-bij-acuut-hartfalen/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/01/apothekerzorg-bij-poliklinisch-hf-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/03/10/overleving-na-revascularisatie-met-paclitaxel-gecoate-ballonnen/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/11/01/gemiddelde-bloeddruk-en-visit-to-visit-variabiliteit-als-gecombineerde-voorspell/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/01/07/verminderd-bloeddrukverlagend-effect-van-renale-denervatie-bij-geisoleerde-systo/","published":"2017-01-07"},{"url":"https://hartvaat.nl/2016/11/01/vochtstatustelemonitoring-bij-hartfalen-gerandomiseerde-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lawrence-a-leiter","type":"person","url":"https://hartvaat.nl/mensen/lawrence-a-leiter/","name":"Lawrence A Leiter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":52,"articles":[{"url":"https://hartvaat.nl/2026/05/19/peulvruchten-in-de-voeding-verlagen-ldl-en-non-hdl-dose-response-meta-analyse-va/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/05/12/management-van-stabiel-coronairlijden-bij-diabetes-type-2-aha-scientific-stateme/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-fase-3-bij-verhoogd-ldl-nejm-orion-10-en-orion-11/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/11/12/bempedoinezuur-toegevoegd-aan-statines-bij-hoog-cv-risico-jama-clear-harmony/","published":"2019-11-12"},{"url":"https://hartvaat.nl/2019/11/01/inclisiran-1-of-2-dosis-en-ldl-cholesterol-orion-1-1-jaarsfollow-up/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/10/27/albiglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-harmony-ou/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2018/09/25/sirna-tegen-pcsk9-en-atherogene-lipoproteinen-orion-1-secundaire-eindpunten/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"},{"url":"https://hartvaat.nl/2016/10/14/geen-effect-van-pcsk9-remmer-alirocumab-op-diabetes-incidentie-odyssey-analyse/","published":"2016-10-14"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-f-hernandez","type":"person","url":"https://hartvaat.nl/mensen/adrian-f-hernandez/","name":"Adrian F Hernandez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":51,"articles":[{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/03/01/ziekenhuisgebaseerde-kwaliteitsinterventies-bij-hartfalen-systematische-review/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2018/10/27/albiglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-harmony-ou/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-azeem-latib","type":"person","url":"https://hartvaat.nl/mensen/dr-azeem-latib/","name":"Dr. Azeem Latib","title":"Hoofd Interventiecardiologie, Montefiore Medical Center, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2021/08/24/de-escalatie-van-dapt-bij-acs-jacc-review/","published":"2021-08-24"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2020/03/10/overleving-na-revascularisatie-met-paclitaxel-gecoate-ballonnen/","published":"2020-03-10"}],"videos":[{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/hi-peitho-katheter-trombolyse-longembolie/","title":"HI-PEITHO: Kathetergeleide trombolyse bij intermediair-risico longembolie"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/champion-af-hartoorocclusie-versus-doacs/","title":"CHAMPION-AF: Linker hartoorocclusie versus DOAC's bij atriumfibrilleren"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/spirrit-hfpef-spironolacton-hartfalen/","title":"SPIRRIT-HFpEF: Spironolacton bij hartfalen met behouden en licht verlaagde ejectiefractie"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/stemi-dtu-ontlading-voor-primaire-pci/","title":"STEMI-DTU: Ontladingsstrategie vóór primaire PCI bij anterieur STEMI"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/chip-bcis3-impella-hoog-risico-pci/","title":"CHIP-BCIS3: Impella-ondersteuning bij hoog-risico PCI"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/orbita-cto-gecontroleerde-cto-pci/","title":"ORBITA-CTO: Placebogecontroleerde PCI bij chronische totaalocclusie"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/all-rise-fast-iii-ffrangio-vffr/","title":"ALL-RISE & FAST III: Angiografie-gebaseerde FFR versus draadgebaseerde FFR"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/optimal-beeldgeleide-pci-complex/","title":"OPTIMAL: Intravasculaire beeldgeleide PCI bij complexe coronairziekte"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/ivus-chip-echogeleide-hoog-risico-pci/","title":"IVUS-CHIP: Intravasculaire echogeleide hoog-risico PCI"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/dkcrush-viii-ivus-bifurcatie/","title":"DKCRUSH-VIII: IVUS-geleide DK Crush-techniek bij complexe bifurcatielaesies"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/pro-tavi-pci-versus-uitstel-bij-tavi/","title":"PRO-TAVI: Routinematige PCI versus uitstel bij patiënten die TAVI ondergaan"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/protect-h2h-cerebrale-bescherming-tavi/","title":"Protect H2H: Directe vergelijking van emboliebescherming tijdens TAVI"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/trifr-transcatheter-tricuspidalisreparatie/","title":"Tri.Fr: Transcatheter tricuspidalisreparatie"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/triscend-ii-evoque-tricuspidalisklepvervanging/","title":"TRISCEND II: Evoque transcatheter tricuspidalisklepvervanging bij ernstige regurgitatie"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-h-alexander","type":"person","url":"https://hartvaat.nl/mensen/john-h-alexander/","name":"John H Alexander","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":50,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/01/19/stoppen-versus-doorgaan-met-ace-remmers-arb-s-bij-gehospitaliseerde-patienten-ja/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salim-yusuf","type":"person","url":"https://hartvaat.nl/mensen/salim-yusuf/","name":"Salim Yusuf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":48,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/08/24/vaste-dosiscombinatietherapie-voor-primaire-cv-preventie-ipd-meta-analyse/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2023/02/01/aspirine-en-cardiovasculaire-uitkomsten-bij-chronische-nierziekte/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/10/21/digoxine-en-mortaliteit-gerandomiseerd-versus-observationeel-in-de-dig-trial/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/10/05/uitgebreide-community-interventie-bij-hypertensie-lancet-hope-4/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/07/01/hospitalisatieredenen-en-mortaliteitsrisico-bij-af-met-dabigatran-versus-warfari/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/05/14/rivaroxaban-plus-aspirine-bij-vaatlijden-met-nierdisfunctie-compass/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/09/risico-s-van-overinterpretatie-van-interimdata-lessen-uit-de-total-trial/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/11/01/gemiddelde-bloeddruk-en-visit-to-visit-variabiliteit-als-gecombineerde-voorspell/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/07/01/dabigatran-naar-leeftijd-bij-atriumfibrilleren-re-ly-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2017/05/16/statines-voor-primaire-preventie-bij-ouderen-meta-analyse-van-jupiter-en-hope-3/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/11/01/intensieve-bloeddrukbehandeling-120-80-mmhg-antagonist-standpunt/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"silvio-e-inzucchi","type":"person","url":"https://hartvaat.nl/mensen/silvio-e-inzucchi/","name":"Silvio E Inzucchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":48,"articles":[{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/15/empagliflozine-bij-hartfalen-diuretische-en-cardiorenale-effecten/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/05/12/management-van-stabiel-coronairlijden-bij-diabetes-type-2-aha-scientific-stateme/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/07/hypoglykemie-cv-uitkomsten-en-empagliflozine-empa-reg-outcome/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/08/01/empagliflozine-voorkomt-progressie-van-ckd-empa-reg-outcome-renale-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/23/empagliflozine-bij-diabetes-type-2-met-perifeer-vaatlijden-empa-reg-outcome/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-p-cannon","type":"person","url":"https://hartvaat.nl/mensen/christopher-p-cannon/","name":"Christopher P Cannon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":47,"articles":[{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/06/25/vasculair-zorgteam-versus-educatie-bij-perifeer-arterieel-vaatlijden/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/06/04/drive-remote-management-verbetert-richtlijnmedicatie-bij-hartfalen/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/10/12/baseline-ldl-en-klinische-uitkomsten-van-ezetimibe-plus-statine-improve-it/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/09/01/simvastatine-ezetimibe-versus-simvastatine-na-acs-bij-75-plussers-jama-cardiolog/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/07/14/ldl-verlaging-en-cv-events-met-pcsk9-remmers-meta-analyse-van-gerandomiseerde-tr/","published":"2018-07-14"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/12/21/ezetimibe-bij-post-cabg-patienten-met-acs-improve-it-subanalyse/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/12/13/alirocumab-en-reductie-in-atherogene-lipiden-en-cardiovasculaire-events-10-odyss/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/12/01/empagliflozine-en-bloeddruk-bij-diabetes-type-2-met-hypertensie-naar-achtergrond/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/04/12/protonpompremmers-verminderen-gastro-intestinale-events-ongeacht-aspirinedosis-b/","published":"2016-04-12"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-nicolas-van-mieghem","type":"person","url":"https://hartvaat.nl/mensen/prof-nicolas-van-mieghem/","name":"Nicolas Van Mieghem","title":"Hoogleraar Interventiecardiologie","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"}],"videos":[{"url":"https://hartvaat.nl/video/esc26-preview-trials-to-watch/esc26-trials-to-watch-gesprek/","title":"ESC 2026 Trials to Watch: het volledige gesprek"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/hi-peitho-katheter-trombolyse-longembolie/","title":"HI-PEITHO: Kathetergeleide trombolyse bij intermediair-risico longembolie"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/champion-af-hartoorocclusie-versus-doacs/","title":"CHAMPION-AF: Linker hartoorocclusie versus DOAC's bij atriumfibrilleren"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/spirrit-hfpef-spironolacton-hartfalen/","title":"SPIRRIT-HFpEF: Spironolacton bij hartfalen met behouden en licht verlaagde ejectiefractie"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/stemi-dtu-ontlading-voor-primaire-pci/","title":"STEMI-DTU: Ontladingsstrategie vóór primaire PCI bij anterieur STEMI"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/chip-bcis3-impella-hoog-risico-pci/","title":"CHIP-BCIS3: Impella-ondersteuning bij hoog-risico PCI"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/orbita-cto-gecontroleerde-cto-pci/","title":"ORBITA-CTO: Placebogecontroleerde PCI bij chronische totaalocclusie"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/all-rise-fast-iii-ffrangio-vffr/","title":"ALL-RISE & FAST III: Angiografie-gebaseerde FFR versus draadgebaseerde FFR"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/optimal-beeldgeleide-pci-complex/","title":"OPTIMAL: Intravasculaire beeldgeleide PCI bij complexe coronairziekte"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/ivus-chip-echogeleide-hoog-risico-pci/","title":"IVUS-CHIP: Intravasculaire echogeleide hoog-risico PCI"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/dkcrush-viii-ivus-bifurcatie/","title":"DKCRUSH-VIII: IVUS-geleide DK Crush-techniek bij complexe bifurcatielaesies"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/pro-tavi-pci-versus-uitstel-bij-tavi/","title":"PRO-TAVI: Routinematige PCI versus uitstel bij patiënten die TAVI ondergaan"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/protect-h2h-cerebrale-bescherming-tavi/","title":"Protect H2H: Directe vergelijking van emboliebescherming tijdens TAVI"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/trifr-transcatheter-tricuspidalisreparatie/","title":"Tri.Fr: Transcatheter tricuspidalisreparatie"},{"url":"https://hartvaat.nl/video/acc26-preview-latib-van-mieghem/triscend-ii-evoque-tricuspidalisklepvervanging/","title":"TRISCEND II: Evoque transcatheter tricuspidalisklepvervanging bij ernstige regurgitatie"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-y-h-lip","type":"person","url":"https://hartvaat.nl/mensen/gregory-y-h-lip/","name":"Gregory Y H Lip","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":46,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/27/prognose-takotsubo-syndroom-versus-hartfalen-op-de-lange-termijn/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/27/van-vitamine-k-antagonist-naar-doac-bij-kwetsbare-ouderen-met-af/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2026/02/19/cardiovasculair-renaal-metabool-samenspel-bij-patienten-met-atriumfibrilleren/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/02/03/mortaliteit-en-hospitalisaties-bij-hfpef-versus-hfref-vergelijkende-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/comorbiditeitsbelasting-en-uitkomsten-van-ablatie-versus-medicatie-bij-af/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/01/piek-vo2-en-prognose-bij-hartfalen-meta-analyse/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/08/01/opnameduur-en-eerdere-hf-opnames-bij-frailteit-en-hartfalen-systematische-review/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2025/04/01/ambulante-behandeling-van-gedecompenseerd-hartfalen-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/10/01/natriuretische-peptiden-en-crp-bij-hartfalen-en-ondervoeding-systematische-revie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/10/05/rivaroxaban-dosering-bij-af-on-label-versus-off-label-in-azie-en-niet-azie/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2022/06/01/edoxaban-15-mg-bij-zeer-oude-patienten-met-atriumfibrilleren-eldercare-subanalys/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/03/02/kenmerken-van-patienten-met-atriale-high-rate-episodes-bij-icd-crt/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2022/01/04/sglt2-remmers-en-plotse-hartdood-ventriculaire-aritmie-meta-analyse/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2021/09/14/copd-bij-af-prevalentie-management-en-impact-meta-analyse/","published":"2021-09-14"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2020/10/29/laaggedoseerd-edoxaban-bij-zeer-oude-af-patienten-nejm-eldercare-af/","published":"2020-10-29"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2020/01/01/weglaten-van-aspirine-bij-gecombineerde-antitrombotische-therapie-voor-af-acs-he/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/12/01/edoxaban-verhoogt-behandeltevredenheid-en-vermindert-zorggebruik-engage-af-timi-/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2018/03/13/doac-s-bij-af-met-ckd-systematische-review-werkzaamheid-en-veiligheid/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/01/bloeddrukvariabiliteit-en-uitkomsten-bij-af-affirm-studie/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-p-bonaca","type":"person","url":"https://hartvaat.nl/mensen/marc-p-bonaca/","name":"Marc P Bonaca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":46,"articles":[{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/05/03/semaglutide-en-loopafstand-bij-perifeer-vaatlijden-en-diabetes/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/06/25/vasculair-zorgteam-versus-educatie-bij-perifeer-arterieel-vaatlijden/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/03/15/plaatjesremming-met-ticagrelor-60-mg-versus-90-mg-in-de-pegasus-timi-54-trial/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/03/08/acute-ledischemie-en-vorapaxar-bij-perifeer-arterieel-vaatlijden-tra-2p-timi-50-/","published":"2016-03-08"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-metra","type":"person","url":"https://hartvaat.nl/mensen/marco-metra/","name":"Marco Metra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":46,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/03/25/meta-analyse-glp-1-agonisten-voorkomen-hartfalen-in-type-2-diabetes-sterkste-eff/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/10/01/sacubitril-valsartan-in-real-life-europese-hfref-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/12/01/hoogtepunten-in-hartfalen-2019/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christie-m-ballantyne","type":"person","url":"https://hartvaat.nl/mensen/christie-m-ballantyne/","name":"Christie M Ballantyne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":42,"articles":[{"url":"https://hartvaat.nl/2026/03/25/mendeliaanse-randomisatie-lp-a-verhoogt-coronarialijden-onafhankelijk-van-ldl-c-/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/02/05/orale-pcsk9-remmer-enlicitide-verlaagt-ldl-met-57-placebogecontroleerde-trial/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/13/enlicitide-orale-pcsk9-remmer-bij-heterozygote-fh-fase-3/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/05/20/plozasiran-en-lipoproteine-deeltjesgrootte-bij-hypertriglyceridemie/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/09/12/plozasiran-sirna-tegen-apoc3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/07/01/plozasiran-sirna-tegen-apoc3-bij-ernstige-hypertriglyceridemie-shasta-2/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/05/02/gepersonaliseerde-beslisondersteuning-verhoogt-statinegebruik-bij-ascvd/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/25/mk-0616-eerste-orale-pcsk9-remmer-in-fase-2b/","published":"2023-04-25"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/2022-acc-expert-consensus-niet-statine-therapieen-voor-ldl-verlaging-bij-ascvd/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/03/14/bempedoinezuur-voor-ldl-verlaging-nejm-veiligheid-en-werkzaamheid/","published":"2019-03-14"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/10/03/2017-acc-gerichte-update-niet-statinetherapie-voor-ldl-verlaging/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/ldl-cholesterol/","title":"Sessie 2: LDL-cholesterol"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darren-k-mcguire","type":"person","url":"https://hartvaat.nl/mensen/darren-k-mcguire/","name":"Darren K McGuire","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":44,"articles":[{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-r-zile","type":"person","url":"https://hartvaat.nl/mensen/michael-r-zile/","name":"Michael R Zile","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":44,"articles":[{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/07/29/summit-bmi-centrale-adipositas-en-gewichtsverlies-beinvloeden-tirzepatide-effect/","published":"2025-07-29"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/05/13/summit-tirzepatide-en-ckd-interactie-bij-hfpef-met-obesitas/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/10/20/praliciguat-en-piek-vo2-bij-hfpef-jama-capacity-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/07/07/baroreflexactivatietherapie-bij-hfref-beat-hf/","published":"2020-07-07"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/12/01/number-needed-to-treat-met-arni-voor-preventie-van-cv-dood-of-hf-hospitalisatie/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/19/sacubitril-valsartan-en-30-daagse-heropname-na-hartfalenhospitalisatie/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-senni","type":"person","url":"https://hartvaat.nl/mensen/michele-senni/","name":"Michele Senni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":44,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/02/01/diabetes-en-sacubitril-valsartan-titratie-bij-hartfalen-na-opname/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/12/01/vericiguat-en-nt-probnp-bij-hfref-victoria-subanalyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/01/sacubitril-valsartan-in-real-life-europese-hfref-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2017/02/07/doodsoorzaken-bij-hartfalen-met-behouden-ejectiefractie/","published":"2017-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-michael-gibson","type":"person","url":"https://hartvaat.nl/mensen/c-michael-gibson/","name":"C Michael Gibson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":43,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/01/19/stoppen-versus-doorgaan-met-ace-remmers-arb-s-bij-gehospitaliseerde-patienten-ja/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/07/10/fatale-of-irreversibele-bloedingen-en-ischemische-events-met-rivaroxaban-bij-acs/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rafael-diaz","type":"person","url":"https://hartvaat.nl/mensen/rafael-diaz/","name":"Rafael Díaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":43,"articles":[{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-c-nicolau","type":"person","url":"https://hartvaat.nl/mensen/jose-c-nicolau/","name":"José C Nicolau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":42,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/03/16/plaatjesreactiviteit-bij-acs-in-afwachting-van-chirurgische-revascularisatie/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/28/morfine-en-cv-uitkomsten-bij-nste-acs-jacc-analyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-wallentin","type":"person","url":"https://hartvaat.nl/mensen/lars-wallentin/","name":"Lars Wallentin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":42,"articles":[{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/11/25/abc-af-risicoscores-voor-gepersonaliseerde-af-behandeling/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/10/01/neurofilament-light-chain-en-cva-risico-bij-af/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2018/04/01/fibrinestoleigenschappen-en-klinische-uitkomsten-na-acs-plato-substudie/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/07/01/dabigatran-naar-leeftijd-bij-atriumfibrilleren-re-ly-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-d-wiviott","type":"person","url":"https://hartvaat.nl/mensen/stephen-d-wiviott/","name":"Stephen D Wiviott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":42,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/08/24/reprieve-pitavastatine-vermindert-cv-events-bij-hiv-nejm/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/10/29/langetermijn-werkzaamheid-en-veiligheid-van-evolocumab-bij-hypercholesterolemie/","published":"2019-10-29"},{"url":"https://hartvaat.nl/2019/10/15/triglyceridenverlaging-en-cv-risicoreductie-over-therapeutische-klassen-meta-ana/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/09/01/verdere-ldl-verlaging-bij-reeds-zeer-lage-niveaus-jama-cardiology-meta-analyse/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/09/27/ldl-c-verlaging-en-cardiovasculaire-risicoreductie-jama-systematische-review-en-/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/05/31/dapt-score-validatie-bij-patienten-met-en-zonder-eerder-myocardinfarct/","published":"2016-05-31"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-j-nicholls","type":"person","url":"https://hartvaat.nl/mensen/stephen-j-nicholls/","name":"Stephen J Nicholls","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":42,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/05/20/solbinsiran-angptl3-remming-van-preklinisch-tot-eerste-humane-studies/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2025/05/03/solbinsiran-langwerkend-sirna-tegen-angptl3-duurzaamheid-en-effectiviteit/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2025/01/21/muvalaplin-orale-lp-a-verlaging-nejm-gerandomiseerde-trial/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/07/01/plozasiran-sirna-tegen-apoc3-bij-ernstige-hypertriglyceridemie-shasta-2/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/28/apabetalone-en-cv-events-bij-acs-met-diabetes-type-2-jama-betonmace/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-a-morrow","type":"person","url":"https://hartvaat.nl/mensen/david-a-morrow/","name":"David A Morrow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":40,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/bestaande-cv-data-benutten-voor-hypertensiedetectie-en-behandeling-vital-trial/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/09/01/arni-naar-hf-voorgeschiedenis-en-raas-antagonistgebruik/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/02/01/arni-initiatie-na-acuut-gedecompenseerd-hf-pioneer-hf-open-label-extensie/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/07/angiotensine-neprilysineremming-bij-acuut-gedecompenseerd-hf-nejm-pioneer-hf/","published":"2019-02-07"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/03/08/acute-ledischemie-en-vorapaxar-bij-perifeer-arterieel-vaatlijden-tra-2p-timi-50-/","published":"2016-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"holger-thiele","type":"person","url":"https://hartvaat.nl/mensen/holger-thiele/","name":"Holger Thiele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":40,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/10/01/galectine-3-en-langetermijnuitkomsten-bij-hartfalen-meta-analyse/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"},{"url":"https://hartvaat.nl/2016/08/16/intracoronair-abciximab-bij-diabetespatienten-met-primaire-pci-1-jaarsresultaten/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/08/01/cabg-versus-pci-en-risico-op-myocardinfarct-en-revascularisatie-bij-ckd-patiente/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/04/12/infarctgrootte-en-uitkomsten-na-primaire-pci-patientanalyse-uit-10-trials/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yoshinobu-onuma","type":"person","url":"https://hartvaat.nl/mensen/yoshinobu-onuma/","name":"Yoshinobu Onuma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":40,"articles":[{"url":"https://hartvaat.nl/2026/02/24/invloed-van-coronaire-ziekte-patronen-op-klinische-uitkomsten-pullback-pressure-/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joao-pedro-ferreira","type":"person","url":"https://hartvaat.nl/mensen/joao-pedro-ferreira/","name":"João Pedro Ferreira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":39,"articles":[{"url":"https://hartvaat.nl/2026/05/10/porthos-nt-probnp-afkapwaarden-onbetrouwbaar-bij-obese-patienten-risico-op-gemis/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2025/08/05/sglt2-remmer-met-en-zonder-mra-bij-hartfalen-gecombineerde-analyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/19/therapeutische-doelen-voor-hf-via-proteomics-en-mendeliaanse-randomisatie/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/04/17/nt-probnp-geleide-therapie-bij-acuut-gedecompenseerd-hartfalen-prima-ii/","published":"2018-04-17"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kausik-k-ray","type":"person","url":"https://hartvaat.nl/mensen/kausik-k-ray/","name":"Kausik K Ray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":39,"articles":[{"url":"https://hartvaat.nl/2026/05/19/ehj-review-dyslipidemie-bij-kankerpatienten-verhoogd-ascvd-risico-beperkte-data-/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/04/24/santorini-uk-ldl-doel-onbereikt-bij-meerderheid-van-hoogrisicopatienten-na-1-jaa/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2026/01/16/non-hdl-c-doelen-halen-in-de-eerste-en-tweede-lijn-een-da-vinci-deelanalyse/","published":"2026-01-16"},{"url":"https://hartvaat.nl/2026/01/11/zeventien-jaar-voor-verandering-doorbreken-de-2025-esc-eas-dyslipidemierichtlijn/","published":"2026-01-11"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/05/20/solbinsiran-angptl3-remming-van-preklinisch-tot-eerste-humane-studies/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/05/03/solbinsiran-langwerkend-sirna-tegen-angptl3-duurzaamheid-en-effectiviteit/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/06/02/prevalentie-van-fh-bij-atherosclerotische-cv-ziekte-meta-analyse/","published":"2020-06-02"},{"url":"https://hartvaat.nl/2020/04/28/apabetalone-en-cv-events-bij-acs-met-diabetes-type-2-jama-betonmace/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-fase-3-bij-verhoogd-ldl-nejm-orion-10-en-orion-11/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2019/11/01/inclisiran-1-of-2-dosis-en-ldl-cholesterol-orion-1-1-jaarsfollow-up/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/03/14/bempedoinezuur-voor-ldl-verlaging-nejm-veiligheid-en-werkzaamheid/","published":"2019-03-14"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/10/01/geschat-individueel-levensvoordeel-van-pcsk9-remming-bij-statinebehandelde-cad-p/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/09/25/sirna-tegen-pcsk9-en-atherogene-lipoproteinen-orion-1-secundaire-eindpunten/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/07/14/ldl-verlaging-en-cv-events-met-pcsk9-remmers-meta-analyse-van-gerandomiseerde-tr/","published":"2018-07-14"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/11/14/ldl-verlaging-voor-primaire-preventie-bij-mannen-met-primaire-ldl-verhoging/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"},{"url":"https://hartvaat.nl/2016/12/13/alirocumab-en-reductie-in-atherogene-lipiden-en-cardiovasculaire-events-10-odyss/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-a-harrington","type":"person","url":"https://hartvaat.nl/mensen/robert-a-harrington/","name":"Robert A Harrington","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":39,"articles":[{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felix-mahfoud","type":"person","url":"https://hartvaat.nl/mensen/felix-mahfoud/","name":"Felix Mahfoud","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":38,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/07/aldosteronsynthaseremming-bij-resistente-hypertensie-beloften-en-onzekerheden/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2020/03/10/overleving-na-revascularisatie-met-paclitaxel-gecoate-ballonnen/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2017/01/07/verminderd-bloeddrukverlagend-effect-van-renale-denervatie-bij-geisoleerde-systo/","published":"2017-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-k-james","type":"person","url":"https://hartvaat.nl/mensen/stefan-k-james/","name":"Stefan K James","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":38,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/12/11/ticagrelor-plus-aspirine-versus-aspirine-na-cabg-voor-acs-gerandomiseerde-trial/","published":"2025-12-11"},{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/01/zuurstof-bij-verdenking-acuut-mi-meta-analyse-van-gerandomiseerde-trials/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2018/04/01/fibrinestoleigenschappen-en-klinische-uitkomsten-na-acs-plato-substudie/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-engstrm","type":"person","url":"https://hartvaat.nl/mensen/thomas-engstrm/","name":"Thomas Engstrøm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":38,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2026/02/03/coronaire-vaatspasmen-bij-overlevenden-van-hartstilstand/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/11/01/ifr-versus-ffr-en-vijfjaarsmortaliteit-swedeheart-en-define-flair/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/02/14/danami-2-16-jaarsfollow-up-primaire-pci-versus-fibrinolyse/","published":"2020-02-14"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-cohen","type":"person","url":"https://hartvaat.nl/mensen/david-j-cohen/","name":"David J Cohen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":37,"articles":[{"url":"https://hartvaat.nl/2026/05/25/1-op-5-oudere-patienten-heeft-hartfalen-opname-binnen-jaar-na-tavr-1-jaarsmortal/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/01/kccq-interpretatie-bij-hartfalen-patient-ankering/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/25/kwaliteit-van-leven-na-chirurgie-of-des-bij-drienvaten-of-hoofdstamlijden/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felipe-a-martinez","type":"person","url":"https://hartvaat.nl/mensen/felipe-a-martinez/","name":"Felipe A Martinez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":37,"articles":[{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-j-p-kastelein","type":"person","url":"https://hartvaat.nl/mensen/john-j-p-kastelein/","name":"John J P Kastelein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2026/05/14/mendeliaanse-randomisatie-hmgcr-remming-verhoogt-diabetesrisico-andere-lipidendo/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/01/30/orion-5-inclisiran-bij-homozygote-fh/","published":"2024-01-30"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-fase-3-bij-verhoogd-ldl-nejm-orion-10-en-orion-11/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2019/11/01/inclisiran-1-of-2-dosis-en-ldl-cholesterol-orion-1-1-jaarsfollow-up/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/01/geschat-individueel-levensvoordeel-van-pcsk9-remming-bij-statinebehandelde-cad-p/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/09/25/sirna-tegen-pcsk9-en-atherogene-lipoproteinen-orion-1-secundaire-eindpunten/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/11/14/ldl-verlaging-voor-primaire-preventie-bij-mannen-met-primaire-ldl-verhoging/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/08/29/rosuvastatine-bij-kinderen-met-homozygote-familiaire-hypercholesterolemie/","published":"2017-08-29"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"},{"url":"https://hartvaat.nl/2016/05/01/ly3015014-een-nieuw-monoklonaal-pcsk9-antilichaam-gerandomiseerde-fase-2-trial/","published":"2016-05-01"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/ldl-cholesterol/","title":"Sessie 2: LDL-cholesterol"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aldo-p-maggioni","type":"person","url":"https://hartvaat.nl/mensen/aldo-p-maggioni/","name":"Aldo P Maggioni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":36,"articles":[{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/28/g-csf-voor-stamcelmobilisatie-na-acuut-mi-meta-analyse/","published":"2024-10-28"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/06/01/betablokkers-bij-systolisch-hartfalen-en-pacemakerritme-mortaliteitseffect/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dominick-j-angiolillo","type":"person","url":"https://hartvaat.nl/mensen/dominick-j-angiolillo/","name":"Dominick J Angiolillo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":36,"articles":[{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/04/17/geleide-versus-standaard-antiplaatjestherapie-na-pci-lancet-meta-analyse/","published":"2021-04-17"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/03/15/plaatjesremming-met-ticagrelor-60-mg-versus-90-mg-in-de-pegasus-timi-54-trial/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/02/16/ticagrelor-versus-clopidogrel-bij-troponine-negatieve-laagrisico-acs-met-ad-hoc-/","published":"2016-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-l-rouleau","type":"person","url":"https://hartvaat.nl/mensen/jean-l-rouleau/","name":"Jean L Rouleau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":36,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/12/01/number-needed-to-treat-met-arni-voor-preventie-van-cv-dood-of-hf-hospitalisatie/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/07/19/sacubitril-valsartan-en-30-daagse-heropname-na-hartfalenhospitalisatie/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"justin-a-ezekowitz","type":"person","url":"https://hartvaat.nl/mensen/justin-a-ezekowitz/","name":"Justin A Ezekowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":36,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/16/farmacologische-behandeling-van-hfref-geactualiseerde-systematische-review/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/08/01/hoog-versus-laag-zuurstof-bij-acuut-hartfalen-hilo-hf-pilot/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/10/01/zuurstof-bij-verdenking-acuut-mi-meta-analyse-van-gerandomiseerde-trials/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stuart-j-connolly","type":"person","url":"https://hartvaat.nl/mensen/stuart-j-connolly/","name":"Stuart J Connolly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":36,"articles":[{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/15/prevalentie-van-linkeratriumtrombus-bij-geanticoaguleerde-af-patienten/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2021/05/01/screening-op-af-bij-ouderen-jama-cardiology-gerandomiseerde-trial/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/07/01/hospitalisatieredenen-en-mortaliteitsrisico-bij-af-met-dabigatran-versus-warfari/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/05/14/rivaroxaban-plus-aspirine-bij-vaatlijden-met-nierdisfunctie-compass/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/26/patientgerichte-transitional-care-bij-hf-hospitalisatie-jama-pact-hf/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/01/dabigatran-naar-leeftijd-bij-atriumfibrilleren-re-ly-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/02/01/reductie-van-onnodige-ventriculaire-pacing-en-klinische-uitkomsten-bij-behouden-/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-t-ruff","type":"person","url":"https://hartvaat.nl/mensen/christian-t-ruff/","name":"Christian T Ruff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":35,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/01/11/inadequate-noac-dosering-bij-af-uitkomsten-en-oorzaken-meta-analyse/","published":"2023-01-11"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/03/09/halve-versus-volle-dosis-edoxaban-bij-af-gerandomiseerde-vergelijking/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/05/14/edoxaban-bij-aziatische-af-patienten-concentraties-en-anti-xa-activiteit/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/10/30/endogene-factor-xa-activiteit-en-edoxaban-farmacodynamische-marker-en-klinische-/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/nieuwe-risicovoorspellingsscore-bij-af-voor-netto-klinisch-resultaat-engage-af-t/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/07/05/nierfunctie-en-uitkomsten-met-edoxaban-in-de-engage-af-timi-48-trial/","published":"2016-07-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dalane-w-kitzman","type":"person","url":"https://hartvaat.nl/mensen/dalane-w-kitzman/","name":"Dalane W Kitzman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":35,"articles":[{"url":"https://hartvaat.nl/2025/06/01/humain-hfpef-nieuwe-metabole-accelerator-bij-obesitas-hfpef-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/bloeddrukcontrole-en-arteriele-stijfheidsmechanismen-in-sprint/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/01/amethyst-verinurad-plus-allopurinol-bij-hfpef-negatieve-trial/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/07/12/frailteit-beinvloedt-effect-van-inspanningstraining-bij-hartfalen-hf-action-anal/","published":"2022-07-12"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2020/12/22/lichaamssamenstelling-en-risico-op-hartfalen-en-mi-prospectieve-analyse/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2019/06/04/neladenoson-bialanaat-en-inspanningscapaciteit-bij-hfpef-jama-panache/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/04/04/inspanningstraining-bij-chronisch-hartfalen-met-atriumfibrilleren/","published":"2017-04-04"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/01/05/calorierestrictie-of-aerobe-training-bij-obese-ouderen-met-hfpef-effect-op-vo2-p/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-l-januzzi","type":"person","url":"https://hartvaat.nl/mensen/james-l-januzzi/","name":"James L Januzzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":35,"articles":[{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/18/2025-acc-scientific-statement-obesitasmanagement-bij-hartfalen/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/07/01/bestaande-cv-data-benutten-voor-hypertensiedetectie-en-behandeling-vital-trial/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/08/08/stop-ca-atorvastatine-beschermt-tegen-antracycline-cardiotoxiciteit/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/05/09/2023-acc-expert-consensus-management-van-hfpef/","published":"2023-05-09"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/10/18/dosisrespons-van-sacubitril-valsartan-bij-hfref/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/08/01/klinische-fenotypen-zijn-effectiever-dan-ef-categorieen-voor-hf-uitkomsten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/08/08/canagliflozine-en-cardiovasculaire-biomarkers-bij-oudere-diabetespatienten/","published":"2017-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-g-f-cleland","type":"person","url":"https://hartvaat.nl/mensen/john-g-f-cleland/","name":"John G F Cleland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":35,"articles":[{"url":"https://hartvaat.nl/2026/05/04/congestie-bij-chronisch-hartfalen-echografie-vult-klinisch-onderzoek-aan-en-voor/","published":"2026-07-01"},{"url":"https://hartvaat.nl/2026/02/23/ijzertekort-bij-chronische-nierziekte-en-hartfalen-expertperspectieven/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/04/01/ambulante-behandeling-van-gedecompenseerd-hartfalen-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/01/thuismonitoring-met-technologie-ondersteund-management-bij-chronisch-hf-gerandom/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/12/01/orale-morfine-bij-dyspneu-bij-chronisch-hartfalen-gerandomiseerde-placebogecontr/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-w-eikelboom","type":"person","url":"https://hartvaat.nl/mensen/john-w-eikelboom/","name":"John W Eikelboom","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":35,"articles":[{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/10/01/neurofilament-light-chain-en-cva-risico-bij-af/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/05/14/rivaroxaban-plus-aspirine-bij-vaatlijden-met-nierdisfunctie-compass/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2017/07/01/dabigatran-naar-leeftijd-bij-atriumfibrilleren-re-ly-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-j-mentz","type":"person","url":"https://hartvaat.nl/mensen/robert-j-mentz/","name":"Robert J Mentz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":35,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2026/02/03/intraveneus-ijzer-bij-hartfalen-met-ijzertekort-meta-analyse-met-trial-sequentie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/10/01/amethyst-verinurad-plus-allopurinol-bij-hfpef-negatieve-trial/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/04/01/intraveneus-ijzer-bij-hartfalen-meta-analyse-op-studieniveau/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/07/12/frailteit-beinvloedt-effect-van-inspanningstraining-bij-hartfalen-hf-action-anal/","published":"2022-07-12"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/03/01/poliklinische-verslechtering-van-hartfalen-als-therapiedoel-jama-cardiology-revi/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2017/04/04/inspanningstraining-bij-chronisch-hartfalen-met-atriumfibrilleren/","published":"2017-04-04"},{"url":"https://hartvaat.nl/2017/03/21/werkzaamheid-en-veiligheid-van-tolvaptan-bij-gehospitaliseerd-acuut-hartfalen/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-a-borlaug","type":"person","url":"https://hartvaat.nl/mensen/barry-a-borlaug/","name":"Barry A Borlaug","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2026/04/27/nierfunctiestoornis-verergert-pulmonale-vaatziekte-bij-hfpef/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/07/29/summit-bmi-centrale-adipositas-en-gewichtsverlies-beinvloeden-tirzepatide-effect/","published":"2025-07-29"},{"url":"https://hartvaat.nl/2025/06/01/humain-hfpef-nieuwe-metabole-accelerator-bij-obesitas-hfpef-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/05/13/summit-tirzepatide-en-ckd-interactie-bij-hfpef-met-obesitas/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/09/01/dapagliflozine-en-rv-pulmonale-interactie-bij-hfpef/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/09/05/cameo-dapa-cardiale-en-metabole-effecten-van-dapagliflozine-bij-hfpef/","published":"2023-09-05"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2017/07/11/arteriele-verstijving-bij-inspanning-bij-hfpef/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregg-c-fonarow","type":"person","url":"https://hartvaat.nl/mensen/gregg-c-fonarow/","name":"Gregg C Fonarow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2026/05/19/sglt2-remmers-bij-oudere-patienten-opgenomen-voor-hfref-24-sterfte-en-16-heropna/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2026/02/03/intraveneus-ijzer-bij-hartfalen-met-ijzertekort-meta-analyse-met-trial-sequentie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/01/iv-ijzer-bij-hartfalen-en-ijzerdeficientie-geactualiseerde-meta-analyse-van-rct-/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2024/04/01/interventies-voor-optimalisatie-van-richtlijnmedicatie-bij-hartfalen-systematisc/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-uitgebreide-fda-labeling-jama-cardiology-implicaties/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2021/04/01/eiwitrijk-versus-standaard-dieet-bij-obees-hf-met-diabetes/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2021/01/26/2020-acc-aha-kwaliteitsmaten-voor-af-geactualiseerd/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"},{"url":"https://hartvaat.nl/2020/06/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-acs-trials-jama-cardiology/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/01/number-needed-to-treat-met-arni-voor-preventie-van-cv-dood-of-hf-hospitalisatie/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/11/01/raas-blokkade-bij-hfpef-systematische-review-en-meta-analyse/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/06/01/primaire-preventie-icd-bij-niet-ischemische-cardiomyopathie-meta-analyse/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joann-lindenfeld","type":"person","url":"https://hartvaat.nl/mensen/joann-lindenfeld/","name":"JoAnn Lindenfeld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2026/05/05/apture-shunt-verlaagt-hartfalen-heropnames-bij-patienten-met-hfpef-hfmref-alt-fl/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2024/04/09/dapagliflozine-bij-acuut-hartfalen-effectiviteit-en-veiligheid/","published":"2024-04-09"},{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/07/07/baroreflexactivatietherapie-bij-hfref-beat-hf/","published":"2020-07-07"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/03/28/adaptieve-servoventilatie-bij-hartfalen-de-cat-hf-trial/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-j-anstrom","type":"person","url":"https://hartvaat.nl/mensen/kevin-j-anstrom/","name":"Kevin J Anstrom","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2017/03/28/adaptieve-servoventilatie-bij-hartfalen-de-cat-hf-trial/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-mack","type":"person","url":"https://hartvaat.nl/mensen/michael-j-mack/","name":"Michael J Mack","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2025/01/01/mitralisklepherstel-bij-degeneratief-mr-met-matige-tricuspidalisinsufficientie-2/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-szarek","type":"person","url":"https://hartvaat.nl/mensen/michael-szarek/","name":"Michael Szarek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/06/25/vasculair-zorgteam-versus-educatie-bij-perifeer-arterieel-vaatlijden/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/05/05/atorvastatine-vermindert-eerste-en-volgende-vasculaire-events-sparcl/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-vranckx","type":"person","url":"https://hartvaat.nl/mensen/pascal-vranckx/","name":"Pascal Vranckx","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/12/07/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-veiligheid-en-werk/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-juni","type":"person","url":"https://hartvaat.nl/mensen/peter-juni/","name":"Peter Jüni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":34,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/10/01/natuurlijk-beloop-van-asymptomatische-ernstige-aortastenose-jama-cardiology-meta/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2019/04/01/restrictieve-versus-liberale-transfusie-bij-hartchirurgie-meta-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2018/01/30/kosteneffectiviteit-van-ffr-geleide-pci-bij-stabiele-coronairlijden/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dirk-j-van-veldhuisen","type":"person","url":"https://hartvaat.nl/mensen/dirk-j-van-veldhuisen/","name":"Dirk J van Veldhuisen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":33,"articles":[{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/10/decision-onttrekkingssubstudie-stoppen-van-digoxine-na-lange-behandeling-leidt-t/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/13/tubulaire-nierschade-hangt-samen-met-natriumretentie-en-diureticarespons-bij-acu/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/05/21/bariatrische-chirurgie-en-cardiovasculaire-ziekte-meta-analyse/","published":"2022-05-21"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/10/05/ketonlichamen-en-functionele-uitkomsten-na-stemi/","published":"2021-10-05"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/12/01/pro-gastrin-releasing-peptide-en-uitkomsten-bij-hf-met-anemie-red-hf/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2016/07/12/nervus-vagus-stimulatie-bij-hartfalen-de-inovate-hf-trial/","published":"2016-07-12"},{"url":"https://hartvaat.nl/2016/03/22/zelfmanagementinterventies-bij-hartfalen-individuele-patientdata-meta-analyse/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-wouter-jukema","type":"person","url":"https://hartvaat.nl/mensen/j-wouter-jukema/","name":"J Wouter Jukema","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":33,"articles":[{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/04/profylactische-icd-bij-dialysepatienten-ter-preventie-van-plotse-hartdood/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2016/07/19/visit-to-visit-ldl-cholesterolvariabiliteit-en-cognitieve-functie/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prashanthan-sanders","type":"person","url":"https://hartvaat.nl/mensen/prashanthan-sanders/","name":"Prashanthan Sanders","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":33,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/01/27/decaf-cafeinehoudende-koffie-en-af-gerandomiseerde-trial/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/10/21/dieet-en-af-risico-systematische-review/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/12/01/langetermijnmortaliteit-bij-hfmref-systematische-review-en-meta-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2021/10/09/klinische-risicofactoren-voor-cva-bij-anticoagulantie-naieve-af-meta-analyse/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2021/07/18/procedurevolume-en-complicaties-bij-af-ablatie-meta-analyse/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/01/geintegreerde-gespecialiseerde-af-poliklinieken-verlagen-totale-mortaliteit-post/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/01/01/slokdarmletsel-bij-af-ablatie-prevalentie-en-preventie-meta-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/07/01/rotorablatie-bij-atriumfibrilleren-systematische-review/","published":"2018-07-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2018/02/01/katheterablatie-bij-af-met-hartfalen-nejm-castle-af/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/12/01/geintegreerde-zorg-bij-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/05/21/af-type-en-risico-op-trombo-embolie-mortaliteit-en-bloedingen-systematische-revi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rudolf-a-de-boer","type":"person","url":"https://hartvaat.nl/mensen/rudolf-a-de-boer/","name":"Rudolf A de Boer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":33,"articles":[{"url":"https://hartvaat.nl/2026/05/22/epicardiaal-vetweefsel-voorspelt-aritmieen-en-hartfalen-events-bij-genotype-posi/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2026/02/28/hartfalen-bij-ouderen-van-epidemiologie-tot-behandeling/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2025/08/14/hartfalen-mondiale-economische-ziektelast/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/04/01/socio-economische-ongelijkheid-en-hartfalenuitkomsten-systematische-review/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/telemonitoring-bij-hartfalen-meta-analyse-van-alle-strategieen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/10/01/bloedbiomerkers-voor-prognose-bij-hypertrofische-cardiomyopathie-meta-analyse/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/05/21/bariatrische-chirurgie-en-cardiovasculaire-ziekte-meta-analyse/","published":"2022-05-21"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shamir-r-mehta","type":"person","url":"https://hartvaat.nl/mensen/shamir-r-mehta/","name":"Shamir R Mehta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":33,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"},{"url":"https://hartvaat.nl/2016/01/05/varenicline-voor-stoppen-met-roken-bij-patienten-opgenomen-met-acuut-coronair-sy/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-e-nissen","type":"person","url":"https://hartvaat.nl/mensen/steven-e-nissen/","name":"Steven E Nissen","title":"Cleveland Clinic, Ohio, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":30,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"},{"url":"https://hartvaat.nl/2025/01/21/muvalaplin-orale-lp-a-verlaging-nejm-gerandomiseerde-trial/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/07/13/traverse-testosteronsubstitutie-cardiovasculair-veilig-bij-hypogonadisme/","published":"2023-07-13"},{"url":"https://hartvaat.nl/2023/04/15/inflammatie-en-cholesterol-als-cv-voorspellers-onder-statinetherapie-lancet-anal/","published":"2023-04-15"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/01/28/cryoballonablatie-als-initiele-therapie-voor-af-nejm-early-af/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/02/16/bariatrische-chirurgie-versus-intensieve-medicamenteuze-therapie-bij-diabetes-5-/","published":"2017-02-16"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"},{"url":"https://hartvaat.nl/2016/05/01/ly3015014-een-nieuw-monoklonaal-pcsk9-antilichaam-gerandomiseerde-fase-2-trial/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/03/08/naltrexon-bupropion-en-cardiovasculaire-events-bij-obesitas-gerandomiseerde-tria/","published":"2016-03-08"}],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/expert-surpass-cvot-tirzepatide-nissen/","title":"Expertinterview: SURPASS-CVOT — tirzepatide versus dulaglutide met Steven Nissen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arie-pieter-kappetein","type":"person","url":"https://hartvaat.nl/mensen/arie-pieter-kappetein/","name":"Arie Pieter Kappetein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":32,"articles":[{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/10/01/natuurlijk-beloop-van-asymptomatische-ernstige-aortastenose-jama-cardiology-meta/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/04/25/kwaliteit-van-leven-na-chirurgie-of-des-bij-drienvaten-of-hoofdstamlijden/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dik-heg","type":"person","url":"https://hartvaat.nl/mensen/dik-heg/","name":"Dik Heg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":32,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"g-michael-felker","type":"person","url":"https://hartvaat.nl/mensen/g-michael-felker/","name":"G Michael Felker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":32,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2022/10/18/dosisrespons-van-sacubitril-valsartan-bij-hfref/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2018/03/01/poliklinische-verslechtering-van-hartfalen-als-therapiedoel-jama-cardiology-revi/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/03/21/werkzaamheid-en-veiligheid-van-tolvaptan-bij-gehospitaliseerd-acuut-hartfalen/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"},{"url":"https://hartvaat.nl/2016/03/19/serca2a-gentherapie-bij-hartfalen-de-cupid-2-trial/","published":"2016-03-19"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-g-schwartz","type":"person","url":"https://hartvaat.nl/mensen/gregory-g-schwartz/","name":"Gregory G Schwartz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":32,"articles":[{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/28/apabetalone-en-cv-events-bij-acs-met-diabetes-type-2-jama-betonmace/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keith-a-a-fox","type":"person","url":"https://hartvaat.nl/mensen/keith-a-a-fox/","name":"Keith A A Fox","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":32,"articles":[{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/05/14/rivaroxaban-plus-aspirine-bij-vaatlijden-met-nierdisfunctie-compass/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naveed-sattar","type":"person","url":"https://hartvaat.nl/mensen/naveed-sattar/","name":"Naveed Sattar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":32,"articles":[{"url":"https://hartvaat.nl/2026/04/07/kosteneffectiviteit-van-stapsgewijze-lipidenverlaging-na-coronaire-bypasschirurg/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/03/25/leeftijds-en-sekseverschillen-in-effectiviteit-van-diabetesbehandeling-netwerk-m/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/09/16/tirzepatide-en-bloeddrukverlaging-surmount-1-gestratificeerde-analyse/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2017/08/08/canagliflozine-en-cardiovasculaire-biomarkers-bij-oudere-diabetespatienten/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-m-ridker","type":"person","url":"https://hartvaat.nl/mensen/paul-m-ridker/","name":"Paul M Ridker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":29,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/05/inflammatie-cholesterol-lp-a-en-30-jaars-cv-uitkomsten-bij-vrouwen/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/04/15/inflammatie-en-cholesterol-als-cv-voorspellers-onder-statinetherapie-lancet-anal/","published":"2023-04-15"},{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/08/14/il-6-crp-en-ldl-als-biomarkers-van-residueel-risico-vergelijking/","published":"2020-08-14"},{"url":"https://hartvaat.nl/2020/05/05/triglyceriderijk-lipoproteinecholesterol-small-dense-ldl-en-cv-events/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/02/01/il-1-remming-en-bloeddruk-hypertensie-en-residueel-inflammatoir-risico-cantos/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2018/07/10/residueel-inflammatoir-risico-bij-pcsk9-remming-plus-statine/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/12/21/lilrb5-variant-geassocieerd-met-statine-intolerantie-en-myalgie/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/10/21/canakinumab-en-longkankerincidentie-bij-atherosclerose-lancet-cantos-exploratief/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/06/20/cholesteroleffluxcapaciteit-hdl-deeltjesaantal-en-cv-events-jupiter-analyse/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/05/16/statines-voor-primaire-preventie-bij-ouderen-meta-analyse-van-jupiter-en-hope-3/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2016/05/01/lipoproteinen-insulineresistentie-en-rosuvastatine-bij-incident-type-2-diabetes/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/05/01/procentuele-ldl-verlaging-bij-hoogintensieve-statinetherapie-implicaties-voor-ri/","published":"2016-05-01"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/implementatie-lipidenmanagement/","title":"Sessie 4: Implementatie van lipidenmanagement — praktische uitdagingen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulf-landmesser","type":"person","url":"https://hartvaat.nl/mensen/ulf-landmesser/","name":"Ulf Landmesser","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":32,"articles":[{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/10/01/oraal-butyraat-verlaagt-bloeddruk-bij-hypertensie-rct/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/03/02/intravasculaire-beeldvorming-bij-des-implantatie-lancet-netwerk-meta-analyse/","published":"2024-03-02"},{"url":"https://hartvaat.nl/2024/01/14/residuele-lekkage-na-laa-occlusie-en-uitkomsten-meta-analyse/","published":"2024-01-14"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/02/10/propionaat-vermindert-atherosclerose-via-immuunregulatie-van-intestinaal-cholest/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/11/08/closed-loop-stimulatie-en-cardiopulmonale-variabelen-bij-chronisch-hf-met-chrono/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2019/11/01/inclisiran-1-of-2-dosis-en-ldl-cholesterol-orion-1-1-jaarsfollow-up/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/25/sirna-tegen-pcsk9-en-atherogene-lipoproteinen-orion-1-secundaire-eindpunten/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/07/14/ldl-verlaging-en-cv-events-met-pcsk9-remmers-meta-analyse-van-gerandomiseerde-tr/","published":"2018-07-14"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-t-abraham","type":"person","url":"https://hartvaat.nl/mensen/william-t-abraham/","name":"William T Abraham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":32,"articles":[{"url":"https://hartvaat.nl/2025/02/01/transveneuze-frenische-zenuwstimulatie-bij-centraal-slaapapneu-en-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/07/07/baroreflexactivatietherapie-bij-hfref-beat-hf/","published":"2020-07-07"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/10/10/pulmonalisdrukgeleide-therapie-bij-hfref/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/04/21/aliskiren-enalapril-of-de-combinatie-bij-hartfalen-nejm-atmosphere-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/01/30/hemodynamische-telemonitoring-bij-chronisch-hartfalen-volledige-champion-resulta/","published":"2016-01-30"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manesh-r-patel","type":"person","url":"https://hartvaat.nl/mensen/manesh-r-patel/","name":"Manesh R Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":31,"articles":[{"url":"https://hartvaat.nl/2026/04/07/confident-hfpef-machine-learning-voorspelt-sterfte-en-opname-beter-dan-bestaande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/04/01/prevent-risicoscore-presteert-robuust-in-de-dagelijkse-ehr-praktijk/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2025/01/01/ffr-versus-ifr-bij-coronaire-revascularisatie-vijfjaars-follow-up/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2022/02/01/ccta-afgeleide-ffr-prognostische-waarde-meta-analyse/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/05/14/verlaagde-dosis-doac-bij-af-werkzaamheid-en-veiligheid-meta-analyse/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/02/07/acc-aats-aha-2016-criteria-voor-gepaste-coronaire-revascularisatie-bij-acs-en-st/","published":"2017-02-07"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/12/infarctgrootte-en-uitkomsten-na-primaire-pci-patientanalyse-uit-10-trials/","published":"2016-04-12"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-claude-morice","type":"person","url":"https://hartvaat.nl/mensen/marie-claude-morice/","name":"Marie-Claude Morice","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":31,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/08/01/seksegerelateerde-uitkomsten-bij-hoog-bloedingsrisico-na-pci-leaders-free/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/04/25/kwaliteit-van-leven-na-chirurgie-of-des-bij-drienvaten-of-hoofdstamlijden/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2017/04/01/polymeervrije-biolimus-stent-bij-hoog-bloedingsrisico-met-acs-leaders-free-subst/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martina-brueckmann","type":"person","url":"https://hartvaat.nl/mensen/martina-brueckmann/","name":"Martina Brueckmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":31,"articles":[{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2019/07/01/hospitalisatieredenen-en-mortaliteitsrisico-bij-af-met-dabigatran-versus-warfari/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2018/03/13/doac-s-bij-af-met-ckd-systematische-review-werkzaamheid-en-veiligheid/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-c-cushman","type":"person","url":"https://hartvaat.nl/mensen/william-c-cushman/","name":"William C Cushman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":31,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukcontrole-en-cerebrale-small-vessel-disease-markers/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/08/01/combinatietabletten-voor-intensieve-bloeddrukbehandeling-sprint-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/12/29/chloortalidon-versus-hydrochloorthiazide-geen-verschil-in-cv-events/","published":"2022-12-29"},{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2021/02/01/therapietrouw-aan-single-pill-versus-vrije-combinatietherapie-bij-hypertensie-me/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"},{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-maria-langkilde","type":"person","url":"https://hartvaat.nl/mensen/anna-maria-langkilde/","name":"Anna Maria Langkilde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":30,"articles":[{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gilles-montalescot","type":"person","url":"https://hartvaat.nl/mensen/gilles-montalescot/","name":"Gilles Montalescot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":30,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-g-p-tijssen","type":"person","url":"https://hartvaat.nl/mensen/jan-g-p-tijssen/","name":"Jan G P Tijssen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":30,"articles":[{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/10/decision-onttrekkingssubstudie-stoppen-van-digoxine-na-lange-behandeling-leidt-t/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2021/12/07/gold-force-multi-elektrode-rf-versus-irrigated-rf-bij-af-gerandomiseerde-trial/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/12/07/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-veiligheid-en-werk/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/04/17/nt-probnp-geleide-therapie-bij-acuut-gedecompenseerd-hartfalen-prima-ii/","published":"2018-04-17"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/04/18/vroeg-invasief-versus-selectieve-strategie-bij-nste-acs-ictus-trial-langetermijn/","published":"2017-04-18"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeff-s-healey","type":"person","url":"https://hartvaat.nl/mensen/jeff-s-healey/","name":"Jeff S Healey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":30,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/07/mra-s-verminderen-af-risico-meta-analyse-van-klinische-trials/","published":"2024-03-07"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2021/06/15/prevalentie-van-linkeratriumtrombus-bij-geanticoaguleerde-af-patienten/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2021/05/01/screening-op-af-bij-ouderen-jama-cardiology-gerandomiseerde-trial/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/08/01/vernakalant-voor-cardioversie-van-recent-onset-af-meta-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/07/01/hospitalisatieredenen-en-mortaliteitsrisico-bij-af-met-dabigatran-versus-warfari/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2018/05/08/vasopressine-plus-catecholamines-en-af-bij-distributieve-shock-jama-meta-analyse/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/02/01/reductie-van-onnodige-ventriculaire-pacing-en-klinische-uitkomsten-bij-behouden-/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-f-kuder","type":"person","url":"https://hartvaat.nl/mensen/julia-f-kuder/","name":"Julia F Kuder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":30,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"},{"url":"https://hartvaat.nl/2016/07/05/nierfunctie-en-uitkomsten-met-edoxaban-in-de-engage-af-timi-48-trial/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/03/15/plaatjesremming-met-ticagrelor-60-mg-versus-90-mg-in-de-pegasus-timi-54-trial/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-f-storey","type":"person","url":"https://hartvaat.nl/mensen/robert-f-storey/","name":"Robert F Storey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":30,"articles":[{"url":"https://hartvaat.nl/2026/03/05/doac-of-vka-bij-kwetsbare-ouderen-met-atriumfibrilleren/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/04/01/fibrinestoleigenschappen-en-klinische-uitkomsten-na-acs-plato-substudie/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/03/15/plaatjesremming-met-ticagrelor-60-mg-versus-90-mg-in-de-pegasus-timi-54-trial/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-e-kandzari","type":"person","url":"https://hartvaat.nl/mensen/david-e-kandzari/","name":"David E Kandzari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":29,"articles":[{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-l-bakris","type":"person","url":"https://hartvaat.nl/mensen/george-l-bakris/","name":"George L Bakris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":29,"articles":[{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2023/07/20/zilebesiran-rna-interferentietherapie-voor-hypertensie-nejm/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/01/kbp-5074-en-bloeddruk-bij-gevorderde-ckd-block-ckd/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/07/01/mra-bij-hypertensie-met-gevorderde-ckd-block-ckd-trial/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2018/11/01/therapieresistente-hypertensie-aha-scientific-statement-over-detectie-evaluatie-/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/05/01/aanhoudende-bloeddrukreductie-met-baroreceptoractivatietherapie-6-jaarsfollow-up/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/02/01/bereikte-bloeddruk-en-cardiovasculaire-uitkomsten-bij-oudere-patienten-met-geiso/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/07/verminderd-bloeddrukverlagend-effect-van-renale-denervatie-bij-geisoleerde-systo/","published":"2017-01-07"},{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/09/01/patiromer-verlaagt-aldosteron-bij-ckd-patienten-met-hyperkaliemie-op-raas-remmer/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/03/08/naltrexon-bupropion-en-cardiovasculaire-events-bij-obesitas-gerandomiseerde-tria/","published":"2016-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kurt-huber","type":"person","url":"https://hartvaat.nl/mensen/kurt-huber/","name":"Kurt Huber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":29,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paulus-kirchhof","type":"person","url":"https://hartvaat.nl/mensen/paulus-kirchhof/","name":"Paulus Kirchhof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":29,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/03/28/athena-post-hoc-dronedaron-als-effectieve-vroege-ritmecontrole/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2023/05/19/east-afnet-4-vroege-ritmecontrole-bij-af-is-kosteneffectief/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2023/01/24/axadia-afnet-8-apixaban-versus-vka-bij-af-op-hemodialyse/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/01/predictie-van-af-recidief-na-ablatie-systematische-review-van-prognostische-mode/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2018/10/16/doac-s-halveren-trombo-embolische-events-na-af-cardioversie-versus-warfarine/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-versus-heparine-vka-bij-cardioversie-voor-af-emanate-trial/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/de-tien-geboden-van-de-2016-esc-af-richtlijn/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evald-hoj-christiansen","type":"person","url":"https://hartvaat.nl/mensen/evald-hoj-christiansen/","name":"Evald Høj Christiansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":28,"articles":[{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/03/02/intravasculaire-beeldvorming-bij-des-implantatie-lancet-netwerk-meta-analyse/","published":"2024-03-02"},{"url":"https://hartvaat.nl/2023/11/01/ifr-versus-ffr-en-vijfjaarsmortaliteit-swedeheart-en-define-flair/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/12/04/ffr-versus-angiografie-geleide-cabg/","published":"2018-12-04"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerhard-hindricks","type":"person","url":"https://hartvaat.nl/mensen/gerhard-hindricks/","name":"Gerhard Hindricks","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":28,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/02/03/upgrade-van-draadloze-pacemaker-van-enkelvoudig-naar-tweekamersysteem/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/03/05/biventriculair-versus-rv-pacing-bij-patienten-met-verwachte-frequente-pacing/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/02/16/p-golfduur-voorspelt-af-recidief-na-catheterablatie-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2021/05/21/firm-ablatie-versus-pvi-bij-paroxysmaal-af-gerandomiseerde-resultaten/","published":"2021-05-21"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/10/01/slokdarmsonde-bij-rf-ablatie-voor-af-opera-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/01/01/weglaten-van-aspirine-bij-gecombineerde-antitrombotische-therapie-voor-af-acs-he/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/06/07/dagelijkse-telemonitoring-van-icd-s-gepoolde-analyse-van-drie-gerandomiseerde-tr/","published":"2017-06-07"},{"url":"https://hartvaat.nl/2017/03/01/katheterablatie-als-eerstelijnsbehandeling-bij-paroxysmaal-af-5-jaarsresultaten/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"inder-s-anand","type":"person","url":"https://hartvaat.nl/mensen/inder-s-anand/","name":"Inder S Anand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":28,"articles":[{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/02/01/autonome-regulatietherapie-bij-hfpef-anthem-hfpef/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-cosedis-nielsen","type":"person","url":"https://hartvaat.nl/mensen/jens-cosedis-nielsen/","name":"Jens Cosedis Nielsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":28,"articles":[{"url":"https://hartvaat.nl/2026/02/03/klinische-impact-van-veiligheidswaarschuwingen-voor-implanteerbare-pacemakers-en/","published":"2026-04-05"},{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/10/21/minimalisatie-van-atriale-pacing-bij-sinusknoopziekte-vermindert-af/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/12/01/enkelvoudige-versus-tweekamer-pacing-bij-sick-sinus-syndroom-danpace-langetermij/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/03/01/katheterablatie-als-eerstelijnsbehandeling-bij-paroxysmaal-af-5-jaarsresultaten/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyungah-im","type":"person","url":"https://hartvaat.nl/mensen/kyungah-im/","name":"KyungAh Im","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":28,"articles":[{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/28/morfine-en-cv-uitkomsten-bij-nste-acs-jacc-analyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/10/15/triglyceridenverlaging-en-cv-risicoreductie-over-therapeutische-klassen-meta-ana/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/09/01/verdere-ldl-verlaging-bij-reeds-zeer-lage-niveaus-jama-cardiology-meta-analyse/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2016/09/27/ldl-c-verlaging-en-cardiovasculaire-risicoreductie-jama-systematische-review-en-/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-p-lefkowitz","type":"person","url":"https://hartvaat.nl/mensen/martin-p-lefkowitz/","name":"Martin P Lefkowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":28,"articles":[{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/19/sacubitril-valsartan-en-30-daagse-heropname-na-hartfalenhospitalisatie/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-n-parkhomenko","type":"person","url":"https://hartvaat.nl/mensen/alexander-n-parkhomenko/","name":"Alexander N Parkhomenko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bjorn-redfors","type":"person","url":"https://hartvaat.nl/mensen/bjorn-redfors/","name":"Björn Redfors","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2026/05/25/1-op-5-oudere-patienten-heeft-hartfalen-opname-binnen-jaar-na-tavr-1-jaarsmortal/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2021/04/01/ventriculaire-aritmie-of-overlijden-na-stemi-versus-takotsubo/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2016/12/20/bloedingen-voor-coronairangiografie-bij-nste-acs/","published":"2016-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-w-hamm","type":"person","url":"https://hartvaat.nl/mensen/christian-w-hamm/","name":"Christian W Hamm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-m-o-connor","type":"person","url":"https://hartvaat.nl/mensen/christopher-m-o-connor/","name":"Christopher M O'Connor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/07/12/frailteit-beinvloedt-effect-van-inspanningstraining-bij-hartfalen-hf-action-anal/","published":"2022-07-12"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/04/04/inspanningstraining-bij-chronisch-hartfalen-met-atriumfibrilleren/","published":"2017-04-04"},{"url":"https://hartvaat.nl/2017/03/28/adaptieve-servoventilatie-bij-hartfalen-de-cat-hf-trial/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/werkzaamheid-en-veiligheid-van-tolvaptan-bij-gehospitaliseerd-acuut-hartfalen/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-boriani","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-boriani/","name":"Giuseppe Boriani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/27/prognose-takotsubo-syndroom-versus-hartfalen-op-de-lange-termijn/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2026/02/25/alcoholgebruik-en-het-ontstaan-van-atriumfibrilleren-dosis-risico-en-dogma-herov/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/02/03/atriumfibrilleren-bij-kankerpatienten-de-esc-richtlijn-2025-in-de-praktijk/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/08/03/device-algoritmen-voor-rv-pacingminimalisatie-meta-analyse-van-uitkomsten/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2024/08/03/dagontslag-versus-overnachting-na-af-ablatie-uitgebreide-meta-analyse/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2024/08/01/alcohol-en-hypertensierisico-dosis-respons-meta-analyse-van-niet-experimentele-s/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/10/01/alcoholconsumptie-en-bloeddruk-dosis-respons-meta-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2021/10/01/katheterablatie-als-eerstelijns-paf-therapie-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/09/14/copd-bij-af-prevalentie-management-en-impact-meta-analyse/","published":"2021-09-14"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/06/01/preventie-van-atriumfibrilleren-beoordeling-van-huidig-bewijs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/01/risicostratificatie-met-geintegreerde-devicediagnostiek-bij-hartfalen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/03/01/vaste-versus-responsieve-pacingfrequentie-bij-permanent-af-met-pacemakerindicati/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/02/01/reductie-van-onnodige-ventriculaire-pacing-en-klinische-uitkomsten-bij-behouden-/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harry-j-g-m-crijns","type":"person","url":"https://hartvaat.nl/mensen/harry-j-g-m-crijns/","name":"Harry J G M Crijns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/03/28/athena-post-hoc-dronedaron-als-effectieve-vroege-ritmecontrole/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/08/03/anticoagulatie-bij-postoperatief-af-na-geisoleerde-cabg-meta-analyse/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2023/11/10/rate-control-bij-af-calciumantagonisten-versus-betablokkers/","published":"2023-11-10"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/05/19/east-afnet-4-vroege-ritmecontrole-bij-af-is-kosteneffectief/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2021/11/08/preoperatieve-tte-voor-voorspelling-van-postoperatief-af-meta-analyse/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/12/01/geintegreerde-gespecialiseerde-af-poliklinieken-verlagen-totale-mortaliteit-post/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/19/beeldvorming-geleide-versus-routinezorg-bij-nstemi-jacc/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-a-pfeffer","type":"person","url":"https://hartvaat.nl/mensen/marc-a-pfeffer/","name":"Marc A Pfeffer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/02/01/regionale-hartdisfunctie-en-prognose-na-myocardinfarct-met-lv-disfunctie-of-hart/","published":"2016-02-01"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-d-flather","type":"person","url":"https://hartvaat.nl/mensen/marcus-d-flather/","name":"Marcus D Flather","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2022/09/01/timing-van-invasieve-strategie-bij-nste-acs-meta-analyse-van-rct-s/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"},{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/06/postoperatief-af-en-langetermijn-cva-risico-na-geisoleerde-cabg/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/08/01/radiale-arterie-graft-als-aanvulling-op-mammaria-interna-grafts-bij-cabg/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2016/12/29/bilaterale-versus-enkelvoudige-a-mammaria-interna-grafts-nejm-art-trial/","published":"2016-12-29"},{"url":"https://hartvaat.nl/2016/06/07/ischemie-en-infarct-bij-stemi-met-multivatenlijden-cvlprit-nucleaire-substudie/","published":"2016-06-07"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-a-weber","type":"person","url":"https://hartvaat.nl/mensen/michael-a-weber/","name":"Michael A Weber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/07/01/value-trial-cv-uitkomsten-bij-hypertensie-met-perifeer-vaatlijden/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/06/01/arb-versus-calciumantagonist-bloeddrukprofiel-en-klinische-effecten-vergelijking/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2017/01/07/verminderd-bloeddrukverlagend-effect-van-renale-denervatie-bij-geisoleerde-systo/","published":"2017-01-07"},{"url":"https://hartvaat.nl/2016/03/21/cardiovasculaire-uitkomsten-bij-verschillende-bereiktestreefdrukken-in-de-value-/","published":"2016-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-pordy","type":"person","url":"https://hartvaat.nl/mensen/robert-pordy/","name":"Robert Pordy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"},{"url":"https://hartvaat.nl/2016/12/13/alirocumab-en-reductie-in-atherogene-lipiden-en-cardiovasculaire-events-10-odyss/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/10/14/geen-effect-van-pcsk9-remmer-alirocumab-op-diabetes-incidentie-odyssey-analyse/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-jung-park","type":"person","url":"https://hartvaat.nl/mensen/seung-jung-park/","name":"Seung-Jung Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":27,"articles":[{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-c-keech","type":"person","url":"https://hartvaat.nl/mensen/anthony-c-keech/","name":"Anthony C Keech","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/07/10/intracoronaire-trombolyse-bij-stemi-meta-analyse/","published":"2024-07-10"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-neal","type":"person","url":"https://hartvaat.nl/mensen/bruce-neal/","name":"Bruce Neal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2026/01/01/consistentie-van-bloeddrukrespons-op-kaliumverrijkt-zout-ssass-subanalyse/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/04/11/heterogeniteit-in-bloeddrukrespons-op-antihypertensiva-jama-cross-over-rct/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/07/11/positieve-luchtwegdruk-en-cv-events-bij-slaapapneu-jama-meta-analyse/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-wanner","type":"person","url":"https://hartvaat.nl/mensen/christoph-wanner/","name":"Christoph Wanner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2026/03/03/cardiovasculaire-mortaliteit-bij-chronische-nierziekte-en-dialyse-een-tweestappe/","published":"2026-04-08"},{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/21/patientgerapporteerde-uitkomsten-verbeteren-voorspelling-van-mortaliteit-bij-dia/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/01/24/axadia-afnet-8-apixaban-versus-vka-bij-af-op-hemodialyse/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/01/07/hypoglykemie-cv-uitkomsten-en-empagliflozine-empa-reg-outcome/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/08/01/empagliflozine-voorkomt-progressie-van-ckd-empa-reg-outcome-renale-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/04/microvasculaire-ziekte-en-cv-events-bij-diabetes-type-2/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2019/04/01/spironolacton-en-lv-massa-bij-hemodialysepatienten-gerandomiseerde-trial/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"},{"url":"https://hartvaat.nl/2016/06/01/langetermijneffecten-van-atorvastatine-bij-diabetes-type-2-op-hemodialyse-4d-tri/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-b-mark","type":"person","url":"https://hartvaat.nl/mensen/daniel-b-mark/","name":"Daniel B Mark","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/07/13/ablatie-versus-medicatie-bij-af-naar-ras-en-etniciteit/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2017/06/01/primaire-preventie-icd-bij-niet-ischemische-cardiomyopathie-meta-analyse/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-gaudet","type":"person","url":"https://hartvaat.nl/mensen/daniel-gaudet/","name":"Daniel Gaudet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":23,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2026/02/01/de-verborgen-nierschade-bij-chylomicronemiesyndromen/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"},{"url":"https://hartvaat.nl/2025/05/20/plozasiran-en-lipoproteine-deeltjesgrootte-bij-hypertriglyceridemie/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/05/03/solbinsiran-langwerkend-sirna-tegen-angptl3-duurzaamheid-en-effectiviteit/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/09/12/plozasiran-sirna-tegen-apoc3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/07/01/plozasiran-sirna-tegen-apoc3-bij-ernstige-hypertriglyceridemie-shasta-2/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2017/08/29/rosuvastatine-bij-kinderen-met-homozygote-familiaire-hypercholesterolemie/","published":"2017-08-29"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/triglyceriden-en-remnantdeeltjes/","title":"Sessie 1: Triglyceriden en remnantdeeltjes"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erik-stroes","type":"person","url":"https://hartvaat.nl/mensen/erik-stroes/","name":"Erik S.G. Stroes","title":"Amsterdam UMC, Amsterdam","dutch_institution":true,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/27/macrofaagbelasting-in-carotisplaque-voorspelt-cardiovasculaire-events-na-endarte/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/13/enlicitide-orale-pcsk9-remmer-bij-heterozygote-fh-fase-3/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/09/21/pcsk9-remming-en-geoxideerde-fosfolipiden/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/11/12/bempedoinezuur-toegevoegd-aan-statines-bij-hoog-cv-risico-jama-clear-harmony/","published":"2019-11-12"},{"url":"https://hartvaat.nl/2019/09/01/persisterende-arteriele-wandinflammatie-bij-verhoogd-lp-a-ondanks-lage-ldl/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/triglyceriden-en-remnantdeeltjes/","title":"Sessie 1: Triglyceriden en remnantdeeltjes"},{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/implementatie-lipidenmanagement/","title":"Sessie 4: Implementatie van lipidenmanagement — praktische uitdagingen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-a-spertus","type":"person","url":"https://hartvaat.nl/mensen/john-a-spertus/","name":"John A Spertus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2026/01/27/vroege-versus-late-gestageerde-pci-na-subintimale-re-entry-bij-cto/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/01/01/kccq-interpretatie-bij-hartfalen-patient-ankering/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/05/28/pro-hf-routine-prom-meting-in-hartfalenpolikliniek-verbetert-uitkomsten/","published":"2024-05-28"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/06/klinisch-beslisondersteuning-vermindert-acute-nierschade-bij-coronairangiografie/","published":"2022-09-06"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/04/30/leefstijl-hba1c-en-overleving-bij-stabiel-coronairlijden-met-diabetes/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonas-oldgren","type":"person","url":"https://hartvaat.nl/mensen/jonas-oldgren/","name":"Jonas Oldgren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/25/abc-af-risicoscores-voor-gepersonaliseerde-af-behandeling/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/10/01/neurofilament-light-chain-en-cva-risico-bij-af/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/10/04/timing-vroege-versus-late-noac-start-na-ischemisch-cva-bij-af/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-versus-heparine-vka-bij-cardioversie-voor-af-emanate-trial/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/01/dabigatran-naar-leeftijd-bij-atriumfibrilleren-re-ly-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morten-schou","type":"person","url":"https://hartvaat.nl/mensen/morten-schou/","name":"Morten Schou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2026/10/01/voorgebruik-van-opioiden-verhoogt-sterfte-en-ziekenhuisopnames-na-tavi-deens-coh/","published":"2026-08-21"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/22/thoracentese-bij-acuut-hartfalen-gerandomiseerde-trial/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ori-ben-yehuda","type":"person","url":"https://hartvaat.nl/mensen/ori-ben-yehuda/","name":"Ori Ben-Yehuda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"},{"url":"https://hartvaat.nl/2016/04/12/infarctgrootte-en-uitkomsten-na-primaire-pci-patientanalyse-uit-10-trials/","published":"2016-04-12"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-k-whelton","type":"person","url":"https://hartvaat.nl/mensen/paul-k-whelton/","name":"Paul K Whelton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/11/01/optimale-antihypertensieve-systolische-bloeddruk-meta-analyse/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/08/01/alcohol-en-hypertensierisico-dosis-respons-meta-analyse-van-niet-experimentele-s/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/10/01/alcoholconsumptie-en-bloeddruk-dosis-respons-meta-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/09/20/harmonisatie-van-acc-aha-en-esc-esh-bloeddrukrichtlijnen/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/01/01/farmacologische-hypertensiebehandeling-bij-volwassenen-who-richtlijn-samenvattin/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/04/20/natriumreductie-en-bloeddruk-dosis-respons-meta-analyse-van-experimentele-studie/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/04/01/2017-acc-aha-richtlijn-voor-hoge-bloeddruk-bij-volwassenen-jama-cardiology-overz/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/01/systolische-bloeddrukreductie-en-cv-risico-netwerkmeta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/10/11/natriuminname-en-totale-mortaliteit-over-20-jaar-trials-of-hypertension-preventi/","published":"2016-10-11"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roland-e-schmieder","type":"person","url":"https://hartvaat.nl/mensen/roland-e-schmieder/","name":"Roland E Schmieder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":26,"articles":[{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/12/01/empagliflozine-en-vaatfunctie-bij-chronisch-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/11/21/sacubitril-valsartan-versus-olmesartan-en-cardiovasculaire-remodellering-bij-hyp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/11/01/gemiddelde-bloeddruk-en-visit-to-visit-variabiliteit-als-gecombineerde-voorspell/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/19/empagliflozine-en-vasculaire-functie-en-centrale-hemodynamiek-bij-diabetes-type-/","published":"2017-09-19"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-rodgers","type":"person","url":"https://hartvaat.nl/mensen/anthony-rodgers/","name":"Anthony Rodgers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2026/01/01/consistentie-van-bloeddrukrespons-op-kaliumverrijkt-zout-ssass-subanalyse/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/06/01/lage-dosis-drievoudige-viervoudige-combinatiepil-versus-monotherapie-bij-hyperte/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/04/25/mk-0616-eerste-orale-pcsk9-remmer-in-fase-2b/","published":"2023-04-25"},{"url":"https://hartvaat.nl/2023/03/01/korttermijn-bloeddrukmetingen-voorspellen-langetermijneffect-van-behandeling/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/07/11/positieve-luchtwegdruk-en-cv-events-bij-slaapapneu-jama-meta-analyse/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/03/05/bloeddrukverlaging-ter-preventie-van-hart-en-vaatziekten-systematische-review-en/","published":"2016-03-05"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-e-newby","type":"person","url":"https://hartvaat.nl/mensen/david-e-newby/","name":"David E Newby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/02/03/klinische-risicopredictie-ct-coronairangiografie-en-cv-events-bij-nieuwe-angina/","published":"2025-02-03"},{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/01/inspannings-ecg-versus-ccta-bij-stabiele-angina-post-hoc-vergelijking/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/04/01/sekseverschillen-in-effectiviteit-van-orale-p2y12-remmers-meta-analyse/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/12/27/hoog-sensitief-troponine-statinetherapie-en-risico-op-coronairlijden/","published":"2016-12-27"},{"url":"https://hartvaat.nl/2016/04/30/fluticason-vilanterol-en-overleving-bij-copd-met-verhoogd-cardiovasculair-risico/","published":"2016-04-30"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emanuele-barbato","type":"person","url":"https://hartvaat.nl/mensen/emanuele-barbato/","name":"Emanuele Barbato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2025/03/13/minoca-pathologische-bevindingen-bij-invasieve-beoordeling-meta-analyse/","published":"2025-03-13"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/09/01/periprocedureel-mi-na-pci-en-langetermijnmortaliteit-meta-analyse/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/12/20/ticagrelor-versus-prasugrel-en-coronaire-microcirculatie-bij-pci/","published":"2023-12-20"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/01/30/kosteneffectiviteit-van-ffr-geleide-pci-bij-stabiele-coronairlijden/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/01/01/ontwikkeling-van-linkerventrikelhypertrofie-bij-behandelde-hypertensie-campania-/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"},{"url":"https://hartvaat.nl/2016/09/13/clopidogrel-versus-ticagrelor-bij-diabetes-na-pci-gerandomiseerde-trial/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/07/12/prasugrel-versus-clopidogrel-en-coronaire-microvasculaire-functie-bij-electieve-/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javier-escaned","type":"person","url":"https://hartvaat.nl/mensen/javier-escaned/","name":"Javier Escaned","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/01/01/ffr-versus-ifr-bij-coronaire-revascularisatie-vijfjaars-follow-up/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/01/15/linker-hartoorsluiting-versus-medicamenteuze-behandeling-bij-af-netwerkmeta-anal/","published":"2017-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-claude-tardif","type":"person","url":"https://hartvaat.nl/mensen/jean-claude-tardif/","name":"Jean-Claude Tardif","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2026/01/13/enlicitide-orale-pcsk9-remmer-bij-heterozygote-fh-fase-3/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2019/12/01/gunstige-effecten-van-ivabradine-bij-hf-met-lage-ef-en-hartfrequentie-77-bpm/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"},{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/10/18/canakinumab-en-arteriele-effecten-bij-atherosclerose-met-diabetes-of-glucosetole/","published":"2016-10-18"},{"url":"https://hartvaat.nl/2016/01/26/p-selectine-antagonist-inclacumab-bij-coronaire-bypasschirurgie-select-cabg-tria/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-swedberg","type":"person","url":"https://hartvaat.nl/mensen/karl-swedberg/","name":"Karl Swedberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/08/01/candesartan-dosering-bij-mannen-versus-vrouwen-met-chronisch-hartfalen/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/12/01/gunstige-effecten-van-ivabradine-bij-hf-met-lage-ef-en-hartfrequentie-77-bpm/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/12/01/number-needed-to-treat-met-arni-voor-preventie-van-cv-dood-of-hf-hospitalisatie/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/19/sacubitril-valsartan-en-30-daagse-heropname-na-hartfalenhospitalisatie/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuomi-kario","type":"person","url":"https://hartvaat.nl/mensen/kazuomi-kario/","name":"Kazuomi Kario","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2026/05/11/wisdom-hmod-nachtelijke-pols-bloeddrukmeting-voorspelt-onafhankelijk-linkerventr/","published":"2026-07-09"},{"url":"https://hartvaat.nl/2026/03/04/winterhypertensie-koude-als-cardiovasculaire-risicofactor/","published":"2026-04-05"},{"url":"https://hartvaat.nl/2026/02/10/nieuwe-medicamenteuze-therapieen-voor-hypertensie/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/10/21/digitale-therapeutica-bij-essentiele-hypertensie-herb-dh1-pivottrial/","published":"2021-10-21"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/06/01/interarmbloeddrukverschil-en-beroerte-ipd-meta-analyse/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/03/01/sacubitril-valsartan-versus-olmesartan-op-centrale-hemodynamiek-bij-ouderen-para/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2017/01/07/verminderd-bloeddrukverlagend-effect-van-renale-denervatie-bij-geisoleerde-systo/","published":"2017-01-07"},{"url":"https://hartvaat.nl/2016/04/01/prognostisch-effect-van-nachtelijke-bloeddrukdaling-bij-hypertensie-de-abc-h-stu/","published":"2016-04-01"}],"videos":[{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/nieuwe-data-in-praktijk-kario/","title":"Wat betekent nieuwe data voor de praktijk? — Kazuomi Kario"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kieran-f-docherty","type":"person","url":"https://hartvaat.nl/mensen/kieran-f-docherty/","name":"Kieran F Docherty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/03/sglt2-remmers-bij-hartfalen-mega-meta-analyse-van-vijf-grote-trials/","published":"2022-09-03"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-r-poulter","type":"person","url":"https://hartvaat.nl/mensen/neil-r-poulter/","name":"Neil R Poulter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2025/07/28/ascot-legacy-atorvastatine-verlaagt-cv-events-over-20-jaar/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/korttermijn-bloeddrukmetingen-voorspellen-langetermijneffect-van-behandeling/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-bij-diabetes-type-2-met-ckd-leader-renale-analyse/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/10/01/ochtend-versus-avonddosering-van-antihypertensiva-gerandomiseerde-crossover-tria/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/09/29/langetermijnmortaliteit-na-bloeddruk-en-lipidenverlaging-bij-hypertensie-ascot-l/","published":"2018-09-29"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/06/24/bijwerkingen-bij-niet-geblindeerde-versus-geblindeerde-statinetherapie-lancet-as/","published":"2017-06-24"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/11/07/ace-remmer-en-groeisnelheid-van-kleine-abdominale-aorta-aneurysmata-gerandomisee/","published":"2016-11-07"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-peter-libby","type":"person","url":"https://hartvaat.nl/mensen/dr-peter-libby/","name":"Peter Libby","title":"Brigham and Women's Hospital, Boston, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2020/02/01/il-1-remming-en-bloeddruk-hypertensie-en-residueel-inflammatoir-risico-cantos/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/10/21/canakinumab-en-longkankerincidentie-bij-atherosclerose-lancet-cantos-exploratief/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/welkom-en-introductie/","title":"Welkom en introductie"},{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/keynote-lipiden-pathogenese-plaquemodulatie/","title":"Keynote: Lipiden bij hart- en vaatziekten — van pathogenese tot plaquemodulatie"},{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/lipoproteïne-a/","title":"Sessie 3: Lipoproteïne(a)"},{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/samenvatting-en-afsluiting/","title":"Samenvatting en afsluiting"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-s-sever","type":"person","url":"https://hartvaat.nl/mensen/peter-s-sever/","name":"Peter S Sever","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/07/28/ascot-legacy-atorvastatine-verlaagt-cv-events-over-20-jaar/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/01/ochtend-versus-avonddosering-van-antihypertensiva-gerandomiseerde-crossover-tria/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/09/29/langetermijnmortaliteit-na-bloeddruk-en-lipidenverlaging-bij-hypertensie-ascot-l/","published":"2018-09-29"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/06/24/bijwerkingen-bij-niet-geblindeerde-versus-geblindeerde-statinetherapie-lancet-as/","published":"2017-06-24"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-h-hohnloser","type":"person","url":"https://hartvaat.nl/mensen/stefan-h-hohnloser/","name":"Stefan H Hohnloser","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":25,"articles":[{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/03/28/athena-post-hoc-dronedaron-als-effectieve-vroege-ritmecontrole/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2022/11/22/athena-subanalyse-dronedaron-effectief-ongeacht-leeftijd-en-geslacht-bij-af/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/10/09/voorspellers-van-sinusritme-6-weken-na-af-cardioversie-x-vert/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2019/10/01/quadripolaire-versus-bipolaire-lv-leads-bij-crt-klinische-uitkomsten/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2019/07/01/hospitalisatieredenen-en-mortaliteitsrisico-bij-af-met-dabigatran-versus-warfari/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"},{"url":"https://hartvaat.nl/2016/12/01/rivaroxaban-versus-vka-bij-periprocedurele-antistolling-rond-af-ablatie/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-john-camm","type":"person","url":"https://hartvaat.nl/mensen/a-john-camm/","name":"A John Camm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/03/28/athena-post-hoc-dronedaron-als-effectieve-vroege-ritmecontrole/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2025/03/28/geinhaleerde-flecainide-voor-cardioversie-van-recent-onset-af-lancet/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2023/05/19/east-afnet-4-vroege-ritmecontrole-bij-af-is-kosteneffectief/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claes-held","type":"person","url":"https://hartvaat.nl/mensen/claes-held/","name":"Claes Held","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/04/11/heterogeniteit-in-bloeddrukrespons-op-antihypertensiva-jama-cross-over-rct/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"colin-berry","type":"person","url":"https://hartvaat.nl/mensen/colin-berry/","name":"Colin Berry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2026/02/03/coronaire-vaatspasmen-bij-overlevenden-van-hartstilstand/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/12/15/infarctgrootte-en-linkerkamerremodellering-na-preventieve-pci/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-saibal-kar","type":"person","url":"https://hartvaat.nl/mensen/dr-saibal-kar/","name":"Dr. Saibal Kar","title":"Los Robles Regional Medical Center, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2017/12/19/5-jaarsuitkomsten-na-linker-hartoorsluiting-prevail-en-protect-af/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/champion-af-hartoorocclusie-late-breaker/","title":"CHAMPION-AF: Hartoorocclusie versus orale antistolling — resultaten en implicaties"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-ruschitzka","type":"person","url":"https://hartvaat.nl/mensen/frank-ruschitzka/","name":"Frank Ruschitzka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2026/05/05/vericiguat-en-sgc-stimulatoren-bij-hartfalen-werkingsmechanisme-en-plaats-na-vic/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-woodward","type":"person","url":"https://hartvaat.nl/mensen/mark-woodward/","name":"Mark Woodward","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2026/04/09/sekseverschillen-in-lipiden-en-lipoproteinen-en-het-cardiovasculaire-risico-uk-b/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2026/03/24/systemische-inflammatie-en-recidief-na-een-af-gerelateerd-herseninfarct/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/03/01/korttermijn-bloeddrukmetingen-voorspellen-langetermijneffect-van-behandeling/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/thuismonitoring-met-technologie-ondersteund-management-bij-chronisch-hf-gerandom/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/11/01/tijdsverloop-van-bloeddrukverandering-door-zoutreductie-en-dash-dieet/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-w-armstrong","type":"person","url":"https://hartvaat.nl/mensen/paul-w-armstrong/","name":"Paul W Armstrong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/11/01/invloed-van-acs-trials-buiten-de-primaire-hypothese-systematische-review/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/01/02/preventie-van-cardiogene-shock-na-acuut-mi/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-van-der-meer","type":"person","url":"https://hartvaat.nl/mensen/peter-van-der-meer/","name":"Peter van der Meer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/10/decision-onttrekkingssubstudie-stoppen-van-digoxine-na-lange-behandeling-leidt-t/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/05/10/decision-lage-dosis-digoxine-mist-primair-eindpunt-bij-hf-m-ref-maar-suggereert-/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/03/03/spierstofwisseling-bij-hfpef-verminderde-oxidatieve-capaciteit-los-van-ijzergebr/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/07/20/ni006-antilichaam-voor-afbraak-van-cardiale-transthyretine-amyloid-nejm-fase-1/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takeshi-kimura","type":"person","url":"https://hartvaat.nl/mensen/takeshi-kimura/","name":"Takeshi Kimura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vlado-perkovic","type":"person","url":"https://hartvaat.nl/mensen/vlado-perkovic/","name":"Vlado Perkovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":24,"articles":[{"url":"https://hartvaat.nl/2026/06/19/vrouwen-met-ckd-krijgen-minder-vaak-ras-remmers-en-sglt2-remmers-dan-mannen/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2026/01/20/voorspelling-van-individuele-corticosteroidrespons-bij-iga-nefropathie-testing-t/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/07/11/positieve-luchtwegdruk-en-cv-events-bij-slaapapneu-jama-meta-analyse/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antoni-bayes-genis","type":"person","url":"https://hartvaat.nl/mensen/antoni-bayes-genis/","name":"Antoni Bayés-Genís","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":23,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/03/03/tien-jaar-real-world-sacubitril-valsartan-mortaliteitsreductie-bevestigd-maar-sl/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/01/colica-colchicine-bij-acuut-gedecompenseerd-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/04/14/sildenafil-bij-persisterende-pulmonale-hypertensie-na-klepchirurgie/","published":"2018-04-14"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-de-bruyne","type":"person","url":"https://hartvaat.nl/mensen/bernard-de-bruyne/","name":"Bernard De Bruyne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":23,"articles":[{"url":"https://hartvaat.nl/2026/03/28/coronaire-autoregulatie-samenspel-van-epicardiale-en-microvasculaire-weerstand/","published":"2026-03-28"},{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/10/16/hoge-coronaire-shear-stress-voorspelt-myocardinfarct/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/01/30/kosteneffectiviteit-van-ffr-geleide-pci-bij-stabiele-coronairlijden/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/12/prasugrel-versus-clopidogrel-en-coronaire-microvasculaire-functie-bij-electieve-/","published":"2016-07-12"},{"url":"https://hartvaat.nl/2016/04/12/prognostische-waarde-van-residuele-coronairstenosen-na-functioneel-complete-reva/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-h-cornel","type":"person","url":"https://hartvaat.nl/mensen/jan-h-cornel/","name":"Jan H Cornel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":23,"articles":[{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/09/27/intensieve-glucoseregulatie-bij-hyperglycemisch-acs-langetermijnfollow-up-biomar/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jung-min-ahn","type":"person","url":"https://hartvaat.nl/mensen/jung-min-ahn/","name":"Jung-Min Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":23,"articles":[{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-b-leon","type":"person","url":"https://hartvaat.nl/mensen/martin-b-leon/","name":"Martin B Leon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":23,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/07/16/revascularisatiestrategieen-na-mi-systematische-review-en-meta-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/05/gelijktijdige-laa-occlusie-en-tavr-bij-af-haalbaarheid/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sripal-bangalore","type":"person","url":"https://hartvaat.nl/mensen/sripal-bangalore/","name":"Sripal Bangalore","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":23,"articles":[{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/01/timing-van-antihypertensiva-meta-analyse-van-rct-s-bevestigt-flexibiliteit/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/routine-revascularisatie-versus-medicamenteus-bij-stabiel-coronairlijden-meta-an/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2020/01/28/orale-antistolling-bij-af-op-langdurige-hemodialyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2018/11/13/ultradunne-versus-dikkere-drug-eluting-stents-systematische-review/","published":"2018-11-13"},{"url":"https://hartvaat.nl/2017/04/06/gewichtsfluctuaties-en-cardiovasculaire-uitkomsten-bij-coronairlijden-nejm/","published":"2017-04-06"},{"url":"https://hartvaat.nl/2016/06/01/pci-bij-insulinebehandelde-versus-niet-insulinebehandelde-diabetes-freedom-trial/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valentin-fuster","type":"person","url":"https://hartvaat.nl/mensen/valentin-fuster/","name":"Valentín Fuster","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":23,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2017/01/17/dapt-versus-aspirine-monotherapie-bij-diabetes-met-multivatenlijden-na-cabg-free/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/10/timing-van-metoprolol-bij-stemi-effect-op-infarctgrootte-en-ventrikelfunctie/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/02/09/peergroepinterventie-voor-cardiovasculaire-risicofactoren-de-fifty-fifty-trial/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adnan-kastrati","type":"person","url":"https://hartvaat.nl/mensen/adnan-kastrati/","name":"Adnan Kastrati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/10/01/pci-versus-cabg-bij-linker-hoofdstamstenose-jama-cardiology-systematische-review/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elliott-m-antman","type":"person","url":"https://hartvaat.nl/mensen/elliott-m-antman/","name":"Elliott M Antman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2021/03/09/halve-versus-volle-dosis-edoxaban-bij-af-gerandomiseerde-vergelijking/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/05/14/edoxaban-bij-aziatische-af-patienten-concentraties-en-anti-xa-activiteit/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/30/endogene-factor-xa-activiteit-en-edoxaban-farmacodynamische-marker-en-klinische-/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/nieuwe-risicovoorspellingsscore-bij-af-voor-netto-klinisch-resultaat-engage-af-t/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/08/02/omega-3-vetzuren-en-linkerkamerremodellering-na-acuut-mi-omega-remodel-trial/","published":"2016-08-02"},{"url":"https://hartvaat.nl/2016/07/05/nierfunctie-en-uitkomsten-met-edoxaban-in-de-engage-af-timi-48-trial/","published":"2016-07-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianluca-campo","type":"person","url":"https://hartvaat.nl/mensen/gianluca-campo/","name":"Gianluca Campo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-p-piccini","type":"person","url":"https://hartvaat.nl/mensen/jonathan-p-piccini/","name":"Jonathan P Piccini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2026/04/07/zorgpaden-na-nieuw-vastgesteld-atriumfibrilleren-rol-van-de-elektrofysioloog-en-/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/28/athena-post-hoc-dronedaron-als-effectieve-vroege-ritmecontrole/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/06/01/continue-cardiale-monitoring-versus-standaardzorg-bij-cryptogeen-cva-jama/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisette-okkels-jensen","type":"person","url":"https://hartvaat.nl/mensen/lisette-okkels-jensen/","name":"Lisette Okkels Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/11/01/ifr-versus-ffr-en-vijfjaarsmortaliteit-swedeheart-en-define-flair/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2018/12/04/ffr-versus-angiografie-geleide-cabg/","published":"2018-12-04"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-t-roe","type":"person","url":"https://hartvaat.nl/mensen/matthew-t-roe/","name":"Matthew T Roe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-l-o-donoghue","type":"person","url":"https://hartvaat.nl/mensen/michelle-l-o-donoghue/","name":"Michelle L O'Donoghue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/lp-a-verhoogt-risico-op-veneuze-trombo-embolie-bij-premenopauzale-vrouwen-en-hor/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2020/08/11/veiligheid-van-aspirinestaken-met-p2y12-achtergrond-na-pci-meta-analyse/","published":"2020-08-11"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/10/15/triglyceridenverlaging-en-cv-risicoreductie-over-therapeutische-klassen-meta-ana/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"orly-vardeny","type":"person","url":"https://hartvaat.nl/mensen/orly-vardeny/","name":"Orly Vardeny","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2026/05/26/state-of-the-art-mra-s-bij-hartfalen-en-nierziekte-over-alle-ejectiefracties/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/05/11/finearts-hf-subanalyse-virale-luchtweginfecties-triggeren-hartfalen-verslechteri/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sotirios-tsimikas","type":"person","url":"https://hartvaat.nl/mensen/sotirios-tsimikas/","name":"Sotirios Tsimikas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2026/02/23/analytische-validatie-van-een-directe-lp-a-cholesterolbepaling/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/03/22/pelacarsen-op-lp-a-cholesterol-en-gecorrigeerd-ldl-cholesterol/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2021/09/21/pcsk9-remming-en-geoxideerde-fosfolipiden/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2020/06/21/statinetherapie-verhoogt-lipoproteine-a-spiegels/","published":"2020-06-21"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/09/01/galnac-geconjugeerd-antisense-tegen-apoc3-triglyceriden-en-atherogene-lipoprotei/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2017/07/20/angptl3-antisense-oligonucleotiden-cardiovasculaire-en-metabole-effecten-nejm/","published":"2017-07-20"},{"url":"https://hartvaat.nl/2017/01/17/geoxideerde-fosfolipiden-op-apob-100-en-recidiverende-ischemische-events-na-cva/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steffen-desch","type":"person","url":"https://hartvaat.nl/mensen/steffen-desch/","name":"Steffen Desch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":22,"articles":[{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"},{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-michael-lincoff","type":"person","url":"https://hartvaat.nl/mensen/a-michael-lincoff/","name":"A Michael Lincoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2023/07/13/traverse-testosteronsubstitutie-cardiovasculair-veilig-bij-hypogonadisme/","published":"2023-07-13"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-goette","type":"person","url":"https://hartvaat.nl/mensen/andreas-goette/","name":"Andreas Goette","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/12/07/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-veiligheid-en-werk/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2018/12/01/edoxaban-verhoogt-behandeltevredenheid-en-vermindert-zorggebruik-engage-af-timi-/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/05/01/data-mining-van-de-antipaf-afnet-2-trial-angiotensine-ii-antagonisten-en-paroxys/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-m-zeiher","type":"person","url":"https://hartvaat.nl/mensen/andreas-m-zeiher/","name":"Andreas M Zeiher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2016/06/01/herhaalde-intracoronaire-beenmergcelinjectie-bij-hartfalen-resultaten-uit-een-re/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"basil-s-lewis","type":"person","url":"https://hartvaat.nl/mensen/basil-s-lewis/","name":"Basil S Lewis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bryan-williams","type":"person","url":"https://hartvaat.nl/mensen/bryan-williams/","name":"Bryan Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/02/10/nieuwe-medicamenteuze-therapieen-voor-hypertensie/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/09/20/harmonisatie-van-acc-aha-en-esc-esh-bloeddrukrichtlijnen/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/08/01/polsgolfcalibratie-en-implicaties-voor-bloeddrukmeting-meta-analyse/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/10/26/patiromer-voor-spironolactongebruik-bij-resistente-hypertensie-met-ckd-lancet-am/","published":"2019-10-26"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2017/03/01/sacubitril-valsartan-versus-olmesartan-op-centrale-hemodynamiek-bij-ouderen-para/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-p-taggart","type":"person","url":"https://hartvaat.nl/mensen/david-p-taggart/","name":"David P Taggart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/06/postoperatief-af-en-langetermijn-cva-risico-na-geisoleerde-cabg/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/08/01/radiale-arterie-graft-als-aanvulling-op-mammaria-interna-grafts-bij-cabg/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/12/29/bilaterale-versus-enkelvoudige-a-mammaria-interna-grafts-nejm-art-trial/","published":"2016-12-29"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-clara-saldarriaga","type":"person","url":"https://hartvaat.nl/mensen/dr-clara-saldarriaga/","name":"Dr. Clara Saldarriaga","title":"Hoogleraar Cardiologie, Universidad de Antioquia, Medellín, Colombia","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/05/off-label-dosering-van-sacubitril-valsartan-wijdverspreid-in-de-praktijk/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"}],"videos":[{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/samenvatting-en-kernpunten/","title":"Samenvatting en kernboodschappen"},{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/context-en-ziektelast/","title":"Context en ziektelast"},{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/rationale-voor-de-trial/","title":"Rationale voor de studie"},{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/trialresultaten/","title":"Trialresultaten"},{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/klinische-implicaties/","title":"Klinische implicaties"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"duk-woo-park","type":"person","url":"https://hartvaat.nl/mensen/duk-woo-park/","name":"Duk-Woo Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eileen-o-meara","type":"person","url":"https://hartvaat.nl/mensen/eileen-o-meara/","name":"Eileen O'Meara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/12/01/gunstige-effecten-van-ivabradine-bij-hf-met-lage-ef-en-hartfrequentie-77-bpm/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-j-velazquez","type":"person","url":"https://hartvaat.nl/mensen/eric-j-velazquez/","name":"Eric J Velazquez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/09/01/arni-naar-hf-voorgeschiedenis-en-raas-antagonistgebruik/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/02/01/arni-initiatie-na-acuut-gedecompenseerd-hf-pioneer-hf-open-label-extensie/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/07/angiotensine-neprilysineremming-bij-acuut-gedecompenseerd-hf-nejm-pioneer-hf/","published":"2019-02-07"},{"url":"https://hartvaat.nl/2018/12/01/mitraclip-plus-medicamenteus-versus-medicamenteus-alleen-bij-hf-met-mr-meta-anal/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"goran-stankovic","type":"person","url":"https://hartvaat.nl/mensen/goran-stankovic/","name":"Goran Stanković","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-ford","type":"person","url":"https://hartvaat.nl/mensen/ian-ford/","name":"Ian Ford","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2020/09/19/trimetazidine-na-pci-lancet-atpci-gerandomiseerde-trial/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/12/01/gunstige-effecten-van-ivabradine-bij-hf-met-lage-ef-en-hartfrequentie-77-bpm/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/11/14/ldl-verlaging-voor-primaire-preventie-bij-mannen-met-primaire-ldl-verhoging/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/12/27/hoog-sensitief-troponine-statinetherapie-en-risico-op-coronairlijden/","published":"2016-12-27"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-p-howard","type":"person","url":"https://hartvaat.nl/mensen/james-p-howard/","name":"James P Howard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/02/14/tricorder-ai-stethoscoop-voor-triple-cv-ziektedetectie/","published":"2026-02-14"},{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/16/revascularisatiestrategieen-na-mi-systematische-review-en-meta-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/11/remote-beoordeling-na-acs-gerandomiseerde-trial/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2019/08/01/optimale-laesieset-bij-persisterend-af-ablatie-meta-regressie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johann-bauersachs","type":"person","url":"https://hartvaat.nl/mensen/johann-bauersachs/","name":"Johann Bauersachs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/05/10/hf-revert-antisense-mirna-remmer-cdr132l-mist-primair-eindpunt-na-infarct-met-ve/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/06/veroudering-en-myocarddisfunctie-het-hart-jong-houden/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2026/02/28/hartfalen-bij-ouderen-van-epidemiologie-tot-behandeling/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2026/02/23/verhoogd-activine-a-bij-peripartum-cardiomyopathie-en-tijdens-lv-herstel/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/rv-disfunctie-voorspelt-langetermijnherstel-bij-de-novo-hfref-prolong-ii/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2021/01/07/antisense-tegen-microrna-132-bij-hartfalen-fase-1b-resultaten/","published":"2021-01-07"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/10/21/digoxine-en-mortaliteit-gerandomiseerd-versus-observationeel-in-de-dig-trial/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-r-teerlink","type":"person","url":"https://hartvaat.nl/mensen/john-r-teerlink/","name":"John R Teerlink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keith-g-oldroyd","type":"person","url":"https://hartvaat.nl/mensen/keith-g-oldroyd/","name":"Keith G Oldroyd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2016/12/15/infarctgrootte-en-linkerkamerremodellering-na-preventieve-pci/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-j-price","type":"person","url":"https://hartvaat.nl/mensen/matthew-j-price/","name":"Matthew J Price","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2017/12/19/5-jaarsuitkomsten-na-linker-hartoorsluiting-prevail-en-protect-af/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michiel-rienstra","type":"person","url":"https://hartvaat.nl/mensen/michiel-rienstra/","name":"Michiel Rienstra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/05/28/atriumfibrilleren-en-hartfalen-versterken-elkaar-en-verhogen-sterfte-aanzienlijk/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/03/28/geinhaleerde-flecainide-voor-cardioversie-van-recent-onset-af-lancet/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/11/10/rate-control-bij-af-calciumantagonisten-versus-betablokkers/","published":"2023-11-10"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/05/21/bariatrische-chirurgie-en-cardiovasculaire-ziekte-meta-analyse/","published":"2022-05-21"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2020/07/01/subklinische-atherosclerose-en-incident-af-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/05/01/predictiemodellen-voor-af-in-de-community-meta-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-l-mills","type":"person","url":"https://hartvaat.nl/mensen/nicholas-l-mills/","name":"Nicholas L Mills","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2022/11/01/arteriele-stijfheid-en-endotheeldysfunctie-bij-anca-geassocieerde-vasculitis/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/01/13/risicofactoren-voor-type-1-en-type-2-mi/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2020/08/01/inspannings-ecg-versus-ccta-bij-stabiele-angina-post-hoc-vergelijking/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/01/endothelinereceptorantagonisme-verbetert-lipidenprofielen-en-verlaagt-pcsk9-bij-/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/04/01/sekseverschillen-in-effectiviteit-van-orale-p2y12-remmers-meta-analyse/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/12/27/hoog-sensitief-troponine-statinetherapie-en-risico-op-coronairlijden/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"otavio-berwanger","type":"person","url":"https://hartvaat.nl/mensen/otavio-berwanger/","name":"Otávio Berwanger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-en-evidence-based-prescriptie-bij-hoog-cv-risico-jama-card/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/01/07/preoperatief-statinegebruik-en-cardiovasculaire-complicaties-bij-niet-cardiale-c/","published":"2016-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-genereux","type":"person","url":"https://hartvaat.nl/mensen/philippe-genereux/","name":"Philippe Généreux","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/07/orbusneich-combo-stent-japan-usa-harmonee-gerandomiseerde-multicenter-trial/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/12/20/bloedingen-voor-coronairangiografie-bij-nste-acs/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vera-a-bittner","type":"person","url":"https://hartvaat.nl/mensen/vera-a-bittner/","name":"Vera A Bittner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/02/04/aanhoudende-ldl-verlaging-met-alirocumab-in-odyssey-outcomes/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wolfgang-koenig","type":"person","url":"https://hartvaat.nl/mensen/wolfgang-koenig/","name":"Wolfgang Koenig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":21,"articles":[{"url":"https://hartvaat.nl/2026/03/02/barrieres-bij-implementatie-van-lipidenverlagende-therapie-in-de-praktijk/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-fase-3-bij-verhoogd-ldl-nejm-orion-10-en-orion-11/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-zinman","type":"person","url":"https://hartvaat.nl/mensen/bernard-zinman/","name":"Bernard Zinman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2020/01/07/hypoglykemie-cv-uitkomsten-en-empagliflozine-empa-reg-outcome/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/08/01/empagliflozine-voorkomt-progressie-van-ckd-empa-reg-outcome-renale-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2019/06/04/microvasculaire-ziekte-en-cv-events-bij-diabetes-type-2/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/23/empagliflozine-bij-diabetes-type-2-met-perifeer-vaatlijden-empa-reg-outcome/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"burkert-pieske","type":"person","url":"https://hartvaat.nl/mensen/burkert-pieske/","name":"Burkert Pieske","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/12/01/vericiguat-en-nt-probnp-bij-hfref-victoria-subanalyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/10/01/verschillende-trainingsvormen-en-hdl-functie-bij-hfpef-optimex-substudie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/11/16/sacubitril-valsartan-versus-standaardtherapie-op-nt-probnp-en-inspanningscapacit/","published":"2021-11-16"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/06/01/economische-impact-van-hfpef-aldo-dhf-inzichten/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/08/01/strain-encoded-mri-voor-beoordeling-van-myocardiale-deformatie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-m-reid","type":"person","url":"https://hartvaat.nl/mensen/christopher-m-reid/","name":"Christopher M Reid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2026/02/23/pathfinder-trial-betere-naleving-van-hartfalenrichtlijnen-in-de-huisartsenprakti/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/06/01/bloeddrukverlaging-bij-centrale-hypertensie-gerandomiseerde-trial/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","published":"2020-07-07"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/08/01/door-to-balloon-tijd-en-uitkomsten-bij-stemi-meta-analyse/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/08/19/vergelijking-van-fibrinolytica-bij-stemi-lancet-netwerkmeta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darrel-p-francis","type":"person","url":"https://hartvaat.nl/mensen/darrel-p-francis/","name":"Darrel P Francis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/11/remote-beoordeling-na-acs-gerandomiseerde-trial/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2019/08/01/optimale-laesieset-bij-persisterend-af-ablatie-meta-regressie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/04/17/sglt2-remmers-glp-1-agonisten-en-dpp-4-remmers-vergelijkende-cardiovasculaire-me/","published":"2018-04-17"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/07/01/crt-werkingsmechanismen-en-mogelijkheden-voor-verdere-verbetering/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-mancia","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-mancia/","name":"Giuseppe Mancia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2025/08/01/sympathische-overactiviteit-bij-resistente-hypertensie-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/14/hartfrequentieverlagende-middelen-en-uitkomsten-bij-hypertensie-cvd-meta-analyse/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2025/01/01/reproduceerbaarheid-en-behandeleffect-op-kantoor-versus-ambulante-bloeddrukrelat/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/07/01/value-trial-cv-uitkomsten-bij-hypertensie-met-perifeer-vaatlijden/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2024/05/01/bloeddrukstreefwaarden-en-residueel-risico-systematische-review-en-meta-regressi/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/03/01/renale-denervatie-en-sympathische-activiteit-systematische-review/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2023/03/01/korttermijn-bloeddrukmetingen-voorspellen-langetermijneffect-van-behandeling/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/09/20/harmonisatie-van-acc-aha-en-esc-esh-bloeddrukrichtlijnen/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2020/06/01/arb-versus-calciumantagonist-bloeddrukprofiel-en-klinische-effecten-vergelijking/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/01/sympathische-zenuwactivatie-bij-essentiele-hypertensie-meta-analyse/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/11/01/gemiddelde-bloeddruk-en-visit-to-visit-variabiliteit-als-gecombineerde-voorspell/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2017/01/07/verminderd-bloeddrukverlagend-effect-van-renale-denervatie-bij-geisoleerde-systo/","published":"2017-01-07"},{"url":"https://hartvaat.nl/2016/12/01/empagliflozine-en-bloeddruk-bij-diabetes-type-2-met-hypertensie-naar-achtergrond/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/03/21/cardiovasculaire-uitkomsten-bij-verschillende-bereiktestreefdrukken-in-de-value-/","published":"2016-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabelle-c-van-gelder","type":"person","url":"https://hartvaat.nl/mensen/isabelle-c-van-gelder/","name":"Isabelle C Van Gelder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/11/10/rate-control-bij-af-calciumantagonisten-versus-betablokkers/","published":"2023-11-10"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/07/01/subklinische-atherosclerose-en-incident-af-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-rossing","type":"person","url":"https://hartvaat.nl/mensen/peter-rossing/","name":"Peter Rossing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/23/semaglutide-vermindert-infectierisico-bij-diabetes-en-chronische-nierziekte/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2019/10/01/bardoxolone-en-urine-albumine-creatinine-ratio-bij-diabetes-met-ckd-stadium-4/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yangsoo-jang","type":"person","url":"https://hartvaat.nl/mensen/yangsoo-jang/","name":"Yangsoo Jang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ziad-hijazi","type":"person","url":"https://hartvaat.nl/mensen/ziad-hijazi/","name":"Ziad Hijazi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2025/11/25/abc-af-risicoscores-voor-gepersonaliseerde-af-behandeling/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/12/03/nt-probnp-en-ecg-screening-bij-75-jarigen-voor-af-detectie-rct/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/10/01/neurofilament-light-chain-en-cva-risico-bij-af/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2022/10/04/timing-vroege-versus-late-noac-start-na-ischemisch-cva-bij-af/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2017/08/01/nt-probnp-bij-systematische-screening-op-atriumfibrilleren/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-vicaut","type":"person","url":"https://hartvaat.nl/mensen/eric-vicaut/","name":"Éric Vicaut","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":20,"articles":[{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/20/afbouw-van-antihypertensieve-behandeling-bij-verpleeghuisbewoners-rct/","published":"2025-11-20"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ajay-j-kirtane","type":"person","url":"https://hartvaat.nl/mensen/ajay-j-kirtane/","name":"Ajay J Kirtane","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/09/15/ami-management-tijdens-covid-19-scai-positiedocument/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/04/09/sham-gecontroleerde-rct-s-van-renale-denervatie-meta-analyse/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/02/19/lv-unloading-tijdens-ecmo-bij-cardiogene-shock/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2016/12/20/bloedingen-voor-coronairangiografie-bij-nste-acs/","published":"2016-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"axel-linke","type":"person","url":"https://hartvaat.nl/mensen/axel-linke/","name":"Axel Linke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/10/01/verschillende-trainingsvormen-en-hdl-functie-bij-hfpef-optimex-substudie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-hassager","type":"person","url":"https://hartvaat.nl/mensen/christian-hassager/","name":"Christian Hassager","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-juhl-terkelsen","type":"person","url":"https://hartvaat.nl/mensen/christian-juhl-terkelsen/","name":"Christian Juhl Terkelsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/10/01/voorgebruik-van-opioiden-verhoogt-sterfte-en-ziekenhuisopnames-na-tavi-deens-coh/","published":"2026-08-21"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/12/aromi-prehospitale-copeptine-versnelt-mi-uitsluiting/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/07/01/remote-ischemische-conditionering-en-vertraging-van-het-zorgsysteem-bij-stemi/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-eik-hofsten","type":"person","url":"https://hartvaat.nl/mensen/dan-eik-hofsten/","name":"Dan Eik Høfsten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/04/22/thoracentese-bij-acuut-hartfalen-gerandomiseerde-trial/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dragos-vinereanu","type":"person","url":"https://hartvaat.nl/mensen/dragos-vinereanu/","name":"Dragos Vinereanu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-d-dangas","type":"person","url":"https://hartvaat.nl/mensen/george-d-dangas/","name":"George D Dangas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-m-c-rosano","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-m-c-rosano/","name":"Giuseppe M C Rosano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2023/04/01/intraveneus-ijzer-bij-hartfalen-meta-analyse-op-studieniveau/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hussein-r-al-khalidi","type":"person","url":"https://hartvaat.nl/mensen/hussein-r-al-khalidi/","name":"Hussein R Al-Khalidi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/07/13/ablatie-versus-medicatie-bij-af-naar-ras-en-etniciteit/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/07/orbusneich-combo-stent-japan-usa-harmonee-gerandomiseerde-multicenter-trial/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jesper-hastrup-svendsen","type":"person","url":"https://hartvaat.nl/mensen/jesper-hastrup-svendsen/","name":"Jesper Hastrup Svendsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/01/20/af-screening-naar-genetisch-risico-loop-subanalyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/07/01/qt-als-voorspeller-van-af-recidief-na-ablatie-en-amiodaronimpact-amio-cat/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"},{"url":"https://hartvaat.nl/2016/02/01/peri-infarctpacing-ter-preventie-van-linkerkamerremodellering-na-groot-myocardin/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-chalmers","type":"person","url":"https://hartvaat.nl/mensen/john-chalmers/","name":"John Chalmers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/03/01/korttermijn-bloeddrukmetingen-voorspellen-langetermijneffect-van-behandeling/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"},{"url":"https://hartvaat.nl/2016/03/05/bloeddrukverlaging-ter-preventie-van-hart-en-vaatziekten-systematische-review-en/","published":"2016-03-05"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lorenz-raber","type":"person","url":"https://hartvaat.nl/mensen/lorenz-raber/","name":"Lorenz Räber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/04/07/statines-en-niet-statine-ldl-verlagers-en-cardiovasculaire-uitkomsten-meta-analy/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mandeep-r-mehra","type":"person","url":"https://hartvaat.nl/mensen/mandeep-r-mehra/","name":"Mandeep R Mehra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/08/06/doac-bij-heartmate-3-lvad-eerste-gerandomiseerde-trial/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2018/06/01/maatschappelijk-werker-palliatieve-zorg-bij-hoogrisico-hf-swap-hf-pilot/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"},{"url":"https://hartvaat.nl/2017/01/01/richtlijnen-voor-listing-van-harttransplantatiekandidaten-10-jaarsupdate/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marianna-adamo","type":"person","url":"https://hartvaat.nl/mensen/marianna-adamo/","name":"Marianna Adamo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2019/12/01/hoogtepunten-in-hartfalen-2019/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/12/01/mitraclip-plus-medicamenteus-versus-medicamenteus-alleen-bij-hf-met-mr-meta-anal/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-a-marston","type":"person","url":"https://hartvaat.nl/mensen/nicholas-a-marston/","name":"Nicholas A Marston","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/10/15/triglyceridenverlaging-en-cv-risicoreductie-over-therapeutische-klassen-meta-ana/","published":"2019-10-15"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/triglyceriden-en-remnantdeeltjes/","title":"Sessie 1: Triglyceriden en remnantdeeltjes"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-gabor-kiss","type":"person","url":"https://hartvaat.nl/mensen/robert-gabor-kiss/","name":"Róbert Gábor Kiss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suzanne-oparil","type":"person","url":"https://hartvaat.nl/mensen/suzanne-oparil/","name":"Suzanne Oparil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/05/12/behandeling-van-milde-chronische-hypertensie-in-de-zwangerschap-nejm-chap/","published":"2022-05-12"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/02/01/nauwkeurigheid-van-bloeddrukmeters-in-de-zwangerschap-systematische-review/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2017/02/01/bereikte-bloeddruk-en-cardiovasculaire-uitkomsten-bij-oudere-patienten-met-geiso/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/11/01/intensieve-bloeddrukbehandeling-120-80-mmhg-bij-cardiovasculair-risico-protagoni/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-f-mcintyre","type":"person","url":"https://hartvaat.nl/mensen/william-f-mcintyre/","name":"William F McIntyre","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/07/mra-s-verminderen-af-risico-meta-analyse-van-klinische-trials/","published":"2024-03-07"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2021/06/15/prevalentie-van-linkeratriumtrombus-bij-geanticoaguleerde-af-patienten/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2021/05/01/screening-op-af-bij-ouderen-jama-cardiology-gerandomiseerde-trial/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/08/01/vernakalant-voor-cardioversie-van-recent-onset-af-meta-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/05/08/vasopressine-plus-catecholamines-en-af-bij-distributieve-shock-jama-meta-analyse/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ziad-a-ali","type":"person","url":"https://hartvaat.nl/mensen/ziad-a-ali/","name":"Ziad A Ali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":19,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/03/02/intravasculaire-beeldvorming-bij-des-implantatie-lancet-netwerk-meta-analyse/","published":"2024-03-02"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alvaro-a-avezum","type":"person","url":"https://hartvaat.nl/mensen/alvaro-a-avezum/","name":"Alvaro A Avezum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"axel-brandes","type":"person","url":"https://hartvaat.nl/mensen/axel-brandes/","name":"Axel Brandes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/01/20/af-screening-naar-genetisch-risico-loop-subanalyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/07/01/subklinische-atherosclerose-en-incident-af-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byeong-keuk-kim","type":"person","url":"https://hartvaat.nl/mensen/byeong-keuk-kim/","name":"Byeong-Keuk Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-m-wojdyla","type":"person","url":"https://hartvaat.nl/mensen/daniel-m-wojdyla/","name":"Daniel M Wojdyla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/04/01/prevent-risicoscore-presteert-robuust-in-de-dagelijkse-ehr-praktijk/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-r-holmes","type":"person","url":"https://hartvaat.nl/mensen/david-r-holmes/","name":"David R Holmes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"},{"url":"https://hartvaat.nl/2017/12/19/5-jaarsuitkomsten-na-linker-hartoorsluiting-prevail-en-protect-af/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-ambarish-pandey","type":"person","url":"https://hartvaat.nl/mensen/dr-ambarish-pandey/","name":"Dr. Ambarish Pandey","title":"Cardioloog, UT Southwestern Medical Center, Dallas, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/06/26/finerenone-verlaagt-hart-en-vaatrisico-via-vroege-daling-van-uacr-en-systolische/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2025/01/01/ai-voorspelt-hartfalen-op-basis-van-12-afleidingen-ecg-in-grote-cohortanalyse/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/06/01/humain-hfpef-nieuwe-metabole-accelerator-bij-obesitas-hfpef-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/07/12/frailteit-beinvloedt-effect-van-inspanningstraining-bij-hartfalen-hf-action-anal/","published":"2022-07-12"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2020/12/22/lichaamssamenstelling-en-risico-op-hartfalen-en-mi-prospectieve-analyse/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/05/21/vroegtijdig-staken-van-ticagrelor-bij-secundaire-cv-preventie-jacc-review/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2017/11/01/totale-occlusie-van-de-culprit-arterie-bij-nstemi-meta-analyse/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/08/01/sedentair-gedrag-en-cardiovasculair-risico-continue-dosis-responsrelatie-in-meta/","published":"2016-08-01"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/transform-hf-diureticaresistentie/","title":"TRANSFORM-HF — Inzichten in diureticaresistentie bij hartfalen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"e-magnus-ohman","type":"person","url":"https://hartvaat.nl/mensen/e-magnus-ohman/","name":"E Magnus Ohman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/04/12/infarctgrootte-en-uitkomsten-na-primaire-pci-patientanalyse-uit-10-trials/","published":"2016-04-12"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erica-l-goodrich","type":"person","url":"https://hartvaat.nl/mensen/erica-l-goodrich/","name":"Erica L Goodrich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-eiskjaer","type":"person","url":"https://hartvaat.nl/mensen/hans-eiskjaer/","name":"Hans Eiskjær","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-d-puskas","type":"person","url":"https://hartvaat.nl/mensen/john-d-puskas/","name":"John D Puskas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-m-kalman","type":"person","url":"https://hartvaat.nl/mensen/jonathan-m-kalman/","name":"Jonathan M Kalman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2021/07/18/procedurevolume-en-complicaties-bij-af-ablatie-meta-analyse/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/07/01/rotorablatie-bij-atriumfibrilleren-systematische-review/","published":"2018-07-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-luis-lopez-sendon","type":"person","url":"https://hartvaat.nl/mensen/jose-luis-lopez-sendon/","name":"Jose Luis Lopez-Sendon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/12/01/vericiguat-en-nt-probnp-bij-hfref-victoria-subanalyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jurrien-m-ten-berg","type":"person","url":"https://hartvaat.nl/mensen/jurrien-m-ten-berg/","name":"Jurriën M Ten Berg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2018/03/13/doac-s-bij-af-met-ckd-systematische-review-werkzaamheid-en-veiligheid/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/01/1-jaarsmortaliteit-bivalirudine-versus-heparine-in-de-ambulance-bij-stemi-matrix/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lene-holmvang","type":"person","url":"https://hartvaat.nl/mensen/lene-holmvang/","name":"Lene Holmvang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manel-sabate","type":"person","url":"https://hartvaat.nl/mensen/manel-sabate/","name":"Manel Sabaté","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-alings","type":"person","url":"https://hartvaat.nl/mensen/marco-alings/","name":"Marco Alings","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/10/decision-onttrekkingssubstudie-stoppen-van-digoxine-na-lange-behandeling-leidt-t/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-d-ezekowitz","type":"person","url":"https://hartvaat.nl/mensen/michael-d-ezekowitz/","name":"Michael D Ezekowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/10/09/voorspellers-van-sinusritme-6-weken-na-af-cardioversie-x-vert/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/07/01/hospitalisatieredenen-en-mortaliteitsrisico-bij-af-met-dabigatran-versus-warfari/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/12/01/edoxaban-verhoogt-behandeltevredenheid-en-vermindert-zorggebruik-engage-af-timi-/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-versus-heparine-vka-bij-cardioversie-voor-af-emanate-trial/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/01/dabigatran-naar-leeftijd-bij-atriumfibrilleren-re-ly-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-e-farkouh","type":"person","url":"https://hartvaat.nl/mensen/michael-e-farkouh/","name":"Michael E Farkouh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/03/16/plaatjesreactiviteit-bij-acs-in-afwachting-van-chirurgische-revascularisatie/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/11/01/interventies-voor-statinevoorschrijving-bij-primaire-cv-preventie-meta-analyse/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/12/19/chirurgische-versus-percutane-revascularisatie-bij-diabetes-met-acs/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/01/17/dapt-versus-aspirine-monotherapie-bij-diabetes-met-multivatenlijden-na-cabg-free/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-maeng","type":"person","url":"https://hartvaat.nl/mensen/michael-maeng/","name":"Michael Mæng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/02/14/danami-2-16-jaarsfollow-up-primaire-pci-versus-fibrinolyse/","published":"2020-02-14"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salvatore-brugaletta","type":"person","url":"https://hartvaat.nl/mensen/salvatore-brugaletta/","name":"Salvatore Brugaletta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/08/07/adenosine-en-ticagrelorspiegels-bij-patienten-met-en-zonder-ticagrelor-dyspneu/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-leonardi","type":"person","url":"https://hartvaat.nl/mensen/sergio-leonardi/","name":"Sergio Leonardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"usman-baber","type":"person","url":"https://hartvaat.nl/mensen/usman-baber/","name":"Usman Baber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2016/09/06/duur-van-dapt-systematische-review-voor-de-acc-aha-gerichte-update-2016/","published":"2016-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"w-schuyler-jones","type":"person","url":"https://hartvaat.nl/mensen/w-schuyler-jones/","name":"W Schuyler Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":18,"articles":[{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"assen-r-goudev","type":"person","url":"https://hartvaat.nl/mensen/assen-r-goudev/","name":"Assen R Goudev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clyde-w-yancy","type":"person","url":"https://hartvaat.nl/mensen/clyde-w-yancy/","name":"Clyde W Yancy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/05/19/sglt2-remmers-bij-oudere-patienten-opgenomen-voor-hfref-24-sterfte-en-16-heropna/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/05/09/2023-acc-expert-consensus-management-van-hfpef/","published":"2023-05-09"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/12/06/comorbiditeiten-bij-hartfalen-hypertensie-obesitas-diabetes-hyperlipidemie-en-me/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/05/01/intracoronaire-adenylylcyclase-6-gentherapie-bij-hartfalen-gerandomiseerde-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-erlinge","type":"person","url":"https://hartvaat.nl/mensen/david-erlinge/","name":"David Erlinge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2025/12/11/ticagrelor-plus-aspirine-versus-aspirine-na-cabg-voor-acs-gerandomiseerde-trial/","published":"2025-12-11"},{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/08/01/sekseverschillen-in-effectiviteit-van-hartfalenmedicatie-meta-analyse/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eldrin-f-lewis","type":"person","url":"https://hartvaat.nl/mensen/eldrin-f-lewis/","name":"Eldrin F Lewis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/06/01/variatie-in-uitkomsten-tussen-complexe-hfpef-fenotypen/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/07/05/advance-care-planning-video-bij-gevorderd-hartfalen-gerandomiseerde-trial/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erin-a-bohula","type":"person","url":"https://hartvaat.nl/mensen/erin-a-bohula/","name":"Erin A Bohula","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2019/09/01/simvastatine-ezetimibe-versus-simvastatine-na-acs-bij-75-plussers-jama-cardiolog/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2016/12/21/ezetimibe-bij-post-cabg-patienten-met-acs-improve-it-subanalyse/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/07/05/nierfunctie-en-uitkomsten-met-edoxaban-in-de-engage-af-timi-48-trial/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"finn-gustafsson","type":"person","url":"https://hartvaat.nl/mensen/finn-gustafsson/","name":"Finn Gustafsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/04/22/thoracentese-bij-acuut-hartfalen-gerandomiseerde-trial/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/02/01/herhaalde-levosimendan-infusies-bij-gevorderd-chronisch-hf-in-de-kwetsbare-postd/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/01/kenmerken-en-prognose-van-hfmref-versus-hfref-en-hfpef-langetermijn/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-a-wells","type":"person","url":"https://hartvaat.nl/mensen/george-a-wells/","name":"George A Wells","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2022/02/01/sekse-en-gender-in-crt-studies-systematische-review/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2020/02/01/elektrische-versus-farmacologische-cardioversie-bij-acuut-af-op-de-seh-lancet-ra/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2018/01/09/risico-s-van-overinterpretatie-van-interimdata-lessen-uit-de-total-trial/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hein-heidbuchel","type":"person","url":"https://hartvaat.nl/mensen/hein-heidbuchel/","name":"Hein Heidbüchel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/02/03/kortste-af-cycluslengte-in-de-longvenen-identificeert-pvi-responders/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/02/05/smartphone-ppg-voor-af-detectie-en-management-verbeterde-screening/","published":"2025-02-05"},{"url":"https://hartvaat.nl/2024/12/26/gerichte-patienteneducatie-vermindert-ongeplande-cv-events-bij-af/","published":"2024-12-26"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/01/01/weglaten-van-aspirine-bij-gecombineerde-antitrombotische-therapie-voor-af-acs-he/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2018/04/21/telemonitoring-verbetert-doac-therapietrouw-bij-af/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heribert-schunkert","type":"person","url":"https://hartvaat.nl/mensen/heribert-schunkert/","name":"Heribert Schunkert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/05/de-erfelijke-basis-van-coronairlijden-nejm-overzicht/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/02/01/katheterablatie-bij-af-met-hartfalen-nejm-castle-af/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/10/01/pci-versus-cabg-bij-linker-hoofdstamstenose-jama-cardiology-systematische-review/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyo-soo-kim","type":"person","url":"https://hartvaat.nl/mensen/hyo-soo-kim/","name":"Hyo-Soo Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacob-a-udell","type":"person","url":"https://hartvaat.nl/mensen/jacob-a-udell/","name":"Jacob A Udell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/11/01/interventies-voor-statinevoorschrijving-bij-primaire-cv-preventie-meta-analyse/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/09/05/cardiovasculair-risico-na-fertiliteitstherapie-systematische-review-en-meta-anal/","published":"2017-09-05"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeong-gun-park","type":"person","url":"https://hartvaat.nl/mensen/jeong-gun-park/","name":"Jeong-Gun Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/baseline-ldl-en-klinische-uitkomsten-van-ezetimibe-plus-statine-improve-it/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/03/09/halve-versus-volle-dosis-edoxaban-bij-af-gerandomiseerde-vergelijking/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/12/21/ezetimibe-bij-post-cabg-patienten-met-acs-improve-it-subanalyse/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johanne-silvain","type":"person","url":"https://hartvaat.nl/mensen/johanne-silvain/","name":"Johanne Silvain","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johannes-f-e-mann","type":"person","url":"https://hartvaat.nl/mensen/johannes-f-e-mann/","name":"Johannes F E Mann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/02/23/semaglutide-vermindert-infectierisico-bij-diabetes-en-chronische-nierziekte/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2023/02/01/aspirine-en-cardiovasculaire-uitkomsten-bij-chronische-nierziekte/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-bij-diabetes-type-2-met-ckd-leader-renale-analyse/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"},{"url":"https://hartvaat.nl/2016/06/01/langetermijneffecten-van-atorvastatine-bij-diabetes-type-2-op-hemodialyse-4d-tri/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-sliwa","type":"person","url":"https://hartvaat.nl/mensen/karen-sliwa/","name":"Karen Sliwa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lluis-mont","type":"person","url":"https://hartvaat.nl/mensen/lluis-mont/","name":"Lluís Mont","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/06/02/autonoom-remodelling-vormt-onafhankelijk-domein-binnen-atriale-cardiomyopathie/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/10/01/optimale-interlaesieafstand-bij-ablatie-index-geleide-af-ablatie-gerandomiseerde/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2019/05/01/thoracoscopische-versus-katheterablatie-bij-af-langetermijn-fast-trial/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/12/01/av-junctieablatie-plus-crt-bij-permanent-af-gerandomiseerde-trial/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/02/01/rechterkamerseptumpacing-versus-apexpacing-bij-crt-defibrillator-gerandomiseerde/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-j-shun-shin","type":"person","url":"https://hartvaat.nl/mensen/matthew-j-shun-shin/","name":"Matthew J Shun-Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/08/01/optimale-laesieset-bij-persisterend-af-ablatie-meta-regressie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/04/17/sglt2-remmers-glp-1-agonisten-en-dpp-4-remmers-vergelijkende-cardiovasculaire-me/","published":"2018-04-17"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"myeong-ki-hong","type":"person","url":"https://hartvaat.nl/mensen/myeong-ki-hong/","name":"Myeong-Ki Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-muntner","type":"person","url":"https://hartvaat.nl/mensen/paul-muntner/","name":"Paul Muntner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/04/09/sekseverschillen-in-lipiden-en-lipoproteinen-en-het-cardiovasculaire-risico-uk-b/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/03/02/barrieres-bij-implementatie-van-lipidenverlagende-therapie-in-de-praktijk/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/10/01/intensieve-versus-standaard-bloeddrukbehandeling-op-white-coat-effect-en-gemaske/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/02/01/nauwkeurigheid-van-bloeddrukmeters-in-de-zwangerschap-systematische-review/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/02/09/generaliseerbaarheid-van-sprint-resultaten-naar-de-algemene-bevolking/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-e-aylward","type":"person","url":"https://hartvaat.nl/mensen/philip-e-aylward/","name":"Philip E Aylward","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/21/af-type-en-risico-op-trombo-embolie-mortaliteit-en-bloedingen-systematische-revi/","published":"2016-05-21"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philipp-lurz","type":"person","url":"https://hartvaat.nl/mensen/philipp-lurz/","name":"Philipp Lurz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pieter-c-smits","type":"person","url":"https://hartvaat.nl/mensen/pieter-c-smits/","name":"Pieter C Smits","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pim-a-l-tonino","type":"person","url":"https://hartvaat.nl/mensen/pim-a-l-tonino/","name":"Pim A L Tonino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/01/30/kosteneffectiviteit-van-ffr-geleide-pci-bij-stabiele-coronairlijden/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/04/12/prognostische-waarde-van-residuele-coronairstenosen-na-functioneel-complete-reva/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raymond-r-townsend","type":"person","url":"https://hartvaat.nl/mensen/raymond-r-townsend/","name":"Raymond R Townsend","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/03/01/kaliumnitraat-bij-hfpef-gerandomiseerde-trial/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/11/01/therapieresistente-hypertensie-na-sprint-evaluatie-en-management/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raul-moreno","type":"person","url":"https://hartvaat.nl/mensen/raul-moreno/","name":"Raúl Moreno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samir-r-kapadia","type":"person","url":"https://hartvaat.nl/mensen/samir-r-kapadia/","name":"Samir R Kapadia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/09/01/anemie-verergert-mortaliteit-en-hartfalenheropnames-na-tavr-bij-patienten-boven-/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/05/gelijktijdige-laa-occlusie-en-tavr-bij-af-haalbaarheid/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/13/dapt-na-pci-met-des-netwerkmeta-analyse-van-duur-en-intensiteit/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sigrun-halvorsen","type":"person","url":"https://hartvaat.nl/mensen/sigrun-halvorsen/","name":"Sigrun Halvorsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"terje-r-pedersen","type":"person","url":"https://hartvaat.nl/mensen/terje-r-pedersen/","name":"Terje R Pedersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"uwe-zeymer","type":"person","url":"https://hartvaat.nl/mensen/uwe-zeymer/","name":"Uwe Zeymer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/07/01/1-jaarsmortaliteit-bivalirudine-versus-heparine-in-de-ambulance-bij-stemi-matrix/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-c-shi","type":"person","url":"https://hartvaat.nl/mensen/victor-c-shi/","name":"Victor C Shi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/11/16/sacubitril-valsartan-versus-standaardtherapie-op-nt-probnp-en-inspanningscapacit/","published":"2021-11-16"},{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/01/01/verminderd-hyperkaliemierisico-met-mra-door-sacubitril-valsartan-bij-hartfalen/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/19/sacubitril-valsartan-en-30-daagse-heropname-na-hartfalenhospitalisatie/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilfried-mullens","type":"person","url":"https://hartvaat.nl/mensen/wilfried-mullens/","name":"Wilfried Mullens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":17,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/05/05/off-label-dosering-van-sacubitril-valsartan-wijdverspreid-in-de-praktijk/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/05/09/praise-mr-sacubitril-valsartan-verbetert-inspanningshemodynamiek-bij-hfpef-met-a/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/03/25/inspanningsecho-identificeert-hcm-patienten-die-baat-hebben-bij-mavacamten/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2018/06/01/implementatie-van-sacubitril-valsartan-in-de-klinische-praktijk-inzichten/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandre-mebazaa","type":"person","url":"https://hartvaat.nl/mensen/alexandre-mebazaa/","name":"Alexandre Mebazaa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/03/03/tien-jaar-real-world-sacubitril-valsartan-mortaliteitsreductie-bevestigd-maar-sl/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/03/16/natrium-hf-subanalyse-natriuretische-peptiden-lopen-achter-op-de-klinische-ontst/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2020/11/17/seh-zorgbundel-en-30-daags-ontslag-en-overleving-bij-oudere-hf-patienten-jama/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-j-s-coats","type":"person","url":"https://hartvaat.nl/mensen/andrew-j-s-coats/","name":"Andrew J S Coats","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/12/01/ijzercarboxymaltose-bij-ijzerdeficient-hartfalen-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-h-gershlick","type":"person","url":"https://hartvaat.nl/mensen/anthony-h-gershlick/","name":"Anthony H Gershlick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/12/24/langetermijnfollow-up-van-complete-versus-laesie-only-revascularisatie-bij-stemi/","published":"2019-12-24"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/06/21/strategieen-om-microvasculaire-obstructie-te-verminderen-bij-primaire-pci-relief/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/06/07/ischemie-en-infarct-bij-stemi-met-multivatenlijden-cvlprit-nucleaire-substudie/","published":"2016-06-07"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bon-kwon-koo","type":"person","url":"https://hartvaat.nl/mensen/bon-kwon-koo/","name":"Bon-Kwon Koo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daichi-shimbo","type":"person","url":"https://hartvaat.nl/mensen/daichi-shimbo/","name":"Daichi Shimbo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/01/01/ultra-lage-dosis-combinatiepil-als-startbehandeling-voor-hypertensie/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2026/01/22/verschil-tussen-klinische-en-ambulante-bloeddruk-en-valrisico-bij-ouderen/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/07/27/heeft-deze-volwassene-hypertensie-jama-rational-clinical-examination/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2020/10/01/intensieve-versus-standaard-bloeddrukbehandeling-op-white-coat-effect-en-gemaske/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/02/01/nauwkeurigheid-van-bloeddrukmeters-in-de-zwangerschap-systematische-review/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/02/09/generaliseerbaarheid-van-sprint-resultaten-naar-de-algemene-bevolking/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-maron","type":"person","url":"https://hartvaat.nl/mensen/david-j-maron/","name":"David J Maron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/02/28/incidenteel-coronair-calcium-op-ct-thorax-ai-gestuurde-screening-verbetert-stati/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/09/01/routine-revascularisatie-versus-medicamenteus-bij-stabiel-coronairlijden-meta-an/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/04/30/leefstijl-hba1c-en-overleving-bij-stabiel-coronairlijden-met-diabetes/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2017/02/07/acc-aats-aha-2016-criteria-voor-gepaste-coronaire-revascularisatie-bij-acs-en-st/","published":"2017-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-whellan","type":"person","url":"https://hartvaat.nl/mensen/david-j-whellan/","name":"David J Whellan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/07/12/frailteit-beinvloedt-effect-van-inspanningstraining-bij-hartfalen-hf-action-anal/","published":"2022-07-12"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/04/04/inspanningstraining-bij-chronisch-hartfalen-met-atriumfibrilleren/","published":"2017-04-04"},{"url":"https://hartvaat.nl/2017/03/28/adaptieve-servoventilatie-bij-hartfalen-de-cat-hf-trial/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dean-j-kereiakes","type":"person","url":"https://hartvaat.nl/mensen/dean-j-kereiakes/","name":"Dean J Kereiakes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/10/31/laesiecomplexiteit-en-uitkomsten-van-verlengde-dapt-na-pci/","published":"2017-10-31"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/05/02/mi-risico-na-stoppen-van-thienopyridine-dapt-studie/","published":"2017-05-02"},{"url":"https://hartvaat.nl/2016/10/04/impact-van-optimale-medicamenteuze-therapie-in-de-dapt-studie/","published":"2016-10-04"},{"url":"https://hartvaat.nl/2016/05/31/dapt-score-validatie-bij-patienten-met-en-zonder-eerder-myocardinfarct/","published":"2016-05-31"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dipak-kotecha","type":"person","url":"https://hartvaat.nl/mensen/dipak-kotecha/","name":"Dipak Kotecha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2025/03/26/rate-af-kosteneffectiviteit-van-digoxine-versus-betablokkers-bij-permanent-af/","published":"2025-03-26"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2022/09/26/smartphone-detectie-van-af-via-fotoplethysmografie-meta-analyse/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"},{"url":"https://hartvaat.nl/2021/07/01/transformatie-van-klinisch-onderzoek-door-patientbetrokkenheid-rate-af/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2020/05/01/predictie-van-af-recidief-na-ablatie-systematische-review-van-prognostische-mode/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/05/01/thoracoscopische-versus-katheterablatie-bij-af-langetermijn-fast-trial/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2018/10/16/doac-s-halveren-trombo-embolische-events-na-af-cardioversie-versus-warfarine/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/09/01/validiteit-en-reproduceerbaarheid-van-echocardiografie-bij-af-systematische-revi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guillaume-cayla","type":"person","url":"https://hartvaat.nl/mensen/guillaume-cayla/","name":"Guillaume Cayla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"itamar-raz","type":"person","url":"https://hartvaat.nl/mensen/itamar-raz/","name":"Itamar Raz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-bij-diabetes-type-2-met-ckd-leader-renale-analyse/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jackson-t-wright","type":"person","url":"https://hartvaat.nl/mensen/jackson-t-wright/","name":"Jackson T Wright","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jindrich-spinar","type":"person","url":"https://hartvaat.nl/mensen/jindrich-spinar/","name":"Jindřich Špinar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-b-buse","type":"person","url":"https://hartvaat.nl/mensen/john-b-buse/","name":"John B Buse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/12/01/eerste-en-recidiverende-cv-events-met-liraglutide-bij-diabetes-type-2-leader/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/03/08/naltrexon-bupropion-en-cardiovasculaire-events-bij-obesitas-gerandomiseerde-tria/","published":"2016-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-f-sabik","type":"person","url":"https://hartvaat.nl/mensen/joseph-f-sabik/","name":"Joseph F Sabik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julio-nunez","type":"person","url":"https://hartvaat.nl/mensen/julio-nunez/","name":"Julio Núñez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/06/26/machine-learning-voorspelt-diureticumrespons-bij-acuut-hartfalen-drc-ahf/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/04/20/raas-blokkade-in-de-levenscyclus-van-de-nier-actuele-behandelstandaard/","published":"2026-05-02"},{"url":"https://hartvaat.nl/2026/03/03/expertopinie-hierarchische-eindpunten-op-basis-van-verslechterend-hartfalen-voor/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/bio-impedantie-voor-vochtstatusbepaling-en-prognose-bij-chronisch-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/01/colica-colchicine-bij-acuut-gedecompenseerd-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/iv-ferricarboxymaltose-verbetert-linkeratriale-strain-bij-hartfalen-myocardial-i/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"junbo-ge","type":"person","url":"https://hartvaat.nl/mensen/junbo-ge/","name":"Junbo Ge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/04/10/vroege-evolocumab-na-hartinfarct-verlaagt-mace-bij-uitgestelde-randstenosen/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2025/06/09/remote-ischemische-preconditionering-en-nierschade-na-coronairangiografie/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/02/01/maggic-score-voor-mortaliteitsvoorspelling-bij-klepziekte/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/01/17/option-indobufen-als-aspirine-alternatief-in-dapt-na-pci/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-mauri","type":"person","url":"https://hartvaat.nl/mensen/laura-mauri/","name":"Laura Mauri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/10/31/laesiecomplexiteit-en-uitkomsten-van-verlengde-dapt-na-pci/","published":"2017-10-31"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/05/02/mi-risico-na-stoppen-van-thienopyridine-dapt-studie/","published":"2017-05-02"},{"url":"https://hartvaat.nl/2016/10/04/impact-van-optimale-medicamenteuze-therapie-in-de-dapt-studie/","published":"2016-10-04"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/05/31/dapt-score-validatie-bij-patienten-met-en-zonder-eerder-myocardinfarct/","published":"2016-05-31"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-a-hlatky","type":"person","url":"https://hartvaat.nl/mensen/mark-a-hlatky/","name":"Mark A Hlatky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/01/01/vitamine-d-voorkomt-statine-gerelateerde-spierklachten-niet/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/10/09/hypoglykemie-en-troponine-elevatie-bij-diabetes-met-coronairlijden/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/01/30/kosteneffectiviteit-van-ffr-geleide-pci-bij-stabiele-coronairlijden/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/03/29/drug-eluting-versus-bare-metal-stents-bij-pci-patienten-met-eindstadium-nierziek/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"muhammad-shahzeb-khan","type":"person","url":"https://hartvaat.nl/mensen/muhammad-shahzeb-khan/","name":"Muhammad Shahzeb Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/12/01/ijzercarboxymaltose-bij-ijzerdeficient-hartfalen-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/13/dapt-na-pci-met-des-netwerkmeta-analyse-van-duur-en-intensiteit/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/09/01/icd-en-overleving-bij-gevorderd-hf-met-continue-flow-lvad/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/11/01/raas-blokkade-bij-hfpef-systematische-review-en-meta-analyse/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nick-curzen","type":"person","url":"https://hartvaat.nl/mensen/nick-curzen/","name":"Nick Curzen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/09/01/timing-van-invasieve-strategie-bij-nste-acs-meta-analyse-van-rct-s/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/05/25/jbs-richtlijn-management-van-hartstilstand-in-het-cathlab/","published":"2022-05-25"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/12/24/langetermijnfollow-up-van-complete-versus-laesie-only-revascularisatie-bij-stemi/","published":"2019-12-24"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nico-h-j-pijls","type":"person","url":"https://hartvaat.nl/mensen/nico-h-j-pijls/","name":"Nico H J Pijls","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/03/28/coronaire-autoregulatie-samenspel-van-epicardiale-en-microvasculaire-weerstand/","published":"2026-03-28"},{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/01/30/kosteneffectiviteit-van-ffr-geleide-pci-bij-stabiele-coronairlijden/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/04/12/prognostische-waarde-van-residuele-coronairstenosen-na-functioneel-complete-reva/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"norman-mangner","type":"person","url":"https://hartvaat.nl/mensen/norman-mangner/","name":"Norman Mangner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-rossignol","type":"person","url":"https://hartvaat.nl/mensen/patrick-rossignol/","name":"Patrick Rossignol","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/11/20/afbouw-van-antihypertensieve-behandeling-bij-verpleeghuisbewoners-rct/","published":"2025-11-20"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/10/26/patiromer-voor-spironolactongebruik-bij-resistente-hypertensie-met-ckd-lancet-am/","published":"2019-10-26"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-a-heidenreich","type":"person","url":"https://hartvaat.nl/mensen/paul-a-heidenreich/","name":"Paul A Heidenreich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/05/28/pro-hf-routine-prom-meting-in-hartfalenpolikliniek-verbetert-uitkomsten/","published":"2024-05-28"},{"url":"https://hartvaat.nl/2023/01/11/metamfetamine-geassocieerd-hartfalen-systematische-review/","published":"2023-01-11"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/04/27/2021-acc-aha-kerngegevenselementen-voor-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/01/26/2020-acc-aha-kwaliteitsmaten-voor-af-geactualiseerd/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-kala","type":"person","url":"https://hartvaat.nl/mensen/petr-kala/","name":"Petr Kala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-harriette-van-spall","type":"person","url":"https://hartvaat.nl/mensen/prof-harriette-van-spall/","name":"Prof. Harriette Van Spall","title":"Cardioloog, McMaster University, Hamilton, Canada","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/03/03/expertopinie-hierarchische-eindpunten-op-basis-van-verslechterend-hartfalen-voor/","published":"2026-03-03"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/masterclass-globalising-hf-zannad-van-spall/","title":"Masterclass — Hartfalen-evidence wereldwijd inclusiever maken"},{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/champion-af-hartoorocclusie-late-breaker/","title":"CHAMPION-AF: Hartoorocclusie versus orale antistolling — resultaten en implicaties"},{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/alert-onderbehandeling-aortastenose-mitralisinsufficiëntie/","title":"ALERT: Onderbehandeling bij aortastenose en mitralisinsufficiëntie"},{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/pro-tavi-pci-bij-tavi-late-breaker/","title":"PRO-TAVI: Routinematige PCI bij TAVI — nodig of niet?"},{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/dig-rhd-digoxine-reumatische-hartziekte/","title":"Dig-RHD: Digoxine bij reumatische hartziekte"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raffaele-de-caterina","type":"person","url":"https://hartvaat.nl/mensen/raffaele-de-caterina/","name":"Raffaele De Caterina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/16/doac-s-halveren-trombo-embolische-events-na-af-cardioversie-versus-warfarine/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/06/14/langetermijnuitkomsten-bij-angina-zonder-obstructief-coronairlijden-systematisch/","published":"2018-06-14"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/doac-s-bij-af-met-kleplijden-jacc-review/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-e-pratley","type":"person","url":"https://hartvaat.nl/mensen/richard-e-pratley/","name":"Richard E Pratley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/23/semaglutide-vermindert-infectierisico-bij-diabetes-en-chronische-nierziekte/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-s-rosenson","type":"person","url":"https://hartvaat.nl/mensen/robert-s-rosenson/","name":"Robert S Rosenson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/03/02/barrieres-bij-implementatie-van-lipidenverlagende-therapie-in-de-praktijk/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2025/05/20/plozasiran-en-lipoproteine-deeltjesgrootte-bij-hypertriglyceridemie/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/05/03/solbinsiran-langwerkend-sirna-tegen-angptl3-duurzaamheid-en-effectiviteit/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/09/12/plozasiran-sirna-tegen-apoc3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/07/01/plozasiran-sirna-tegen-apoc3-bij-ernstige-hypertriglyceridemie-shasta-2/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/05/26/evolocumab-bij-hiv-met-dyslipidemie-beijerinck-gerandomiseerde-studie/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2017/09/26/sams-ci-score-toegepast-op-gerandomiseerde-trial-over-statine-myopathie/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sunil-v-rao","type":"person","url":"https://hartvaat.nl/mensen/sunil-v-rao/","name":"Sunil V Rao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-consensus-same-day-ontslag-na-pci/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2020/09/15/ami-management-tijdens-covid-19-scai-positiedocument/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-friede","type":"person","url":"https://hartvaat.nl/mensen/tim-friede/","name":"Tim Friede","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/05/05/reduce-mfa-dzhk25-trial-naar-antifibrotische-therapie-tegen-myocardfibrose-na-ta/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vijay-k-chopra","type":"person","url":"https://hartvaat.nl/mensen/vijay-k-chopra/","name":"Vijay K Chopra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vivek-y-reddy","type":"person","url":"https://hartvaat.nl/mensen/vivek-y-reddy/","name":"Vivek Y Reddy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/10/15/lage-voorspelde-adherentie-verhoogt-stroke-risico-bij-af-patienten-die-starten-m/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2026/02/03/upgrade-van-draadloze-pacemaker-van-enkelvoudig-naar-tweekamersysteem/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/07/02/pfa-versus-thermale-ablatie-bij-paroxysmaal-af-aritmielastanalyse/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2023/02/08/redo-firm-firm-geleide-ablatie-verbetert-uitkomst-niet-bij-recidief-af/","published":"2023-02-08"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2021/06/01/katheterablatie-of-antiaritmica-als-eerstelijnstherapie-bij-af-jama-cardiology-m/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/laa-sluiting-versus-oac-bij-af-meta-analyse-van-gerandomiseerde-trials/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/11/17/transcatheter-bariatrische-embolotherapie-voor-gewichtsreductie-bij-obesitas/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2017/12/19/5-jaarsuitkomsten-na-linker-hartoorsluiting-prevail-en-protect-af/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-f-fearon","type":"person","url":"https://hartvaat.nl/mensen/william-f-fearon/","name":"William F Fearon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":16,"articles":[{"url":"https://hartvaat.nl/2026/01/06/caviar-alirocumab-bij-cardiale-allograft-vasculopathie-na-harttransplantatie/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/10/16/hoge-coronaire-shear-stress-voorspelt-myocardinfarct/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/01/30/kosteneffectiviteit-van-ffr-geleide-pci-bij-stabiele-coronairlijden/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/04/12/prognostische-waarde-van-residuele-coronairstenosen-na-functioneel-complete-reva/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-p-banning","type":"person","url":"https://hartvaat.nl/mensen/adrian-p-banning/","name":"Adrian P Banning","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2022/09/01/timing-van-invasieve-strategie-bij-nste-acs-meta-analyse-van-rct-s/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alasdair-d-henderson","type":"person","url":"https://hartvaat.nl/mensen/alasdair-d-henderson/","name":"Alasdair D Henderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberico-l-catapano","type":"person","url":"https://hartvaat.nl/mensen/alberico-l-catapano/","name":"Alberico L Catapano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/05/22/orale-pcsk9-remmers-meta-analyse-bevestigt-krachtige-ldl-daling/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/04/24/santorini-uk-ldl-doel-onbereikt-bij-meerderheid-van-hoogrisicopatienten-na-1-jaa/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2026/04/22/angptl3-remmers-verlagen-breed-lipidenspectrum-vooral-remnant-en-triglyceriden/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2026/02/05/orale-pcsk9-remmer-enlicitide-verlaagt-ldl-met-57-placebogecontroleerde-trial/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/13/enlicitide-orale-pcsk9-remmer-bij-heterozygote-fh-fase-3/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2023/04/25/mk-0616-eerste-orale-pcsk9-remmer-in-fase-2b/","published":"2023-04-25"},{"url":"https://hartvaat.nl/2019/03/14/bempedoinezuur-voor-ldl-verlaging-nejm-veiligheid-en-werkzaamheid/","published":"2019-03-14"},{"url":"https://hartvaat.nl/2018/07/14/ldl-verlaging-en-cv-events-met-pcsk9-remmers-meta-analyse-van-gerandomiseerde-tr/","published":"2018-07-14"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/11/14/ldl-verlaging-voor-primaire-preventie-bij-mannen-met-primaire-ldl-verhoging/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-natale","type":"person","url":"https://hartvaat.nl/mensen/andrea-natale/","name":"Andrea Natale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/04/07/zorgpaden-na-nieuw-vastgesteld-atriumfibrilleren-rol-van-de-elektrofysioloog-en-/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2025/09/01/sedatie-versus-narcose-bij-af-catheterablatie-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"},{"url":"https://hartvaat.nl/2020/10/27/af-ablatie-met-vena-van-marshall-ethanol-versus-ablatie-alleen-jama-venus/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/12/01/rivaroxaban-versus-vka-bij-periprocedurele-antistolling-rond-af-ablatie/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-m-scirica","type":"person","url":"https://hartvaat.nl/mensen/benjamin-m-scirica/","name":"Benjamin M Scirica","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/07/01/bestaande-cv-data-benutten-voor-hypertensiedetectie-en-behandeling-vital-trial/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2024/06/04/drive-remote-management-verbetert-richtlijnmedicatie-bij-hartfalen/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"},{"url":"https://hartvaat.nl/2016/03/08/acute-ledischemie-en-vorapaxar-bij-perifeer-arterieel-vaatlijden-tra-2p-timi-50-/","published":"2016-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carsten-skurk","type":"person","url":"https://hartvaat.nl/mensen/carsten-skurk/","name":"Carsten Skurk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-atar","type":"person","url":"https://hartvaat.nl/mensen/dan-atar/","name":"Dan Atar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/de-tien-geboden-van-de-2016-esc-af-richtlijn/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-c-wheeler","type":"person","url":"https://hartvaat.nl/mensen/david-c-wheeler/","name":"David C Wheeler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/02/23/ijzertekort-bij-chronische-nierziekte-en-hartfalen-expertperspectieven/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/11/25/zenith-ckd-zibotentan-plus-dapagliflozine-bij-ckd-lancet/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-hildick-smith","type":"person","url":"https://hartvaat.nl/mensen/david-hildick-smith/","name":"David Hildick-Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antiplaatjestherapie-bij-cryptogeen-cva-nejm-close/","published":"2017-09-14"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-david-berg","type":"person","url":"https://hartvaat.nl/mensen/dr-david-berg/","name":"Dr. David Berg","title":"Cardioloog, Brigham and Women's Hospital; Harvard Medical School, Boston, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/samenvatting-en-kernpunten/","title":"Samenvatting en kernboodschappen"},{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/context-en-ziektelast/","title":"Context en ziektelast"},{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/rationale-voor-de-trial/","title":"Rationale voor de studie"},{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/trialresultaten/","title":"Trialresultaten"},{"url":"https://hartvaat.nl/video/sglt2-initiatie-hartfalen-opname/klinische-implicaties/","title":"Klinische implicaties"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrico-frigoli","type":"person","url":"https://hartvaat.nl/mensen/enrico-frigoli/","name":"Enrico Frigoli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gennaro-sardella","type":"person","url":"https://hartvaat.nl/mensen/gennaro-sardella/","name":"Gennaro Sardella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/04/01/sacubitril-valsartan-na-acuut-mi-meta-analyse-van-in-hospital-initiatie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/08/08/prasugrel-of-ticagrelor-bij-stemi-met-diabetes/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiddo-j-l-heerspink","type":"person","url":"https://hartvaat.nl/mensen/hiddo-j-l-heerspink/","name":"Hiddo J L Heerspink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/04/24/nkf-consensus-standaardiseer-urine-afname-om-albuminurie-betrouwbaar-te-meten/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/01/dapagliflozine-bij-cv-risico-met-zonder-diabetes-cardiorenale-effecten/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/11/25/zenith-ckd-zibotentan-plus-dapagliflozine-bij-ckd-lancet/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/10/01/bardoxolone-en-urine-albumine-creatinine-ratio-bij-diabetes-met-ckd-stadium-4/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ileana-l-pina","type":"person","url":"https://hartvaat.nl/mensen/ileana-l-pina/","name":"Ileana L Piña","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/dosisrespons-van-sacubitril-valsartan-bij-hfref/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/04/04/inspanningstraining-bij-chronisch-hartfalen-met-atriumfibrilleren/","published":"2017-04-04"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ingo-eitel","type":"person","url":"https://hartvaat.nl/mensen/ingo-eitel/","name":"Ingo Eitel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2025/10/07/laa-occlusie-bij-terminale-nierziekte-ipd-meta-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"},{"url":"https://hartvaat.nl/2016/08/16/intracoronair-abciximab-bij-diabetespatienten-met-primaire-pci-1-jaarsresultaten/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/04/12/infarctgrootte-en-uitkomsten-na-primaire-pci-patientanalyse-uit-10-trials/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irene-m-lang","type":"person","url":"https://hartvaat.nl/mensen/irene-m-lang/","name":"Irene M Lang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/05/25/longembolie-epidemiologie-stijgende-last-bij-vergrijzing-preventiestrategieen-bl/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/09/21/riociguat-bij-pulmonale-hypertensie-en-hfpef-haemodynamic-trial/","published":"2022-09-21"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/01/seksegerelateerde-uitkomsten-bij-hoog-bloedingsrisico-na-pci-leaders-free/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/04/01/prehospitale-hypothermie-bij-stemi-gerandomiseerde-trial/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-belohlavek","type":"person","url":"https://hartvaat.nl/mensen/jan-belohlavek/","name":"Jan Bělohlávek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/01/16/watchful-leefstijl-wandelinterventie-bij-hfref/","published":"2024-01-16"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/02/07/ecmo-cs-ecmo-bij-cardiogene-shock-verbetert-overleving-niet/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2023/02/01/diabetes-en-sacubitril-valsartan-titratie-bij-hartfalen-na-opname/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2020/10/01/accelerometrie-bij-cv-patienten-systematische-review-met-praktische-aanbevelinge/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-l-sapp","type":"person","url":"https://hartvaat.nl/mensen/john-l-sapp/","name":"John L Sapp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/01/01/haptoglobinefenotype-en-cv-risico-accord-bloeddruk-rct/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2020/02/11/haptoglobinefenotype-wijzigt-het-effect-van-intensieve-glycemische-controle-op-c/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joo-yong-hahn","type":"person","url":"https://hartvaat.nl/mensen/joo-yong-hahn/","name":"Joo-Yong Hahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-francisco-kerr-saraiva","type":"person","url":"https://hartvaat.nl/mensen/jose-francisco-kerr-saraiva/","name":"José Francisco Kerr Saraiva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-en-evidence-based-prescriptie-bij-hoog-cv-risico-jama-card/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kuniaki-takahashi","type":"person","url":"https://hartvaat.nl/mensen/kuniaki-takahashi/","name":"Kuniaki Takahashi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/01/06/caviar-alirocumab-bij-cardiale-allograft-vasculopathie-na-harttransplantatie/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-cecilia-bahit","type":"person","url":"https://hartvaat.nl/mensen/m-cecilia-bahit/","name":"M Cecilia Bahit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-girerd","type":"person","url":"https://hartvaat.nl/mensen/nicolas-girerd/","name":"Nicolas Girerd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/08/18/tafamidis-bij-attr-cardiomyopathie-kosteffectiviteit-onder-de-maat-in-vier-europ/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/23/paradise-cohort-hartfalen-en-copd-samen-verhogen-de-langetermijnmortaliteit-met-/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/05/10/hartfalen-en-infarct-verdrievoudigen-het-risico-op-kanker-vooral-hematologisch/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/03/vroeg-starten-met-mra-na-acuut-hartfalen-of-myocardinfarct-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-versus-tirzepatide-bij-patienten-met-obesitas-en-hfpef/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2025/10/01/ambulante-iv-diurese-bij-chronisch-hf-decongest-inzichten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olof-bengtsson","type":"person","url":"https://hartvaat.nl/mensen/olof-bengtsson/","name":"Olof Bengtsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ovidiu-chioncel","type":"person","url":"https://hartvaat.nl/mensen/ovidiu-chioncel/","name":"Ovidiu Chioncel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/25/het-spectrum-van-congestie-bij-hartfalen-pathofysiologie-en-diagnostische-strate/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/03/20/evolution-hf-cee-ba-real-world-dapagliflozin-bij-hfref-in-centraal-en-oost-europ/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-nordbeck","type":"person","url":"https://hartvaat.nl/mensen/peter-nordbeck/","name":"Peter Nordbeck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/11/08/closed-loop-stimulatie-en-cardiopulmonale-variabelen-bij-chronisch-hf-met-chrono/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajiv-agarwal","type":"person","url":"https://hartvaat.nl/mensen/rajiv-agarwal/","name":"Rajiv Agarwal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/06/26/finerenone-verlaagt-hart-en-vaatrisico-via-vroege-daling-van-uacr-en-systolische/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/30/chlorthalidon-bij-hypertensie-met-gevorderde-ckd-nejm-click/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/10/26/patiromer-voor-spironolactongebruik-bij-resistente-hypertensie-met-ckd-lancet-am/","published":"2019-10-26"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rasha-k-al-lamee","type":"person","url":"https://hartvaat.nl/mensen/rasha-k-al-lamee/","name":"Rasha K Al-Lamee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/06/11/remote-beoordeling-na-acs-gerandomiseerde-trial/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjit-s-jolly","type":"person","url":"https://hartvaat.nl/mensen/sanjit-s-jolly/","name":"Sanjit S Jolly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2018/01/09/risico-s-van-overinterpretatie-van-interimdata-lessen-uit-de-total-trial/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scot-garg","type":"person","url":"https://hartvaat.nl/mensen/scot-garg/","name":"Scot Garg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/02/24/invloed-van-coronaire-ziekte-patronen-op-klinische-uitkomsten-pullback-pressure-/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sung-jin-hong","type":"person","url":"https://hartvaat.nl/mensen/sung-jin-hong/","name":"Sung-Jin Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrich-schotten","type":"person","url":"https://hartvaat.nl/mensen/ulrich-schotten/","name":"Ulrich Schotten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2026/06/02/smartphone-app-voor-symptoomregistratie-na-ablatie-bij-atriumfibrilleren-isolati/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2021/11/08/preoperatieve-tte-voor-voorspelling-van-postoperatief-af-meta-analyse/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vijay-kunadian","type":"person","url":"https://hartvaat.nl/mensen/vijay-kunadian/","name":"Vijay Kunadian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":15,"articles":[{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2016/06/21/strategieen-om-microvasculaire-obstructie-te-verminderen-bij-primaire-pci-relief/","published":"2016-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akiko-maehara","type":"person","url":"https://hartvaat.nl/mensen/akiko-maehara/","name":"Akiko Maehara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/03/02/intravasculaire-beeldvorming-bij-des-implantatie-lancet-netwerk-meta-analyse/","published":"2024-03-02"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2018/07/07/orbusneich-combo-stent-japan-usa-harmonee-gerandomiseerde-multicenter-trial/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"},{"url":"https://hartvaat.nl/2016/04/12/infarctgrootte-en-uitkomsten-na-primaire-pci-patientanalyse-uit-10-trials/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrzej-budaj","type":"person","url":"https://hartvaat.nl/mensen/andrzej-budaj/","name":"Andrzej Budaj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anoop-s-v-shah","type":"person","url":"https://hartvaat.nl/mensen/anoop-s-v-shah/","name":"Anoop S V Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/12/27/hoog-sensitief-troponine-statinetherapie-en-risico-op-coronairlijden/","published":"2016-12-27"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"biykem-bozkurt","type":"person","url":"https://hartvaat.nl/mensen/biykem-bozkurt/","name":"Biykem Bozkurt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/03/03/tien-jaar-real-world-sacubitril-valsartan-mortaliteitsreductie-bevestigd-maar-sl/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/04/27/2021-acc-aha-kerngegevenselementen-voor-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/12/06/comorbiditeiten-bij-hartfalen-hypertensie-obesitas-diabetes-hyperlipidemie-en-me/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-a-bergmark","type":"person","url":"https://hartvaat.nl/mensen/brian-a-bergmark/","name":"Brian A Bergmark","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/03/17/non-culprit-mi-na-pci-bij-acs/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-briguori","type":"person","url":"https://hartvaat.nl/mensen/carlo-briguori/","name":"Carlo Briguori","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/01/periprocedureel-mi-na-pci-en-langetermijnmortaliteit-meta-analyse/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/19/nierschade-na-minimale-contrasttoediening-bij-acs/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-torp-pedersen","type":"person","url":"https://hartvaat.nl/mensen/christian-torp-pedersen/","name":"Christian Torp-Pedersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/03/28/athena-post-hoc-dronedaron-als-effectieve-vroege-ritmecontrole/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/06/07/dagelijkse-telemonitoring-van-icd-s-gepoolde-analyse-van-drie-gerandomiseerde-tr/","published":"2017-06-07"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davide-capodanno","type":"person","url":"https://hartvaat.nl/mensen/davide-capodanno/","name":"Davide Capodanno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/08/18/glp-1-agonisten-verlagen-cardiovasculaire-risicos-bij-diabetes-en-obesitas-overz/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/02/ivus-versus-oct-versus-angiografie-voor-pci-begeleiding-meta-analyse/","published":"2024-04-02"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/04/17/geleide-versus-standaard-antiplaatjestherapie-na-pci-lancet-meta-analyse/","published":"2021-04-17"},{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dorairaj-prabhakaran","type":"person","url":"https://hartvaat.nl/mensen/dorairaj-prabhakaran/","name":"Dorairaj Prabhakaran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/09/01/pm2-5-blootstelling-versnelt-daling-van-egfr-bij-volwassenen/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/04/07/yoga-gebaseerde-hartrevalidatie-na-acuut-mi-gerandomiseerde-trial/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2019/03/01/ziekenhuisgebaseerde-kwaliteitsinterventies-bij-hartfalen-systematische-review/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/02/13/kwaliteitsverbeteringsinterventie-bij-acuut-mi-in-india-jama-acs-quik/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emilie-p-belley-cote","type":"person","url":"https://hartvaat.nl/mensen/emilie-p-belley-cote/","name":"Emilie P Belley-Côté","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2021/06/15/prevalentie-van-linkeratriumtrombus-bij-geanticoaguleerde-af-patienten/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2018/09/01/chirurgische-af-ablatie-systematische-review-en-meta-analyse-van-rct-s/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/05/08/vasopressine-plus-catecholamines-en-af-bij-distributieve-shock-jama-meta-analyse/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"g-kees-hovingh","type":"person","url":"https://hartvaat.nl/mensen/g-kees-hovingh/","name":"G Kees Hovingh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/05/01/ly3015014-een-nieuw-monoklonaal-pcsk9-antilichaam-gerandomiseerde-fase-2-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-esposito","type":"person","url":"https://hartvaat.nl/mensen/giovanni-esposito/","name":"Giovanni Esposito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/03/langetermijnwaarde-van-inspanningstesten-bij-hypertrofische-cardiomyopathie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2024/03/19/nierschade-na-minimale-contrasttoediening-bij-acs/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/10/14/tmao-als-cardiovasculaire-risicobiomarker-systematische-review-en-meta-analyse/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/01/01/ontwikkeling-van-linkerventrikelhypertrofie-bij-behandelde-hypertensie-campania-/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacob-eifer-moller","type":"person","url":"https://hartvaat.nl/mensen/jacob-eifer-moller/","name":"Jacob Eifer Møller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"},{"url":"https://hartvaat.nl/2021/10/01/aortaklepcalcificatie-en-cv-risicofactoren-bij-oudere-deense-mannen/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacob-thomsen-lonborg","type":"person","url":"https://hartvaat.nl/mensen/jacob-thomsen-lonborg/","name":"Jacob Thomsen Lønborg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-a-staessen","type":"person","url":"https://hartvaat.nl/mensen/jan-a-staessen/","name":"Jan A Staessen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/01/lichaamshouding-en-orthostatische-hypotensie-bij-hypertensie-syst-eur-analyse/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/08/01/antidiabetica-en-cardiovasculaire-geneeskunde-meta-analyse-en-perspectief/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2018/10/01/prognostische-waarde-van-gemaskeerd-ongecontroleerde-hypertensie/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jawad-h-butt","type":"person","url":"https://hartvaat.nl/mensen/jawad-h-butt/","name":"Jawad H Butt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeff-d-williamson","type":"person","url":"https://hartvaat.nl/mensen/jeff-d-williamson/","name":"Jeff D Williamson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/03/01/thuisbloeddruk-geleide-farmacotherapie-via-telezorg-meta-analyse-van-vs-trials/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ji-guang-wang","type":"person","url":"https://hartvaat.nl/mensen/ji-guang-wang/","name":"Ji-Guang Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/11/10/chinese-kruidenformule-voor-gemaskeerde-hypertensie-gerandomiseerde-placebogecon/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josef-kautzner","type":"person","url":"https://hartvaat.nl/mensen/josef-kautzner/","name":"Josef Kautzner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2025/10/07/cti-blok-na-pfa-versus-rf-cryo-ablatie-gerandomiseerde-vergelijking/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2018/07/01/echogeleide-versus-conventionele-femorale-venepunctie-bij-af-ablatie-gerandomise/","published":"2018-07-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"judith-s-hochman","type":"person","url":"https://hartvaat.nl/mensen/judith-s-hochman/","name":"Judith S Hochman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/09/01/routine-revascularisatie-versus-medicamenteus-bij-stabiel-coronairlijden-meta-an/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/07/01/thuisluchtzuivering-en-bloeddruk-systematische-review/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julio-rosenstock","type":"person","url":"https://hartvaat.nl/mensen/julio-rosenstock/","name":"Julio Rosenstock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2025/09/18/orforglipron-bij-vroeg-type-2-diabetes-nejm-fase-3/","published":"2025-09-18"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2023/09/07/orforglipron-dagelijkse-orale-glp-1-agonist-bij-obesitas-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","published":"2023-08-12"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/04/25/mk-0616-eerste-orale-pcsk9-remmer-in-fase-2b/","published":"2023-04-25"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2021/07/10/tirzepatide-bij-diabetes-type-2-lancet-surpass-1-fase-3/","published":"2021-07-10"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kavita-sharma","type":"person","url":"https://hartvaat.nl/mensen/kavita-sharma/","name":"Kavita Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/06/01/humain-hfpef-nieuwe-metabole-accelerator-bij-obesitas-hfpef-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-tsioufis","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-tsioufis/","name":"Konstantinos Tsioufis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/06/24/sglt2-remmers-en-bloeddrukdoelen-bij-hypertensief-hfpef-een-overzicht-van-richtl/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2026/02/26/lp-a-geassocieerd-met-microvasculaire-disfunctie-bij-niet-obstructief-coronairli/","published":"2026-03-10"},{"url":"https://hartvaat.nl/2025/07/14/hartfrequentieverlagende-middelen-en-uitkomsten-bij-hypertensie-cvd-meta-analyse/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2024/05/01/bloeddrukstreefwaarden-en-residueel-risico-systematische-review-en-meta-regressi/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-h-lund","type":"person","url":"https://hartvaat.nl/mensen/lars-h-lund/","name":"Lars H Lund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/04/07/confident-hfpef-machine-learning-voorspelt-sterfte-en-opname-beter-dan-bestaande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/03/27/nt-probnp-afkapwaarden-voor-hartfalentrials-optimaliseren-swedehf/","published":"2026-03-27"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/12/01/re-perfuse-relaxinereceptoragonist-en-renale-perfusie-bij-hfref-fase-1b/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/06/09/acyl-ghreline-verbetert-hartfunctie-bij-hartfalen/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2018/06/01/hemodynamische-effecten-van-levosimendan-bij-gevorderd-stabiel-chronisch-hartfal/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-j-budoff","type":"person","url":"https://hartvaat.nl/mensen/matthew-j-budoff/","name":"Matthew J Budoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/08/27/stop-semaglutide-vermindert-epicardiaal-vetweefsel-bij-type-2-diabetes/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/06/01/geisoleerde-diastolische-hypertensie-cohort-en-meta-analyse-voor-behandeldrempel/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/21/icosapent-ethyl-en-coronaire-atheroscleroseprogressie-bij-verhoogde-triglyceride/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2020/08/25/machine-learning-voor-lv-diastolische-functie-op-ecg/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2017/11/21/coronair-calcium-en-prognostische-waarde-bij-pijn-op-de-borst-promise-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melanie-j-davies","type":"person","url":"https://hartvaat.nl/mensen/melanie-j-davies/","name":"Melanie J Davies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/08/14/cagrisema-gecombineerd-cagrilintide-en-semaglutide-bij-overgewicht-nejm/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2022/01/01/sglt2-remmers-over-het-cv-ziektespectrum-overzicht/","published":"2022-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-azizi","type":"person","url":"https://hartvaat.nl/mensen/michel-azizi/","name":"Michel Azizi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/02/10/nieuwe-medicamenteuze-therapieen-voor-hypertensie/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/10/01/sequentiele-nefronblokkade-met-gecombineerde-diuretica-bij-resistente-hypertensi/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikaela-sjostrand","type":"person","url":"https://hartvaat.nl/mensen/mikaela-sjostrand/","name":"Mikaela Sjöstrand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/11/01/langetermijn-event-vrije-en-totale-overleving-met-dapagliflozine-bij-hfref-jama-/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milan-milojevic","type":"person","url":"https://hartvaat.nl/mensen/milan-milojevic/","name":"Milan Milojevic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2025/01/01/vroege-heropnames-na-chirurgische-aortaklepvervanging-beinvloeden-trial-eindpunt/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ofri-mosenzon","type":"person","url":"https://hartvaat.nl/mensen/ofri-mosenzon/","name":"Ofri Mosenzon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/08/29/orale-semaglutide-en-cv-uitkomsten-bij-diabetes-type-2-nejm-pioneer-6/","published":"2019-08-29"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-bij-diabetes-type-2-met-ckd-leader-renale-analyse/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ovidiu-dressler","type":"person","url":"https://hartvaat.nl/mensen/ovidiu-dressler/","name":"Ovidiu Dressler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-clemmensen","type":"person","url":"https://hartvaat.nl/mensen/peter-clemmensen/","name":"Peter Clemmensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-nir-uriel","type":"person","url":"https://hartvaat.nl/mensen/prof-nir-uriel/","name":"Prof. Nir Uriel","title":"Hoogleraar, Director Advanced HF en Harttransplantatie, Columbia University, New York, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/overleving-gevorderd-hartfalen-ouderen/","title":"Overleving bij gevorderd hartfalen — LVAD versus harttransplantatie bij middelbare en oudere patiënten"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-j-glynn","type":"person","url":"https://hartvaat.nl/mensen/robert-j-glynn/","name":"Robert J Glynn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2023/04/15/inflammatie-en-cholesterol-als-cv-voorspellers-onder-statinetherapie-lancet-anal/","published":"2023-04-15"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2020/08/14/il-6-crp-en-ldl-als-biomarkers-van-residueel-risico-vergelijking/","published":"2020-08-14"},{"url":"https://hartvaat.nl/2020/02/01/il-1-remming-en-bloeddruk-hypertensie-en-residueel-inflammatoir-risico-cantos/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2017/10/21/canakinumab-en-longkankerincidentie-bij-atherosclerose-lancet-cantos-exploratief/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/06/20/cholesteroleffluxcapaciteit-hdl-deeltjesaantal-en-cv-events-jupiter-analyse/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/06/01/voedingsstatus-en-langetermijn-multivitaminegebruik-en-cv-risico-phs-ii-analyse/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2016/05/01/lipoproteinen-insulineresistentie-en-rosuvastatine-bij-incident-type-2-diabetes/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rolf-wachter","type":"person","url":"https://hartvaat.nl/mensen/rolf-wachter/","name":"Rolf Wachter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/02/01/diabetes-en-sacubitril-valsartan-titratie-bij-hartfalen-na-opname/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/12/01/baseline-parameters-en-1-jaars-qol-bij-hf-na-crt-d-esc-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2021/11/16/sacubitril-valsartan-versus-standaardtherapie-op-nt-probnp-en-inspanningscapacit/","published":"2021-11-16"},{"url":"https://hartvaat.nl/2021/05/01/screening-op-af-bij-ouderen-jama-cardiology-gerandomiseerde-trial/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/06/01/economische-impact-van-hfpef-aldo-dhf-inzichten/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sasko-kedev","type":"person","url":"https://hartvaat.nl/mensen/sasko-kedev/","name":"Sasko Kedev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sidney-c-smith","type":"person","url":"https://hartvaat.nl/mensen/sidney-c-smith/","name":"Sidney C Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2022/10/04/2022-acc-expert-consensus-niet-statine-therapieen-voor-ldl-verlaging-bij-ascvd/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2017/10/03/2017-acc-gerichte-update-niet-statinetherapie-voor-ldl-verlaging/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simone-biscaglia","type":"person","url":"https://hartvaat.nl/mensen/simone-biscaglia/","name":"Simone Biscaglia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-willems","type":"person","url":"https://hartvaat.nl/mensen/stephan-willems/","name":"Stephan Willems","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2021/03/08/katheterablatie-om-af-progressie-te-vertragen-attest-gerandomiseerde-trial/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/01/01/energiebron-en-vroeg-af-recidief-cryoballon-versus-radiofrequentie/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-j-greene","type":"person","url":"https://hartvaat.nl/mensen/stephen-j-greene/","name":"Stephen J Greene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/05/19/sglt2-remmers-bij-oudere-patienten-opgenomen-voor-hfref-24-sterfte-en-16-heropna/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2026/02/03/intraveneus-ijzer-bij-hartfalen-met-ijzertekort-meta-analyse-met-trial-sequentie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-uitgebreide-fda-labeling-jama-cardiology-implicaties/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/06/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-acs-trials-jama-cardiology/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/03/01/poliklinische-verslechtering-van-hartfalen-als-therapiedoel-jama-cardiology-revi/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2017/11/01/raas-blokkade-bij-hfpef-systematische-review-en-meta-analyse/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sren-rasmussen","type":"person","url":"https://hartvaat.nl/mensen/sren-rasmussen/","name":"Søren Rasmussen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2019/12/01/eerste-en-recidiverende-cv-events-met-liraglutide-bij-diabetes-type-2-leader/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tabassome-simon","type":"person","url":"https://hartvaat.nl/mensen/tabassome-simon/","name":"Tabassome Simon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/11/17/seh-zorgbundel-en-30-daags-ontslag-en-overleving-bij-oudere-hf-patienten-jama/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"venu-menon","type":"person","url":"https://hartvaat.nl/mensen/venu-menon/","name":"Venu Menon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/03/05/gelijktijdige-laa-occlusie-en-tavr-bij-af-haalbaarheid/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wang","type":"person","url":"https://hartvaat.nl/mensen/wang/","name":"Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/04/10/subklinische-atherosclerose-bij-vrouwen-na-pre-eclampsie-systematische-review-en/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/10/proteomics-onthult-vier-subgroepen-van-acuut-hfpef-met-eigen-biologische-routes-/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/17/verhoogd-crp-voorspelt-hartfalen-bij-kankeroverlevenden-uk-biobank/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/05/26/asymptomatische-matige-ernstige-aortaklepinsufficientie-niet-benigne-meta-analys/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/04/24/astma-geassocieerd-met-verhoogd-risico-op-degeneratieve-hartklepziekte-uk-bioban/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/04/24/cardiovasculaire-ziekte-bij-sikkelcelziekte-ondergediagnosticeerde-drijver-van-m/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/03/25/geleidelijk-afbouwen-van-rilonacept-bij-recidiverende-pericarditis-voorkomt-vake/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/26/hiv-infectie-hangt-onafhankelijk-samen-met-meer-en-kwetsbaardere-halsslagaderpla/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2026/02/12/ct-coronairangiografie-bij-nstemi-uitstekende-diagnostische-nauwkeurigheid-maar-/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/02/machine-learning-nomogram-voorspelt-vroeg-transplantaatfalen-na-harttransplantat/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2026/01/30/off-label-lage-dosis-bloedplaatjesremmers-bij-coronairlijden-minder-infarcten-en/","published":"2026-01-30"},{"url":"https://hartvaat.nl/2026/01/29/lineaire-ablatie-van-de-voorwand-van-het-linkeratrium-vermindert-af-recidieven-b/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/09/littekenweefsel-voorspelt-plotse-hartdood-na-een-infarct-grotendeels-buiten-de-e/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-li","type":"person","url":"https://hartvaat.nl/mensen/yan-li/","name":"Yan Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":14,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/effect-van-baduanjin-op-bloeddruk-bij-hoog-normaal-bloeddruk-gerandomiseerde-tri/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/11/10/chinese-kruidenformule-voor-gemaskeerde-hypertensie-gerandomiseerde-placebogecon/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-d-devore","type":"person","url":"https://hartvaat.nl/mensen/adam-d-devore/","name":"Adam D DeVore","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/10/24/inhalatief-epoprostenol-versus-no-bij-rechterventrikel-falen-na-hartchirurgie/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2020/09/01/arni-naar-hf-voorgeschiedenis-en-raas-antagonistgebruik/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/02/01/arni-initiatie-na-acuut-gedecompenseerd-hf-pioneer-hf-open-label-extensie/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/07/angiotensine-neprilysineremming-bij-acuut-gedecompenseerd-hf-nejm-pioneer-hf/","published":"2019-02-07"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alain-cohen-solal","type":"person","url":"https://hartvaat.nl/mensen/alain-cohen-solal/","name":"Alain Cohen-Solal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/12/01/vericiguat-en-nt-probnp-bij-hfref-victoria-subanalyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-p-benz","type":"person","url":"https://hartvaat.nl/mensen/alexander-p-benz/","name":"Alexander P Benz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/01/neurofilament-light-chain-en-cva-risico-bij-af/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/07/mra-s-verminderen-af-risico-meta-analyse-van-klinische-trials/","published":"2024-03-07"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2021/05/01/screening-op-af-bij-ouderen-jama-cardiology-gerandomiseerde-trial/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/10/01/quadripolaire-versus-bipolaire-lv-leads-bij-crt-klinische-uitkomsten/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-p-ambrosy","type":"person","url":"https://hartvaat.nl/mensen/andrew-p-ambrosy/","name":"Andrew P Ambrosy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/30/kp-chemo-cumulatieve-incidentie-cancer-therapy-related-cardiac-dysfunction-8-4-h/","published":"2026-07-02"},{"url":"https://hartvaat.nl/2026/05/25/het-spectrum-van-congestie-bij-hartfalen-pathofysiologie-en-diagnostische-strate/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/04/01/intraveneus-ijzer-bij-hartfalen-meta-analyse-op-studieniveau/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/09/01/arni-naar-hf-voorgeschiedenis-en-raas-antagonistgebruik/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/02/01/arni-initiatie-na-acuut-gedecompenseerd-hf-pioneer-hf-open-label-extensie/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/07/angiotensine-neprilysineremming-bij-acuut-gedecompenseerd-hf-nejm-pioneer-hf/","published":"2019-02-07"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atul-verma","type":"person","url":"https://hartvaat.nl/mensen/atul-verma/","name":"Atul Verma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/10/31/vrouwen-met-persisterend-af-pvi-alleen-is-onvoldoende/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2023/05/30/complicaties-van-af-ablatie-actueel-overzicht/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"baris-gencer","type":"person","url":"https://hartvaat.nl/mensen/baris-gencer/","name":"Baris Gencer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/17/schildklierdisfunctie-en-hart-en-vaatziekten-ehj-overzicht/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/12/21/langdurige-omega-3-suppletie-en-af-risico-meta-analyse-van-cv-trials/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/11/21/ldl-verlaging-bij-ouderen-lancet-meta-analyse-werkzaamheid-en-veiligheid/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-david-mazer","type":"person","url":"https://hartvaat.nl/mensen/c-david-mazer/","name":"C David Mazer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2021/12/01/sglt2-remmers-en-cardiale-remodellering-meta-analyse-van-mri-trials/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/04/01/restrictieve-versus-liberale-transfusie-bij-hartchirurgie-meta-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2018/01/23/empagliflozine-bij-diabetes-type-2-met-perifeer-vaatlijden-empa-reg-outcome/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"craig-s-anderson","type":"person","url":"https://hartvaat.nl/mensen/craig-s-anderson/","name":"Craig S Anderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2017/07/11/positieve-luchtwegdruk-en-cv-events-bij-slaapapneu-jama-meta-analyse/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dariusz-dudek","type":"person","url":"https://hartvaat.nl/mensen/dariusz-dudek/","name":"Dariusz Dudek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-h-birnie","type":"person","url":"https://hartvaat.nl/mensen/david-h-birnie/","name":"David H Birnie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/02/01/sekse-en-gender-in-crt-studies-systematische-review/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/02/01/elektrische-versus-farmacologische-cardioversie-bij-acuut-af-op-de-seh-lancet-ra/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"denis-xavier","type":"person","url":"https://hartvaat.nl/mensen/denis-xavier/","name":"Denis Xavier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2023/02/01/aspirine-en-cardiovasculaire-uitkomsten-bij-chronische-nierziekte/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dirk-sibbing","type":"person","url":"https://hartvaat.nl/mensen/dirk-sibbing/","name":"Dirk Sibbing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"do-yoon-kang","type":"person","url":"https://hartvaat.nl/mensen/do-yoon-kang/","name":"Do-Yoon Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donald-m-lloyd-jones","type":"person","url":"https://hartvaat.nl/mensen/donald-m-lloyd-jones/","name":"Donald M Lloyd-Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2022/10/04/2022-acc-expert-consensus-niet-statine-therapieen-voor-ldl-verlaging-bij-ascvd/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/02/13/kwaliteitsverbeteringsinterventie-bij-acuut-mi-in-india-jama-acs-quik/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/10/03/2017-acc-gerichte-update-niet-statinetherapie-voor-ldl-verlaging/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2017/02/01/bereikte-bloeddruk-en-cardiovasculaire-uitkomsten-bij-oudere-patienten-met-geiso/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edgar-pete-r-miller","type":"person","url":"https://hartvaat.nl/mensen/edgar-pete-r-miller/","name":"Edgar Pete R Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/01/06/gofresh-dash-boodschappen-en-bloeddrukeffect-rct/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/07/16/rich-life-gelijkwaardige-hypertensiezorg-voor-achtergestelde-populaties/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/11/01/rustduur-voor-bloeddrukmeting-best-rest-trial/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/06/01/dieet-en-natriumreductie-op-cardiale-schade-en-inflammatie-dash-sodium/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/03/01/natriumreductie-en-energie-metabolisme-gewicht-en-dorst-dash-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/01/hypertensiebehandeling-en-orthostatische-hypotensie-relatie-met-cv-ziekte/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/12/12/natriumreductie-en-dash-dieet-naar-uitgangs-bloeddruk/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/11/01/tijdsverloop-van-bloeddrukverandering-door-zoutreductie-en-dash-dieet/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-boersma","type":"person","url":"https://hartvaat.nl/mensen/eric-boersma/","name":"Eric Boersma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/28/geen-sekseverschillen-in-werkzaamheid-van-hartfalenmedicatie-meta-analyse-van-13/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/telemonitoring-bij-hartfalen-meta-analyse-van-alle-strategieen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2019/10/01/telemedicine-en-mortaliteit-bij-acuut-mi-systematische-review-en-meta-analyse/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2018/03/01/twee-geavanceerde-en-verlengde-hartrevalidatieprogramma-s-gerandomiseerde-trial/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2016/09/27/intensieve-glucoseregulatie-bij-hyperglycemisch-acs-langetermijnfollow-up-biomar/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/01/05/ct-coronairangiografie-bij-verdenking-acs-in-het-tijdperk-van-hoog-sensitief-tro/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-d-peterson","type":"person","url":"https://hartvaat.nl/mensen/eric-d-peterson/","name":"Eric D Peterson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/12/01/cardiovasculaire-risicocommunicatie-en-patientperceptie-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gad-cotter","type":"person","url":"https://hartvaat.nl/mensen/gad-cotter/","name":"Gad Cotter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/03/16/natrium-hf-subanalyse-natriuretische-peptiden-lopen-achter-op-de-klinische-ontst/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/12/01/gelijktijdige-griep-en-rsv-vaccinatie-bij-hoogrisico-hartfalenpatienten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gaetano-m-de-ferrari","type":"person","url":"https://hartvaat.nl/mensen/gaetano-m-de-ferrari/","name":"Gaetano M De Ferrari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/04/29/vroege-iabp-bij-hartfalen-gerelateerde-cardiogene-shock-gerandomiseerde-trial/","published":"2025-04-29"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/12/09/ideale-blankingperiode-na-af-ablatie-bewijs-voor-herziening/","published":"2022-12-09"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"glenn-m-chertow","type":"person","url":"https://hartvaat.nl/mensen/glenn-m-chertow/","name":"Glenn M Chertow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/01/01/dialysaat-kalium-3-0-mmol-l-met-natriumzirconiumcyclosilicaat-bij-dialyse/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2019/10/01/bardoxolone-en-urine-albumine-creatinine-ratio-bij-diabetes-met-ckd-stadium-4/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"graham-s-hillis","type":"person","url":"https://hartvaat.nl/mensen/graham-s-hillis/","name":"Graham S Hillis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2026/02/23/pathfinder-trial-betere-naleving-van-hartfalenrichtlijnen-in-de-huisartsenprakti/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henning-kelbk","type":"person","url":"https://hartvaat.nl/mensen/henning-kelbk/","name":"Henning Kelbæk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ibrahim-akin","type":"person","url":"https://hartvaat.nl/mensen/ibrahim-akin/","name":"Ibrahim Akin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/07/laa-occlusie-bij-terminale-nierziekte-ipd-meta-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-a-de-lemos","type":"person","url":"https://hartvaat.nl/mensen/james-a-de-lemos/","name":"James A de Lemos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2024/09/16/tirzepatide-en-bloeddrukverlaging-surmount-1-gestratificeerde-analyse/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2016/08/01/sedentair-gedrag-en-cardiovasculair-risico-continue-dosis-responsrelatie-in-meta/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-c-fang","type":"person","url":"https://hartvaat.nl/mensen/james-c-fang/","name":"James C Fang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2024/10/15/aha-scientific-statement-nierdisfunctie-bij-gevorderd-hartfalen/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-biegus","type":"person","url":"https://hartvaat.nl/mensen/jan-biegus/","name":"Jan Biegus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/06/26/machine-learning-voorspelt-diureticumrespons-bij-acuut-hartfalen-drc-ahf/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/05/26/adipokineprofiel-bij-acuut-hartfalen-voorspelt-natriuretische-respons-en-mortali/","published":"2026-05-30"},{"url":"https://hartvaat.nl/2026/05/10/delta-hf-thoracale-duct-lymfedecongestie-via-elym-systeem-haalbaar-bij-acute-har/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/03/expertopinie-hierarchische-eindpunten-op-basis-van-verslechterend-hartfalen-voor/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/12/01/gelijktijdige-griep-en-rsv-vaccinatie-bij-hoogrisico-hartfalenpatienten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-j-piek","type":"person","url":"https://hartvaat.nl/mensen/jan-j-piek/","name":"Jan J Piek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeehoon-kang","type":"person","url":"https://hartvaat.nl/mensen/jeehoon-kang/","name":"Jeehoon Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-b-green","type":"person","url":"https://hartvaat.nl/mensen/jennifer-b-green/","name":"Jennifer B Green","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2018/10/27/albiglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-harmony-ou/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jing-li","type":"person","url":"https://hartvaat.nl/mensen/jing-li/","name":"Jing Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/12/01/klebsiella-pneumoniae-als-mogelijke-oorzaak-van-hypertensie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/08/09/vertraagde-afgifteformulering-van-ivabradine-bij-systolisch-hartfalen/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/07/27/veiligheid-van-pcsk9-remmers-systematische-review-en-meta-analyse/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-a-cairns","type":"person","url":"https://hartvaat.nl/mensen/john-a-cairns/","name":"John A Cairns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2018/01/09/risico-s-van-overinterpretatie-van-interimdata-lessen-uit-de-total-trial/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josep-comin-colet","type":"person","url":"https://hartvaat.nl/mensen/josep-comin-colet/","name":"Josep Comin-Colet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/17/atriumfibrilleren-in-catalonie-prevalentie-gestabiliseerd-incidentie-gedaald-2-v/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jung-sun-kim","type":"person","url":"https://hartvaat.nl/mensen/jung-sun-kim/","name":"Jung-Sun Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kerry-l-lee","type":"person","url":"https://hartvaat.nl/mensen/kerry-l-lee/","name":"Kerry L Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/11/21/coronair-calcium-en-prognostische-waarde-bij-pijn-op-de-borst-promise-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/06/01/primaire-preventie-icd-bij-niet-ischemische-cardiomyopathie-meta-analyse/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyeong-ho-yun","type":"person","url":"https://hartvaat.nl/mensen/kyeong-ho-yun/","name":"Kyeong Ho Yun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyung-woo-park","type":"person","url":"https://hartvaat.nl/mensen/kyung-woo-park/","name":"Kyung Woo Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-billot","type":"person","url":"https://hartvaat.nl/mensen/laurent-billot/","name":"Laurent Billot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2026/01/20/voorspelling-van-individuele-corticosteroidrespons-bij-iga-nefropathie-testing-t/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lawrence-j-appel","type":"person","url":"https://hartvaat.nl/mensen/lawrence-j-appel/","name":"Lawrence J Appel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/07/01/metabolomics-en-bloeddrukrespons-op-dash-dieet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2021/11/01/rustduur-voor-bloeddrukmeting-best-rest-trial/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/06/01/dieet-en-natriumreductie-op-cardiale-schade-en-inflammatie-dash-sodium/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/03/01/natriumreductie-en-energie-metabolisme-gewicht-en-dorst-dash-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/01/21/voedingscholesterol-en-cv-risico-aha-science-advisory/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2018/10/01/hypertensiebehandeling-en-orthostatische-hypotensie-relatie-met-cv-ziekte/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/05/01/natriuminname-en-bloeddruk-varieren-met-energie-inname-dash-secundaire-analyse/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/12/12/natriumreductie-en-dash-dieet-naar-uitgangs-bloeddruk/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/11/01/tijdsverloop-van-bloeddrukverandering-door-zoutreductie-en-dash-dieet/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/10/11/natriuminname-en-totale-mortaliteit-over-20-jaar-trials-of-hypertension-preventi/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-cohen","type":"person","url":"https://hartvaat.nl/mensen/marc-cohen/","name":"Marc Cohen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/12/protonpompremmers-verminderen-gastro-intestinale-events-ongeacht-aspirinedosis-b/","published":"2016-04-12"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/03/15/plaatjesremming-met-ticagrelor-60-mg-versus-90-mg-in-de-pegasus-timi-54-trial/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-markus-schlaich","type":"person","url":"https://hartvaat.nl/mensen/prof-markus-schlaich/","name":"Markus Schlaich","title":"Nefroloog en hypertensiespecialist, Royal Perth Hospital en University of Western Australia","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"}],"videos":[{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/kernboodschappen/","title":"Kernboodschappen"},{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/onvervulde-behoeften-hypertensie-aldosteron/","title":"Onvervulde behoeften bij hypertensie en de rol van aldosteron"},{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/bax-htn-resultaten/","title":"Bax-HTN studieresultaten"},{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/bax-htn-implicaties-praktijk/","title":"De Bax-HTN resultaten en implicaties voor de praktijk"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-fahy","type":"person","url":"https://hartvaat.nl/mensen/martin-fahy/","name":"Martin Fahy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/01/07/verminderd-bloeddrukverlagend-effect-van-renale-denervatie-bij-geisoleerde-systo/","published":"2017-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-m-van-mieghem","type":"person","url":"https://hartvaat.nl/mensen/nicolas-m-van-mieghem/","name":"Nicolas M Van Mieghem","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/08/18/echocardiografie-overschatte-drukgradienten-na-tav-in-tav-met-ballon-expandable-/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/08/14/hartfalen-mondiale-economische-ziektelast/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2025/04/01/socio-economische-ongelijkheid-en-hartfalenuitkomsten-systematische-review/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/10/01/natuurlijk-beloop-van-asymptomatische-ernstige-aortastenose-jama-cardiology-meta/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"p-christian-schulze","type":"person","url":"https://hartvaat.nl/mensen/p-christian-schulze/","name":"P Christian Schulze","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/07/26/empag-hf-vroege-empagliflozine-bij-acuut-hartfalen-verbetert-diurese/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrice-desvigne-nickens","type":"person","url":"https://hartvaat.nl/mensen/patrice-desvigne-nickens/","name":"Patrice Desvigne-Nickens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2023/08/24/reprieve-pitavastatine-vermindert-cv-events-bij-hiv-nejm/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-d-o-kane","type":"person","url":"https://hartvaat.nl/mensen/peter-d-o-kane/","name":"Peter D O'Kane","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-m-kistler","type":"person","url":"https://hartvaat.nl/mensen/peter-m-kistler/","name":"Peter M Kistler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2021/07/18/procedurevolume-en-complicaties-bij-af-ablatie-meta-analyse/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2018/07/01/rotorablatie-bij-atriumfibrilleren-systematische-review/","published":"2018-07-01"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-r-sinnaeve","type":"person","url":"https://hartvaat.nl/mensen/peter-r-sinnaeve/","name":"Peter R Sinnaeve","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/05/26/subcutaan-selatogrel-remt-plaatjesaggregatie-bij-acuut-mi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2019/01/02/preventie-van-cardiogene-shock-na-acuut-mi/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"remo-h-m-furtado","type":"person","url":"https://hartvaat.nl/mensen/remo-h-m-furtado/","name":"Remo H M Furtado","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/03/16/plaatjesreactiviteit-bij-acs-in-afwachting-van-chirurgische-revascularisatie/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/28/morfine-en-cv-uitkomsten-bij-nste-acs-jacc-analyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-a-shlofmitz","type":"person","url":"https://hartvaat.nl/mensen/richard-a-shlofmitz/","name":"Richard A Shlofmitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-p-whitlock","type":"person","url":"https://hartvaat.nl/mensen/richard-p-whitlock/","name":"Richard P Whitlock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2019/08/01/vernakalant-voor-cardioversie-van-recent-onset-af-meta-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2018/09/01/chirurgische-af-ablatie-systematische-review-en-meta-analyse-van-rct-s/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/05/08/vasopressine-plus-catecholamines-en-af-bij-distributieve-shock-jama-meta-analyse/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robbert-j-de-winter","type":"person","url":"https://hartvaat.nl/mensen/robbert-j-de-winter/","name":"Robbert J de Winter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/01/bloeddruk-na-stenting-bij-aortacoarctatie-systematische-review-en-meta-analyse/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/12/05/j-curve-bij-gerandomiseerde-bloeddrukstreefwaarden-sprint-experimentele-analyse/","published":"2017-12-05"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/04/18/vroeg-invasief-versus-selectieve-strategie-bij-nste-acs-ictus-trial-langetermijn/","published":"2017-04-18"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-ho-hur","type":"person","url":"https://hartvaat.nl/mensen/seung-ho-hur/","name":"Seung-Ho Hur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2018/04/01/valsartan-en-linkerkamerremodellering-na-mi/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shelley-zieroth","type":"person","url":"https://hartvaat.nl/mensen/shelley-zieroth/","name":"Shelley Zieroth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steen-pehrson","type":"person","url":"https://hartvaat.nl/mensen/steen-pehrson/","name":"Steen Pehrson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/07/01/qt-als-voorspeller-van-af-recidief-na-ablatie-en-amiodaronimpact-amio-cat/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-p-juraschek","type":"person","url":"https://hartvaat.nl/mensen/stephen-p-juraschek/","name":"Stephen P Juraschek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/01/06/gofresh-dash-boodschappen-en-bloeddrukeffect-rct/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/04/01/hypotensieve-episodes-op-24-uurs-abpm-en-cognitieve-functie-sprint-inzichten/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/04/01/lichaamshouding-en-orthostatische-hypotensie-bij-hypertensie-syst-eur-analyse/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2021/06/01/dieet-en-natriumreductie-op-cardiale-schade-en-inflammatie-dash-sodium/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/05/01/langetermijnvoordeel-van-intensieve-bloeddrukcontrole-op-resterende-levensduur-s/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/03/01/natriumreductie-en-energie-metabolisme-gewicht-en-dorst-dash-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/10/01/antihypertensivaklasse-en-vallen-syncope-en-orthostatische-hypotensie-bij-oudere/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2018/10/01/hypertensiebehandeling-en-orthostatische-hypotensie-relatie-met-cv-ziekte/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/12/12/natriumreductie-en-dash-dieet-naar-uitgangs-bloeddruk/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/11/01/tijdsverloop-van-bloeddrukverandering-door-zoutreductie-en-dash-dieet/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stuart-j-head","type":"person","url":"https://hartvaat.nl/mensen/stuart-j-head/","name":"Stuart J Head","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/10/01/natuurlijk-beloop-van-asymptomatische-ernstige-aortastenose-jama-cardiology-meta/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sukhjinder-s-nijjer","type":"person","url":"https://hartvaat.nl/mensen/sukhjinder-s-nijjer/","name":"Sukhjinder S Nijjer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/01/ffr-versus-ifr-bij-coronaire-revascularisatie-vijfjaars-follow-up/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"timothy-d-henry","type":"person","url":"https://hartvaat.nl/mensen/timothy-d-henry/","name":"Timothy D Henry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2023/03/07/mesenchymale-precursorcellen-bij-hfref-gerandomiseerde-trial/","published":"2023-03-07"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/09/15/ami-management-tijdens-covid-19-scai-positiedocument/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/06/11/ixmyelocel-t-bij-ischemisch-hartfalen-lancet-dubbelblinde-gerandomiseerde-trial/","published":"2016-06-11"},{"url":"https://hartvaat.nl/2016/05/01/intracoronaire-adenylylcyclase-6-gentherapie-bij-hartfalen-gerandomiseerde-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valentina-kutyifa","type":"person","url":"https://hartvaat.nl/mensen/valentina-kutyifa/","name":"Valentina Kutyifa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2017/11/01/klinische-presentatie-bij-eerste-hartfalenhospitalisatie-voorspelt-geen-heropnam/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/05/16/comorbiditeiten-en-crt-respons-madit-crt-langetermijnfollow-up/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/20/volledig-linkszijdig-reverse-remodelling-bij-crt-madit-crt-substudie/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/01/26/relatieve-wanddikte-en-risico-op-ventriculaire-tachyaritmieen-bij-linkerkamerdis/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"w-h-wilson-tang","type":"person","url":"https://hartvaat.nl/mensen/w-h-wilson-tang/","name":"W H Wilson Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2024/10/15/aha-scientific-statement-nierdisfunctie-bij-gevorderd-hartfalen/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/02/28/myocardiaal-herstel-bij-systolisch-hartfalen-met-auto-antilichamen-tegen-1-adren/","published":"2017-02-28"},{"url":"https://hartvaat.nl/2016/05/17/verminderde-cardiac-index-is-niet-de-primaire-oorzaak-van-nierdisfunctie-bij-har/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"waheed-jamal","type":"person","url":"https://hartvaat.nl/mensen/waheed-jamal/","name":"Waheed Jamal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-e-boden","type":"person","url":"https://hartvaat.nl/mensen/william-e-boden/","name":"William E Boden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/02/23/het-jaar-in-de-cardiovasculaire-geneeskunde-2025-top-10-publicaties-ischemische-/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/13/traverse-testosteronsubstitutie-cardiovasculair-veilig-bij-hypogonadisme/","published":"2023-07-13"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/04/30/leefstijl-hba1c-en-overleving-bij-stabiel-coronairlijden-met-diabetes/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wojciech-wojakowski","type":"person","url":"https://hartvaat.nl/mensen/wojciech-wojakowski/","name":"Wojciech Wojakowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":13,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/02/26/cardiogene-shock-bij-myocardinfarct-resultaten-van-het-shock-pol-register/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/03/levosimendan-infusies-en-klinisch-beloop-bij-hartfalen-levo-d-resultaten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-p-bress","type":"person","url":"https://hartvaat.nl/mensen/adam-p-bress/","name":"Adam P Bress","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukcontrole-en-cerebrale-small-vessel-disease-markers/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2023/08/01/combinatietabletten-voor-intensieve-bloeddrukbehandeling-sprint-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2016/02/09/generaliseerbaarheid-van-sprint-resultaten-naar-de-algemene-bevolking/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"agneta-siegbahn","type":"person","url":"https://hartvaat.nl/mensen/agneta-siegbahn/","name":"Agneta Siegbahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/04/01/fibrinestoleigenschappen-en-klinische-uitkomsten-na-acs-plato-substudie/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"albertino-damasceno","type":"person","url":"https://hartvaat.nl/mensen/albertino-damasceno/","name":"Albertino Damasceno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-ana-maria-cebrian-cuenca","type":"person","url":"https://hartvaat.nl/mensen/dr-ana-maria-cebrian-cuenca/","name":"Ana María Cebrián Cuenca","title":"Huisarts, Murcia; Universitair docent, Miguel Hernández Universiteit, Spanje","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/kernboodschappen/","title":"Kernboodschappen"},{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/onvervulde-behoeften-hypertensie-aldosteron/","title":"Onvervulde behoeften bij hypertensie en de rol van aldosteron"},{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/bax-htn-resultaten/","title":"Bax-HTN studieresultaten"},{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/bax-htn-implicaties-praktijk/","title":"De Bax-HTN resultaten en implicaties voor de praktijk"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-metzner","type":"person","url":"https://hartvaat.nl/mensen/andreas-metzner/","name":"Andreas Metzner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2023/05/19/east-afnet-4-vroege-ritmecontrole-bij-af-is-kosteneffectief/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-s-p-sharp","type":"person","url":"https://hartvaat.nl/mensen/andrew-s-p-sharp/","name":"Andrew S P Sharp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-franzone","type":"person","url":"https://hartvaat.nl/mensen/anna-franzone/","name":"Anna Franzone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2017/10/14/tmao-als-cardiovasculaire-risicobiomarker-systematische-review-en-meta-analyse/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-colombo","type":"person","url":"https://hartvaat.nl/mensen/antonio-colombo/","name":"Antonio Colombo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arnoud-w-j-van-t-hof","type":"person","url":"https://hartvaat.nl/mensen/arnoud-w-j-van-t-hof/","name":"Arnoud W J van 't Hof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/07/01/1-jaarsmortaliteit-bivalirudine-versus-heparine-in-de-ambulance-bij-stemi-matrix/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernhard-witzenbichler","type":"person","url":"https://hartvaat.nl/mensen/bernhard-witzenbichler/","name":"Bernhard Witzenbichler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beth-a-davison","type":"person","url":"https://hartvaat.nl/mensen/beth-a-davison/","name":"Beth A Davison","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/03/16/natrium-hf-subanalyse-natriuretische-peptiden-lopen-achter-op-de-klinische-ontst/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmelo-a-milano","type":"person","url":"https://hartvaat.nl/mensen/carmelo-a-milano/","name":"Carmelo A Milano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2023/10/24/inhalatief-epoprostenol-versus-no-bij-rechterventrikel-falen-na-hartchirurgie/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/02/02/intrapericardiale-lvad-bij-gevorderd-hartfalen-nejm/","published":"2017-02-02"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chern-en-chiang","type":"person","url":"https://hartvaat.nl/mensen/chern-en-chiang/","name":"Chern-En Chiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/05/14/verlaagde-dosis-doac-bij-af-werkzaamheid-en-veiligheid-meta-analyse/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chris-p-gale","type":"person","url":"https://hartvaat.nl/mensen/chris-p-gale/","name":"Chris P Gale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2026/03/25/meta-analyse-glp-1-agonisten-voorkomen-hartfalen-in-type-2-diabetes-sterkste-eff/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/09/01/timing-van-invasieve-strategie-bij-nste-acs-meta-analyse-van-rct-s/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/06/10/voorspelling-van-atriumfibrilleren-in-elektronische-gezondheidsdossiers-systemat/","published":"2022-06-10"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2021/03/01/langetermijn-overlevingsvoordeel-van-ramipril-bij-mi-met-hf/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chul-min-ahn","type":"person","url":"https://hartvaat.nl/mensen/chul-min-ahn/","name":"Chul-Min Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clemens-von-birgelen","type":"person","url":"https://hartvaat.nl/mensen/clemens-von-birgelen/","name":"Clemens von Birgelen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2020/04/25/clopidogrel-versus-ticagrelor-of-prasugrel-bij-70-plussers-met-nste-acs-lancet-p/","published":"2020-04-25"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-w-jones","type":"person","url":"https://hartvaat.nl/mensen/daniel-w-jones/","name":"Daniel W Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-a-mcallister","type":"person","url":"https://hartvaat.nl/mensen/david-a-mcallister/","name":"David A McAllister","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/07/kosteneffectiviteit-van-stapsgewijze-lipidenverlaging-na-coronaire-bypasschirurg/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2025/03/25/leeftijds-en-sekseverschillen-in-effectiviteit-van-diabetesbehandeling-netwerk-m/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/04/01/sekseverschillen-in-effectiviteit-van-orale-p2y12-remmers-meta-analyse/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/12/27/hoog-sensitief-troponine-statinetherapie-en-risico-op-coronairlijden/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-kallend","type":"person","url":"https://hartvaat.nl/mensen/david-kallend/","name":"David Kallend","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2024/09/01/lerodalcibep-bij-ascvd-of-hoog-risico-fase-3-resultaten/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/10/21/lerodalcibep-bij-familiaire-hypercholesterolemie-liberate-hefh-langetermijndata/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-fase-3-bij-verhoogd-ldl-nejm-orion-10-en-orion-11/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2019/11/01/inclisiran-1-of-2-dosis-en-ldl-cholesterol-orion-1-1-jaarsfollow-up/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/09/25/sirna-tegen-pcsk9-en-atherogene-lipoproteinen-orion-1-secundaire-eindpunten/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"},{"url":"https://hartvaat.nl/2017/01/05/inclisiran-een-langwerkende-rna-interferentie-pcsk9-remmer-nejm/","published":"2017-01-05"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-z-i-cherney","type":"person","url":"https://hartvaat.nl/mensen/david-z-i-cherney/","name":"David Z I Cherney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/01/dapagliflozine-bij-cv-risico-met-zonder-diabetes-cardiorenale-effecten/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2022/08/09/renale-en-vasculaire-effecten-van-gecombineerde-sglt2-en-ace-remming/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2019/08/01/empagliflozine-voorkomt-progressie-van-ckd-empa-reg-outcome-renale-analyse/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donghoon-choi","type":"person","url":"https://hartvaat.nl/mensen/donghoon-choi/","name":"Donghoon Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"doyeon-hwang","type":"person","url":"https://hartvaat.nl/mensen/doyeon-hwang/","name":"Doyeon Hwang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"efthymios-n-deliargyris","type":"person","url":"https://hartvaat.nl/mensen/efthymios-n-deliargyris/","name":"Efthymios N Deliargyris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/07/01/1-jaarsmortaliteit-bivalirudine-versus-heparine-in-de-ambulance-bij-stemi-matrix/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/20/bloedingen-voor-coronairangiografie-bij-nste-acs/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elaine-m-hylek","type":"person","url":"https://hartvaat.nl/mensen/elaine-m-hylek/","name":"Elaine M Hylek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elmir-omerovic","type":"person","url":"https://hartvaat.nl/mensen/elmir-omerovic/","name":"Elmir Omerovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/04/01/ventriculaire-aritmie-of-overlijden-na-stemi-versus-takotsubo/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-van-belle","type":"person","url":"https://hartvaat.nl/mensen/eric-van-belle/","name":"Eric Van Belle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-m-lonn","type":"person","url":"https://hartvaat.nl/mensen/eva-m-lonn/","name":"Eva M Lonn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2023/02/01/diabetes-en-sacubitril-valsartan-titratie-bij-hartfalen-na-opname/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2017/05/16/statines-voor-primaire-preventie-bij-ouderen-meta-analyse-van-jupiter-en-hope-3/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/11/01/intensieve-bloeddrukbehandeling-120-80-mmhg-antagonist-standpunt/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fozia-z-ahmed","type":"person","url":"https://hartvaat.nl/mensen/fozia-z-ahmed/","name":"Fozia Z Ahmed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/02/23/ijzertekort-bij-chronische-nierziekte-en-hartfalen-expertperspectieven/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/04/01/ambulante-behandeling-van-gedecompenseerd-hartfalen-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-w-rockhold","type":"person","url":"https://hartvaat.nl/mensen/frank-w-rockhold/","name":"Frank W Rockhold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frans-van-de-werf","type":"person","url":"https://hartvaat.nl/mensen/frans-van-de-werf/","name":"Frans Van de Werf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2019/01/02/preventie-van-cardiogene-shock-na-acuut-mi/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"franz-josef-neumann","type":"person","url":"https://hartvaat.nl/mensen/franz-josef-neumann/","name":"Franz-Josef Neumann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"},{"url":"https://hartvaat.nl/2016/07/19/immatuur-plaatjesaantal-versus-gevestigde-voorspellers-van-plaatjesreactiviteit-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francois-mach","type":"person","url":"https://hartvaat.nl/mensen/francois-mach/","name":"François Mach","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/04/07/statines-en-niet-statine-ldl-verlagers-en-cardiovasculaire-uitkomsten-meta-analy/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederick-j-raal","type":"person","url":"https://hartvaat.nl/mensen/frederick-j-raal/","name":"Frederick J Raal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/01/30/orion-5-inclisiran-bij-homozygote-fh/","published":"2024-01-30"},{"url":"https://hartvaat.nl/2023/10/21/lerodalcibep-bij-familiaire-hypercholesterolemie-liberate-hefh-langetermijndata/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-fase-3-bij-verhoogd-ldl-nejm-orion-10-en-orion-11/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2019/10/29/langetermijn-werkzaamheid-en-veiligheid-van-evolocumab-bij-hypercholesterolemie/","published":"2019-10-29"},{"url":"https://hartvaat.nl/2017/08/29/rosuvastatine-bij-kinderen-met-homozygote-familiaire-hypercholesterolemie/","published":"2017-08-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-ducrocq","type":"person","url":"https://hartvaat.nl/mensen/gregory-ducrocq/","name":"Grégory Ducrocq","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harmony-r-reynolds","type":"person","url":"https://hartvaat.nl/mensen/harmony-r-reynolds/","name":"Harmony R Reynolds","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/04/11/ambulante-beslisondersteuning-verbetert-mra-voorschrijving-bij-hfref/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jackie-bosch","type":"person","url":"https://hartvaat.nl/mensen/jackie-bosch/","name":"Jackie Bosch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2020/05/19/bloeddrukverlaging-en-dementie-of-cognitieve-stoornis-jama-meta-analyse/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-flensted-lassen","type":"person","url":"https://hartvaat.nl/mensen/jens-flensted-lassen/","name":"Jens Flensted Lassen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-jakob-thune","type":"person","url":"https://hartvaat.nl/mensen/jens-jakob-thune/","name":"Jens Jakob Thune","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/04/22/thoracentese-bij-acuut-hartfalen-gerandomiseerde-trial/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"},{"url":"https://hartvaat.nl/2016/02/01/regionale-hartdisfunctie-en-prognose-na-myocardinfarct-met-lv-disfunctie-of-hart/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiang-he","type":"person","url":"https://hartvaat.nl/mensen/jiang-he/","name":"Jiang He","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/02/01/antihypertensieve-behandeling-na-acuut-ischemisch-cva-continueren-of-niet/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2024/11/01/optimale-antihypertensieve-systolische-bloeddruk-meta-analyse/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2021/04/01/aerobe-training-bevordert-angiogenese-en-verlaagt-bloeddruk-bij-hypertensie-exca/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2017/09/19/community-health-worker-interventie-voor-bloeddrukcontrole-in-argentina-jama-tri/","published":"2017-09-19"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/07/01/systolische-bloeddrukreductie-en-cv-risico-netwerkmeta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-m-massaro","type":"person","url":"https://hartvaat.nl/mensen/joseph-m-massaro/","name":"Joseph M Massaro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/10/31/laesiecomplexiteit-en-uitkomsten-van-verlengde-dapt-na-pci/","published":"2017-10-31"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/05/02/mi-risico-na-stoppen-van-thienopyridine-dapt-studie/","published":"2017-05-02"},{"url":"https://hartvaat.nl/2017/03/21/kortetermijneffecten-van-tolvaptan-bij-acuut-hartfalen-met-volume-overbelasting/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/10/04/impact-van-optimale-medicamenteuze-therapie-in-de-dapt-studie/","published":"2016-10-04"},{"url":"https://hartvaat.nl/2016/05/31/dapt-score-validatie-bij-patienten-met-en-zonder-eerder-myocardinfarct/","published":"2016-05-31"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jozine-m-ter-maaten","type":"person","url":"https://hartvaat.nl/mensen/jozine-m-ter-maaten/","name":"Jozine M Ter Maaten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/08/01/candesartan-dosering-bij-mannen-versus-vrouwen-met-chronisch-hartfalen/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2016/05/17/verminderde-cardiac-index-is-niet-de-primaire-oorzaak-van-nierdisfunctie-bij-har/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-ludwig-laugwitz","type":"person","url":"https://hartvaat.nl/mensen/karl-ludwig-laugwitz/","name":"Karl-Ludwig Laugwitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/05/05/perifere-zuurstofextractie-bepaalt-belasting-bij-arrhythmogene-cardiomyopathie-f/","published":"2026-07-31"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/03/01/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-geactualiseerde-meta/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazem-rahimi","type":"person","url":"https://hartvaat.nl/mensen/kazem-rahimi/","name":"Kazem Rahimi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2025/03/26/rate-af-kosteneffectiviteit-van-digoxine-versus-betablokkers-bij-permanent-af/","published":"2025-03-26"},{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2020/10/01/thuismonitoring-met-technologie-ondersteund-management-bij-chronisch-hf-gerandom/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/05/01/inflammatiemarkers-en-risico-op-hypertensie-meta-analyse-van-cohortstudies/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2016/03/05/bloeddrukverlaging-ter-preventie-van-hart-en-vaatziekten-systematische-review-en/","published":"2016-03-05"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-r-bainey","type":"person","url":"https://hartvaat.nl/mensen/kevin-r-bainey/","name":"Kevin R Bainey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/05/01/remote-ischemische-conditionering-bij-stemi-registergebaseerde-gerandomiseerde-t/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-li","type":"person","url":"https://hartvaat.nl/mensen/li-li/","name":"Li Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/02/16/fibrilline-1-is-een-nieuw-ligand-van-de-egf-receptor-dat-mesangiumcellen-activee/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucas-petri-damiani","type":"person","url":"https://hartvaat.nl/mensen/lucas-petri-damiani/","name":"Lucas Petri Damiani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/03/17/answer-hf-sacubitril-valsartan-versus-enalapril-bij-chagas-hf-primaire-resultate/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-en-evidence-based-prescriptie-bij-hoog-cv-risico-jama-card/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-roffi","type":"person","url":"https://hartvaat.nl/mensen/marco-roffi/","name":"Marco Roffi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mario-f-gaudino","type":"person","url":"https://hartvaat.nl/mensen/mario-f-gaudino/","name":"Mario F Gaudino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/05/13/aha-scientific-statement-2026-secundaire-preventie-na-coronaire-bypassoperatie-e/","published":"2026-05-15"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"},{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/06/postoperatief-af-en-langetermijn-cva-risico-na-geisoleerde-cabg/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-van-royen","type":"person","url":"https://hartvaat.nl/mensen/niels-van-royen/","name":"Niels van Royen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/05/14/prehospitale-troponine-voor-uitsluiting-nste-acs-gerandomiseerde-trial/","published":"2023-05-14"},{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolaus-marx","type":"person","url":"https://hartvaat.nl/mensen/nikolaus-marx/","name":"Nikolaus Marx","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/12/lipidenmanagement-bij-type-2-diabetes-richt-je-op-alle-atherogene-lipoproteinen-/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2026/04/16/pcsk9-remmers-verlagen-events-bij-ascvd-zonder-eerder-infarct-of-beroerte-real-w/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/08/01/empagliflozine-vermindert-nierletselmarkers-bij-acuut-hartfalen/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"p-j-devereaux","type":"person","url":"https://hartvaat.nl/mensen/p-j-devereaux/","name":"P J Devereaux","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/08/15/overleving-na-geisoleerde-postoperatieve-troponine-elevatie/","published":"2017-08-15"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/01/07/preoperatief-statinegebruik-en-cardiovasculaire-complicaties-bij-niet-cardiale-c/","published":"2016-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patricio-lopez-jaramillo","type":"person","url":"https://hartvaat.nl/mensen/patricio-lopez-jaramillo/","name":"Patricio López-Jaramillo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2022/01/01/farmacologische-hypertensiebehandeling-bij-volwassenen-who-richtlijn-samenvattin/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/10/05/uitgebreide-community-interventie-bij-hypertensie-lancet-hope-4/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-widimsky","type":"person","url":"https://hartvaat.nl/mensen/petr-widimsky/","name":"Petr Widimský","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/09/19/trimetazidine-na-pci-lancet-atpci-gerandomiseerde-trial/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/02/01/spironolacton-versus-renale-denervatie-bij-therapieresistente-hypertensie-prague/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-d-adamson","type":"person","url":"https://hartvaat.nl/mensen/philip-d-adamson/","name":"Philip D Adamson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/08/01/inspannings-ecg-versus-ccta-bij-stabiele-angina-post-hoc-vergelijking/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/04/01/sekseverschillen-in-effectiviteit-van-orale-p2y12-remmers-meta-analyse/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiang-li","type":"person","url":"https://hartvaat.nl/mensen/qiang-li/","name":"Qiang Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2025/12/09/nieuw-bifasisch-pfa-systeem-versus-thermale-ablatie-bij-paroxysmaal-af/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/01/voorkeur-voor-pikant-eten-versterkt-zoutwaarneming-en-vermindert-zoutinname-en-b/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"},{"url":"https://hartvaat.nl/2016/03/01/taurinesuppletie-verlaagt-bloeddruk-en-verbetert-vaatfunctie-bij-prehypertensie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ran-kornowski","type":"person","url":"https://hartvaat.nl/mensen/ran-kornowski/","name":"Ran Kornowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ricardo-petraco","type":"person","url":"https://hartvaat.nl/mensen/ricardo-petraco/","name":"Ricardo Petraco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/01/ffr-versus-ifr-bij-coronaire-revascularisatie-vijfjaars-follow-up/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-j-mcmanus","type":"person","url":"https://hartvaat.nl/mensen/richard-j-mcmanus/","name":"Richard J McManus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-w-yeh","type":"person","url":"https://hartvaat.nl/mensen/robert-w-yeh/","name":"Robert W Yeh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2017/10/31/laesiecomplexiteit-en-uitkomsten-van-verlengde-dapt-na-pci/","published":"2017-10-31"},{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/05/02/mi-risico-na-stoppen-van-thienopyridine-dapt-studie/","published":"2017-05-02"},{"url":"https://hartvaat.nl/2016/10/04/impact-van-optimale-medicamenteuze-therapie-in-de-dapt-studie/","published":"2016-10-04"},{"url":"https://hartvaat.nl/2016/05/31/dapt-score-validatie-bij-patienten-met-en-zonder-eerder-myocardinfarct/","published":"2016-05-31"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"runlin-gao","type":"person","url":"https://hartvaat.nl/mensen/runlin-gao/","name":"Runlin Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/02/01/maggic-score-voor-mortaliteitsvoorspelling-bij-klepziekte/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2020/05/01/werkplek-multicomponentinterventie-voor-hypertensie-jama-cardiology/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samantha-sartori","type":"person","url":"https://hartvaat.nl/mensen/samantha-sartori/","name":"Samantha Sartori","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sayan-sen","type":"person","url":"https://hartvaat.nl/mensen/sayan-sen/","name":"Sayan Sen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/01/ffr-versus-ifr-bij-coronaire-revascularisatie-vijfjaars-follow-up/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-m-wasserman","type":"person","url":"https://hartvaat.nl/mensen/scott-m-wasserman/","name":"Scott M Wasserman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2019/10/29/langetermijn-werkzaamheid-en-veiligheid-van-evolocumab-bij-hypercholesterolemie/","published":"2019-10-29"},{"url":"https://hartvaat.nl/2019/09/01/persisterende-arteriele-wandinflammatie-bij-verhoogd-lp-a-ondanks-lage-ldl/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-a-m-thom","type":"person","url":"https://hartvaat.nl/mensen/simon-a-m-thom/","name":"Simon A M Thom","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/01/ochtend-versus-avonddosering-van-antihypertensiva-gerandomiseerde-crossover-tria/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-p-janssens","type":"person","url":"https://hartvaat.nl/mensen/stefan-p-janssens/","name":"Stefan P Janssens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/04/01/betrokkenheid-van-huisartsenzorg-bij-multidisciplinair-hf-management-meta-analys/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/08/18/optimale-bloeddruk-bij-shock-na-mi-en-hartstilstand/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2020/08/01/antidiabetica-en-cardiovasculaire-geneeskunde-meta-analyse-en-perspectief/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steffen-schneider","type":"person","url":"https://hartvaat.nl/mensen/steffen-schneider/","name":"Steffen Schneider","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-e-fremes","type":"person","url":"https://hartvaat.nl/mensen/stephen-e-fremes/","name":"Stephen E Fremes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/07/kosteneffectiviteit-van-stapsgewijze-lipidenverlaging-na-coronaire-bypasschirurg/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"},{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tienush-rassaf","type":"person","url":"https://hartvaat.nl/mensen/tienush-rassaf/","name":"Tienush Rassaf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/10/01/bnp-nt-probnp-stratificeert-prognose-gelijk-met-en-zonder-hartfalen-meta-analyse/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/08/01/hartfalen-door-kankerbehandeling-kunnen-we-het-voorkomen/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tzvetana-katova","type":"person","url":"https://hartvaat.nl/mensen/tzvetana-katova/","name":"Tzvetana Katova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"umberto-benedetto","type":"person","url":"https://hartvaat.nl/mensen/umberto-benedetto/","name":"Umberto Benedetto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/06/postoperatief-af-en-langetermijn-cva-risico-na-geisoleerde-cabg/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2017/08/01/radiale-arterie-graft-als-aanvulling-op-mammaria-interna-grafts-bij-cabg/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/12/29/bilaterale-versus-enkelvoudige-a-mammaria-interna-grafts-nejm-art-trial/","published":"2016-12-29"},{"url":"https://hartvaat.nl/2016/02/07/impact-van-pcsk9-remmers-op-lipidenniveaus-en-uitkomsten-netwerkmeta-analyse/","published":"2016-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-wijns","type":"person","url":"https://hartvaat.nl/mensen/william-wijns/","name":"William Wijns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/07/12/prasugrel-versus-clopidogrel-en-coronaire-microvasculaire-functie-bij-electieve-/","published":"2016-07-12"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yaling-han","type":"person","url":"https://hartvaat.nl/mensen/yaling-han/","name":"Yaling Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/06/01/sglt2-remmers-bij-hartfalen-geupdatete-meta-analyse-bevestigt-breed-voordeel/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/10/17/farmaco-invasieve-strategie-met-halve-dosis-alteplase-versus-primaire-pci-bij-st/","published":"2017-10-17"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-huo","type":"person","url":"https://hartvaat.nl/mensen/yong-huo/","name":"Yong Huo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/06/26/inclisiran-als-monotherapie-verlaagt-ldl-c-met-47-5-in-chinese-volwassenen-victo/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2025/01/01/langetermijn-cardiovasculaire-en-niet-cardiovasculaire-mortaliteit-na-acuut-coro/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2022/06/01/interatriale-shuntdevices-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"},{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-guk-ko","type":"person","url":"https://hartvaat.nl/mensen/young-guk-ko/","name":"Young-Guk Ko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":12,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abdul-salam","type":"person","url":"https://hartvaat.nl/mensen/abdul-salam/","name":"Abdul Salam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alaide-chieffo","type":"person","url":"https://hartvaat.nl/mensen/alaide-chieffo/","name":"Alaide Chieffo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amin-polzin","type":"person","url":"https://hartvaat.nl/mensen/amin-polzin/","name":"Amin Polzin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anders-junker","type":"person","url":"https://hartvaat.nl/mensen/anders-junker/","name":"Anders Junker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2018/12/04/ffr-versus-angiografie-geleide-cabg/","published":"2018-12-04"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arif-elvan","type":"person","url":"https://hartvaat.nl/mensen/arif-elvan/","name":"Arif Elvan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2021/12/07/gold-force-multi-elektrode-rf-versus-irrigated-rf-bij-af-gerandomiseerde-trial/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/08/07/geintegreerd-af-management-in-de-huisartsenpraktijk-all-in-clustergerandomiseerd/","published":"2020-08-07"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"avivit-cahn","type":"person","url":"https://hartvaat.nl/mensen/avivit-cahn/","name":"Avivit Cahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bong-ki-lee","type":"person","url":"https://hartvaat.nl/mensen/bong-ki-lee/","name":"Bong-Ki Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-k-whisenant","type":"person","url":"https://hartvaat.nl/mensen/brian-k-whisenant/","name":"Brian K Whisenant","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2024/03/05/gelijktijdige-laa-occlusie-en-tavr-bij-af-haalbaarheid/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carol-m-mangione","type":"person","url":"https://hartvaat.nl/mensen/carol-m-mangione/","name":"Carol M Mangione","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang-wook-nam","type":"person","url":"https://hartvaat.nl/mensen/chang-wook-nam/","name":"Chang-Wook Nam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/04/12/prognostische-waarde-van-residuele-coronairstenosen-na-functioneel-complete-reva/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chao-gao","type":"person","url":"https://hartvaat.nl/mensen/chao-gao/","name":"Chao Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-a-simonton","type":"person","url":"https://hartvaat.nl/mensen/charles-a-simonton/","name":"Charles A Simonton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-mueller","type":"person","url":"https://hartvaat.nl/mensen/christian-mueller/","name":"Christian Mueller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/26/subcutaan-selatogrel-remt-plaatjesaggregatie-bij-acuut-mi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-bode","type":"person","url":"https://hartvaat.nl/mensen/christoph-bode/","name":"Christoph Bode","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-a-rajkumar","type":"person","url":"https://hartvaat.nl/mensen/christopher-a-rajkumar/","name":"Christopher A Rajkumar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clara-k-chow","type":"person","url":"https://hartvaat.nl/mensen/clara-k-chow/","name":"Clara K Chow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/06/01/lage-dosis-drievoudige-viervoudige-combinatiepil-versus-monotherapie-bij-hyperte/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/08/01/diagnostische-nauwkeurigheid-van-handheld-ecg-devices-voor-af-community-versus-z/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/12/01/lacunes-in-hypertensierichtlijnen-in-lage-en-middeninkomenslanden-systematische-/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"d-scott-lim","type":"person","url":"https://hartvaat.nl/mensen/d-scott-lim/","name":"D Scott Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-lindholm","type":"person","url":"https://hartvaat.nl/mensen/daniel-lindholm/","name":"Daniel Lindholm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-a-wood","type":"person","url":"https://hartvaat.nl/mensen/david-a-wood/","name":"David A Wood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/06/27/tavr-bij-patienten-65-jaar-hogere-sterfte-en-heropnames-dan-chirurgie-maar-onvol/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/08/01/complete-versus-culprit-only-revascularisatie-bij-stemi-jama-cardiology-meta-ana/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-l-mann","type":"person","url":"https://hartvaat.nl/mensen/douglas-l-mann/","name":"Douglas L Mann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"},{"url":"https://hartvaat.nl/2016/07/12/nervus-vagus-stimulatie-bij-hartfalen-de-inovate-hf-trial/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-l-packer","type":"person","url":"https://hartvaat.nl/mensen/douglas-l-packer/","name":"Douglas L Packer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/12/01/comorbiditeitsbelasting-en-uitkomsten-van-ablatie-versus-medicatie-bij-af/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2021/07/13/ablatie-versus-medicatie-bij-af-naar-ras-en-etniciteit/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-kevin-damman","type":"person","url":"https://hartvaat.nl/mensen/dr-kevin-damman/","name":"Dr. Kevin Damman","title":"Cardioloog, Universitair Medisch Centrum Groningen","dutch_institution":true,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2022/08/09/initiele-egfr-dip-na-start-dapagliflozine-bij-hfref-dapa-hf-analyse/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/decision-digit-hf-dig-meta-digitalis/","title":"Digitalis in hartfalen — DECISION + DIGIT-HF + DIG meta-analyse"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-michiel-voskuil","type":"person","url":"https://hartvaat.nl/mensen/dr-michiel-voskuil/","name":"Dr. Michiel Voskuil","title":"UMC Utrecht, Nederland","dutch_institution":true,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/04/25/clopidogrel-versus-ticagrelor-of-prasugrel-bij-70-plussers-met-nste-acs-lancet-p/","published":"2020-04-25"},{"url":"https://hartvaat.nl/2019/10/01/bloeddruk-na-stenting-bij-aortacoarctatie-systematische-review-en-meta-analyse/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2017/04/01/medicatietrouw-en-het-effect-van-renale-denervatie-de-sympathy-trial/","published":"2017-04-01"}],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/pro-tavi-pci-bij-tavi-late-breaker/","title":"PRO-TAVI: Routinematige PCI bij TAVI — nodig of niet?"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eun-seok-shin","type":"person","url":"https://hartvaat.nl/mensen/eun-seok-shin/","name":"Eun-Seok Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabrizio-d-ascenzo","type":"person","url":"https://hartvaat.nl/mensen/fabrizio-d-ascenzo/","name":"Fabrizio D'Ascenzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/04/01/sacubitril-valsartan-na-acuut-mi-meta-analyse-van-in-hospital-initiatie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/10/01/crt-bij-inotroop-afhankelijk-hartfalen-meta-analyse/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/02/01/geautomatiseerde-praktijkmeting-versus-andere-bloeddrukmeetmethoden/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/01/farmacologische-behandeling-van-hypertensie-bij-kinderen-netwerkmeta-analyse/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/05/30/tijdstrends-in-complicaties-van-bioresorbeerbare-versus-metallic-stents/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fady-i-malik","type":"person","url":"https://hartvaat.nl/mensen/fady-i-malik/","name":"Fady I Malik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fausto-j-pinto","type":"person","url":"https://hartvaat.nl/mensen/fausto-j-pinto/","name":"Fausto J Pinto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/03/01/griepvaccinatie-bij-hartfalen-meta-analyse-van-observationele-studies/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fernando-alfonso","type":"person","url":"https://hartvaat.nl/mensen/fernando-alfonso/","name":"Fernando Alfonso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-edelmann","type":"person","url":"https://hartvaat.nl/mensen/frank-edelmann/","name":"Frank Edelmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/12/01/baseline-parameters-en-1-jaars-qol-bij-hf-na-crt-d-esc-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/06/01/economische-impact-van-hfpef-aldo-dhf-inzichten/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francois-roubille","type":"person","url":"https://hartvaat.nl/mensen/francois-roubille/","name":"François Roubille","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/08/18/tafamidis-bij-attr-cardiomyopathie-kosteffectiviteit-onder-de-maat-in-vier-europ/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georg-fuernau","type":"person","url":"https://hartvaat.nl/mensen/georg-fuernau/","name":"Georg Fuernau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerd-hasenfuss","type":"person","url":"https://hartvaat.nl/mensen/gerd-hasenfuss/","name":"Gerd Hasenfuß","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/05/05/reduce-mfa-dzhk25-trial-naar-antifibrotische-therapie-tegen-myocardfibrose-na-ta/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/12/01/baseline-parameters-en-1-jaars-qol-bij-hf-na-crt-d-esc-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/06/01/economische-impact-van-hfpef-aldo-dhf-inzichten/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerry-p-mccann","type":"person","url":"https://hartvaat.nl/mensen/gerry-p-mccann/","name":"Gerry P McCann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2022/09/01/timing-van-invasieve-strategie-bij-nste-acs-meta-analyse-van-rct-s/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/01/01/sglt2-remmers-over-het-cv-ziektespectrum-overzicht/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/12/24/langetermijnfollow-up-van-complete-versus-laesie-only-revascularisatie-bij-stemi/","published":"2019-12-24"},{"url":"https://hartvaat.nl/2018/12/01/dagelijkse-remote-ischemische-conditionering-na-acuut-mi-gerandomiseerde-trial/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2016/06/21/strategieen-om-microvasculaire-obstructie-te-verminderen-bij-primaire-pci-relief/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/06/07/ischemie-en-infarct-bij-stemi-met-multivatenlijden-cvlprit-nucleaire-substudie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianluigi-savarese","type":"person","url":"https://hartvaat.nl/mensen/gianluigi-savarese/","name":"Gianluigi Savarese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/03/03/tien-jaar-real-world-sacubitril-valsartan-mortaliteitsreductie-bevestigd-maar-sl/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/03/27/nt-probnp-afkapwaarden-voor-hartfalentrials-optimaliseren-swedehf/","published":"2026-03-27"},{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/03/vroeg-starten-met-mra-na-acuut-hartfalen-of-myocardinfarct-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-versus-tirzepatide-bij-patienten-met-obesitas-en-hfpef/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/04/01/intraveneus-ijzer-bij-hartfalen-meta-analyse-op-studieniveau/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gilles-r-dagenais","type":"person","url":"https://hartvaat.nl/mensen/gilles-r-dagenais/","name":"Gilles R Dagenais","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2023/08/24/vaste-dosiscombinatietherapie-voor-primaire-cv-preventie-ipd-meta-analyse/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-gargiulo","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-gargiulo/","name":"Giuseppe Gargiulo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/12/07/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-veiligheid-en-werk/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/10/14/tmao-als-cardiovasculaire-risicobiomarker-systematische-review-en-meta-analyse/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gunter-breithardt","type":"person","url":"https://hartvaat.nl/mensen/gunter-breithardt/","name":"Günter Breithardt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2023/01/24/axadia-afnet-8-apixaban-versus-vka-bij-af-op-hemodialyse/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-erik-botker","type":"person","url":"https://hartvaat.nl/mensen/hans-erik-botker/","name":"Hans Erik Bøtker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/02/14/danami-2-16-jaarsfollow-up-primaire-pci-versus-fibrinolyse/","published":"2020-02-14"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/07/01/remote-ischemische-conditionering-en-vertraging-van-het-zorgsysteem-bij-stemi/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyeon-cheol-gwon","type":"person","url":"https://hartvaat.nl/mensen/hyeon-cheol-gwon/","name":"Hyeon-Cheol Gwon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-lay-flurrie","type":"person","url":"https://hartvaat.nl/mensen/james-lay-flurrie/","name":"James Lay-Flurrie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-steffel","type":"person","url":"https://hartvaat.nl/mensen/jan-steffel/","name":"Jan Steffel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/03/09/halve-versus-volle-dosis-edoxaban-bij-af-gerandomiseerde-vergelijking/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-m-testani","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-m-testani/","name":"Jeffrey M Testani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/04/27/nierfunctiestoornis-verergert-pulmonale-vaatziekte-bij-hfpef/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2026/03/23/clorotic-subanalyse-acute-egfr-daling-door-thiaziden-bij-acuut-hf-is-geen-progno/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/09/15/empagliflozine-bij-hartfalen-diuretische-en-cardiorenale-effecten/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2016/05/17/verminderde-cardiac-index-is-niet-de-primaire-oorzaak-van-nierdisfunctie-bij-har/","published":"2016-05-17"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeroen-j-bax","type":"person","url":"https://hartvaat.nl/mensen/jeroen-j-bax/","name":"Jeroen J Bax","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/02/01/peri-infarctpacing-ter-preventie-van-linkerkamerremodellering-na-groot-myocardin/","published":"2016-02-01"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-ok-jeong","type":"person","url":"https://hartvaat.nl/mensen/jin-ok-jeong/","name":"Jin-Ok Jeong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joanna-j-wykrzykowska","type":"person","url":"https://hartvaat.nl/mensen/joanna-j-wykrzykowska/","name":"Joanna J Wykrzykowska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-p-greenwood","type":"person","url":"https://hartvaat.nl/mensen/john-p-greenwood/","name":"John P Greenwood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2020/07/21/levothyroxine-bij-subklinische-hypothyreoidie-na-acuut-mi-jama/","published":"2020-07-21"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/12/24/langetermijnfollow-up-van-complete-versus-laesie-only-revascularisatie-bij-stemi/","published":"2019-12-24"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/06/21/strategieen-om-microvasculaire-obstructie-te-verminderen-bij-primaire-pci-relief/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-p-h-wilding","type":"person","url":"https://hartvaat.nl/mensen/john-p-h-wilding/","name":"John P H Wilding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/08/14/cagrisema-gecombineerd-cagrilintide-en-semaglutide-bij-overgewicht-nejm/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-l-witztum","type":"person","url":"https://hartvaat.nl/mensen/joseph-l-witztum/","name":"Joseph L Witztum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/03/22/pelacarsen-op-lp-a-cholesterol-en-gecorrigeerd-ldl-cholesterol/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2020/06/21/statinetherapie-verhoogt-lipoproteine-a-spiegels/","published":"2020-06-21"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/09/01/galnac-geconjugeerd-antisense-tegen-apoc3-triglyceriden-en-atherogene-lipoprotei/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2017/07/20/angptl3-antisense-oligonucleotiden-cardiovasculaire-en-metabole-effecten-nejm/","published":"2017-07-20"},{"url":"https://hartvaat.nl/2017/01/17/geoxideerde-fosfolipiden-op-apob-100-en-recidiverende-ischemische-events-na-cva/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karina-w-davidson","type":"person","url":"https://hartvaat.nl/mensen/karina-w-davidson/","name":"Karina W Davidson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-heinz-kuck","type":"person","url":"https://hartvaat.nl/mensen/karl-heinz-kuck/","name":"Karl-Heinz Kuck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2021/03/08/katheterablatie-om-af-progressie-te-vertragen-attest-gerandomiseerde-trial/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/10/01/lage-arteriele-compliance-en-cv-morbiditeit-bij-aortaklepstenose/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-macle","type":"person","url":"https://hartvaat.nl/mensen/laurent-macle/","name":"Laurent Macle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2023/05/30/complicaties-van-af-ablatie-actueel-overzicht/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2020/02/01/elektrische-versus-farmacologische-cardioversie-bij-acuut-af-op-de-seh-lancet-ra/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-di-biase","type":"person","url":"https://hartvaat.nl/mensen/luigi-di-biase/","name":"Luigi Di Biase","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-m-ruilope","type":"person","url":"https://hartvaat.nl/mensen/luis-m-ruilope/","name":"Luis M Ruilope","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/12/01/acute-aerobe-training-en-kortdurende-ambulante-bloeddrukreductie-bij-hypertensie/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2018/10/01/prognostische-waarde-van-gemaskeerd-ongecontroleerde-hypertensie/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lynne-warner-stevenson","type":"person","url":"https://hartvaat.nl/mensen/lynne-warner-stevenson/","name":"Lynne Warner Stevenson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/06/01/maatschappelijk-werker-palliatieve-zorg-bij-hoogrisico-hf-swap-hf-pilot/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/10/10/pulmonalisdrukgeleide-therapie-bij-hfref/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/07/05/advance-care-planning-video-bij-gevorderd-hartfalen-gerandomiseerde-trial/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/01/30/hemodynamische-telemonitoring-bij-chronisch-hartfalen-volledige-champion-resulta/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-r-dweck","type":"person","url":"https://hartvaat.nl/mensen/marc-r-dweck/","name":"Marc R Dweck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2020/08/01/inspannings-ecg-versus-ccta-bij-stabiele-angina-post-hoc-vergelijking/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/implementatie-lipidenmanagement/","title":"Sessie 4: Implementatie van lipidenmanagement — praktische uitdagingen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-p-schlaich","type":"person","url":"https://hartvaat.nl/mensen/markus-p-schlaich/","name":"Markus P Schlaich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/06/01/renale-denervatie-langetermijn-bloeddrukeffect-bevestigd-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-m-givertz","type":"person","url":"https://hartvaat.nl/mensen/michael-m-givertz/","name":"Michael M Givertz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2017/10/10/pulmonalisdrukgeleide-therapie-bij-hfref/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-miller","type":"person","url":"https://hartvaat.nl/mensen/michael-miller/","name":"Michael Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-f-mercuri","type":"person","url":"https://hartvaat.nl/mensen/michele-f-mercuri/","name":"Michele F Mercuri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2023/07/20/ni006-antilichaam-voor-afbraak-van-cardiale-transthyretine-amyloid-nejm-fase-1/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/05/14/edoxaban-bij-aziatische-af-patienten-concentraties-en-anti-xa-activiteit/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/30/endogene-factor-xa-activiteit-en-edoxaban-farmacodynamische-marker-en-klinische-/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/nieuwe-risicovoorspellingsscore-bij-af-voor-netto-klinisch-resultaat-engage-af-t/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mitchell-w-krucoff","type":"person","url":"https://hartvaat.nl/mensen/mitchell-w-krucoff/","name":"Mitchell W Krucoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2018/07/07/orbusneich-combo-stent-japan-usa-harmonee-gerandomiseerde-multicenter-trial/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nelson-wang","type":"person","url":"https://hartvaat.nl/mensen/nelson-wang/","name":"Nelson Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/01/01/consistentie-van-bloeddrukrespons-op-kaliumverrijkt-zout-ssass-subanalyse/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/06/01/lage-dosis-drievoudige-viervoudige-combinatiepil-versus-monotherapie-bij-hyperte/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/01/korttermijn-bloeddrukmetingen-voorspellen-langetermijneffect-van-behandeling/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/02/01/tricuspidalisinsufficientie-en-mortaliteit-onafhankelijk-van-ph-en-rechterventri/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/03/01/voorspellers-van-succesvolle-cto-pci-systematische-review-en-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-m-pajewski","type":"person","url":"https://hartvaat.nl/mensen/nicholas-m-pajewski/","name":"Nicholas M Pajewski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukcontrole-en-cerebrale-small-vessel-disease-markers/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ole-de-backer","type":"person","url":"https://hartvaat.nl/mensen/ole-de-backer/","name":"Ole De Backer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/02/19/geleidingsstoornissen-na-transkatheter-aortaklepimplantatie/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/04/01/notion-10-jaar-tavr-versus-chirurgie-bij-laagrisico-aortastenose/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-g-m-de-barros-e-silva","type":"person","url":"https://hartvaat.nl/mensen/pedro-g-m-de-barros-e-silva/","name":"Pedro G M de Barros E Silva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2021/01/19/stoppen-versus-doorgaan-met-ace-remmers-arb-s-bij-gehospitaliseerde-patienten-ja/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peggy-gao","type":"person","url":"https://hartvaat.nl/mensen/peggy-gao/","name":"Peggy Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2023/08/24/vaste-dosiscombinatietherapie-voor-primaire-cv-preventie-ipd-meta-analyse/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2023/02/01/aspirine-en-cardiovasculaire-uitkomsten-bij-chronische-nierziekte/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2018/01/09/risico-s-van-overinterpretatie-van-interimdata-lessen-uit-de-total-trial/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierluigi-tricoci","type":"person","url":"https://hartvaat.nl/mensen/pierluigi-tricoci/","name":"Pierluigi Tricoci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prabhakar-viswanathan","type":"person","url":"https://hartvaat.nl/mensen/prabhakar-viswanathan/","name":"Prabhakar Viswanathan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/01/finearts-hf-geschatte-langetermijnvoordelen-van-finerenon-bij-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prem-pais","type":"person","url":"https://hartvaat.nl/mensen/prem-pais/","name":"Prem Pais","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2023/08/24/vaste-dosiscombinatietherapie-voor-primaire-cv-preventie-ipd-meta-analyse/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2023/02/01/aspirine-en-cardiovasculaire-uitkomsten-bij-chronische-nierziekte/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramon-corbalan","type":"person","url":"https://hartvaat.nl/mensen/ramon-corbalan/","name":"Ramón Corbalán","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/26/atherotrombotische-risicostratificatie-en-vorapaxar-bij-stabiel-ischemisch-hartl/","published":"2016-07-26"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-jan-m-van-geuns","type":"person","url":"https://hartvaat.nl/mensen/robert-jan-m-van-geuns/","name":"Robert-Jan M van Geuns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/05/14/prehospitale-troponine-voor-uitsluiting-nste-acs-gerandomiseerde-trial/","published":"2023-05-14"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salvatore-cassese","type":"person","url":"https://hartvaat.nl/mensen/salvatore-cassese/","name":"Salvatore Cassese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/10/01/pci-versus-cabg-bij-linker-hoofdstamstenose-jama-cardiology-systematische-review/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-d-berkowitz","type":"person","url":"https://hartvaat.nl/mensen/scott-d-berkowitz/","name":"Scott D Berkowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-jun-lee","type":"person","url":"https://hartvaat.nl/mensen/seung-jun-lee/","name":"Seung-Jun Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-woon-rha","type":"person","url":"https://hartvaat.nl/mensen/seung-woon-rha/","name":"Seung-Woon Rha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/05/21/bij-coronaire-vasospasmen-zonder-significante-stenose-voorspelt-verhoogd-lp-a-ge/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheldon-e-litwin","type":"person","url":"https://hartvaat.nl/mensen/sheldon-e-litwin/","name":"Sheldon E Litwin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/06/01/humain-hfpef-nieuwe-metabole-accelerator-bij-obesitas-hfpef-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sung-cheol-yun","type":"person","url":"https://hartvaat.nl/mensen/sung-cheol-yun/","name":"Sung-Cheol Yun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2024/06/11/effort-ertugliflozine-bij-functionele-mitralisinsufficientie-en-hartfalen/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/03/12/arni-bij-functionele-mitralisklepinsufficientie/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamar-s-polonsky","type":"person","url":"https://hartvaat.nl/mensen/tamar-s-polonsky/","name":"Tamar S Polonsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2020/01/21/voedingscholesterol-en-cv-risico-aha-science-advisory/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/06/25/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn-jacc/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-a-zelniker","type":"person","url":"https://hartvaat.nl/mensen/thomas-a-zelniker/","name":"Thomas A Zelniker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/05/05/dapa-hd-eerste-gerandomiseerde-studie-naar-dapagliflozin-bij-hemodialyse-patient/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"timothy-collier","type":"person","url":"https://hartvaat.nl/mensen/timothy-collier/","name":"Timothy Collier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-greene","type":"person","url":"https://hartvaat.nl/mensen/tom-greene/","name":"Tom Greene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2018/05/01/natriuminname-en-bloeddruk-varieren-met-energie-inname-dash-secundaire-analyse/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vidal-essebag","type":"person","url":"https://hartvaat.nl/mensen/vidal-essebag/","name":"Vidal Essebag","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xin-du","type":"person","url":"https://hartvaat.nl/mensen/xin-du/","name":"Xin Du","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukverlaging-bij-ongediagnosticeerde-hfpef-met-hoog-risico/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-joon-lee","type":"person","url":"https://hartvaat.nl/mensen/yong-joon-lee/","name":"Yong-Joon Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":11,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aaron-crowley","type":"person","url":"https://hartvaat.nl/mensen/aaron-crowley/","name":"Aaron Crowley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aleksandr-voskoboinik","type":"person","url":"https://hartvaat.nl/mensen/aleksandr-voskoboinik/","name":"Aleksandr Voskoboinik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2018/07/01/rotorablatie-bij-atriumfibrilleren-systematische-review/","published":"2018-07-01"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alfred-k-cheung","type":"person","url":"https://hartvaat.nl/mensen/alfred-k-cheung/","name":"Alfred K Cheung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/02/01/sprint-resultaten-en-implicaties-voor-de-nefrologie/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anders-himmelmann","type":"person","url":"https://hartvaat.nl/mensen/anders-himmelmann/","name":"Anders Himmelmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/04/01/fibrinestoleigenschappen-en-klinische-uitkomsten-na-acs-plato-substudie/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-santarelli","type":"person","url":"https://hartvaat.nl/mensen/andrea-santarelli/","name":"Andrea Santarelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-l-clark","type":"person","url":"https://hartvaat.nl/mensen/andrew-l-clark/","name":"Andrew L Clark","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/04/congestie-bij-chronisch-hartfalen-echografie-vult-klinisch-onderzoek-aan-en-voor/","published":"2026-07-01"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2019/12/01/orale-morfine-bij-dyspneu-bij-chronisch-hartfalen-gerandomiseerde-placebogecontr/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2016/04/01/effect-van-extra-zuurstof-op-inspanningsprestatie-bij-chronisch-hartfalen/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonia-zapf","type":"person","url":"https://hartvaat.nl/mensen/antonia-zapf/","name":"Antonia Zapf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/12/02/geindividualiseerd-perioperatief-bloeddrukmanagement-bij-grote-buikchirurgie/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2020/06/01/economische-impact-van-hfpef-aldo-dhf-inzichten/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anushka-patel","type":"person","url":"https://hartvaat.nl/mensen/anushka-patel/","name":"Anushka Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/06/01/lage-dosis-drievoudige-viervoudige-combinatiepil-versus-monotherapie-bij-hyperte/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"armando-lira-pineda","type":"person","url":"https://hartvaat.nl/mensen/armando-lira-pineda/","name":"Armando Lira Pineda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"borja-ibanez","type":"person","url":"https://hartvaat.nl/mensen/borja-ibanez/","name":"Borja Ibáñez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2024/12/01/colica-colchicine-bij-acuut-gedecompenseerd-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/10/timing-van-metoprolol-bij-stemi-effect-op-infarctgrootte-en-ventrikelfunctie/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brendan-m-everett","type":"person","url":"https://hartvaat.nl/mensen/brendan-m-everett/","name":"Brendan M Everett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/20/biomarkers-voor-atherosclerotische-events-bij-reumatoide-artritis-lp-a-als-voors/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/10/09/hypoglykemie-en-troponine-elevatie-bij-diabetes-met-coronairlijden/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/10/21/canakinumab-en-longkankerincidentie-bij-atherosclerose-lancet-cantos-exploratief/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"changsheng-ma","type":"person","url":"https://hartvaat.nl/mensen/changsheng-ma/","name":"Changsheng Ma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/09/01/inflammatie-als-risicofactor-krijgt-onvoldoende-ruimte-in-de-ascvd-en-ckd-prakti/","published":"2026-07-26"},{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-sticherling","type":"person","url":"https://hartvaat.nl/mensen/christian-sticherling/","name":"Christian Sticherling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/11/02/duurzaamheid-van-pvi-bij-af-meta-analyse/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-conen","type":"person","url":"https://hartvaat.nl/mensen/david-conen/","name":"David Conen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/07/mra-s-verminderen-af-risico-meta-analyse-van-klinische-trials/","published":"2024-03-07"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/12/01/linkeratriumdimensie-en-cv-uitkomsten-bij-patienten-met-en-zonder-af-meta-analys/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derek-p-chew","type":"person","url":"https://hartvaat.nl/mensen/derek-p-chew/","name":"Derek P Chew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/11/01/pneumokokkenvaccinatie-en-cv-eventpreventie-ipd-meta-analyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/10/01/acute-pleiotrope-effecten-van-dapagliflozine-bij-diabetes-type-2-met-hfref-cross/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/05/21/af-type-en-risico-op-trombo-embolie-mortaliteit-en-bloedingen-systematische-revi/","published":"2016-05-21"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donald-e-cutlip","type":"person","url":"https://hartvaat.nl/mensen/donald-e-cutlip/","name":"Donald E Cutlip","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2017/10/31/laesiecomplexiteit-en-uitkomsten-van-verlengde-dapt-na-pci/","published":"2017-10-31"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/05/02/mi-risico-na-stoppen-van-thienopyridine-dapt-studie/","published":"2017-05-02"},{"url":"https://hartvaat.nl/2016/10/04/impact-van-optimale-medicamenteuze-therapie-in-de-dapt-studie/","published":"2016-10-04"},{"url":"https://hartvaat.nl/2016/05/31/dapt-score-validatie-bij-patienten-met-en-zonder-eerder-myocardinfarct/","published":"2016-05-31"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-anuradha-lala","type":"person","url":"https://hartvaat.nl/mensen/dr-anuradha-lala/","name":"Dr. Anuradha Lala","title":"Icahn School of Medicine at Mount Sinai, New York, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"}],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/highlights-stemi-dtu-gofresh-hi-peitho/","title":"Highlights: STEMI-DTU, GoFreshRx en HI-PEITHO samengevat"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eliot-a-brinton","type":"person","url":"https://hartvaat.nl/mensen/eliot-a-brinton/","name":"Eliot A Brinton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-m-asch","type":"person","url":"https://hartvaat.nl/mensen/federico-m-asch/","name":"Federico M Asch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/05/27/multimodaal-ai-model-verhoogt-accuratesse-van-echo-diagnose-cardiale-amyloidose/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"filippo-crea","type":"person","url":"https://hartvaat.nl/mensen/filippo-crea/","name":"Filippo Crea","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/05/cardio-oncologie-een-snel-veranderend-vakgebied/","published":"2026-04-02"},{"url":"https://hartvaat.nl/2026/02/23/ehj-editoriaal-hartfalen-en-cardiomyopathieen/","published":"2026-04-01"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2022/07/21/permanente-pacemaker-na-tavi-langetermijneffect-op-klinische-uitkomsten/","published":"2022-07-21"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"},{"url":"https://hartvaat.nl/2020/04/01/intracraniele-bloedingen-versus-stenttrombose-met-doac-antiplaatjes-versus-tripl/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/05/30/tijdstrends-in-complicaties-van-bioresorbeerbare-versus-metallic-stents/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frants-pedersen","type":"person","url":"https://hartvaat.nl/mensen/frants-pedersen/","name":"Frants Pedersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gbenga-ogedegbe","type":"person","url":"https://hartvaat.nl/mensen/gbenga-ogedegbe/","name":"Gbenga Ogedegbe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/07/02/thuisbloeddruktelemonitoring-en-nurse-case-management-na-cva-jama-rct/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geoffrey-lee","type":"person","url":"https://hartvaat.nl/mensen/geoffrey-lee/","name":"Geoffrey Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2018/07/01/rotorablatie-bij-atriumfibrilleren-systematische-review/","published":"2018-07-01"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerard-c-m-linssen","type":"person","url":"https://hartvaat.nl/mensen/gerard-c-m-linssen/","name":"Gerard C M Linssen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gilles-lemesle","type":"person","url":"https://hartvaat.nl/mensen/gilles-lemesle/","name":"Gilles Lemesle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/06/27/oac-monotherapie-is-superieur-aan-combinatie-met-antiplatelets-bij-stabiele-ccs-/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-d-lewis","type":"person","url":"https://hartvaat.nl/mensen/gregory-d-lewis/","name":"Gregory D Lewis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/06/01/humain-hfpef-nieuwe-metabole-accelerator-bij-obesitas-hfpef-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/10/01/amethyst-verinurad-plus-allopurinol-bij-hfpef-negatieve-trial/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2020/10/20/praliciguat-en-piek-vo2-bij-hfpef-jama-capacity-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"han-mo-yang","type":"person","url":"https://hartvaat.nl/mensen/han-mo-yang/","name":"Han-Mo Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harlan-m-krumholz","type":"person","url":"https://hartvaat.nl/mensen/harlan-m-krumholz/","name":"Harlan M. Krumholz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/01/01/wat-betekent-verbetering-bij-hypertrofische-cardiomyopathie/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/01/01/van-overleving-naar-rentmeesterschap-hypergespecialiseerde-cardiovasculaire-zorg/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/langdurige-blootstelling-aan-bosbranden-pm2-5-en-cardiovasculaire-ziekenhuisopna/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/wanneer-zorg-autonoom-wordt-ai-en-de-toekomst-van-de-cardiovasculaire-geneeskund/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/cardiovasculaire-gezondheid-van-vrouwen-van-inclusie-naar-onderzoeksontwerp/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/09/16/tirzepatide-en-bloeddrukverlaging-surmount-1-gestratificeerde-analyse/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2019/11/16/vergelijking-van-eerstelijns-antihypertensiva-lancet-systematische-multinational/","published":"2019-11-16"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2017/07/01/heterogeniteit-in-vroege-respons-op-antihypertensiva-allhat/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iain-b-squire","type":"person","url":"https://hartvaat.nl/mensen/iain-b-squire/","name":"Iain B Squire","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/04/01/ambulante-behandeling-van-gedecompenseerd-hartfalen-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2022/01/01/sglt2-remmers-over-het-cv-ziektespectrum-overzicht/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"islam-y-elgendy","type":"person","url":"https://hartvaat.nl/mensen/islam-y-elgendy/","name":"Islam Y Elgendy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/05/mavacamten-in-de-praktijk-zwarte-patienten-krijgen-55-minder-vaak-toegang-atrium/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2025/08/01/lipideparameters-en-prognose-bij-hartfalen-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2022/10/25/2022-acc-aha-datadefinities-voor-pijn-op-de-borst-en-acuut-myocardinfarct/","published":"2022-10-25"},{"url":"https://hartvaat.nl/2022/10/13/ffr-geleide-versus-angiografie-geleide-revascularisatie-meta-analyse-van-rct-s/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2017/09/01/provisional-versus-twee-stentstrategie-bij-bifurcatielaesies-meta-analyse/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/11/01/langetermijnmortaliteit-bij-hypertensie-met-coronairlijden-invest-us-cohort/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/08/02/impact-van-coronaire-laesielengte-op-uitkomsten-bij-ivus-geleide-pci/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-c-spratt","type":"person","url":"https://hartvaat.nl/mensen/james-c-spratt/","name":"James C Spratt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jamie-p-dwyer","type":"person","url":"https://hartvaat.nl/mensen/jamie-p-dwyer/","name":"Jamie P Dwyer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jayne-prats","type":"person","url":"https://hartvaat.nl/mensen/jayne-prats/","name":"Jayne Prats","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2018/12/07/laesiecomplexiteit-en-periprocedurele-events-bij-potente-iv-antiplaatjestherapie/","published":"2018-12-07"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/19/werkzaamheid-en-veiligheid-van-cangrelor-bij-vrouwen-versus-mannen-tijdens-pci-c/","published":"2016-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-francois-tanguay","type":"person","url":"https://hartvaat.nl/mensen/jean-francois-tanguay/","name":"Jean-François Tanguay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-a-white","type":"person","url":"https://hartvaat.nl/mensen/jennifer-a-white/","name":"Jennifer A White","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2020/01/28/morfine-en-cv-uitkomsten-bij-nste-acs-jacc-analyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/09/01/simvastatine-ezetimibe-versus-simvastatine-na-acs-bij-75-plussers-jama-cardiolog/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/12/21/ezetimibe-bij-post-cabg-patienten-met-acs-improve-it-subanalyse/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jing-chen","type":"person","url":"https://hartvaat.nl/mensen/jing-chen/","name":"Jing Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/01/antihypertensieve-behandeling-na-acuut-ischemisch-cva-continueren-of-niet/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/10/14/heparine-bij-eerste-medisch-contact-versus-voor-primaire-pci-bij-stemi/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2017/09/19/community-health-worker-interventie-voor-bloeddrukcontrole-in-argentina-jama-tri/","published":"2017-09-19"},{"url":"https://hartvaat.nl/2017/07/01/systolische-bloeddrukreductie-en-cv-risico-netwerkmeta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/03/01/taurinesuppletie-verlaagt-bloeddruk-en-verbetert-vaatfunctie-bij-prehypertensie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-r-davies","type":"person","url":"https://hartvaat.nl/mensen/john-r-davies/","name":"John R Davies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-l-halperin","type":"person","url":"https://hartvaat.nl/mensen/jonathan-l-halperin/","name":"Jonathan L Halperin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2023/03/14/real-time-remote-monitoring-voorspelt-maligne-ventriculaire-aritmieen/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/03/02/kenmerken-van-patienten-met-atriale-high-rate-episodes-bij-icd-crt/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-versus-heparine-vka-bij-cardioversie-voor-af-emanate-trial/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jong-young-lee","type":"person","url":"https://hartvaat.nl/mensen/jong-young-lee/","name":"Jong-Young Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joon-hyung-doh","type":"person","url":"https://hartvaat.nl/mensen/joon-hyung-doh/","name":"Joon-Hyung Doh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joost-daemen","type":"person","url":"https://hartvaat.nl/mensen/joost-daemen/","name":"Joost Daemen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/08/18/echocardiografie-overschatte-drukgradienten-na-tav-in-tav-met-ballon-expandable-/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jung-kyu-han","type":"person","url":"https://hartvaat.nl/mensen/jung-kyu-han/","name":"Jung-Kyu Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"justin-e-davies","type":"person","url":"https://hartvaat.nl/mensen/justin-e-davies/","name":"Justin E Davies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/01/01/ffr-versus-ifr-bij-coronaire-revascularisatie-vijfjaars-follow-up/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kathy-wolski","type":"person","url":"https://hartvaat.nl/mensen/kathy-wolski/","name":"Kathy Wolski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"},{"url":"https://hartvaat.nl/2024/03/05/gelijktijdige-laa-occlusie-en-tavr-bij-af-haalbaarheid/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/07/13/traverse-testosteronsubstitutie-cardiovasculair-veilig-bij-hypogonadisme/","published":"2023-07-13"},{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/02/16/bariatrische-chirurgie-versus-intensieve-medicamenteuze-therapie-bij-diabetes-5-/","published":"2017-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katrina-e-donahue","type":"person","url":"https://hartvaat.nl/mensen/katrina-e-donahue/","name":"Katrina E Donahue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/07/27/heeft-deze-volwassene-hypertensie-jama-rational-clinical-examination/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keith-c-ferdinand","type":"person","url":"https://hartvaat.nl/mensen/keith-c-ferdinand/","name":"Keith C Ferdinand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2019/04/30/empagliflozine-antihyperglycemische-en-bloeddrukeffecten-bij-zwarte-diabetespati/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ken-okumura","type":"person","url":"https://hartvaat.nl/mensen/ken-okumura/","name":"Ken Okumura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/19/eldercare-af-post-hoc-edoxaban-spiegel-en-pt-13s-voorspellen-bloedingsrisico-bij/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2022/06/01/edoxaban-15-mg-bij-zeer-oude-patienten-met-atriumfibrilleren-eldercare-subanalys/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/03/01/edoxaban-15-mg-naar-nierfunctie-bij-zeer-oude-af-eldercare-subanalyse/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2020/10/29/laaggedoseerd-edoxaban-bij-zeer-oude-af-patienten-nejm-eldercare-af/","published":"2020-10-29"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"},{"url":"https://hartvaat.nl/2016/12/27/hotballoon-pulmonaalvene-ablatie-bij-paroxysmaal-af-japanse-multicenter-trial/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenji-ando","type":"person","url":"https://hartvaat.nl/mensen/kenji-ando/","name":"Kenji Ando","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-dickstein","type":"person","url":"https://hartvaat.nl/mensen/kenneth-dickstein/","name":"Kenneth Dickstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/04/21/aliskiren-enalapril-of-de-combinatie-bij-hartfalen-nejm-atmosphere-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krzysztof-narkiewicz","type":"person","url":"https://hartvaat.nl/mensen/krzysztof-narkiewicz/","name":"Krzysztof Narkiewicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lale-tokgozoglu","type":"person","url":"https://hartvaat.nl/mensen/lale-tokgozoglu/","name":"Lale Tokgözoğlu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pcsk9-remmers-verlagen-events-bij-ascvd-zonder-eerder-infarct-of-beroerte-real-w/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/ldl-cholesterol/","title":"Sessie 2: LDL-cholesterol"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-eckardt","type":"person","url":"https://hartvaat.nl/mensen/lars-eckardt/","name":"Lars Eckardt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/12/07/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-veiligheid-en-werk/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-videbk","type":"person","url":"https://hartvaat.nl/mensen/lars-videbk/","name":"Lars Videbæk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurence-d-sterns","type":"person","url":"https://hartvaat.nl/mensen/laurence-d-sterns/","name":"Laurence D Sterns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2019/08/01/optimale-laesieset-bij-persisterend-af-ablatie-meta-regressie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lena-rivard","type":"person","url":"https://hartvaat.nl/mensen/lena-rivard/","name":"Lena Rivard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leslie-cho","type":"person","url":"https://hartvaat.nl/mensen/leslie-cho/","name":"Leslie Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/lipoproteïne-a/","title":"Sessie 3: Lipoproteïne(a)"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"magnus-petersson","type":"person","url":"https://hartvaat.nl/mensen/magnus-petersson/","name":"Magnus Petersson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/04/01/dapagliflozine-verlaagt-urinezuur-en-vermindert-jichtaanvallen-bij-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marat-fudim","type":"person","url":"https://hartvaat.nl/mensen/marat-fudim/","name":"Marat Fudim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/04/07/confident-hfpef-machine-learning-voorspelt-sterfte-en-opname-beter-dan-bestaande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/intraveneus-ijzer-bij-hartfalen-met-ijzertekort-meta-analyse-met-trial-sequentie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/gelijktijdige-griep-en-rsv-vaccinatie-bij-hoogrisico-hartfalenpatienten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/02/01/iv-ijzer-bij-hartfalen-en-ijzerdeficientie-geactualiseerde-meta-analyse-van-rct-/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/01/intraveneus-ijzer-bij-hartfalen-meta-analyse-op-studieniveau/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2021/10/26/vroege-impedantie-geleide-interventie-verbetert-langetermijn-hf-uitkomsten/","published":"2021-10-26"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margaret-m-redfield","type":"person","url":"https://hartvaat.nl/mensen/margaret-m-redfield/","name":"Margaret M Redfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2020/10/20/praliciguat-en-piek-vo2-bij-hfpef-jama-capacity-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-halle","type":"person","url":"https://hartvaat.nl/mensen/martin-halle/","name":"Martin Halle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/05/perifere-zuurstofextractie-bepaalt-belasting-bij-arrhythmogene-cardiomyopathie-f/","published":"2026-07-31"},{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/10/01/verschillende-trainingsvormen-en-hdl-functie-bij-hfpef-optimex-substudie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masaharu-akao","type":"person","url":"https://hartvaat.nl/mensen/masaharu-akao/","name":"Masaharu Akao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/19/eldercare-af-post-hoc-edoxaban-spiegel-en-pt-13s-voorspellen-bloedingsrisico-bij/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2022/06/01/edoxaban-15-mg-bij-zeer-oude-patienten-met-atriumfibrilleren-eldercare-subanalys/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/03/01/edoxaban-15-mg-naar-nierfunctie-bij-zeer-oude-af-eldercare-subanalyse/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2020/10/29/laaggedoseerd-edoxaban-bij-zeer-oude-af-patienten-nejm-eldercare-af/","published":"2020-10-29"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-hanna","type":"person","url":"https://hartvaat.nl/mensen/michael-hanna/","name":"Michael Hanna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-barry","type":"person","url":"https://hartvaat.nl/mensen/michael-j-barry/","name":"Michael J Barry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-r-gold","type":"person","url":"https://hartvaat.nl/mensen/michael-r-gold/","name":"Michael R Gold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2022/09/27/linkerbundeltakpacing-versus-biventriculaire-pacing-voor-crt-gerandomiseerde-tri/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/08/20/2018-acc-aha-hrs-richtlijn-voor-bradycardie-en-geleidingsstoornissen/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2016/07/12/nervus-vagus-stimulatie-bij-hartfalen-de-inovate-hf-trial/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mitja-lainscak","type":"person","url":"https://hartvaat.nl/mensen/mitja-lainscak/","name":"Mitja Lainscak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-editorial-cleland-wereldwijde-hartfalenprevalentie-overschrijdt-600-miljoen-/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/02/01/transveneuze-frenische-zenuwstimulatie-bij-centraal-slaapapneu-en-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mona-fiuzat","type":"person","url":"https://hartvaat.nl/mensen/mona-fiuzat/","name":"Mona Fiuzat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2017/04/04/inspanningstraining-bij-chronisch-hartfalen-met-atriumfibrilleren/","published":"2017-04-04"},{"url":"https://hartvaat.nl/2017/03/28/adaptieve-servoventilatie-bij-hartfalen-de-cat-hf-trial/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/werkzaamheid-en-veiligheid-van-tolvaptan-bij-gehospitaliseerd-acuut-hartfalen/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-danchin","type":"person","url":"https://hartvaat.nl/mensen/nicolas-danchin/","name":"Nicolas Danchin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/09/19/trimetazidine-na-pci-lancet-atpci-gerandomiseerde-trial/","published":"2020-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ole-frobert","type":"person","url":"https://hartvaat.nl/mensen/ole-frobert/","name":"Ole Fröbert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/06/13/griepvaccinatie-en-cardiovasculaire-bescherming-inflammatie-heroverwogen-bij-isc/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-calabro","type":"person","url":"https://hartvaat.nl/mensen/paolo-calabro/","name":"Paolo Calabrò","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-t-ellinor","type":"person","url":"https://hartvaat.nl/mensen/patrick-t-ellinor/","name":"Patrick T Ellinor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2022/03/29/af-screening-bij-ouderen-in-de-huisartsenpraktijk-vital-af-gerandomiseerde-trial/","published":"2022-03-29"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-a-grayburn","type":"person","url":"https://hartvaat.nl/mensen/paul-a-grayburn/","name":"Paul A Grayburn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philipp-sommer","type":"person","url":"https://hartvaat.nl/mensen/philipp-sommer/","name":"Philipp Sommer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/02/03/varipure-studie-pulsed-field-ablatie-in-de-dagelijkse-af-praktijk/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/02/08/redo-firm-firm-geleide-ablatie-verbetert-uitkomst-niet-bij-recidief-af/","published":"2023-02-08"},{"url":"https://hartvaat.nl/2021/05/21/firm-ablatie-versus-pvi-bij-paroxysmaal-af-gerandomiseerde-resultaten/","published":"2021-05-21"},{"url":"https://hartvaat.nl/2020/10/01/slokdarmsonde-bij-rf-ablatie-voor-af-opera-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-amarenco","type":"person","url":"https://hartvaat.nl/mensen/pierre-amarenco/","name":"Pierre Amarenco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/05/05/atorvastatine-vermindert-eerste-en-volgende-vasculaire-events-sparcl/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pieter-martens","type":"person","url":"https://hartvaat.nl/mensen/pieter-martens/","name":"Pieter Martens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/09/praise-mr-sacubitril-valsartan-verbetert-inspanningshemodynamiek-bij-hfpef-met-a/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/25/inspanningsecho-identificeert-hcm-patienten-die-baat-hebben-bij-mavacamten/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2024/10/15/aha-scientific-statement-nierdisfunctie-bij-gevorderd-hartfalen/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2018/06/01/implementatie-van-sacubitril-valsartan-in-de-klinische-praktijk-inzichten/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pim-van-der-harst","type":"person","url":"https://hartvaat.nl/mensen/pim-van-der-harst/","name":"Pim van der Harst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/10/05/ketonlichamen-en-functionele-uitkomsten-na-stemi/","published":"2021-10-05"},{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piroze-m-davierwala","type":"person","url":"https://hartvaat.nl/mensen/piroze-m-davierwala/","name":"Piroze M Davierwala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pradeep-natarajan","type":"person","url":"https://hartvaat.nl/mensen/pradeep-natarajan/","name":"Pradeep Natarajan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/28/lp-a-verhoogt-risico-op-veneuze-trombo-embolie-bij-premenopauzale-vrouwen-en-hor/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/26/acc-verklaring-2026-gen-editing-als-therapie-bij-hart-en-vaatziekten/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2026/03/04/genetisch-bevestigde-familiaire-hypercholesterolemie-in-de-vs-prevalentie-en-ond/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2025/01/01/polygeen-risico-gestuurde-detectie-en-behandeling-van-subklinische-coronaire-ath/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/22/genetische-voorspelling-van-lp-a-spiegels-in-diverse-populaties/","published":"2026-02-22"},{"url":"https://hartvaat.nl/2026/02/05/de-erfelijke-basis-van-coronairlijden-nejm-overzicht/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2025/12/24/genomische-ontdekking-bij-nefrotisch-syndroom-mefv-varianten-als-risicofactor-vo/","published":"2025-12-24"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-marianna-fontana","type":"person","url":"https://hartvaat.nl/mensen/prof-marianna-fontana/","name":"Prof. Marianna Fontana","title":"Hoogleraar cardiologie, National Amyloidosis Centre, University College London, VK","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/22/cardiale-amyloidose-komt-frequent-voor-bij-hfpef-aortastenose-en-lvh-meta-analys/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/05/27/multimodaal-ai-model-verhoogt-accuratesse-van-echo-diagnose-cardiale-amyloidose/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hf-verslechtering-bij-attr-cm-attr-act-subanalyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hartfalenverslechtering-bij-attr-cardiomyopathie-attr-act-analyse/","published":"2025-02-25"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/attribute-cm-outpatient-worsening-fontana/","title":"ATTRibute-CM — Acoramidis en poliklinische verslechtering van hartfalen"},{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/attribute-cm-peer-to-peer-fontana-lopez/","title":"ATTRibute-CM peer-to-peer — Van trial naar dagelijkse praktijk"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rasmus-paulin-beske","type":"person","url":"https://hartvaat.nl/mensen/rasmus-paulin-beske/","name":"Rasmus Paulin Beske","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ratika-parkash","type":"person","url":"https://hartvaat.nl/mensen/ratika-parkash/","name":"Ratika Parkash","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebecca-t-hahn","type":"person","url":"https://hartvaat.nl/mensen/rebecca-t-hahn/","name":"Rebecca T Hahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rishi-puri","type":"person","url":"https://hartvaat.nl/mensen/rishi-puri/","name":"Rishi Puri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/09/01/anemie-verergert-mortaliteit-en-hartfalenheropnames-na-tavr-bij-patienten-boven-/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-a-byrne","type":"person","url":"https://hartvaat.nl/mensen/robert-a-byrne/","name":"Robert A Byrne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2017/10/01/pci-versus-cabg-bij-linker-hoofdstamstenose-jama-cardiology-systematische-review/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-c-welsh","type":"person","url":"https://hartvaat.nl/mensen/robert-c-welsh/","name":"Robert C Welsh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2022/05/01/remote-ischemische-conditionering-bij-stemi-registergebaseerde-gerandomiseerde-t/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sakis-themistoclakis","type":"person","url":"https://hartvaat.nl/mensen/sakis-themistoclakis/","name":"Sakis Themistoclakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samia-mora","type":"person","url":"https://hartvaat.nl/mensen/samia-mora/","name":"Samia Mora","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/01/01/vitamine-d-voorkomt-statine-gerelateerde-spierklachten-niet/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2017/06/20/cholesteroleffluxcapaciteit-hdl-deeltjesaantal-en-cv-events-jupiter-analyse/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2016/05/01/lipoproteinen-insulineresistentie-en-rosuvastatine-bij-incident-type-2-diabetes/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/05/01/procentuele-ldl-verlaging-bij-hoogintensieve-statinetherapie-implicaties-voor-ri/","published":"2016-05-01"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/lipoproteïne-a/","title":"Sessie 3: Lipoproteïne(a)"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samin-k-sharma","type":"person","url":"https://hartvaat.nl/mensen/samin-k-sharma/","name":"Samin K Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seth-j-baum","type":"person","url":"https://hartvaat.nl/mensen/seth-j-baum/","name":"Seth J Baum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/11/12/bempedoinezuur-toegevoegd-aan-statines-bij-hoog-cv-risico-jama-clear-harmony/","published":"2019-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shinya-goto","type":"person","url":"https://hartvaat.nl/mensen/shinya-goto/","name":"Shinya Goto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/04/01/niet-ernstige-bloedingen-met-apixaban-versus-warfarine-bij-af/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"siddharth-m-patel","type":"person","url":"https://hartvaat.nl/mensen/siddharth-m-patel/","name":"Siddharth M Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steffen-massberg","type":"person","url":"https://hartvaat.nl/mensen/steffen-massberg/","name":"Steffen Massberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/10/01/cardiale-amyloidose-komt-bij-9-van-tavi-patienten-voor-ongeacht-stromingspatroon/","published":"2026-08-27"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/05/14/ecls-bij-cardiogene-shock-na-acuut-mi/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/07/14/voorspelling-van-plotse-versus-niet-plotse-hartdood-na-mi-met-verminderde-lvef/","published":"2017-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-g-ellis","type":"person","url":"https://hartvaat.nl/mensen/stephen-g-ellis/","name":"Stephen G Ellis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stuart-kupfer","type":"person","url":"https://hartvaat.nl/mensen/stuart-kupfer/","name":"Stuart Kupfer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tariq-ahmad","type":"person","url":"https://hartvaat.nl/mensen/tariq-ahmad/","name":"Tariq Ahmad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/08/01/klinische-fenotypen-zijn-effectiever-dan-ef-categorieen-voor-hf-uitkomsten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/09/15/empagliflozine-bij-hartfalen-diuretische-en-cardiorenale-effecten/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2016/05/17/verminderde-cardiac-index-is-niet-de-primaire-oorzaak-van-nierdisfunctie-bij-har/","published":"2016-05-17"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"terry-a-jacobson","type":"person","url":"https://hartvaat.nl/mensen/terry-a-jacobson/","name":"Terry A Jacobson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"},{"url":"https://hartvaat.nl/2017/09/26/sams-ci-score-toegepast-op-gerandomiseerde-trial-over-statine-myopathie/","published":"2017-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-f-luscher","type":"person","url":"https://hartvaat.nl/mensen/thomas-f-luscher/","name":"Thomas F Lüscher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/07/14/ldl-verlaging-en-cv-events-met-pcsk9-remmers-meta-analyse-van-gerandomiseerde-tr/","published":"2018-07-14"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"upendra-kaul","type":"person","url":"https://hartvaat.nl/mensen/upendra-kaul/","name":"Upendra Kaul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2016/06/01/pci-bij-insulinebehandelde-versus-niet-insulinebehandelde-diabetes-freedom-trial/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vinod-h-thourani","type":"person","url":"https://hartvaat.nl/mensen/vinod-h-thourani/","name":"Vinod H Thourani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-e-kraus","type":"person","url":"https://hartvaat.nl/mensen/william-e-kraus/","name":"William E Kraus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2023/01/10/dagelijkse-stappen-en-cardiovasculaire-ziekte-geharmoniseerde-meta-analyse/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/07/12/frailteit-beinvloedt-effect-van-inspanningstraining-bij-hartfalen-hf-action-anal/","published":"2022-07-12"},{"url":"https://hartvaat.nl/2021/10/12/leefstijlmodificatie-bij-resistente-hypertensie-triumph-gerandomiseerde-trial/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"},{"url":"https://hartvaat.nl/2017/04/04/inspanningstraining-bij-chronisch-hartfalen-met-atriumfibrilleren/","published":"2017-04-04"},{"url":"https://hartvaat.nl/2016/04/05/hartrevalidatie-versterkt-met-stressmanagementtraining-gerandomiseerde-trial/","published":"2016-04-05"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"},{"url":"https://hartvaat.nl/2016/01/05/calorierestrictie-of-aerobe-training-bij-obese-ouderen-met-hfpef-effect-op-vo2-p/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xavier-rossello","type":"person","url":"https://hartvaat.nl/mensen/xavier-rossello/","name":"Xavier Rossello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yogesh-n-v-reddy","type":"person","url":"https://hartvaat.nl/mensen/yogesh-n-v-reddy/","name":"Yogesh N V Reddy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2026/04/27/nierfunctiestoornis-verergert-pulmonale-vaatziekte-bij-hfpef/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/01/dapagliflozine-en-rv-pulmonale-interactie-bij-hfpef/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/09/05/cameo-dapa-cardiale-en-metabole-effecten-van-dapagliflozine-bij-hfpef/","published":"2023-09-05"},{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2017/07/11/arteriele-verstijving-bij-inspanning-bij-hfpef/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-bin-song","type":"person","url":"https://hartvaat.nl/mensen/young-bin-song/","name":"Young Bin Song","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuliya-lokhnygina","type":"person","url":"https://hartvaat.nl/mensen/yuliya-lokhnygina/","name":"Yuliya Lokhnygina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2019/09/01/simvastatine-ezetimibe-versus-simvastatine-na-acs-bij-75-plussers-jama-cardiolog/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yves-rosenberg","type":"person","url":"https://hartvaat.nl/mensen/yves-rosenberg/","name":"Yves Rosenberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":10,"articles":[{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-j-nelson","type":"person","url":"https://hartvaat.nl/mensen/adam-j-nelson/","name":"Adam J Nelson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/05/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adel-aminian","type":"person","url":"https://hartvaat.nl/mensen/adel-aminian/","name":"Adel Aminian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"albert-wiegman","type":"person","url":"https://hartvaat.nl/mensen/albert-wiegman/","name":"Albert Wiegman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/24/cascadescreening-op-verhoogd-lp-a-via-kinderen-opbrengst-in-de-praktijk-amsterda/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2026/02/03/statine-intolerantie-bij-kinderen-met-familiaire-hypercholesterolemie-15-jaar-kl/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"},{"url":"https://hartvaat.nl/2025/06/24/inclisiran-bij-adolescenten-met-homozygote-fh-effectiviteit-en-veiligheid/","published":"2025-06-24"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2017/08/29/rosuvastatine-bij-kinderen-met-homozygote-familiaire-hypercholesterolemie/","published":"2017-08-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aletta-e-schutte","type":"person","url":"https://hartvaat.nl/mensen/aletta-e-schutte/","name":"Aletta E Schutte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/11/01/magnesiumsuppletie-en-bloeddruk-meta-analyse-van-rct-s/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-schafer","type":"person","url":"https://hartvaat.nl/mensen/andreas-schafer/","name":"Andreas Schäfer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-m-tonkin","type":"person","url":"https://hartvaat.nl/mensen/andrew-m-tonkin/","name":"Andrew M Tonkin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/11/01/pneumokokkenvaccinatie-en-cv-eventpreventie-ipd-meta-analyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","published":"2020-07-07"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andre-zimerman","type":"person","url":"https://hartvaat.nl/mensen/andre-zimerman/","name":"André Zimerman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/11/21/diureticastaken-bij-stabiel-mild-hf-zonder-vochtretentie/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anita-deswal","type":"person","url":"https://hartvaat.nl/mensen/anita-deswal/","name":"Anita Deswal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/05/vroege-harttoxiciteit-na-doxorubicine-bij-jongvolwassenen-met-sarcoom/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/05/27/multimodaal-ai-model-verhoogt-accuratesse-van-echo-diagnose-cardiale-amyloidose/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2023/05/09/2023-acc-expert-consensus-management-van-hfpef/","published":"2023-05-09"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2016/12/06/comorbiditeiten-bij-hartfalen-hypertensie-obesitas-diabetes-hyperlipidemie-en-me/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-j-dalby","type":"person","url":"https://hartvaat.nl/mensen/anthony-j-dalby/","name":"Anthony J Dalby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ashkan-eftekhari","type":"person","url":"https://hartvaat.nl/mensen/ashkan-eftekhari/","name":"Ashkan Eftekhari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/10/01/voorgebruik-van-opioiden-verhoogt-sterfte-en-ziekenhuisopnames-na-tavi-deens-coh/","published":"2026-08-21"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2023/11/01/ifr-versus-ffr-en-vijfjaarsmortaliteit-swedeheart-en-define-flair/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atul-anand","type":"person","url":"https://hartvaat.nl/mensen/atul-anand/","name":"Atul Anand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/01/endothelinereceptorantagonisme-verbetert-lipidenprofielen-en-verlaagt-pcsk9-bij-/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/04/01/sekseverschillen-in-effectiviteit-van-orale-p2y12-remmers-meta-analyse/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-r-davis","type":"person","url":"https://hartvaat.nl/mensen/barry-r-davis/","name":"Barry R Davis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2019/10/01/antihypertensivaklasse-en-vallen-syncope-en-orthostatische-hypotensie-bij-oudere/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2017/07/01/heterogeniteit-in-vroege-respons-op-antihypertensiva-allhat/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-j-gersh","type":"person","url":"https://hartvaat.nl/mensen/bernard-j-gersh/","name":"Bernard J Gersh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2017/02/14/doac-s-bij-af-met-kleplijden-excl-significante-mitralisstenose-meta-analyse/","published":"2017-02-14"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"boyoung-joung","type":"person","url":"https://hartvaat.nl/mensen/boyoung-joung/","name":"Boyoung Joung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2024/12/03/ct-gestuurde-atriale-wanddiktemapping-bij-cryoballon-pvi/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brendon-l-neuen","type":"person","url":"https://hartvaat.nl/mensen/brendon-l-neuen/","name":"Brendon L Neuen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/24/risicovoorspellingsmodellen-voor-ouderen-met-chronische-nierziekte/","published":"2025-12-24"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-r-da-costa","type":"person","url":"https://hartvaat.nl/mensen/bruno-r-da-costa/","name":"Bruno R da Costa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2020/10/01/natuurlijk-beloop-van-asymptomatische-ernstige-aortastenose-jama-cardiology-meta/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/04/01/restrictieve-versus-liberale-transfusie-bij-hartchirurgie-meta-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brge-g-nordestgaard","type":"person","url":"https://hartvaat.nl/mensen/brge-g-nordestgaard/","name":"Børge G Nordestgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/03/02/barrieres-bij-implementatie-van-lipidenverlagende-therapie-in-de-praktijk/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2020/05/26/wereldwijde-prevalentie-van-familiaire-hypercholesterolemie-meta-analyse-van-11-/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/09/17/ldl-cholesterol-en-micro-versus-macrovasculaire-ziekte-mendeliaanse-randomisatie/","published":"2019-09-17"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-collet","type":"person","url":"https://hartvaat.nl/mensen/carlos-collet/","name":"Carlos Collet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chetan-b-patel","type":"person","url":"https://hartvaat.nl/mensen/chetan-b-patel/","name":"Chetan B Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/10/24/inhalatief-epoprostenol-versus-no-bij-rechterventrikel-falen-na-hartchirurgie/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/03/21/werkzaamheid-en-veiligheid-van-tolvaptan-bij-gehospitaliseerd-acuut-hartfalen/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-e-singer","type":"person","url":"https://hartvaat.nl/mensen/daniel-e-singer/","name":"Daniel E Singer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2024/11/19/screening-op-niet-gediagnosticeerd-af-voor-cva-preventie-gerandomiseerde-trial/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2022/03/29/af-screening-bij-ouderen-in-de-huisartsenpraktijk-vital-af-gerandomiseerde-trial/","published":"2022-03-29"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-j-f-m-thuijs","type":"person","url":"https://hartvaat.nl/mensen/daniel-j-f-m-thuijs/","name":"Daniel J F M Thuijs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-kaye","type":"person","url":"https://hartvaat.nl/mensen/david-m-kaye/","name":"David M Kaye","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"},{"url":"https://hartvaat.nl/2016/03/01/effect-van-aanvullende-zuurstoftoediening-op-myocardschade-bij-stemi/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-reboussin","type":"person","url":"https://hartvaat.nl/mensen/david-m-reboussin/","name":"David M Reboussin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukcontrole-en-cerebrale-small-vessel-disease-markers/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davide-cao","type":"person","url":"https://hartvaat.nl/mensen/davide-cao/","name":"Davide Cao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dirk-von-lewinski","type":"person","url":"https://hartvaat.nl/mensen/dirk-von-lewinski/","name":"Dirk von Lewinski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2022/11/01/emmy-empagliflozine-na-acuut-myocardinfarct-verbetert-nt-probnp-en-remodelling/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eloi-marijon","type":"person","url":"https://hartvaat.nl/mensen/eloi-marijon/","name":"Eloi Marijon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/03/uitgebreide-versus-standaard-remote-monitoring-bij-crt-en-hartfalen/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/03/01/doodsoorzaken-bij-crt-met-en-zonder-defibrillator-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elsayed-z-soliman","type":"person","url":"https://hartvaat.nl/mensen/elsayed-z-soliman/","name":"Elsayed Z Soliman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/20/biomarkers-voorspellen-coronairlijden-bij-atriumfibrilleren-regards/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/06/01/intensieve-bloeddrukcontrole-en-geleidingsziekten-sprint-post-hoc-analyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/08/01/vitamine-d-en-incidentie-van-atriumfibrilleren-de-aric-studie/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"etienne-puymirat","type":"person","url":"https://hartvaat.nl/mensen/etienne-puymirat/","name":"Etienne Puymirat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-prescott","type":"person","url":"https://hartvaat.nl/mensen/eva-prescott/","name":"Eva Prescott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florentina-a-simader","type":"person","url":"https://hartvaat.nl/mensen/florentina-a-simader/","name":"Florentina A Simader","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"folkert-w-asselbergs","type":"person","url":"https://hartvaat.nl/mensen/folkert-w-asselbergs/","name":"Folkert W Asselbergs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/24/kwaliteitscriteria-voor-ai-implementatie-in-de-cardiologie-bijgewerkt/","published":"2026-04-01"},{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2022/10/01/bloedbiomerkers-voor-prognose-bij-hypertrofische-cardiomyopathie-meta-analyse/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/09/26/smartphone-detectie-van-af-via-fotoplethysmografie-meta-analyse/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-bedogni","type":"person","url":"https://hartvaat.nl/mensen/francesco-bedogni/","name":"Francesco Bedogni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2017/05/30/tijdstrends-in-complicaties-van-bioresorbeerbare-versus-metallic-stents/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-e-harrell","type":"person","url":"https://hartvaat.nl/mensen/frank-e-harrell/","name":"Frank E Harrell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2024/04/09/dapagliflozine-bij-acuut-hartfalen-effectiviteit-en-veiligheid/","published":"2024-04-09"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-c-m-siontis","type":"person","url":"https://hartvaat.nl/mensen/george-c-m-siontis/","name":"George C M Siontis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/04/07/statines-en-niet-statine-ldl-verlagers-en-cardiovasculaire-uitkomsten-meta-analy/","published":"2018-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerald-f-watts","type":"person","url":"https://hartvaat.nl/mensen/gerald-f-watts/","name":"Gerald F Watts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/04/01/risicofactoren-voor-cardiovasculaire-events-bij-heterozygote-familiaire-hypercho/","published":"2026-05-06"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/07/01/plozasiran-sirna-tegen-apoc3-bij-ernstige-hypertriglyceridemie-shasta-2/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/06/02/prevalentie-van-fh-bij-atherosclerotische-cv-ziekte-meta-analyse/","published":"2020-06-02"},{"url":"https://hartvaat.nl/2017/11/14/ldl-verlaging-voor-primaire-preventie-bij-mannen-met-primaire-ldl-verhoging/","published":"2017-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianni-casella","type":"person","url":"https://hartvaat.nl/mensen/gianni-casella/","name":"Gianni Casella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-biondi-zoccai","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-biondi-zoccai/","name":"Giuseppe Biondi-Zoccai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/02/07/impact-van-pcsk9-remmers-op-lipidenniveaus-en-uitkomsten-netwerkmeta-analyse/","published":"2016-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"graham-d-cole","type":"person","url":"https://hartvaat.nl/mensen/graham-d-cole/","name":"Graham D Cole","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guy-amit","type":"person","url":"https://hartvaat.nl/mensen/guy-amit/","name":"Guy Amit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/06/15/prevalentie-van-linkeratriumtrombus-bij-geanticoaguleerde-af-patienten/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/07/01/werkzaamheid-van-katheterablatie-bij-niet-paroxysmaal-atriumfibrilleren-jama-car/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hariharan-sugumar","type":"person","url":"https://hartvaat.nl/mensen/hariharan-sugumar/","name":"Hariharan Sugumar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henrik-schmidt","type":"person","url":"https://hartvaat.nl/mensen/henrik-schmidt/","name":"Henrik Schmidt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hironori-hara","type":"person","url":"https://hartvaat.nl/mensen/hironori-hara/","name":"Hironori Hara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"huei-wang","type":"person","url":"https://hartvaat.nl/mensen/huei-wang/","name":"Huei Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hwee-teoh","type":"person","url":"https://hartvaat.nl/mensen/hwee-teoh/","name":"Hwee Teoh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ildiko-lingvay","type":"person","url":"https://hartvaat.nl/mensen/ildiko-lingvay/","name":"Ildiko Lingvay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2019/08/29/orale-semaglutide-en-cv-uitkomsten-bij-diabetes-type-2-nejm-pioneer-6/","published":"2019-08-29"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ingrid-a-m-gause-nilsson","type":"person","url":"https://hartvaat.nl/mensen/ingrid-a-m-gause-nilsson/","name":"Ingrid A M Gause-Nilsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2021/07/01/dapagliflozine-naar-nierfunctie-en-albuminurie-bij-diabetes-declare/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ioanna-kosmidou","type":"person","url":"https://hartvaat.nl/mensen/ioanna-kosmidou/","name":"Ioanna Kosmidou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-e-udelson","type":"person","url":"https://hartvaat.nl/mensen/james-e-udelson/","name":"James E Udelson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2020/10/20/praliciguat-en-piek-vo2-bij-hfpef-jama-capacity-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2019/01/15/lv-unloading-voor-reperfusie-bij-anterieure-stemi-dtu-stemi-pilot/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2017/03/21/kortetermijneffecten-van-tolvaptan-bij-acuut-hartfalen-met-volume-overbelasting/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/04/12/infarctgrootte-en-uitkomsten-na-primaire-pci-patientanalyse-uit-10-trials/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janine-poss","type":"person","url":"https://hartvaat.nl/mensen/janine-poss/","name":"Janine Pöss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jason-g-andrade","type":"person","url":"https://hartvaat.nl/mensen/jason-g-andrade/","name":"Jason G Andrade","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2023/05/30/complicaties-van-af-ablatie-actueel-overzicht/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/12/01/hartfalen-en-atriumflutter-systematische-review/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jasper-j-brugts","type":"person","url":"https://hartvaat.nl/mensen/jasper-j-brugts/","name":"Jasper J Brugts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/28/geen-sekseverschillen-in-werkzaamheid-van-hartfalenmedicatie-meta-analyse-van-13/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2025/08/14/hartfalen-mondiale-economische-ziektelast/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2025/04/01/socio-economische-ongelijkheid-en-hartfalenuitkomsten-systematische-review/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/14/telemonitoring-bij-hartfalen-meta-analyse-van-alle-strategieen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-s-berger","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-s-berger/","name":"Jeffrey S Berger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/07/01/timing-van-antihypertensiva-meta-analyse-van-rct-s-bevestigt-flexibiliteit/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jian-an-wang","type":"person","url":"https://hartvaat.nl/mensen/jian-an-wang/","name":"Jian'an Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/25/explorer-cn-week-78-langetermijneffect-en-veiligheid-van-mavacamten-bij-chinese-/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/09/vertraagde-afgifteformulering-van-ivabradine-bij-systolisch-hartfalen/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianjian-gong","type":"person","url":"https://hartvaat.nl/mensen/jianjian-gong/","name":"Jianjian Gong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianzeng-dong","type":"person","url":"https://hartvaat.nl/mensen/jianzeng-dong/","name":"Jianzeng Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukverlaging-bij-ongediagnosticeerde-hfpef-met-hoog-risico/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joann-e-manson","type":"person","url":"https://hartvaat.nl/mensen/joann-e-manson/","name":"JoAnn E Manson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/10/01/langetermijneffect-van-cacao-extract-op-incident-hypertensie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2023/01/01/vitamine-d-voorkomt-statine-gerelateerde-spierklachten-niet/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/12/21/langdurige-omega-3-suppletie-en-af-risico-meta-analyse-van-cv-trials/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/11/10/vitamine-d-omega-3-of-krachttraining-en-klinische-uitkomsten-bij-ouderen-jama-do/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2017/06/01/voedingsstatus-en-langetermijn-multivitaminegebruik-en-cv-risico-phs-ii-analyse/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-b-wong","type":"person","url":"https://hartvaat.nl/mensen/john-b-wong/","name":"John B Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-d-newman","type":"person","url":"https://hartvaat.nl/mensen/jonathan-d-newman/","name":"Jonathan D Newman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2023/07/01/timing-van-antihypertensiva-meta-analyse-van-rct-s-bevestigt-flexibiliteit/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/07/01/thuisluchtzuivering-en-bloeddruk-systematische-review/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/05/12/management-van-stabiel-coronairlijden-bij-diabetes-type-2-aha-scientific-stateme/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joo-myung-lee","type":"person","url":"https://hartvaat.nl/mensen/joo-myung-lee/","name":"Joo Myung Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josep-rodes-cabau","type":"person","url":"https://hartvaat.nl/mensen/josep-rodes-cabau/","name":"Josep Rodés-Cabau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/02/19/geleidingsstoornissen-na-transkatheter-aortaklepimplantatie/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-doac-versus-dapt-na-laa-occlusie-gerandomiseerde-trial/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-c-cleveland","type":"person","url":"https://hartvaat.nl/mensen/joseph-c-cleveland/","name":"Joseph C Cleveland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josephine-harrington","type":"person","url":"https://hartvaat.nl/mensen/josephine-harrington/","name":"Josephine Harrington","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/18/2025-acc-scientific-statement-obesitasmanagement-bij-hartfalen/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-p-s-henriques","type":"person","url":"https://hartvaat.nl/mensen/jose-p-s-henriques/","name":"José P S Henriques","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-ondersteuning-versus-iabp-bij-cardiogene-shock-meta-analys/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jyothis-t-george","type":"person","url":"https://hartvaat.nl/mensen/jyothis-t-george/","name":"Jyothis T George","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2020/01/07/hypoglykemie-cv-uitkomsten-en-empagliflozine-empa-reg-outcome/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/06/04/microvasculaire-ziekte-en-cv-events-bij-diabetes-type-2/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2019/04/30/empagliflozine-antihyperglycemische-en-bloeddrukeffecten-bij-zwarte-diabetespati/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/23/empagliflozine-bij-diabetes-type-2-met-perifeer-vaatlijden-empa-reg-outcome/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katherine-r-tuttle","type":"person","url":"https://hartvaat.nl/mensen/katherine-r-tuttle/","name":"Katherine R Tuttle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/10/nieuwe-medicamenteuze-therapieen-voor-hypertensie/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/23/semaglutide-vermindert-infectierisico-bij-diabetes-en-chronische-nierziekte/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/14/glp-1-receptoragonisten-en-de-volgende-generatie-incretinegebaseerde-middelen/","published":"2026-01-14"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kim-k-birtcher","type":"person","url":"https://hartvaat.nl/mensen/kim-k-birtcher/","name":"Kim K Birtcher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2022/10/04/2022-acc-expert-consensus-niet-statine-therapieen-voor-ldl-verlaging-bij-ascvd/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2017/10/03/2017-acc-gerichte-update-niet-statinetherapie-voor-ldl-verlaging/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kirkwood-f-adams","type":"person","url":"https://hartvaat.nl/mensen/kirkwood-f-adams/","name":"Kirkwood F Adams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2024/04/09/dapagliflozine-bij-acuut-hartfalen-effectiviteit-en-veiligheid/","published":"2024-04-09"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/03/21/werkzaamheid-en-veiligheid-van-tolvaptan-bij-gehospitaliseerd-acuut-hartfalen/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koon-k-teo","type":"person","url":"https://hartvaat.nl/mensen/koon-k-teo/","name":"Koon K Teo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/04/30/leefstijl-hba1c-en-overleving-bij-stabiel-coronairlijden-met-diabetes/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/11/01/gemiddelde-bloeddruk-en-visit-to-visit-variabiliteit-als-gecombineerde-voorspell/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kreton-mavromatis","type":"person","url":"https://hartvaat.nl/mensen/kreton-mavromatis/","name":"Kreton Mavromatis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leslie-l-davis","type":"person","url":"https://hartvaat.nl/mensen/leslie-l-davis/","name":"Leslie L Davis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/05/09/2023-acc-expert-consensus-management-van-hfpef/","published":"2023-05-09"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucas-lauder","type":"person","url":"https://hartvaat.nl/mensen/lucas-lauder/","name":"Lucas Lauder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/07/aldosteronsynthaseremming-bij-resistente-hypertensie-beloften-en-onzekerheden/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2026/02/27/bloeddruk-time-in-target-range-voorspelt-sterfte-bij-hypertensie/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maciej-banach","type":"person","url":"https://hartvaat.nl/mensen/maciej-banach/","name":"Maciej Banach","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/03/vochtbeperking-versus-liberale-inname-bij-hartfalen-meta-analyse-van-rct-s/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2022/09/07/prevalentie-van-statine-intolerantie-meta-analyse-nuanceert-het-probleem/","published":"2022-09-07"},{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2018/12/01/edoxaban-verhoogt-behandeltevredenheid-en-vermindert-zorggebruik-engage-af-timi-/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manish-saxena","type":"person","url":"https://hartvaat.nl/mensen/manish-saxena/","name":"Manish Saxena","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/08/05/lorundrostat-bij-ongecontroleerde-en-therapieresistente-hypertensie-fase-3-resul/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/07/01/kardia-2-zilebesiran-als-toevoeging-bij-ongecontroleerde-hypertensie-rct/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-h-drazner","type":"person","url":"https://hartvaat.nl/mensen/mark-h-drazner/","name":"Mark H Drazner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/17/glp-1-receptoragonisten-geassocieerd-met-lagere-mortaliteit-bij-hfref/","published":"2026-05-26"},{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martine-gilard","type":"person","url":"https://hartvaat.nl/mensen/martine-gilard/","name":"Martine Gilard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masafumi-ono","type":"person","url":"https://hartvaat.nl/mensen/masafumi-ono/","name":"Masafumi Ono","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-tebaldi","type":"person","url":"https://hartvaat.nl/mensen/matteo-tebaldi/","name":"Matteo Tebaldi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-r-weir","type":"person","url":"https://hartvaat.nl/mensen/matthew-r-weir/","name":"Matthew R Weir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2025/08/05/lorundrostat-bij-ongecontroleerde-en-therapieresistente-hypertensie-fase-3-resul/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"},{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/04/06/nierfunctiebeoordeling-en-eindpuntbepaling-in-klinische-trials-ehj/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2019/08/01/empagliflozine-voorkomt-progressie-van-ckd-empa-reg-outcome-renale-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/09/01/patiromer-verlaagt-aldosteron-bij-ckd-patienten-met-hyperkaliemie-op-raas-remmer/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mattia-branca","type":"person","url":"https://hartvaat.nl/mensen/mattia-branca/","name":"Mattia Branca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-a-blazing","type":"person","url":"https://hartvaat.nl/mensen/michael-a-blazing/","name":"Michael A Blazing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/10/12/baseline-ldl-en-klinische-uitkomsten-van-ezetimibe-plus-statine-improve-it/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2019/09/01/simvastatine-ezetimibe-versus-simvastatine-na-acs-bij-75-plussers-jama-cardiolog/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/04/10/ezetimibe-bij-diabetes-versus-zonder-diabetes-improve-it-subanalyse/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/12/21/ezetimibe-bij-post-cabg-patienten-met-acs-improve-it-subanalyse/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-foley","type":"person","url":"https://hartvaat.nl/mensen/michael-j-foley/","name":"Michael J Foley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-joner","type":"person","url":"https://hartvaat.nl/mensen/michael-joner/","name":"Michael Joner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2017/10/01/pci-versus-cabg-bij-linker-hoofdstamstenose-jama-cardiology-systematische-review/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-komajda","type":"person","url":"https://hartvaat.nl/mensen/michel-komajda/","name":"Michel Komajda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/12/01/gunstige-effecten-van-ivabradine-bij-hf-met-lage-ef-en-hartfrequentie-77-bpm/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-c-williams","type":"person","url":"https://hartvaat.nl/mensen/michelle-c-williams/","name":"Michelle C Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/02/03/klinische-risicopredictie-ct-coronairangiografie-en-cv-events-bij-nieuwe-angina/","published":"2025-02-03"},{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2020/08/01/inspannings-ecg-versus-ccta-bij-stabiele-angina-post-hoc-vergelijking/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morgan-e-grams","type":"person","url":"https://hartvaat.nl/mensen/morgan-e-grams/","name":"Morgan E. Grams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2026/03/03/kdigo-versnelt-richtlijnontwikkeling-voor-nierziekten/","published":"2026-03-27"},{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2026/02/18/groene-dialyse-duurzame-zorg-groei-en-innovatie-kdigo-conferentie/","published":"2026-02-18"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2016/02/04/risicoprojectie-voor-nierfalen-bij-levende-nierdonorkandidaten/","published":"2016-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nancy-r-cook","type":"person","url":"https://hartvaat.nl/mensen/nancy-r-cook/","name":"Nancy R Cook","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2024/12/05/inflammatie-cholesterol-lp-a-en-30-jaars-cv-uitkomsten-bij-vrouwen/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2023/01/01/vitamine-d-voorkomt-statine-gerelateerde-spierklachten-niet/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/12/21/langdurige-omega-3-suppletie-en-af-risico-meta-analyse-van-cv-trials/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/05/05/triglyceriderijk-lipoproteinecholesterol-small-dense-ldl-en-cv-events/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2016/10/11/natriuminname-en-totale-mortaliteit-over-20-jaar-trials-of-hypertension-preventi/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"narimon-honarpour","type":"person","url":"https://hartvaat.nl/mensen/narimon-honarpour/","name":"Narimon Honarpour","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/07/10/inflammatie-en-cholesterol-in-de-fourier-trial/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/05/04/evolocumab-en-klinische-uitkomsten-bij-cardiovasculaire-ziekte-nejm-fourier/","published":"2017-05-04"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-e-bruun","type":"person","url":"https://hartvaat.nl/mensen/niels-e-bruun/","name":"Niels E Bruun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/11/20/kaliumverhoging-bij-hoogrisicopatienten-voor-ventriculaire-aritmieen-rct/","published":"2025-11-20"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"oskar-angeras","type":"person","url":"https://hartvaat.nl/mensen/oskar-angeras/","name":"Oskar Angerås","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-m-moriarty","type":"person","url":"https://hartvaat.nl/mensen/patrick-m-moriarty/","name":"Patrick M Moriarty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/19/lipoproteine-aferese-blijft-relevant-in-het-tijdperk-van-pcsk9-remmers-en-sirna/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-t-o-gara","type":"person","url":"https://hartvaat.nl/mensen/patrick-t-o-gara/","name":"Patrick T O'Gara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-a-gurbel","type":"person","url":"https://hartvaat.nl/mensen/paul-a-gurbel/","name":"Paul A Gurbel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/01/24/pcsk9-remming-bij-covid-19-anti-inflammatoir-potentieel-onderzocht/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/03/16/plaatjesreactiviteit-bij-acs-in-afwachting-van-chirurgische-revascularisatie/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2018/04/17/uitgangs-ldl-en-mortaliteitsreductie-na-ldl-verlaging-jama-meta-analyse/","published":"2018-04-17"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-e-carson","type":"person","url":"https://hartvaat.nl/mensen/peter-e-carson/","name":"Peter E Carson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-held","type":"person","url":"https://hartvaat.nl/mensen/peter-held/","name":"Peter Held","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-jarolim","type":"person","url":"https://hartvaat.nl/mensen/petr-jarolim/","name":"Petr Jarolim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/08/08/canagliflozine-en-cardiovasculaire-biomarkers-bij-oudere-diabetespatienten/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/07/19/serieel-cardiaal-troponine-met-hoog-sensitieve-assay-bij-stabiel-ischemisch-hart/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierpaolo-pellicori","type":"person","url":"https://hartvaat.nl/mensen/pierpaolo-pellicori/","name":"Pierpaolo Pellicori","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/04/congestie-bij-chronisch-hartfalen-echografie-vult-klinisch-onderzoek-aan-en-voor/","published":"2026-07-01"},{"url":"https://hartvaat.nl/2026/05/11/ehj-editorial-cleland-wereldwijde-hartfalenprevalentie-overschrijdt-600-miljoen-/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2016/04/01/effect-van-extra-zuurstof-op-inspanningsprestatie-bij-chronisch-hartfalen/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"r-scott-wright","type":"person","url":"https://hartvaat.nl/mensen/r-scott-wright/","name":"R Scott Wright","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/07/22/victorion-initiate-inclisiran-monotherapie-bij-patienten-zonder-ascvd/","published":"2025-07-22"},{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-fase-3-bij-verhoogd-ldl-nejm-orion-10-en-orion-11/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2019/11/01/inclisiran-1-of-2-dosis-en-ldl-cholesterol-orion-1-1-jaarsfollow-up/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/09/25/sirna-tegen-pcsk9-en-atherogene-lipoproteinen-orion-1-secundaire-eindpunten/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raffaele-piccolo","type":"person","url":"https://hartvaat.nl/mensen/raffaele-piccolo/","name":"Raffaele Piccolo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/04/07/statines-en-niet-statine-ldl-verlagers-en-cardiovasculaire-uitkomsten-meta-analy/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"},{"url":"https://hartvaat.nl/2016/08/16/intracoronair-abciximab-bij-diabetespatienten-met-primaire-pci-1-jaarsresultaten/","published":"2016-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajeev-k-pathak","type":"person","url":"https://hartvaat.nl/mensen/rajeev-k-pathak/","name":"Rajeev K Pathak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/12/01/langetermijnmortaliteit-bij-hfmref-systematische-review-en-meta-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"renate-b-schnabel","type":"person","url":"https://hartvaat.nl/mensen/renate-b-schnabel/","name":"Renate B Schnabel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/05/01/predictiemodellen-voor-af-in-de-community-meta-analyse/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-d-brook","type":"person","url":"https://hartvaat.nl/mensen/robert-d-brook/","name":"Robert D Brook","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/19/mobiele-screeningseenheid-in-detroit-70-van-inwoners-in-achtergestelde-wijken-he/","published":"2026-06-11"},{"url":"https://hartvaat.nl/2021/09/01/ace-remmer-plus-calciumantagonist-bij-zwarte-hypertensieve-patienten/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/03/03/verminderde-verkeersgerelateerde-luchtvervuiling-en-bloeddruk-gerandomiseerde-cr/","published":"2021-03-03"},{"url":"https://hartvaat.nl/2018/11/01/therapieresistente-hypertensie-aha-scientific-statement-over-detectie-evaluatie-/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/04/30/fluticason-vilanterol-en-overleving-bij-copd-met-verhoogd-cardiovasculair-risico/","published":"2016-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rodrigo-modolo","type":"person","url":"https://hartvaat.nl/mensen/rodrigo-modolo/","name":"Rodrigo Modolo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2021/06/01/serumkalium-en-prognose-bij-symptomatisch-hf/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roger-s-blumenthal","type":"person","url":"https://hartvaat.nl/mensen/roger-s-blumenthal/","name":"Roger S Blumenthal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/03/16/the-lancet-commentaar-vroege-atheroma-preventie-als-kosteneffectieve-route-naar-/","published":"2026-04-28"},{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2021/06/01/geisoleerde-diastolische-hypertensie-cohort-en-meta-analyse-voor-behandeldrempel/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/01/16/intraveneus-fentanyl-en-ticagrelorabsorptie-bij-pci/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-m-o-brien","type":"person","url":"https://hartvaat.nl/mensen/sean-m-o-brien/","name":"Sean M O'Brien","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastian-zimmer","type":"person","url":"https://hartvaat.nl/mensen/sebastian-zimmer/","name":"Sebastian Zimmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shao-liang-chen","type":"person","url":"https://hartvaat.nl/mensen/shao-liang-chen/","name":"Shao-Liang Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"soon-jun-hong","type":"person","url":"https://hartvaat.nl/mensen/soon-jun-hong/","name":"Soon Jun Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-stork","type":"person","url":"https://hartvaat.nl/mensen/stefan-stork/","name":"Stefan Störk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2019/04/01/spironolacton-en-lv-massa-bij-hemodialysepatienten-gerandomiseerde-trial/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/02/01/herhaalde-levosimendan-infusies-bij-gevorderd-chronisch-hf-in-de-kwetsbare-postd/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-b-felix","type":"person","url":"https://hartvaat.nl/mensen/stephan-b-felix/","name":"Stephan B Felix","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2018/12/01/ularitide-en-andere-vasoactieve-stoffen-bij-acuut-hf-systematische-review/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-b-heitner","type":"person","url":"https://hartvaat.nl/mensen/stephen-b-heitner/","name":"Stephen B Heitner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-c-bain","type":"person","url":"https://hartvaat.nl/mensen/stephen-c-bain/","name":"Stephen C Bain","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/12/20/orforglipron-bij-obesitas-nejm-definitieve-fase-3-resultaten/","published":"2025-12-20"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/12/01/eerste-en-recidiverende-cv-events-met-liraglutide-bij-diabetes-type-2-leader/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/29/orale-semaglutide-en-cv-uitkomsten-bij-diabetes-type-2-nejm-pioneer-6/","published":"2019-08-29"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-e-kahn","type":"person","url":"https://hartvaat.nl/mensen/steven-e-kahn/","name":"Steven E Kahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2021/11/13/tirzepatide-versus-insuline-glargine-bij-diabetes-type-2-met-hoog-cv-risico-lanc/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stylianos-tzeis","type":"person","url":"https://hartvaat.nl/mensen/stylianos-tzeis/","name":"Stylianos Tzeis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2026/05/06/circulerend-mir-10b-5p-voorspelt-af-recidief-na-ablatie/","published":"2026-05-06"},{"url":"https://hartvaat.nl/2026/03/30/linear-trial-lattice-tip-katheter-verslaat-standaard-irrigatie-bij-cti-ablatie-v/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/af-ablatie-timing-naar-af-duur-impact-op-aritmierecidief/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/02/08/voorspellers-van-af-recidief-na-ablatie-en-cardioversie-umbrella-review/","published":"2023-02-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"svend-eggert-jensen","type":"person","url":"https://hartvaat.nl/mensen/svend-eggert-jensen/","name":"Svend Eggert Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2018/12/04/ffr-versus-angiografie-geleide-cabg/","published":"2018-12-04"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-kellerth","type":"person","url":"https://hartvaat.nl/mensen/thomas-kellerth/","name":"Thomas Kellerth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-munzel","type":"person","url":"https://hartvaat.nl/mensen/thomas-munzel/","name":"Thomas Münzel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/02/26/cardiologen-onderschatten-omgevingsrisicofactoren/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/01/20/milieustressoren-en-cardiovasculaire-gezondheid-gezamenlijk-statement-esc-acc-ah/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/09/01/clopidogrel-versus-prasugrel-versus-ticagrelor-op-endotheelfunctie-en-inflammati/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2016/03/01/bioresorbeerbare-scaffold-trombose-multicenteranalyse-van-klinische-presentatie-/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobias-geisler","type":"person","url":"https://hartvaat.nl/mensen/tobias-geisler/","name":"Tobias Geisler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ton-oude-ophuis","type":"person","url":"https://hartvaat.nl/mensen/ton-oude-ophuis/","name":"Ton Oude Ophuis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vojtech-melenovsky","type":"person","url":"https://hartvaat.nl/mensen/vojtech-melenovsky/","name":"Vojtěch Melenovský","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/27/nierfunctiestoornis-verergert-pulmonale-vaatziekte-bij-hfpef/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/08/06/doac-bij-heartmate-3-lvad-eerste-gerandomiseerde-trial/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2017/07/11/arteriele-verstijving-bij-inspanning-bij-hfpef/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"walter-p-abhayaratna","type":"person","url":"https://hartvaat.nl/mensen/walter-p-abhayaratna/","name":"Walter P Abhayaratna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/01/pneumokokkenvaccinatie-en-cv-eventpreventie-ipd-meta-analyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/06/01/bloeddrukverlaging-bij-centrale-hypertensie-gerandomiseerde-trial/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2022/12/01/langetermijnmortaliteit-bij-hfmref-systematische-review-en-meta-analyse/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wolfram-doehner","type":"person","url":"https://hartvaat.nl/mensen/wolfram-doehner/","name":"Wolfram Doehner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":9,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/12/01/ijzercarboxymaltose-bij-ijzerdeficient-hartfalen-meta-analyse/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abhinav-sharma","type":"person","url":"https://hartvaat.nl/mensen/abhinav-sharma/","name":"Abhinav Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/22/kosteneffectiviteit-van-sglt2-remmers-en-glp-1-agonisten-bij-hoog-cardiovasculai/","published":"2026-02-22"},{"url":"https://hartvaat.nl/2025/08/05/sglt2-remmer-met-en-zonder-mra-bij-hartfalen-gecombineerde-analyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/02/01/geschiktheid-voor-sglt2-remmers-bij-diabetespatienten-opgenomen-met-hartfalen/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-quan","type":"person","url":"https://hartvaat.nl/mensen/adrian-quan/","name":"Adrian Quan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-aimo","type":"person","url":"https://hartvaat.nl/mensen/alberto-aimo/","name":"Alberto Aimo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/06/22/cardiale-amyloidose-komt-frequent-voor-bij-hfpef-aortastenose-en-lvh-meta-analys/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/05/05/sterftecijfers-in-controle-armen-van-hartfalen-rcts-dalen-niet-ondanks-betere-ac/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2025/01/01/atriale-mechanische-contractie-voorspelt-cerebrovasculair-risico-bij-transthyret/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/serum-transthyretine-voor-en-na-tafamidisstart-als-uitkomstvoorspeller-bij-attr-/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/12/01/colica-colchicine-bij-acuut-gedecompenseerd-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2018/05/01/crt-voordeel-bij-concordant-versus-discordant-linksbundeltakblok-esc-hf-pilot/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-h-krist","type":"person","url":"https://hartvaat.nl/mensen/alex-h-krist/","name":"Alex H Krist","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-jobs","type":"person","url":"https://hartvaat.nl/mensen/alexander-jobs/","name":"Alexander Jobs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandre-b-cavalcanti","type":"person","url":"https://hartvaat.nl/mensen/alexandre-b-cavalcanti/","name":"Alexandre B Cavalcanti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2016/01/07/preoperatief-statinegebruik-en-cardiovasculaire-complicaties-bij-niet-cardiale-c/","published":"2016-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amit-v-khera","type":"person","url":"https://hartvaat.nl/mensen/amit-v-khera/","name":"Amit V Khera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/10/genprobcad-gecombineerde-monogene-en-polygene-risicobepaling-voor-coronairlijden/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2019/06/25/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn-jacc/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2017/06/20/cholesteroleffluxcapaciteit-hdl-deeltjesaantal-en-cv-events-jupiter-analyse/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-rillig","type":"person","url":"https://hartvaat.nl/mensen/andreas-rillig/","name":"Andreas Rillig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2023/05/19/east-afnet-4-vroege-ritmecontrole-bij-af-is-kosteneffectief/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrejs-erglis","type":"person","url":"https://hartvaat.nl/mensen/andrejs-erglis/","name":"Andrejs Erglis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-r-chapman","type":"person","url":"https://hartvaat.nl/mensen/andrew-r-chapman/","name":"Andrew R Chapman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/01/13/risicofactoren-voor-type-1-en-type-2-mi/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andres-iniguez","type":"person","url":"https://hartvaat.nl/mensen/andres-iniguez/","name":"Andrés Iñiguez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ann-marie-navar","type":"person","url":"https://hartvaat.nl/mensen/ann-marie-navar/","name":"Ann Marie Navar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/19/victorion-inception-vroege-inclisiran-na-acuut-coronair-syndroom-verviervoudigt-/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2026/02/05/orale-pcsk9-remmer-enlicitide-verlaagt-ldl-met-57-placebogecontroleerde-trial/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/13/enlicitide-orale-pcsk9-remmer-bij-heterozygote-fh-fase-3/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/01/21/muvalaplin-orale-lp-a-verlaging-nejm-gerandomiseerde-trial/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2018/12/01/cardiovasculaire-risicocommunicatie-en-patientperceptie-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-freund","type":"person","url":"https://hartvaat.nl/mensen/anne-freund/","name":"Anne Freund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/01/01/coact-trial-langetermijnlessen-over-coronairangiografie-na-reanimatie/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-p-carnicelli","type":"person","url":"https://hartvaat.nl/mensen/anthony-p-carnicelli/","name":"Anthony P Carnicelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arend-mosterd","type":"person","url":"https://hartvaat.nl/mensen/arend-mosterd/","name":"Arend Mosterd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-r-chaitman","type":"person","url":"https://hartvaat.nl/mensen/bernard-r-chaitman/","name":"Bernard R Chaitman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carina-blomstrom-lundqvist","type":"person","url":"https://hartvaat.nl/mensen/carina-blomstrom-lundqvist/","name":"Carina Blomström-Lundqvist","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/10/07/vroege-substraatablatie-versus-antiaritmica-bij-vt-gerandomiseerde-trial/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2023/01/11/inadequate-noac-dosering-bij-af-uitkomsten-en-oorzaken-meta-analyse/","published":"2023-01-11"},{"url":"https://hartvaat.nl/2019/03/19/katheterablatie-versus-antiaritmica-en-kwaliteit-van-leven-bij-af-jama-captaf/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/11/01/kwaliteit-van-leven-na-mitralisklepchirurgie-met-en-zonder-epicardiale-cryoablat/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/01/enkele-versus-dubbele-cryoballon-applicatie-bij-af-effectiviteit-en-veiligheid/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-a-morillo","type":"person","url":"https://hartvaat.nl/mensen/carlos-a-morillo/","name":"Carlos A Morillo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2020/10/27/af-ablatie-met-vena-van-marshall-ethanol-versus-ablatie-alleen-jama-venus/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2017/07/01/werkzaamheid-van-katheterablatie-bij-niet-paroxysmaal-atriumfibrilleren-jama-car/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chan-joon-kim","type":"person","url":"https://hartvaat.nl/mensen/chan-joon-kim/","name":"Chan Joon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chao-jiang","type":"person","url":"https://hartvaat.nl/mensen/chao-jiang/","name":"Chao Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukverlaging-bij-ongediagnosticeerde-hfpef-met-hoog-risico/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chim-c-lang","type":"person","url":"https://hartvaat.nl/mensen/chim-c-lang/","name":"Chim C Lang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2020/11/03/sglt2-remming-plus-lisdiuretica-bij-diabetes-type-2-met-ckd-renale-en-cv-effecte/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/09/21/dapagliflozine-op-lv-hypertrofie-bij-diabetes-type-2-dapa-lvh-gerandomiseerde-tr/","published":"2020-09-21"},{"url":"https://hartvaat.nl/2019/11/01/metformine-en-linkerventrikelhypertrofie-bij-coronairlijden-zonder-diabetes-gera/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/02/12/genetisch-risico-op-coronairlijden-en-ontwikkeling-van-hfref-versus-hfpef/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-jung","type":"person","url":"https://hartvaat.nl/mensen/christian-jung/","name":"Christian Jung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-leclercq","type":"person","url":"https://hartvaat.nl/mensen/christophe-leclercq/","name":"Christophe Leclercq","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/03/uitgebreide-versus-standaard-remote-monitoring-bij-crt-en-hartfalen/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"},{"url":"https://hartvaat.nl/2016/02/01/rechterkamerseptumpacing-versus-apexpacing-bij-crt-defibrillator-gerandomiseerde/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-edwards","type":"person","url":"https://hartvaat.nl/mensen/christopher-edwards/","name":"Christopher Edwards","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/16/natrium-hf-subanalyse-natriuretische-peptiden-lopen-achter-op-de-klinische-ontst/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-m-kramer","type":"person","url":"https://hartvaat.nl/mensen/christopher-m-kramer/","name":"Christopher M Kramer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/07/29/summit-bmi-centrale-adipositas-en-gewichtsverlies-beinvloeden-tirzepatide-effect/","published":"2025-07-29"},{"url":"https://hartvaat.nl/2025/05/13/summit-tirzepatide-en-ckd-interactie-bij-hfpef-met-obesitas/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ciaran-j-mcmullan","type":"person","url":"https://hartvaat.nl/mensen/ciaran-j-mcmullan/","name":"Ciaran J McMullan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2017/05/01/melatoninesecretie-en-myocardinfarctrisico-geneste-case-controlstudie/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/02/01/urinezuurverlagende-middelen-en-endotheelfunctie-gerandomiseerde-trial/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudio-tondo","type":"person","url":"https://hartvaat.nl/mensen/claudio-tondo/","name":"Claudio Tondo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cordula-zeller","type":"person","url":"https://hartvaat.nl/mensen/cordula-zeller/","name":"Cordula Zeller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-en-renale-uitkomsten-bij-hartfalen-nejm-emperor-reduced-renal/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2016/12/01/empagliflozine-en-bloeddruk-bij-diabetes-type-2-met-hypertensie-naar-achtergrond/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-burkhoff","type":"person","url":"https://hartvaat.nl/mensen/daniel-burkhoff/","name":"Daniel Burkhoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-j-goldstein","type":"person","url":"https://hartvaat.nl/mensen/daniel-j-goldstein/","name":"Daniel J Goldstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-scherr","type":"person","url":"https://hartvaat.nl/mensen/daniel-scherr/","name":"Daniel Scherr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/02/03/varipure-studie-pulsed-field-ablatie-in-de-dagelijkse-af-praktijk/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniele-giacoppo","type":"person","url":"https://hartvaat.nl/mensen/daniele-giacoppo/","name":"Daniele Giacoppo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/08/18/glp-1-agonisten-verlagen-cardiovasculaire-risicos-bij-diabetes-en-obesitas-overz/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2024/04/02/ivus-versus-oct-versus-angiografie-voor-pci-begeleiding-meta-analyse/","published":"2024-04-02"},{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2017/10/01/pci-versus-cabg-bij-linker-hoofdstamstenose-jama-cardiology-systematische-review/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-chieng","type":"person","url":"https://hartvaat.nl/mensen/david-chieng/","name":"David Chieng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-moliterno","type":"person","url":"https://hartvaat.nl/mensen/david-j-moliterno/","name":"David J Moliterno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-l-demets","type":"person","url":"https://hartvaat.nl/mensen/david-l-demets/","name":"David L DeMets","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deok-kyu-cho","type":"person","url":"https://hartvaat.nl/mensen/deok-kyu-cho/","name":"Deok-Kyu Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dhanunjaya-lakkireddy","type":"person","url":"https://hartvaat.nl/mensen/dhanunjaya-lakkireddy/","name":"Dhanunjaya Lakkireddy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"},{"url":"https://hartvaat.nl/2018/01/01/linkeratriumvolume-voorspelt-af-recidief-na-radiofrequentieablatie-meta-analyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diana-a-gorog","type":"person","url":"https://hartvaat.nl/mensen/diana-a-gorog/","name":"Diana A Gorog","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2026/02/23/het-jaar-in-de-cardiovasculaire-geneeskunde-2025-top-10-publicaties-ischemische-/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2023/01/24/pcsk9-remming-bij-covid-19-anti-inflammatoir-potentieel-onderzocht/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dion-stub","type":"person","url":"https://hartvaat.nl/mensen/dion-stub/","name":"Dion Stub","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/10/14/lignocaine-versus-opioiden-op-antiplaatjeseffect-van-ticagrelor-local-trial/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2020/11/24/vroege-coronairangiografie-versus-uitstel-na-hartstilstand-zonder-st-elevatie-pi/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/03/01/ambulancedienst-vertragingen-bij-stemi-meta-analyse/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2018/10/01/zuurstof-bij-verdenking-acuut-mi-meta-analyse-van-gerandomiseerde-trials/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/03/01/effect-van-aanvullende-zuurstoftoediening-op-myocardschade-bij-stemi/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"domenico-d-amario","type":"person","url":"https://hartvaat.nl/mensen/domenico-d-amario/","name":"Domenico D'Amario","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2026/03/24/myocardiale-brug-praktische-gids-voor-diagnose-en-behandeling-in-het-ccta-tijdpe/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2026/02/03/vroeg-starten-met-mra-na-acuut-hartfalen-of-myocardinfarct-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/07/09/coronaire-plaquefenotypeveranderingen-bij-lipidenverlagende-therapie-en-cardiova/","published":"2025-07-09"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2022/07/21/permanente-pacemaker-na-tavi-langetermijneffect-op-klinische-uitkomsten/","published":"2022-07-21"},{"url":"https://hartvaat.nl/2021/04/17/geleide-versus-standaard-antiplaatjestherapie-na-pci-lancet-meta-analyse/","published":"2021-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-guillaume-baudry","type":"person","url":"https://hartvaat.nl/mensen/dr-guillaume-baudry/","name":"Dr. Guillaume Baudry","title":"Cardioloog, CHRU Nancy, Frankrijk","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/08/18/tafamidis-bij-attr-cardiomyopathie-kosteffectiviteit-onder-de-maat-in-vier-europ/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/09/uf-care-trial-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-geen-significante-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/23/paradise-cohort-hartfalen-en-copd-samen-verhogen-de-langetermijnmortaliteit-met-/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/05/10/paradise-gelijktijdig-acuut-hartfalen-plus-luchtweginfectie-verhoogt-sterfte-tij/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-versus-tirzepatide-bij-patienten-met-obesitas-en-hfpef/","published":"2026-02-03"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/uf-care-ultrafiltratie-cardiorenaal/","title":"UF-CARE — Ultrafiltratie bij type-2 cardiorenaal syndroom"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edimar-alcides-bocchi","type":"person","url":"https://hartvaat.nl/mensen/edimar-alcides-bocchi/","name":"Edimar Alcides Bocchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/17/answer-hf-sacubitril-valsartan-versus-enalapril-bij-chagas-hf-primaire-resultate/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2018/06/01/ivabradine-bij-hartfalen-door-chagas-ziekte-shift-post-hoc-analyse/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edward-p-gerstenfeld","type":"person","url":"https://hartvaat.nl/mensen/edward-p-gerstenfeld/","name":"Edward P Gerstenfeld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/27/decaf-cafeinehoudende-koffie-en-af-gerandomiseerde-trial/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/07/02/pfa-versus-thermale-ablatie-bij-paroxysmaal-af-aritmielastanalyse/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edwin-j-r-van-beek","type":"person","url":"https://hartvaat.nl/mensen/edwin-j-r-van-beek/","name":"Edwin J R van Beek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2020/08/01/inspannings-ecg-versus-ccta-bij-stabiele-angina-post-hoc-vergelijking/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emile-ferrari","type":"person","url":"https://hartvaat.nl/mensen/emile-ferrari/","name":"Emile Ferrari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emma-svennberg","type":"person","url":"https://hartvaat.nl/mensen/emma-svennberg/","name":"Emma Svennberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/12/03/nt-probnp-en-ecg-screening-bij-75-jarigen-voor-af-detectie-rct/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/01/14/strokestop-af-screening-is-kosteneffectief-bij-75-76-jarigen/","published":"2023-01-14"},{"url":"https://hartvaat.nl/2021/10/23/systematische-af-screening-en-klinische-uitkomsten-lancet-strokestop/","published":"2021-10-23"},{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/08/01/nt-probnp-bij-systematische-screening-op-atriumfibrilleren/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/02/01/stapsgewijze-massascreening-op-af-met-nt-probnp-strokestop-ii-studieontwerp/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"farzin-beygui","type":"person","url":"https://hartvaat.nl/mensen/farzin-beygui/","name":"Farzin Beygui","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ferdinando-varbella","type":"person","url":"https://hartvaat.nl/mensen/ferdinando-varbella/","name":"Ferdinando Varbella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"finnian-r-mc-causland","type":"person","url":"https://hartvaat.nl/mensen/finnian-r-mc-causland/","name":"Finnian R Mc Causland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/12/matige-koffiedrinken-waarschijnlijk-veilig-en-mogelijk-gunstig-bij-chronische-ni/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/03/01/deliver-dapagliflozine-vermindert-plotse-hartdood-bij-verbeterde-ef/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-franchi","type":"person","url":"https://hartvaat.nl/mensen/francesco-franchi/","name":"Francesco Franchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/04/17/geleide-versus-standaard-antiplaatjestherapie-na-pci-lancet-meta-analyse/","published":"2021-04-17"},{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/03/15/plaatjesremming-met-ticagrelor-60-mg-versus-90-mg-in-de-pegasus-timi-54-trial/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/02/16/ticagrelor-versus-clopidogrel-bij-troponine-negatieve-laagrisico-acs-met-ad-hoc-/","published":"2016-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-l-j-visseren","type":"person","url":"https://hartvaat.nl/mensen/frank-l-j-visseren/","name":"Frank L J Visseren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/10/01/smartphone-app-thuisbloeddrukmeting-versus-kantoor-en-ambulante-meting/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/01/01/plasmatrogconcentraties-van-antihypertensiva-voor-therapietrouwbeoordeling-meta-/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2018/10/01/geschat-individueel-levensvoordeel-van-pcsk9-remming-bij-statinebehandelde-cad-p/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frans-h-rutten","type":"person","url":"https://hartvaat.nl/mensen/frans-h-rutten/","name":"Frans H Rutten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/05/nederlandse-huisartsenpost-1-op-20-contacten-voor-benauwdheid-betreft-hartfalen-/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/01/23/switchen-van-vka-naar-noac-bij-fragiele-ouderen-met-af-veilig/","published":"2024-01-23"},{"url":"https://hartvaat.nl/2021/10/01/apothekerzorg-bij-poliklinisch-hf-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/08/07/geintegreerd-af-management-in-de-huisartsenpraktijk-all-in-clustergerandomiseerd/","published":"2020-08-07"},{"url":"https://hartvaat.nl/2018/08/01/opportunistische-hf-screening-met-natriuretische-peptiden-bij-af-ipd-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francois-schiele","type":"person","url":"https://hartvaat.nl/mensen/francois-schiele/","name":"François Schiele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gary-s-mintz","type":"person","url":"https://hartvaat.nl/mensen/gary-s-mintz/","name":"Gary S Mintz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianfranco-parati","type":"person","url":"https://hartvaat.nl/mensen/gianfranco-parati/","name":"Gianfranco Parati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/01/cardioselectieve-betablokkers-veilig-en-nuttig-bij-copd-systematische-review/","published":"2026-08-01"},{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2022/10/01/inspanningshemodynamiek-bij-hfpef-systematische-review-en-meta-analyse/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2021/02/01/therapietrouw-aan-single-pill-versus-vrije-combinatietherapie-bij-hypertensie-me/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/06/01/arb-versus-calciumantagonist-bloeddrukprofiel-en-klinische-effecten-vergelijking/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giles-roditi","type":"person","url":"https://hartvaat.nl/mensen/giles-roditi/","name":"Giles Roditi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giora-weisz","type":"person","url":"https://hartvaat.nl/mensen/giora-weisz/","name":"Giora Weisz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulio-g-stefanini","type":"person","url":"https://hartvaat.nl/mensen/giulio-g-stefanini/","name":"Giulio G Stefanini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-tarantini","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-tarantini/","name":"Giuseppe Tarantini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-m-marcus","type":"person","url":"https://hartvaat.nl/mensen/gregory-m-marcus/","name":"Gregory M Marcus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/27/decaf-cafeinehoudende-koffie-en-af-gerandomiseerde-trial/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/10/21/dieet-en-af-risico-systematische-review/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2023/06/01/intensieve-bloeddrukcontrole-en-geleidingsziekten-sprint-post-hoc-analyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/02/01/geindividualiseerde-triggerstudies-bij-paroxysmaal-af-jama-i-stop-afib/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2016/04/01/orale-antistolling-bij-atriumfibrilleren-over-het-spectrum-van-beroerterisico-ga/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hakim-moulay-dehbi","type":"person","url":"https://hartvaat.nl/mensen/hakim-moulay-dehbi/","name":"Hakim-Moulay Dehbi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2025/01/01/ffr-versus-ifr-bij-coronaire-revascularisatie-vijfjaars-follow-up/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"haran-burri","type":"person","url":"https://hartvaat.nl/mensen/haran-burri/","name":"Haran Burri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/02/03/intracardiale-elektrogrammen-bij-perforatie-tijdens-linkerbundeltakpacing/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"},{"url":"https://hartvaat.nl/2018/05/01/risicostratificatie-met-geintegreerde-devicediagnostiek-bij-hartfalen/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helen-m-colhoun","type":"person","url":"https://hartvaat.nl/mensen/helen-m-colhoun/","name":"Helen M Colhoun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2017/12/21/lilrb5-variant-geassocieerd-met-statine-intolerantie-en-myalgie/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2016/10/14/geen-effect-van-pcsk9-remmer-alirocumab-op-diabetes-incidentie-odyssey-analyse/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henry-krum","type":"person","url":"https://hartvaat.nl/mensen/henry-krum/","name":"Henry Krum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"},{"url":"https://hartvaat.nl/2016/04/21/aliskiren-enalapril-of-de-combinatie-bij-hartfalen-nejm-atmosphere-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henry-n-ginsberg","type":"person","url":"https://hartvaat.nl/mensen/henry-n-ginsberg/","name":"Henry N Ginsberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2020/04/28/apabetalone-en-cv-events-bij-acs-met-diabetes-type-2-jama-betonmace/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2020/02/11/haptoglobinefenotype-wijzigt-het-effect-van-intensieve-glycemische-controle-op-c/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/12/13/alirocumab-en-reductie-in-atherogene-lipiden-en-cardiovasculaire-events-10-odyss/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/10/14/geen-effect-van-pcsk9-remmer-alirocumab-op-diabetes-incidentie-odyssey-analyse/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hirotoshi-watanabe","type":"person","url":"https://hartvaat.nl/mensen/hirotoshi-watanabe/","name":"Hirotoshi Watanabe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hisao-ogawa","type":"person","url":"https://hartvaat.nl/mensen/hisao-ogawa/","name":"Hisao Ogawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"},{"url":"https://hartvaat.nl/2019/06/07/febuxostat-voor-cerebraal-en-cardiorenovasculaire-eventpreventie-freed/","published":"2019-06-07"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/02/14/laaggedoseerde-aspirine-voor-primaire-cardiovasculaire-preventie-bij-diabetes-ty/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hugh-calkins","type":"person","url":"https://hartvaat.nl/mensen/hugh-calkins/","name":"Hugh Calkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/07/02/pfa-versus-thermale-ablatie-bij-paroxysmaal-af-aritmielastanalyse/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/02/amaze-pvi-met-of-zonder-laa-ligatie-bij-af-jama-rct/","published":"2024-04-02"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hector-bueno","type":"person","url":"https://hartvaat.nl/mensen/hector-bueno/","name":"Héctor Bueno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2018/12/21/culprit-shock-integratie-in-2017-esc-stemi-richtlijn-richtlijncommissie-standpun/","published":"2018-12-21"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-j-kulac","type":"person","url":"https://hartvaat.nl/mensen/ian-j-kulac/","name":"Ian J Kulac","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ioanna-gouni-berthold","type":"person","url":"https://hartvaat.nl/mensen/ioanna-gouni-berthold/","name":"Ioanna Gouni-Berthold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/01/vitamine-d-en-mortaliteit-bij-hartfalen-de-evita-3-jaars-gerandomiseerde-trial/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacek-kubica","type":"person","url":"https://hartvaat.nl/mensen/jacek-kubica/","name":"Jacek Kubica","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/02/03/levosimendan-infusies-en-klinisch-beloop-bij-hartfalen-levo-d-resultaten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2023/01/24/pcsk9-remming-bij-covid-19-anti-inflammatoir-potentieel-onderzocht/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/04/17/uitgangs-ldl-en-mortaliteitsreductie-na-ldl-verlaging-jama-meta-analyse/","published":"2018-04-17"},{"url":"https://hartvaat.nl/2016/01/14/morfine-vertraagt-en-vermindert-de-werking-van-ticagrelor-bij-myocardinfarct-de-/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-basile","type":"person","url":"https://hartvaat.nl/mensen/jan-basile/","name":"Jan Basile","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jang-whan-bae","type":"person","url":"https://hartvaat.nl/mensen/jang-whan-bae/","name":"Jang-Whan Bae","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-g-macfadyen","type":"person","url":"https://hartvaat.nl/mensen/jean-g-macfadyen/","name":"Jean G MacFadyen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/04/15/inflammatie-en-cholesterol-als-cv-voorspellers-onder-statinetherapie-lancet-anal/","published":"2023-04-15"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2020/08/14/il-6-crp-en-ldl-als-biomarkers-van-residueel-risico-vergelijking/","published":"2020-08-14"},{"url":"https://hartvaat.nl/2020/02/01/il-1-remming-en-bloeddruk-hypertensie-en-residueel-inflammatoir-risico-cantos/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2017/10/21/canakinumab-en-longkankerincidentie-bij-atherosclerose-lancet-cantos-exploratief/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-francois-roux","type":"person","url":"https://hartvaat.nl/mensen/jean-francois-roux/","name":"Jean-Francois Roux","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-t-bates","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-t-bates/","name":"Jeffrey T Bates","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-haarbo","type":"person","url":"https://hartvaat.nl/mensen/jens-haarbo/","name":"Jens Haarbo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/10/21/minimalisatie-van-atriale-pacing-bij-sinusknoopziekte-vermindert-af/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jerome-l-fleg","type":"person","url":"https://hartvaat.nl/mensen/jerome-l-fleg/","name":"Jerome L Fleg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joakim-alfredsson","type":"person","url":"https://hartvaat.nl/mensen/joakim-alfredsson/","name":"Joakim Alfredsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/12/11/ticagrelor-plus-aspirine-versus-aspirine-na-cabg-voor-acs-gerandomiseerde-trial/","published":"2025-12-11"},{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jochen-wohrle","type":"person","url":"https://hartvaat.nl/mensen/jochen-wohrle/","name":"Jochen Wöhrle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-sundstrom","type":"person","url":"https://hartvaat.nl/mensen/johan-sundstrom/","name":"Johan Sundström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/01/consistentie-van-bloeddrukrespons-op-kaliumverrijkt-zout-ssass-subanalyse/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/04/11/heterogeniteit-in-bloeddrukrespons-op-antihypertensiva-jama-cross-over-rct/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2022/04/19/therapeutische-doelen-voor-hf-via-proteomics-en-mendeliaanse-randomisatie/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-e-deanfield","type":"person","url":"https://hartvaat.nl/mensen/john-e-deanfield/","name":"John E Deanfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-m-flack","type":"person","url":"https://hartvaat.nl/mensen/john-m-flack/","name":"John M Flack","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2018/11/01/therapieresistente-hypertensie-aha-scientific-statement-over-detectie-evaluatie-/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-g-howlett","type":"person","url":"https://hartvaat.nl/mensen/jonathan-g-howlett/","name":"Jonathan G Howlett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joris-r-de-groot","type":"person","url":"https://hartvaat.nl/mensen/joris-r-de-groot/","name":"Joris R de Groot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/10/15/lage-voorspelde-adherentie-verhoogt-stroke-risico-bij-af-patienten-die-starten-m/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2023/01/11/inadequate-noac-dosering-bij-af-uitkomsten-en-oorzaken-meta-analyse/","published":"2023-01-11"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/09/01/last-van-atriale-high-rate-episodes-en-cva-risico-systematische-review/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/09/13/ganglionplexusablatie-bij-gevorderd-atriumfibrilleren-de-afact-studie/","published":"2016-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josep-brugada","type":"person","url":"https://hartvaat.nl/mensen/josep-brugada/","name":"Josep Brugada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/03/07/contractiliteitssensor-geleide-crt-optimalisatie-respond-crt-trial/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-b-morton","type":"person","url":"https://hartvaat.nl/mensen/joseph-b-morton/","name":"Joseph B Morton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-l-zamorano","type":"person","url":"https://hartvaat.nl/mensen/jose-l-zamorano/","name":"José L Zamorano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-ramon-gonzalez-juanatey","type":"person","url":"https://hartvaat.nl/mensen/jose-ramon-gonzalez-juanatey/","name":"José Ramón González-Juanatey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/18/naar-precisiecardiologie-na-het-hartinfarct-opkomende-biomarkers-voor-risicostra/","published":"2026-06-18"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2024/12/01/colica-colchicine-bij-acuut-gedecompenseerd-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2018/04/14/sildenafil-bij-persisterende-pulmonale-hypertensie-na-klepchirurgie/","published":"2018-04-14"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jozef-bartunek","type":"person","url":"https://hartvaat.nl/mensen/jozef-bartunek/","name":"Jozef Bartunek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2023/12/20/ticagrelor-versus-prasugrel-en-coronaire-microcirculatie-bij-pci/","published":"2023-12-20"},{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/07/12/prasugrel-versus-clopidogrel-en-coronaire-microvasculaire-functie-bij-electieve-/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-sanchis","type":"person","url":"https://hartvaat.nl/mensen/juan-sanchis/","name":"Juan Sanchis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/02/03/bio-impedantie-voor-vochtstatusbepaling-en-prognose-bij-chronisch-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/iv-ferricarboxymaltose-verbetert-linkeratriale-strain-bij-hartfalen-myocardial-i/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-cai","type":"person","url":"https://hartvaat.nl/mensen/jun-cai/","name":"Jun Cai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/08/01/voordeel-en-risico-van-intensieve-bloeddrukcontrole-naar-cv-risico/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/09/01/hypertensieduur-en-effect-van-intensieve-bloeddrukbehandeling/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/12/01/step-trial-diastolische-bloeddruk-beinvloedt-effect-van-intensieve-behandeling/","published":"2023-12-01"},{"url":"https://hartvaat.nl/2023/09/01/step-substudie-intensieve-bloeddrukverlaging-verbetert-lvh-bij-ouderen/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/12/01/klebsiella-pneumoniae-als-mogelijke-oorzaak-van-hypertensie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-p-alexander","type":"person","url":"https://hartvaat.nl/mensen/karen-p-alexander/","name":"Karen P Alexander","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-wegscheider","type":"person","url":"https://hartvaat.nl/mensen/karl-wegscheider/","name":"Karl Wegscheider","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2023/05/19/east-afnet-4-vroege-ritmecontrole-bij-af-is-kosteneffectief/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karsten-t-veien","type":"person","url":"https://hartvaat.nl/mensen/karsten-t-veien/","name":"Karsten T Veien","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2018/12/04/ffr-versus-angiografie-geleide-cabg/","published":"2018-12-04"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-a-ellenbogen","type":"person","url":"https://hartvaat.nl/mensen/kenneth-a-ellenbogen/","name":"Kenneth A Ellenbogen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/09/01/la-low-voltage-prevalentie-en-voorspellers-bij-paroxysmaal-versus-niet-paroxysma/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2022/09/27/linkerbundeltakpacing-versus-biventriculaire-pacing-voor-crt-gerandomiseerde-tri/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2020/10/27/af-ablatie-met-vena-van-marshall-ethanol-versus-ablatie-alleen-jama-venus/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2019/08/20/2018-acc-aha-hrs-richtlijn-voor-bradycardie-en-geleidingsstoornissen/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/05/17/institutionele-en-operateurvereisten-voor-linker-hartoorocclusie-scai-acc-hrs-st/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ketil-jorgen-haugan","type":"person","url":"https://hartvaat.nl/mensen/ketil-jorgen-haugan/","name":"Ketil Jørgen Haugan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/20/af-screening-naar-genetisch-risico-loop-subanalyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/11/20/kaliumverhoging-bij-hoogrisicopatienten-voor-ventriculaire-aritmieen-rct/","published":"2025-11-20"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koji-takagi","type":"person","url":"https://hartvaat.nl/mensen/koji-takagi/","name":"Koji Takagi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/16/natrium-hf-subanalyse-natriuretische-peptiden-lopen-achter-op-de-klinische-ontst/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leanne-dyal","type":"person","url":"https://hartvaat.nl/mensen/leanne-dyal/","name":"Leanne Dyal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leonardo-calo","type":"person","url":"https://hartvaat.nl/mensen/leonardo-calo/","name":"Leonardo Calò","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"},{"url":"https://hartvaat.nl/2018/12/01/av-junctieablatie-plus-crt-bij-permanent-af-gerandomiseerde-trial/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-shen","type":"person","url":"https://hartvaat.nl/mensen/li-shen/","name":"Li Shen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lixia-jiao","type":"person","url":"https://hartvaat.nl/mensen/lixia-jiao/","name":"Lixia Jiao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucy-c-chappell","type":"person","url":"https://hartvaat.nl/mensen/lucy-c-chappell/","name":"Lucy C Chappell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2023/07/29/cradle-4-geplande-bevalling-versus-afwachten-bij-laat-preterm-pre-eclampsie-in-l/","published":"2023-07-29"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/05/04/plgf-voor-beoordeling-van-pre-eclampsie-lancet-parrot-stepped-wedge-trial/","published":"2019-05-04"},{"url":"https://hartvaat.nl/2017/11/01/labetalol-versus-nifedipine-bij-chronische-hypertensie-in-de-zwangerschap-gerand/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"malte-kelm","type":"person","url":"https://hartvaat.nl/mensen/malte-kelm/","name":"Malte Kelm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/02/01/nnt-van-nieuwe-antidiabetica-voor-cv-uitkomsten-meta-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mamas-a-mamas","type":"person","url":"https://hartvaat.nl/mensen/mamas-a-mamas/","name":"Mamas A Mamas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/22/brede-inzet-van-oraal-semaglutide-in-de-vs-zou-jaarlijks-tot-60-000-cardiovascul/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2023/05/19/slokdarmkoeling-voorkomt-oesofagale-schade-bij-af-ablatie-meta-analyse/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/08/01/klinische-fenotypen-zijn-effectiever-dan-ef-categorieen-voor-hf-uitkomsten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2021/01/27/mobiele-gezondheidstoepassingen-voor-af-detectie-systematische-review/","published":"2021-01-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margaret-f-prescott","type":"person","url":"https://hartvaat.nl/mensen/margaret-f-prescott/","name":"Margaret F Prescott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2022/10/18/dosisrespons-van-sacubitril-valsartan-bij-hfref/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/02/26/sacubitril-valsartan-en-biomarkers-van-extracellulaire-matrixregulatie-bij-hfref/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2017/01/01/sacubitril-valsartan-en-natriurese-diurese-en-bloeddruk-bij-zoutgevoelige-hypert/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/06/prognostische-implicaties-van-nt-probnp-veranderingen-bij-hartfalen/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martha-kubik","type":"person","url":"https://hartvaat.nl/mensen/martha-kubik/","name":"Martha Kubik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mary-n-walsh","type":"person","url":"https://hartvaat.nl/mensen/mary-n-walsh/","name":"Mary N Walsh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mathew-s-maurer","type":"person","url":"https://hartvaat.nl/mensen/mathew-s-maurer/","name":"Mathew S Maurer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/27/multimodaal-ai-model-verhoogt-accuratesse-van-echo-diagnose-cardiale-amyloidose/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/02/10/2025-acc-attr-cm-evaluatie-en-management-beknopte-klinische-richtlijn/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2025/05/27/vutrisiran-bij-attr-cm-impact-van-hartfalenernst-op-effectiviteit/","published":"2025-05-27"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hf-verslechtering-bij-attr-cm-attr-act-subanalyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hartfalenverslechtering-bij-attr-cardiomyopathie-attr-act-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-pagnesi","type":"person","url":"https://hartvaat.nl/mensen/matteo-pagnesi/","name":"Matteo Pagnesi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/06/26/machine-learning-voorspelt-diureticumrespons-bij-acuut-hartfalen-drc-ahf/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-dupont","type":"person","url":"https://hartvaat.nl/mensen/matthias-dupont/","name":"Matthias Dupont","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2020/08/18/optimale-bloeddruk-bij-shock-na-mi-en-hartstilstand/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2018/06/01/implementatie-van-sacubitril-valsartan-in-de-klinische-praktijk-inzichten/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matyas-keltai","type":"person","url":"https://hartvaat.nl/mensen/matyas-keltai/","name":"Matyas Keltai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meg-j-jardine","type":"person","url":"https://hartvaat.nl/mensen/meg-j-jardine/","name":"Meg J Jardine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/24/risicovoorspellingsmodellen-voor-ouderen-met-chronische-nierziekte/","published":"2025-12-24"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meike-brinker","type":"person","url":"https://hartvaat.nl/mensen/meike-brinker/","name":"Meike Brinker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-a-nauck","type":"person","url":"https://hartvaat.nl/mensen/michael-a-nauck/","name":"Michael A Nauck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/14/glp-1-receptoragonisten-en-de-volgende-generatie-incretinegebaseerde-middelen/","published":"2026-01-14"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/12/01/eerste-en-recidiverende-cv-events-met-liraglutide-bij-diabetes-type-2-leader/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/11/17/ly3298176-duale-gip-glp-1-agonist-bij-diabetes-type-2-lancet-tirzepatide-fase-2/","published":"2018-11-17"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-d-hill","type":"person","url":"https://hartvaat.nl/mensen/michael-d-hill/","name":"Michael D Hill","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/06/17/bedmed-timing-van-antihypertensieve-medicatie-en-cv-events-jama-definitieve-tria/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/06/01/implanteerbare-versus-verlengde-externe-ecg-monitoring-voor-af-na-ischemisch-cva/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2016/05/05/perioperatief-rosuvastatine-bij-hartchirurgie-nejm-trial/","published":"2016-05-05"},{"url":"https://hartvaat.nl/2016/03/17/langetermijnresultaten-van-stenting-versus-endarteriectomie-bij-carotisstenose/","published":"2016-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-silverstein","type":"person","url":"https://hartvaat.nl/mensen/michael-silverstein/","name":"Michael Silverstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-v-rocco","type":"person","url":"https://hartvaat.nl/mensen/michael-v-rocco/","name":"Michael V Rocco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2020/12/01/intensieve-bloeddrukcontrole-en-alle-hospitalisaties-sprint/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/02/01/sprint-resultaten-en-implicaties-voor-de-nefrologie/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michal-tendera","type":"person","url":"https://hartvaat.nl/mensen/michal-tendera/","name":"Michal Tendera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2020/09/19/trimetazidine-na-pci-lancet-atpci-gerandomiseerde-trial/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2018/09/22/aspirine-voor-primaire-preventie-bij-matig-cv-risico-lancet-arrive/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-robertson","type":"person","url":"https://hartvaat.nl/mensen/michele-robertson/","name":"Michele Robertson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/11/14/ldl-verlaging-voor-primaire-preventie-bij-mannen-met-primaire-ldl-verhoging/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-m-kittleson","type":"person","url":"https://hartvaat.nl/mensen/michelle-m-kittleson/","name":"Michelle M Kittleson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/10/2025-acc-attr-cm-evaluatie-en-management-beknopte-klinische-richtlijn/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2025/11/18/2025-acc-scientific-statement-obesitasmanagement-bij-hartfalen/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2023/05/09/2023-acc-expert-consensus-management-van-hfpef/","published":"2023-05-09"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/01/26/2020-acc-aha-kwaliteitsmaten-voor-af-geactualiseerd/","published":"2021-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikhail-sumin","type":"person","url":"https://hartvaat.nl/mensen/mikhail-sumin/","name":"Mikhail Sumin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"myung-ho-jeong","type":"person","url":"https://hartvaat.nl/mensen/myung-ho-jeong/","name":"Myung Ho Jeong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2018/07/24/escitalopram-versus-placebo-bij-depressie-na-acs-en-langetermijn-cardiale-uitkom/","published":"2018-07-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-j-weissman","type":"person","url":"https://hartvaat.nl/mensen/neil-j-weissman/","name":"Neil J Weissman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-r-holm","type":"person","url":"https://hartvaat.nl/mensen/niels-r-holm/","name":"Niels R Holm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/03/02/intravasculaire-beeldvorming-bij-des-implantatie-lancet-netwerk-meta-analyse/","published":"2024-03-02"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nisha-bansal","type":"person","url":"https://hartvaat.nl/mensen/nisha-bansal/","name":"Nisha Bansal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2024/10/15/aha-scientific-statement-nierdisfunctie-bij-gevorderd-hartfalen/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ollie-ostlund","type":"person","url":"https://hartvaat.nl/mensen/ollie-ostlund/","name":"Ollie Östlund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/04/11/heterogeniteit-in-bloeddrukrespons-op-antihypertensiva-jama-cross-over-rct/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"panos-vardas","type":"person","url":"https://hartvaat.nl/mensen/panos-vardas/","name":"Panos Vardas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/30/linear-trial-lattice-tip-katheter-verslaat-standaard-irrigatie-bij-cti-ablatie-v/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2023/05/19/east-afnet-4-vroege-ritmecontrole-bij-af-is-kosteneffectief/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-novak","type":"person","url":"https://hartvaat.nl/mensen/paul-novak/","name":"Paul Novak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-kelly","type":"person","url":"https://hartvaat.nl/mensen/peter-j-kelly/","name":"Peter J Kelly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/24/systemische-inflammatie-en-recidief-na-een-af-gerelateerd-herseninfarct/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2026/02/19/secundaire-preventie-na-ischemisch-cva-overzicht-uit-het-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-kolkhof","type":"person","url":"https://hartvaat.nl/mensen/peter-kolkhof/","name":"Peter Kolkhof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-s-pang","type":"person","url":"https://hartvaat.nl/mensen/peter-s-pang/","name":"Peter S Pang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-jansky","type":"person","url":"https://hartvaat.nl/mensen/petr-jansky/","name":"Petr Jansky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raj-r-makkar","type":"person","url":"https://hartvaat.nl/mensen/raj-r-makkar/","name":"Raj R Makkar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajiv-mahajan","type":"person","url":"https://hartvaat.nl/mensen/rajiv-mahajan/","name":"Rajiv Mahajan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2022/09/01/af-voorspelt-cognitieve-achteruitgang-meta-analyse-van-2-8-miljoen-personen/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2017/12/01/geintegreerde-zorg-bij-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralph-t-doyle","type":"person","url":"https://hartvaat.nl/mensen/ralph-t-doyle/","name":"Ralph T Doyle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"randall-c-starling","type":"person","url":"https://hartvaat.nl/mensen/randall-c-starling/","name":"Randall C Starling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"},{"url":"https://hartvaat.nl/2017/02/28/myocardiaal-herstel-bij-systolisch-hartfalen-met-auto-antilichamen-tegen-1-adren/","published":"2017-02-28"},{"url":"https://hartvaat.nl/2016/07/12/nervus-vagus-stimulatie-bij-hartfalen-de-inovate-hf-trial/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"riccardo-cappato","type":"person","url":"https://hartvaat.nl/mensen/riccardo-cappato/","name":"Riccardo Cappato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/10/09/voorspellers-van-sinusritme-6-weken-na-af-cardioversie-x-vert/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/12/01/rivaroxaban-versus-vka-bij-periprocedurele-antistolling-rond-af-ablatie/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rita-pavasini","type":"person","url":"https://hartvaat.nl/mensen/rita-pavasini/","name":"Rita Pavasini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-g-tieleman","type":"person","url":"https://hartvaat.nl/mensen/robert-g-tieleman/","name":"Robert G Tieleman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/11/10/rate-control-bij-af-calciumantagonisten-versus-betablokkers/","published":"2023-11-10"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/12/01/geintegreerde-gespecialiseerde-af-poliklinieken-verlagen-totale-mortaliteit-post/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-s-mckelvie","type":"person","url":"https://hartvaat.nl/mensen/robert-s-mckelvie/","name":"Robert S McKelvie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rodica-pop-busui","type":"person","url":"https://hartvaat.nl/mensen/rodica-pop-busui/","name":"Rodica Pop-Busui","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/09/01/cardiorenale-bescherming-door-sglt2-remmers-glp-1-agonisten-en-mra-s-bij-type-1-/","published":"2026-08-07"},{"url":"https://hartvaat.nl/2026/09/01/cardiorenale-risicos-bij-type-1-diabetes-een-overzicht-van-de-huidige-stand-van-/","published":"2026-08-07"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rodrigo-estevez-loureiro","type":"person","url":"https://hartvaat.nl/mensen/rodrigo-estevez-loureiro/","name":"Rodrigo Estévez-Loureiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ron-t-gansevoort","type":"person","url":"https://hartvaat.nl/mensen/ron-t-gansevoort/","name":"Ron T Gansevoort","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/29/lichaamsrondheidsindex-bri-voorspelt-sterfte-bij-nierpatienten-beter-dan-bmi/","published":"2026-07-27"},{"url":"https://hartvaat.nl/2026/04/24/nkf-consensus-standaardiseer-urine-afname-om-albuminurie-betrouwbaar-te-meten/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rory-collins","type":"person","url":"https://hartvaat.nl/mensen/rory-collins/","name":"Rory Collins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2019/07/01/kosteneffectiviteit-van-statines-en-ezetimibe-bij-chronische-nierziekte/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2018/02/01/differentiele-effecten-van-pcsk9-varianten-op-coronairlijden-versus-ischemisch-c/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/06/24/bijwerkingen-bij-niet-geblindeerde-versus-geblindeerde-statinetherapie-lancet-as/","published":"2017-06-24"},{"url":"https://hartvaat.nl/2016/05/05/perioperatief-rosuvastatine-bij-hartchirurgie-nejm-trial/","published":"2016-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rury-r-holman","type":"person","url":"https://hartvaat.nl/mensen/rury-r-holman/","name":"Rury R Holman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/30/empagliflozine-en-cardiale-energiestofwisseling-bij-hartfalen-empa-vision/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2022/11/01/emmy-empagliflozine-na-acuut-myocardinfarct-verbetert-nt-probnp-en-remodelling/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rutao-wang","type":"person","url":"https://hartvaat.nl/mensen/rutao-wang/","name":"Rutao Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruth-webster","type":"person","url":"https://hartvaat.nl/mensen/ruth-webster/","name":"Ruth Webster","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/06/01/lage-dosis-drievoudige-viervoudige-combinatiepil-versus-monotherapie-bij-hyperte/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salim-s-virani","type":"person","url":"https://hartvaat.nl/mensen/salim-s-virani/","name":"Salim S Virani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/24/lipide-aferese-verlaagt-lp-a-met-60-75-systematische-review-en-meta-analyse/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2023/05/02/gepersonaliseerde-beslisondersteuning-verhoogt-statinegebruik-bij-ascvd/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/12/01/cardiovasculaire-risicocommunicatie-en-patientperceptie-jama-cardiology/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sana-m-al-khatib","type":"person","url":"https://hartvaat.nl/mensen/sana-m-al-khatib/","name":"Sana M Al-Khatib","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/06/01/primaire-preventie-icd-bij-niet-ischemische-cardiomyopathie-meta-analyse/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/05/16/comorbiditeiten-en-crt-respons-madit-crt-langetermijnfollow-up/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandeep-prabhu","type":"person","url":"https://hartvaat.nl/mensen/sandeep-prabhu/","name":"Sandeep Prabhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandra-j-taler","type":"person","url":"https://hartvaat.nl/mensen/sandra-j-taler/","name":"Sandra J Taler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2018/11/01/therapieresistente-hypertensie-aha-scientific-statement-over-detectie-evaluatie-/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satoru-suwa","type":"person","url":"https://hartvaat.nl/mensen/satoru-suwa/","name":"Satoru Suwa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/12/01/daprodustat-bij-anemie-en-hartfalen-met-ckd-gerandomiseerde-studie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastian-ewen","type":"person","url":"https://hartvaat.nl/mensen/sebastian-ewen/","name":"Sebastian Ewen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2020/03/10/overleving-na-revascularisatie-met-paclitaxel-gecoate-ballonnen/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2017/01/07/verminderd-bloeddrukverlagend-effect-van-renale-denervatie-bij-geisoleerde-systo/","published":"2017-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastian-kufner","type":"person","url":"https://hartvaat.nl/mensen/sebastian-kufner/","name":"Sebastian Kufner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serge-korjian","type":"person","url":"https://hartvaat.nl/mensen/serge-korjian/","name":"Serge Korjian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shih-ann-chen","type":"person","url":"https://hartvaat.nl/mensen/shih-ann-chen/","name":"Shih-Ann Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2019/05/14/edoxaban-bij-aziatische-af-patienten-concentraties-en-anti-xa-activiteit/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shun-fu-lee","type":"person","url":"https://hartvaat.nl/mensen/shun-fu-lee/","name":"Shun Fu Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2021/08/01/klinische-fenotypen-zijn-effectiever-dan-ef-categorieen-voor-hf-uitkomsten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2019/02/26/patientgerichte-transitional-care-bij-hf-hospitalisatie-jama-pact-hf/","published":"2019-02-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steffen-helqvist","type":"person","url":"https://hartvaat.nl/mensen/steffen-helqvist/","name":"Steffen Helqvist","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-b-ketchum","type":"person","url":"https://hartvaat.nl/mensen/steven-b-ketchum/","name":"Steven B Ketchum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-o-marx","type":"person","url":"https://hartvaat.nl/mensen/steven-o-marx/","name":"Steven O Marx","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takeshi-morimoto","type":"person","url":"https://hartvaat.nl/mensen/takeshi-morimoto/","name":"Takeshi Morimoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2017/02/14/laaggedoseerde-aspirine-voor-primaire-cardiovasculaire-preventie-bij-diabetes-ty/","published":"2017-02-14"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tara-i-chang","type":"person","url":"https://hartvaat.nl/mensen/tara-i-chang/","name":"Tara I Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/03/29/drug-eluting-versus-bare-metal-stents-bij-pci-patienten-met-eindstadium-nierziek/","published":"2016-03-29"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tej-sheth","type":"person","url":"https://hartvaat.nl/mensen/tej-sheth/","name":"Tej Sheth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"theresa-mcdonagh","type":"person","url":"https://hartvaat.nl/mensen/theresa-mcdonagh/","name":"Theresa McDonagh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/02/19/competenties-na-certificering-en-cardiovasculaire-zorgverlening/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2019/05/21/ijzerisomaltosides-en-skeletspierdenergie-bij-chronisch-hf-met-ijzerdeficientie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2018/03/01/medicamenteuze-behandeling-en-uitkomsten-bij-hfpef-systematische-review-en-meta-/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thilo-noack","type":"person","url":"https://hartvaat.nl/mensen/thilo-noack/","name":"Thilo Noack","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-pilgrim","type":"person","url":"https://hartvaat.nl/mensen/thomas-pilgrim/","name":"Thomas Pilgrim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/19/geleidingsstoornissen-na-transkatheter-aortaklepimplantatie/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-r-keeble","type":"person","url":"https://hartvaat.nl/mensen/thomas-r-keeble/","name":"Thomas R Keeble","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/05/25/jbs-richtlijn-management-van-hartstilstand-in-het-cathlab/","published":"2022-05-25"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tommaso-gori","type":"person","url":"https://hartvaat.nl/mensen/tommaso-gori/","name":"Tommaso Gori","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/09/01/clopidogrel-versus-prasugrel-versus-ticagrelor-op-endotheelfunctie-en-inflammati/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2016/03/01/bioresorbeerbare-scaffold-trombose-multicenteranalyse-van-klinische-presentatie-/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"urs-fischer","type":"person","url":"https://hartvaat.nl/mensen/urs-fischer/","name":"Urs Fischer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valeria-paradies","type":"person","url":"https://hartvaat.nl/mensen/valeria-paradies/","name":"Valeria Paradies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2024/07/09/cangrelor-en-infarctgrootte-bij-stemi-gerandomiseerde-trial/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2018/06/19/cardioprotectieve-therapieen-en-area-at-risk-bij-gereperfuseerd-stemi-cmr-analys/","published":"2018-06-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincenzo-guiducci","type":"person","url":"https://hartvaat.nl/mensen/vincenzo-guiducci/","name":"Vincenzo Guiducci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"w-morris-brown","type":"person","url":"https://hartvaat.nl/mensen/w-morris-brown/","name":"W Morris Brown","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wolfgang-rottbauer","type":"person","url":"https://hartvaat.nl/mensen/wolfgang-rottbauer/","name":"Wolfgang Rottbauer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"woong-chol-kang","type":"person","url":"https://hartvaat.nl/mensen/woong-chol-kang/","name":"Woong Chol Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xu-liu","type":"person","url":"https://hartvaat.nl/mensen/xu-liu/","name":"Xu Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/10/31/herhaalde-in-situ-ablatie-versus-uitgebreide-ablatie-bij-recidief-persisterend-a/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/08/12/catheterablatie-versus-rate-control-bij-persisterend-af-en-ouder-hartfalen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2021/05/21/extrapulmonale-vein-driver-mapping-bij-persisterend-af-bij-obese-patienten/","published":"2021-05-21"},{"url":"https://hartvaat.nl/2021/05/21/katheterablatie-versus-medicatie-bij-persisterend-en-langdurig-persisterend-af-l/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-zhang","type":"person","url":"https://hartvaat.nl/mensen/yan-zhang/","name":"Yan Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/12/31/annexine-a1-verergert-activatie-van-eilandjessterrecellen-via-triglyceridenafbra/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/01/01/gedeeltelijke-cardiale-denervatie-voorkomt-af-na-cabg-rct/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2022/06/01/interatriale-shuntdevices-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/04/01/sarcopenie-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yangfeng-wu","type":"person","url":"https://hartvaat.nl/mensen/yangfeng-wu/","name":"Yangfeng Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/01/01/consistentie-van-bloeddrukrespons-op-kaliumverrijkt-zout-ssass-subanalyse/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/20/zoutvervanger-voorkomt-hypertensie-bij-normotensieve-volwassenen/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/07/26/chinees-hartgezond-dieet-verlaagt-bloeddruk-effectief-gerandomiseerde-trial/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-li","type":"person","url":"https://hartvaat.nl/mensen/yi-li/","name":"Yi Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/07/14/depressietrajecten-bij-hfpef-impact-op-uitkomsten/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2022/06/01/sglt2-remmers-bij-hartfalen-geupdatete-meta-analyse-bevestigt-breed-voordeel/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-joon-hong","type":"person","url":"https://hartvaat.nl/mensen/young-joon-hong/","name":"Young Joon Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2018/07/24/escitalopram-versus-placebo-bij-depressie-na-acs-en-langetermijn-cardiale-uitkom/","published":"2018-07-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yousif-ahmad","type":"person","url":"https://hartvaat.nl/mensen/yousif-ahmad/","name":"Yousif Ahmad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/07/16/revascularisatiestrategieen-na-mi-systematische-review-en-meta-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/03/02/intravasculaire-beeldvorming-bij-des-implantatie-lancet-netwerk-meta-analyse/","published":"2024-03-02"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yundai-chen","type":"person","url":"https://hartvaat.nl/mensen/yundai-chen/","name":"Yundai Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yvonne-commodore-mensah","type":"person","url":"https://hartvaat.nl/mensen/yvonne-commodore-mensah/","name":"Yvonne Commodore-Mensah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2024/08/01/sociale-determinanten-en-hypertensie-uitkomsten-systematische-review/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zsolt-piroth","type":"person","url":"https://hartvaat.nl/mensen/zsolt-piroth/","name":"Zsolt Piroth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":8,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abdourahmane-diallo","type":"person","url":"https://hartvaat.nl/mensen/abdourahmane-diallo/","name":"Abdourahmane Diallo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/20/afbouw-van-antihypertensieve-behandeling-bij-verpleeghuisbewoners-rct/","published":"2025-11-20"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-witkowski","type":"person","url":"https://hartvaat.nl/mensen/adam-witkowski/","name":"Adam Witkowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"addison-a-taylor","type":"person","url":"https://hartvaat.nl/mensen/addison-a-taylor/","name":"Addison A Taylor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/12/29/chloortalidon-versus-hydrochloorthiazide-geen-verschil-in-cv-events/","published":"2022-12-29"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adeera-levin","type":"person","url":"https://hartvaat.nl/mensen/adeera-levin/","name":"Adeera Levin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/06/19/vrouwen-met-ckd-krijgen-minder-vaak-ras-remmers-en-sglt2-remmers-dan-mannen/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-j-mclellan","type":"person","url":"https://hartvaat.nl/mensen/alex-j-mclellan/","name":"Alex J McLellan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandre-abizaid","type":"person","url":"https://hartvaat.nl/mensen/alexandre-abizaid/","name":"Alexandre Abizaid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/19/kanker-en-coronaire-atherosclerotische-plaquebelasting-inzichten-uit-de-bravado-/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alfredo-e-rodriguez","type":"person","url":"https://hartvaat.nl/mensen/alfredo-e-rodriguez/","name":"Alfredo E Rodriguez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/08/01/cabg-versus-pci-en-risico-op-myocardinfarct-en-revascularisatie-bij-ckd-patiente/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amir-a-mahabadi","type":"person","url":"https://hartvaat.nl/mensen/amir-a-mahabadi/","name":"Amir A Mahabadi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/10/01/bnp-nt-probnp-stratificeert-prognose-gelijk-met-en-zonder-hartfalen-meta-analyse/","published":"2022-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-baumbach","type":"person","url":"https://hartvaat.nl/mensen/andreas-baumbach/","name":"Andreas Baumbach","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/05/07/esc-eapci-taskforce-rapport-over-bioresorbeerbare-scaffolds-executive-summary/","published":"2018-05-07"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angele-moryusef","type":"person","url":"https://hartvaat.nl/mensen/angele-moryusef/","name":"Angèle Moryusef","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-mathur","type":"person","url":"https://hartvaat.nl/mensen/anthony-mathur/","name":"Anthony Mathur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"},{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2017/04/01/intracoronair-nitriet-onderdrukt-de-inflammatoire-respons-na-primaire-pci/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-s-l-tang","type":"person","url":"https://hartvaat.nl/mensen/anthony-s-l-tang/","name":"Anthony S L Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arman-qamar","type":"person","url":"https://hartvaat.nl/mensen/arman-qamar/","name":"Arman Qamar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/10/genprobcad-gecombineerde-monogene-en-polygene-risicobepaling-voor-coronairlijden/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2022/12/01/serieel-hoog-sensitief-troponine-t-voorspelt-cv-events-na-acs-odyssey-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/05/21/vroegtijdig-staken-van-ticagrelor-bij-secundaire-cv-preventie-jacc-review/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arno-w-hoes","type":"person","url":"https://hartvaat.nl/mensen/arno-w-hoes/","name":"Arno W Hoes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/01/23/switchen-van-vka-naar-noac-bij-fragiele-ouderen-met-af-veilig/","published":"2024-01-23"},{"url":"https://hartvaat.nl/2021/06/01/diagnostiek-van-hartfalen-in-de-huisartsenpraktijk-ipd-meta-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/08/07/geintegreerd-af-management-in-de-huisartsenpraktijk-all-in-clustergerandomiseerd/","published":"2020-08-07"},{"url":"https://hartvaat.nl/2018/08/01/opportunistische-hf-screening-met-natriuretische-peptiden-bij-af-ipd-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/03/22/zelfmanagementinterventies-bij-hartfalen-individuele-patientdata-meta-analyse/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-casadei","type":"person","url":"https://hartvaat.nl/mensen/barbara-casadei/","name":"Barbara Casadei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/10/21/amalfi-remote-screening-voor-asymptomatisch-af-gerandomiseerde-trial/","published":"2025-10-21"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/05/05/perioperatief-rosuvastatine-bij-hartchirurgie-nejm-trial/","published":"2016-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"behnood-bikdeli","type":"person","url":"https://hartvaat.nl/mensen/behnood-bikdeli/","name":"Behnood Bikdeli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2026/05/25/longembolie-epidemiologie-stijgende-last-bij-vergrijzing-preventiestrategieen-bl/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/03/28/lp-a-verhoogt-risico-op-veneuze-trombo-embolie-bij-premenopauzale-vrouwen-en-hor/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benoit-lattuca","type":"person","url":"https://hartvaat.nl/mensen/benoit-lattuca/","name":"Benoit Lattuca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/07/01/calcified-oct-versus-angiografie-bij-pci-van-verkalkte-laesies/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-chevalier","type":"person","url":"https://hartvaat.nl/mensen/bernard-chevalier/","name":"Bernard Chevalier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2019/12/01/absorb-scaffold-5-jaarsresultaten-systematische-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bjrn-bendz","type":"person","url":"https://hartvaat.nl/mensen/bjrn-bendz/","name":"Bjørn Bendz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"},{"url":"https://hartvaat.nl/2016/03/12/invasieve-versus-conservatieve-strategie-bij-80-plussers-met-nstemi-gerandomisee/","published":"2016-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cara-east","type":"person","url":"https://hartvaat.nl/mensen/cara-east/","name":"Cara East","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2016/06/11/ixmyelocel-t-bij-ischemisch-hartfalen-lancet-dubbelblinde-gerandomiseerde-trial/","published":"2016-06-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carl-e-orringer","type":"person","url":"https://hartvaat.nl/mensen/carl-e-orringer/","name":"Carl E Orringer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/10/04/2022-acc-expert-consensus-niet-statine-therapieen-voor-ldl-verlaging-bij-ascvd/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2017/10/03/2017-acc-gerichte-update-niet-statinetherapie-voor-ldl-verlaging/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carl-j-pepine","type":"person","url":"https://hartvaat.nl/mensen/carl-j-pepine/","name":"Carl J Pepine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2016/11/01/langetermijnmortaliteit-bij-hypertensie-met-coronairlijden-invest-us-cohort/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cecilia-linde","type":"person","url":"https://hartvaat.nl/mensen/cecilia-linde/","name":"Cecilia Linde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/09/prefers-stockholm-nieuw-ontstaan-hfpef-heeft-slechtere-langetermijnuitkomsten-da/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2026/02/19/competenties-na-certificering-en-cardiovasculaire-zorgverlening/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chen","type":"person","url":"https://hartvaat.nl/mensen/chen/","name":"Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/03/machine-learningmodel-voorspelt-periprocedurele-complicaties-bij-tavi-voor-bicus/","published":"2026-07-25"},{"url":"https://hartvaat.nl/2026/03/03/voorspelmodellen-voor-hartfalen-bij-patienten-met-instabiele-angina-pectoris/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/26/hiv-infectie-hangt-onafhankelijk-samen-met-meer-en-kwetsbaardere-halsslagaderpla/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2026/02/23/luchtvervuiling-en-multimorbiditeit-verhogen-het-risico-op-atriumfibrilleren/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/02/machine-learning-nomogram-voorspelt-vroeg-transplantaatfalen-na-harttransplantat/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2026/01/29/lineaire-ablatie-van-de-voorwand-van-het-linkeratrium-vermindert-af-recidieven-b/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/09/littekenweefsel-voorspelt-plotse-hartdood-na-een-infarct-grotendeels-buiten-de-e/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheol-whan-lee","type":"person","url":"https://hartvaat.nl/mensen/cheol-whan-lee/","name":"Cheol Whan Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chien-wen-tseng","type":"person","url":"https://hartvaat.nl/mensen/chien-wen-tseng/","name":"Chien-Wen Tseng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christine-m-albert","type":"person","url":"https://hartvaat.nl/mensen/christine-m-albert/","name":"Christine M Albert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/10/21/dieet-en-af-risico-systematische-review/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/12/21/langdurige-omega-3-suppletie-en-af-risico-meta-analyse-van-cv-trials/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-kaiser","type":"person","url":"https://hartvaat.nl/mensen/christoph-kaiser/","name":"Christoph Kaiser","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-t-salerno","type":"person","url":"https://hartvaat.nl/mensen/christopher-t-salerno/","name":"Christopher T Salerno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claus-graff","type":"person","url":"https://hartvaat.nl/mensen/claus-graff/","name":"Claus Graff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/20/af-screening-naar-genetisch-risico-loop-subanalyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cora-e-lewis","type":"person","url":"https://hartvaat.nl/mensen/cora-e-lewis/","name":"Cora E Lewis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/11/01/intensieve-bloeddrukbehandeling-120-80-mmhg-bij-cardiovasculair-risico-protagoni/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"corinne-hanotin","type":"person","url":"https://hartvaat.nl/mensen/corinne-hanotin/","name":"Corinne Hanotin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniela-tomasoni","type":"person","url":"https://hartvaat.nl/mensen/daniela-tomasoni/","name":"Daniela Tomasoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2021/10/01/sacubitril-valsartan-in-real-life-europese-hfref-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/01/hoogtepunten-in-hartfalen-2019/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"danielle-m-brennan","type":"person","url":"https://hartvaat.nl/mensen/danielle-m-brennan/","name":"Danielle M Brennan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-fitchett","type":"person","url":"https://hartvaat.nl/mensen/david-fitchett/","name":"David Fitchett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/01/07/hypoglykemie-cv-uitkomsten-en-empagliflozine-empa-reg-outcome/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/06/04/microvasculaire-ziekte-en-cv-events-bij-diabetes-type-2/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/23/empagliflozine-bij-diabetes-type-2-met-perifeer-vaatlijden-empa-reg-outcome/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-charytan","type":"person","url":"https://hartvaat.nl/mensen/david-m-charytan/","name":"David M Charytan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2025/01/01/dialysaat-kalium-3-0-mmol-l-met-natriumzirconiumcyclosilicaat-bij-dialyse/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2016/08/01/cabg-versus-pci-en-risico-op-myocardinfarct-en-revascularisatie-bij-ckd-patiente/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-leistner","type":"person","url":"https://hartvaat.nl/mensen/david-m-leistner/","name":"David M Leistner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/02/10/propionaat-vermindert-atherosclerose-via-immuunregulatie-van-intestinaal-cholest/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-thompson","type":"person","url":"https://hartvaat.nl/mensen/david-m-thompson/","name":"David M Thompson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/01/ochtend-versus-avonddosering-van-antihypertensiva-gerandomiseerde-crossover-tria/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/06/24/bijwerkingen-bij-niet-geblindeerde-versus-geblindeerde-statinetherapie-lancet-as/","published":"2017-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-sim","type":"person","url":"https://hartvaat.nl/mensen/david-sim/","name":"David Sim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derk-w-krieger","type":"person","url":"https://hartvaat.nl/mensen/derk-w-krieger/","name":"Derk W Krieger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/20/af-screening-naar-genetisch-risico-loop-subanalyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dick-de-zeeuw","type":"person","url":"https://hartvaat.nl/mensen/dick-de-zeeuw/","name":"Dick de Zeeuw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"},{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diego-ardissino","type":"person","url":"https://hartvaat.nl/mensen/diego-ardissino/","name":"Diego Ardissino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2018/05/01/farmacogenomisch-gestuurd-antiplaatjestherapie-bij-acs-pharmclo-trial/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dietmar-trenk","type":"person","url":"https://hartvaat.nl/mensen/dietmar-trenk/","name":"Dietmar Trenk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/07/19/immatuur-plaatjesaantal-versus-gevestigde-voorspellers-van-plaatjesreactiviteit-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dirk-j-blom","type":"person","url":"https://hartvaat.nl/mensen/dirk-j-blom/","name":"Dirk J Blom","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/02/05/orale-pcsk9-remmer-enlicitide-verlaagt-ldl-met-57-placebogecontroleerde-trial/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2023/10/21/lerodalcibep-bij-familiaire-hypercholesterolemie-liberate-hefh-langetermijndata/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dominik-linz","type":"person","url":"https://hartvaat.nl/mensen/dominik-linz/","name":"Dominik Linz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/06/02/smartphone-app-voor-symptoomregistratie-na-ablatie-bij-atriumfibrilleren-isolati/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2024/10/21/dieet-en-af-risico-systematische-review/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2023/12/01/adaptieve-servoventilatie-en-hypoxemische-belasting-bij-hartfalen/","published":"2023-12-01"},{"url":"https://hartvaat.nl/2022/09/01/af-voorspelt-cognitieve-achteruitgang-meta-analyse-van-2-8-miljoen-personen/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donald-e-casey","type":"person","url":"https://hartvaat.nl/mensen/donald-e-casey/","name":"Donald E Casey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emelia-j-benjamin","type":"person","url":"https://hartvaat.nl/mensen/emelia-j-benjamin/","name":"Emelia J Benjamin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/18/2025-acc-scientific-statement-obesitasmanagement-bij-hartfalen/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emeline-m-van-craenenbroeck","type":"person","url":"https://hartvaat.nl/mensen/emeline-m-van-craenenbroeck/","name":"Emeline M Van Craenenbroeck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/23/lp-a-en-ai-ccta-onthullen-onzichtbaar-restrisico-voorbij-de-calciumscore/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/10/01/verschillende-trainingsvormen-en-hdl-functie-bij-hfpef-optimex-substudie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrico-cerrato","type":"person","url":"https://hartvaat.nl/mensen/enrico-cerrato/","name":"Enrico Cerrato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erik-jrgensen","type":"person","url":"https://hartvaat.nl/mensen/erik-jrgensen/","name":"Erik Jørgensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"esa-m-davis","type":"person","url":"https://hartvaat.nl/mensen/esa-m-davis/","name":"Esa M Davis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"etienne-gayat","type":"person","url":"https://hartvaat.nl/mensen/etienne-gayat/","name":"Etienne Gayat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/09/08/gepersonaliseerde-bloeddrukregeling-tijdens-thrombectomie-verbetert-functionele-/","published":"2026-08-19"},{"url":"https://hartvaat.nl/2025/09/01/preoperatief-cv-risico-en-raas-remmergebruik-postoperatieve-uitkomsten/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-c-jensen","type":"person","url":"https://hartvaat.nl/mensen/eva-c-jensen/","name":"Eva C Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"f-d-richard-hobbs","type":"person","url":"https://hartvaat.nl/mensen/f-d-richard-hobbs/","name":"F D Richard Hobbs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/06/01/natriuretisch-peptide-screening-voor-lv-disfunctie-diagnostische-nauwkeurigheid/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/06/01/diagnostiek-van-hartfalen-in-de-huisartsenpraktijk-ipd-meta-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabiana-rollini","type":"person","url":"https://hartvaat.nl/mensen/fabiana-rollini/","name":"Fabiana Rollini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/04/17/geleide-versus-standaard-antiplaatjestherapie-na-pci-lancet-meta-analyse/","published":"2021-04-17"},{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/03/15/plaatjesremming-met-ticagrelor-60-mg-versus-90-mg-in-de-pegasus-timi-54-trial/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"faisal-sharif","type":"person","url":"https://hartvaat.nl/mensen/faisal-sharif/","name":"Faisal Sharif","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felicita-andreotti","type":"person","url":"https://hartvaat.nl/mensen/felicita-andreotti/","name":"Felicita Andreotti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2023/01/24/pcsk9-remming-bij-covid-19-anti-inflammatoir-potentieel-onderzocht/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/04/01/intracraniele-bloedingen-versus-stenttrombose-met-doac-antiplaatjes-versus-tripl/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/04/17/uitgangs-ldl-en-mortaliteitsreductie-na-ldl-verlaging-jama-meta-analyse/","published":"2018-04-17"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fiona-e-strachan","type":"person","url":"https://hartvaat.nl/mensen/fiona-e-strachan/","name":"Fiona E Strachan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/12/27/hoog-sensitief-troponine-statinetherapie-en-risico-op-coronairlijden/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fiyyaz-ahmed-jushuf","type":"person","url":"https://hartvaat.nl/mensen/fiyyaz-ahmed-jushuf/","name":"Fiyyaz Ahmed-Jushuf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-burzotta","type":"person","url":"https://hartvaat.nl/mensen/francesco-burzotta/","name":"Francesco Burzotta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2022/07/21/permanente-pacemaker-na-tavi-langetermijneffect-op-klinische-uitkomsten/","published":"2022-07-21"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-maisano","type":"person","url":"https://hartvaat.nl/mensen/francesco-maisano/","name":"Francesco Maisano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francis-d-pagani","type":"person","url":"https://hartvaat.nl/mensen/francis-d-pagani/","name":"Francis D Pagani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2017/02/02/intrapericardiale-lvad-bij-gevorderd-hartfalen-nejm/","published":"2017-02-02"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-m-sacks","type":"person","url":"https://hartvaat.nl/mensen/frank-m-sacks/","name":"Frank M Sacks","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2021/06/01/dieet-en-natriumreductie-op-cardiale-schade-en-inflammatie-dash-sodium/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2019/12/01/genetische-gevoeligheid-eiwitinname-en-bloeddrukverandering-pounds-lost/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/03/27/hdl-subspecies-met-apoliproteine-c-iii-en-coronairlijden-vier-cohorten/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/11/01/tijdsverloop-van-bloeddrukverandering-door-zoutreductie-en-dash-dieet/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederik-m-zimmermann","type":"person","url":"https://hartvaat.nl/mensen/frederik-m-zimmermann/","name":"Frederik M Zimmermann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/06/caviar-alirocumab-bij-cardiale-allograft-vasculopathie-na-harttransplantatie/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"friedrich-w-mohr","type":"person","url":"https://hartvaat.nl/mensen/friedrich-w-mohr/","name":"Friedrich W Mohr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"g-b-john-mancini","type":"person","url":"https://hartvaat.nl/mensen/g-b-john-mancini/","name":"G B John Mancini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/04/30/leefstijl-hba1c-en-overleving-bij-stabiel-coronairlijden-met-diabetes/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2017/12/19/chirurgische-versus-percutane-revascularisatie-bij-diabetes-met-acs/","published":"2017-12-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"garen-manvelian","type":"person","url":"https://hartvaat.nl/mensen/garen-manvelian/","name":"Garen Manvelian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"},{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2017/09/26/sams-ci-score-toegepast-op-gerandomiseerde-trial-over-statine-myopathie/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gemma-a-figtree","type":"person","url":"https://hartvaat.nl/mensen/gemma-a-figtree/","name":"Gemma A Figtree","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gennaro-giustino","type":"person","url":"https://hartvaat.nl/mensen/gennaro-giustino/","name":"Gennaro Giustino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/10/10/dagelijks-ischemie-en-bloedingsrisico-na-primaire-pci-voor-stemi/","published":"2017-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gian-luca-di-tanna","type":"person","url":"https://hartvaat.nl/mensen/gian-luca-di-tanna/","name":"Gian Luca Di Tanna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianluca-pontone","type":"person","url":"https://hartvaat.nl/mensen/gianluca-pontone/","name":"Gianluca Pontone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulia-magnani","type":"person","url":"https://hartvaat.nl/mensen/giulia-magnani/","name":"Giulia Magnani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/07/ischemisch-risico-en-werkzaamheid-van-ticagrelor-in-relatie-tot-stoptijd-p2y12-r/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-ando","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-ando/","name":"Giuseppe Andò","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"h-asita-de-silva","type":"person","url":"https://hartvaat.nl/mensen/h-asita-de-silva/","name":"H Asita de Silva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/02/20/community-interventie-voor-hypertensie-in-ruraal-zuid-azie-nejm/","published":"2020-02-20"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"handrean-soran","type":"person","url":"https://hartvaat.nl/mensen/handrean-soran/","name":"Handrean Soran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/02/14/cholesterolniveaus-en-de-rol-bij-het-identificeren-van-statinenontvangers/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-christoph-diener","type":"person","url":"https://hartvaat.nl/mensen/hans-christoph-diener/","name":"Hans-Christoph Diener","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-henrik-tilsted","type":"person","url":"https://hartvaat.nl/mensen/hans-henrik-tilsted/","name":"Hans-Henrik Tilsted","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-peter-brunner-la-rocca","type":"person","url":"https://hartvaat.nl/mensen/hans-peter-brunner-la-rocca/","name":"Hans-Peter Brunner-La Rocca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2019/11/19/beeldvorming-geleide-versus-routinezorg-bij-nstemi-jacc/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harriette-g-c-van-spall","type":"person","url":"https://hartvaat.nl/mensen/harriette-g-c-van-spall/","name":"Harriette G C Van Spall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/26/state-of-the-art-mra-s-bij-hartfalen-en-nierziekte-over-alle-ejectiefracties/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/02/23/nierbescherming-na-harttransplantatie-risicoreductie-en-therapeutische-mogelijkh/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/08/01/klinische-fenotypen-zijn-effectiever-dan-ef-categorieen-voor-hf-uitkomsten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/01/27/mobiele-gezondheidstoepassingen-voor-af-detectie-systematische-review/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2019/02/26/patientgerichte-transitional-care-bij-hf-hospitalisatie-jama-pact-hf/","published":"2019-02-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hertzel-c-gerstein","type":"person","url":"https://hartvaat.nl/mensen/hertzel-c-gerstein/","name":"Hertzel C Gerstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hideyuki-kawashima","type":"person","url":"https://hartvaat.nl/mensen/hideyuki-kawashima/","name":"Hideyuki Kawashima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/10/06/periprocedureel-mi-en-uitkomsten-na-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hillary-mulder","type":"person","url":"https://hartvaat.nl/mensen/hillary-mulder/","name":"Hillary Mulder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroshi-ito","type":"person","url":"https://hartvaat.nl/mensen/hiroshi-ito/","name":"Hiroshi Ito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2022/02/01/luseogliflozine-en-geschat-plasmavolume-bij-hfpef/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroyuki-tsutsui","type":"person","url":"https://hartvaat.nl/mensen/hiroyuki-tsutsui/","name":"Hiroyuki Tsutsui","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/01/30/edoxaban-versus-warfarine-bij-chronische-trombo-embolische-pulmonale-hypertensie/","published":"2024-01-30"},{"url":"https://hartvaat.nl/2022/08/01/thuisrevalidatie-met-ict-voor-fragiele-hartfalenpatienten/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"italo-porto","type":"person","url":"https://hartvaat.nl/mensen/italo-porto/","name":"Italo Porto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2021/10/01/sacubitril-valsartan-in-real-life-europese-hfref-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/04/17/geleide-versus-standaard-antiplaatjestherapie-na-pci-lancet-meta-analyse/","published":"2021-04-17"},{"url":"https://hartvaat.nl/2020/04/01/intracraniele-bloedingen-versus-stenttrombose-met-doac-antiplaatjes-versus-tripl/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-dawn-abbott","type":"person","url":"https://hartvaat.nl/mensen/j-dawn-abbott/","name":"J Dawn Abbott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2017/09/01/provisional-versus-twee-stentstrategie-bij-bifurcatielaesies-meta-analyse/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-a","type":"person","url":"https://hartvaat.nl/mensen/j-a/","name":"J. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/03/warrior-trial-intensieve-medicamenteuze-behandeling-verbetert-de-uitkomsten-niet/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/04/10/zuinig-machine-learningmodel-voorspelt-1-jaarssterfte-en-zinloosheid-na-tavi/","published":"2026-07-23"},{"url":"https://hartvaat.nl/2026/04/10/proteomics-onthult-vier-subgroepen-van-acuut-hfpef-met-eigen-biologische-routes-/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/05/26/asymptomatische-matige-ernstige-aortaklepinsufficientie-niet-benigne-meta-analys/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/02/10/welke-hartfalenpatienten-ontwikkelen-ernstige-mitralisinsufficientie-voorspellen/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2026/01/23/etnische-verschillen-in-aortadiameters-indiase-versus-nederlandse-patienten-amst/","published":"2026-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-w","type":"person","url":"https://hartvaat.nl/mensen/j-w/","name":"J. W.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/sekseverschillen-bij-infectieuze-endocarditis-vrouwen-vaker-conservatief-behande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/04/29/geisoleerde-secundaire-tricuspidalisinsufficientie-na-linkszijdige-klepchirurgie/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/04/29/erasmus-mc-linkeratrium-strain-voorspelt-aritmieen-na-chirurgische-correctie-van/","published":"2026-07-11"},{"url":"https://hartvaat.nl/2026/05/21/million-women-study-ernstige-obesitas-verviervoudigt-risico-op-af-en-hartfalen-s/","published":"2026-07-05"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-myocardinfarct-winratio-analyse-uit-de-cle/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacob-m-mishell","type":"person","url":"https://hartvaat.nl/mensen/jacob-m-mishell/","name":"Jacob M Mishell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-stevermer","type":"person","url":"https://hartvaat.nl/mensen/james-stevermer/","name":"James Stevermer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-w-choi","type":"person","url":"https://hartvaat.nl/mensen/james-w-choi/","name":"James W Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jamie-layland","type":"person","url":"https://hartvaat.nl/mensen/jamie-layland/","name":"Jamie Layland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/07/10/intracoronaire-trombolyse-bij-stemi-meta-analyse/","published":"2024-07-10"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jay-m-edelberg","type":"person","url":"https://hartvaat.nl/mensen/jay-m-edelberg/","name":"Jay M Edelberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-champagne","type":"person","url":"https://hartvaat.nl/mensen/jean-champagne/","name":"Jean Champagne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-philippe-collet","type":"person","url":"https://hartvaat.nl/mensen/jean-philippe-collet/","name":"Jean-Philippe Collet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeanne-e-poole","type":"person","url":"https://hartvaat.nl/mensen/jeanne-e-poole/","name":"Jeanne E Poole","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/07/13/ablatie-versus-medicatie-bij-af-naar-ras-en-etniciteit/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-l-probstfield","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-l-probstfield/","name":"Jeffrey L Probstfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-aaroe","type":"person","url":"https://hartvaat.nl/mensen/jens-aaroe/","name":"Jens Aarøe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jia-wang","type":"person","url":"https://hartvaat.nl/mensen/jia-wang/","name":"Jia Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/06/15/prevalentie-van-linkeratriumtrombus-bij-geanticoaguleerde-af-patienten/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/01/dabigatran-naar-leeftijd-bij-atriumfibrilleren-re-ly-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiamin-liu","type":"person","url":"https://hartvaat.nl/mensen/jiamin-liu/","name":"Jiamin Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/effect-van-baduanjin-op-bloeddruk-bij-hoog-normaal-bloeddruk-gerandomiseerde-tri/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"},{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiri-jarkovsky","type":"person","url":"https://hartvaat.nl/mensen/jiri-jarkovsky/","name":"Jiri Jarkovsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/07/08/catheterablatie-versus-leefstijlmodificatie-plus-antiaritmica-bij-af-gerandomise/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/02/07/ecmo-cs-ecmo-bij-cardiogene-shock-verbetert-overleving-niet/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joachim-h-ix","type":"person","url":"https://hartvaat.nl/mensen/joachim-h-ix/","name":"Joachim H Ix","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/08/20/aangetaste-tubulaire-secretiecapaciteit-verhoogt-cardiovasculaire-sterfte-hunt-s/","published":"2026-08-28"},{"url":"https://hartvaat.nl/2026/03/13/tubulaire-nierschade-hangt-samen-met-natriumretentie-en-diureticarespons-bij-acu/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-engdahl","type":"person","url":"https://hartvaat.nl/mensen/johan-engdahl/","name":"Johan Engdahl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systematische-af-screening-met-gedetailleerde-fenotypering-en-risicopredictie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/03/nt-probnp-en-ecg-screening-bij-75-jarigen-voor-af-detectie-rct/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/01/14/strokestop-af-screening-is-kosteneffectief-bij-75-76-jarigen/","published":"2023-01-14"},{"url":"https://hartvaat.nl/2021/10/23/systematische-af-screening-en-klinische-uitkomsten-lancet-strokestop/","published":"2021-10-23"},{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/08/01/nt-probnp-bij-systematische-screening-op-atriumfibrilleren/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/02/01/stapsgewijze-massascreening-op-af-met-nt-probnp-strokestop-ii-studieontwerp/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-gregson","type":"person","url":"https://hartvaat.nl/mensen/john-gregson/","name":"John Gregson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-j-atherton","type":"person","url":"https://hartvaat.nl/mensen/john-j-atherton/","name":"John J Atherton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/23/pathfinder-trial-betere-naleving-van-hartfalenrichtlijnen-in-de-huisartsenprakti/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/10/01/sglt2-remmers-en-hf-hospitalisatie-en-hartfunctie-systematische-review/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-m-lachin","type":"person","url":"https://hartvaat.nl/mensen/john-m-lachin/","name":"John M Lachin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/04/20/frequentie-van-evidence-based-retinopathiescreening-bij-diabetes-type-1-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-w-epling","type":"person","url":"https://hartvaat.nl/mensen/john-w-epling/","name":"John W Epling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-w-mcevoy","type":"person","url":"https://hartvaat.nl/mensen/john-w-mcevoy/","name":"John W McEvoy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/10/07/semaglutide-en-bloeddruk-ipd-meta-analyse/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/01/geisoleerde-diastolische-hypertensie-cohort-en-meta-analyse-voor-behandeldrempel/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/01/16/intraveneus-fentanyl-en-ticagrelorabsorptie-bij-pci/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josep-redon","type":"person","url":"https://hartvaat.nl/mensen/josep-redon/","name":"Josep Redon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/11/01/gemiddelde-bloeddruk-en-visit-to-visit-variabiliteit-als-gecombineerde-voorspell/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-j-saseen","type":"person","url":"https://hartvaat.nl/mensen/joseph-j-saseen/","name":"Joseph J Saseen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2024/06/25/vasculair-zorgteam-versus-educatie-bij-perifeer-arterieel-vaatlijden/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2016/11/22/management-van-klinisch-significante-geneesmiddelinteracties-met-statines-aha-aa/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-f-iglesias","type":"person","url":"https://hartvaat.nl/mensen/juan-f-iglesias/","name":"Juan F Iglesias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2020/12/22/fentanyl-versus-morfine-op-ticagrelor-plaatjesremming-bij-stemi/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-e-buring","type":"person","url":"https://hartvaat.nl/mensen/julie-e-buring/","name":"Julie E Buring","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/12/05/inflammatie-cholesterol-lp-a-en-30-jaars-cv-uitkomsten-bij-vrouwen/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2023/01/01/vitamine-d-voorkomt-statine-gerelateerde-spierklachten-niet/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/05/05/triglyceriderijk-lipoproteinecholesterol-small-dense-ldl-en-cv-events/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2017/06/01/voedingsstatus-en-langetermijn-multivitaminegebruik-en-cv-risico-phs-ii-analyse/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-pu","type":"person","url":"https://hartvaat.nl/mensen/jun-pu/","name":"Jun Pu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/26/ai-clustering-identificeert-functionele-risicofenotypen-bij-hartfalen/","published":"2026-04-06"},{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/12/06/gemodificeerde-transseptale-punctie-bij-laa-occlusie-rct/","published":"2023-12-06"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2017/10/17/farmaco-invasieve-strategie-met-halve-dosis-alteplase-versus-primaire-pci-bij-st/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-zhu","type":"person","url":"https://hartvaat.nl/mensen/jun-zhu/","name":"Jun Zhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorg-hausleiter","type":"person","url":"https://hartvaat.nl/mensen/jorg-hausleiter/","name":"Jörg Hausleiter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2019/05/14/ecls-bij-cardiogene-shock-na-acuut-mi/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karina-v-bunting","type":"person","url":"https://hartvaat.nl/mensen/karina-v-bunting/","name":"Karina V Bunting","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/03/26/rate-af-kosteneffectiviteit-van-digoxine-versus-betablokkers-bij-permanent-af/","published":"2025-03-26"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2022/09/26/smartphone-detectie-van-af-via-fotoplethysmografie-meta-analyse/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"},{"url":"https://hartvaat.nl/2021/07/01/transformatie-van-klinisch-onderzoek-door-patientbetrokkenheid-rate-af/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-georg-haeusler","type":"person","url":"https://hartvaat.nl/mensen/karl-georg-haeusler/","name":"Karl Georg Haeusler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2023/01/24/axadia-afnet-8-apixaban-versus-vka-bij-af-op-hemodialyse/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karol-e-watson","type":"person","url":"https://hartvaat.nl/mensen/karol-e-watson/","name":"Karol E Watson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/02/barrieres-bij-implementatie-van-lipidenverlagende-therapie-in-de-praktijk/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katherine-l-tucker","type":"person","url":"https://hartvaat.nl/mensen/katherine-l-tucker/","name":"Katherine L Tucker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katsumi-miyauchi","type":"person","url":"https://hartvaat.nl/mensen/katsumi-miyauchi/","name":"Katsumi Miyauchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2022/12/01/daprodustat-bij-anemie-en-hartfalen-met-ckd-gerandomiseerde-studie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuo-kimura","type":"person","url":"https://hartvaat.nl/mensen/kazuo-kimura/","name":"Kazuo Kimura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"},{"url":"https://hartvaat.nl/2019/06/07/febuxostat-voor-cerebraal-en-cardiorenovasculaire-eventpreventie-freed/","published":"2019-06-07"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-j-mukamal","type":"person","url":"https://hartvaat.nl/mensen/kenneth-j-mukamal/","name":"Kenneth J Mukamal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/06/gofresh-dash-boodschappen-en-bloeddrukeffect-rct/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/04/01/lichaamshouding-en-orthostatische-hypotensie-bij-hypertensie-syst-eur-analyse/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2021/06/01/dieet-en-natriumreductie-op-cardiale-schade-en-inflammatie-dash-sodium/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2019/10/01/antihypertensivaklasse-en-vallen-syncope-en-orthostatische-hypotensie-bij-oudere/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2018/10/01/hypertensiebehandeling-en-orthostatische-hypotensie-relatie-met-cv-ziekte/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/03/27/hdl-subspecies-met-apoliproteine-c-iii-en-coronairlijden-vier-cohorten/","published":"2018-03-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khalid-yusoff","type":"person","url":"https://hartvaat.nl/mensen/khalid-yusoff/","name":"Khalid Yusoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2019/10/05/uitgebreide-community-interventie-bij-hypertensie-lancet-hope-4/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kim-a-connelly","type":"person","url":"https://hartvaat.nl/mensen/kim-a-connelly/","name":"Kim A Connelly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kiyoshi-hibi","type":"person","url":"https://hartvaat.nl/mensen/kiyoshi-hibi/","name":"Kiyoshi Hibi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/11/07/optische-frequentiedomeinbeeldvorming-versus-ivus-bij-pci-opinion-trial/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kuan-ken-lee","type":"person","url":"https://hartvaat.nl/mensen/kuan-ken-lee/","name":"Kuan Ken Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/04/01/sekseverschillen-in-effectiviteit-van-orale-p2y12-remmers-meta-analyse/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"larry-a-allen","type":"person","url":"https://hartvaat.nl/mensen/larry-a-allen/","name":"Larry A Allen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-gullestad","type":"person","url":"https://hartvaat.nl/mensen/lars-gullestad/","name":"Lars Gullestad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2018/12/01/pro-gastrin-releasing-peptide-en-uitkomsten-bij-hf-met-anemie-red-hf/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"},{"url":"https://hartvaat.nl/2016/03/12/invasieve-versus-conservatieve-strategie-bij-80-plussers-met-nstemi-gerandomisee/","published":"2016-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-jakobsen","type":"person","url":"https://hartvaat.nl/mensen/lars-jakobsen/","name":"Lars Jakobsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-lind","type":"person","url":"https://hartvaat.nl/mensen/lars-lind/","name":"Lars Lind","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/03/plasma-eiwitprofielen-onthullen-gedeelde-en-fenotype-specifieke-routes-bij-hartf/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2023/04/11/heterogeniteit-in-bloeddrukrespons-op-antihypertensiva-jama-cross-over-rct/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2022/04/19/therapeutische-doelen-voor-hf-via-proteomics-en-mendeliaanse-randomisatie/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurence-s-sperling","type":"person","url":"https://hartvaat.nl/mensen/laurence-s-sperling/","name":"Laurence S Sperling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leopoldo-s-piegas","type":"person","url":"https://hartvaat.nl/mensen/leopoldo-s-piegas/","name":"Leopoldo S Piegas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liang-han-ling","type":"person","url":"https://hartvaat.nl/mensen/liang-han-ling/","name":"Liang-Han Ling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lilin-she","type":"person","url":"https://hartvaat.nl/mensen/lilin-she/","name":"Lilin She","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lori-pbert","type":"person","url":"https://hartvaat.nl/mensen/lori-pbert/","name":"Lori Pbert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"louise-segan","type":"person","url":"https://hartvaat.nl/mensen/louise-segan/","name":"Louise Segan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laszlo-geller","type":"person","url":"https://hartvaat.nl/mensen/laszlo-geller/","name":"László Gellér","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/21/eplerenon-halveert-recidief-ventriculaire-tachycardie-versus-spironolacton-bij-h/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2021/03/08/katheterablatie-om-af-progressie-te-vertragen-attest-gerandomiseerde-trial/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2017/11/01/klinische-presentatie-bij-eerste-hartfalenhospitalisatie-voorspelt-geen-heropnam/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-a","type":"person","url":"https://hartvaat.nl/mensen/m-a/","name":"M. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/03/warrior-trial-intensieve-medicamenteuze-behandeling-verbetert-de-uitkomsten-niet/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/04/22/een-op-de-tien-volwassenen-met-een-aangeboren-hartafwijking-heeft-een-syndroom-e/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/04/29/geleidingssysteem-pacing-slaat-rechterventrikel-pacing-bij-av-blok-70-hartfalen-/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/04/24/verminderde-nierfunctie-verhoogt-hartfalenrisico-bij-ouderen-aspree-cohort/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2026/03/25/waarom-de-sterfte-na-een-hartinfarct-daalde-15-jaar-nationale-data-uit-engeland-/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/03/10/machine-learning-voorspelt-30-daagse-sterfte-na-een-dotterbehandeling-australisc/","published":"2026-03-10"},{"url":"https://hartvaat.nl/2026/02/23/objectief-gemeten-lichaamsbeweging-en-levenskwaliteit-bij-hypertrofische-cardiom/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mahesh-j-patel","type":"person","url":"https://hartvaat.nl/mensen/mahesh-j-patel/","name":"Mahesh J Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-proietti","type":"person","url":"https://hartvaat.nl/mensen/marco-proietti/","name":"Marco Proietti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2022/10/13/cerebrale-microbloedingen-en-risico-bij-af-systematische-review/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/09/14/copd-bij-af-prevalentie-management-en-impact-meta-analyse/","published":"2021-09-14"},{"url":"https://hartvaat.nl/2020/01/01/weglaten-van-aspirine-bij-gecombineerde-antitrombotische-therapie-voor-af-acs-he/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/06/01/preventie-van-atriumfibrilleren-beoordeling-van-huidig-bewijs/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/11/01/bloeddrukvariabiliteit-en-uitkomsten-bij-af-affirm-studie/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margaret-mcentegart","type":"person","url":"https://hartvaat.nl/mensen/margaret-mcentegart/","name":"Margaret McEntegart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/12/15/infarctgrootte-en-linkerkamerremodellering-na-preventieve-pci/","published":"2016-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-novosadova","type":"person","url":"https://hartvaat.nl/mensen/maria-novosadova/","name":"Maria Novosadova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-a-supiano","type":"person","url":"https://hartvaat.nl/mensen/mark-a-supiano/","name":"Mark A Supiano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/06/01/bloeddrukcontrole-en-arteriele-stijfheidsmechanismen-in-sprint/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-r-nelson","type":"person","url":"https://hartvaat.nl/mensen/mark-r-nelson/","name":"Mark R Nelson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","published":"2020-07-07"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-a-cavender","type":"person","url":"https://hartvaat.nl/mensen/matthew-a-cavender/","name":"Matthew A Cavender","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2017/07/18/sglt2-remmers-en-lager-risico-op-hartfalen-en-sterfte-versus-andere-glucoseverla/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/06/consistente-reductie-in-periprocedureel-mi-met-cangrelor-champion-analyses/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mehmet-b-yilmaz","type":"person","url":"https://hartvaat.nl/mensen/mehmet-b-yilmaz/","name":"Mehmet B Yilmaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/25/frequente-pvc-s-en-risico-op-af-hf-cva-en-sterfte/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melissa-e-middeldorp","type":"person","url":"https://hartvaat.nl/mensen/melissa-e-middeldorp/","name":"Melissa E Middeldorp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/21/dieet-en-af-risico-systematische-review/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2021/10/09/klinische-risicofactoren-voor-cva-bij-anticoagulantie-naieve-af-meta-analyse/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2017/12/01/geintegreerde-zorg-bij-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-cabana","type":"person","url":"https://hartvaat.nl/mensen/michael-cabana/","name":"Michael Cabana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"},{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-d-shapiro","type":"person","url":"https://hartvaat.nl/mensen/michael-d-shapiro/","name":"Michael D Shapiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/16/lp-a-en-hscrp-voorspellen-ascvd-bij-mensen-zonder-klassieke-risicofactoren/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/05/15/aspirine-voor-primaire-preventie-bij-verhoogd-lp-a-of-lpa-varianten-levert-geen-/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-blaha","type":"person","url":"https://hartvaat.nl/mensen/michael-j-blaha/","name":"Michael J Blaha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2021/06/01/geisoleerde-diastolische-hypertensie-cohort-en-meta-analyse-voor-behandeldrempel/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2020/07/28/evolocumab-op-atherogene-lipoproteinen-in-de-peri-infarctperiode-gerandomiseerde/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-k-parides","type":"person","url":"https://hartvaat.nl/mensen/michael-k-parides/","name":"Michael K Parides","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michaela-mattheus","type":"person","url":"https://hartvaat.nl/mensen/michaela-mattheus/","name":"Michaela Mattheus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2020/01/07/hypoglykemie-cv-uitkomsten-en-empagliflozine-empa-reg-outcome/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-jadoul","type":"person","url":"https://hartvaat.nl/mensen/michel-jadoul/","name":"Michel Jadoul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2026/03/03/kdigo-versnelt-richtlijnontwikkeling-voor-nierziekten/","published":"2026-03-27"},{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2026/02/24/effecten-van-micro-en-nanoplastics-op-de-nieren/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/18/groene-dialyse-duurzame-zorg-groei-en-innovatie-kdigo-conferentie/","published":"2026-02-18"},{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michela-casella","type":"person","url":"https://hartvaat.nl/mensen/michela-casella/","name":"Michela Casella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/02/26/fluoroscopieminimalisatie-bij-svt-ablatie-door-vrouwelijke-elektrofysiologen/","published":"2026-04-06"},{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-emdin","type":"person","url":"https://hartvaat.nl/mensen/michele-emdin/","name":"Michele Emdin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/06/22/cardiale-amyloidose-komt-frequent-voor-bij-hfpef-aortastenose-en-lvh-meta-analys/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/05/05/sterftecijfers-in-controle-armen-van-hartfalen-rcts-dalen-niet-ondanks-betere-ac/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/05/19/lipoproteine-aferese-blijft-relevant-in-het-tijdperk-van-pcsk9-remmers-en-sirna/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2018/05/01/crt-voordeel-bij-concordant-versus-discordant-linksbundeltakblok-esc-hf-pilot/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2017/09/12/centrale-apneus-gedurende-24-uur-en-prognose-bij-hartfalen/","published":"2017-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natalie-a-bello","type":"person","url":"https://hartvaat.nl/mensen/natalie-a-bello/","name":"Natalie A Bello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2018/02/01/nauwkeurigheid-van-bloeddrukmeters-in-de-zwangerschap-systematische-review/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-collins","type":"person","url":"https://hartvaat.nl/mensen/nicholas-collins/","name":"Nicholas Collins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2024/12/16/scoff-nuchter-versus-niet-nuchter-voor-hartkatheterisatie-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2022/07/01/behandeling-van-acuut-coronair-syndroom-in-ruraal-australie-moracs-trial/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/07/01/camkii-delta-remming-en-ventriculaire-remodellering-na-mi-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-j-lembo","type":"person","url":"https://hartvaat.nl/mensen/nicholas-j-lembo/","name":"Nicholas J Lembo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-meneveau","type":"person","url":"https://hartvaat.nl/mensen/nicolas-meneveau/","name":"Nicolas Meneveau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2025/07/01/calcified-oct-versus-angiografie-bij-pci-van-verkalkte-laesies/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nils-witt","type":"person","url":"https://hartvaat.nl/mensen/nils-witt/","name":"Nils Witt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"odd-erik-johansen","type":"person","url":"https://hartvaat.nl/mensen/odd-erik-johansen/","name":"Odd Erik Johansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/01/07/hypoglykemie-cv-uitkomsten-en-empagliflozine-empa-reg-outcome/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/12/01/empagliflozine-en-bloeddruk-bij-diabetes-type-2-met-hypertensie-naar-achtergrond/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pamela-s-douglas","type":"person","url":"https://hartvaat.nl/mensen/pamela-s-douglas/","name":"Pamela S Douglas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/02/03/klinische-risicopredictie-ct-coronairangiografie-en-cv-events-bij-nieuwe-angina/","published":"2025-02-03"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/08/24/reprieve-pitavastatine-vermindert-cv-events-bij-hiv-nejm/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2020/06/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-acs-trials-jama-cardiology/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2017/11/21/coronair-calcium-en-prognostische-waarde-bij-pijn-op-de-borst-promise-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-sganzerla","type":"person","url":"https://hartvaat.nl/mensen/paolo-sganzerla/","name":"Paolo Sganzerla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-motreff","type":"person","url":"https://hartvaat.nl/mensen/pascal-motreff/","name":"Pascal Motreff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-leeson","type":"person","url":"https://hartvaat.nl/mensen/paul-leeson/","name":"Paul Leeson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/07/01/bewegingsadvies-als-behandeling-van-prehypertensie-en-hypertensie-bij-jongvolwas/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-welsh","type":"person","url":"https://hartvaat.nl/mensen/paul-welsh/","name":"Paul Welsh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pavel-osmancik","type":"person","url":"https://hartvaat.nl/mensen/pavel-osmancik/","name":"Pavel Osmančík","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/26/pfa-sham-pulsed-field-ablatie-verslaat-sham-procedure-overtuigend-bij-atriumfibr/","published":"2026-07-02"},{"url":"https://hartvaat.nl/2025/07/22/cooperative-pfa-driearmige-gerandomiseerde-trial-van-pfa-versus-rf-versus-cryo/","published":"2025-07-22"},{"url":"https://hartvaat.nl/2025/07/08/catheterablatie-versus-leefstijlmodificatie-plus-antiaritmica-bij-af-gerandomise/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/02/01/sequentiele-hybride-ablatie-versus-chirurgische-cryomaze-bij-af-met-structurele-/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/12/08/laa-sluiting-versus-oac-bij-af-meta-analyse-van-gerandomiseerde-trials/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"per-johanson","type":"person","url":"https://hartvaat.nl/mensen/per-johanson/","name":"Per Johanson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/11/01/klinische-toepassing-van-hs-troponine-in-het-ascvd-raamwerk-jama-cardiology/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"perry-m-elliott","type":"person","url":"https://hartvaat.nl/mensen/perry-m-elliott/","name":"Perry M Elliott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2019/10/01/beeldvorming-bij-cardiale-amyloidose-diagnostische-prestatie-meta-analyse/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/03/01/trimetazidine-bij-niet-obstructieve-hcm-jama-cardiology-gerandomiseerde-trial/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"},{"url":"https://hartvaat.nl/2016/10/01/katheterablatie-bij-af-met-hypertrofische-cardiomyopathie-systematische-review-e/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petar-m-seferovic","type":"person","url":"https://hartvaat.nl/mensen/petar-m-seferovic/","name":"Petar M Seferovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-l-j-wijngaard","type":"person","url":"https://hartvaat.nl/mensen/peter-l-j-wijngaard/","name":"Peter L J Wijngaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-fase-3-bij-verhoogd-ldl-nejm-orion-10-en-orion-11/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2019/11/01/inclisiran-1-of-2-dosis-en-ldl-cholesterol-orion-1-1-jaarsfollow-up/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/09/25/sirna-tegen-pcsk9-en-atherogene-lipoproteinen-orion-1-secundaire-eindpunten/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"},{"url":"https://hartvaat.nl/2017/01/05/inclisiran-een-langwerkende-rna-interferentie-pcsk9-remmer-nejm/","published":"2017-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-verhamme","type":"person","url":"https://hartvaat.nl/mensen/peter-verhamme/","name":"Peter Verhamme","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ply-chichareon","type":"person","url":"https://hartvaat.nl/mensen/ply-chichareon/","name":"Ply Chichareon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"poornima-sood","type":"person","url":"https://hartvaat.nl/mensen/poornima-sood/","name":"Poornima Sood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-mathew-s-maurer","type":"person","url":"https://hartvaat.nl/mensen/prof-mathew-s-maurer/","name":"Prof. Mathew S. Maurer","title":"Hoogleraar cardiologie, Columbia University Irving Medical Center, New York, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2025/01/01/stijging-van-serum-transthyretine-na-tafamidis-voorspelt-betere-overleving-bij-a/","published":"2026-03-01"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/cardio-ttransform-deep-dive-maurer/","title":"CARDIO-TTRansform — Studieopzet en baseline-karakteristieken"},{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/cardio-ttransform-peer-to-peer-maurer-davis/","title":"CARDIO-TTRansform peer-to-peer — Silencer- versus stabilisator-therapie"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajesh-k-kharbanda","type":"person","url":"https://hartvaat.nl/mensen/rajesh-k-kharbanda/","name":"Rajesh K Kharbanda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raul-d-santos","type":"person","url":"https://hartvaat.nl/mensen/raul-d-santos/","name":"Raul D Santos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ravinay-bhindi","type":"person","url":"https://hartvaat.nl/mensen/ravinay-bhindi/","name":"Ravinay Bhindi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raymond-tukkie","type":"person","url":"https://hartvaat.nl/mensen/raymond-tukkie/","name":"Raymond Tukkie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"renato-h-n-santos","type":"person","url":"https://hartvaat.nl/mensen/renato-h-n-santos/","name":"Renato H N Santos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-haynes","type":"person","url":"https://hartvaat.nl/mensen/richard-haynes/","name":"Richard Haynes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2019/07/01/kosteneffectiviteit-van-statines-en-ezetimibe-bij-chronische-nierziekte/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-d-toto","type":"person","url":"https://hartvaat.nl/mensen/robert-d-toto/","name":"Robert D Toto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/08/10/urine-albumine-en-natrium-hebben-prognostische-waarde-bij-hartfalen-experimentel/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2024/04/04/pragmatische-trial-van-hospitalisatieratio-bij-ckd-nejm/","published":"2024-04-04"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roland-richard-tilz","type":"person","url":"https://hartvaat.nl/mensen/roland-richard-tilz/","name":"Roland Richard Tilz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2022/07/15/geindividualiseerde-versus-standaard-cryoballonablatie-bij-paroxysmaal-af/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2021/05/21/firm-ablatie-versus-pvi-bij-paroxysmaal-af-gerandomiseerde-resultaten/","published":"2021-05-21"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ron-blankstein","type":"person","url":"https://hartvaat.nl/mensen/ron-blankstein/","name":"Ron Blankstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2025/07/01/bestaande-cv-data-benutten-voor-hypertensiedetectie-en-behandeling-vital-trial/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2016/08/02/omega-3-vetzuren-en-linkerkamerremodellering-na-acuut-mi-omega-remodel-trial/","published":"2016-08-02"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/implementatie-lipidenmanagement/","title":"Sessie 4: Implementatie van lipidenmanagement — praktische uitdagingen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronald-aronson","type":"person","url":"https://hartvaat.nl/mensen/ronald-aronson/","name":"Ronald Aronson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samer-mansour","type":"person","url":"https://hartvaat.nl/mensen/samer-mansour/","name":"Samer Mansour","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandeep-brar","type":"person","url":"https://hartvaat.nl/mensen/sandeep-brar/","name":"Sandeep Brar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-ho-jo","type":"person","url":"https://hartvaat.nl/mensen/sang-ho-jo/","name":"Sang-Ho Jo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-s-emerson","type":"person","url":"https://hartvaat.nl/mensen/scott-s-emerson/","name":"Scott S Emerson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serge-boveda","type":"person","url":"https://hartvaat.nl/mensen/serge-boveda/","name":"Serge Boveda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2022/01/04/enkele-freeze-cryoballonablatie-bij-af-ehra-systematische-review/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/03/01/doodsoorzaken-bij-crt-met-en-zonder-defibrillator-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shahar-lavi","type":"person","url":"https://hartvaat.nl/mensen/shahar-lavi/","name":"Shahar Lavi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shmuel-chen","type":"person","url":"https://hartvaat.nl/mensen/shmuel-chen/","name":"Shmuel Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/07/31/bnp-bij-linker-hoofdstamrevascularisatie-excel-analyse/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sonia-s-anand","type":"person","url":"https://hartvaat.nl/mensen/sonia-s-anand/","name":"Sonia S Anand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/08/01/digitale-gezondheidsinterventie-voor-cardiovasculaire-risicoverlaging-gerandomis/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-stortecky","type":"person","url":"https://hartvaat.nl/mensen/stefan-stortecky/","name":"Stefan Stortecky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefanie-schupke","type":"person","url":"https://hartvaat.nl/mensen/stefanie-schupke/","name":"Stefanie Schüpke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-corda","type":"person","url":"https://hartvaat.nl/mensen/stefano-corda/","name":"Stefano Corda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/05/05/vericiguat-en-sgc-stimulatoren-bij-hartfalen-werkingsmechanisme-en-plaats-na-vic/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/04/01/vericiguat-voordeel-geprojecteerd-op-paradigm-hf-en-dapa-hf-populaties/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-del-prato","type":"person","url":"https://hartvaat.nl/mensen/stefano-del-prato/","name":"Stefano Del Prato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/11/13/tirzepatide-versus-insuline-glargine-bij-diabetes-type-2-met-hoog-cv-risico-lanc/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2018/10/27/albiglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-harmony-ou/","published":"2018-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-baldus","type":"person","url":"https://hartvaat.nl/mensen/stephan-baldus/","name":"Stephan Baldus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2023/03/21/coronairangiografie-na-hartstilstand-zonder-stemi-netwerk-meta-analyse/","published":"2023-03-21"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2017/04/01/oscillerende-whole-body-vibratie-verbetert-inspanningscapaciteit-bij-pah/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-von-haehling","type":"person","url":"https://hartvaat.nl/mensen/stephan-von-haehling/","name":"Stephan von Haehling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2022/07/26/empag-hf-vroege-empagliflozine-bij-acuut-hartfalen-verbetert-diurese/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/12/01/ijzercarboxymaltose-bij-ijzerdeficient-hartfalen-meta-analyse/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-a-lubitz","type":"person","url":"https://hartvaat.nl/mensen/steven-a-lubitz/","name":"Steven A Lubitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2024/11/19/screening-op-niet-gediagnosticeerd-af-voor-cva-preventie-gerandomiseerde-trial/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2022/03/29/af-screening-bij-ouderen-in-de-huisartsenpraktijk-vital-af-gerandomiseerde-trial/","published":"2022-03-29"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/04/01/orale-antistolling-bij-atriumfibrilleren-over-het-spectrum-van-beroerterisico-ga/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-e-mcnulty","type":"person","url":"https://hartvaat.nl/mensen/steven-e-mcnulty/","name":"Steven E McNulty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/08/01/gdf-15-en-liraglutide-behandeling-bij-hf-patienten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-p-marso","type":"person","url":"https://hartvaat.nl/mensen/steven-p-marso/","name":"Steven P Marso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suzanne-de-waha-thiele","type":"person","url":"https://hartvaat.nl/mensen/suzanne-de-waha-thiele/","name":"Suzanne de Waha-Thiele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sylvain-losdat","type":"person","url":"https://hartvaat.nl/mensen/sylvain-losdat/","name":"Sylvain Losdat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sren-hjberg","type":"person","url":"https://hartvaat.nl/mensen/sren-hjberg/","name":"Søren Højberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/20/af-screening-naar-genetisch-risico-loop-subanalyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sren-zoga-diederichsen","type":"person","url":"https://hartvaat.nl/mensen/sren-zoga-diederichsen/","name":"Søren Zöga Diederichsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/07/01/qt-als-voorspeller-van-af-recidief-na-ablatie-en-amiodaronimpact-amio-cat/","published":"2019-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-cuisset","type":"person","url":"https://hartvaat.nl/mensen/thomas-cuisset/","name":"Thomas Cuisset","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2021/08/24/de-escalatie-van-dapt-bij-acs-jacc-review/","published":"2021-08-24"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/11/01/switchen-van-dapt-na-acs-de-topic-trial/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-h-marwick","type":"person","url":"https://hartvaat.nl/mensen/thomas-h-marwick/","name":"Thomas H Marwick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2024/09/16/langetermijn-hartfalenrisico-bij-volwassen-kankeroverlevenden-meta-analyse/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/06/01/bloeddrukverlaging-bij-centrale-hypertensie-gerandomiseerde-trial/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/10/01/niet-invasieve-technieken-en-biomarkers-voor-poliklinisch-vochtmanagement-bij-hf/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/04/01/lv-longitudinale-systolische-functieparameters-als-voorspellers-bij-hfpef/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2016/10/25/aldosteronantagonisme-en-inspanningstolerantie-bij-hfpef/","published":"2016-10-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thompson-g-robinson","type":"person","url":"https://hartvaat.nl/mensen/thompson-g-robinson/","name":"Thompson G Robinson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2017/05/01/voortzetten-of-tijdelijk-stoppen-van-antihypertensiva-bij-acuut-cva-ipd-meta-ana/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thorsten-lewalter","type":"person","url":"https://hartvaat.nl/mensen/thorsten-lewalter/","name":"Thorsten Lewalter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2019/12/07/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-veiligheid-en-werk/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/07/dagelijkse-telemonitoring-van-icd-s-gepoolde-analyse-van-drie-gerandomiseerde-tr/","published":"2017-06-07"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toru-kondo","type":"person","url":"https://hartvaat.nl/mensen/toru-kondo/","name":"Toru Kondo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2023/06/25/cystatine-c-voor-gfr-schatting-bij-hartfalen-paradigm-hf-analyse/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/10/01/neuromusculaire-elektrische-stimulatie-bij-acuut-hartfalen-haalbaarheid/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrich-p-jorde","type":"person","url":"https://hartvaat.nl/mensen/ulrich-p-jorde/","name":"Ulrich P Jorde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vasileios-panoulas","type":"person","url":"https://hartvaat.nl/mensen/vasileios-panoulas/","name":"Vasileios Panoulas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veronica-j-alexander","type":"person","url":"https://hartvaat.nl/mensen/veronica-j-alexander/","name":"Veronica J Alexander","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2019/09/01/galnac-geconjugeerd-antisense-tegen-apoc3-triglyceriden-en-atherogene-lipoprotei/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"viveka-frykman","type":"person","url":"https://hartvaat.nl/mensen/viveka-frykman/","name":"Viveka Frykman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/11/25/abc-af-risicoscores-voor-gepersonaliseerde-af-behandeling/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2024/12/03/nt-probnp-en-ecg-screening-bij-75-jarigen-voor-af-detectie-rct/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/01/14/strokestop-af-screening-is-kosteneffectief-bij-75-76-jarigen/","published":"2023-01-14"},{"url":"https://hartvaat.nl/2021/10/23/systematische-af-screening-en-klinische-uitkomsten-lancet-strokestop/","published":"2021-10-23"},{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/08/01/nt-probnp-bij-systematische-screening-op-atriumfibrilleren/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/02/01/stapsgewijze-massascreening-op-af-met-nt-probnp-strokestop-ii-studieontwerp/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"walter-t-ambrosius","type":"person","url":"https://hartvaat.nl/mensen/walter-t-ambrosius/","name":"Walter T Ambrosius","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weon-kim","type":"person","url":"https://hartvaat.nl/mensen/weon-kim/","name":"Weon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-b-white","type":"person","url":"https://hartvaat.nl/mensen/william-b-white/","name":"William B White","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/12/01/hoog-versus-laag-natrium-oxybaat-en-bloeddruk-bij-narcolepsie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2019/11/12/intensieve-versus-standaard-ambulante-bloeddrukcontrole-en-cerebrovasculaire-uit/","published":"2019-11-12"},{"url":"https://hartvaat.nl/2019/10/26/patiromer-voor-spironolactongebruik-bij-resistente-hypertensie-met-ckd-lancet-am/","published":"2019-10-26"},{"url":"https://hartvaat.nl/2019/04/09/sham-gecontroleerde-rct-s-van-renale-denervatie-meta-analyse/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/11/01/therapieresistente-hypertensie-aha-scientific-statement-over-detectie-evaluatie-/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-g-herrington","type":"person","url":"https://hartvaat.nl/mensen/william-g-herrington/","name":"William G Herrington","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2019/07/01/kosteneffectiviteit-van-statines-en-ezetimibe-bij-chronische-nierziekte/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"y-joseph-woo","type":"person","url":"https://hartvaat.nl/mensen/y-joseph-woo/","name":"Y Joseph Woo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2020/03/24/screening-en-profylactisch-amiodaron-vermindert-postoperatief-af/","published":"2020-03-24"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-wang","type":"person","url":"https://hartvaat.nl/mensen/yang-wang/","name":"Yang Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/03/01/lichaamsbeweging-beinvloedt-de-relatie-tussen-crp-triglyceriden-en-coronaire-ath/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/gedeeltelijke-cardiale-denervatie-voorkomt-af-na-cabg-rct/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2022/07/27/veiligheid-van-pcsk9-remmers-systematische-review-en-meta-analyse/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-ling-yu","type":"person","url":"https://hartvaat.nl/mensen/yu-ling-yu/","name":"Yu-Ling Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":7,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/04/01/lichaamshouding-en-orthostatische-hypotensie-bij-hypertensie-syst-eur-analyse/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adel-r-rizkala","type":"person","url":"https://hartvaat.nl/mensen/adel-r-rizkala/","name":"Adel R Rizkala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2016/06/07/klinische-verslechtering-van-poliklinisch-behandeld-hartfalen-paradigm-hf-analys/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-d-elliott","type":"person","url":"https://hartvaat.nl/mensen/adrian-d-elliott/","name":"Adrian D Elliott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2022/09/01/af-voorspelt-cognitieve-achteruitgang-meta-analyse-van-2-8-miljoen-personen/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2017/12/01/geintegreerde-zorg-bij-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-j-moskowitz","type":"person","url":"https://hartvaat.nl/mensen/alan-j-moskowitz/","name":"Alan J Moskowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alasdair-gray","type":"person","url":"https://hartvaat.nl/mensen/alasdair-gray/","name":"Alasdair Gray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alastair-m-gray","type":"person","url":"https://hartvaat.nl/mensen/alastair-m-gray/","name":"Alastair M Gray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/06/postoperatief-af-en-langetermijn-cva-risico-na-geisoleerde-cabg/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/07/01/kosteneffectiviteit-van-statines-en-ezetimibe-bij-chronische-nierziekte/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2017/08/01/radiale-arterie-graft-als-aanvulling-op-mammaria-interna-grafts-bij-cabg/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/12/29/bilaterale-versus-enkelvoudige-a-mammaria-interna-grafts-nejm-art-trial/","published":"2016-12-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-menozzi","type":"person","url":"https://hartvaat.nl/mensen/alberto-menozzi/","name":"Alberto Menozzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-ortiz","type":"person","url":"https://hartvaat.nl/mensen/alberto-ortiz/","name":"Alberto Ortiz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/02/25/de-mondiale-ziektelast-van-chronische-nierziekte-elke-20-seconden-een-sterfgeval/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"},{"url":"https://hartvaat.nl/2026/01/15/populatiegebaseerde-egfr-verdelingen-voor-vroege-identificatie-van-chronische-ni/","published":"2026-01-15"},{"url":"https://hartvaat.nl/2026/01/02/albuminurie-en-cardiovasculair-risico-gemiste-kans-in-de-2025-esc-eas-dyslipidem/","published":"2026-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-c-fanaroff","type":"person","url":"https://hartvaat.nl/mensen/alexander-c-fanaroff/","name":"Alexander C Fanaroff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/05/01/apothekerverwijzingen-voor-statine-start-twee-cluster-rct-s/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2024/09/03/augustus-4-weg-vergelijking-antitrombotische-strategieen-bij-af-na-acs-pci/","published":"2024-09-03"},{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-romanov","type":"person","url":"https://hartvaat.nl/mensen/alexander-romanov/","name":"Alexander Romanov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/02/22/temporaire-ruggenmergstimulatie-ter-preventie-van-postoperatief-af/","published":"2022-02-22"},{"url":"https://hartvaat.nl/2021/03/08/katheterablatie-om-af-progressie-te-vertragen-attest-gerandomiseerde-trial/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-n-nowbar","type":"person","url":"https://hartvaat.nl/mensen/alexandra-n-nowbar/","name":"Alexandra N Nowbar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amanda-hunter","type":"person","url":"https://hartvaat.nl/mensen/amanda-hunter/","name":"Amanda Hunter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amer-joseph","type":"person","url":"https://hartvaat.nl/mensen/amer-joseph/","name":"Amer Joseph","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andre-lamy","type":"person","url":"https://hartvaat.nl/mensen/andre-lamy/","name":"Andre Lamy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-m-russo","type":"person","url":"https://hartvaat.nl/mensen/andrea-m-russo/","name":"Andrea M Russo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/07/zorgpaden-na-nieuw-vastgesteld-atriumfibrilleren-rol-van-de-elektrofysioloog-en-/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-scalise","type":"person","url":"https://hartvaat.nl/mensen/andrea-scalise/","name":"Andrea Scalise","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrei-carvalho-sposito","type":"person","url":"https://hartvaat.nl/mensen/andrei-carvalho-sposito/","name":"Andrei Carvalho Sposito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/08/14/dapagliflozin-verlaagt-serum-klotho-bij-dialysepatienten-zonder-effect-op-botbio/","published":"2026-08-22"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2023/04/01/aspirine-in-primaire-preventie-en-hartfalenrisico-meta-analyse/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2021/06/01/serumkalium-en-prognose-bij-symptomatisch-hf/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-e-moran","type":"person","url":"https://hartvaat.nl/mensen/andrew-e-moran/","name":"Andrew E Moran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/06/01/team-based-care-bij-hypertensie-meta-analyse-bevestigt-effectiviteit-en-kostenef/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/01/01/farmacologische-hypertensiebehandeling-bij-volwassenen-who-richtlijn-samenvattin/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-t-yan","type":"person","url":"https://hartvaat.nl/mensen/andrew-t-yan/","name":"Andrew T Yan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andre-d-avila","type":"person","url":"https://hartvaat.nl/mensen/andre-d-avila/","name":"André d'Avila","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/09/01/sedatie-versus-narcose-bij-af-catheterablatie-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/07/02/pfa-versus-thermale-ablatie-bij-paroxysmaal-af-aritmielastanalyse/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ankeet-s-bhatt","type":"person","url":"https://hartvaat.nl/mensen/ankeet-s-bhatt/","name":"Ankeet S Bhatt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/30/kp-chemo-cumulatieve-incidentie-cancer-therapy-related-cardiac-dysfunction-8-4-h/","published":"2026-07-02"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-uitgebreide-fda-labeling-jama-cardiology-implicaties/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/04/27/pneumonie-incidentie-en-uitkomsten-bij-hartfalen/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-s-hellkamp","type":"person","url":"https://hartvaat.nl/mensen/anne-s-hellkamp/","name":"Anne S Hellkamp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annetine-c-gelijns","type":"person","url":"https://hartvaat.nl/mensen/annetine-c-gelijns/","name":"Annetine C Gelijns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antoine-kimmoun","type":"person","url":"https://hartvaat.nl/mensen/antoine-kimmoun/","name":"Antoine Kimmoun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonino-di-franco","type":"person","url":"https://hartvaat.nl/mensen/antonino-di-franco/","name":"Antonino Di Franco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"},{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-popolo-rubbio","type":"person","url":"https://hartvaat.nl/mensen/antonio-popolo-rubbio/","name":"Antonio Popolo Rubbio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arian-sultan","type":"person","url":"https://hartvaat.nl/mensen/arian-sultan/","name":"Arian Sultan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2025/05/07/hoog-vermogen-korte-duur-rf-ablatie-versus-cryoballon-bij-paroxysmaal-af-rct/","published":"2025-05-07"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aris-moschovitis","type":"person","url":"https://hartvaat.nl/mensen/aris-moschovitis/","name":"Aris Moschovitis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arthur-j-moss","type":"person","url":"https://hartvaat.nl/mensen/arthur-j-moss/","name":"Arthur J Moss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2018/05/01/crt-voordeel-bij-concordant-versus-discordant-linksbundeltakblok-esc-hf-pilot/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/11/01/klinische-presentatie-bij-eerste-hartfalenhospitalisatie-voorspelt-geen-heropnam/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/05/16/comorbiditeiten-en-crt-respons-madit-crt-langetermijnfollow-up/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/20/volledig-linkszijdig-reverse-remodelling-bij-crt-madit-crt-substudie/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/01/26/relatieve-wanddikte-en-risico-op-ventriculaire-tachyaritmieen-bij-linkerkamerdis/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"axel-haupt","type":"person","url":"https://hartvaat.nl/mensen/axel-haupt/","name":"Axel Haupt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/05/03/solbinsiran-langwerkend-sirna-tegen-angptl3-duurzaamheid-en-effectiviteit/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2025/01/21/muvalaplin-orale-lp-a-verlaging-nejm-gerandomiseerde-trial/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2023/09/07/orforglipron-dagelijkse-orale-glp-1-agonist-bij-obesitas-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","published":"2023-08-12"},{"url":"https://hartvaat.nl/2022/11/26/triple-gip-glp-1-glucagonreceptoragonist-bij-type-2-diabetes-fase-1b/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2018/11/17/ly3298176-duale-gip-glp-1-agonist-bij-diabetes-type-2-lancet-tirzepatide-fase-2/","published":"2018-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-greenberg","type":"person","url":"https://hartvaat.nl/mensen/barry-greenberg/","name":"Barry Greenberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/03/07/mesenchymale-precursorcellen-bij-hfref-gerandomiseerde-trial/","published":"2023-03-07"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2016/03/19/serca2a-gentherapie-bij-hartfalen-de-cupid-2-trial/","published":"2016-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bent-raungaard","type":"person","url":"https://hartvaat.nl/mensen/bent-raungaard/","name":"Bent Raungaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-thibault","type":"person","url":"https://hartvaat.nl/mensen/bernard-thibault/","name":"Bernard Thibault","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"},{"url":"https://hartvaat.nl/2017/04/01/aanvullende-elektroden-op-de-quartet-lv-lead-bieden-meer-crt-programmeringsmogel/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bertil-lindahl","type":"person","url":"https://hartvaat.nl/mensen/bertil-lindahl/","name":"Bertil Lindahl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2019/01/12/visualisatie-van-asymptomatische-atherosclerose-voor-cv-preventie-lancet-vipviza/","published":"2019-01-12"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bin-wang","type":"person","url":"https://hartvaat.nl/mensen/bin-wang/","name":"Bin Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/26/intensieve-bloeddrukbehandeling-en-cognitieve-functie-een-gerandomiseerde-klinis/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2016/03/01/taurinesuppletie-verlaagt-bloeddruk-en-verbetert-vaatfunctie-bij-prehypertensie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"binita-shah","type":"person","url":"https://hartvaat.nl/mensen/binita-shah/","name":"Binita Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bo-yu","type":"person","url":"https://hartvaat.nl/mensen/bo-yu/","name":"Bo Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2024/09/24/colchicine-en-coronaire-plaquestabiliteit-na-acs-oct-studie/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2021/05/21/katheterablatie-versus-medicatie-bij-persisterend-en-langdurig-persisterend-af-l/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"boris-schmidt","type":"person","url":"https://hartvaat.nl/mensen/boris-schmidt/","name":"Boris Schmidt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-m-psaty","type":"person","url":"https://hartvaat.nl/mensen/bruce-m-psaty/","name":"Bruce M Psaty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/06/01/geisoleerde-diastolische-hypertensie-cohort-en-meta-analyse-voor-behandeldrempel/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-r-nascimento","type":"person","url":"https://hartvaat.nl/mensen/bruno-r-nascimento/","name":"Bruno R Nascimento","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/10/31/antitrombotische-therapie-na-laa-occlusie-netwerk-meta-analyse/","published":"2023-10-31"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/01/01/implementatie-van-mi-zorgsystemen-in-lage-en-middeninkomenslanden/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caihua-sang","type":"person","url":"https://hartvaat.nl/mensen/caihua-sang/","name":"Caihua Sang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"camilla-hage","type":"person","url":"https://hartvaat.nl/mensen/camilla-hage/","name":"Camilla Hage","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/06/27/frailte-versnelt-hartfalenprogressie-en-vermindert-therapietolerantie/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2026/04/09/prefers-stockholm-nieuw-ontstaan-hfpef-heeft-slechtere-langetermijnuitkomsten-da/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/06/09/acyl-ghreline-verbetert-hartfunctie-bij-hartfalen/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2018/06/01/hemodynamische-effecten-van-levosimendan-bij-gevorderd-stabiel-chronisch-hartfal/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carl-e-schotborgh","type":"person","url":"https://hartvaat.nl/mensen/carl-e-schotborgh/","name":"Carl E Schotborgh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmen-a-peralta","type":"person","url":"https://hartvaat.nl/mensen/carmen-a-peralta/","name":"Carmen A Peralta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2016/02/09/intensieve-versus-standaard-bloeddrukcontrole-en-nierfunctie-na-lacunair-herseni/","published":"2016-02-09"},{"url":"https://hartvaat.nl/2016/01/01/bereikte-bloeddruk-en-uitkomsten-in-de-sps3-trial-bij-lacunaire-herseninfarcten/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chenxi-jiang","type":"person","url":"https://hartvaat.nl/mensen/chenxi-jiang/","name":"Chenxi Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chenyang-jiang","type":"person","url":"https://hartvaat.nl/mensen/chenyang-jiang/","name":"Chenyang Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/12/09/nieuw-bifasisch-pfa-systeem-versus-thermale-ablatie-bij-paroxysmaal-af/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chinthanie-ramasundarahettige","type":"person","url":"https://hartvaat.nl/mensen/chinthanie-ramasundarahettige/","name":"Chinthanie Ramasundarahettige","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-besler","type":"person","url":"https://hartvaat.nl/mensen/christian-besler/","name":"Christian Besler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-ott","type":"person","url":"https://hartvaat.nl/mensen/christian-ott/","name":"Christian Ott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/12/01/empagliflozine-en-vaatfunctie-bij-chronisch-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/11/21/sacubitril-valsartan-versus-olmesartan-en-cardiovasculaire-remodellering-bij-hyp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/09/19/empagliflozine-en-vasculaire-functie-en-centrale-hemodynamiek-bij-diabetes-type-/","published":"2017-09-19"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christiane-e-angermann","type":"person","url":"https://hartvaat.nl/mensen/christiane-e-angermann/","name":"Christiane E Angermann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/04/22/anemie-beinvloedt-ijzerhomeostase-en-empagliflozine-respons-bij-hf/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-liebetrau","type":"person","url":"https://hartvaat.nl/mensen/christoph-liebetrau/","name":"Christoph Liebetrau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-c-nessel","type":"person","url":"https://hartvaat.nl/mensen/christopher-c-nessel/","name":"Christopher C Nessel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-e-kurtz","type":"person","url":"https://hartvaat.nl/mensen/christopher-e-kurtz/","name":"Christopher E Kurtz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/01/01/interindividuele-variatie-in-ldl-verlaging-met-evolocumab-fourier-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chyke-a-doubeni","type":"person","url":"https://hartvaat.nl/mensen/chyke-a-doubeni/","name":"Chyke A Doubeni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"colin-baigent","type":"person","url":"https://hartvaat.nl/mensen/colin-baigent/","name":"Colin Baigent","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2019/07/01/kosteneffectiviteit-van-statines-en-ezetimibe-bij-chronische-nierziekte/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"craig-granowitz","type":"person","url":"https://hartvaat.nl/mensen/craig-granowitz/","name":"Craig Granowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cyril-camaro","type":"person","url":"https://hartvaat.nl/mensen/cyril-camaro/","name":"Cyril Camaro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/02/therapietrouw-aan-lipidenverlagende-medicatie-na-pci-in-nederland/","published":"2026-03-28"},{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2023/05/14/prehospitale-troponine-voor-uitsluiting-nste-acs-gerandomiseerde-trial/","published":"2023-05-14"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-wichterle","type":"person","url":"https://hartvaat.nl/mensen/dan-wichterle/","name":"Dan Wichterle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2025/10/07/cti-blok-na-pfa-versus-rf-cryo-ablatie-gerandomiseerde-vergelijking/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/02/01/sequentiele-hybride-ablatie-versus-chirurgische-cryomaze-bij-af-met-structurele-/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2018/07/01/echogeleide-versus-conventionele-femorale-venepunctie-bij-af-ablatie-gerandomise/","published":"2018-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-a-jones","type":"person","url":"https://hartvaat.nl/mensen/daniel-a-jones/","name":"Daniel A Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"},{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2017/04/01/intracoronair-nitriet-onderdrukt-de-inflammatoire-respons-na-primaire-pci/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-i-sessler","type":"person","url":"https://hartvaat.nl/mensen/daniel-i-sessler/","name":"Daniel I Sessler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/02/geindividualiseerd-perioperatief-bloeddrukmanagement-bij-grote-buikchirurgie/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2025/09/23/intensief-versus-conventioneel-intraoperatief-bloeddrukmanagement-en-cv-events-n/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2020/07/18/dexmedetomidine-voor-af-en-delier-na-hartchirurgie-lancet-decade/","published":"2020-07-18"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/08/15/overleving-na-geisoleerde-postoperatieve-troponine-elevatie/","published":"2017-08-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-d-berg","type":"person","url":"https://hartvaat.nl/mensen/david-d-berg/","name":"David D Berg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/05/01/time-to-clinical-benefit-van-dapagliflozine-bij-hfref-dapa-hf/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dennis-h-lau","type":"person","url":"https://hartvaat.nl/mensen/dennis-h-lau/","name":"Dennis H Lau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2022/09/01/af-voorspelt-cognitieve-achteruitgang-meta-analyse-van-2-8-miljoen-personen/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/10/09/klinische-risicofactoren-voor-cva-bij-anticoagulantie-naieve-af-meta-analyse/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2017/12/01/geintegreerde-zorg-bij-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derek-j-hausenloy","type":"person","url":"https://hartvaat.nl/mensen/derek-j-hausenloy/","name":"Derek J Hausenloy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/07/09/cangrelor-en-infarctgrootte-bij-stemi-gerandomiseerde-trial/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2023/06/01/remote-ischemische-conditionering-bij-milde-hypertensie-zonder-medicatie-rct/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/07/01/remote-post-ontslag-behandeling-na-mi-door-paramedici-versus-standaardzorg-jama-/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2018/06/19/cardioprotectieve-therapieen-en-area-at-risk-bij-gereperfuseerd-stemi-cmr-analys/","published":"2018-06-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deyong-long","type":"person","url":"https://hartvaat.nl/mensen/deyong-long/","name":"Deyong Long","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"didier-carrie","type":"person","url":"https://hartvaat.nl/mensen/didier-carrie/","name":"Didier Carrié","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diederick-e-grobbee","type":"person","url":"https://hartvaat.nl/mensen/diederick-e-grobbee/","name":"Diederick E Grobbee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"domingo-a-pascual-figal","type":"person","url":"https://hartvaat.nl/mensen/domingo-a-pascual-figal/","name":"Domingo A Pascual-Figal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2024/12/01/colica-colchicine-bij-acuut-gedecompenseerd-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/02/01/diabetes-en-sacubitril-valsartan-titratie-bij-hartfalen-na-opname/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-purvi-parwani","type":"person","url":"https://hartvaat.nl/mensen/dr-purvi-parwani/","name":"Dr. Purvi Parwani","title":"Cardioloog, Loma Linda University, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/between-sessions-champion-af-hi-peitho-stemi-dtu/","title":"Tussen de sessies: CHAMPION-AF, HI-PEITHO en STEMI-DTU samengevat"},{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/between-sessions-vesalius-kardinal-chip-bcis3/","title":"Tussen de sessies: VESALIUS-CV, KARDINAL, CHIP-BCIS3 en meer"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-sara-saberi","type":"person","url":"https://hartvaat.nl/mensen/dr-sara-saberi/","name":"Dr. Sara Saberi","title":"Expert erfelijke hart- en vaatziekten","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/aficamten-en-de-toekomst-van-obstructieve-hcm-behandeling/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[{"url":"https://hartvaat.nl/video/cardiomyopathie-diagnose-hcm-saberi/diagnostiek-hypertrofische-cardiomyopathie/","title":"Diagnostiek van hypertrofische cardiomyopathie"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emilia-bagiella","type":"person","url":"https://hartvaat.nl/mensen/emilia-bagiella/","name":"Emilia Bagiella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eri-t-kato","type":"person","url":"https://hartvaat.nl/mensen/eri-t-kato/","name":"Eri T Kato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/04/23/glp-1-agonisten-versus-sglt2-remmers-voor-cv-en-renale-preventie-vergelijkende-m/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2019/01/05/sglt2-remmers-voor-primaire-en-secundaire-cv-en-renale-preventie-bij-diabetes-la/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-bruckert","type":"person","url":"https://hartvaat.nl/mensen/eric-bruckert/","name":"Eric Bruckert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/06/24/inclisiran-bij-adolescenten-met-homozygote-fh-effectiviteit-en-veiligheid/","published":"2025-06-24"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erwan-donal","type":"person","url":"https://hartvaat.nl/mensen/erwan-donal/","name":"Erwan Donal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/22/m-teer-werkt-over-het-volledige-lvef-spectrum-vergroot-linkeratrium-volume-voors/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/02/03/effect-van-mavacamten-op-risicoscores-voor-plotse-hartdood-bij-hypertrofische-ca/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2023/07/20/ni006-antilichaam-voor-afbraak-van-cardiale-transthyretine-amyloid-nejm-fase-1/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"estella-kanevsky","type":"person","url":"https://hartvaat.nl/mensen/estella-kanevsky/","name":"Estella Kanevsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/02/01/cv-uitkomsten-naar-albumin-en-nierziekte-bij-diabetes-type-2-met-hoog-cv-risico/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-goncalvesova","type":"person","url":"https://hartvaat.nl/mensen/eva-goncalvesova/","name":"Eva Goncalvesova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-kleine","type":"person","url":"https://hartvaat.nl/mensen/eva-kleine/","name":"Eva Kleine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2018/03/13/doac-s-bij-af-met-ckd-systematische-review-werkzaamheid-en-veiligheid/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-korup","type":"person","url":"https://hartvaat.nl/mensen/eva-korup/","name":"Eva Korup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evgeny-pokushalov","type":"person","url":"https://hartvaat.nl/mensen/evgeny-pokushalov/","name":"Evgeny Pokushalov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/12/01/av-junctieablatie-plus-crt-bij-permanent-af-gerandomiseerde-trial/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/02/01/katheterablatie-bij-af-met-hartfalen-nejm-castle-af/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ewa-a-jankowska","type":"person","url":"https://hartvaat.nl/mensen/ewa-a-jankowska/","name":"Ewa A Jankowska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/04/01/lv-longitudinale-systolische-functieparameters-als-voorspellers-bij-hfpef/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ewa-karwatowska-prokopczuk","type":"person","url":"https://hartvaat.nl/mensen/ewa-karwatowska-prokopczuk/","name":"Ewa Karwatowska-Prokopczuk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2022/03/22/pelacarsen-op-lp-a-cholesterol-en-gecorrigeerd-ldl-cholesterol/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fan-fan-hou","type":"person","url":"https://hartvaat.nl/mensen/fan-fan-hou/","name":"Fan Fan Hou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/27/smoothened-signalering-bevordert-nierfibrose-via-autofagieremming/","published":"2026-04-10"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fang-fei-wei","type":"person","url":"https://hartvaat.nl/mensen/fang-fei-wei/","name":"Fang-Fei Wei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/06/01/hypertensie-wijzigt-de-relatie-tussen-lp-a-en-mortaliteit-bij-acuut-gedecompense/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2020/11/10/chinese-kruidenformule-voor-gemaskeerde-hypertensie-gerandomiseerde-placebogecon/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"faris-al-khalili","type":"person","url":"https://hartvaat.nl/mensen/faris-al-khalili/","name":"Faris Al-Khalili","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/12/03/nt-probnp-en-ecg-screening-bij-75-jarigen-voor-af-detectie-rct/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/01/14/strokestop-af-screening-is-kosteneffectief-bij-75-76-jarigen/","published":"2023-01-14"},{"url":"https://hartvaat.nl/2021/10/23/systematische-af-screening-en-klinische-uitkomsten-lancet-strokestop/","published":"2021-10-23"},{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/08/01/nt-probnp-bij-systematische-screening-op-atriumfibrilleren/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/02/01/stapsgewijze-massascreening-op-af-met-nt-probnp-strokestop-ii-studieontwerp/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-de-marco","type":"person","url":"https://hartvaat.nl/mensen/federico-de-marco/","name":"Federico De Marco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2017/05/30/tijdstrends-in-complicaties-van-bioresorbeerbare-versus-metallic-stents/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felice-gragnano","type":"person","url":"https://hartvaat.nl/mensen/felice-gragnano/","name":"Felice Gragnano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florence-leclercq","type":"person","url":"https://hartvaat.nl/mensen/florence-leclercq/","name":"Florence Leclercq","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florian-kronenberg","type":"person","url":"https://hartvaat.nl/mensen/florian-kronenberg/","name":"Florian Kronenberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/11/zeventien-jaar-voor-verandering-doorbreken-de-2025-esc-eas-dyslipidemierichtlijn/","published":"2026-01-11"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/lipoproteïne-a/","title":"Sessie 3: Lipoproteïne(a)"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-costa","type":"person","url":"https://hartvaat.nl/mensen/francesco-costa/","name":"Francesco Costa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/01/21/langdurige-duale-antiplaatjestherapie-bij-patienten-met-eerder-myocardinfarct-me/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-nordio","type":"person","url":"https://hartvaat.nl/mensen/francesco-nordio/","name":"Francesco Nordio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/nieuwe-risicovoorspellingsscore-bij-af-voor-netto-klinisch-resultaat-engage-af-t/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"franck-boccara","type":"person","url":"https://hartvaat.nl/mensen/franck-boccara/","name":"Franck Boccara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/02/01/therapeutische-innovaties-in-de-secundaire-preventie-van-cardiovasculair-risico/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2020/05/26/evolocumab-bij-hiv-met-dyslipidemie-beijerinck-gerandomiseerde-studie/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"franco-fabbiocchi","type":"person","url":"https://hartvaat.nl/mensen/franco-fabbiocchi/","name":"Franco Fabbiocchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2017/04/01/polymeervrije-biolimus-stent-bij-hoog-bloedingsrisico-met-acs-leaders-free-subst/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederick-a-masoudi","type":"person","url":"https://hartvaat.nl/mensen/frederick-a-masoudi/","name":"Frederick A Masoudi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederic-anselme","type":"person","url":"https://hartvaat.nl/mensen/frederic-anselme/","name":"Frédéric Anselme","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerald-s-bloomfield","type":"person","url":"https://hartvaat.nl/mensen/gerald-s-bloomfield/","name":"Gerald S Bloomfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/08/24/reprieve-pitavastatine-vermindert-cv-events-bij-hiv-nejm/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2023/02/01/cv-risicomodellen-bij-hiv-patienten-systematische-review/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2018/07/01/hypertensie-bij-hiv-nieuwe-pathofysiologische-mechanismen/","published":"2018-07-01"},{"url":"https://hartvaat.nl/2016/12/01/lacunes-in-hypertensierichtlijnen-in-lage-en-middeninkomenslanden-systematische-/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gert-richardt","type":"person","url":"https://hartvaat.nl/mensen/gert-richardt/","name":"Gert Richardt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulio-guagliumi","type":"person","url":"https://hartvaat.nl/mensen/giulio-guagliumi/","name":"Giulio Guagliumi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gorav-ailawadi","type":"person","url":"https://hartvaat.nl/mensen/gorav-ailawadi/","name":"Gorav Ailawadi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-f-michaud","type":"person","url":"https://hartvaat.nl/mensen/gregory-f-michaud/","name":"Gregory F Michaud","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guido-grassi","type":"person","url":"https://hartvaat.nl/mensen/guido-grassi/","name":"Guido Grassi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/08/01/sympathische-overactiviteit-bij-resistente-hypertensie-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/01/01/reproduceerbaarheid-en-behandeleffect-op-kantoor-versus-ambulante-bloeddrukrelat/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/03/01/renale-denervatie-en-sympathische-activiteit-systematische-review/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2018/08/01/sympathische-zenuwactivatie-bij-essentiele-hypertensie-meta-analyse/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/07/01/sport-versus-beroepsmatige-lichamelijke-activiteit-en-cardiovasculair-risico/","published":"2018-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"haibo-zhang","type":"person","url":"https://hartvaat.nl/mensen/haibo-zhang/","name":"Haibo Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/effect-van-baduanjin-op-bloeddruk-bij-hoog-normaal-bloeddruk-gerandomiseerde-tri/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hardi-mundl","type":"person","url":"https://hartvaat.nl/mensen/hardi-mundl/","name":"Hardi Mundl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helge-mollmann","type":"person","url":"https://hartvaat.nl/mensen/helge-mollmann/","name":"Helge Möllmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hisatomi-arima","type":"person","url":"https://hartvaat.nl/mensen/hisatomi-arima/","name":"Hisatomi Arima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyo-suk-ahn","type":"person","url":"https://hartvaat.nl/mensen/hyo-suk-ahn/","name":"Hyo-Suk Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyun-jae-kang","type":"person","url":"https://hartvaat.nl/mensen/hyun-jae-kang/","name":"Hyun-Jae Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"havard-dalen","type":"person","url":"https://hartvaat.nl/mensen/havard-dalen/","name":"Håvard Dalen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/08/01/telerevalidatie-haalbaar-voor-hartfalenpatienten-zonder-toegang-tot-poliklinisch/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/08/01/cardiorenaal-syndroom-en-fitheid-bij-hartfalen-telerevalidatie-trial/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2022/06/01/vijf-jaar-inspanningstraining-verbetert-cardiovasculair-risicoprofiel-bij-oudere/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iginio-colaiori","type":"person","url":"https://hartvaat.nl/mensen/iginio-colaiori/","name":"Iginio Colaiori","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/12/20/ticagrelor-versus-prasugrel-en-coronaire-microcirculatie-bij-pci/","published":"2023-12-20"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2016/09/13/clopidogrel-versus-ticagrelor-bij-diabetes-na-pci-gerandomiseerde-trial/","published":"2016-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"imre-ungi","type":"person","url":"https://hartvaat.nl/mensen/imre-ungi/","name":"Imre Ungi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-michael-gaziano","type":"person","url":"https://hartvaat.nl/mensen/j-michael-gaziano/","name":"J Michael Gaziano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2019/01/10/endoscopische-versus-open-veneoogst-bij-cabg-nejm-regroup/","published":"2019-01-10"},{"url":"https://hartvaat.nl/2018/09/22/aspirine-voor-primaire-preventie-bij-matig-cv-risico-lancet-arrive/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2018/04/10/geen-verband-tussen-hartfalen-en-kankerincidentie/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2017/06/01/voedingsstatus-en-langetermijn-multivitaminegebruik-en-cv-risico-phs-ii-analyse/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jagmeet-p-singh","type":"person","url":"https://hartvaat.nl/mensen/jagmeet-p-singh/","name":"Jagmeet P Singh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2021/08/06/ventriculaire-aritmie-bij-crt-responders-en-super-responders-meta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/03/07/contractiliteitssensor-geleide-crt-optimalisatie-respond-crt-trial/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janet-m-schnee","type":"person","url":"https://hartvaat.nl/mensen/janet-m-schnee/","name":"Janet M Schnee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jarett-d-berry","type":"person","url":"https://hartvaat.nl/mensen/jarett-d-berry/","name":"Jarett D Berry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/12/22/lichaamssamenstelling-en-risico-op-hartfalen-en-mi-prospectieve-analyse/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2016/08/01/sedentair-gedrag-en-cardiovasculair-risico-continue-dosis-responsrelatie-in-meta/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jasper-tromp","type":"person","url":"https://hartvaat.nl/mensen/jasper-tromp/","name":"Jasper Tromp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/28/atriumfibrilleren-en-hartfalen-versterken-elkaar-en-verhogen-sterfte-aanzienlijk/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/03/05/ai-echocardiografie-door-niet-specialisten-kosteneffectiviteitsanalyse-uit-singa/","published":"2026-04-08"},{"url":"https://hartvaat.nl/2025/12/16/farmacologische-behandeling-van-hfref-geactualiseerde-systematische-review/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2019/08/06/leeftijdsafhankelijke-kenmerken-en-uitkomsten-bij-hfpef/","published":"2019-08-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-guillaume-dillinger","type":"person","url":"https://hartvaat.nl/mensen/jean-guillaume-dillinger/","name":"Jean-Guillaume Dillinger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/22/lge-granulariteit-op-cmr-voorspelt-sterfte-bij-eindstadium-hypertrofische-cardio/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeanine-e-roeters-van-lennep","type":"person","url":"https://hartvaat.nl/mensen/jeanine-e-roeters-van-lennep/","name":"Jeanine E Roeters van Lennep","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/04/19/fh-vrouwen-verliezen-mediaan-2-9-jaar-lipidenverlagende-behandeling-rond-elke-ki/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2026/04/28/geen-sekseverschillen-in-werkzaamheid-van-hartfalenmedicatie-meta-analyse-van-13/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2026/01/16/statinegebruik-in-de-zwangerschap-en-congenitale-afwijkingen-noors-cohort/","published":"2026-01-16"},{"url":"https://hartvaat.nl/2025/11/26/lipideveranderingen-bij-vrouwen-met-fh-tijdens-de-menopauzale-transitie/","published":"2025-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-a-cutler","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-a-cutler/","name":"Jeffrey A Cutler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-i-weitz","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-i-weitz/","name":"Jeffrey I Weitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"},{"url":"https://hartvaat.nl/2018/10/30/endogene-factor-xa-activiteit-en-edoxaban-farmacodynamische-marker-en-klinische-/","published":"2018-10-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-s-borer","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-s-borer/","name":"Jeffrey S Borer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2019/12/01/gunstige-effecten-van-ivabradine-bij-hf-met-lage-ef-en-hartfrequentie-77-bpm/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-whittle","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-whittle/","name":"Jeffrey Whittle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jenifer-m-brown","type":"person","url":"https://hartvaat.nl/mensen/jenifer-m-brown/","name":"Jenifer M Brown","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/10/nieuwe-medicamenteuze-therapieen-voor-hypertensie/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-s-lees","type":"person","url":"https://hartvaat.nl/mensen/jennifer-s-lees/","name":"Jennifer S Lees","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/06/30/kfre-aangepast-voor-multimorbiditeit-verbetert-schatting-nierfalenrisico/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/02/25/de-mondiale-ziektelast-van-chronische-nierziekte-elke-20-seconden-een-sterfgeval/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-erik-nielsen-kudsk","type":"person","url":"https://hartvaat.nl/mensen/jens-erik-nielsen-kudsk/","name":"Jens Erik Nielsen-Kudsk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/06/02/doac-gebruik-na-ablatie-voor-atriumfibrilleren-aanhouderij-daalt-na-drie-jaar/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-ulrik-staehr-jensen","type":"person","url":"https://hartvaat.nl/mensen/jens-ulrik-staehr-jensen/","name":"Jens Ulrik Stæhr Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeong-hoon-yang","type":"person","url":"https://hartvaat.nl/mensen/jeong-hoon-yang/","name":"Jeong Hoon Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeroen-dauw","type":"person","url":"https://hartvaat.nl/mensen/jeroen-dauw/","name":"Jeroen Dauw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeroen-m-l-hendriks","type":"person","url":"https://hartvaat.nl/mensen/jeroen-m-l-hendriks/","name":"Jeroen M L Hendriks","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/01/geintegreerde-gespecialiseerde-af-poliklinieken-verlagen-totale-mortaliteit-post/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2017/12/01/geintegreerde-zorg-bij-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jerome-i-rotter","type":"person","url":"https://hartvaat.nl/mensen/jerome-i-rotter/","name":"Jerome I Rotter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/gwas-van-pr-interval-bij-hispanic-latino-s-nieuw-locus-bij-id2/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jesper-kjaergaard","type":"person","url":"https://hartvaat.nl/mensen/jesper-kjaergaard/","name":"Jesper Kjærgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jessica-tyrwhitt","type":"person","url":"https://hartvaat.nl/mensen/jessica-tyrwhitt/","name":"Jessica Tyrwhitt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2023/02/01/aspirine-en-cardiovasculaire-uitkomsten-bij-chronische-nierziekte/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianhua-wu","type":"person","url":"https://hartvaat.nl/mensen/jianhua-wu/","name":"Jianhua Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2026/03/25/meta-analyse-glp-1-agonisten-voorkomen-hartfalen-in-type-2-diabetes-sterkste-eff/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/06/10/voorspelling-van-atriumfibrilleren-in-elektronische-gezondheidsdossiers-systemat/","published":"2022-06-10"},{"url":"https://hartvaat.nl/2021/03/01/langetermijn-overlevingsvoordeel-van-ramipril-bij-mi-met-hf/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jie-yu","type":"person","url":"https://hartvaat.nl/mensen/jie-yu/","name":"Jie Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2017/07/11/positieve-luchtwegdruk-en-cv-events-bij-slaapapneu-jama-meta-analyse/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiguang-wang","type":"person","url":"https://hartvaat.nl/mensen/jiguang-wang/","name":"Jiguang Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2026/02/01/innovatieve-wereldwijde-modellen-voor-ckd-zorg-casestudies-en-strategieen/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2021/02/01/therapietrouw-aan-single-pill-versus-vrije-combinatietherapie-bij-hypertensie-me/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jing-kan","type":"person","url":"https://hartvaat.nl/mensen/jing-kan/","name":"Jing Kan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jing-wang","type":"person","url":"https://hartvaat.nl/mensen/jing-wang/","name":"Jing Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/06/vereenvoudigde-linkervoorhoofdaanhangsel-occlusie-onder-fluoroscopie-met-watchma/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/02/21/pelacarsen-vermindert-de-behoefte-aan-lipoproteine-a-aferese-lp-a-frontiers-aphe/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2026/02/12/aanhoudende-monocytactivatie-door-geoxideerd-ldl-en-vrij-cholesterol/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2021/06/01/sglt2-remmers-versus-arni-bij-hfref-meta-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2019/09/01/metformine-en-aorta-aneurysma-systematische-review-en-meta-analyse/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joachim-weil","type":"person","url":"https://hartvaat.nl/mensen/joachim-weil/","name":"Joachim Weil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johannes-brachmann","type":"person","url":"https://hartvaat.nl/mensen/johannes-brachmann/","name":"Johannes Brachmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2018/02/01/katheterablatie-bij-af-met-hartfalen-nejm-castle-af/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/03/07/contractiliteitssensor-geleide-crt-optimalisatie-respond-crt-trial/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/vochtstatustelemonitoring-bij-hartfalen-gerandomiseerde-trial/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-d-varigos","type":"person","url":"https://hartvaat.nl/mensen/john-d-varigos/","name":"John D Varigos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-k-french","type":"person","url":"https://hartvaat.nl/mensen/john-k-french/","name":"John K French","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2022/07/01/behandeling-van-acuut-coronair-syndroom-in-ruraal-australie-moracs-trial/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-mant","type":"person","url":"https://hartvaat.nl/mensen/jonathan-mant/","name":"Jonathan Mant","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jong-hwa-ahn","type":"person","url":"https://hartvaat.nl/mensen/jong-hwa-ahn/","name":"Jong-Hwa Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jordana-b-cohen","type":"person","url":"https://hartvaat.nl/mensen/jordana-b-cohen/","name":"Jordana B Cohen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/03/01/kaliumnitraat-bij-hfpef-gerandomiseerde-trial/","published":"2025-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorge-plutzky","type":"person","url":"https://hartvaat.nl/mensen/jorge-plutzky/","name":"Jorge Plutzky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2024/06/04/drive-remote-management-verbetert-richtlijnmedicatie-bij-hartfalen/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-luis-merino","type":"person","url":"https://hartvaat.nl/mensen/jose-luis-merino/","name":"Jose Luis Merino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/03/28/geinhaleerde-flecainide-voor-cardioversie-van-recent-onset-af-lancet/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-vogler","type":"person","url":"https://hartvaat.nl/mensen/julia-vogler/","name":"Julia Vogler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2022/07/15/geindividualiseerde-versus-standaard-cryoballonablatie-bij-paroxysmaal-af/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2021/05/21/firm-ablatie-versus-pvi-bij-paroxysmaal-af-gerandomiseerde-resultaten/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kari-saunamaki","type":"person","url":"https://hartvaat.nl/mensen/kari-saunamaki/","name":"Kari Saunamäki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-fengler","type":"person","url":"https://hartvaat.nl/mensen/karl-fengler/","name":"Karl Fengler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-patrik-kresoja","type":"person","url":"https://hartvaat.nl/mensen/karl-patrik-kresoja/","name":"Karl-Patrik Kresoja","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katharina-mayer","type":"person","url":"https://hartvaat.nl/mensen/katharina-mayer/","name":"Katharina Mayer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katie-harris","type":"person","url":"https://hartvaat.nl/mensen/katie-harris/","name":"Katie Harris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/09/sekseverschillen-in-lipiden-en-lipoproteinen-en-het-cardiovasculaire-risico-uk-b/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/03/24/systemische-inflammatie-en-recidief-na-een-af-gerelateerd-herseninfarct/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2025/11/01/magnesiumsuppletie-en-bloeddruk-meta-analyse-van-rct-s/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2023/03/01/korttermijn-bloeddrukmetingen-voorspellen-langetermijneffect-van-behandeling/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katrin-borof","type":"person","url":"https://hartvaat.nl/mensen/katrin-borof/","name":"Katrin Borof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-kausik-ray","type":"person","url":"https://hartvaat.nl/mensen/prof-kausik-ray/","name":"Kausik Ray","title":"Imperial College London, VK","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/ldl-cholesterol/","title":"Sessie 2: LDL-cholesterol"},{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/implementatie-lipidenmanagement/","title":"Sessie 4: Implementatie van lipidenmanagement — praktische uitdagingen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kelley-r-h-branch","type":"person","url":"https://hartvaat.nl/mensen/kelley-r-h-branch/","name":"Kelley R H Branch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2021/09/02/efpeglenatide-en-cv-en-renale-uitkomsten-bij-diabetes-type-2-nejm-amplitude-o/","published":"2021-09-02"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-b-margulies","type":"person","url":"https://hartvaat.nl/mensen/kenneth-b-margulies/","name":"Kenneth B Margulies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/03/01/kaliumnitraat-bij-hfpef-gerandomiseerde-trial/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khaja-m-chinnakondepalli","type":"person","url":"https://hartvaat.nl/mensen/khaja-m-chinnakondepalli/","name":"Khaja M Chinnakondepalli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ki-hong-choi","type":"person","url":"https://hartvaat.nl/mensen/ki-hong-choi/","name":"Ki Hong Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kirsten-b-holven","type":"person","url":"https://hartvaat.nl/mensen/kirsten-b-holven/","name":"Kirsten B. Holven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/04/19/fh-vrouwen-verliezen-mediaan-2-9-jaar-lipidenverlagende-behandeling-rond-elke-ki/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2026/02/19/enkelvoudige-onverzadigde-vetzuren-in-vetweefsel-en-het-risico-op-perifeer-vaatl/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/01/16/statinegebruik-in-de-zwangerschap-en-congenitale-afwijkingen-noors-cohort/","published":"2026-01-16"},{"url":"https://hartvaat.nl/2025/11/26/lipideveranderingen-bij-vrouwen-met-fh-tijdens-de-menopauzale-transitie/","published":"2025-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-c-koskinas","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-c-koskinas/","name":"Konstantinos C Koskinas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2018/04/07/statines-en-niet-statine-ldl-verlagers-en-cardiovasculaire-uitkomsten-meta-analy/","published":"2018-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristi-h-monahan","type":"person","url":"https://hartvaat.nl/mensen/kristi-h-monahan/","name":"Kristi H Monahan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/07/13/ablatie-versus-medicatie-bij-af-naar-ras-en-etniciteit/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristian-wachtell","type":"person","url":"https://hartvaat.nl/mensen/kristian-wachtell/","name":"Kristian Wachtell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/05/veroorzaken-betablokkers-depressie-systematische-review-en-meta-analyse/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kunihiro-matsushita","type":"person","url":"https://hartvaat.nl/mensen/kunihiro-matsushita/","name":"Kunihiro Matsushita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/27/albuminurie-geassocieerd-met-verhoogd-risico-op-abdominaal-aorta-aneurysma/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/11/01/rustduur-voor-bloeddrukmeting-best-rest-trial/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"},{"url":"https://hartvaat.nl/2016/02/04/risicoprojectie-voor-nierfalen-bij-levende-nierdonorkandidaten/","published":"2016-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lama-ghazi","type":"person","url":"https://hartvaat.nl/mensen/lama-ghazi/","name":"Lama Ghazi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/03/28/secundaire-hypertensie-bij-kinderen-jama-klinische-diagnostiek/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2020/10/01/intensieve-versus-standaard-bloeddrukbehandeling-op-white-coat-effect-en-gemaske/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"larissa-fabritz","type":"person","url":"https://hartvaat.nl/mensen/larissa-fabritz/","name":"Larissa Fabritz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2020/05/01/predictie-van-af-recidief-na-ablatie-systematische-review-van-prognostische-mode/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-s-maier","type":"person","url":"https://hartvaat.nl/mensen/lars-s-maier/","name":"Lars S Maier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/23/residuele-linker-atriale-v-golf-voorspelt-de-uitkomst-van-mitralisklep-edge-to-e/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-a-magee","type":"person","url":"https://hartvaat.nl/mensen/laura-a-magee/","name":"Laura A Magee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/03/01/orale-antihypertensiva-bij-niet-ernstige-zwangerschapshypertensie-netwerkmeta-an/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2019/09/21/orale-antihypertensiva-bij-ernstige-hypertensie-in-de-zwangerschap-lancet-vergel/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2018/06/01/amenorroe-duur-bij-start-antihypertensiva-in-de-zwangerschap-chips-secundaire-an/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/12/01/placental-growth-factor-als-prognostisch-instrument-bij-hypertensieve-zwangersch/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lawton-s-cooper","type":"person","url":"https://hartvaat.nl/mensen/lawton-s-cooper/","name":"Lawton S Cooper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leif-friberg","type":"person","url":"https://hartvaat.nl/mensen/leif-friberg/","name":"Leif Friberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/12/03/nt-probnp-en-ecg-screening-bij-75-jarigen-voor-af-detectie-rct/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/01/14/strokestop-af-screening-is-kosteneffectief-bij-75-76-jarigen/","published":"2023-01-14"},{"url":"https://hartvaat.nl/2021/10/23/systematische-af-screening-en-klinische-uitkomsten-lancet-strokestop/","published":"2021-10-23"},{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/08/01/nt-probnp-bij-systematische-screening-op-atriumfibrilleren/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/02/01/stapsgewijze-massascreening-op-af-met-nt-probnp-strokestop-ii-studieontwerp/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lene-klvgaard","type":"person","url":"https://hartvaat.nl/mensen/lene-klvgaard/","name":"Lene Kløvgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lia-evi-bang","type":"person","url":"https://hartvaat.nl/mensen/lia-evi-bang/","name":"Lia Evi Bang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/coronaire-vaatspasmen-bij-overlevenden-van-hartstilstand/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lianglong-chen","type":"person","url":"https://hartvaat.nl/mensen/lianglong-chen/","name":"Lianglong Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/10/17/farmaco-invasieve-strategie-met-halve-dosis-alteplase-versus-primaire-pci-bij-st/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ling-tao","type":"person","url":"https://hartvaat.nl/mensen/ling-tao/","name":"Ling Tao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lionel-tarassenko","type":"person","url":"https://hartvaat.nl/mensen/lionel-tarassenko/","name":"Lionel Tarassenko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/10/01/thuismonitoring-met-technologie-ondersteund-management-bij-chronisch-hf-gerandom/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/02/09/sms-berichten-ter-ondersteuning-van-therapietrouw-bij-hoge-bloeddruk-de-star-tri/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liu-he","type":"person","url":"https://hartvaat.nl/mensen/liu-he/","name":"Liu He","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luc-janssens","type":"person","url":"https://hartvaat.nl/mensen/luc-janssens/","name":"Luc Janssens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/01/02/preventie-van-cardiogene-shock-na-acuut-mi/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucy-mackillop","type":"person","url":"https://hartvaat.nl/mensen/lucy-mackillop/","name":"Lucy Mackillop","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-nombela-franco","type":"person","url":"https://hartvaat.nl/mensen/luis-nombela-franco/","name":"Luis Nombela-Franco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2017/01/15/linker-hartoorsluiting-versus-medicamenteuze-behandeling-bij-af-netwerkmeta-anal/","published":"2017-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-ortega-paz","type":"person","url":"https://hartvaat.nl/mensen/luis-ortega-paz/","name":"Luis Ortega-Paz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2018/08/07/adenosine-en-ticagrelorspiegels-bij-patienten-met-en-zonder-ticagrelor-dyspneu/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lutgarde-thijs","type":"person","url":"https://hartvaat.nl/mensen/lutgarde-thijs/","name":"Lutgarde Thijs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2020/08/01/antidiabetica-en-cardiovasculaire-geneeskunde-meta-analyse-en-perspectief/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2018/10/01/prognostische-waarde-van-gemaskeerd-ongecontroleerde-hypertensie/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mahboob-rahman","type":"person","url":"https://hartvaat.nl/mensen/mahboob-rahman/","name":"Mahboob Rahman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mandeep-s-sidhu","type":"person","url":"https://hartvaat.nl/mensen/mandeep-s-sidhu/","name":"Mandeep S Sidhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-w-deyell","type":"person","url":"https://hartvaat.nl/mensen/marc-w-deyell/","name":"Marc W Deyell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-borentain","type":"person","url":"https://hartvaat.nl/mensen/maria-borentain/","name":"Maria Borentain","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-dorobantu","type":"person","url":"https://hartvaat.nl/mensen/maria-dorobantu/","name":"Maria Dorobantu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-rosa-costanzo","type":"person","url":"https://hartvaat.nl/mensen/maria-rosa-costanzo/","name":"Maria Rosa Costanzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/05/off-label-dosering-van-sacubitril-valsartan-wijdverspreid-in-de-praktijk/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2025/02/01/transveneuze-frenische-zenuwstimulatie-bij-centraal-slaapapneu-en-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariell-jessup","type":"person","url":"https://hartvaat.nl/mensen/mariell-jessup/","name":"Mariell Jessup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/12/06/comorbiditeiten-bij-hartfalen-hypertensie-obesitas-diabetes-hyperlipidemie-en-me/","published":"2016-12-06"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marius-m-hoeper","type":"person","url":"https://hartvaat.nl/mensen/marius-m-hoeper/","name":"Marius M Hoeper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2024/06/18/sildenafil-dosisvergelijking-bij-pulmonale-arteriele-hypertensie/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/01/hemodynamische-effecten-van-riociguat-bij-inoperabel-cteph/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marius-placzek","type":"person","url":"https://hartvaat.nl/mensen/marius-placzek/","name":"Marius Placzek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/05/reduce-mfa-dzhk25-trial-naar-antifibrotische-therapie-tegen-myocardfibrose-na-ta/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marko-noc","type":"person","url":"https://hartvaat.nl/mensen/marko-noc/","name":"Marko Noc","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2020/11/24/vroege-coronairangiografie-versus-uitstel-na-hartstilstand-zonder-st-elevatie-pi/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2016/12/20/ticagrelor-versus-clopidogrel-bij-comateuze-overlevenden-van-reanimatie-met-pci/","published":"2016-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-f-scheerer","type":"person","url":"https://hartvaat.nl/mensen/markus-f-scheerer/","name":"Markus F Scheerer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martina-rothenbuhler","type":"person","url":"https://hartvaat.nl/mensen/martina-rothenbuhler/","name":"Martina Rothenbühler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marwah-abdalla","type":"person","url":"https://hartvaat.nl/mensen/marwah-abdalla/","name":"Marwah Abdalla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maryam-kavousi","type":"person","url":"https://hartvaat.nl/mensen/maryam-kavousi/","name":"Maryam Kavousi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2023/02/08/stolling-en-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2023-02-08"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masafumi-kitakaze","type":"person","url":"https://hartvaat.nl/mensen/masafumi-kitakaze/","name":"Masafumi Kitakaze","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2020/08/01/canagliflozine-bij-diabetes-type-2-met-chronisch-hf-candle-gerandomiseerde-trial/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masahiro-murakami","type":"person","url":"https://hartvaat.nl/mensen/masahiro-murakami/","name":"Masahiro Murakami","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/07/29/summit-bmi-centrale-adipositas-en-gewichtsverlies-beinvloeden-tirzepatide-effect/","published":"2025-07-29"},{"url":"https://hartvaat.nl/2025/05/13/summit-tirzepatide-en-ckd-interactie-bij-hfpef-met-obesitas/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massimo-grimaldi","type":"person","url":"https://hartvaat.nl/mensen/massimo-grimaldi/","name":"Massimo Grimaldi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-bossard","type":"person","url":"https://hartvaat.nl/mensen/matthias-bossard/","name":"Matthias Bossard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mattia-galli","type":"person","url":"https://hartvaat.nl/mensen/mattia-galli/","name":"Mattia Galli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/04/17/geleide-versus-standaard-antiplaatjestherapie-na-pci-lancet-meta-analyse/","published":"2021-04-17"},{"url":"https://hartvaat.nl/2020/04/01/intracraniele-bloedingen-versus-stenttrombose-met-doac-antiplaatjes-versus-tripl/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurizio-ferrario","type":"person","url":"https://hartvaat.nl/mensen/maurizio-ferrario/","name":"Maurizio Ferrario","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melchior-seyfarth","type":"person","url":"https://hartvaat.nl/mensen/melchior-seyfarth/","name":"Melchior Seyfarth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-ondersteuning-versus-iabp-bij-cardiogene-shock-meta-analys/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melvin-d-lobo","type":"person","url":"https://hartvaat.nl/mensen/melvin-d-lobo/","name":"Melvin D Lobo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-cheung","type":"person","url":"https://hartvaat.nl/mensen/michael-cheung/","name":"Michael Cheung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2026/02/18/groene-dialyse-duurzame-zorg-groei-en-innovatie-kdigo-conferentie/","published":"2026-02-18"},{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-e-nassif","type":"person","url":"https://hartvaat.nl/mensen/michael-e-nassif/","name":"Michael E Nassif","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2021/04/27/empagliflozine-en-pulmonalisdruk-bij-hf-embrace-hf/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-g-shlipak","type":"person","url":"https://hartvaat.nl/mensen/michael-g-shlipak/","name":"Michael G Shlipak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/08/20/aangetaste-tubulaire-secretiecapaciteit-verhoogt-cardiovasculaire-sterfte-hunt-s/","published":"2026-08-28"},{"url":"https://hartvaat.nl/2026/03/13/tubulaire-nierschade-hangt-samen-met-natriumretentie-en-diureticarespons-bij-acu/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-reardon","type":"person","url":"https://hartvaat.nl/mensen/michael-j-reardon/","name":"Michael J Reardon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2020/10/01/natuurlijk-beloop-van-asymptomatische-ernstige-aortastenose-jama-cardiology-meta/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-kuhne","type":"person","url":"https://hartvaat.nl/mensen/michael-kuhne/","name":"Michael Kühne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/03/30/leadless-atriaal-pacen-geeft-minder-complicaties-dan-transveneus-1-jaars-medicar/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2023/11/02/duurzaamheid-van-pvi-bij-af-meta-analyse/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-t-lu","type":"person","url":"https://hartvaat.nl/mensen/michael-t-lu/","name":"Michael T Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/28/epic-hiv-trial-pcsk9-remming-ter-cardiovasculaire-preventie-bij-hiv-patienten/","published":"2026-04-06"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2023/08/24/reprieve-pitavastatine-vermindert-cv-events-bij-hiv-nejm/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2017/11/21/coronair-calcium-en-prognostische-waarde-bij-pijn-op-de-borst-promise-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikael-dellborg","type":"person","url":"https://hartvaat.nl/mensen/mikael-dellborg/","name":"Mikael Dellborg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/05/24/dapagliflozine-naar-baseline-bloeddruk-bij-diabetes-type-2-declare-timi-58/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2016/06/14/ticagrelor-ter-preventie-van-ischemische-events-bij-mi-patienten-met-perifeer-va/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milad-nazarzadeh","type":"person","url":"https://hartvaat.nl/mensen/milad-nazarzadeh/","name":"Milad Nazarzadeh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2020/10/01/thuismonitoring-met-technologie-ondersteund-management-bij-chronisch-hf-gerandom/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/05/01/inflammatiemarkers-en-risico-op-hypertensie-meta-analyse-van-cohortstudies/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-chul-kim","type":"person","url":"https://hartvaat.nl/mensen/min-chul-kim/","name":"Min Chul Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2018/07/24/escitalopram-versus-placebo-bij-depressie-na-acs-en-langetermijn-cardiale-uitkom/","published":"2018-07-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mina-k-chung","type":"person","url":"https://hartvaat.nl/mensen/mina-k-chung/","name":"Mina K Chung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mirvat-alasnag","type":"person","url":"https://hartvaat.nl/mensen/mirvat-alasnag/","name":"Mirvat Alasnag","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mitsuaki-matsumura","type":"person","url":"https://hartvaat.nl/mensen/mitsuaki-matsumura/","name":"Mitsuaki Matsumura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"modele-o-ogunniyi","type":"person","url":"https://hartvaat.nl/mensen/modele-o-ogunniyi/","name":"Modele O Ogunniyi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2024/10/15/aha-scientific-statement-nierdisfunctie-bij-gevorderd-hartfalen/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monica-m-colvin","type":"person","url":"https://hartvaat.nl/mensen/monica-m-colvin/","name":"Monica M Colvin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"moussa-mansour","type":"person","url":"https://hartvaat.nl/mensen/moussa-mansour/","name":"Moussa Mansour","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/07/02/pfa-versus-thermale-ablatie-bij-paroxysmaal-af-aritmielastanalyse/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mu-qin","type":"person","url":"https://hartvaat.nl/mensen/mu-qin/","name":"Mu Qin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/10/31/herhaalde-in-situ-ablatie-versus-uitgebreide-ablatie-bij-recidief-persisterend-a/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/08/12/catheterablatie-versus-rate-control-bij-persisterend-af-en-ouder-hartfalen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2021/05/21/extrapulmonale-vein-driver-mapping-bij-persisterend-af-bij-obese-patienten/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mukul-sharma","type":"person","url":"https://hartvaat.nl/mensen/mukul-sharma/","name":"Mukul Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-j-stone","type":"person","url":"https://hartvaat.nl/mensen/neil-j-stone/","name":"Neil J Stone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/01/01/vitamine-d-voorkomt-statine-gerelateerde-spierklachten-niet/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-a-boon","type":"person","url":"https://hartvaat.nl/mensen/nicholas-a-boon/","name":"Nicholas A Boon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-delarche","type":"person","url":"https://hartvaat.nl/mensen/nicolas-delarche/","name":"Nicolas Delarche","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicole-karam","type":"person","url":"https://hartvaat.nl/mensen/nicole-karam/","name":"Nicole Karam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolaos-dagres","type":"person","url":"https://hartvaat.nl/mensen/nikolaos-dagres/","name":"Nikolaos Dagres","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/02/16/p-golfduur-voorspelt-af-recidief-na-catheterablatie-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2020/01/01/weglaten-van-aspirine-bij-gecombineerde-antitrombotische-therapie-voor-af-acs-he/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"norihiro-kogame","type":"person","url":"https://hartvaat.nl/mensen/norihiro-kogame/","name":"Norihiro Kogame","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/04/23/hedendaagse-uitkomsten-na-cabg-voor-hoofdstamlijden/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"oleg-averkov","type":"person","url":"https://hartvaat.nl/mensen/oleg-averkov/","name":"Oleg Averkov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-barthelemy","type":"person","url":"https://hartvaat.nl/mensen/olivier-barthelemy/","name":"Olivier Barthélémy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-f-bertrand","type":"person","url":"https://hartvaat.nl/mensen/olivier-f-bertrand/","name":"Olivier F Bertrand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-garcia-pavia","type":"person","url":"https://hartvaat.nl/mensen/pablo-garcia-pavia/","name":"Pablo Garcia-Pavia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/05/27/vutrisiran-bij-attr-cm-impact-van-hartfalenernst-op-effectiviteit/","published":"2025-05-27"},{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2023/07/20/ni006-antilichaam-voor-afbraak-van-cardiale-transthyretine-amyloid-nejm-fase-1/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pamela-b-morris","type":"person","url":"https://hartvaat.nl/mensen/pamela-b-morris/","name":"Pamela B Morris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/10/04/2022-acc-expert-consensus-niet-statine-therapieen-voor-ldl-verlaging-bij-ascvd/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2017/10/03/2017-acc-gerichte-update-niet-statinetherapie-voor-ldl-verlaging/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2016/11/22/management-van-klinisch-significante-geneesmiddelinteracties-met-statines-aha-aa/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pantelis-a-sarafidis","type":"person","url":"https://hartvaat.nl/mensen/pantelis-a-sarafidis/","name":"Pantelis A Sarafidis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/27/consensus-breid-het-cardio-renaal-metabool-syndroom-uit-met-de-lever-cklms-in-de/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2026/01/27/aldosteronsynthase-remmers-bij-ongecontroleerde-en-resistente-hypertensie-bij-ck/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/06/01/longechogeleide-drooggewichtreductie-en-ambulante-bloeddruk-bij-hemodialyse/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-b-mark","type":"person","url":"https://hartvaat.nl/mensen/patrick-b-mark/","name":"Patrick B Mark","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/06/30/kfre-aangepast-voor-multimorbiditeit-verbetert-schatting-nierfalenrisico/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/05/29/cardiovasculaire-ziekte-blijft-leidend-na-niertransplantatie-overzicht-van-uitda/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/02/25/de-mondiale-ziektelast-van-chronische-nierziekte-elke-20-seconden-een-sterfgeval/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-goldstein","type":"person","url":"https://hartvaat.nl/mensen/patrick-goldstein/","name":"Patrick Goldstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-elliott","type":"person","url":"https://hartvaat.nl/mensen/paul-elliott/","name":"Paul Elliott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/07/30/visinname-en-visgerelateerde-metabolieten-geassocieerd-met-lagere-triglyceriden-/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"},{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-j-l-ong","type":"person","url":"https://hartvaat.nl/mensen/paul-j-l-ong/","name":"Paul J L Ong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2017/04/01/polymeervrije-biolimus-stent-bij-hoog-bloedingsrisico-met-acs-leaders-free-subst/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-r-kalra","type":"person","url":"https://hartvaat.nl/mensen/paul-r-kalra/","name":"Paul R Kalra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/23/ijzertekort-bij-chronische-nierziekte-en-hartfalen-expertperspectieven/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-a-lemos","type":"person","url":"https://hartvaat.nl/mensen/pedro-a-lemos/","name":"Pedro A Lemos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-k-smith","type":"person","url":"https://hartvaat.nl/mensen/peter-k-smith/","name":"Peter K Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2017/02/07/acc-aats-aha-2016-criteria-voor-gepaste-coronaire-revascularisatie-bij-acs-en-st/","published":"2017-02-07"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-leong-sit","type":"person","url":"https://hartvaat.nl/mensen/peter-leong-sit/","name":"Peter Leong-Sit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-von-dadelszen","type":"person","url":"https://hartvaat.nl/mensen/peter-von-dadelszen/","name":"Peter von Dadelszen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/03/01/orale-antihypertensiva-bij-niet-ernstige-zwangerschapshypertensie-netwerkmeta-an/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2019/09/21/orale-antihypertensiva-bij-ernstige-hypertensie-in-de-zwangerschap-lancet-vergel/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2018/06/01/amenorroe-duur-bij-start-antihypertensiva-in-de-zwangerschap-chips-secundaire-an/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/12/01/placental-growth-factor-als-prognostisch-instrument-bij-hypertensieve-zwangersch/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-neuzil","type":"person","url":"https://hartvaat.nl/mensen/petr-neuzil/","name":"Petr Neuzil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/upgrade-van-draadloze-pacemaker-van-enkelvoudig-naar-tweekamersysteem/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/12/08/laa-sluiting-versus-oac-bij-af-meta-analyse-van-gerandomiseerde-trials/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2017/12/19/5-jaarsuitkomsten-na-linker-hartoorsluiting-prevail-en-protect-af/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petra-nijst","type":"person","url":"https://hartvaat.nl/mensen/petra-nijst/","name":"Petra Nijst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-a-kalra","type":"person","url":"https://hartvaat.nl/mensen/philip-a-kalra/","name":"Philip A Kalra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/23/ijzertekort-bij-chronische-nierziekte-en-hartfalen-expertperspectieven/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-joseph","type":"person","url":"https://hartvaat.nl/mensen/philip-joseph/","name":"Philip Joseph","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/05/13/wereldwijde-hf-registry-fev1-is-een-onafhankelijke-prognostische-factor-pleidooi/","published":"2026-05-15"},{"url":"https://hartvaat.nl/2023/08/24/vaste-dosiscombinatietherapie-voor-primaire-cv-preventie-ipd-meta-analyse/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2023/02/01/aspirine-en-cardiovasculaire-uitkomsten-bij-chronische-nierziekte/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-gosse","type":"person","url":"https://hartvaat.nl/mensen/philippe-gosse/","name":"Philippe Gosse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-voisine","type":"person","url":"https://hartvaat.nl/mensen/pierre-voisine/","name":"Pierre Voisine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/01/01/mitralisklepherstel-bij-degeneratief-mr-met-matige-tricuspidalisinsufficientie-2/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pooja-dewan","type":"person","url":"https://hartvaat.nl/mensen/pooja-dewan/","name":"Pooja Dewan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/08/01/candesartan-dosering-bij-mannen-versus-vrouwen-met-chronisch-hartfalen/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"poulabi-banerjee","type":"person","url":"https://hartvaat.nl/mensen/poulabi-banerjee/","name":"Poulabi Banerjee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-deepak-l-bhatt","type":"person","url":"https://hartvaat.nl/mensen/prof-deepak-l-bhatt/","name":"Prof. Deepak L. Bhatt","title":"Directeur, Mount Sinai Fuster Heart Hospital, New York, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/expert-momentum-hypercortisolisme-hypertensie-bhatt/","title":"Expertinterview: MOMENTUM — hypercortisolisme bij resistente hypertensie"},{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/highlights-surpass-cvot-hi-peitho-surviv/","title":"Highlights: SURPASS-CVOT, HI-PEITHO en SURVIV samengevat"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ransi-somaratne","type":"person","url":"https://hartvaat.nl/mensen/ransi-somaratne/","name":"Ransi Somaratne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/23/ldl-verlaging-met-evolocumab-en-uitkomsten-bij-pav-fourier-inzichten/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebecca-a-juliano","type":"person","url":"https://hartvaat.nl/mensen/rebecca-a-juliano/","name":"Rebecca A Juliano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/06/11/icosapent-ethyl-en-totale-ischemische-events-reduce-it-analyse/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/01/03/icosapent-ethyl-en-cardiovasculaire-uitkomsten-bij-hypertriglyceridemie-nejm-red/","published":"2019-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"renicus-s-hermanides","type":"person","url":"https://hartvaat.nl/mensen/renicus-s-hermanides/","name":"Renicus S Hermanides","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ribo-tang","type":"person","url":"https://hartvaat.nl/mensen/ribo-tang/","name":"Ribo Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ricardo-correa-rotter","type":"person","url":"https://hartvaat.nl/mensen/ricardo-correa-rotter/","name":"Ricardo Correa-Rotter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/20/raas-blokkade-in-de-levenscyclus-van-de-nier-actuele-behandelstandaard/","published":"2026-05-02"},{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/03/01/niergezonheid-voor-iedereen-zorg-voor-mensen-bescherming-van-de-planeet/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-c-becker","type":"person","url":"https://hartvaat.nl/mensen/richard-c-becker/","name":"Richard C Becker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-j-schilling","type":"person","url":"https://hartvaat.nl/mensen/richard-j-schilling/","name":"Richard J Schilling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/11/01/ablatie-index-geleide-af-ablatie-geactualiseerde-meta-analyse/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"},{"url":"https://hartvaat.nl/2016/03/01/intrathoracale-impedantiemonitoring-bij-chronisch-hartfalen-de-limit-chf-studie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-a-hegele","type":"person","url":"https://hartvaat.nl/mensen/robert-a-hegele/","name":"Robert A Hegele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/06/24/inclisiran-bij-adolescenten-met-homozygote-fh-effectiviteit-en-veiligheid/","published":"2025-06-24"},{"url":"https://hartvaat.nl/2025/05/20/plozasiran-en-lipoproteine-deeltjesgrootte-bij-hypertriglyceridemie/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-gil","type":"person","url":"https://hartvaat.nl/mensen/robert-gil/","name":"Robert Gil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/03/05/nationaal-cardiologisch-netwerk-als-nieuwe-zorgstandaard-in-polen/","published":"2026-04-12"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-latini","type":"person","url":"https://hartvaat.nl/mensen/roberto-latini/","name":"Roberto Latini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robin-hofmann","type":"person","url":"https://hartvaat.nl/mensen/robin-hofmann/","name":"Robin Hofmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/10/01/zuurstof-bij-verdenking-acuut-mi-meta-analyse-van-gerandomiseerde-trials/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robin-lemmens","type":"person","url":"https://hartvaat.nl/mensen/robin-lemmens/","name":"Robin Lemmens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2020/08/18/optimale-bloeddruk-bij-shock-na-mi-en-hartstilstand/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rod-s-taylor","type":"person","url":"https://hartvaat.nl/mensen/rod-s-taylor/","name":"Rod S Taylor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/24/cochrane-review-interventies-om-deelname-aan-hartrevalidatie-te-bevorderen/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/12/01/hartrevalidatie-en-kwaliteit-van-leven-bij-hfpef-meta-analyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/02/07/inspanningsgerichte-hartrevalidatie-bij-coronairlijden-geactualiseerde-meta-anal/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/09/01/hartrevalidatie-en-lichamelijke-activiteit-systematische-review-en-meta-analyse/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronald-b-goldberg","type":"person","url":"https://hartvaat.nl/mensen/ronald-b-goldberg/","name":"Ronald B Goldberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rui-providencia","type":"person","url":"https://hartvaat.nl/mensen/rui-providencia/","name":"Rui Providência","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/10/01/crt-bij-inotroop-afhankelijk-hartfalen-meta-analyse/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/01/04/enkele-freeze-cryoballonablatie-bij-af-ehra-systematische-review/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/11/01/ablatie-index-geleide-af-ablatie-geactualiseerde-meta-analyse/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/03/01/doodsoorzaken-bij-crt-met-en-zonder-defibrillator-meta-analyse/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2016/10/01/katheterablatie-bij-af-met-hypertrofische-cardiomyopathie-systematische-review-e/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rune-wiseth","type":"person","url":"https://hartvaat.nl/mensen/rune-wiseth/","name":"Rune Wiseth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sadiya-s-khan","type":"person","url":"https://hartvaat.nl/mensen/sadiya-s-khan/","name":"Sadiya S Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanghamitra-mohanty","type":"person","url":"https://hartvaat.nl/mensen/sanghamitra-mohanty/","name":"Sanghamitra Mohanty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/09/01/sedatie-versus-narcose-bij-af-catheterablatie-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saqib-chowdhary","type":"person","url":"https://hartvaat.nl/mensen/saqib-chowdhary/","name":"Saqib Chowdhary","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-mcnitt","type":"person","url":"https://hartvaat.nl/mensen/scott-mcnitt/","name":"Scott McNitt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2018/05/01/crt-voordeel-bij-concordant-versus-discordant-linksbundeltakblok-esc-hf-pilot/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/11/01/klinische-presentatie-bij-eerste-hartfalenhospitalisatie-voorspelt-geen-heropnam/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/07/14/voorspelling-van-plotse-versus-niet-plotse-hartdood-na-mi-met-verminderde-lvef/","published":"2017-07-14"},{"url":"https://hartvaat.nl/2017/05/16/comorbiditeiten-en-crt-respons-madit-crt-langetermijnfollow-up/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/20/volledig-linkszijdig-reverse-remodelling-bij-crt-madit-crt-substudie/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/01/26/relatieve-wanddikte-en-risico-op-ventriculaire-tachyaritmieen-bij-linkerkamerdis/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-d-pokorney","type":"person","url":"https://hartvaat.nl/mensen/sean-d-pokorney/","name":"Sean D Pokorney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/07/zorgpaden-na-nieuw-vastgesteld-atriumfibrilleren-rol-van-de-elektrofysioloog-en-/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-p-collins","type":"person","url":"https://hartvaat.nl/mensen/sean-p-collins/","name":"Sean P Collins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/04/09/dapagliflozine-bij-acuut-hartfalen-effectiviteit-en-veiligheid/","published":"2024-04-09"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shayna-chotai","type":"person","url":"https://hartvaat.nl/mensen/shayna-chotai/","name":"Shayna Chotai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shazia-ali","type":"person","url":"https://hartvaat.nl/mensen/shazia-ali/","name":"Shazia Ali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shrikant-i-bangdiwala","type":"person","url":"https://hartvaat.nl/mensen/shrikant-i-bangdiwala/","name":"Shrikant I Bangdiwala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2019/10/05/uitgebreide-community-interventie-bij-hypertensie-lancet-hope-4/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"siddique-a-abbasi","type":"person","url":"https://hartvaat.nl/mensen/siddique-a-abbasi/","name":"Siddique A Abbasi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2016/08/02/omega-3-vetzuren-en-linkerkamerremodellering-na-acuut-mi-omega-remodel-trial/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sjoerd-h-hofma","type":"person","url":"https://hartvaat.nl/mensen/sjoerd-h-hofma/","name":"Sjoerd H Hofma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/04/25/clopidogrel-versus-ticagrelor-of-prasugrel-bij-70-plussers-met-nste-acs-lancet-p/","published":"2020-04-25"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"songnan-li","type":"person","url":"https://hartvaat.nl/mensen/songnan-li/","name":"Songnan Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/09/nieuw-bifasisch-pfa-systeem-versus-thermale-ablatie-bij-paroxysmaal-af/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-rosenkranz","type":"person","url":"https://hartvaat.nl/mensen/stephan-rosenkranz/","name":"Stephan Rosenkranz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/12/cadence-sotatercept-verlaagt-pulmonale-vaatweerstand-bij-gecombineerde-pre-postc/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"},{"url":"https://hartvaat.nl/2017/04/01/oscillerende-whole-body-vibratie-verbetert-inspanningscapaciteit-bij-pah/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/01/01/inspanningstraining-verbetert-zuurstofopname-en-hemodynamiek-bij-ernstige-pulmon/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-gerry","type":"person","url":"https://hartvaat.nl/mensen/stephen-gerry/","name":"Stephen Gerry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/06/postoperatief-af-en-langetermijn-cva-risico-na-geisoleerde-cabg/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2017/08/01/radiale-arterie-graft-als-aanvulling-op-mammaria-interna-grafts-bij-cabg/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/12/29/bilaterale-versus-enkelvoudige-a-mammaria-interna-grafts-nejm-art-trial/","published":"2016-12-29"},{"url":"https://hartvaat.nl/2016/07/01/bewegingsadvies-als-behandeling-van-prehypertensie-en-hypertensie-bij-jongvolwas/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephane-cook","type":"person","url":"https://hartvaat.nl/mensen/stephane-cook/","name":"Stéphane Cook","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/06/27/tavr-bij-patienten-65-jaar-hogere-sterfte-en-heropnames-dan-chirurgie-maar-onvol/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suneel-talwar","type":"person","url":"https://hartvaat.nl/mensen/suneel-talwar/","name":"Suneel Talwar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sung-gyun-ahn","type":"person","url":"https://hartvaat.nl/mensen/sung-gyun-ahn/","name":"Sung Gyun Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susanna-price","type":"person","url":"https://hartvaat.nl/mensen/susanna-price/","name":"Susanna Price","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/13/hypothese-falen-van-het-raas-verklaart-inappropriate-vasodilatatie-bij-cardiogen/","published":"2026-06-21"},{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/02/19/competenties-na-certificering-en-cardiovasculaire-zorgverlening/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suzanne-v-arnold","type":"person","url":"https://hartvaat.nl/mensen/suzanne-v-arnold/","name":"Suzanne V Arnold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/01/01/kccq-interpretatie-bij-hartfalen-patient-ankering/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2020/05/12/management-van-stabiel-coronairlijden-bij-diabetes-type-2-aha-scientific-stateme/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sven-schnaidt","type":"person","url":"https://hartvaat.nl/mensen/sven-schnaidt/","name":"Sven Schnaidt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"taek-kyu-park","type":"person","url":"https://hartvaat.nl/mensen/taek-kyu-park/","name":"Taek Kyu Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takashi-akasaka","type":"person","url":"https://hartvaat.nl/mensen/takashi-akasaka/","name":"Takashi Akasaka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2017/11/07/optische-frequentiedomeinbeeldvorming-versus-ivus-bij-pci-opinion-trial/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"taoufik-ouarrak","type":"person","url":"https://hartvaat.nl/mensen/taoufik-ouarrak/","name":"Taoufik Ouarrak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thibault-lhermusier","type":"person","url":"https://hartvaat.nl/mensen/thibault-lhermusier/","name":"Thibault Lhermusier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2016/02/07/impact-van-pcsk9-remmers-op-lipidenniveaus-en-uitkomsten-netwerkmeta-analyse/","published":"2016-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-hovasse","type":"person","url":"https://hartvaat.nl/mensen/thomas-hovasse/","name":"Thomas Hovasse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/22/lge-granulariteit-op-cmr-voorspelt-sterfte-bij-eindstadium-hypertrofische-cardio/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-j-povsic","type":"person","url":"https://hartvaat.nl/mensen/thomas-j-povsic/","name":"Thomas J Povsic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2019/07/01/p2y12-remmerwisseling-op-basis-van-cyp2c19-status-na-acs-jama-cardiology/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-de-potter","type":"person","url":"https://hartvaat.nl/mensen/tom-de-potter/","name":"Tom De Potter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/02/03/varipure-studie-pulsed-field-ablatie-in-de-dagelijkse-af-praktijk/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/10/31/vrouwen-met-persisterend-af-pvi-alleen-is-onvoldoende/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/04/21/pvi-met-versus-zonder-antiaritmica-bij-recidiverend-af-powder-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tor-biering-srensen","type":"person","url":"https://hartvaat.nl/mensen/tor-biering-srensen/","name":"Tor Biering-Sørensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"},{"url":"https://hartvaat.nl/2023/06/01/intensieve-bloeddrukcontrole-en-geleidingsziekten-sprint-post-hoc-analyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tracy-y-wang","type":"person","url":"https://hartvaat.nl/mensen/tracy-y-wang/","name":"Tracy Y Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/01/cardiovasculaire-risicocommunicatie-en-patientperceptie-jama-cardiology/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tristram-d-bahnson","type":"person","url":"https://hartvaat.nl/mensen/tristram-d-bahnson/","name":"Tristram D Bahnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/07/13/ablatie-versus-medicatie-bij-af-naar-ras-en-etniciteit/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tushar-kotecha","type":"person","url":"https://hartvaat.nl/mensen/tushar-kotecha/","name":"Tushar Kotecha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ugo-limbruno","type":"person","url":"https://hartvaat.nl/mensen/ugo-limbruno/","name":"Ugo Limbruno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrica-wilderang","type":"person","url":"https://hartvaat.nl/mensen/ulrica-wilderang/","name":"Ulrica Wilderäng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrich-laufs","type":"person","url":"https://hartvaat.nl/mensen/ulrich-laufs/","name":"Ulrich Laufs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/26/niet-statine-therapie-welk-middel-voor-welke-patient/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2021/10/01/apothekerzorg-bij-poliklinisch-hf-meta-analyse/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrika-andersson","type":"person","url":"https://hartvaat.nl/mensen/ulrika-andersson/","name":"Ulrika Andersson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/16/biomarkers-voor-specifieke-doodsoorzaken-bij-af/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/01/apixaban-versus-warfarine-bij-af-in-relatie-tot-nierfunctie-aristotle-analyse/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valeria-caso","type":"person","url":"https://hartvaat.nl/mensen/valeria-caso/","name":"Valeria Caso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/01/11/inadequate-noac-dosering-bij-af-uitkomsten-en-oorzaken-meta-analyse/","published":"2023-01-11"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vijay-nambi","type":"person","url":"https://hartvaat.nl/mensen/vijay-nambi/","name":"Vijay Nambi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/23/top-liberaal-versus-restrictief-transfusiebeleid-bij-hoogrisico-hartchirurgie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vladimir-dzavik","type":"person","url":"https://hartvaat.nl/mensen/vladimir-dzavik/","name":"Vladimír Džavík","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2018/01/09/risico-s-van-overinterpretatie-van-interimdata-lessen-uit-de-total-trial/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wanpen-vongpatanasin","type":"person","url":"https://hartvaat.nl/mensen/wanpen-vongpatanasin/","name":"Wanpen Vongpatanasin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2023/12/01/kaliummagnesiumcitraat-versus-kaliumchloride-bij-thiazide-bijwerkingen/","published":"2023-12-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/10/01/prognostische-waarde-van-gemaskeerd-ongecontroleerde-hypertensie/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"warren-j-cantor","type":"person","url":"https://hartvaat.nl/mensen/warren-j-cantor/","name":"Warren J Cantor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wayne-shaw","type":"person","url":"https://hartvaat.nl/mensen/wayne-shaw/","name":"Wayne Shaw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-li","type":"person","url":"https://hartvaat.nl/mensen/wei-li/","name":"Wei Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/06/vereenvoudigde-linkervoorhoofdaanhangsel-occlusie-onder-fluoroscopie-met-watchma/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2025/12/15/m7g-methyltransferase-mettl1-bevordert-acuut-nierletsel-via-mitochondriale-disfu/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/09/nieuw-bifasisch-pfa-systeem-versus-thermale-ablatie-bij-paroxysmaal-af/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/09/01/pvi-met-of-zonder-empirische-svc-isolatie-bij-af-ablatie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2018/12/04/echocardiografische-screening-op-ph-bij-aangeboren-hartafwijkingen-jacc-review/","published":"2018-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"whady-a-hueb","type":"person","url":"https://hartvaat.nl/mensen/whady-a-hueb/","name":"Whady A Hueb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/08/01/cabg-versus-pci-en-risico-op-myocardinfarct-en-revascularisatie-bij-ckd-patiente/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wojciech-zareba","type":"person","url":"https://hartvaat.nl/mensen/wojciech-zareba/","name":"Wojciech Zareba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2018/05/01/crt-voordeel-bij-concordant-versus-discordant-linksbundeltakblok-esc-hf-pilot/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/07/14/voorspelling-van-plotse-versus-niet-plotse-hartdood-na-mi-met-verminderde-lvef/","published":"2017-07-14"},{"url":"https://hartvaat.nl/2017/05/16/comorbiditeiten-en-crt-respons-madit-crt-langetermijnfollow-up/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/20/volledig-linkszijdig-reverse-remodelling-bij-crt-madit-crt-substudie/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/01/26/relatieve-wanddikte-en-risico-op-ventriculaire-tachyaritmieen-bij-linkerkamerdis/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xia-wang","type":"person","url":"https://hartvaat.nl/mensen/xia-wang/","name":"Xia Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/02/01/multifactoriele-optimalisatie-van-chronisch-hartfalen-gerandomiseerde-studie/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xianhui-qin","type":"person","url":"https://hartvaat.nl/mensen/xianhui-qin/","name":"Xianhui Qin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/23/plasma-proteomische-biomarkers-voor-risico-en-therapeutische-doelen-bij-abdomina/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoying-chen","type":"person","url":"https://hartvaat.nl/mensen/xiaoying-chen/","name":"Xiaoying Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xueyuan-guo","type":"person","url":"https://hartvaat.nl/mensen/xueyuan-guo/","name":"Xueyuan Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang","type":"person","url":"https://hartvaat.nl/mensen/yang/","name":"Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/03/machine-learningmodel-voorspelt-periprocedurele-complicaties-bij-tavi-voor-bicus/","published":"2026-07-25"},{"url":"https://hartvaat.nl/2026/04/17/verhoogd-crp-voorspelt-hartfalen-bij-kankeroverlevenden-uk-biobank/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/26/hiv-infectie-hangt-onafhankelijk-samen-met-meer-en-kwetsbaardere-halsslagaderpla/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2026/02/20/geintegreerd-machine-learningmodel-voorspelt-cardiovasculair-risico-beter-dan-de/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2026/01/09/littekenweefsel-voorspelt-plotse-hartdood-na-een-infarct-grotendeels-buiten-de-e/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-ou","type":"person","url":"https://hartvaat.nl/mensen/yang-ou/","name":"Yang Ou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/07/29/summit-bmi-centrale-adipositas-en-gewichtsverlies-beinvloeden-tirzepatide-effect/","published":"2025-07-29"},{"url":"https://hartvaat.nl/2025/05/13/summit-tirzepatide-en-ckd-interactie-bij-hfpef-met-obesitas/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ying-sun","type":"person","url":"https://hartvaat.nl/mensen/ying-sun/","name":"Ying Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/effect-van-baduanjin-op-bloeddruk-bij-hoog-normaal-bloeddruk-gerandomiseerde-tri/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ying-wang","type":"person","url":"https://hartvaat.nl/mensen/ying-wang/","name":"Ying Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/08/15/3d-ct-fluoroscopie-fusie-maakt-laac-efficienter-minder-contrast-minder-straling-/","published":"2026-07-01"},{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/06/01/remote-ischemische-conditionering-bij-milde-hypertensie-zonder-medicatie-rct/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yohei-sotomi","type":"person","url":"https://hartvaat.nl/mensen/yohei-sotomi/","name":"Yohei Sotomi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yongjun-wang","type":"person","url":"https://hartvaat.nl/mensen/yongjun-wang/","name":"Yongjun Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/02/01/antihypertensieve-behandeling-na-acuut-ischemisch-cva-continueren-of-niet/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2026/01/01/insulineresistentie-en-bloeddrukcontrole-op-cognitieve-uitkomsten/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2016/09/15/intensieve-bloeddrukverlaging-bij-acute-hersenbloeding-nejm-atach-2-trial/","published":"2016-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-hak-kim","type":"person","url":"https://hartvaat.nl/mensen/young-hak-kim/","name":"Young-Hak Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-hoon-kim","type":"person","url":"https://hartvaat.nl/mensen/young-hoon-kim/","name":"Young-Hoon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/04/01/lineaire-versus-focale-cfae-ablatie-bij-niet-paroxysmaal-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-hyo-lim","type":"person","url":"https://hartvaat.nl/mensen/young-hyo-lim/","name":"Young-Hyo Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-zhang","type":"person","url":"https://hartvaat.nl/mensen/yu-zhang/","name":"Yu Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/31/herhaalde-in-situ-ablatie-versus-uitgebreide-ablatie-bij-recidief-persisterend-a/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/08/12/catheterablatie-versus-rate-control-bij-persisterend-af-en-ouder-hartfalen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/08/09/vertraagde-afgifteformulering-van-ivabradine-bij-systolisch-hartfalen/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/05/21/extrapulmonale-vein-driver-mapping-bij-persisterend-af-bij-obese-patienten/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yun-hyeong-cho","type":"person","url":"https://hartvaat.nl/mensen/yun-hyeong-cho/","name":"Yun-Hyeong Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zachary-i-whinnett","type":"person","url":"https://hartvaat.nl/mensen/zachary-i-whinnett/","name":"Zachary I Whinnett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/05/03/triventriculaire-pacing-bij-hf-strive-hf-gerandomiseerde-trial/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2017/07/01/crt-werkingsmechanismen-en-mogelijkheden-voor-verdere-verbetering/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhang","type":"person","url":"https://hartvaat.nl/mensen/zhang/","name":"Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/04/03/machine-learningmodel-voorspelt-periprocedurele-complicaties-bij-tavi-voor-bicus/","published":"2026-07-25"},{"url":"https://hartvaat.nl/2026/03/03/voorspelmodellen-voor-hartfalen-bij-patienten-met-instabiele-angina-pectoris/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/26/hiv-infectie-hangt-onafhankelijk-samen-met-meer-en-kwetsbaardere-halsslagaderpla/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2026/02/23/luchtvervuiling-en-multimorbiditeit-verhogen-het-risico-op-atriumfibrilleren/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/20/kosteneffectiviteit-van-mavacamten-bij-obstructieve-hcm-gezondheidswinst-maar-ee/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2026/01/29/lineaire-ablatie-van-de-voorwand-van-het-linkeratrium-vermindert-af-recidieven-b/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhen-wang","type":"person","url":"https://hartvaat.nl/mensen/zhen-wang/","name":"Zhen Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/08/20/ouderlijke-obesitas-verhoogt-cardiorenale-risico-s-bij-nakomelingen-review/","published":"2026-08-28"},{"url":"https://hartvaat.nl/2026/01/08/atriale-strain-overtreft-ventriculaire-strain-bij-detectie-van-hypertensieve-hfp/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/06/01/remote-ischemische-conditionering-bij-milde-hypertensie-zonder-medicatie-rct/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/06/01/roken-en-hartfalen-mendeliaanse-randomisatie-en-mediatie-analyse/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhou","type":"person","url":"https://hartvaat.nl/mensen/zhou/","name":"Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":6,"articles":[{"url":"https://hartvaat.nl/2026/05/26/recidief-linkerventrikel-trombus-12-recidief-actieve-eerdere-maligniteit-verzesv/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/04/24/verminderde-nierfunctie-verhoogt-hartfalenrisico-bij-ouderen-aspree-cohort/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2026/03/31/gespecialiseerde-hartklepklinieken-leiden-tot-betere-richtlijnconforme-zorg/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/03/03/voorspelmodellen-voor-hartfalen-bij-patienten-met-instabiele-angina-pectoris/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/01/09/littekenweefsel-voorspelt-plotse-hartdood-na-een-infarct-grotendeels-buiten-de-e/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-marc-gillinov","type":"person","url":"https://hartvaat.nl/mensen/a-marc-gillinov/","name":"A Marc Gillinov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aaron-b-caughey","type":"person","url":"https://hartvaat.nl/mensen/aaron-b-caughey/","name":"Aaron B Caughey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-aanbeveling-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-herbevestiging-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-d-timmis","type":"person","url":"https://hartvaat.nl/mensen/adam-d-timmis/","name":"Adam D Timmis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-wlodarczak","type":"person","url":"https://hartvaat.nl/mensen/adrian-wlodarczak/","name":"Adrian Wlodarczak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-m-al-kaisey","type":"person","url":"https://hartvaat.nl/mensen/ahmed-m-al-kaisey/","name":"Ahmed M Al-Kaisey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahran-d-arnold","type":"person","url":"https://hartvaat.nl/mensen/ahran-d-arnold/","name":"Ahran D Arnold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akinobu-itoh","type":"person","url":"https://hartvaat.nl/mensen/akinobu-itoh/","name":"Akinobu Itoh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-mcconnachie","type":"person","url":"https://hartvaat.nl/mensen/alex-mcconnachie/","name":"Alex McConnachie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-hapfelmeier","type":"person","url":"https://hartvaat.nl/mensen/alexander-hapfelmeier/","name":"Alexander Hapfelmeier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-hirsch","type":"person","url":"https://hartvaat.nl/mensen/alexander-hirsch/","name":"Alexander Hirsch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/08/18/echocardiografie-overschatte-drukgradienten-na-tav-in-tav-met-ballon-expandable-/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/22/epicardiaal-vetweefsel-voorspelt-aritmieen-en-hartfalen-events-bij-genotype-posi/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/04/18/vroeg-invasief-versus-selectieve-strategie-bij-nste-acs-ictus-trial-langetermijn/","published":"2017-04-18"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-t-sandhu","type":"person","url":"https://hartvaat.nl/mensen/alexander-t-sandhu/","name":"Alexander T Sandhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/05/28/pro-hf-routine-prom-meting-in-hartfalenpolikliniek-verbetert-uitkomsten/","published":"2024-05-28"},{"url":"https://hartvaat.nl/2023/02/28/incidenteel-coronair-calcium-op-ct-thorax-ai-gestuurde-screening-verbetert-stati/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandre-persu","type":"person","url":"https://hartvaat.nl/mensen/alexandre-persu/","name":"Alexandre Persu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alf-inge-larsen","type":"person","url":"https://hartvaat.nl/mensen/alf-inge-larsen/","name":"Alf Inge Larsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"allan-d-struthers","type":"person","url":"https://hartvaat.nl/mensen/allan-d-struthers/","name":"Allan D Struthers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2020/11/03/sglt2-remming-plus-lisdiuretica-bij-diabetes-type-2-met-ckd-renale-en-cv-effecte/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/09/21/dapagliflozine-op-lv-hypertrofie-bij-diabetes-type-2-dapa-lvh-gerandomiseerde-tr/","published":"2020-09-21"},{"url":"https://hartvaat.nl/2019/11/01/metformine-en-linkerventrikelhypertrofie-bij-coronairlijden-zonder-diabetes-gera/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alun-d-hughes","type":"person","url":"https://hartvaat.nl/mensen/alun-d-hughes/","name":"Alun D Hughes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2020/04/07/yoga-gebaseerde-hartrevalidatie-na-acuut-mi-gerandomiseerde-trial/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2019/10/01/arteriele-golfvormclusters-en-langetermijn-klinisch-nut/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/07/01/crt-werkingsmechanismen-en-mogelijkheden-voor-verdere-verbetering/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amy-v-ferry","type":"person","url":"https://hartvaat.nl/mensen/amy-v-ferry/","name":"Amy V Ferry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amy-w-talbot","type":"person","url":"https://hartvaat.nl/mensen/amy-w-talbot/","name":"Amy W Talbot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anastasia-lesogor","type":"person","url":"https://hartvaat.nl/mensen/anastasia-lesogor/","name":"Anastasia Lesogor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/22/victorion-initiate-inclisiran-monotherapie-bij-patienten-zonder-ascvd/","published":"2025-07-22"},{"url":"https://hartvaat.nl/2025/06/24/inclisiran-bij-adolescenten-met-homozygote-fh-effectiviteit-en-veiligheid/","published":"2025-06-24"},{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2024/01/30/orion-5-inclisiran-bij-homozygote-fh/","published":"2024-01-30"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-lage","type":"person","url":"https://hartvaat.nl/mensen/andrea-lage/","name":"Andrea Lage","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-saglietto","type":"person","url":"https://hartvaat.nl/mensen/andrea-saglietto/","name":"Andrea Saglietto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/08/01/linkeratriale-strain-en-prognose-bij-acuut-en-chronisch-hartfalen-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"},{"url":"https://hartvaat.nl/2022/12/09/ideale-blankingperiode-na-af-ablatie-bewijs-voor-herziening/","published":"2022-12-09"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-sarkozy","type":"person","url":"https://hartvaat.nl/mensen/andrea-sarkozy/","name":"Andrea Sarkozy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/02/03/kortste-af-cycluslengte-in-de-longvenen-identificeert-pvi-responders/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2018/04/21/pvi-met-versus-zonder-antiaritmica-bij-recidiverend-af-powder-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-ruck","type":"person","url":"https://hartvaat.nl/mensen/andreas-ruck/","name":"Andreas Rück","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrzej-bochenek","type":"person","url":"https://hartvaat.nl/mensen/andrzej-bochenek/","name":"Andrzej Bochenek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrzej-wiecek","type":"person","url":"https://hartvaat.nl/mensen/andrzej-wiecek/","name":"Andrzej Więcek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-m-thgersen","type":"person","url":"https://hartvaat.nl/mensen/anna-m-thgersen/","name":"Anna M Thøgersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-sannino","type":"person","url":"https://hartvaat.nl/mensen/anna-sannino/","name":"Anna Sannino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2017/10/14/tmao-als-cardiovasculaire-risicobiomarker-systematische-review-en-meta-analyse/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annapoorna-s-kini","type":"person","url":"https://hartvaat.nl/mensen/annapoorna-s-kini/","name":"Annapoorna S Kini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-c-goldberg","type":"person","url":"https://hartvaat.nl/mensen/anne-c-goldberg/","name":"Anne C Goldberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2019/11/12/bempedoinezuur-toegevoegd-aan-statines-bij-hoog-cv-risico-jama-clear-harmony/","published":"2019-11-12"},{"url":"https://hartvaat.nl/2018/12/01/cardiovasculaire-risicocommunicatie-en-patientperceptie-jama-cardiology/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annica-ravn-fischer","type":"person","url":"https://hartvaat.nl/mensen/annica-ravn-fischer/","name":"Annica Ravn-Fischer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/11/25/abc-af-risicoscores-voor-gepersonaliseerde-af-behandeling/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-dans","type":"person","url":"https://hartvaat.nl/mensen/antonio-dans/","name":"Antonio Dans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-fernandez-ortiz","type":"person","url":"https://hartvaat.nl/mensen/antonio-fernandez-ortiz/","name":"Antonio Fernández-Ortiz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2017/01/15/linker-hartoorsluiting-versus-medicamenteuze-behandeling-bij-af-netwerkmeta-anal/","published":"2017-01-15"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/10/timing-van-metoprolol-bij-stemi-effect-op-infarctgrootte-en-ventrikelfunctie/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antony-walton","type":"person","url":"https://hartvaat.nl/mensen/antony-walton/","name":"Antony Walton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/06/01/renale-denervatie-langetermijn-bloeddrukeffect-bevestigd-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atsushi-hirayama","type":"person","url":"https://hartvaat.nl/mensen/atsushi-hirayama/","name":"Atsushi Hirayama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"augustin-coisne","type":"person","url":"https://hartvaat.nl/mensen/augustin-coisne/","name":"Augustin Coisne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bastiaan-geelhoed","type":"person","url":"https://hartvaat.nl/mensen/bastiaan-geelhoed/","name":"Bastiaan Geelhoed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"belinda-lees","type":"person","url":"https://hartvaat.nl/mensen/belinda-lees/","name":"Belinda Lees","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/01/05/leeftijd-en-10-jaarsuitkomsten-na-cabg-art-trial/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/10/06/postoperatief-af-en-langetermijn-cva-risico-na-geisoleerde-cabg/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2017/08/01/radiale-arterie-graft-als-aanvulling-op-mammaria-interna-grafts-bij-cabg/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/12/29/bilaterale-versus-enkelvoudige-a-mammaria-interna-grafts-nejm-art-trial/","published":"2016-12-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benedikt-schrage","type":"person","url":"https://hartvaat.nl/mensen/benedikt-schrage/","name":"Benedikt Schrage","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-hibbert","type":"person","url":"https://hartvaat.nl/mensen/benjamin-hibbert/","name":"Benjamin Hibbert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/05/apture-shunt-verlaagt-hartfalen-heropnames-bij-patienten-met-hfpef-hfmref-alt-fl/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/02/19/lv-unloading-tijdens-ecmo-bij-cardiogene-shock/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernardo-cortese","type":"person","url":"https://hartvaat.nl/mensen/bernardo-cortese/","name":"Bernardo Cortese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernhard-ludvik","type":"person","url":"https://hartvaat.nl/mensen/bernhard-ludvik/","name":"Bernhard Ludvik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/05/dapa-hd-eerste-gerandomiseerde-studie-naar-dapagliflozin-bij-hemodialyse-patient/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/05/03/semaglutide-en-loopafstand-bij-perifeer-vaatlijden-en-diabetes/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2021/08/14/tirzepatide-versus-insuline-degludec-bij-diabetes-type-2-lancet-surpass-3/","published":"2021-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bharathi-upadhya","type":"person","url":"https://hartvaat.nl/mensen/bharathi-upadhya/","name":"Bharathi Upadhya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/06/23/lifestyle-modificatie-en-metabole-therapieen-bij-cardiometabole-hfpef-overzicht/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2025/06/01/bloeddrukcontrole-en-arteriele-stijfheidsmechanismen-in-sprint/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"birgit-vogel","type":"person","url":"https://hartvaat.nl/mensen/birgit-vogel/","name":"Birgit Vogel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brandi-meeks","type":"person","url":"https://hartvaat.nl/mensen/brandi-meeks/","name":"Brandi Meeks","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-a-ference","type":"person","url":"https://hartvaat.nl/mensen/brian-a-ference/","name":"Brian A Ference","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2019/10/15/triglyceridenverlaging-en-cv-risicoreductie-over-therapeutische-klassen-meta-ana/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2018/07/14/ldl-verlaging-en-cv-events-met-pcsk9-remmers-meta-analyse-van-gerandomiseerde-tr/","published":"2018-07-14"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/09/27/ldl-c-verlaging-en-cardiovasculaire-risicoreductie-jama-systematische-review-en-/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-rayner","type":"person","url":"https://hartvaat.nl/mensen/brian-rayner/","name":"Brian Rayner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/23/semaglutide-vermindert-infectierisico-bij-diabetes-en-chronische-nierziekte/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/01/01/farmacologische-hypertensiebehandeling-bij-volwassenen-who-richtlijn-samenvattin/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"},{"url":"https://hartvaat.nl/2016/02/09/sms-berichten-ter-ondersteuning-van-therapietrouw-bij-hoge-bloeddruk-de-star-tri/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-hug","type":"person","url":"https://hartvaat.nl/mensen/bruce-hug/","name":"Bruce Hug","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-garcia-del-blanco","type":"person","url":"https://hartvaat.nl/mensen/bruno-garcia-del-blanco/","name":"Bruno García Del Blanco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carl-schultz","type":"person","url":"https://hartvaat.nl/mensen/carl-schultz/","name":"Carl Schultz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2021/07/01/camkii-delta-remming-en-ventriculaire-remodellering-na-mi-jama-cardiology/","published":"2021-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-pappone","type":"person","url":"https://hartvaat.nl/mensen/carlo-pappone/","name":"Carlo Pappone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/varipure-studie-pulsed-field-ablatie-in-de-dagelijkse-af-praktijk/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2017/04/01/aanvullende-elektroden-op-de-quartet-lv-lead-bieden-meer-crt-programmeringsmogel/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-roberto-jaen","type":"person","url":"https://hartvaat.nl/mensen/carlos-roberto-jaen/","name":"Carlos Roberto Jaén","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmine-g-de-pasquale","type":"person","url":"https://hartvaat.nl/mensen/carmine-g-de-pasquale/","name":"Carmine G De Pasquale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2021/10/01/acute-pleiotrope-effecten-van-dapagliflozine-bij-diabetes-type-2-met-hfref-cross/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carol-i-duffy","type":"person","url":"https://hartvaat.nl/mensen/carol-i-duffy/","name":"Carol I Duffy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/09/01/arni-naar-hf-voorgeschiedenis-en-raas-antagonistgebruik/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/02/01/arni-initiatie-na-acuut-gedecompenseerd-hf-pioneer-hf-open-label-extensie/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/07/angiotensine-neprilysineremming-bij-acuut-gedecompenseerd-hf-nejm-pioneer-hf/","published":"2019-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"catherine-g-derington","type":"person","url":"https://hartvaat.nl/mensen/catherine-g-derington/","name":"Catherine G Derington","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2023/08/01/combinatietabletten-voor-intensieve-bloeddrukbehandeling-sprint-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chandan-m-devireddy","type":"person","url":"https://hartvaat.nl/mensen/chandan-m-devireddy/","name":"Chandan M Devireddy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"changdong-guan","type":"person","url":"https://hartvaat.nl/mensen/changdong-guan/","name":"Changdong Guan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charalambos-antoniades","type":"person","url":"https://hartvaat.nl/mensen/charalambos-antoniades/","name":"Charalambos Antoniades","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2023/05/30/empagliflozine-en-cardiale-energiestofwisseling-bij-hartfalen-empa-vision/","published":"2023-05-30"}],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/implementatie-lipidenmanagement/","title":"Sessie 4: Implementatie van lipidenmanagement — praktische uitdagingen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chen-liu","type":"person","url":"https://hartvaat.nl/mensen/chen-liu/","name":"Chen Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/06/01/hypertensie-wijzigt-de-relatie-tussen-lp-a-en-mortaliteit-bij-acuut-gedecompense/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/07/14/depressietrajecten-bij-hfpef-impact-op-uitkomsten/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/06/01/s2i2n0-3-score-voorspelt-mortaliteit-bij-hfref-guide-it-subanalyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chiadi-e-ndumele","type":"person","url":"https://hartvaat.nl/mensen/chiadi-e-ndumele/","name":"Chiadi E Ndumele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christiaan-j-vrints","type":"person","url":"https://hartvaat.nl/mensen/christiaan-j-vrints/","name":"Christiaan J Vrints","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/02/03/klinische-risicopredictie-ct-coronairangiografie-en-cv-events-bij-nieuwe-angina/","published":"2025-02-03"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-spaulding","type":"person","url":"https://hartvaat.nl/mensen/christian-spaulding/","name":"Christian Spaulding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/coact-trial-langetermijnlessen-over-coronairangiografie-na-reanimatie/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2020/08/01/seksegerelateerde-uitkomsten-bij-hoog-bloedingsrisico-na-pci-leaders-free/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christianne-l-roumie","type":"person","url":"https://hartvaat.nl/mensen/christianne-l-roumie/","name":"Christianne L Roumie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-a-rinaldi","type":"person","url":"https://hartvaat.nl/mensen/christopher-a-rinaldi/","name":"Christopher A Rinaldi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/05/03/triventriculaire-pacing-bij-hf-strive-hf-gerandomiseerde-trial/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"},{"url":"https://hartvaat.nl/2017/04/01/aanvullende-elektroden-op-de-quartet-lv-lead-bieden-meer-crt-programmeringsmogel/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-m-cook","type":"person","url":"https://hartvaat.nl/mensen/christopher-m-cook/","name":"Christopher M Cook","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-r-ellis","type":"person","url":"https://hartvaat.nl/mensen/christopher-r-ellis/","name":"Christopher R Ellis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/04/02/amaze-pvi-met-of-zonder-laa-ligatie-bij-af-jama-rct/","published":"2024-04-02"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clara-ines-saldarriaga","type":"person","url":"https://hartvaat.nl/mensen/clara-ines-saldarriaga/","name":"Clara Inés Saldarriaga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cynthia-m-westerhout","type":"person","url":"https://hartvaat.nl/mensen/cynthia-m-westerhout/","name":"Cynthia M Westerhout","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2020/11/01/invloed-van-acs-trials-buiten-de-primaire-hypothese-systematische-review/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"candida-fonseca","type":"person","url":"https://hartvaat.nl/mensen/candida-fonseca/","name":"Cândida Fonseca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-obesitas-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-j-rader","type":"person","url":"https://hartvaat.nl/mensen/daniel-j-rader/","name":"Daniel J Rader","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"},{"url":"https://hartvaat.nl/2017/06/20/cholesteroleffluxcapaciteit-hdl-deeltjesaantal-en-cv-events-jupiter-analyse/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2016/05/01/ly3015014-een-nieuw-monoklonaal-pcsk9-antilichaam-gerandomiseerde-fase-2-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-l-jacoby","type":"person","url":"https://hartvaat.nl/mensen/daniel-l-jacoby/","name":"Daniel L Jacoby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2020/09/15/empagliflozine-bij-hartfalen-diuretische-en-cardiorenale-effecten/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"},{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-steven","type":"person","url":"https://hartvaat.nl/mensen/daniel-steven/","name":"Daniel Steven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/05/07/hoog-vermogen-korte-duur-rf-ablatie-versus-cryoballon-bij-paroxysmaal-af-rct/","published":"2025-05-07"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-weilenmann","type":"person","url":"https://hartvaat.nl/mensen/daniel-weilenmann/","name":"Daniel Weilenmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-aguilar","type":"person","url":"https://hartvaat.nl/mensen/david-aguilar/","name":"David Aguilar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2016/12/06/comorbiditeiten-bij-hartfalen-hypertensie-obesitas-diabetes-hyperlipidemie-en-me/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-d-waters","type":"person","url":"https://hartvaat.nl/mensen/david-d-waters/","name":"David D Waters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2017/04/06/gewichtsfluctuaties-en-cardiovasculaire-uitkomsten-bij-coronairlijden-nejm/","published":"2017-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-wilber","type":"person","url":"https://hartvaat.nl/mensen/david-j-wilber/","name":"David J Wilber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/04/02/amaze-pvi-met-of-zonder-laa-ligatie-bij-af-jama-rct/","published":"2024-04-02"},{"url":"https://hartvaat.nl/2023/02/08/redo-firm-firm-geleide-ablatie-verbetert-uitkomst-niet-bij-recidief-af/","published":"2023-02-08"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-preiss","type":"person","url":"https://hartvaat.nl/mensen/david-preiss/","name":"David Preiss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/02/01/nicotinezuurtherapie-en-het-risico-op-diabetes-meta-analyse-van-gerandomiseerde-/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davor-milicic","type":"person","url":"https://hartvaat.nl/mensen/davor-milicic/","name":"Davor Milicic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"de-wei-an","type":"person","url":"https://hartvaat.nl/mensen/de-wei-an/","name":"De-Wei An","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"debbie-l-cohen","type":"person","url":"https://hartvaat.nl/mensen/debbie-l-cohen/","name":"Debbie L Cohen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"denis-angoulvant","type":"person","url":"https://hartvaat.nl/mensen/denis-angoulvant/","name":"Denis Angoulvant","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dennis-wolf","type":"person","url":"https://hartvaat.nl/mensen/dennis-wolf/","name":"Dennis Wolf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derek-v-exner","type":"person","url":"https://hartvaat.nl/mensen/derek-v-exner/","name":"Derek V Exner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/03/upgrade-van-draadloze-pacemaker-van-enkelvoudig-naar-tweekamersysteem/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2021/06/01/implanteerbare-versus-verlengde-externe-ecg-monitoring-voor-af-na-ischemisch-cva/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dhiraj-gupta","type":"person","url":"https://hartvaat.nl/mensen/dhiraj-gupta/","name":"Dhiraj Gupta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/10/01/katheterablatie-als-eerstelijns-paf-therapie-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2017/05/01/ablatie-index-als-marker-voor-ablatielaesiekwaliteit-voorspelling-van-pv-reconne/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diana-aguiar-de-sousa","type":"person","url":"https://hartvaat.nl/mensen/diana-aguiar-de-sousa/","name":"Diana Aguiar de Sousa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"didier-tchetche","type":"person","url":"https://hartvaat.nl/mensen/didier-tchetche/","name":"Didier Tchétché","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dike-b-ojji","type":"person","url":"https://hartvaat.nl/mensen/dike-b-ojji/","name":"Dike B Ojji","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitri-karmpaliotis","type":"person","url":"https://hartvaat.nl/mensen/dimitri-karmpaliotis/","name":"Dimitri Karmpaliotis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-farmakis","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-farmakis/","name":"Dimitrios Farmakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2024/05/01/bloeddrukstreefwaarden-en-residueel-risico-systematische-review-en-meta-regressi/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"divaka-perera","type":"person","url":"https://hartvaat.nl/mensen/divaka-perera/","name":"Divaka Perera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/28/coronaire-autoregulatie-samenspel-van-epicardiale-en-microvasculaire-weerstand/","published":"2026-03-28"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/11/24/protecct-ct-bij-verdenking-acs-met-intermediaire-troponinewaarden/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-g-altman","type":"person","url":"https://hartvaat.nl/mensen/douglas-g-altman/","name":"Douglas G Altman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/08/01/radiale-arterie-graft-als-aanvulling-op-mammaria-interna-grafts-bij-cabg/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2016/12/29/bilaterale-versus-enkelvoudige-a-mammaria-interna-grafts-nejm-art-trial/","published":"2016-12-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-horstmanshof","type":"person","url":"https://hartvaat.nl/mensen/douglas-horstmanshof/","name":"Douglas Horstmanshof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-david-zizek","type":"person","url":"https://hartvaat.nl/mensen/dr-david-zizek/","name":"Dr. David Žižek","title":"Cardioloog-elektrofysioloog, UMC Ljubljana, Slovenië","dutch_institution":true,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/csp-sync-geleidingssysteempacing-versus-biventriculaire-pacing-voor-crt-rct/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/05/02/preventieve-substraatablatie-vermindert-icd-interventies-bij-ischemische-cmp/","published":"2024-05-02"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/conduct-af-conductiesysteem-pacing/","title":"CONDUCT-AF — Conductiesysteem-pacing versus biventriculaire pacing na AV-knoopablatie"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-wayne-batchelor","type":"person","url":"https://hartvaat.nl/mensen/dr-wayne-batchelor/","name":"Dr. Wayne Batchelor","title":"Inova Heart and Vascular Institute, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"}],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/alert-onderbehandeling-aortastenose-mitralisinsufficiëntie/","title":"ALERT: Onderbehandeling bij aortastenose en mitralisinsufficiëntie"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"duolao-wang","type":"person","url":"https://hartvaat.nl/mensen/duolao-wang/","name":"Duolao Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"},{"url":"https://hartvaat.nl/2019/12/24/langetermijnfollow-up-van-complete-versus-laesie-only-revascularisatie-bij-stemi/","published":"2019-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edoardo-casiglia","type":"person","url":"https://hartvaat.nl/mensen/edoardo-casiglia/","name":"Edoardo Casiglia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"egon-pfarr","type":"person","url":"https://hartvaat.nl/mensen/egon-pfarr/","name":"Egon Pfarr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2019/03/12/empagliflozine-vermindert-mortaliteit-en-hf-hospitalisatie-over-het-cv-risicospe/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eik-vettorazzi","type":"person","url":"https://hartvaat.nl/mensen/eik-vettorazzi/","name":"Eik Vettorazzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/02/geindividualiseerd-perioperatief-bloeddrukmanagement-bij-grote-buikchirurgie/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2022/09/13/east-afnet4-vroege-ritmecontrole-effectief-ook-bij-hoge-comorbiditeit/","published":"2022-09-13"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ekkehard-grunig","type":"person","url":"https://hartvaat.nl/mensen/ekkehard-grunig/","name":"Ekkehard Grünig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"},{"url":"https://hartvaat.nl/2022/09/21/riociguat-bij-pulmonale-hypertensie-en-hfpef-haemodynamic-trial/","published":"2022-09-21"},{"url":"https://hartvaat.nl/2021/06/14/gestandaardiseerde-inspanningstraining-bij-pah-en-cteph-haalbaarheid-en-veilighe/","published":"2021-06-14"},{"url":"https://hartvaat.nl/2017/04/01/hemodynamische-effecten-van-riociguat-bij-inoperabel-cteph/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/01/01/inspanningstraining-verbetert-zuurstofopname-en-hemodynamiek-bij-ernstige-pulmon/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eliana-vieira-santucci","type":"person","url":"https://hartvaat.nl/mensen/eliana-vieira-santucci/","name":"Eliana Vieira Santucci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eliano-p-navarese","type":"person","url":"https://hartvaat.nl/mensen/eliano-p-navarese/","name":"Eliano P Navarese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/01/24/pcsk9-remming-bij-covid-19-anti-inflammatoir-potentieel-onderzocht/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2021/12/07/minimaal-onderbroken-versus-continue-doac-bij-af-ablatie-meta-analyse/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/04/17/uitgangs-ldl-en-mortaliteitsreductie-na-ldl-verlaging-jama-meta-analyse/","published":"2018-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ellen-g-moquete","type":"person","url":"https://hartvaat.nl/mensen/ellen-g-moquete/","name":"Ellen G Moquete","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elvin-kedhi","type":"person","url":"https://hartvaat.nl/mensen/elvin-kedhi/","name":"Elvin Kedhi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emilio-ros","type":"person","url":"https://hartvaat.nl/mensen/emilio-ros/","name":"Emilio Ros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2019/05/01/walnotendieet-en-24-uurs-ambulante-bloeddruk-bij-ouderen/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emily-r-atkins","type":"person","url":"https://hartvaat.nl/mensen/emily-r-atkins/","name":"Emily R Atkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/06/01/lage-dosis-drievoudige-viervoudige-combinatiepil-versus-monotherapie-bij-hyperte/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrique-santas","type":"person","url":"https://hartvaat.nl/mensen/enrique-santas/","name":"Enrique Santas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/03/expertopinie-hierarchische-eindpunten-op-basis-van-verslechterend-hartfalen-voor/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/bio-impedantie-voor-vochtstatusbepaling-en-prognose-bij-chronisch-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/iv-ferricarboxymaltose-verbetert-linkeratriale-strain-bij-hartfalen-myocardial-i/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-b-rimm","type":"person","url":"https://hartvaat.nl/mensen/eric-b-rimm/","name":"Eric B Rimm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/01/haptoglobinefenotype-en-cv-risico-accord-bloeddruk-rct/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2020/02/11/haptoglobinefenotype-wijzigt-het-effect-van-intensieve-glycemische-controle-op-c/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/03/27/hdl-subspecies-met-apoliproteine-c-iii-en-coronairlijden-vier-cohorten/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/05/01/melatoninesecretie-en-myocardinfarctrisico-geneste-case-controlstudie/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-boerwinkle","type":"person","url":"https://hartvaat.nl/mensen/eric-boerwinkle/","name":"Eric Boerwinkle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-s-leifer","type":"person","url":"https://hartvaat.nl/mensen/eric-s-leifer/","name":"Eric S Leifer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erion-xhepa","type":"person","url":"https://hartvaat.nl/mensen/erion-xhepa/","name":"Erion Xhepa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erlend-eriksen","type":"person","url":"https://hartvaat.nl/mensen/erlend-eriksen/","name":"Erlend Eriksen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-ondersteuning-versus-iabp-bij-cardiogene-shock-meta-analys/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ernest-spitzer","type":"person","url":"https://hartvaat.nl/mensen/ernest-spitzer/","name":"Ernest Spitzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eugene-s-chung","type":"person","url":"https://hartvaat.nl/mensen/eugene-s-chung/","name":"Eugene S Chung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2016/05/10/biventriculaire-versus-rechterkamerpacing-klinische-verbetering-in-de-block-hf-s/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/02/01/peri-infarctpacing-ter-preventie-van-linkerkamerremodellering-na-groot-myocardin/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-a-mistry","type":"person","url":"https://hartvaat.nl/mensen/eva-a-mistry/","name":"Eva A Mistry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2023/09/05/best-ii-bloeddrukmanagement-na-trombectomie-bij-cva-jama/","published":"2023-09-05"},{"url":"https://hartvaat.nl/2020/03/01/bloeddruk-en-uitkomsten-bij-acute-beroerte-trombectomie/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evelyne-meekers","type":"person","url":"https://hartvaat.nl/mensen/evelyne-meekers/","name":"Evelyne Meekers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/09/praise-mr-sacubitril-valsartan-verbetert-inspanningshemodynamiek-bij-hfpef-met-a/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eugene-p-mcfadden","type":"person","url":"https://hartvaat.nl/mensen/eugene-p-mcfadden/","name":"Eùgene P McFadden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"f-perry-wilson","type":"person","url":"https://hartvaat.nl/mensen/f-perry-wilson/","name":"F Perry Wilson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/03/28/secundaire-hypertensie-bij-kinderen-jama-klinische-diagnostiek/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2020/09/15/empagliflozine-bij-hartfalen-diuretische-en-cardiorenale-effecten/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2016/05/17/verminderde-cardiac-index-is-niet-de-primaire-oorzaak-van-nierdisfunctie-bij-har/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabien-praz","type":"person","url":"https://hartvaat.nl/mensen/fabien-praz/","name":"Fabien Praz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-mangiacapra","type":"person","url":"https://hartvaat.nl/mensen/fabio-mangiacapra/","name":"Fabio Mangiacapra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/09/01/periprocedureel-mi-na-pci-en-langetermijnmortaliteit-meta-analyse/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/12/20/ticagrelor-versus-prasugrel-en-coronaire-microcirculatie-bij-pci/","published":"2023-12-20"},{"url":"https://hartvaat.nl/2016/09/13/clopidogrel-versus-ticagrelor-bij-diabetes-na-pci-gerandomiseerde-trial/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/07/12/prasugrel-versus-clopidogrel-en-coronaire-microvasculaire-functie-bij-electieve-/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feifan-ouyang","type":"person","url":"https://hartvaat.nl/mensen/feifan-ouyang/","name":"Feifan Ouyang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/09/nieuw-bifasisch-pfa-systeem-versus-thermale-ablatie-bij-paroxysmaal-af/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2021/03/08/katheterablatie-om-af-progressie-te-vertragen-attest-gerandomiseerde-trial/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fiorenzo-gaita","type":"person","url":"https://hartvaat.nl/mensen/fiorenzo-gaita/","name":"Fiorenzo Gaita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/12/09/ideale-blankingperiode-na-af-ablatie-bewijs-voor-herziening/","published":"2022-12-09"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"},{"url":"https://hartvaat.nl/2016/05/01/katheterablatie-van-af-bij-chronisch-hartfalen-state-of-the-art-en-toekomstpersp/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flaviana-amarante","type":"person","url":"https://hartvaat.nl/mensen/flaviana-amarante/","name":"Flaviana Amarante","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florian-rader","type":"person","url":"https://hartvaat.nl/mensen/florian-rader/","name":"Florian Rader","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-fioretti","type":"person","url":"https://hartvaat.nl/mensen/francesco-fioretti/","name":"Francesco Fioretti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/05/apture-shunt-verlaagt-hartfalen-heropnames-bij-patienten-met-hfpef-hfmref-alt-fl/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/04/21/jacc-beschouwing-placebo-in-trials-met-incretine-therapie-bij-hartfalen-wetensch/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/12/01/hfpef-fenotypen-in-device-en-chirurgische-trials-karakterisatie/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-leyva","type":"person","url":"https://hartvaat.nl/mensen/francisco-leyva/","name":"Francisco Leyva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/08/03/dagontslag-versus-overnachting-na-af-ablatie-uitgebreide-meta-analyse/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/07/01/crt-werkingsmechanismen-en-mogelijkheden-voor-verdere-verbetering/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francois-philippon","type":"person","url":"https://hartvaat.nl/mensen/francois-philippon/","name":"François Philippon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/19/geleidingsstoornissen-na-transkatheter-aortaklepimplantatie/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederic-kontny","type":"person","url":"https://hartvaat.nl/mensen/frederic-kontny/","name":"Frederic Kontny","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederik-h-verbrugge","type":"person","url":"https://hartvaat.nl/mensen/frederik-h-verbrugge/","name":"Frederik H Verbrugge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/09/praise-mr-sacubitril-valsartan-verbetert-inspanningshemodynamiek-bij-hfpef-met-a/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"g-andre-ng","type":"person","url":"https://hartvaat.nl/mensen/g-andre-ng/","name":"G André Ng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/01/geleidingssysteempacing-versus-biventriculaire-pacing-bij-av-blok-vergelijkende-/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-ntaios","type":"person","url":"https://hartvaat.nl/mensen/george-ntaios/","name":"George Ntaios","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerald-chi","type":"person","url":"https://hartvaat.nl/mensen/gerald-chi/","name":"Gerald Chi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gilles-chatellier","type":"person","url":"https://hartvaat.nl/mensen/gilles-chatellier/","name":"Gilles Chatellier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gilles-rioufol","type":"person","url":"https://hartvaat.nl/mensen/gilles-rioufol/","name":"Gilles Rioufol","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gintaras-kalinauskas","type":"person","url":"https://hartvaat.nl/mensen/gintaras-kalinauskas/","name":"Gintaras Kalinauskas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giorgio-e-m-melloni","type":"person","url":"https://hartvaat.nl/mensen/giorgio-e-m-melloni/","name":"Giorgio E M Melloni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulia-masiero","type":"person","url":"https://hartvaat.nl/mensen/giulia-masiero/","name":"Giulia Masiero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulia-renda","type":"person","url":"https://hartvaat.nl/mensen/giulia-renda/","name":"Giulia Renda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/10/01/sglt2-remmers-geassocieerd-met-lagere-sterfte-bij-attr-cardiomyopathie-meta-anal/","published":"2026-08-21"},{"url":"https://hartvaat.nl/2018/10/16/doac-s-halveren-trombo-embolische-events-na-af-cardioversie-versus-warfarine/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/doac-s-bij-af-met-kleplijden-jacc-review/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gjin-ndrepepa","type":"person","url":"https://hartvaat.nl/mensen/gjin-ndrepepa/","name":"Gjin Ndrepepa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gladys-n-janssens","type":"person","url":"https://hartvaat.nl/mensen/gladys-n-janssens/","name":"Gladys N Janssens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"govinda-j-weerakkody","type":"person","url":"https://hartvaat.nl/mensen/govinda-j-weerakkody/","name":"Govinda J Weerakkody","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2021/11/13/tirzepatide-versus-insuline-glargine-bij-diabetes-type-2-met-hoog-cv-risico-lanc/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-w-evans","type":"person","url":"https://hartvaat.nl/mensen/gregory-w-evans/","name":"Gregory W Evans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregoire-range","type":"person","url":"https://hartvaat.nl/mensen/gregoire-range/","name":"Grégoire Range","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gunnar-engstrom","type":"person","url":"https://hartvaat.nl/mensen/gunnar-engstrom/","name":"Gunnar Engström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/20/darmmicrobiota-en-geschatte-glomerulaire-filtratiesnelheid-in-twee-zweedse-cohor/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guosheng-fu","type":"person","url":"https://hartvaat.nl/mensen/guosheng-fu/","name":"Guosheng Fu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"habib-samady","type":"person","url":"https://hartvaat.nl/mensen/habib-samady/","name":"Habib Samady","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/16/hoge-coronaire-shear-stress-voorspelt-myocardinfarct/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hadiza-saidu","type":"person","url":"https://hartvaat.nl/mensen/hadiza-saidu/","name":"Hadiza Saidu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-peter-stoll","type":"person","url":"https://hartvaat.nl/mensen/hans-peter-stoll/","name":"Hans-Peter Stoll","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/08/01/seksegerelateerde-uitkomsten-bij-hoog-bloedingsrisico-na-pci-leaders-free/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hany-eteiba","type":"person","url":"https://hartvaat.nl/mensen/hany-eteiba/","name":"Hany Eteiba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/12/15/infarctgrootte-en-linkerkamerremodellering-na-preventieve-pci/","published":"2016-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harald-sourij","type":"person","url":"https://hartvaat.nl/mensen/harald-sourij/","name":"Harald Sourij","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/06/metabool-cardiovasculair-risico-nieuwe-mechanismen-en-therapiekansen/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/05/03/semaglutide-en-loopafstand-bij-perifeer-vaatlijden-en-diabetes/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2022/11/01/emmy-empagliflozine-na-acuut-myocardinfarct-verbetert-nt-probnp-en-remodelling/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heather-m-johnson","type":"person","url":"https://hartvaat.nl/mensen/heather-m-johnson/","name":"Heather M Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helen-routledge","type":"person","url":"https://hartvaat.nl/mensen/helen-routledge/","name":"Helen Routledge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helina-kassahun","type":"person","url":"https://hartvaat.nl/mensen/helina-kassahun/","name":"Helina Kassahun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/25/mendeliaanse-randomisatie-lp-a-verhoogt-coronarialijden-onafhankelijk-van-ldl-c-/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2019/09/01/persisterende-arteriele-wandinflammatie-bij-verhoogd-lp-a-ondanks-lage-ldl/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henrik-steen-hansen","type":"person","url":"https://hartvaat.nl/mensen/henrik-steen-hansen/","name":"Henrik Steen Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/02/14/danami-2-16-jaarsfollow-up-primaire-pci-versus-fibrinolyse/","published":"2020-02-14"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henry-seligman","type":"person","url":"https://hartvaat.nl/mensen/henry-seligman/","name":"Henry Seligman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/06/11/remote-beoordeling-na-acs-gerandomiseerde-trial/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hesong-zeng","type":"person","url":"https://hartvaat.nl/mensen/hesong-zeng/","name":"Hesong Zeng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hitoshi-matsuo","type":"person","url":"https://hartvaat.nl/mensen/hitoshi-matsuo/","name":"Hitoshi Matsuo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2022/02/01/ccta-afgeleide-ffr-prognostische-waarde-meta-analyse/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hong-zhang","type":"person","url":"https://hartvaat.nl/mensen/hong-zhang/","name":"Hong Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/20/voorspelling-van-individuele-corticosteroidrespons-bij-iga-nefropathie-testing-t/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2026/01/20/multi-omics-onthult-pathogene-rol-van-iga-7-cellen-bij-iga-nefropathie/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"howard-c-herrmann","type":"person","url":"https://hartvaat.nl/mensen/howard-c-herrmann/","name":"Howard C Herrmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hugo-a-katus","type":"person","url":"https://hartvaat.nl/mensen/hugo-a-katus/","name":"Hugo A Katus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2019/08/01/strain-encoded-mri-voor-beoordeling-van-myocardiale-deformatie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"i-min-lee","type":"person","url":"https://hartvaat.nl/mensen/i-min-lee/","name":"I-Min Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/05/inflammatie-cholesterol-lp-a-en-30-jaars-cv-uitkomsten-bij-vrouwen/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2023/01/10/dagelijkse-stappen-en-cardiovasculaire-ziekte-geharmoniseerde-meta-analyse/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2023/01/01/vitamine-d-voorkomt-statine-gerelateerde-spierklachten-niet/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iain-c-macdougall","type":"person","url":"https://hartvaat.nl/mensen/iain-c-macdougall/","name":"Iain C Macdougall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilan-goldenberg","type":"person","url":"https://hartvaat.nl/mensen/ilan-goldenberg/","name":"Ilan Goldenberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/05/03/radiale-strain-geleide-leadplaatsing-voor-crt-bij-ischemisch-hf/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/09/20/volledig-linkszijdig-reverse-remodelling-bij-crt-madit-crt-substudie/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/01/26/relatieve-wanddikte-en-risico-op-ventriculaire-tachyaritmieen-bij-linkerkamerdis/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ingebjrg-seljeflot","type":"person","url":"https://hartvaat.nl/mensen/ingebjrg-seljeflot/","name":"Ingebjørg Seljeflot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2021/02/09/omega-3-vetzuren-bij-oudere-mi-patienten-omemi-gerandomiseerde-trial/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2018/07/10/il-8-en-infarctgrootte-en-klinische-uitkomsten-bij-stemi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/06/01/complementactivatie-bij-acuut-hartfalen-na-mi-correlatie-met-ernst/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabell-bernlochner","type":"person","url":"https://hartvaat.nl/mensen/isabell-bernlochner/","name":"Isabell Bernlochner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivo-petrov","type":"person","url":"https://hartvaat.nl/mensen/ivo-petrov/","name":"Ivo Petrov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-antonio-g-lopez","type":"person","url":"https://hartvaat.nl/mensen/j-antonio-g-lopez/","name":"J Antonio G López","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/25/mendeliaanse-randomisatie-lp-a-verhoogt-coronarialijden-onafhankelijk-van-ldl-c-/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2020/05/26/evolocumab-bij-hiv-met-dyslipidemie-beijerinck-gerandomiseerde-studie/","published":"2020-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-jaime-miranda","type":"person","url":"https://hartvaat.nl/mensen/j-jaime-miranda/","name":"J Jaime Miranda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2021/05/11/digitale-interventie-voor-depressie-bij-hypertensie-diabetes-in-brazilie-en-peru/","published":"2021-05-11"},{"url":"https://hartvaat.nl/2019/06/01/zoutsubstituten-met-laag-natrium-en-bloeddruk-cva-en-mortaliteit-meta-analyse/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2016/12/01/lacunes-in-hypertensierichtlijnen-in-lage-en-middeninkomenslanden-systematische-/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacob-joseph","type":"person","url":"https://hartvaat.nl/mensen/jacob-joseph/","name":"Jacob Joseph","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2021/08/06/ventriculaire-aritmie-bij-crt-responders-en-super-responders-meta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jae-young-cho","type":"person","url":"https://hartvaat.nl/mensen/jae-young-cho/","name":"Jae Young Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaemin-shim","type":"person","url":"https://hartvaat.nl/mensen/jaemin-shim/","name":"Jaemin Shim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2022/10/13/gecombineerde-epicardiale-en-endocardiale-redo-ablatie-bij-persisterend-af/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/04/01/lineaire-versus-focale-cfae-ablatie-bij-niet-paroxysmaal-af/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-hodgkinson","type":"person","url":"https://hartvaat.nl/mensen/james-hodgkinson/","name":"James Hodgkinson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-ravkilde","type":"person","url":"https://hartvaat.nl/mensen/jan-ravkilde/","name":"Jan Ravkilde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-henk-e-dambrink","type":"person","url":"https://hartvaat.nl/mensen/jan-henk-e-dambrink/","name":"Jan-Henk E Dambrink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jana-buccola","type":"person","url":"https://hartvaat.nl/mensen/jana-buccola/","name":"Jana Buccola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janet-wittes","type":"person","url":"https://hartvaat.nl/mensen/janet-wittes/","name":"Janet Wittes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"},{"url":"https://hartvaat.nl/2019/10/21/digoxine-en-mortaliteit-gerandomiseerd-versus-observationeel-in-de-dig-trial/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jang-ho-bae","type":"person","url":"https://hartvaat.nl/mensen/jang-ho-bae/","name":"Jang-Ho Bae","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaydeep-sarma","type":"person","url":"https://hartvaat.nl/mensen/jaydeep-sarma/","name":"Jaydeep Sarma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/25/jbs-richtlijn-management-van-hartstilstand-in-het-cathlab/","published":"2022-05-25"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-noel-trochu","type":"person","url":"https://hartvaat.nl/mensen/jean-noel-trochu/","name":"Jean-Noël Trochu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeff-whittle","type":"person","url":"https://hartvaat.nl/mensen/jeff-whittle/","name":"Jeff Whittle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-a-rymer","type":"person","url":"https://hartvaat.nl/mensen/jennifer-a-rymer/","name":"Jennifer A Rymer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-consensus-same-day-ontslag-na-pci/","published":"2021-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-hellawell","type":"person","url":"https://hartvaat.nl/mensen/jennifer-hellawell/","name":"Jennifer Hellawell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/05/20/plozasiran-en-lipoproteine-deeltjesgrootte-bij-hypertriglyceridemie/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/09/12/plozasiran-sirna-tegen-apoc3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/07/01/plozasiran-sirna-tegen-apoc3-bij-ernstige-hypertriglyceridemie-shasta-2/","published":"2024-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jerzy-k-wranicz","type":"person","url":"https://hartvaat.nl/mensen/jerzy-k-wranicz/","name":"Jerzy K Wranicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jesper-moller-jensen","type":"person","url":"https://hartvaat.nl/mensen/jesper-moller-jensen/","name":"Jesper Møller Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jesse-dawson","type":"person","url":"https://hartvaat.nl/mensen/jesse-dawson/","name":"Jesse Dawson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jian-zhang","type":"person","url":"https://hartvaat.nl/mensen/jian-zhang/","name":"Jian Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2020/06/07/hartfalentrials-tijdens-en-na-covid-19-expert-consensus/","published":"2020-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianping-guo","type":"person","url":"https://hartvaat.nl/mensen/jianping-guo/","name":"Jianping Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2020/01/28/morfine-en-cv-uitkomsten-bij-nste-acs-jacc-analyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2018/06/01/fgf-23-en-recidiverende-cv-events-na-acs/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianping-li","type":"person","url":"https://hartvaat.nl/mensen/jianping-li/","name":"Jianping Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/luchtvervuiling-verhoogt-sterfte-door-hypertensie-case-crossover-studie-bij-2-1-/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jing-yu","type":"person","url":"https://hartvaat.nl/mensen/jing-yu/","name":"Jing Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/01/non-hdl-hdl-ratio-als-voorspeller-van-cardiovasculaire-ziekte-bij-ckm-syndroom/","published":"2026-04-07"},{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/09/01/step-substudie-intensieve-bloeddrukverlaging-verbetert-lvh-bij-ouderen/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/01/01/farmacologische-hypertensiebehandeling-bij-volwassenen-who-richtlijn-samenvattin/","published":"2022-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jocelyn-carter","type":"person","url":"https://hartvaat.nl/mensen/jocelyn-carter/","name":"Jocelyn Carter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-bennett","type":"person","url":"https://hartvaat.nl/mensen/johan-bennett/","name":"Johan Bennett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-lindback","type":"person","url":"https://hartvaat.nl/mensen/johan-lindback/","name":"Johan Lindbäck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/10/01/neurofilament-light-chain-en-cva-risico-bij-af/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2018/02/07/abc-doodsscore-bij-af-biomarkergebaseerde-risicoscore-voor-mortaliteit/","published":"2018-02-07"},{"url":"https://hartvaat.nl/2016/11/29/biomarkergebaseerde-cva-risicoscore-bij-atriumfibrilleren-validatie/","published":"2016-11-29"},{"url":"https://hartvaat.nl/2016/06/04/abc-bloedingsscore-bij-atriumfibrilleren-de-nieuwe-biomarkergebaseerde-risicosco/","published":"2016-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-vijgen","type":"person","url":"https://hartvaat.nl/mensen/johan-vijgen/","name":"Johan Vijgen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/26/gerichte-patienteneducatie-vermindert-ongeplande-cv-events-bij-af/","published":"2024-12-26"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2018/04/21/telemonitoring-verbetert-doac-therapietrouw-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-arnlov","type":"person","url":"https://hartvaat.nl/mensen/johan-arnlov/","name":"Johan Ärnlöv","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/20/darmmicrobiota-en-geschatte-glomerulaire-filtratiesnelheid-in-twee-zweedse-cohor/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2022/04/19/therapeutische-doelen-voor-hf-via-proteomics-en-mendeliaanse-randomisatie/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johannes-c-kelder","type":"person","url":"https://hartvaat.nl/mensen/johannes-c-kelder/","name":"Johannes C Kelder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/06/01/diagnostiek-van-hartfalen-in-de-huisartsenpraktijk-ipd-meta-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2020/04/25/clopidogrel-versus-ticagrelor-of-prasugrel-bij-70-plussers-met-nste-acs-lancet-p/","published":"2020-04-25"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2019/05/01/thoracoscopische-versus-katheterablatie-bij-af-langetermijn-fast-trial/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-amerena","type":"person","url":"https://hartvaat.nl/mensen/john-amerena/","name":"John Amerena","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-camm","type":"person","url":"https://hartvaat.nl/mensen/john-camm/","name":"John Camm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/03/26/rate-af-kosteneffectiviteit-van-digoxine-versus-betablokkers-bij-permanent-af/","published":"2025-03-26"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-forbes","type":"person","url":"https://hartvaat.nl/mensen/john-forbes/","name":"John Forbes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-m-ruiz","type":"person","url":"https://hartvaat.nl/mensen/john-m-ruiz/","name":"John M Ruiz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonas-dominik-haner","type":"person","url":"https://hartvaat.nl/mensen/jonas-dominik-haner/","name":"Jonas Dominik Häner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-w-cunningham","type":"person","url":"https://hartvaat.nl/mensen/jonathan-w-cunningham/","name":"Jonathan W Cunningham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2020/07/11/levenslang-voordeel-van-uitgebreide-hfref-farmacotherapie-lancet-schatting/","published":"2020-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathon-leipsic","type":"person","url":"https://hartvaat.nl/mensen/jonathon-leipsic/","name":"Jonathon Leipsic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/02/01/ccta-afgeleide-ffr-prognostische-waarde-meta-analyse/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorge-a-wong","type":"person","url":"https://hartvaat.nl/mensen/jorge-a-wong/","name":"Jorge A Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/07/mra-s-verminderen-af-risico-meta-analyse-van-klinische-trials/","published":"2024-03-07"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2021/06/15/prevalentie-van-linkeratriumtrombus-bij-geanticoaguleerde-af-patienten/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2021/05/01/screening-op-af-bij-ouderen-jama-cardiology-gerandomiseerde-trial/","published":"2021-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-b-selvanayagam","type":"person","url":"https://hartvaat.nl/mensen/joseph-b-selvanayagam/","name":"Joseph B Selvanayagam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/10/01/acute-pleiotrope-effecten-van-dapagliflozine-bij-diabetes-type-2-met-hfref-cross/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/01/camkii-delta-remming-en-ventriculaire-remodellering-na-mi-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2016/05/21/af-type-en-risico-op-trombo-embolie-mortaliteit-en-bloedingen-systematische-revi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-yeboah","type":"person","url":"https://hartvaat.nl/mensen/joseph-yeboah/","name":"Joseph Yeboah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joshua-hawson","type":"person","url":"https://hartvaat.nl/mensen/joshua-hawson/","name":"Joshua Hawson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/02/16/hoog-vermogen-korte-duur-versus-laag-vermogen-langere-duur-posteriore-ablatie-bi/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ju-han-kim","type":"person","url":"https://hartvaat.nl/mensen/ju-han-kim/","name":"Ju Han Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2018/07/24/escitalopram-versus-placebo-bij-depressie-na-acs-en-langetermijn-cardiale-uitkom/","published":"2018-07-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-j-carrero","type":"person","url":"https://hartvaat.nl/mensen/juan-j-carrero/","name":"Juan J Carrero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/27/albuminurie-geassocieerd-met-verhoogd-risico-op-abdominaal-aorta-aneurysma/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/01/15/populatiegebaseerde-egfr-verdelingen-voor-vroege-identificatie-van-chronische-ni/","published":"2026-01-15"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/11/22/cva-risicoscores-bij-af-vergeleken-cha2ds2-vasc-blijft-de-beste/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"judy-w-hung","type":"person","url":"https://hartvaat.nl/mensen/judy-w-hung/","name":"Judy W Hung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/mitralisklepherstel-bij-degeneratief-mr-met-matige-tricuspidalisinsufficientie-2/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juha-hartikainen","type":"person","url":"https://hartvaat.nl/mensen/juha-hartikainen/","name":"Juha Hartikainen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/19/finacaf-n-229-565-hartfalen-verhoogt-cva-risico-bij-af-vooral-bij-jongere-patien/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2025/10/07/vroege-substraatablatie-versus-antiaritmica-bij-vt-gerandomiseerde-trial/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/03/01/katheterablatie-als-eerstelijnsbehandeling-bij-paroxysmaal-af-5-jaarsresultaten/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-grapsa","type":"person","url":"https://hartvaat.nl/mensen/julia-grapsa/","name":"Julia Grapsa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-w-erath","type":"person","url":"https://hartvaat.nl/mensen/julia-w-erath/","name":"Julia W Erath","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2019/10/01/quadripolaire-versus-bipolaire-lv-leads-bij-crt-klinische-uitkomsten/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jung-ho-heo","type":"person","url":"https://hartvaat.nl/mensen/jung-ho-heo/","name":"Jung Ho Heo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorg-lauermann","type":"person","url":"https://hartvaat.nl/mensen/jorg-lauermann/","name":"Jörg Lauermann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kai-xu","type":"person","url":"https://hartvaat.nl/mensen/kai-xu/","name":"Kai Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/12/catheterablatie-versus-rate-control-bij-persisterend-af-en-ouder-hartfalen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2024/04/01/halp-score-hemoglobine-albumine-lymfocyten-trombocyten-en-mortaliteit-bij-hartfa/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2021/05/21/extrapulmonale-vein-driver-mapping-bij-persisterend-af-bij-obese-patienten/","published":"2021-05-21"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kamlesh-khunti","type":"person","url":"https://hartvaat.nl/mensen/kamlesh-khunti/","name":"Kamlesh Khunti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2017/07/18/sglt2-remmers-en-lager-risico-op-hartfalen-en-sterfte-versus-andere-glucoseverla/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kare-tang","type":"person","url":"https://hartvaat.nl/mensen/kare-tang/","name":"Kare Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-c-johnson","type":"person","url":"https://hartvaat.nl/mensen/karen-c-johnson/","name":"Karen C Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2020/12/22/lichaamssamenstelling-en-risico-op-hartfalen-en-mi-prospectieve-analyse/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-j-collins","type":"person","url":"https://hartvaat.nl/mensen/karen-j-collins/","name":"Karen J Collins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katalin-keltai","type":"person","url":"https://hartvaat.nl/mensen/katalin-keltai/","name":"Katalin Keltai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katharina-mueller","type":"person","url":"https://hartvaat.nl/mensen/katharina-mueller/","name":"Katharina Mueller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/07/finearts-hf-finerenon-effectief-over-het-hele-ef-spectrum-bij-hfmref-hfpef/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaycee-m-sink","type":"person","url":"https://hartvaat.nl/mensen/kaycee-m-sink/","name":"Kaycee M Sink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuya-kawai","type":"person","url":"https://hartvaat.nl/mensen/kazuya-kawai/","name":"Kazuya Kawai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-egstrup","type":"person","url":"https://hartvaat.nl/mensen/kenneth-egstrup/","name":"Kenneth Egstrup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2021/10/01/aortaklepcalcificatie-en-cv-risicofactoren-bij-oudere-deense-mannen/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-j-winters","type":"person","url":"https://hartvaat.nl/mensen/kenneth-j-winters/","name":"Kenneth J Winters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-mangion","type":"person","url":"https://hartvaat.nl/mensen/kenneth-mangion/","name":"Kenneth Mangion","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/25/klassieke-lv-gls-overtreft-nieuwe-atriale-cmr-parameters-bij-voorspelling-van-lv/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2016/12/15/infarctgrootte-en-linkerkamerremodellering-na-preventieve-pci/","published":"2016-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-duarte","type":"person","url":"https://hartvaat.nl/mensen/kevin-duarte/","name":"Kevin Duarte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/23/paradise-cohort-hartfalen-en-copd-samen-verhogen-de-langetermijnmortaliteit-met-/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-versus-tirzepatide-bij-patienten-met-obesitas-en-hfpef/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-e-thorpe","type":"person","url":"https://hartvaat.nl/mensen/kevin-e-thorpe/","name":"Kevin E Thorpe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"},{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-j-um","type":"person","url":"https://hartvaat.nl/mensen/kevin-j-um/","name":"Kevin J Um","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/05/08/vasopressine-plus-catecholamines-en-af-bij-distributieve-shock-jama-meta-analyse/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-mccague","type":"person","url":"https://hartvaat.nl/mensen/kevin-mccague/","name":"Kevin McCague","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/09/01/arni-naar-hf-voorgeschiedenis-en-raas-antagonistgebruik/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/02/01/arni-initiatie-na-acuut-gedecompenseerd-hf-pioneer-hf-open-label-extensie/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/07/angiotensine-neprilysineremming-bij-acuut-gedecompenseerd-hf-nejm-pioneer-hf/","published":"2019-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khadijah-breathett","type":"person","url":"https://hartvaat.nl/mensen/khadijah-breathett/","name":"Khadijah Breathett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/23/nierbescherming-na-harttransplantatie-risicoreductie-en-therapeutische-mogelijkh/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kintur-sanghvi","type":"person","url":"https://hartvaat.nl/mensen/kintur-sanghvi/","name":"Kintur Sanghvi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kirk-u-knowlton","type":"person","url":"https://hartvaat.nl/mensen/kirk-u-knowlton/","name":"Kirk U Knowlton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/19/victorion-inception-vroege-inclisiran-na-acuut-coronair-syndroom-verviervoudigt-/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kiyuk-chang","type":"person","url":"https://hartvaat.nl/mensen/kiyuk-chang/","name":"Kiyuk Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"klaus-f-kofoed","type":"person","url":"https://hartvaat.nl/mensen/klaus-f-kofoed/","name":"Klaus F Kofoed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kris-bogaerts","type":"person","url":"https://hartvaat.nl/mensen/kris-bogaerts/","name":"Kris Bogaerts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2019/01/02/preventie-van-cardiogene-shock-na-acuut-mi/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kunihiko-matsui","type":"person","url":"https://hartvaat.nl/mensen/kunihiko-matsui/","name":"Kunihiko Matsui","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"},{"url":"https://hartvaat.nl/2019/06/07/febuxostat-voor-cerebraal-en-cardiorenovasculaire-eventpreventie-freed/","published":"2019-06-07"},{"url":"https://hartvaat.nl/2017/08/01/ldl-cholesterol-streefwaarden-met-pitavastatine-ezetimibe-bij-acs-met-dyslipidem/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"l-kristin-newby","type":"person","url":"https://hartvaat.nl/mensen/l-kristin-newby/","name":"L Kristin Newby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2020/01/28/morfine-en-cv-uitkomsten-bij-nste-acs-jacc-analyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2019/12/17/uitkomsten-van-vrouwen-versus-mannen-na-nste-acs/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-nepper-christensen","type":"person","url":"https://hartvaat.nl/mensen/lars-nepper-christensen/","name":"Lars Nepper-Christensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-ryden","type":"person","url":"https://hartvaat.nl/mensen/lars-ryden/","name":"Lars Rydén","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-sndergaard","type":"person","url":"https://hartvaat.nl/mensen/lars-sndergaard/","name":"Lars Søndergaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/04/01/notion-10-jaar-tavr-versus-chirurgie-bij-laagrisico-aortastenose/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antiplaatjestherapie-bij-cryptogeen-cva-nejm-close/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lawrence-j-fine","type":"person","url":"https://hartvaat.nl/mensen/lawrence-j-fine/","name":"Lawrence J Fine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lehana-thabane","type":"person","url":"https://hartvaat.nl/mensen/lehana-thabane/","name":"Lehana Thabane","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/11/01/gemaskeerde-hypertensie-bij-kinderen-prevalentie-en-cv-risico-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/06/01/eindorgaanschade-bij-kinderen-met-primaire-hypertensie-meta-analyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2019/10/05/uitgebreide-community-interventie-bij-hypertensie-lancet-hope-4/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/02/26/patientgerichte-transitional-care-bij-hf-hospitalisatie-jama-pact-hf/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2016/12/01/lacunes-in-hypertensierichtlijnen-in-lage-en-middeninkomenslanden-systematische-/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lei-song","type":"person","url":"https://hartvaat.nl/mensen/lei-song/","name":"Lei Song","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/eheart-trial-real-time-hartteam-verbetert-besluitvorming-bij-complexe-coronaire-/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leif-thuesen","type":"person","url":"https://hartvaat.nl/mensen/leif-thuesen/","name":"Leif Thuesen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/02/14/danami-2-16-jaarsfollow-up-primaire-pci-versus-fibrinolyse/","published":"2020-02-14"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lien-desteghe","type":"person","url":"https://hartvaat.nl/mensen/lien-desteghe/","name":"Lien Desteghe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/02/05/smartphone-ppg-voor-af-detectie-en-management-verbeterde-screening/","published":"2025-02-05"},{"url":"https://hartvaat.nl/2024/12/26/gerichte-patienteneducatie-vermindert-ongeplande-cv-events-bij-af/","published":"2024-12-26"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2018/04/21/telemonitoring-verbetert-doac-therapietrouw-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liffert-vogt","type":"person","url":"https://hartvaat.nl/mensen/liffert-vogt/","name":"Liffert Vogt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/29/cardiovasculaire-ziekte-blijft-leidend-na-niertransplantatie-overzicht-van-uitda/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2026/01/01/renale-histologie-bij-maligne-hypertensie-systematische-review/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/08/05/lorundrostat-bij-ongecontroleerde-en-therapieresistente-hypertensie-fase-3-resul/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2018/12/01/creatininestijging-tijdens-bloeddrukbehandeling-en-uitkomsten-bij-diabetes-type-/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lili-song","type":"person","url":"https://hartvaat.nl/mensen/lili-song/","name":"Lili Song","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"linda-davidson-ray","type":"person","url":"https://hartvaat.nl/mensen/linda-davidson-ray/","name":"Linda Davidson-Ray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liping-huang","type":"person","url":"https://hartvaat.nl/mensen/liping-huang/","name":"Liping Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/01/consistentie-van-bloeddrukrespons-op-kaliumverrijkt-zout-ssass-subanalyse/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-a-kaltenbach","type":"person","url":"https://hartvaat.nl/mensen/lisa-a-kaltenbach/","name":"Lisa A Kaltenbach","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lothar-roessig","type":"person","url":"https://hartvaat.nl/mensen/lothar-roessig/","name":"Lothar Roessig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/12/01/vericiguat-en-nt-probnp-bij-hfref-victoria-subanalyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"louis-st-l-o-dea","type":"person","url":"https://hartvaat.nl/mensen/louis-st-l-o-dea/","name":"Louis St L O'Dea","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/09/01/galnac-geconjugeerd-antisense-tegen-apoc3-triglyceriden-en-atherogene-lipoprotei/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"louise-bowman","type":"person","url":"https://hartvaat.nl/mensen/louise-bowman/","name":"Louise Bowman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/21/amalfi-remote-screening-voor-asymptomatisch-af-gerandomiseerde-trial/","published":"2025-10-21"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-monzo","type":"person","url":"https://hartvaat.nl/mensen/luca-monzo/","name":"Luca Monzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/08/18/tafamidis-bij-attr-cardiomyopathie-kosteffectiviteit-onder-de-maat-in-vier-europ/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/23/paradise-cohort-hartfalen-en-copd-samen-verhogen-de-langetermijnmortaliteit-met-/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/05/10/paradise-gelijktijdig-acuut-hartfalen-plus-luchtweginfectie-verhoogt-sterfte-tij/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/05/09/telesat-prior-hf-telemonitoring-na-hartfalenopname-verbonden-met-46-lagere-morta/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-versus-tirzepatide-bij-patienten-met-obesitas-en-hfpef/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-testa","type":"person","url":"https://hartvaat.nl/mensen/luca-testa/","name":"Luca Testa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2017/05/30/tijdstrends-in-complicaties-van-bioresorbeerbare-versus-metallic-stents/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-tavazzi","type":"person","url":"https://hartvaat.nl/mensen/luigi-tavazzi/","name":"Luigi Tavazzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/01/betablokkers-bij-systolisch-hartfalen-en-pacemakerritme-mortaliteitseffect/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2019/12/01/gunstige-effecten-van-ivabradine-bij-hf-met-lage-ef-en-hartfrequentie-77-bpm/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lukas-hunziker","type":"person","url":"https://hartvaat.nl/mensen/lukas-hunziker/","name":"Lukas Hunziker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lukasz-koltowski","type":"person","url":"https://hartvaat.nl/mensen/lukasz-koltowski/","name":"Lukasz Koltowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ly-mee-yu","type":"person","url":"https://hartvaat.nl/mensen/ly-mee-yu/","name":"Ly-Mee Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/02/09/sms-berichten-ter-ondersteuning-van-therapietrouw-bij-hoge-bloeddruk-de-star-tri/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maarten-a-h-van-leeuwen","type":"person","url":"https://hartvaat.nl/mensen/maarten-a-h-van-leeuwen/","name":"Maarten A H van Leeuwen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maciej-lesiak","type":"person","url":"https://hartvaat.nl/mensen/maciej-lesiak/","name":"Maciej Lesiak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mads-brix-kronborg","type":"person","url":"https://hartvaat.nl/mensen/mads-brix-kronborg/","name":"Mads Brix Kronborg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/06/02/doac-gebruik-na-ablatie-voor-atriumfibrilleren-aanhouderij-daalt-na-drie-jaar/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2023/10/21/minimalisatie-van-atriale-pacing-bij-sinusknoopziekte-vermindert-af/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mahesh-v-madhavan","type":"person","url":"https://hartvaat.nl/mensen/mahesh-v-madhavan/","name":"Mahesh V Madhavan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/07/16/revascularisatiestrategieen-na-mi-systematische-review-en-meta-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mahir-karakas","type":"person","url":"https://hartvaat.nl/mensen/mahir-karakas/","name":"Mahir Karakas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manisha-desai","type":"person","url":"https://hartvaat.nl/mensen/manisha-desai/","name":"Manisha Desai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2016/08/01/cabg-versus-pci-en-risico-op-myocardinfarct-en-revascularisatie-bij-ckd-patiente/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-ditmarsch","type":"person","url":"https://hartvaat.nl/mensen/marc-ditmarsch/","name":"Marc Ditmarsch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/14/mendeliaanse-randomisatie-hmgcr-remming-verhoogt-diabetesrisico-andere-lipidendo/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-ruel","type":"person","url":"https://hartvaat.nl/mensen/marc-ruel/","name":"Marc Ruel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/13/aha-scientific-statement-2026-secundaire-preventie-na-coronaire-bypassoperatie-e/","published":"2026-05-15"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcello-arca","type":"person","url":"https://hartvaat.nl/mensen/marcello-arca/","name":"Marcello Arca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/01/de-verborgen-nierschade-bij-chylomicronemiesyndromen/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcello-tonelli","type":"person","url":"https://hartvaat.nl/mensen/marcello-tonelli/","name":"Marcello Tonelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2016/07/19/glucoseverlagende-medicatie-en-cardiovasculaire-events-bij-diabetes-type-2-jama-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-zuin","type":"person","url":"https://hartvaat.nl/mensen/marco-zuin/","name":"Marco Zuin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/25/longembolie-epidemiologie-stijgende-last-bij-vergrijzing-preventiestrategieen-bl/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2026/02/25/alcoholgebruik-en-het-ontstaan-van-atriumfibrilleren-dosis-risico-en-dogma-herov/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2024/08/03/device-algoritmen-voor-rv-pacingminimalisatie-meta-analyse-van-uitkomsten/","published":"2024-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-a-pabon","type":"person","url":"https://hartvaat.nl/mensen/maria-a-pabon/","name":"Maria A Pabon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/28/lp-a-verhoogt-risico-op-veneuze-trombo-embolie-bij-premenopauzale-vrouwen-en-hor/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-bij-hartfalen-met-verbeterde-ejectiefractie/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-modus-van-overlijden-bij-hfmref-hfpef/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-mori-brooks","type":"person","url":"https://hartvaat.nl/mensen/maria-mori-brooks/","name":"Maria Mori Brooks","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2018/10/09/hypoglykemie-en-troponine-elevatie-bij-diabetes-met-coronairlijden/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2016/08/01/cabg-versus-pci-en-risico-op-myocardinfarct-en-revascularisatie-bij-ckd-patiente/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marian-branny","type":"person","url":"https://hartvaat.nl/mensen/marian-branny/","name":"Marian Branny","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/02/01/spironolacton-versus-renale-denervatie-bij-therapieresistente-hypertensie-prague/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marianela-barros","type":"person","url":"https://hartvaat.nl/mensen/marianela-barros/","name":"Marianela Barros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-t-baccara-dinet","type":"person","url":"https://hartvaat.nl/mensen/marie-t-baccara-dinet/","name":"Marie T Baccara-Dinet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2017/09/26/sams-ci-score-toegepast-op-gerandomiseerde-trial-over-statine-myopathie/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2016/10/14/geen-effect-van-pcsk9-remmer-alirocumab-op-diabetes-incidentie-odyssey-analyse/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marija-zdravkovic","type":"person","url":"https://hartvaat.nl/mensen/marija-zdravkovic/","name":"Marija Zdravkovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2021/04/01/cardio-microstroomdevice-bij-chronisch-hf-eerste-klinische-studie/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariko-harada-shiba","type":"person","url":"https://hartvaat.nl/mensen/mariko-harada-shiba/","name":"Mariko Harada-Shiba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/19/lipoproteine-aferese-blijft-relevant-in-het-tijdperk-van-pcsk9-remmers-en-sirna/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marissa-a-miller","type":"person","url":"https://hartvaat.nl/mensen/marissa-a-miller/","name":"Marissa A Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariusz-tomaniak","type":"person","url":"https://hartvaat.nl/mensen/mariusz-tomaniak/","name":"Mariusz Tomaniak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/24/invloed-van-coronaire-ziekte-patronen-op-klinische-uitkomsten-pullback-pressure-/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/11/01/aspirine-plus-ticagrelor-bij-acs-voordeel-risicoanalyse-van-global-leaders/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-d-huffman","type":"person","url":"https://hartvaat.nl/mensen/mark-d-huffman/","name":"Mark D Huffman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2019/03/01/ziekenhuisgebaseerde-kwaliteitsinterventies-bij-hartfalen-systematische-review/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/02/13/kwaliteitsverbeteringsinterventie-bij-acuut-mi-in-india-jama-acs-quik/","published":"2018-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-s-link","type":"person","url":"https://hartvaat.nl/mensen/mark-s-link/","name":"Mark S Link","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-w-parsons","type":"person","url":"https://hartvaat.nl/mensen/mark-w-parsons/","name":"Mark W Parsons","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-j-landray","type":"person","url":"https://hartvaat.nl/mensen/martin-j-landray/","name":"Martin J Landray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2019/07/01/kosteneffectiviteit-van-statines-en-ezetimibe-bij-chronische-nierziekte/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-j-swaans","type":"person","url":"https://hartvaat.nl/mensen/martin-j-swaans/","name":"Martin J Swaans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2021/12/07/gold-force-multi-elektrode-rf-versus-irrigated-rf-bij-af-gerandomiseerde-trial/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/12/01/mitraclip-plus-medicamenteus-versus-medicamenteus-alleen-bij-hf-met-mr-meta-anal/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masahiro-natsuaki","type":"person","url":"https://hartvaat.nl/mensen/masahiro-natsuaki/","name":"Masahiro Natsuaki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massar-omar","type":"person","url":"https://hartvaat.nl/mensen/massar-omar/","name":"Massar Omar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/09/01/dapagliflozine-en-rv-pulmonale-interactie-bij-hfpef/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/09/05/cameo-dapa-cardiale-en-metabole-effecten-van-dapagliflozine-bij-hfpef/","published":"2023-09-05"},{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massimo-f-piepoli","type":"person","url":"https://hartvaat.nl/mensen/massimo-f-piepoli/","name":"Massimo F Piepoli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matias-nordaby","type":"person","url":"https://hartvaat.nl/mensen/matias-nordaby/","name":"Matias Nordaby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2019/06/01/heparinedosering-bij-ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-re/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/05/14/dabigatran-duale-therapie-met-ticagrelor-of-clopidogrel-na-pci-bij-af-re-dual-pc/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2017/10/19/dubbele-antitrombotische-therapie-met-dabigatran-na-pci-bij-af-nejm-re-dual-pci/","published":"2017-10-19"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-bertini","type":"person","url":"https://hartvaat.nl/mensen/matteo-bertini/","name":"Matteo Bertini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/02/25/alcoholgebruik-en-het-ontstaan-van-atriumfibrilleren-dosis-risico-en-dogma-herov/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2024/08/03/device-algoritmen-voor-rv-pacingminimalisatie-meta-analyse-van-uitkomsten/","published":"2024-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-ginks","type":"person","url":"https://hartvaat.nl/mensen/matthew-ginks/","name":"Matthew Ginks","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2018/01/01/endocardiale-linkerkamer-pacing-voor-crt-systematische-review-en-meta-analyse/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-m-y-lee","type":"person","url":"https://hartvaat.nl/mensen/matthew-m-y-lee/","name":"Matthew M Y Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/06/25/raas-blokkade-bij-hartfalen-voordeel-onafhankelijk-van-etniciteit-jama-meta-anal/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/05/15/implanteerbare-hemodynamische-monitoring-bij-hartfalen-meta-analyse-over-ef-spec/","published":"2023-05-15"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mattias-duytschaever","type":"person","url":"https://hartvaat.nl/mensen/mattias-duytschaever/","name":"Mattias Duytschaever","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/03/varipure-studie-pulsed-field-ablatie-in-de-dagelijkse-af-praktijk/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2019/08/01/eenvoudige-techniek-voor-pvi-van-linker-longvenen-gerandomiseerde-studie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/04/21/pvi-met-versus-zonder-antiaritmica-bij-recidiverend-af-powder-af/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mauricio-g-cohen","type":"person","url":"https://hartvaat.nl/mensen/mauricio-g-cohen/","name":"Mauricio G Cohen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/10/25/2022-acc-aha-datadefinities-voor-pijn-op-de-borst-en-acuut-myocardinfarct/","published":"2022-10-25"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurizio-menichelli","type":"person","url":"https://hartvaat.nl/mensen/maurizio-menichelli/","name":"Maurizio Menichelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mauro-biffi","type":"person","url":"https://hartvaat.nl/mensen/mauro-biffi/","name":"Mauro Biffi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/30/leadless-atriaal-pacen-geeft-minder-complicaties-dan-transveneus-1-jaars-medicar/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2026/03/30/crt-zonder-atriale-lead-tweeledig-crt-dx-systeem-non-inferieur-aan-klassieke-dri/","published":"2026-04-25"},{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mauro-chiarito","type":"person","url":"https://hartvaat.nl/mensen/mauro-chiarito/","name":"Mauro Chiarito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maximilian-von-eynatten","type":"person","url":"https://hartvaat.nl/mensen/maximilian-von-eynatten/","name":"Maximilian von Eynatten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/08/01/empagliflozine-voorkomt-progressie-van-ckd-empa-reg-outcome-renale-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"magorzata-lelonek","type":"person","url":"https://hartvaat.nl/mensen/magorzata-lelonek/","name":"Małgorzata Lelonek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-argenziano","type":"person","url":"https://hartvaat.nl/mensen/michael-argenziano/","name":"Michael Argenziano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-fu","type":"person","url":"https://hartvaat.nl/mensen/michael-fu/","name":"Michael Fu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-g-palazzolo","type":"person","url":"https://hartvaat.nl/mensen/michael-g-palazzolo/","name":"Michael G Palazzolo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/08/12/combine-af-overstap-naar-nieuwer-anticoagulans-versus-warfarine-bij-ouderen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/19/combine-af-noac-s-versus-warfarine-over-bmi-spectrum-bij-af/","published":"2024-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-glikson","type":"person","url":"https://hartvaat.nl/mensen/michael-glikson/","name":"Michael Glikson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2022/05/03/radiale-strain-geleide-leadplaatsing-voor-crt-bij-ischemisch-hf/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-h-davidson","type":"person","url":"https://hartvaat.nl/mensen/michael-h-davidson/","name":"Michael H Davidson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2016/12/13/alirocumab-en-reductie-in-atherogene-lipiden-en-cardiovasculaire-events-10-odyss/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-bloch","type":"person","url":"https://hartvaat.nl/mensen/michael-j-bloch/","name":"Michael J Bloch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-pencina","type":"person","url":"https://hartvaat.nl/mensen/michael-j-pencina/","name":"Michael J Pencina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/01/prevent-risicoscore-presteert-robuust-in-de-dagelijkse-ehr-praktijk/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-rinaldi","type":"person","url":"https://hartvaat.nl/mensen/michael-j-rinaldi/","name":"Michael J Rinaldi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-wong","type":"person","url":"https://hartvaat.nl/mensen/michael-wong/","name":"Michael Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michiel-l-bots","type":"person","url":"https://hartvaat.nl/mensen/michiel-l-bots/","name":"Michiel L Bots","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/10/01/smartphone-app-thuisbloeddrukmeting-versus-kantoor-en-ambulante-meting/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/01/01/plasmatrogconcentraties-van-antihypertensiva-voor-therapietrouwbeoordeling-meta-/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/04/01/medicatietrouw-en-het-effect-van-renale-denervatie-de-sympathy-trial/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mihai-gheorghiade","type":"person","url":"https://hartvaat.nl/mensen/mihai-gheorghiade/","name":"Mihai Gheorghiade","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"},{"url":"https://hartvaat.nl/2017/11/01/raas-blokkade-bij-hfpef-systematische-review-en-meta-analyse/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/02/07/doodsoorzaken-bij-hartfalen-met-behouden-ejectiefractie/","published":"2017-02-07"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mika-laine","type":"person","url":"https://hartvaat.nl/mensen/mika-laine/","name":"Mika Laine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/08/01/baroreflexactivatietherapie-bij-resistente-hypertensie-sham-gecontroleerde-pilot/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mingming-yang","type":"person","url":"https://hartvaat.nl/mensen/mingming-yang/","name":"Mingming Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2023/08/14/cva-bij-hartfalen-met-gereduceerde-versus-behouden-ejectiefractie/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mirjam-kessler","type":"person","url":"https://hartvaat.nl/mensen/mirjam-kessler/","name":"Mirjam Kessler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohamed-abdel-wahab","type":"person","url":"https://hartvaat.nl/mensen/mohamed-abdel-wahab/","name":"Mohamed Abdel-Wahab","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monika-diek","type":"person","url":"https://hartvaat.nl/mensen/monika-diek/","name":"Monika Diek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/10/05/iv-ferricarboxymaltose-en-inspanningscapaciteit-bij-hfpef-met-ijzerdeficientie/","published":"2024-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"muhammad-shariq-usman","type":"person","url":"https://hartvaat.nl/mensen/muhammad-shariq-usman/","name":"Muhammad Shariq Usman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/09/26/geblindeerde-stopstudie-voordelen-empagliflozine-verdwijnen-na-staken-bij-hf/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2022/04/01/robuustheid-van-sglt2-remmer-hf-trials-evaluatie/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2020/12/01/sglt2-remmers-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/12/01/ijzercarboxymaltose-bij-ijzerdeficient-hartfalen-meta-analyse/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marten-rosenqvist","type":"person","url":"https://hartvaat.nl/mensen/marten-rosenqvist/","name":"Mårten Rosenqvist","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/03/nt-probnp-en-ecg-screening-bij-75-jarigen-voor-af-detectie-rct/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/01/14/strokestop-af-screening-is-kosteneffectief-bij-75-76-jarigen/","published":"2023-01-14"},{"url":"https://hartvaat.nl/2021/10/23/systematische-af-screening-en-klinische-uitkomsten-lancet-strokestop/","published":"2021-10-23"},{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/02/01/stapsgewijze-massascreening-op-af-met-nt-probnp-strokestop-ii-studieontwerp/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nassir-f-marrouche","type":"person","url":"https://hartvaat.nl/mensen/nassir-f-marrouche/","name":"Nassir F Marrouche","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/05/02/decaaf-ii-af-last-en-symptoomreductie-na-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/08/02/decaaf-ii-fibroselocatie-beinvloedt-af-recidief-na-ablatie/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2018/02/01/katheterablatie-bij-af-met-hartfalen-nejm-castle-af/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natalia-pinilla-echeverri","type":"person","url":"https://hartvaat.nl/mensen/natalia-pinilla-echeverri/","name":"Natalia Pinilla-Echeverri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natalie-staplin","type":"person","url":"https://hartvaat.nl/mensen/natalie-staplin/","name":"Natalie Staplin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neal-o-jeffries","type":"person","url":"https://hartvaat.nl/mensen/neal-o-jeffries/","name":"Neal O Jeffries","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neha-j-pagidipati","type":"person","url":"https://hartvaat.nl/mensen/neha-j-pagidipati/","name":"Neha J Pagidipati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-o-leary","type":"person","url":"https://hartvaat.nl/mensen/neil-o-leary/","name":"Neil O'Leary","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/10/28/pci-versus-cabg-bij-drievatslijden-met-proximale-lad-betrokkenheid/","published":"2022-10-28"},{"url":"https://hartvaat.nl/2022/03/31/enkele-of-meervoudige-arteriele-cabg-versus-pci-bij-drievaten-hoofdstam-meta-ana/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/06/08/10-jaarsfollow-up-na-revascularisatie-bij-oudere-patienten-met-complex-coronairl/","published":"2021-06-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nian-liu","type":"person","url":"https://hartvaat.nl/mensen/nian-liu/","name":"Nian Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-amabile","type":"person","url":"https://hartvaat.nl/mensen/nicolas-amabile/","name":"Nicolas Amabile","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/07/01/calcified-oct-versus-angiografie-bij-pci-van-verkalkte-laesies/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-noiseux","type":"person","url":"https://hartvaat.nl/mensen/nicolas-noiseux/","name":"Nicolas Noiseux","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicoletta-de-cesare","type":"person","url":"https://hartvaat.nl/mensen/nicoletta-de-cesare/","name":"Nicoletta de Cesare","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nieves-gonzalo","type":"person","url":"https://hartvaat.nl/mensen/nieves-gonzalo/","name":"Nieves Gonzalo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2017/01/15/linker-hartoorsluiting-versus-medicamenteuze-behandeling-bij-af-netwerkmeta-anal/","published":"2017-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niklas-dyrby-johansen","type":"person","url":"https://hartvaat.nl/mensen/niklas-dyrby-johansen/","name":"Niklas Dyrby Johansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/hoge-dosis-griepvaccinatie-bij-atherosclerotisch-vaatlijden-flunity-hd-analyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/10/hoog-gedoseerd-griepvaccin-vermindert-cardiovasculaire-events-bij-ouderen/","published":"2025-11-10"},{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikola-kozhuharov","type":"person","url":"https://hartvaat.nl/mensen/nikola-kozhuharov/","name":"Nikola Kozhuharov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikos-werner","type":"person","url":"https://hartvaat.nl/mensen/nikos-werner/","name":"Nikos Werner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nilesh-j-samani","type":"person","url":"https://hartvaat.nl/mensen/nilesh-j-samani/","name":"Nilesh J Samani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/09/01/metformin-verlaagt-risico-op-buikaorta-aneurysma-mr-en-cohortanalyse/","published":"2026-08-20"},{"url":"https://hartvaat.nl/2026/02/05/de-erfelijke-basis-van-coronairlijden-nejm-overzicht/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2018/12/01/dagelijkse-remote-ischemische-conditionering-na-acuut-mi-gerandomiseerde-trial/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuhisa-hagiwara","type":"person","url":"https://hartvaat.nl/mensen/nobuhisa-hagiwara/","name":"Nobuhisa Hagiwara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2017/08/01/ldl-cholesterol-streefwaarden-met-pitavastatine-ezetimibe-bij-acs-met-dyslipidem/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"norbert-frey","type":"person","url":"https://hartvaat.nl/mensen/norbert-frey/","name":"Norbert Frey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/19/tirzepatide-bij-hfpef-obesitas-niet-kosteneffectief-en-niet-betaalbaar-tegen-hui/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/02/03/neuromusculaire-elektrostimulatie-bij-ernstig-hartfalen-functionele-verbetering/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-salinas","type":"person","url":"https://hartvaat.nl/mensen/pablo-salinas/","name":"Pablo Salinas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2017/01/15/linker-hartoorsluiting-versus-medicamenteuze-behandeling-bij-af-netwerkmeta-anal/","published":"2017-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"panagiotis-theofilis","type":"person","url":"https://hartvaat.nl/mensen/panagiotis-theofilis/","name":"Panagiotis Theofilis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/08/15/injecteerbare-lipidendalers-bij-gevorderde-chronische-nierziekte-en-dialyse-narr/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2026/05/06/circulerend-mir-10b-5p-voorspelt-af-recidief-na-ablatie/","published":"2026-05-06"},{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/af-ablatie-timing-naar-af-duur-impact-op-aritmierecidief/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pankaj-puar","type":"person","url":"https://hartvaat.nl/mensen/pankaj-puar/","name":"Pankaj Puar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2021/12/01/sglt2-remmers-en-cardiale-remodellering-meta-analyse-van-mri-trials/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-canova","type":"person","url":"https://hartvaat.nl/mensen/paolo-canova/","name":"Paolo Canova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patricia-o-guimaraes","type":"person","url":"https://hartvaat.nl/mensen/patricia-o-guimaraes/","name":"Patricia O Guimarães","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/17/answer-hf-sacubitril-valsartan-versus-enalapril-bij-chagas-hf-primaire-resultate/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-badertscher","type":"person","url":"https://hartvaat.nl/mensen/patrick-badertscher/","name":"Patrick Badertscher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2023/11/02/duurzaamheid-van-pvi-bij-af-meta-analyse/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-schloemer","type":"person","url":"https://hartvaat.nl/mensen/patrick-schloemer/","name":"Patrick Schloemer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-nieruitkomsten-bij-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2021/02/09/finerenon-en-cardiovasculaire-uitkomsten-bij-ckd-met-diabetes-type-2-fidelio-dkd/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-guedeney","type":"person","url":"https://hartvaat.nl/mensen/paul-guedeney/","name":"Paul Guedeney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-khairy","type":"person","url":"https://hartvaat.nl/mensen/paul-khairy/","name":"Paul Khairy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2023/05/30/complicaties-van-af-ablatie-actueel-overzicht/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-w-x-foley","type":"person","url":"https://hartvaat.nl/mensen/paul-w-x-foley/","name":"Paul W X Foley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pavel-cervinka","type":"person","url":"https://hartvaat.nl/mensen/pavel-cervinka/","name":"Pavel Cervinka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peep-laanmets","type":"person","url":"https://hartvaat.nl/mensen/peep-laanmets/","name":"Peep Laanmets","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-haworth","type":"person","url":"https://hartvaat.nl/mensen/peter-haworth/","name":"Peter Haworth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/27/orbita-2-leeftijd-en-pci-effectiviteit-bij-stabiel-coronairlijden/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-m-van-de-ven","type":"person","url":"https://hartvaat.nl/mensen/peter-m-van-de-ven/","name":"Peter M van de Ven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/01/23/switchen-van-vka-naar-noac-bij-fragiele-ouderen-met-af-veilig/","published":"2024-01-23"},{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-w-f-wilson","type":"person","url":"https://hartvaat.nl/mensen/peter-w-f-wilson/","name":"Peter W F Wilson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/25/glp-1-agonisten-en-gezonde-leefstijl-samen-sterker-tegen-hart-en-vaatziekten/","published":"2026-03-08"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2019/06/25/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn-jacc/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/12/01/cardiovasculaire-risicocommunicatie-en-patientperceptie-jama-cardiology/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-ostadal","type":"person","url":"https://hartvaat.nl/mensen/petr-ostadal/","name":"Petr Ostadal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/02/07/ecmo-cs-ecmo-bij-cardiogene-shock-verbetert-overleving-niet/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-peichl","type":"person","url":"https://hartvaat.nl/mensen/petr-peichl/","name":"Petr Peichl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2025/10/07/cti-blok-na-pfa-versus-rf-cryo-ablatie-gerandomiseerde-vergelijking/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2018/07/01/echogeleide-versus-conventionele-femorale-venepunctie-bij-af-ablatie-gerandomise/","published":"2018-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-g-jones","type":"person","url":"https://hartvaat.nl/mensen/philip-g-jones/","name":"Philip G Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/27/vroege-versus-late-gestageerde-pci-na-subintimale-re-entry-bij-cto/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/01/01/kccq-interpretatie-bij-hartfalen-patient-ankering/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2020/04/23/gezondheidsstatus-na-invasieve-of-conservatieve-zorg-bij-coronairlijden-met-gevo/","published":"2020-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-roberts-thomson","type":"person","url":"https://hartvaat.nl/mensen/philip-roberts-thomson/","name":"Philip Roberts-Thomson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/06/01/bloeddrukverlaging-bij-centrale-hypertensie-gerandomiseerde-trial/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philipp-lauten","type":"person","url":"https://hartvaat.nl/mensen/philipp-lauten/","name":"Philipp Lauten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-garot","type":"person","url":"https://hartvaat.nl/mensen/philippe-garot/","name":"Philippe Garot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/22/lge-granulariteit-op-cmr-voorspelt-sterfte-bij-eindstadium-hypertrofische-cardio/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2023/10/31/antitrombotische-therapie-na-laa-occlusie-netwerk-meta-analyse/","published":"2023-10-31"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-l-l-allier","type":"person","url":"https://hartvaat.nl/mensen/philippe-l-l-allier/","name":"Philippe L L'Allier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2016/10/18/canakinumab-en-arteriele-effecten-bij-atherosclerose-met-diabetes-of-glucosetole/","published":"2016-10-18"},{"url":"https://hartvaat.nl/2016/01/26/p-selectine-antagonist-inclacumab-bij-coronaire-bypasschirurgie-select-cabg-tria/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-mabo","type":"person","url":"https://hartvaat.nl/mensen/philippe-mabo/","name":"Philippe Mabo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2022/02/02/remote-monitoring-en-klinische-uitkomsten-bij-europese-hf-met-icd-langetermijn/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2019/09/01/remote-monitoring-en-patientgerapporteerde-uitkomsten-bij-europese-hf-patienten-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-pibarot","type":"person","url":"https://hartvaat.nl/mensen/philippe-pibarot/","name":"Philippe Pibarot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2020/10/01/natuurlijk-beloop-van-asymptomatische-ernstige-aortastenose-jama-cardiology-meta/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pil-hyung-lee","type":"person","url":"https://hartvaat.nl/mensen/pil-hyung-lee/","name":"Pil Hyung Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pilar-jimenez-quevedo","type":"person","url":"https://hartvaat.nl/mensen/pilar-jimenez-quevedo/","name":"Pilar Jiménez-Quevedo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2017/01/15/linker-hartoorsluiting-versus-medicamenteuze-behandeling-bij-af-netwerkmeta-anal/","published":"2017-01-15"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pranas-serpytis","type":"person","url":"https://hartvaat.nl/mensen/pranas-serpytis/","name":"Pranas Serpytis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prateeti-khazanie","type":"person","url":"https://hartvaat.nl/mensen/prateeti-khazanie/","name":"Prateeti Khazanie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/23/nierbescherming-na-harttransplantatie-risicoreductie-en-therapeutische-mogelijkh/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-ganesan-karthikeyan","type":"person","url":"https://hartvaat.nl/mensen/prof-ganesan-karthikeyan/","name":"Prof. Ganesan Karthikeyan","title":"Centre for Chronic Disease Control, India","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/10/dig-rhd-digoxine-verlaagt-sterfte-en-hartfalen-bij-symptomatische-reumatische-ha/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"}],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/dig-rhd-digoxine-reumatische-hartziekte/","title":"Dig-RHD: Digoxine bij reumatische hartziekte"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pal-aukrust","type":"person","url":"https://hartvaat.nl/mensen/pal-aukrust/","name":"Pål Aukrust","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2018/12/01/pro-gastrin-releasing-peptide-en-uitkomsten-bij-hf-met-anemie-red-hf/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/06/01/complementactivatie-bij-acuut-hartfalen-na-mi-correlatie-met-ernst/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiang-zhao","type":"person","url":"https://hartvaat.nl/mensen/qiang-zhao/","name":"Qiang Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qing-zhang","type":"person","url":"https://hartvaat.nl/mensen/qing-zhang/","name":"Qing Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/25/explorer-cn-week-78-langetermijneffect-en-veiligheid-van-mavacamten-bij-chinese-/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/01/31/wereldwijde-ziektelast-van-chronische-nierziekte-bij-kinderen-en-adolescenten/","published":"2026-01-31"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2019/02/01/sms-na-ontslag-verbetert-kortetermijnuitkomsten-en-zelfzorg-bij-chronisch-hf/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2016/04/01/katheterablatie-bij-atriumfibrilleren-met-hypertrofische-cardiomyopathie-meta-an/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raban-v-jeger","type":"person","url":"https://hartvaat.nl/mensen/raban-v-jeger/","name":"Raban V Jeger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/03/10/overleving-na-revascularisatie-met-paclitaxel-gecoate-ballonnen/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rainer-hambrecht","type":"person","url":"https://hartvaat.nl/mensen/rainer-hambrecht/","name":"Rainer Hambrecht","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raj-verma","type":"person","url":"https://hartvaat.nl/mensen/raj-verma/","name":"Raj Verma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2021/12/01/sglt2-remmers-en-cardiale-remodellering-meta-analyse-van-mri-trials/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajibul-mian","type":"person","url":"https://hartvaat.nl/mensen/rajibul-mian/","name":"Rajibul Mian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralf-e-harskamp","type":"person","url":"https://hartvaat.nl/mensen/ralf-e-harskamp/","name":"Ralf E Harskamp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/02/08/antitrombotische-therapie-bij-af-na-acs-of-pci-jacc-overzicht/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/05/01/predictiemodellen-voor-af-in-de-community-meta-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/01/frequente-premature-atriale-contracties-en-af-hersenischemie-en-mortaliteit-meta/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramesh-nadarajah","type":"person","url":"https://hartvaat.nl/mensen/ramesh-nadarajah/","name":"Ramesh Nadarajah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2026/03/25/meta-analyse-glp-1-agonisten-voorkomen-hartfalen-in-type-2-diabetes-sterkste-eff/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/06/10/voorspelling-van-atriumfibrilleren-in-elektronische-gezondheidsdossiers-systemat/","published":"2022-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reinhold-kreutz","type":"person","url":"https://hartvaat.nl/mensen/reinhold-kreutz/","name":"Reinhold Kreutz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/27/consensus-breid-het-cardio-renaal-metabool-syndroom-uit-met-de-lever-cklms-in-de/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2025/08/01/ctrh-als-biomarker-voor-medicijneffectiviteit-real-world-bewijs/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2022/09/20/harmonisatie-van-acc-aha-en-esc-esh-bloeddrukrichtlijnen/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/01/ramipril-bij-hypertensieve-kinderen-op-hemodialyse-search-trial/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/05/05/veroorzaken-betablokkers-depressie-systematische-review-en-meta-analyse/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reza-jabbari","type":"person","url":"https://hartvaat.nl/mensen/reza-jabbari/","name":"Reza Jabbari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/07/31/uit-het-hospitaal-hartstilstand-komt-12-keer-vaker-voor-bij-niet-ischemische-car/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2026/02/03/coronaire-vaatspasmen-bij-overlevenden-van-hartstilstand/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ricardo-rocha","type":"person","url":"https://hartvaat.nl/mensen/ricardo-rocha/","name":"Ricardo Rocha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/09/01/arni-naar-hf-voorgeschiedenis-en-raas-antagonistgebruik/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2020/02/01/arni-initiatie-na-acuut-gedecompenseerd-hf-pioneer-hf-open-label-extensie/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/07/angiotensine-neprilysineremming-bij-acuut-gedecompenseerd-hf-nejm-pioneer-hf/","published":"2019-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-rokyta","type":"person","url":"https://hartvaat.nl/mensen/richard-rokyta/","name":"Richard Rokyta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2023/02/07/ecmo-cs-ecmo-bij-cardiogene-shock-verbetert-overleving-niet/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-s-geary","type":"person","url":"https://hartvaat.nl/mensen/richard-s-geary/","name":"Richard S Geary","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2019/09/01/galnac-geconjugeerd-antisense-tegen-apoc3-triglyceriden-en-atherogene-lipoprotei/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2017/07/20/angptl3-antisense-oligonucleotiden-cardiovasculaire-en-metabole-effecten-nejm/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-d-anderson","type":"person","url":"https://hartvaat.nl/mensen/robert-d-anderson/","name":"Robert D Anderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2016/06/11/ixmyelocel-t-bij-ischemisch-hartfalen-lancet-dubbelblinde-gerandomiseerde-trial/","published":"2016-06-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-m-carey","type":"person","url":"https://hartvaat.nl/mensen/robert-m-carey/","name":"Robert M Carey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/09/20/harmonisatie-van-acc-aha-en-esc-esh-bloeddrukrichtlijnen/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2018/11/01/therapieresistente-hypertensie-aha-scientific-statement-over-detectie-evaluatie-/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/04/01/2017-acc-aha-richtlijn-voor-hoge-bloeddruk-bij-volwassenen-jama-cardiology-overz/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-diletti","type":"person","url":"https://hartvaat.nl/mensen/roberto-diletti/","name":"Roberto Diletti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robin-nijveldt","type":"person","url":"https://hartvaat.nl/mensen/robin-nijveldt/","name":"Robin Nijveldt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rodney-h-stables","type":"person","url":"https://hartvaat.nl/mensen/rodney-h-stables/","name":"Rodney H Stables","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rodney-p-horton","type":"person","url":"https://hartvaat.nl/mensen/rodney-p-horton/","name":"Rodney P Horton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/04/02/amaze-pvi-met-of-zonder-laa-ligatie-bij-af-jama-rct/","published":"2024-04-02"},{"url":"https://hartvaat.nl/2017/12/19/5-jaarsuitkomsten-na-linker-hartoorsluiting-prevail-en-protect-af/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ron-j-g-peters","type":"person","url":"https://hartvaat.nl/mensen/ron-j-g-peters/","name":"Ron J G Peters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2018/12/01/creatininestijging-tijdens-bloeddrukbehandeling-en-uitkomsten-bij-diabetes-type-/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ross-t-campbell","type":"person","url":"https://hartvaat.nl/mensen/ross-t-campbell/","name":"Ross T Campbell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2018/10/01/associatie-is-geen-causaliteit-behandeleffecten-bij-hartfalen-en-observationele-/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ross-t-tsuyuki","type":"person","url":"https://hartvaat.nl/mensen/ross-t-tsuyuki/","name":"Ross T Tsuyuki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2021/10/01/apothekerzorg-bij-poliklinisch-hf-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2016/06/21/apothekerinterventies-en-cardiovasculair-risico-de-multicenter-rxeach-trial/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/03/22/zelfmanagementinterventies-bij-hartfalen-individuele-patientdata-meta-analyse/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruth-peters","type":"person","url":"https://hartvaat.nl/mensen/ruth-peters/","name":"Ruth Peters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2018/09/01/orthostatische-hypotensie-verhoogt-risico-op-cognitieve-stoornissen/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samer-al-said","type":"person","url":"https://hartvaat.nl/mensen/samer-al-said/","name":"Samer Al Said","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/24/systemische-embolieen-bij-af-ipd-mega-meta-analyse-van-71-683-patienten/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/01/30/systemische-embolische-events-bij-boezemfibrilleren-een-meta-analyse-op-patientn/","published":"2026-01-30"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandrine-stepien","type":"person","url":"https://hartvaat.nl/mensen/sandrine-stepien/","name":"Sandrine Stepien","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-min-kim","type":"person","url":"https://hartvaat.nl/mensen/sang-min-kim/","name":"Sang Min Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-hyup-lee","type":"person","url":"https://hartvaat.nl/mensen/sang-hyup-lee/","name":"Sang-Hyup Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanobar-parkar","type":"person","url":"https://hartvaat.nl/mensen/sanobar-parkar/","name":"Sanobar Parkar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satoshi-yasuda","type":"person","url":"https://hartvaat.nl/mensen/satoshi-yasuda/","name":"Satoshi Yasuda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/01/30/edoxaban-versus-warfarine-bij-chronische-trombo-embolische-pulmonale-hypertensie/","published":"2024-01-30"},{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saurabh-kumar","type":"person","url":"https://hartvaat.nl/mensen/saurabh-kumar/","name":"Saurabh Kumar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2021/07/18/procedurevolume-en-complicaties-bij-af-ablatie-meta-analyse/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2019/02/01/contact-force-sensing-en-veiligheid-werkzaamheid-van-af-ablatie-geactualiseerde-/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-l-hummel","type":"person","url":"https://hartvaat.nl/mensen/scott-l-hummel/","name":"Scott L Hummel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-m-grundy","type":"person","url":"https://hartvaat.nl/mensen/scott-m-grundy/","name":"Scott M Grundy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2016/09/27/ldl-c-verlaging-en-cardiovasculaire-risicoreductie-jama-systematische-review-en-/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seokhun-yang","type":"person","url":"https://hartvaat.nl/mensen/seokhun-yang/","name":"Seokhun Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergey-tereshchenko","type":"person","url":"https://hartvaat.nl/mensen/sergey-tereshchenko/","name":"Sergey Tereshchenko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-raposeiras-roubin","type":"person","url":"https://hartvaat.nl/mensen/sergio-raposeiras-roubin/","name":"Sergio Raposeiras-Roubín","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2026/01/20/es-bempedacs-triple-versus-duale-lipidenbehandeling-na-acs/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-hyuk-choi","type":"person","url":"https://hartvaat.nl/mensen/seung-hyuk-choi/","name":"Seung-Hyuk Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shachi-patel","type":"person","url":"https://hartvaat.nl/mensen/shachi-patel/","name":"Shachi Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shangyu-wen","type":"person","url":"https://hartvaat.nl/mensen/shangyu-wen/","name":"Shangyu Wen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shingo-matsumoto","type":"person","url":"https://hartvaat.nl/mensen/shingo-matsumoto/","name":"Shingo Matsumoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/07/01/finearts-hf-finerenon-en-atriumfibrilleren-bij-hartfalen/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-kalium-en-klinische-uitkomsten-bij-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/29/asymptomatische-versus-symptomatische-hypotensie-bij-sacubitril-valsartan-en-hfr/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/06/18/mra-bij-hartfalen-met-nierfunctiestoornissen-veiligheid-en-effectiviteit/","published":"2024-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shuting-xia","type":"person","url":"https://hartvaat.nl/mensen/shuting-xia/","name":"Shuting Xia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2022/03/22/pelacarsen-op-lp-a-cholesterol-en-gecorrigeerd-ldl-cholesterol/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2020/01/16/lp-a-verlaging-bij-cardiovasculaire-ziekte-nejm/","published":"2020-01-16"},{"url":"https://hartvaat.nl/2019/09/01/galnac-geconjugeerd-antisense-tegen-apoc3-triglyceriden-en-atherogene-lipoprotei/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sidney-a-cohen","type":"person","url":"https://hartvaat.nl/mensen/sidney-a-cohen/","name":"Sidney A Cohen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sigrid-sandner","type":"person","url":"https://hartvaat.nl/mensen/sigrid-sandner/","name":"Sigrid Sandner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/13/aha-scientific-statement-2026-secundaire-preventie-na-coronaire-bypassoperatie-e/","published":"2026-05-15"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stacey-l-schott","type":"person","url":"https://hartvaat.nl/mensen/stacey-l-schott/","name":"Stacey L Schott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steen-husted","type":"person","url":"https://hartvaat.nl/mensen/steen-husted/","name":"Steen Husted","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steen-z-abildstrm","type":"person","url":"https://hartvaat.nl/mensen/steen-z-abildstrm/","name":"Steen Z Abildstrøm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-agewall","type":"person","url":"https://hartvaat.nl/mensen/stefan-agewall/","name":"Stefan Agewall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-toggweiler","type":"person","url":"https://hartvaat.nl/mensen/stefan-toggweiler/","name":"Stefan Toggweiler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/21/1-op-10-patienten-heroptname-binnen-30-dagen-na-tavi-sterfterisico-na-1-jaar-ver/","published":"2026-06-09"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephane-fournier","type":"person","url":"https://hartvaat.nl/mensen/stephane-fournier/","name":"Stephane Fournier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/10/16/hoge-coronaire-shear-stress-voorspelt-myocardinfarct/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephanie-brunner","type":"person","url":"https://hartvaat.nl/mensen/stephanie-brunner/","name":"Stephanie Brunner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/21/1-op-10-patienten-heroptname-binnen-30-dagen-na-tavi-sterfterisico-na-1-jaar-ver/","published":"2026-06-09"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-quinn","type":"person","url":"https://hartvaat.nl/mensen/stephen-quinn/","name":"Stephen Quinn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steve-e-humphries","type":"person","url":"https://hartvaat.nl/mensen/steve-e-humphries/","name":"Steve E Humphries","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/08/01/verhoogde-lp-a-komt-vaker-voor-bij-kinderen-met-familiaire-hypercholesterolemie-/","published":"2026-08-02"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-j-keteyian","type":"person","url":"https://hartvaat.nl/mensen/steven-j-keteyian/","name":"Steven J Keteyian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/01/heart-camp-connect-beweegadherentie-bij-hfpef-patienten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2017/04/04/inspanningstraining-bij-chronisch-hartfalen-met-atriumfibrilleren/","published":"2017-04-04"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-m-hollenberg","type":"person","url":"https://hartvaat.nl/mensen/steven-m-hollenberg/","name":"Steven M Hollenberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stuart-watkins","type":"person","url":"https://hartvaat.nl/mensen/stuart-watkins/","name":"Stuart Watkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"svend-aakhus","type":"person","url":"https://hartvaat.nl/mensen/svend-aakhus/","name":"Svend Aakhus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"},{"url":"https://hartvaat.nl/2016/03/12/invasieve-versus-conservatieve-strategie-bij-80-plussers-met-nstemi-gerandomisee/","published":"2016-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sverre-e-kjeldsen","type":"person","url":"https://hartvaat.nl/mensen/sverre-e-kjeldsen/","name":"Sverre E Kjeldsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2024/07/01/value-trial-cv-uitkomsten-bij-hypertensie-met-perifeer-vaatlijden/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2020/06/01/arb-versus-calciumantagonist-bloeddrukprofiel-en-klinische-effecten-vergelijking/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2016/03/21/cardiovasculaire-uitkomsten-bij-verschillende-bereiktestreefdrukken-in-de-value-/","published":"2016-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tatsuhiko-otsuka","type":"person","url":"https://hartvaat.nl/mensen/tatsuhiko-otsuka/","name":"Tatsuhiko Otsuka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-idorn","type":"person","url":"https://hartvaat.nl/mensen/thomas-idorn/","name":"Thomas Idorn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2019/12/01/eerste-en-recidiverende-cv-events-met-liraglutide-bij-diabetes-type-2-leader/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-bij-diabetes-type-2-met-ckd-leader-renale-analyse/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-viethen","type":"person","url":"https://hartvaat.nl/mensen/thomas-viethen/","name":"Thomas Viethen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2019/06/04/neladenoson-bialanaat-en-inspanningscapaciteit-bij-hfpef-jama-panache/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2017/04/01/oscillerende-whole-body-vibratie-verbetert-inspanningscapaciteit-bij-pah/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thor-ueland","type":"person","url":"https://hartvaat.nl/mensen/thor-ueland/","name":"Thor Ueland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2018/12/01/pro-gastrin-releasing-peptide-en-uitkomsten-bij-hf-met-anemie-red-hf/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-s-nawrot","type":"person","url":"https://hartvaat.nl/mensen/tim-s-nawrot/","name":"Tim S Nawrot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-usherwood","type":"person","url":"https://hartvaat.nl/mensen/tim-usherwood/","name":"Tim Usherwood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tiziano-moccetti","type":"person","url":"https://hartvaat.nl/mensen/tiziano-moccetti/","name":"Tiziano Moccetti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2020/05/26/subcutaan-selatogrel-remt-plaatjesaggregatie-bij-acuut-mi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobias-graf","type":"person","url":"https://hartvaat.nl/mensen/tobias-graf/","name":"Tobias Graf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomas-jernberg","type":"person","url":"https://hartvaat.nl/mensen/tomas-jernberg/","name":"Tomas Jernberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomasz-j-guzik","type":"person","url":"https://hartvaat.nl/mensen/tomasz-j-guzik/","name":"Tomasz J Guzik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/24/parodontale-behandeling-remt-progressie-van-atherosclerose/","published":"2026-04-01"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2020/02/01/il-1-remming-en-bloeddruk-hypertensie-en-residueel-inflammatoir-risico-cantos/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/11/01/causaal-verband-periodontitis-en-hypertensie-mendeliaanse-randomisatie-en-rct/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"torsten-doenst","type":"person","url":"https://hartvaat.nl/mensen/torsten-doenst/","name":"Torsten Doenst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toshiaki-ohkuma","type":"person","url":"https://hartvaat.nl/mensen/toshiaki-ohkuma/","name":"Toshiaki Ohkuma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/10/01/thuismonitoring-met-technologie-ondersteund-management-bij-chronisch-hf-gerandom/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/06/01/interarmbloeddrukverschil-en-beroerte-ipd-meta-analyse/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toshiki-kuno","type":"person","url":"https://hartvaat.nl/mensen/toshiki-kuno/","name":"Toshiki Kuno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/08/14/vereenvoudigd-crt-systeem-zonder-atriale-pacing-niet-slechter-dan-conventioneel-/","published":"2026-08-21"},{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2021/08/24/de-escalatie-van-dapt-bij-acs-jacc-review/","published":"2021-08-24"},{"url":"https://hartvaat.nl/2020/01/28/orale-antistolling-bij-af-op-langdurige-hemodialyse/","published":"2020-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toyoaki-murohara","type":"person","url":"https://hartvaat.nl/mensen/toyoaki-murohara/","name":"Toyoaki Murohara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2024/01/30/edoxaban-versus-warfarine-bij-chronische-trombo-embolische-pulmonale-hypertensie/","published":"2024-01-30"},{"url":"https://hartvaat.nl/2020/08/01/canagliflozine-bij-diabetes-type-2-met-chronisch-hf-candle-gerandomiseerde-trial/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/10/01/neuromusculaire-elektrische-stimulatie-bij-acuut-hartfalen-haalbaarheid/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/04/01/periprocedurele-antistolling-en-silent-stroke-na-af-ablatie/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tumaini-rucker-coker","type":"person","url":"https://hartvaat.nl/mensen/tumaini-rucker-coker/","name":"Tumaini Rucker Coker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tze-fan-chao","type":"person","url":"https://hartvaat.nl/mensen/tze-fan-chao/","name":"Tze-Fan Chao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2026/02/19/cardiovasculair-renaal-metabool-samenspel-bij-patienten-met-atriumfibrilleren/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/10/05/rivaroxaban-dosering-bij-af-on-label-versus-off-label-in-azie-en-niet-azie/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2019/05/14/edoxaban-bij-aziatische-af-patienten-concentraties-en-anti-xa-activiteit/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"udo-hoffmann","type":"person","url":"https://hartvaat.nl/mensen/udo-hoffmann/","name":"Udo Hoffmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/08/24/reprieve-pitavastatine-vermindert-cv-events-bij-hiv-nejm/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2017/11/21/coronair-calcium-en-prognostische-waarde-bij-pijn-op-de-borst-promise-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/08/02/omega-3-vetzuren-en-linkerkamerremodellering-na-acuut-mi-omega-remodel-trial/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrik-m-mogensen","type":"person","url":"https://hartvaat.nl/mensen/ulrik-m-mogensen/","name":"Ulrik M Mogensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2017/11/14/af-type-en-uitkomsten-bij-hfref/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"umjeet-jolly","type":"person","url":"https://hartvaat.nl/mensen/umjeet-jolly/","name":"Umjeet Jolly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ung-kim","type":"person","url":"https://hartvaat.nl/mensen/ung-kim/","name":"Ung Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanessa-debruin","type":"person","url":"https://hartvaat.nl/mensen/vanessa-debruin/","name":"Vanessa DeBruin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanja-vlajnic","type":"person","url":"https://hartvaat.nl/mensen/vanja-vlajnic/","name":"Vanja Vlajnic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2020/10/20/vericiguat-en-kwaliteit-van-leven-bij-hfpef-jama-vitality-hfpef/","published":"2020-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victoria-y-ding","type":"person","url":"https://hartvaat.nl/mensen/victoria-y-ding/","name":"Victoria Y Ding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vivekanand-jha","type":"person","url":"https://hartvaat.nl/mensen/vivekanand-jha/","name":"Vivekanand Jha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/18/groene-dialyse-duurzame-zorg-groei-en-innovatie-kdigo-conferentie/","published":"2026-02-18"},{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"volker-rudolph","type":"person","url":"https://hartvaat.nl/mensen/volker-rudolph/","name":"Volker Rudolph","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wendy-c-taddei-peters","type":"person","url":"https://hartvaat.nl/mensen/wendy-c-taddei-peters/","name":"Wendy C Taddei-Peters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilbert-s-aronow","type":"person","url":"https://hartvaat.nl/mensen/wilbert-s-aronow/","name":"Wilbert S Aronow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2020/03/01/gewicht-en-werkzaamheid-veiligheid-van-doac-s-bij-niet-valvulair-af-meta-analyse/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/09/01/oac-bij-af-met-kleplijden-en-bioprothese-overzicht/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2017/07/01/bioresorbeerbare-scaffold-versus-des-2-jaars-meta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilhelm-ridderstrale","type":"person","url":"https://hartvaat.nl/mensen/wilhelm-ridderstrale/","name":"Wilhelm Ridderstråle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"willem-j-m-dewilde","type":"person","url":"https://hartvaat.nl/mensen/willem-j-m-dewilde/","name":"Willem J M Dewilde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2018/03/13/doac-s-bij-af-met-ckd-systematische-review-werkzaamheid-en-veiligheid/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-d-toff","type":"person","url":"https://hartvaat.nl/mensen/william-d-toff/","name":"William D Toff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-j-sasiela","type":"person","url":"https://hartvaat.nl/mensen/william-j-sasiela/","name":"William J Sasiela","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-s-weintraub","type":"person","url":"https://hartvaat.nl/mensen/william-s-weintraub/","name":"William S Weintraub","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2021/04/27/2021-acc-aha-kerngegevenselementen-voor-hartfalen/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/04/30/leefstijl-hba1c-en-overleving-bij-stabiel-coronairlijden-met-diabetes/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wolfgang-c-winkelmayer","type":"person","url":"https://hartvaat.nl/mensen/wolfgang-c-winkelmayer/","name":"Wolfgang C Winkelmayer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/dialysaat-kalium-3-0-mmol-l-met-natriumzirconiumcyclosilicaat-bij-dialyse/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2016/08/01/cabg-versus-pci-en-risico-op-myocardinfarct-en-revascularisatie-bij-ckd-patiente/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/03/29/drug-eluting-versus-bare-metal-stents-bij-pci-patienten-met-eindstadium-nierziek/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"won-jang-kim","type":"person","url":"https://hartvaat.nl/mensen/won-jang-kim/","name":"Won-Jang Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yanqing-wu","type":"person","url":"https://hartvaat.nl/mensen/yanqing-wu/","name":"Yanqing Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/01/sophocarpine-beschermt-tegen-pulmonale-hypertensie-in-preklinische-modellen/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasushi-ueki","type":"person","url":"https://hartvaat.nl/mensen/yasushi-ueki/","name":"Yasushi Ueki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-liu","type":"person","url":"https://hartvaat.nl/mensen/yi-liu/","name":"Yi Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/01/01/varenicline-vermindert-ventriculaire-ectopie-na-myocardinfarct/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/01/effect-van-finerenon-op-de-nierfunctie-bij-diabetische-nefropathie-type-2/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yingxian-sun","type":"person","url":"https://hartvaat.nl/mensen/yingxian-sun/","name":"Yingxian Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/10/01/financiele-prikkels-verbeteren-hypertensiecontrole-chinese-rct/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yingying-sang","type":"person","url":"https://hartvaat.nl/mensen/yingying-sang/","name":"Yingying Sang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"},{"url":"https://hartvaat.nl/2016/02/04/risicoprojectie-voor-nierfalen-bij-levende-nierdonorkandidaten/","published":"2016-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yiwei-lai","type":"person","url":"https://hartvaat.nl/mensen/yiwei-lai/","name":"Yiwei Lai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yoshifumi-naka","type":"person","url":"https://hartvaat.nl/mensen/yoshifumi-naka/","name":"Yoshifumi Naka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yoshihiro-morino","type":"person","url":"https://hartvaat.nl/mensen/yoshihiro-morino/","name":"Yoshihiro Morino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2017/11/07/optische-frequentiedomeinbeeldvorming-versus-ivus-bij-pci-opinion-trial/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"youngkeun-ahn","type":"person","url":"https://hartvaat.nl/mensen/youngkeun-ahn/","name":"Youngkeun Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2018/07/24/escitalopram-versus-placebo-bij-depressie-na-acs-en-langetermijn-cardiale-uitkom/","published":"2018-07-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuhei-kobayashi","type":"person","url":"https://hartvaat.nl/mensen/yuhei-kobayashi/","name":"Yuhei Kobayashi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2016/04/12/prognostische-waarde-van-residuele-coronairstenosen-na-functioneel-complete-reva/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuichiro-yano","type":"person","url":"https://hartvaat.nl/mensen/yuichiro-yano/","name":"Yuichiro Yano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/02/01/reactie-op-kanttekeningen-bij-statistiek-van-orale-microbioomdiversiteit-en-mort/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2022/11/01/checkpoint-remmers-verhogen-korttermijnrisico-op-hypertensie-niet-meta-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2021/07/27/heeft-deze-volwassene-hypertensie-jama-rational-clinical-examination/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2017/02/01/bereikte-bloeddruk-en-cardiovasculaire-uitkomsten-bij-oudere-patienten-met-geiso/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yukio-ozaki","type":"person","url":"https://hartvaat.nl/mensen/yukio-ozaki/","name":"Yukio Ozaki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2022/09/27/verkorte-antiplaatjestherapie-na-stenting-bij-hoog-bloedingsrisico-en-acs/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/10/28/dapt-na-pci-bij-hoog-bloedingsrisico-nejm-master-dapt/","published":"2021-10-28"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zbigniew-kalarus","type":"person","url":"https://hartvaat.nl/mensen/zbigniew-kalarus/","name":"Zbigniew Kalarus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/05/01/remote-monitoring-vermindert-hospitalisaties-bij-icd-patienten-result-studie/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhao","type":"person","url":"https://hartvaat.nl/mensen/zhao/","name":"Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/04/10/proteomics-onthult-vier-subgroepen-van-acuut-hfpef-met-eigen-biologische-routes-/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/17/verhoogd-crp-voorspelt-hartfalen-bij-kankeroverlevenden-uk-biobank/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/04/24/astma-geassocieerd-met-verhoogd-risico-op-degeneratieve-hartklepziekte-uk-bioban/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/02/26/hiv-infectie-hangt-onafhankelijk-samen-met-meer-en-kwetsbaardere-halsslagaderpla/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2026/01/09/littekenweefsel-voorspelt-plotse-hartdood-na-een-infarct-grotendeels-buiten-de-e/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhifang-wang","type":"person","url":"https://hartvaat.nl/mensen/zhifang-wang/","name":"Zhifang Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zi-michael-miao","type":"person","url":"https://hartvaat.nl/mensen/zi-michael-miao/","name":"Zi Michael Miao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2025/01/14/finearts-hf-finerenon-met-en-zonder-sglt2-remmer-bij-hfpef/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zixuan-zhang","type":"person","url":"https://hartvaat.nl/mensen/zixuan-zhang/","name":"Zixuan Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2026/12/01/cardiometabole-index-en-sarcopenie-voorspellen-sterfte-bij-chronische-nierziekte/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/05/05/gezondheidsstatus-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yvind-ellingsen","type":"person","url":"https://hartvaat.nl/mensen/yvind-ellingsen/","name":"Øyvind Ellingsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":5,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/08/01/telerevalidatie-haalbaar-voor-hartfalenpatienten-zonder-toegang-tot-poliklinisch/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/08/01/cardiorenaal-syndroom-en-fitheid-bij-hartfalen-telerevalidatie-trial/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-j","type":"person","url":"https://hartvaat.nl/mensen/a-j/","name":"A. J.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/17/niet-invasieve-endotypering-met-stress-mri-verbetert-de-behandeling-van-angina-z/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/05/04/angina-toevoegen-aan-de-h2fpef-score-verbetert-hfpef-diagnose-bij-vrouwen-geen-w/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/03/31/titine-cardiomyopathie-meestal-dcm-of-linksdominante-acm-met-blijvend-ritmestoor/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/02/12/ct-coronairangiografie-bij-nstemi-uitstekende-diagnostische-nauwkeurigheid-maar-/","published":"2026-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-p-silverstein","type":"person","url":"https://hartvaat.nl/mensen/adam-p-silverstein/","name":"Adam P Silverstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/07/13/ablatie-versus-medicatie-bij-af-naar-ras-en-etniciteit/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-torbicki","type":"person","url":"https://hartvaat.nl/mensen/adam-torbicki/","name":"Adam Torbicki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/04/01/hemodynamische-effecten-van-riociguat-bij-inoperabel-cteph/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-coles","type":"person","url":"https://hartvaat.nl/mensen/adrian-coles/","name":"Adrian Coles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2017/11/21/coronair-calcium-en-prognostische-waarde-bij-pijn-op-de-borst-promise-studie/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/06/27/hospitalisatie-voor-nieuw-gediagnosticeerd-versus-verslechterend-chronisch-hartf/","published":"2017-06-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"afshin-salsali","type":"person","url":"https://hartvaat.nl/mensen/afshin-salsali/","name":"Afshin Salsali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2019/04/30/empagliflozine-antihyperglycemische-en-bloeddrukeffecten-bij-zwarte-diabetespati/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmad-masri","type":"person","url":"https://hartvaat.nl/mensen/ahmad-masri/","name":"Ahmad Masri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aiwen-xing","type":"person","url":"https://hartvaat.nl/mensen/aiwen-xing/","name":"Aiwen Xing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-c-yeung","type":"person","url":"https://hartvaat.nl/mensen/alan-c-yeung/","name":"Alan C Yeung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-maisel","type":"person","url":"https://hartvaat.nl/mensen/alan-maisel/","name":"Alan Maisel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2016/05/01/intracoronaire-adenylylcyclase-6-gentherapie-bij-hartfalen-gerandomiseerde-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-reid","type":"person","url":"https://hartvaat.nl/mensen/alan-reid/","name":"Alan Reid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"albert-ariza-sole","type":"person","url":"https://hartvaat.nl/mensen/albert-ariza-sole/","name":"Albert Ariza-Solé","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/20/es-bempedacs-triple-versus-duale-lipidenbehandeling-na-acs/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"albert-h-m-van-straten","type":"person","url":"https://hartvaat.nl/mensen/albert-h-m-van-straten/","name":"Albert H M van Straten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-dominguez-rodriguez","type":"person","url":"https://hartvaat.nl/mensen/alberto-dominguez-rodriguez/","name":"Alberto Dominguez-Rodriguez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2016/08/16/intracoronair-abciximab-bij-diabetespatienten-met-primaire-pci-1-jaarsresultaten/","published":"2016-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-j-lorenzatti","type":"person","url":"https://hartvaat.nl/mensen/alberto-j-lorenzatti/","name":"Alberto J Lorenzatti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-palazzuoli","type":"person","url":"https://hartvaat.nl/mensen/alberto-palazzuoli/","name":"Alberto Palazzuoli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/het-spectrum-van-congestie-bij-hartfalen-pathofysiologie-en-diagnostische-strate/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2017/11/01/iv-lisdiuretica-bij-acuut-hartfalen-diur-ahf-studieontwerp/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aleksander-zurakowski","type":"person","url":"https://hartvaat.nl/mensen/aleksander-zurakowski/","name":"Aleksander Zurakowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-sciahbasi","type":"person","url":"https://hartvaat.nl/mensen/alessandro-sciahbasi/","name":"Alessandro Sciahbasi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-sionis","type":"person","url":"https://hartvaat.nl/mensen/alessandro-sionis/","name":"Alessandro Sionis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessia-urbinati","type":"person","url":"https://hartvaat.nl/mensen/alessia-urbinati/","name":"Alessia Urbinati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-r-kemper","type":"person","url":"https://hartvaat.nl/mensen/alex-r-kemper/","name":"Alex R Kemper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-popma","type":"person","url":"https://hartvaat.nl/mensen/alexandra-popma/","name":"Alexandra Popma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/1-op-5-oudere-patienten-heeft-hartfalen-opname-binnen-jaar-na-tavr-1-jaarsmortal/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandros-briasoulis","type":"person","url":"https://hartvaat.nl/mensen/alexandros-briasoulis/","name":"Alexandros Briasoulis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2022/11/01/checkpoint-remmers-verhogen-korttermijnrisico-op-hypertensie-niet-meta-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/08/24/de-escalatie-van-dapt-bij-acs-jacc-review/","published":"2021-08-24"},{"url":"https://hartvaat.nl/2020/01/28/orale-antistolling-bij-af-op-langdurige-hemodialyse/","published":"2020-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alison-l-bailey","type":"person","url":"https://hartvaat.nl/mensen/alison-l-bailey/","name":"Alison L Bailey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alison-seed","type":"person","url":"https://hartvaat.nl/mensen/alison-seed/","name":"Alison Seed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2017/08/07/remote-management-van-hartfalen-met-implanteerbare-devices-overzicht/","published":"2017-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alp-aytekin","type":"person","url":"https://hartvaat.nl/mensen/alp-aytekin/","name":"Alp Aytekin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alvin-chandra","type":"person","url":"https://hartvaat.nl/mensen/alvin-chandra/","name":"Alvin Chandra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2018/06/01/sacubitril-valsartan-en-fysieke-en-sociale-activiteitsbeperkingen-bij-hf-paradig/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amanda-adler","type":"person","url":"https://hartvaat.nl/mensen/amanda-adler/","name":"Amanda Adler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/03/25/leeftijds-en-sekseverschillen-in-effectiviteit-van-diabetesbehandeling-netwerk-m/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2023/05/30/empagliflozine-en-cardiale-energiestofwisseling-bij-hartfalen-empa-vision/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amanda-r-vest","type":"person","url":"https://hartvaat.nl/mensen/amanda-r-vest/","name":"Amanda R Vest","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/18/2025-acc-scientific-statement-obesitasmanagement-bij-hartfalen/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amar-krishnaswamy","type":"person","url":"https://hartvaat.nl/mensen/amar-krishnaswamy/","name":"Amar Krishnaswamy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/09/01/anemie-verergert-mortaliteit-en-hartfalenheropnames-na-tavr-bij-patienten-boven-/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2024/03/05/gelijktijdige-laa-occlusie-en-tavr-bij-af-haalbaarheid/","published":"2024-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amerjeet-s-banning","type":"person","url":"https://hartvaat.nl/mensen/amerjeet-s-banning/","name":"Amerjeet S Banning","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2019/12/24/langetermijnfollow-up-van-complete-versus-laesie-only-revascularisatie-bij-stemi/","published":"2019-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amitava-banerjee","type":"person","url":"https://hartvaat.nl/mensen/amitava-banerjee/","name":"Amitava Banerjee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2024/10/01/crt-bij-inotroop-afhankelijk-hartfalen-meta-analyse/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2022/09/26/smartphone-detectie-van-af-via-fotoplethysmografie-meta-analyse/","published":"2022-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anders-g-olsson","type":"person","url":"https://hartvaat.nl/mensen/anders-g-olsson/","name":"Anders G Olsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anders-gaarsdal-holst","type":"person","url":"https://hartvaat.nl/mensen/anders-gaarsdal-holst/","name":"Anders Gaarsdal Holst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-erriquez","type":"person","url":"https://hartvaat.nl/mensen/andrea-erriquez/","name":"Andrea Erriquez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-picchi","type":"person","url":"https://hartvaat.nl/mensen/andrea-picchi/","name":"Andrea Picchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-m-demchuk","type":"person","url":"https://hartvaat.nl/mensen/andrew-m-demchuk/","name":"Andrew M Demchuk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2021/06/01/implanteerbare-versus-verlengde-externe-ecg-monitoring-voor-af-na-ischemisch-cva/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-m-tershakovec","type":"person","url":"https://hartvaat.nl/mensen/andrew-m-tershakovec/","name":"Andrew M Tershakovec","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/10/12/baseline-ldl-en-klinische-uitkomsten-van-ezetimibe-plus-statine-improve-it/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2017/12/19/cva-preventie-met-ezetimibe-bij-acs-improve-it-analyse/","published":"2017-12-19"},{"url":"https://hartvaat.nl/2017/05/01/langetermijnveiligheid-van-zeer-lage-ldl-cholesterolniveaus-improve-it-analyse/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrzej-januszewicz","type":"person","url":"https://hartvaat.nl/mensen/andrzej-januszewicz/","name":"Andrzej Januszewicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/27/consensus-breid-het-cardio-renaal-metabool-syndroom-uit-met-de-lever-cklms-in-de/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angel-cequier","type":"person","url":"https://hartvaat.nl/mensen/angel-cequier/","name":"Angel Cequier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-sonia-petronio","type":"person","url":"https://hartvaat.nl/mensen/anna-sonia-petronio/","name":"Anna Sonia Petronio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2018/12/01/mitraclip-plus-medicamenteus-versus-medicamenteus-alleen-bij-hf-met-mr-meta-anal/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annamaria-kosztin","type":"person","url":"https://hartvaat.nl/mensen/annamaria-kosztin/","name":"Annamária Kosztin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2017/11/01/klinische-presentatie-bij-eerste-hartfalenhospitalisatie-voorspelt-geen-heropnam/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-b-curtis","type":"person","url":"https://hartvaat.nl/mensen/anne-b-curtis/","name":"Anne B Curtis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/11/22/athena-subanalyse-dronedaron-effectief-ongeacht-leeftijd-en-geslacht-bij-af/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/05/10/biventriculaire-versus-rechterkamerpacing-klinische-verbetering-in-de-block-hf-s/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-h-hobbelt","type":"person","url":"https://hartvaat.nl/mensen/anne-h-hobbelt/","name":"Anne H Hobbelt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-marie-valente","type":"person","url":"https://hartvaat.nl/mensen/anne-marie-valente/","name":"Anne Marie Valente","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/aangeboren-hartafwijkingen-bij-volwassenen-nieuwe-richtlijnen-kennishiaten-en-ka/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/wat-is-veranderd-sinds-de-eerste-richtlijn-voor-volwassenen-met-aangeboren-harta/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-pernille-ofstad","type":"person","url":"https://hartvaat.nl/mensen/anne-pernille-ofstad/","name":"Anne Pernille Ofstad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/08/30/empagliflozine-bij-hfpef-consistent-effect-met-en-zonder-diabetes/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/09/28/empagliflozine-verbetert-cv-en-renale-uitkomsten-ongeacht-systolische-bloeddruk-/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2020/09/19/sglt2-remmers-bij-hfref-meta-analyse-van-emperor-reduced-en-dapa-hf/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2019/06/04/microvasculaire-ziekte-en-cv-events-bij-diabetes-type-2/","published":"2019-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-a-bavry","type":"person","url":"https://hartvaat.nl/mensen/anthony-a-bavry/","name":"Anthony A Bavry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"},{"url":"https://hartvaat.nl/2016/11/01/langetermijnmortaliteit-bij-hypertensie-met-coronairlijden-invest-us-cohort/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/08/02/impact-van-coronaire-laesielengte-op-uitkomsten-bij-ivus-geleide-pci/","published":"2016-08-02"},{"url":"https://hartvaat.nl/2016/05/17/institutionele-en-operateurvereisten-voor-linker-hartoorocclusie-scai-acc-hrs-st/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antone-j-tatooles","type":"person","url":"https://hartvaat.nl/mensen/antone-j-tatooles/","name":"Antone J Tatooles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/intrapericardiale-lvad-bij-gevorderd-hartfalen-nejm/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-dello-russo","type":"person","url":"https://hartvaat.nl/mensen/antonio-dello-russo/","name":"Antonio Dello Russo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-serra","type":"person","url":"https://hartvaat.nl/mensen/antonio-serra/","name":"Antonio Serra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ariel-roguin","type":"person","url":"https://hartvaat.nl/mensen/ariel-roguin/","name":"Ariel Roguin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2021/10/26/vroege-impedantie-geleide-interventie-verbetert-langetermijn-hf-uitkomsten/","published":"2021-10-26"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arne-johannessen","type":"person","url":"https://hartvaat.nl/mensen/arne-johannessen/","name":"Arne Johannessen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/10/07/vroege-substraatablatie-versus-antiaritmica-bij-vt-gerandomiseerde-trial/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2019/07/01/qt-als-voorspeller-van-af-recidief-na-ablatie-en-amiodaronimpact-amio-cat/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/03/01/katheterablatie-als-eerstelijnsbehandeling-bij-paroxysmaal-af-5-jaarsresultaten/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"asma-khalil","type":"person","url":"https://hartvaat.nl/mensen/asma-khalil/","name":"Asma Khalil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/03/01/orale-antihypertensiva-bij-niet-ernstige-zwangerschapshypertensie-netwerkmeta-an/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2020/07/01/white-coat-hypertensie-in-de-zwangerschap-maternale-en-perinatale-uitkomsten/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/11/01/labetalol-versus-nifedipine-bij-chronische-hypertensie-in-de-zwangerschap-gerand/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"attila-kovacs","type":"person","url":"https://hartvaat.nl/mensen/attila-kovacs/","name":"Attila Kovács","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"azfar-zaman","type":"person","url":"https://hartvaat.nl/mensen/azfar-zaman/","name":"Azfar Zaman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/07/21/levothyroxine-bij-subklinische-hypothyreoidie-na-acuut-mi-jama/","published":"2020-07-21"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bahira-shahim","type":"person","url":"https://hartvaat.nl/mensen/bahira-shahim/","name":"Bahira Shahim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/03/19/heropname-na-revascularisatie-voor-hoofdstamziekte-incidentie-en-impact/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-e-stahli","type":"person","url":"https://hartvaat.nl/mensen/barbara-e-stahli/","name":"Barbara E Stähli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2016/01/26/p-selectine-antagonist-inclacumab-bij-coronaire-bypasschirurgie-select-cabg-tria/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bart-maesen","type":"person","url":"https://hartvaat.nl/mensen/bart-maesen/","name":"Bart Maesen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2021/11/08/preoperatieve-tte-voor-voorspelling-van-postoperatief-af-meta-analyse/","published":"2021-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bartolome-r-celli","type":"person","url":"https://hartvaat.nl/mensen/bartolome-r-celli/","name":"Bartolome R Celli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/04/30/fluticason-vilanterol-en-overleving-bij-copd-met-verhoogd-cardiovasculair-risico/","published":"2016-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"basky-thilaganathan","type":"person","url":"https://hartvaat.nl/mensen/basky-thilaganathan/","name":"Basky Thilaganathan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2020/07/01/white-coat-hypertensie-in-de-zwangerschap-maternale-en-perinatale-uitkomsten/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-d-levine","type":"person","url":"https://hartvaat.nl/mensen/benjamin-d-levine/","name":"Benjamin D Levine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/12/19/synchronisatie-van-voetstap-en-hartfase-bij-crt-patienten/","published":"2023-12-19"},{"url":"https://hartvaat.nl/2023/01/31/hfpef-inspanningsbeperking-niet-alleen-door-hemodynamiek/","published":"2023-01-31"},{"url":"https://hartvaat.nl/2021/09/21/1-jaar-inspanningstraining-keert-lv-stijfheid-om-bij-stadium-b-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2018/04/10/sedentaire-veroudering-omkeren-op-middelbare-leeftijd-gerandomiseerde-trial-voor/","published":"2018-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benno-j-w-m-rensing","type":"person","url":"https://hartvaat.nl/mensen/benno-j-w-m-rensing/","name":"Benno J W M Rensing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/01/05/ct-coronairangiografie-bij-verdenking-acs-in-het-tijdperk-van-hoog-sensitief-tro/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-cosyns","type":"person","url":"https://hartvaat.nl/mensen/bernard-cosyns/","name":"Bernard Cosyns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"binyan-wang","type":"person","url":"https://hartvaat.nl/mensen/binyan-wang/","name":"Binyan Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bjarne-linde-norgaard","type":"person","url":"https://hartvaat.nl/mensen/bjarne-linde-norgaard/","name":"Bjarne Linde Nørgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/02/01/ccta-afgeleide-ffr-prognostische-waarde-meta-analyse/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bo-lagerqvist","type":"person","url":"https://hartvaat.nl/mensen/bo-lagerqvist/","name":"Bo Lagerqvist","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bo-xu","type":"person","url":"https://hartvaat.nl/mensen/bo-xu/","name":"Bo Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"boback-ziaeian","type":"person","url":"https://hartvaat.nl/mensen/boback-ziaeian/","name":"Boback Ziaeian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/sglt2-remmers-bij-oudere-patienten-opgenomen-voor-hfref-24-sterfte-en-16-heropna/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bogdan-alexandru-popescu","type":"person","url":"https://hartvaat.nl/mensen/bogdan-alexandru-popescu/","name":"Bogdan Alexandru Popescu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2017/09/01/validiteit-en-reproduceerbaarheid-van-echocardiografie-bij-af-systematische-revi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bonnie-ky","type":"person","url":"https://hartvaat.nl/mensen/bonnie-ky/","name":"Bonnie Ky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/20/ecog-acrin-eaq191-intensieve-bloeddrukcontrole-tijdens-vegfr-tki-therapie-haalba/","published":"2026-07-07"},{"url":"https://hartvaat.nl/2026/05/26/car-t-therapie-bij-ouderen-5-8-mace-en-sterk-verhoogde-mortaliteit-cardio-oncolo/","published":"2026-05-30"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/08/08/stop-ca-atorvastatine-beschermt-tegen-antracycline-cardiotoxiciteit/","published":"2023-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brent-egan","type":"person","url":"https://hartvaat.nl/mensen/brent-egan/","name":"Brent Egan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-g-katona","type":"person","url":"https://hartvaat.nl/mensen/brian-g-katona/","name":"Brian G Katona","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bridget-anne-kirwan","type":"person","url":"https://hartvaat.nl/mensen/bridget-anne-kirwan/","name":"Bridget-Anne Kirwan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bronwyn-a-kingwell","type":"person","url":"https://hartvaat.nl/mensen/bronwyn-a-kingwell/","name":"Bronwyn A Kingwell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2019/04/01/ochtendbeweging-met-of-zonder-zitonderbrekingen-en-bloeddruk-bij-ouderen/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-pereira","type":"person","url":"https://hartvaat.nl/mensen/bruno-pereira/","name":"Bruno Pereira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2017/10/10/geindividualiseerd-versus-standaard-bloeddrukbeleid-bij-hoog-risico-chirurgiepat/","published":"2017-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-scheller","type":"person","url":"https://hartvaat.nl/mensen/bruno-scheller/","name":"Bruno Scheller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/03/10/overleving-na-revascularisatie-met-paclitaxel-gecoate-ballonnen/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bulent-gorenek","type":"person","url":"https://hartvaat.nl/mensen/bulent-gorenek/","name":"Bulent Gorenek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bum-kee-hong","type":"person","url":"https://hartvaat.nl/mensen/bum-kee-hong/","name":"Bum-Kee Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/02/01/alternatieve-ldl-verlagingsstrategie-versus-hoge-dosis-statine-bij-ascvd-meta-an/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2022/07/30/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-coronairlijden-lance/","published":"2022-07-30"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-jan-willem-borleffs","type":"person","url":"https://hartvaat.nl/mensen/c-jan-willem-borleffs/","name":"C Jan Willem Borleffs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-seth-landefeld","type":"person","url":"https://hartvaat.nl/mensen/c-seth-landefeld/","name":"C Seth Landefeld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-j","type":"person","url":"https://hartvaat.nl/mensen/c-j/","name":"C. J.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/03/warrior-trial-intensieve-medicamenteuze-behandeling-verbetert-de-uitkomsten-niet/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/05/20/scapis-cohort-diastolische-dysfunctie-even-vaak-bij-prediabetes-als-diabetes-ple/","published":"2026-07-07"},{"url":"https://hartvaat.nl/2026/05/26/recidief-linkerventrikel-trombus-12-recidief-actieve-eerdere-maligniteit-verzesv/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/01/06/machine-learning-algoritme-mi3-helpt-een-infarct-uitsluiten-bij-een-onduidelijke/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carine-j-m-doggen","type":"person","url":"https://hartvaat.nl/mensen/carine-j-m-doggen/","name":"Carine J M Doggen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-de-asmundis","type":"person","url":"https://hartvaat.nl/mensen/carlo-de-asmundis/","name":"Carlo de Asmundis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2022/01/04/enkele-freeze-cryoballonablatie-bij-af-ehra-systematische-review/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2021/12/07/minimaal-onderbroken-versus-continue-doac-bij-af-ablatie-meta-analyse/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmine-zoccali","type":"person","url":"https://hartvaat.nl/mensen/carmine-zoccali/","name":"Carmine Zoccali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/06/01/longechogeleide-drooggewichtreductie-en-ambulante-bloeddruk-bij-hemodialyse/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/08/01/sympathische-zenuwactivatie-bij-essentiele-hypertensie-meta-analyse/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carol-pollock","type":"person","url":"https://hartvaat.nl/mensen/carol-pollock/","name":"Carol Pollock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carsten-tschope","type":"person","url":"https://hartvaat.nl/mensen/carsten-tschope/","name":"Carsten Tschöpe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"catherine-p-benziger","type":"person","url":"https://hartvaat.nl/mensen/catherine-p-benziger/","name":"Catherine P Benziger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"catriona-keerie","type":"person","url":"https://hartvaat.nl/mensen/catriona-keerie/","name":"Catriona Keerie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cecilia-ronnback","type":"person","url":"https://hartvaat.nl/mensen/cecilia-ronnback/","name":"Cecilia Rönnbäck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/27/step-hfpef-semaglutide-even-effectief-bij-mannen-en-vrouwen/","published":"2024-08-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"celso-amodeo","type":"person","url":"https://hartvaat.nl/mensen/celso-amodeo/","name":"Celso Amodeo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-en-evidence-based-prescriptie-bij-hoog-cv-risico-jama-card/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/04/01/spironolacton-versus-clonidine-als-vierde-middel-bij-resistente-hypertensie-reho/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charlotta-e-a-ljungman","type":"person","url":"https://hartvaat.nl/mensen/charlotta-e-a-ljungman/","name":"Charlotta E A Ljungman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charlotte-eitel","type":"person","url":"https://hartvaat.nl/mensen/charlotte-eitel/","name":"Charlotte Eitel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2022/07/15/geindividualiseerde-versus-standaard-cryoballonablatie-bij-paroxysmaal-af/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/05/21/firm-ablatie-versus-pvi-bij-paroxysmaal-af-gerandomiseerde-resultaten/","published":"2021-05-21"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chen-chen","type":"person","url":"https://hartvaat.nl/mensen/chen-chen/","name":"Chen Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/nucleair-ago2-verergert-hfpef-via-myocardiale-ketogenese/","published":"2026-04-03"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2019/02/01/sms-na-ontslag-verbetert-kortetermijnuitkomsten-en-zelfzorg-bij-chronisch-hf/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheol-hyun-lee","type":"person","url":"https://hartvaat.nl/mensen/cheol-hyun-lee/","name":"Cheol Hyun Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chintan-trivedi","type":"person","url":"https://hartvaat.nl/mensen/chintan-trivedi/","name":"Chintan Trivedi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-butter","type":"person","url":"https://hartvaat.nl/mensen/christian-butter/","name":"Christian Butter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2021/11/08/closed-loop-stimulatie-en-cardiopulmonale-variabelen-bij-chronisch-hf-met-chrono/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2016/11/01/vochtstatustelemonitoring-bij-hartfalen-gerandomiseerde-trial/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-hagl","type":"person","url":"https://hartvaat.nl/mensen/christian-hagl/","name":"Christian Hagl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2019/05/14/ecls-bij-cardiogene-shock-na-acuut-mi/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-meyer","type":"person","url":"https://hartvaat.nl/mensen/christian-meyer/","name":"Christian Meyer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2018/01/01/energiebron-en-vroeg-af-recidief-cryoballon-versus-radiofrequentie/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-sohns","type":"person","url":"https://hartvaat.nl/mensen/christian-sohns/","name":"Christian Sohns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/03/varipure-studie-pulsed-field-ablatie-in-de-dagelijkse-af-praktijk/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-valina","type":"person","url":"https://hartvaat.nl/mensen/christian-valina/","name":"Christian Valina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christina-nowack","type":"person","url":"https://hartvaat.nl/mensen/christina-nowack/","name":"Christina Nowack","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/12/01/finerenon-bloeddrukeffecten-en-cardiorenale-uitkomsten-bij-ckd-en-diabetes/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2021/12/09/finerenon-bij-nierziekte-met-diabetes-type-2-nejm-figaro-dkd/","published":"2021-12-09"},{"url":"https://hartvaat.nl/2016/07/14/finerenon-versus-eplerenon-bij-hartfalen-met-diabetes-en-verslechterende-nierfun/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-grani","type":"person","url":"https://hartvaat.nl/mensen/christoph-grani/","name":"Christoph Gräni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-piot","type":"person","url":"https://hartvaat.nl/mensen/christophe-piot/","name":"Christophe Piot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-j-weir","type":"person","url":"https://hartvaat.nl/mensen/christopher-j-weir/","name":"Christopher J Weir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-s-lee","type":"person","url":"https://hartvaat.nl/mensen/christopher-s-lee/","name":"Christopher S Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/27/frailte-versnelt-hartfalenprogressie-en-vermindert-therapietolerantie/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christos-iliadis","type":"person","url":"https://hartvaat.nl/mensen/christos-iliadis/","name":"Christos Iliadis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claire-bouleti","type":"person","url":"https://hartvaat.nl/mensen/claire-bouleti/","name":"Claire Bouleti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clare-arnott","type":"person","url":"https://hartvaat.nl/mensen/clare-arnott/","name":"Clare Arnott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/27/sglt2-remmers-verminderen-epicardiaal-vetweefsel-meta-analyse-van-11-studies/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clare-j-taylor","type":"person","url":"https://hartvaat.nl/mensen/clare-j-taylor/","name":"Clare J Taylor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/06/01/natriuretisch-peptide-screening-voor-lv-disfunctie-diagnostische-nauwkeurigheid/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/06/01/diagnostiek-van-hartfalen-in-de-huisartsenpraktijk-ipd-meta-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2019/12/01/gewichtsverandering-en-risico-op-af-systematische-review-en-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clinton-b-wright","type":"person","url":"https://hartvaat.nl/mensen/clinton-b-wright/","name":"Clinton B Wright","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukcontrole-en-cerebrale-small-vessel-disease-markers/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"courtney-crim","type":"person","url":"https://hartvaat.nl/mensen/courtney-crim/","name":"Courtney Crim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/04/30/fluticason-vilanterol-en-overleving-bij-copd-met-verhoogd-cardiovasculair-risico/","published":"2016-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"craig-beam","type":"person","url":"https://hartvaat.nl/mensen/craig-beam/","name":"Craig Beam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"d-wyn-davies","type":"person","url":"https://hartvaat.nl/mensen/d-wyn-davies/","name":"D Wyn Davies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dabit-arzamendi","type":"person","url":"https://hartvaat.nl/mensen/dabit-arzamendi/","name":"Dabit Arzamendi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-doac-versus-dapt-na-laa-occlusie-gerandomiseerde-trial/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dahlia-garza","type":"person","url":"https://hartvaat.nl/mensen/dahlia-garza/","name":"Dahlia Garza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/10/26/patiromer-voor-spironolactongebruik-bij-resistente-hypertensie-met-ckd-lancet-am/","published":"2019-10-26"},{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/09/01/patiromer-verlaagt-aldosteron-bij-ckd-patienten-met-hyperkaliemie-op-raas-remmer/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"damien-bonnet","type":"person","url":"https://hartvaat.nl/mensen/damien-bonnet/","name":"Damien Bonnet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2017/09/05/ivabradine-bij-kinderen-met-dilaterende-cardiomyopathie-en-symptomatisch-hartfal/","published":"2017-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"damras-tresukosol","type":"person","url":"https://hartvaat.nl/mensen/damras-tresukosol/","name":"Damras Tresukosol","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-ioanes","type":"person","url":"https://hartvaat.nl/mensen/dan-ioanes/","name":"Dan Ioanes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-cotton","type":"person","url":"https://hartvaat.nl/mensen/daniel-cotton/","name":"Daniel Cotton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/11/14/regionale-en-etnische-invloeden-op-empagliflozine-bij-hfref-emperor-reduced/","published":"2021-11-14"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-e-forman","type":"person","url":"https://hartvaat.nl/mensen/daniel-e-forman/","name":"Daniel E Forman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-e-weiner","type":"person","url":"https://hartvaat.nl/mensen/daniel-e-weiner/","name":"Daniel E Weiner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-isaza","type":"person","url":"https://hartvaat.nl/mensen/daniel-isaza/","name":"Daniel Isaza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/02/02/reductie-in-totale-cardiovasculaire-events-met-ezetimibe-simvastatine-na-acs-imp/","published":"2016-02-02"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-levy","type":"person","url":"https://hartvaat.nl/mensen/daniel-levy/","name":"Daniel Levy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-modin","type":"person","url":"https://hartvaat.nl/mensen/daniel-modin/","name":"Daniel Modin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/hoge-dosis-griepvaccinatie-bij-atherosclerotisch-vaatlijden-flunity-hd-analyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-munoz","type":"person","url":"https://hartvaat.nl/mensen/daniel-munoz/","name":"Daniel Muñoz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2019/09/19/polypil-voor-cv-preventie-bij-onderbehandelde-populatie-nejm/","published":"2019-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-s-berman","type":"person","url":"https://hartvaat.nl/mensen/daniel-s-berman/","name":"Daniel S Berman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2019/04/30/leefstijl-hba1c-en-overleving-bij-stabiel-coronairlijden-met-diabetes/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-t-lackland","type":"person","url":"https://hartvaat.nl/mensen/daniel-t-lackland/","name":"Daniel T Lackland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/11/01/therapieresistente-hypertensie-aha-scientific-statement-over-detectie-evaluatie-/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniela-trabattoni","type":"person","url":"https://hartvaat.nl/mensen/daniela-trabattoni/","name":"Daniela Trabattoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"danielle-duffy","type":"person","url":"https://hartvaat.nl/mensen/danielle-duffy/","name":"Danielle Duffy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/26/aegis-ii-subanalyse-apoa-i-infusie-en-ischemische-eventlast-na-mi/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darren-mylotte","type":"person","url":"https://hartvaat.nl/mensen/darren-mylotte/","name":"Darren Mylotte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darwin-r-labarthe","type":"person","url":"https://hartvaat.nl/mensen/darwin-r-labarthe/","name":"Darwin R Labarthe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-austin","type":"person","url":"https://hartvaat.nl/mensen/david-austin/","name":"David Austin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2020/07/21/levothyroxine-bij-subklinische-hypothyreoidie-na-acuut-mi-jama/","published":"2020-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-b-delurgio","type":"person","url":"https://hartvaat.nl/mensen/david-b-delurgio/","name":"David B DeLurgio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2020/10/27/af-ablatie-met-vena-van-marshall-ethanol-versus-ablatie-alleen-jama-venus/","published":"2020-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-brieger","type":"person","url":"https://hartvaat.nl/mensen/david-brieger/","name":"David Brieger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-chelmow","type":"person","url":"https://hartvaat.nl/mensen/david-chelmow/","name":"David Chelmow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/04/26/aspirine-voor-cv-preventie-uspstf-aanbeveling-2022/","published":"2022-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-d-mcmanus","type":"person","url":"https://hartvaat.nl/mensen/david-d-mcmanus/","name":"David D McManus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2024/11/19/screening-op-niet-gediagnosticeerd-af-voor-cva-preventie-gerandomiseerde-trial/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2022/03/29/af-screening-bij-ouderen-in-de-huisartsenpraktijk-vital-af-gerandomiseerde-trial/","published":"2022-03-29"},{"url":"https://hartvaat.nl/2021/01/26/2020-acc-aha-kwaliteitsmaten-voor-af-geactualiseerd/","published":"2021-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-e-lanfear","type":"person","url":"https://hartvaat.nl/mensen/david-e-lanfear/","name":"David E Lanfear","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-webb","type":"person","url":"https://hartvaat.nl/mensen/david-j-webb/","name":"David J Webb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/07/20/zilebesiran-rna-interferentietherapie-voor-hypertensie-nejm/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2022/11/01/arteriele-stijfheid-en-endotheeldysfunctie-bij-anca-geassocieerde-vasculitis/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2019/08/01/endothelinereceptorantagonisme-verbetert-lipidenprofielen-en-verlaagt-pcsk9-bij-/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-nathan","type":"person","url":"https://hartvaat.nl/mensen/david-m-nathan/","name":"David M Nathan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2017/04/20/frequentie-van-evidence-based-retinopathiescreening-bij-diabetes-type-1-nejm/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-messika-zeitoun","type":"person","url":"https://hartvaat.nl/mensen/david-messika-zeitoun/","name":"David Messika-Zeitoun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-p-lee","type":"person","url":"https://hartvaat.nl/mensen/david-p-lee/","name":"David P Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-r-matthews","type":"person","url":"https://hartvaat.nl/mensen/david-r-matthews/","name":"David R Matthews","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davide-stolfo","type":"person","url":"https://hartvaat.nl/mensen/davide-stolfo/","name":"Davide Stolfo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davis-gates","type":"person","url":"https://hartvaat.nl/mensen/davis-gates/","name":"Davis Gates","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dean-a-fergusson","type":"person","url":"https://hartvaat.nl/mensen/dean-a-fergusson/","name":"Dean A Fergusson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"debabrata-mukherjee","type":"person","url":"https://hartvaat.nl/mensen/debabrata-mukherjee/","name":"Debabrata Mukherjee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"debbie-a-lawlor","type":"person","url":"https://hartvaat.nl/mensen/debbie-a-lawlor/","name":"Debbie A Lawlor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deirdre-a-lane","type":"person","url":"https://hartvaat.nl/mensen/deirdre-a-lane/","name":"Deirdre A Lane","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"denise-mason","type":"person","url":"https://hartvaat.nl/mensen/denise-mason/","name":"Denise Mason","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derek-s-chew","type":"person","url":"https://hartvaat.nl/mensen/derek-s-chew/","name":"Derek S Chew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/06/01/implanteerbare-versus-verlengde-externe-ecg-monitoring-voor-af-na-ischemisch-cva/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derick-m-todd","type":"person","url":"https://hartvaat.nl/mensen/derick-m-todd/","name":"Derick M Todd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/05/01/ablatie-index-als-marker-voor-ablatielaesiekwaliteit-voorspelling-van-pv-reconne/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dexter-canoy","type":"person","url":"https://hartvaat.nl/mensen/dexter-canoy/","name":"Dexter Canoy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong","type":"person","url":"https://hartvaat.nl/mensen/dong/","name":"Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/21/chirurgie-voor-aortaklependocarditis-blijft-hoogrisico-spoed-en-inotropie-sterks/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/04/24/cardiovasculaire-ziekte-bij-sikkelcelziekte-ondergediagnosticeerde-drijver-van-m/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/02/02/machine-learning-nomogram-voorspelt-vroeg-transplantaatfalen-na-harttransplantat/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2026/01/09/littekenweefsel-voorspelt-plotse-hartdood-na-een-infarct-grotendeels-buiten-de-e/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-ju-choi","type":"person","url":"https://hartvaat.nl/mensen/dong-ju-choi/","name":"Dong-Ju Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/harttransplantatie-bij-hoogste-urgentie-meer-vroege-infecties-en-sterfte-mede-do/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dongfeng-gu","type":"person","url":"https://hartvaat.nl/mensen/dongfeng-gu/","name":"Dongfeng Gu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/13/nt-probnp-en-af-risico-systematische-review-en-meta-analyse/","published":"2025-01-13"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/09/01/interactieve-mobiele-gezondheidsinterventie-en-bloeddrukmanagement/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donogh-maguire","type":"person","url":"https://hartvaat.nl/mensen/donogh-maguire/","name":"Donogh Maguire","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-kling","type":"person","url":"https://hartvaat.nl/mensen/douglas-kling/","name":"Douglas Kling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-ross-t-campbell","type":"person","url":"https://hartvaat.nl/mensen/dr-ross-t-campbell/","name":"Dr. Ross T. Campbell","title":"Senior Lecturer / Cardioloog, University of Glasgow","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/05/09/subcut-hf-ii-subcutane-furosemide-thuis-verlaagt-opnameduur-met-5-5-dagen-na-har/","published":"2026-05-11"}],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/subcut-hf-ii/","title":"SUBCUT HF II — Subcutane furosemide thuis verlaagt opnameduur met 5,5 dagen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dragana-kosevic","type":"person","url":"https://hartvaat.nl/mensen/dragana-kosevic/","name":"Dragana Kosevic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2021/04/01/cardio-microstroomdevice-bij-chronisch-hf-eerste-klinische-studie/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-aradi","type":"person","url":"https://hartvaat.nl/mensen/daniel-aradi/","name":"Dániel Aradi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edouard-benit","type":"person","url":"https://hartvaat.nl/mensen/edouard-benit/","name":"Edouard Benit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eduardo-perna","type":"person","url":"https://hartvaat.nl/mensen/eduardo-perna/","name":"Eduardo Perna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elena-arbelo","type":"person","url":"https://hartvaat.nl/mensen/elena-arbelo/","name":"Elena Arbelo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/04/09/cardiale-screening-van-jonge-sporters-eerste-eapc-aepc-consensus-voor-kinderen/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-a-magnuson","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-a-magnuson/","name":"Elizabeth A Magnuson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"},{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/25/kwaliteit-van-leven-na-chirurgie-of-des-bij-drienvaten-of-hoofdstamlijden/","published":"2017-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-a-thomson","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-a-thomson/","name":"Elizabeth A Thomson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elke-schueler","type":"person","url":"https://hartvaat.nl/mensen/elke-schueler/","name":"Elke Schueler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"else-charlotte-sandset","type":"person","url":"https://hartvaat.nl/mensen/else-charlotte-sandset/","name":"Else Charlotte Sandset","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2020/03/01/bloeddruk-en-uitkomsten-bij-acute-beroerte-trombectomie/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emil-hagstrom","type":"person","url":"https://hartvaat.nl/mensen/emil-hagstrom/","name":"Emil Hagström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/04/11/heterogeniteit-in-bloeddrukrespons-op-antihypertensiva-jama-cross-over-rct/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emily-sammons","type":"person","url":"https://hartvaat.nl/mensen/emily-sammons/","name":"Emily Sammons","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrico-fabris","type":"person","url":"https://hartvaat.nl/mensen/enrico-fabris/","name":"Enrico Fabris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/01/1-jaarsmortaliteit-bivalirudine-versus-heparine-in-de-ambulance-bij-stemi-matrix/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-a-rose","type":"person","url":"https://hartvaat.nl/mensen/eric-a-rose/","name":"Eric A Rose","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erick-schampaert","type":"person","url":"https://hartvaat.nl/mensen/erick-schampaert/","name":"Erick Schampaert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erik-lipsic","type":"person","url":"https://hartvaat.nl/mensen/erik-lipsic/","name":"Erik Lipsic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2021/10/05/ketonlichamen-en-functionele-uitkomsten-na-stemi/","published":"2021-10-05"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erin-d-michos","type":"person","url":"https://hartvaat.nl/mensen/erin-d-michos/","name":"Erin D Michos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/10/13/dapt-na-pci-met-des-netwerkmeta-analyse-van-duur-en-intensiteit/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2016/08/01/vitamine-d-en-incidentie-van-atriumfibrilleren-de-aric-studie/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eue-keun-choi","type":"person","url":"https://hartvaat.nl/mensen/eue-keun-choi/","name":"Eue-Keun Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/27/van-vitamine-k-antagonist-naar-doac-bij-kwetsbare-ouderen-met-af/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eun-ho-choo","type":"person","url":"https://hartvaat.nl/mensen/eun-ho-choo/","name":"Eun Ho Choo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eunju-hurh","type":"person","url":"https://hartvaat.nl/mensen/eunju-hurh/","name":"Eunju Hurh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"},{"url":"https://hartvaat.nl/2019/09/01/galnac-geconjugeerd-antisense-tegen-apoc3-triglyceriden-en-atherogene-lipoprotei/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/07/20/angptl3-antisense-oligonucleotiden-cardiovasculaire-en-metabole-effecten-nejm/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-gerdts","type":"person","url":"https://hartvaat.nl/mensen/eva-gerdts/","name":"Eva Gerdts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2019/10/01/lage-arteriele-compliance-en-cv-morbiditeit-bij-aortaklepstenose/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2017/09/01/slagvolume-en-cardiovasculair-risico-bij-progressie-van-aortaklepstenose/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evgeny-kretov","type":"person","url":"https://hartvaat.nl/mensen/evgeny-kretov/","name":"Evgeny Kretov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fang-chen","type":"person","url":"https://hartvaat.nl/mensen/fang-chen/","name":"Fang Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fangfang-fan","type":"person","url":"https://hartvaat.nl/mensen/fangfang-fan/","name":"Fangfang Fan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2022/06/01/interatriale-shuntdevices-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federica-galimberti","type":"person","url":"https://hartvaat.nl/mensen/federica-galimberti/","name":"Federica Galimberti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/22/orale-pcsk9-remmers-meta-analyse-bevestigt-krachtige-ldl-daling/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/04/22/angptl3-remmers-verlagen-breed-lipidenspectrum-vooral-remnant-en-triglyceriden/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fei-ye","type":"person","url":"https://hartvaat.nl/mensen/fei-ye/","name":"Fei Ye","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felix-bohm","type":"person","url":"https://hartvaat.nl/mensen/felix-bohm/","name":"Felix Böhm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feng-j-he","type":"person","url":"https://hartvaat.nl/mensen/feng-j-he/","name":"Feng J He","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/01/bloeddrukverlagende-medicatie-en-natriumbeperking-gecombineerd-effect/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2020/07/01/natriumreductie-verhoogt-korte-keten-vetzuren-bij-onbehandelde-hypertensie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/07/01/natriumreductie-metaboloom-en-cv-risico-bij-onbehandelde-zwarte-hypertensie/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2016/06/01/matige-zoutreductie-verlaagt-bloeddruk-en-albuminurie-bij-gestoorde-glucosetoler/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feng-xie","type":"person","url":"https://hartvaat.nl/mensen/feng-xie/","name":"Feng Xie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/01/sophocarpine-beschermt-tegen-pulmonale-hypertensie-in-preklinische-modellen/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/02/26/patientgerichte-transitional-care-bij-hf-hospitalisatie-jama-pact-hf/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ferenc-horkay","type":"person","url":"https://hartvaat.nl/mensen/ferenc-horkay/","name":"Ferenc Horkay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"filip-casselman","type":"person","url":"https://hartvaat.nl/mensen/filip-casselman/","name":"Filip Casselman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"filippo-ottani","type":"person","url":"https://hartvaat.nl/mensen/filippo-ottani/","name":"Filippo Ottani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"filippo-russo","type":"person","url":"https://hartvaat.nl/mensen/filippo-russo/","name":"Filippo Russo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"finlay-a-mcalister","type":"person","url":"https://hartvaat.nl/mensen/finlay-a-mcalister/","name":"Finlay A McAlister","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/17/bedmed-timing-van-antihypertensieve-medicatie-en-cv-events-jama-definitieve-tria/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2019/08/01/hoog-versus-laag-zuurstof-bij-acuut-hartfalen-hilo-hf-pilot/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/05/01/verlaging-van-diastolische-druk-bij-patienten-met-en-zonder-cardiovasculaire-zie/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florian-m-m-baeres","type":"person","url":"https://hartvaat.nl/mensen/florian-m-m-baeres/","name":"Florian M M Baeres","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"},{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"},{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florim-cuculi","type":"person","url":"https://hartvaat.nl/mensen/florim-cuculi/","name":"Florim Cuculi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/21/1-op-10-patienten-heroptname-binnen-30-dagen-na-tavi-sterfterisico-na-1-jaar-ver/","published":"2026-06-09"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/03/01/bioresorbeerbare-scaffold-trombose-multicenteranalyse-van-klinische-presentatie-/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fosca-quarti-trevano","type":"person","url":"https://hartvaat.nl/mensen/fosca-quarti-trevano/","name":"Fosca Quarti-Trevano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/01/sympathische-overactiviteit-bij-resistente-hypertensie-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/01/01/reproduceerbaarheid-en-behandeleffect-op-kantoor-versus-ambulante-bloeddrukrelat/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2023/03/01/renale-denervatie-en-sympathische-activiteit-systematische-review/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2018/08/01/sympathische-zenuwactivatie-bij-essentiele-hypertensie-meta-analyse/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-cosentino","type":"person","url":"https://hartvaat.nl/mensen/francesco-cosentino/","name":"Francesco Cosentino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-prati","type":"person","url":"https://hartvaat.nl/mensen/francesco-prati/","name":"Francesco Prati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"franz-h-messerli","type":"person","url":"https://hartvaat.nl/mensen/franz-h-messerli/","name":"Franz H Messerli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/07/01/timing-van-antihypertensiva-meta-analyse-van-rct-s-bevestigt-flexibiliteit/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2017/04/06/gewichtsfluctuaties-en-cardiovasculaire-uitkomsten-bij-coronairlijden-nejm/","published":"2017-04-06"},{"url":"https://hartvaat.nl/2016/06/01/selectieve-hartfrequentieverlaging-met-ivabradine-verhoogt-centrale-bloeddruk-bi/","published":"2016-06-01"},{"url":"https://hartvaat.nl/2016/02/02/vergelijking-chlorthalidon-en-hydrochloorthiazide-op-24-uurs-ambulante-bloeddruk/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fraser-j-graham","type":"person","url":"https://hartvaat.nl/mensen/fraser-j-graham/","name":"Fraser J Graham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/23/ijzertekort-bij-chronische-nierziekte-en-hartfalen-expertperspectieven/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fred-m-kusumoto","type":"person","url":"https://hartvaat.nl/mensen/fred-m-kusumoto/","name":"Fred M Kusumoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/08/20/2018-acc-aha-hrs-richtlijn-voor-bradycardie-en-geleidingsstoornissen/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2016/05/17/institutionele-en-operateurvereisten-voor-linker-hartoorocclusie-scai-acc-hrs-st/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fred-s-apple","type":"person","url":"https://hartvaat.nl/mensen/fred-s-apple/","name":"Fred S Apple","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fredrik-calais","type":"person","url":"https://hartvaat.nl/mensen/fredrik-calais/","name":"Fredrik Calais","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"freek-w-a-verheugt","type":"person","url":"https://hartvaat.nl/mensen/freek-w-a-verheugt/","name":"Freek W A Verheugt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"friedrich-koehler","type":"person","url":"https://hartvaat.nl/mensen/friedrich-koehler/","name":"Friedrich Koehler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"friedrich-wilhelm-mohr","type":"person","url":"https://hartvaat.nl/mensen/friedrich-wilhelm-mohr/","name":"Friedrich-Wilhelm Mohr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/07/13/10-jaars-mortaliteit-naar-compleetheid-van-revascularisatie-bij-drievaten-hoofds/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/07/06/optimale-medicamenteuze-therapie-en-10-jaarsmortaliteit-na-revascularisatie/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/02/09/10-jaarsmortaliteit-na-pci-of-cabg-bij-totale-coronairocclusie/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-s-silveira","type":"person","url":"https://hartvaat.nl/mensen/fabio-s-silveira/","name":"Fábio S Silveira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabor-g-toth","type":"person","url":"https://hartvaat.nl/mensen/gabor-g-toth/","name":"Gabor G Toth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabor-z-duray","type":"person","url":"https://hartvaat.nl/mensen/gabor-z-duray/","name":"Gabor Z Duray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geert-jan-geersing","type":"person","url":"https://hartvaat.nl/mensen/geert-jan-geersing/","name":"Geert-Jan Geersing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/nederlandse-huisartsenpost-1-op-20-contacten-voor-benauwdheid-betreft-hartfalen-/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2024/01/23/switchen-van-vka-naar-noac-bij-fragiele-ouderen-met-af-veilig/","published":"2024-01-23"},{"url":"https://hartvaat.nl/2020/08/07/geintegreerd-af-management-in-de-huisartsenpraktijk-all-in-clustergerandomiseerd/","published":"2020-08-07"},{"url":"https://hartvaat.nl/2018/08/01/opportunistische-hf-screening-met-natriuretische-peptiden-bij-af-ipd-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gema-minana","type":"person","url":"https://hartvaat.nl/mensen/gema-minana/","name":"Gema Miñana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/03/expertopinie-hierarchische-eindpunten-op-basis-van-verslechterend-hartfalen-voor/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/bio-impedantie-voor-vochtstatusbepaling-en-prognose-bij-chronisch-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/04/01/iv-ferricarboxymaltose-verbetert-linkeratriale-strain-bij-hartfalen-myocardial-i/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geoffrey-wong","type":"person","url":"https://hartvaat.nl/mensen/geoffrey-wong/","name":"Geoffrey Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-d-yancopoulos","type":"person","url":"https://hartvaat.nl/mensen/george-d-yancopoulos/","name":"George D Yancopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/03/23/photon-aflibercept-8-mg-bij-diabetisch-macula-oedeem-verlengd-doseerinterval/","published":"2024-03-23"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-giannakoulas","type":"person","url":"https://hartvaat.nl/mensen/george-giannakoulas/","name":"George Giannakoulas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/01/14/residuele-lekkage-na-laa-occlusie-en-uitkomsten-meta-analyse/","published":"2024-01-14"},{"url":"https://hartvaat.nl/2023/11/10/transcatheter-asd-sluiting-bij-ouderen-systematische-review-en-meta-analyse/","published":"2023-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-s-stergiou","type":"person","url":"https://hartvaat.nl/mensen/george-s-stergiou/","name":"George S Stergiou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/01/af-screening-tijdens-bloeddrukmeting-diagnostische-nauwkeurigheid/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/01/01/centrale-versus-perifere-bloeddruk-en-doelorgaanschade-systematische-review-en-m/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georgios-tsivgoulis","type":"person","url":"https://hartvaat.nl/mensen/georgios-tsivgoulis/","name":"Georgios Tsivgoulis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-bij-basilarisocclusie-tot-24-uur-veelbelovende-lancet-data/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2020/03/01/bloeddruk-en-uitkomsten-bij-acute-beroerte-trombectomie/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/01/01/bloeddrukverlaging-en-secundaire-cva-preventie-meta-regressieanalyse/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gheorghe-doros","type":"person","url":"https://hartvaat.nl/mensen/gheorghe-doros/","name":"Gheorghe Doros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/10/01/atriumfibrilleren-bij-wild-type-transthyretine-cardiale-amyloidose-review/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/05/14/dubbele-versus-triple-antitrombotische-therapie-bij-af-na-pci-meta-analyse/","published":"2018-05-14"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2016/04/12/protonpompremmers-verminderen-gastro-intestinale-events-ongeacht-aspirinedosis-b/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giacomo-ruotolo","type":"person","url":"https://hartvaat.nl/mensen/giacomo-ruotolo/","name":"Giacomo Ruotolo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/20/solbinsiran-angptl3-remming-van-preklinisch-tot-eerste-humane-studies/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/05/03/solbinsiran-langwerkend-sirna-tegen-angptl3-duurzaamheid-en-effectiviteit/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giedrius-davidavicius","type":"person","url":"https://hartvaat.nl/mensen/giedrius-davidavicius/","name":"Giedrius Davidavičius","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gilbert-gosselin","type":"person","url":"https://hartvaat.nl/mensen/gilbert-gosselin/","name":"Gilbert Gosselin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gilbert-habib","type":"person","url":"https://hartvaat.nl/mensen/gilbert-habib/","name":"Gilbert Habib","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/02/03/effect-van-mavacamten-op-risicoscores-voor-plotse-hartdood-bij-hypertrofische-ca/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2016/02/01/rechterkamerseptumpacing-versus-apexpacing-bij-crt-defibrillator-gerandomiseerde/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gillian-a-j-jessurun","type":"person","url":"https://hartvaat.nl/mensen/gillian-a-j-jessurun/","name":"Gillian A J Jessurun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giorgio-sacchetta","type":"person","url":"https://hartvaat.nl/mensen/giorgio-sacchetta/","name":"Giorgio Sacchetta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-pedrazzini","type":"person","url":"https://hartvaat.nl/mensen/giovanni-pedrazzini/","name":"Giovanni Pedrazzini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulio-francesco-romiti","type":"person","url":"https://hartvaat.nl/mensen/giulio-francesco-romiti/","name":"Giulio Francesco Romiti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/19/cardiovasculair-renaal-metabool-samenspel-bij-patienten-met-atriumfibrilleren/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2022/10/13/cerebrale-microbloedingen-en-risico-bij-af-systematische-review/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/09/14/copd-bij-af-prevalentie-management-en-impact-meta-analyse/","published":"2021-09-14"},{"url":"https://hartvaat.nl/2017/11/01/bloeddrukvariabiliteit-en-uitkomsten-bij-af-affirm-studie/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-de-luca","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-de-luca/","name":"Giuseppe De Luca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-di-pasquale","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-di-pasquale/","name":"Giuseppe Di Pasquale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2020/11/07/complete-revascularisatie-vermindert-cv-dood-bij-stemi-met-multivatenlijden-meta/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-ferrante","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-ferrante/","name":"Giuseppe Ferrante","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-patti","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-patti/","name":"Giuseppe Patti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/24/myocardiale-brug-praktische-gids-voor-diagnose-en-behandeling-in-het-ccta-tijdpe/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2026/02/03/vroeg-starten-met-mra-na-acuut-hartfalen-of-myocardinfarct-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/07/09/coronaire-plaquefenotypeveranderingen-bij-lipidenverlagende-therapie-en-cardiova/","published":"2025-07-09"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-vadala","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-vadala/","name":"Giuseppe Vadalà","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gonzalo-pizarro","type":"person","url":"https://hartvaat.nl/mensen/gonzalo-pizarro/","name":"Gonzalo Pizarro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/10/timing-van-metoprolol-bij-stemi-effect-op-infarctgrootte-en-ventrikelfunctie/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gordon-r-reeves","type":"person","url":"https://hartvaat.nl/mensen/gordon-r-reeves/","name":"Gordon R Reeves","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/07/12/frailteit-beinvloedt-effect-van-inspanningstraining-bij-hartfalen-hf-action-anal/","published":"2022-07-12"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"greg-fulcher","type":"person","url":"https://hartvaat.nl/mensen/greg-fulcher/","name":"Greg Fulcher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregor-fahrni","type":"person","url":"https://hartvaat.nl/mensen/gregor-fahrni/","name":"Gregor Fahrni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/02/paclitaxel-gecoate-ballonnen-versus-des-bij-kleine-vaten-ipd-meta-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2020/05/26/subcutaan-selatogrel-remt-plaatjesaggregatie-bij-acuut-mi/","published":"2020-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregor-leibundgut","type":"person","url":"https://hartvaat.nl/mensen/gregor-leibundgut/","name":"Gregor Leibundgut","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-a-ewald","type":"person","url":"https://hartvaat.nl/mensen/gregory-a-ewald/","name":"Gregory A Ewald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"greta-carrara","type":"person","url":"https://hartvaat.nl/mensen/greta-carrara/","name":"Greta Carrara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2019/02/26/postprocedurele-bivalirudine-infusie-bij-acs-vol-versus-laag-regime/","published":"2019-02-26"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"grzegorz-smolka","type":"person","url":"https://hartvaat.nl/mensen/grzegorz-smolka/","name":"Grzegorz Smolka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/02/26/cardiogene-shock-bij-myocardinfarct-resultaten-van-het-shock-pol-register/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guang-ning","type":"person","url":"https://hartvaat.nl/mensen/guang-ning/","name":"Guang Ning","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guido-tavazzi","type":"person","url":"https://hartvaat.nl/mensen/guido-tavazzi/","name":"Guido Tavazzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/04/29/vroege-iabp-bij-hartfalen-gerelateerde-cardiogene-shock-gerandomiseerde-trial/","published":"2025-04-29"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guillaume-bonnet","type":"person","url":"https://hartvaat.nl/mensen/guillaume-bonnet/","name":"Guillaume Bonnet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2017/11/01/switchen-van-dapt-na-acs-de-topic-trial/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gunnar-gislason","type":"person","url":"https://hartvaat.nl/mensen/gunnar-gislason/","name":"Gunnar Gislason","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/07/31/uit-het-hospitaal-hartstilstand-komt-12-keer-vaker-voor-bij-niet-ischemische-car/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guozhe-sun","type":"person","url":"https://hartvaat.nl/mensen/guozhe-sun/","name":"Guozhe Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gustavs-latkovskis","type":"person","url":"https://hartvaat.nl/mensen/gustavs-latkovskis/","name":"Gustavs Latkovskis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerald-simonneau","type":"person","url":"https://hartvaat.nl/mensen/gerald-simonneau/","name":"Gérald Simonneau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/04/01/hemodynamische-effecten-van-riociguat-bij-inoperabel-cteph/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerard-helft","type":"person","url":"https://hartvaat.nl/mensen/gerard-helft/","name":"Gérard Helft","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geraud-souteyrand","type":"person","url":"https://hartvaat.nl/mensen/geraud-souteyrand/","name":"Géraud Souteyrand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/07/01/calcified-oct-versus-angiografie-bij-pci-van-verkalkte-laesies/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"habib-gamra","type":"person","url":"https://hartvaat.nl/mensen/habib-gamra/","name":"Habib Gamra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/02/01/aspirine-en-cardiovasculaire-uitkomsten-bij-chronische-nierziekte/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"haiying-chen","type":"person","url":"https://hartvaat.nl/mensen/haiying-chen/","name":"Haiying Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-j-woerle","type":"person","url":"https://hartvaat.nl/mensen/hans-j-woerle/","name":"Hans J Woerle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/12/01/empagliflozine-en-bloeddruk-bij-diabetes-type-2-met-hypertensie-naar-achtergrond/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-josef-feistritzer","type":"person","url":"https://hartvaat.nl/mensen/hans-josef-feistritzer/","name":"Hans-Josef Feistritzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hao-zhou","type":"person","url":"https://hartvaat.nl/mensen/hao-zhou/","name":"Hao Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harpreet-s-bhatia","type":"person","url":"https://hartvaat.nl/mensen/harpreet-s-bhatia/","name":"Harpreet S Bhatia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2021/09/21/pcsk9-remming-en-geoxideerde-fosfolipiden/","published":"2021-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"he-huang","type":"person","url":"https://hartvaat.nl/mensen/he-huang/","name":"He Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2021/05/21/katheterablatie-versus-medicatie-bij-persisterend-en-langdurig-persisterend-af-l/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hee-tae-yu","type":"person","url":"https://hartvaat.nl/mensen/hee-tae-yu/","name":"Hee Tae Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/12/03/ct-gestuurde-atriale-wanddiktemapping-bij-cryoballon-pvi/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helen-reeve-stoffer","type":"person","url":"https://hartvaat.nl/mensen/helen-reeve-stoffer/","name":"Helen Reeve-Stoffer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helmut-purerfellner","type":"person","url":"https://hartvaat.nl/mensen/helmut-purerfellner/","name":"Helmut Pürerfellner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2024/08/03/dagontslag-versus-overnachting-na-af-ablatie-uitgebreide-meta-analyse/","published":"2024-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helmut-schumacher","type":"person","url":"https://hartvaat.nl/mensen/helmut-schumacher/","name":"Helmut Schumacher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/07/01/cv-uitkomsten-en-bereikte-bloeddruk-bij-hoog-cv-risico-met-en-zonder-diabetes/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/09/01/bereikte-diastolische-bloeddruk-en-polsdruk-bij-streef-sbp-en-cv-uitkomsten-bij-/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/11/01/gemiddelde-bloeddruk-en-visit-to-visit-variabiliteit-als-gecombineerde-voorspell/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/06/03/bereikte-bloeddruk-en-cv-uitkomsten-bij-hoogrisicopatienten-ontarget-transcend/","published":"2017-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henri-lu","type":"person","url":"https://hartvaat.nl/mensen/henri-lu/","name":"Henri Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/11/finearts-hf-subanalyse-virale-luchtweginfecties-triggeren-hartfalen-verslechteri/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2024/11/01/sacubitril-valsartan-vermindert-alle-hospitalisaties-bij-hartfalen-post-hoc-anal/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henrik-kjaerulf-jensen","type":"person","url":"https://hartvaat.nl/mensen/henrik-kjaerulf-jensen/","name":"Henrik Kjærulf Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henrik-renlund","type":"person","url":"https://hartvaat.nl/mensen/henrik-renlund/","name":"Henrik Renlund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/25/abc-af-risicoscores-voor-gepersonaliseerde-af-behandeling/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henrik-wiggers","type":"person","url":"https://hartvaat.nl/mensen/henrik-wiggers/","name":"Henrik Wiggers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/03/metformine-remt-proliferatie-van-fibro-adipogene-stamcellen-uit-falende-harten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroki-shiomi","type":"person","url":"https://hartvaat.nl/mensen/hiroki-shiomi/","name":"Hiroki Shiomi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroshi-suzuki","type":"person","url":"https://hartvaat.nl/mensen/hiroshi-suzuki/","name":"Hiroshi Suzuki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hisato-takagi","type":"person","url":"https://hartvaat.nl/mensen/hisato-takagi/","name":"Hisato Takagi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2021/08/24/de-escalatie-van-dapt-bij-acs-jacc-review/","published":"2021-08-24"},{"url":"https://hartvaat.nl/2020/01/28/orale-antistolling-bij-af-op-langdurige-hemodialyse/","published":"2020-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hong-jiang","type":"person","url":"https://hartvaat.nl/mensen/hong-jiang/","name":"Hong Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/10/14/heparine-bij-eerste-medisch-contact-versus-voor-primaire-pci-bij-stemi/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2021/05/21/katheterablatie-versus-medicatie-bij-persisterend-en-langdurig-persisterend-af-l/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hong-nie","type":"person","url":"https://hartvaat.nl/mensen/hong-nie/","name":"Hong Nie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"horst-sievert","type":"person","url":"https://hartvaat.nl/mensen/horst-sievert/","name":"Horst Sievert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hossein-ardeschir-ghofrani","type":"person","url":"https://hartvaat.nl/mensen/hossein-ardeschir-ghofrani/","name":"Hossein-Ardeschir Ghofrani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/04/01/hemodynamische-effecten-van-riociguat-bij-inoperabel-cteph/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"howard-a-cooper","type":"person","url":"https://hartvaat.nl/mensen/howard-a-cooper/","name":"Howard A Cooper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2020/03/01/gewicht-en-werkzaamheid-veiligheid-van-doac-s-bij-niet-valvulair-af-meta-analyse/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/09/01/oac-bij-af-met-kleplijden-en-bioprothese-overzicht/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hoyun-kim","type":"person","url":"https://hartvaat.nl/mensen/hoyun-kim/","name":"Hoyun Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hui-nam-pak","type":"person","url":"https://hartvaat.nl/mensen/hui-nam-pak/","name":"Hui-Nam Pak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/12/03/ct-gestuurde-atriale-wanddiktemapping-bij-cryoballon-pvi/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hwanhee-hong","type":"person","url":"https://hartvaat.nl/mensen/hwanhee-hong/","name":"Hwanhee Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyejung-jung","type":"person","url":"https://hartvaat.nl/mensen/hyejung-jung/","name":"Hyejung Jung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyuck-jun-yoon","type":"person","url":"https://hartvaat.nl/mensen/hyuck-jun-yoon/","name":"Hyuck-Jun Yoon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helio-penna-guimaraes","type":"person","url":"https://hartvaat.nl/mensen/helio-penna-guimaraes/","name":"Hélio Penna Guimarães","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-en-evidence-based-prescriptie-bij-hoog-cv-risico-jama-card/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iacopo-olivotto","type":"person","url":"https://hartvaat.nl/mensen/iacopo-olivotto/","name":"Iacopo Olivotto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/01/maple-hcm-is-aficamten-een-keerpunt-bij-obstructieve-hcm/","published":"2026-03-18"},{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iain-findlay","type":"person","url":"https://hartvaat.nl/mensen/iain-findlay/","name":"Iain Findlay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-graham","type":"person","url":"https://hartvaat.nl/mensen/ian-graham/","name":"Ian Graham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ida-gustafsson","type":"person","url":"https://hartvaat.nl/mensen/ida-gustafsson/","name":"Ida Gustafsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iftikhar-j-kullo","type":"person","url":"https://hartvaat.nl/mensen/iftikhar-j-kullo/","name":"Iftikhar J Kullo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/06/01/familiaire-belasting-en-statine-initiatie-bij-intermediair-cardiovasculair-risic/","published":"2016-06-01"},{"url":"https://hartvaat.nl/2016/03/22/genetische-risicoscore-en-ldl-cholesterolbehandeling-bij-coronairlijden/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ify-r-mordi","type":"person","url":"https://hartvaat.nl/mensen/ify-r-mordi/","name":"Ify R Mordi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2020/11/03/sglt2-remming-plus-lisdiuretica-bij-diabetes-type-2-met-ckd-renale-en-cv-effecte/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2019/11/01/metformine-en-linkerventrikelhypertrofie-bij-coronairlijden-zonder-diabetes-gera/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/02/12/genetisch-risico-op-coronairlijden-en-ontwikkeling-van-hfref-versus-hfpef/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ignacio-amat-santos","type":"person","url":"https://hartvaat.nl/mensen/ignacio-amat-santos/","name":"Ignacio Amat Santos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ignacio-cruz-gonzalez","type":"person","url":"https://hartvaat.nl/mensen/ignacio-cruz-gonzalez/","name":"Ignacio Cruz-González","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-doac-versus-dapt-na-laa-occlusie-gerandomiseerde-trial/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilya-m-nasrallah","type":"person","url":"https://hartvaat.nl/mensen/ilya-m-nasrallah/","name":"Ilya M Nasrallah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukcontrole-en-cerebrale-small-vessel-disease-markers/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"imad-sheiban","type":"person","url":"https://hartvaat.nl/mensen/imad-sheiban/","name":"Imad Sheiban","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ingrid-hopper","type":"person","url":"https://hartvaat.nl/mensen/ingrid-hopper/","name":"Ingrid Hopper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/pneumokokkenvaccinatie-en-cv-eventpreventie-ipd-meta-analyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iqbal-s-malik","type":"person","url":"https://hartvaat.nl/mensen/iqbal-s-malik/","name":"Iqbal S Malik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irina-barash","type":"person","url":"https://hartvaat.nl/mensen/irina-barash/","name":"Irina Barash","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/victor-vericiguat-bij-chronisch-hfref-dubbelblinde-fase-3b-trial/","published":"2025-09-27"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"itaru-hisauchi","type":"person","url":"https://hartvaat.nl/mensen/itaru-hisauchi/","name":"Itaru Hisauchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2020/08/01/canagliflozine-bij-diabetes-type-2-met-chronisch-hf-candle-gerandomiseerde-trial/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"itsuro-morishima","type":"person","url":"https://hartvaat.nl/mensen/itsuro-morishima/","name":"Itsuro Morishima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivo-m-van-dongen","type":"person","url":"https://hartvaat.nl/mensen/ivo-m-van-dongen/","name":"Ivo M van Dongen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-c","type":"person","url":"https://hartvaat.nl/mensen/j-c/","name":"J. C.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/29/geleidingssysteem-pacing-slaat-rechterventrikel-pacing-bij-av-blok-70-hartfalen-/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/02/23/invasieve-coronaire-functietest-bij-anoca-verandert-de-behandeling-bij-driekwart/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-myocardinfarct-winratio-analyse-uit-de-cle/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/29/obesitasparadox-bij-het-takotsubosyndroom-ondergewicht-geeft-de-hoogste-sterfte-/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-j","type":"person","url":"https://hartvaat.nl/mensen/j-j/","name":"J. J.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/29/geisoleerde-secundaire-tricuspidalisinsufficientie-na-linkszijdige-klepchirurgie/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/05/26/asymptomatische-matige-ernstige-aortaklepinsufficientie-niet-benigne-meta-analys/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/04/24/grote-ziekenhuisvariatie-in-mcs-gebruik-bij-myocardinfarct-met-cardiogene-shock/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/01/09/hartfalendiagnostiek-na-corona-bijna-niemand-kreeg-de-echo-binnen-de-aanbevolen-/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacob-tfelt-hansen","type":"person","url":"https://hartvaat.nl/mensen/jacob-tfelt-hansen/","name":"Jacob Tfelt-Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/07/31/uit-het-hospitaal-hartstilstand-komt-12-keer-vaker-voor-bij-niet-ischemische-car/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2026/02/03/coronaire-vaatspasmen-bij-overlevenden-van-hartstilstand/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacopo-francesco-imberti","type":"person","url":"https://hartvaat.nl/mensen/jacopo-francesco-imberti/","name":"Jacopo Francesco Imberti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2024/08/03/device-algoritmen-voor-rv-pacingminimalisatie-meta-analyse-van-uitkomsten/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2024/08/03/dagontslag-versus-overnachting-na-af-ablatie-uitgebreide-meta-analyse/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2021/10/01/katheterablatie-als-eerstelijns-paf-therapie-meta-analyse/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacqueline-e-tamis-holland","type":"person","url":"https://hartvaat.nl/mensen/jacqueline-e-tamis-holland/","name":"Jacqueline E Tamis-Holland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacques-genest","type":"person","url":"https://hartvaat.nl/mensen/jacques-genest/","name":"Jacques Genest","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/14/sekseverschillen-in-fh-behandeling-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/09/07/aortastenose-bij-homozygote-familiaire-hypercholesterolemie-paradigmaverschuivin/","published":"2022-09-07"},{"url":"https://hartvaat.nl/2020/06/02/prevalentie-van-fh-bij-atherosclerotische-cv-ziekte-meta-analyse/","published":"2020-06-02"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jae-woong-choi","type":"person","url":"https://hartvaat.nl/mensen/jae-woong-choi/","name":"Jae Woong Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jae-sun-uhm","type":"person","url":"https://hartvaat.nl/mensen/jae-sun-uhm/","name":"Jae-Sun Uhm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/12/03/ct-gestuurde-atriale-wanddiktemapping-bij-cryoballon-pvi/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jagat-narula","type":"person","url":"https://hartvaat.nl/mensen/jagat-narula/","name":"Jagat Narula","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/09/02/coronaire-flow-capaciteits-geleide-revascularisatie-versus-standaardzorg-rct/","published":"2025-09-02"},{"url":"https://hartvaat.nl/2020/08/25/machine-learning-voor-lv-diastolische-functie-op-ecg/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaimini-cegla","type":"person","url":"https://hartvaat.nl/mensen/jaimini-cegla/","name":"Jaimini Cegla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/ehj-review-dyslipidemie-bij-kankerpatienten-verhoogd-ascvd-risico-beperkte-data-/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-a-blumenthal","type":"person","url":"https://hartvaat.nl/mensen/james-a-blumenthal/","name":"James A Blumenthal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/12/01/acute-aerobe-training-en-kortdurende-ambulante-bloeddrukreductie-bij-hypertensie/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/10/12/leefstijlmodificatie-bij-resistente-hypertensie-triumph-gerandomiseerde-trial/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2016/04/05/hartrevalidatie-versterkt-met-stressmanagementtraining-gerandomiseerde-trial/","published":"2016-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-k-min","type":"person","url":"https://hartvaat.nl/mensen/james-k-min/","name":"James K Min","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2018/10/16/hoge-coronaire-shear-stress-voorspelt-myocardinfarct/","published":"2018-10-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-l-velianou","type":"person","url":"https://hartvaat.nl/mensen/james-l-velianou/","name":"James L Velianou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-s-gammie","type":"person","url":"https://hartvaat.nl/mensen/james-s-gammie/","name":"James S Gammie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-f-gummert","type":"person","url":"https://hartvaat.nl/mensen/jan-f-gummert/","name":"Jan F Gummert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2017/08/01/vitamine-d-en-mortaliteit-bij-hartfalen-de-evita-3-jaars-gerandomiseerde-trial/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-filipovsky","type":"person","url":"https://hartvaat.nl/mensen/jan-filipovsky/","name":"Jan Filipovský","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jang-hyun-cho","type":"person","url":"https://hartvaat.nl/mensen/jang-hyun-cho/","name":"Jang Hyun Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janice-pogue","type":"person","url":"https://hartvaat.nl/mensen/janice-pogue/","name":"Janice Pogue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaroslaw-drozdz","type":"person","url":"https://hartvaat.nl/mensen/jaroslaw-drozdz/","name":"Jaroslaw Drozdz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2020/10/27/dapagliflozine-en-poliklinische-verslechtering-bij-hfref-dapa-hf/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaros-aw-drozdz","type":"person","url":"https://hartvaat.nl/mensen/jaros-aw-drozdz/","name":"Jarosław Drożdż","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jason-n-dungu","type":"person","url":"https://hartvaat.nl/mensen/jason-n-dungu/","name":"Jason N Dungu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jawdat-abdulla","type":"person","url":"https://hartvaat.nl/mensen/jawdat-abdulla/","name":"Jawdat Abdulla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/02/01/ccta-afgeleide-ffr-prognostische-waarde-meta-analyse/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/kenmerken-en-prognose-van-hfmref-versus-hfref-en-hfpef-langetermijn/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-louis-georges","type":"person","url":"https://hartvaat.nl/mensen/jean-louis-georges/","name":"Jean-Louis Georges","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-b-washam","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-b-washam/","name":"Jeffrey B Washam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-e-olgin","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-e-olgin/","name":"Jeffrey E Olgin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/decaf-cafeinehoudende-koffie-en-af-gerandomiseerde-trial/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2022/02/01/geindividualiseerde-triggerstudies-bij-paroxysmaal-af-jama-i-stop-afib/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2016/03/15/voorspelling-van-persisterende-lv-disfunctie-na-myocardinfarct-de-predicts-studi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-l-carson","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-l-carson/","name":"Jeffrey L Carson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/23/top-liberaal-versus-restrictief-transfusiebeleid-bij-hoogrisico-hartchirurgie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-s-riesmeyer","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-s-riesmeyer/","name":"Jeffrey S Riesmeyer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/11/13/tirzepatide-versus-insuline-glargine-bij-diabetes-type-2-met-hoog-cv-risico-lanc/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jelena-celutkiene","type":"person","url":"https://hartvaat.nl/mensen/jelena-celutkiene/","name":"Jelena Celutkiene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/06/strong-hf-optitratie-effectief-over-het-hele-ef-spectrum-na-hf-opname/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/12/03/strong-hf-snelle-optitratie-van-hartfalenmedicatie-na-ziekenhuis-is-veilig-en-ef/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-g-robinson","type":"person","url":"https://hartvaat.nl/mensen/jennifer-g-robinson/","name":"Jennifer G Robinson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/12/01/cardiovasculaire-risicocommunicatie-en-patientperceptie-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/04/17/uitgangs-ldl-en-mortaliteitsreductie-na-ldl-verlaging-jama-meta-analyse/","published":"2018-04-17"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2016/10/14/geen-effect-van-pcsk9-remmer-alirocumab-op-diabetes-incidentie-odyssey-analyse/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-k-sun","type":"person","url":"https://hartvaat.nl/mensen/jennifer-k-sun/","name":"Jennifer K Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/08/25/aflibercept-versus-bevacizumab-eerst-bij-diabetisch-macula-oedeem/","published":"2022-08-25"},{"url":"https://hartvaat.nl/2022/02/19/faricimab-bij-diabetisch-maculaoedeem-met-verlengde-dosering-lancet/","published":"2022-02-19"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-s-herrick","type":"person","url":"https://hartvaat.nl/mensen/jennifer-s-herrick/","name":"Jennifer S Herrick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/08/01/combinatietabletten-voor-intensieve-bloeddrukbehandeling-sprint-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-von-stein","type":"person","url":"https://hartvaat.nl/mensen/jennifer-von-stein/","name":"Jennifer von Stein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/05/25/1-op-5-oudere-patienten-heeft-hartfalen-opname-binnen-jaar-na-tavr-1-jaarsmortal/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-kastrup","type":"person","url":"https://hartvaat.nl/mensen/jens-kastrup/","name":"Jens Kastrup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/01/science-ii-mesenchymale-stamcellen-bij-niet-ischemisch-hartfalen-negatieve-trial/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-wiebe","type":"person","url":"https://hartvaat.nl/mensen/jens-wiebe/","name":"Jens Wiebe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/10/01/pci-versus-cabg-bij-linker-hoofdstamstenose-jama-cardiology-systematische-review/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeremy-william","type":"person","url":"https://hartvaat.nl/mensen/jeremy-william/","name":"Jeremy William","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jian-liu","type":"person","url":"https://hartvaat.nl/mensen/jian-liu/","name":"Jian Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/23/intensief-versus-conventioneel-intraoperatief-bloeddrukmanagement-en-cv-events-n/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2019/10/01/sekseverschillen-bij-katheterablatie-van-af-meta-analyse/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiang","type":"person","url":"https://hartvaat.nl/mensen/jiang/","name":"Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/03/voorspelmodellen-voor-hartfalen-bij-patienten-met-instabiele-angina-pectoris/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/26/ai-clustering-onthult-drie-functionele-risicoprofielen-bij-hartfalen/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2026/02/20/kosteneffectiviteit-van-mavacamten-bij-obstructieve-hcm-gezondheidswinst-maar-ee/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2026/02/20/geintegreerd-machine-learningmodel-voorspelt-cardiovasculair-risico-beter-dan-de/","published":"2026-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiangling-liu","type":"person","url":"https://hartvaat.nl/mensen/jiangling-liu/","name":"Jiangling Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jim-hansen","type":"person","url":"https://hartvaat.nl/mensen/jim-hansen/","name":"Jim Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/07/01/qt-als-voorspeller-van-af-recidief-na-ablatie-en-amiodaronimpact-amio-cat/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-bae-lee","type":"person","url":"https://hartvaat.nl/mensen/jin-bae-lee/","name":"Jin Bae Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-sin-koh","type":"person","url":"https://hartvaat.nl/mensen/jin-sin-koh/","name":"Jin-Sin Koh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jinho-lee","type":"person","url":"https://hartvaat.nl/mensen/jinho-lee/","name":"Jinho Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiyan-chen","type":"person","url":"https://hartvaat.nl/mensen/jiyan-chen/","name":"Jiyan Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/27/verhoogd-lp-a-en-diabetes-verergeren-samen-de-prognose-bij-coronairlijden/","published":"2026-02-27"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joban-sehmi","type":"person","url":"https://hartvaat.nl/mensen/joban-sehmi/","name":"Joban Sehmi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joel-singer","type":"person","url":"https://hartvaat.nl/mensen/joel-singer/","name":"Joel Singer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/03/01/orale-antihypertensiva-bij-niet-ernstige-zwangerschapshypertensie-netwerkmeta-an/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2018/06/01/amenorroe-duur-bij-start-antihypertensiva-in-de-zwangerschap-chips-secundaire-an/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joerg-koglin","type":"person","url":"https://hartvaat.nl/mensen/joerg-koglin/","name":"Joerg Koglin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"},{"url":"https://hartvaat.nl/2020/05/14/vericiguat-bij-hfref-nejm-victoria/","published":"2020-05-14"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johannes-holzmeister","type":"person","url":"https://hartvaat.nl/mensen/johannes-holzmeister/","name":"Johannes Holzmeister","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johannes-petutschnigg","type":"person","url":"https://hartvaat.nl/mensen/johannes-petutschnigg/","name":"Johannes Petutschnigg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2020/06/01/economische-impact-van-hfpef-aldo-dhf-inzichten/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johannes-sperzel","type":"person","url":"https://hartvaat.nl/mensen/johannes-sperzel/","name":"Johannes Sperzel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"},{"url":"https://hartvaat.nl/2017/04/01/aanvullende-elektroden-op-de-quartet-lv-lead-bieden-meer-crt-programmeringsmogel/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-henderson","type":"person","url":"https://hartvaat.nl/mensen/john-henderson/","name":"John Henderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-kjekshus","type":"person","url":"https://hartvaat.nl/mensen/john-kjekshus/","name":"John Kjekshus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-w-ostrominski","type":"person","url":"https://hartvaat.nl/mensen/john-w-ostrominski/","name":"John W Ostrominski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johnson","type":"person","url":"https://hartvaat.nl/mensen/johnson/","name":"Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/30/etnische-verschillen-in-sterfte-na-acuut-coronair-syndroom-hogere-mortaliteit-bi/","published":"2026-07-11"},{"url":"https://hartvaat.nl/2026/02/20/virtuele-afdeling-met-thuismonitoring-is-veilig-voor-patienten-die-wachten-op-sp/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2026/01/23/multidisciplinair-cardiogene-shockteam-verbetert-de-1-jaarsoverleving-bij-infarc/","published":"2026-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-emberson","type":"person","url":"https://hartvaat.nl/mensen/jonathan-emberson/","name":"Jonathan Emberson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/07/01/kosteneffectiviteit-van-statines-en-ezetimibe-bij-chronische-nierziekte/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/05/05/perioperatief-rosuvastatine-bij-hartchirurgie-nejm-trial/","published":"2016-05-05"},{"url":"https://hartvaat.nl/2016/03/05/bloeddrukverlaging-ter-preventie-van-hart-en-vaatziekten-systematische-review-en/","published":"2016-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-h-ward","type":"person","url":"https://hartvaat.nl/mensen/jonathan-h-ward/","name":"Jonathan H Ward","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2022/10/18/dosisrespons-van-sacubitril-valsartan-bij-hfref/","published":"2022-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-m-hill","type":"person","url":"https://hartvaat.nl/mensen/jonathan-m-hill/","name":"Jonathan M Hill","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joni-k-snyder","type":"person","url":"https://hartvaat.nl/mensen/joni-k-snyder/","name":"Joni K Snyder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jordi-salas-salvado","type":"person","url":"https://hartvaat.nl/mensen/jordi-salas-salvado/","name":"Jordi Salas-Salvadó","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-h-flores-arredondo","type":"person","url":"https://hartvaat.nl/mensen/jose-h-flores-arredondo/","name":"Jose H Flores-Arredondo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josef-coresh","type":"person","url":"https://hartvaat.nl/mensen/josef-coresh/","name":"Josef Coresh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2016/02/04/risicoprojectie-voor-nierfalen-bij-levende-nierdonorkandidaten/","published":"2016-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-e-marine","type":"person","url":"https://hartvaat.nl/mensen/joseph-e-marine/","name":"Joseph E Marine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/26/2020-acc-aha-kwaliteitsmaten-voor-af-geactualiseerd/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/08/20/2018-acc-aha-hrs-richtlijn-voor-bradycardie-en-geleidingsstoornissen/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-faiella-tommasino","type":"person","url":"https://hartvaat.nl/mensen/joseph-faiella-tommasino/","name":"Joseph Faiella-Tommasino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-boggia","type":"person","url":"https://hartvaat.nl/mensen/jose-boggia/","name":"José Boggia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-tunon","type":"person","url":"https://hartvaat.nl/mensen/jose-tunon/","name":"José Tuñón","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pcsk9-remmers-verlagen-events-bij-ascvd-zonder-eerder-infarct-of-beroerte-real-w/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2023/08/01/bio-impedantieanalyse-bij-overgewicht-en-acuut-hartfalen-pilotstudie/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joyce-peper","type":"person","url":"https://hartvaat.nl/mensen/joyce-peper/","name":"Joyce Peper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julian-k-r-chun","type":"person","url":"https://hartvaat.nl/mensen/julian-k-r-chun/","name":"Julian K R Chun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2026/02/03/atriumfibrilleren-bij-kankerpatienten-de-esc-richtlijn-2025-in-de-praktijk/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-a-anderson","type":"person","url":"https://hartvaat.nl/mensen/julie-a-anderson/","name":"Julie A Anderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/04/30/fluticason-vilanterol-en-overleving-bij-copd-met-verhoogd-cardiovasculair-risico/","published":"2016-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julinda-mehilli","type":"person","url":"https://hartvaat.nl/mensen/julinda-mehilli/","name":"Julinda Mehilli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julio-a-panza","type":"person","url":"https://hartvaat.nl/mensen/julio-a-panza/","name":"Julio A Panza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/03/01/gewicht-en-werkzaamheid-veiligheid-van-doac-s-bij-niet-valvulair-af-meta-analyse/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/09/01/oac-bij-af-met-kleplijden-en-bioprothese-overzicht/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-won-lee","type":"person","url":"https://hartvaat.nl/mensen/jun-won-lee/","name":"Jun-Won Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jung-hee-lee","type":"person","url":"https://hartvaat.nl/mensen/jung-hee-lee/","name":"Jung-Hee Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jurgen-a-h-r-claassen","type":"person","url":"https://hartvaat.nl/mensen/jurgen-a-h-r-claassen/","name":"Jurgen A H R Claassen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/05/01/antihypertensieve-behandeling-en-cerebrale-bloedflow-meta-analyse/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/11/01/bloeddrukvariabiliteit-en-progressie-van-klinische-alzheimer/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/08/01/nilvadipine-en-cerebrale-bloedflow-bij-alzheimer-gerandomiseerde-trial/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"justin-g-l-m-luermans","type":"person","url":"https://hartvaat.nl/mensen/justin-g-l-m-luermans/","name":"Justin G L M Luermans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorg-taubel","type":"person","url":"https://hartvaat.nl/mensen/jorg-taubel/","name":"Jörg Täubel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2023/07/20/zilebesiran-rna-interferentietherapie-voor-hypertensie-nejm/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2021/01/07/antisense-tegen-microrna-132-bij-hartfalen-fase-1b-resultaten/","published":"2021-01-07"},{"url":"https://hartvaat.nl/2017/01/05/inclisiran-een-langwerkende-rna-interferentie-pcsk9-remmer-nejm/","published":"2017-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jrgen-vestbo","type":"person","url":"https://hartvaat.nl/mensen/jrgen-vestbo/","name":"Jørgen Vestbo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/04/30/fluticason-vilanterol-en-overleving-bij-copd-met-verhoogd-cardiovasculair-risico/","published":"2016-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"k-r-julian-chun","type":"person","url":"https://hartvaat.nl/mensen/k-r-julian-chun/","name":"K R Julian Chun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kalina-kawecka-jaszcz","type":"person","url":"https://hartvaat.nl/mensen/kalina-kawecka-jaszcz/","name":"Kalina Kawecka-Jaszcz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kamal-gupta","type":"person","url":"https://hartvaat.nl/mensen/kamal-gupta/","name":"Kamal Gupta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karel-g-m-moons","type":"person","url":"https://hartvaat.nl/mensen/karel-g-m-moons/","name":"Karel G M Moons","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/08/07/geintegreerd-af-management-in-de-huisartsenpraktijk-all-in-clustergerandomiseerd/","published":"2020-08-07"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/08/01/opportunistische-hf-screening-met-natriuretische-peptiden-bij-af-ipd-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/02/21/fibrinogeenconcentraat-bij-intraoperatief-bloedverlies-tijdens-hoog-risico-hartc/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-l-furie","type":"person","url":"https://hartvaat.nl/mensen/karen-l-furie/","name":"Karen L Furie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/19/secundaire-preventie-na-ischemisch-cva-overzicht-uit-het-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-l-o-sullivan","type":"person","url":"https://hartvaat.nl/mensen/karen-l-o-sullivan/","name":"Karen L O'Sullivan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karin-h-humphries","type":"person","url":"https://hartvaat.nl/mensen/karin-h-humphries/","name":"Karin H Humphries","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/06/14/langetermijnuitkomsten-bij-angina-zonder-obstructief-coronairlijden-systematisch/","published":"2018-06-14"},{"url":"https://hartvaat.nl/2018/05/01/verlaging-van-diastolische-druk-bij-patienten-met-en-zonder-cardiovasculaire-zie/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/12/19/chirurgische-versus-percutane-revascularisatie-bij-diabetes-met-acs/","published":"2017-12-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-wallendszus","type":"person","url":"https://hartvaat.nl/mensen/karl-wallendszus/","name":"Karl Wallendszus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karoline-liisberg","type":"person","url":"https://hartvaat.nl/mensen/karoline-liisberg/","name":"Karoline Liisberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/22/inflammatie-bij-obesitas-gerelateerd-hfpef-step-hfpef-mechanistisch-inzicht/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/16/semaglutide-en-nyha-klasse-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kasper-kyhl","type":"person","url":"https://hartvaat.nl/mensen/kasper-kyhl/","name":"Kasper Kyhl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katarzyna-stolarz-skrzypek","type":"person","url":"https://hartvaat.nl/mensen/katarzyna-stolarz-skrzypek/","name":"Katarzyna Stolarz-Skrzypek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katia-audisio","type":"person","url":"https://hartvaat.nl/mensen/katia-audisio/","name":"Katia Audisio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katja-rohwedder","type":"person","url":"https://hartvaat.nl/mensen/katja-rohwedder/","name":"Katja Rohwedder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-bij-recent-verslechterend-hartfalen/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katja-zeppenfeld","type":"person","url":"https://hartvaat.nl/mensen/katja-zeppenfeld/","name":"Katja Zeppenfeld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2017/04/01/beperkte-chirurgische-linkeratriumablatie-bij-af-effectief-maar-vermindert-la-fu/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuma-oyama","type":"person","url":"https://hartvaat.nl/mensen/kazuma-oyama/","name":"Kazuma Oyama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/09/01/dapagliflozine-effectief-ongeacht-cv-achtergrondmedicatie-declare-subanalyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2022/08/14/obesitas-en-dapagliflozine-bij-type-2-diabetes-declare-timi-58-subanalyse/","published":"2022-08-14"},{"url":"https://hartvaat.nl/2021/10/12/baseline-ldl-en-klinische-uitkomsten-van-ezetimibe-plus-statine-improve-it/","published":"2021-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazushige-kadota","type":"person","url":"https://hartvaat.nl/mensen/kazushige-kadota/","name":"Kazushige Kadota","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kengo-kusano","type":"person","url":"https://hartvaat.nl/mensen/kengo-kusano/","name":"Kengo Kusano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2016/12/27/hotballoon-pulmonaalvene-ablatie-bij-paroxysmaal-af-japanse-multicenter-trial/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kengo-tanabe","type":"person","url":"https://hartvaat.nl/mensen/kengo-tanabe/","name":"Kengo Tanabe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kent-r-bailey","type":"person","url":"https://hartvaat.nl/mensen/kent-r-bailey/","name":"Kent R Bailey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/06/01/familiaire-belasting-en-statine-initiatie-bij-intermediair-cardiovasculair-risic/","published":"2016-06-01"},{"url":"https://hartvaat.nl/2016/03/22/genetische-risicoscore-en-ldl-cholesterolbehandeling-bij-coronairlijden/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kershaw-v-patel","type":"person","url":"https://hartvaat.nl/mensen/kershaw-v-patel/","name":"Kershaw V Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2020/12/22/lichaamssamenstelling-en-risico-op-hartfalen-en-mi-prospectieve-analyse/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-l-thomas","type":"person","url":"https://hartvaat.nl/mensen/kevin-l-thomas/","name":"Kevin L Thomas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2021/07/13/ablatie-versus-medicatie-bij-af-naar-ras-en-etniciteit/","published":"2021-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ki-dong-yoo","type":"person","url":"https://hartvaat.nl/mensen/ki-dong-yoo/","name":"Ki-Dong Yoo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kim-fox","type":"person","url":"https://hartvaat.nl/mensen/kim-fox/","name":"Kim Fox","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2020/09/19/trimetazidine-na-pci-lancet-atpci-gerandomiseerde-trial/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kim-houlind","type":"person","url":"https://hartvaat.nl/mensen/kim-houlind/","name":"Kim Houlind","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/05/03/semaglutide-en-loopafstand-bij-perifeer-vaatlijden-en-diabetes/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2023/05/27/best-cli-veneuze-bypass-versus-endovasculair-bij-chronische-kritieke-ischemie/","published":"2023-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kim-rajappan","type":"person","url":"https://hartvaat.nl/mensen/kim-rajappan/","name":"Kim Rajappan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/10/13/dagopname-na-af-ablatie-even-veilig-als-overnachting-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2018/01/01/endocardiale-linkerkamer-pacing-voor-crt-systematische-review-en-meta-analyse/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kirstine-brown-frandsen","type":"person","url":"https://hartvaat.nl/mensen/kirstine-brown-frandsen/","name":"Kirstine Brown-Frandsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"klaus-k-witte","type":"person","url":"https://hartvaat.nl/mensen/klaus-k-witte/","name":"Klaus K Witte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/02/01/diabetes-en-sacubitril-valsartan-titratie-bij-hartfalen-na-opname/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2017/08/07/remote-management-van-hartfalen-met-implanteerbare-devices-overzicht/","published":"2017-08-07"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ko-yamamoto","type":"person","url":"https://hartvaat.nl/mensen/ko-yamamoto/","name":"Ko Yamamoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koichi-nakao","type":"person","url":"https://hartvaat.nl/mensen/koichi-nakao/","name":"Koichi Nakao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2017/08/01/ldl-cholesterol-streefwaarden-met-pitavastatine-ezetimibe-bij-acs-met-dyslipidem/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantina-chalkou","type":"person","url":"https://hartvaat.nl/mensen/konstantina-chalkou/","name":"Konstantina Chalkou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-c-siontis","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-c-siontis/","name":"Konstantinos C Siontis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/08/02/af-ablatie-bij-hypertrofische-cardiomyopathie-meta-analyse/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2017/02/14/doac-s-bij-af-met-kleplijden-excl-significante-mitralisstenose-meta-analyse/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-d-rizas","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-d-rizas/","name":"Konstantinos D Rizas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2017/07/14/voorspelling-van-plotse-versus-niet-plotse-hartdood-na-mi-met-verminderde-lvef/","published":"2017-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-pamporis","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-pamporis/","name":"Konstantinos Pamporis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/30/linear-trial-lattice-tip-katheter-verslaat-standaard-irrigatie-bij-cti-ablatie-v/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/af-ablatie-timing-naar-af-duur-impact-op-aritmierecidief/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-prokopidis","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-prokopidis/","name":"Konstantinos Prokopidis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/03/mortaliteit-en-hospitalisaties-bij-hfpef-versus-hfref-vergelijkende-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/01/piek-vo2-en-prognose-bij-hartfalen-meta-analyse/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/08/01/opnameduur-en-eerdere-hf-opnames-bij-frailteit-en-hartfalen-systematische-review/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/01/natriuretische-peptiden-en-crp-bij-hartfalen-en-ondervoeding-systematische-revie/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kumar-balasubramanian","type":"person","url":"https://hartvaat.nl/mensen/kumar-balasubramanian/","name":"Kumar Balasubramanian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kwan-yong-lee","type":"person","url":"https://hartvaat.nl/mensen/kwan-yong-lee/","name":"Kwan Yong Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyohei-yamaji","type":"person","url":"https://hartvaat.nl/mensen/kyohei-yamaji/","name":"Kyohei Yamaji","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laine-thomas","type":"person","url":"https://hartvaat.nl/mensen/laine-thomas/","name":"Laine Thomas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-fauchier","type":"person","url":"https://hartvaat.nl/mensen/laurent-fauchier/","name":"Laurent Fauchier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-m-haegeli","type":"person","url":"https://hartvaat.nl/mensen/laurent-m-haegeli/","name":"Laurent M Haegeli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2016/01/01/gesimuleerde-obstructieve-slaapapneu-bevordert-ritmestoornissen-bij-paroxysmaal-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leanne-t-bloedon","type":"person","url":"https://hartvaat.nl/mensen/leanne-t-bloedon/","name":"LeAnne T Bloedon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2019/11/12/bempedoinezuur-toegevoegd-aan-statines-bij-hoog-cv-risico-jama-clear-harmony/","published":"2019-11-12"},{"url":"https://hartvaat.nl/2019/03/14/bempedoinezuur-voor-ldl-verlaging-nejm-veiligheid-en-werkzaamheid/","published":"2019-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lenore-j-launer","type":"person","url":"https://hartvaat.nl/mensen/lenore-j-launer/","name":"Lenore J Launer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leonhard-bruch","type":"person","url":"https://hartvaat.nl/mensen/leonhard-bruch/","name":"Leonhard Bruch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leslee-j-shaw","type":"person","url":"https://hartvaat.nl/mensen/leslee-j-shaw/","name":"Leslee J Shaw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lewis-a-lipsitz","type":"person","url":"https://hartvaat.nl/mensen/lewis-a-lipsitz/","name":"Lewis A Lipsitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/01/hypotensieve-episodes-op-24-uurs-abpm-en-cognitieve-functie-sprint-inzichten/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/04/01/lichaamshouding-en-orthostatische-hypotensie-bij-hypertensie-syst-eur-analyse/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2018/10/01/hypertensiebehandeling-en-orthostatische-hypotensie-relatie-met-cv-ziekte/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lijing-l-yan","type":"person","url":"https://hartvaat.nl/mensen/lijing-l-yan/","name":"Lijing L Yan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/02/barrieres-bij-implementatie-van-lipidenverlagende-therapie-in-de-praktijk/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"likun-ma","type":"person","url":"https://hartvaat.nl/mensen/likun-ma/","name":"Likun Ma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liping-zhang","type":"person","url":"https://hartvaat.nl/mensen/liping-zhang/","name":"Liping Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liqun-zhang","type":"person","url":"https://hartvaat.nl/mensen/liqun-zhang/","name":"Liqun Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-m-wruck","type":"person","url":"https://hartvaat.nl/mensen/lisa-m-wruck/","name":"Lisa M Wruck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisheng-liu","type":"person","url":"https://hartvaat.nl/mensen/lisheng-liu/","name":"Lisheng Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/08/17/cholesterol-en-bloeddrukverlaging-na-hope-3-8-7-jaars-follow-up/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lluis-serra-majem","type":"person","url":"https://hartvaat.nl/mensen/lluis-serra-majem/","name":"Lluís Serra-Majem","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lorraine-c-nnacheta","type":"person","url":"https://hartvaat.nl/mensen/lorraine-c-nnacheta/","name":"Lorraine C Nnacheta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"louis-p-perrault","type":"person","url":"https://hartvaat.nl/mensen/louis-p-perrault/","name":"Louis P Perrault","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luciano-f-drager","type":"person","url":"https://hartvaat.nl/mensen/luciano-f-drager/","name":"Luciano F Drager","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/04/01/spironolacton-versus-clonidine-als-vierde-middel-bij-resistente-hypertensie-reho/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucio-d-anna","type":"person","url":"https://hartvaat.nl/mensen/lucio-d-anna/","name":"Lucio D'Anna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-padeletti","type":"person","url":"https://hartvaat.nl/mensen/luigi-padeletti/","name":"Luigi Padeletti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2018/05/01/crt-voordeel-bij-concordant-versus-discordant-linksbundeltakblok-esc-hf-pilot/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/03/07/contractiliteitssensor-geleide-crt-optimalisatie-respond-crt-trial/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2017/02/01/reductie-van-onnodige-ventriculaire-pacing-en-klinische-uitkomsten-bij-behouden-/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-e-rohde","type":"person","url":"https://hartvaat.nl/mensen/luis-e-rohde/","name":"Luis E Rohde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/02/01/nyha-klasse-versus-objectieve-metingen-bij-mild-hartfalen-paradigm-hf-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/11/21/diureticastaken-bij-stabiel-mild-hf-zonder-vochtretentie/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-manzano","type":"person","url":"https://hartvaat.nl/mensen/luis-manzano/","name":"Luis Manzano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/02/01/clorotic-thiazide-toevoegen-aan-lisdiureticum-bij-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lukas-stolz","type":"person","url":"https://hartvaat.nl/mensen/lukas-stolz/","name":"Lukas Stolz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lynne-t-braun","type":"person","url":"https://hartvaat.nl/mensen/lynne-t-braun/","name":"Lynne T Braun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-angelyn-bethel","type":"person","url":"https://hartvaat.nl/mensen/m-angelyn-bethel/","name":"M Angelyn Bethel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-n","type":"person","url":"https://hartvaat.nl/mensen/m-n/","name":"M. N.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/20/hypochloremie-bij-opname-voor-acuut-hartfalen-voorspelt-onafhankelijk-30-daagse-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/03/10/machine-learning-voorspelt-30-daagse-sterfte-na-een-dotterbehandeling-australisc/","published":"2026-03-10"},{"url":"https://hartvaat.nl/2026/01/30/lager-opleidingsniveau-hangt-samen-met-meer-halsslagaderplaques-los-van-risicofa/","published":"2026-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"madhu-k-natarajan","type":"person","url":"https://hartvaat.nl/mensen/madhu-k-natarajan/","name":"Madhu K Natarajan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maja-cikes","type":"person","url":"https://hartvaat.nl/mensen/maja-cikes/","name":"Maja Cikes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"makoto-hibino","type":"person","url":"https://hartvaat.nl/mensen/makoto-hibino/","name":"Makoto Hibino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/04/01/sglt2-remmers-bij-hfref-of-hfpef-meta-analyse/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manas-sinha","type":"person","url":"https://hartvaat.nl/mensen/manas-sinha/","name":"Manas Sinha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mansoor-husain","type":"person","url":"https://hartvaat.nl/mensen/mansoor-husain/","name":"Mansoor Husain","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/08/29/orale-semaglutide-en-cv-uitkomsten-bij-diabetes-type-2-nejm-pioneer-6/","published":"2019-08-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manuel-martinez-selles","type":"person","url":"https://hartvaat.nl/mensen/manuel-martinez-selles/","name":"Manuel Martínez-Sellés","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/01/colica-colchicine-bij-acuut-gedecompenseerd-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/12/01/intermitterend-levosimendan-bij-gevorderd-hf-laica-studie/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maoyi-tian","type":"person","url":"https://hartvaat.nl/mensen/maoyi-tian/","name":"Maoyi Tian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marat-v-ezhov","type":"person","url":"https://hartvaat.nl/mensen/marat-v-ezhov/","name":"Marat V Ezhov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/lp-a-verstoort-de-ldl-cholesterolberekening-welke-formule-is-het-meest-betrouwba/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-sapoval","type":"person","url":"https://hartvaat.nl/mensen/marc-sapoval/","name":"Marc Sapoval","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-vanderheyden","type":"person","url":"https://hartvaat.nl/mensen/marc-vanderheyden/","name":"Marc Vanderheyden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-andre-d-entremont","type":"person","url":"https://hartvaat.nl/mensen/marc-andre-d-entremont/","name":"Marc-André d'Entremont","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcelle-d-smit","type":"person","url":"https://hartvaat.nl/mensen/marcelle-d-smit/","name":"Marcelle D Smit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-de-carlo","type":"person","url":"https://hartvaat.nl/mensen/marco-de-carlo/","name":"Marco De Carlo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2018/12/01/mitraclip-plus-medicamenteus-versus-medicamenteus-alleen-bij-hf-met-mr-meta-anal/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-trevisan","type":"person","url":"https://hartvaat.nl/mensen/marco-trevisan/","name":"Marco Trevisan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/11/22/cva-risicoscores-bij-af-vergeleken-cha2ds2-vasc-blijft-de-beste/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2017/03/28/edoxaban-bij-af-met-bioprothese-hartkleppen-trombo-emboliepreventie/","published":"2017-03-28"},{"url":"https://hartvaat.nl/2017/03/21/kleplijden-en-edoxaban-versus-warfarine-bij-af-engage-af-timi-48/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/nieuwe-risicovoorspellingsscore-bij-af-voor-netto-klinisch-resultaat-engage-af-t/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-sandri","type":"person","url":"https://hartvaat.nl/mensen/marcus-sandri/","name":"Marcus Sandri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marialuisa-zedde","type":"person","url":"https://hartvaat.nl/mensen/marialuisa-zedde/","name":"Marialuisa Zedde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/05/19/stop-cad-1-op-6-cervicale-arteriedissecties-wordt-aanvankelijk-verkeerd-gediagno/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariama-akodad","type":"person","url":"https://hartvaat.nl/mensen/mariama-akodad/","name":"Mariama Akodad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/27/tavr-bij-patienten-65-jaar-hogere-sterfte-en-heropnames-dan-chirurgie-maar-onvol/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2026/05/22/lge-granulariteit-op-cmr-voorspelt-sterfte-bij-eindstadium-hypertrofische-cardio/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariana-almudi-souza","type":"person","url":"https://hartvaat.nl/mensen/mariana-almudi-souza/","name":"Mariana Almudi Souza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-hauguel-moreau","type":"person","url":"https://hartvaat.nl/mensen/marie-hauguel-moreau/","name":"Marie Hauguel-Moreau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marilyn-borgman","type":"person","url":"https://hartvaat.nl/mensen/marilyn-borgman/","name":"Marilyn Borgman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/09/01/hdl-mimeticum-met-recombinant-apoa-i-milano-en-coronairlijden-jama-cardiology/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marino-labinaz","type":"person","url":"https://hartvaat.nl/mensen/marino-labinaz/","name":"Marino Labinaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariusz-kowalewski","type":"person","url":"https://hartvaat.nl/mensen/mariusz-kowalewski/","name":"Mariusz Kowalewski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2021/04/01/va-ecls-bij-harttransplantatie-en-vad-centra-meta-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2018/04/17/uitgangs-ldl-en-mortaliteitsreductie-na-ldl-verlaging-jama-meta-analyse/","published":"2018-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-a-espeland","type":"person","url":"https://hartvaat.nl/mensen/mark-a-espeland/","name":"Mark A Espeland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-b-effron","type":"person","url":"https://hartvaat.nl/mensen/mark-b-effron/","name":"Mark B Effron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-j-sarnak","type":"person","url":"https://hartvaat.nl/mensen/mark-j-sarnak/","name":"Mark J Sarnak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/23/clorotic-subanalyse-acute-egfr-daling-door-thiaziden-bij-acuut-hf-is-geen-progno/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2026/03/02/staken-van-ras-remmers-na-acute-egfr-daling-hangt-samen-met-meer-nierfalen-en-st/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2019/11/01/acute-egfr-daling-door-enalapril-en-mortaliteit-bij-hf-met-ckd/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-y-chan","type":"person","url":"https://hartvaat.nl/mensen/mark-y-chan/","name":"Mark Y Chan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/09/cangrelor-en-infarctgrootte-bij-stemi-gerandomiseerde-trial/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/05/07/mandibulaire-advancementsplint-versus-cpap-voor-bloeddrukverlaging-bij-osa/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2021/07/01/remote-post-ontslag-behandeling-na-mi-door-paramedici-versus-standaardzorg-jama-/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2018/06/19/cardioprotectieve-therapieen-en-area-at-risk-bij-gereperfuseerd-stemi-cmr-analys/","published":"2018-06-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-meyer","type":"person","url":"https://hartvaat.nl/mensen/markus-meyer/","name":"Markus Meyer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/10/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-klinische-uitkomsten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/04/01/clip-hfpef-cilostazol-bij-hfpef-gerandomiseerde-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/03/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-met-pacemaker/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marlene-s-williams","type":"person","url":"https://hartvaat.nl/mensen/marlene-s-williams/","name":"Marlene S Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/10/25/2022-acc-aha-datadefinities-voor-pijn-op-de-borst-en-acuut-myocardinfarct/","published":"2022-10-25"},{"url":"https://hartvaat.nl/2020/07/28/evolocumab-op-atherogene-lipoproteinen-in-de-peri-infarctperiode-gerandomiseerde/","published":"2020-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marlies-m-kok","type":"person","url":"https://hartvaat.nl/mensen/marlies-m-kok/","name":"Marlies M Kok","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marloes-franssen","type":"person","url":"https://hartvaat.nl/mensen/marloes-franssen/","name":"Marloes Franssen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martha-gulati","type":"person","url":"https://hartvaat.nl/mensen/martha-gulati/","name":"Martha Gulati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-op-een-blik/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2022/10/25/2022-acc-aha-datadefinities-voor-pijn-op-de-borst-en-acuut-myocardinfarct/","published":"2022-10-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-fredriksson","type":"person","url":"https://hartvaat.nl/mensen/martin-fredriksson/","name":"Martin Fredriksson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/05/01/cardiale-biomarkers-en-cv-events-bij-diabetes-declare-timi-58-subanalyse/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-cv-uitkomsten-bij-diabetes-type-2-met-eerder-mi/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-frydland","type":"person","url":"https://hartvaat.nl/mensen/martin-frydland/","name":"Martin Frydland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-g-stoel","type":"person","url":"https://hartvaat.nl/mensen/martin-g-stoel/","name":"Martin G Stoel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-hadamitzky","type":"person","url":"https://hartvaat.nl/mensen/martin-hadamitzky/","name":"Martin Hadamitzky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/04/zeer-hoog-vermogen-70w-rf-ablatie-met-flexibele-tip-voor-pvi-bij-af/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-hellmich","type":"person","url":"https://hartvaat.nl/mensen/martin-hellmich/","name":"Martin Hellmich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2017/04/01/oscillerende-whole-body-vibratie-verbetert-inspanningscapaciteit-bij-pah/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-m-zenni","type":"person","url":"https://hartvaat.nl/mensen/martin-m-zenni/","name":"Martin M Zenni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-r-cowie","type":"person","url":"https://hartvaat.nl/mensen/martin-r-cowie/","name":"Martin R Cowie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/11/16/sacubitril-valsartan-versus-standaardtherapie-op-nt-probnp-en-inspanningscapacit/","published":"2021-11-16"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2017/08/07/remote-management-van-hartfalen-met-implanteerbare-devices-overzicht/","published":"2017-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-s-maron","type":"person","url":"https://hartvaat.nl/mensen/martin-s-maron/","name":"Martin S Maron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/mavacamten-in-de-praktijk-zwarte-patienten-krijgen-55-minder-vaak-toegang-atrium/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martina-m-mcgrath","type":"person","url":"https://hartvaat.nl/mensen/martina-m-mcgrath/","name":"Martina M McGrath","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/02/01/deliver-egfr-dip-na-dapagliflozine-bij-hfpef-is-veilig/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/01/01/deliver-dapagliflozine-beschermt-ook-de-nieren-bij-hfpef/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/10/04/deliver-dapagliflozine-effectief-bij-recent-gehospitaliseerde-hfpef-patienten/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2020/09/29/arni-en-renale-uitkomsten-bij-hfpef-paragon-hf/","published":"2020-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mary-cushman","type":"person","url":"https://hartvaat.nl/mensen/mary-cushman/","name":"Mary Cushman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/20/biomarkers-voorspellen-coronairlijden-bij-atriumfibrilleren-regards/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masaharu-masuda","type":"person","url":"https://hartvaat.nl/mensen/masaharu-masuda/","name":"Masaharu Masuda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2018/09/01/pace-capture-geleide-ablatie-na-contact-force-pvi-dragon-gerandomiseerde-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masanori-taniwaki","type":"person","url":"https://hartvaat.nl/mensen/masanori-taniwaki/","name":"Masanori Taniwaki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masatoshi-koga","type":"person","url":"https://hartvaat.nl/mensen/masatoshi-koga/","name":"Masatoshi Koga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/03/prasugrel-vs-clopidogrel-invloed-van-patientkenmerken-op-trombocytenremming-bij-/","published":"2026-04-12"},{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masayuki-fukuzawa","type":"person","url":"https://hartvaat.nl/mensen/masayuki-fukuzawa/","name":"Masayuki Fukuzawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/eldercare-af-post-hoc-edoxaban-spiegel-en-pt-13s-voorspellen-bloedingsrisico-bij/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2022/06/01/edoxaban-15-mg-bij-zeer-oude-patienten-met-atriumfibrilleren-eldercare-subanalys/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/03/01/edoxaban-15-mg-naar-nierfunctie-bij-zeer-oude-af-eldercare-subanalyse/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2020/10/29/laaggedoseerd-edoxaban-bij-zeer-oude-af-patienten-nejm-eldercare-af/","published":"2020-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massimo-mancone","type":"person","url":"https://hartvaat.nl/mensen/massimo-mancone/","name":"Massimo Mancone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/01/sacubitril-valsartan-na-acuut-mi-meta-analyse-van-in-hospital-initiatie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2017/08/08/prasugrel-of-ticagrelor-bij-stemi-met-diabetes/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-anselmino","type":"person","url":"https://hartvaat.nl/mensen/matteo-anselmino/","name":"Matteo Anselmino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2022/12/09/ideale-blankingperiode-na-af-ablatie-bewijs-voor-herziening/","published":"2022-12-09"},{"url":"https://hartvaat.nl/2016/05/01/katheterablatie-van-af-bij-chronisch-hartfalen-state-of-the-art-en-toekomstpersp/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-bennett","type":"person","url":"https://hartvaat.nl/mensen/matthew-bennett/","name":"Matthew Bennett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/02/16/circa-dose-af-progressie-na-cryoablatie-versus-rf-ablatie/","published":"2024-02-16"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-c-riddle","type":"person","url":"https://hartvaat.nl/mensen/matthew-c-riddle/","name":"Matthew C Riddle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-bluher","type":"person","url":"https://hartvaat.nl/mensen/matthias-bluher/","name":"Matthias Blüher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/14/glp-1-receptoragonisten-en-de-volgende-generatie-incretinegebaseerde-middelen/","published":"2026-01-14"},{"url":"https://hartvaat.nl/2025/08/14/cagrisema-gecombineerd-cagrilintide-en-semaglutide-bij-overgewicht-nejm/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2018/03/13/leefstijlinterventies-en-mobilisatie-van-vetstapeling-central-mri-gerandomiseerd/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-gotberg","type":"person","url":"https://hartvaat.nl/mensen/matthias-gotberg/","name":"Matthias Götberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mattia-arrigo","type":"person","url":"https://hartvaat.nl/mensen/mattia-arrigo/","name":"Mattia Arrigo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/02/01/diureticaresistentie-bij-acuut-hartfalen-prevalentie-en-kenmerken/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mauro-santos","type":"person","url":"https://hartvaat.nl/mensen/mauro-santos/","name":"Mauro Santos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"megan-k-yee","type":"person","url":"https://hartvaat.nl/mensen/megan-k-yee/","name":"Megan K Yee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"},{"url":"https://hartvaat.nl/2018/07/10/fatale-of-irreversibele-bloedingen-en-ischemische-events-met-rivaroxaban-bij-acs/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"megan-l-neely","type":"person","url":"https://hartvaat.nl/mensen/megan-l-neely/","name":"Megan L Neely","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"},{"url":"https://hartvaat.nl/2016/03/01/cyp2c19-metaboliseerdersstatus-en-uitkomsten-bij-acs-prasugrel-versus-clopidogre/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mehul-desai","type":"person","url":"https://hartvaat.nl/mensen/mehul-desai/","name":"Mehul Desai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"},{"url":"https://hartvaat.nl/2017/08/08/canagliflozine-en-cardiovasculaire-biomarkers-bij-oudere-diabetespatienten/","published":"2017-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melanie-r-daniels","type":"person","url":"https://hartvaat.nl/mensen/melanie-r-daniels/","name":"Melanie R Daniels","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melissa-a-simon","type":"person","url":"https://hartvaat.nl/mensen/melissa-a-simon/","name":"Melissa A Simon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-cv-preventie-bij-risicoadulten-jama-uspstf-evidence-revie/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/11/10/screening-op-hoge-bloeddruk-bij-kinderen-uspstf-aanbeveling-2020/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melissa-l-magwire","type":"person","url":"https://hartvaat.nl/mensen/melissa-l-magwire/","name":"Melissa L Magwire","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-a-acker","type":"person","url":"https://hartvaat.nl/mensen/michael-a-acker/","name":"Michael A Acker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-g-silverman","type":"person","url":"https://hartvaat.nl/mensen/michael-g-silverman/","name":"Michael G Silverman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/10/15/triglyceridenverlaging-en-cv-risicoreductie-over-therapeutische-klassen-meta-ana/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"},{"url":"https://hartvaat.nl/2016/09/27/ldl-c-verlaging-en-cardiovasculaire-risicoreductie-jama-systematische-review-en-/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-domanski","type":"person","url":"https://hartvaat.nl/mensen/michael-j-domanski/","name":"Michael J Domanski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-koren","type":"person","url":"https://hartvaat.nl/mensen/michael-j-koren/","name":"Michael J Koren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"},{"url":"https://hartvaat.nl/2025/06/03/pursuit-orale-pcsk9-remmer-voor-hypercholesterolemie-gerandomiseerde-trial/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2019/10/29/langetermijn-werkzaamheid-en-veiligheid-van-evolocumab-bij-hypercholesterolemie/","published":"2019-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-magro","type":"person","url":"https://hartvaat.nl/mensen/michael-magro/","name":"Michael Magro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-zeitouni","type":"person","url":"https://hartvaat.nl/mensen/michel-zeitouni/","name":"Michel Zeitouni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-samuel","type":"person","url":"https://hartvaat.nl/mensen/michelle-samuel/","name":"Michelle Samuel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miguel-angel-martinez-gonzalez","type":"person","url":"https://hartvaat.nl/mensen/miguel-angel-martinez-gonzalez/","name":"Miguel Ángel Martínez-González","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mila-menozzi","type":"person","url":"https://hartvaat.nl/mensen/mila-menozzi/","name":"Mila Menozzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milos-taborsky","type":"person","url":"https://hartvaat.nl/mensen/milos-taborsky/","name":"Milos Taborsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/01/16/watchful-leefstijl-wandelinterventie-bij-hfref/","published":"2024-01-16"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miodrag-peric","type":"person","url":"https://hartvaat.nl/mensen/miodrag-peric/","name":"Miodrag Peric","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2021/04/01/cardio-microstroomdevice-bij-chronisch-hf-eerste-klinische-studie/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miquel-fiol","type":"person","url":"https://hartvaat.nl/mensen/miquel-fiol/","name":"Miquel Fiol","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mirta-diez","type":"person","url":"https://hartvaat.nl/mensen/mirta-diez/","name":"Mirta Diez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/06/01/dapagliflozine-bij-hfref-naar-geslacht-dapa-hf-pre-gespecificeerde-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-en-symptomen-functie-en-qol-bij-hfref-dapa-hf/","published":"2020-01-14"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mitchell-lindsay","type":"person","url":"https://hartvaat.nl/mensen/mitchell-lindsay/","name":"Mitchell Lindsay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohammad-kassar","type":"person","url":"https://hartvaat.nl/mensen/mohammad-kassar/","name":"Mohammad Kassar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"molly-szerlip","type":"person","url":"https://hartvaat.nl/mensen/molly-szerlip/","name":"Molly Szerlip","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"montserrat-fito","type":"person","url":"https://hartvaat.nl/mensen/montserrat-fito/","name":"Montserrat Fitó","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morgane-cibotti-sun","type":"person","url":"https://hartvaat.nl/mensen/morgane-cibotti-sun/","name":"Morgane Cibotti-Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/richtlijn-volwassenen-met-aangeboren-hartafwijkingen-2025-in-een-oogopslag/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/richtlijn-acute-longembolie-2026-in-een-oogopslag/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-op-een-blik/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2024/01/02/2023-af-richtlijn-op-een-blik-samenvatting/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morten-salling-olesen","type":"person","url":"https://hartvaat.nl/mensen/morten-salling-olesen/","name":"Morten Salling Olesen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morten-wang-fagerland","type":"person","url":"https://hartvaat.nl/mensen/morten-wang-fagerland/","name":"Morten Wang Fagerland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2021/02/09/omega-3-vetzuren-bij-oudere-mi-patienten-omemi-gerandomiseerde-trial/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2016/06/01/preventie-van-cardiale-disfunctie-bij-borstkankerbehandeling-de-prada-trial/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mustafa-arici","type":"person","url":"https://hartvaat.nl/mensen/mustafa-arici/","name":"Mustafa Arici","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"},{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mykela-m-moore","type":"person","url":"https://hartvaat.nl/mensen/mykela-m-moore/","name":"Mykela M. Moore","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/richtlijn-volwassenen-met-aangeboren-hartafwijkingen-2025-in-een-oogopslag/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/richtlijn-acute-longembolie-2026-in-een-oogopslag/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-op-een-blik/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2024/01/02/2023-af-richtlijn-op-een-blik-samenvatting/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"n-m-s-natasja-de-groot","type":"person","url":"https://hartvaat.nl/mensen/n-m-s-natasja-de-groot/","name":"N M S Natasja de Groot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/02/08/stolling-en-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2023-02-08"},{"url":"https://hartvaat.nl/2019/01/01/hotspots-van-gefractioneerde-elektrogrammen-in-linker-en-rechter-atrium-bij-af/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"na-li","type":"person","url":"https://hartvaat.nl/mensen/na-li/","name":"Na Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/09/bempedoinezuur-versus-statines-vergelijking-van-cv-voordelen/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/03/01/clear-outcomes-bempedoinezuur-vermindert-totale-cv-events-bij-statine-intolerant/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2022/08/01/b-lijnen-geleide-hartfalenbehandeling-verbetert-uitkomsten-na-ontslag/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nader-rifai","type":"person","url":"https://hartvaat.nl/mensen/nader-rifai/","name":"Nader Rifai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/05/inflammatie-cholesterol-lp-a-en-30-jaars-cv-uitkomsten-bij-vrouwen/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"},{"url":"https://hartvaat.nl/2020/08/14/il-6-crp-en-ldl-als-biomarkers-van-residueel-risico-vergelijking/","published":"2020-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nagwa-khilla","type":"person","url":"https://hartvaat.nl/mensen/nagwa-khilla/","name":"Nagwa Khilla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nanna-louise-junker-udesen","type":"person","url":"https://hartvaat.nl/mensen/nanna-louise-junker-udesen/","name":"Nanna Louise Junker Udesen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nanxiang-ouyang","type":"person","url":"https://hartvaat.nl/mensen/nanxiang-ouyang/","name":"Nanxiang Ouyang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naomi-d-l-fisher","type":"person","url":"https://hartvaat.nl/mensen/naomi-d-l-fisher/","name":"Naomi D L Fisher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nathan-mewton","type":"person","url":"https://hartvaat.nl/mensen/nathan-mewton/","name":"Nathan Mewton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/off-label-dosering-van-sacubitril-valsartan-wijdverspreid-in-de-praktijk/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"navdeep-tangri","type":"person","url":"https://hartvaat.nl/mensen/navdeep-tangri/","name":"Navdeep Tangri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/02/staken-van-ras-remmers-na-acute-egfr-daling-hangt-samen-met-meer-nierfalen-en-st/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2025/12/24/risicovoorspellingsmodellen-voor-ouderen-met-chronische-nierziekte/","published":"2025-12-24"},{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2018/06/12/sglt2-remmers-en-cardiovasculaire-events-de-cvd-real-2-real-world-studie/","published":"2018-06-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nazzareno-galie","type":"person","url":"https://hartvaat.nl/mensen/nazzareno-galie/","name":"Nazzareno Galiè","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/01/02/macitentan-bij-eisenmenger-syndroom/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-sulke","type":"person","url":"https://hartvaat.nl/mensen/neil-sulke/","name":"Neil Sulke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/11/01/nmarq-pvac-en-thoracoscopische-ablatie-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/07/01/implanteerbare-monitors-als-goudstandaard-voor-af-detectie-gerandomiseerde-verge/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/03/01/eerste-trial-met-specifieke-ikach-blokker-toont-geen-reductie-in-af-last-bij-par/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-j-leeper","type":"person","url":"https://hartvaat.nl/mensen/nicholas-j-leeper/","name":"Nicholas J Leeper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/24/van-biobank-naar-voorspelling-polygenetische-risicoscores-voor-perifeer-vaatlijd/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/05/20/plozasiran-en-lipoproteine-deeltjesgrootte-bij-hypertriglyceridemie/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/09/12/plozasiran-sirna-tegen-apoc3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-s-peters","type":"person","url":"https://hartvaat.nl/mensen/nicholas-s-peters/","name":"Nicholas S Peters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/14/tricorder-ai-stethoscoop-voor-triple-cv-ziektedetectie/","published":"2026-02-14"},{"url":"https://hartvaat.nl/2024/06/11/remote-beoordeling-na-acs-gerandomiseerde-trial/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2019/08/01/optimale-laesieset-bij-persisterend-af-ablatie-meta-regressie/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-vejlstrup","type":"person","url":"https://hartvaat.nl/mensen/niels-vejlstrup/","name":"Niels Vejlstrup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"},{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikhil-mistry","type":"person","url":"https://hartvaat.nl/mensen/nikhil-mistry/","name":"Nikhil Mistry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/12/01/sglt2-remmers-en-cardiale-remodellering-meta-analyse-van-mri-trials/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/04/01/restrictieve-versus-liberale-transfusie-bij-hartchirurgie-meta-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikola-jagic","type":"person","url":"https://hartvaat.nl/mensen/nikola-jagic/","name":"Nikola Jagic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolaos-fragakis","type":"person","url":"https://hartvaat.nl/mensen/nikolaos-fragakis/","name":"Nikolaos Fragakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/af-ablatie-timing-naar-af-duur-impact-op-aritmierecidief/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/01/14/residuele-lekkage-na-laa-occlusie-en-uitkomsten-meta-analyse/","published":"2024-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolaos-ostlund-papadogeorgos","type":"person","url":"https://hartvaat.nl/mensen/nikolaos-ostlund-papadogeorgos/","name":"Nikolaos Östlund-Papadogeorgos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nina-w-van-der-hoeven","type":"person","url":"https://hartvaat.nl/mensen/nina-w-van-der-hoeven/","name":"Nina W van der Hoeven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ninian-n-lang","type":"person","url":"https://hartvaat.nl/mensen/ninian-n-lang/","name":"Ninian N Lang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niraj-varma","type":"person","url":"https://hartvaat.nl/mensen/niraj-varma/","name":"Niraj Varma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2017/11/01/defibrillatie-drempelwaarden-bij-rechtspectorale-icd-en-golfvorm-tuning/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/06/07/dagelijkse-telemonitoring-van-icd-s-gepoolde-analyse-van-drie-gerandomiseerde-tr/","published":"2017-06-07"},{"url":"https://hartvaat.nl/2017/05/01/automatische-pacing-timingaanpassingen-en-effectieve-lv-pacing-bij-crt/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niteesh-k-choudhry","type":"person","url":"https://hartvaat.nl/mensen/niteesh-k-choudhry/","name":"Niteesh K Choudhry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/07/01/bestaande-cv-data-benutten-voor-hypertensiedetectie-en-behandeling-vital-trial/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"norrina-b-allen","type":"person","url":"https://hartvaat.nl/mensen/norrina-b-allen/","name":"Norrina B Allen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nuccia-morici","type":"person","url":"https://hartvaat.nl/mensen/nuccia-morici/","name":"Nuccia Morici","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/29/vroege-iabp-bij-hartfalen-gerelateerde-cardiogene-shock-gerandomiseerde-trial/","published":"2025-04-29"},{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nuria-lopez-pajares","type":"person","url":"https://hartvaat.nl/mensen/nuria-lopez-pajares/","name":"Nuria Lopez-Pajares","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"okechukwu-s-ogah","type":"person","url":"https://hartvaat.nl/mensen/okechukwu-s-ogah/","name":"Okechukwu S Ogah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olaf-wendler","type":"person","url":"https://hartvaat.nl/mensen/olaf-wendler/","name":"Olaf Wendler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/05/31/kwaliteit-van-leven-na-ffr-geleide-pci-versus-coronaire-bypasschirurgie/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ole-ahlehoff","type":"person","url":"https://hartvaat.nl/mensen/ole-ahlehoff/","name":"Ole Ahlehoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olga-bockeria","type":"person","url":"https://hartvaat.nl/mensen/olga-bockeria/","name":"Olga Bockeria","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olga-castaner","type":"person","url":"https://hartvaat.nl/mensen/olga-castaner/","name":"Olga Castañer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olga-shestakovska","type":"person","url":"https://hartvaat.nl/mensen/olga-shestakovska/","name":"Olga Shestakovska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2020/06/09/combinatie-antiplaatjes-antistolling-bij-diabetes-met-cv-ziekte-compass-inzichte/","published":"2020-06-09"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/05/14/rivaroxaban-plus-aspirine-bij-vaatlijden-met-nierdisfunctie-compass/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-muller","type":"person","url":"https://hartvaat.nl/mensen/olivier-muller/","name":"Olivier Muller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-varenne","type":"person","url":"https://hartvaat.nl/mensen/olivier-varenne/","name":"Olivier Varenne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ota-hlinomaz","type":"person","url":"https://hartvaat.nl/mensen/ota-hlinomaz/","name":"Ota Hlinomaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"otilia-tica","type":"person","url":"https://hartvaat.nl/mensen/otilia-tica/","name":"Otilia Tica","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/03/beeldvorming-bij-atriale-cardiomyopathie-esc-scientific-statement/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"},{"url":"https://hartvaat.nl/2021/07/01/transformatie-van-klinisch-onderzoek-door-patientbetrokkenheid-rate-af/","published":"2021-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"p-a","type":"person","url":"https://hartvaat.nl/mensen/p-a/","name":"P. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/10/zuinig-machine-learningmodel-voorspelt-1-jaarssterfte-en-zinloosheid-na-tavi/","published":"2026-07-23"},{"url":"https://hartvaat.nl/2026/04/29/geisoleerde-secundaire-tricuspidalisinsufficientie-na-linkszijdige-klepchirurgie/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/05/26/asymptomatische-matige-ernstige-aortaklepinsufficientie-niet-benigne-meta-analys/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/02/12/ct-coronairangiografie-bij-nstemi-uitstekende-diagnostische-nauwkeurigheid-maar-/","published":"2026-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-b-nery","type":"person","url":"https://hartvaat.nl/mensen/pablo-b-nery/","name":"Pablo B Nery","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pam-r-taub","type":"person","url":"https://hartvaat.nl/mensen/pam-r-taub/","name":"Pam R Taub","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/21/glp-1-agonisten-kosten-geen-spiermassa-tijdens-intensieve-hartrevalidatie/","published":"2026-06-09"},{"url":"https://hartvaat.nl/2025/07/22/victorion-initiate-inclisiran-monotherapie-bij-patienten-zonder-ascvd/","published":"2025-07-22"},{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pamela-n-peterson","type":"person","url":"https://hartvaat.nl/mensen/pamela-n-peterson/","name":"Pamela N Peterson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/08/20/fysiologische-versus-rechterkamerpacing-bij-lvef-35/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-mulatero","type":"person","url":"https://hartvaat.nl/mensen/paolo-mulatero/","name":"Paolo Mulatero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2018/08/01/farmacologische-behandeling-van-hypertensie-bij-kinderen-netwerkmeta-analyse/","published":"2018-08-01"}],"videos":[{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/nieuwe-data-in-praktijk-mulatero/","title":"Wat betekent nieuwe data voor de praktijk? — Paolo Mulatero"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-tosi","type":"person","url":"https://hartvaat.nl/mensen/paolo-tosi/","name":"Paolo Tosi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-verdecchia","type":"person","url":"https://hartvaat.nl/mensen/paolo-verdecchia/","name":"Paolo Verdecchia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/11/01/gemiddelde-bloeddruk-en-visit-to-visit-variabiliteit-als-gecombineerde-voorspell/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/09/01/intensievere-versus-minder-intensieve-bloeddrukverlaging-cumulatief-bewijs-en-tr/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/04/01/prognostisch-effect-van-nachtelijke-bloeddrukdaling-bij-hypertensie-de-abc-h-stu/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-defaye","type":"person","url":"https://hartvaat.nl/mensen/pascal-defaye/","name":"Pascal Defaye","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/03/upgrade-van-draadloze-pacemaker-van-enkelvoudig-naar-tweekamersysteem/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2016/02/01/rechterkamerseptumpacing-versus-apexpacing-bij-crt-defibrillator-gerandomiseerde/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paschalis-karakasis","type":"person","url":"https://hartvaat.nl/mensen/paschalis-karakasis/","name":"Paschalis Karakasis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/30/linear-trial-lattice-tip-katheter-verslaat-standaard-irrigatie-bij-cti-ablatie-v/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/af-ablatie-timing-naar-af-duur-impact-op-aritmierecidief/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascual-bordes","type":"person","url":"https://hartvaat.nl/mensen/pascual-bordes/","name":"Pascual Bordes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-beckers","type":"person","url":"https://hartvaat.nl/mensen/paul-beckers/","name":"Paul Beckers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-dendale","type":"person","url":"https://hartvaat.nl/mensen/paul-dendale/","name":"Paul Dendale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/26/gerichte-patienteneducatie-vermindert-ongeplande-cv-events-bij-af/","published":"2024-12-26"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"},{"url":"https://hartvaat.nl/2018/04/21/telemonitoring-verbetert-doac-therapietrouw-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-e-drawz","type":"person","url":"https://hartvaat.nl/mensen/paul-e-drawz/","name":"Paul E Drawz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/01/mhealth-interventie-verbetert-hypertensiezorg-bij-hoogrisicopatienten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/04/01/hypotensieve-episodes-op-24-uurs-abpm-en-cognitieve-functie-sprint-inzichten/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2020/10/01/intensieve-versus-standaard-bloeddrukbehandeling-op-white-coat-effect-en-gemaske/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-o-collinson","type":"person","url":"https://hartvaat.nl/mensen/paul-o-collinson/","name":"Paul O Collinson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/01/21/hoog-sensitief-troponine-en-de-universele-mi-definitie/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-sorajja","type":"person","url":"https://hartvaat.nl/mensen/paul-sorajja/","name":"Paul Sorajja","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/zesjaarsuitkomsten-van-transkatheter-versus-chirurgische-aortaklepvervanging-bij/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-egbert-reimitz","type":"person","url":"https://hartvaat.nl/mensen/paul-egbert-reimitz/","name":"Paul-Egbert Reimitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pavan-atluri","type":"person","url":"https://hartvaat.nl/mensen/pavan-atluri/","name":"Pavan Atluri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pavel-jansa","type":"person","url":"https://hartvaat.nl/mensen/pavel-jansa/","name":"Pavel Jansa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/06/18/sildenafil-dosisvergelijking-bij-pulmonale-arteriele-hypertensie/","published":"2024-06-18"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2017/04/01/hemodynamische-effecten-van-riociguat-bij-inoperabel-cteph/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pawe-e-buszman","type":"person","url":"https://hartvaat.nl/mensen/pawe-e-buszman/","name":"Paweł E Buszman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2016/08/01/cabg-versus-pci-en-risico-op-myocardinfarct-en-revascularisatie-bij-ckd-patiente/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pekka-raatikainen","type":"person","url":"https://hartvaat.nl/mensen/pekka-raatikainen/","name":"Pekka Raatikainen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/10/07/vroege-substraatablatie-versus-antiaritmica-bij-vt-gerandomiseerde-trial/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2019/03/19/katheterablatie-versus-antiaritmica-en-kwaliteit-van-leven-bij-af-jama-captaf/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/03/01/katheterablatie-als-eerstelijnsbehandeling-bij-paroxysmaal-af-5-jaarsresultaten/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"per-h-nielsen","type":"person","url":"https://hartvaat.nl/mensen/per-h-nielsen/","name":"Per H Nielsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2021/12/18/pci-met-des-versus-cabg-bij-hoofdstamlijden-lancet-precombat-10-jaars/","published":"2021-12-18"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-a-johansson","type":"person","url":"https://hartvaat.nl/mensen/peter-a-johansson/","name":"Peter A Johansson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2020/08/25/dapagliflozine-en-cardiale-renale-en-ledemaat-uitkomsten-bij-pav-declare-timi-58/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/05/28/dapagliflozine-en-hartfalen-en-mortaliteit-bij-diabetes-type-2-declare-timi-58-h/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-boekstegers","type":"person","url":"https://hartvaat.nl/mensen/peter-boekstegers/","name":"Peter Boekstegers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-greasley","type":"person","url":"https://hartvaat.nl/mensen/peter-j-greasley/","name":"Peter J Greasley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/04/16/sglt2-remming-waterconservatie-domineert-over-osmotische-diurese-bij-hf/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/11/25/zenith-ckd-zibotentan-plus-dapagliflozine-bij-ckd-lancet/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/14/dapagliflozine-bij-hf-met-en-zonder-diabetes-jama-dapa-hf-uitkomsten/","published":"2020-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-schwartz","type":"person","url":"https://hartvaat.nl/mensen/peter-j-schwartz/","name":"Peter J Schwartz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/13/mtmr4-modifier-heeft-tegenovergestelde-invloed-op-aritmierisico-bij-lqt1-en-lqt2/","published":"2026-06-22"},{"url":"https://hartvaat.nl/2026/02/03/plotse-hartstilstand-tijdens-duursporten-tien-jaar-parijse-registerdata/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2016/07/12/nervus-vagus-stimulatie-bij-hartfalen-de-inovate-hf-trial/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-l-thompson","type":"person","url":"https://hartvaat.nl/mensen/peter-l-thompson/","name":"Peter L Thompson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2020/08/01/cardiovasculaire-risicovoorspelling-bij-inheemse-australiers/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-m-rothwell","type":"person","url":"https://hartvaat.nl/mensen/peter-m-rothwell/","name":"Peter M Rothwell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/24/systemische-inflammatie-en-recidief-na-een-af-gerelateerd-herseninfarct/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2020/06/01/arb-versus-calciumantagonist-bloeddrukprofiel-en-klinische-effecten-vergelijking/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/09/22/aspirine-voor-primaire-preventie-bij-matig-cv-risico-lancet-arrive/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-w-danse","type":"person","url":"https://hartvaat.nl/mensen/peter-w-danse/","name":"Peter W Danse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/02/therapietrouw-aan-lipidenverlagende-medicatie-na-pci-in-nederland/","published":"2026-03-28"},{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-willeit","type":"person","url":"https://hartvaat.nl/mensen/peter-willeit/","name":"Peter Willeit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-b-adamson","type":"person","url":"https://hartvaat.nl/mensen/philip-b-adamson/","name":"Philip B Adamson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2016/01/30/hemodynamische-telemonitoring-bij-chronisch-hartfalen-volledige-champion-resulta/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-j-barter","type":"person","url":"https://hartvaat.nl/mensen/philip-j-barter/","name":"Philip J Barter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-m-bath","type":"person","url":"https://hartvaat.nl/mensen/philip-m-bath/","name":"Philip M Bath","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2017/05/01/voortzetten-of-tijdelijk-stoppen-van-antihypertensiva-bij-acuut-cva-ipd-meta-ana/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-urban","type":"person","url":"https://hartvaat.nl/mensen/philip-urban/","name":"Philip Urban","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/08/01/seksegerelateerde-uitkomsten-bij-hoog-bloedingsrisico-na-pci-leaders-free/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2017/04/01/polymeervrije-biolimus-stent-bij-hoog-bloedingsrisico-met-acs-leaders-free-subst/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philipp-blanke","type":"person","url":"https://hartvaat.nl/mensen/philipp-blanke/","name":"Philipp Blanke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-bertrand","type":"person","url":"https://hartvaat.nl/mensen/philippe-bertrand/","name":"Philippe Bertrand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/03/25/inspanningsecho-identificeert-hcm-patienten-die-baat-hebben-bij-mavacamten/","published":"2026-03-25"}],"videos":[{"url":"https://hartvaat.nl/video/esc26-preview-trials-to-watch/esc26-trials-to-watch-gesprek/","title":"ESC 2026 Trials to Watch: het volledige gesprek"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"phillip-d-levy","type":"person","url":"https://hartvaat.nl/mensen/phillip-d-levy/","name":"Phillip D Levy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/mobiele-screeningseenheid-in-detroit-70-van-inwoners-in-achtergestelde-wijken-he/","published":"2026-06-11"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2017/08/07/trv027-biased-ligand-van-de-angiotensine-ii-receptor-bij-acuut-hartfalen-gerando/","published":"2017-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-deharo","type":"person","url":"https://hartvaat.nl/mensen/pierre-deharo/","name":"Pierre Deharo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2021/08/24/de-escalatie-van-dapt-bij-acs-jacc-review/","published":"2021-08-24"},{"url":"https://hartvaat.nl/2017/11/14/timing-van-angiografie-bij-hoogrisico-nstemi-acuity-analyse/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2017/11/01/switchen-van-dapt-na-acs-de-topic-trial/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pietro-ameri","type":"person","url":"https://hartvaat.nl/mensen/pietro-ameri/","name":"Pietro Ameri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/05/10/hartfalen-en-infarct-verdrievoudigen-het-risico-op-kanker-vooral-hematologisch/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2021/10/01/sacubitril-valsartan-in-real-life-europese-hfref-meta-analyse/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pietro-palmisano","type":"person","url":"https://hartvaat.nl/mensen/pietro-palmisano/","name":"Pietro Palmisano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2018/12/01/av-junctieablatie-plus-crt-bij-permanent-af-gerandomiseerde-trial/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/03/01/vaste-versus-responsieve-pacingfrequentie-bij-permanent-af-met-pacemakerindicati/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ping-li","type":"person","url":"https://hartvaat.nl/mensen/ping-li/","name":"Ping Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/22/werkzaamheid-en-veiligheid-van-finerenon-bij-primair-aldosteronisme/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2021/04/01/sarcopenie-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piotr-suwalski","type":"person","url":"https://hartvaat.nl/mensen/piotr-suwalski/","name":"Piotr Suwalski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2021/04/01/va-ecls-bij-harttransplantatie-en-vad-centra-meta-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prakriti-gaba","type":"person","url":"https://hartvaat.nl/mensen/prakriti-gaba/","name":"Prakriti Gaba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/05/03/icosapent-ethyl-en-cv-preventie-bij-eerder-mi-reduce-it/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prithwish-banerjee","type":"person","url":"https://hartvaat.nl/mensen/prithwish-banerjee/","name":"Prithwish Banerjee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2018/08/01/laagfrequente-elektrische-spierstimulatie-en-endotheelfunctie-bij-gevorderd-hart/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qi-zhang","type":"person","url":"https://hartvaat.nl/mensen/qi-zhang/","name":"Qi Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qi-fang-huang","type":"person","url":"https://hartvaat.nl/mensen/qi-fang-huang/","name":"Qi-Fang Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/11/10/chinese-kruidenformule-voor-gemaskeerde-hypertensie-gerandomiseerde-placebogecon/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qian-h-li","type":"person","url":"https://hartvaat.nl/mensen/qian-h-li/","name":"Qian H Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiang-lv","type":"person","url":"https://hartvaat.nl/mensen/qiang-lv/","name":"Qiang Lv","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukverlaging-bij-ongediagnosticeerde-hfpef-met-hoog-risico/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qirui-song","type":"person","url":"https://hartvaat.nl/mensen/qirui-song/","name":"Qirui Song","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/08/01/voordeel-en-risico-van-intensieve-bloeddrukcontrole-naar-cv-risico/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/09/01/hypertensieduur-en-effect-van-intensieve-bloeddrukbehandeling/","published":"2024-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rachel-hess","type":"person","url":"https://hartvaat.nl/mensen/rachel-hess/","name":"Rachel Hess","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2016/02/09/generaliseerbaarheid-van-sprint-resultaten-naar-de-algemene-bevolking/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rafael-cavalcante","type":"person","url":"https://hartvaat.nl/mensen/rafael-cavalcante/","name":"Rafael Cavalcante","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/07/01/syntax-scores-en-uitkomsten-bij-diabetes-met-multivatenlijden-gepoolde-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rafael-romaguera","type":"person","url":"https://hartvaat.nl/mensen/rafael-romaguera/","name":"Rafael Romaguera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rafael-de-la-espriella","type":"person","url":"https://hartvaat.nl/mensen/rafael-de-la-espriella/","name":"Rafael de la Espriella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/03/expertopinie-hierarchische-eindpunten-op-basis-van-verslechterend-hartfalen-voor/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/03/01/bij-niervervanging-bescherm-het-hart/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/03/bio-impedantie-voor-vochtstatusbepaling-en-prognose-bij-chronisch-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralf-westenfeld","type":"person","url":"https://hartvaat.nl/mensen/ralf-westenfeld/","name":"Ralf Westenfeld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/17/danger-shock-impella-en-nieruitkomsten-bij-cardiogene-shock/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/02/01/nnt-van-nieuwe-antidiabetica-voor-cv-uitkomsten-meta-analyse/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralph-b-d-agostino","type":"person","url":"https://hartvaat.nl/mensen/ralph-b-d-agostino/","name":"Ralph B D'Agostino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/10/27/albiglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-harmony-ou/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2017/05/02/mi-risico-na-stoppen-van-thienopyridine-dapt-studie/","published":"2017-05-02"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralph-stephan-von-bardeleben","type":"person","url":"https://hartvaat.nl/mensen/ralph-stephan-von-bardeleben/","name":"Ralph Stephan von Bardeleben","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramanathan-parameswaran","type":"person","url":"https://hartvaat.nl/mensen/ramanathan-parameswaran/","name":"Ramanathan Parameswaran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2018/07/01/rotorablatie-bij-atriumfibrilleren-systematische-review/","published":"2018-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramzi-khamis","type":"person","url":"https://hartvaat.nl/mensen/ramzi-khamis/","name":"Ramzi Khamis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2024/06/11/remote-beoordeling-na-acs-gerandomiseerde-trial/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramon-estruch","type":"person","url":"https://hartvaat.nl/mensen/ramon-estruch/","name":"Ramón Estruch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebecca-anthopolos","type":"person","url":"https://hartvaat.nl/mensen/rebecca-anthopolos/","name":"Rebecca Anthopolos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rene-j-van-der-schaaf","type":"person","url":"https://hartvaat.nl/mensen/rene-j-van-der-schaaf/","name":"René J van der Schaaf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rianne-a-a-de-heus","type":"person","url":"https://hartvaat.nl/mensen/rianne-a-a-de-heus/","name":"Rianne A A de Heus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/05/01/antihypertensieve-behandeling-en-cerebrale-bloedflow-meta-analyse/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/11/01/bloeddrukvariabiliteit-en-progressie-van-klinische-alzheimer/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/08/01/nilvadipine-en-cerebrale-bloedflow-bij-alzheimer-gerandomiseerde-trial/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-ceska","type":"person","url":"https://hartvaat.nl/mensen/richard-ceska/","name":"Richard Ceška","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-d-weisel","type":"person","url":"https://hartvaat.nl/mensen/richard-d-weisel/","name":"Richard D Weisel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-troughton","type":"person","url":"https://hartvaat.nl/mensen/richard-troughton/","name":"Richard Troughton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-initiele-egfr-dip-met-finerenon-bij-hfpef-is-veilig/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rikke-srensen","type":"person","url":"https://hartvaat.nl/mensen/rikke-srensen/","name":"Rikke Sørensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2020/01/01/ischemische-postconditionering-en-trombectomie-bij-stemi-interactie-analyse/","published":"2020-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-a-fletcher","type":"person","url":"https://hartvaat.nl/mensen/robert-a-fletcher/","name":"Robert A Fletcher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2026/01/20/sglt2-remmers-en-nieruitkomsten-naar-gfr-en-albuminurie-mega-meta-analyse/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-j-mcgreevy","type":"person","url":"https://hartvaat.nl/mensen/robert-j-mcgreevy/","name":"Robert J McGreevy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-m-a-van-der-boon","type":"person","url":"https://hartvaat.nl/mensen/robert-m-a-van-der-boon/","name":"Robert M A van der Boon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/28/geen-sekseverschillen-in-werkzaamheid-van-hartfalenmedicatie-meta-analyse-van-13/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2025/08/14/hartfalen-mondiale-economische-ziektelast/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2025/04/01/socio-economische-ongelijkheid-en-hartfalenuitkomsten-systematische-review/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/08/14/telemonitoring-bij-hartfalen-meta-analyse-van-alle-strategieen/","published":"2023-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-t-gerber","type":"person","url":"https://hartvaat.nl/mensen/robert-t-gerber/","name":"Robert T Gerber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-vogel","type":"person","url":"https://hartvaat.nl/mensen/robert-vogel/","name":"Robert Vogel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-w-mcnutt","type":"person","url":"https://hartvaat.nl/mensen/robert-w-mcnutt/","name":"Robert W McNutt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-barriales-villa","type":"person","url":"https://hartvaat.nl/mensen/roberto-barriales-villa/","name":"Roberto Barriales-Villa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-ferrari","type":"person","url":"https://hartvaat.nl/mensen/roberto-ferrari/","name":"Roberto Ferrari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2020/09/19/trimetazidine-na-pci-lancet-atpci-gerandomiseerde-trial/","published":"2020-09-19"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-garbo","type":"person","url":"https://hartvaat.nl/mensen/roberto-garbo/","name":"Roberto Garbo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-lorusso","type":"person","url":"https://hartvaat.nl/mensen/roberto-lorusso/","name":"Roberto Lorusso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/05/inotropica-bij-low-output-hartfalen-vergelijkbare-hemodynamische-effecten-in-met/","published":"2026-05-24"},{"url":"https://hartvaat.nl/2021/04/01/va-ecls-bij-harttransplantatie-en-vad-centra-meta-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-scarsini","type":"person","url":"https://hartvaat.nl/mensen/roberto-scarsini/","name":"Roberto Scarsini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rocco-vergallo","type":"person","url":"https://hartvaat.nl/mensen/rocco-vergallo/","name":"Rocco Vergallo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/26/weer-een-stap-vooruit-in-de-verlaging-van-ernstige-hypertriglyceridemie/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2024/08/16/impella-cp-bij-door-mi-gecompliceerde-cardiogene-shock-journal-scan/","published":"2024-08-16"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2022/07/21/permanente-pacemaker-na-tavi-langetermijneffect-op-klinische-uitkomsten/","published":"2022-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rogerio-souza","type":"person","url":"https://hartvaat.nl/mensen/rogerio-souza/","name":"Rogério Souza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ron-waksman","type":"person","url":"https://hartvaat.nl/mensen/ron-waksman/","name":"Ron Waksman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2016/02/16/ticagrelor-versus-clopidogrel-bij-troponine-negatieve-laagrisico-acs-met-ad-hoc-/","published":"2016-02-16"},{"url":"https://hartvaat.nl/2016/02/07/impact-van-pcsk9-remmers-op-lipidenniveaus-en-uitkomsten-netwerkmeta-analyse/","published":"2016-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronak-rajani","type":"person","url":"https://hartvaat.nl/mensen/ronak-rajani/","name":"Ronak Rajani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2022/11/24/protecct-ct-bij-verdenking-acs-met-intermediaire-troponinewaarden/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rong-zhou","type":"person","url":"https://hartvaat.nl/mensen/rong-zhou/","name":"Rong Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/20/plozasiran-en-lipoproteine-deeltjesgrootte-bij-hypertriglyceridemie/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/09/12/plozasiran-sirna-tegen-apoc3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rongjie-huang","type":"person","url":"https://hartvaat.nl/mensen/rongjie-huang/","name":"Rongjie Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/12/01/step-trial-diastolische-bloeddruk-beinvloedt-effect-van-intensieve-behandeling/","published":"2023-12-01"},{"url":"https://hartvaat.nl/2023/09/01/step-substudie-intensieve-bloeddrukverlaging-verbetert-lvh-bij-ouderen/","published":"2023-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roni-nielsen","type":"person","url":"https://hartvaat.nl/mensen/roni-nielsen/","name":"Roni Nielsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roopinder-k-sandhu","type":"person","url":"https://hartvaat.nl/mensen/roopinder-k-sandhu/","name":"Roopinder K Sandhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/07/zorgpaden-na-nieuw-vastgesteld-atriumfibrilleren-rol-van-de-elektrofysioloog-en-/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roos-hesselink","type":"person","url":"https://hartvaat.nl/mensen/roos-hesselink/","name":"Roos-Hesselink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/sekseverschillen-bij-infectieuze-endocarditis-vrouwen-vaker-conservatief-behande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/04/29/erasmus-mc-linkeratrium-strain-voorspelt-aritmieen-na-chirurgische-correctie-van/","published":"2026-07-11"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rosa-coppolecchia","type":"person","url":"https://hartvaat.nl/mensen/rosa-coppolecchia/","name":"Rosa Coppolecchia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/01/oceanic-af-asundexian-naar-eerder-oac-gebruik/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2018/09/22/aspirine-voor-primaire-preventie-bij-matig-cv-risico-lancet-arrive/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rose-crowley","type":"person","url":"https://hartvaat.nl/mensen/rose-crowley/","name":"Rose Crowley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2025/01/07/pvi-met-versus-zonder-posteriore-wand-isolatie-bij-persisterend-af-rct/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/08/03/catheterablatie-bij-persisterend-af-recidiefpatronen-en-kwaliteit-van-leven/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/11/01/posterior-wand-isolatie-bij-af-ablatie-en-systolisch-hartfalen-castle-af-subanal/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rupert-williams","type":"person","url":"https://hartvaat.nl/mensen/rupert-williams/","name":"Rupert Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"russell-l-rothman","type":"person","url":"https://hartvaat.nl/mensen/russell-l-rothman/","name":"Russell L Rothman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruth-frikke-schmidt","type":"person","url":"https://hartvaat.nl/mensen/ruth-frikke-schmidt/","name":"Ruth Frikke-Schmidt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2023/07/21/vegetarisch-of-veganistisch-dieet-en-bloedlipiden-meta-analyse-van-rct-s/","published":"2023-07-21"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ryota-kakizaki","type":"person","url":"https://hartvaat.nl/mensen/ryota-kakizaki/","name":"Ryota Kakizaki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rudiger-smolnik","type":"person","url":"https://hartvaat.nl/mensen/rudiger-smolnik/","name":"Rüdiger Smolnik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"safi-u-khan","type":"person","url":"https://hartvaat.nl/mensen/safi-u-khan/","name":"Safi U Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/07/27/veiligheid-van-pcsk9-remmers-systematische-review-en-meta-analyse/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2020/10/13/dapt-na-pci-met-des-netwerkmeta-analyse-van-duur-en-intensiteit/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/06/21/cpap-en-cardiovasculaire-events-bij-obstructieve-slaapapneu-meta-analyse/","published":"2018-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saket-girotra","type":"person","url":"https://hartvaat.nl/mensen/saket-girotra/","name":"Saket Girotra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salim-s-hayek","type":"person","url":"https://hartvaat.nl/mensen/salim-s-hayek/","name":"Salim S Hayek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/supar-en-uitkomsten-bij-hfpef-topcat-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samuel-copt","type":"person","url":"https://hartvaat.nl/mensen/samuel-copt/","name":"Samuel Copt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/08/01/seksegerelateerde-uitkomsten-bij-hoog-bloedingsrisico-na-pci-leaders-free/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2017/04/01/polymeervrije-biolimus-stent-bij-hoog-bloedingsrisico-met-acs-leaders-free-subst/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samuel-s-gidding","type":"person","url":"https://hartvaat.nl/mensen/samuel-s-gidding/","name":"Samuel S Gidding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2018/11/01/therapieresistente-hypertensie-aha-scientific-statement-over-detectie-evaluatie-/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sana-shan","type":"person","url":"https://hartvaat.nl/mensen/sana-shan/","name":"Sana Shan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2026/01/20/voorspelling-van-individuele-corticosteroidrespons-bij-iga-nefropathie-testing-t/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandeep-k-jain","type":"person","url":"https://hartvaat.nl/mensen/sandeep-k-jain/","name":"Sandeep K Jain","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sander-van-doorn","type":"person","url":"https://hartvaat.nl/mensen/sander-van-doorn/","name":"Sander van Doorn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/nederlandse-huisartsenpost-1-op-20-contacten-voor-benauwdheid-betreft-hartfalen-/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2024/01/23/switchen-van-vka-naar-noac-bij-fragiele-ouderen-met-af-veilig/","published":"2024-01-23"},{"url":"https://hartvaat.nl/2020/08/07/geintegreerd-af-management-in-de-huisartsenpraktijk-all-in-clustergerandomiseerd/","published":"2020-08-07"},{"url":"https://hartvaat.nl/2018/08/01/opportunistische-hf-screening-met-natriuretische-peptiden-bij-af-ipd-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-yeub-lee","type":"person","url":"https://hartvaat.nl/mensen/sang-yeub-lee/","name":"Sang Yeub Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanghoon-shin","type":"person","url":"https://hartvaat.nl/mensen/sanghoon-shin/","name":"Sanghoon Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarah-de-ferranti","type":"person","url":"https://hartvaat.nl/mensen/sarah-de-ferranti/","name":"Sarah de Ferranti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-volledig-rapport/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/25/2018-aha-acc-cholesterolrichtlijn-jacc-executive-summary/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-volledig-rapport/","published":"2019-06-18"},{"url":"https://hartvaat.nl/2019/06/18/2018-aha-acc-cholesterolrichtlijn-executive-summary/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sashiananthan-ganesananthan","type":"person","url":"https://hartvaat.nl/mensen/sashiananthan-ganesananthan/","name":"Sashiananthan Ganesananthan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satyam-sarma","type":"person","url":"https://hartvaat.nl/mensen/satyam-sarma/","name":"Satyam Sarma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/12/19/synchronisatie-van-voetstap-en-hartfase-bij-crt-patienten/","published":"2023-12-19"},{"url":"https://hartvaat.nl/2023/01/31/hfpef-inspanningsbeperking-niet-alleen-door-hemodynamiek/","published":"2023-01-31"},{"url":"https://hartvaat.nl/2021/09/21/1-jaar-inspanningstraining-keert-lv-stijfheid-om-bij-stadium-b-hf/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2018/04/10/sedentaire-veroudering-omkeren-op-middelbare-leeftijd-gerandomiseerde-trial-voor/","published":"2018-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"savitri-e-fedson","type":"person","url":"https://hartvaat.nl/mensen/savitri-e-fedson/","name":"Savitri E Fedson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/15/aha-scientific-statement-nierdisfunctie-bij-gevorderd-hartfalen/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastiaan-dhont","type":"person","url":"https://hartvaat.nl/mensen/sebastiaan-dhont/","name":"Sebastiaan Dhont","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/09/praise-mr-sacubitril-valsartan-verbetert-inspanningshemodynamica-bij-hfpef-met-a/","published":"2026-07-09"},{"url":"https://hartvaat.nl/2026/05/09/praise-mr-sacubitril-valsartan-verbetert-inspanningshemodynamiek-bij-hfpef-met-a/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/03/25/inspanningsecho-identificeert-hcm-patienten-die-baat-hebben-bij-mavacamten/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seong-wook-park","type":"person","url":"https://hartvaat.nl/mensen/seong-wook-park/","name":"Seong-Wook Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-fazio","type":"person","url":"https://hartvaat.nl/mensen/sergio-fazio/","name":"Sergio Fazio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/26/odyssey-outcomes-post-hoc-hscrp-en-il-6-zijn-complementaire-prognostische-marker/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2025/12/16/geoxideerde-fosfolipiden-lp-a-en-cv-uitkomsten-na-acs/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2019/03/19/lp-a-pcsk9-remming-en-cardiovasculair-risico/","published":"2019-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-jae-lee","type":"person","url":"https://hartvaat.nl/mensen/seung-jae-lee/","name":"Seung-Jae Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/intravasculaire-beeldvorming-superieur-aan-angiografie-bij-complexe-pci-5-jaarsr/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-whan-lee","type":"person","url":"https://hartvaat.nl/mensen/seung-whan-lee/","name":"Seung-Whan Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shah","type":"person","url":"https://hartvaat.nl/mensen/shah/","name":"Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/30/etnische-verschillen-in-sterfte-na-acuut-coronair-syndroom-hogere-mortaliteit-bi/","published":"2026-07-11"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-myocardinfarct-winratio-analyse-uit-de-cle/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/23/regulering-van-ai-in-de-cardiologie-door-de-fda-een-scoping-review/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shannon-m-dunlay","type":"person","url":"https://hartvaat.nl/mensen/shannon-m-dunlay/","name":"Shannon M Dunlay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/23/nierbescherming-na-harttransplantatie-risicoreductie-en-therapeutische-mogelijkh/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheila-m-hegde","type":"person","url":"https://hartvaat.nl/mensen/sheila-m-hegde/","name":"Sheila M Hegde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/12/01/deliver-snel-voordeel-van-dapagliflozine-bij-hfpef-binnen-weken-merkbaar/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shengxian-tu","type":"person","url":"https://hartvaat.nl/mensen/shengxian-tu/","name":"Shengxian Tu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shira-perl","type":"person","url":"https://hartvaat.nl/mensen/shira-perl/","name":"Shira Perl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"},{"url":"https://hartvaat.nl/2024/10/01/amethyst-verinurad-plus-allopurinol-bij-hfpef-negatieve-trial/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shubin-qiao","type":"person","url":"https://hartvaat.nl/mensen/shubin-qiao/","name":"Shubin Qiao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-b-ascher","type":"person","url":"https://hartvaat.nl/mensen/simon-b-ascher/","name":"Simon B Ascher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/08/20/aangetaste-tubulaire-secretiecapaciteit-verhoogt-cardiovasculaire-sterfte-hunt-s/","published":"2026-08-28"},{"url":"https://hartvaat.nl/2025/04/01/hypotensieve-episodes-op-24-uurs-abpm-en-cognitieve-functie-sprint-inzichten/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-j-walsh","type":"person","url":"https://hartvaat.nl/mensen/simon-j-walsh/","name":"Simon J Walsh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-kouz","type":"person","url":"https://hartvaat.nl/mensen/simon-kouz/","name":"Simon Kouz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sonali-r-gnanenthiran","type":"person","url":"https://hartvaat.nl/mensen/sonali-r-gnanenthiran/","name":"Sonali R Gnanenthiran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2017/12/01/revascularisatie-versus-medicamenteus-beleid-bij-nste-acs-bij-ouderen-meta-analy/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sondra-m-depalma","type":"person","url":"https://hartvaat.nl/mensen/sondra-m-depalma/","name":"Sondra M DePalma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/10/04/2022-acc-expert-consensus-niet-statine-therapieen-voor-ldl-verlaging-bij-ascvd/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2017/10/03/2017-acc-gerichte-update-niet-statinetherapie-voor-ldl-verlaging/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sophie-degrauwe","type":"person","url":"https://hartvaat.nl/mensen/sophie-degrauwe/","name":"Sophie Degrauwe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2020/12/22/fentanyl-versus-morfine-op-ticagrelor-plaatjesremming-bij-stemi/","published":"2020-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"srinath-adusumalli","type":"person","url":"https://hartvaat.nl/mensen/srinath-adusumalli/","name":"Srinath Adusumalli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/05/01/apothekerverwijzingen-voor-statine-start-twee-cluster-rct-s/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2025/03/01/kaliumnitraat-bij-hfpef-gerandomiseerde-trial/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"srinivas-r-dukkipati","type":"person","url":"https://hartvaat.nl/mensen/srinivas-r-dukkipati/","name":"Srinivas R Dukkipati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/06/01/katheterablatie-of-antiaritmica-als-eerstelijnstherapie-bij-af-jama-cardiology-m/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/laa-sluiting-versus-oac-bij-af-meta-analyse-van-gerandomiseerde-trials/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"srinivasan-beddhu","type":"person","url":"https://hartvaat.nl/mensen/srinivasan-beddhu/","name":"Srinivasan Beddhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/05/20/intensieve-versus-standaard-bloeddrukcontrole-nejm-sprint-definitief-rapport/","published":"2021-05-20"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddrukmeting-in-sprint-methodologische-overwegingen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steen-dalby-kristensen","type":"person","url":"https://hartvaat.nl/mensen/steen-dalby-kristensen/","name":"Steen Dalby Kristensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2020/02/14/danami-2-16-jaarsfollow-up-primaire-pci-versus-fibrinolyse/","published":"2020-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-kaab","type":"person","url":"https://hartvaat.nl/mensen/stefan-kaab/","name":"Stefan Kääb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/03/plotse-hartstilstand-tijdens-duursporten-tien-jaar-parijse-registerdata/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2017/07/14/voorspelling-van-plotse-versus-niet-plotse-hartdood-na-mi-met-verminderde-lvef/","published":"2017-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-osswald","type":"person","url":"https://hartvaat.nl/mensen/stefan-osswald/","name":"Stefan Osswald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/12/01/linkeratriumdimensie-en-cv-uitkomsten-bij-patienten-met-en-zonder-af-meta-analys/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-benenati","type":"person","url":"https://hartvaat.nl/mensen/stefano-benenati/","name":"Stefano Benenati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2021/10/01/sacubitril-valsartan-in-real-life-europese-hfref-meta-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/04/17/geleide-versus-standaard-antiplaatjestherapie-na-pci-lancet-meta-analyse/","published":"2021-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-savonitto","type":"person","url":"https://hartvaat.nl/mensen/stefano-savonitto/","name":"Stefano Savonitto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-achenbach","type":"person","url":"https://hartvaat.nl/mensen/stephan-achenbach/","name":"Stephan Achenbach","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/12/01/empagliflozine-en-vaatfunctie-bij-chronisch-hf/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephane-heymans","type":"person","url":"https://hartvaat.nl/mensen/stephane-heymans/","name":"Stephane Heymans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-burgess","type":"person","url":"https://hartvaat.nl/mensen/stephen-burgess/","name":"Stephen Burgess","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-harrap","type":"person","url":"https://hartvaat.nl/mensen/stephen-harrap/","name":"Stephen Harrap","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/03/01/korttermijn-bloeddrukmetingen-voorspellen-langetermijneffect-van-behandeling/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-g-terra","type":"person","url":"https://hartvaat.nl/mensen/steven-g-terra/","name":"Steven G Terra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"subhash-banerjee","type":"person","url":"https://hartvaat.nl/mensen/subhash-banerjee/","name":"Subhash Banerjee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-j-curry","type":"person","url":"https://hartvaat.nl/mensen/susan-j-curry/","name":"Susan J Curry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-r-heckbert","type":"person","url":"https://hartvaat.nl/mensen/susan-r-heckbert/","name":"Susan R Heckbert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2018/06/01/gwas-van-pr-interval-bij-hispanic-latino-s-nieuw-locus-bij-id2/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susanne-greber-platzer","type":"person","url":"https://hartvaat.nl/mensen/susanne-greber-platzer/","name":"Susanne Greber-Platzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susanne-s-pedersen","type":"person","url":"https://hartvaat.nl/mensen/susanne-s-pedersen/","name":"Susanne S Pedersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/07/04/cognitieve-gedragstherapie-verbetert-kwaliteit-van-leven-bij-symptomatisch-af/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2022/02/02/remote-monitoring-en-klinische-uitkomsten-bij-europese-hf-met-icd-langetermijn/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2019/09/01/remote-monitoring-en-patientgerapporteerde-uitkomsten-bij-europese-hf-patienten-/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susheel-k-kodali","type":"person","url":"https://hartvaat.nl/mensen/susheel-k-kodali/","name":"Susheel K Kodali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suzanne-de-waha","type":"person","url":"https://hartvaat.nl/mensen/suzanne-de-waha/","name":"Suzanne de Waha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sven-mobius-winkler","type":"person","url":"https://hartvaat.nl/mensen/sven-mobius-winkler/","name":"Sven Möbius-Winkler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2022/07/26/empag-hf-vroege-empagliflozine-bij-acuut-hartfalen-verbetert-diurese/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"soren-lund-kristensen","type":"person","url":"https://hartvaat.nl/mensen/soren-lund-kristensen/","name":"Søren Lund Kristensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/10/poseidon-4-op-10-patienten-met-hartfalen-wereldwijd-heeft-inflammatoir-verhoogd-/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2025/10/01/ambulante-iv-diurese-bij-chronisch-hf-decongest-inzichten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tae-soo-kang","type":"person","url":"https://hartvaat.nl/mensen/tae-soo-kang/","name":"Tae Soo Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tae-hoon-kim","type":"person","url":"https://hartvaat.nl/mensen/tae-hoon-kim/","name":"Tae-Hoon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/12/03/ct-gestuurde-atriale-wanddiktemapping-bij-cryoballon-pvi/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tae-hyun-yang","type":"person","url":"https://hartvaat.nl/mensen/tae-hyun-yang/","name":"Tae-Hyun Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2018/04/01/valsartan-en-linkerkamerremodellering-na-mi/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takayoshi-ohkubo","type":"person","url":"https://hartvaat.nl/mensen/takayoshi-ohkubo/","name":"Takayoshi Ohkubo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2019/01/01/levenslangrisico-op-cva-en-coronairlijden-naar-bloeddrukniveau-epoch-japan/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/06/01/interarmbloeddrukverschil-en-beroerte-ipd-meta-analyse/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takenori-domei","type":"person","url":"https://hartvaat.nl/mensen/takenori-domei/","name":"Takenori Domei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takeshi-yamashita","type":"person","url":"https://hartvaat.nl/mensen/takeshi-yamashita/","name":"Takeshi Yamashita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/eldercare-af-post-hoc-edoxaban-spiegel-en-pt-13s-voorspellen-bloedingsrisico-bij/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2022/06/01/edoxaban-15-mg-bij-zeer-oude-patienten-met-atriumfibrilleren-eldercare-subanalys/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/03/01/edoxaban-15-mg-naar-nierfunctie-bij-zeer-oude-af-eldercare-subanalyse/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2020/10/29/laaggedoseerd-edoxaban-bij-zeer-oude-af-patienten-nejm-eldercare-af/","published":"2020-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takuya-hayashi","type":"person","url":"https://hartvaat.nl/mensen/takuya-hayashi/","name":"Takuya Hayashi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/eldercare-af-post-hoc-edoxaban-spiegel-en-pt-13s-voorspellen-bloedingsrisico-bij/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2022/06/01/edoxaban-15-mg-bij-zeer-oude-patienten-met-atriumfibrilleren-eldercare-subanalys/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2022/03/01/edoxaban-15-mg-naar-nierfunctie-bij-zeer-oude-af-eldercare-subanalyse/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2020/10/29/laaggedoseerd-edoxaban-bij-zeer-oude-af-patienten-nejm-eldercare-af/","published":"2020-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tara-mccready","type":"person","url":"https://hartvaat.nl/mensen/tara-mccready/","name":"Tara McCready","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2019/10/05/uitgebreide-community-interventie-bij-hypertensie-lancet-hope-4/","published":"2019-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tatjana-s-potpara","type":"person","url":"https://hartvaat.nl/mensen/tatjana-s-potpara/","name":"Tatjana S Potpara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/01/01/weglaten-van-aspirine-bij-gecombineerde-antitrombotische-therapie-voor-af-acs-he/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"taye-h-hamza","type":"person","url":"https://hartvaat.nl/mensen/taye-h-hamza/","name":"Taye H Hamza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"},{"url":"https://hartvaat.nl/2017/01/17/dapt-versus-aspirine-monotherapie-bij-diabetes-met-multivatenlijden-na-cabg-free/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"teguh-santoso","type":"person","url":"https://hartvaat.nl/mensen/teguh-santoso/","name":"Teguh Santoso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"theodore-a-bass","type":"person","url":"https://hartvaat.nl/mensen/theodore-a-bass/","name":"Theodore A Bass","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thierry-lefevre","type":"person","url":"https://hartvaat.nl/mensen/thierry-lefevre/","name":"Thierry Lefèvre","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-a-prohaska","type":"person","url":"https://hartvaat.nl/mensen/thomas-a-prohaska/","name":"Thomas A Prohaska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-familiaire-chylomicronemie-nejm-fase-3/","published":"2024-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-j-wang","type":"person","url":"https://hartvaat.nl/mensen/thomas-j-wang/","name":"Thomas J Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2019/09/19/polypil-voor-cv-preventie-bij-onderbehandelde-populatie-nejm/","published":"2019-09-19"},{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-jon-jensen","type":"person","url":"https://hartvaat.nl/mensen/thomas-jon-jensen/","name":"Thomas Jon Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/22/af-en-semaglutide-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-m-maddox","type":"person","url":"https://hartvaat.nl/mensen/thomas-m-maddox/","name":"Thomas M Maddox","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2017/02/07/acc-aats-aha-2016-criteria-voor-gepaste-coronaire-revascularisatie-bij-acs-en-st/","published":"2017-02-07"},{"url":"https://hartvaat.nl/2016/04/01/orale-antistolling-bij-atriumfibrilleren-over-het-spectrum-van-beroerterisico-ga/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-mcandrew","type":"person","url":"https://hartvaat.nl/mensen/thomas-mcandrew/","name":"Thomas McAndrew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2019/06/21/impact-van-groot-periprocedureel-mi-op-mortaliteit-na-pci-en-cabg/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-nestelberger","type":"person","url":"https://hartvaat.nl/mensen/thomas-nestelberger/","name":"Thomas Nestelberger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2025/01/01/esc-0-1-uur-versus-0-2-of-0-3-uur-hoog-sensitief-troponine-algoritmen-bij-verden/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-w-johnson","type":"person","url":"https://hartvaat.nl/mensen/thomas-w-johnson/","name":"Thomas W Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2017/11/01/switchen-van-dapt-na-acs-de-topic-trial/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thor-trovik","type":"person","url":"https://hartvaat.nl/mensen/thor-trovik/","name":"Thor Trovik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"},{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"timo-makikallio","type":"person","url":"https://hartvaat.nl/mensen/timo-makikallio/","name":"Timo Mäkikallio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobias-reichlin","type":"person","url":"https://hartvaat.nl/mensen/tobias-reichlin/","name":"Tobias Reichlin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tolga-agdirlioglu","type":"person","url":"https://hartvaat.nl/mensen/tolga-agdirlioglu/","name":"Tolga Agdirlioglu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-thuren","type":"person","url":"https://hartvaat.nl/mensen/tom-thuren/","name":"Tom Thuren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/02/01/il-1-remming-en-bloeddruk-hypertensie-en-residueel-inflammatoir-risico-cantos/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"},{"url":"https://hartvaat.nl/2017/10/21/canakinumab-en-longkankerincidentie-bij-atherosclerose-lancet-cantos-exploratief/","published":"2017-10-21"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomas-freiberger","type":"person","url":"https://hartvaat.nl/mensen/tomas-freiberger/","name":"Tomas Freiberger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomasz-gasior","type":"person","url":"https://hartvaat.nl/mensen/tomasz-gasior/","name":"Tomasz Gasior","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/empagliflozine-na-mi-met-en-zonder-diabetes-en-ckd-empact-mi-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomoko-iwata","type":"person","url":"https://hartvaat.nl/mensen/tomoko-iwata/","name":"Tomoko Iwata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2021/03/23/empagliflozine-bij-hfref-met-volume-overbelasting-emperor-reduced/","published":"2021-03-23"},{"url":"https://hartvaat.nl/2021/02/11/neprilysineremming-en-empagliflozine-bij-chronisch-hfref-emperor-reduced-interac/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ton-a-c-m-heestermans","type":"person","url":"https://hartvaat.nl/mensen/ton-a-c-m-heestermans/","name":"Ton A C M Heestermans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/04/25/clopidogrel-versus-ticagrelor-of-prasugrel-bij-70-plussers-met-nste-acs-lancet-p/","published":"2020-04-25"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toshiharu-ninomiya","type":"person","url":"https://hartvaat.nl/mensen/toshiharu-ninomiya/","name":"Toshiharu Ninomiya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2018/06/01/interarmbloeddrukverschil-en-beroerte-ipd-meta-analyse/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"traci-turner","type":"person","url":"https://hartvaat.nl/mensen/traci-turner/","name":"Traci Turner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"troels-thim","type":"person","url":"https://hartvaat.nl/mensen/troels-thim/","name":"Troels Thim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"truls-ramunddal","type":"person","url":"https://hartvaat.nl/mensen/truls-ramunddal/","name":"Truls Råmunddal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tullio-palmerini","type":"person","url":"https://hartvaat.nl/mensen/tullio-palmerini/","name":"Tullio Palmerini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2020/02/18/stent-gerelateerde-events-1-jaar-na-pci/","published":"2020-02-18"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tuvia-ben-gal","type":"person","url":"https://hartvaat.nl/mensen/tuvia-ben-gal/","name":"Tuvia Ben-Gal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/09/14/semaglutide-en-diureticagebruik-bij-hfpef-met-obesitas-step-hfpef-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tyler-massaro","type":"person","url":"https://hartvaat.nl/mensen/tyler-massaro/","name":"Tyler Massaro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrik-wislff","type":"person","url":"https://hartvaat.nl/mensen/ulrik-wislff/","name":"Ulrik Wisløff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2022/10/01/verschillende-trainingsvormen-en-hdl-functie-bij-hfpef-optimex-substudie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2022/06/01/vijf-jaar-inspanningstraining-verbetert-cardiovasculair-risicoprofiel-bij-oudere/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"umberto-barbero","type":"person","url":"https://hartvaat.nl/mensen/umberto-barbero/","name":"Umberto Barbero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"urh-groselj","type":"person","url":"https://hartvaat.nl/mensen/urh-groselj/","name":"Urh Groselj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/02/24/lp-a-spiegels-bij-kinderen-met-hypercholesterolemie-impact-op-ldl-c-interpretati/","published":"2026-02-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"urszula-masiukiewicz","type":"person","url":"https://hartvaat.nl/mensen/urszula-masiukiewicz/","name":"Urszula Masiukiewicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valerio-lanzilotti","type":"person","url":"https://hartvaat.nl/mensen/valerio-lanzilotti/","name":"Valerio Lanzilotti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-en-hoog-bloedin/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valluvan-jeevanandam","type":"person","url":"https://hartvaat.nl/mensen/valluvan-jeevanandam/","name":"Valluvan Jeevanandam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/intrapericardiale-lvad-bij-gevorderd-hartfalen-nejm/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanessa-selak","type":"person","url":"https://hartvaat.nl/mensen/vanessa-selak/","name":"Vanessa Selak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vasilios-papademetriou","type":"person","url":"https://hartvaat.nl/mensen/vasilios-papademetriou/","name":"Vasilios Papademetriou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veikko-salomaa","type":"person","url":"https://hartvaat.nl/mensen/veikko-salomaa/","name":"Veikko Salomaa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veli-pekka-harjola","type":"person","url":"https://hartvaat.nl/mensen/veli-pekka-harjola/","name":"Veli-Pekka Harjola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/11/28/xenon-inhalatie-vermindert-myocardschade-bij-overlevenden-van-hartstilstand-xe-h/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-aboyans","type":"person","url":"https://hartvaat.nl/mensen/victor-aboyans/","name":"Victor Aboyans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincent-fabien","type":"person","url":"https://hartvaat.nl/mensen/vincent-fabien/","name":"Vincent Fabien","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/05/30/affirm-ahf-hemoglobine-beinvloedt-iv-ijzereffect-bij-acuut-hartfalen/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincent-w-v-jaddoe","type":"person","url":"https://hartvaat.nl/mensen/vincent-w-v-jaddoe/","name":"Vincent W V Jaddoe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"virend-k-somers","type":"person","url":"https://hartvaat.nl/mensen/virend-k-somers/","name":"Virend K Somers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/hoog-versus-laag-natrium-oxybaat-en-bloeddruk-bij-narcolepsie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/09/01/slaaprestrictie-en-ambulante-en-slaap-bloeddruk-gerandomiseerde-crossover/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vivek-rajagopal","type":"person","url":"https://hartvaat.nl/mensen/vivek-rajagopal/","name":"Vivek Rajagopal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wadea-m-tarhuni","type":"person","url":"https://hartvaat.nl/mensen/wadea-m-tarhuni/","name":"Wadea M Tarhuni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2020/08/25/machine-learning-voor-lv-diastolische-functie-op-ecg/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wanda-k-nicholson","type":"person","url":"https://hartvaat.nl/mensen/wanda-k-nicholson/","name":"Wanda K Nicholson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2022/08/23/uspstf-aanbeveling-statinegebruik-voor-primaire-cardiovasculaire-preventie/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2022/07/26/uspstf-gedragsinterventies-voor-gezonde-leefstijl-bij-cardiovasculaire-preventie/","published":"2022-07-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wang-soo-lee","type":"person","url":"https://hartvaat.nl/mensen/wang-soo-lee/","name":"Wang Soo Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wataru-shimizu","type":"person","url":"https://hartvaat.nl/mensen/wataru-shimizu/","name":"Wataru Shimizu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2022/03/01/edoxaban-15-mg-naar-nierfunctie-bij-zeer-oude-af-eldercare-subanalyse/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2021/10/01/empagliflozine-en-nierprotectie-bij-acuut-mi-met-diabetes-pilot/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-xu","type":"person","url":"https://hartvaat.nl/mensen/wei-xu/","name":"Wei Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/12/31/annexine-a1-verergert-activatie-van-eilandjessterrecellen-via-triglyceridenafbra/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/09/01/pvi-met-of-zonder-empirische-svc-isolatie-bij-af-ablatie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2020/07/01/bloeddruk-en-cognitieve-stoornis-en-dementie-meta-analyse-van-209-studies/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weifeng-jiang","type":"person","url":"https://hartvaat.nl/mensen/weifeng-jiang/","name":"Weifeng Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/08/12/catheterablatie-versus-rate-control-bij-persisterend-af-en-ouder-hartfalen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2021/05/21/extrapulmonale-vein-driver-mapping-bij-persisterend-af-bij-obese-patienten/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weiqing-wang","type":"person","url":"https://hartvaat.nl/mensen/weiqing-wang/","name":"Weiqing Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wen-hua-hsieh","type":"person","url":"https://hartvaat.nl/mensen/wen-hua-hsieh/","name":"Wen-Hua Hsieh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2017/05/02/mi-risico-na-stoppen-van-thienopyridine-dapt-studie/","published":"2017-05-02"},{"url":"https://hartvaat.nl/2016/10/04/impact-van-optimale-medicamenteuze-therapie-in-de-dapt-studie/","published":"2016-10-04"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/12/protonpompremmers-verminderen-gastro-intestinale-events-ongeacht-aspirinedosis-b/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wen-yi-yang","type":"person","url":"https://hartvaat.nl/mensen/wen-yi-yang/","name":"Wen-Yi Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wendimagegn-alemayehu","type":"person","url":"https://hartvaat.nl/mensen/wendimagegn-alemayehu/","name":"Wendimagegn Alemayehu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/geografische-variatie-in-hfref-patientkenmerken-en-behandeling/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2020/07/01/barrieres-voor-optimale-hf-medicatie-guide-it-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/08/01/hoog-versus-laag-zuurstof-bij-acuut-hartfalen-hilo-hf-pilot/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wendy-s-post","type":"person","url":"https://hartvaat.nl/mensen/wendy-s-post/","name":"Wendy S Post","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/06/01/geisoleerde-diastolische-hypertensie-cohort-en-meta-analyse-voor-behandeldrempel/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2018/03/27/hdl-subspecies-met-apoliproteine-c-iii-en-coronairlijden-vier-cohorten/","published":"2018-03-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wengen-zhu","type":"person","url":"https://hartvaat.nl/mensen/wengen-zhu/","name":"Wengen Zhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/01/hypertensie-wijzigt-de-relatie-tussen-lp-a-en-mortaliteit-bij-acuut-gedecompense/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/04/01/copd-en-slechtere-uitkomsten-bij-hfpef-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/12/01/nt-probnp-voorspelt-nieuw-ontstaan-af-bij-hfpef/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/06/01/s2i2n0-3-score-voorspelt-mortaliteit-bij-hfref-guide-it-subanalyse/","published":"2024-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wessel-ganzevoort","type":"person","url":"https://hartvaat.nl/mensen/wessel-ganzevoort/","name":"Wessel Ganzevoort","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/06/01/amenorroe-duur-bij-start-antihypertensiva-in-de-zwangerschap-chips-secundaire-an/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/11/01/sildenafil-tijdens-de-zwangerschap-preklinische-meta-analyse-over-foetale-groei-/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilko-reents","type":"person","url":"https://hartvaat.nl/mensen/wilko-reents/","name":"Wilko Reents","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilko-spiering","type":"person","url":"https://hartvaat.nl/mensen/wilko-spiering/","name":"Wilko Spiering","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2022/10/01/smartphone-app-thuisbloeddrukmeting-versus-kantoor-en-ambulante-meting/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/01/01/plasmatrogconcentraties-van-antihypertensiva-voor-therapietrouwbeoordeling-meta-/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-e-haley","type":"person","url":"https://hartvaat.nl/mensen/william-e-haley/","name":"William E Haley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-j-kostis","type":"person","url":"https://hartvaat.nl/mensen/william-j-kostis/","name":"William J Kostis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"willibald-hochholzer","type":"person","url":"https://hartvaat.nl/mensen/willibald-hochholzer/","name":"Willibald Hochholzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2023/04/17/in-stent-restenose-tienjaarsuitkomsten-plain-balloon-vs-dcb-vs-des-isar-desire-3/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"},{"url":"https://hartvaat.nl/2016/07/19/immatuur-plaatjesaantal-versus-gevestigde-voorspellers-van-plaatjesreactiviteit-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"winfried-marz","type":"person","url":"https://hartvaat.nl/mensen/winfried-marz/","name":"Winfried März","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2016/06/01/langetermijneffecten-van-atorvastatine-bij-diabetes-type-2-op-hemodialyse-4d-tri/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wouter-ouwerkerk","type":"person","url":"https://hartvaat.nl/mensen/wouter-ouwerkerk/","name":"Wouter Ouwerkerk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/31/hfpef-fenotype-duidt-op-hogere-sterfte-na-tavi-bij-laagstroom-laaggradient-aorta/","published":"2026-07-27"},{"url":"https://hartvaat.nl/2025/12/16/farmacologische-behandeling-van-hfref-geactualiseerde-systematische-review/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2022/08/01/sekseverschillen-in-effectiviteit-van-hartfalenmedicatie-meta-analyse/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xavier-girerd","type":"person","url":"https://hartvaat.nl/mensen/xavier-girerd/","name":"Xavier Girerd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiang-cheng","type":"person","url":"https://hartvaat.nl/mensen/xiang-cheng/","name":"Xiang Cheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/25/explorer-cn-week-78-langetermijneffect-en-veiligheid-van-mavacamten-bij-chinese-/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/05/nucleair-ago2-verergert-hfpef-via-myocardiale-ketogenese/","published":"2026-04-03"},{"url":"https://hartvaat.nl/2025/01/01/varenicline-vermindert-ventriculaire-ectopie-na-myocardinfarct/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2024/09/24/colchicine-en-coronaire-plaquestabiliteit-na-acs-oct-studie/","published":"2024-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaofan-guo","type":"person","url":"https://hartvaat.nl/mensen/xiaofan-guo/","name":"Xiaofan Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaofang-yan","type":"person","url":"https://hartvaat.nl/mensen/xiaofang-yan/","name":"Xiaofang Yan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoshu-cheng","type":"person","url":"https://hartvaat.nl/mensen/xiaoshu-cheng/","name":"Xiaoshu Cheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/01/metabole-score-voor-visceraal-vet-en-risico-op-perifeer-arterieel-vaatlijden-bij/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoxia-liu","type":"person","url":"https://hartvaat.nl/mensen/xiaoxia-liu/","name":"Xiaoxia Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/09/01/inflammatie-als-risicofactor-krijgt-onvoldoende-ruimte-in-de-ascvd-en-ckd-prakti/","published":"2026-07-26"},{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinhua-wang","type":"person","url":"https://hartvaat.nl/mensen/xinhua-wang/","name":"Xinhua Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/16/sluiting-van-het-linker-hartoor-versus-doac-s-na-longembolie/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinyang-hu","type":"person","url":"https://hartvaat.nl/mensen/xinyang-hu/","name":"Xinyang Hu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/varenicline-vermindert-ventriculaire-ectopie-na-myocardinfarct/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinyi-zhang","type":"person","url":"https://hartvaat.nl/mensen/xinyi-zhang/","name":"Xinyi Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/01/01/apolipoproteine-e-genpolymorfismen-en-het-risico-op-coronairlijden/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xuejun-yin","type":"person","url":"https://hartvaat.nl/mensen/xuejun-yin/","name":"Xuejun Yin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yader-sandoval","type":"person","url":"https://hartvaat.nl/mensen/yader-sandoval/","name":"Yader Sandoval","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-wang","type":"person","url":"https://hartvaat.nl/mensen/yan-wang/","name":"Yan Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2023/06/01/remote-ischemische-conditionering-bij-milde-hypertensie-zonder-medicatie-rct/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-liu","type":"person","url":"https://hartvaat.nl/mensen/yang-liu/","name":"Yang Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/01/01/langdurige-blootstelling-aan-bosbranden-pm2-5-en-cardiovasculaire-ziekenhuisopna/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/31/herhaalde-in-situ-ablatie-versus-uitgebreide-ablatie-bij-recidief-persisterend-a/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/08/12/catheterablatie-versus-rate-control-bij-persisterend-af-en-ouder-hartfalen/","published":"2025-08-12"},{"url":"https://hartvaat.nl/2023/02/01/hartfalenrisicoscores-vergelijking-voor-mortaliteit-en-heropname/","published":"2023-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yanyan-zhao","type":"person","url":"https://hartvaat.nl/mensen/yanyan-zhao/","name":"Yanyan Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2024/02/01/maggic-score-voor-mortaliteitsvoorspelling-bij-klepziekte/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yared-gurmu","type":"person","url":"https://hartvaat.nl/mensen/yared-gurmu/","name":"Yared Gurmu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2019/10/21/cv-biomarkers-bij-acuut-gedecompenseerd-hf-met-sacubitril-valsartan-pioneer-hf/","published":"2019-10-21"},{"url":"https://hartvaat.nl/2019/05/07/sacubitril-valsartan-of-enalapril-bij-acuut-gedecompenseerd-hf-pioneer-hf-klinis/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasuyuki-egami","type":"person","url":"https://hartvaat.nl/mensen/yasuyuki-egami/","name":"Yasuyuki Egami","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2025/06/01/dapagliflozine-bij-acuut-gedecompenseerd-hartfalen-en-nierfunctie-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yazan-daaboul","type":"person","url":"https://hartvaat.nl/mensen/yazan-daaboul/","name":"Yazan Daaboul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yeonwoo-choi","type":"person","url":"https://hartvaat.nl/mensen/yeonwoo-choi/","name":"Yeonwoo Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-bang-cheng","type":"person","url":"https://hartvaat.nl/mensen/yi-bang-cheng/","name":"Yi-Bang Cheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/11/10/chinese-kruidenformule-voor-gemaskeerde-hypertensie-gerandomiseerde-placebogecon/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yolanda-van-der-graaf","type":"person","url":"https://hartvaat.nl/mensen/yolanda-van-der-graaf/","name":"Yolanda van der Graaf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2018/10/01/geschat-individueel-levensvoordeel-van-pcsk9-remming-bij-statinebehandelde-cad-p/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-liu","type":"person","url":"https://hartvaat.nl/mensen/yong-liu/","name":"Yong Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/02/27/verhoogd-lp-a-en-diabetes-verergeren-samen-de-prognose-bij-coronairlijden/","published":"2026-02-27"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-hoon-yoon","type":"person","url":"https://hartvaat.nl/mensen/yong-hoon-yoon/","name":"Yong-Hoon Yoon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-un-kim","type":"person","url":"https://hartvaat.nl/mensen/yong-un-kim/","name":"Yong-Un Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/03/16/alirocumab-naar-bereikte-ldl-na-acs-odyssey-outcomes/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2020/05/19/pav-en-vte-na-acs-rol-van-lp-a-en-modificatie-door-alirocumab/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yoshihisa-nakagawa","type":"person","url":"https://hartvaat.nl/mensen/yoshihisa-nakagawa/","name":"Yoshihisa Nakagawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-xu","type":"person","url":"https://hartvaat.nl/mensen/yu-xu/","name":"Yu Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuan-ma","type":"person","url":"https://hartvaat.nl/mensen/yuan-ma/","name":"Yuan Ma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/04/01/hypotensieve-episodes-op-24-uurs-abpm-en-cognitieve-functie-sprint-inzichten/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/11/01/bloeddrukverlagende-medicatie-en-natriumbeperking-gecombineerd-effect/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yue-deng","type":"person","url":"https://hartvaat.nl/mensen/yue-deng/","name":"Yue Deng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/01/hypertensieduur-en-effect-van-intensieve-bloeddrukbehandeling/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/09/01/step-substudie-intensieve-bloeddrukverlaging-verbetert-lvh-bij-ouderen/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/12/01/klebsiella-pneumoniae-als-mogelijke-oorzaak-van-hypertensie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yue-li","type":"person","url":"https://hartvaat.nl/mensen/yue-li/","name":"Yue Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/03/darmmicrobioom-bevordert-atriumfibrilleren-bij-chronische-nierziekte-via-nlrp3-i/","published":"2026-04-07"},{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yufang-bi","type":"person","url":"https://hartvaat.nl/mensen/yufang-bi/","name":"Yufang Bi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuki-katagiri","type":"person","url":"https://hartvaat.nl/mensen/yuki-katagiri/","name":"Yuki Katagiri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuki-obayashi","type":"person","url":"https://hartvaat.nl/mensen/yuki-obayashi/","name":"Yuki Obayashi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yunpeng-zhu","type":"person","url":"https://hartvaat.nl/mensen/yunpeng-zhu/","name":"Yunpeng Zhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/05/01/p2y12-monotherapie-versus-dapt-na-pci-ipd-meta-analyse/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/02/14/p2y12-monotherapie-versus-dapt-na-complexe-pci/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuri-lopatin","type":"person","url":"https://hartvaat.nl/mensen/yuri-lopatin/","name":"Yuri Lopatin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yves-louvard","type":"person","url":"https://hartvaat.nl/mensen/yves-louvard/","name":"Yves Louvard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zenon-huczek","type":"person","url":"https://hartvaat.nl/mensen/zenon-huczek/","name":"Zenon Huczek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhen-ge","type":"person","url":"https://hartvaat.nl/mensen/zhen-ge/","name":"Zhen Ge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/07/de-escalatie-naar-ticagrelor-monotherapie-bij-diabetespatienten-na-acs/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhen-huang","type":"person","url":"https://hartvaat.nl/mensen/zhen-huang/","name":"Zhen Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhen-zhang","type":"person","url":"https://hartvaat.nl/mensen/zhen-zhang/","name":"Zhen Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/03/02/extracellulaire-vesikels-medieren-adipocyt-cardiomyocytcommunicatie-bij-diabetis/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2018/01/30/absorb-bioresorbeerbare-scaffold-3-jaarsresultaten-ipd-meta-analyse/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/08/19/absorb-bioresorbeerbare-scaffold-lancet-2-jaars-systematische-review-en-meta-ana/","published":"2017-08-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhipeng-zhou","type":"person","url":"https://hartvaat.nl/mensen/zhipeng-zhou/","name":"Zhipeng Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2022/11/15/coapt-mitraclip-vermindert-hospitalisaties-bij-secundaire-mr-en-hartfalen/","published":"2022-11-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhiyan-wang","type":"person","url":"https://hartvaat.nl/mensen/zhiyan-wang/","name":"Zhiyan Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukverlaging-bij-ongediagnosticeerde-hfpef-met-hoog-risico/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhuhua-yao","type":"person","url":"https://hartvaat.nl/mensen/zhuhua-yao/","name":"Zhuhua Yao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/06/26/inclisiran-als-monotherapie-verlaagt-ldl-c-met-47-5-in-chinese-volwassenen-victo/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zuzana-motovska","type":"person","url":"https://hartvaat.nl/mensen/zuzana-motovska/","name":"Zuzana Motovska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zeljko-reiner","type":"person","url":"https://hartvaat.nl/mensen/zeljko-reiner/","name":"Željko Reiner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":4,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2022/09/07/prevalentie-van-statine-intolerantie-meta-analyse-nuanceert-het-probleem/","published":"2022-09-07"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-c","type":"person","url":"https://hartvaat.nl/mensen/a-c/","name":"A. C.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/21/genetische-test-bij-cardiomyopathie-huidige-britse-criteria-missen-een-op-de-zev/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2026/01/16/nt-probnp-voorspelt-sterfte-na-een-stemi-onafhankelijk-van-de-ejectiefractie/","published":"2026-01-16"},{"url":"https://hartvaat.nl/2026/01/06/machine-learning-algoritme-mi3-helpt-een-infarct-uitsluiten-bij-een-onduidelijke/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-m","type":"person","url":"https://hartvaat.nl/mensen/a-m/","name":"A. M.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/04/24/verminderde-nierfunctie-verhoogt-hartfalenrisico-bij-ouderen-aspree-cohort/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2026/03/31/titine-cardiomyopathie-meestal-dcm-of-linksdominante-acm-met-blijvend-ritmestoor/","published":"2026-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-o","type":"person","url":"https://hartvaat.nl/mensen/a-o/","name":"A. O.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/10/risicostratificatie-bij-longembolie-hoe-bruikbaar-zijn-de-huidige-instrumenten/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/01/30/lager-opleidingsniveau-hangt-samen-met-meer-halsslagaderplaques-los-van-risicofa/","published":"2026-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-s","type":"person","url":"https://hartvaat.nl/mensen/a-s/","name":"A. S.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/31/titine-cardiomyopathie-meestal-dcm-of-linksdominante-acm-met-blijvend-ritmestoor/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/02/06/jonge-patienten-met-een-hartinfarct-meer-leefstijl-en-psychosociale-risicofactor/","published":"2026-02-06"},{"url":"https://hartvaat.nl/2026/01/27/minimaal-invasieve-mitralisklepchirurgie-sneller-herstel-even-veilig-als-de-conv/","published":"2026-01-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aadil-shaukat","type":"person","url":"https://hartvaat.nl/mensen/aadil-shaukat/","name":"Aadil Shaukat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abbas-dehghan","type":"person","url":"https://hartvaat.nl/mensen/abbas-dehghan/","name":"Abbas Dehghan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ad-j-van-boven","type":"person","url":"https://hartvaat.nl/mensen/ad-j-van-boven/","name":"Ad J van Boven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-j-lewandowski","type":"person","url":"https://hartvaat.nl/mensen/adam-j-lewandowski/","name":"Adam J Lewandowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-r-glassman","type":"person","url":"https://hartvaat.nl/mensen/adam-r-glassman/","name":"Adam R Glassman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/25/aflibercept-versus-bevacizumab-eerst-bij-diabetisch-macula-oedeem/","published":"2022-08-25"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-s-cifu","type":"person","url":"https://hartvaat.nl/mensen/adam-s-cifu/","name":"Adam S Cifu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/06/08/interventies-bij-secundaire-mitralisklepinsufficientie-jama-klinisch-overzicht/","published":"2021-06-08"},{"url":"https://hartvaat.nl/2021/01/05/management-van-pfo-patienten-met-cva-of-tia-jama-klinisch-overzicht/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2019/03/19/management-van-af-jama-klinisch-overzicht/","published":"2019-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-stefanski","type":"person","url":"https://hartvaat.nl/mensen/adam-stefanski/","name":"Adam Stefanski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/20/orforglipron-bij-obesitas-nejm-definitieve-fase-3-resultaten/","published":"2025-12-20"},{"url":"https://hartvaat.nl/2025/11/06/orforglipron-voor-obesitasbehandeling-nejm-fase-3/","published":"2025-11-06"},{"url":"https://hartvaat.nl/2024/09/16/tirzepatide-en-bloeddrukverlaging-surmount-1-gestratificeerde-analyse/","published":"2024-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aditya-surapaneni","type":"person","url":"https://hartvaat.nl/mensen/aditya-surapaneni/","name":"Aditya Surapaneni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-baranchuk","type":"person","url":"https://hartvaat.nl/mensen/adrian-baranchuk/","name":"Adrian Baranchuk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2019/08/01/vernakalant-voor-cardioversie-van-recent-onset-af-meta-analyse/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-ma","type":"person","url":"https://hartvaat.nl/mensen/adrian-ma/","name":"Adrian Ma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adriana-m-hung","type":"person","url":"https://hartvaat.nl/mensen/adriana-m-hung/","name":"Adriana M Hung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aernoud-t-l-fiolet","type":"person","url":"https://hartvaat.nl/mensen/aernoud-t-l-fiolet/","name":"Aernoud T L Fiolet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aeron-m-small","type":"person","url":"https://hartvaat.nl/mensen/aeron-m-small/","name":"Aeron M Small","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmad","type":"person","url":"https://hartvaat.nl/mensen/ahmad/","name":"Ahmad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/17/direct-naar-ct-coronairangiografie-bij-verdenking-angina-snellere-diagnose-en-mi/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/relatieve-apicale-sparing-op-strain-echo-voor-cardiale-amyloidose-meta-analyse-v/","published":"2026-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-abdelalim","type":"person","url":"https://hartvaat.nl/mensen/ahmed-abdelalim/","name":"Ahmed Abdelalim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-elghamaz","type":"person","url":"https://hartvaat.nl/mensen/ahmed-elghamaz/","name":"Ahmed Elghamaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-nasreldein","type":"person","url":"https://hartvaat.nl/mensen/ahmed-nasreldein/","name":"Ahmed Nasreldein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aishwarya-krishnaraj","type":"person","url":"https://hartvaat.nl/mensen/aishwarya-krishnaraj/","name":"Aishwarya Krishnaraj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aitor-uribarri","type":"person","url":"https://hartvaat.nl/mensen/aitor-uribarri/","name":"Aitor Uribarri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/01/20/es-bempedacs-triple-versus-duale-lipidenbehandeling-na-acs/","published":"2026-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ajay-gupta","type":"person","url":"https://hartvaat.nl/mensen/ajay-gupta/","name":"Ajay Gupta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/28/ascot-legacy-atorvastatine-verlaagt-cv-events-over-20-jaar/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2018/09/29/langetermijnmortaliteit-na-bloeddruk-en-lipidenverlaging-bij-hypertensie-ascot-l/","published":"2018-09-29"},{"url":"https://hartvaat.nl/2017/06/24/bijwerkingen-bij-niet-geblindeerde-versus-geblindeerde-statinetherapie-lancet-as/","published":"2017-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ajay-m-shah","type":"person","url":"https://hartvaat.nl/mensen/ajay-m-shah/","name":"Ajay M Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/05/21/ijzerisomaltosides-en-skeletspierdenergie-bij-chronisch-hf-met-ijzerdeficientie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2018/03/01/medicamenteuze-behandeling-en-uitkomsten-bij-hfpef-systematische-review-en-meta-/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akihiro-sunaga","type":"person","url":"https://hartvaat.nl/mensen/akihiro-sunaga/","name":"Akihiro Sunaga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2018/09/01/pace-capture-geleide-ablatie-na-contact-force-pvi-dragon-gerandomiseerde-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alain-combes","type":"person","url":"https://hartvaat.nl/mensen/alain-combes/","name":"Alain Combes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2026/01/06/levoecmo-levosimendan-bij-ecmo-weaning-bij-cardiogene-shock/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alain-furber","type":"person","url":"https://hartvaat.nl/mensen/alain-furber/","name":"Alain Furber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alain-g-bertoni","type":"person","url":"https://hartvaat.nl/mensen/alain-g-bertoni/","name":"Alain G Bertoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2020/12/22/lichaamssamenstelling-en-risico-op-hartfalen-en-mi-prospectieve-analyse/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-hinderliter","type":"person","url":"https://hartvaat.nl/mensen/alan-hinderliter/","name":"Alan Hinderliter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/07/27/heeft-deze-volwassene-hypertensie-jama-rational-clinical-examination/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2016/04/05/hartrevalidatie-versterkt-met-stressmanagementtraining-gerandomiseerde-trial/","published":"2016-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-j-lerner","type":"person","url":"https://hartvaat.nl/mensen/alan-j-lerner/","name":"Alan J Lerner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-s-rigby","type":"person","url":"https://hartvaat.nl/mensen/alan-s-rigby/","name":"Alan S Rigby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alastair-j-moss","type":"person","url":"https://hartvaat.nl/mensen/alastair-j-moss/","name":"Alastair J Moss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"albert-c-van-rossum","type":"person","url":"https://hartvaat.nl/mensen/albert-c-van-rossum/","name":"Albert C van Rossum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/01/trimetazidine-bij-hfpef-gerandomiseerde-cross-over-trial/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-fior","type":"person","url":"https://hartvaat.nl/mensen/alberto-fior/","name":"Alberto Fior","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aldobrando-broccolini","type":"person","url":"https://hartvaat.nl/mensen/aldobrando-broccolini/","name":"Aldobrando Broccolini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alec-vahanian","type":"person","url":"https://hartvaat.nl/mensen/alec-vahanian/","name":"Alec Vahanian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aleksander-prejbisz","type":"person","url":"https://hartvaat.nl/mensen/aleksander-prejbisz/","name":"Aleksander Prejbisz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/01/01/bijniervenesampling-als-voorkeursmethode-bij-primair-hyperaldosteronisme/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ales-linhart","type":"person","url":"https://hartvaat.nl/mensen/ales-linhart/","name":"Ales Linhart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/16/watchful-leefstijl-wandelinterventie-bij-hfref/","published":"2024-01-16"},{"url":"https://hartvaat.nl/2023/02/07/ecmo-cs-ecmo-bij-cardiogene-shock-verbetert-overleving-niet/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2020/10/01/accelerometrie-bij-cv-patienten-systematische-review-met-praktische-aanbevelinge/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-lupi","type":"person","url":"https://hartvaat.nl/mensen/alessandro-lupi/","name":"Alessandro Lupi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-sticchi","type":"person","url":"https://hartvaat.nl/mensen/alessandro-sticchi/","name":"Alessandro Sticchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessio-gargaro","type":"person","url":"https://hartvaat.nl/mensen/alessio-gargaro/","name":"Alessio Gargaro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-r-chang","type":"person","url":"https://hartvaat.nl/mensen/alex-r-chang/","name":"Alex R Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/06/01/dieet-en-natriumreductie-op-cardiale-schade-en-inflammatie-dash-sodium/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2016/02/04/risicoprojectie-voor-nierfalen-bij-levende-nierdonorkandidaten/","published":"2016-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-c-razavi","type":"person","url":"https://hartvaat.nl/mensen/alexander-c-razavi/","name":"Alexander C Razavi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-p-auchus","type":"person","url":"https://hartvaat.nl/mensen/alexander-p-auchus/","name":"Alexander P Auchus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-peikert","type":"person","url":"https://hartvaat.nl/mensen/alexander-peikert/","name":"Alexander Peikert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/01/centrale-adipositas-bijna-universeel-bij-hfpef-fenotypering/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-r-lyon","type":"person","url":"https://hartvaat.nl/mensen/alexander-r-lyon/","name":"Alexander R Lyon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/ehj-review-dyslipidemie-bij-kankerpatienten-verhoogd-ascvd-risico-beperkte-data-/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2026/02/03/atriumfibrilleren-bij-kankerpatienten-de-esc-richtlijn-2025-in-de-praktijk/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2016/03/19/serca2a-gentherapie-bij-hartfalen-de-cupid-2-trial/","published":"2016-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-r-zheutlin","type":"person","url":"https://hartvaat.nl/mensen/alexander-r-zheutlin/","name":"Alexander R Zheutlin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2023/08/01/combinatietabletten-voor-intensieve-bloeddrukbehandeling-sprint-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-arias-mendoza","type":"person","url":"https://hartvaat.nl/mensen/alexandra-arias-mendoza/","name":"Alexandra Arias-Mendoza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-rousseau","type":"person","url":"https://hartvaat.nl/mensen/alexandra-rousseau/","name":"Alexandra Rousseau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-scrymgeour","type":"person","url":"https://hartvaat.nl/mensen/alexandra-scrymgeour/","name":"Alexandra Scrymgeour","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/23/top-liberaal-versus-restrictief-transfusiebeleid-bij-hoogrisico-hartchirurgie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2019/01/10/endoscopische-versus-open-veneoogst-bij-cabg-nejm-regroup/","published":"2019-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandre-almorad","type":"person","url":"https://hartvaat.nl/mensen/alexandre-almorad/","name":"Alexandre Almorad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/varipure-studie-pulsed-field-ablatie-in-de-dagelijkse-af-praktijk/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2019/08/01/eenvoudige-techniek-voor-pvi-van-linker-longvenen-gerandomiseerde-studie/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandre-soeiro","type":"person","url":"https://hartvaat.nl/mensen/alexandre-soeiro/","name":"Alexandre Soeiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexios-karagiannis","type":"person","url":"https://hartvaat.nl/mensen/alexios-karagiannis/","name":"Alexios Karagiannis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/08/07/adenosine-en-ticagrelorspiegels-bij-patienten-met-en-zonder-ticagrelor-dyspneu/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alfonso-ielasi","type":"person","url":"https://hartvaat.nl/mensen/alfonso-ielasi/","name":"Alfonso Ielasi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"allan-skanes","type":"person","url":"https://hartvaat.nl/mensen/allan-skanes/","name":"Allan Skanes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"allen-jeremias","type":"person","url":"https://hartvaat.nl/mensen/allen-jeremias/","name":"Allen Jeremias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"almeida","type":"person","url":"https://hartvaat.nl/mensen/almeida/","name":"Almeida","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/24/bayesiaanse-netwerkmeta-analyse-vergelijkt-revascularisatie-bij-stabiele-ischemi/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/01/27/minimaal-invasieve-mitralisklepchirurgie-sneller-herstel-even-veilig-als-de-conv/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/16/sekseverschillen-na-tavi-vrouwen-lagere-sterfte-bij-intermediair-risico-maar-mee/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amanda-stebbins","type":"person","url":"https://hartvaat.nl/mensen/amanda-stebbins/","name":"Amanda Stebbins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ameer-kabour","type":"person","url":"https://hartvaat.nl/mensen/ameer-kabour/","name":"Ameer Kabour","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amil-m-shah","type":"person","url":"https://hartvaat.nl/mensen/amil-m-shah/","name":"Amil M Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amirhossein-sahebkar","type":"person","url":"https://hartvaat.nl/mensen/amirhossein-sahebkar/","name":"Amirhossein Sahebkar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/24/lipide-aferese-verlaagt-lp-a-met-60-75-systematische-review-en-meta-analyse/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2022/09/07/prevalentie-van-statine-intolerantie-meta-analyse-nuanceert-het-probleem/","published":"2022-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amit-n-vora","type":"person","url":"https://hartvaat.nl/mensen/amit-n-vora/","name":"Amit N Vora","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/01/augustus-analyse-apixaban-versus-warfarine-bij-af-na-acs-of-pci/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2020/03/03/stenttrombose-bij-af-na-coronaire-stenting-augustus-trial/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amra-karegren","type":"person","url":"https://hartvaat.nl/mensen/amra-karegren/","name":"Amra Kåregren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amret-t-hawfield","type":"person","url":"https://hartvaat.nl/mensen/amret-t-hawfield/","name":"Amret T Hawfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/01/intensieve-bloeddrukcontrole-en-alle-hospitalisaties-sprint/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amy-m-pastva","type":"person","url":"https://hartvaat.nl/mensen/amy-m-pastva/","name":"Amy M Pastva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amy-wohltman","type":"person","url":"https://hartvaat.nl/mensen/amy-wohltman/","name":"Amy Wohltman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-catarina-fonseca","type":"person","url":"https://hartvaat.nl/mensen/ana-catarina-fonseca/","name":"Ana Catarina Fonseca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-catarina-pinho-gomes","type":"person","url":"https://hartvaat.nl/mensen/ana-catarina-pinho-gomes/","name":"Ana-Catarina Pinho-Gomes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2020/10/01/thuismonitoring-met-technologie-ondersteund-management-bij-chronisch-hf-gerandom/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/02/13/richtlijngetrouwe-medicamenteuze-therapie-in-contemporaine-revascularisatietrial/","published":"2018-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anand-thiyagarajah","type":"person","url":"https://hartvaat.nl/mensen/anand-thiyagarajah/","name":"Anand Thiyagarajah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/01/af-voorspelt-cognitieve-achteruitgang-meta-analyse-van-2-8-miljoen-personen/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anastase-dzudie","type":"person","url":"https://hartvaat.nl/mensen/anastase-dzudie/","name":"Anastase Dzudie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anda-bularga","type":"person","url":"https://hartvaat.nl/mensen/anda-bularga/","name":"Anda Bularga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/de-troponine-i-t-ratio-bij-myocardschade-een-multicohort-synthese/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2022/01/13/risicofactoren-voor-type-1-en-type-2-mi/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anders-sommer","type":"person","url":"https://hartvaat.nl/mensen/anders-sommer/","name":"Anders Sommer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-ruzza","type":"person","url":"https://hartvaat.nl/mensen/andrea-ruzza/","name":"Andrea Ruzza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/10/29/langetermijn-werkzaamheid-en-veiligheid-van-evolocumab-bij-hypercholesterolemie/","published":"2019-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-scotti","type":"person","url":"https://hartvaat.nl/mensen/andrea-scotti/","name":"Andrea Scotti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-zini","type":"person","url":"https://hartvaat.nl/mensen/andrea-zini/","name":"Andrea Zini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-b-gevaert","type":"person","url":"https://hartvaat.nl/mensen/andreas-b-gevaert/","name":"Andreas B Gevaert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2021/08/01/klinische-fenotypen-zijn-effectiever-dan-ef-categorieen-voor-hf-uitkomsten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-bollmann","type":"person","url":"https://hartvaat.nl/mensen/andreas-bollmann/","name":"Andreas Bollmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2023/02/16/p-golfduur-voorspelt-af-recidief-na-catheterablatie-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-brieke","type":"person","url":"https://hartvaat.nl/mensen/andreas-brieke/","name":"Andreas Brieke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-fach","type":"person","url":"https://hartvaat.nl/mensen/andreas-fach/","name":"Andreas Fach","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-l-birkenfeld","type":"person","url":"https://hartvaat.nl/mensen/andreas-l-birkenfeld/","name":"Andreas L Birkenfeld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2019/08/29/orale-semaglutide-en-cv-uitkomsten-bij-diabetes-type-2-nejm-pioneer-6/","published":"2019-08-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-rieth","type":"person","url":"https://hartvaat.nl/mensen/andreas-rieth/","name":"Andreas Rieth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-schuster","type":"person","url":"https://hartvaat.nl/mensen/andreas-schuster/","name":"Andreas Schuster","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/reduce-mfa-dzhk25-trial-naar-antifibrotische-therapie-tegen-myocardfibrose-na-ta/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrei-mircea-catarig","type":"person","url":"https://hartvaat.nl/mensen/andrei-mircea-catarig/","name":"Andrei-Mircea Catarig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/05/03/semaglutide-en-loopafstand-bij-perifeer-vaatlijden-en-diabetes/","published":"2025-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andres-m-pineda","type":"person","url":"https://hartvaat.nl/mensen/andres-m-pineda/","name":"Andres M Pineda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-farmer","type":"person","url":"https://hartvaat.nl/mensen/andrew-farmer/","name":"Andrew Farmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-hsieh","type":"person","url":"https://hartvaat.nl/mensen/andrew-hsieh/","name":"Andrew Hsieh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/obicetrapib-verlaagt-naast-ldl-en-apob-ook-lipoproteine-a/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/10/07/obicetrapib-en-mace-bij-hoogrisicopatienten-gepoolde-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-j-boyle","type":"person","url":"https://hartvaat.nl/mensen/andrew-j-boyle/","name":"Andrew J Boyle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/01/behandeling-van-acuut-coronair-syndroom-in-ruraal-australie-moracs-trial/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/07/01/camkii-delta-remming-en-ventriculaire-remodellering-na-mi-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-j-sauer","type":"person","url":"https://hartvaat.nl/mensen/andrew-j-sauer/","name":"Andrew J Sauer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/01/humain-hfpef-nieuwe-metabole-accelerator-bij-obesitas-hfpef-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-j-taylor","type":"person","url":"https://hartvaat.nl/mensen/andrew-j-taylor/","name":"Andrew J Taylor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"},{"url":"https://hartvaat.nl/2016/03/01/effect-van-aanvullende-zuurstoftoediening-op-myocardschade-bij-stemi/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-kaplan","type":"person","url":"https://hartvaat.nl/mensen/andrew-kaplan/","name":"Andrew Kaplan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-lin","type":"person","url":"https://hartvaat.nl/mensen/andrew-lin/","name":"Andrew Lin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2026/05/27/sglt2-remmers-verminderen-epicardiaal-vetweefsel-meta-analyse-van-11-studies/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/05/13/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-m-goldsweig","type":"person","url":"https://hartvaat.nl/mensen/andrew-m-goldsweig/","name":"Andrew M Goldsweig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-maiorana","type":"person","url":"https://hartvaat.nl/mensen/andrew-maiorana/","name":"Andrew Maiorana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/pathfinder-trial-betere-naleving-van-hartfalenrichtlijnen-in-de-huisartsenprakti/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-s-levey","type":"person","url":"https://hartvaat.nl/mensen/andrew-s-levey/","name":"Andrew S Levey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2016/02/04/risicoprojectie-voor-nierfalen-bij-levende-nierdonorkandidaten/","published":"2016-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-s-mugglin","type":"person","url":"https://hartvaat.nl/mensen/andrew-s-mugglin/","name":"Andrew S Mugglin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-sherwood","type":"person","url":"https://hartvaat.nl/mensen/andrew-sherwood/","name":"Andrew Sherwood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/12/leefstijlmodificatie-bij-resistente-hypertensie-triumph-gerandomiseerde-trial/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2016/04/05/hartrevalidatie-versterkt-met-stressmanagementtraining-gerandomiseerde-trial/","published":"2016-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-whitehouse","type":"person","url":"https://hartvaat.nl/mensen/andrew-whitehouse/","name":"Andrew Whitehouse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/28/ascot-legacy-atorvastatine-verlaagt-cv-events-over-20-jaar/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2018/09/29/langetermijnmortaliteit-na-bloeddruk-en-lipidenverlaging-bij-hypertensie-ascot-l/","published":"2018-09-29"},{"url":"https://hartvaat.nl/2017/06/24/bijwerkingen-bij-niet-geblindeerde-versus-geblindeerde-statinetherapie-lancet-as/","published":"2017-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andras-komocsi","type":"person","url":"https://hartvaat.nl/mensen/andras-komocsi/","name":"András Komócsi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andre-rivera","type":"person","url":"https://hartvaat.nl/mensen/andre-rivera/","name":"André Rivera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/nieuwe-aldosteronsynthase-remmers-bij-hypertensie-bayesiaanse-meta-analyse/","published":"2026-03-08"},{"url":"https://hartvaat.nl/2025/09/01/sedatie-versus-narcose-bij-af-catheterablatie-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andy-yong","type":"person","url":"https://hartvaat.nl/mensen/andy-yong/","name":"Andy Yong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/10/intracoronaire-trombolyse-bij-stemi-meta-analyse/","published":"2024-07-10"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angela-m-thompson-paul","type":"person","url":"https://hartvaat.nl/mensen/angela-m-thompson-paul/","name":"Angela M Thompson-Paul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angelo-cascio-rizzo","type":"person","url":"https://hartvaat.nl/mensen/angelo-cascio-rizzo/","name":"Angelo Cascio Rizzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anique-ducharme","type":"person","url":"https://hartvaat.nl/mensen/anique-ducharme/","name":"Anique Ducharme","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anja-sandek","type":"person","url":"https://hartvaat.nl/mensen/anja-sandek/","name":"Anja Sandek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2021/12/01/baseline-parameters-en-1-jaars-qol-bij-hf-na-crt-d-esc-hf/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anja-vogt","type":"person","url":"https://hartvaat.nl/mensen/anja-vogt/","name":"Anja Vogt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/lipoproteine-aferese-blijft-relevant-in-het-tijdperk-van-pcsk9-remmers-en-sirna/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2026/02/21/pelacarsen-vermindert-de-behoefte-aan-lipoproteine-a-aferese-lp-a-frontiers-aphe/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anjay-rastogi","type":"person","url":"https://hartvaat.nl/mensen/anjay-rastogi/","name":"Anjay Rastogi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ann-e-kurth","type":"person","url":"https://hartvaat.nl/mensen/ann-e-kurth/","name":"Ann E Kurth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-giczewska","type":"person","url":"https://hartvaat.nl/mensen/anna-giczewska/","name":"Anna Giczewska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/15/leeftijd-en-uitkomsten-van-katheterablatie-versus-medicatie-bij-af-cabana/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-marie-chang","type":"person","url":"https://hartvaat.nl/mensen/anna-marie-chang/","name":"Anna Marie Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/25/2022-acc-aha-datadefinities-voor-pijn-op-de-borst-en-acuut-myocardinfarct/","published":"2022-10-25"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2017/11/28/ct-coronairangiografie-en-initiatie-van-cardioprotectieve-medicatie/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-suling","type":"person","url":"https://hartvaat.nl/mensen/anna-suling/","name":"Anna Suling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-maria-langkilde","type":"person","url":"https://hartvaat.nl/mensen/anna-maria-langkilde/","name":"Anna-Maria Langkilde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/01/24/dapagliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-declare-t/","published":"2019-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annabelle-frost","type":"person","url":"https://hartvaat.nl/mensen/annabelle-frost/","name":"Annabelle Frost","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-cruickshank","type":"person","url":"https://hartvaat.nl/mensen/anne-cruickshank/","name":"Anne Cruickshank","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-tybjrg-hansen","type":"person","url":"https://hartvaat.nl/mensen/anne-tybjrg-hansen/","name":"Anne Tybjærg-Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2019/09/17/ldl-cholesterol-en-micro-versus-macrovasculaire-ziekte-mendeliaanse-randomisatie/","published":"2019-09-17"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-laure-faucon","type":"person","url":"https://hartvaat.nl/mensen/anne-laure-faucon/","name":"Anne-Laure Faucon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/30/kfre-aangepast-voor-multimorbiditeit-verbetert-schatting-nierfalenrisico/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/02/27/albuminurie-geassocieerd-met-verhoogd-risico-op-abdominaal-aorta-aneurysma/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2026/01/15/populatiegebaseerde-egfr-verdelingen-voor-vroege-identificatie-van-chronische-ni/","published":"2026-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annette-peters","type":"person","url":"https://hartvaat.nl/mensen/annette-peters/","name":"Annette Peters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-a-killeen","type":"person","url":"https://hartvaat.nl/mensen/anthony-a-killeen/","name":"Anthony A Killeen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/10/18/intensieve-bloeddrukverlaging-bij-maligne-linkerventrikel-hypertrofie/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antoine-da-costa","type":"person","url":"https://hartvaat.nl/mensen/antoine-da-costa/","name":"Antoine Da Costa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/autonoom-remodelling-vormt-onafhankelijk-domein-binnen-atriale-cardiomyopathie/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2023/05/30/complicaties-van-af-ablatie-actueel-overzicht/","published":"2023-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-berruezo","type":"person","url":"https://hartvaat.nl/mensen/antonio-berruezo/","name":"Antonio Berruezo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"},{"url":"https://hartvaat.nl/2022/04/19/substraatablatie-versus-antiaritmica-bij-symptomatische-vt/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-de-mase","type":"person","url":"https://hartvaat.nl/mensen/antonio-de-mase/","name":"Antonio De Mase","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-j-vallejo-vaz","type":"person","url":"https://hartvaat.nl/mensen/antonio-j-vallejo-vaz/","name":"Antonio J Vallejo-Vaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/06/02/prevalentie-van-fh-bij-atherosclerotische-cv-ziekte-meta-analyse/","published":"2020-06-02"},{"url":"https://hartvaat.nl/2017/11/14/ldl-verlaging-voor-primaire-preventie-bij-mannen-met-primaire-ldl-verhoging/","published":"2017-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-landi","type":"person","url":"https://hartvaat.nl/mensen/antonio-landi/","name":"Antonio Landi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-luiz-p-ribeiro","type":"person","url":"https://hartvaat.nl/mensen/antonio-luiz-p-ribeiro/","name":"Antonio Luiz P Ribeiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2019/01/01/implementatie-van-mi-zorgsystemen-in-lage-en-middeninkomenslanden/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonis-s-manolis","type":"person","url":"https://hartvaat.nl/mensen/antonis-s-manolis/","name":"Antonis S Manolis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antti-jula","type":"person","url":"https://hartvaat.nl/mensen/antti-jula/","name":"Antti Jula","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/strip-20-jaarsresultaten-van-dieetinterventie-vanaf-de-zuigelingenleeftijd/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2017/08/01/cardiometabole-determinanten-van-carotis-en-aortadistensibiliteit-van-kindertijd/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anubha-agarwal","type":"person","url":"https://hartvaat.nl/mensen/anubha-agarwal/","name":"Anubha Agarwal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2025/01/01/kwaliteit-van-hartfalenzorg-bij-aziatische-patienten-in-de-vs/","published":"2026-04-08"},{"url":"https://hartvaat.nl/2019/03/01/ziekenhuisgebaseerde-kwaliteitsinterventies-bij-hartfalen-systematische-review/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"apostolos-tzikas","type":"person","url":"https://hartvaat.nl/mensen/apostolos-tzikas/","name":"Apostolos Tzikas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/01/14/residuele-lekkage-na-laa-occlusie-en-uitkomsten-meta-analyse/","published":"2024-01-14"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arash-arya","type":"person","url":"https://hartvaat.nl/mensen/arash-arya/","name":"Arash Arya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/16/p-golfduur-voorspelt-af-recidief-na-catheterablatie-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2020/10/01/slokdarmsonde-bij-rf-ablatie-voor-af-opera-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arnaldo-dimagli","type":"person","url":"https://hartvaat.nl/mensen/arnaldo-dimagli/","name":"Arnaldo Dimagli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2020/10/06/postoperatief-af-en-langetermijn-cva-risico-na-geisoleerde-cabg/","published":"2020-10-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arnhild-bakken","type":"person","url":"https://hartvaat.nl/mensen/arnhild-bakken/","name":"Arnhild Bakken","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arturo-ausiello","type":"person","url":"https://hartvaat.nl/mensen/arturo-ausiello/","name":"Arturo Ausiello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arun-krishnamoorthy","type":"person","url":"https://hartvaat.nl/mensen/arun-krishnamoorthy/","name":"Arun Krishnamoorthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aruna-d-pradhan","type":"person","url":"https://hartvaat.nl/mensen/aruna-d-pradhan/","name":"Aruna D Pradhan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/04/15/inflammatie-en-cholesterol-als-cv-voorspellers-onder-statinetherapie-lancet-anal/","published":"2023-04-15"},{"url":"https://hartvaat.nl/2020/05/05/triglyceriderijk-lipoproteinecholesterol-small-dense-ldl-en-cv-events/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2018/07/10/residueel-inflammatoir-risico-bij-pcsk9-remming-plus-statine/","published":"2018-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"asbjrn-stylen","type":"person","url":"https://hartvaat.nl/mensen/asbjrn-stylen/","name":"Asbjørn Støylen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/06/01/vijf-jaar-inspanningstraining-verbetert-cardiovasculair-risicoprofiel-bij-oudere/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"asita-de-silva","type":"person","url":"https://hartvaat.nl/mensen/asita-de-silva/","name":"Asita de Silva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2023/06/01/lage-dosis-drievoudige-viervoudige-combinatiepil-versus-monotherapie-bij-hyperte/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"astin-lee","type":"person","url":"https://hartvaat.nl/mensen/astin-lee/","name":"Astin Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atefeh-talebi","type":"person","url":"https://hartvaat.nl/mensen/atefeh-talebi/","name":"Atefeh Talebi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/21/finearts-hf-finerenon-en-kccq-bij-hfmref-hfpef/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/09/21/mra-bij-hartfalen-ipd-meta-analyse-bevestigt-overlevingsvoordeel/","published":"2024-09-21"},{"url":"https://hartvaat.nl/2024/05/21/dapa-hf-dapagliflozine-en-dagen-in-volledige-gezondheid/","published":"2024-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atsushi-kobori","type":"person","url":"https://hartvaat.nl/mensen/atsushi-kobori/","name":"Atsushi Kobori","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aurelia-zauli","type":"person","url":"https://hartvaat.nl/mensen/aurelia-zauli/","name":"Aurelia Zauli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"axel-bauer","type":"person","url":"https://hartvaat.nl/mensen/axel-bauer/","name":"Axel Bauer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/08/03/cardiale-shockwave-therapie-bij-cabg-verbetert-myocardfunctie/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2017/07/14/voorspelling-van-plotse-versus-niet-plotse-hartdood-na-mi-met-verminderde-lvef/","published":"2017-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"axel-schmid","type":"person","url":"https://hartvaat.nl/mensen/axel-schmid/","name":"Axel Schmid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"azmil-h-abdul-rahim","type":"person","url":"https://hartvaat.nl/mensen/azmil-h-abdul-rahim/","name":"Azmil H Abdul-Rahim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2018/02/20/cva-risico-bij-verminderde-ef-na-mi-zonder-af/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"b-daan-westenbrink","type":"person","url":"https://hartvaat.nl/mensen/b-daan-westenbrink/","name":"B Daan Westenbrink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/22/epicardiaal-vetweefsel-voorspelt-aritmieen-en-hartfalen-events-bij-genotype-posi/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2026/03/03/spierstofwisseling-bij-hfpef-verminderde-oxidatieve-capaciteit-los-van-ijzergebr/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2021/10/05/ketonlichamen-en-functionele-uitkomsten-na-stemi/","published":"2021-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-casolla","type":"person","url":"https://hartvaat.nl/mensen/barbara-casolla/","name":"Barbara Casolla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-heude","type":"person","url":"https://hartvaat.nl/mensen/barbara-heude/","name":"Barbara Heude","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-riegel","type":"person","url":"https://hartvaat.nl/mensen/barbara-riegel/","name":"Barbara Riegel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/08/01/motivational-interviewing-en-zorggebruik-en-mortaliteit-bij-hf-motivate-hf/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/06/01/motivational-interviewing-bij-hartfalen-voor-zelfzorg-motivate-hf-gerandomiseerd/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2016/03/22/zelfmanagementinterventies-bij-hartfalen-individuele-patientdata-meta-analyse/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-s-wiggins","type":"person","url":"https://hartvaat.nl/mensen/barbara-s-wiggins/","name":"Barbara S Wiggins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-af-richtlijn-op-een-blik-samenvatting/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"},{"url":"https://hartvaat.nl/2016/11/22/management-van-klinisch-significante-geneesmiddelinteracties-met-statines-aha-aa/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-bertolet","type":"person","url":"https://hartvaat.nl/mensen/barry-bertolet/","name":"Barry Bertolet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-i-freedman","type":"person","url":"https://hartvaat.nl/mensen/barry-i-freedman/","name":"Barry I Freedman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/01/intensieve-bloeddrukcontrole-en-alle-hospitalisaties-sprint/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-miller","type":"person","url":"https://hartvaat.nl/mensen/barry-miller/","name":"Barry Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/12/cadence-sotatercept-verlaagt-pulmonale-vaatweerstand-bij-gecombineerde-pre-postc/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bart-gerritse","type":"person","url":"https://hartvaat.nl/mensen/bart-gerritse/","name":"Bart Gerritse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2016/11/01/vochtstatustelemonitoring-bij-hartfalen-gerandomiseerde-trial/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beatrice-mariottoni","type":"person","url":"https://hartvaat.nl/mensen/beatrice-mariottoni/","name":"Beatrice Mariottoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bei-wang","type":"person","url":"https://hartvaat.nl/mensen/bei-wang/","name":"Bei Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ben-hurdus","type":"person","url":"https://hartvaat.nl/mensen/ben-hurdus/","name":"Ben Hurdus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/25/meta-analyse-glp-1-agonisten-voorkomen-hartfalen-in-type-2-diabetes-sterkste-eff/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2022/09/01/collaterale-schade-van-covid-19-aan-cardiovasculaire-zorg-meta-analyse/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2022/06/10/voorspelling-van-atriumfibrilleren-in-elektronische-gezondheidsdossiers-systemat/","published":"2022-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-blank","type":"person","url":"https://hartvaat.nl/mensen/benjamin-blank/","name":"Benjamin Blank","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-deniau","type":"person","url":"https://hartvaat.nl/mensen/benjamin-deniau/","name":"Benjamin Deniau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/16/natrium-hf-subanalyse-natriuretische-peptiden-lopen-achter-op-de-klinische-ontst/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-honton","type":"person","url":"https://hartvaat.nl/mensen/benjamin-honton/","name":"Benjamin Honton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/07/01/calcified-oct-versus-angiografie-bij-pci-van-verkalkte-laesies/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-landau","type":"person","url":"https://hartvaat.nl/mensen/benjamin-landau/","name":"Benjamin Landau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-neely","type":"person","url":"https://hartvaat.nl/mensen/benjamin-neely/","name":"Benjamin Neely","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/08/01/voorspelling-van-bloedingsrisico-tijdens-dapt-na-acs/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/03/22/spontaan-myocardinfarct-na-nstemi-zonder-revascularisatie-trilogy-acs-trial/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernadette-mazurek-melnyk","type":"person","url":"https://hartvaat.nl/mensen/bernadette-mazurek-melnyk/","name":"Bernadette Mazurek Melnyk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-charbonnel","type":"person","url":"https://hartvaat.nl/mensen/bernard-charbonnel/","name":"Bernard Charbonnel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernardo-antunes","type":"person","url":"https://hartvaat.nl/mensen/bernardo-antunes/","name":"Bernardo Antunes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernhard-reimers","type":"person","url":"https://hartvaat.nl/mensen/bernhard-reimers/","name":"Bernhard Reimers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bert-andersson","type":"person","url":"https://hartvaat.nl/mensen/bert-andersson/","name":"Bert Andersson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bert-ferdinande","type":"person","url":"https://hartvaat.nl/mensen/bert-ferdinande/","name":"Bert Ferdinande","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2020/08/18/optimale-bloeddruk-bij-shock-na-mi-en-hartstilstand/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bert-jan-h-van-den-born","type":"person","url":"https://hartvaat.nl/mensen/bert-jan-h-van-den-born/","name":"Bert-Jan H van den Born","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/01/oraal-butyraat-verlaagt-bloeddruk-bij-hypertensie-rct/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2018/12/01/creatininestijging-tijdens-bloeddrukbehandeling-en-uitkomsten-bij-diabetes-type-/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/12/05/j-curve-bij-gerandomiseerde-bloeddrukstreefwaarden-sprint-experimentele-analyse/","published":"2017-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bin-yang","type":"person","url":"https://hartvaat.nl/mensen/bin-yang/","name":"Bin Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/16/sluiting-van-het-linker-hartoor-versus-doac-s-na-longembolie/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/04/01/sglt2-remmers-raas-remmers-en-arni-vergeleken-bij-hartfalen-meta-analyse/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bing-han","type":"person","url":"https://hartvaat.nl/mensen/bing-han/","name":"Bing Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bjoern-goebel","type":"person","url":"https://hartvaat.nl/mensen/bjoern-goebel/","name":"Bjoern Goebel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"blanca-fuentes","type":"person","url":"https://hartvaat.nl/mensen/blanca-fuentes/","name":"Blanca Fuentes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bo-norrving","type":"person","url":"https://hartvaat.nl/mensen/bo-norrving/","name":"Bo Norrving","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2022/10/04/timing-vroege-versus-late-noac-start-na-ischemisch-cva-bij-af/","published":"2022-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bo-zhou","type":"person","url":"https://hartvaat.nl/mensen/bo-zhou/","name":"Bo Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"boaz-hirshberg","type":"person","url":"https://hartvaat.nl/mensen/boaz-hirshberg/","name":"Boaz Hirshberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/23/photon-aflibercept-8-mg-bij-diabetisch-macula-oedeem-verlengd-doseerinterval/","published":"2024-03-23"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2018/06/30/glp-1-glucagon-duale-agonist-bij-obesitas-met-diabetes-type-2-lancet-fase-2/","published":"2018-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bob-weijs","type":"person","url":"https://hartvaat.nl/mensen/bob-weijs/","name":"Bob Weijs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bojan-vrtovec","type":"person","url":"https://hartvaat.nl/mensen/bojan-vrtovec/","name":"Bojan Vrtovec","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/01/science-ii-mesenchymale-stamcellen-bij-niet-ischemisch-hartfalen-negatieve-trial/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2019/02/01/herhaalde-levosimendan-infusies-bij-gevorderd-chronisch-hf-in-de-kwetsbare-postd/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bongani-mayosi","type":"person","url":"https://hartvaat.nl/mensen/bongani-mayosi/","name":"Bongani Mayosi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"borislav-dinov","type":"person","url":"https://hartvaat.nl/mensen/borislav-dinov/","name":"Borislav Dinov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/16/p-golfduur-voorspelt-af-recidief-na-catheterablatie-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2020/10/01/slokdarmsonde-bij-rf-ablatie-voor-af-opera-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brad-sutton","type":"person","url":"https://hartvaat.nl/mensen/brad-sutton/","name":"Brad Sutton","title":"Boston Scientific","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/market-watch-boston-scientific-laac-pfa/","title":"Market Watch: Boston Scientific over LAAC, PFA en het atriumfibrilleren-traject"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brad-wilson","type":"person","url":"https://hartvaat.nl/mensen/brad-wilson/","name":"Brad Wilson","title":"Boston Scientific","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/market-watch-boston-scientific-laac-pfa/","title":"Market Watch: Boston Scientific over LAAC, PFA en het atriumfibrilleren-traject"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"braden-j-manns","type":"person","url":"https://hartvaat.nl/mensen/braden-j-manns/","name":"Braden J Manns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/17/bedmed-timing-van-antihypertensieve-medicatie-en-cv-events-jama-definitieve-tria/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brage-h-amundsen","type":"person","url":"https://hartvaat.nl/mensen/brage-h-amundsen/","name":"Brage H Amundsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"},{"url":"https://hartvaat.nl/2016/02/02/aerobe-intervaltraining-vermindert-de-last-van-atriumfibrilleren-gerandomiseerde/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brenda-r-hemmelgarn","type":"person","url":"https://hartvaat.nl/mensen/brenda-r-hemmelgarn/","name":"Brenda R Hemmelgarn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2016/06/21/apothekerinterventies-en-cardiovasculair-risico-de-multicenter-rxeach-trial/","published":"2016-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-olshansky","type":"person","url":"https://hartvaat.nl/mensen/brian-olshansky/","name":"Brian Olshansky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2020/02/04/reduce-it-usa-resultaten-bij-3-146-amerikaanse-deelnemers/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2017/11/01/bloeddrukvariabiliteit-en-uitkomsten-bij-af-affirm-studie/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-r-ott","type":"person","url":"https://hartvaat.nl/mensen/brian-r-ott/","name":"Brian R Ott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/05/12/cognitie-na-ldl-verlaging-met-evolocumab-fourier-follow-up/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"},{"url":"https://hartvaat.nl/2017/08/17/cognitieve-functie-in-de-fourier-trial-met-evolocumab-nejm-ebbinghaus/","published":"2017-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-ovbiagele","type":"person","url":"https://hartvaat.nl/mensen/bruce-ovbiagele/","name":"Bruce Ovbiagele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/12/01/lacunes-in-hypertensierichtlijnen-in-lage-en-middeninkomenslanden-systematische-/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-levy","type":"person","url":"https://hartvaat.nl/mensen/bruno-levy/","name":"Bruno Levy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/06/levoecmo-levosimendan-bij-ecmo-weaning-bij-cardiogene-shock/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-david-sjostrom","type":"person","url":"https://hartvaat.nl/mensen/c-david-sjostrom/","name":"C David Sjöström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/01/amethyst-verinurad-plus-allopurinol-bij-hfpef-negatieve-trial/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"},{"url":"https://hartvaat.nl/2020/10/08/dapagliflozine-bij-chronische-nierziekte-nejm-dapa-ckd/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-m","type":"person","url":"https://hartvaat.nl/mensen/c-m/","name":"C. M.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/24/verminderde-nierfunctie-verhoogt-hartfalenrisico-bij-ouderen-aspree-cohort/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/03/10/machine-learning-voorspelt-30-daagse-sterfte-na-een-dotterbehandeling-australisc/","published":"2026-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-p","type":"person","url":"https://hartvaat.nl/mensen/c-p/","name":"C. P.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/17/niet-invasieve-endotypering-met-stress-mri-verbetert-de-behandeling-van-angina-z/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/05/20/klinisch-en-genetisch-risico-op-atriumfibrilleren-versterken-elkaar-additief-13-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caio-a-m-tavares","type":"person","url":"https://hartvaat.nl/mensen/caio-a-m-tavares/","name":"Caio A M Tavares","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/17/answer-hf-sacubitril-valsartan-versus-enalapril-bij-chagas-hf-primaire-resultate/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"calvin-yeang","type":"person","url":"https://hartvaat.nl/mensen/calvin-yeang/","name":"Calvin Yeang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/22/pelacarsen-op-lp-a-cholesterol-en-gecorrigeerd-ldl-cholesterol/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2021/09/21/pcsk9-remming-en-geoxideerde-fosfolipiden/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/06/21/statinetherapie-verhoogt-lipoproteine-a-spiegels/","published":"2020-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"campbell","type":"person","url":"https://hartvaat.nl/mensen/campbell/","name":"Campbell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/17/direct-naar-ct-coronairangiografie-bij-verdenking-angina-snellere-diagnose-en-mi/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/01/09/hartfalendiagnostiek-na-corona-bijna-niemand-kreeg-de-echo-binnen-de-aanbevolen-/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"campbell-rogers","type":"person","url":"https://hartvaat.nl/mensen/campbell-rogers/","name":"Campbell Rogers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/02/01/ccta-afgeleide-ffr-prognostische-waarde-meta-analyse/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"candace-k-mcclure","type":"person","url":"https://hartvaat.nl/mensen/candace-k-mcclure/","name":"Candace K McClure","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carl-d-langefeld","type":"person","url":"https://hartvaat.nl/mensen/carl-d-langefeld/","name":"Carl D Langefeld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/01/intensieve-bloeddrukcontrole-en-alle-hospitalisaties-sprint/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2016/11/08/onbehandelde-hypertensie-als-risicofactor-voor-lobaire-en-non-lobaire-hersenbloe/","published":"2016-11-08"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carl-heneghan","type":"person","url":"https://hartvaat.nl/mensen/carl-heneghan/","name":"Carl Heneghan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-di-mario","type":"person","url":"https://hartvaat.nl/mensen/carlo-di-mario/","name":"Carlo Di Mario","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-penzo","type":"person","url":"https://hartvaat.nl/mensen/carlo-penzo/","name":"Carlo Penzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-tumscitz","type":"person","url":"https://hartvaat.nl/mensen/carlo-tumscitz/","name":"Carlo Tumscitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-brotons","type":"person","url":"https://hartvaat.nl/mensen/carlos-brotons/","name":"Carlos Brotons","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/22/aspirine-voor-primaire-preventie-bij-matig-cv-risico-lancet-arrive/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-hervas","type":"person","url":"https://hartvaat.nl/mensen/carlos-hervas/","name":"Carlos Hervás","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-j-rodriguez","type":"person","url":"https://hartvaat.nl/mensen/carlos-j-rodriguez/","name":"Carlos J Rodriguez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-macaya","type":"person","url":"https://hartvaat.nl/mensen/carlos-macaya/","name":"Carlos Macaya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2017/01/15/linker-hartoorsluiting-versus-medicamenteuze-behandeling-bij-af-netwerkmeta-anal/","published":"2017-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-tajer","type":"person","url":"https://hartvaat.nl/mensen/carlos-tajer/","name":"Carlos Tajer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmelo-velardo","type":"person","url":"https://hartvaat.nl/mensen/carmelo-velardo/","name":"Carmelo Velardo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmine-pizzi","type":"person","url":"https://hartvaat.nl/mensen/carmine-pizzi/","name":"Carmine Pizzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/03/13/minoca-pathologische-bevindingen-bij-invasieve-beoordeling-meta-analyse/","published":"2025-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carole-crawford","type":"person","url":"https://hartvaat.nl/mensen/carole-crawford/","name":"Carole Crawford","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caroline-alsweiler","type":"person","url":"https://hartvaat.nl/mensen/caroline-alsweiler/","name":"Caroline Alsweiler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caroline-kistorp","type":"person","url":"https://hartvaat.nl/mensen/caroline-kistorp/","name":"Caroline Kistorp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carolyn-h-still","type":"person","url":"https://hartvaat.nl/mensen/carolyn-h-still/","name":"Carolyn H Still","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/01/werving-van-zwarte-mannen-met-beroerte-voor-een-gerandomiseerde-klinische-trial/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"celine-gallagher","type":"person","url":"https://hartvaat.nl/mensen/celine-gallagher/","name":"Celine Gallagher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/12/01/geintegreerde-gespecialiseerde-af-poliklinieken-verlagen-totale-mortaliteit-post/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2017/12/01/geintegreerde-zorg-bij-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chan-joo-lee","type":"person","url":"https://hartvaat.nl/mensen/chan-joo-lee/","name":"Chan Joo Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang","type":"person","url":"https://hartvaat.nl/mensen/chang/","name":"Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/10/proteomics-onthult-vier-subgroepen-van-acuut-hfpef-met-eigen-biologische-routes-/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/05/26/acute-bloeddrukverhoging-tijdens-ziekenhuisopname-hoe-te-handelen-bij-asymptomat/","published":"2026-07-04"},{"url":"https://hartvaat.nl/2026/02/23/biologische-versus-mechanische-prothesen-bij-aortaklepvervanging-op-middelbare-l/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang-hua","type":"person","url":"https://hartvaat.nl/mensen/chang-hua/","name":"Chang Hua","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukverlaging-bij-ongediagnosticeerde-hfpef-met-hoog-risico/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang-wang","type":"person","url":"https://hartvaat.nl/mensen/chang-wang/","name":"Chang Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang-hwan-yoon","type":"person","url":"https://hartvaat.nl/mensen/chang-hwan-yoon/","name":"Chang-Hwan Yoon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang-sheng-ma","type":"person","url":"https://hartvaat.nl/mensen/chang-sheng-ma/","name":"Chang-Sheng Ma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang-sheng-sheng","type":"person","url":"https://hartvaat.nl/mensen/chang-sheng-sheng/","name":"Chang-Sheng Sheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/11/10/chinese-kruidenformule-voor-gemaskeerde-hypertensie-gerandomiseerde-placebogecon/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-a-herzog","type":"person","url":"https://hartvaat.nl/mensen/charles-a-herzog/","name":"Charles A Herzog","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/dialysaat-kalium-3-0-mmol-l-met-natriumzirconiumcyclosilicaat-bij-dialyse/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2019/06/04/profylactische-icd-bij-dialysepatienten-ter-preventie-van-plotse-hartdood/","published":"2019-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-delagardelle","type":"person","url":"https://hartvaat.nl/mensen/charles-delagardelle/","name":"Charles Delagardelle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-mondo","type":"person","url":"https://hartvaat.nl/mensen/charles-mondo/","name":"Charles Mondo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chengxing-shen","type":"person","url":"https://hartvaat.nl/mensen/chengxing-shen/","name":"Chengxing Shen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheryl-westlake","type":"person","url":"https://hartvaat.nl/mensen/cheryl-westlake/","name":"Cheryl Westlake","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chi-wang","type":"person","url":"https://hartvaat.nl/mensen/chi-wang/","name":"Chi Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chi-hang-lee","type":"person","url":"https://hartvaat.nl/mensen/chi-hang-lee/","name":"Chi-Hang Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/09/cangrelor-en-infarctgrootte-bij-stemi-gerandomiseerde-trial/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/05/07/mandibulaire-advancementsplint-versus-cpap-voor-bloeddrukverlaging-bij-osa/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2021/07/01/remote-post-ontslag-behandeling-na-mi-door-paramedici-versus-standaardzorg-jama-/","published":"2021-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chinmay-patel","type":"person","url":"https://hartvaat.nl/mensen/chinmay-patel/","name":"Chinmay Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chirag-d-jhaveri","type":"person","url":"https://hartvaat.nl/mensen/chirag-d-jhaveri/","name":"Chirag D Jhaveri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/25/aflibercept-versus-bevacizumab-eerst-bij-diabetisch-macula-oedeem/","published":"2022-08-25"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chris-watson","type":"person","url":"https://hartvaat.nl/mensen/chris-watson/","name":"Chris Watson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/01/sglt2-remming-en-cardiale-reverse-remodelling-bij-hartfalen-systematische-review/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/01/parable-sacubitril-valsartan-vermindert-linkeratriumvolume-bij-pre-hfpef/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2019/06/01/klinische-predictieregels-voor-diagnostiek-van-chronisch-hartfalen-systematische/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christersson","type":"person","url":"https://hartvaat.nl/mensen/christersson/","name":"Christersson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/17/langetermijnuitkomsten-na-de-ross-operatie-een-op-de-vier-krijgt-een-heroperatie/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/01/29/verminderde-pompfunctie-na-een-hartinfarct-hoge-symptoomlast-en-slechtere-secund/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-delles","type":"person","url":"https://hartvaat.nl/mensen/christian-delles/","name":"Christian Delles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2017/11/21/sacubitril-valsartan-versus-olmesartan-en-cardiovasculaire-remodellering-bij-hyp/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-erikstrup","type":"person","url":"https://hartvaat.nl/mensen/christian-erikstrup/","name":"Christian Erikstrup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/13/griepvaccinatie-en-cardiovasculaire-bescherming-inflammatie-heroverwogen-bij-isc/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-gerdes","type":"person","url":"https://hartvaat.nl/mensen/christian-gerdes/","name":"Christian Gerdes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/21/minimalisatie-van-atriale-pacing-bij-sinusknoopziekte-vermindert-af/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-heeger","type":"person","url":"https://hartvaat.nl/mensen/christian-heeger/","name":"Christian Heeger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2021/05/21/firm-ablatie-versus-pvi-bij-paroxysmaal-af-gerandomiseerde-resultaten/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-hengstenberg","type":"person","url":"https://hartvaat.nl/mensen/christian-hengstenberg/","name":"Christian Hengstenberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/dapa-hd-eerste-gerandomiseerde-studie-naar-dapagliflozin-bij-hemodialyse-patient/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2022/09/21/riociguat-bij-pulmonale-hypertensie-en-hfpef-haemodynamic-trial/","published":"2022-09-21"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-m-matter","type":"person","url":"https://hartvaat.nl/mensen/christian-m-matter/","name":"Christian M Matter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2019/11/19/evolocumab-voor-vroege-ldl-verlaging-bij-acs-evopacs/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-m-shaffer","type":"person","url":"https://hartvaat.nl/mensen/christian-m-shaffer/","name":"Christian M Shaffer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-templin","type":"person","url":"https://hartvaat.nl/mensen/christian-templin/","name":"Christian Templin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-veltmann","type":"person","url":"https://hartvaat.nl/mensen/christian-veltmann/","name":"Christian Veltmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2025/06/01/rv-disfunctie-voorspelt-langetermijnherstel-bij-de-novo-hfref-prolong-ii/","published":"2025-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-weber","type":"person","url":"https://hartvaat.nl/mensen/christian-weber/","name":"Christian Weber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/microrna-s-in-de-celkern-sturen-hartmetabolisme-bij-hfpef/","published":"2026-04-03"},{"url":"https://hartvaat.nl/2026/03/06/metabool-cardiovasculair-risico-nieuwe-mechanismen-en-therapiekansen/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2025/12/03/galectine-1-herprogrammeert-macrofagen-en-moduleert-t-celimmuniteit-bij-atherosc/","published":"2025-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-hendrik-heeger","type":"person","url":"https://hartvaat.nl/mensen/christian-hendrik-heeger/","name":"Christian-Hendrik Heeger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christina-christersson","type":"person","url":"https://hartvaat.nl/mensen/christina-christersson/","name":"Christina Christersson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/11/volwassenen-met-aangeboren-hartafwijking-hebben-vergelijkbare-overleving-na-hart/","published":"2026-06-24"},{"url":"https://hartvaat.nl/2020/03/17/klinische-en-farmacologische-effecten-van-apixaban-dosisaanpassing-aristotle/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2019/02/01/apixaban-versus-warfarine-en-coagulatiemerkers-bij-af/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christina-magnussen","type":"person","url":"https://hartvaat.nl/mensen/christina-magnussen/","name":"Christina Magnussen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-herrmann-lingen","type":"person","url":"https://hartvaat.nl/mensen/christoph-herrmann-lingen/","name":"Christoph Herrmann-Lingen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2021/12/01/baseline-parameters-en-1-jaars-qol-bij-hf-na-crt-d-esc-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-pauschinger","type":"person","url":"https://hartvaat.nl/mensen/christoph-pauschinger/","name":"Christoph Pauschinger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-dubois","type":"person","url":"https://hartvaat.nl/mensen/christophe-dubois/","name":"Christophe Dubois","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/04/01/polymeervrije-biolimus-stent-bij-hoog-bloedingsrisico-met-acs-leaders-free-subst/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-pouillot","type":"person","url":"https://hartvaat.nl/mensen/christophe-pouillot/","name":"Christophe Pouillot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-tzourio","type":"person","url":"https://hartvaat.nl/mensen/christophe-tzourio/","name":"Christophe Tzourio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/01/hypotensieve-episodes-op-24-uurs-abpm-en-cognitieve-functie-sprint-inzichten/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-b-fordyce","type":"person","url":"https://hartvaat.nl/mensen/christopher-b-fordyce/","name":"Christopher B Fordyce","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2016/07/05/verslechterende-nierfunctie-en-uitkomsten-met-rivaroxaban-versus-warfarine-rocke/","published":"2016-07-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-levi","type":"person","url":"https://hartvaat.nl/mensen/christopher-levi/","name":"Christopher Levi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/pneumokokkenvaccinatie-en-cv-eventpreventie-ipd-meta-analyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-m-hearon","type":"person","url":"https://hartvaat.nl/mensen/christopher-m-hearon/","name":"Christopher M Hearon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/12/19/synchronisatie-van-voetstap-en-hartfase-bij-crt-patienten/","published":"2023-12-19"},{"url":"https://hartvaat.nl/2023/01/31/hfpef-inspanningsbeperking-niet-alleen-door-hemodynamiek/","published":"2023-01-31"},{"url":"https://hartvaat.nl/2021/09/21/1-jaar-inspanningstraining-keert-lv-stijfheid-om-bij-stadium-b-hf/","published":"2021-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-w-schneider","type":"person","url":"https://hartvaat.nl/mensen/christopher-w-schneider/","name":"Christopher W Schneider","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/02/pfa-versus-thermale-ablatie-bij-paroxysmaal-af-aritmielastanalyse/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-x-wong","type":"person","url":"https://hartvaat.nl/mensen/christopher-x-wong/","name":"Christopher X Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/decaf-cafeinehoudende-koffie-en-af-gerandomiseerde-trial/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/10/21/dieet-en-af-risico-systematische-review/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2017/12/01/geintegreerde-zorg-bij-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chul-soo-park","type":"person","url":"https://hartvaat.nl/mensen/chul-soo-park/","name":"Chul Soo Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chun-chin-chang","type":"person","url":"https://hartvaat.nl/mensen/chun-chin-chang/","name":"Chun Chin Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/10/22/ticagrelor-monotherapie-bij-multivaten-pci-werkzaamheid-en-veiligheid/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chung-shiuan-chen","type":"person","url":"https://hartvaat.nl/mensen/chung-shiuan-chen/","name":"Chung-Shiuan Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"},{"url":"https://hartvaat.nl/2017/09/19/community-health-worker-interventie-voor-bloeddrukcontrole-in-argentina-jama-tri/","published":"2017-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chuning-shi","type":"person","url":"https://hartvaat.nl/mensen/chuning-shi/","name":"Chuning Shi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ciantel-a-blyler","type":"person","url":"https://hartvaat.nl/mensen/ciantel-a-blyler/","name":"Ciantel A Blyler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudia-raineri","type":"person","url":"https://hartvaat.nl/mensen/claudia-raineri/","name":"Claudia Raineri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudia-s-moy","type":"person","url":"https://hartvaat.nl/mensen/claudia-s-moy/","name":"Claudia S Moy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2016/09/15/intensieve-bloeddrukverlaging-bij-acute-hersenbloeding-nejm-atach-2-trial/","published":"2016-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudia-stefanutti","type":"person","url":"https://hartvaat.nl/mensen/claudia-stefanutti/","name":"Claudia Stefanutti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/lipoproteine-aferese-blijft-relevant-in-het-tijdperk-van-pcsk9-remmers-en-sirna/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudia-torino","type":"person","url":"https://hartvaat.nl/mensen/claudia-torino/","name":"Claudia Torino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/29/cardiovasculaire-ziekte-blijft-leidend-na-niertransplantatie-overzicht-van-uitda/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/01/21/patientgerapporteerde-uitkomsten-verbeteren-voorspelling-van-mortaliteit-bij-dia/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudio-gimpelewicz","type":"person","url":"https://hartvaat.nl/mensen/claudio-gimpelewicz/","name":"Claudio Gimpelewicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudio-laudani","type":"person","url":"https://hartvaat.nl/mensen/claudio-laudani/","name":"Claudio Laudani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/04/02/ivus-versus-oct-versus-angiografie-voor-pci-begeleiding-meta-analyse/","published":"2024-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudio-moretti","type":"person","url":"https://hartvaat.nl/mensen/claudio-moretti/","name":"Claudio Moretti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudio-passino","type":"person","url":"https://hartvaat.nl/mensen/claudio-passino/","name":"Claudio Passino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2017/09/12/centrale-apneus-gedurende-24-uur-en-prognose-bij-hartfalen/","published":"2017-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudius-jacobshagen","type":"person","url":"https://hartvaat.nl/mensen/claudius-jacobshagen/","name":"Claudius Jacobshagen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clive-rosendorff","type":"person","url":"https://hartvaat.nl/mensen/clive-rosendorff/","name":"Clive Rosendorff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/12/06/comorbiditeiten-bij-hartfalen-hypertensie-obesitas-diabetes-hyperlipidemie-en-me/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"colby-ayers","type":"person","url":"https://hartvaat.nl/mensen/colby-ayers/","name":"Colby Ayers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2016/08/01/sedentair-gedrag-en-cardiovasculair-risico-continue-dosis-responsrelatie-in-meta/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"colm-g-hanratty","type":"person","url":"https://hartvaat.nl/mensen/colm-g-hanratty/","name":"Colm G Hanratty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"conference-participants","type":"person","url":"https://hartvaat.nl/mensen/conference-participants/","name":"Conference Participants","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2026/02/18/groene-dialyse-duurzame-zorg-groei-en-innovatie-kdigo-conferentie/","published":"2026-02-18"},{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"connie-n-hess","type":"person","url":"https://hartvaat.nl/mensen/connie-n-hess/","name":"Connie N Hess","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/25/vasculair-zorgteam-versus-educatie-bij-perifeer-arterieel-vaatlijden/","published":"2024-06-25"},{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-consensus-same-day-ontslag-na-pci/","published":"2021-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"conrado-r-hoffmann-filho","type":"person","url":"https://hartvaat.nl/mensen/conrado-r-hoffmann-filho/","name":"Conrado R Hoffmann Filho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"corinne-v-evans","type":"person","url":"https://hartvaat.nl/mensen/corinne-v-evans/","name":"Corinne V Evans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/18/uspstf-evidence-review-lipidescreening-bij-kinderen-geactualiseerd/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-evidence-update-2021/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-gezond-dieet-en-beweging-bij-cv-risico-jama-uspstf/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"corrine-y-jurgens","type":"person","url":"https://hartvaat.nl/mensen/corrine-y-jurgens/","name":"Corrine Y Jurgens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2021/01/26/2020-acc-aha-kwaliteitsmaten-voor-af-geactualiseerd/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cosmo-godino","type":"person","url":"https://hartvaat.nl/mensen/cosmo-godino/","name":"Cosmo Godino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"costas-thomopoulos","type":"person","url":"https://hartvaat.nl/mensen/costas-thomopoulos/","name":"Costas Thomopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/01/sympathische-overactiviteit-bij-resistente-hypertensie-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/14/hartfrequentieverlagende-middelen-en-uitkomsten-bij-hypertensie-cvd-meta-analyse/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2024/05/01/bloeddrukstreefwaarden-en-residueel-risico-systematische-review-en-meta-regressi/","published":"2024-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"craig-h-selzman","type":"person","url":"https://hartvaat.nl/mensen/craig-h-selzman/","name":"Craig H Selzman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cramer","type":"person","url":"https://hartvaat.nl/mensen/cramer/","name":"Cramer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/04/angina-toevoegen-aan-de-h2fpef-score-verbetert-hfpef-diagnose-bij-vrouwen-geen-w/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cristian-roman","type":"person","url":"https://hartvaat.nl/mensen/cristian-roman/","name":"Cristian Roman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"crystal-c-tyson","type":"person","url":"https://hartvaat.nl/mensen/crystal-c-tyson/","name":"Crystal C Tyson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/01/digitale-interventie-voor-dash-dieet-en-bloeddrukverlaging-bij-vs-volwassenen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/10/09/24-uurs-ambulante-bloeddrukreductie-na-renale-denervatie-spyral-htn-off-med/","published":"2018-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cynthia-r-stockdale","type":"person","url":"https://hartvaat.nl/mensen/cynthia-r-stockdale/","name":"Cynthia R Stockdale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/25/aflibercept-versus-bevacizumab-eerst-bij-diabetisch-macula-oedeem/","published":"2022-08-25"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cyril-jean-marie-martel","type":"person","url":"https://hartvaat.nl/mensen/cyril-jean-marie-martel/","name":"Cyril Jean-Marie Martel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"d-s","type":"person","url":"https://hartvaat.nl/mensen/d-s/","name":"D. S.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/02/25/langetermijnincidentie-van-atriumfibrilleren-en-het-risico-op-beroerte-20-jaar-f/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/01/09/endocarditis-van-de-natieve-klep-verschuift-naar-ouderen-chirurgie-blijft-levens/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"d-t","type":"person","url":"https://hartvaat.nl/mensen/d-t/","name":"D. T.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/20/hypochloremie-bij-opname-voor-acuut-hartfalen-voorspelt-onafhankelijk-30-daagse-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/03/10/machine-learning-voorspelt-30-daagse-sterfte-na-een-dotterbehandeling-australisc/","published":"2026-03-10"},{"url":"https://hartvaat.nl/2026/03/02/is-depressie-een-onafhankelijke-risicofactor-voor-sterfte-bij-hart-en-vaatziekte/","published":"2026-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daehoon-kim","type":"person","url":"https://hartvaat.nl/mensen/daehoon-kim/","name":"Daehoon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/12/03/ct-gestuurde-atriale-wanddiktemapping-bij-cryoballon-pvi/","published":"2024-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dagmar-m-ouweneel","type":"person","url":"https://hartvaat.nl/mensen/dagmar-m-ouweneel/","name":"Dagmar M Ouweneel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/12/14/mechanische-ondersteuning-bij-cardiogene-shock-systematische-review-en-meta-anal/","published":"2017-12-14"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-ondersteuning-versus-iabp-bij-cardiogene-shock-meta-analys/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dalibor-herman","type":"person","url":"https://hartvaat.nl/mensen/dalibor-herman/","name":"Dalibor Herman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/08/catheterablatie-versus-leefstijlmodificatie-plus-antiaritmica-bij-af-gerandomise/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-bloomfield","type":"person","url":"https://hartvaat.nl/mensen/dan-bloomfield/","name":"Dan Bloomfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/11/01/abelacimab-bij-af-naar-nierfunctie-veiligheidssubanalyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/05/abelacimab-versus-rivaroxaban-bij-af-op-antiplaatjestherapie-subanalyse/","published":"2025-08-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-r-berlowitz","type":"person","url":"https://hartvaat.nl/mensen/dan-r-berlowitz/","name":"Dan R Berlowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dana-dabelea","type":"person","url":"https://hartvaat.nl/mensen/dana-dabelea/","name":"Dana Dabelea","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-benjamin-fyenbo","type":"person","url":"https://hartvaat.nl/mensen/daniel-benjamin-fyenbo/","name":"Daniel Benjamin Fyenbo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-duerschmied","type":"person","url":"https://hartvaat.nl/mensen/daniel-duerschmied/","name":"Daniel Duerschmied","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-e-jonas","type":"person","url":"https://hartvaat.nl/mensen/daniel-e-jonas/","name":"Daniel E Jonas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-geactualiseerde-evidence-report-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2021/07/27/heeft-deze-volwassene-hypertensie-jama-rational-clinical-examination/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-evidence-report-en-systematische-review/","published":"2018-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-f-martin","type":"person","url":"https://hartvaat.nl/mensen/daniel-f-martin/","name":"Daniel F Martin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/25/aflibercept-versus-bevacizumab-eerst-bij-diabetisch-macula-oedeem/","published":"2022-08-25"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-gras","type":"person","url":"https://hartvaat.nl/mensen/daniel-gras/","name":"Daniel Gras","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-h-solomon","type":"person","url":"https://hartvaat.nl/mensen/daniel-h-solomon/","name":"Daniel H Solomon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/20/biomarkers-voor-atherosclerotische-events-bij-reumatoide-artritis-lp-a-als-voors/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-kalbacher","type":"person","url":"https://hartvaat.nl/mensen/daniel-kalbacher/","name":"Daniel Kalbacher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-keene","type":"person","url":"https://hartvaat.nl/mensen/daniel-keene/","name":"Daniel Keene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-l-lustgarten","type":"person","url":"https://hartvaat.nl/mensen/daniel-l-lustgarten/","name":"Daniel L Lustgarten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-klinische-uitkomsten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2023/03/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-met-pacemaker/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2016/05/17/institutionele-en-operateurvereisten-voor-linker-hartoorocclusie-scai-acc-hrs-st/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-p-morin","type":"person","url":"https://hartvaat.nl/mensen/daniel-p-morin/","name":"Daniel P Morin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/01/dubbele-versus-enkele-cardioversie-bij-af-en-obesitas-jama-cardiology-rct/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2016/03/15/voorspelling-van-persisterende-lv-disfunctie-na-myocardinfarct-de-predicts-studi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-zimpfer","type":"person","url":"https://hartvaat.nl/mensen/daniel-zimpfer/","name":"Daniel Zimpfer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniele-giacopelli","type":"person","url":"https://hartvaat.nl/mensen/daniele-giacopelli/","name":"Daniele Giacopelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dao-wen-wang","type":"person","url":"https://hartvaat.nl/mensen/dao-wen-wang/","name":"Dao Wen Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/varenicline-vermindert-ventriculaire-ectopie-na-myocardinfarct/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daoquan-peng","type":"person","url":"https://hartvaat.nl/mensen/daoquan-peng/","name":"Daoquan Peng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/26/inclisiran-als-monotherapie-verlaagt-ldl-c-met-47-5-in-chinese-volwassenen-victo/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2026/05/25/explorer-cn-week-78-langetermijneffect-en-veiligheid-van-mavacamten-bij-chinese-/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darlington-o-okonko","type":"person","url":"https://hartvaat.nl/mensen/darlington-o-okonko/","name":"Darlington O Okonko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/01/ijzercarboxymaltose-en-plasmavolumestatus-bij-hf-fair-hf-substudie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/21/ijzerisomaltosides-en-skeletspierdenergie-bij-chronisch-hf-met-ijzerdeficientie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2018/03/01/medicamenteuze-behandeling-en-uitkomsten-bij-hfpef-systematische-review-en-meta-/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darryl-p-leong","type":"person","url":"https://hartvaat.nl/mensen/darryl-p-leong/","name":"Darryl P Leong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dave-l-dixon","type":"person","url":"https://hartvaat.nl/mensen/dave-l-dixon/","name":"Dave L Dixon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/09/2023-acc-expert-consensus-management-van-hfpef/","published":"2023-05-09"},{"url":"https://hartvaat.nl/2021/09/01/arts-apotheker-samenwerkingsmodel-en-time-in-target-bloeddruk-post-hoc-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/03/16/systolische-bloeddruk-time-in-target-en-cv-uitkomsten-bij-hypertensie/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-a-garcia","type":"person","url":"https://hartvaat.nl/mensen/david-a-garcia/","name":"David A Garcia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"},{"url":"https://hartvaat.nl/2018/10/02/periprocedurele-uitkomsten-van-doac-versus-warfarine-bij-niet-valvulair-af/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-a-hess","type":"person","url":"https://hartvaat.nl/mensen/david-a-hess/","name":"David A Hess","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-c-grossman","type":"person","url":"https://hartvaat.nl/mensen/david-c-grossman/","name":"David C Grossman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-c-tong","type":"person","url":"https://hartvaat.nl/mensen/david-c-tong/","name":"David C Tong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-callans","type":"person","url":"https://hartvaat.nl/mensen/david-callans/","name":"David Callans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/01/01/axafa-afnet-5-apixaban-versus-vka-bij-af-ablatie-studieprotocol/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-h-adams","type":"person","url":"https://hartvaat.nl/mensen/david-h-adams/","name":"David H Adams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-hong","type":"person","url":"https://hartvaat.nl/mensen/david-hong/","name":"David Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-seiffge","type":"person","url":"https://hartvaat.nl/mensen/david-j-seiffge/","name":"David J Seiffge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-wright","type":"person","url":"https://hartvaat.nl/mensen/david-j-wright/","name":"David J Wright","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-o-williams","type":"person","url":"https://hartvaat.nl/mensen/david-o-williams/","name":"David O Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/23/pci-versus-cabg-en-gezondheidsstatus-bij-stabiel-coronairlijden/","published":"2025-09-23"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-o-donnell","type":"person","url":"https://hartvaat.nl/mensen/david-o-donnell/","name":"David O'Donnell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2019/01/01/slokdarmletsel-bij-af-ablatie-prevalentie-en-preventie-meta-analyse/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/04/01/aanvullende-elektroden-op-de-quartet-lv-lead-bieden-meer-crt-programmeringsmogel/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-p-faxon","type":"person","url":"https://hartvaat.nl/mensen/david-p-faxon/","name":"David P Faxon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2018/07/31/antitrombotische-therapie-bij-af-met-oac-na-pci-aha-scientific-statement/","published":"2018-07-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-peiris","type":"person","url":"https://hartvaat.nl/mensen/david-peiris/","name":"David Peiris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-r-van-wagoner","type":"person","url":"https://hartvaat.nl/mensen/david-r-van-wagoner/","name":"David R Van Wagoner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-sparv","type":"person","url":"https://hartvaat.nl/mensen/david-sparv/","name":"David Sparv","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-spirk","type":"person","url":"https://hartvaat.nl/mensen/david-spirk/","name":"David Spirk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-t-martin","type":"person","url":"https://hartvaat.nl/mensen/david-t-martin/","name":"David T Martin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/14/real-time-remote-monitoring-voorspelt-maligne-ventriculaire-aritmieen/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2022/03/02/kenmerken-van-patienten-met-atriale-high-rate-episodes-bij-icd-crt/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2021/08/06/ventriculaire-aritmie-bij-crt-responders-en-super-responders-meta-analyse/","published":"2021-08-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-w-johnson","type":"person","url":"https://hartvaat.nl/mensen/david-w-johnson/","name":"David W Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/30/combinatietherapie-met-vier-pilaren-verlaagt-nierfalenrisico-bij-ckd/","published":"2026-08-02"},{"url":"https://hartvaat.nl/2026/05/29/lichaamsrondheidsindex-bri-voorspelt-sterfte-bij-nierpatienten-beter-dan-bmi/","published":"2026-07-27"},{"url":"https://hartvaat.nl/2016/07/19/glucoseverlagende-medicatie-en-cardiovasculaire-events-bij-diabetes-type-2-jama-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-van-klaveren","type":"person","url":"https://hartvaat.nl/mensen/david-van-klaveren/","name":"David van Klaveren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"},{"url":"https://hartvaat.nl/2020/08/25/sekseverschillen-in-mortaliteit-na-complexe-coronaire-revascularisatie-10-jaar/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dayi-hu","type":"person","url":"https://hartvaat.nl/mensen/dayi-hu/","name":"Dayi Hu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dejan-milasinovic","type":"person","url":"https://hartvaat.nl/mensen/dejan-milasinovic/","name":"Dejan Milasinovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"delu-yin","type":"person","url":"https://hartvaat.nl/mensen/delu-yin/","name":"Delu Yin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dennis-kannenkeril","type":"person","url":"https://hartvaat.nl/mensen/dennis-kannenkeril/","name":"Dennis Kannenkeril","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/12/01/empagliflozine-en-vaatfunctie-bij-chronisch-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2017/09/19/empagliflozine-en-vasculaire-functie-en-centrale-hemodynamiek-bij-diabetes-type-/","published":"2017-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dennis-t-ko","type":"person","url":"https://hartvaat.nl/mensen/dennis-t-ko/","name":"Dennis T Ko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/08/01/klinische-fenotypen-zijn-effectiever-dan-ef-categorieen-voor-hf-uitkomsten/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2019/11/01/interventies-voor-statinevoorschrijving-bij-primaire-cv-preventie-meta-analyse/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/02/26/patientgerichte-transitional-care-bij-hf-hospitalisatie-jama-pact-hf/","published":"2019-02-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dharam-j-kumbhani","type":"person","url":"https://hartvaat.nl/mensen/dharam-j-kumbhani/","name":"Dharam J Kumbhani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2019/05/21/vroegtijdig-staken-van-ticagrelor-bij-secundaire-cv-preventie-jacc-review/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2016/08/01/sedentair-gedrag-en-cardiovasculair-risico-continue-dosis-responsrelatie-in-meta/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dian-a-munawar","type":"person","url":"https://hartvaat.nl/mensen/dian-a-munawar/","name":"Dian A Munawar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/01/af-voorspelt-cognitieve-achteruitgang-meta-analyse-van-2-8-miljoen-personen/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diana-bonderman","type":"person","url":"https://hartvaat.nl/mensen/diana-bonderman/","name":"Diana Bonderman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/21/riociguat-bij-pulmonale-hypertensie-en-hfpef-haemodynamic-trial/","published":"2022-09-21"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diego-penela","type":"person","url":"https://hartvaat.nl/mensen/diego-penela/","name":"Diego Penela","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/atriumfibrilleren-bij-kankerpatienten-de-esc-richtlijn-2025-in-de-praktijk/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-alexopoulos","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-alexopoulos/","name":"Dimitrios Alexopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2018/10/02/cangrelor-bij-ticagrelor-geladen-stemi-patienten-tijdens-primaire-pci/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2017/10/17/laaggedoseerd-ticagrelor-versus-clopidogrel-na-eerder-mi/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-asvestas","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-asvestas/","name":"Dimitrios Asvestas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2026/05/06/circulerend-mir-10b-5p-voorspelt-af-recidief-na-ablatie/","published":"2026-05-06"},{"url":"https://hartvaat.nl/2026/03/30/linear-trial-lattice-tip-katheter-verslaat-standaard-irrigatie-bij-cti-ablatie-v/","published":"2026-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-konstantinidis","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-konstantinidis/","name":"Dimitrios Konstantinidis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/15/injecteerbare-lipidendalers-bij-gevorderde-chronische-nierziekte-en-dialyse-narr/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2024/05/01/bloeddrukstreefwaarden-en-residueel-risico-systematische-review-en-meta-regressi/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-venetsanos","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-venetsanos/","name":"Dimitrios Venetsanos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diogo-d-f-moia","type":"person","url":"https://hartvaat.nl/mensen/diogo-d-f-moia/","name":"Diogo D F Moia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dion-h-zappe","type":"person","url":"https://hartvaat.nl/mensen/dion-h-zappe/","name":"Dion H Zappe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/01/kardia-2-zilebesiran-als-toevoeging-bij-ongecontroleerde-hypertensie-rct/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2017/03/01/sacubitril-valsartan-versus-olmesartan-op-centrale-hemodynamiek-bij-ouderen-para/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/03/21/cardiovasculaire-uitkomsten-bij-verschillende-bereiktestreefdrukken-in-de-value-/","published":"2016-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dirk-westermann","type":"person","url":"https://hartvaat.nl/mensen/dirk-westermann/","name":"Dirk Westermann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"divya-gupta","type":"person","url":"https://hartvaat.nl/mensen/divya-gupta/","name":"Divya Gupta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2017/03/21/kortetermijneffecten-van-tolvaptan-bij-acuut-hartfalen-met-volume-overbelasting/","published":"2017-03-21"},{"url":"https://hartvaat.nl/2017/03/21/werkzaamheid-en-veiligheid-van-tolvaptan-bij-gehospitaliseerd-acuut-hartfalen/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dmitry-ponomarev","type":"person","url":"https://hartvaat.nl/mensen/dmitry-ponomarev/","name":"Dmitry Ponomarev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/02/22/temporaire-ruggenmergstimulatie-ter-preventie-van-postoperatief-af/","published":"2022-02-22"},{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/21/renale-denervatie-plus-katheterablatie-versus-ablatie-alleen-bij-af-met-hyperten/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dmitry-zamoryakhin","type":"person","url":"https://hartvaat.nl/mensen/dmitry-zamoryakhin/","name":"Dmitry Zamoryakhin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/12/01/edoxaban-verhoogt-behandeltevredenheid-en-vermindert-zorggebruik-engage-af-timi-/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"do-sun-lim","type":"person","url":"https://hartvaat.nl/mensen/do-sun-lim/","name":"Do-Sun Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dolores-corella","type":"person","url":"https://hartvaat.nl/mensen/dolores-corella/","name":"Dolores Corella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"domenico-maisano","type":"person","url":"https://hartvaat.nl/mensen/domenico-maisano/","name":"Domenico Maisano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"domenico-paparella","type":"person","url":"https://hartvaat.nl/mensen/domenico-paparella/","name":"Domenico Paparella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dominik-steubl","type":"person","url":"https://hartvaat.nl/mensen/dominik-steubl/","name":"Dominik Steubl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2022/11/01/empagliflozine-vermindert-albuminurie-bij-hartfalen-emperor-pooled-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/03/23/mra-en-empagliflozine-interactie-bij-hf-emperor-reduced/","published":"2021-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donato-santovito","type":"person","url":"https://hartvaat.nl/mensen/donato-santovito/","name":"Donato Santovito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/microrna-s-in-de-celkern-sturen-hartmetabolisme-bij-hfpef/","published":"2026-04-03"},{"url":"https://hartvaat.nl/2026/03/06/metabool-cardiovasculair-risico-nieuwe-mechanismen-en-therapiekansen/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2025/12/03/galectine-1-herprogrammeert-macrofagen-en-moduleert-t-celimmuniteit-bij-atherosc/","published":"2025-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-geum-shin","type":"person","url":"https://hartvaat.nl/mensen/dong-geum-shin/","name":"Dong Geum Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/19/fluoroscopievrije-cryoballonablatie-met-ice-begeleiding-bij-af/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/07/21/posterior-wand-isolatie-met-cryoballon-bij-persisterend-af-meerwaarde-onderzocht/","published":"2022-07-21"},{"url":"https://hartvaat.nl/2020/10/01/high-power-short-duration-ablatie-bij-af-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-ho-shin","type":"person","url":"https://hartvaat.nl/mensen/dong-ho-shin/","name":"Dong-Ho Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-yan-zhang","type":"person","url":"https://hartvaat.nl/mensen/dong-yan-zhang/","name":"Dong-Yan Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2020/11/10/chinese-kruidenformule-voor-gemaskeerde-hypertensie-gerandomiseerde-placebogecon/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donna-h-ryan","type":"person","url":"https://hartvaat.nl/mensen/donna-h-ryan/","name":"Donna H Ryan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/12/20/orforglipron-bij-obesitas-nejm-definitieve-fase-3-resultaten/","published":"2025-12-20"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"doo-sun-sim","type":"person","url":"https://hartvaat.nl/mensen/doo-sun-sim/","name":"Doo Sun Sim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"},{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"doo-il-kim","type":"person","url":"https://hartvaat.nl/mensen/doo-il-kim/","name":"Doo-Il Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dorien-m-kimenai","type":"person","url":"https://hartvaat.nl/mensen/dorien-m-kimenai/","name":"Dorien M Kimenai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/01/13/risicofactoren-voor-type-1-en-type-2-mi/","published":"2022-01-13"},{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"doron-zahger","type":"person","url":"https://hartvaat.nl/mensen/doron-zahger/","name":"Doron Zahger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-k-owens","type":"person","url":"https://hartvaat.nl/mensen/douglas-k-owens/","name":"Douglas K Owens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-aanbeveling-2018/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-n-gibson","type":"person","url":"https://hartvaat.nl/mensen/douglas-n-gibson/","name":"Douglas N Gibson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2017/12/19/5-jaarsuitkomsten-na-linker-hartoorsluiting-prevail-en-protect-af/","published":"2017-12-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-s-lee","type":"person","url":"https://hartvaat.nl/mensen/douglas-s-lee/","name":"Douglas S Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-babar-basir","type":"person","url":"https://hartvaat.nl/mensen/dr-babar-basir/","name":"Dr. Babar Basir","title":"Henry Ford Health, Detroit, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/expert-stemi-dtu-basir-al-azizi/","title":"Expertinterview: STEMI Door-to-Unload trial met Basir en Al-Azizi"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-esther-gonzalez-lopez","type":"person","url":"https://hartvaat.nl/mensen/dr-esther-gonzalez-lopez/","name":"Dr. Esther González López","title":"Cardioloog, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spanje","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/attribute-cm-peer-to-peer-fontana-lopez/","title":"ATTRibute-CM peer-to-peer — Van trial naar dagelijkse praktijk"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-felipe-martinez","type":"person","url":"https://hartvaat.nl/mensen/dr-felipe-martinez/","name":"Dr. Felipe Martínez","title":"Universidad Nacional de Córdoba, Argentinië","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/expert-hartfalen-2026-lessen-martinez/","title":"Expertinterview: Hartfalen in 2026 — praktische therapielessen met Felipe Martínez"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-ida-arentz-taraldsen","type":"person","url":"https://hartvaat.nl/mensen/dr-ida-arentz-taraldsen/","name":"Dr. Ida Arentz Taraldsen","title":"Anesthesioloog / cardiologisch onderzoeker, Kopenhagen Universitair Ziekenhuis, Denemarken","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/redox-ahf/","title":"REDOX-AHF — Restrictieve versus liberale oxygenatie bij acuut hartfalen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-karim-al-azizi","type":"person","url":"https://hartvaat.nl/mensen/dr-karim-al-azizi/","name":"Dr. Karim Al-Azizi","title":"Henry Ford Health, Detroit, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/expert-stemi-dtu-basir-al-azizi/","title":"Expertinterview: STEMI Door-to-Unload trial met Basir en Al-Azizi"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-margot-k-davis","type":"person","url":"https://hartvaat.nl/mensen/dr-margot-k-davis/","name":"Dr. Margot K. Davis","title":"Cardioloog, University of British Columbia, Vancouver, Canada","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/cardio-ttransform-peer-to-peer-maurer-davis/","title":"CARDIO-TTRansform peer-to-peer — Silencer- versus stabilisator-therapie"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-rui-baptista","type":"person","url":"https://hartvaat.nl/mensen/dr-rui-baptista/","name":"Dr. Rui Baptista","title":"Cardioloog, Hospital de Santa Cruz / iCBR Coimbra, Portugal","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/porthos-obesitas-natriuretische-peptiden/","title":"PORTHOS — NT-proBNP-afkapwaarden onbetrouwbaar bij obese patiënten"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dr-vivek-reddy","type":"person","url":"https://hartvaat.nl/mensen/dr-vivek-reddy/","name":"Dr. Vivek Reddy","title":"Icahn School of Medicine at Mount Sinai, New York, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/af-symposium-2026-cva-beleid-na-ablatie/cva-beleid-na-af-ablatie/","title":"CVA-beleid na atriumfibrilleren-ablatie"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dragan-simic","type":"person","url":"https://hartvaat.nl/mensen/dragan-simic/","name":"Dragan Simic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"duane-s-pinto","type":"person","url":"https://hartvaat.nl/mensen/duane-s-pinto/","name":"Duane S Pinto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/12/reductie-in-ischemische-events-door-onderzoekers-en-adjudicatiecommissie-reduce-/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"e-karin-arkenbout","type":"person","url":"https://hartvaat.nl/mensen/e-karin-arkenbout/","name":"E Karin Arkenbout","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/02/therapietrouw-aan-lipidenverlagende-medicatie-na-pci-in-nederland/","published":"2026-03-28"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eamon-dolan","type":"person","url":"https://hartvaat.nl/mensen/eamon-dolan/","name":"Eamon Dolan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/04/01/prognostisch-effect-van-nachtelijke-bloeddrukdaling-bij-hypertensie-de-abc-h-stu/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eberhard-standl","type":"person","url":"https://hartvaat.nl/mensen/eberhard-standl/","name":"Eberhard Standl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2017/11/01/hypertensiecontrole-bij-diabetes-met-recidiverende-cv-events-tecos-globale-resul/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edina-cenko","type":"person","url":"https://hartvaat.nl/mensen/edina-cenko/","name":"Edina Cenko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/03/05/ongelijke-toegang-tot-cardiovasculaire-zorg-in-europa/","published":"2026-04-10"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eduardo-g-bertoldi","type":"person","url":"https://hartvaat.nl/mensen/eduardo-g-bertoldi/","name":"Eduardo G Bertoldi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/11/21/diureticastaken-bij-stabiel-mild-hf-zonder-vochtretentie/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ehtisham-mahmud","type":"person","url":"https://hartvaat.nl/mensen/ehtisham-mahmud/","name":"Ehtisham Mahmud","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2020/09/15/ami-management-tijdens-covid-19-scai-positiedocument/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2020/04/01/p2y12-remmers-met-oac-bij-af-na-pci-meta-analyse/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elena-minguzzi","type":"person","url":"https://hartvaat.nl/mensen/elena-minguzzi/","name":"Elena Minguzzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elena-olmastroni","type":"person","url":"https://hartvaat.nl/mensen/elena-olmastroni/","name":"Elena Olmastroni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/22/orale-pcsk9-remmers-meta-analyse-bevestigt-krachtige-ldl-daling/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2026/04/22/angptl3-remmers-verlagen-breed-lipidenspectrum-vooral-remnant-en-triglyceriden/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elham-bidar","type":"person","url":"https://hartvaat.nl/mensen/elham-bidar/","name":"Elham Bidar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2021/11/08/preoperatieve-tte-voor-voorspelling-van-postoperatief-af-meta-analyse/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2021/04/01/va-ecls-bij-harttransplantatie-en-vad-centra-meta-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elisabeth-pieske-kraigher","type":"person","url":"https://hartvaat.nl/mensen/elisabeth-pieske-kraigher/","name":"Elisabeth Pieske-Kraigher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2017/04/14/vericiguat-bij-verslechterend-chronisch-hfpef-socrates-preserved-resultaten/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elisabeth-steinhagen-thiessen","type":"person","url":"https://hartvaat.nl/mensen/elisabeth-steinhagen-thiessen/","name":"Elisabeth Steinhagen-Thiessen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/02/21/pelacarsen-vermindert-de-behoefte-aan-lipoproteine-a-aferese-lp-a-frontiers-aphe/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eliseo-guallar","type":"person","url":"https://hartvaat.nl/mensen/eliseo-guallar/","name":"Eliseo Guallar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-asztalos","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-asztalos/","name":"Elizabeth Asztalos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/06/01/amenorroe-duur-bij-start-antihypertensiva-in-de-zwangerschap-chips-secundaire-an/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-m-albrecht","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-m-albrecht/","name":"Elizabeth M Albrecht","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/02/pfa-versus-thermale-ablatie-bij-paroxysmaal-af-aritmielastanalyse/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-misner","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-misner/","name":"Elizabeth Misner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-selvin","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-selvin/","name":"Elizabeth Selvin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2016/08/01/vitamine-d-en-incidentie-van-atriumfibrilleren-de-aric-studie/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elke-platz","type":"person","url":"https://hartvaat.nl/mensen/elke-platz/","name":"Elke Platz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ellen-mcerlean","type":"person","url":"https://hartvaat.nl/mensen/ellen-mcerlean/","name":"Ellen McErlean","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/10/01/crp-op-lp-a-geassocieerd-cv-risico-bij-optimaal-behandelde-hoogrisicopatienten/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emanuela-falaschetti","type":"person","url":"https://hartvaat.nl/mensen/emanuela-falaschetti/","name":"Emanuela Falaschetti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2018/10/01/ochtend-versus-avonddosering-van-antihypertensiva-gerandomiseerde-crossover-tria/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/11/07/ace-remmer-en-groeisnelheid-van-kleine-abdominale-aorta-aneurysmata-gerandomisee/","published":"2016-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emanuele-bertaglia","type":"person","url":"https://hartvaat.nl/mensen/emanuele-bertaglia/","name":"Emanuele Bertaglia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emanuele-spina","type":"person","url":"https://hartvaat.nl/mensen/emanuele-spina/","name":"Emanuele Spina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emily-oken","type":"person","url":"https://hartvaat.nl/mensen/emily-oken/","name":"Emily Oken","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emily-p-zeitler","type":"person","url":"https://hartvaat.nl/mensen/emily-p-zeitler/","name":"Emily P Zeitler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/07/zorgpaden-na-nieuw-vastgesteld-atriumfibrilleren-rol-van-de-elektrofysioloog-en-/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2022/11/22/athena-subanalyse-dronedaron-effectief-ongeacht-leeftijd-en-geslacht-bij-af/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2017/05/16/comorbiditeiten-en-crt-respons-madit-crt-langetermijnfollow-up/","published":"2017-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emma-copland","type":"person","url":"https://hartvaat.nl/mensen/emma-copland/","name":"Emma Copland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emmanouil-s-brilakis","type":"person","url":"https://hartvaat.nl/mensen/emmanouil-s-brilakis/","name":"Emmanouil S Brilakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/10/13/ffr-geleide-versus-angiografie-geleide-revascularisatie-meta-analyse-van-rct-s/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emmanuel-teiger","type":"person","url":"https://hartvaat.nl/mensen/emmanuel-teiger/","name":"Emmanuel Teiger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emmanuelle-vidal-petiot","type":"person","url":"https://hartvaat.nl/mensen/emmanuelle-vidal-petiot/","name":"Emmanuelle Vidal-Petiot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/creatinine-cystatine-c-of-beide-voor-gfr-schatting-bij-niertransplantatiepatient/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/12/26/pth-suppressieprofielen-na-orale-calciumbelasting-bij-niertransplantatiepatiente/","published":"2025-12-26"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrico-ammirati","type":"person","url":"https://hartvaat.nl/mensen/enrico-ammirati/","name":"Enrico Ammirati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/06/natuurlijk-beloop-van-histologisch-bewezen-acute-eosinofiele-myocarditis/","published":"2026-02-06"},{"url":"https://hartvaat.nl/2026/01/05/klinisch-spectrum-van-parvovirus-b19-geassocieerde-acute-myocarditis-bij-kindere/","published":"2026-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrico-romagnoli","type":"person","url":"https://hartvaat.nl/mensen/enrico-romagnoli/","name":"Enrico Romagnoli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/21/permanente-pacemaker-na-tavi-langetermijneffect-op-klinische-uitkomsten/","published":"2022-07-21"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrico-tartaglia","type":"person","url":"https://hartvaat.nl/mensen/enrico-tartaglia/","name":"Enrico Tartaglia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/prognose-takotsubo-syndroom-versus-hartfalen-op-de-lange-termijn/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2024/08/03/device-algoritmen-voor-rv-pacingminimalisatie-meta-analyse-van-uitkomsten/","published":"2024-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrique-gomez-gracia","type":"person","url":"https://hartvaat.nl/mensen/enrique-gomez-gracia/","name":"Enrique Gómez-Gracia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enzo-lusebrink","type":"person","url":"https://hartvaat.nl/mensen/enzo-lusebrink/","name":"Enzo Lüsebrink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ephraim-b-winzer","type":"person","url":"https://hartvaat.nl/mensen/ephraim-b-winzer/","name":"Ephraim B Winzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2022/10/01/verschillende-trainingsvormen-en-hdl-functie-bij-hfpef-optimex-substudie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eraldo-occhetta","type":"person","url":"https://hartvaat.nl/mensen/eraldo-occhetta/","name":"Eraldo Occhetta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2020/02/01/crt-bij-verlengd-av-interval-real-crt-gerandomiseerde-trial/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2018/12/01/av-junctieablatie-plus-crt-bij-permanent-af-gerandomiseerde-trial/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ercole-vellone","type":"person","url":"https://hartvaat.nl/mensen/ercole-vellone/","name":"Ercole Vellone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/27/frailte-versnelt-hartfalenprogressie-en-vermindert-therapietolerantie/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2021/08/01/motivational-interviewing-en-zorggebruik-en-mortaliteit-bij-hf-motivate-hf/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/06/01/motivational-interviewing-bij-hartfalen-voor-zelfzorg-motivate-hf-gerandomiseerd/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erhan-tenekecioglu","type":"person","url":"https://hartvaat.nl/mensen/erhan-tenekecioglu/","name":"Erhan Tenekecioglu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-a-finkelstein","type":"person","url":"https://hartvaat.nl/mensen/eric-a-finkelstein/","name":"Eric A Finkelstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/02/20/community-interventie-voor-hypertensie-in-ruraal-zuid-azie-nejm/","published":"2020-02-20"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-b-larson","type":"person","url":"https://hartvaat.nl/mensen/eric-b-larson/","name":"Eric B Larson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/01/bloed-hersenbarriere-kruisende-raas-middelen-en-cognitie-bij-ouderen-meta-analys/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-l-eisenstein","type":"person","url":"https://hartvaat.nl/mensen/eric-l-eisenstein/","name":"Eric L Eisenstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-vittinghoff","type":"person","url":"https://hartvaat.nl/mensen/eric-vittinghoff/","name":"Eric Vittinghoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/intensieve-bloeddrukcontrole-en-geleidingsziekten-sprint-post-hoc-analyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2016/03/15/voorspelling-van-persisterende-lv-disfunctie-na-myocardinfarct-de-predicts-studi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erica-s-spatz","type":"person","url":"https://hartvaat.nl/mensen/erica-s-spatz/","name":"Erica S Spatz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/02/gezamenlijke-besluitvorming-bij-percutane-linker-atriumoorsluiting/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2017/07/01/heterogeniteit-in-vroege-respons-op-antihypertensiva-allhat/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erin-morton","type":"person","url":"https://hartvaat.nl/mensen/erin-morton/","name":"Erin Morton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eugene-yang","type":"person","url":"https://hartvaat.nl/mensen/eugene-yang/","name":"Eugene Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/15/aspirine-voor-primaire-preventie-bij-verhoogd-lp-a-of-lpa-varianten-levert-geen-/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/11/04/risicobeoordeling-voor-bloeddrukmanagement-begeleidend-document/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/09/16/risicobeoordeling-voor-bloeddrukmanagement-bij-primaire-preventie/","published":"2025-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-muehlhofer","type":"person","url":"https://hartvaat.nl/mensen/eva-muehlhofer/","name":"Eva Muehlhofer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2021/07/01/cv-gevolgen-van-stoppen-met-laaggedoseerd-rivaroxaban-bij-chronisch-vaatlijden/","published":"2021-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evan-a-stein","type":"person","url":"https://hartvaat.nl/mensen/evan-a-stein/","name":"Evan A Stein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/lerodalcibep-bij-ascvd-of-hoog-risico-fase-3-resultaten/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2017/08/29/rosuvastatine-bij-kinderen-met-homozygote-familiaire-hypercholesterolemie/","published":"2017-08-29"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evangelos-liberopoulos","type":"person","url":"https://hartvaat.nl/mensen/evangelos-liberopoulos/","name":"Evangelos Liberopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evelien-kolkman","type":"person","url":"https://hartvaat.nl/mensen/evelien-kolkman/","name":"Evelien Kolkman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"f-gerry-r-fowkes","type":"person","url":"https://hartvaat.nl/mensen/f-gerry-r-fowkes/","name":"F Gerry R Fowkes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"f-russell-quinn","type":"person","url":"https://hartvaat.nl/mensen/f-russell-quinn/","name":"F Russell Quinn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2021/06/01/implanteerbare-versus-verlengde-externe-ecg-monitoring-voor-af-na-ischemisch-cva/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/screening-op-af-bij-ouderen-jama-cardiology-gerandomiseerde-trial/","published":"2021-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"f-a","type":"person","url":"https://hartvaat.nl/mensen/f-a/","name":"F. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/10/risicostratificatie-bij-longembolie-hoe-bruikbaar-zijn-de-huidige-instrumenten/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/02/10/welke-hartfalenpatienten-ontwikkelen-ernstige-mitralisinsufficientie-voorspellen/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2026/01/27/minimaal-invasieve-mitralisklepchirurgie-sneller-herstel-even-veilig-als-de-conv/","published":"2026-01-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabian-voss","type":"person","url":"https://hartvaat.nl/mensen/fabian-voss/","name":"Fabian Voss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabrizio-ugo","type":"person","url":"https://hartvaat.nl/mensen/fabrizio-ugo/","name":"Fabrizio Ugo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fan-jiang","type":"person","url":"https://hartvaat.nl/mensen/fan-jiang/","name":"Fan Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fang-wang","type":"person","url":"https://hartvaat.nl/mensen/fang-wang/","name":"Fang Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/06/vereenvoudigde-linkervoorhoofdaanhangsel-occlusie-onder-fluoroscopie-met-watchma/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/05/15/verhoogde-albuminurie-drijft-hypercholesterolemie-bij-patienten-met-het-syndroom/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/05/25/explorer-cn-week-78-langetermijneffect-en-veiligheid-van-mavacamten-bij-chinese-/","published":"2026-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"faouzi-kallel","type":"person","url":"https://hartvaat.nl/mensen/faouzi-kallel/","name":"Faouzi Kallel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"farooq-h-sheikh","type":"person","url":"https://hartvaat.nl/mensen/farooq-h-sheikh/","name":"Farooq H Sheikh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/05/27/vutrisiran-bij-attr-cm-impact-van-hartfalenernst-op-effectiviteit/","published":"2025-05-27"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fausto-feres","type":"person","url":"https://hartvaat.nl/mensen/fausto-feres/","name":"Fausto Feres","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/14/dapt-duur-na-pci-bij-hoog-bloedingsrisico-meta-analyse-van-rct-s/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federica-ferrari","type":"person","url":"https://hartvaat.nl/mensen/federica-ferrari/","name":"Federica Ferrari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-de-santis","type":"person","url":"https://hartvaat.nl/mensen/federico-de-santis/","name":"Federico De Santis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-mazzacane","type":"person","url":"https://hartvaat.nl/mensen/federico-mazzacane/","name":"Federico Mazzacane","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-pappalardo","type":"person","url":"https://hartvaat.nl/mensen/federico-pappalardo/","name":"Federico Pappalardo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/04/29/vroege-iabp-bij-hartfalen-gerelateerde-cardiogene-shock-gerandomiseerde-trial/","published":"2025-04-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feifeng-liu","type":"person","url":"https://hartvaat.nl/mensen/feifeng-liu/","name":"Feifeng Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fengxiang-zhang","type":"person","url":"https://hartvaat.nl/mensen/fengxiang-zhang/","name":"Fengxiang Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/04/pvi-met-versus-zonder-lineaire-ablatie-bij-persisterend-af-gerandomiseerde-trial/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2024/03/01/svc-isolatie-bij-paroxysmaal-af-zonder-geinduceerde-svc-aritmieen/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fernando-bacal","type":"person","url":"https://hartvaat.nl/mensen/fernando-bacal/","name":"Fernando Bacal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fernando-j-martinez","type":"person","url":"https://hartvaat.nl/mensen/fernando-j-martinez/","name":"Fernando J Martinez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fernando-lanas","type":"person","url":"https://hartvaat.nl/mensen/fernando-lanas/","name":"Fernando Lanas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"filipe-a-moura","type":"person","url":"https://hartvaat.nl/mensen/filipe-a-moura/","name":"Filipe A Moura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"filippo-pigazzani","type":"person","url":"https://hartvaat.nl/mensen/filippo-pigazzani/","name":"Filippo Pigazzani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2018/05/01/farmacogenomisch-gestuurd-antiplaatjestherapie-bij-acs-pharmclo-trial/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"firas-zahr","type":"person","url":"https://hartvaat.nl/mensen/firas-zahr/","name":"Firas Zahr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/apture-shunt-verlaagt-hartfalen-heropnames-bij-patienten-met-hfpef-hfmref-alt-fl/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flavien-vincent","type":"person","url":"https://hartvaat.nl/mensen/flavien-vincent/","name":"Flavien Vincent","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flemming-h-steffensen","type":"person","url":"https://hartvaat.nl/mensen/flemming-h-steffensen/","name":"Flemming H Steffensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florian-krackhardt","type":"person","url":"https://hartvaat.nl/mensen/florian-krackhardt/","name":"Florian Krackhardt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fotini-iatridi","type":"person","url":"https://hartvaat.nl/mensen/fotini-iatridi/","name":"Fotini Iatridi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/29/cardiovasculaire-ziekte-blijft-leidend-na-niertransplantatie-overzicht-van-uitda/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2026/01/27/aldosteronsynthase-remmers-bij-ongecontroleerde-en-resistente-hypertensie-bij-ck/","published":"2026-01-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesca-bernocchi","type":"person","url":"https://hartvaat.nl/mensen/francesca-bernocchi/","name":"Francesca Bernocchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesca-gabriele","type":"person","url":"https://hartvaat.nl/mensen/francesca-gabriele/","name":"Francesca Gabriele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesca-mallamaci","type":"person","url":"https://hartvaat.nl/mensen/francesca-mallamaci/","name":"Francesca Mallamaci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/08/01/sympathische-zenuwactivatie-bij-essentiele-hypertensie-meta-analyse/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-cannata","type":"person","url":"https://hartvaat.nl/mensen/francesco-cannata/","name":"Francesco Cannata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-giorgino","type":"person","url":"https://hartvaat.nl/mensen/francesco-giorgino/","name":"Francesco Giorgino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2021/08/14/tirzepatide-versus-insuline-degludec-bij-diabetes-type-2-lancet-surpass-3/","published":"2021-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-mele","type":"person","url":"https://hartvaat.nl/mensen/francesco-mele/","name":"Francesco Mele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-pentimalli","type":"person","url":"https://hartvaat.nl/mensen/francesco-pentimalli/","name":"Francesco Pentimalli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2018/12/01/av-junctieablatie-plus-crt-bij-permanent-af-gerandomiseerde-trial/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-tomassini","type":"person","url":"https://hartvaat.nl/mensen/francesco-tomassini/","name":"Francesco Tomassini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-vitali","type":"person","url":"https://hartvaat.nl/mensen/francesco-vitali/","name":"Francesco Vitali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francis-e-marchlinski","type":"person","url":"https://hartvaat.nl/mensen/francis-e-marchlinski/","name":"Francis E Marchlinski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/12/01/rivaroxaban-versus-vka-bij-periprocedurele-antistolling-rond-af-ablatie/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-b-hu","type":"person","url":"https://hartvaat.nl/mensen/frank-b-hu/","name":"Frank B Hu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/25/glp-1-agonisten-en-gezonde-leefstijl-samen-sterker-tegen-hart-en-vaatziekten/","published":"2026-03-08"},{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2019/04/09/rood-vlees-en-cardiovasculaire-risicofactoren-meta-analyse-van-gerandomiseerde-t/","published":"2019-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-smart","type":"person","url":"https://hartvaat.nl/mensen/frank-smart/","name":"Frank Smart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"franz-weidinger","type":"person","url":"https://hartvaat.nl/mensen/franz-weidinger/","name":"Franz Weidinger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/competenties-na-certificering-en-cardiovasculaire-zorgverlening/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/11/01/emmy-empagliflozine-na-acuut-myocardinfarct-verbetert-nt-probnp-en-remodelling/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederic-bouisset","type":"person","url":"https://hartvaat.nl/mensen/frederic-bouisset/","name":"Frederic Bouisset","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederic-sacher","type":"person","url":"https://hartvaat.nl/mensen/frederic-sacher/","name":"Frederic Sacher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/01/ventriculaire-aritmieen-na-lvad-implantatie-meta-analyse/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederick-k-kamanu","type":"person","url":"https://hartvaat.nl/mensen/frederick-k-kamanu/","name":"Frederick K Kamanu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederick-l-ruberg","type":"person","url":"https://hartvaat.nl/mensen/frederick-l-ruberg/","name":"Frederick L Ruberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/27/multimodaal-ai-model-verhoogt-accuratesse-van-echo-diagnose-cardiale-amyloidose/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/02/10/2025-acc-attr-cm-evaluatie-en-management-beknopte-klinische-richtlijn/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2018/10/01/atriumfibrilleren-bij-wild-type-transthyretine-cardiale-amyloidose-review/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederico-monfardini","type":"person","url":"https://hartvaat.nl/mensen/frederico-monfardini/","name":"Frederico Monfardini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frieder-braunschweig","type":"person","url":"https://hartvaat.nl/mensen/frieder-braunschweig/","name":"Frieder Braunschweig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/08/03/dagontslag-versus-overnachting-na-af-ablatie-uitgebreide-meta-analyse/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2023/07/04/cognitieve-gedragstherapie-verbetert-kwaliteit-van-leven-bij-symptomatisch-af/","published":"2023-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frits-h-a-f-de-man","type":"person","url":"https://hartvaat.nl/mensen/frits-h-a-f-de-man/","name":"Frits H A F de Man","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"g-p","type":"person","url":"https://hartvaat.nl/mensen/g-p/","name":"G. P.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/22/een-op-de-tien-volwassenen-met-een-aangeboren-hartafwijking-heeft-een-syndroom-e/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/03/25/waarom-de-sterfte-na-een-hartinfarct-daalde-15-jaar-nationale-data-uit-engeland-/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabor-bogats","type":"person","url":"https://hartvaat.nl/mensen/gabor-bogats/","name":"Gabor Bogáts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriel-paiva-da-silva-lima","type":"person","url":"https://hartvaat.nl/mensen/gabriel-paiva-da-silva-lima/","name":"Gabriel Paiva da Silva Lima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriel-sayer","type":"person","url":"https://hartvaat.nl/mensen/gabriel-sayer/","name":"Gabriel Sayer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriele-prandin","type":"person","url":"https://hartvaat.nl/mensen/gabriele-prandin/","name":"Gabriele Prandin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gail-hogan","type":"person","url":"https://hartvaat.nl/mensen/gail-hogan/","name":"Gail Hogan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gaku-nakazawa","type":"person","url":"https://hartvaat.nl/mensen/gaku-nakazawa/","name":"Gaku Nakazawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2017/11/07/optische-frequentiedomeinbeeldvorming-versus-ivus-bij-pci-opinion-trial/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gallego","type":"person","url":"https://hartvaat.nl/mensen/gallego/","name":"Gallego","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/26/routine-huisarts-emd-voorspelt-5-jaars-cardiovasculair-risico-betrouwbaar-austra/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/03/25/aortacoarctatie-voorspelt-langetermijnmorbiditeit-na-de-arteriele-switchoperatie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gang-tian","type":"person","url":"https://hartvaat.nl/mensen/gang-tian/","name":"Gang Tian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/12/31/inter-enkel-bloeddrukverschil-correleert-met-microalbuminurie-bij-hypertensiepat/","published":"2026-08-17"},{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gang-yang","type":"person","url":"https://hartvaat.nl/mensen/gang-yang/","name":"Gang Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/05/07/aanvullende-substraatmodificatie-bij-persisterend-af-met-low-voltage-gebieden/","published":"2025-05-07"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-na-acuut-mi-meta-analyse/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gary-a-ford","type":"person","url":"https://hartvaat.nl/mensen/gary-a-ford/","name":"Gary A Ford","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gemma-pelargonio","type":"person","url":"https://hartvaat.nl/mensen/gemma-pelargonio/","name":"Gemma Pelargonio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2022/07/21/permanente-pacemaker-na-tavi-langetermijneffect-op-klinische-uitkomsten/","published":"2022-07-21"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gemma-vilahur","type":"person","url":"https://hartvaat.nl/mensen/gemma-vilahur/","name":"Gemma Vilahur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/03/06/metabool-cardiovasculair-risico-nieuwe-mechanismen-en-therapiekansen/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"genfu-tang","type":"person","url":"https://hartvaat.nl/mensen/genfu-tang/","name":"Genfu Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gennaro-galasso","type":"person","url":"https://hartvaat.nl/mensen/gennaro-galasso/","name":"Gennaro Galasso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2016/08/16/intracoronair-abciximab-bij-diabetespatienten-met-primaire-pci-1-jaarsresultaten/","published":"2016-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georg-hansmann","type":"person","url":"https://hartvaat.nl/mensen/georg-hansmann/","name":"Georg Hansmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2016/05/01/genetische-diagnostiek-en-biomarkers-bij-pediatrische-pulmonale-hypertensie-expe/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/05/01/cardiale-mri-en-ct-bij-kinderen-met-pulmonale-hypertensie-expertconsensus/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georg-nickenig","type":"person","url":"https://hartvaat.nl/mensen/georg-nickenig/","name":"Georg Nickenig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georg-noelker","type":"person","url":"https://hartvaat.nl/mensen/georg-noelker/","name":"Georg Noelker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2017/03/07/contractiliteitssensor-geleide-crt-optimalisatie-respond-crt-trial/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georg-nolker","type":"person","url":"https://hartvaat.nl/mensen/georg-nolker/","name":"Georg Nölker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/08/redo-firm-firm-geleide-ablatie-verbetert-uitkomst-niet-bij-recidief-af/","published":"2023-02-08"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georgina-buck","type":"person","url":"https://hartvaat.nl/mensen/georgina-buck/","name":"Georgina Buck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/21/amalfi-remote-screening-voor-asymptomatisch-af-gerandomiseerde-trial/","published":"2025-10-21"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georgios-j-vlachojannis","type":"person","url":"https://hartvaat.nl/mensen/georgios-j-vlachojannis/","name":"Georgios J Vlachojannis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerald-clesham","type":"person","url":"https://hartvaat.nl/mensen/gerald-clesham/","name":"Gerald Clesham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geraldine-mendizabal","type":"person","url":"https://hartvaat.nl/mensen/geraldine-mendizabal/","name":"Geraldine Mendizabal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/05/orale-pcsk9-remmer-enlicitide-verlaagt-ldl-met-57-placebogecontroleerde-trial/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/13/enlicitide-orale-pcsk9-remmer-bij-heterozygote-fh-fase-3/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2023/04/25/mk-0616-eerste-orale-pcsk9-remmer-in-fase-2b/","published":"2023-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerrit-anne-van-es","type":"person","url":"https://hartvaat.nl/mensen/gerrit-anne-van-es/","name":"Gerrit Anne van Es","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"},{"url":"https://hartvaat.nl/2016/01/14/bioresorbeerbare-versus-metallic-everolimus-eluting-stent-bij-stemi-gerandomisee/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gert-j-de-borst","type":"person","url":"https://hartvaat.nl/mensen/gert-j-de-borst/","name":"Gert J de Borst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/macrofaagbelasting-in-carotisplaque-voorspelt-cardiovasculaire-events-na-endarte/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ghil-schwarz","type":"person","url":"https://hartvaat.nl/mensen/ghil-schwarz/","name":"Ghil Schwarz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gi-byoung-nam","type":"person","url":"https://hartvaat.nl/mensen/gi-byoung-nam/","name":"Gi-Byoung Nam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giacomo-pucci","type":"person","url":"https://hartvaat.nl/mensen/giacomo-pucci/","name":"Giacomo Pucci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2016/02/01/betablokkers-met-en-zonder-vasodilaterende-eigenschappen-en-centrale-bloeddruk-m/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giampaolo-niccoli","type":"person","url":"https://hartvaat.nl/mensen/giampaolo-niccoli/","name":"Giampaolo Niccoli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/30/tijdstrends-in-complicaties-van-bioresorbeerbare-versus-metallic-stents/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gian-battista-chierchia","type":"person","url":"https://hartvaat.nl/mensen/gian-battista-chierchia/","name":"Gian-Battista Chierchia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2021/12/07/minimaal-onderbroken-versus-continue-doac-bij-af-ablatie-meta-analyse/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianpaolo-reboldi","type":"person","url":"https://hartvaat.nl/mensen/gianpaolo-reboldi/","name":"Gianpaolo Reboldi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/09/01/intensievere-versus-minder-intensieve-bloeddrukverlaging-cumulatief-bewijs-en-tr/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/04/01/prognostisch-effect-van-nachtelijke-bloeddrukdaling-bij-hypertensie-de-abc-h-stu/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gilbert-h-l-tang","type":"person","url":"https://hartvaat.nl/mensen/gilbert-h-l-tang/","name":"Gilbert H L Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gina-m-peloso","type":"person","url":"https://hartvaat.nl/mensen/gina-m-peloso/","name":"Gina M Peloso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/04/genetisch-bevestigde-familiaire-hypercholesterolemie-in-de-vs-prevalentie-en-ond/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2024/04/01/lp-a-en-hscrp-als-cv-risicofactoren-primaire-en-secundaire-preventie/","published":"2024-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanna-viticchi","type":"person","url":"https://hartvaat.nl/mensen/giovanna-viticchi/","name":"Giovanna Viticchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-di-mauro","type":"person","url":"https://hartvaat.nl/mensen/giovanni-di-mauro/","name":"Giovanni Di Mauro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-frisullo","type":"person","url":"https://hartvaat.nl/mensen/giovanni-frisullo/","name":"Giovanni Frisullo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-landoni","type":"person","url":"https://hartvaat.nl/mensen/giovanni-landoni/","name":"Giovanni Landoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2025/10/28/prince-remote-ischemische-preconditionering-en-myocardletsel-bij-niet-cardiale-c/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-luca-botto","type":"person","url":"https://hartvaat.nl/mensen/giovanni-luca-botto/","name":"Giovanni Luca Botto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2020/02/01/crt-bij-verlengd-av-interval-real-crt-gerandomiseerde-trial/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-merlino","type":"person","url":"https://hartvaat.nl/mensen/giovanni-merlino/","name":"Giovanni Merlino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"girish-n-nadkarni","type":"person","url":"https://hartvaat.nl/mensen/girish-n-nadkarni/","name":"Girish N Nadkarni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2016/02/04/risicoprojectie-voor-nierfalen-bij-levende-nierdonorkandidaten/","published":"2016-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulia-bugani","type":"person","url":"https://hartvaat.nl/mensen/giulia-bugani/","name":"Giulia Bugani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-biondi-zoccai","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-biondi-zoccai/","name":"Giuseppe Biondi Zoccai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2024/03/19/nierschade-na-minimale-contrasttoediening-bij-acs/","published":"2024-03-19"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-ciconte","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-ciconte/","name":"Giuseppe Ciconte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-reale","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-reale/","name":"Giuseppe Reale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-rinaldi","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-rinaldi/","name":"Giuseppe Rinaldi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-scopelliti","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-scopelliti/","name":"Giuseppe Scopelliti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gordon-guyatt","type":"person","url":"https://hartvaat.nl/mensen/gordon-guyatt/","name":"Gordon Guyatt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/27/veiligheid-van-pcsk9-remmers-systematische-review-en-meta-analyse/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/12/01/predictieve-modellen-voor-cv-en-renale-uitkomsten-bij-diabetes-type-2-meta-analy/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"goutham-rao","type":"person","url":"https://hartvaat.nl/mensen/goutham-rao/","name":"Goutham Rao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/01/cultureel-aangepaste-leefstijlinterventie-voor-zuid-aziatische-volwassenen-met-c/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gracjan-iwanek","type":"person","url":"https://hartvaat.nl/mensen/gracjan-iwanek/","name":"Gracjan Iwanek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/26/machine-learning-voorspelt-diureticumrespons-bij-acuut-hartfalen-drc-ahf/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/05/26/adipokineprofiel-bij-acuut-hartfalen-voorspelt-natriuretische-respons-en-mortali/","published":"2026-05-30"},{"url":"https://hartvaat.nl/2025/12/01/gelijktijdige-griep-en-rsv-vaccinatie-bij-hoogrisico-hartfalenpatienten/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"graeme-j-hankey","type":"person","url":"https://hartvaat.nl/mensen/graeme-j-hankey/","name":"Graeme J Hankey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-m-t-hare","type":"person","url":"https://hartvaat.nl/mensen/gregory-m-t-hare/","name":"Gregory M T Hare","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/01/restrictieve-versus-liberale-transfusie-bij-hartchirurgie-meta-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-piazza","type":"person","url":"https://hartvaat.nl/mensen/gregory-piazza/","name":"Gregory Piazza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/longembolie-epidemiologie-stijgende-last-bij-vergrijzing-preventiestrategieen-bl/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2020/03/07/alert-gebaseerde-beslissingsondersteuning-voor-anticoagulatie-bij-af-in-het-ziek/","published":"2020-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gretchen-heizer","type":"person","url":"https://hartvaat.nl/mensen/gretchen-heizer/","name":"Gretchen Heizer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"grewal","type":"person","url":"https://hartvaat.nl/mensen/grewal/","name":"Grewal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/01/23/etnische-verschillen-in-aortadiameters-indiase-versus-nederlandse-patienten-amst/","published":"2026-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"grzegorz-opolski","type":"person","url":"https://hartvaat.nl/mensen/grzegorz-opolski/","name":"Grzegorz Opolski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guangping-li","type":"person","url":"https://hartvaat.nl/mensen/guangping-li/","name":"Guangping Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/17/option-indobufen-als-aspirine-alternatief-in-dapt-na-pci/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/01/04/sglt2-remmers-en-plotse-hartdood-ventriculaire-aritmie-meta-analyse/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2016/05/01/mineralocorticoidreceptorantagonisten-en-atriumfibrilleren-meta-analyse/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guangxiao-li","type":"person","url":"https://hartvaat.nl/mensen/guangxiao-li/","name":"Guangxiao Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guillaume-bobrie","type":"person","url":"https://hartvaat.nl/mensen/guillaume-bobrie/","name":"Guillaume Bobrie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/10/01/sequentiele-nefronblokkade-met-gecombineerde-diuretica-bij-resistente-hypertensi/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guillaume-lecorps","type":"person","url":"https://hartvaat.nl/mensen/guillaume-lecorps/","name":"Guillaume Lecorps","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/07/09/alirocumab-en-mortaliteit-na-acs-odyssey-outcomes-analyse/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2019/02/05/alirocumab-vermindert-totale-niet-fatale-cv-en-fatale-events-odyssey-outcomes/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/11/29/alirocumab-en-cardiovasculaire-uitkomsten-na-acs-nejm-odyssey-outcomes/","published":"2018-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guillaume-leurent","type":"person","url":"https://hartvaat.nl/mensen/guillaume-leurent/","name":"Guillaume Leurent","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/22/m-teer-werkt-over-het-volledige-lvef-spectrum-vergroot-linkeratrium-volume-voors/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guillaume-marquis-gravel","type":"person","url":"https://hartvaat.nl/mensen/guillaume-marquis-gravel/","name":"Guillaume Marquis-Gravel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guofang-chen","type":"person","url":"https://hartvaat.nl/mensen/guofang-chen/","name":"Guofang Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gyung-min-park","type":"person","url":"https://hartvaat.nl/mensen/gyung-min-park/","name":"Gyung-Min Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gotz-thomalla","type":"person","url":"https://hartvaat.nl/mensen/gotz-thomalla/","name":"Götz Thomalla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hadi-skouri","type":"person","url":"https://hartvaat.nl/mensen/hadi-skouri/","name":"Hadi Skouri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hae-young-lee","type":"person","url":"https://hartvaat.nl/mensen/hae-young-lee/","name":"Hae-Young Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/harttransplantatie-bij-hoogste-urgentie-meer-vroege-infecties-en-sterfte-mede-do/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2017/01/01/sacubitril-valsartan-en-natriurese-diurese-en-bloeddruk-bij-zoutgevoelige-hypert/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"haidong-zhu","type":"person","url":"https://hartvaat.nl/mensen/haidong-zhu/","name":"Haidong Zhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/07/01/natriumreductie-verhoogt-korte-keten-vetzuren-bij-onbehandelde-hypertensie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/07/01/natriumreductie-metaboloom-en-cv-risico-bij-onbehandelde-zwarte-hypertensie/","published":"2019-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hanbit-park","type":"person","url":"https://hartvaat.nl/mensen/hanbit-park/","name":"Hanbit Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hani-jneid","type":"person","url":"https://hartvaat.nl/mensen/hani-jneid/","name":"Hani Jneid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/finerenon-plus-sglt2-remmer-additief-cardiorenal-voordeel-bij-diabetische-nierzi/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2022/10/13/ffr-geleide-versus-angiografie-geleide-revascularisatie-meta-analyse-van-rct-s/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hanna-lagstrom","type":"person","url":"https://hartvaat.nl/mensen/hanna-lagstrom/","name":"Hanna Lagström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/strip-20-jaarsresultaten-van-dieetinterventie-vanaf-de-zuigelingenleeftijd/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hanna-szwed","type":"person","url":"https://hartvaat.nl/mensen/hanna-szwed/","name":"Hanna Szwed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/10/01/antazoline-voor-snelle-cardioversie-van-paroxysmaal-af-de-anpaf-studie/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hanne-elming","type":"person","url":"https://hartvaat.nl/mensen/hanne-elming/","name":"Hanne Elming","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hannu-romppanen","type":"person","url":"https://hartvaat.nl/mensen/hannu-romppanen/","name":"Hannu Romppanen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2019/07/20/drug-coated-balloon-bij-de-novo-coronairlaesies-met-hoog-bloedingsrisico-lancet-/","published":"2019-07-20"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-j-lanz","type":"person","url":"https://hartvaat.nl/mensen/hans-j-lanz/","name":"Hans J Lanz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/05/abc-scores-voor-cva-en-bloedingsrisico-bij-af-prestatieverbetering/","published":"2019-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-l-hillege","type":"person","url":"https://hartvaat.nl/mensen/hans-l-hillege/","name":"Hans L Hillege","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-wedel","type":"person","url":"https://hartvaat.nl/mensen/hans-wedel/","name":"Hans Wedel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-dirk-dungen","type":"person","url":"https://hartvaat.nl/mensen/hans-dirk-dungen/","name":"Hans-Dirk Düngen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2019/10/24/sacubitril-valsartan-bij-hfpef-nejm-paragon-hf/","published":"2019-10-24"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-joachim-lanz","type":"person","url":"https://hartvaat.nl/mensen/hans-joachim-lanz/","name":"Hans-Joachim Lanz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harald-darius","type":"person","url":"https://hartvaat.nl/mensen/harald-darius/","name":"Harald Darius","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"},{"url":"https://hartvaat.nl/2018/09/22/aspirine-voor-primaire-preventie-bij-matig-cv-risico-lancet-arrive/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harold-snieder","type":"person","url":"https://hartvaat.nl/mensen/harold-snieder/","name":"Harold Snieder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/mendeliaanse-randomisatie-hmgcr-remming-verhoogt-diabetesrisico-andere-lipidendo/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harri-niinikoski","type":"person","url":"https://hartvaat.nl/mensen/harri-niinikoski/","name":"Harri Niinikoski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/strip-20-jaarsresultaten-van-dieetinterventie-vanaf-de-zuigelingenleeftijd/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2017/08/01/cardiometabole-determinanten-van-carotis-en-aortadistensibiliteit-van-kindertijd/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harris","type":"person","url":"https://hartvaat.nl/mensen/harris/","name":"Harris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/03/warrior-trial-intensieve-medicamenteuze-behandeling-verbetert-de-uitkomsten-niet/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/01/29/tavi-versus-afwachtend-beleid-bij-ernstige-aortastenose-groot-en-blijvend-overle/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harry-klimis","type":"person","url":"https://hartvaat.nl/mensen/harry-klimis/","name":"Harry Klimis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2020/08/01/diagnostische-nauwkeurigheid-van-handheld-ecg-devices-voor-af-community-versus-z/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hayato-tada","type":"person","url":"https://hartvaat.nl/mensen/hayato-tada/","name":"Hayato Tada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/20/hokuriku-plus-genetische-diagnose-bij-familiaire-hypercholesterolemie-verlaagt-m/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/02/28/onbeantwoorde-vragen-over-lipoproteine-a-en-atherosclerose/","published":"2026-04-02"},{"url":"https://hartvaat.nl/2026/01/30/familiaire-hypercholesterolemie-gemaskeerd-door-een-pcsk9-verlies-van-functievar/","published":"2026-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heath-adams","type":"person","url":"https://hartvaat.nl/mensen/heath-adams/","name":"Heath Adams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hee-yeol-kim","type":"person","url":"https://hartvaat.nl/mensen/hee-yeol-kim/","name":"Hee-Yeol Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heerajnarain-bulluck","type":"person","url":"https://hartvaat.nl/mensen/heerajnarain-bulluck/","name":"Heerajnarain Bulluck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/09/cangrelor-en-infarctgrootte-bij-stemi-gerandomiseerde-trial/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"},{"url":"https://hartvaat.nl/2018/06/19/cardioprotectieve-therapieen-en-area-at-risk-bij-gereperfuseerd-stemi-cmr-analys/","published":"2018-06-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helen-nguyen","type":"person","url":"https://hartvaat.nl/mensen/helen-nguyen/","name":"Helen Nguyen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/13/complete-revascularisation-evaluation-meta-analyse-van-individuele-patientdata/","published":"2025-12-13"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helena-l-chang","type":"person","url":"https://hartvaat.nl/mensen/helena-l-chang/","name":"Helena L Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helena-pereira","type":"person","url":"https://hartvaat.nl/mensen/helena-pereira/","name":"Helena Pereira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helio-halpern","type":"person","url":"https://hartvaat.nl/mensen/helio-halpern/","name":"Helio Halpern","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hemal-gada","type":"person","url":"https://hartvaat.nl/mensen/hemal-gada/","name":"Hemal Gada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hendrik-b-sager","type":"person","url":"https://hartvaat.nl/mensen/hendrik-b-sager/","name":"Hendrik B Sager","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henk-c-p-m-van-weert","type":"person","url":"https://hartvaat.nl/mensen/henk-c-p-m-van-weert/","name":"Henk C P M van Weert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/05/01/predictiemodellen-voor-af-in-de-community-meta-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/05/01/frequente-premature-atriale-contracties-en-af-hersenischemie-en-mortaliteit-meta/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2018/09/01/last-van-atriale-high-rate-episodes-en-cva-risico-systematische-review/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henk-j-g-bilo","type":"person","url":"https://hartvaat.nl/mensen/henk-j-g-bilo/","name":"Henk J G Bilo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/08/07/geintegreerd-af-management-in-de-huisartsenpraktijk-all-in-clustergerandomiseerd/","published":"2020-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henning-bundgaard","type":"person","url":"https://hartvaat.nl/mensen/henning-bundgaard/","name":"Henning Bundgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/20/kaliumverhoging-bij-hoogrisicopatienten-voor-ventriculaire-aritmieen-rct/","published":"2025-11-20"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henrik-wagner","type":"person","url":"https://hartvaat.nl/mensen/henrik-wagner/","name":"Henrik Wagner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hermann-brenner","type":"person","url":"https://hartvaat.nl/mensen/hermann-brenner/","name":"Hermann Brenner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hidehira-fukaya","type":"person","url":"https://hartvaat.nl/mensen/hidehira-fukaya/","name":"Hidehira Fukaya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/off-label-dosering-van-sacubitril-valsartan-wijdverspreid-in-de-praktijk/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"himanshu-agarwal","type":"person","url":"https://hartvaat.nl/mensen/himanshu-agarwal/","name":"Himanshu Agarwal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2024/03/05/gelijktijdige-laa-occlusie-en-tavr-bij-af-haalbaarheid/","published":"2024-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiram-g-bezerra","type":"person","url":"https://hartvaat.nl/mensen/hiram-g-bezerra/","name":"Hiram G Bezerra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroaki-shimokawa","type":"person","url":"https://hartvaat.nl/mensen/hiroaki-shimokawa/","name":"Hiroaki Shimokawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/01/gestoorde-glucosetolerantie-en-albuminurie-bij-chronisch-hf-support-trial/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroaki-takashima","type":"person","url":"https://hartvaat.nl/mensen/hiroaki-takashima/","name":"Hiroaki Takashima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroki-sakamoto","type":"person","url":"https://hartvaat.nl/mensen/hiroki-sakamoto/","name":"Hiroki Sakamoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroshi-kajio","type":"person","url":"https://hartvaat.nl/mensen/hiroshi-kajio/","name":"Hiroshi Kajio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/08/01/intensieve-bloeddrukbehandeling-bij-diabetes-type-2-zonder-intensieve-glycemisch/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/12/05/abdominale-obesitas-en-totale-mortaliteit-bij-hfpef/","published":"2017-12-05"},{"url":"https://hartvaat.nl/2017/07/01/cardiovasculair-risico-bij-diabetes-op-betablokkers/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hirotaka-shibata","type":"person","url":"https://hartvaat.nl/mensen/hirotaka-shibata/","name":"Hirotaka Shibata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/10/09/baxdrostat-bij-ongecontroleerde-en-resistente-hypertensie-effectiviteit-en-veili/","published":"2025-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroyoshi-yokoi","type":"person","url":"https://hartvaat.nl/mensen/hiroyoshi-yokoi/","name":"Hiroyoshi Yokoi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hisao-otsuki","type":"person","url":"https://hartvaat.nl/mensen/hisao-otsuki/","name":"Hisao Otsuki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"holger-reinecke","type":"person","url":"https://hartvaat.nl/mensen/holger-reinecke/","name":"Holger Reinecke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/24/axadia-afnet-8-apixaban-versus-vka-bij-af-op-hemodialyse/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hong-euy-lim","type":"person","url":"https://hartvaat.nl/mensen/hong-euy-lim/","name":"Hong Euy Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/19/fluoroscopievrije-cryoballonablatie-met-ice-begeleiding-bij-af/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/07/21/posterior-wand-isolatie-met-cryoballon-bij-persisterend-af-meerwaarde-onderzocht/","published":"2022-07-21"},{"url":"https://hartvaat.nl/2020/10/01/high-power-short-duration-ablatie-bij-af-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"horng-h-chen","type":"person","url":"https://hartvaat.nl/mensen/horng-h-chen/","name":"Horng H Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/03/01/bnp-en-cardiale-remodellering-na-mi-gerandomiseerde-trial/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hossam-shokri","type":"person","url":"https://hartvaat.nl/mensen/hossam-shokri/","name":"Hossam Shokri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"howard-d-sesso","type":"person","url":"https://hartvaat.nl/mensen/howard-d-sesso/","name":"Howard D Sesso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/01/langetermijneffect-van-cacao-extract-op-incident-hypertensie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2018/04/10/geen-verband-tussen-hartfalen-en-kankerincidentie/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2017/06/01/voedingsstatus-en-langetermijn-multivitaminegebruik-en-cv-risico-phs-ii-analyse/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hoyoun-won","type":"person","url":"https://hartvaat.nl/mensen/hoyoun-won/","name":"Hoyoun Won","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hrvoje-budincevic","type":"person","url":"https://hartvaat.nl/mensen/hrvoje-budincevic/","name":"Hrvoje Budincevic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hsien-li-kao","type":"person","url":"https://hartvaat.nl/mensen/hsien-li-kao/","name":"Hsien-Li Kao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"huihui-bao","type":"person","url":"https://hartvaat.nl/mensen/huihui-bao/","name":"Huihui Bao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/01/metabole-score-voor-visceraal-vet-en-risico-op-perifeer-arterieel-vaatlijden-bij/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"huimin-chu","type":"person","url":"https://hartvaat.nl/mensen/huimin-chu/","name":"Huimin Chu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/16/sluiting-van-het-linker-hartoor-versus-doac-s-na-longembolie/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2025/12/09/nieuw-bifasisch-pfa-systeem-versus-thermale-ablatie-bij-paroxysmaal-af/","published":"2025-12-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hung-fat-tse","type":"person","url":"https://hartvaat.nl/mensen/hung-fat-tse/","name":"Hung-Fat Tse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/13/mtmr4-modifier-heeft-tegenovergestelde-invloed-op-aritmierisico-bij-lqt1-en-lqt2/","published":"2026-06-22"},{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-b-a-menown","type":"person","url":"https://hartvaat.nl/mensen/ian-b-a-menown/","name":"Ian B A Menown","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-j-sarembock","type":"person","url":"https://hartvaat.nl/mensen/ian-j-sarembock/","name":"Ian J Sarembock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/coapt-vijfjaarsresultaten-mitraclip-duurzaam-effectief-bij-secundaire-mr/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/03/02/3-jaarsuitkomsten-van-transcatheter-mitraalklepherstel-bij-hf-coapt/","published":"2021-03-02"},{"url":"https://hartvaat.nl/2018/12/13/transcatheter-mitraalklepherstel-bij-hartfalen-nejm-coapt/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-m-kronish","type":"person","url":"https://hartvaat.nl/mensen/ian-m-kronish/","name":"Ian M Kronish","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/team-based-care-bij-hypertensie-meta-analyse-bevestigt-effectiviteit-en-kostenef/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-t-meredith","type":"person","url":"https://hartvaat.nl/mensen/ian-t-meredith/","name":"Ian T Meredith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/03/01/effect-van-aanvullende-zuurstoftoediening-op-myocardschade-bij-stemi/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"igor-sibon","type":"person","url":"https://hartvaat.nl/mensen/igor-sibon/","name":"Igor Sibon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilaria-cova","type":"person","url":"https://hartvaat.nl/mensen/ilaria-cova/","name":"Ilaria Cova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilona-kowalik","type":"person","url":"https://hartvaat.nl/mensen/ilona-kowalik/","name":"Ilona Kowalik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/10/01/antazoline-voor-snelle-cardioversie-van-paroxysmaal-af-de-anpaf-studie/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"in-ho-chae","type":"person","url":"https://hartvaat.nl/mensen/in-ho-chae/","name":"In-Ho Chae","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ingo-voigt","type":"person","url":"https://hartvaat.nl/mensen/ingo-voigt/","name":"Ingo Voigt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ira-gantz","type":"person","url":"https://hartvaat.nl/mensen/ira-gantz/","name":"Ira Gantz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irakli-khintibidze","type":"person","url":"https://hartvaat.nl/mensen/irakli-khintibidze/","name":"Irakli Khintibidze","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irbaz-hameed","type":"person","url":"https://hartvaat.nl/mensen/irbaz-hameed/","name":"Irbaz Hameed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irina-chazova","type":"person","url":"https://hartvaat.nl/mensen/irina-chazova/","name":"Irina Chazova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2016/05/26/bloeddrukverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculaire-/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/cholesterolverlaging-bij-personen-met-intermediair-risico-zonder-cardiovasculair/","published":"2016-05-26"},{"url":"https://hartvaat.nl/2016/05/26/bloeddruk-en-cholesterolverlaging-bij-personen-zonder-cardiovasculaire-ziekte-ho/","published":"2016-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iris-baumgartner","type":"person","url":"https://hartvaat.nl/mensen/iris-baumgartner/","name":"Iris Baumgartner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iris-e-beldhuis","type":"person","url":"https://hartvaat.nl/mensen/iris-e-beldhuis/","name":"Iris E Beldhuis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/25/systolische-bloeddruk-en-polsdruk-bij-hartfalen-gepoolde-ipd-analyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabel-deisenhofer","type":"person","url":"https://hartvaat.nl/mensen/isabel-deisenhofer/","name":"Isabel Deisenhofer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2025/10/31/vrouwen-met-persisterend-af-pvi-alleen-is-onvoldoende/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/08/04/zeer-hoog-vermogen-70w-rf-ablatie-met-flexibele-tip-voor-pvi-bij-af/","published":"2025-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabella-kardys","type":"person","url":"https://hartvaat.nl/mensen/isabella-kardys/","name":"Isabella Kardys","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/echocardiografie-overschatte-drukgradienten-na-tav-in-tav-met-ballon-expandable-/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/04/28/geen-sekseverschillen-in-werkzaamheid-van-hartfalenmedicatie-meta-analyse-van-13/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2016/09/27/intensieve-glucoseregulatie-bij-hyperglycemisch-acs-langetermijnfollow-up-biomar/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabella-zwiener","type":"person","url":"https://hartvaat.nl/mensen/isabella-zwiener/","name":"Isabella Zwiener","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2019/06/04/microvasculaire-ziekte-en-cv-events-bij-diabetes-type-2/","published":"2019-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabelle-nault","type":"person","url":"https://hartvaat.nl/mensen/isabelle-nault/","name":"Isabelle Nault","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isao-taguchi","type":"person","url":"https://hartvaat.nl/mensen/isao-taguchi/","name":"Isao Taguchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2020/08/01/canagliflozine-bij-diabetes-type-2-met-chronisch-hf-candle-gerandomiseerde-trial/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isla-s-mackenzie","type":"person","url":"https://hartvaat.nl/mensen/isla-s-mackenzie/","name":"Isla S Mackenzie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"issam-d-moussa","type":"person","url":"https://hartvaat.nl/mensen/issam-d-moussa/","name":"Issam D Moussa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/25/2022-acc-aha-datadefinities-voor-pijn-op-de-borst-en-acuut-myocardinfarct/","published":"2022-10-25"},{"url":"https://hartvaat.nl/2016/05/17/institutionele-en-operateurvereisten-voor-linker-hartoorocclusie-scai-acc-hrs-st/","published":"2016-05-17"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"istvan-osztheimer","type":"person","url":"https://hartvaat.nl/mensen/istvan-osztheimer/","name":"István Osztheimer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/21/eplerenon-halveert-recidief-ventriculaire-tachycardie-versus-spironolacton-bij-h/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"italo-biaggioni","type":"person","url":"https://hartvaat.nl/mensen/italo-biaggioni/","name":"Italo Biaggioni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2016/10/01/autonome-blokkade-herstelt-endotheeldisfunctie-bij-obesitasgerelateerde-hyperten/","published":"2016-10-01"},{"url":"https://hartvaat.nl/2016/02/01/mineralocorticoidreceptoractivatie-draagt-bij-aan-supiene-hypertensie-bij-autono/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"itaru-takamisawa","type":"person","url":"https://hartvaat.nl/mensen/itaru-takamisawa/","name":"Itaru Takamisawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iulia-iatan","type":"person","url":"https://hartvaat.nl/mensen/iulia-iatan/","name":"Iulia Iatan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2025/11/26/lipideveranderingen-bij-vrouwen-met-fh-tijdens-de-menopauzale-transitie/","published":"2025-11-26"},{"url":"https://hartvaat.nl/2024/09/14/sekseverschillen-in-fh-behandeling-meta-analyse/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivan-netuka","type":"person","url":"https://hartvaat.nl/mensen/ivan-netuka/","name":"Ivan Netuka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/08/06/doac-bij-heartmate-3-lvad-eerste-gerandomiseerde-trial/","published":"2024-08-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivo-bernat","type":"person","url":"https://hartvaat.nl/mensen/ivo-bernat/","name":"Ivo Bernat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-aaron-grantham","type":"person","url":"https://hartvaat.nl/mensen/j-aaron-grantham/","name":"J Aaron Grantham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/vroege-versus-late-gestageerde-pci-na-subintimale-re-entry-bij-cto/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-antonio-gutierrez","type":"person","url":"https://hartvaat.nl/mensen/j-antonio-gutierrez/","name":"J Antonio Gutierrez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/16/2021-acc-consensus-same-day-ontslag-na-pci/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/03/08/acute-ledischemie-en-vorapaxar-bij-perifeer-arterieel-vaatlijden-tra-2p-timi-50-/","published":"2016-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-stephen-jenkins","type":"person","url":"https://hartvaat.nl/mensen/j-stephen-jenkins/","name":"J Stephen Jenkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-b","type":"person","url":"https://hartvaat.nl/mensen/j-b/","name":"J. B.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/04/24/verminderde-nierfunctie-verhoogt-hartfalenrisico-bij-ouderen-aspree-cohort/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2026/01/28/risicocommunicatie-instrument-in-de-huisartsenpraktijk-verlaagt-bloeddruk-en-cho/","published":"2026-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-p","type":"person","url":"https://hartvaat.nl/mensen/j-p/","name":"J. P.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/17/niet-invasieve-endotypering-met-stress-mri-verbetert-de-behandeling-van-angina-z/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/05/26/12-leads-ecg-onderscheidt-rasopathie-hcm-van-sarcomere-hcm-bij-kinderen-superieu/","published":"2026-07-04"},{"url":"https://hartvaat.nl/2026/01/06/machine-learning-algoritme-mi3-helpt-een-infarct-uitsluiten-bij-een-onduidelijke/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-s","type":"person","url":"https://hartvaat.nl/mensen/j-s/","name":"J. S.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/03/25/geleidelijk-afbouwen-van-rilonacept-bij-recidiverende-pericarditis-voorkomt-vake/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/01/09/endocarditis-van-de-natieve-klep-verschuift-naar-ouderen-chirurgie-blijft-levens/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaap-a-joles","type":"person","url":"https://hartvaat.nl/mensen/jaap-a-joles/","name":"Jaap A Joles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/03/01/foetale-groeirestrictie-en-bloeddruk-tegenstrijdige-effecten-bij-mens-en-rat-met/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/01/01/renale-hemodynamische-effecten-van-dapagliflozine-postglomerulaire-vasodilatatie/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/11/01/sildenafil-tijdens-de-zwangerschap-preklinische-meta-analyse-over-foetale-groei-/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacqueline-saw","type":"person","url":"https://hartvaat.nl/mensen/jacqueline-saw/","name":"Jacqueline Saw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/14/residuele-lekkage-na-laa-occlusie-en-uitkomsten-meta-analyse/","published":"2024-01-14"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2018/05/08/spontane-coronaire-arterie-dissectie-aha-scientific-statement/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jae-k-oh","type":"person","url":"https://hartvaat.nl/mensen/jae-k-oh/","name":"Jae K Oh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/03/radiale-strain-geleide-leadplaatsing-voor-crt-bij-ischemisch-hf/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jakob-luker","type":"person","url":"https://hartvaat.nl/mensen/jakob-luker/","name":"Jakob Lüker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/07/hoog-vermogen-korte-duur-rf-ablatie-versus-cryoballon-bij-paroxysmaal-af-rct/","published":"2025-05-07"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2019/09/24/interne-versus-externe-cardioversie-bij-atriale-aritmieen-met-icd/","published":"2019-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-cockburn","type":"person","url":"https://hartvaat.nl/mensen/james-cockburn/","name":"James Cockburn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-e-sharman","type":"person","url":"https://hartvaat.nl/mensen/james-e-sharman/","name":"James E Sharman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/06/01/bloeddrukverlaging-bij-centrale-hypertensie-gerandomiseerde-trial/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-jin","type":"person","url":"https://hartvaat.nl/mensen/james-jin/","name":"James Jin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-p-curtain","type":"person","url":"https://hartvaat.nl/mensen/james-p-curtain/","name":"James P Curtain","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2023/05/15/implanteerbare-hemodynamische-monitoring-bij-hartfalen-meta-analyse-over-ef-spec/","published":"2023-05-15"},{"url":"https://hartvaat.nl/2021/09/21/dapagliflozine-en-ventriculaire-aritmieen-en-plotse-dood-bij-hf-dapa-hf/","published":"2021-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-p-macnamara","type":"person","url":"https://hartvaat.nl/mensen/james-p-macnamara/","name":"James P MacNamara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/12/19/synchronisatie-van-voetstap-en-hartfase-bij-crt-patienten/","published":"2023-12-19"},{"url":"https://hartvaat.nl/2023/01/31/hfpef-inspanningsbeperking-niet-alleen-door-hemodynamiek/","published":"2023-01-31"},{"url":"https://hartvaat.nl/2021/09/21/1-jaar-inspanningstraining-keert-lv-stijfheid-om-bij-stadium-b-hf/","published":"2021-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-r-edgerton","type":"person","url":"https://hartvaat.nl/mensen/james-r-edgerton/","name":"James R Edgerton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/20/2018-acc-aha-hrs-richtlijn-voor-bradycardie-en-geleidingsstoornissen/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-v-freeman","type":"person","url":"https://hartvaat.nl/mensen/james-v-freeman/","name":"James V Freeman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/02/02/gezamenlijke-besluitvorming-bij-percutane-linker-atriumoorsluiting/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-w-long","type":"person","url":"https://hartvaat.nl/mensen/james-w-long/","name":"James W Long","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jamie-kitt","type":"person","url":"https://hartvaat.nl/mensen/jamie-kitt/","name":"Jamie Kitt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-chovancik","type":"person","url":"https://hartvaat.nl/mensen/jan-chovancik/","name":"Jan Chovancik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/08/catheterablatie-versus-leefstijlmodificatie-plus-antiaritmica-bij-af-gerandomise/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-halbritter","type":"person","url":"https://hartvaat.nl/mensen/jan-halbritter/","name":"Jan Halbritter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/15/verhoogde-albuminurie-drijft-hypercholesterolemie-bij-patienten-met-het-syndroom/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/02/12/fenotype-eerst-een-datagestuurde-benadering-van-genetische-penetrantie/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/01/19/genotype-fenotypekenmerken-bij-fan1-gerelateerde-karyomegale-tubulointerstitiele/","published":"2026-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-komtebedde","type":"person","url":"https://hartvaat.nl/mensen/jan-komtebedde/","name":"Jan Komtebedde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-kristian-damas","type":"person","url":"https://hartvaat.nl/mensen/jan-kristian-damas/","name":"Jan Kristian Damås","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-westerink","type":"person","url":"https://hartvaat.nl/mensen/jan-westerink/","name":"Jan Westerink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/12/07/individueel-levenslang-voordeel-en-bloedingsrisico-van-rivaroxaban-plus-aspirine/","published":"2019-12-07"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jane-armitage","type":"person","url":"https://hartvaat.nl/mensen/jane-armitage/","name":"Jane Armitage","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jane-holmes","type":"person","url":"https://hartvaat.nl/mensen/jane-holmes/","name":"Jane Holmes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jane-sandall","type":"person","url":"https://hartvaat.nl/mensen/jane-sandall/","name":"Jane Sandall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/29/cradle-4-geplande-bevalling-versus-afwachten-bij-laat-preterm-pre-eclampsie-in-l/","published":"2023-07-29"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janina-stepinska","type":"person","url":"https://hartvaat.nl/mensen/janina-stepinska/","name":"Janina Stepinska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jari-lahti","type":"person","url":"https://hartvaat.nl/mensen/jari-lahti/","name":"Jari Lahti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaroslaw-d-kasprzak","type":"person","url":"https://hartvaat.nl/mensen/jaroslaw-d-kasprzak/","name":"Jaroslaw D Kasprzak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaroslaw-trebacz","type":"person","url":"https://hartvaat.nl/mensen/jaroslaw-trebacz/","name":"Jaroslaw Trebacz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jason-n-katz","type":"person","url":"https://hartvaat.nl/mensen/jason-n-katz/","name":"Jason N Katz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javier-botas","type":"person","url":"https://hartvaat.nl/mensen/javier-botas/","name":"Javier Botas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2018/04/14/sildenafil-bij-persisterende-pulmonale-hypertensie-na-klepchirurgie/","published":"2018-04-14"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javier-diez","type":"person","url":"https://hartvaat.nl/mensen/javier-diez/","name":"Javier Diez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javier-goicolea","type":"person","url":"https://hartvaat.nl/mensen/javier-goicolea/","name":"Javier Goicolea","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jay-young-rhew","type":"person","url":"https://hartvaat.nl/mensen/jay-young-rhew/","name":"Jay Young Rhew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-bergeron","type":"person","url":"https://hartvaat.nl/mensen/jean-bergeron/","name":"Jean Bergeron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-c-gregoire","type":"person","url":"https://hartvaat.nl/mensen/jean-c-gregoire/","name":"Jean C Grégoire","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-jacques-noubiap","type":"person","url":"https://hartvaat.nl/mensen/jean-jacques-noubiap/","name":"Jean Jacques Noubiap","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/10/09/klinische-risicofactoren-voor-cva-bij-anticoagulantie-naieve-af-meta-analyse/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2019/01/01/globale-prevalentie-van-therapieresistente-hypertensie-meta-analyse-van-3-2-milj/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-m-connors","type":"person","url":"https://hartvaat.nl/mensen/jean-m-connors/","name":"Jean M Connors","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/08/06/doac-bij-heartmate-3-lvad-eerste-gerandomiseerde-trial/","published":"2024-08-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-francois-sarrazin","type":"person","url":"https://hartvaat.nl/mensen/jean-francois-sarrazin/","name":"Jean-Francois Sarrazin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-francois-morelle","type":"person","url":"https://hartvaat.nl/mensen/jean-francois-morelle/","name":"Jean-François Morelle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-jacques-mourad","type":"person","url":"https://hartvaat.nl/mensen/jean-jacques-mourad/","name":"Jean-Jacques Mourad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-lucien-rouleau","type":"person","url":"https://hartvaat.nl/mensen/jean-lucien-rouleau/","name":"Jean-Lucien Rouleau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-paul-albenque","type":"person","url":"https://hartvaat.nl/mensen/jean-paul-albenque/","name":"Jean-Paul Albenque","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/31/vrouwen-met-persisterend-af-pvi-alleen-is-onvoldoende/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeanne-du-fay-de-lavallaz","type":"person","url":"https://hartvaat.nl/mensen/jeanne-du-fay-de-lavallaz/","name":"Jeanne du Fay de Lavallaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-klinische-uitkomsten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/04/01/clip-hfpef-cilostazol-bij-hfpef-gerandomiseerde-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/11/02/duurzaamheid-van-pvi-bij-af-meta-analyse/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-j-popma","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-j-popma/","name":"Jeffrey J Popma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/1-op-5-oudere-patienten-heeft-hartfalen-opname-binnen-jaar-na-tavr-1-jaarsmortal/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-l-saver","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-l-saver/","name":"Jeffrey L Saver","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-r-misialek","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-r-misialek/","name":"Jeffrey R Misialek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/08/01/vitamine-d-en-incidentie-van-atriumfibrilleren-de-aric-studie/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-s-healey","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-s-healey/","name":"Jeffrey S Healey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jehangir-din","type":"person","url":"https://hartvaat.nl/mensen/jehangir-din/","name":"Jehangir Din","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jei-keon-chae","type":"person","url":"https://hartvaat.nl/mensen/jei-keon-chae/","name":"Jei Keon Chae","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-hommel","type":"person","url":"https://hartvaat.nl/mensen/jennifer-hommel/","name":"Jennifer Hommel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2022/10/01/verschillende-trainingsvormen-en-hdl-functie-bij-hfpef-optimex-substudie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-m-king","type":"person","url":"https://hartvaat.nl/mensen/jennifer-m-king/","name":"Jennifer M. King","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2026/02/18/groene-dialyse-duurzame-zorg-groei-en-innovatie-kdigo-conferentie/","published":"2026-02-18"},{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-mcginniss","type":"person","url":"https://hartvaat.nl/mensen/jennifer-mcginniss/","name":"Jennifer McGinniss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-brock-johansen","type":"person","url":"https://hartvaat.nl/mensen/jens-brock-johansen/","name":"Jens Brock Johansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/10/21/minimalisatie-van-atriale-pacing-bij-sinusknoopziekte-vermindert-af/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2017/12/01/enkelvoudige-versus-tweekamer-pacing-bij-sick-sinus-syndroom-danpace-langetermij/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-dahlgaard-hove","type":"person","url":"https://hartvaat.nl/mensen/jens-dahlgaard-hove/","name":"Jens Dahlgaard Hove","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-kristensen","type":"person","url":"https://hartvaat.nl/mensen/jens-kristensen/","name":"Jens Kristensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/21/minimalisatie-van-atriale-pacing-bij-sinusknoopziekte-vermindert-af/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/05/03/multimodaliteitsbeeldvorming-geleide-lv-leadplaatsing-bij-crt-langetermijn/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeong-cheon-choe","type":"person","url":"https://hartvaat.nl/mensen/jeong-cheon-choe/","name":"Jeong Cheon Choe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeremy-a-mazurek","type":"person","url":"https://hartvaat.nl/mensen/jeremy-a-mazurek/","name":"Jeremy A Mazurek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/06/01/pah-behandeling-ipd-netwerk-meta-analyse-van-alle-therapieen/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jernberg","type":"person","url":"https://hartvaat.nl/mensen/jernberg/","name":"Jernberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/21/swedeheart-na-een-eerste-hartinfarct-is-fysieke-fitheid-bij-start-cardiale-reval/","published":"2026-07-05"},{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/01/29/verminderde-pompfunctie-na-een-hartinfarct-hoge-symptoomlast-en-slechtere-secund/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeroen-schaap","type":"person","url":"https://hartvaat.nl/mensen/jeroen-schaap/","name":"Jeroen Schaap","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/14/hartfalen-mondiale-economische-ziektelast/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2025/04/01/socio-economische-ongelijkheid-en-hartfalenuitkomsten-systematische-review/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2016/01/05/ct-coronairangiografie-bij-verdenking-acs-in-het-tijdperk-van-hoog-sensitief-tro/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jerremy-weerts","type":"person","url":"https://hartvaat.nl/mensen/jerremy-weerts/","name":"Jerremy Weerts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/07/confident-hfpef-machine-learning-voorspelt-sterfte-en-opname-beter-dan-bestaande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/03/03/beeldvorming-bij-atriale-cardiomyopathie-esc-scientific-statement/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2026/03/03/spierstofwisseling-bij-hfpef-verminderde-oxidatieve-capaciteit-los-van-ijzergebr/","published":"2026-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jesper-j-linde","type":"person","url":"https://hartvaat.nl/mensen/jesper-j-linde/","name":"Jesper J Linde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jess-lambrechtsen","type":"person","url":"https://hartvaat.nl/mensen/jess-lambrechtsen/","name":"Jess Lambrechtsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"},{"url":"https://hartvaat.nl/2021/10/01/aortaklepcalcificatie-en-cv-risicofactoren-bij-oudere-deense-mannen/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jessica-r-overbey","type":"person","url":"https://hartvaat.nl/mensen/jessica-r-overbey/","name":"Jessica R Overbey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jessica-vincent","type":"person","url":"https://hartvaat.nl/mensen/jessica-vincent/","name":"Jessica Vincent","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jesus-d-melgarejo","type":"person","url":"https://hartvaat.nl/mensen/jesus-d-melgarejo/","name":"Jesus D Melgarejo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ji-yong-jang","type":"person","url":"https://hartvaat.nl/mensen/ji-yong-jang/","name":"Ji-Yong Jang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jian-chen","type":"person","url":"https://hartvaat.nl/mensen/jian-chen/","name":"Jian Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2022/02/02/cryoballon-versus-rf-bij-persisterend-af-noorse-no-pers-af-gerandomiseerde-trial/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jian-yang","type":"person","url":"https://hartvaat.nl/mensen/jian-yang/","name":"Jian Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/06/dronedaron-na-af-ablatie-gelijke-werkzaamheid-minder-bijwerkingen-dan-amiodaron/","published":"2026-05-03"},{"url":"https://hartvaat.nl/2025/12/09/nieuw-bifasisch-pfa-systeem-versus-thermale-ablatie-bij-paroxysmaal-af/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2025/10/14/heparine-bij-eerste-medisch-contact-versus-voor-primaire-pci-bij-stemi/","published":"2025-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianghao-li","type":"person","url":"https://hartvaat.nl/mensen/jianghao-li/","name":"Jianghao Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/18/orforglipron-bij-vroeg-type-2-diabetes-nejm-fase-3/","published":"2025-09-18"},{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianlong-sheng","type":"person","url":"https://hartvaat.nl/mensen/jianlong-sheng/","name":"Jianlong Sheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianzheng-liu","type":"person","url":"https://hartvaat.nl/mensen/jianzheng-liu/","name":"Jianzheng Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jicheng-lv","type":"person","url":"https://hartvaat.nl/mensen/jicheng-lv/","name":"Jicheng Lv","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/20/voorspelling-van-individuele-corticosteroidrespons-bij-iga-nefropathie-testing-t/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2026/01/20/multi-omics-onthult-pathogene-rol-van-iga-7-cellen-bij-iga-nefropathie/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jieli-lu","type":"person","url":"https://hartvaat.nl/mensen/jieli-lu/","name":"Jieli Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-won-kim","type":"person","url":"https://hartvaat.nl/mensen/jin-won-kim/","name":"Jin Won Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jinhee-ahn","type":"person","url":"https://hartvaat.nl/mensen/jinhee-ahn/","name":"Jinhee Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/19/fluoroscopievrije-cryoballonablatie-met-ice-begeleiding-bij-af/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/07/21/posterior-wand-isolatie-met-cryoballon-bij-persisterend-af-meerwaarde-onderzocht/","published":"2022-07-21"},{"url":"https://hartvaat.nl/2020/10/01/high-power-short-duration-ablatie-bij-af-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jinlong-zhang","type":"person","url":"https://hartvaat.nl/mensen/jinlong-zhang/","name":"Jinlong Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jinyu-huang","type":"person","url":"https://hartvaat.nl/mensen/jinyu-huang/","name":"Jinyu Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jinzhuo-ge","type":"person","url":"https://hartvaat.nl/mensen/jinzhuo-ge/","name":"Jinzhuo Ge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joakim-nordanstig","type":"person","url":"https://hartvaat.nl/mensen/joakim-nordanstig/","name":"Joakim Nordanstig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/05/03/semaglutide-en-loopafstand-bij-perifeer-vaatlijden-en-diabetes/","published":"2025-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joan-antoni-gomez-hospital","type":"person","url":"https://hartvaat.nl/mensen/joan-antoni-gomez-hospital/","name":"Joan Antoni Gómez-Hospital","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joan-walter","type":"person","url":"https://hartvaat.nl/mensen/joan-walter/","name":"Joan Walter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/de-troponine-i-t-ratio-bij-myocardschade-een-multicohort-synthese/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joanna-szachniewicz","type":"person","url":"https://hartvaat.nl/mensen/joanna-szachniewicz/","name":"Joanna Szachniewicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joe-cuthbert","type":"person","url":"https://hartvaat.nl/mensen/joe-cuthbert/","name":"Joe Cuthbert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/04/congestie-bij-chronisch-hartfalen-echografie-vult-klinisch-onderzoek-aan-en-voor/","published":"2026-07-01"},{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-herlitz","type":"person","url":"https://hartvaat.nl/mensen/johan-herlitz/","name":"Johan Herlitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-lassus","type":"person","url":"https://hartvaat.nl/mensen/johan-lassus/","name":"Johan Lassus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/04/18/risicostratificatie-bij-cardiogene-shock-na-acuut-myocardinfarct/","published":"2017-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-saenen","type":"person","url":"https://hartvaat.nl/mensen/johan-saenen/","name":"Johan Saenen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/02/03/kortste-af-cycluslengte-in-de-longvenen-identificeert-pvi-responders/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/12/26/gerichte-patienteneducatie-vermindert-ongeplande-cv-events-bij-af/","published":"2024-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-a-bittl","type":"person","url":"https://hartvaat.nl/mensen/john-a-bittl/","name":"John A Bittl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2016/09/06/duur-van-dapt-systematische-review-voor-de-acc-aha-gerichte-update-2016/","published":"2016-09-06"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-altman","type":"person","url":"https://hartvaat.nl/mensen/john-altman/","name":"John Altman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-attia","type":"person","url":"https://hartvaat.nl/mensen/john-attia/","name":"John Attia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/pneumokokkenvaccinatie-en-cv-eventpreventie-ipd-meta-analyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/12/16/scoff-nuchter-versus-niet-nuchter-voor-hartkatheterisatie-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2022/07/01/behandeling-van-acuut-coronair-syndroom-in-ruraal-australie-moracs-trial/","published":"2022-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-b-kostis","type":"person","url":"https://hartvaat.nl/mensen/john-b-kostis/","name":"John B Kostis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2016/11/22/management-van-klinisch-significante-geneesmiddelinteracties-met-statines-aha-aa/","published":"2016-11-22"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-g-webb","type":"person","url":"https://hartvaat.nl/mensen/john-g-webb/","name":"John G Webb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-gorcsan","type":"person","url":"https://hartvaat.nl/mensen/john-gorcsan/","name":"John Gorcsan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-j-mcneil","type":"person","url":"https://hartvaat.nl/mensen/john-j-mcneil/","name":"John J McNeil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","published":"2020-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-l-p-thompson","type":"person","url":"https://hartvaat.nl/mensen/john-l-p-thompson/","name":"John L P Thompson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/lv-dimensies-en-cv-uitkomsten-bij-systolisch-hf-warcef/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-munkhaugen","type":"person","url":"https://hartvaat.nl/mensen/john-munkhaugen/","name":"John Munkhaugen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-nord","type":"person","url":"https://hartvaat.nl/mensen/john-nord/","name":"John Nord","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-norrie","type":"person","url":"https://hartvaat.nl/mensen/john-norrie/","name":"John Norrie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-simes","type":"person","url":"https://hartvaat.nl/mensen/john-simes/","name":"John Simes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/28/lp-a-en-ldl-cholesterol-onafhankelijke-cv-risicopaden/","published":"2025-01-28"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-wikstrand","type":"person","url":"https://hartvaat.nl/mensen/john-wikstrand/","name":"John Wikstrand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johny-nicolas","type":"person","url":"https://hartvaat.nl/mensen/johny-nicolas/","name":"Johny Nicolas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonas-andersson","type":"person","url":"https://hartvaat.nl/mensen/jonas-andersson/","name":"Jonas Andersson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonas-lanz","type":"person","url":"https://hartvaat.nl/mensen/jonas-lanz/","name":"Jonas Lanz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-barratt","type":"person","url":"https://hartvaat.nl/mensen/jonathan-barratt/","name":"Jonathan Barratt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/17/albuminurie-of-proteinurie-bij-glomerulaire-ziekte-en-ckd-wat-te-gebruiken/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2026/01/28/kdigo-2026-richtlijn-anemie-bij-chronische-nierziekte-europees-commentaar/","published":"2026-01-28"},{"url":"https://hartvaat.nl/2026/01/20/multi-omics-onthult-pathogene-rol-van-iga-7-cellen-bij-iga-nefropathie/","published":"2026-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-c-hsu","type":"person","url":"https://hartvaat.nl/mensen/jonathan-c-hsu/","name":"Jonathan C Hsu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ai-gestuurde-ecg-lokalisatie-verbetert-ablatie-bij-instabiele-ventriculaire-tach/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2020/04/01/p2y12-remmers-met-oac-bij-af-na-pci-meta-analyse/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2016/04/01/orale-antistolling-bij-atriumfibrilleren-over-het-spectrum-van-beroerterisico-ga/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-e-shaw","type":"person","url":"https://hartvaat.nl/mensen/jonathan-e-shaw/","name":"Jonathan E Shaw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2020/08/01/cardiovasculaire-risicovoorspelling-bij-inheemse-australiers/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-j-deeks","type":"person","url":"https://hartvaat.nl/mensen/jonathan-j-deeks/","name":"Jonathan J Deeks","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/27/best-cli-veneuze-bypass-versus-endovasculair-bij-chronische-kritieke-ischemie/","published":"2023-05-27"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2020/05/01/predictie-van-af-recidief-na-ablatie-systematische-review-van-prognostische-mode/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-s-steinberg","type":"person","url":"https://hartvaat.nl/mensen/jonathan-s-steinberg/","name":"Jonathan S Steinberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/02/22/temporaire-ruggenmergstimulatie-ter-preventie-van-postoperatief-af/","published":"2022-02-22"},{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/21/renale-denervatie-plus-katheterablatie-versus-ablatie-alleen-bij-af-met-hyperten/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jones","type":"person","url":"https://hartvaat.nl/mensen/jones/","name":"Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/20/virtuele-afdeling-met-thuismonitoring-is-veilig-voor-patienten-die-wachten-op-sp/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2026/02/12/ct-coronairangiografie-bij-nstemi-uitstekende-diagnostische-nauwkeurigheid-maar-/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2026/01/06/biomarkers-onderscheiden-type-2-hartinfarct-nog-onvoldoende-van-type-1/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joni-j-byun","type":"person","url":"https://hartvaat.nl/mensen/joni-j-byun/","name":"Joni J Byun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jordan-a-anderson","type":"person","url":"https://hartvaat.nl/mensen/jordan-a-anderson/","name":"Jordan A Anderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorge-ferreira","type":"person","url":"https://hartvaat.nl/mensen/jorge-ferreira/","name":"Jorge Ferreira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2018/08/21/klinisch-voordeel-van-evolocumab-naar-ernst-van-coronairlijden-fourier/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorge-romero","type":"person","url":"https://hartvaat.nl/mensen/jorge-romero/","name":"Jorge Romero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"},{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorrit-s-lemkes","type":"person","url":"https://hartvaat.nl/mensen/jorrit-s-lemkes/","name":"Jorrit S Lemkes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-l-leiva-pons","type":"person","url":"https://hartvaat.nl/mensen/jose-l-leiva-pons/","name":"Jose L Leiva-Pons","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2016/08/01/eerder-clopidogrelgebruik-en-uitkomsten-bij-conservatief-behandeld-acs/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-pomar","type":"person","url":"https://hartvaat.nl/mensen/jose-pomar/","name":"Jose Pomar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/10/06/implicaties-van-alternatieve-mi-definities-na-coronaire-revascularisatie/","published":"2020-10-06"},{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/04/09/cabg-of-stenting-bij-hoofdstamlijden-bij-diabetes/","published":"2019-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josep-gomez-lara","type":"person","url":"https://hartvaat.nl/mensen/josep-gomez-lara/","name":"Josep Gomez-Lara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-g-akar","type":"person","url":"https://hartvaat.nl/mensen/joseph-g-akar/","name":"Joseph G Akar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/14/real-time-remote-monitoring-voorspelt-maligne-ventriculaire-aritmieen/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-g-rogers","type":"person","url":"https://hartvaat.nl/mensen/joseph-g-rogers/","name":"Joseph G Rogers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"},{"url":"https://hartvaat.nl/2017/02/02/intrapericardiale-lvad-bij-gevorderd-hartfalen-nejm/","published":"2017-02-02"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joshua-a-jacobs","type":"person","url":"https://hartvaat.nl/mensen/joshua-a-jacobs/","name":"Joshua A Jacobs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2023/08/01/combinatietabletten-voor-intensieve-bloeddrukbehandeling-sprint-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/07/01/leeftijdsbias-draagt-bij-aan-therapeutische-inertie-bij-bloeddrukmanagement/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joshua-c-denny","type":"person","url":"https://hartvaat.nl/mensen/joshua-c-denny/","name":"Joshua C Denny","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/22/genetische-voorspelling-van-lp-a-spiegels-in-diverse-populaties/","published":"2026-02-22"},{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joshua-d-bundy","type":"person","url":"https://hartvaat.nl/mensen/joshua-d-bundy/","name":"Joshua D Bundy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/09/20/harmonisatie-van-acc-aha-en-esc-esh-bloeddrukrichtlijnen/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2017/07/01/systolische-bloeddrukreductie-en-cv-risico-netwerkmeta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-a-joglar","type":"person","url":"https://hartvaat.nl/mensen/jose-a-joglar/","name":"José A Joglar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/08/20/2018-acc-aha-hrs-richtlijn-voor-bradycardie-en-geleidingsstoornissen/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-lapetra","type":"person","url":"https://hartvaat.nl/mensen/jose-lapetra/","name":"José Lapetra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-luis-diez-gil","type":"person","url":"https://hartvaat.nl/mensen/jose-luis-diez-gil/","name":"José Luis Díez Gil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-r-banegas","type":"person","url":"https://hartvaat.nl/mensen/jose-r-banegas/","name":"José R Banegas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2018/10/01/prognostische-waarde-van-gemaskeerd-ongecontroleerde-hypertensie/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joyce-chuang","type":"person","url":"https://hartvaat.nl/mensen/joyce-chuang/","name":"Joyce Chuang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joelle-elias","type":"person","url":"https://hartvaat.nl/mensen/joelle-elias/","name":"Joëlle Elias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-benezet-mazuecos","type":"person","url":"https://hartvaat.nl/mensen/juan-benezet-mazuecos/","name":"Juan Benezet-Mazuecos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/kosteneffectiviteit-van-apixaban-versus-aspirine-bij-hoogrisico-subclinisch-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/07/23/artesia-apixaban-versus-aspirine-naar-cha2ds2-vasc-bij-subclinisch-af/","published":"2024-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-carlos-diaz","type":"person","url":"https://hartvaat.nl/mensen/juan-carlos-diaz/","name":"Juan Carlos Diaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"},{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-f-granada","type":"person","url":"https://hartvaat.nl/mensen/juan-f-granada/","name":"Juan F Granada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/1-op-5-oudere-patienten-heeft-hartfalen-opname-binnen-jaar-na-tavr-1-jaarsmortal/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2023/07/11/ondervoeding-verslechtert-prognose-bij-hartfalen-en-mr-coapt-analyse/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-j-badimon","type":"person","url":"https://hartvaat.nl/mensen/juan-j-badimon/","name":"Juan J Badimon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/22/anemie-beinvloedt-ijzerhomeostase-en-empagliflozine-respons-bij-hf/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-jesus-carrero","type":"person","url":"https://hartvaat.nl/mensen/juan-jesus-carrero/","name":"Juan-Jesus Carrero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/30/kfre-aangepast-voor-multimorbiditeit-verbetert-schatting-nierfalenrisico/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2026/01/22/medicatiebeheer-van-ras-remmers-en-sglt2-remmers-bij-chronische-nierziekte/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"judith-a-finegold","type":"person","url":"https://hartvaat.nl/mensen/judith-a-finegold/","name":"Judith A Finegold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2017/07/01/crt-werkingsmechanismen-en-mogelijkheden-voor-verdere-verbetering/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-b-lewis","type":"person","url":"https://hartvaat.nl/mensen/julia-b-lewis/","name":"Julia B Lewis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-ellert","type":"person","url":"https://hartvaat.nl/mensen/julia-ellert/","name":"Julia Ellert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-seller","type":"person","url":"https://hartvaat.nl/mensen/julia-seller/","name":"Julia Seller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/13/verisec-register-vericiguat-halveert-hartfalen-decompensaties-bij-hfref-in-dagel/","published":"2026-06-21"},{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julian-d-gillmore","type":"person","url":"https://hartvaat.nl/mensen/julian-d-gillmore/","name":"Julian D Gillmore","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/27/vutrisiran-bij-attr-cm-impact-van-hartfalenernst-op-effectiviteit/","published":"2025-05-27"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hf-verslechtering-bij-attr-cm-attr-act-subanalyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hartfalenverslechtering-bij-attr-cardiomyopathie-attr-act-analyse/","published":"2025-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-allen","type":"person","url":"https://hartvaat.nl/mensen/julie-allen/","name":"Julie Allen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-e-park","type":"person","url":"https://hartvaat.nl/mensen/julie-e-park/","name":"Julie E Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2018/05/01/verlaging-van-diastolische-druk-bij-patienten-met-en-zonder-cardiovasculaire-zie/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/12/19/chirurgische-versus-percutane-revascularisatie-bij-diabetes-met-acs/","published":"2017-12-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-pester","type":"person","url":"https://hartvaat.nl/mensen/julie-pester/","name":"Julie Pester","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-yates","type":"person","url":"https://hartvaat.nl/mensen/julie-yates/","name":"Julie Yates","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/04/30/fluticason-vilanterol-en-overleving-bij-copd-met-verhoogd-cardiovasculair-risico/","published":"2016-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juliet-nakamya","type":"person","url":"https://hartvaat.nl/mensen/juliet-nakamya/","name":"Juliet Nakamya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"},{"url":"https://hartvaat.nl/2017/07/01/dabigatran-naar-leeftijd-bij-atriumfibrilleren-re-ly-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-jiang","type":"person","url":"https://hartvaat.nl/mensen/jun-jiang/","name":"Jun Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-zhang","type":"person","url":"https://hartvaat.nl/mensen/jun-zhang/","name":"Jun Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-jie-zhang","type":"person","url":"https://hartvaat.nl/mensen/jun-jie-zhang/","name":"Jun-Jie Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jung-won-suh","type":"person","url":"https://hartvaat.nl/mensen/jung-won-suh/","name":"Jung-Won Suh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"junya-ako","type":"person","url":"https://hartvaat.nl/mensen/junya-ako/","name":"Junya Ako","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeremie-abtan","type":"person","url":"https://hartvaat.nl/mensen/jeremie-abtan/","name":"Jérémie Abtan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jurgen-floege","type":"person","url":"https://hartvaat.nl/mensen/jurgen-floege/","name":"Jürgen Floege","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/pdgf-b-uit-tubulusepitheel-drijft-nierfibrose-aan/","published":"2026-04-10"},{"url":"https://hartvaat.nl/2026/02/17/albuminurie-of-proteinurie-bij-glomerulaire-ziekte-en-ckd-wat-te-gebruiken/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2022/08/01/empagliflozine-vermindert-nierletselmarkers-bij-acuut-hartfalen/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"k-martijn-akkerhuis","type":"person","url":"https://hartvaat.nl/mensen/k-martijn-akkerhuis/","name":"K Martijn Akkerhuis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/08/07/adenosine-en-ticagrelorspiegels-bij-patienten-met-en-zonder-ticagrelor-dyspneu/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2016/09/27/intensieve-glucoseregulatie-bij-hyperglycemisch-acs-langetermijnfollow-up-biomar/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ka-chun-li","type":"person","url":"https://hartvaat.nl/mensen/ka-chun-li/","name":"Ka-Chun Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kai-c-wollert","type":"person","url":"https://hartvaat.nl/mensen/kai-c-wollert/","name":"Kai C Wollert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kalman-toth","type":"person","url":"https://hartvaat.nl/mensen/kalman-toth/","name":"Kalman Toth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kamile-cerlinskaite-bajore","type":"person","url":"https://hartvaat.nl/mensen/kamile-cerlinskaite-bajore/","name":"Kamilė Čerlinskaitė-Bajorė","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/01/strong-hf-socio-economische-status-beinvloedt-gdmt-effect-niet/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/07/23/snelle-optitratie-van-neurohormonale-blokkade-en-duurzame-decongestie-bij-hf/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2023/08/14/strong-hf-nt-probnp-geleide-intensieve-optitratie-na-acuut-hf/","published":"2023-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karel-t-koch","type":"person","url":"https://hartvaat.nl/mensen/karel-t-koch/","name":"Karel T Koch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-chiswell","type":"person","url":"https://hartvaat.nl/mensen/karen-chiswell/","name":"Karen Chiswell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/sglt2-remmers-bij-oudere-patienten-opgenomen-voor-hfref-24-sterfte-en-16-heropna/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-bij-stabiel-coronairlijden-stability-inzic/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-l-margolis","type":"person","url":"https://hartvaat.nl/mensen/karen-l-margolis/","name":"Karen L Margolis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/12/01/apotheker-geleide-telezorg-versus-poliklinische-zorg-bij-ongecontroleerde-hypert/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-m-olsson","type":"person","url":"https://hartvaat.nl/mensen/karen-m-olsson/","name":"Karen M Olsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kari-kervinen","type":"person","url":"https://hartvaat.nl/mensen/kari-kervinen/","name":"Kari Kervinen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-heinz-kuck","type":"person","url":"https://hartvaat.nl/mensen/karl-heinz-kuck/","name":"Karl Heinz Kuck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/15/geindividualiseerde-versus-standaard-cryoballonablatie-bij-paroxysmaal-af/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-stangl","type":"person","url":"https://hartvaat.nl/mensen/karl-stangl/","name":"Karl Stangl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2020/10/01/optimale-interlaesieafstand-bij-ablatie-index-geleide-af-ablatie-gerandomiseerde/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-philipp-rommel","type":"person","url":"https://hartvaat.nl/mensen/karl-philipp-rommel/","name":"Karl-Philipp Rommel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karla-c-hurt","type":"person","url":"https://hartvaat.nl/mensen/karla-c-hurt/","name":"Karla C Hurt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/11/summit-tirzepatide-en-klinisch-traject-bij-hfpef-met-obesitas-langetermijn/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karola-jering","type":"person","url":"https://hartvaat.nl/mensen/karola-jering/","name":"Karola Jering","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kars-neven","type":"person","url":"https://hartvaat.nl/mensen/kars-neven/","name":"Kars Neven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaspar-broch","type":"person","url":"https://hartvaat.nl/mensen/kaspar-broch/","name":"Kaspar Broch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katarzyna-nabrdalik","type":"person","url":"https://hartvaat.nl/mensen/katarzyna-nabrdalik/","name":"Katarzyna Nabrdalik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/mortaliteit-en-hospitalisaties-bij-hfpef-versus-hfref-vergelijkende-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/01/piek-vo2-en-prognose-bij-hartfalen-meta-analyse/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2024/10/01/natriuretische-peptiden-en-crp-bij-hartfalen-en-ondervoeding-systematische-revie/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katherine-t-mills","type":"person","url":"https://hartvaat.nl/mensen/katherine-t-mills/","name":"Katherine T Mills","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/01/optimale-antihypertensieve-systolische-bloeddruk-meta-analyse/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2017/09/19/community-health-worker-interventie-voor-bloeddrukcontrole-in-argentina-jama-tri/","published":"2017-09-19"},{"url":"https://hartvaat.nl/2017/07/01/systolische-bloeddrukreductie-en-cv-risico-netwerkmeta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katheryn-brady","type":"person","url":"https://hartvaat.nl/mensen/katheryn-brady/","name":"Katheryn Brady","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2023/10/24/laaos-iii-laa-occlusie-en-anticoagulatiegebruik/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katie-suriano","type":"person","url":"https://hartvaat.nl/mensen/katie-suriano/","name":"Katie Suriano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katja-pahkala","type":"person","url":"https://hartvaat.nl/mensen/katja-pahkala/","name":"Katja Pahkala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/strip-20-jaarsresultaten-van-dieetinterventie-vanaf-de-zuigelingenleeftijd/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2017/08/01/cardiometabole-determinanten-van-carotis-en-aortadistensibiliteit-van-kindertijd/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katrin-kemp-gudmundsdottir","type":"person","url":"https://hartvaat.nl/mensen/katrin-kemp-gudmundsdottir/","name":"Katrin Kemp Gudmundsdottir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/03/nt-probnp-en-ecg-screening-bij-75-jarigen-voor-af-detectie-rct/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/02/01/stapsgewijze-massascreening-op-af-met-nt-probnp-strokestop-ii-studieontwerp/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kay-tee-khaw","type":"person","url":"https://hartvaat.nl/mensen/kay-tee-khaw/","name":"Kay-Tee Khaw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/06/01/maandelijks-hooggedoseerd-vitamine-d-en-cardiovasculaire-ziekte-gerandomiseerde-/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuaki-kaitani","type":"person","url":"https://hartvaat.nl/mensen/kazuaki-kaitani/","name":"Kazuaki Kaitani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2016/12/27/hotballoon-pulmonaalvene-ablatie-bij-paroxysmaal-af-japanse-multicenter-trial/","published":"2016-12-27"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kee-sik-kim","type":"person","url":"https://hartvaat.nl/mensen/kee-sik-kim/","name":"Kee-Sik Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kefei-dou","type":"person","url":"https://hartvaat.nl/mensen/kefei-dou/","name":"Kefei Dou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/eheart-trial-real-time-hartteam-verbetert-besluitvorming-bij-complexe-coronaire-/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kei-asayama","type":"person","url":"https://hartvaat.nl/mensen/kei-asayama/","name":"Kei Asayama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2019/01/01/levenslangrisico-op-cva-en-coronairlijden-naar-bloeddrukniveau-epoch-japan/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ken-kozuma","type":"person","url":"https://hartvaat.nl/mensen/ken-kozuma/","name":"Ken Kozuma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2017/11/07/optische-frequentiedomeinbeeldvorming-versus-ivus-bij-pci-opinion-trial/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-a-jamerson","type":"person","url":"https://hartvaat.nl/mensen/kenneth-a-jamerson/","name":"Kenneth A Jamerson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/01/ace-remmer-plus-calciumantagonist-bij-zwarte-hypertensieve-patienten/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-m-stein","type":"person","url":"https://hartvaat.nl/mensen/kenneth-m-stein/","name":"Kenneth M Stein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-mcdonald","type":"person","url":"https://hartvaat.nl/mensen/kenneth-mcdonald/","name":"Kenneth McDonald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/04/01/parable-sacubitril-valsartan-vermindert-linkeratriumvolume-bij-pre-hfpef/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/06/01/klinische-predictieregels-voor-diagnostiek-van-chronisch-hartfalen-systematische/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kensuke-takagi","type":"person","url":"https://hartvaat.nl/mensen/kensuke-takagi/","name":"Kensuke Takagi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-f-kennedy","type":"person","url":"https://hartvaat.nl/mensen/kevin-f-kennedy/","name":"Kevin F Kennedy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/09/01/icd-en-overleving-bij-gevorderd-hf-met-continue-flow-lvad/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/04/09/sham-gecontroleerde-rct-s-van-renale-denervatie-meta-analyse/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2016/04/01/orale-antistolling-bij-atriumfibrilleren-over-het-spectrum-van-beroerterisico-ga/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-g-volpp","type":"person","url":"https://hartvaat.nl/mensen/kevin-g-volpp/","name":"Kevin G Volpp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/01/apothekerverwijzingen-voor-statine-start-twee-cluster-rct-s/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-vernooy","type":"person","url":"https://hartvaat.nl/mensen/kevin-vernooy/","name":"Kevin Vernooy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/smartphone-app-voor-symptoomregistratie-na-ablatie-bij-atriumfibrilleren-isolati/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kim-overvad","type":"person","url":"https://hartvaat.nl/mensen/kim-overvad/","name":"Kim Overvad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/03/27/hdl-subspecies-met-apoliproteine-c-iii-en-coronairlijden-vier-cohorten/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kirsten-bibbins-domingo","type":"person","url":"https://hartvaat.nl/mensen/kirsten-bibbins-domingo/","name":"Kirsten Bibbins-Domingo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"klara-benesova","type":"person","url":"https://hartvaat.nl/mensen/klara-benesova/","name":"Klara Benesova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/08/catheterablatie-versus-leefstijlmodificatie-plus-antiaritmica-bij-af-gerandomise/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koen-ameloot","type":"person","url":"https://hartvaat.nl/mensen/koen-ameloot/","name":"Koen Ameloot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2020/08/18/optimale-bloeddruk-bij-shock-na-mi-en-hartstilstand/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koen-nieman","type":"person","url":"https://hartvaat.nl/mensen/koen-nieman/","name":"Koen Nieman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2022/02/01/ccta-afgeleide-ffr-prognostische-waarde-meta-analyse/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2016/01/05/ct-coronairangiografie-bij-verdenking-acs-in-het-tijdperk-van-hoog-sensitief-tro/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koen-teeuwen","type":"person","url":"https://hartvaat.nl/mensen/koen-teeuwen/","name":"Koen Teeuwen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koh-ono","type":"person","url":"https://hartvaat.nl/mensen/koh-ono/","name":"Koh Ono","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kohei-wakabayashi","type":"person","url":"https://hartvaat.nl/mensen/kohei-wakabayashi/","name":"Kohei Wakabayashi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koichi-inoue","type":"person","url":"https://hartvaat.nl/mensen/koichi-inoue/","name":"Koichi Inoue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koichi-kaikita","type":"person","url":"https://hartvaat.nl/mensen/koichi-kaikita/","name":"Koichi Kaikita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koichiro-kumagai","type":"person","url":"https://hartvaat.nl/mensen/koichiro-kumagai/","name":"Koichiro Kumagai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/12/27/hotballoon-pulmonaalvene-ablatie-bij-paroxysmaal-af-japanse-multicenter-trial/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-dimopoulos","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-dimopoulos/","name":"Konstantinos Dimopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/nieuwe-acc-aha-richtlijn-2025-voor-volwassenen-met-aangeboren-hartafwijkingen/","published":"2026-03-11"},{"url":"https://hartvaat.nl/2021/06/01/palliatieve-zorg-bij-ph-met-congenitaal-hartlijden-expertopinie/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2018/12/04/echocardiografische-screening-op-ph-bij-aangeboren-hartafwijkingen-jacc-review/","published":"2018-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kook-jin-chun","type":"person","url":"https://hartvaat.nl/mensen/kook-jin-chun/","name":"Kook-Jin Chun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2020/10/10/prasugrel-gebaseerde-dapt-de-escalatie-na-pci-bij-acs-lancet-host-reduce-polytec/","published":"2020-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koshiro-sakai","type":"person","url":"https://hartvaat.nl/mensen/koshiro-sakai/","name":"Koshiro Sakai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krishnan-ramanathan","type":"person","url":"https://hartvaat.nl/mensen/krishnan-ramanathan/","name":"Krishnan Ramanathan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2017/12/19/chirurgische-versus-percutane-revascularisatie-bij-diabetes-met-acs/","published":"2017-12-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristen-k-patton","type":"person","url":"https://hartvaat.nl/mensen/kristen-k-patton/","name":"Kristen K Patton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/08/20/2018-acc-aha-hrs-richtlijn-voor-bradycardie-en-geleidingsstoornissen/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristin-m-williamson","type":"person","url":"https://hartvaat.nl/mensen/kristin-m-williamson/","name":"Kristin M Williamson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/08/14/sacubitril-valsartan-bij-hfmref-hfpef-gepoolde-analyse-van-drie-trials/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krzysztof-irlik","type":"person","url":"https://hartvaat.nl/mensen/krzysztof-irlik/","name":"Krzysztof Irlik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/mortaliteit-en-hospitalisaties-bij-hfpef-versus-hfref-vergelijkende-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/01/piek-vo2-en-prognose-bij-hartfalen-meta-analyse/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2024/10/01/natriuretische-peptiden-en-crp-bij-hartfalen-en-ondervoeding-systematische-revie/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krzysztof-milewski","type":"person","url":"https://hartvaat.nl/mensen/krzysztof-milewski/","name":"Krzysztof Milewski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2020/05/01/remote-monitoring-vermindert-hospitalisaties-bij-icd-patienten-result-studie/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krzysztof-reczuch","type":"person","url":"https://hartvaat.nl/mensen/krzysztof-reczuch/","name":"Krzysztof Reczuch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/gelijktijdige-griep-en-rsv-vaccinatie-bij-hoogrisico-hartfalenpatienten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kwangdeok-lee","type":"person","url":"https://hartvaat.nl/mensen/kwangdeok-lee/","name":"Kwangdeok Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyoung-min-park","type":"person","url":"https://hartvaat.nl/mensen/kyoung-min-park/","name":"Kyoung-Min Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyriakos-dimitriadis","type":"person","url":"https://hartvaat.nl/mensen/kyriakos-dimitriadis/","name":"Kyriakos Dimitriadis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/24/sglt2-remmers-en-bloeddrukdoelen-bij-hypertensief-hfpef-een-overzicht-van-richtl/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2026/02/26/lp-a-geassocieerd-met-microvasculaire-disfunctie-bij-niet-obstructief-coronairli/","published":"2026-03-10"},{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyungil-park","type":"person","url":"https://hartvaat.nl/mensen/kyungil-park/","name":"Kyungil Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"},{"url":"https://hartvaat.nl/2018/04/01/valsartan-en-linkerkamerremodellering-na-mi/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"l-j","type":"person","url":"https://hartvaat.nl/mensen/l-j/","name":"L. J.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/03/25/aortacoarctatie-voorspelt-langetermijnmorbiditeit-na-de-arteriele-switchoperatie/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/01/29/tavi-versus-afwachtend-beleid-bij-ernstige-aortastenose-groot-en-blijvend-overle/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lance-berman","type":"person","url":"https://hartvaat.nl/mensen/lance-berman/","name":"Lance Berman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/09/01/patiromer-verlaagt-aldosteron-bij-ckd-patienten-met-hyperkaliemie-op-raas-remmer/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lang-hong","type":"person","url":"https://hartvaat.nl/mensen/lang-hong/","name":"Lang Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"larry-j-fine","type":"person","url":"https://hartvaat.nl/mensen/larry-j-fine/","name":"Larry J Fine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-norgren","type":"person","url":"https://hartvaat.nl/mensen/lars-norgren/","name":"Lars Norgren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laszlo-szekely","type":"person","url":"https://hartvaat.nl/mensen/laszlo-szekely/","name":"Laszlo Szekely","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"latonya-been","type":"person","url":"https://hartvaat.nl/mensen/latonya-been/","name":"Latonya Been","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-fernandez-lando","type":"person","url":"https://hartvaat.nl/mensen/laura-fernandez-lando/","name":"Laura Fernández Landó","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/18/orforglipron-bij-vroeg-type-2-diabetes-nejm-fase-3/","published":"2025-09-18"},{"url":"https://hartvaat.nl/2021/08/14/tirzepatide-versus-insuline-degludec-bij-diabetes-type-2-lancet-surpass-3/","published":"2021-08-14"},{"url":"https://hartvaat.nl/2021/07/10/tirzepatide-bij-diabetes-type-2-lancet-surpass-1-fase-3/","published":"2021-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-fusini","type":"person","url":"https://hartvaat.nl/mensen/laura-fusini/","name":"Laura Fusini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2025/08/01/linkeratriale-strain-en-prognose-bij-acuut-en-chronisch-hartfalen-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-m-willemsen","type":"person","url":"https://hartvaat.nl/mensen/laura-m-willemsen/","name":"Laura M Willemsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-perrotta","type":"person","url":"https://hartvaat.nl/mensen/laura-perrotta/","name":"Laura Perrotta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/atriumfibrilleren-bij-kankerpatienten-de-esc-richtlijn-2025-in-de-praktijk/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-tudisco","type":"person","url":"https://hartvaat.nl/mensen/laura-tudisco/","name":"Laura Tudisco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurens-f-reeskamp","type":"person","url":"https://hartvaat.nl/mensen/laurens-f-reeskamp/","name":"Laurens F Reeskamp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lawrence-i-deckelbaum","type":"person","url":"https://hartvaat.nl/mensen/lawrence-i-deckelbaum/","name":"Lawrence I Deckelbaum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lee-m-jampol","type":"person","url":"https://hartvaat.nl/mensen/lee-m-jampol/","name":"Lee M Jampol","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/25/aflibercept-versus-bevacizumab-eerst-bij-diabetisch-macula-oedeem/","published":"2022-08-25"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lei-gao","type":"person","url":"https://hartvaat.nl/mensen/lei-gao/","name":"Lei Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/trem-1-remming-vermindert-in-stent-neoatherosclerose-in-diermodel/","published":"2026-04-12"},{"url":"https://hartvaat.nl/2024/02/01/urinezuur-als-biomarker-maar-niet-therapeutisch-doel-bij-hartfalen-meta-analyse/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2019/10/01/sekseverschillen-bij-katheterablatie-van-af-meta-analyse/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leo-timmers","type":"person","url":"https://hartvaat.nl/mensen/leo-timmers/","name":"Leo Timmers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leonard-n-girardi","type":"person","url":"https://hartvaat.nl/mensen/leonard-n-girardi/","name":"Leonard N Girardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leonardo-bolognese","type":"person","url":"https://hartvaat.nl/mensen/leonardo-bolognese/","name":"Leonardo Bolognese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leonardo-pantoni","type":"person","url":"https://hartvaat.nl/mensen/leonardo-pantoni/","name":"Leonardo Pantoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leonardo-tamariz","type":"person","url":"https://hartvaat.nl/mensen/leonardo-tamariz/","name":"Leonardo Tamariz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lesley-j-burgess","type":"person","url":"https://hartvaat.nl/mensen/lesley-j-burgess/","name":"Lesley J Burgess","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/lerodalcibep-bij-ascvd-of-hoog-risico-fase-3-resultaten/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-chen","type":"person","url":"https://hartvaat.nl/mensen/li-chen/","name":"Li Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/07/01/natriumreductie-verhoogt-korte-keten-vetzuren-bij-onbehandelde-hypertensie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2019/07/01/natriumreductie-metaboloom-en-cv-risico-bij-onbehandelde-zwarte-hypertensie/","published":"2019-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-zuo","type":"person","url":"https://hartvaat.nl/mensen/li-zuo/","name":"Li Zuo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liam-r-brunham","type":"person","url":"https://hartvaat.nl/mensen/liam-r-brunham/","name":"Liam R Brunham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2024/09/14/sekseverschillen-in-fh-behandeling-meta-analyse/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liane-porepa","type":"person","url":"https://hartvaat.nl/mensen/liane-porepa/","name":"Liane Porepa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2019/02/26/patientgerichte-transitional-care-bij-hf-hospitalisatie-jama-pact-hf/","published":"2019-02-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liefke-c-van-der-heijden","type":"person","url":"https://hartvaat.nl/mensen/liefke-c-van-der-heijden/","name":"Liefke C van der Heijden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liesbeth-bruckers","type":"person","url":"https://hartvaat.nl/mensen/liesbeth-bruckers/","name":"Liesbeth Bruckers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/29/advor-acetazolamide-bij-acuut-gedecompenseerd-hartfalen-met-volumeoverbelasting/","published":"2022-09-29"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lihong-huang","type":"person","url":"https://hartvaat.nl/mensen/lihong-huang/","name":"Lihong Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lijiang-tang","type":"person","url":"https://hartvaat.nl/mensen/lijiang-tang/","name":"Lijiang Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lijun-guo","type":"person","url":"https://hartvaat.nl/mensen/lijun-guo/","name":"Lijun Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lijun-liu","type":"person","url":"https://hartvaat.nl/mensen/lijun-liu/","name":"Lijun Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/20/multi-omics-onthult-pathogene-rol-van-iga-7-cellen-bij-iga-nefropathie/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lilian-mazza-barbosa","type":"person","url":"https://hartvaat.nl/mensen/lilian-mazza-barbosa/","name":"Lilian Mazza Barbosa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lina-badimon","type":"person","url":"https://hartvaat.nl/mensen/lina-badimon/","name":"Lina Badimon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"linda-r-evers","type":"person","url":"https://hartvaat.nl/mensen/linda-r-evers/","name":"Linda R Evers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-executive-summary/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-jacc-editie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/2022-aha-acc-hfsa-hartfalenrichtlijn-circulation-editie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lingshan-zhao","type":"person","url":"https://hartvaat.nl/mensen/lingshan-zhao/","name":"Lingshan Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"linong-ji","type":"person","url":"https://hartvaat.nl/mensen/linong-ji/","name":"Linong Ji","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-claude","type":"person","url":"https://hartvaat.nl/mensen/lisa-claude/","name":"Lisa Claude","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-gross","type":"person","url":"https://hartvaat.nl/mensen/lisa-gross/","name":"Lisa Gross","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lixin-jiang","type":"person","url":"https://hartvaat.nl/mensen/lixin-jiang/","name":"Lixin Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2016/05/05/perioperatief-rosuvastatine-bij-hartchirurgie-nejm-trial/","published":"2016-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lizhen-xu","type":"person","url":"https://hartvaat.nl/mensen/lizhen-xu/","name":"Lizhen Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"loek-van-heerebeek","type":"person","url":"https://hartvaat.nl/mensen/loek-van-heerebeek/","name":"Loek van Heerebeek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/01/socio-economische-ongelijkheid-en-hartfalenuitkomsten-systematische-review/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2020/06/01/poliklinische-iv-en-sc-diureticabehandeling-bij-verslechterend-hf-systematische-/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lorenzo-barba","type":"person","url":"https://hartvaat.nl/mensen/lorenzo-barba/","name":"Lorenzo Barba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"loreto-gesualdo","type":"person","url":"https://hartvaat.nl/mensen/loreto-gesualdo/","name":"Loreto Gesualdo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/deep-endotypering-onthult-heterogeniteit-van-nierschade-bij-diabetes-type-2/","published":"2026-03-27"},{"url":"https://hartvaat.nl/2026/02/01/de-verborgen-nierschade-bij-chylomicronemiesyndromen/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/12/24/genomische-ontdekking-bij-nefrotisch-syndroom-mefv-varianten-als-risicofactor-vo/","published":"2025-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lorne-gula","type":"person","url":"https://hartvaat.nl/mensen/lorne-gula/","name":"Lorne Gula","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/15/vt-ablatie-versus-antiaritmica-bij-myocardinfarct-locatie-maakt-uit/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lorraine-s-evangelista","type":"person","url":"https://hartvaat.nl/mensen/lorraine-s-evangelista/","name":"Lorraine S Evangelista","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/nierbescherming-na-harttransplantatie-risicoreductie-en-therapeutische-mogelijkh/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2021/04/01/eiwitrijk-versus-standaard-dieet-bij-obees-hf-met-diabetes/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lu-may-chiang","type":"person","url":"https://hartvaat.nl/mensen/lu-may-chiang/","name":"Lu-May Chiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/10/cognitieve-disfunctie-bij-hfpef-klinische-correlaten-en-prognostische-impact/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/07/23/sacubitril-valsartan-en-cognitieve-functie-bij-hfpef/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2020/08/04/sacubitril-valsartan-en-ecm-biomarkers-bij-hfpef-paragon-hf/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luc-maillard","type":"person","url":"https://hartvaat.nl/mensen/luc-maillard/","name":"Luc Maillard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-paolucci","type":"person","url":"https://hartvaat.nl/mensen/luca-paolucci/","name":"Luca Paolucci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/14/ffr-versus-angiografie-voor-pci-begeleiding-ipd-meta-analyse/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/09/01/periprocedureel-mi-na-pci-en-langetermijnmortaliteit-meta-analyse/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/12/20/ticagrelor-versus-prasugrel-en-coronaire-microcirculatie-bij-pci/","published":"2023-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucas-hofmeister","type":"person","url":"https://hartvaat.nl/mensen/lucas-hofmeister/","name":"Lucas Hofmeister","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucas-v-a-boersma","type":"person","url":"https://hartvaat.nl/mensen/lucas-v-a-boersma/","name":"Lucas V A Boersma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2021/12/07/gold-force-multi-elektrode-rf-versus-irrigated-rf-bij-af-gerandomiseerde-trial/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2019/05/01/thoracoscopische-versus-katheterablatie-bij-af-langetermijn-fast-trial/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucas-yixi-xing","type":"person","url":"https://hartvaat.nl/mensen/lucas-yixi-xing/","name":"Lucas Yixi Xing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2023/06/13/loop-substudie-nt-probnp-verbetert-af-screeningsopbrengst/","published":"2023-06-13"},{"url":"https://hartvaat.nl/2022/09/01/bloeddruk-beinvloedt-opbrengst-van-af-screening-loop-substudie/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucie-blondeau","type":"person","url":"https://hartvaat.nl/mensen/lucie-blondeau/","name":"Lucie Blondeau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2016/01/26/p-selectine-antagonist-inclacumab-bij-coronaire-bypasschirurgie-select-cabg-tria/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ludovica-migliaccio","type":"person","url":"https://hartvaat.nl/mensen/ludovica-migliaccio/","name":"Ludovica Migliaccio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-di-serafino","type":"person","url":"https://hartvaat.nl/mensen/luigi-di-serafino/","name":"Luigi Di Serafino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2016/07/12/prasugrel-versus-clopidogrel-en-coronaire-microvasculaire-functie-bij-electieve-/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-costa","type":"person","url":"https://hartvaat.nl/mensen/luis-costa/","name":"Luis Costa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luisa-vinciguerra","type":"person","url":"https://hartvaat.nl/mensen/luisa-vinciguerra/","name":"Luisa Vinciguerra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luiz-c-danzmann","type":"person","url":"https://hartvaat.nl/mensen/luiz-c-danzmann/","name":"Luiz C Danzmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/11/21/diureticastaken-bij-stabiel-mild-hf-zonder-vochtretentie/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lynda-m-rose","type":"person","url":"https://hartvaat.nl/mensen/lynda-m-rose/","name":"Lynda M Rose","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/07/10/residueel-inflammatoir-risico-bij-pcsk9-remming-plus-statine/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-benjamin-nelson","type":"person","url":"https://hartvaat.nl/mensen/m-benjamin-nelson/","name":"M Benjamin Nelson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-john-chapman","type":"person","url":"https://hartvaat.nl/mensen/m-john-chapman/","name":"M John Chapman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-martine-altieri","type":"person","url":"https://hartvaat.nl/mensen/m-martine-altieri/","name":"M Martine Altieri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/04/2025-aha-acc-hypertensierichtlijn-circulation-editie/","published":"2025-11-04"},{"url":"https://hartvaat.nl/2025/10/01/2025-aha-acc-hypertensierichtlijn-jacc-editie/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/09/16/2025-aha-acc-hypertensierichtlijn-preventie-detectie-en-management/","published":"2025-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-c","type":"person","url":"https://hartvaat.nl/mensen/m-c/","name":"M. C.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/03/warrior-trial-intensieve-medicamenteuze-behandeling-verbetert-de-uitkomsten-niet/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/04/29/geleidingssysteem-pacing-slaat-rechterventrikel-pacing-bij-av-blok-70-hartfalen-/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/01/09/hartfalendiagnostiek-na-corona-bijna-niemand-kreeg-de-echo-binnen-de-aanbevolen-/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-i","type":"person","url":"https://hartvaat.nl/mensen/m-i/","name":"M. I.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/24/relatieve-apicale-sparing-op-strain-echo-voor-cardiale-amyloidose-meta-analyse-v/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/04/29/geisoleerde-secundaire-tricuspidalisinsufficientie-na-linkszijdige-klepchirurgie/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/02/06/nierfunctiebeloop-bij-nieuw-ontstaan-hfref-voorspelt-de-uitkomst/","published":"2026-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-j","type":"person","url":"https://hartvaat.nl/mensen/m-j/","name":"M. J.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/04/angina-toevoegen-aan-de-h2fpef-score-verbetert-hfpef-diagnose-bij-vrouwen-geen-w/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/04/24/bayesiaanse-netwerkmeta-analyse-vergelijkt-revascularisatie-bij-stabiele-ischemi/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/02/04/pulsed-field-ablatie-bereikt-vaker-complete-achterwandisolatie-dan-radiofrequent/","published":"2026-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maarten-a-vink","type":"person","url":"https://hartvaat.nl/mensen/maarten-a-vink/","name":"Maarten A Vink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"magdalena-madero","type":"person","url":"https://hartvaat.nl/mensen/magdalena-madero/","name":"Magdalena Madero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","published":"2026-03-15"},{"url":"https://hartvaat.nl/2026/01/20/het-onbekende-uit-ckdu-halen-optimale-benaderingen-voor-epidemische-nierziekte/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mahmoud-u-sani","type":"person","url":"https://hartvaat.nl/mensen/mahmoud-u-sani/","name":"Mahmoud U Sani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mahn-won-park","type":"person","url":"https://hartvaat.nl/mensen/mahn-won-park/","name":"Mahn-Won Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maja-lisa-lchen","type":"person","url":"https://hartvaat.nl/mensen/maja-lisa-lchen/","name":"Maja-Lisa Løchen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manabu-ogita","type":"person","url":"https://hartvaat.nl/mensen/manabu-ogita/","name":"Manabu Ogita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manan-pareek","type":"person","url":"https://hartvaat.nl/mensen/manan-pareek/","name":"Manan Pareek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/hoge-dosis-griepvaccinatie-bij-atherosclerotisch-vaatlijden-flunity-hd-analyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manlin-zhao","type":"person","url":"https://hartvaat.nl/mensen/manlin-zhao/","name":"Manlin Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/comorbiditeitsbelasting-en-uitkomsten-van-ablatie-versus-medicatie-bij-af/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manuel-anguita","type":"person","url":"https://hartvaat.nl/mensen/manuel-anguita/","name":"Manuel Anguita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manuel-barreiro-perez","type":"person","url":"https://hartvaat.nl/mensen/manuel-barreiro-perez/","name":"Manuel Barreiro-Perez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manuel-pan","type":"person","url":"https://hartvaat.nl/mensen/manuel-pan/","name":"Manuel Pan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manuela-casula","type":"person","url":"https://hartvaat.nl/mensen/manuela-casula/","name":"Manuela Casula","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/22/orale-pcsk9-remmers-meta-analyse-bevestigt-krachtige-ldl-daling/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2026/04/22/angptl3-remmers-verlagen-breed-lipidenspectrum-vooral-remnant-en-triglyceriden/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marat-ezhov","type":"person","url":"https://hartvaat.nl/mensen/marat-ezhov/","name":"Marat Ezhov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-a-brouwer","type":"person","url":"https://hartvaat.nl/mensen/marc-a-brouwer/","name":"Marc A Brouwer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/07/minimaal-onderbroken-versus-continue-doac-bij-af-ablatie-meta-analyse/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2017/04/27/ononderbroken-dabigatran-versus-warfarine-bij-af-ablatie-nejm-re-circuit/","published":"2017-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-d-lemoine","type":"person","url":"https://hartvaat.nl/mensen/marc-d-lemoine/","name":"Marc D Lemoine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2025/10/07/atriale-cardiomyopathie-bij-recent-gediagnosticeerd-af-prevalentie-en-ernst/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-humbert","type":"person","url":"https://hartvaat.nl/mensen/marc-humbert/","name":"Marc Humbert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcella-caggiula","type":"person","url":"https://hartvaat.nl/mensen/marcella-caggiula/","name":"Marcella Caggiula","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcello-dominici","type":"person","url":"https://hartvaat.nl/mensen/marcello-dominici/","name":"Marcello Dominici","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcelo-franken","type":"person","url":"https://hartvaat.nl/mensen/marcelo-franken/","name":"Marcelo Franken","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marciane-m-rover","type":"person","url":"https://hartvaat.nl/mensen/marciane-m-rover/","name":"Marciane M Rover","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/11/21/diureticastaken-bij-stabiel-mild-hf-zonder-vochtretentie/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-barbierato","type":"person","url":"https://hartvaat.nl/mensen/marco-barbierato/","name":"Marco Barbierato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-r-di-tullio","type":"person","url":"https://hartvaat.nl/mensen/marco-r-di-tullio/","name":"Marco R Di Tullio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/lv-dimensies-en-cv-uitkomsten-bij-systolisch-hf-warcef/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-vinceti","type":"person","url":"https://hartvaat.nl/mensen/marco-vinceti/","name":"Marco Vinceti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/08/01/alcohol-en-hypertensierisico-dosis-respons-meta-analyse-van-niet-experimentele-s/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/10/01/alcoholconsumptie-en-bloeddruk-dosis-respons-meta-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2021/04/20/natriumreductie-en-bloeddruk-dosis-respons-meta-analyse-van-experimentele-studie/","published":"2021-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcoli-cyrille","type":"person","url":"https://hartvaat.nl/mensen/marcoli-cyrille/","name":"Marcoli Cyrille","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"},{"url":"https://hartvaat.nl/2020/05/26/evolocumab-bij-hiv-met-dyslipidemie-beijerinck-gerandomiseerde-studie/","published":"2020-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-dorr","type":"person","url":"https://hartvaat.nl/mensen/marcus-dorr/","name":"Marcus Dörr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-thuresson","type":"person","url":"https://hartvaat.nl/mensen/marcus-thuresson/","name":"Marcus Thuresson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2018/06/12/sglt2-remmers-en-cardiovasculaire-events-de-cvd-real-2-real-world-studie/","published":"2018-06-12"},{"url":"https://hartvaat.nl/2017/07/18/sglt2-remmers-en-lager-risico-op-hartfalen-en-sterfte-versus-andere-glucoseverla/","published":"2017-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-v-simoes","type":"person","url":"https://hartvaat.nl/mensen/marcus-v-simoes/","name":"Marcus V Simões","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/11/21/diureticastaken-bij-stabiel-mild-hf-zonder-vochtretentie/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mardi-gomberg-maitland","type":"person","url":"https://hartvaat.nl/mensen/mardi-gomberg-maitland/","name":"Mardi Gomberg-Maitland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/12/cadence-sotatercept-verlaagt-pulmonale-vaatweerstand-bij-gecombineerde-pre-postc/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margus-viigimaa","type":"person","url":"https://hartvaat.nl/mensen/margus-viigimaa/","name":"Margus Viigimaa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-na-cabg-effecten-op-cv-events-odyssey-outcomes/","published":"2019-09-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-bertilsson","type":"person","url":"https://hartvaat.nl/mensen/maria-bertilsson/","name":"Maria Bertilsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/04/timing-vroege-versus-late-noac-start-na-ischemisch-cva-bij-af/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2018/04/01/fibrinestoleigenschappen-en-klinische-uitkomsten-na-acs-plato-substudie/","published":"2018-04-01"},{"url":"https://hartvaat.nl/2016/04/21/gdf-15-voorspelt-bloedingen-en-cardiovasculaire-events-bij-acuut-coronair-syndro/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-c-alu","type":"person","url":"https://hartvaat.nl/mensen/maria-c-alu/","name":"Maria C Alu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/1-op-5-oudere-patienten-heeft-hartfalen-opname-binnen-jaar-na-tavr-1-jaarsmortal/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-g-crespo-leiro","type":"person","url":"https://hartvaat.nl/mensen/maria-g-crespo-leiro/","name":"Maria G Crespo-Leiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-giulia-mosconi","type":"person","url":"https://hartvaat.nl/mensen/maria-giulia-mosconi/","name":"Maria Giulia Mosconi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-grazia-piscaglia","type":"person","url":"https://hartvaat.nl/mensen/maria-grazia-piscaglia/","name":"Maria Grazia Piscaglia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-laura-monsalvo","type":"person","url":"https://hartvaat.nl/mensen/maria-laura-monsalvo/","name":"Maria Laura Monsalvo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-maddalena-viola","type":"person","url":"https://hartvaat.nl/mensen/maria-maddalena-viola/","name":"Maria Maddalena Viola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-rosaria-bagnato","type":"person","url":"https://hartvaat.nl/mensen/maria-rosaria-bagnato/","name":"Maria Rosaria Bagnato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-sessa","type":"person","url":"https://hartvaat.nl/mensen/maria-sessa/","name":"Maria Sessa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marianne-benn","type":"person","url":"https://hartvaat.nl/mensen/marianne-benn/","name":"Marianne Benn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2019/09/17/ldl-cholesterol-en-micro-versus-macrovasculaire-ziekte-mendeliaanse-randomisatie/","published":"2019-09-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariarosaria-valente","type":"person","url":"https://hartvaat.nl/mensen/mariarosaria-valente/","name":"Mariarosaria Valente","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-evans","type":"person","url":"https://hartvaat.nl/mensen/marie-evans/","name":"Marie Evans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/21/patientgerapporteerde-uitkomsten-verbeteren-voorspelling-van-mortaliteit-bij-dia/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2026/01/15/populatiegebaseerde-egfr-verdelingen-voor-vroege-identificatie-van-chronische-ni/","published":"2026-01-15"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-krousel-wood","type":"person","url":"https://hartvaat.nl/mensen/marie-krousel-wood/","name":"Marie Krousel-Wood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/09/19/community-health-worker-interventie-voor-bloeddrukcontrole-in-argentina-jama-tri/","published":"2017-09-19"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-l-lindegaard","type":"person","url":"https://hartvaat.nl/mensen/marie-l-lindegaard/","name":"Marie L Lindegaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"},{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-claude-guertin","type":"person","url":"https://hartvaat.nl/mensen/marie-claude-guertin/","name":"Marie-Claude Guertin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2016/01/26/p-selectine-antagonist-inclacumab-bij-coronaire-bypasschirurgie-select-cabg-tria/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-france-hivert","type":"person","url":"https://hartvaat.nl/mensen/marie-france-hivert/","name":"Marie-France Hivert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-pierre-dube","type":"person","url":"https://hartvaat.nl/mensen/marie-pierre-dube/","name":"Marie-Pierre Dubé","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-vasculaire-preventie-meta-analyse-van-lange-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marielle-andersson","type":"person","url":"https://hartvaat.nl/mensen/marielle-andersson/","name":"Marielle Andersson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marina-mannino","type":"person","url":"https://hartvaat.nl/mensen/marina-mannino/","name":"Marina Mannino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marine-cachanado","type":"person","url":"https://hartvaat.nl/mensen/marine-cachanado/","name":"Marine Cachanado","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/11/17/seh-zorgbundel-en-30-daags-ontslag-en-overleving-bij-oudere-hf-patienten-jama/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mario-iannaccone","type":"person","url":"https://hartvaat.nl/mensen/mario-iannaccone/","name":"Mario Iannaccone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2017/03/14/drie-arteriele-grafts-verbeteren-langetermijnoverleving-meta-analyse-van-propens/","published":"2017-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mario-schiffer","type":"person","url":"https://hartvaat.nl/mensen/mario-schiffer/","name":"Mario Schiffer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/gerichte-immunotherapie-bij-nierziekten-b-cel-targeting-en-car-t/","published":"2026-04-04"},{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/12/01/empagliflozine-en-vaatfunctie-bij-chronisch-hf/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marion-delcroix","type":"person","url":"https://hartvaat.nl/mensen/marion-delcroix/","name":"Marion Delcroix","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/06/14/gestandaardiseerde-inspanningstraining-bij-pah-en-cteph-haalbaarheid-en-veilighe/","published":"2021-06-14"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marion-mafham","type":"person","url":"https://hartvaat.nl/mensen/marion-mafham/","name":"Marion Mafham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marisa-avvedimento","type":"person","url":"https://hartvaat.nl/mensen/marisa-avvedimento/","name":"Marisa Avvedimento","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-e-cooper","type":"person","url":"https://hartvaat.nl/mensen/mark-e-cooper/","name":"Mark E Cooper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-heise","type":"person","url":"https://hartvaat.nl/mensen/mark-heise/","name":"Mark Heise","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/apoa-i-infusie-na-mi-naar-lp-a-niveau-aegis-ii-subanalyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-j-pletcher","type":"person","url":"https://hartvaat.nl/mensen/mark-j-pletcher/","name":"Mark J Pletcher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/02/01/geindividualiseerde-triggerstudies-bij-paroxysmaal-af-jama-i-stop-afib/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2016/03/15/voorspelling-van-persisterende-lv-disfunctie-na-myocardinfarct-de-predicts-studi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-j-ricciardi","type":"person","url":"https://hartvaat.nl/mensen/mark-j-ricciardi/","name":"Mark J Ricciardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-s-spence","type":"person","url":"https://hartvaat.nl/mensen/mark-s-spence/","name":"Mark S Spence","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2018/12/04/echocardiografische-screening-op-ph-bij-aangeboren-hartafwijkingen-jacc-review/","published":"2018-12-04"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-haass","type":"person","url":"https://hartvaat.nl/mensen/markus-haass/","name":"Markus Haass","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-juonala","type":"person","url":"https://hartvaat.nl/mensen/markus-juonala/","name":"Markus Juonala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/strip-20-jaarsresultaten-van-dieetinterventie-vanaf-de-zuigelingenleeftijd/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2017/08/01/cardiometabole-determinanten-van-carotis-en-aortadistensibiliteit-van-kindertijd/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-s-anker","type":"person","url":"https://hartvaat.nl/mensen/markus-s-anker/","name":"Markus S Anker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martha-grogan","type":"person","url":"https://hartvaat.nl/mensen/martha-grogan/","name":"Martha Grogan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/13/ai-echo-verslaat-ai-ecg-en-klinische-score-voor-diagnose-cardiale-amyloidose-aur/","published":"2026-06-22"},{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martha-r-mayo","type":"person","url":"https://hartvaat.nl/mensen/martha-r-mayo/","name":"Martha R Mayo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/10/26/patiromer-voor-spironolactongebruik-bij-resistente-hypertensie-met-ckd-lancet-am/","published":"2019-10-26"},{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/09/01/patiromer-verlaagt-aldosteron-bij-ckd-patienten-met-hyperkaliemie-op-raas-remmer/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martijn-meuwissen","type":"person","url":"https://hartvaat.nl/mensen/martijn-meuwissen/","name":"Martijn Meuwissen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"},{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-o-donnell","type":"person","url":"https://hartvaat.nl/mensen/martin-o-donnell/","name":"Martin O'Donnell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-coronairlijden-lancet-compass/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martina-gaia-di-donna","type":"person","url":"https://hartvaat.nl/mensen/martina-gaia-di-donna/","name":"Martina Gaia Di Donna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marvin-a-konstam","type":"person","url":"https://hartvaat.nl/mensen/marvin-a-konstam/","name":"Marvin A Konstam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/10/20/praliciguat-en-piek-vo2-bij-hfpef-jama-capacity-hfpef/","published":"2020-10-20"},{"url":"https://hartvaat.nl/2017/09/01/spironolacton-bij-acuut-hartfalen-de-athena-hf-gerandomiseerde-trial/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/03/21/kortetermijneffecten-van-tolvaptan-bij-acuut-hartfalen-met-volume-overbelasting/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mary-stanbury","type":"person","url":"https://hartvaat.nl/mensen/mary-stanbury/","name":"Mary Stanbury","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/26/rate-af-kosteneffectiviteit-van-digoxine-versus-betablokkers-bij-permanent-af/","published":"2025-03-26"},{"url":"https://hartvaat.nl/2021/07/01/transformatie-van-klinisch-onderzoek-door-patientbetrokkenheid-rate-af/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masato-kawasaki","type":"person","url":"https://hartvaat.nl/mensen/masato-kawasaki/","name":"Masato Kawasaki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2020/06/01/tolvaptan-en-sympathische-activiteit-bij-acuut-hfpef/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masayuki-takamura","type":"person","url":"https://hartvaat.nl/mensen/masayuki-takamura/","name":"Masayuki Takamura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/20/hokuriku-plus-genetische-diagnose-bij-familiaire-hypercholesterolemie-verlaagt-m/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/02/28/onbeantwoorde-vragen-over-lipoproteine-a-en-atherosclerose/","published":"2026-04-02"},{"url":"https://hartvaat.nl/2026/01/30/familiaire-hypercholesterolemie-gemaskeerd-door-een-pcsk9-verlies-van-functievar/","published":"2026-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massimiliano-fusaro","type":"person","url":"https://hartvaat.nl/mensen/massimiliano-fusaro/","name":"Massimiliano Fusaro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2016/02/06/bioresorbeerbare-versus-metallic-stents-meta-analyse-van-gerandomiseerde-trials/","published":"2016-02-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mateusz-guzik","type":"person","url":"https://hartvaat.nl/mensen/mateusz-guzik/","name":"Mateusz Guzik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/26/machine-learning-voorspelt-diureticumrespons-bij-acuut-hartfalen-drc-ahf/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/05/26/adipokineprofiel-bij-acuut-hartfalen-voorspelt-natriuretische-respons-en-mortali/","published":"2026-05-30"},{"url":"https://hartvaat.nl/2025/12/01/gelijktijdige-griep-en-rsv-vaccinatie-bij-hoogrisico-hartfalenpatienten/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mathangi-shanthakumar","type":"person","url":"https://hartvaat.nl/mensen/mathangi-shanthakumar/","name":"Mathangi Shanthakumar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mathias-h-konstandin","type":"person","url":"https://hartvaat.nl/mensen/mathias-h-konstandin/","name":"Mathias H Konstandin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matias-g-lindholm","type":"person","url":"https://hartvaat.nl/mensen/matias-g-lindholm/","name":"Matias G Lindholm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mats-c-hjbjerg-lassen","type":"person","url":"https://hartvaat.nl/mensen/mats-c-hjbjerg-lassen/","name":"Mats C Højbjerg Lassen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/18/adipositas-gerelateerde-antropometrie-en-uitkomsten-bij-hfmref-hfpef/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/04/07/sglt2-remmers-voorkomen-nieuw-ontstane-diabetes-bij-cv-en-nierziekte/","published":"2025-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-foschi","type":"person","url":"https://hartvaat.nl/mensen/matteo-foschi/","name":"Matteo Foschi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-paolucci","type":"person","url":"https://hartvaat.nl/mensen/matteo-paolucci/","name":"Matteo Paolucci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-serenelli","type":"person","url":"https://hartvaat.nl/mensen/matteo-serenelli/","name":"Matteo Serenelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/01/14/dapagliflozine-bij-hfref-naar-leeftijd-dapa-hf-inzichten/","published":"2020-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-ziacchi","type":"person","url":"https://hartvaat.nl/mensen/matteo-ziacchi/","name":"Matteo Ziacchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2017/03/01/vaste-versus-responsieve-pacingfrequentie-bij-permanent-af-met-pacemakerindicati/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthaios-didagelos","type":"person","url":"https://hartvaat.nl/mensen/matthaios-didagelos/","name":"Matthaios Didagelos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/10/02/cangrelor-bij-ticagrelor-geladen-stemi-patienten-tijdens-primaire-pci/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-dodd","type":"person","url":"https://hartvaat.nl/mensen/matthew-dodd/","name":"Matthew Dodd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-horsfall","type":"person","url":"https://hartvaat.nl/mensen/matthew-horsfall/","name":"Matthew Horsfall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/01/acute-pleiotrope-effecten-van-dapagliflozine-bij-diabetes-type-2-met-hfref-cross/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-sibbald","type":"person","url":"https://hartvaat.nl/mensen/matthew-sibbald/","name":"Matthew Sibbald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-t-v-chan","type":"person","url":"https://hartvaat.nl/mensen/matthew-t-v-chan/","name":"Matthew T V Chan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/08/vision-postoperatief-atriumfibrilleren-na-hartchirurgie-verhoogt-sterfte-na-een-/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2017/08/15/overleving-na-geisoleerde-postoperatieve-troponine-elevatie/","published":"2017-08-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-w-segar","type":"person","url":"https://hartvaat.nl/mensen/matthew-w-segar/","name":"Matthew W Segar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/11/look-ahead-intensieve-leefstijlinterventie-cardiale-biomarkers-en-cv-uitkomsten-/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2022/07/12/frailteit-beinvloedt-effect-van-inspanningstraining-bij-hartfalen-hf-action-anal/","published":"2022-07-12"},{"url":"https://hartvaat.nl/2021/10/19/diabetes-met-cardiomyopathie-in-de-community-prevalentie-en-prognose/","published":"2021-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-totzeck","type":"person","url":"https://hartvaat.nl/mensen/matthias-totzeck/","name":"Matthias Totzeck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2022/10/01/bnp-nt-probnp-stratificeert-prognose-gelijk-met-en-zonder-hartfalen-meta-analyse/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/08/01/hartfalen-door-kankerbehandeling-kunnen-we-het-voorkomen/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matti-niemela","type":"person","url":"https://hartvaat.nl/mensen/matti-niemela/","name":"Matti Niemelä","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maureen-g-phipps","type":"person","url":"https://hartvaat.nl/mensen/maureen-g-phipps/","name":"Maureen G Phipps","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/07/11/gedragscounseling-voor-gezonde-voeding-en-beweging-ter-cv-preventie-jama-uspstf-/","published":"2017-07-11"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurits-t-dirksen","type":"person","url":"https://hartvaat.nl/mensen/maurits-t-dirksen/","name":"Maurits T Dirksen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/02/18/lage-dosis-sirolimus-bdp-stent-versus-tweede-generatie-des-non-inferioriteit/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurizio-volterrani","type":"person","url":"https://hartvaat.nl/mensen/maurizio-volterrani/","name":"Maurizio Volterrani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/sacubitril-valsartan-na-acuut-mi-meta-analyse-van-in-hospital-initiatie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mauro-silvestrini","type":"person","url":"https://hartvaat.nl/mensen/mauro-silvestrini/","name":"Mauro Silvestrini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maximilian-von-roeder","type":"person","url":"https://hartvaat.nl/mensen/maximilian-von-roeder/","name":"Maximilian von Roeder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/03/01/slagvolumeveranderingen-na-renale-denervatie-cardiale-mri-inzichten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mayank-dalakoti","type":"person","url":"https://hartvaat.nl/mensen/mayank-dalakoti/","name":"Mayank Dalakoti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/03/06/veroudering-en-myocarddisfunctie-het-hart-jong-houden/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2022/04/01/glucoseverlagende-middelen-bij-niet-diabetisch-hf-bayesiaanse-netwerkmeta-analys/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mayanna-lund","type":"person","url":"https://hartvaat.nl/mensen/mayanna-lund/","name":"Mayanna Lund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mehmet-hamid","type":"person","url":"https://hartvaat.nl/mensen/mehmet-hamid/","name":"Mehmet Hamid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mehmet-kanbay","type":"person","url":"https://hartvaat.nl/mensen/mehmet-kanbay/","name":"Mehmet Kanbay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/19/angiotensinogeen-als-nieuw-aangrijppunt-bij-hypertensie-opkomst-van-rna-medicijn/","published":"2026-03-19"},{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melana-yuzefpolskaya","type":"person","url":"https://hartvaat.nl/mensen/melana-yuzefpolskaya/","name":"Melana Yuzefpolskaya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melanie-a-gunawardene","type":"person","url":"https://hartvaat.nl/mensen/melanie-a-gunawardene/","name":"Melanie A Gunawardene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2018/01/01/energiebron-en-vroeg-af-recidief-cryoballon-versus-radiofrequentie/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mette-nygaard-einfeldt","type":"person","url":"https://hartvaat.nl/mensen/mette-nygaard-einfeldt/","name":"Mette Nygaard Einfeldt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2024/07/02/semaglutide-en-nt-probnp-bij-hfpef-met-obesitas-step-hfpef-programma/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/27/semaglutide-bij-hfpef-met-obesitas-lancet-gepoolde-analyse-van-twee-nejm-trials/","published":"2024-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mian-li","type":"person","url":"https://hartvaat.nl/mensen/mian-li/","name":"Mian Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mian-wang","type":"person","url":"https://hartvaat.nl/mensen/mian-wang/","name":"Mian Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miaohan-qiu","type":"person","url":"https://hartvaat.nl/mensen/miaohan-qiu/","name":"Miaohan Qiu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-behnes","type":"person","url":"https://hartvaat.nl/mensen/michael-behnes/","name":"Michael Behnes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-burke","type":"person","url":"https://hartvaat.nl/mensen/michael-burke/","name":"Michael Burke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"},{"url":"https://hartvaat.nl/2016/07/19/glucoseverlagende-medicatie-en-cardiovasculaire-events-bij-diabetes-type-2-jama-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-d-jensen","type":"person","url":"https://hartvaat.nl/mensen/michael-d-jensen/","name":"Michael D Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/01/dapagliflozine-en-rv-pulmonale-interactie-bij-hfpef/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/09/05/cameo-dapa-cardiale-en-metabole-effecten-van-dapagliflozine-bij-hfpef/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-e-griswold","type":"person","url":"https://hartvaat.nl/mensen/michael-e-griswold/","name":"Michael E Griswold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-g-nanna","type":"person","url":"https://hartvaat.nl/mensen/michael-g-nanna/","name":"Michael G Nanna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/16/revascularisatiestrategieen-na-mi-systematische-review-en-meta-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2021/10/12/overbrugging-van-antiplaatjestherapie-na-pci-jacc-review/","published":"2021-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-moroney","type":"person","url":"https://hartvaat.nl/mensen/michael-moroney/","name":"Michael Moroney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/nlr-en-cardiale-remodelling-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/06/01/diabetesduur-beinvloedt-lv-massaregressie-met-empagliflozine/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-pfeifer","type":"person","url":"https://hartvaat.nl/mensen/michael-pfeifer/","name":"Michael Pfeifer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/12/01/adaptieve-servoventilatie-en-hypoxemische-belasting-bij-hartfalen/","published":"2023-12-01"},{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-schluter","type":"person","url":"https://hartvaat.nl/mensen/michael-schluter/","name":"Michael Schlüter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/15/geindividualiseerde-versus-standaard-cryoballonablatie-bij-paroxysmaal-af/","published":"2022-07-15"},{"url":"https://hartvaat.nl/2021/03/08/katheterablatie-om-af-progressie-te-vertragen-attest-gerandomiseerde-trial/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-tsang","type":"person","url":"https://hartvaat.nl/mensen/michael-tsang/","name":"Michael Tsang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michal-j-kawczynski","type":"person","url":"https://hartvaat.nl/mensen/michal-j-kawczynski/","name":"Michal J Kawczynski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2021/11/08/preoperatieve-tte-voor-voorspelling-van-postoperatief-af-meta-analyse/","published":"2021-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michal-svoboda","type":"person","url":"https://hartvaat.nl/mensen/michal-svoboda/","name":"Michal Svoboda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/16/watchful-leefstijl-wandelinterventie-bij-hfref/","published":"2024-01-16"},{"url":"https://hartvaat.nl/2023/02/07/ecmo-cs-ecmo-bij-cardiogene-shock-verbetert-overleving-niet/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michal-vrablik","type":"person","url":"https://hartvaat.nl/mensen/michal-vrablik/","name":"Michal Vrablik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-chonchol","type":"person","url":"https://hartvaat.nl/mensen/michel-chonchol/","name":"Michel Chonchol","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/01/auteurs-reageren-pravastatine-bij-autosomaal-dominante-polycysteuze-nierziekte/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-haissaguerre","type":"person","url":"https://hartvaat.nl/mensen/michel-haissaguerre/","name":"Michel Haissaguerre","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-le-may","type":"person","url":"https://hartvaat.nl/mensen/michel-le-may/","name":"Michel Le May","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/radiale-versus-femorale-toegang-bij-coronairangiografie-meta-analyse-toont-morta/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-marre","type":"person","url":"https://hartvaat.nl/mensen/michel-marre/","name":"Michel Marre","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-scemama","type":"person","url":"https://hartvaat.nl/mensen/michel-scemama/","name":"Michel Scemama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/10/triglyceriden-alirocumab-en-cv-uitkomsten-na-acs/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/08/30/apob-en-residueel-cv-risico-na-acs-effect-van-alirocumab/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2021/08/03/lp-a-en-pcsk9-remmingsvoordeel-bij-nominaal-gecontroleerd-ldl/","published":"2021-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-mcgrady","type":"person","url":"https://hartvaat.nl/mensen/michele-mcgrady/","name":"Michele McGrady","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2019/02/01/tricuspidalisinsufficientie-en-mortaliteit-onafhankelijk-van-ph-en-rechterventri/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miguel-ruiz-canela","type":"person","url":"https://hartvaat.nl/mensen/miguel-ruiz-canela/","name":"Miguel Ruiz-Canela","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/urinair-wijnzuur-als-biomarker-voor-wijnconsumptie-en-cv-risico-predimed/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miguel-serodio","type":"person","url":"https://hartvaat.nl/mensen/miguel-serodio/","name":"Miguel Serôdio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mihir-a-kelshiker","type":"person","url":"https://hartvaat.nl/mensen/mihir-a-kelshiker/","name":"Mihir A Kelshiker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/14/tricorder-ai-stethoscoop-voor-triple-cv-ziektedetectie/","published":"2026-02-14"},{"url":"https://hartvaat.nl/2024/06/11/remote-beoordeling-na-acs-gerandomiseerde-trial/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2022/04/19/coronaire-flowreserve-en-cardiovasculaire-uitkomsten-meta-analyse/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikael-danielewicz","type":"person","url":"https://hartvaat.nl/mensen/mikael-danielewicz/","name":"Mikael Danielewicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikael-laredo","type":"person","url":"https://hartvaat.nl/mensen/mikael-laredo/","name":"Mikael Laredo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikhail-ruda","type":"person","url":"https://hartvaat.nl/mensen/mikhail-ruda/","name":"Mikhail Ruda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikko-pietila","type":"person","url":"https://hartvaat.nl/mensen/mikko-pietila/","name":"Mikko Pietilä","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2019/07/20/drug-coated-balloon-bij-de-novo-coronairlaesies-met-hoog-bloedingsrisico-lancet-/","published":"2019-07-20"},{"url":"https://hartvaat.nl/2017/11/28/xenon-inhalatie-vermindert-myocardschade-bij-overlevenden-van-hartstilstand-xe-h/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milad-el-haddad","type":"person","url":"https://hartvaat.nl/mensen/milad-el-haddad/","name":"Milad El Haddad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/11/01/ablatie-index-geleide-af-ablatie-geactualiseerde-meta-analyse/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/08/01/eenvoudige-techniek-voor-pvi-van-linker-longvenen-gerandomiseerde-studie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/04/21/pvi-met-versus-zonder-antiaritmica-bij-recidiverend-af-powder-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milan-gupta","type":"person","url":"https://hartvaat.nl/mensen/milan-gupta/","name":"Milan Gupta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milan-hromadka","type":"person","url":"https://hartvaat.nl/mensen/milan-hromadka/","name":"Milan Hromadka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/07/ecmo-cs-ecmo-bij-cardiogene-shock-verbetert-overleving-niet/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miller","type":"person","url":"https://hartvaat.nl/mensen/miller/","name":"Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/17/direct-naar-ct-coronairangiografie-bij-verdenking-angina-snellere-diagnose-en-mi/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/02/10/welke-hartfalenpatienten-ontwikkelen-ernstige-mitralisinsufficientie-voorspellen/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2026/01/06/machine-learning-algoritme-mi3-helpt-een-infarct-uitsluiten-bij-een-onduidelijke/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-fu","type":"person","url":"https://hartvaat.nl/mensen/min-fu/","name":"Min Fu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-gyu-kang","type":"person","url":"https://hartvaat.nl/mensen/min-gyu-kang/","name":"Min Gyu Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-jun","type":"person","url":"https://hartvaat.nl/mensen/min-jun/","name":"Min Jun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/08/01/bloeddrukvariabiliteit-en-vasculaire-events-bij-diabetes-type-2/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-qian","type":"person","url":"https://hartvaat.nl/mensen/min-qian/","name":"Min Qian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/lv-dimensies-en-cv-uitkomsten-bij-systolisch-hf-warcef/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-xu","type":"person","url":"https://hartvaat.nl/mensen/min-xu/","name":"Min Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-ji-charng","type":"person","url":"https://hartvaat.nl/mensen/min-ji-charng/","name":"Min-Ji Charng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/08/29/rosuvastatine-bij-kinderen-met-homozygote-familiaire-hypercholesterolemie/","published":"2017-08-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"minglong-chen","type":"person","url":"https://hartvaat.nl/mensen/minglong-chen/","name":"Minglong Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/05/07/aanvullende-substraatmodificatie-bij-persisterend-af-met-low-voltage-gebieden/","published":"2025-05-07"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mingxing-wu","type":"person","url":"https://hartvaat.nl/mensen/mingxing-wu/","name":"Mingxing Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/08/01/b-lijnen-geleide-hartfalenbehandeling-verbetert-uitkomsten-na-ontslag/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mingyang-gao","type":"person","url":"https://hartvaat.nl/mensen/mingyang-gao/","name":"Mingyang Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miriam-lacharie","type":"person","url":"https://hartvaat.nl/mensen/miriam-lacharie/","name":"Miriam Lacharie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mirjam-g-wild","type":"person","url":"https://hartvaat.nl/mensen/mirjam-g-wild/","name":"Mirjam G Wild","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miroslaw-ferenc","type":"person","url":"https://hartvaat.nl/mensen/miroslaw-ferenc/","name":"Miroslaw Ferenc","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mitchell-a-psotka","type":"person","url":"https://hartvaat.nl/mensen/mitchell-a-psotka/","name":"Mitchell A Psotka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mitesh-s-patel","type":"person","url":"https://hartvaat.nl/mensen/mitesh-s-patel/","name":"Mitesh S Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/06/01/digitale-gamificatie-interventie-verhoogt-lichaamsbeweging-na-hypertensieve-zwan/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mitsuru-abe","type":"person","url":"https://hartvaat.nl/mensen/mitsuru-abe/","name":"Mitsuru Abe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohamad-alkhouli","type":"person","url":"https://hartvaat.nl/mensen/mohamad-alkhouli/","name":"Mohamad Alkhouli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohamad-el-kasty","type":"person","url":"https://hartvaat.nl/mensen/mohamad-el-kasty/","name":"Mohamad El Kasty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohammed-k-ali","type":"person","url":"https://hartvaat.nl/mensen/mohammed-k-ali/","name":"Mohammed K Ali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/09/01/pm2-5-blootstelling-versnelt-daling-van-egfr-bij-volwassenen/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2020/08/18/collaboratieve-zorg-voor-depressie-hba1c-bloeddruk-en-cholesterol-bij-diabetes-j/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2016/04/01/effecten-van-dieetinterventies-op-bloeddruk-systematische-review-en-meta-analyse/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohaned-egred","type":"person","url":"https://hartvaat.nl/mensen/mohaned-egred/","name":"Mohaned Egred","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"molly-b-conroy","type":"person","url":"https://hartvaat.nl/mensen/molly-b-conroy/","name":"Molly B Conroy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/29/reset-bp-minder-sedentair-gedrag-verlaagt-bloeddruk-bij-kantoorwerkers/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2023/08/01/combinatietabletten-voor-intensieve-bloeddrukbehandeling-sprint-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monika-zdanyte","type":"person","url":"https://hartvaat.nl/mensen/monika-zdanyte/","name":"Monika Zdanyte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"moo-yong-rhee","type":"person","url":"https://hartvaat.nl/mensen/moo-yong-rhee/","name":"Moo-Yong Rhee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2017/01/01/sacubitril-valsartan-en-natriurese-diurese-en-bloeddruk-bij-zoutgevoelige-hypert/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morris-j-brown","type":"person","url":"https://hartvaat.nl/mensen/morris-j-brown/","name":"Morris J Brown","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/02/baxdrostat-aldosteronsynthaseremmer-bij-resistente-hypertensie-nejm-fase-2/","published":"2023-02-02"},{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2017/11/01/zoutbuffering-in-de-huid-bij-mensen-een-nieuw-mechanisme/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mouna-sassi-sayadi","type":"person","url":"https://hartvaat.nl/mensen/mouna-sassi-sayadi/","name":"Mouna Sassi-Sayadi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"muhammad-elboghday","type":"person","url":"https://hartvaat.nl/mensen/muhammad-elboghday/","name":"Muhammad Elboghday","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"myriam-fornage","type":"person","url":"https://hartvaat.nl/mensen/myriam-fornage/","name":"Myriam Fornage","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"myung-ho-jeong","type":"person","url":"https://hartvaat.nl/mensen/myung-ho-jeong/","name":"Myung-Ho Jeong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadia-bouabdallaoui","type":"person","url":"https://hartvaat.nl/mensen/nadia-bouabdallaoui/","name":"Nadia Bouabdallaoui","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/01/gunstige-effecten-van-ivabradine-bij-hf-met-lage-ef-en-hartfrequentie-77-bpm/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadia-giannetti","type":"person","url":"https://hartvaat.nl/mensen/nadia-giannetti/","name":"Nadia Giannetti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadine-shehata","type":"person","url":"https://hartvaat.nl/mensen/nadine-shehata/","name":"Nadine Shehata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/01/restrictieve-versus-liberale-transfusie-bij-hartchirurgie-meta-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naeem-d-khan","type":"person","url":"https://hartvaat.nl/mensen/naeem-d-khan/","name":"Naeem D Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/01/01/medicatie-copay-vouchers-en-p2y12-gebruik-en-cv-events-na-mi-jama/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nailiang-tian","type":"person","url":"https://hartvaat.nl/mensen/nailiang-tian/","name":"Nailiang Tian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nam-ho-lee","type":"person","url":"https://hartvaat.nl/mensen/nam-ho-lee/","name":"Nam Ho Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nana-pogosova","type":"person","url":"https://hartvaat.nl/mensen/nana-pogosova/","name":"Nana Pogosova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nanci-valeis","type":"person","url":"https://hartvaat.nl/mensen/nanci-valeis/","name":"Nanci Valeis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nancy-k-sweitzer","type":"person","url":"https://hartvaat.nl/mensen/nancy-k-sweitzer/","name":"Nancy K Sweitzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/09/12/lichamelijke-activiteit-en-prognose-bij-hfpef-topcat-analyse/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naoki-sato","type":"person","url":"https://hartvaat.nl/mensen/naoki-sato/","name":"Naoki Sato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/01/finearts-hf-finerenon-naar-frailteit-bij-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/10/01/intraveneus-tolvaptan-versus-orale-formulering-bij-congestief-hartfalen/","published":"2022-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nasrien-e-ibrahim","type":"person","url":"https://hartvaat.nl/mensen/nasrien-e-ibrahim/","name":"Nasrien E Ibrahim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/09/selectieve-aldosereductaseremmer-bij-diabetische-cardiomyopathie-rct/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nawwar-al-attar","type":"person","url":"https://hartvaat.nl/mensen/nawwar-al-attar/","name":"Nawwar Al-Attar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neda-rasouli","type":"person","url":"https://hartvaat.nl/mensen/neda-rasouli/","name":"Neda Rasouli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2025/05/03/semaglutide-en-loopafstand-bij-perifeer-vaatlijden-en-diabetes/","published":"2025-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neeraj-dhaun","type":"person","url":"https://hartvaat.nl/mensen/neeraj-dhaun/","name":"Neeraj Dhaun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/arteriele-stijfheid-en-endotheeldysfunctie-bij-anca-geassocieerde-vasculitis/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2019/08/01/endothelinereceptorantagonisme-verbetert-lipidenprofielen-en-verlaagt-pcsk9-bij-/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-ruparelia","type":"person","url":"https://hartvaat.nl/mensen/neil-ruparelia/","name":"Neil Ruparelia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nele-gessler","type":"person","url":"https://hartvaat.nl/mensen/nele-gessler/","name":"Nele Gessler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/east-afnet-4-diabetes-obesitas-en-vroege-ritmecontrole-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nessa-johnson","type":"person","url":"https://hartvaat.nl/mensen/nessa-johnson/","name":"Nessa Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-r-jones","type":"person","url":"https://hartvaat.nl/mensen/nicholas-r-jones/","name":"Nicholas R Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/21/amalfi-remote-screening-voor-asymptomatisch-af-gerandomiseerde-trial/","published":"2025-10-21"},{"url":"https://hartvaat.nl/2023/06/01/natriuretisch-peptide-screening-voor-lv-disfunctie-diagnostische-nauwkeurigheid/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2019/12/01/gewichtsverandering-en-risico-op-af-systematische-review-en-meta-analyse/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-valettas","type":"person","url":"https://hartvaat.nl/mensen/nicholas-valettas/","name":"Nicholas Valettas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nick-nurmohamed","type":"person","url":"https://hartvaat.nl/mensen/nick-nurmohamed/","name":"Nick Nurmohamed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/nieuwe-horizonten-dyslipidemie-2026/implementatie-lipidenmanagement/","title":"Sessie 4: Implementatie van lipidenmanagement — praktische uitdagingen"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicola-davide-loizzo","type":"person","url":"https://hartvaat.nl/mensen/nicola-davide-loizzo/","name":"Nicola Davide Loizzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicola-greenlaw","type":"person","url":"https://hartvaat.nl/mensen/nicola-greenlaw/","name":"Nicola Greenlaw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"},{"url":"https://hartvaat.nl/2016/04/21/aliskiren-enalapril-of-de-combinatie-bij-hartfalen-nejm-atmosphere-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-piriou","type":"person","url":"https://hartvaat.nl/mensen/nicolas-piriou/","name":"Nicolas Piriou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-rodondi","type":"person","url":"https://hartvaat.nl/mensen/nicolas-rodondi/","name":"Nicolas Rodondi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/17/schildklierdisfunctie-en-hart-en-vaatziekten-ehj-overzicht/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2021/05/11/geindividualiseerde-voedingsondersteuning-bij-gehospitaliseerd-chronisch-hf/","published":"2021-05-11"},{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-mller","type":"person","url":"https://hartvaat.nl/mensen/niels-mller/","name":"Niels Møller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-thue-olsen","type":"person","url":"https://hartvaat.nl/mensen/niels-thue-olsen/","name":"Niels Thue Olsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2023/11/01/ifr-versus-ffr-en-vijfjaarsmortaliteit-swedeheart-en-define-flair/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nihar-r-desai","type":"person","url":"https://hartvaat.nl/mensen/nihar-r-desai/","name":"Nihar R Desai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/victorion-inception-vroege-inclisiran-na-acuut-coronair-syndroom-verviervoudigt-/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikhil-tandon","type":"person","url":"https://hartvaat.nl/mensen/nikhil-tandon/","name":"Nikhil Tandon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/09/01/pm2-5-blootstelling-versnelt-daling-van-egfr-bij-volwassenen/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2020/08/18/collaboratieve-zorg-voor-depressie-hba1c-bloeddruk-en-cholesterol-bij-diabetes-j/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2020/04/07/yoga-gebaseerde-hartrevalidatie-na-acuut-mi-gerandomiseerde-trial/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikki-a-h-a-pluymaekers","type":"person","url":"https://hartvaat.nl/mensen/nikki-a-h-a-pluymaekers/","name":"Nikki A H A Pluymaekers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikola-sprigg","type":"person","url":"https://hartvaat.nl/mensen/nikola-sprigg/","name":"Nikola Sprigg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2017/05/01/voortzetten-of-tijdelijk-stoppen-van-antihypertensiva-bij-acuut-cva-ipd-meta-ana/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nils-p-johnson","type":"person","url":"https://hartvaat.nl/mensen/nils-p-johnson/","name":"Nils P Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/02/coronaire-flow-capaciteits-geleide-revascularisatie-versus-standaardzorg-rct/","published":"2025-09-02"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2016/11/29/natuurlijk-beloop-van-coronaire-atherosclerose-met-ffr-prospectieve-studie/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nina-becher","type":"person","url":"https://hartvaat.nl/mensen/nina-becher/","name":"Nina Becher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2024/03/26/doac-s-bij-device-gedetecteerd-af-meta-analyse-noah-afnet-6-en-artesia/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nina-gotcheva","type":"person","url":"https://hartvaat.nl/mensen/nina-gotcheva/","name":"Nina Gotcheva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nina-p-paynter","type":"person","url":"https://hartvaat.nl/mensen/nina-p-paynter/","name":"Nina P Paynter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2017/05/16/statines-voor-primaire-preventie-bij-ouderen-meta-analyse-van-jupiter-en-hope-3/","published":"2017-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nirav-y-raval","type":"person","url":"https://hartvaat.nl/mensen/nirav-y-raval/","name":"Nirav Y Raval","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/10/01/cardiale-contractiliteitsmodulatie-bij-hf-uitgebreide-ipd-meta-analyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nitesh-nerlekar","type":"person","url":"https://hartvaat.nl/mensen/nitesh-nerlekar/","name":"Nitesh Nerlekar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2026/05/27/sglt2-remmers-verminderen-epicardiaal-vetweefsel-meta-analyse-van-11-studies/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/05/13/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nitish-naik","type":"person","url":"https://hartvaat.nl/mensen/nitish-naik/","name":"Nitish Naik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"octavio-m-pontes-neto","type":"person","url":"https://hartvaat.nl/mensen/octavio-m-pontes-neto/","name":"Octavio M Pontes-Neto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"odilson-m-silvestre","type":"person","url":"https://hartvaat.nl/mensen/odilson-m-silvestre/","name":"Odilson M Silvestre","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/11/21/diureticastaken-bij-stabiel-mild-hf-zonder-vochtretentie/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"offer-amir","type":"person","url":"https://hartvaat.nl/mensen/offer-amir/","name":"Offer Amir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ola-kleveland","type":"person","url":"https://hartvaat.nl/mensen/ola-kleveland/","name":"Ola Kleveland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olav-wendelboe-nielsen","type":"person","url":"https://hartvaat.nl/mensen/olav-wendelboe-nielsen/","name":"Olav Wendelboe Nielsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/22/flow-semaglutide-vermindert-hartfalen-bij-diabetes-en-ckd/","published":"2024-10-22"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-morel","type":"person","url":"https://hartvaat.nl/mensen/olivier-morel/","name":"Olivier Morel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olle-melander","type":"person","url":"https://hartvaat.nl/mensen/olle-melander/","name":"Olle Melander","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olli-a-kajander","type":"person","url":"https://hartvaat.nl/mensen/olli-a-kajander/","name":"Olli A Kajander","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olli-t-raitakari","type":"person","url":"https://hartvaat.nl/mensen/olli-t-raitakari/","name":"Olli T Raitakari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2017/08/01/cardiometabole-determinanten-van-carotis-en-aortadistensibiliteit-van-kindertijd/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"osama-soliman","type":"person","url":"https://hartvaat.nl/mensen/osama-soliman/","name":"Osama Soliman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"osung-kwon","type":"person","url":"https://hartvaat.nl/mensen/osung-kwon/","name":"Osung Kwon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"p-barton-duell","type":"person","url":"https://hartvaat.nl/mensen/p-barton-duell/","name":"P Barton Duell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2019/11/12/bempedoinezuur-toegevoegd-aan-statines-bij-hoog-cv-risico-jama-clear-harmony/","published":"2019-11-12"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-diez-villanueva","type":"person","url":"https://hartvaat.nl/mensen/pablo-diez-villanueva/","name":"Pablo Díez-Villanueva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/off-label-dosering-van-sacubitril-valsartan-wijdverspreid-in-de-praktijk/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/05/13/verisec-register-vericiguat-halveert-hartfalen-decompensaties-bij-hfref-in-dagel/","published":"2026-06-21"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-e-pergola","type":"person","url":"https://hartvaat.nl/mensen/pablo-e-pergola/","name":"Pablo E Pergola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/07/01/kbp-5074-en-bloeddruk-bij-gevorderde-ckd-block-ckd/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2019/10/01/bardoxolone-en-urine-albumine-creatinine-ratio-bij-diabetes-met-ckd-stadium-4/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2016/01/01/bereikte-bloeddruk-en-uitkomsten-in-de-sps3-trial-bij-lacunaire-herseninfarcten/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-lapuerta","type":"person","url":"https://hartvaat.nl/mensen/pablo-lapuerta/","name":"Pablo Lapuerta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-ckd-nejm-scored/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2016/04/12/protonpompremmers-verminderen-gastro-intestinale-events-ongeacht-aspirinedosis-b/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pallab-k-maulik","type":"person","url":"https://hartvaat.nl/mensen/pallab-k-maulik/","name":"Pallab K Maulik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pamela-duncan","type":"person","url":"https://hartvaat.nl/mensen/pamela-duncan/","name":"Pamela Duncan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/01/fysieke-revalidatie-bij-fragiele-ouderen-met-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"panagiotis-xaplanteris","type":"person","url":"https://hartvaat.nl/mensen/panagiotis-xaplanteris/","name":"Panagiotis Xaplanteris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2018/07/19/5-jaarsuitkomsten-van-ffr-geleide-pci-nejm-fame-2/","published":"2018-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paola-forti","type":"person","url":"https://hartvaat.nl/mensen/paola-forti/","name":"Paola Forti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-c-colombo","type":"person","url":"https://hartvaat.nl/mensen/paolo-c-colombo/","name":"Paolo C Colombo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-candelaresi","type":"person","url":"https://hartvaat.nl/mensen/paolo-candelaresi/","name":"Paolo Candelaresi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-cimaglia","type":"person","url":"https://hartvaat.nl/mensen/paolo-cimaglia/","name":"Paolo Cimaglia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-denti","type":"person","url":"https://hartvaat.nl/mensen/paolo-denti/","name":"Paolo Denti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-zocca","type":"person","url":"https://hartvaat.nl/mensen/paolo-zocca/","name":"Paolo Zocca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"parisa-danaietash","type":"person","url":"https://hartvaat.nl/mensen/parisa-danaietash/","name":"Parisa Danaietash","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2020/04/01/aprocitentan-bij-hypertensie-gerandomiseerde-dosis-responsstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"partha-sardar","type":"person","url":"https://hartvaat.nl/mensen/partha-sardar/","name":"Partha Sardar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/09/sham-gecontroleerde-rct-s-van-renale-denervatie-meta-analyse/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2017/09/01/provisional-versus-twee-stentstrategie-bij-bifurcatielaesies-meta-analyse/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/07/01/bioresorbeerbare-scaffold-versus-des-2-jaars-meta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-bovet","type":"person","url":"https://hartvaat.nl/mensen/pascal-bovet/","name":"Pascal Bovet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2020/04/01/verhoogde-bloeddruk-op-kinder-adolescentenleeftijd-en-cv-uitkomsten-bij-volwasse/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-delsart","type":"person","url":"https://hartvaat.nl/mensen/pascal-delsart/","name":"Pascal Delsart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-geldsetzer","type":"person","url":"https://hartvaat.nl/mensen/pascal-geldsetzer/","name":"Pascal Geldsetzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/16/landelijk-aki-alarmsysteem-effecten-op-zorg-en-patientuitkomsten/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-lim","type":"person","url":"https://hartvaat.nl/mensen/pascal-lim/","name":"Pascal Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-r-d-clephas","type":"person","url":"https://hartvaat.nl/mensen/pascal-r-d-clephas/","name":"Pascal R D Clephas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-de-groote","type":"person","url":"https://hartvaat.nl/mensen/pascal-de-groote/","name":"Pascal de Groote","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2024/10/03/uitgebreide-versus-standaard-remote-monitoring-bij-crt-en-hartfalen/","published":"2024-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pasquale-perrone-filardi","type":"person","url":"https://hartvaat.nl/mensen/pasquale-perrone-filardi/","name":"Pasquale Perrone Filardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pcsk9-remmers-verlagen-events-bij-ascvd-zonder-eerder-infarct-of-beroerte-real-w/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2026/05/25/semaglutide-verlaagt-mortaliteit-cv-events-en-nierschade-in-alle-stadia-van-ckm-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/09/14/glp-1-agonisten-bij-diabetes-type-2-met-en-zonder-cvd-meta-analyse/","published":"2020-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patel","type":"person","url":"https://hartvaat.nl/mensen/patel/","name":"Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patricia-a-cowper","type":"person","url":"https://hartvaat.nl/mensen/patricia-a-cowper/","name":"Patricia A Cowper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-e-mcbride","type":"person","url":"https://hartvaat.nl/mensen/patrick-e-mcbride/","name":"Patrick E McBride","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-jacc-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2017/08/08/2017-acc-aha-hfsa-gerichte-update-hartfalenmanagement-circulation-editie/","published":"2017-08-08"},{"url":"https://hartvaat.nl/2016/09/27/2016-acc-aha-hfsa-gerichte-update-nieuwe-farmacologische-hartfalentherapie/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-henry","type":"person","url":"https://hartvaat.nl/mensen/patrick-henry/","name":"Patrick Henry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-j-smith","type":"person","url":"https://hartvaat.nl/mensen/patrick-j-smith/","name":"Patrick J Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/12/leefstijlmodificatie-bij-resistente-hypertensie-triumph-gerandomiseerde-trial/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2016/04/05/hartrevalidatie-versterkt-met-stressmanagementtraining-gerandomiseerde-trial/","published":"2016-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-ohlmann","type":"person","url":"https://hartvaat.nl/mensen/patrick-ohlmann/","name":"Patrick Ohlmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrik-michel","type":"person","url":"https://hartvaat.nl/mensen/patrik-michel/","name":"Patrik Michel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-a-bateman","type":"person","url":"https://hartvaat.nl/mensen/paul-a-bateman/","name":"Paul A Bateman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-a-reilly","type":"person","url":"https://hartvaat.nl/mensen/paul-a-reilly/","name":"Paul A Reilly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-achouh","type":"person","url":"https://hartvaat.nl/mensen/paul-achouh/","name":"Paul Achouh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-angaran","type":"person","url":"https://hartvaat.nl/mensen/paul-angaran/","name":"Paul Angaran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-c-hebert","type":"person","url":"https://hartvaat.nl/mensen/paul-c-hebert/","name":"Paul C Hébert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-d-thompson","type":"person","url":"https://hartvaat.nl/mensen/paul-d-thompson/","name":"Paul D Thompson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2022/09/07/prevalentie-van-statine-intolerantie-meta-analyse-nuanceert-het-probleem/","published":"2022-09-07"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-f-kantor","type":"person","url":"https://hartvaat.nl/mensen/paul-f-kantor/","name":"Paul F Kantor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2017/09/05/ivabradine-bij-kinderen-met-dilaterende-cardiomyopathie-en-symptomatisch-hartfal/","published":"2017-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-j-young","type":"person","url":"https://hartvaat.nl/mensen/paul-j-young/","name":"Paul J Young","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2018/04/28/liberale-versus-conservatieve-zuurstoftherapie-bij-acuut-zieke-volwassenen-lance/","published":"2018-04-28"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-knaapen","type":"person","url":"https://hartvaat.nl/mensen/paul-knaapen/","name":"Paul Knaapen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-l-hess","type":"person","url":"https://hartvaat.nl/mensen/paul-l-hess/","name":"Paul L Hess","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2016/05/17/institutionele-en-operateurvereisten-voor-linker-hartoorocclusie-scai-acc-hrs-st/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-l-kimmel","type":"person","url":"https://hartvaat.nl/mensen/paul-l-kimmel/","name":"Paul L Kimmel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-s-chan","type":"person","url":"https://hartvaat.nl/mensen/paul-s-chan/","name":"Paul S Chan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/01/01/kccq-interpretatie-bij-hartfalen-patient-ankering/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-t-seed","type":"person","url":"https://hartvaat.nl/mensen/paul-t-seed/","name":"Paul T Seed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/29/cradle-4-geplande-bevalling-versus-afwachten-bij-laat-preterm-pre-eclampsie-in-l/","published":"2023-07-29"},{"url":"https://hartvaat.nl/2019/05/04/plgf-voor-beoordeling-van-pre-eclampsie-lancet-parrot-stepped-wedge-trial/","published":"2019-05-04"},{"url":"https://hartvaat.nl/2017/11/01/labetalol-versus-nifedipine-bij-chronische-hypertensie-in-de-zwangerschap-gerand/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-w-a-janssen","type":"person","url":"https://hartvaat.nl/mensen/paul-w-a-janssen/","name":"Paul W A Janssen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pavel-hoffmann","type":"person","url":"https://hartvaat.nl/mensen/pavel-hoffmann/","name":"Pavel Hoffmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2018/07/10/il-8-en-infarctgrootte-en-klinische-uitkomsten-bij-stemi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2016/06/01/preventie-van-cardiale-disfunctie-bij-borstkankerbehandeling-de-prada-trial/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"payam-dehghani","type":"person","url":"https://hartvaat.nl/mensen/payam-dehghani/","name":"Payam Dehghani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2016/01/05/varenicline-voor-stoppen-met-roken-bij-patienten-opgenomen-met-acuut-coronair-sy/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peder-langeland-myhre","type":"person","url":"https://hartvaat.nl/mensen/peder-langeland-myhre/","name":"Peder Langeland Myhre","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/09/omega-3-vetzuren-bij-oudere-mi-patienten-omemi-gerandomiseerde-trial/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2019/03/26/bnp-tijdens-sacubitril-valsartan-paradigm-hf/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2018/10/01/natriuretische-peptiden-en-cardiovasculaire-prognose-bij-hfpef-topcat/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-beraldo-de-andrade","type":"person","url":"https://hartvaat.nl/mensen/pedro-beraldo-de-andrade/","name":"Pedro Beraldo de Andrade","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/vip-acs-dubbele-dosis-griepvaccinatie-na-acs-verbetert-uitkomsten-niet/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-p-teixeira","type":"person","url":"https://hartvaat.nl/mensen/pedro-p-teixeira/","name":"Pedro P Teixeira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/11/victor-vericiguat-en-mortaliteit-bij-hfref-definitieve-analyse/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/12/16/victor-vericiguat-en-totale-hartfalengebeurtenissen-bij-stabiel-hfref/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/27/vericiguat-over-het-risicospectrum-bij-hfref/","published":"2025-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peng-chen","type":"person","url":"https://hartvaat.nl/mensen/peng-chen/","name":"Peng Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"penny-m-kris-etherton","type":"person","url":"https://hartvaat.nl/mensen/penny-m-kris-etherton/","name":"Penny M Kris-Etherton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/10/voedingspatronen-en-macronutrientenvervanging-verlagen-triglyceriden-bij-hypertr/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2020/01/21/voedingscholesterol-en-cv-risico-aha-science-advisory/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"per-hildebrandt","type":"person","url":"https://hartvaat.nl/mensen/per-hildebrandt/","name":"Per Hildebrandt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"per-m-hellstrom","type":"person","url":"https://hartvaat.nl/mensen/per-m-hellstrom/","name":"Per M Hellström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/06/09/acyl-ghreline-verbetert-hartfunctie-bij-hartfalen/","published":"2023-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"per-wester","type":"person","url":"https://hartvaat.nl/mensen/per-wester/","name":"Per Wester","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2022/10/04/timing-vroege-versus-late-noac-start-na-ischemisch-cva-bij-af/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2019/01/12/visualisatie-van-asymptomatische-atherosclerose-voor-cv-preventie-lancet-vipviza/","published":"2019-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petar-vukovic","type":"person","url":"https://hartvaat.nl/mensen/petar-vukovic/","name":"Petar Vukovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2021/04/01/cardio-microstroomdevice-bij-chronisch-hf-eerste-klinische-studie/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-frambach","type":"person","url":"https://hartvaat.nl/mensen/peter-frambach/","name":"Peter Frambach","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-m-a-calverley","type":"person","url":"https://hartvaat.nl/mensen/peter-m-a-calverley/","name":"Peter M A Calverley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/04/30/fluticason-vilanterol-en-overleving-bij-copd-met-verhoogd-cardiovasculair-risico/","published":"2016-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-macdonald","type":"person","url":"https://hartvaat.nl/mensen/peter-macdonald/","name":"Peter Macdonald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-paul-delnoy","type":"person","url":"https://hartvaat.nl/mensen/peter-paul-delnoy/","name":"Peter Paul Delnoy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"},{"url":"https://hartvaat.nl/2017/03/07/contractiliteitssensor-geleide-crt-optimalisatie-respond-crt-trial/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-r-kowey","type":"person","url":"https://hartvaat.nl/mensen/peter-r-kowey/","name":"Peter R Kowey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/28/geinhaleerde-flecainide-voor-cardioversie-van-recent-onset-af-lancet/","published":"2025-03-28"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-riis-hansen","type":"person","url":"https://hartvaat.nl/mensen/peter-riis-hansen/","name":"Peter Riis Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/02/23/ct-coronairangiografie-bij-75-jarigen-met-nste-acs/","published":"2023-02-23"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-sogaard","type":"person","url":"https://hartvaat.nl/mensen/peter-sogaard/","name":"Peter Sogaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"},{"url":"https://hartvaat.nl/2016/01/01/persisterende-echocardiografische-dyssynchronie-voorspelt-ongunstige-uitkomsten-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-wildgoose","type":"person","url":"https://hartvaat.nl/mensen/peter-wildgoose/","name":"Peter Wildgoose","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-otahal","type":"person","url":"https://hartvaat.nl/mensen/petr-otahal/","name":"Petr Otahal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/06/01/bloeddrukverlaging-bij-centrale-hypertensie-gerandomiseerde-trial/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petra-crnac","type":"person","url":"https://hartvaat.nl/mensen/petra-crnac/","name":"Petra Crnac","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petra-hoppmann","type":"person","url":"https://hartvaat.nl/mensen/petra-hoppmann/","name":"Petra Hoppmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/15/10-jaarsuitkomsten-van-drie-limus-eluting-stents-coating-vergelijking/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/03/01/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-geactualiseerde-meta/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petra-laeis","type":"person","url":"https://hartvaat.nl/mensen/petra-laeis/","name":"Petra Laeis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-maccarthy","type":"person","url":"https://hartvaat.nl/mensen/philip-maccarthy/","name":"Philip MacCarthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philipp-krisai","type":"person","url":"https://hartvaat.nl/mensen/philipp-krisai/","name":"Philipp Krisai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2023/11/02/duurzaamheid-van-pvi-bij-af-meta-analyse/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philipp-schlegel","type":"person","url":"https://hartvaat.nl/mensen/philipp-schlegel/","name":"Philipp Schlegel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-brunel","type":"person","url":"https://hartvaat.nl/mensen/philippe-brunel/","name":"Philippe Brunel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-moulin","type":"person","url":"https://hartvaat.nl/mensen/philippe-moulin/","name":"Philippe Moulin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/01/is-er-een-nieuwe-keerzijde-van-persisterende-chylomicronemie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"phillip-j-schulte","type":"person","url":"https://hartvaat.nl/mensen/phillip-j-schulte/","name":"Phillip J Schulte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2016/04/19/trends-in-behandeling-en-uitkomsten-bij-nste-acs-naar-leeftijd/","published":"2016-04-19"},{"url":"https://hartvaat.nl/2016/04/01/veiligheid-en-werkzaamheid-van-ticagrelor-versus-clopidogrel-bij-primaire-pci-vo/","published":"2016-04-01"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"phillip-j-tully","type":"person","url":"https://hartvaat.nl/mensen/phillip-j-tully/","name":"Phillip J Tully","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/01/af-voorspelt-cognitieve-achteruitgang-meta-analyse-van-2-8-miljoen-personen/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/11/01/bloeddrukvariabiliteit-en-progressie-van-klinische-alzheimer/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pier-andrea-rizzo","type":"person","url":"https://hartvaat.nl/mensen/pier-andrea-rizzo/","name":"Pier Andrea Rizzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piera-capranzano","type":"person","url":"https://hartvaat.nl/mensen/piera-capranzano/","name":"Piera Capranzano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierfrancesco-agostoni","type":"person","url":"https://hartvaat.nl/mensen/pierfrancesco-agostoni/","name":"Pierfrancesco Agostoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piergiorgio-lochner","type":"person","url":"https://hartvaat.nl/mensen/piergiorgio-lochner/","name":"Piergiorgio Lochner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piergiuseppe-agostoni","type":"person","url":"https://hartvaat.nl/mensen/piergiuseppe-agostoni/","name":"Piergiuseppe Agostoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2021/02/11/empagliflozine-en-inspanningsvermogen-bij-hfref-en-hfpef-emperial/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-jais","type":"person","url":"https://hartvaat.nl/mensen/pierre-jais/","name":"Pierre Jais","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-lantelme","type":"person","url":"https://hartvaat.nl/mensen/pierre-lantelme/","name":"Pierre Lantelme","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-page","type":"person","url":"https://hartvaat.nl/mensen/pierre-page/","name":"Pierre Pagé","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2018/02/20/nieuw-onset-af-na-pci-of-cabg-bij-hoofdstamziekte-excel-trial/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-theroux","type":"person","url":"https://hartvaat.nl/mensen/pierre-theroux/","name":"Pierre Theroux","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/09/12/werkzaamheid-en-veiligheid-van-ticagrelor-over-tijd-na-mi-pegasus-timi-54/","published":"2017-09-12"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnverdraagbaarheid-van-ticagrelor-voor-secundaire-cardiovasculaire-pre/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/04/19/losmapimod-en-cardiovasculaire-uitkomsten-na-acuut-myocardinfarct-jama-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piet-w-boonstra","type":"person","url":"https://hartvaat.nl/mensen/piet-w-boonstra/","name":"Piet W Boonstra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pietro-caliandro","type":"person","url":"https://hartvaat.nl/mensen/pietro-caliandro/","name":"Pietro Caliandro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ping-yang","type":"person","url":"https://hartvaat.nl/mensen/ping-yang/","name":"Ping Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/explorer-cn-week-78-langetermijneffect-en-veiligheid-van-mavacamten-bij-chinese-/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ping-zhang","type":"person","url":"https://hartvaat.nl/mensen/ping-zhang/","name":"Ping Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"plinio-cirillo","type":"person","url":"https://hartvaat.nl/mensen/plinio-cirillo/","name":"Plinio Cirillo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2020/08/04/cangrelor-tirofiban-en-prasugrel-bij-stemi-primaire-resultaten/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pontus-lindroos","type":"person","url":"https://hartvaat.nl/mensen/pontus-lindroos/","name":"Pontus Lindroos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prapa-kanagaratnam","type":"person","url":"https://hartvaat.nl/mensen/prapa-kanagaratnam/","name":"Prapa Kanagaratnam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2019/08/01/optimale-laesieset-bij-persisterend-af-ablatie-meta-regressie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2017/07/01/crt-werkingsmechanismen-en-mogelijkheden-voor-verdere-verbetering/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-ajay-j-kirtane","type":"person","url":"https://hartvaat.nl/mensen/prof-ajay-j-kirtane/","name":"Prof. Ajay J. Kirtane","title":"Columbia University Irving Medical Center, New York, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/expert-all-rise-coronaire-fysiologie-kirtane/","title":"Expertinterview: ALL-RISE — angiografie-gebaseerde FFR met Ajay Kirtane"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-lars-h-lund","type":"person","url":"https://hartvaat.nl/mensen/prof-lars-h-lund/","name":"Prof. Lars H. Lund","title":"Hoogleraar cardiologie, Karolinska Institutet, Stockholm, Zweden","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/hfa-2026-late-breaking-science/ac01-orale-inotroop-goal-hf1/","title":"GOAL-HF1 — Orale inotroop AC01 bij HFrEF: veiligheid en werkzaamheid"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prof-navin-k-kapur","type":"person","url":"https://hartvaat.nl/mensen/prof-navin-k-kapur/","name":"Prof. Navin K. Kapur","title":"Tufts Medical Center, Boston, VS","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/acc26-late-breaking-science/expert-stemi-dtu-mechanische-ondersteuning-kapur/","title":"Expertinterview: STEMI-DTU — mechanische circulatoire ondersteuning met Navin Kapur"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"puja-b-parikh","type":"person","url":"https://hartvaat.nl/mensen/puja-b-parikh/","name":"Puja B Parikh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"},{"url":"https://hartvaat.nl/2024/04/25/dapa-mi-empagliflozine-na-acuut-mi-zonder-hf-of-diabetes-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"puja-banka","type":"person","url":"https://hartvaat.nl/mensen/puja-banka/","name":"Puja Banka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/05/orale-pcsk9-remmer-enlicitide-verlaagt-ldl-met-57-placebogecontroleerde-trial/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/13/enlicitide-orale-pcsk9-remmer-bij-heterozygote-fh-fase-3/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2023/04/25/mk-0616-eerste-orale-pcsk9-remmer-in-fase-2b/","published":"2023-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qi-guo","type":"person","url":"https://hartvaat.nl/mensen/qi-guo/","name":"Qi Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiang-liu","type":"person","url":"https://hartvaat.nl/mensen/qiang-liu/","name":"Qiang Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qianhui-ling","type":"person","url":"https://hartvaat.nl/mensen/qianhui-ling/","name":"Qianhui Ling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/08/01/voordeel-en-risico-van-intensieve-bloeddrukcontrole-naar-cv-risico/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/09/01/hypertensieduur-en-effect-van-intensieve-bloeddrukbehandeling/","published":"2024-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qidong-zheng","type":"person","url":"https://hartvaat.nl/mensen/qidong-zheng/","name":"Qidong Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"r-nick-bryan","type":"person","url":"https://hartvaat.nl/mensen/r-nick-bryan/","name":"R Nick Bryan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"r-a","type":"person","url":"https://hartvaat.nl/mensen/r-a/","name":"R. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/31/stemi-uitgestelde-primaire-pci-gaat-gepaard-met-hogere-sterfte-dan-trombolyse-ie/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/02/23/objectief-gemeten-lichaamsbeweging-en-levenskwaliteit-bij-hypertrofische-cardiom/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/04/pulsed-field-ablatie-bereikt-vaker-complete-achterwandisolatie-dan-radiofrequent/","published":"2026-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rachel-laskey","type":"person","url":"https://hartvaat.nl/mensen/rachel-laskey/","name":"Rachel Laskey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/05/05/atorvastatine-vermindert-eerste-en-volgende-vasculaire-events-sparcl/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2017/04/06/gewichtsfluctuaties-en-cardiovasculaire-uitkomsten-bij-coronairlijden-nejm/","published":"2017-04-06"},{"url":"https://hartvaat.nl/2017/01/17/geoxideerde-fosfolipiden-op-apob-100-en-recidiverende-ischemische-events-na-cva/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rachele-tortorella","type":"person","url":"https://hartvaat.nl/mensen/rachele-tortorella/","name":"Rachele Tortorella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raffaele-bugiardini","type":"person","url":"https://hartvaat.nl/mensen/raffaele-bugiardini/","name":"Raffaele Bugiardini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/03/05/ongelijke-toegang-tot-cardiovasculaire-zorg-in-europa/","published":"2026-04-10"},{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raffaele-ornello","type":"person","url":"https://hartvaat.nl/mensen/raffaele-ornello/","name":"Raffaele Ornello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raffaele-salerno","type":"person","url":"https://hartvaat.nl/mensen/raffaele-salerno/","name":"Raffaele Salerno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raisa-kurlyandskaya","type":"person","url":"https://hartvaat.nl/mensen/raisa-kurlyandskaya/","name":"Raisa Kurlyandskaya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajan-sharma","type":"person","url":"https://hartvaat.nl/mensen/rajan-sharma/","name":"Rajan Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/01/cardiale-structuur-en-functie-bij-hypertensieve-zwangerschapsstoornissen-systema/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2022/02/01/myocardiale-mechanica-bij-hypertensieve-zwangerschapsaandoeningen-meta-analyse/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajesh-vedanthan","type":"person","url":"https://hartvaat.nl/mensen/rajesh-vedanthan/","name":"Rajesh Vedanthan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"},{"url":"https://hartvaat.nl/2016/02/09/peergroepinterventie-voor-cardiovasculaire-risicofactoren-de-fifty-fifty-trial/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajiv-gulati","type":"person","url":"https://hartvaat.nl/mensen/rajiv-gulati/","name":"Rajiv Gulati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-consensus-same-day-ontslag-na-pci/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2018/05/08/spontane-coronaire-arterie-dissectie-aha-scientific-statement/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rakesh-gopinathannair","type":"person","url":"https://hartvaat.nl/mensen/rakesh-gopinathannair/","name":"Rakesh Gopinathannair","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2018/01/01/linkeratriumvolume-voorspelt-af-recidief-na-radiofrequentieablatie-meta-analyse/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralph-l-sacco","type":"person","url":"https://hartvaat.nl/mensen/ralph-l-sacco/","name":"Ralph L Sacco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rama-guggilla","type":"person","url":"https://hartvaat.nl/mensen/rama-guggilla/","name":"Rama Guggilla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramachandran-s-vasan","type":"person","url":"https://hartvaat.nl/mensen/ramachandran-s-vasan/","name":"Ramachandran S Vasan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2023/01/10/dagelijkse-stappen-en-cardiovasculaire-ziekte-geharmoniseerde-meta-analyse/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramzi-a-ajjan","type":"person","url":"https://hartvaat.nl/mensen/ramzi-a-ajjan/","name":"Ramzi A Ajjan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/25/meta-analyse-glp-1-agonisten-voorkomen-hartfalen-in-type-2-diabetes-sterkste-eff/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/03/06/veroudering-en-myocarddisfunctie-het-hart-jong-houden/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2018/04/01/fibrinestoleigenschappen-en-klinische-uitkomsten-na-acs-plato-substudie/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rana-fayyad","type":"person","url":"https://hartvaat.nl/mensen/rana-fayyad/","name":"Rana Fayyad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/05/05/atorvastatine-vermindert-eerste-en-volgende-vasculaire-events-sparcl/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2017/11/21/bloeddrukeffecten-van-ibuprofen-naproxen-en-celecoxib-bij-artritis-precision-abp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2017/04/06/gewichtsfluctuaties-en-cardiovasculaire-uitkomsten-bij-coronairlijden-nejm/","published":"2017-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"randal-j-thomas","type":"person","url":"https://hartvaat.nl/mensen/randal-j-thomas/","name":"Randal J Thomas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"randall-s-stafford","type":"person","url":"https://hartvaat.nl/mensen/randall-s-stafford/","name":"Randall S Stafford","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/03/01/voorschrijfpatronen-van-thiazidediuretica-in-de-sprint-trial/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ranjit-john","type":"person","url":"https://hartvaat.nl/mensen/ranjit-john/","name":"Ranjit John","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raphael-twerenbold","type":"person","url":"https://hartvaat.nl/mensen/raphael-twerenbold/","name":"Raphael Twerenbold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raquel-lopez-vilella","type":"person","url":"https://hartvaat.nl/mensen/raquel-lopez-vilella/","name":"Raquel López-Vilella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/13/verisec-register-vericiguat-halveert-hartfalen-decompensaties-bij-hfref-in-dagel/","published":"2026-06-21"},{"url":"https://hartvaat.nl/2026/05/13/verisec-vericiguat-in-de-praktijk-halveert-hartfalen-decompensaties-bij-hfref-sp/","published":"2026-05-15"},{"url":"https://hartvaat.nl/2025/04/01/ultrafiltratie-bij-cardiorenaal-syndroom-systematische-review/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rasmus-rrth","type":"person","url":"https://hartvaat.nl/mensen/rasmus-rrth/","name":"Rasmus Rørth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/09/01/antistolling-bij-hf-met-sinusritme-systematische-review-en-meta-analyse/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ravi-b-patel","type":"person","url":"https://hartvaat.nl/mensen/ravi-b-patel/","name":"Ravi B Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2017/02/07/doodsoorzaken-bij-hartfalen-met-behouden-ejectiefractie/","published":"2017-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raymond-y-kwong","type":"person","url":"https://hartvaat.nl/mensen/raymond-y-kwong/","name":"Raymond Y Kwong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/08/08/stop-ca-atorvastatine-beschermt-tegen-antracycline-cardiotoxiciteit/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2016/08/02/omega-3-vetzuren-en-linkerkamerremodellering-na-acuut-mi-omega-remodel-trial/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebecca-cogswell","type":"person","url":"https://hartvaat.nl/mensen/rebecca-cogswell/","name":"Rebecca Cogswell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reda-ibrahim","type":"person","url":"https://hartvaat.nl/mensen/reda-ibrahim/","name":"Reda Ibrahim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"},{"url":"https://hartvaat.nl/2017/01/01/percutane-linker-hartoorsluiting-munchen-consensusdocument-over-definities-en-ei/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reem-a-mustafa","type":"person","url":"https://hartvaat.nl/mensen/reem-a-mustafa/","name":"Reem A Mustafa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2022/01/01/farmacologische-hypertensiebehandeling-bij-volwassenen-who-richtlijn-samenvattin/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/12/01/predictieve-modellen-voor-cv-en-renale-uitkomsten-bij-diabetes-type-2-meta-analy/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"regitze-videbk","type":"person","url":"https://hartvaat.nl/mensen/regitze-videbk/","name":"Regitze Videbæk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reinoud-e-knops","type":"person","url":"https://hartvaat.nl/mensen/reinoud-e-knops/","name":"Reinoud E Knops","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/lage-voorspelde-adherentie-verhoogt-stroke-risico-bij-af-patienten-die-starten-m/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2026/02/03/upgrade-van-draadloze-pacemaker-van-enkelvoudig-naar-tweekamersysteem/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2017/12/05/j-curve-bij-gerandomiseerde-bloeddrukstreefwaarden-sprint-experimentele-analyse/","published":"2017-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"renzo-laborante","type":"person","url":"https://hartvaat.nl/mensen/renzo-laborante/","name":"Renzo Laborante","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/24/myocardiale-brug-praktische-gids-voor-diagnose-en-behandeling-in-het-ccta-tijdpe/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2026/02/03/vroeg-starten-met-mra-na-acuut-hartfalen-of-myocardinfarct-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reto-gamma","type":"person","url":"https://hartvaat.nl/mensen/reto-gamma/","name":"Reto Gamma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reza-malekzadeh","type":"person","url":"https://hartvaat.nl/mensen/reza-malekzadeh/","name":"Reza Malekzadeh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/08/24/vaste-dosiscombinatietherapie-voor-primaire-cv-preventie-ipd-meta-analyse/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2019/08/24/polypil-voor-primaire-en-secundaire-cv-preventie-lancet-polyiran/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rhonda-m-cooper-dehoff","type":"person","url":"https://hartvaat.nl/mensen/rhonda-m-cooper-dehoff/","name":"Rhonda M Cooper-DeHoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/langetermijnmortaliteit-bij-hypertensie-met-coronairlijden-invest-us-cohort/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ricardo-rigual","type":"person","url":"https://hartvaat.nl/mensen/ricardo-rigual/","name":"Ricardo Rigual","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-buchsbaum","type":"person","url":"https://hartvaat.nl/mensen/richard-buchsbaum/","name":"Richard Buchsbaum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/lv-dimensies-en-cv-uitkomsten-bij-systolisch-hf-warcef/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-evans","type":"person","url":"https://hartvaat.nl/mensen/richard-evans/","name":"Richard Evans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/24/tight-k-kaliumsuppletie-voorkomt-af-na-hartchirurgie-rct/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-good","type":"person","url":"https://hartvaat.nl/mensen/richard-good/","name":"Richard Good","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-hobbs","type":"person","url":"https://hartvaat.nl/mensen/richard-hobbs/","name":"Richard Hobbs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":0,"articles":[],"videos":[{"url":"https://hartvaat.nl/video/aldosteron-ontregeling-hypertensie-esc/nieuwe-data-in-praktijk-hobbs/","title":"Wat betekent nieuwe data voor de praktijk? — Richard Hobbs"}],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-i-lindley","type":"person","url":"https://hartvaat.nl/mensen/richard-i-lindley/","name":"Richard I Lindley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-j-folkeringa","type":"person","url":"https://hartvaat.nl/mensen/richard-j-folkeringa/","name":"Richard J Folkeringa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-k-cheng","type":"person","url":"https://hartvaat.nl/mensen/richard-k-cheng/","name":"Richard K Cheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/nierbescherming-na-harttransplantatie-risicoreductie-en-therapeutische-mogelijkh/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/02/10/2025-acc-attr-cm-evaluatie-en-management-beknopte-klinische-richtlijn/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-lee","type":"person","url":"https://hartvaat.nl/mensen/richard-lee/","name":"Richard Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/20/2018-acc-aha-hrs-richtlijn-voor-bradycardie-en-geleidingsstoornissen/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rikard-linder","type":"person","url":"https://hartvaat.nl/mensen/rikard-linder/","name":"Rikard Linder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"},{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rishi-rikhi","type":"person","url":"https://hartvaat.nl/mensen/rishi-rikhi/","name":"Rishi Rikhi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/16/lp-a-en-hscrp-voorspellen-ascvd-bij-mensen-zonder-klassieke-risicofactoren/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"risto-o-roine","type":"person","url":"https://hartvaat.nl/mensen/risto-o-roine/","name":"Risto O Roine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2017/11/28/xenon-inhalatie-vermindert-myocardschade-bij-overlevenden-van-hartstilstand-xe-h/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antiplaatjestherapie-bij-cryptogeen-cva-nejm-close/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-clarke","type":"person","url":"https://hartvaat.nl/mensen/robert-clarke/","name":"Robert Clarke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-e-michler","type":"person","url":"https://hartvaat.nl/mensen/robert-e-michler/","name":"Robert E Michler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-edwards","type":"person","url":"https://hartvaat.nl/mensen/robert-edwards/","name":"Robert Edwards","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/02/04/canagliflozine-bij-diabetes-type-2-met-ckd-evaluatie-van-cv-en-renale-events/","published":"2020-02-04"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-g-hart","type":"person","url":"https://hartvaat.nl/mensen/robert-g-hart/","name":"Robert G Hart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"},{"url":"https://hartvaat.nl/2016/01/01/bereikte-bloeddruk-en-uitkomsten-in-de-sps3-trial-bij-lacunaire-herseninfarcten/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-g-josse","type":"person","url":"https://hartvaat.nl/mensen/robert-g-josse/","name":"Robert G Josse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/peulvruchten-in-de-voeding-verlagen-ldl-en-non-hdl-dose-response-meta-analyse-va/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-h-eckel","type":"person","url":"https://hartvaat.nl/mensen/robert-h-eckel/","name":"Robert H Eckel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2016/12/13/alirocumab-en-reductie-in-atherogene-lipiden-en-cardiovasculaire-events-10-odyss/","published":"2016-12-13"},{"url":"https://hartvaat.nl/2016/10/14/geen-effect-van-pcsk9-remmer-alirocumab-op-diabetes-incidentie-odyssey-analyse/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-m-clare","type":"person","url":"https://hartvaat.nl/mensen/robert-m-clare/","name":"Robert M Clare","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2017/03/14/afweging-myocardinfarct-versus-bloedingstype-en-mortaliteit-na-acs-tra-2p-timi-5/","published":"2017-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-zymlinski","type":"person","url":"https://hartvaat.nl/mensen/robert-zymlinski/","name":"Robert Zymliński","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/26/machine-learning-voorspelt-diureticumrespons-bij-acuut-hartfalen-drc-ahf/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2026/05/26/adipokineprofiel-bij-acuut-hartfalen-voorspelt-natriuretische-respons-en-mortali/","published":"2026-05-30"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-galea","type":"person","url":"https://hartvaat.nl/mensen/roberto-galea/","name":"Roberto Galea","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/08/amulet-versus-watchman-flx-driejaarsresultaten-laa-sluiting/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2024/02/06/swiss-apero-amulet-versus-watchman-na-1-jaar-voor-laa-sluiting/","published":"2024-02-06"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-kalil-filho","type":"person","url":"https://hartvaat.nl/mensen/roberto-kalil-filho/","name":"Roberto Kalil Filho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/kanker-en-coronaire-atherosclerotische-plaquebelasting-inzichten-uit-de-bravado-/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2021/10/01/inspiratoire-spiertraining-plus-aerobe-training-en-neurovasculaire-controle-bij-/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-pisoni","type":"person","url":"https://hartvaat.nl/mensen/roberto-pisoni/","name":"Roberto Pisoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/05/05/intensieve-bloeddruk-en-aortastijfheid-sprint-heart/","published":"2021-05-05"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robin-young","type":"person","url":"https://hartvaat.nl/mensen/robin-young/","name":"Robin Young","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2017/04/14/systolische-bloeddruk-en-werkzaamheid-van-sacubitril-valsartan-bij-chronisch-hfr/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roby-rakhit","type":"person","url":"https://hartvaat.nl/mensen/roby-rakhit/","name":"Roby Rakhit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robyn-l-mcclelland","type":"person","url":"https://hartvaat.nl/mensen/robyn-l-mcclelland/","name":"Robyn L McClelland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/01/pah-behandeling-ipd-netwerk-meta-analyse-van-alle-therapieen/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2018/03/27/hdl-subspecies-met-apoliproteine-c-iii-en-coronairlijden-vier-cohorten/","published":"2018-03-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robyn-l-woods","type":"person","url":"https://hartvaat.nl/mensen/robyn-l-woods/","name":"Robyn L Woods","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","published":"2020-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roger-chou","type":"person","url":"https://hartvaat.nl/mensen/roger-chou/","name":"Roger Chou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/23/uspstf-evidence-review-statines-voor-primaire-cv-preventie-geactualiseerd/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/05/25/gedragsinterventies-voor-gezond-gewicht-in-de-zwangerschap-jama-uspstf-evidence-/","published":"2021-05-25"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-evidence-report/","published":"2016-11-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roland-f-dreier","type":"person","url":"https://hartvaat.nl/mensen/roland-f-dreier/","name":"Roland F Dreier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roland-p-t-troquay","type":"person","url":"https://hartvaat.nl/mensen/roland-p-t-troquay/","name":"Roland P T Troquay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/04/13/inclisiran-bij-patienten-met-hoog-cv-risico-en-verhoogd-ldl-nejm-orion-1/","published":"2017-04-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roland-veltkamp","type":"person","url":"https://hartvaat.nl/mensen/roland-veltkamp/","name":"Roland Veltkamp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roland-wensel","type":"person","url":"https://hartvaat.nl/mensen/roland-wensel/","name":"Roland Wensel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/01/orbita-substudie-inspanningstesten-en-pci-effectiviteit/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronak-delewi","type":"person","url":"https://hartvaat.nl/mensen/ronak-delewi/","name":"Ronak Delewi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronan-collins","type":"person","url":"https://hartvaat.nl/mensen/ronan-collins/","name":"Ronan Collins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronen-durst","type":"person","url":"https://hartvaat.nl/mensen/ronen-durst/","name":"Ronen Durst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2024/01/30/orion-5-inclisiran-bij-homozygote-fh/","published":"2024-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rong-bing","type":"person","url":"https://hartvaat.nl/mensen/rong-bing/","name":"Rong Bing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2020/08/01/inspannings-ecg-versus-ccta-bij-stabiele-angina-post-hoc-vergelijking/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/10/22/ccta-geleide-therapie-verbetert-uitkomsten-bij-stabiele-pijn-op-de-borst/","published":"2019-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rong-liu","type":"person","url":"https://hartvaat.nl/mensen/rong-liu/","name":"Rong Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/18/orforglipron-bij-vroeg-type-2-diabetes-nejm-fase-3/","published":"2025-09-18"},{"url":"https://hartvaat.nl/2025/09/06/panda-ii-griepvaccinatie-bij-acuut-hartfalen-multicenter-rct/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/09/07/orforglipron-dagelijkse-orale-glp-1-agonist-bij-obesitas-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rose-a-hamershock","type":"person","url":"https://hartvaat.nl/mensen/rose-a-hamershock/","name":"Rose A Hamershock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/05/14/edoxaban-bij-aziatische-af-patienten-concentraties-en-anti-xa-activiteit/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2019/02/01/edoxaban-en-implanteerbare-cardiale-devices-engage-af-timi-48/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roser-torra","type":"person","url":"https://hartvaat.nl/mensen/roser-torra/","name":"Roser Torra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/02/25/de-mondiale-ziektelast-van-chronische-nierziekte-elke-20-seconden-een-sterfgeval/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roumeisa-khalil","type":"person","url":"https://hartvaat.nl/mensen/roumeisa-khalil/","name":"Roumeisa Khalil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roza-meyer-saraei","type":"person","url":"https://hartvaat.nl/mensen/roza-meyer-saraei/","name":"Roza Meyer-Saraei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"},{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruben-casado-arroyo","type":"person","url":"https://hartvaat.nl/mensen/ruben-casado-arroyo/","name":"Ruben Casado-Arroyo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2024/08/03/dagontslag-versus-overnachting-na-af-ablatie-uitgebreide-meta-analyse/","published":"2024-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruijuan-zhang","type":"person","url":"https://hartvaat.nl/mensen/ruijuan-zhang/","name":"Ruijuan Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/20/zoutvervanger-voorkomt-hypertensie-bij-normotensieve-volwassenen/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruka-yoshida","type":"person","url":"https://hartvaat.nl/mensen/ruka-yoshida/","name":"Ruka Yoshida","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"russell-scott","type":"person","url":"https://hartvaat.nl/mensen/russell-scott/","name":"Russell Scott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/13/enlicitide-orale-pcsk9-remmer-bij-heterozygote-fh-fase-3/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2024/09/01/lerodalcibep-bij-ascvd-of-hoog-risico-fase-3-resultaten/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/10/21/lerodalcibep-bij-familiaire-hypercholesterolemie-liberate-hefh-langetermijndata/","published":"2023-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruth-owen","type":"person","url":"https://hartvaat.nl/mensen/ruth-owen/","name":"Ruth Owen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruth-alma-n-turkson-ocran","type":"person","url":"https://hartvaat.nl/mensen/ruth-alma-n-turkson-ocran/","name":"Ruth-Alma N Turkson-Ocran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/06/gofresh-dash-boodschappen-en-bloeddrukeffect-rct/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/08/01/sociale-determinanten-en-hypertensie-uitkomsten-systematische-review/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/04/01/lichaamshouding-en-orthostatische-hypotensie-bij-hypertensie-syst-eur-analyse/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ryan-wereski","type":"person","url":"https://hartvaat.nl/mensen/ryan-wereski/","name":"Ryan Wereski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2022/01/13/risicofactoren-voor-type-1-en-type-2-mi/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ryusuke-nishikawa","type":"person","url":"https://hartvaat.nl/mensen/ryusuke-nishikawa/","name":"Ryusuke Nishikawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"s-chris-malaisrie","type":"person","url":"https://hartvaat.nl/mensen/s-chris-malaisrie/","name":"S Chris Malaisrie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"s-matthijs-boekholdt","type":"person","url":"https://hartvaat.nl/mensen/s-matthijs-boekholdt/","name":"S Matthijs Boekholdt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2018/10/01/geschat-individueel-levensvoordeel-van-pcsk9-remming-bij-statinebehandelde-cad-p/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"s-m","type":"person","url":"https://hartvaat.nl/mensen/s-m/","name":"S. M.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/03/warrior-trial-intensieve-medicamenteuze-behandeling-verbetert-de-uitkomsten-niet/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/04/24/relatieve-apicale-sparing-op-strain-echo-voor-cardiale-amyloidose-meta-analyse-v/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sadeesh-k-srinathan","type":"person","url":"https://hartvaat.nl/mensen/sadeesh-k-srinathan/","name":"Sadeesh K Srinathan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2016/01/07/preoperatief-statinegebruik-en-cardiovasculaire-complicaties-bij-niet-cardiale-c/","published":"2016-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saeid-mirzai","type":"person","url":"https://hartvaat.nl/mensen/saeid-mirzai/","name":"Saeid Mirzai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/16/lp-a-en-hscrp-voorspellen-ascvd-bij-mensen-zonder-klassieke-risicofactoren/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"safia-chatur","type":"person","url":"https://hartvaat.nl/mensen/safia-chatur/","name":"Safia Chatur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/06/04/sacubitril-valsartan-bij-hartfalen-over-het-nierfunctiespectrum/","published":"2024-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sam-j-lehman","type":"person","url":"https://hartvaat.nl/mensen/sam-j-lehman/","name":"Sam J Lehman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"},{"url":"https://hartvaat.nl/2016/04/19/evolocumab-versus-ezetimibe-bij-statine-intolerante-patienten-de-gauss-3-trial/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sam-mort","type":"person","url":"https://hartvaat.nl/mensen/sam-mort/","name":"Sam Mort","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saman-rasoul","type":"person","url":"https://hartvaat.nl/mensen/saman-rasoul/","name":"Saman Rasoul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sameer-bansilal","type":"person","url":"https://hartvaat.nl/mensen/sameer-bansilal/","name":"Sameer Bansilal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/02/06/ticagrelor-voor-secundaire-preventie-bij-multivaten-coronairlijden/","published":"2018-02-06"},{"url":"https://hartvaat.nl/2016/06/14/reductie-van-ischemische-events-met-ticagrelor-bij-diabetes-na-myocardinfarct-pe/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/02/09/peergroepinterventie-voor-cardiovasculaire-risicofactoren-de-fifty-fifty-trial/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samer-somi","type":"person","url":"https://hartvaat.nl/mensen/samer-somi/","name":"Samer Somi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samuel-f-sears","type":"person","url":"https://hartvaat.nl/mensen/samuel-f-sears/","name":"Samuel F Sears","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samuel-z-goldhaber","type":"person","url":"https://hartvaat.nl/mensen/samuel-z-goldhaber/","name":"Samuel Z Goldhaber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/longembolie-epidemiologie-stijgende-last-bij-vergrijzing-preventiestrategieen-bl/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2020/03/07/alert-gebaseerde-beslissingsondersteuning-voor-anticoagulatie-bij-af-in-het-ziek/","published":"2020-03-07"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandeep-buddha","type":"person","url":"https://hartvaat.nl/mensen/sandeep-buddha/","name":"Sandeep Buddha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandeep-r-das","type":"person","url":"https://hartvaat.nl/mensen/sandeep-r-das/","name":"Sandeep R Das","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2019/05/21/vroegtijdig-staken-van-ticagrelor-bij-secundaire-cv-preventie-jacc-review/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandra-ahmed","type":"person","url":"https://hartvaat.nl/mensen/sandra-ahmed/","name":"Sandra Ahmed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-gon-lee","type":"person","url":"https://hartvaat.nl/mensen/sang-gon-lee/","name":"Sang-Gon Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/04/01/valsartan-en-linkerkamerremodellering-na-mi/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-hyun-kim","type":"person","url":"https://hartvaat.nl/mensen/sang-hyun-kim/","name":"Sang-Hyun Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjay-k-prasad","type":"person","url":"https://hartvaat.nl/mensen/sanjay-k-prasad/","name":"Sanjay K Prasad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjay-kaul","type":"person","url":"https://hartvaat.nl/mensen/sanjay-kaul/","name":"Sanjay Kaul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjib-k-sharma","type":"person","url":"https://hartvaat.nl/mensen/sanjib-k-sharma/","name":"Sanjib K Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sara-ariotti","type":"person","url":"https://hartvaat.nl/mensen/sara-ariotti/","name":"Sara Ariotti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/08/07/adenosine-en-ticagrelorspiegels-bij-patienten-met-en-zonder-ticagrelor-dyspneu/","published":"2018-08-07"},{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sara-paul","type":"person","url":"https://hartvaat.nl/mensen/sara-paul/","name":"Sara Paul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/13/implanteerbare-hemodynamische-monitoren-verbeteren-overleving-bij-hfref/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarah-a-gaussoin","type":"person","url":"https://hartvaat.nl/mensen/sarah-a-gaussoin/","name":"Sarah A Gaussoin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/22/lichaamssamenstelling-en-risico-op-hartfalen-en-mi-prospectieve-analyse/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarah-mullen","type":"person","url":"https://hartvaat.nl/mensen/sarah-mullen/","name":"Sarah Mullen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2022/02/01/ccta-afgeleide-ffr-prognostische-waarde-meta-analyse/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sasha-koul","type":"person","url":"https://hartvaat.nl/mensen/sasha-koul/","name":"Sasha Koul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satoshi-honda","type":"person","url":"https://hartvaat.nl/mensen/satoshi-honda/","name":"Satoshi Honda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satoshi-hoshide","type":"person","url":"https://hartvaat.nl/mensen/satoshi-hoshide/","name":"Satoshi Hoshide","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/06/01/interarmbloeddrukverschil-en-beroerte-ipd-meta-analyse/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/04/01/prognostisch-effect-van-nachtelijke-bloeddrukdaling-bij-hypertensie-de-abc-h-stu/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satoshi-shizuta","type":"person","url":"https://hartvaat.nl/mensen/satoshi-shizuta/","name":"Satoshi Shizuta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saumil-oza","type":"person","url":"https://hartvaat.nl/mensen/saumil-oza/","name":"Saumil Oza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2025/10/31/vrouwen-met-persisterend-af-pvi-alleen-is-onvoldoende/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"savina-nodari","type":"person","url":"https://hartvaat.nl/mensen/savina-nodari/","name":"Savina Nodari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-c-silvestry","type":"person","url":"https://hartvaat.nl/mensen/scott-c-silvestry/","name":"Scott C Silvestry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"se-hun-kang","type":"person","url":"https://hartvaat.nl/mensen/se-hun-kang/","name":"Se Hun Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-pinney","type":"person","url":"https://hartvaat.nl/mensen/sean-pinney/","name":"Sean Pinney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2019/10/01/verbetering-van-communicatie-bij-hartfalenpatientenzorg/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-van-diepen","type":"person","url":"https://hartvaat.nl/mensen/sean-van-diepen/","name":"Sean van Diepen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/01/hoog-versus-laag-zuurstof-bij-acuut-hartfalen-hilo-hf-pilot/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"},{"url":"https://hartvaat.nl/2017/01/17/dapt-versus-aspirine-monotherapie-bij-diabetes-met-multivatenlijden-na-cabg-free/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastian-rosch","type":"person","url":"https://hartvaat.nl/mensen/sebastian-rosch/","name":"Sebastian Rosch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastiano-gili","type":"person","url":"https://hartvaat.nl/mensen/sebastiano-gili/","name":"Sebastiano Gili","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"senthil-selvaraj","type":"person","url":"https://hartvaat.nl/mensen/senthil-selvaraj/","name":"Senthil Selvaraj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/04/14/systolische-bloeddruk-bij-hfpef-behandeld-met-sacubitril-valsartan-paragon-hf/","published":"2020-04-14"},{"url":"https://hartvaat.nl/2018/04/10/geen-verband-tussen-hartfalen-en-kankerincidentie/","published":"2018-04-10"},{"url":"https://hartvaat.nl/2016/11/29/presentatie-buiten-kantoortijden-versus-tijdens-kantoortijden-bij-stemi-champion/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seok-yeon-kim","type":"person","url":"https://hartvaat.nl/mensen/seok-yeon-kim/","name":"Seok Yeon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seok-min-kang","type":"person","url":"https://hartvaat.nl/mensen/seok-min-kang/","name":"Seok-Min Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/harttransplantatie-bij-hoogste-urgentie-meer-vroege-infecties-en-sterfte-mede-do/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2024/06/11/effort-ertugliflozine-bij-functionele-mitralisinsufficientie-en-hartfalen/","published":"2024-06-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serban-puricel","type":"person","url":"https://hartvaat.nl/mensen/serban-puricel/","name":"Serban Puricel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/27/tavr-bij-patienten-65-jaar-hogere-sterfte-en-heropnames-dan-chirurgie-maar-onvol/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/03/01/bioresorbeerbare-scaffold-trombose-multicenteranalyse-van-klinische-presentatie-/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serdar-farhan","type":"person","url":"https://hartvaat.nl/mensen/serdar-farhan/","name":"Serdar Farhan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/12/01/culprit-laesielocatie-en-uitkomsten-van-culprit-only-vs-multivaten-pci-culprit-s/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serena-caglioni","type":"person","url":"https://hartvaat.nl/mensen/serena-caglioni/","name":"Serena Caglioni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-ho-hur","type":"person","url":"https://hartvaat.nl/mensen/seung-ho-hur/","name":"Seung Ho Hur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-hun-lee","type":"person","url":"https://hartvaat.nl/mensen/seung-hun-lee/","name":"Seung Hun Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-hwan-han","type":"person","url":"https://hartvaat.nl/mensen/seung-hwan-han/","name":"Seung Hwan Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-jea-tahk","type":"person","url":"https://hartvaat.nl/mensen/seung-jea-tahk/","name":"Seung-Jea Tahk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2020/05/05/des-versus-cabg-bij-linker-hoofdstam-10-jaarsresultaten-excel-extended/","published":"2020-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seunghwan-kim","type":"person","url":"https://hartvaat.nl/mensen/seunghwan-kim/","name":"Seunghwan Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaoping-nie","type":"person","url":"https://hartvaat.nl/mensen/shaoping-nie/","name":"Shaoping Nie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sharon-l-mulvagh","type":"person","url":"https://hartvaat.nl/mensen/sharon-l-mulvagh/","name":"Sharon L Mulvagh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shay-mcguinness","type":"person","url":"https://hartvaat.nl/mensen/shay-mcguinness/","name":"Shay McGuinness","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheila-greenfield","type":"person","url":"https://hartvaat.nl/mensen/sheila-greenfield/","name":"Sheila Greenfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shelby-d-reed","type":"person","url":"https://hartvaat.nl/mensen/shelby-d-reed/","name":"Shelby D Reed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2021/07/15/fysieke-revalidatie-bij-oudere-gehospitaliseerde-hf-patienten-nejm-rehab-hf/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheldon-m-singh","type":"person","url":"https://hartvaat.nl/mensen/sheldon-m-singh/","name":"Sheldon M Singh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shelley-hall","type":"person","url":"https://hartvaat.nl/mensen/shelley-hall/","name":"Shelley Hall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shigeru-saito","type":"person","url":"https://hartvaat.nl/mensen/shigeru-saito/","name":"Shigeru Saito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"},{"url":"https://hartvaat.nl/2018/07/07/orbusneich-combo-stent-japan-usa-harmonee-gerandomiseerde-multicenter-trial/","published":"2018-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shih-jen-hwang","type":"person","url":"https://hartvaat.nl/mensen/shih-jen-hwang/","name":"Shih-Jen Hwang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shinwan-kany","type":"person","url":"https://hartvaat.nl/mensen/shinwan-kany/","name":"Shinwan Kany","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2025/09/09/pathogene-cardiomyopathie-genvarianten-en-prognose-bij-af/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2023/05/19/east-afnet-4-vroege-ritmecontrole-bij-af-is-kosteneffectief/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shoaib-afzal","type":"person","url":"https://hartvaat.nl/mensen/shoaib-afzal/","name":"Shoaib Afzal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/lipidegerelateerd-cv-risico-voorbij-ldl-focus-verschuift-naar-remnant-cholestero/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/01/01/risico-op-atherosclerotische-hart-en-vaatziekten-bij-familiaire-restanthyperlipi/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shofiqul-islam","type":"person","url":"https://hartvaat.nl/mensen/shofiqul-islam/","name":"Shofiqul Islam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/05/13/wereldwijde-hf-registry-fev1-is-een-onafhankelijke-prognostische-factor-pleidooi/","published":"2026-05-15"},{"url":"https://hartvaat.nl/2019/10/05/uitgebreide-community-interventie-bij-hypertensie-lancet-hope-4/","published":"2019-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shoshana-h-ballew","type":"person","url":"https://hartvaat.nl/mensen/shoshana-h-ballew/","name":"Shoshana H Ballew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shoujiang-you","type":"person","url":"https://hartvaat.nl/mensen/shoujiang-you/","name":"Shoujiang You","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shouling-wu","type":"person","url":"https://hartvaat.nl/mensen/shouling-wu/","name":"Shouling Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/cumulatieve-blootstelling-aan-cardiometabole-index-en-risico-op-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shuanglu-zhang","type":"person","url":"https://hartvaat.nl/mensen/shuanglu-zhang/","name":"Shuanglu Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2024/05/16/olezarsen-bij-hypertriglyceridemie-en-hoog-cv-risico-nejm/","published":"2024-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shuhong-su","type":"person","url":"https://hartvaat.nl/mensen/shuhong-su/","name":"Shuhong Su","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shun-kohsaka","type":"person","url":"https://hartvaat.nl/mensen/shun-kohsaka/","name":"Shun Kohsaka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/08/24/de-escalatie-van-dapt-bij-acs-jacc-review/","published":"2021-08-24"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2018/06/12/sglt2-remmers-en-cardiovasculaire-events-de-cvd-real-2-real-world-studie/","published":"2018-06-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shungo-hikoso","type":"person","url":"https://hartvaat.nl/mensen/shungo-hikoso/","name":"Shungo Hikoso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/12/01/egfr-variabiliteit-en-uitkomsten-bij-real-world-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shunichi-homma","type":"person","url":"https://hartvaat.nl/mensen/shunichi-homma/","name":"Shunichi Homma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/lv-dimensies-en-cv-uitkomsten-bij-systolisch-hf-warcef/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"si-wan-choi","type":"person","url":"https://hartvaat.nl/mensen/si-wan-choi/","name":"Si Wan Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"silvia-ulrich","type":"person","url":"https://hartvaat.nl/mensen/silvia-ulrich/","name":"Silvia Ulrich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/06/14/gestandaardiseerde-inspanningstraining-bij-pah-en-cteph-haalbaarheid-en-veilighe/","published":"2021-06-14"},{"url":"https://hartvaat.nl/2017/04/14/zuurstofverrijkte-lucht-en-inspanningsprestatie-bij-precapillaire-pulmonale-hype/","published":"2017-04-14"},{"url":"https://hartvaat.nl/2016/01/01/inspanningstraining-verbetert-zuurstofopname-en-hemodynamiek-bij-ernstige-pulmon/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simona-sacco","type":"person","url":"https://hartvaat.nl/mensen/simona-sacco/","name":"Simona Sacco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simone-marschner","type":"person","url":"https://hartvaat.nl/mensen/simone-marschner/","name":"Simone Marschner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2020/08/01/diagnostische-nauwkeurigheid-van-handheld-ecg-devices-voor-af-community-versus-z/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simrat-k-gill","type":"person","url":"https://hartvaat.nl/mensen/simrat-k-gill/","name":"Simrat K Gill","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sitong-li","type":"person","url":"https://hartvaat.nl/mensen/sitong-li/","name":"Sitong Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"siva-suryadevara","type":"person","url":"https://hartvaat.nl/mensen/siva-suryadevara/","name":"Siva Suryadevara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sofia-malyutina","type":"person","url":"https://hartvaat.nl/mensen/sofia-malyutina/","name":"Sofia Malyutina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"song-lin","type":"person","url":"https://hartvaat.nl/mensen/song-lin/","name":"Song Lin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"song-zuo","type":"person","url":"https://hartvaat.nl/mensen/song-zuo/","name":"Song Zuo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"songyue-liu","type":"person","url":"https://hartvaat.nl/mensen/songyue-liu/","name":"Songyue Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sonia-azzopardi","type":"person","url":"https://hartvaat.nl/mensen/sonia-azzopardi/","name":"Sonia Azzopardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"soo-jin-kang","type":"person","url":"https://hartvaat.nl/mensen/soo-jin-kang/","name":"Soo-Jin Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2016/04/19/statinebehandeling-en-plaquesamenstelling-dubbelblinde-gerandomiseerde-studie/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sophia-zoungas","type":"person","url":"https://hartvaat.nl/mensen/sophia-zoungas/","name":"Sophia Zoungas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sorel-goland","type":"person","url":"https://hartvaat.nl/mensen/sorel-goland/","name":"Sorel Goland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stanley-l-hazen","type":"person","url":"https://hartvaat.nl/mensen/stanley-l-hazen/","name":"Stanley L Hazen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/01/oraal-butyraat-verlaagt-bloeddruk-bij-hypertensie-rct/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/02/10/propionaat-vermindert-atherosclerose-via-immuunregulatie-van-intestinaal-cholest/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steen-hvitfeldt-poulsen","type":"person","url":"https://hartvaat.nl/mensen/steen-hvitfeldt-poulsen/","name":"Steen Hvitfeldt Poulsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/bisoprolol-versus-verapamil-bij-niet-obstructieve-hcm-gerandomiseerde-crossover-/","published":"2026-03-18"},{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-blankenberg","type":"person","url":"https://hartvaat.nl/mensen/stefan-blankenberg/","name":"Stefan Blankenberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefanie-abend","type":"person","url":"https://hartvaat.nl/mensen/stefanie-abend/","name":"Stefanie Abend","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-benussi","type":"person","url":"https://hartvaat.nl/mensen/stefano-benussi/","name":"Stefano Benussi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/de-tien-geboden-van-de-2016-esc-af-richtlijn/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-bordignon","type":"person","url":"https://hartvaat.nl/mensen/stefano-bordignon/","name":"Stefano Bordignon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-de-servi","type":"person","url":"https://hartvaat.nl/mensen/stefano-de-servi/","name":"Stefano De Servi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-forlivesi","type":"person","url":"https://hartvaat.nl/mensen/stefano-forlivesi/","name":"Stefano Forlivesi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-garducci","type":"person","url":"https://hartvaat.nl/mensen/stefano-garducci/","name":"Stefano Garducci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steffen-christensen","type":"person","url":"https://hartvaat.nl/mensen/steffen-christensen/","name":"Steffen Christensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stepan-havranek","type":"person","url":"https://hartvaat.nl/mensen/stepan-havranek/","name":"Stepan Havranek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/08/catheterablatie-versus-leefstijlmodificatie-plus-antiaritmica-bij-af-gerandomise/","published":"2025-07-08"},{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-fichtlscherer","type":"person","url":"https://hartvaat.nl/mensen/stephan-fichtlscherer/","name":"Stephan Fichtlscherer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-b-wilton","type":"person","url":"https://hartvaat.nl/mensen/stephen-b-wilton/","name":"Stephen B Wilton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/09/06/klinisch-beslisondersteuning-vermindert-acute-nierschade-bij-coronairangiografie/","published":"2022-09-06"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-jan","type":"person","url":"https://hartvaat.nl/mensen/stephen-jan/","name":"Stephen Jan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/06/01/lage-dosis-drievoudige-combinatietherapie-bij-hypertensie-triumph-secundaire-ana/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/11/01/lage-dosis-triple-combinatie-en-therapeutische-inertie-bij-hypertensie-jama-card/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2018/08/14/drievoudige-lage-dosis-antihypertensivacombinatie-versus-standaardzorg-jama-gera/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-s-furniss","type":"person","url":"https://hartvaat.nl/mensen/stephen-s-furniss/","name":"Stephen S Furniss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/07/01/implanteerbare-monitors-als-goudstandaard-voor-af-detectie-gerandomiseerde-verge/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/03/01/eerste-trial-met-specifieke-ikach-blokker-toont-geen-reductie-in-af-last-bij-par/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-e-s-miner","type":"person","url":"https://hartvaat.nl/mensen/steven-e-s-miner/","name":"Steven E S Miner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/26/ffr-geleide-pci-versus-cabg-langetermijn-uitkomsten-vergelijking/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2023/09/19/fame-3-driejaarsresultaten-ffr-geleide-pci-versus-cabg-bij-drievatslijden/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2022/01/13/ffr-geleide-pci-versus-cabg-nejm-fame-3/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-g-hughes","type":"person","url":"https://hartvaat.nl/mensen/steven-g-hughes/","name":"Steven G Hughes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/09/01/galnac-geconjugeerd-antisense-tegen-apoc3-triglyceriden-en-atherogene-lipoprotei/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2017/07/20/angptl3-antisense-oligonucleotiden-cardiovasculaire-en-metabole-effecten-nejm/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-j-atlas","type":"person","url":"https://hartvaat.nl/mensen/steven-j-atlas/","name":"Steven J Atlas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2024/11/19/screening-op-niet-gediagnosticeerd-af-voor-cva-preventie-gerandomiseerde-trial/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2022/03/29/af-screening-bij-ouderen-in-de-huisartsenpraktijk-vital-af-gerandomiseerde-trial/","published":"2022-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-r-smith","type":"person","url":"https://hartvaat.nl/mensen/steven-r-smith/","name":"Steven R Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2016/03/08/naltrexon-bupropion-en-cardiovasculaire-events-bij-obesitas-gerandomiseerde-tria/","published":"2016-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stevo-julius","type":"person","url":"https://hartvaat.nl/mensen/stevo-julius/","name":"Stevo Julius","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/01/value-trial-cv-uitkomsten-bij-hypertensie-met-perifeer-vaatlijden/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2020/06/01/arb-versus-calciumantagonist-bloeddrukprofiel-en-klinische-effecten-vergelijking/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2016/03/21/cardiovasculaire-uitkomsten-bij-verschillende-bereiktestreefdrukken-in-de-value-/","published":"2016-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"su-nam-lee","type":"person","url":"https://hartvaat.nl/mensen/su-nam-lee/","name":"Su Nam Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"},{"url":"https://hartvaat.nl/2022/09/08/post-pci-routine-functionele-testen-versus-standaardzorg-na-pci-bij-hoog-risico/","published":"2022-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sue-jowett","type":"person","url":"https://hartvaat.nl/mensen/sue-jowett/","name":"Sue Jowett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/26/rate-af-kosteneffectiviteit-van-digoxine-versus-betablokkers-bij-permanent-af/","published":"2025-03-26"},{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suleman-aktaa","type":"person","url":"https://hartvaat.nl/mensen/suleman-aktaa/","name":"Suleman Aktaa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2022/06/10/voorspelling-van-atriumfibrilleren-in-elektronische-gezondheidsdossiers-systemat/","published":"2022-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suma-vupputuri","type":"person","url":"https://hartvaat.nl/mensen/suma-vupputuri/","name":"Suma Vupputuri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sung-hee-shin","type":"person","url":"https://hartvaat.nl/mensen/sung-hee-shin/","name":"Sung-Hee Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/11/effort-ertugliflozine-bij-functionele-mitralisinsufficientie-en-hartfalen/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2019/03/12/arni-bij-functionele-mitralisklepinsufficientie/","published":"2019-03-12"},{"url":"https://hartvaat.nl/2016/02/01/regionale-hartdisfunctie-en-prognose-na-myocardinfarct-met-lv-disfunctie-of-hart/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sung-ho-her","type":"person","url":"https://hartvaat.nl/mensen/sung-ho-her/","name":"Sung-Ho Her","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sungha-park","type":"person","url":"https://hartvaat.nl/mensen/sungha-park/","name":"Sungha Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"},{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sunil-kripalani","type":"person","url":"https://hartvaat.nl/mensen/sunil-kripalani/","name":"Sunil Kripalani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sunil-v-badve","type":"person","url":"https://hartvaat.nl/mensen/sunil-v-badve/","name":"Sunil V Badve","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2016/07/19/glucoseverlagende-medicatie-en-cardiovasculaire-events-bij-diabetes-type-2-jama-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susanne-sehner","type":"person","url":"https://hartvaat.nl/mensen/susanne-sehner/","name":"Susanne Sehner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/22/anemie-beinvloedt-ijzerhomeostase-en-empagliflozine-respons-bij-hf/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suxin-luo","type":"person","url":"https://hartvaat.nl/mensen/suxin-luo/","name":"Suxin Luo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"svati-h-shah","type":"person","url":"https://hartvaat.nl/mensen/svati-h-shah/","name":"Svati H Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/24/inhalatief-epoprostenol-versus-no-bij-rechterventrikel-falen-na-hartchirurgie/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sven-knecht","type":"person","url":"https://hartvaat.nl/mensen/sven-knecht/","name":"Sven Knecht","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2023/11/02/duurzaamheid-van-pvi-bij-af-meta-analyse/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sven-poli","type":"person","url":"https://hartvaat.nl/mensen/sven-poli/","name":"Sven Poli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sren-hardt-lindberg","type":"person","url":"https://hartvaat.nl/mensen/sren-hardt-lindberg/","name":"Søren Hardt-Lindberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"},{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takashi-kanda","type":"person","url":"https://hartvaat.nl/mensen/takashi-kanda/","name":"Takashi Kanda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2018/09/01/pace-capture-geleide-ablatie-na-contact-force-pvi-dragon-gerandomiseerde-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"taku-asano","type":"person","url":"https://hartvaat.nl/mensen/taku-asano/","name":"Taku Asano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takuya-mizukami","type":"person","url":"https://hartvaat.nl/mensen/takuya-mizukami/","name":"Takuya Mizukami","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamara-kovacevic-preradovic","type":"person","url":"https://hartvaat.nl/mensen/tamara-kovacevic-preradovic/","name":"Tamara Kovacevic-Preradovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2023/06/01/sglt2-remmers-bij-hartfalen-systematisch-overzicht-van-mechanismen-en-kliniek/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamer-roushdy","type":"person","url":"https://hartvaat.nl/mensen/tamer-roushdy/","name":"Tamer Roushdy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tan-xu","type":"person","url":"https://hartvaat.nl/mensen/tan-xu/","name":"Tan Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/01/antihypertensieve-behandeling-na-acuut-ischemisch-cva-continueren-of-niet/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tanika-n-kelly","type":"person","url":"https://hartvaat.nl/mensen/tanika-n-kelly/","name":"Tanika N Kelly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2017/07/01/systolische-bloeddrukreductie-en-cv-risico-netwerkmeta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tapani-ronnemaa","type":"person","url":"https://hartvaat.nl/mensen/tapani-ronnemaa/","name":"Tapani Rönnemaa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/strip-20-jaarsresultaten-van-dieetinterventie-vanaf-de-zuigelingenleeftijd/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2017/08/01/cardiometabole-determinanten-van-carotis-en-aortadistensibiliteit-van-kindertijd/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tara-latimer","type":"person","url":"https://hartvaat.nl/mensen/tara-latimer/","name":"Tara Latimer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tariq-e-farrah","type":"person","url":"https://hartvaat.nl/mensen/tariq-e-farrah/","name":"Tariq E Farrah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/01/arteriele-stijfheid-en-endotheeldysfunctie-bij-anca-geassocieerde-vasculitis/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2019/08/01/endothelinereceptorantagonisme-verbetert-lipidenprofielen-en-verlaagt-pcsk9-bij-/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tariq-jamal-siddiqi","type":"person","url":"https://hartvaat.nl/mensen/tariq-jamal-siddiqi/","name":"Tariq Jamal Siddiqi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/27/sglt2-remmers-en-cv-uitkomsten-over-patientpopulaties-jacc-overzicht/","published":"2023-06-27"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"terje-steigen","type":"person","url":"https://hartvaat.nl/mensen/terje-steigen/","name":"Terje Steigen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"terry-lee","type":"person","url":"https://hartvaat.nl/mensen/terry-lee/","name":"Terry Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/06/01/amenorroe-duur-bij-start-antihypertensiva-in-de-zwangerschap-chips-secundaire-an/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"terry-levy","type":"person","url":"https://hartvaat.nl/mensen/terry-levy/","name":"Terry Levy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"teruo-noguchi","type":"person","url":"https://hartvaat.nl/mensen/teruo-noguchi/","name":"Teruo Noguchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"},{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tetsuro-tsujimoto","type":"person","url":"https://hartvaat.nl/mensen/tetsuro-tsujimoto/","name":"Tetsuro Tsujimoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/08/01/intensieve-bloeddrukbehandeling-bij-diabetes-type-2-zonder-intensieve-glycemisch/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/12/05/abdominale-obesitas-en-totale-mortaliteit-bij-hfpef/","published":"2017-12-05"},{"url":"https://hartvaat.nl/2017/07/01/cardiovasculair-risico-bij-diabetes-op-betablokkers/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tetsuya-amano","type":"person","url":"https://hartvaat.nl/mensen/tetsuya-amano/","name":"Tetsuya Amano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2019/04/01/periprocedurele-antistolling-en-silent-stroke-na-af-ablatie/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tetsuya-matoba","type":"person","url":"https://hartvaat.nl/mensen/tetsuya-matoba/","name":"Tetsuya Matoba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2021/11/01/aspirine-versus-p2y12-remmer-met-antistolling-bij-af/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tetsuya-watanabe","type":"person","url":"https://hartvaat.nl/mensen/tetsuya-watanabe/","name":"Tetsuya Watanabe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thalia-s-field","type":"person","url":"https://hartvaat.nl/mensen/thalia-s-field/","name":"Thalia S Field","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/stop-cad-1-op-6-cervicale-arteriedissecties-wordt-aanvankelijk-verkeerd-gediagno/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2016/01/01/bereikte-bloeddruk-en-uitkomsten-in-de-sps3-trial-bij-lacunaire-herseninfarcten/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"theingi-aung","type":"person","url":"https://hartvaat.nl/mensen/theingi-aung/","name":"Theingi Aung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"theodore-e-spiro","type":"person","url":"https://hartvaat.nl/mensen/theodore-e-spiro/","name":"Theodore E Spiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-engstm","type":"person","url":"https://hartvaat.nl/mensen/thomas-engstm/","name":"Thomas Engstøm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/01/danger-shock-hemodynamische-effecten-van-impella-bij-stemi-en-cardiogene-shock/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2025/02/18/impella-bij-ouderen-met-cardiogene-shock-is-het-veilig/","published":"2025-02-18"},{"url":"https://hartvaat.nl/2025/01/01/danger-shock-hemodynamische-en-metabole-effecten-van-impella-bij-cardiogene-shoc/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-fetsch","type":"person","url":"https://hartvaat.nl/mensen/thomas-fetsch/","name":"Thomas Fetsch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/10/01/vroege-ritmecontrole-bij-af-nejm-east-afnet-4/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-fink","type":"person","url":"https://hartvaat.nl/mensen/thomas-fink/","name":"Thomas Fink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/07/laa-occlusie-bij-terminale-nierziekte-ipd-meta-analyse/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-g-von-lueder","type":"person","url":"https://hartvaat.nl/mensen/thomas-g-von-lueder/","name":"Thomas G von Lueder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/12/10/nierfunctiestoornis-en-betablokkereffectiviteit-bij-hartfalen/","published":"2019-12-10"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-gattringer","type":"person","url":"https://hartvaat.nl/mensen/thomas-gattringer/","name":"Thomas Gattringer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-godec","type":"person","url":"https://hartvaat.nl/mensen/thomas-godec/","name":"Thomas Godec","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/28/ascot-legacy-atorvastatine-verlaagt-cv-events-over-20-jaar/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"},{"url":"https://hartvaat.nl/2018/09/29/langetermijnmortaliteit-na-bloeddruk-en-lipidenverlaging-bij-hypertensie-ascot-l/","published":"2018-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-j-ford","type":"person","url":"https://hartvaat.nl/mensen/thomas-j-ford/","name":"Thomas J Ford","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-m-macdonald","type":"person","url":"https://hartvaat.nl/mensen/thomas-m-macdonald/","name":"Thomas M MacDonald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-schmitz","type":"person","url":"https://hartvaat.nl/mensen/thomas-schmitz/","name":"Thomas Schmitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-weber","type":"person","url":"https://hartvaat.nl/mensen/thomas-weber/","name":"Thomas Weber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thor-edvardsen","type":"person","url":"https://hartvaat.nl/mensen/thor-edvardsen/","name":"Thor Edvardsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tiago-v-pereira","type":"person","url":"https://hartvaat.nl/mensen/tiago-v-pereira/","name":"Tiago V Pereira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"},{"url":"https://hartvaat.nl/2019/04/01/restrictieve-versus-liberale-transfusie-bij-hartchirurgie-meta-analyse/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tiange-wang","type":"person","url":"https://hartvaat.nl/mensen/tiange-wang/","name":"Tiange Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tibor-kempf","type":"person","url":"https://hartvaat.nl/mensen/tibor-kempf/","name":"Tibor Kempf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/01/rv-disfunctie-voorspelt-langetermijnherstel-bij-de-novo-hfref-prolong-ii/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2023/01/21/gdf-15-en-cardiovasculair-risico-ipd-meta-analyse/","published":"2023-01-21"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tiffany-patterson","type":"person","url":"https://hartvaat.nl/mensen/tiffany-patterson/","name":"Tiffany Patterson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-clayton","type":"person","url":"https://hartvaat.nl/mensen/tim-clayton/","name":"Tim Clayton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-heise","type":"person","url":"https://hartvaat.nl/mensen/tim-heise/","name":"Tim Heise","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2018/06/30/glp-1-glucagon-duale-agonist-bij-obesitas-met-diabetes-type-2-lancet-fase-2/","published":"2018-06-30"},{"url":"https://hartvaat.nl/2018/01/01/sacubitril-valsartan-en-inspanningsgemedieerd-lipidenmetabolisme-bij-obesitas-me/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"timo-strandberg","type":"person","url":"https://hartvaat.nl/mensen/timo-strandberg/","name":"Timo Strandberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/12/01/ezetimibe-als-monotherapie-voor-primaire-preventie-bij-75-plussers/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2022/06/01/finger-trial-multidomein-leefstijlinterventie-verlaagt-cardiovasculair-risico-bi/","published":"2022-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"timothy-b-plante","type":"person","url":"https://hartvaat.nl/mensen/timothy-b-plante/","name":"Timothy B Plante","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-klinische-uitkomsten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2023/03/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-met-pacemaker/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"timothy-fairbairn","type":"person","url":"https://hartvaat.nl/mensen/timothy-fairbairn/","name":"Timothy Fairbairn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tine-w-hansen","type":"person","url":"https://hartvaat.nl/mensen/tine-w-hansen/","name":"Tine W Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tiong-kiam-ong","type":"person","url":"https://hartvaat.nl/mensen/tiong-kiam-ong/","name":"Tiong Kiam Ong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2021/07/18/smartphone-ecg-voor-af-detectie-na-cerebrovasculair-event-multicenter-rct/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobias-d-trippel","type":"person","url":"https://hartvaat.nl/mensen/tobias-d-trippel/","name":"Tobias D Trippel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/baseline-parameters-en-1-jaars-qol-bij-hf-na-crt-d-esc-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/06/01/economische-impact-van-hfpef-aldo-dhf-inzichten/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobias-kister","type":"person","url":"https://hartvaat.nl/mensen/tobias-kister/","name":"Tobias Kister","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tohru-minamino","type":"person","url":"https://hartvaat.nl/mensen/tohru-minamino/","name":"Tohru Minamino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/01/hepcidine-heeft-beperkte-waarde-voor-het-sturen-van-anemietherapie-bij-ckd/","published":"2026-08-23"},{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2022/12/01/daprodustat-bij-anemie-en-hartfalen-met-ckd-gerandomiseerde-studie/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-briffa","type":"person","url":"https://hartvaat.nl/mensen/tom-briffa/","name":"Tom Briffa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/pneumokokkenvaccinatie-en-cv-eventpreventie-ipd-meta-analyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-f-brouwer","type":"person","url":"https://hartvaat.nl/mensen/tom-f-brouwer/","name":"Tom F Brouwer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/lage-voorspelde-adherentie-verhoogt-stroke-risico-bij-af-patienten-die-starten-m/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2018/12/01/creatininestijging-tijdens-bloeddrukbehandeling-en-uitkomsten-bij-diabetes-type-/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/12/05/j-curve-bij-gerandomiseerde-bloeddrukstreefwaarden-sprint-experimentele-analyse/","published":"2017-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tommaso-filippini","type":"person","url":"https://hartvaat.nl/mensen/tommaso-filippini/","name":"Tommaso Filippini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/08/01/alcohol-en-hypertensierisico-dosis-respons-meta-analyse-van-niet-experimentele-s/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/10/01/alcoholconsumptie-en-bloeddruk-dosis-respons-meta-analyse/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2021/04/20/natriumreductie-en-bloeddruk-dosis-respons-meta-analyse-van-experimentele-studie/","published":"2021-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomonari-harada","type":"person","url":"https://hartvaat.nl/mensen/tomonari-harada/","name":"Tomonari Harada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/27/nierfunctiestoornis-verergert-pulmonale-vaatziekte-bij-hfpef/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2025/01/01/sotatercept-bij-pah-centrale-hematologische-en-perifere-werkingsmechanismen/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomas-pulido","type":"person","url":"https://hartvaat.nl/mensen/tomas-pulido/","name":"Tomás Pulido","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/02/macitentan-bij-eisenmenger-syndroom/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ton-slagboom","type":"person","url":"https://hartvaat.nl/mensen/ton-slagboom/","name":"Ton Slagboom","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2018/09/15/ticagrelor-monotherapie-na-1-maand-dapt-lancet-global-leaders/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tong-liu","type":"person","url":"https://hartvaat.nl/mensen/tong-liu/","name":"Tong Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/01/04/sglt2-remmers-en-plotse-hartdood-ventriculaire-aritmie-meta-analyse/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2016/05/01/mineralocorticoidreceptorantagonisten-en-atriumfibrilleren-meta-analyse/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"torbjrn-omland","type":"person","url":"https://hartvaat.nl/mensen/torbjrn-omland/","name":"Torbjørn Omland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2016/06/01/preventie-van-cardiale-disfunctie-bij-borstkankerbehandeling-de-prada-trial/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"torstein-hole","type":"person","url":"https://hartvaat.nl/mensen/torstein-hole/","name":"Torstein Hole","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"torstein-valborgland","type":"person","url":"https://hartvaat.nl/mensen/torstein-valborgland/","name":"Torstein Valborgland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tracy-a-dewald","type":"person","url":"https://hartvaat.nl/mensen/tracy-a-dewald/","name":"Tracy A DeWald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"trevor-j-orchard","type":"person","url":"https://hartvaat.nl/mensen/trevor-j-orchard/","name":"Trevor J Orchard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2018/10/09/hypoglykemie-en-troponine-elevatie-bij-diabetes-met-coronairlijden/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"trine-karlsen","type":"person","url":"https://hartvaat.nl/mensen/trine-karlsen/","name":"Trine Karlsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"troels-yndigegn","type":"person","url":"https://hartvaat.nl/mensen/troels-yndigegn/","name":"Troels Yndigegn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2018/12/11/langetermijneffecten-van-zuurstof-op-sterfte-of-hf-hospitalisatie-na-verdenking-/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tsong-hai-lee","type":"person","url":"https://hartvaat.nl/mensen/tsong-hai-lee/","name":"Tsong-Hai Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tsuneo-konta","type":"person","url":"https://hartvaat.nl/mensen/tsuneo-konta/","name":"Tsuneo Konta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tsuyoshi-isawa","type":"person","url":"https://hartvaat.nl/mensen/tsuyoshi-isawa/","name":"Tsuyoshi Isawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tzung-dau-wang","type":"person","url":"https://hartvaat.nl/mensen/tzung-dau-wang/","name":"Tzung-Dau Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"},{"url":"https://hartvaat.nl/2017/01/01/sacubitril-valsartan-en-natriurese-diurese-en-bloeddruk-bij-zoutgevoelige-hypert/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"uday-trivedi","type":"person","url":"https://hartvaat.nl/mensen/uday-trivedi/","name":"Uday Trivedi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"udo-bavendiek","type":"person","url":"https://hartvaat.nl/mensen/udo-bavendiek/","name":"Udo Bavendiek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2025/06/01/rv-disfunctie-voorspelt-langetermijnherstel-bij-de-novo-hfref-prolong-ii/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2019/10/21/digoxine-en-mortaliteit-gerandomiseerd-versus-observationeel-in-de-dig-trial/","published":"2019-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulf-dahlstrom","type":"person","url":"https://hartvaat.nl/mensen/ulf-dahlstrom/","name":"Ulf Dahlström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/27/nt-probnp-afkapwaarden-voor-hartfalentrials-optimaliseren-swedehf/","published":"2026-03-27"},{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"uli-c-broedl","type":"person","url":"https://hartvaat.nl/mensen/uli-c-broedl/","name":"Uli C Broedl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/01/09/empagliflozine-bij-diabetes-type-2-met-cardiovasculaire-ziekte-en-ckd-empa-reg-o/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/12/01/empagliflozine-en-bloeddruk-bij-diabetes-type-2-met-hypertensie-naar-achtergrond/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/07/28/empagliflozine-en-progressie-van-nierziekte-bij-diabetes-type-2-nejm-empa-reg-re/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrich-schafer","type":"person","url":"https://hartvaat.nl/mensen/ulrich-schafer/","name":"Ulrich Schäfer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrik-abildgaard","type":"person","url":"https://hartvaat.nl/mensen/ulrik-abildgaard/","name":"Ulrik Abildgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/02/14/danami-2-16-jaarsfollow-up-primaire-pci-versus-fibrinolyse/","published":"2020-02-14"},{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrik-dixen","type":"person","url":"https://hartvaat.nl/mensen/ulrik-dixen/","name":"Ulrik Dixen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vadim-bubes","type":"person","url":"https://hartvaat.nl/mensen/vadim-bubes/","name":"Vadim Bubes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/01/vitamine-d-voorkomt-statine-gerelateerde-spierklachten-niet/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2017/06/01/voedingsstatus-en-langetermijn-multivitaminegebruik-en-cv-risico-phs-ii-analyse/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vagner-madrini","type":"person","url":"https://hartvaat.nl/mensen/vagner-madrini/","name":"Vagner Madrini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/17/answer-hf-sacubitril-valsartan-versus-enalapril-bij-chagas-hf-primaire-resultate/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valentina-barone","type":"person","url":"https://hartvaat.nl/mensen/valentina-barone/","name":"Valentina Barone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valentine-gillion","type":"person","url":"https://hartvaat.nl/mensen/valentine-gillion/","name":"Valentine Gillion","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/15/verhoogde-albuminurie-drijft-hypercholesterolemie-bij-patienten-met-het-syndroom/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/03/01/adpkd-samen-met-primaire-hyperoxalurie-type-3/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/03/01/tsc2-pkd1-contigue-gendeletiesyndroom/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valeria-raparelli","type":"person","url":"https://hartvaat.nl/mensen/valeria-raparelli/","name":"Valeria Raparelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/10/13/cerebrale-microbloedingen-en-risico-bij-af-systematische-review/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/09/14/copd-bij-af-prevalentie-management-en-impact-meta-analyse/","published":"2021-09-14"},{"url":"https://hartvaat.nl/2019/01/08/hfref-differentiele-impact-op-mannen-en-vrouwen/","published":"2019-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valeria-terruso","type":"person","url":"https://hartvaat.nl/mensen/valeria-terruso/","name":"Valeria Terruso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vallerie-v-mclaughlin","type":"person","url":"https://hartvaat.nl/mensen/vallerie-v-mclaughlin/","name":"Vallerie V McLaughlin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanita-r-aroda","type":"person","url":"https://hartvaat.nl/mensen/vanita-r-aroda/","name":"Vanita R Aroda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vasil-velchev","type":"person","url":"https://hartvaat.nl/mensen/vasil-velchev/","name":"Vasil Velchev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vasilis-babaliaros","type":"person","url":"https://hartvaat.nl/mensen/vasilis-babaliaros/","name":"Vasilis Babaliaros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"velibor-ristic","type":"person","url":"https://hartvaat.nl/mensen/velibor-ristic/","name":"Velibor Ristic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2021/04/01/cardio-microstroomdevice-bij-chronisch-hf-eerste-klinische-studie/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vera-fortmeier","type":"person","url":"https://hartvaat.nl/mensen/vera-fortmeier/","name":"Vera Fortmeier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"verghese-mathew","type":"person","url":"https://hartvaat.nl/mensen/verghese-mathew/","name":"Verghese Mathew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"},{"url":"https://hartvaat.nl/2017/12/19/chirurgische-versus-percutane-revascularisatie-bij-diabetes-met-acs/","published":"2017-12-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veronique-l-roger","type":"person","url":"https://hartvaat.nl/mensen/veronique-l-roger/","name":"Veronique L Roger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/28/hartfalen-bij-ouderen-van-epidemiologie-tot-behandeling/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2018/12/01/cardiovasculaire-risicocommunicatie-en-patientperceptie-jama-cardiology/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vesa-anttila","type":"person","url":"https://hartvaat.nl/mensen/vesa-anttila/","name":"Vesa Anttila","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/11/ticagrelor-plus-aspirine-versus-aspirine-na-cabg-voor-acs-gerandomiseerde-trial/","published":"2025-12-11"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veselin-mitrovic","type":"person","url":"https://hartvaat.nl/mensen/veselin-mitrovic/","name":"Veselin Mitrovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2018/12/01/ularitide-en-andere-vasoactieve-stoffen-bij-acuut-hf-systematische-review/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vibeke-videm","type":"person","url":"https://hartvaat.nl/mensen/vibeke-videm/","name":"Vibeke Videm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vicente-mainar","type":"person","url":"https://hartvaat.nl/mensen/vicente-mainar/","name":"Vicente Mainar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-guetta","type":"person","url":"https://hartvaat.nl/mensen/victor-guetta/","name":"Victor Guetta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/12/01/kauwen-versus-slikken-van-ticagrelor-en-plaatjesremming-bij-stemi/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-roth-cardoso","type":"person","url":"https://hartvaat.nl/mensen/victor-roth-cardoso/","name":"Victor Roth Cardoso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2022/09/26/smartphone-detectie-van-af-via-fotoplethysmografie-meta-analyse/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victoria-delgado","type":"person","url":"https://hartvaat.nl/mensen/victoria-delgado/","name":"Victoria Delgado","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2017/03/07/lv-global-longitudinal-strain-en-prognose-bij-hartfalen-met-smal-qrs-en-crt/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"viktoria-musienko","type":"person","url":"https://hartvaat.nl/mensen/viktoria-musienko/","name":"Viktoria Musienko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vilma-irazola","type":"person","url":"https://hartvaat.nl/mensen/vilma-irazola/","name":"Vilma Irazola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/12/01/lage-richtlijnconformiteit-en-zorgcontinuiteit-bij-hypertensie-in-uruguay/","published":"2026-08-17"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2017/09/19/community-health-worker-interventie-voor-bloeddrukcontrole-in-argentina-jama-tri/","published":"2017-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vilmundur-gudnason","type":"person","url":"https://hartvaat.nl/mensen/vilmundur-gudnason/","name":"Vilmundur Gudnason","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincent-auffret","type":"person","url":"https://hartvaat.nl/mensen/vincent-auffret/","name":"Vincent Auffret","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/22/m-teer-werkt-over-het-volledige-lvef-spectrum-vergroot-linkeratrium-volume-voors/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincenzo-andreone","type":"person","url":"https://hartvaat.nl/mensen/vincenzo-andreone/","name":"Vincenzo Andreone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincenzo-laterza","type":"person","url":"https://hartvaat.nl/mensen/vincenzo-laterza/","name":"Vincenzo Laterza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"viola-vaccarino","type":"person","url":"https://hartvaat.nl/mensen/viola-vaccarino/","name":"Viola Vaccarino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2016/04/01/effecten-van-dieetinterventies-op-bloeddruk-systematische-review-en-meta-analyse/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"virginia-g-wadley","type":"person","url":"https://hartvaat.nl/mensen/virginia-g-wadley/","name":"Virginia G Wadley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"viswanathan-mohan","type":"person","url":"https://hartvaat.nl/mensen/viswanathan-mohan/","name":"Viswanathan Mohan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/09/01/pm2-5-blootstelling-versnelt-daling-van-egfr-bij-volwassenen/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2023/06/08/behandeling-van-vroeg-gediagnosticeerde-zwangerschapsdiabetes-nejm-trial/","published":"2023-06-08"},{"url":"https://hartvaat.nl/2020/08/18/collaboratieve-zorg-voor-depressie-hba1c-bloeddruk-en-cholesterol-bij-diabetes-j/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"volker-adams","type":"person","url":"https://hartvaat.nl/mensen/volker-adams/","name":"Volker Adams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2022/10/01/verschillende-trainingsvormen-en-hdl-functie-bij-hfpef-optimex-substudie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"w-m-monique-verschuren","type":"person","url":"https://hartvaat.nl/mensen/w-m-monique-verschuren/","name":"W M Monique Verschuren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wai-hong-wilson-tang","type":"person","url":"https://hartvaat.nl/mensen/wai-hong-wilson-tang/","name":"Wai Hong Wilson Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/01/advor-nierfunctie-en-decongestie-met-acetazolamide/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"waleed-alhazzani","type":"person","url":"https://hartvaat.nl/mensen/waleed-alhazzani/","name":"Waleed Alhazzani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/08/06/orale-antiaritmica-voor-cardioversie-van-recent-onset-af-netwerkmeta-analyse/","published":"2021-08-06"},{"url":"https://hartvaat.nl/2018/05/08/vasopressine-plus-catecholamines-en-af-bij-distributieve-shock-jama-meta-analyse/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2018/04/28/liberale-versus-conservatieve-zuurstoftherapie-bij-acuut-zieke-volwassenen-lance/","published":"2018-04-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"walter-c-willett","type":"person","url":"https://hartvaat.nl/mensen/walter-c-willett/","name":"Walter C Willett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/25/glp-1-agonisten-en-gezonde-leefstijl-samen-sterker-tegen-hart-en-vaatziekten/","published":"2026-03-08"},{"url":"https://hartvaat.nl/2020/11/10/vitamine-d-omega-3-of-krachttraining-en-klinische-uitkomsten-bij-ouderen-jama-do/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2019/04/09/rood-vlees-en-cardiovasculaire-risicofactoren-meta-analyse-van-gerandomiseerde-t/","published":"2019-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"warren-m-jackman","type":"person","url":"https://hartvaat.nl/mensen/warren-m-jackman/","name":"Warren M Jackman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/04/colchicine-voorkomt-postoperatief-af-na-hartchirurgie-meta-analyse/","published":"2023-07-04"},{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wayne-c-levy","type":"person","url":"https://hartvaat.nl/mensen/wayne-c-levy/","name":"Wayne C Levy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/06/01/betablokkers-bij-systolisch-hartfalen-en-pacemakerritme-mortaliteitseffect/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2016/06/01/herhaalde-intracoronaire-beenmergcelinjectie-bij-hartfalen-resultaten-uit-een-re/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-huang","type":"person","url":"https://hartvaat.nl/mensen/wei-huang/","name":"Wei Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/16/apolipoproteine-c3-verergert-vaatverkalking-via-ferroptose-bij-chronisch-nierfal/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2022/12/01/digitale-hartrevalidatie-bij-hartfalen-systematische-review/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/05/03/af-risico-bij-laag-matig-alcoholgebruik-naar-geslacht-en-regio-meta-analyse/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-wang","type":"person","url":"https://hartvaat.nl/mensen/wei-wang/","name":"Wei Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/05/trem-1-remming-vermindert-in-stent-neoatherosclerose-in-diermodel/","published":"2026-04-12"},{"url":"https://hartvaat.nl/2024/04/01/halp-score-hemoglobine-albumine-lymfocyten-trombocyten-en-mortaliteit-bij-hartfa/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-zhou","type":"person","url":"https://hartvaat.nl/mensen/wei-zhou/","name":"Wei Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/06/vereenvoudigde-linkervoorhoofdaanhangsel-occlusie-onder-fluoroscopie-met-watchma/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/01/01/metabole-score-voor-visceraal-vet-en-risico-op-perifeer-arterieel-vaatlijden-bij/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weichung-j-shih","type":"person","url":"https://hartvaat.nl/mensen/weichung-j-shih/","name":"Weichung J Shih","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenbo-zhao","type":"person","url":"https://hartvaat.nl/mensen/wenbo-zhao/","name":"Wenbo Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/14/sprint-accord-gepoold-bloeddrukvariabiliteit-is-even-prognostisch-als-gemiddelde/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2026/05/14/bloeddrukvariabiliteit-sprint-accord-ipd-meta-even-prognostisch-als-gemiddelde-b/","published":"2026-05-15"},{"url":"https://hartvaat.nl/2023/06/01/remote-ischemische-conditionering-bij-milde-hypertensie-zonder-medicatie-rct/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenming-he","type":"person","url":"https://hartvaat.nl/mensen/wenming-he/","name":"Wenming He","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"werner-hacke","type":"person","url":"https://hartvaat.nl/mensen/werner-hacke/","name":"Werner Hacke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2016/08/01/hospitalisaties-bij-atriumfibrilleren-analyse-uit-rocket-af/","published":"2016-08-01"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/01/26/polyfarmacie-en-werkzaamheid-van-rivaroxaban-versus-warfarine-bij-atriumfibrille/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilhelm-haverkamp","type":"person","url":"https://hartvaat.nl/mensen/wilhelm-haverkamp/","name":"Wilhelm Haverkamp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"will-stevens","type":"person","url":"https://hartvaat.nl/mensen/will-stevens/","name":"Will Stevens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-m-byra","type":"person","url":"https://hartvaat.nl/mensen/william-m-byra/","name":"William M Byra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-r-hiatt","type":"person","url":"https://hartvaat.nl/mensen/william-r-hiatt/","name":"William R Hiatt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2019/01/01/mi-bij-pav-patienten-incidentie-en-uitkomsten-euclid/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2018/12/25/cv-en-ledemaat-uitkomsten-bij-diabetes-met-pav-euclid/","published":"2018-12-25"},{"url":"https://hartvaat.nl/2018/10/02/cv-uitkomsten-na-endovasculaire-versus-chirurgische-revascularisatie-onderste-le/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-whang","type":"person","url":"https://hartvaat.nl/mensen/william-whang/","name":"William Whang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2021/06/01/katheterablatie-of-antiaritmica-als-eerstelijnstherapie-bij-af-jama-cardiology-m/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilson-mathias","type":"person","url":"https://hartvaat.nl/mensen/wilson-mathias/","name":"Wilson Mathias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/17/answer-hf-sacubitril-valsartan-versus-enalapril-bij-chagas-hf-primaire-resultate/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilson-nadruz","type":"person","url":"https://hartvaat.nl/mensen/wilson-nadruz/","name":"Wilson Nadruz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/03/evolocumab-naast-empagliflozine-verandert-ldl-subdeeltjes-bij-type-2-diabetes/","published":"2026-04-08"},{"url":"https://hartvaat.nl/2021/06/01/serumkalium-en-prognose-bij-symptomatisch-hf/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2016/11/29/bmi-en-nauwkeurigheid-van-nt-probnp-en-bnp-voor-diagnose-van-acuut-hartfalen/","published":"2016-11-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wilson-y-szeto","type":"person","url":"https://hartvaat.nl/mensen/wilson-y-szeto/","name":"Wilson Y Szeto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wim-a-m-lucassen","type":"person","url":"https://hartvaat.nl/mensen/wim-a-m-lucassen/","name":"Wim A M Lucassen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/05/01/predictiemodellen-voor-af-in-de-community-meta-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/05/01/frequente-premature-atriale-contracties-en-af-hersenischemie-en-mortaliteit-meta/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2018/09/01/last-van-atriale-high-rate-episodes-en-cva-risico-systematische-review/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"winok-lapidaire","type":"person","url":"https://hartvaat.nl/mensen/winok-lapidaire/","name":"Winok Lapidaire","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"witold-ruzyllo","type":"person","url":"https://hartvaat.nl/mensen/witold-ruzyllo/","name":"Witold Ruzyllo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2016/09/01/apixaban-5-mg-bij-af-met-hoge-leeftijd-laag-gewicht-of-hoog-creatinine-aristotle/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/05/10/validatie-van-barc-bloedingscriteria-bij-acuut-coronair-syndroom-tracer-trial/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wojciech-kosmala","type":"person","url":"https://hartvaat.nl/mensen/wojciech-kosmala/","name":"Wojciech Kosmala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/03/beeldvorming-bij-atriale-cardiomyopathie-esc-scientific-statement/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2021/04/01/lv-longitudinale-systolische-functieparameters-als-voorspellers-bij-hfpef/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2016/10/25/aldosteronantagonisme-en-inspanningstolerantie-bij-hfpef/","published":"2016-10-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wojciech-szczeklik","type":"person","url":"https://hartvaat.nl/mensen/wojciech-szczeklik/","name":"Wojciech Szczeklik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2018/04/28/liberale-versus-conservatieve-zuurstoftherapie-bij-acuut-zieke-volwassenen-lance/","published":"2018-04-28"},{"url":"https://hartvaat.nl/2016/01/07/preoperatief-statinegebruik-en-cardiovasculaire-complicaties-bij-niet-cardiale-c/","published":"2016-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wolfgang-dichtl","type":"person","url":"https://hartvaat.nl/mensen/wolfgang-dichtl/","name":"Wolfgang Dichtl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"},{"url":"https://hartvaat.nl/2017/03/07/contractiliteitssensor-geleide-crt-optimalisatie-respond-crt-trial/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"woo-jin-jang","type":"person","url":"https://hartvaat.nl/mensen/woo-jin-jang/","name":"Woo Jin Jang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"woong-gil-choi","type":"person","url":"https://hartvaat.nl/mensen/woong-gil-choi/","name":"Woong Gil Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xavier-jouven","type":"person","url":"https://hartvaat.nl/mensen/xavier-jouven/","name":"Xavier Jouven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/03/plotse-hartstilstand-tijdens-duursporten-tien-jaar-parijse-registerdata/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xavier-pinto","type":"person","url":"https://hartvaat.nl/mensen/xavier-pinto/","name":"Xavier Pintó","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xi-li","type":"person","url":"https://hartvaat.nl/mensen/xi-li/","name":"Xi Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/gedeeltelijke-cardiale-denervatie-voorkomt-af-na-cabg-rct/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiang-chen","type":"person","url":"https://hartvaat.nl/mensen/xiang-chen/","name":"Xiang Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/29/uk-biobank-hogere-intensiteit-van-beweging-belangrijker-dan-totale-tijd-voor-car/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiang-li","type":"person","url":"https://hartvaat.nl/mensen/xiang-li/","name":"Xiang Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/01/zwangerschapsdiabetes-en-hypertensierisico-meta-analyse-met-dosis-respons/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/07/26/chinees-hartgezond-dieet-verlaagt-bloeddruk-effectief-gerandomiseerde-trial/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2019/12/01/genetische-gevoeligheid-eiwitinname-en-bloeddrukverandering-pounds-lost/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiangxian-feng","type":"person","url":"https://hartvaat.nl/mensen/xiangxian-feng/","name":"Xiangxian Feng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/20/zoutvervanger-voorkomt-hypertensie-bij-normotensieve-volwassenen/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaobin-wang","type":"person","url":"https://hartvaat.nl/mensen/xiaobin-wang/","name":"Xiaobin Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaofei-gao","type":"person","url":"https://hartvaat.nl/mensen/xiaofei-gao/","name":"Xiaofei Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoqiu-liu","type":"person","url":"https://hartvaat.nl/mensen/xiaoqiu-liu/","name":"Xiaoqiu Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaosu-ma","type":"person","url":"https://hartvaat.nl/mensen/xiaosu-ma/","name":"Xiaosu Ma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/20/solbinsiran-angptl3-remming-van-preklinisch-tot-eerste-humane-studies/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/05/03/solbinsiran-langwerkend-sirna-tegen-angptl3-duurzaamheid-en-effectiviteit/","published":"2025-05-03"},{"url":"https://hartvaat.nl/2023/09/07/orforglipron-dagelijkse-orale-glp-1-agonist-bij-obesitas-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaowen-wang","type":"person","url":"https://hartvaat.nl/mensen/xiaowen-wang/","name":"Xiaowen Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/03/26/fine-heart-vrouwen-met-cardiovasculair-renaal-metabool-syndroom-worden-systemati/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/10/22/semaglutide-en-cardiale-structuur-functie-bij-hfpef-step-hfpef-echoanalyse/","published":"2024-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoyan-wang","type":"person","url":"https://hartvaat.nl/mensen/xiaoyan-wang/","name":"Xiaoyan Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/06/09/remote-ischemische-preconditionering-en-nierschade-na-coronairangiografie/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2023/01/17/option-indobufen-als-aspirine-alternatief-in-dapt-na-pci/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xilan-dong","type":"person","url":"https://hartvaat.nl/mensen/xilan-dong/","name":"Xilan Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/08/01/voordeel-en-risico-van-intensieve-bloeddrukcontrole-naar-cv-risico/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/09/01/hypertensieduur-en-effect-van-intensieve-bloeddrukbehandeling/","published":"2024-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xin-zhao","type":"person","url":"https://hartvaat.nl/mensen/xin-zhao/","name":"Xin Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/03/30/biatriale-tachycardieen-ablatiestrategie-en-linkeratriale-epicardiale-geleiding/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/01/17/option-indobufen-als-aspirine-alternatief-in-dapt-na-pci/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2019/11/12/bempedoinezuur-toegevoegd-aan-statines-bij-hoog-cv-risico-jama-clear-harmony/","published":"2019-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinhui-ran","type":"person","url":"https://hartvaat.nl/mensen/xinhui-ran/","name":"Xinhui Ran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/05/20/intensieve-ldl-verlaging-met-evolocumab-bij-auto-immuunziekten-rct/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/02/11/langetermijn-evolocumab-bij-ouderen-effectiviteit-en-veiligheid/","published":"2025-02-11"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinkai-qu","type":"person","url":"https://hartvaat.nl/mensen/xinkai-qu/","name":"Xinkai Qu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/12/gdmt-na-functioneel-complete-revascularisatie-prognostische-impact/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiuqing-guo","type":"person","url":"https://hartvaat.nl/mensen/xiuqing-guo/","name":"Xiuqing Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2018/06/01/gwas-van-pr-interval-bij-hispanic-latino-s-nieuw-locus-bij-id2/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xue-li","type":"person","url":"https://hartvaat.nl/mensen/xue-li/","name":"Xue Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/07/13/traverse-testosteronsubstitutie-cardiovasculair-veilig-bij-hypogonadisme/","published":"2023-07-13"},{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2017/06/01/impact-van-ischemisch-cva-op-af-gerelateerde-zorgkosten-systematische-review/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xue-qiao-zhao","type":"person","url":"https://hartvaat.nl/mensen/xue-qiao-zhao/","name":"Xue-Qiao Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2016/02/01/nicotinezuurtherapie-en-het-risico-op-diabetes-meta-analyse-van-gerandomiseerde-/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xumin-hou","type":"person","url":"https://hartvaat.nl/mensen/xumin-hou/","name":"Xumin Hou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/08/12/catheterablatie-versus-rate-control-bij-persisterend-af-en-ouder-hartfalen/","published":"2025-08-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ya-ling-han","type":"person","url":"https://hartvaat.nl/mensen/ya-ling-han/","name":"Ya-Ling Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/ticagrelor-monotherapie-versus-dapt-na-pci-bij-nstemi-subanalyse/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2019/11/21/ticagrelor-met-of-zonder-aspirine-na-pci-bij-hoog-risico-nejm-twilight/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yale-wang","type":"person","url":"https://hartvaat.nl/mensen/yale-wang/","name":"Yale Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/03/05/radiance-gepoolde-analyse-ultrageluid-renale-denervatie-na-medicatie-optitratie/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/02/28/radiance-ii-ultrageluid-renale-denervatie-bij-milde-tot-matige-hypertensie/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-gong","type":"person","url":"https://hartvaat.nl/mensen/yan-gong/","name":"Yan Gong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/11/01/langetermijnmortaliteit-bij-hypertensie-met-coronairlijden-invest-us-cohort/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-liu","type":"person","url":"https://hartvaat.nl/mensen/yan-liu/","name":"Yan Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/21/body-roundness-index-en-mortaliteit-bij-hemodialysepatienten/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2022/11/15/fgf21-sirtuin-3-hoe-inspanning-beschermt-tegen-diabetische-cardiomyopathie/","published":"2022-11-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yanbin-dong","type":"person","url":"https://hartvaat.nl/mensen/yanbin-dong/","name":"Yanbin Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/07/01/natriumreductie-verhoogt-korte-keten-vetzuren-bij-onbehandelde-hypertensie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/07/01/natriumreductie-metaboloom-en-cv-risico-bij-onbehandelde-zwarte-hypertensie/","published":"2019-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-chen","type":"person","url":"https://hartvaat.nl/mensen/yang-chen/","name":"Yang Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/01/overgewicht-en-de-tyg-index-als-voorspellers-van-sterfte-bij-diabetes-type-2/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/12/01/comorbiditeitsbelasting-en-uitkomsten-van-ablatie-versus-medicatie-bij-af/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/03/01/bnp-en-cardiale-remodellering-na-mi-gerandomiseerde-trial/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-song","type":"person","url":"https://hartvaat.nl/mensen/yang-song/","name":"Yang Song","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yanhong-li","type":"person","url":"https://hartvaat.nl/mensen/yanhong-li/","name":"Yanhong Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/03/vericiguat-bij-hfref-is-kosteneffectief-victoria-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/08/16/cabana-catheterablatie-bij-af-is-kosteneffectief-vergeleken-met-antiaritmica/","published":"2022-08-16"},{"url":"https://hartvaat.nl/2022/02/01/economische-uitkomsten-van-revalidatie-bij-ouderen-met-acuut-hf-rehab-hf/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yao-wang","type":"person","url":"https://hartvaat.nl/mensen/yao-wang/","name":"Yao Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2022/11/15/fgf21-sirtuin-3-hoe-inspanning-beschermt-tegen-diabetische-cardiomyopathie/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2022/09/27/linkerbundeltakpacing-versus-biventriculaire-pacing-voor-crt-gerandomiseerde-tri/","published":"2022-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yaojun-zhang","type":"person","url":"https://hartvaat.nl/mensen/yaojun-zhang/","name":"Yaojun Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yashashwi-pokharel","type":"person","url":"https://hartvaat.nl/mensen/yashashwi-pokharel/","name":"Yashashwi Pokharel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/team-gebaseerde-telehealth-bloeddrukbehandeling-acceptabel-en-haalbaar-in-achter/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2024/03/01/thuisbloeddruk-geleide-farmacotherapie-via-telezorg-meta-analyse-van-vs-trials/","published":"2024-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasuhiro-matsuda","type":"person","url":"https://hartvaat.nl/mensen/yasuhiro-matsuda/","name":"Yasuhiro Matsuda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2018/09/01/pace-capture-geleide-ablatie-na-contact-force-pvi-dragon-gerandomiseerde-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasuo-okumura","type":"person","url":"https://hartvaat.nl/mensen/yasuo-okumura/","name":"Yasuo Okumura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/antistolling-alleen-of-met-plaatjesremming-bij-coronairlijden-meta-analyse/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/03/25/anticoagulatie-en-antiplaatjestherapie-bij-af-en-stabiel-coronairlijden-meta-ana/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2022/12/01/daprodustat-bij-anemie-en-hartfalen-met-ckd-gerandomiseerde-studie/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasushi-sakata","type":"person","url":"https://hartvaat.nl/mensen/yasushi-sakata/","name":"Yasushi Sakata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/12/01/egfr-variabiliteit-en-uitkomsten-bij-real-world-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ying-xian","type":"person","url":"https://hartvaat.nl/mensen/ying-xian/","name":"Ying Xian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ying-zhou","type":"person","url":"https://hartvaat.nl/mensen/ying-zhou/","name":"Ying Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yinong-zhou","type":"person","url":"https://hartvaat.nl/mensen/yinong-zhou/","name":"Yinong Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/12/06/paradise-mi-sacubitril-valsartan-vermindert-coronaire-events-niet-na-mi/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yiran-zhang","type":"person","url":"https://hartvaat.nl/mensen/yiran-zhang/","name":"Yiran Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2020/04/14/langetermijnuitkomsten-bij-vrouwen-en-mannen-na-pci/","published":"2020-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yitschak-biton","type":"person","url":"https://hartvaat.nl/mensen/yitschak-biton/","name":"Yitschak Biton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2017/11/01/klinische-presentatie-bij-eerste-hartfalenhospitalisatie-voorspelt-geen-heropnam/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/05/16/comorbiditeiten-en-crt-respons-madit-crt-langetermijnfollow-up/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/01/26/relatieve-wanddikte-en-risico-op-ventriculaire-tachyaritmieen-bij-linkerkamerdis/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yiyi-zhang","type":"person","url":"https://hartvaat.nl/mensen/yiyi-zhang/","name":"Yiyi Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/01/01/impact-van-vroege-uitgestelde-of-onderbroken-behandeling-bij-kinderen-met-famili/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2023/06/01/team-based-care-bij-hypertensie-meta-analyse-bevestigt-effectiviteit-en-kostenef/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-hoon-kim","type":"person","url":"https://hartvaat.nl/mensen/yong-hoon-kim/","name":"Yong Hoon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/05/02/korte-versus-standaard-dapt-na-pci-met-moderne-des-meta-analyse/","published":"2023-05-02"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-hwan-park","type":"person","url":"https://hartvaat.nl/mensen/yong-hwan-park/","name":"Yong Hwan Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-xu","type":"person","url":"https://hartvaat.nl/mensen/yong-xu/","name":"Yong Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/08/15/tirzepatide-verlaagt-hypertensierisico-maar-verhoogt-hypotensie-meta-analyse/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2026/05/04/microbioom-vriendelijk-dieet-di-gm-geassocieerd-met-27-minder-hartfalen-bij-pred/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2026/01/26/isolinderalacton-remt-nlrp3-inflammasoomactivatie-bij-atherosclerose/","published":"2026-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yongjian-wu","type":"person","url":"https://hartvaat.nl/mensen/yongjian-wu/","name":"Yongjian Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/02/01/maggic-score-voor-mortaliteitsvoorspelling-bij-klepziekte/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yongsung-suh","type":"person","url":"https://hartvaat.nl/mensen/yongsung-suh/","name":"Yongsung Suh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yongyue-wei","type":"person","url":"https://hartvaat.nl/mensen/yongyue-wei/","name":"Yongyue Wei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2022/09/27/linkerbundeltakpacing-versus-biventriculaire-pacing-voor-crt-gerandomiseerde-tri/","published":"2022-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yoshihiko-saito","type":"person","url":"https://hartvaat.nl/mensen/yoshihiko-saito/","name":"Yoshihiko Saito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2019/06/07/febuxostat-voor-cerebraal-en-cardiorenovasculaire-eventpreventie-freed/","published":"2019-06-07"},{"url":"https://hartvaat.nl/2017/02/14/laaggedoseerde-aspirine-voor-primaire-cardiovasculaire-preventie-bij-diabetes-ty/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yoshiki-hata","type":"person","url":"https://hartvaat.nl/mensen/yoshiki-hata/","name":"Yoshiki Hata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/02/01/luseogliflozine-en-geschat-plasmavolume-bij-hfpef/","published":"2022-02-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yoshio-furukawa","type":"person","url":"https://hartvaat.nl/mensen/yoshio-furukawa/","name":"Yoshio Furukawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"},{"url":"https://hartvaat.nl/2020/06/01/tolvaptan-en-sympathische-activiteit-bij-acuut-hfpef/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-dae-kim","type":"person","url":"https://hartvaat.nl/mensen/young-dae-kim/","name":"Young Dae Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/vertraagde-intracraniele-bloeding-na-trombectomie-geassocieerd-met-slechtere-fun/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-hoon-jeong","type":"person","url":"https://hartvaat.nl/mensen/young-hoon-jeong/","name":"Young-Hoon Jeong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-huang","type":"person","url":"https://hartvaat.nl/mensen/yu-huang/","name":"Yu Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/22/eiwithandtekening-voorspelt-nierschade-bij-hypertensie-uk-biobank-nieuwe-risicos/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/03/01/non-hdl-hdl-ratio-als-voorspeller-van-cardiovasculaire-ziekte-bij-ckm-syndroom/","published":"2026-04-07"},{"url":"https://hartvaat.nl/2025/12/23/plasma-proteomische-biomarkers-voor-risico-en-therapeutische-doelen-bij-abdomina/","published":"2025-12-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-liu","type":"person","url":"https://hartvaat.nl/mensen/yu-liu/","name":"Yu Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/09/01/pvi-met-of-zonder-empirische-svc-isolatie-bij-af-ablatie/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2017/05/01/lichamelijke-activiteit-en-incidentie-van-hypertensie-dosis-responsemeta-analyse/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-mi-kang","type":"person","url":"https://hartvaat.nl/mensen/yu-mi-kang/","name":"Yu Mi Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-wang","type":"person","url":"https://hartvaat.nl/mensen/yu-wang/","name":"Yu Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/02/medische-kosten-en-productiviteitsverlies-door-atriumfibrilleren-in-de-vs/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2026/01/21/body-roundness-index-en-mortaliteit-bij-hemodialysepatienten/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2022/11/15/fgf21-sirtuin-3-hoe-inspanning-beschermt-tegen-diabetische-cardiomyopathie/","published":"2022-11-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuchiao-chang","type":"person","url":"https://hartvaat.nl/mensen/yuchiao-chang/","name":"Yuchiao Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2022/03/29/af-screening-bij-ouderen-in-de-huisartsenpraktijk-vital-af-gerandomiseerde-trial/","published":"2022-03-29"},{"url":"https://hartvaat.nl/2016/07/05/advance-care-planning-video-bij-gevorderd-hartfalen-gerandomiseerde-trial/","published":"2016-07-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yue-peng","type":"person","url":"https://hartvaat.nl/mensen/yue-peng/","name":"Yue Peng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/01/01/effect-van-baduanjin-op-bloeddruk-bij-hoog-normaal-bloeddruk-gerandomiseerde-tri/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yufeng-wang","type":"person","url":"https://hartvaat.nl/mensen/yufeng-wang/","name":"Yufeng Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yugang-dong","type":"person","url":"https://hartvaat.nl/mensen/yugang-dong/","name":"Yugang Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/06/01/hypertensie-wijzigt-de-relatie-tussen-lp-a-en-mortaliteit-bij-acuut-gedecompense/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/06/01/s2i2n0-3-score-voorspelt-mortaliteit-bij-hfref-guide-it-subanalyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuhong-chen","type":"person","url":"https://hartvaat.nl/mensen/yuhong-chen/","name":"Yuhong Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuji-ikari","type":"person","url":"https://hartvaat.nl/mensen/yuji-ikari/","name":"Yuji Ikari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yujie-zhou","type":"person","url":"https://hartvaat.nl/mensen/yujie-zhou/","name":"Yujie Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuko-onishi","type":"person","url":"https://hartvaat.nl/mensen/yuko-onishi/","name":"Yuko Onishi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuling-hong","type":"person","url":"https://hartvaat.nl/mensen/yuling-hong/","name":"Yuling Hong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-systematische-review-circulation/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/06/01/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn-hypertension-edit/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2018/05/15/systematische-review-voor-de-2017-acc-aha-hypertensierichtlijn/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yun-kyeong-cho","type":"person","url":"https://hartvaat.nl/mensen/yun-kyeong-cho/","name":"Yun-Kyeong Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"},{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yutaka-furukawa","type":"person","url":"https://hartvaat.nl/mensen/yutaka-furukawa/","name":"Yutaka Furukawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yutaka-imai","type":"person","url":"https://hartvaat.nl/mensen/yutaka-imai/","name":"Yutaka Imai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2019/01/01/levenslangrisico-op-cva-en-coronairlijden-naar-bloeddrukniveau-epoch-japan/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/02/01/bereikte-bloeddruk-en-cardiovasculaire-uitkomsten-bij-oudere-patienten-met-geiso/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuya-matsue","type":"person","url":"https://hartvaat.nl/mensen/yuya-matsue/","name":"Yuya Matsue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/10/01/hepcidine-heeft-beperkte-waarde-voor-het-sturen-van-anemietherapie-bij-ckd/","published":"2026-08-23"},{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2022/12/01/daprodustat-bij-anemie-en-hartfalen-met-ckd-gerandomiseerde-studie/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuyin-liu","type":"person","url":"https://hartvaat.nl/mensen/yuyin-liu/","name":"Yuyin Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"},{"url":"https://hartvaat.nl/2019/10/03/ticagrelor-bij-stabiel-coronairlijden-met-diabetes-nejm-themis/","published":"2019-10-03"},{"url":"https://hartvaat.nl/2016/04/12/protonpompremmers-verminderen-gastro-intestinale-events-ongeacht-aspirinedosis-b/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yves-cottin","type":"person","url":"https://hartvaat.nl/mensen/yves-cottin/","name":"Yves Cottin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/25/aperitif-trial-laaggedoseerd-rivaroxaban-voorkomt-linkerventrikeltrombose-na-voo/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yvonne-kenworthy","type":"person","url":"https://hartvaat.nl/mensen/yvonne-kenworthy/","name":"Yvonne Kenworthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zachary-d-goldberger","type":"person","url":"https://hartvaat.nl/mensen/zachary-d-goldberger/","name":"Zachary D Goldberger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zbigniew-a-gaciong","type":"person","url":"https://hartvaat.nl/mensen/zbigniew-a-gaciong/","name":"Zbigniew A Gaciong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2019/07/01/evolocumab-en-totale-cv-events-bij-cardiovasculaire-ziekte-fourier-analyse/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zeinab-bidel","type":"person","url":"https://hartvaat.nl/mensen/zeinab-bidel/","name":"Zeinab Bidel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2023/11/01/sekseverschillen-in-effect-van-bloeddrukverlaging-ipd-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zening-jin","type":"person","url":"https://hartvaat.nl/mensen/zening-jin/","name":"Zening Jin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhao-li","type":"person","url":"https://hartvaat.nl/mensen/zhao-li/","name":"Zhao Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zheng-ji","type":"person","url":"https://hartvaat.nl/mensen/zheng-ji/","name":"Zheng Ji","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhihong-liu","type":"person","url":"https://hartvaat.nl/mensen/zhihong-liu/","name":"Zhihong Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/07/31/finerenone-verhoogt-complete-nierremissie-bij-niet-diabetische-iga-nefropatie/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2026/06/23/rhbnp-therapie-vermindert-congestie-en-dyspnoe-bij-rechterhartfalen-door-longhyp/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhiming-zhu","type":"person","url":"https://hartvaat.nl/mensen/zhiming-zhu/","name":"Zhiming Zhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2017/12/01/voorkeur-voor-pikant-eten-versterkt-zoutwaarneming-en-vermindert-zoutinname-en-b/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/03/01/taurinesuppletie-verlaagt-bloeddruk-en-verbetert-vaatfunctie-bij-prehypertensie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhiyun-zhao","type":"person","url":"https://hartvaat.nl/mensen/zhiyun-zhao/","name":"Zhiyun Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/01/opleiding-intelligentie-en-cognitie-onafhankelijke-verbanden-met-hypertensie/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhizhong-liu","type":"person","url":"https://hartvaat.nl/mensen/zhizhong-liu/","name":"Zhizhong Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhongjie-zhang","type":"person","url":"https://hartvaat.nl/mensen/zhongjie-zhang/","name":"Zhongjie Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-hoog-bloedingsrisico-na-pci-twilight-hbr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/12/01/ticagrelor-monotherapie-bij-ckd-na-pci-twilight-ckd/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2021/09/01/sekseverschillen-bij-ticagrelor-aspirine-na-pci-bij-hoog-risico-twilight/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ziad-boueri","type":"person","url":"https://hartvaat.nl/mensen/ziad-boueri/","name":"Ziad Boueri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2025/07/01/calcified-oct-versus-angiografie-bij-pci-van-verkalkte-laesies/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ziad-nehme","type":"person","url":"https://hartvaat.nl/mensen/ziad-nehme/","name":"Ziad Nehme","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2021/10/14/lignocaine-versus-opioiden-op-antiplaatjeseffect-van-ticagrelor-local-trial/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2020/03/01/ambulancedienst-vertragingen-bij-stemi-meta-analyse/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2016/03/01/effect-van-aanvullende-zuurstoftoediening-op-myocardschade-bij-stemi/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zien-zhou","type":"person","url":"https://hartvaat.nl/mensen/zien-zhou/","name":"Zien Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2023/12/06/gemodificeerde-transseptale-punctie-bij-laa-occlusie-rct/","published":"2023-12-06"},{"url":"https://hartvaat.nl/2017/07/11/positieve-luchtwegdruk-en-cv-events-bij-slaapapneu-jama-meta-analyse/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zlatko-fras","type":"person","url":"https://hartvaat.nl/mensen/zlatko-fras/","name":"Zlatko Fras","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/11/21/alirocumab-lp-a-verlaging-en-totale-cv-eventlast-onafhankelijk-van-ldl-odyssey-o/","published":"2020-11-21"},{"url":"https://hartvaat.nl/2020/01/21/alirocumab-en-lp-a-en-cv-risico-na-acs-odyssey-outcomes/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zvonko-milicevic","type":"person","url":"https://hartvaat.nl/mensen/zvonko-milicevic/","name":"Zvonko Milicevic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","published":"2023-08-12"},{"url":"https://hartvaat.nl/2022/11/26/triple-gip-glp-1-glucagonreceptoragonist-bij-type-2-diabetes-fase-1b/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2018/11/17/ly3298176-duale-gip-glp-1-agonist-bij-diabetes-type-2-lancet-tirzepatide-fase-2/","published":"2018-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alvaro-hernaez","type":"person","url":"https://hartvaat.nl/mensen/alvaro-hernaez/","name":"Álvaro Hernáez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2020/12/08/remnant-cholesterol-versus-ldl-en-incident-cv-ziekte/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ake-hjalmarson","type":"person","url":"https://hartvaat.nl/mensen/ake-hjalmarson/","name":"Åke Hjalmarson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":3,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2018/01/01/betablokkers-bij-hfref-hfmref-en-hfpef-individuele-patientanalyse/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/06/20/hartfrequentie-en-ritme-en-het-voordeel-van-betablokkers-bij-hartfalen/","published":"2017-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-h-jan-danser","type":"person","url":"https://hartvaat.nl/mensen/a-h-jan-danser/","name":"A H Jan Danser","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/oraal-butyraat-verlaagt-bloeddruk-bij-hypertensie-rct/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2020/01/01/renale-hemodynamische-effecten-van-dapagliflozine-postglomerulaire-vasodilatatie/","published":"2020-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-mark-richards","type":"person","url":"https://hartvaat.nl/mensen/a-mark-richards/","name":"A Mark Richards","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/07/mandibulaire-advancementsplint-versus-cpap-voor-bloeddrukverlaging-bij-osa/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2021/07/01/remote-post-ontslag-behandeling-na-mi-door-paramedici-versus-standaardzorg-jama-/","published":"2021-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-thomas-mcrae","type":"person","url":"https://hartvaat.nl/mensen/a-thomas-mcrae/","name":"A Thomas McRae","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/09/dapagliflozine-bij-acuut-hartfalen-effectiviteit-en-veiligheid/","published":"2024-04-09"},{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-titia-lely","type":"person","url":"https://hartvaat.nl/mensen/a-titia-lely/","name":"A Titia Lely","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/foetale-groeirestrictie-en-bloeddruk-tegenstrijdige-effecten-bij-mens-en-rat-met/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/11/01/sildenafil-tijdens-de-zwangerschap-preklinische-meta-analyse-over-foetale-groei-/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-d","type":"person","url":"https://hartvaat.nl/mensen/a-d/","name":"A. D.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/cardiovasculaire-ziekte-bij-sikkelcelziekte-ondergediagnosticeerde-drijver-van-m/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/01/21/genetische-test-bij-cardiomyopathie-huidige-britse-criteria-missen-een-op-de-zev/","published":"2026-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-e","type":"person","url":"https://hartvaat.nl/mensen/a-e/","name":"A. E.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/29/erasmus-mc-linkeratrium-strain-voorspelt-aritmieen-na-chirurgische-correctie-van/","published":"2026-07-11"},{"url":"https://hartvaat.nl/2026/01/28/risicocommunicatie-instrument-in-de-huisartsenpraktijk-verlaagt-bloeddruk-en-cho/","published":"2026-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-l","type":"person","url":"https://hartvaat.nl/mensen/a-l/","name":"A. L.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2026/03/25/geleidelijk-afbouwen-van-rilonacept-bij-recidiverende-pericarditis-voorkomt-vake/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"a-r","type":"person","url":"https://hartvaat.nl/mensen/a-r/","name":"A. R.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/sekseverschillen-bij-infectieuze-endocarditis-vrouwen-vaker-conservatief-behande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aamir-jeewa","type":"person","url":"https://hartvaat.nl/mensen/aamir-jeewa/","name":"Aamir Jeewa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/12/aha-scientific-statement-evaluatie-en-behandeling-van-het-kind-met-acuut-gedecom/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aaqib-h-malik","type":"person","url":"https://hartvaat.nl/mensen/aaqib-h-malik/","name":"Aaqib H Malik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/gewicht-en-werkzaamheid-veiligheid-van-doac-s-bij-niet-valvulair-af-meta-analyse/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/09/01/oac-bij-af-met-kleplijden-en-bioprothese-overzicht/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aaron-b-waxman","type":"person","url":"https://hartvaat.nl/mensen/aaron-b-waxman/","name":"Aaron B Waxman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aaron-w-aday","type":"person","url":"https://hartvaat.nl/mensen/aaron-w-aday/","name":"Aaron W Aday","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/05/triglyceriderijk-lipoproteinecholesterol-small-dense-ldl-en-cv-events/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2018/07/10/residueel-inflammatoir-risico-bij-pcsk9-remming-plus-statine/","published":"2018-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aaron-wong","type":"person","url":"https://hartvaat.nl/mensen/aaron-wong/","name":"Aaron Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/09/cangrelor-en-infarctgrootte-bij-stemi-gerandomiseerde-trial/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abbas-ali-qayyum","type":"person","url":"https://hartvaat.nl/mensen/abbas-ali-qayyum/","name":"Abbas Ali Qayyum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/science-ii-mesenchymale-stamcellen-bij-niet-ischemisch-hartfalen-negatieve-trial/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abdallah-al-mohammad","type":"person","url":"https://hartvaat.nl/mensen/abdallah-al-mohammad/","name":"Abdallah Al-Mohammad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abdelhakim-allali","type":"person","url":"https://hartvaat.nl/mensen/abdelhakim-allali/","name":"Abdelhakim Allali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abdul-shakoor","type":"person","url":"https://hartvaat.nl/mensen/abdul-shakoor/","name":"Abdul Shakoor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/14/hartfalen-mondiale-economische-ziektelast/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2025/04/01/socio-economische-ongelijkheid-en-hartfalenuitkomsten-systematische-review/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abdullah-malik","type":"person","url":"https://hartvaat.nl/mensen/abdullah-malik/","name":"Abdullah Malik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2021/12/01/predictieve-modellen-voor-cv-en-renale-uitkomsten-bij-diabetes-type-2-meta-analy/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abhinav-goyal","type":"person","url":"https://hartvaat.nl/mensen/abhinav-goyal/","name":"Abhinav Goyal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"abigail-s-baldridge","type":"person","url":"https://hartvaat.nl/mensen/abigail-s-baldridge/","name":"Abigail S Baldridge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2018/02/13/kwaliteitsverbeteringsinterventie-bij-acuut-mi-in-india-jama-acs-quik/","published":"2018-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-butterworth","type":"person","url":"https://hartvaat.nl/mensen/adam-butterworth/","name":"Adam Butterworth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-c-salisbury","type":"person","url":"https://hartvaat.nl/mensen/adam-c-salisbury/","name":"Adam C Salisbury","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/vroege-versus-late-gestageerde-pci-na-subintimale-re-entry-bij-cto/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-cuker","type":"person","url":"https://hartvaat.nl/mensen/adam-cuker/","name":"Adam Cuker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-j-nelson","type":"person","url":"https://hartvaat.nl/mensen/adam-j-nelson/","name":"Adam J. Nelson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/13/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adam-perkovic","type":"person","url":"https://hartvaat.nl/mensen/adam-perkovic/","name":"Adam Perkovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adelina-yafasova","type":"person","url":"https://hartvaat.nl/mensen/adelina-yafasova/","name":"Adelina Yafasova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adelino-leite-moreira","type":"person","url":"https://hartvaat.nl/mensen/adelino-leite-moreira/","name":"Adelino Leite-Moreira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/05/sglt2-remmer-met-en-zonder-mra-bij-hartfalen-gecombineerde-analyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aditya-bhat","type":"person","url":"https://hartvaat.nl/mensen/aditya-bhat/","name":"Aditya Bhat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/22/clopidogrel-superieur-aan-aspirine-na-pci-10-jaar-host-exam/","published":"2026-08-27"},{"url":"https://hartvaat.nl/2026/05/27/sglt2-remmers-verminderen-epicardiaal-vetweefsel-meta-analyse-van-11-studies/","published":"2026-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adolfo-correa","type":"person","url":"https://hartvaat.nl/mensen/adolfo-correa/","name":"Adolfo Correa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adriaan-o-kraaijeveld","type":"person","url":"https://hartvaat.nl/mensen/adriaan-o-kraaijeveld/","name":"Adriaan O Kraaijeveld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adriaan-wilgenhof","type":"person","url":"https://hartvaat.nl/mensen/adriaan-wilgenhof/","name":"Adriaan Wilgenhof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrian-v-hernandez","type":"person","url":"https://hartvaat.nl/mensen/adrian-v-hernandez/","name":"Adrian V Hernandez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/07/prevalentie-van-statine-intolerantie-meta-analyse-nuanceert-het-probleem/","published":"2022-09-07"},{"url":"https://hartvaat.nl/2019/06/01/zoutsubstituten-met-laag-natrium-en-bloeddruk-cva-en-mortaliteit-meta-analyse/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"adrien-al-wazzan","type":"person","url":"https://hartvaat.nl/mensen/adrien-al-wazzan/","name":"Adrien Al Wazzan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/m-teer-werkt-over-het-volledige-lvef-spectrum-vergroot-linkeratrium-volume-voors/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2026/02/03/effect-van-mavacamten-op-risicoscores-voor-plotse-hartdood-bij-hypertrofische-ca/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ae-young-her","type":"person","url":"https://hartvaat.nl/mensen/ae-young-her/","name":"Ae-Young Her","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"afsar-raza","type":"person","url":"https://hartvaat.nl/mensen/afsar-raza/","name":"Afsar Raza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"afzal-sohaib","type":"person","url":"https://hartvaat.nl/mensen/afzal-sohaib/","name":"Afzal Sohaib","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/21/orbita-2-pci-versus-placebo-bij-stabiele-angina-pectoris-nejm/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2019/08/01/optimale-laesieset-bij-persisterend-af-ablatie-meta-regressie/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"agnes-bosch","type":"person","url":"https://hartvaat.nl/mensen/agnes-bosch/","name":"Agnes Bosch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/12/01/empagliflozine-en-vaatfunctie-bij-chronisch-hf/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"agnes-gasiorek","type":"person","url":"https://hartvaat.nl/mensen/agnes-gasiorek/","name":"Agnes Gasiorek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/12/amycretine-fase-2-subcutaan-toegediend-bij-obesitas/","published":"2025-07-12"},{"url":"https://hartvaat.nl/2025/07/12/amycretine-eerste-glp-1-amyline-agonist-fase-1-veiligheid-en-farmacologie/","published":"2025-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"agnieszka-kapon-cieslicka","type":"person","url":"https://hartvaat.nl/mensen/agnieszka-kapon-cieslicka/","name":"Agnieszka Kapłon-Cieślicka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/02/26/cardiogene-shock-bij-myocardinfarct-resultaten-van-het-shock-pol-register/","published":"2026-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"agnieszka-tycinska","type":"person","url":"https://hartvaat.nl/mensen/agnieszka-tycinska/","name":"Agnieszka Tycińska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/levosimendan-infusies-en-klinisch-beloop-bij-hartfalen-levo-d-resultaten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmad-s-hersi","type":"person","url":"https://hartvaat.nl/mensen/ahmad-s-hersi/","name":"Ahmad S Hersi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed","type":"person","url":"https://hartvaat.nl/mensen/ahmed/","name":"Ahmed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/10/welke-hartfalenpatienten-ontwikkelen-ernstige-mitralisinsufficientie-voorspellen/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2026/02/04/pulsed-field-ablatie-bereikt-vaker-complete-achterwandisolatie-dan-radiofrequent/","published":"2026-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-aly-elbassiouny","type":"person","url":"https://hartvaat.nl/mensen/ahmed-aly-elbassiouny/","name":"Ahmed Aly Elbassiouny","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-aziz","type":"person","url":"https://hartvaat.nl/mensen/ahmed-aziz/","name":"Ahmed Aziz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-elsaid-elsayed","type":"person","url":"https://hartvaat.nl/mensen/ahmed-elsaid-elsayed/","name":"Ahmed Elsaid Elsayed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-farah","type":"person","url":"https://hartvaat.nl/mensen/ahmed-farah/","name":"Ahmed Farah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-hasan","type":"person","url":"https://hartvaat.nl/mensen/ahmed-hasan/","name":"Ahmed Hasan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-ibrahim-ahmed","type":"person","url":"https://hartvaat.nl/mensen/ahmed-ibrahim-ahmed/","name":"Ahmed Ibrahim Ahmed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/coronairverkalkingen-en-myocardiale-flowreserve-na-harttransplantatie/","published":"2026-04-03"},{"url":"https://hartvaat.nl/2025/12/03/risicoverfijning-in-het-tijdperk-van-een-cac-score-van-nul-de-meerwaarde-van-fit/","published":"2025-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-khashaba","type":"person","url":"https://hartvaat.nl/mensen/ahmed-khashaba/","name":"Ahmed Khashaba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-mazen-amin","type":"person","url":"https://hartvaat.nl/mensen/ahmed-mazen-amin/","name":"Ahmed Mazen Amin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/lipideparameters-en-prognose-bij-hartfalen-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/02/01/nieuwe-kaliumbinders-verbeteren-raas-remmer-gebruik-bij-hartfalen-meta-analyse/","published":"2024-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmed-n-mahmoud","type":"person","url":"https://hartvaat.nl/mensen/ahmed-n-mahmoud/","name":"Ahmed N Mahmoud","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/01/provisional-versus-twee-stentstrategie-bij-bifurcatielaesies-meta-analyse/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2016/08/02/impact-van-coronaire-laesielengte-op-uitkomsten-bij-ivus-geleide-pci/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ahmet-fuat","type":"person","url":"https://hartvaat.nl/mensen/ahmet-fuat/","name":"Ahmet Fuat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/santorini-uk-ldl-doel-onbereikt-bij-meerderheid-van-hoogrisicopatienten-na-1-jaa/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2025/04/01/ambulante-behandeling-van-gedecompenseerd-hartfalen-meta-analyse/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aijun-liu","type":"person","url":"https://hartvaat.nl/mensen/aijun-liu/","name":"Aijun Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aikaterini-papagianni","type":"person","url":"https://hartvaat.nl/mensen/aikaterini-papagianni/","name":"Aikaterini Papagianni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/06/01/longechogeleide-drooggewichtreductie-en-ambulante-bloeddruk-bij-hemodialyse/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aimin-xu","type":"person","url":"https://hartvaat.nl/mensen/aimin-xu/","name":"Aimin Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/26/peptidehormooncombinaties-bieden-superieure-effectiviteit-bij-metabole-multimorb/","published":"2026-08-06"},{"url":"https://hartvaat.nl/2022/11/15/fgf21-sirtuin-3-hoe-inspanning-beschermt-tegen-diabetische-cardiomyopathie/","published":"2022-11-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aina-s-lihn","type":"person","url":"https://hartvaat.nl/mensen/aina-s-lihn/","name":"Aina S Lihn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ajay-k-bhatia","type":"person","url":"https://hartvaat.nl/mensen/ajay-k-bhatia/","name":"Ajay K Bhatia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ajay-k-singh","type":"person","url":"https://hartvaat.nl/mensen/ajay-k-singh/","name":"Ajay K Singh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akash-makkar","type":"person","url":"https://hartvaat.nl/mensen/akash-makkar/","name":"Akash Makkar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2020/10/27/af-ablatie-met-vena-van-marshall-ethanol-versus-ablatie-alleen-jama-venus/","published":"2020-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akihiro-nomura","type":"person","url":"https://hartvaat.nl/mensen/akihiro-nomura/","name":"Akihiro Nomura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/20/hokuriku-plus-genetische-diagnose-bij-familiaire-hypercholesterolemie-verlaagt-m/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2021/10/21/digitale-therapeutica-bij-essentiele-hypertensie-herb-dh1-pivottrial/","published":"2021-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akiomi-yoshihisa","type":"person","url":"https://hartvaat.nl/mensen/akiomi-yoshihisa/","name":"Akiomi Yoshihisa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/winteropname-voor-acuut-hartfalen-gaat-gepaard-met-hogere-sterfte/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akriti-naraen","type":"person","url":"https://hartvaat.nl/mensen/akriti-naraen/","name":"Akriti Naraen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"akshay-bagai","type":"person","url":"https://hartvaat.nl/mensen/akshay-bagai/","name":"Akshay Bagai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ala-assaf","type":"person","url":"https://hartvaat.nl/mensen/ala-assaf/","name":"Ala Assaf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/decaaf-ii-af-last-en-symptoomreductie-na-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/08/02/decaaf-ii-fibroselocatie-beinvloedt-af-recidief-na-ablatie/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alain-bouchard","type":"person","url":"https://hartvaat.nl/mensen/alain-bouchard/","name":"Alain Bouchard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/07/mesenchymale-precursorcellen-bij-hfref-gerandomiseerde-trial/","published":"2023-03-07"},{"url":"https://hartvaat.nl/2016/03/19/serca2a-gentherapie-bij-hartfalen-de-cupid-2-trial/","published":"2016-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alain-cariou","type":"person","url":"https://hartvaat.nl/mensen/alain-cariou/","name":"Alain Cariou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/plotse-hartstilstand-tijdens-duursporten-tien-jaar-parijse-registerdata/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-b-storrow","type":"person","url":"https://hartvaat.nl/mensen/alan-b-storrow/","name":"Alan B Storrow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/24/2024-acc-beslispad-klinische-beoordeling-en-trajectmanagement-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-bulava","type":"person","url":"https://hartvaat.nl/mensen/alan-bulava/","name":"Alan Bulava","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/07/cti-blok-na-pfa-versus-rf-cryo-ablatie-gerandomiseerde-vergelijking/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2024/02/01/sequentiele-hybride-ablatie-versus-chirurgische-cryomaze-bij-af-met-structurele-/","published":"2024-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-miller","type":"person","url":"https://hartvaat.nl/mensen/alan-miller/","name":"Alan Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/19/empagliflozine-en-verslechterende-hf-events-bij-hfpef-emperor-preserved-analyse/","published":"2021-10-19"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-en-klinische-stabiliteit-bij-hfref-emperor-reduced/","published":"2021-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-s-go","type":"person","url":"https://hartvaat.nl/mensen/alan-s-go/","name":"Alan S Go","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/30/kp-chemo-cumulatieve-incidentie-cancer-therapy-related-cardiac-dysfunction-8-4-h/","published":"2026-07-02"},{"url":"https://hartvaat.nl/2024/11/19/screening-op-niet-gediagnosticeerd-af-voor-cva-preventie-gerandomiseerde-trial/","published":"2024-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-t-tita","type":"person","url":"https://hartvaat.nl/mensen/alan-t-tita/","name":"Alan T Tita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/12/behandeling-van-milde-chronische-hypertensie-in-de-zwangerschap-nejm-chap/","published":"2022-05-12"},{"url":"https://hartvaat.nl/2018/02/01/nauwkeurigheid-van-bloeddrukmeters-in-de-zwangerschap-systematische-review/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alan-wasserman","type":"person","url":"https://hartvaat.nl/mensen/alan-wasserman/","name":"Alan Wasserman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alasdair-henderson","type":"person","url":"https://hartvaat.nl/mensen/alasdair-henderson/","name":"Alasdair Henderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alastair-n-j-graham","type":"person","url":"https://hartvaat.nl/mensen/alastair-n-j-graham/","name":"Alastair N J Graham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-cordero","type":"person","url":"https://hartvaat.nl/mensen/alberto-cordero/","name":"Alberto Cordero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-esteban-fernandez","type":"person","url":"https://hartvaat.nl/mensen/alberto-esteban-fernandez/","name":"Alberto Esteban-Fernández","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/13/verisec-register-vericiguat-halveert-hartfalen-decompensaties-bij-hfref-in-dagel/","published":"2026-06-21"},{"url":"https://hartvaat.nl/2026/05/13/verisec-vericiguat-in-de-praktijk-halveert-hartfalen-decompensaties-bij-hfref-sp/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-fernandez","type":"person","url":"https://hartvaat.nl/mensen/alberto-fernandez/","name":"Alberto Fernandez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/plotse-dood-na-mi-inzichten-uit-valiant-en-paradise-mi/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-foa","type":"person","url":"https://hartvaat.nl/mensen/alberto-foa/","name":"Alberto Foà","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/13/minoca-pathologische-bevindingen-bij-invasieve-beoordeling-meta-analyse/","published":"2025-03-13"},{"url":"https://hartvaat.nl/2024/05/07/sacubitril-valsartan-en-hypotensie-bij-hfpef-hfmref/","published":"2024-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alberto-giannoni","type":"person","url":"https://hartvaat.nl/mensen/alberto-giannoni/","name":"Alberto Giannoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2017/09/12/centrale-apneus-gedurende-24-uur-en-prognose-bij-hartfalen/","published":"2017-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"albertus-beishuizen","type":"person","url":"https://hartvaat.nl/mensen/albertus-beishuizen/","name":"Albertus Beishuizen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"albree-tower-rader","type":"person","url":"https://hartvaat.nl/mensen/albree-tower-rader/","name":"Albree Tower-Rader","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aldo-bellido","type":"person","url":"https://hartvaat.nl/mensen/aldo-bellido/","name":"Aldo Bellido","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alecia-nickless","type":"person","url":"https://hartvaat.nl/mensen/alecia-nickless/","name":"Alecia Nickless","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aleix-sala-vila","type":"person","url":"https://hartvaat.nl/mensen/aleix-sala-vila/","name":"Aleix Sala-Vila","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2019/05/01/walnotendieet-en-24-uurs-ambulante-bloeddruk-bij-ouderen/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alejandro-lucia","type":"person","url":"https://hartvaat.nl/mensen/alejandro-lucia/","name":"Alejandro Lucia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/acute-aerobe-training-en-kortdurende-ambulante-bloeddrukreductie-bij-hypertensie/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/06/11/inspanningsvoordelen-bij-pulmonale-hypertensie-jacc-review/","published":"2019-06-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aleksandra-kukla","type":"person","url":"https://hartvaat.nl/mensen/aleksandra-kukla/","name":"Aleksandra Kukla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/04/finerenon-bij-diabetische-nierziekte-en-type-1-diabetes-een-editoriaal/","published":"2026-03-19"},{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aleksandra-murawska","type":"person","url":"https://hartvaat.nl/mensen/aleksandra-murawska/","name":"Aleksandra Murawska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aleksandra-radjenovic","type":"person","url":"https://hartvaat.nl/mensen/aleksandra-radjenovic/","name":"Aleksandra Radjenovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-belletti","type":"person","url":"https://hartvaat.nl/mensen/alessandro-belletti/","name":"Alessandro Belletti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/prince-remote-ischemische-preconditionering-en-myocardletsel-bij-niet-cardiale-c/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2017/11/01/rehospitalisatie-na-intermitterend-levosimendan-bij-gevorderd-hartfalen-meta-ana/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-candreva","type":"person","url":"https://hartvaat.nl/mensen/alessandro-candreva/","name":"Alessandro Candreva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-capucci","type":"person","url":"https://hartvaat.nl/mensen/alessandro-capucci/","name":"Alessandro Capucci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/vaste-versus-responsieve-pacingfrequentie-bij-permanent-af-met-pacemakerindicati/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/01/flecainide-metoprolol-combinatie-vermindert-af-recidieven-1-jaarsresultaten/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-fuga","type":"person","url":"https://hartvaat.nl/mensen/alessandro-fuga/","name":"Alessandro Fuga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessandro-spirito","type":"person","url":"https://hartvaat.nl/mensen/alessandro-spirito/","name":"Alessandro Spirito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2020/05/26/subcutaan-selatogrel-remt-plaatjesaggregatie-bij-acuut-mi/","published":"2020-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessia-vuturo","type":"person","url":"https://hartvaat.nl/mensen/alessia-vuturo/","name":"Alessia Vuturo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alessio-alogna","type":"person","url":"https://hartvaat.nl/mensen/alessio-alogna/","name":"Alessio Alogna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/dapagliflozine-en-rv-pulmonale-interactie-bij-hfpef/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/09/05/cameo-dapa-cardiale-en-metabole-effecten-van-dapagliflozine-bij-hfpef/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-brown","type":"person","url":"https://hartvaat.nl/mensen/alex-brown/","name":"Alex Brown","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/01/cardiovasculaire-risicovoorspelling-bij-inheemse-australiers/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-grinvalds","type":"person","url":"https://hartvaat.nl/mensen/alex-grinvalds/","name":"Alex Grinvalds","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/05/13/wereldwijde-hf-registry-fev1-is-een-onafhankelijke-prognostische-factor-pleidooi/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-heyse","type":"person","url":"https://hartvaat.nl/mensen/alex-heyse/","name":"Alex Heyse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/20/ticagrelor-versus-prasugrel-en-coronaire-microcirculatie-bij-pci/","published":"2023-12-20"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alex-koziarz","type":"person","url":"https://hartvaat.nl/mensen/alex-koziarz/","name":"Alex Koziarz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-bennett","type":"person","url":"https://hartvaat.nl/mensen/alexander-bennett/","name":"Alexander Bennett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2016/01/30/intensieve-bloeddrukverlaging-en-cardiovasculaire-en-renale-uitkomsten-systemati/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-bogachev-prokophiev","type":"person","url":"https://hartvaat.nl/mensen/alexander-bogachev-prokophiev/","name":"Alexander Bogachev-Prokophiev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-bufe","type":"person","url":"https://hartvaat.nl/mensen/alexander-bufe/","name":"Alexander Bufe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2018/07/07/revascularisatie-versus-optimale-medicamenteuze-therapie-bij-cto-gerandomiseerde/","published":"2018-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-chernyavskiy","type":"person","url":"https://hartvaat.nl/mensen/alexander-chernyavskiy/","name":"Alexander Chernyavskiy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/01/natriumzirconiumcyclosilicaat-bij-hyperkaliemie-en-hartfalen/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2022/02/22/temporaire-ruggenmergstimulatie-ter-preventie-van-postoperatief-af/","published":"2022-02-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-dick","type":"person","url":"https://hartvaat.nl/mensen/alexander-dick/","name":"Alexander Dick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-furnkranz","type":"person","url":"https://hartvaat.nl/mensen/alexander-furnkranz/","name":"Alexander Fürnkranz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-g-logan","type":"person","url":"https://hartvaat.nl/mensen/alexander-g-logan/","name":"Alexander G Logan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-j-gregory","type":"person","url":"https://hartvaat.nl/mensen/alexander-j-gregory/","name":"Alexander J Gregory","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-j-j-ijsselmuiden","type":"person","url":"https://hartvaat.nl/mensen/alexander-j-j-ijsselmuiden/","name":"Alexander J J IJsselmuiden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-kulik","type":"person","url":"https://hartvaat.nl/mensen/alexander-kulik/","name":"Alexander Kulik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/08/09/ticagrelor-dapt-en-veneuze-graftfalen-na-cabg-systematische-review/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-lauten","type":"person","url":"https://hartvaat.nl/mensen/alexander-lauten/","name":"Alexander Lauten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-m-clark","type":"person","url":"https://hartvaat.nl/mensen/alexander-m-clark/","name":"Alexander M Clark","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/telehealth-verbetert-zelfzorg-bij-kwetsbare-hartfalenpatienten/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2016/05/01/werkzame-mechanismen-van-disease-management-bij-hartfalen-systematische-review/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-nap","type":"person","url":"https://hartvaat.nl/mensen/alexander-nap/","name":"Alexander Nap","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-p-j-vlaar","type":"person","url":"https://hartvaat.nl/mensen/alexander-p-j-vlaar/","name":"Alexander P J Vlaar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-r-cobitz","type":"person","url":"https://hartvaat.nl/mensen/alexander-r-cobitz/","name":"Alexander R Cobitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-schmeisser","type":"person","url":"https://hartvaat.nl/mensen/alexander-schmeisser/","name":"Alexander Schmeisser","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/invasieve-drukvolumelussen-onthullen-mechanisme-van-tricuspidalisinsufficientie-/","published":"2026-06-24"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexander-zarbock","type":"person","url":"https://hartvaat.nl/mensen/alexander-zarbock/","name":"Alexander Zarbock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/02/geindividualiseerd-perioperatief-bloeddrukmanagement-bij-grote-buikchirurgie/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2024/09/24/tight-k-kaliumsuppletie-voorkomt-af-na-hartchirurgie-rct/","published":"2024-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-e-cairns","type":"person","url":"https://hartvaat.nl/mensen/alexandra-e-cairns/","name":"Alexandra E Cairns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-gorelik","type":"person","url":"https://hartvaat.nl/mensen/alexandra-gorelik/","name":"Alexandra Gorelik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/18/procedurevolume-en-complicaties-bij-af-ablatie-meta-analyse/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2018/07/01/rotorablatie-bij-atriumfibrilleren-systematische-review/","published":"2018-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-j-lansky","type":"person","url":"https://hartvaat.nl/mensen/alexandra-j-lansky/","name":"Alexandra J Lansky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/16/revascularisatiestrategieen-na-mi-systematische-review-en-meta-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-p-lengyel","type":"person","url":"https://hartvaat.nl/mensen/alexandra-p-lengyel/","name":"Alexandra P Lengyel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2018/05/08/vasopressine-plus-catecholamines-en-af-bij-distributieve-shock-jama-meta-analyse/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandra-philipsen","type":"person","url":"https://hartvaat.nl/mensen/alexandra-philipsen/","name":"Alexandra Philipsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandre-c-pereira","type":"person","url":"https://hartvaat.nl/mensen/alexandre-c-pereira/","name":"Alexandre C Pereira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/05/glycemische-controle-en-cardiale-auto-immuniteit-bij-diabetes-type-1-en-langeter/","published":"2019-02-05"},{"url":"https://hartvaat.nl/2018/04/01/spironolacton-versus-clonidine-als-vierde-middel-bij-resistente-hypertensie-reho/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandre-ouattara","type":"person","url":"https://hartvaat.nl/mensen/alexandre-ouattara/","name":"Alexandre Ouattara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/levoecmo-levosimendan-bij-ecmo-weaning-bij-cardiogene-shock/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexandros-polymeris","type":"person","url":"https://hartvaat.nl/mensen/alexandros-polymeris/","name":"Alexandros Polymeris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alexis-baass","type":"person","url":"https://hartvaat.nl/mensen/alexis-baass/","name":"Alexis Baass","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/16/polygene-risicoscores-bij-familiaire-hypercholesterolemie-nuttig-of-niet/","published":"2026-03-10"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alf-inge-larsen","type":"person","url":"https://hartvaat.nl/mensen/alf-inge-larsen/","name":"Alf-Inge Larsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"},{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alfred-e-buxton","type":"person","url":"https://hartvaat.nl/mensen/alfred-e-buxton/","name":"Alfred E Buxton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2016/03/15/voorspelling-van-persisterende-lv-disfunctie-na-myocardinfarct-de-predicts-studi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alfredo-gamboa","type":"person","url":"https://hartvaat.nl/mensen/alfredo-gamboa/","name":"Alfredo Gamboa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/10/01/autonome-blokkade-herstelt-endotheeldisfunctie-bij-obesitasgerelateerde-hyperten/","published":"2016-10-01"},{"url":"https://hartvaat.nl/2016/02/01/mineralocorticoidreceptoractivatie-draagt-bij-aan-supiene-hypertensie-bij-autono/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ali-alghamdi","type":"person","url":"https://hartvaat.nl/mensen/ali-alghamdi/","name":"Ali Alghamdi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alice-h-lichtenstein","type":"person","url":"https://hartvaat.nl/mensen/alice-h-lichtenstein/","name":"Alice H Lichtenstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/01/metabolomics-en-bloeddrukrespons-op-dash-dieet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2020/01/21/voedingscholesterol-en-cv-risico-aha-science-advisory/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alice-m-jackson","type":"person","url":"https://hartvaat.nl/mensen/alice-m-jackson/","name":"Alice M Jackson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/21/sacubitril-valsartan-bij-schijnbaar-resistente-hypertensie-met-hfpef/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alice-stanton","type":"person","url":"https://hartvaat.nl/mensen/alice-stanton/","name":"Alice Stanton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/01/polypil-en-cardiovasculaire-preventie-meta-analyse-van-gerandomiseerde-trials/","published":"2019-01-01"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alice-wang","type":"person","url":"https://hartvaat.nl/mensen/alice-wang/","name":"Alice Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/uitkomsten-bij-af-met-oac-bij-mitralis-of-aortakleplijden/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alida-l-p-caforio","type":"person","url":"https://hartvaat.nl/mensen/alida-l-p-caforio/","name":"Alida L P Caforio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alireza-oraii","type":"person","url":"https://hartvaat.nl/mensen/alireza-oraii/","name":"Alireza Oraii","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/07/mra-s-verminderen-af-risico-meta-analyse-van-klinische-trials/","published":"2024-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alison-chisholm","type":"person","url":"https://hartvaat.nl/mensen/alison-chisholm/","name":"Alison Chisholm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alistair-j-roddick","type":"person","url":"https://hartvaat.nl/mensen/alistair-j-roddick/","name":"Alistair J Roddick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/22/aspirine-voor-primaire-preventie-jama-meta-analyse-van-cv-events-en-bloedingen/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/04/17/sglt2-remmers-glp-1-agonisten-en-dpp-4-remmers-vergelijkende-cardiovasculaire-me/","published":"2018-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alistair-royse","type":"person","url":"https://hartvaat.nl/mensen/alistair-royse/","name":"Alistair Royse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"allen-ciuffo","type":"person","url":"https://hartvaat.nl/mensen/allen-ciuffo/","name":"Allen Ciuffo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"allen-young","type":"person","url":"https://hartvaat.nl/mensen/allen-young/","name":"Allen Young","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"allie-s-carew","type":"person","url":"https://hartvaat.nl/mensen/allie-s-carew/","name":"Allie S Carew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/haptoglobinefenotype-en-cv-risico-accord-bloeddruk-rct/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2020/02/11/haptoglobinefenotype-wijzigt-het-effect-van-intensieve-glycemische-controle-op-c/","published":"2020-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"allison-blackorby","type":"person","url":"https://hartvaat.nl/mensen/allison-blackorby/","name":"Allison Blackorby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"allison-k-delong","type":"person","url":"https://hartvaat.nl/mensen/allison-k-delong/","name":"Allison K DeLong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alok-gambhir","type":"person","url":"https://hartvaat.nl/mensen/alok-gambhir/","name":"Alok Gambhir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alonso-mateos","type":"person","url":"https://hartvaat.nl/mensen/alonso-mateos/","name":"Alonso Mateos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"},{"url":"https://hartvaat.nl/2016/05/10/timing-van-metoprolol-bij-stemi-effect-op-infarctgrootte-en-ventrikelfunctie/","published":"2016-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alpana-waldron","type":"person","url":"https://hartvaat.nl/mensen/alpana-waldron/","name":"Alpana Waldron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"},{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alper-oner","type":"person","url":"https://hartvaat.nl/mensen/alper-oner/","name":"Alper Öner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alvaro-alonso","type":"person","url":"https://hartvaat.nl/mensen/alvaro-alonso/","name":"Alvaro Alonso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"},{"url":"https://hartvaat.nl/2016/08/01/vitamine-d-en-incidentie-van-atriumfibrilleren-de-aric-studie/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amanda-g-thrift","type":"person","url":"https://hartvaat.nl/mensen/amanda-g-thrift/","name":"Amanda G Thrift","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/pneumokokkenvaccinatie-en-cv-eventpreventie-ipd-meta-analyse/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2016/12/01/lacunes-in-hypertensierichtlijnen-in-lage-en-middeninkomenslanden-systematische-/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amanda-siriwardana","type":"person","url":"https://hartvaat.nl/mensen/amanda-siriwardana/","name":"Amanda Siriwardana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2025/12/24/risicovoorspellingsmodellen-voor-ouderen-met-chronische-nierziekte/","published":"2025-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amany-elshorbagy","type":"person","url":"https://hartvaat.nl/mensen/amany-elshorbagy/","name":"Amany Elshorbagy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/01/16/non-hdl-c-doelen-halen-in-de-eerste-en-tweede-lijn-een-da-vinci-deelanalyse/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amber-l-beitelshees","type":"person","url":"https://hartvaat.nl/mensen/amber-l-beitelshees/","name":"Amber L Beitelshees","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ambuj-roy","type":"person","url":"https://hartvaat.nl/mensen/ambuj-roy/","name":"Ambuj Roy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/15/opleidingsniveau-verandert-het-effect-van-diabetes-op-de-sterfte-bij-hartfalen-i/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2020/04/07/yoga-gebaseerde-hartrevalidatie-na-acuut-mi-gerandomiseerde-trial/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amedeo-chiribiri","type":"person","url":"https://hartvaat.nl/mensen/amedeo-chiribiri/","name":"Amedeo Chiribiri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amin-bazyani","type":"person","url":"https://hartvaat.nl/mensen/amin-bazyani/","name":"Amin Bazyani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/27/inflammatoire-biomarkers-verbeteren-risicostratificatie-bij-perifeer-arterieel-v/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/02/02/apob-apoa-i-ratio-voor-diagnostiek-en-ernst-van-coronairlijden-bij-statinegebrui/","published":"2026-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amir-askarinejad","type":"person","url":"https://hartvaat.nl/mensen/amir-askarinejad/","name":"Amir Askarinejad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/prognose-takotsubo-syndroom-versus-hartfalen-op-de-lange-termijn/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amiram-gafni","type":"person","url":"https://hartvaat.nl/mensen/amiram-gafni/","name":"Amiram Gafni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amit-n-patel","type":"person","url":"https://hartvaat.nl/mensen/amit-n-patel/","name":"Amit N Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/06/11/ixmyelocel-t-bij-ischemisch-hartfalen-lancet-dubbelblinde-gerandomiseerde-trial/","published":"2016-06-11"},{"url":"https://hartvaat.nl/2016/05/01/intracoronaire-adenylylcyclase-6-gentherapie-bij-hartfalen-gerandomiseerde-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amit-patki","type":"person","url":"https://hartvaat.nl/mensen/amit-patki/","name":"Amit Patki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/polygene-risicoscore-en-chloortalidone-respons/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amparo-l-figueroa","type":"person","url":"https://hartvaat.nl/mensen/amparo-l-figueroa/","name":"Amparo L Figueroa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amr-abdin","type":"person","url":"https://hartvaat.nl/mensen/amr-abdin/","name":"Amr Abdin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2023/10/01/ivabradine-bij-hoogrisico-hartfalenpatienten-shift-analyse/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amrita-ahluwalia","type":"person","url":"https://hartvaat.nl/mensen/amrita-ahluwalia/","name":"Amrita Ahluwalia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"},{"url":"https://hartvaat.nl/2017/04/01/intracoronair-nitriet-onderdrukt-de-inflammatoire-respons-na-primaire-pci/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amy-earley","type":"person","url":"https://hartvaat.nl/mensen/amy-earley/","name":"Amy Earley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amy-m-meadowcroft","type":"person","url":"https://hartvaat.nl/mensen/amy-m-meadowcroft/","name":"Amy M Meadowcroft","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amy-rogers","type":"person","url":"https://hartvaat.nl/mensen/amy-rogers/","name":"Amy Rogers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/22/time-avonddosering-antihypertensiva-biedt-geen-voordeel-boven-ochtenddosering/","published":"2022-10-22"},{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"amy-von-huben","type":"person","url":"https://hartvaat.nl/mensen/amy-von-huben/","name":"Amy Von Huben","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-abreu","type":"person","url":"https://hartvaat.nl/mensen/ana-abreu/","name":"Ana Abreu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-ayesta","type":"person","url":"https://hartvaat.nl/mensen/ana-ayesta/","name":"Ana Ayesta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/20/es-bempedacs-triple-versus-duale-lipidenbehandeling-na-acs/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2017/07/01/1-jaarsmortaliteit-bivalirudine-versus-heparine-in-de-ambulance-bij-stemi-matrix/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-carina-ferreira","type":"person","url":"https://hartvaat.nl/mensen/ana-carina-ferreira/","name":"Ana Carina Ferreira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-garcia-alvarez","type":"person","url":"https://hartvaat.nl/mensen/ana-garcia-alvarez/","name":"Ana García-Álvarez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-h-c-guimaraes","type":"person","url":"https://hartvaat.nl/mensen/ana-h-c-guimaraes/","name":"Ana H C Guimarães","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/09/verminderde-klepbeweging-na-tavr-nejm/","published":"2020-01-09"},{"url":"https://hartvaat.nl/2020/01/09/rivaroxaban-na-tavr-nejm-galileo/","published":"2020-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-m-barbosa","type":"person","url":"https://hartvaat.nl/mensen/ana-m-barbosa/","name":"Ana M Barbosa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ana-vucenovic","type":"person","url":"https://hartvaat.nl/mensen/ana-vucenovic/","name":"Ana Vucenovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/17/bedmed-timing-van-antihypertensieve-medicatie-en-cv-events-jama-definitieve-tria/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2022/09/01/obstructief-slaapapneu-sympathische-activiteit-en-bloeddruk-meta-analyse/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anandita-agarwala","type":"person","url":"https://hartvaat.nl/mensen/anandita-agarwala/","name":"Anandita Agarwala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2021/08/31/2021-acc-consensus-ascvd-risicoreductie-bij-persistente-hypertriglyceridemie/","published":"2021-08-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anastasia-l-armbruster","type":"person","url":"https://hartvaat.nl/mensen/anastasia-l-armbruster/","name":"Anastasia L Armbruster","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anastasios-kollias","type":"person","url":"https://hartvaat.nl/mensen/anastasios-kollias/","name":"Anastasios Kollias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/01/af-screening-tijdens-bloeddrukmeting-diagnostische-nauwkeurigheid/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2016/01/01/centrale-versus-perifere-bloeddruk-en-doelorgaanschade-systematische-review-en-m/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anastasios-milkas","type":"person","url":"https://hartvaat.nl/mensen/anastasios-milkas/","name":"Anastasios Milkas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/ffr-verbetering-na-pci-en-uitkomsten-inclusief-symptoomverlichting/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/16/hoge-coronaire-shear-stress-voorspelt-myocardinfarct/","published":"2018-10-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anat-milman","type":"person","url":"https://hartvaat.nl/mensen/anat-milman/","name":"Anat Milman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2021/01/27/mobiele-gezondheidstoepassingen-voor-af-detectie-systematische-review/","published":"2021-01-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ander-regueiro","type":"person","url":"https://hartvaat.nl/mensen/ander-regueiro/","name":"Ander Regueiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-doac-versus-dapt-na-laa-occlusie-gerandomiseerde-trial/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anders-ahlsson","type":"person","url":"https://hartvaat.nl/mensen/anders-ahlsson/","name":"Anders Ahlsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anders-englund","type":"person","url":"https://hartvaat.nl/mensen/anders-englund/","name":"Anders Englund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/03/01/katheterablatie-als-eerstelijnsbehandeling-bij-paroxysmaal-af-5-jaarsresultaten/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anders-ulvenstam","type":"person","url":"https://hartvaat.nl/mensen/anders-ulvenstam/","name":"Anders Ulvenstam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andersen","type":"person","url":"https://hartvaat.nl/mensen/andersen/","name":"Andersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/klinisch-en-genetisch-risico-op-atriumfibrilleren-versterken-elkaar-additief-13-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/01/28/risicocommunicatie-instrument-in-de-huisartsenpraktijk-verlaagt-bloeddruk-en-cho/","published":"2026-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andra-duncan","type":"person","url":"https://hartvaat.nl/mensen/andra-duncan/","name":"Andra Duncan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/18/dexmedetomidine-voor-af-en-delier-na-hartchirurgie-lancet-decade/","published":"2020-07-18"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andre-keren","type":"person","url":"https://hartvaat.nl/mensen/andre-keren/","name":"Andre Keren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-baldo","type":"person","url":"https://hartvaat.nl/mensen/andrea-baldo/","name":"Andrea Baldo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2016/10/01/langere-versus-korte-dapt-na-pci-met-en-zonder-periprocedureel-mi-jama-cardiolog/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-bellavia","type":"person","url":"https://hartvaat.nl/mensen/andrea-bellavia/","name":"Andrea Bellavia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/04/23/pci-versus-cabg-bij-linker-hoofdstam-met-en-zonder-diabetes-precombat-follow-up/","published":"2024-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-galeazzo-rigutini","type":"person","url":"https://hartvaat.nl/mensen/andrea-galeazzo-rigutini/","name":"Andrea Galeazzo Rigutini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/prognose-takotsubo-syndroom-versus-hartfalen-op-de-lange-termijn/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-garascia","type":"person","url":"https://hartvaat.nl/mensen/andrea-garascia/","name":"Andrea Garascia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-grammatico","type":"person","url":"https://hartvaat.nl/mensen/andrea-grammatico/","name":"Andrea Grammatico","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/03/multipoint-pacing-vermindert-hf-hospitalisaties-en-sterfte-bij-crt-non-responder/","published":"2025-06-03"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-k-roalfe","type":"person","url":"https://hartvaat.nl/mensen/andrea-k-roalfe/","name":"Andrea K Roalfe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/natriuretisch-peptide-screening-voor-lv-disfunctie-diagnostische-nauwkeurigheid/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/06/01/diagnostiek-van-hartfalen-in-de-huisartsenpraktijk-ipd-meta-analyse/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-macdougall","type":"person","url":"https://hartvaat.nl/mensen/andrea-macdougall/","name":"Andrea MacDougall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-ripoli","type":"person","url":"https://hartvaat.nl/mensen/andrea-ripoli/","name":"Andrea Ripoli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/sterftecijfers-in-controle-armen-van-hartfalen-rcts-dalen-niet-ondanks-betere-ac/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-rivas","type":"person","url":"https://hartvaat.nl/mensen/andrea-rivas/","name":"Andrea Rivas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-rubboli","type":"person","url":"https://hartvaat.nl/mensen/andrea-rubboli/","name":"Andrea Rubboli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrea-zito","type":"person","url":"https://hartvaat.nl/mensen/andrea-zito/","name":"Andrea Zito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/prognostische-implicaties-van-universele-definities-van-periprocedureel-mi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2022/07/21/permanente-pacemaker-na-tavi-langetermijneffect-op-klinische-uitkomsten/","published":"2022-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-boening","type":"person","url":"https://hartvaat.nl/mensen/andreas-boening/","name":"Andreas Boening","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-clemens","type":"person","url":"https://hartvaat.nl/mensen/andreas-clemens/","name":"Andreas Clemens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-e-may","type":"person","url":"https://hartvaat.nl/mensen/andreas-e-may/","name":"Andreas E May","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-orfanos","type":"person","url":"https://hartvaat.nl/mensen/andreas-orfanos/","name":"Andreas Orfanos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreas-vegge","type":"person","url":"https://hartvaat.nl/mensen/andreas-vegge/","name":"Andreas Vegge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/12/amycretine-fase-2-subcutaan-toegediend-bij-obesitas/","published":"2025-07-12"},{"url":"https://hartvaat.nl/2025/07/12/amycretine-eerste-glp-1-amyline-agonist-fase-1-veiligheid-en-farmacologie/","published":"2025-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrei-v-alexandrov","type":"person","url":"https://hartvaat.nl/mensen/andrei-v-alexandrov/","name":"Andrei V Alexandrov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/bloeddruk-en-uitkomsten-bij-acute-beroerte-trombectomie/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/01/01/bloeddrukverlaging-en-secundaire-cva-preventie-meta-regressieanalyse/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andreis-erglis","type":"person","url":"https://hartvaat.nl/mensen/andreis-erglis/","name":"Andreis Erglis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrej-dukat","type":"person","url":"https://hartvaat.nl/mensen/andrej-dukat/","name":"Andrej Dukát","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/15/dapagliflozine-en-diureticagebruik-bij-hfref-dapa-hf/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/11/21/dapagliflozine-bij-hartfalen-met-verminderde-ejectiefractie-nejm-dapa-hf/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrej-pernat","type":"person","url":"https://hartvaat.nl/mensen/andrej-pernat/","name":"Andrej Pernat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2024/05/02/preventieve-substraatablatie-vermindert-icd-interventies-bij-ischemische-cmp/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andres-digenio","type":"person","url":"https://hartvaat.nl/mensen/andres-digenio/","name":"Andres Digenio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2017/07/20/angptl3-antisense-oligonucleotiden-cardiovasculaire-en-metabole-effecten-nejm/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-blyth","type":"person","url":"https://hartvaat.nl/mensen/andrew-blyth/","name":"Andrew Blyth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-h-shennan","type":"person","url":"https://hartvaat.nl/mensen/andrew-h-shennan/","name":"Andrew H Shennan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/29/cradle-4-geplande-bevalling-versus-afwachten-bij-laat-preterm-pre-eclampsie-in-l/","published":"2023-07-29"},{"url":"https://hartvaat.nl/2019/05/04/plgf-voor-beoordeling-van-pre-eclampsie-lancet-parrot-stepped-wedge-trial/","published":"2019-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-ha","type":"person","url":"https://hartvaat.nl/mensen/andrew-ha/","name":"Andrew Ha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-hamer","type":"person","url":"https://hartvaat.nl/mensen/andrew-hamer/","name":"Andrew Hamer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/30/biomarkers-voorspellen-complexe-coronaire-revascularisatie-in-fourier/","published":"2022-08-30"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-ladwiniec","type":"person","url":"https://hartvaat.nl/mensen/andrew-ladwiniec/","name":"Andrew Ladwiniec","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2022/09/01/timing-van-invasieve-strategie-bij-nste-acs-meta-analyse-van-rct-s/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-n-antoszyk","type":"person","url":"https://hartvaat.nl/mensen/andrew-n-antoszyk/","name":"Andrew N Antoszyk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-neil","type":"person","url":"https://hartvaat.nl/mensen/andrew-neil/","name":"Andrew Neil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-p-defilippis","type":"person","url":"https://hartvaat.nl/mensen/andrew-p-defilippis/","name":"Andrew P DeFilippis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-p-levy","type":"person","url":"https://hartvaat.nl/mensen/andrew-p-levy/","name":"Andrew P Levy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/haptoglobinefenotype-en-cv-risico-accord-bloeddruk-rct/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2020/02/11/haptoglobinefenotype-wijzigt-het-effect-van-intensieve-glycemische-controle-op-c/","published":"2020-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-wang","type":"person","url":"https://hartvaat.nl/mensen/andrew-wang/","name":"Andrew Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-wragg","type":"person","url":"https://hartvaat.nl/mensen/andrew-wragg/","name":"Andrew Wragg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrew-yu","type":"person","url":"https://hartvaat.nl/mensen/andrew-yu/","name":"Andrew Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/gemaskeerde-hypertensie-bij-kinderen-prevalentie-en-cv-risico-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/06/01/eindorgaanschade-bij-kinderen-met-primaire-hypertensie-meta-analyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andrzej-s-kosinski","type":"person","url":"https://hartvaat.nl/mensen/andrzej-s-kosinski/","name":"Andrzej S Kosinski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/25/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn-jacc/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andras-janosi","type":"person","url":"https://hartvaat.nl/mensen/andras-janosi/","name":"András Jánosi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"andre-duvinage","type":"person","url":"https://hartvaat.nl/mensen/andre-duvinage/","name":"André Duvinage","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anette-varbo","type":"person","url":"https://hartvaat.nl/mensen/anette-varbo/","name":"Anette Varbo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/lipidegerelateerd-cv-risico-voorbij-ldl-focus-verschuift-naar-remnant-cholestero/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2020/05/26/wereldwijde-prevalentie-van-familiaire-hypercholesterolemie-meta-analyse-van-11-/","published":"2020-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angel-alonso-gomez","type":"person","url":"https://hartvaat.nl/mensen/angel-alonso-gomez/","name":"Angel Alonso-Gómez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/04/14/sildenafil-bij-persisterende-pulmonale-hypertensie-na-klepchirurgie/","published":"2018-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angel-j-mulkay","type":"person","url":"https://hartvaat.nl/mensen/angel-j-mulkay/","name":"Angel J Mulkay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angela-cristine-bersch-ferreira","type":"person","url":"https://hartvaat.nl/mensen/angela-cristine-bersch-ferreira/","name":"Angela Cristine Bersch-Ferreira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angela-dispenzieri","type":"person","url":"https://hartvaat.nl/mensen/angela-dispenzieri/","name":"Angela Dispenzieri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/13/ai-echo-verslaat-ai-ecg-en-klinische-score-voor-diagnose-cardiale-amyloidose-aur/","published":"2026-06-22"},{"url":"https://hartvaat.nl/2020/07/07/systemische-amyloidose-herkenning-prognose-en-therapie-jama-systematische-review/","published":"2020-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angela-wood","type":"person","url":"https://hartvaat.nl/mensen/angela-wood/","name":"Angela Wood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angela-yee-moon-wang","type":"person","url":"https://hartvaat.nl/mensen/angela-yee-moon-wang/","name":"Angela Yee-Moon Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angeliki-filippatou","type":"person","url":"https://hartvaat.nl/mensen/angeliki-filippatou/","name":"Angeliki Filippatou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/bloeddruk-en-uitkomsten-bij-acute-beroerte-trombectomie/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/01/01/bloeddrukverlaging-en-secundaire-cva-preventie-meta-regressieanalyse/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angelo-auricchio","type":"person","url":"https://hartvaat.nl/mensen/angelo-auricchio/","name":"Angelo Auricchio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"angelo-oliva","type":"person","url":"https://hartvaat.nl/mensen/angelo-oliva/","name":"Angelo Oliva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2024/02/20/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vroege-aspirinestop/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ania-m-jastreboff","type":"person","url":"https://hartvaat.nl/mensen/ania-m-jastreboff/","name":"Ania M Jastreboff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/12/amycretine-fase-2-subcutaan-toegediend-bij-obesitas/","published":"2025-07-12"},{"url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","published":"2023-08-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anil-seshadri","type":"person","url":"https://hartvaat.nl/mensen/anil-seshadri/","name":"Anil Seshadri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aniruddh-p-patel","type":"person","url":"https://hartvaat.nl/mensen/aniruddh-p-patel/","name":"Aniruddh P Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/genprobcad-gecombineerde-monogene-en-polygene-risicobepaling-voor-coronairlijden/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2026/03/28/lp-a-verhoogt-risico-op-veneuze-trombo-embolie-bij-premenopauzale-vrouwen-en-hor/","published":"2026-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anitha-b-achyutha","type":"person","url":"https://hartvaat.nl/mensen/anitha-b-achyutha/","name":"Anitha B Achyutha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anja-zupan-meznar","type":"person","url":"https://hartvaat.nl/mensen/anja-zupan-meznar/","name":"Anja Zupan Mežnar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/csp-sync-geleidingssysteempacing-versus-biventriculaire-pacing-voor-crt-rct/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/05/02/preventieve-substraatablatie-vermindert-icd-interventies-bij-ischemische-cmp/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anjan-k-chakrabarti","type":"person","url":"https://hartvaat.nl/mensen/anjan-k-chakrabarti/","name":"Anjan K Chakrabarti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/07/10/fatale-of-irreversibele-bloedingen-en-ischemische-events-met-rivaroxaban-bij-acs/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ann-belmans","type":"person","url":"https://hartvaat.nl/mensen/ann-belmans/","name":"Ann Belmans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/18/optimale-bloeddruk-bij-shock-na-mi-en-hartstilstand/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ann-hammarstedt","type":"person","url":"https://hartvaat.nl/mensen/ann-hammarstedt/","name":"Ann Hammarstedt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2022/09/27/ijzerdeficientie-bij-hartfalen-en-het-effect-van-dapagliflozine-dapa-hf/","published":"2022-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ann-m-cavella","type":"person","url":"https://hartvaat.nl/mensen/ann-m-cavella/","name":"Ann M Cavella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ann-mertens","type":"person","url":"https://hartvaat.nl/mensen/ann-mertens/","name":"Ann Mertens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ann-charlotte-karlsson","type":"person","url":"https://hartvaat.nl/mensen/ann-charlotte-karlsson/","name":"Ann-Charlotte Karlsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ann-dorthe-zwisler","type":"person","url":"https://hartvaat.nl/mensen/ann-dorthe-zwisler/","name":"Ann-Dorthe Zwisler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2023/02/07/inspanningsgerichte-hartrevalidatie-bij-coronairlijden-geactualiseerde-meta-anal/","published":"2023-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-bobenko","type":"person","url":"https://hartvaat.nl/mensen/anna-bobenko/","name":"Anna Bobenko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-carrasquer","type":"person","url":"https://hartvaat.nl/mensen/anna-carrasquer/","name":"Anna Carrasquer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/20/es-bempedacs-triple-versus-duale-lipidenbehandeling-na-acs/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-meta-dyrvig-kristensen","type":"person","url":"https://hartvaat.nl/mensen/anna-meta-dyrvig-kristensen/","name":"Anna Meta Dyrvig Kristensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/09/13/betablokkers-na-mi-met-milde-ef-verlaging-ipd-meta-analyse/","published":"2025-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-norhammar","type":"person","url":"https://hartvaat.nl/mensen/anna-norhammar/","name":"Anna Norhammar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2017/07/18/sglt2-remmers-en-lager-risico-op-hartfalen-en-sterfte-versus-andere-glucoseverla/","published":"2017-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-osmukhina","type":"person","url":"https://hartvaat.nl/mensen/anna-osmukhina/","name":"Anna Osmukhina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anna-s-ondracek","type":"person","url":"https://hartvaat.nl/mensen/anna-s-ondracek/","name":"Anna S Ondracek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-kaltoft","type":"person","url":"https://hartvaat.nl/mensen/anne-kaltoft/","name":"Anne Kaltoft","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-p-nelissen","type":"person","url":"https://hartvaat.nl/mensen/anne-p-nelissen/","name":"Anne P Nelissen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/nederlandse-huisartsenpost-1-op-20-contacten-voor-benauwdheid-betreft-hartfalen-/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-pizard","type":"person","url":"https://hartvaat.nl/mensen/anne-pizard/","name":"Anne Pizard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"},{"url":"https://hartvaat.nl/2019/02/01/spironolacton-en-collageenmetabolisme-biomarkers-bij-ongecontroleerde-hypertensi/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-thushara-matthias","type":"person","url":"https://hartvaat.nl/mensen/anne-thushara-matthias/","name":"Anne Thushara Matthias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anne-marie-dupuy","type":"person","url":"https://hartvaat.nl/mensen/anne-marie-dupuy/","name":"Anne-Marie Dupuy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annette-ekblond","type":"person","url":"https://hartvaat.nl/mensen/annette-ekblond/","name":"Annette Ekblond","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/science-ii-mesenchymale-stamcellen-bij-niet-ischemisch-hartfalen-negatieve-trial/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annette-f-baas","type":"person","url":"https://hartvaat.nl/mensen/annette-f-baas/","name":"Annette F Baas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/bloedbiomerkers-voor-prognose-bij-hypertrofische-cardiomyopathie-meta-analyse/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annette-holtdirk","type":"person","url":"https://hartvaat.nl/mensen/annette-holtdirk/","name":"Annette Holtdirk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annette-m-maznyczka","type":"person","url":"https://hartvaat.nl/mensen/annette-m-maznyczka/","name":"Annette M Maznyczka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"annika-e-michelsen","type":"person","url":"https://hartvaat.nl/mensen/annika-e-michelsen/","name":"Annika E Michelsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anno-diegeler","type":"person","url":"https://hartvaat.nl/mensen/anno-diegeler/","name":"Anno Diegeler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ante-anic","type":"person","url":"https://hartvaat.nl/mensen/ante-anic/","name":"Ante Anic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2022/01/04/enkele-freeze-cryoballonablatie-bij-af-ehra-systematische-review/","published":"2022-01-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-chuang","type":"person","url":"https://hartvaat.nl/mensen/anthony-chuang/","name":"Anthony Chuang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-p-kent","type":"person","url":"https://hartvaat.nl/mensen/anthony-p-kent/","name":"Anthony P Kent","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/07/17/oac-plus-nsaid-bij-af-risico-op-ernstige-bloedingen/","published":"2018-07-17"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anthony-walton","type":"person","url":"https://hartvaat.nl/mensen/anthony-walton/","name":"Anthony Walton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antoine-cremer","type":"person","url":"https://hartvaat.nl/mensen/antoine-cremer/","name":"Antoine Cremer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antoinette-cilliers","type":"person","url":"https://hartvaat.nl/mensen/antoinette-cilliers/","name":"Antoinette Cilliers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antoinette-neylon","type":"person","url":"https://hartvaat.nl/mensen/antoinette-neylon/","name":"Antoinette Neylon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/lge-granulariteit-op-cmr-voorspelt-sterfte-bij-eindstadium-hypertrofische-cardio/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anton-b-villadsen","type":"person","url":"https://hartvaat.nl/mensen/anton-b-villadsen/","name":"Anton B Villadsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anton-vonk-noordegraaf","type":"person","url":"https://hartvaat.nl/mensen/anton-vonk-noordegraaf/","name":"Anton Vonk Noordegraaf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/14/gestandaardiseerde-inspanningstraining-bij-pah-en-cteph-haalbaarheid-en-veilighe/","published":"2021-06-14"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-abbate","type":"person","url":"https://hartvaat.nl/mensen/antonio-abbate/","name":"Antonio Abbate","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/13/anti-il-6-therapie-bij-acuut-mi-fase-iia-trial/","published":"2024-08-13"},{"url":"https://hartvaat.nl/2019/03/05/canakinumab-ter-preventie-van-hartfalen-hospitalisatie-cantos-analyse/","published":"2019-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-bartorelli","type":"person","url":"https://hartvaat.nl/mensen/antonio-bartorelli/","name":"Antonio Bartorelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-boccellino","type":"person","url":"https://hartvaat.nl/mensen/antonio-boccellino/","name":"Antonio Boccellino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-cannata","type":"person","url":"https://hartvaat.nl/mensen/antonio-cannata/","name":"Antonio Cannata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/inotropica-bij-low-output-hartfalen-vergelijkbare-hemodynamische-effecten-in-met/","published":"2026-05-24"},{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-coca","type":"person","url":"https://hartvaat.nl/mensen/antonio-coca/","name":"Antonio Coca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/01/therapietrouw-aan-single-pill-versus-vrije-combinatietherapie-bij-hypertensie-me/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-gomez-menchero","type":"person","url":"https://hartvaat.nl/mensen/antonio-gomez-menchero/","name":"Antonio Gómez-Menchero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-izzo","type":"person","url":"https://hartvaat.nl/mensen/antonio-izzo/","name":"Antonio Izzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-pelliccia","type":"person","url":"https://hartvaat.nl/mensen/antonio-pelliccia/","name":"Antonio Pelliccia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/cardiale-screening-van-jonge-sporters-eerste-eapc-aepc-consensus-voor-kinderen/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-rapacciuolo","type":"person","url":"https://hartvaat.nl/mensen/antonio-rapacciuolo/","name":"Antonio Rapacciuolo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-rossillo","type":"person","url":"https://hartvaat.nl/mensen/antonio-rossillo/","name":"Antonio Rossillo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonio-zingarelli","type":"person","url":"https://hartvaat.nl/mensen/antonio-zingarelli/","name":"Antonio Zingarelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonios-douros","type":"person","url":"https://hartvaat.nl/mensen/antonios-douros/","name":"Antonios Douros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/01/doac-s-cox-2-selectieve-nsaid-s-geven-37-minder-gi-bloedingen-dan-doac-s-niet-se/","published":"2026-07-01"},{"url":"https://hartvaat.nl/2025/08/01/ctrh-als-biomarker-voor-medicijneffectiviteit-real-world-bewijs/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonios-p-antoniadis","type":"person","url":"https://hartvaat.nl/mensen/antonios-p-antoniadis/","name":"Antonios P Antoniadis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/af-ablatie-timing-naar-af-duur-impact-op-aritmierecidief/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"antonios-ziakas","type":"person","url":"https://hartvaat.nl/mensen/antonios-ziakas/","name":"Antonios Ziakas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/10/transcatheter-asd-sluiting-bij-ouderen-systematische-review-en-meta-analyse/","published":"2023-11-10"},{"url":"https://hartvaat.nl/2018/10/02/cangrelor-bij-ticagrelor-geladen-stemi-patienten-tijdens-primaire-pci/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anupam-basuray","type":"person","url":"https://hartvaat.nl/mensen/anupam-basuray/","name":"Anupam Basuray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anupam-garrib","type":"person","url":"https://hartvaat.nl/mensen/anupam-garrib/","name":"Anupam Garrib","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aoming-jin","type":"person","url":"https://hartvaat.nl/mensen/aoming-jin/","name":"Aoming Jin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2024/02/20/zoutvervanger-voorkomt-hypertensie-bij-normotensieve-volwassenen/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"apostolos-i-hatzitolios","type":"person","url":"https://hartvaat.nl/mensen/apostolos-i-hatzitolios/","name":"Apostolos I Hatzitolios","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2018/10/01/ochtend-versus-avonddosering-van-antihypertensiva-gerandomiseerde-crossover-tria/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"april-kinninger","type":"person","url":"https://hartvaat.nl/mensen/april-kinninger/","name":"April Kinninger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/27/stop-semaglutide-vermindert-epicardiaal-vetweefsel-bij-type-2-diabetes/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2020/10/21/icosapent-ethyl-en-coronaire-atheroscleroseprogressie-bij-verhoogde-triglyceride/","published":"2020-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"april-m-barbour","type":"person","url":"https://hartvaat.nl/mensen/april-m-barbour/","name":"April M Barbour","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/laroprovstat-eerste-orale-pcsk9-remmer-haalt-80-ldl-reductie-in-combinatie-met-r/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/06/03/pursuit-orale-pcsk9-remmer-voor-hypercholesterolemie-gerandomiseerde-trial/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arantxa-gonzalez","type":"person","url":"https://hartvaat.nl/mensen/arantxa-gonzalez/","name":"Arantxa González","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/16/spironolacton-en-urinaire-proteomics-evidence-uit-homage/","published":"2024-09-16"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arash-aryana","type":"person","url":"https://hartvaat.nl/mensen/arash-aryana/","name":"Arash Aryana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arash-haghikia","type":"person","url":"https://hartvaat.nl/mensen/arash-haghikia/","name":"Arash Haghikia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/oraal-butyraat-verlaagt-bloeddruk-bij-hypertensie-rct/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/02/10/propionaat-vermindert-atherosclerose-via-immuunregulatie-van-intestinaal-cholest/","published":"2022-02-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aravinda-thiagalingam","type":"person","url":"https://hartvaat.nl/mensen/aravinda-thiagalingam/","name":"Aravinda Thiagalingam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"areef-ishani","type":"person","url":"https://hartvaat.nl/mensen/areef-ishani/","name":"Areef Ishani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/29/chloortalidon-versus-hydrochloorthiazide-geen-verschil-in-cv-events/","published":"2022-12-29"},{"url":"https://hartvaat.nl/2022/05/01/antihypertensivaklasse-en-uitkomsten-in-sprint/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aris-baras","type":"person","url":"https://hartvaat.nl/mensen/aris-baras/","name":"Aris Baras","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aristeidis-h-katsanos","type":"person","url":"https://hartvaat.nl/mensen/aristeidis-h-katsanos/","name":"Aristeidis H Katsanos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/bloeddruk-en-uitkomsten-bij-acute-beroerte-trombectomie/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/01/01/bloeddrukverlaging-en-secundaire-cva-preventie-meta-regressieanalyse/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arlene-b-chapman","type":"person","url":"https://hartvaat.nl/mensen/arlene-b-chapman/","name":"Arlene B Chapman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arman-postadzhiyan","type":"person","url":"https://hartvaat.nl/mensen/arman-postadzhiyan/","name":"Arman Postadzhiyan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"armando-garcia-castillo","type":"person","url":"https://hartvaat.nl/mensen/armando-garcia-castillo/","name":"Armando Garcia-Castillo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"armin-koch","type":"person","url":"https://hartvaat.nl/mensen/armin-koch/","name":"Armin Koch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2019/10/21/digoxine-en-mortaliteit-gerandomiseerd-versus-observationeel-in-de-dig-trial/","published":"2019-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arnaud-lazarus","type":"person","url":"https://hartvaat.nl/mensen/arnaud-lazarus/","name":"Arnaud Lazarus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2024/10/03/uitgebreide-versus-standaard-remote-monitoring-bij-crt-en-hartfalen/","published":"2024-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arne-heydorn","type":"person","url":"https://hartvaat.nl/mensen/arne-heydorn/","name":"Arne Heydorn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/12/amycretine-fase-2-subcutaan-toegediend-bij-obesitas/","published":"2025-07-12"},{"url":"https://hartvaat.nl/2025/07/12/amycretine-eerste-glp-1-amyline-agonist-fase-1-veiligheid-en-farmacologie/","published":"2025-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arnold-h-seto","type":"person","url":"https://hartvaat.nl/mensen/arnold-h-seto/","name":"Arnold H Seto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arnt-v-kristen","type":"person","url":"https://hartvaat.nl/mensen/arnt-v-kristen/","name":"Arnt V Kristen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/20/ni006-antilichaam-voor-afbraak-van-cardiale-transthyretine-amyloid-nejm-fase-1/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arpita-ghosh","type":"person","url":"https://hartvaat.nl/mensen/arpita-ghosh/","name":"Arpita Ghosh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/10/dig-rhd-digoxine-verlaagt-sterfte-en-hartfalen-bij-symptomatische-reumatische-ha/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arsany-hakim","type":"person","url":"https://hartvaat.nl/mensen/arsany-hakim/","name":"Arsany Hakim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arsen-d-ristic","type":"person","url":"https://hartvaat.nl/mensen/arsen-d-ristic/","name":"Arsen D Ristić","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2022/04/19/alirocumab-na-acs-bij-patienten-met-hf-voorgeschiedenis-odyssey-outcomes/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arshed-a-quyyumi","type":"person","url":"https://hartvaat.nl/mensen/arshed-a-quyyumi/","name":"Arshed A Quyyumi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2016/06/11/ixmyelocel-t-bij-ischemisch-hartfalen-lancet-dubbelblinde-gerandomiseerde-trial/","published":"2016-06-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"art-schuermans","type":"person","url":"https://hartvaat.nl/mensen/art-schuermans/","name":"Art Schuermans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/lp-a-verhoogt-risico-op-veneuze-trombo-embolie-bij-premenopauzale-vrouwen-en-hor/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2025/06/03/af-ablatie-timing-naar-af-duur-impact-op-aritmierecidief/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arthur-j-labovitz","type":"person","url":"https://hartvaat.nl/mensen/arthur-j-labovitz/","name":"Arthur J Labovitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arthur-l-eberly","type":"person","url":"https://hartvaat.nl/mensen/arthur-l-eberly/","name":"Arthur L Eberly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arthur-nasis","type":"person","url":"https://hartvaat.nl/mensen/arthur-nasis/","name":"Arthur Nasis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"artur-oreziak","type":"person","url":"https://hartvaat.nl/mensen/artur-oreziak/","name":"Artur Oreziak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aruna-pradhan","type":"person","url":"https://hartvaat.nl/mensen/aruna-pradhan/","name":"Aruna Pradhan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/07/confident-hfpef-machine-learning-voorspelt-sterfte-en-opname-beter-dan-bestaande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"arvindh-kanagasundram","type":"person","url":"https://hartvaat.nl/mensen/arvindh-kanagasundram/","name":"Arvindh Kanagasundram","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ashish-pershad","type":"person","url":"https://hartvaat.nl/mensen/ashish-pershad/","name":"Ashish Pershad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/vroege-versus-late-gestageerde-pci-na-subintimale-re-entry-bij-cto/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ashish-sadhu","type":"person","url":"https://hartvaat.nl/mensen/ashish-sadhu/","name":"Ashish Sadhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ashish-sarraju","type":"person","url":"https://hartvaat.nl/mensen/ashish-sarraju/","name":"Ashish Sarraju","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/17/tandem-obicetrapib-plus-ezetimibe-voor-ldl-verlaging-lancet-fase-3/","published":"2025-05-17"},{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ashkan-shoamanesh","type":"person","url":"https://hartvaat.nl/mensen/ashkan-shoamanesh/","name":"Ashkan Shoamanesh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/05/21/prognose-van-ischemisch-cva-onder-orale-anticoagulatie-bij-af/","published":"2023-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ashwin-durairaj","type":"person","url":"https://hartvaat.nl/mensen/ashwin-durairaj/","name":"Ashwin Durairaj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ashwin-ravichandran","type":"person","url":"https://hartvaat.nl/mensen/ashwin-ravichandran/","name":"Ashwin Ravichandran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2021/01/28/inhalatietreprostinil-bij-pulmonale-hypertensie-door-interstitiele-longziekte-ne/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ashwin-venkateshvaran","type":"person","url":"https://hartvaat.nl/mensen/ashwin-venkateshvaran/","name":"Ashwin Venkateshvaran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/07/04/cognitieve-gedragstherapie-verbetert-kwaliteit-van-leven-bij-symptomatisch-af/","published":"2023-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"asim-n-cheema","type":"person","url":"https://hartvaat.nl/mensen/asim-n-cheema/","name":"Asim N Cheema","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/02/trombusaspiratie-bij-hoge-trombuslast-total-trial/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"assunta-iuliano","type":"person","url":"https://hartvaat.nl/mensen/assunta-iuliano/","name":"Assunta Iuliano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/fluoroscopieminimalisatie-bij-svt-ablatie-door-vrouwelijke-elektrofysiologen/","published":"2026-04-06"},{"url":"https://hartvaat.nl/2020/02/01/crt-bij-verlengd-av-interval-real-crt-gerandomiseerde-trial/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"athanasios-samaras","type":"person","url":"https://hartvaat.nl/mensen/athanasios-samaras/","name":"Athanasios Samaras","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/01/14/residuele-lekkage-na-laa-occlusie-en-uitkomsten-meta-analyse/","published":"2024-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"athanasios-saratzis","type":"person","url":"https://hartvaat.nl/mensen/athanasios-saratzis/","name":"Athanasios Saratzis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/27/best-cli-veneuze-bypass-versus-endovasculair-bij-chronische-kritieke-ischemie/","published":"2023-05-27"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atman-p-shah","type":"person","url":"https://hartvaat.nl/mensen/atman-p-shah/","name":"Atman P Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2021/01/05/management-van-pfo-patienten-met-cva-of-tia-jama-klinisch-overzicht/","published":"2021-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atsushi-tada","type":"person","url":"https://hartvaat.nl/mensen/atsushi-tada/","name":"Atsushi Tada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/nierfunctiestoornis-verergert-pulmonale-vaatziekte-bij-hfpef/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atsushi-tanaka","type":"person","url":"https://hartvaat.nl/mensen/atsushi-tanaka/","name":"Atsushi Tanaka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2020/08/01/canagliflozine-bij-diabetes-type-2-met-chronisch-hf-candle-gerandomiseerde-trial/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"attilio-leone","type":"person","url":"https://hartvaat.nl/mensen/attilio-leone/","name":"Attilio Leone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2021/02/02/dalend-hemoglobine-en-prognose-bij-acs-hospitalisatie/","published":"2021-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"atul-pathak","type":"person","url":"https://hartvaat.nl/mensen/atul-pathak/","name":"Atul Pathak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"audrey-agullo","type":"person","url":"https://hartvaat.nl/mensen/audrey-agullo/","name":"Audrey Agullo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aung-myat","type":"person","url":"https://hartvaat.nl/mensen/aung-myat/","name":"Aung Myat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aurelie-bouzelmat","type":"person","url":"https://hartvaat.nl/mensen/aurelie-bouzelmat/","name":"Aurelie Bouzelmat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"austin-seals","type":"person","url":"https://hartvaat.nl/mensen/austin-seals/","name":"Austin Seals","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2024/03/01/thuisbloeddruk-geleide-farmacotherapie-via-telezorg-meta-analyse-van-vs-trials/","published":"2024-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"auxiliadora-graciani","type":"person","url":"https://hartvaat.nl/mensen/auxiliadora-graciani/","name":"Auxiliadora Graciani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"avi-sabbag","type":"person","url":"https://hartvaat.nl/mensen/avi-sabbag/","name":"Avi Sabbag","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2017/12/01/kauwen-versus-slikken-van-ticagrelor-en-plaatjesremming-bij-stemi/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"avraham-karasik","type":"person","url":"https://hartvaat.nl/mensen/avraham-karasik/","name":"Avraham Karasik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/10/mondiale-prevalentie-uitkomsten-en-kosten-van-hartfalen-careme-studie/","published":"2023-03-10"},{"url":"https://hartvaat.nl/2018/06/12/sglt2-remmers-en-cardiovasculaire-events-de-cvd-real-2-real-world-studie/","published":"2018-06-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"aya-kadota","type":"person","url":"https://hartvaat.nl/mensen/aya-kadota/","name":"Aya Kadota","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/30/visinname-en-visgerelateerde-metabolieten-geassocieerd-met-lagere-triglyceriden-/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ayman-elbadawi","type":"person","url":"https://hartvaat.nl/mensen/ayman-elbadawi/","name":"Ayman Elbadawi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/19/slokdarmkoeling-voorkomt-oesofagale-schade-bij-af-ablatie-meta-analyse/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2022/10/13/ffr-geleide-versus-angiografie-geleide-revascularisatie-meta-analyse-van-rct-s/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ayman-samman-tahhan","type":"person","url":"https://hartvaat.nl/mensen/ayman-samman-tahhan/","name":"Ayman Samman Tahhan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-acs-trials-jama-cardiology/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/10/01/inclusie-van-ouderen-vrouwen-en-minderheden-in-hf-trials-jama-cardiology-review/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ayodele-odutayo","type":"person","url":"https://hartvaat.nl/mensen/ayodele-odutayo/","name":"Ayodele Odutayo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"azeem-majeed","type":"person","url":"https://hartvaat.nl/mensen/azeem-majeed/","name":"Azeem Majeed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/14/tricorder-ai-stethoscoop-voor-triple-cv-ziektedetectie/","published":"2026-02-14"},{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"b-k-s-sastry","type":"person","url":"https://hartvaat.nl/mensen/b-k-s-sastry/","name":"B K S Sastry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"b-j","type":"person","url":"https://hartvaat.nl/mensen/b-j/","name":"B. J.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/21/million-women-study-ernstige-obesitas-verviervoudigt-risico-op-af-en-hartfalen-s/","published":"2026-07-05"},{"url":"https://hartvaat.nl/2026/03/25/aortacoarctatie-voorspelt-langetermijnmorbiditeit-na-de-arteriele-switchoperatie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"b-r","type":"person","url":"https://hartvaat.nl/mensen/b-r/","name":"B. R.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/03/warrior-trial-intensieve-medicamenteuze-behandeling-verbetert-de-uitkomsten-niet/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/05/20/infectieuze-endocarditis-na-tavi-diabetes-belangrijkste-risicofactor-e-faecalis-/","published":"2026-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bakhtawar-k-mahmoodi","type":"person","url":"https://hartvaat.nl/mensen/bakhtawar-k-mahmoodi/","name":"Bakhtawar K Mahmoodi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/03/13/doac-s-bij-af-met-ckd-systematische-review-werkzaamheid-en-veiligheid/","published":"2018-03-13"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"balarama-gundapaneni","type":"person","url":"https://hartvaat.nl/mensen/balarama-gundapaneni/","name":"Balarama Gundapaneni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"balbir-singh","type":"person","url":"https://hartvaat.nl/mensen/balbir-singh/","name":"Balbir Singh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"balram-bhargava","type":"person","url":"https://hartvaat.nl/mensen/balram-bhargava/","name":"Balram Bhargava","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"banu-evranos","type":"person","url":"https://hartvaat.nl/mensen/banu-evranos/","name":"Banu Evranos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2021/02/05/slokdarmbescherming-met-temperatuurcontroleren-bij-af-ablatie-impact/","published":"2021-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"baptiste-alvarez","type":"person","url":"https://hartvaat.nl/mensen/baptiste-alvarez/","name":"Baptiste Alvarez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-a-hutten","type":"person","url":"https://hartvaat.nl/mensen/barbara-a-hutten/","name":"Barbara A Hutten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/03/24/cascadescreening-op-verhoogd-lp-a-via-kinderen-opbrengst-in-de-praktijk-amsterda/","published":"2026-03-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-hettinger","type":"person","url":"https://hartvaat.nl/mensen/barbara-hettinger/","name":"Barbara Hettinger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/cardiorenale-bescherming-door-sglt2-remmers-glp-1-agonisten-en-mra-s-bij-type-1-/","published":"2026-08-07"},{"url":"https://hartvaat.nl/2026/09/01/cardiorenale-risicos-bij-type-1-diabetes-een-overzicht-van-de-huidige-stand-van-/","published":"2026-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barbara-thorand","type":"person","url":"https://hartvaat.nl/mensen/barbara-thorand/","name":"Barbara Thorand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-a-franklin","type":"person","url":"https://hartvaat.nl/mensen/barry-a-franklin/","name":"Barry A Franklin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-l-carter","type":"person","url":"https://hartvaat.nl/mensen/barry-l-carter/","name":"Barry L Carter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/01/arts-apotheker-samenwerkingsmodel-en-time-in-target-bloeddruk-post-hoc-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2016/11/01/arts-apotheker-samenwerkingsmodel-verkleint-sociaaleconomische-bloeddrukverschil/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"barry-m-brenner","type":"person","url":"https://hartvaat.nl/mensen/barry-m-brenner/","name":"Barry M Brenner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bart-a-mulder","type":"person","url":"https://hartvaat.nl/mensen/bart-a-mulder/","name":"Bart A Mulder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2020/07/01/subklinische-atherosclerose-en-incident-af-meta-analyse/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bart-van-putte","type":"person","url":"https://hartvaat.nl/mensen/bart-van-putte/","name":"Bart Van Putte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bas-van-den-bogaard","type":"person","url":"https://hartvaat.nl/mensen/bas-van-den-bogaard/","name":"Bas van den Bogaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"basel-ramlawi","type":"person","url":"https://hartvaat.nl/mensen/basel-ramlawi/","name":"Basel Ramlawi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"baskaran-thilaganathan","type":"person","url":"https://hartvaat.nl/mensen/baskaran-thilaganathan/","name":"Baskaran Thilaganathan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/cardiale-structuur-en-functie-bij-hypertensieve-zwangerschapsstoornissen-systema/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2022/02/01/myocardiale-mechanica-bij-hypertensieve-zwangerschapsaandoeningen-meta-analyse/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beat-knusel","type":"person","url":"https://hartvaat.nl/mensen/beat-knusel/","name":"Beat Knusel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"},{"url":"https://hartvaat.nl/2016/03/29/omecamtiv-mecarbil-bij-acuut-hartfalen-de-atomic-ahf-studie/","published":"2016-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beat-mueller","type":"person","url":"https://hartvaat.nl/mensen/beat-mueller/","name":"Beat Mueller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/11/geindividualiseerde-voedingsondersteuning-bij-gehospitaliseerd-chronisch-hf/","published":"2021-05-11"},{"url":"https://hartvaat.nl/2020/06/01/il-1-receptorantagonist-verhoogt-ang-1-7-en-verlaagt-bloeddruk-bij-obesitas/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beata-rezny-kasprzak","type":"person","url":"https://hartvaat.nl/mensen/beata-rezny-kasprzak/","name":"Beata Rezny-Kasprzak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beatriz-araujo","type":"person","url":"https://hartvaat.nl/mensen/beatriz-araujo/","name":"Beatriz Araújo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/nieuwe-aldosteronsynthase-remmers-bij-hypertensie-bayesiaanse-meta-analyse/","published":"2026-03-08"},{"url":"https://hartvaat.nl/2025/09/01/sedatie-versus-narcose-bij-af-catheterablatie-meta-analyse/","published":"2025-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beatriz-calvo-bernal","type":"person","url":"https://hartvaat.nl/mensen/beatriz-calvo-bernal/","name":"Beatriz Calvo-Bernal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/13/verisec-register-vericiguat-halveert-hartfalen-decompensaties-bij-hfref-in-dagel/","published":"2026-06-21"},{"url":"https://hartvaat.nl/2026/05/13/verisec-vericiguat-in-de-praktijk-halveert-hartfalen-decompensaties-bij-hfref-sp/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"belma-pojskic","type":"person","url":"https://hartvaat.nl/mensen/belma-pojskic/","name":"Belma Pojskic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ben-he","type":"person","url":"https://hartvaat.nl/mensen/ben-he/","name":"Ben He","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/16/sluiting-van-het-linker-hartoor-versus-doac-s-na-longembolie/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2017/10/17/farmaco-invasieve-strategie-met-halve-dosis-alteplase-versus-primaire-pci-bij-st/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ben-schottker","type":"person","url":"https://hartvaat.nl/mensen/ben-schottker/","name":"Ben Schöttker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ben-szwejkowski","type":"person","url":"https://hartvaat.nl/mensen/ben-szwejkowski/","name":"Ben Szwejkowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benedict-costello","type":"person","url":"https://hartvaat.nl/mensen/benedict-costello/","name":"Benedict Costello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bengt-johansson","type":"person","url":"https://hartvaat.nl/mensen/bengt-johansson/","name":"Bengt Johansson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/volwassenen-met-aangeboren-hartafwijking-hebben-vergelijkbare-overleving-na-hart/","published":"2026-06-24"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-a-steinberg","type":"person","url":"https://hartvaat.nl/mensen/benjamin-a-steinberg/","name":"Benjamin A Steinberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2016/12/20/off-label-doac-dosering-en-ongunstige-uitkomsten-orbit-af-ii-register/","published":"2016-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-e-peterson","type":"person","url":"https://hartvaat.nl/mensen/benjamin-e-peterson/","name":"Benjamin E Peterson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2021/01/05/revascularisatiereductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2021-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-kably","type":"person","url":"https://hartvaat.nl/mensen/benjamin-kably/","name":"Benjamin Kably","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/01/radiance-htn-trio-renale-denervatie-effectief-na-medicatie-optitratie/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-w-van-tassell","type":"person","url":"https://hartvaat.nl/mensen/benjamin-w-van-tassell/","name":"Benjamin W Van Tassell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/01/arts-apotheker-samenwerkingsmodel-en-time-in-target-bloeddruk-post-hoc-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/03/16/systolische-bloeddruk-time-in-target-en-cv-uitkomsten-bij-hypertensie/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benjamin-xu","type":"person","url":"https://hartvaat.nl/mensen/benjamin-xu/","name":"Benjamin Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benoit-coutu","type":"person","url":"https://hartvaat.nl/mensen/benoit-coutu/","name":"Benoit Coutu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benoit-daneault","type":"person","url":"https://hartvaat.nl/mensen/benoit-daneault/","name":"Benoit Daneault","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"benoit-tavernier","type":"person","url":"https://hartvaat.nl/mensen/benoit-tavernier/","name":"Benoit Tavernier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/08/gepersonaliseerde-bloeddrukregeling-tijdens-thrombectomie-verbetert-functionele-/","published":"2026-08-19"},{"url":"https://hartvaat.nl/2017/10/10/geindividualiseerd-versus-standaard-bloeddrukbeleid-bij-hoog-risico-chirurgiepat/","published":"2017-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"berend-e-westerhof","type":"person","url":"https://hartvaat.nl/mensen/berend-e-westerhof/","name":"Berend E Westerhof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"berit-t-philbert","type":"person","url":"https://hartvaat.nl/mensen/berit-t-philbert/","name":"Berit T Philbert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernadette-corica","type":"person","url":"https://hartvaat.nl/mensen/bernadette-corica/","name":"Bernadette Corica","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/cerebrale-microbloedingen-en-risico-bij-af-systematische-review/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/09/14/copd-bij-af-prevalentie-management-en-impact-meta-analyse/","published":"2021-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-bertrand","type":"person","url":"https://hartvaat.nl/mensen/bernard-bertrand/","name":"Bernard Bertrand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-chamontin","type":"person","url":"https://hartvaat.nl/mensen/bernard-chamontin/","name":"Bernard Chamontin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-prendergast","type":"person","url":"https://hartvaat.nl/mensen/bernard-prendergast/","name":"Bernard Prendergast","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernard-vaisse","type":"person","url":"https://hartvaat.nl/mensen/bernard-vaisse/","name":"Bernard Vaïsse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernardo-stein","type":"person","url":"https://hartvaat.nl/mensen/bernardo-stein/","name":"Bernardo Stein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernd-hohenstein","type":"person","url":"https://hartvaat.nl/mensen/bernd-hohenstein/","name":"Bernd Hohenstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/lipoproteine-aferese-blijft-relevant-in-het-tijdperk-van-pcsk9-remmers-en-sirna/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernhard-gerber","type":"person","url":"https://hartvaat.nl/mensen/bernhard-gerber/","name":"Bernhard Gerber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bernhard-hametner","type":"person","url":"https://hartvaat.nl/mensen/bernhard-hametner/","name":"Bernhard Hametner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2019/10/01/arteriele-golfvormclusters-en-langetermijn-klinisch-nut/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"berry","type":"person","url":"https://hartvaat.nl/mensen/berry/","name":"Berry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/03/warrior-trial-intensieve-medicamenteuze-behandeling-verbetert-de-uitkomsten-niet/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/04/17/niet-invasieve-endotypering-met-stress-mri-verbetert-de-behandeling-van-angina-z/","published":"2026-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bertrand-lapergue","type":"person","url":"https://hartvaat.nl/mensen/bertrand-lapergue/","name":"Bertrand Lapergue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/08/gepersonaliseerde-bloeddrukregeling-tijdens-thrombectomie-verbetert-functionele-/","published":"2026-08-19"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bertrand-rozec","type":"person","url":"https://hartvaat.nl/mensen/bertrand-rozec/","name":"Bertrand Rozec","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/levoecmo-levosimendan-bij-ecmo-weaning-bij-cardiogene-shock/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"betty-raman","type":"person","url":"https://hartvaat.nl/mensen/betty-raman/","name":"Betty Raman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/30/empagliflozine-en-cardiale-energiestofwisseling-bij-hartfalen-empa-vision/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2017/09/05/n-acetylcysteine-met-nitraat-bij-primaire-pci-voor-stemi/","published":"2017-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beverly-winikoff","type":"person","url":"https://hartvaat.nl/mensen/beverly-winikoff/","name":"Beverly Winikoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/21/orale-antihypertensiva-bij-ernstige-hypertensie-in-de-zwangerschap-lancet-vergel/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2017/08/12/foley-katheter-versus-misoprostol-voor-inleiden-bij-hypertensieve-zwangeren-in-i/","published":"2017-08-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bhalla","type":"person","url":"https://hartvaat.nl/mensen/bhalla/","name":"Bhalla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/25/geleidelijk-afbouwen-van-rilonacept-bij-recidiverende-pericarditis-voorkomt-vake/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bhupesh-pathik","type":"person","url":"https://hartvaat.nl/mensen/bhupesh-pathik/","name":"Bhupesh Pathik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bi-cheng-liu","type":"person","url":"https://hartvaat.nl/mensen/bi-cheng-liu/","name":"Bi-Cheng Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"biagio-sassone","type":"person","url":"https://hartvaat.nl/mensen/biagio-sassone/","name":"Biagio Sassone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bianca-m-boxma-de-klerk","type":"person","url":"https://hartvaat.nl/mensen/bianca-m-boxma-de-klerk/","name":"Bianca M Boxma-de Klerk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/07/ffr-geleide-pci-versus-medicamenteuze-therapie-bij-stabiele-coronairlaesies-meta/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bianca-pourmussa","type":"person","url":"https://hartvaat.nl/mensen/bianca-pourmussa/","name":"Bianca Pourmussa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/01/kaliumnitraat-bij-hfpef-gerandomiseerde-trial/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"biff-f-palmer","type":"person","url":"https://hartvaat.nl/mensen/biff-f-palmer/","name":"Biff F Palmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/hif-stabilisatoren-als-orale-alternatief-voor-esas-bij-anemie-bij-chronische-nie/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/02/24/systemische-effecten-van-metabole-acidose/","published":"2026-02-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"biljana-zafirovska","type":"person","url":"https://hartvaat.nl/mensen/biljana-zafirovska/","name":"Biljana Zafirovska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bimmer-e-p-m-claessen","type":"person","url":"https://hartvaat.nl/mensen/bimmer-e-p-m-claessen/","name":"Bimmer E P M Claessen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bin-dong","type":"person","url":"https://hartvaat.nl/mensen/bin-dong/","name":"Bin Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/14/depressietrajecten-bij-hfpef-impact-op-uitkomsten/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bin-li","type":"person","url":"https://hartvaat.nl/mensen/bin-li/","name":"Bin Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/gezond-eetpatroon-verlaagt-cv-risico-bij-kankeroverlevenden-los-van-genetisch-ri/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/10/14/heparine-bij-eerste-medisch-contact-versus-voor-primaire-pci-bij-stemi/","published":"2025-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bin-liu","type":"person","url":"https://hartvaat.nl/mensen/bin-liu/","name":"Bin Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/06/01/sglt2-remmers-versus-arni-bij-hfref-meta-analyse/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bin-zhang","type":"person","url":"https://hartvaat.nl/mensen/bin-zhang/","name":"Bin Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/02/01/maggic-score-voor-mortaliteitsvoorspelling-bij-klepziekte/","published":"2024-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bin-zhu","type":"person","url":"https://hartvaat.nl/mensen/bin-zhu/","name":"Bin Zhu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"birgit-jurlander","type":"person","url":"https://hartvaat.nl/mensen/birgit-jurlander/","name":"Birgit Jurlander","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bjarne-m-nes","type":"person","url":"https://hartvaat.nl/mensen/bjarne-m-nes/","name":"Bjarne M Nes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/01/vijf-jaar-inspanningstraining-verbetert-cardiovasculair-risicoprofiel-bij-oudere/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2016/02/02/aerobe-intervaltraining-vermindert-de-last-van-atriumfibrilleren-gerandomiseerde/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"blandine-mondesert","type":"person","url":"https://hartvaat.nl/mensen/blandine-mondesert/","name":"Blandine Mondesert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/01/cardiale-ct-als-standaard-in-de-electrophysiologie-planning-en-veiligheid-bij-af/","published":"2026-08-23"},{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bleie","type":"person","url":"https://hartvaat.nl/mensen/bleie/","name":"Bleie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/infectieuze-endocarditis-na-tavi-diabetes-belangrijkste-risicofactor-e-faecalis-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/01/16/nt-probnp-voorspelt-sterfte-na-een-stemi-onafhankelijk-van-de-ejectiefractie/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bo-gregers-winkel","type":"person","url":"https://hartvaat.nl/mensen/bo-gregers-winkel/","name":"Bo Gregers Winkel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/31/uit-het-hospitaal-hartstilstand-komt-12-keer-vaker-voor-bij-niet-ischemische-car/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2026/02/03/coronaire-vaatspasmen-bij-overlevenden-van-hartstilstand/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bo-zhang","type":"person","url":"https://hartvaat.nl/mensen/bo-zhang/","name":"Bo Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/cumulatieve-blootstelling-aan-cardiometabole-index-en-risico-op-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2016/07/01/luchtvervuiling-en-hypertensie-systematische-review-en-meta-analyse/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bob-j-w-eikemans","type":"person","url":"https://hartvaat.nl/mensen/bob-j-w-eikemans/","name":"Bob J W Eikemans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bohumil-majtan","type":"person","url":"https://hartvaat.nl/mensen/bohumil-majtan/","name":"Bohumil Majtan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bonnie-c-sachs","type":"person","url":"https://hartvaat.nl/mensen/bonnie-c-sachs/","name":"Bonnie C Sachs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"borek-foldyna","type":"person","url":"https://hartvaat.nl/mensen/borek-foldyna/","name":"Borek Foldyna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/03/klinische-risicopredictie-ct-coronairangiografie-en-cv-events-bij-nieuwe-angina/","published":"2025-02-03"},{"url":"https://hartvaat.nl/2023/08/24/reprieve-pitavastatine-vermindert-cv-events-bij-hiv-nejm/","published":"2023-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"boris-a-hoffmann","type":"person","url":"https://hartvaat.nl/mensen/boris-a-hoffmann/","name":"Boris A Hoffmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2018/01/01/energiebron-en-vroeg-af-recidief-cryoballon-versus-radiofrequentie/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"boris-khanykin","type":"person","url":"https://hartvaat.nl/mensen/boris-khanykin/","name":"Boris Khanykin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"borut-cizman","type":"person","url":"https://hartvaat.nl/mensen/borut-cizman/","name":"Borut Cizman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bouchardy","type":"person","url":"https://hartvaat.nl/mensen/bouchardy/","name":"Bouchardy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/25/aortacoarctatie-voorspelt-langetermijnmorbiditeit-na-de-arteriele-switchoperatie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bouma","type":"person","url":"https://hartvaat.nl/mensen/bouma/","name":"Bouma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/25/aortacoarctatie-voorspelt-langetermijnmorbiditeit-na-de-arteriele-switchoperatie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brack-hattler","type":"person","url":"https://hartvaat.nl/mensen/brack-hattler/","name":"Brack Hattler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/16/connect-palliatieve-telezorg-verbetert-kwaliteit-van-leven-bij-hartfalen-jama/","published":"2024-01-16"},{"url":"https://hartvaat.nl/2019/01/10/endoscopische-versus-open-veneoogst-bij-cabg-nejm-regroup/","published":"2019-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brad-s-sutton","type":"person","url":"https://hartvaat.nl/mensen/brad-s-sutton/","name":"Brad S Sutton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2024/07/02/pfa-versus-thermale-ablatie-bij-paroxysmaal-af-aritmielastanalyse/","published":"2024-07-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bradi-b-granger","type":"person","url":"https://hartvaat.nl/mensen/bradi-b-granger/","name":"Bradi B Granger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bradley-g-hammill","type":"person","url":"https://hartvaat.nl/mensen/bradley-g-hammill/","name":"Bradley G Hammill","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bradley-h-strauss","type":"person","url":"https://hartvaat.nl/mensen/bradley-h-strauss/","name":"Bradley H Strauss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bradley-porter","type":"person","url":"https://hartvaat.nl/mensen/bradley-porter/","name":"Bradley Porter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2022/05/03/triventriculaire-pacing-bij-hf-strive-hf-gerandomiseerde-trial/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bradley-wilsmore","type":"person","url":"https://hartvaat.nl/mensen/bradley-wilsmore/","name":"Bradley Wilsmore","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2024/12/16/scoff-nuchter-versus-niet-nuchter-voor-hartkatheterisatie-rct/","published":"2024-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brandon-k-bellows","type":"person","url":"https://hartvaat.nl/mensen/brandon-k-bellows/","name":"Brandon K Bellows","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/team-based-care-bij-hypertensie-meta-analyse-bevestigt-effectiviteit-en-kostenef/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brandon-m-herbert","type":"person","url":"https://hartvaat.nl/mensen/brandon-m-herbert/","name":"Brandon M Herbert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"branislav-vohnout","type":"person","url":"https://hartvaat.nl/mensen/branislav-vohnout/","name":"Branislav Vohnout","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"branko-beleslin","type":"person","url":"https://hartvaat.nl/mensen/branko-beleslin/","name":"Branko Beleslin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"branko-kopjar","type":"person","url":"https://hartvaat.nl/mensen/branko-kopjar/","name":"Branko Kopjar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/05/lorundrostat-bij-ongecontroleerde-en-therapieresistente-hypertensie-fase-3-resul/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brenda-moura","type":"person","url":"https://hartvaat.nl/mensen/brenda-moura/","name":"Brenda Moura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-a-bruckner","type":"person","url":"https://hartvaat.nl/mensen/brian-a-bruckner/","name":"Brian A Bruckner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-a-lawlor","type":"person","url":"https://hartvaat.nl/mensen/brian-a-lawlor/","name":"Brian A Lawlor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/01/bloeddrukvariabiliteit-en-progressie-van-klinische-alzheimer/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/08/01/nilvadipine-en-cerebrale-bloedflow-bij-alzheimer-gerandomiseerde-trial/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-buxton","type":"person","url":"https://hartvaat.nl/mensen/brian-buxton/","name":"Brian Buxton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2019/01/31/bilaterale-versus-enkele-mammaria-interna-grafts-na-10-jaar-nejm-art/","published":"2019-01-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-d-lowes","type":"person","url":"https://hartvaat.nl/mensen/brian-d-lowes/","name":"Brian D Lowes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-h-rowe","type":"person","url":"https://hartvaat.nl/mensen/brian-h-rowe/","name":"Brian H Rowe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/01/elektrische-versus-farmacologische-cardioversie-bij-acuut-af-op-de-seh-lancet-ra/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2019/08/01/hoog-versus-laag-zuurstof-bij-acuut-hartfalen-hilo-hf-pilot/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-k-jefferson","type":"person","url":"https://hartvaat.nl/mensen/brian-k-jefferson/","name":"Brian K Jefferson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-p-shapiro","type":"person","url":"https://hartvaat.nl/mensen/brian-p-shapiro/","name":"Brian P Shapiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brian-tomlinson","type":"person","url":"https://hartvaat.nl/mensen/brian-tomlinson/","name":"Brian Tomlinson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2017/01/01/sacubitril-valsartan-en-natriurese-diurese-en-bloeddruk-bij-zoutgevoelige-hypert/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"broberg","type":"person","url":"https://hartvaat.nl/mensen/broberg/","name":"Broberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bronislava-polonsky","type":"person","url":"https://hartvaat.nl/mensen/bronislava-polonsky/","name":"Bronislava Polonsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/01/klinische-presentatie-bij-eerste-hartfalenhospitalisatie-voorspelt-geen-heropnam/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/01/26/relatieve-wanddikte-en-risico-op-ventriculaire-tachyaritmieen-bij-linkerkamerdis/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-a-perkins","type":"person","url":"https://hartvaat.nl/mensen/bruce-a-perkins/","name":"Bruce A Perkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/dapagliflozine-bij-cv-risico-met-zonder-diabetes-cardiorenale-effecten/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2022/08/09/renale-en-vasculaire-effecten-van-gecombineerde-sglt2-en-ace-remming/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-d-lindsay","type":"person","url":"https://hartvaat.nl/mensen/bruce-d-lindsay/","name":"Bruce D Lindsay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-francis","type":"person","url":"https://hartvaat.nl/mensen/bruce-francis/","name":"Bruce Francis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-iteld","type":"person","url":"https://hartvaat.nl/mensen/bruce-iteld/","name":"Bruce Iteld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-l-wilkoff","type":"person","url":"https://hartvaat.nl/mensen/bruce-l-wilkoff/","name":"Bruce L Wilkoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2020/10/01/sekseverschillen-in-kenmerken-en-qol-bij-crt-patienten/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruce-levin","type":"person","url":"https://hartvaat.nl/mensen/bruce-levin/","name":"Bruce Levin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruna-gigante","type":"person","url":"https://hartvaat.nl/mensen/bruna-gigante/","name":"Bruna Gigante","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2016/07/01/chocoladeconsumptie-en-risico-op-myocardinfarct-prospectieve-studie-en-meta-anal/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-flamion","type":"person","url":"https://hartvaat.nl/mensen/bruno-flamion/","name":"Bruno Flamion","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2020/04/01/aprocitentan-bij-hypertensie-gerandomiseerde-dosis-responsstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-g-tavares","type":"person","url":"https://hartvaat.nl/mensen/bruno-g-tavares/","name":"Bruno G Tavares","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bruno-trimarco","type":"person","url":"https://hartvaat.nl/mensen/bruno-trimarco/","name":"Bruno Trimarco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/14/tmao-als-cardiovasculaire-risicobiomarker-systematische-review-en-meta-analyse/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/01/01/ontwikkeling-van-linkerventrikelhypertrofie-bij-behandelde-hypertensie-campania-/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bryan-goldman","type":"person","url":"https://hartvaat.nl/mensen/bryan-goldman/","name":"Bryan Goldman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/17/liraglutide-cv-uitkomsten-bij-diabetes-met-of-zonder-hartfalen-leader/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-bij-diabetes-type-2-met-ckd-leader-renale-analyse/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bunny-j-pozehl","type":"person","url":"https://hartvaat.nl/mensen/bunny-j-pozehl/","name":"Bunny J Pozehl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/01/heart-camp-connect-beweegadherentie-bij-hfpef-patienten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"buu-truong","type":"person","url":"https://hartvaat.nl/mensen/buu-truong/","name":"Buu Truong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/04/genetisch-bevestigde-familiaire-hypercholesterolemie-in-de-vs-prevalentie-en-ond/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byrne","type":"person","url":"https://hartvaat.nl/mensen/byrne/","name":"Byrne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/zuinig-machine-learningmodel-voorspelt-1-jaarssterfte-en-zinloosheid-na-tavi/","published":"2026-07-23"},{"url":"https://hartvaat.nl/2026/03/31/stemi-uitgestelde-primaire-pci-gaat-gepaard-met-hogere-sterfte-dan-trombolyse-ie/","published":"2026-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byron-k-lee","type":"person","url":"https://hartvaat.nl/mensen/byron-k-lee/","name":"Byron K Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2016/03/15/voorspelling-van-persisterende-lv-disfunctie-na-myocardinfarct-de-predicts-studi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byung-gyu-kim","type":"person","url":"https://hartvaat.nl/mensen/byung-gyu-kim/","name":"Byung Gyu Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/koreaanse-studie-van-3-7-miljoen-postmenopauzale-vrouwen-hormonale-levensloop-vo/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2025/11/08/host-reduce-dapt-na-pci-naar-bloedingsrisico/","published":"2025-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byung-moon-kim","type":"person","url":"https://hartvaat.nl/mensen/byung-moon-kim/","name":"Byung Moon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/vertraagde-intracraniele-bloeding-na-trombectomie-geassocieerd-met-slechtere-fun/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byung-ok-kim","type":"person","url":"https://hartvaat.nl/mensen/byung-ok-kim/","name":"Byung Ok Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byung-ryul-cho","type":"person","url":"https://hartvaat.nl/mensen/byung-ryul-cho/","name":"Byung Ryul Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byung-hee-hwang","type":"person","url":"https://hartvaat.nl/mensen/byung-hee-hwang/","name":"Byung-Hee Hwang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"byung-su-yoo","type":"person","url":"https://hartvaat.nl/mensen/byung-su-yoo/","name":"Byung-Su Yoo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/tien-jaar-real-world-sacubitril-valsartan-mortaliteitsreductie-bevestigd-maar-sl/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brge-g-nordestgaard","type":"person","url":"https://hartvaat.nl/mensen/brge-g-nordestgaard/","name":"Børge G. Nordestgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/01/01/risico-op-atherosclerotische-hart-en-vaatziekten-bij-familiaire-restanthyperlipi/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-a","type":"person","url":"https://hartvaat.nl/mensen/c-a/","name":"C. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/risicostratificatie-bij-longembolie-hoe-bruikbaar-zijn-de-huidige-instrumenten/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-c","type":"person","url":"https://hartvaat.nl/mensen/c-c/","name":"C. C.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/klinisch-en-genetisch-risico-op-atriumfibrilleren-versterken-elkaar-additief-13-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/03/18/st-elevatie-bij-acute-pericarditis-wijst-op-myocardiale-betrokkenheid/","published":"2026-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-s","type":"person","url":"https://hartvaat.nl/mensen/c-s/","name":"C. S.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/03/06/promise-minimal-risk-score-identificeert-veilig-laagrisicopatienten-met-stabiele/","published":"2026-03-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"c-h","type":"person","url":"https://hartvaat.nl/mensen/c-h/","name":"C.-H.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/recidief-linkerventrikel-trombus-12-recidief-actieve-eerdere-maligniteit-verzesv/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/02/23/biologische-versus-mechanische-prothesen-bij-aortaklepvervanging-op-middelbare-l/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caelan-taggart","type":"person","url":"https://hartvaat.nl/mensen/caelan-taggart/","name":"Caelan Taggart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2022/01/13/risicofactoren-voor-type-1-en-type-2-mi/","published":"2022-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caitlin-c-morrison","type":"person","url":"https://hartvaat.nl/mensen/caitlin-c-morrison/","name":"Caitlin C Morrison","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-familiaire-hypercholesterolemie-uspstf-evidenc/","published":"2016-08-09"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-multifactoriele-dyslipidemie-uspstf-evidence-r/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caitrin-w-mcdonough","type":"person","url":"https://hartvaat.nl/mensen/caitrin-w-mcdonough/","name":"Caitrin W McDonough","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"calum-j-redpath","type":"person","url":"https://hartvaat.nl/mensen/calum-j-redpath/","name":"Calum J Redpath","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"calvin-w-l-chin","type":"person","url":"https://hartvaat.nl/mensen/calvin-w-l-chin/","name":"Calvin W L Chin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/04/16/sglt2-remming-waterconservatie-domineert-over-osmotische-diurese-bij-hf/","published":"2024-04-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cameron-j-hague","type":"person","url":"https://hartvaat.nl/mensen/cameron-j-hague/","name":"Cameron J Hague","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/29/ischemia-atherosclerosekwantificering-en-cv-risico/","published":"2024-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cameron-liu","type":"person","url":"https://hartvaat.nl/mensen/cameron-liu/","name":"Cameron Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"camilo-felix","type":"person","url":"https://hartvaat.nl/mensen/camilo-felix/","name":"Camilo Félix","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2021/07/06/mortaliteitsvoordeel-van-rivaroxaban-plus-aspirine-bij-chronisch-vaatlijden-comp/","published":"2021-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"candice-delcourt","type":"person","url":"https://hartvaat.nl/mensen/candice-delcourt/","name":"Candice Delcourt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cara-ebert","type":"person","url":"https://hartvaat.nl/mensen/cara-ebert/","name":"Cara Ebert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carel-thijs","type":"person","url":"https://hartvaat.nl/mensen/carel-thijs/","name":"Carel Thijs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carisi-anne-polanczyk","type":"person","url":"https://hartvaat.nl/mensen/carisi-anne-polanczyk/","name":"Carisi Anne Polanczyk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/01/aspirine-in-primaire-preventie-en-hartfalenrisico-meta-analyse/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carl-w-baker","type":"person","url":"https://hartvaat.nl/mensen/carl-w-baker/","name":"Carl W Baker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/25/aflibercept-versus-bevacizumab-eerst-bij-diabetisch-macula-oedeem/","published":"2022-08-25"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carla-yunis","type":"person","url":"https://hartvaat.nl/mensen/carla-yunis/","name":"Carla Yunis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carline-j-van-den-dries","type":"person","url":"https://hartvaat.nl/mensen/carline-j-van-den-dries/","name":"Carline J van den Dries","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/nederlandse-huisartsenpost-1-op-20-contacten-voor-benauwdheid-betreft-hartfalen-/","published":"2026-06-27"},{"url":"https://hartvaat.nl/2020/08/07/geintegreerd-af-management-in-de-huisartsenpraktijk-all-in-clustergerandomiseerd/","published":"2020-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-lombardi","type":"person","url":"https://hartvaat.nl/mensen/carlo-lombardi/","name":"Carlo Lombardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-mario-lombardi","type":"person","url":"https://hartvaat.nl/mensen/carlo-mario-lombardi/","name":"Carlo Mario Lombardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2019/12/01/hoogtepunten-in-hartfalen-2019/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlo-trani","type":"person","url":"https://hartvaat.nl/mensen/carlo-trani/","name":"Carlo Trani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2022/07/21/permanente-pacemaker-na-tavi-langetermijneffect-op-klinische-uitkomsten/","published":"2022-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-a-camargo","type":"person","url":"https://hartvaat.nl/mensen/carlos-a-camargo/","name":"Carlos A Camargo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/arteriele-golfvormclusters-en-langetermijn-klinisch-nut/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2017/06/01/maandelijks-hooggedoseerd-vitamine-d-en-cardiovasculaire-ziekte-gerandomiseerde-/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-a-schiavon","type":"person","url":"https://hartvaat.nl/mensen/carlos-a-schiavon/","name":"Carlos A Schiavon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-a-da-fonseca","type":"person","url":"https://hartvaat.nl/mensen/carlos-a-da-fonseca/","name":"Carlos A da Fonseca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-e-rochitte","type":"person","url":"https://hartvaat.nl/mensen/carlos-e-rochitte/","name":"Carlos E Rochitte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-g-santos-gallego","type":"person","url":"https://hartvaat.nl/mensen/carlos-g-santos-gallego/","name":"Carlos G Santos-Gallego","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/22/anemie-beinvloedt-ijzerhomeostase-en-empagliflozine-respons-bij-hf/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-nicolas-perez-garcia","type":"person","url":"https://hartvaat.nl/mensen/carlos-nicolas-perez-garcia/","name":"Carlos Nicolás Pérez-García","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlos-perdomo","type":"person","url":"https://hartvaat.nl/mensen/carlos-perdomo/","name":"Carlos Perdomo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carlotta-sacerdote","type":"person","url":"https://hartvaat.nl/mensen/carlotta-sacerdote/","name":"Carlotta Sacerdote","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmel-m-mceniery","type":"person","url":"https://hartvaat.nl/mensen/carmel-m-mceniery/","name":"Carmel M McEniery","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/01/zoutbuffering-in-de-huid-bij-mensen-een-nieuw-mechanisme/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/11/01/rol-van-het-autonome-zenuwstelsel-bij-regulatie-van-aortastijfheid/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmelo-grasso","type":"person","url":"https://hartvaat.nl/mensen/carmelo-grasso/","name":"Carmelo Grasso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmine-dario-vizza","type":"person","url":"https://hartvaat.nl/mensen/carmine-dario-vizza/","name":"Carmine Dario Vizza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/04/01/sacubitril-valsartan-na-acuut-mi-meta-analyse-van-in-hospital-initiatie/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carol-r-horowitz","type":"person","url":"https://hartvaat.nl/mensen/carol-r-horowitz/","name":"Carol R Horowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carola-gianni","type":"person","url":"https://hartvaat.nl/mensen/carola-gianni/","name":"Carola Gianni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carole-l-white","type":"person","url":"https://hartvaat.nl/mensen/carole-l-white/","name":"Carole L White","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/02/09/intensieve-versus-standaard-bloeddrukcontrole-en-nierfunctie-na-lacunair-herseni/","published":"2016-02-09"},{"url":"https://hartvaat.nl/2016/01/01/bereikte-bloeddruk-en-uitkomsten-in-de-sps3-trial-bij-lacunaire-herseninfarcten/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carole-langlois-jacques","type":"person","url":"https://hartvaat.nl/mensen/carole-langlois-jacques/","name":"Carole Langlois-Jacques","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/09/uf-care-trial-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-geen-significante-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/09/uf-care-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-mist-primair-eindpunt-in/","published":"2026-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carolina-roselli","type":"person","url":"https://hartvaat.nl/mensen/carolina-roselli/","name":"Carolina Roselli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/19/pcsk9-remming-en-risico-op-veneuze-trombo-embolie/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/02/25/genetische-risicoscore-voorspelt-voordeel-van-evolocumab-fourier/","published":"2020-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caroline-j-coats","type":"person","url":"https://hartvaat.nl/mensen/caroline-j-coats/","name":"Caroline J Coats","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2019/03/01/trimetazidine-bij-niet-obstructieve-hcm-jama-cardiology-gerandomiseerde-trial/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caroline-murphy","type":"person","url":"https://hartvaat.nl/mensen/caroline-murphy/","name":"Caroline Murphy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2017/06/03/intravitreaal-aflibercept-versus-panretinale-fotocoagulatie-bij-proliferatieve-d/","published":"2017-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carolyn-pedley","type":"person","url":"https://hartvaat.nl/mensen/carolyn-pedley/","name":"Carolyn Pedley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carrie-j-nobles","type":"person","url":"https://hartvaat.nl/mensen/carrie-j-nobles/","name":"Carrie J Nobles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/01/preconceptiebloeddruk-en-verandering-naar-vroege-zwangerschap-risicofactor-voor-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddruk-voor-conceptie-en-reproductieve-uitkomsten/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carrie-melgaard","type":"person","url":"https://hartvaat.nl/mensen/carrie-melgaard/","name":"Carrie Melgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"},{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carsten-israel","type":"person","url":"https://hartvaat.nl/mensen/carsten-israel/","name":"Carsten Israel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2016/11/01/vochtstatustelemonitoring-bij-hartfalen-gerandomiseerde-trial/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"casper-w-h-beijnink","type":"person","url":"https://hartvaat.nl/mensen/casper-w-h-beijnink/","name":"Casper W H Beijnink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cassandra-key","type":"person","url":"https://hartvaat.nl/mensen/cassandra-key/","name":"Cassandra Key","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/12/amycretine-fase-2-subcutaan-toegediend-bij-obesitas/","published":"2025-07-12"},{"url":"https://hartvaat.nl/2025/07/12/amycretine-eerste-glp-1-amyline-agonist-fase-1-veiligheid-en-farmacologie/","published":"2025-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"caterina-cavazza","type":"person","url":"https://hartvaat.nl/mensen/caterina-cavazza/","name":"Caterina Cavazza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cathal-walsh","type":"person","url":"https://hartvaat.nl/mensen/cathal-walsh/","name":"Cathal Walsh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/24/systemische-inflammatie-en-recidief-na-een-af-gerelateerd-herseninfarct/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"catherine-m-viscoli","type":"person","url":"https://hartvaat.nl/mensen/catherine-m-viscoli/","name":"Catherine M Viscoli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cathy-a-jenkins","type":"person","url":"https://hartvaat.nl/mensen/cathy-a-jenkins/","name":"Cathy A Jenkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/09/dapagliflozine-bij-acuut-hartfalen-effectiviteit-en-veiligheid/","published":"2024-04-09"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cathy-c-laurie","type":"person","url":"https://hartvaat.nl/mensen/cathy-c-laurie/","name":"Cathy C Laurie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2018/06/01/gwas-van-pr-interval-bij-hispanic-latino-s-nieuw-locus-bij-id2/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cecilia-bahit","type":"person","url":"https://hartvaat.nl/mensen/cecilia-bahit/","name":"Cecilia Bahit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/patiromer-faciliteert-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cesare-cuspidi","type":"person","url":"https://hartvaat.nl/mensen/cesare-cuspidi/","name":"Cesare Cuspidi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/sympathische-overactiviteit-bij-resistente-hypertensie-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2023/03/01/renale-denervatie-en-sympathische-activiteit-systematische-review/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chad-mao","type":"person","url":"https://hartvaat.nl/mensen/chad-mao/","name":"Chad Mao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chad-mitchell","type":"person","url":"https://hartvaat.nl/mensen/chad-mitchell/","name":"Chad Mitchell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chan","type":"person","url":"https://hartvaat.nl/mensen/chan/","name":"Chan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/21/chirurgie-voor-aortaklependocarditis-blijft-hoogrisico-spoed-en-inotropie-sterks/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/05/26/recidief-linkerventrikel-trombus-12-recidief-actieve-eerdere-maligniteit-verzesv/","published":"2026-07-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang-hee-kwon","type":"person","url":"https://hartvaat.nl/mensen/chang-hee-kwon/","name":"Chang Hee Kwon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chang-hoon-lee","type":"person","url":"https://hartvaat.nl/mensen/chang-hoon-lee/","name":"Chang Hoon Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"changwei-li","type":"person","url":"https://hartvaat.nl/mensen/changwei-li/","name":"Changwei Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2017/07/01/systolische-bloeddrukreductie-en-cv-risico-netwerkmeta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"changying-xing","type":"person","url":"https://hartvaat.nl/mensen/changying-xing/","name":"Changying Xing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"changyuan-yang","type":"person","url":"https://hartvaat.nl/mensen/changyuan-yang/","name":"Changyuan Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/30/combinatietherapie-met-vier-pilaren-verlaagt-nierfalenrisico-bij-ckd/","published":"2026-08-02"},{"url":"https://hartvaat.nl/2026/05/29/lichaamsrondheidsindex-bri-voorspelt-sterfte-bij-nierpatienten-beter-dan-bmi/","published":"2026-07-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chao-li","type":"person","url":"https://hartvaat.nl/mensen/chao-li/","name":"Chao Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/15/m7g-methyltransferase-mettl1-bevordert-acuut-nierletsel-via-mitochondriale-disfu/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chao-lv","type":"person","url":"https://hartvaat.nl/mensen/chao-lv/","name":"Chao Lv","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charalambos-vlachopoulos","type":"person","url":"https://hartvaat.nl/mensen/charalambos-vlachopoulos/","name":"Charalambos Vlachopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/01/interarmbloeddrukverschil-en-beroerte-ipd-meta-analyse/","published":"2018-06-01"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charan-kantipudi","type":"person","url":"https://hartvaat.nl/mensen/charan-kantipudi/","name":"Charan Kantipudi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/30/adaptresponse-adaptieve-versus-conventionele-crt-bij-hartfalen-lancet/","published":"2023-09-30"},{"url":"https://hartvaat.nl/2017/03/07/contractiliteitssensor-geleide-crt-optimalisatie-respond-crt-trial/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charbel-noujaim","type":"person","url":"https://hartvaat.nl/mensen/charbel-noujaim/","name":"Charbel Noujaim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/decaaf-ii-af-last-en-symptoomreductie-na-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/08/02/decaaf-ii-fibroselocatie-beinvloedt-af-recidief-na-ablatie/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-c-wykoff","type":"person","url":"https://hartvaat.nl/mensen/charles-c-wykoff/","name":"Charles C Wykoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/23/photon-aflibercept-8-mg-bij-diabetisch-macula-oedeem-verlengd-doseerinterval/","published":"2024-03-23"},{"url":"https://hartvaat.nl/2022/02/19/faricimab-bij-diabetisch-maculaoedeem-met-verlengde-dosering-lancet/","published":"2022-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-canter","type":"person","url":"https://hartvaat.nl/mensen/charles-canter/","name":"Charles Canter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-d-resor","type":"person","url":"https://hartvaat.nl/mensen/charles-d-resor/","name":"Charles D Resor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2016/10/04/impact-van-optimale-medicamenteuze-therapie-in-de-dapt-studie/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-f-sherrod","type":"person","url":"https://hartvaat.nl/mensen/charles-f-sherrod/","name":"Charles F Sherrod","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/01/01/kccq-interpretatie-bij-hartfalen-patient-ankering/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-kooperberg","type":"person","url":"https://hartvaat.nl/mensen/charles-kooperberg/","name":"Charles Kooperberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2018/06/01/gwas-van-pr-interval-bij-hispanic-latino-s-nieuw-locus-bij-id2/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-l-shear","type":"person","url":"https://hartvaat.nl/mensen/charles-l-shear/","name":"Charles L Shear","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charles-v-pollack","type":"person","url":"https://hartvaat.nl/mensen/charles-v-pollack/","name":"Charles V Pollack","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/16/doac-s-halveren-trombo-embolische-events-na-af-cardioversie-versus-warfarine/","published":"2018-10-16"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-versus-heparine-vka-bij-cardioversie-voor-af-emanate-trial/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charley-a-budgeon","type":"person","url":"https://hartvaat.nl/mensen/charley-a-budgeon/","name":"Charley A Budgeon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2019/12/24/langetermijnfollow-up-van-complete-versus-laesie-only-revascularisatie-bij-stemi/","published":"2019-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charlotte-glinge","type":"person","url":"https://hartvaat.nl/mensen/charlotte-glinge/","name":"Charlotte Glinge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/15/complete-versus-culprit-only-revascularisatie-bij-stemi-tienjaarsresultaten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charlotte-kragelund","type":"person","url":"https://hartvaat.nl/mensen/charlotte-kragelund/","name":"Charlotte Kragelund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"charlotte-stephansen","type":"person","url":"https://hartvaat.nl/mensen/charlotte-stephansen/","name":"Charlotte Stephansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2019/09/01/elektrisch-versus-beeldvorming-geleide-lv-leadplaatsing-bij-crt-gerandomiseerde-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chayakrit-krittanawong","type":"person","url":"https://hartvaat.nl/mensen/chayakrit-krittanawong/","name":"Chayakrit Krittanawong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/24/myocardiale-brug-praktische-gids-voor-diagnose-en-behandeling-in-het-ccta-tijdpe/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2025/01/01/richtlijn-volwassenen-met-aangeboren-hartafwijkingen-2025-in-een-oogopslag/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chee-ng","type":"person","url":"https://hartvaat.nl/mensen/chee-ng/","name":"Chee Ng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chee-yoong-foo","type":"person","url":"https://hartvaat.nl/mensen/chee-yoong-foo/","name":"Chee Yoong Foo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/door-to-balloon-tijd-en-uitkomsten-bij-stemi-meta-analyse/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/08/19/vergelijking-van-fibrinolytica-bij-stemi-lancet-netwerkmeta-analyse/","published":"2017-08-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chen-yao","type":"person","url":"https://hartvaat.nl/mensen/chen-yao/","name":"Chen Yao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chen-huan-chen","type":"person","url":"https://hartvaat.nl/mensen/chen-huan-chen/","name":"Chen-Huan Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheng-han-ng","type":"person","url":"https://hartvaat.nl/mensen/cheng-han-ng/","name":"Cheng Han Ng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/brede-inzet-van-oraal-semaglutide-in-de-vs-zou-jaarlijks-tot-60-000-cardiovascul/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2022/04/01/glucoseverlagende-middelen-bij-niet-diabetisch-hf-bayesiaanse-netwerkmeta-analys/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheng-wang","type":"person","url":"https://hartvaat.nl/mensen/cheng-wang/","name":"Cheng Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/16/sluiting-van-het-linker-hartoor-versus-doac-s-na-longembolie/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2025/09/01/pvi-met-of-zonder-empirische-svc-isolatie-bij-af-ablatie/","published":"2025-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chengzhi-lu","type":"person","url":"https://hartvaat.nl/mensen/chengzhi-lu/","name":"Chengzhi Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheol-ung-choi","type":"person","url":"https://hartvaat.nl/mensen/cheol-ung-choi/","name":"Cheol Ung Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/21/bij-coronaire-vasospasmen-zonder-significante-stenose-voorspelt-verhoogd-lp-a-ge/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheol-hyun-chung","type":"person","url":"https://hartvaat.nl/mensen/cheol-hyun-chung/","name":"Cheol-Hyun Chung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheryl-a-m-anderson","type":"person","url":"https://hartvaat.nl/mensen/cheryl-a-m-anderson/","name":"Cheryl A M Anderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/natriumreductie-en-energie-metabolisme-gewicht-en-dorst-dash-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2020/01/21/voedingscholesterol-en-cv-risico-aha-science-advisory/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cheryl-dennison-himmelfarb","type":"person","url":"https://hartvaat.nl/mensen/cheryl-dennison-himmelfarb/","name":"Cheryl Dennison Himmelfarb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chiara-bruno","type":"person","url":"https://hartvaat.nl/mensen/chiara-bruno/","name":"Chiara Bruno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chiara-bucciarelli-ducci","type":"person","url":"https://hartvaat.nl/mensen/chiara-bucciarelli-ducci/","name":"Chiara Bucciarelli-Ducci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2018/01/07/2017-esc-richtlijn-voor-stemi-management/","published":"2018-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chiara-donfrancesco","type":"person","url":"https://hartvaat.nl/mensen/chiara-donfrancesco/","name":"Chiara Donfrancesco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chin-hiew","type":"person","url":"https://hartvaat.nl/mensen/chin-hiew/","name":"Chin Hiew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chinwe-ibeh","type":"person","url":"https://hartvaat.nl/mensen/chinwe-ibeh/","name":"Chinwe Ibeh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chirag-mehta","type":"person","url":"https://hartvaat.nl/mensen/chirag-mehta/","name":"Chirag Mehta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chisato-izumi","type":"person","url":"https://hartvaat.nl/mensen/chisato-izumi/","name":"Chisato Izumi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/18/helios-b-post-hoc-vutrisiran-effectief-bij-oost-aziatische-attr-cm-patienten-hr-/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/02/02/jamac-studie-slechte-5-jaarsprognose-bij-mitralisstenose-door-mitralisringverkal/","published":"2026-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chris-gianacas","type":"person","url":"https://hartvaat.nl/mensen/chris-gianacas/","name":"Chris Gianacas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/lage-dosis-triple-combinatiepil-versus-placebo-bij-initiele-hypertensiebehandeli/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/10/19/lage-dosis-triple-combinatiepil-bij-milde-hypertensie-gerandomiseerde-trial/","published":"2024-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chris-hayward","type":"person","url":"https://hartvaat.nl/mensen/chris-hayward/","name":"Chris Hayward","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chris-j-packard","type":"person","url":"https://hartvaat.nl/mensen/chris-j-packard/","name":"Chris J Packard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/14/ldl-verlaging-voor-primaire-preventie-bij-mannen-met-primaire-ldl-verhoging/","published":"2017-11-14"},{"url":"https://hartvaat.nl/2016/12/27/hoog-sensitief-troponine-statinetherapie-en-risico-op-coronairlijden/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chris-stride","type":"person","url":"https://hartvaat.nl/mensen/chris-stride/","name":"Chris Stride","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chris-tuck","type":"person","url":"https://hartvaat.nl/mensen/chris-tuck/","name":"Chris Tuck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/11/risicostratificatie-met-hoog-sensitief-troponine-op-de-seh-veiligheidsanalyse/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2019/10/22/sekse-specifieke-troponinedrempels-bij-verdenking-acs/","published":"2019-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chrishan-j-nalliah","type":"person","url":"https://hartvaat.nl/mensen/chrishan-j-nalliah/","name":"Chrishan J Nalliah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"},{"url":"https://hartvaat.nl/2017/10/17/katheterablatie-versus-frequentiecontrole-bij-af-met-systolische-disfunctie-came/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christi-deaton","type":"person","url":"https://hartvaat.nl/mensen/christi-deaton/","name":"Christi Deaton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/01/disease-management-bij-hfpef-systematische-review/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-apitz","type":"person","url":"https://hartvaat.nl/mensen/christian-apitz/","name":"Christian Apitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/05/01/genetische-diagnostiek-en-biomarkers-bij-pediatrische-pulmonale-hypertensie-expe/","published":"2016-05-01"},{"url":"https://hartvaat.nl/2016/05/01/cardiale-mri-en-ct-bij-kinderen-met-pulmonale-hypertensie-expertconsensus/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-bork","type":"person","url":"https://hartvaat.nl/mensen/christian-bork/","name":"Christian Bork","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/19/enkelvoudige-onverzadigde-vetzuren-in-vetweefsel-en-het-risico-op-perifeer-vaatl/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-bradaric","type":"person","url":"https://hartvaat.nl/mensen/christian-bradaric/","name":"Christian Bradaric","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-eickholt","type":"person","url":"https://hartvaat.nl/mensen/christian-eickholt/","name":"Christian Eickholt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2018/01/01/energiebron-en-vroeg-af-recidief-cryoballon-versus-radiofrequentie/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-frerker","type":"person","url":"https://hartvaat.nl/mensen/christian-frerker/","name":"Christian Frerker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-kronborg","type":"person","url":"https://hartvaat.nl/mensen/christian-kronborg/","name":"Christian Kronborg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/12/ritme-monitoringstrategieen-voor-af-screening-uitgebreide-evaluatie/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2019/12/03/natuurlijk-beloop-van-subklinisch-af-gedetecteerd-door-implanteerbare-looprecord/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-opitz","type":"person","url":"https://hartvaat.nl/mensen/christian-opitz/","name":"Christian Opitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2016/01/01/inspanningstraining-verbetert-zuurstofopname-en-hemodynamiek-bij-ernstige-pulmon/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-schulze","type":"person","url":"https://hartvaat.nl/mensen/christian-schulze/","name":"Christian Schulze","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/11/01/sbp-en-impella-geassocieerde-overleving-bij-cardiogene-shock/","published":"2025-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-stoppe","type":"person","url":"https://hartvaat.nl/mensen/christian-stoppe/","name":"Christian Stoppe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/24/tight-k-kaliumsuppletie-voorkomt-af-na-hartchirurgie-rct/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-tuxen","type":"person","url":"https://hartvaat.nl/mensen/christian-tuxen/","name":"Christian Tuxen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/22/thoracentese-bij-acuut-hartfalen-gerandomiseerde-trial/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2021/06/01/metabole-effecten-van-empagliflozine-bij-hf-empire-hf-metabolic-gerandomiseerde-/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-ukena","type":"person","url":"https://hartvaat.nl/mensen/christian-ukena/","name":"Christian Ukena","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/07/hartfrequentie-en-uitkomsten-van-renale-denervatie-bij-ongecontroleerde-hyperten/","published":"2021-09-07"},{"url":"https://hartvaat.nl/2019/03/01/ambulante-hartfrequentiereductie-na-renale-denervatie-bij-hypertensie-zonder-med/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-weimar","type":"person","url":"https://hartvaat.nl/mensen/christian-weimar/","name":"Christian Weimar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-zanchin","type":"person","url":"https://hartvaat.nl/mensen/christian-zanchin/","name":"Christian Zanchin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/10/alirocumab-plus-statine-op-coronaire-atherosclerose-na-mi-jama-pacman-ami/","published":"2022-05-10"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-de-chillou","type":"person","url":"https://hartvaat.nl/mensen/christian-de-chillou/","name":"Christian de Chillou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christiane-drechsler","type":"person","url":"https://hartvaat.nl/mensen/christiane-drechsler/","name":"Christiane Drechsler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/21/patientgerapporteerde-uitkomsten-verbeteren-voorspelling-van-mortaliteit-bij-dia/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christina-brinkmann","type":"person","url":"https://hartvaat.nl/mensen/christina-brinkmann/","name":"Christina Brinkmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christina-l-fanola","type":"person","url":"https://hartvaat.nl/mensen/christina-l-fanola/","name":"Christina L Fanola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"},{"url":"https://hartvaat.nl/2017/03/21/nieuwe-risicovoorspellingsscore-bij-af-voor-netto-klinisch-resultaat-engage-af-t/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christina-paitazoglou","type":"person","url":"https://hartvaat.nl/mensen/christina-paitazoglou/","name":"Christina Paitazoglou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christine-mccourt","type":"person","url":"https://hartvaat.nl/mensen/christine-mccourt/","name":"Christine McCourt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christine-norton","type":"person","url":"https://hartvaat.nl/mensen/christine-norton/","name":"Christine Norton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christine-vanzandbergen","type":"person","url":"https://hartvaat.nl/mensen/christine-vanzandbergen/","name":"Christine VanZandbergen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoffer-goransson","type":"person","url":"https://hartvaat.nl/mensen/christoffer-goransson/","name":"Christoffer Göransson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-f-ebenbichler","type":"person","url":"https://hartvaat.nl/mensen/christoph-f-ebenbichler/","name":"Christoph F Ebenbichler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/evinacumab-bij-refractaire-hypercholesterolemie-langetermijn-effectiviteit-en-ve/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-gumbinger","type":"person","url":"https://hartvaat.nl/mensen/christoph-gumbinger/","name":"Christoph Gumbinger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-j-binder","type":"person","url":"https://hartvaat.nl/mensen/christoph-j-binder/","name":"Christoph J Binder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-naber","type":"person","url":"https://hartvaat.nl/mensen/christoph-naber/","name":"Christoph Naber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-neumann","type":"person","url":"https://hartvaat.nl/mensen/christoph-neumann/","name":"Christoph Neumann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/02/oceanic-af-asundexian-versus-apixaban-bij-af-nejm/","published":"2025-01-02"},{"url":"https://hartvaat.nl/2022/04/09/asundexian-factor-xia-remmer-versus-apixaban-bij-af-lancet-pacific-af/","published":"2022-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-tasto","type":"person","url":"https://hartvaat.nl/mensen/christoph-tasto/","name":"Christoph Tasto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/08/finerenon-vermindert-incident-hf-bij-ckd-met-diabetes-fidelity/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christoph-weiser","type":"person","url":"https://hartvaat.nl/mensen/christoph-weiser/","name":"Christoph Weiser","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/prehospitale-hypothermie-bij-stemi-gerandomiseerde-trial/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2017/02/01/vernakalant-versus-ibutilide-voor-sinusritme-bij-recent-onset-af-gerandomiseerde/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-a-t-stevens","type":"person","url":"https://hartvaat.nl/mensen/christophe-a-t-stevens/","name":"Christophe A T Stevens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/06/02/prevalentie-van-fh-bij-atherosclerotische-cv-ziekte-meta-analyse/","published":"2020-06-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-bauters","type":"person","url":"https://hartvaat.nl/mensen/christophe-bauters/","name":"Christophe Bauters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2024/10/03/uitgebreide-versus-standaard-remote-monitoring-bij-crt-en-hartfalen/","published":"2024-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-caussin","type":"person","url":"https://hartvaat.nl/mensen/christophe-caussin/","name":"Christophe Caussin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christophe-mariat","type":"person","url":"https://hartvaat.nl/mensen/christophe-mariat/","name":"Christophe Mariat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/gepersonaliseerde-gfr-percentielen-een-nieuw-instrument-voor-ckd-detectie/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/19/creatinine-cystatine-c-of-beide-voor-gfr-schatting-bij-niertransplantatiepatient/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-a-miller","type":"person","url":"https://hartvaat.nl/mensen/christopher-a-miller/","name":"Christopher A Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-baker","type":"person","url":"https://hartvaat.nl/mensen/christopher-baker/","name":"Christopher Baker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-c-y-wong","type":"person","url":"https://hartvaat.nl/mensen/christopher-c-y-wong/","name":"Christopher C Y Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/chirurgisch-unroofing-van-myocardiale-brug-verbetert-angina-klachten-langdurig-m/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2024/07/10/intracoronaire-trombolyse-bij-stemi-meta-analyse/","published":"2024-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-d-nielsen","type":"person","url":"https://hartvaat.nl/mensen/christopher-d-nielsen/","name":"Christopher D Nielsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-j-lindsell","type":"person","url":"https://hartvaat.nl/mensen/christopher-j-lindsell/","name":"Christopher J Lindsell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/09/dapagliflozine-bij-acuut-hartfalen-effectiviteit-en-veiligheid/","published":"2024-04-09"},{"url":"https://hartvaat.nl/2023/09/05/best-ii-bloeddrukmanagement-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-j-o-donnell","type":"person","url":"https://hartvaat.nl/mensen/christopher-j-o-donnell/","name":"Christopher J O'Donnell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-k-snider","type":"person","url":"https://hartvaat.nl/mensen/christopher-k-snider/","name":"Christopher K Snider","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-p-nelson","type":"person","url":"https://hartvaat.nl/mensen/christopher-p-nelson/","name":"Christopher P Nelson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/metformin-verlaagt-risico-op-buikaorta-aneurysma-mr-en-cohortanalyse/","published":"2026-08-20"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-s-wilcox","type":"person","url":"https://hartvaat.nl/mensen/christopher-s-wilcox/","name":"Christopher S Wilcox","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/17/sotagliflozine-en-gezondheidsstatus-bij-verslechterend-hartfalen-soloist-whf/","published":"2024-09-17"},{"url":"https://hartvaat.nl/2021/01/14/sotagliflozine-bij-diabetes-met-recent-verslechterend-hf-nejm-soloist-whf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-tuck","type":"person","url":"https://hartvaat.nl/mensen/christopher-tuck/","name":"Christopher Tuck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christopher-v-desimone","type":"person","url":"https://hartvaat.nl/mensen/christopher-v-desimone/","name":"Christopher V DeSimone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/02/af-ablatie-bij-hypertrofische-cardiomyopathie-meta-analyse/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2023/07/04/colchicine-voorkomt-postoperatief-af-na-hartchirurgie-meta-analyse/","published":"2023-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christos-davatzikos","type":"person","url":"https://hartvaat.nl/mensen/christos-davatzikos/","name":"Christos Davatzikos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christos-savopoulos","type":"person","url":"https://hartvaat.nl/mensen/christos-savopoulos/","name":"Christos Savopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2018/10/01/ochtend-versus-avonddosering-van-antihypertensiva-gerandomiseerde-crossover-tria/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christos-v-bourantas","type":"person","url":"https://hartvaat.nl/mensen/christos-v-bourantas/","name":"Christos V Bourantas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christy-l-avery","type":"person","url":"https://hartvaat.nl/mensen/christy-l-avery/","name":"Christy L Avery","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/mendeliaanse-randomisatie-lp-a-verhoogt-coronarialijden-onafhankelijk-van-ldl-c-/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2018/06/01/gwas-van-pr-interval-bij-hispanic-latino-s-nieuw-locus-bij-id2/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chuanming-hao","type":"person","url":"https://hartvaat.nl/mensen/chuanming-hao/","name":"Chuanming Hao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chung-lieh-hung","type":"person","url":"https://hartvaat.nl/mensen/chung-lieh-hung/","name":"Chung-Lieh Hung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/cardiovasculair-renaal-metabool-samenspel-bij-patienten-met-atriumfibrilleren/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2016/02/01/regionale-hartdisfunctie-en-prognose-na-myocardinfarct-met-lv-disfunctie-of-hart/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chunlin-lai","type":"person","url":"https://hartvaat.nl/mensen/chunlin-lai/","name":"Chunlin Lai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chunmei-zhou","type":"person","url":"https://hartvaat.nl/mensen/chunmei-zhou/","name":"Chunmei Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/06/orforglipron-voor-obesitasbehandeling-nejm-fase-3/","published":"2025-11-06"},{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chunrong-wang","type":"person","url":"https://hartvaat.nl/mensen/chunrong-wang/","name":"Chunrong Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chunxia-zhao","type":"person","url":"https://hartvaat.nl/mensen/chunxia-zhao/","name":"Chunxia Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"chunyu-liu","type":"person","url":"https://hartvaat.nl/mensen/chunyu-liu/","name":"Chunyu Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cindy-grines","type":"person","url":"https://hartvaat.nl/mensen/cindy-grines/","name":"Cindy Grines","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2020/09/15/ami-management-tijdens-covid-19-scai-positiedocument/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cindy-m-martin","type":"person","url":"https://hartvaat.nl/mensen/cindy-m-martin/","name":"Cindy M Martin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/clip-hfpef-cilostazol-bij-hfpef-gerandomiseerde-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cinzia-perrino","type":"person","url":"https://hartvaat.nl/mensen/cinzia-perrino/","name":"Cinzia Perrino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/metabool-cardiovasculair-risico-nieuwe-mechanismen-en-therapiekansen/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2017/10/14/tmao-als-cardiovasculaire-risicobiomarker-systematische-review-en-meta-analyse/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ciro-indolfi","type":"person","url":"https://hartvaat.nl/mensen/ciro-indolfi/","name":"Ciro Indolfi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ciro-mauro","type":"person","url":"https://hartvaat.nl/mensen/ciro-mauro/","name":"Ciro Mauro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claire-lacomblez","type":"person","url":"https://hartvaat.nl/mensen/claire-lacomblez/","name":"Claire Lacomblez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/23/paradise-cohort-hartfalen-en-copd-samen-verhogen-de-langetermijnmortaliteit-met-/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/05/10/paradise-gelijktijdig-acuut-hartfalen-plus-luchtweginfectie-verhoogt-sterfte-tij/","published":"2026-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claire-litherland","type":"person","url":"https://hartvaat.nl/mensen/claire-litherland/","name":"Claire Litherland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/06/01/korte-procedureduur-met-bivalirudine-en-risico-op-acute-stenttrombose-bij-stemi/","published":"2017-06-01"},{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudio-borghi","type":"person","url":"https://hartvaat.nl/mensen/claudio-borghi/","name":"Claudio Borghi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/05/lorundrostat-bij-ongecontroleerde-en-therapieresistente-hypertensie-fase-3-resul/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudio-fresco","type":"person","url":"https://hartvaat.nl/mensen/claudio-fresco/","name":"Claudio Fresco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudio-ronco","type":"person","url":"https://hartvaat.nl/mensen/claudio-ronco/","name":"Claudio Ronco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/23/zwangerschapsgeassocieerd-acuut-nierfalen-pathofysiologie-en-verhoogd-langetermi/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2026/03/01/tijd-voor-een-vijfde-pijler-bij-lichamelijk-onderzoek-van-kinderen-aan-dialyse/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"claudius-mahr","type":"person","url":"https://hartvaat.nl/mensen/claudius-mahr/","name":"Claudius Mahr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"clement-delmas","type":"person","url":"https://hartvaat.nl/mensen/clement-delmas/","name":"Clément Delmas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/ventriculaire-aritmieen-na-lvad-implantatie-meta-analyse/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"colin-n-a-palmer","type":"person","url":"https://hartvaat.nl/mensen/colin-n-a-palmer/","name":"Colin N A Palmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/12/genetisch-risico-op-coronairlijden-en-ontwikkeling-van-hfref-versus-hfpef/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2017/12/21/lilrb5-variant-geassocieerd-met-statine-intolerantie-en-myalgie/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"colin-royse","type":"person","url":"https://hartvaat.nl/mensen/colin-royse/","name":"Colin Royse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"colleen-norris","type":"person","url":"https://hartvaat.nl/mensen/colleen-norris/","name":"Colleen Norris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/telehealth-verbetert-zelfzorg-bij-kwetsbare-hartfalenpatienten/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/06/17/bedmed-timing-van-antihypertensieve-medicatie-en-cv-events-jama-definitieve-tria/","published":"2025-06-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"congxin-huang","type":"person","url":"https://hartvaat.nl/mensen/congxin-huang/","name":"Congxin Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2021/05/21/katheterablatie-versus-medicatie-bij-persisterend-en-langdurig-persisterend-af-l/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"conn-sugihara","type":"person","url":"https://hartvaat.nl/mensen/conn-sugihara/","name":"Conn Sugihara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/nmarq-pvac-en-thoracoscopische-ablatie-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2016/07/01/implanteerbare-monitors-als-goudstandaard-voor-af-detectie-gerandomiseerde-verge/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"conor-d-barrett","type":"person","url":"https://hartvaat.nl/mensen/conor-d-barrett/","name":"Conor D Barrett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"constantinos-h-davos","type":"person","url":"https://hartvaat.nl/mensen/constantinos-h-davos/","name":"Constantinos H Davos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"corinna-lenz","type":"person","url":"https://hartvaat.nl/mensen/corinna-lenz/","name":"Corinna Lenz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/08/closed-loop-stimulatie-en-cardiopulmonale-variabelen-bij-chronisch-hf-met-chrono/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2021/05/21/firm-ablatie-versus-pvi-bij-paroxysmaal-af-gerandomiseerde-resultaten/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"corinne-jufer","type":"person","url":"https://hartvaat.nl/mensen/corinne-jufer/","name":"Corinne Jufer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"corrado-tamburino","type":"person","url":"https://hartvaat.nl/mensen/corrado-tamburino/","name":"Corrado Tamburino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/04/14/aki-en-bloedingen-en-mortaliteit-na-radiale-versus-femorale-toegang-bij-acs/","published":"2019-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"costan-g-magnussen","type":"person","url":"https://hartvaat.nl/mensen/costan-g-magnussen/","name":"Costan G Magnussen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2020/04/01/verhoogde-bloeddruk-op-kinder-adolescentenleeftijd-en-cv-uitkomsten-bij-volwasse/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"courtney-christou","type":"person","url":"https://hartvaat.nl/mensen/courtney-christou/","name":"Courtney Christou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"},{"url":"https://hartvaat.nl/2021/01/21/polypil-met-of-zonder-aspirine-bij-personen-zonder-cvd-nejm-polypill-tips-3/","published":"2021-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"craig-juergens","type":"person","url":"https://hartvaat.nl/mensen/craig-juergens/","name":"Craig Juergens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"craig-r-smith","type":"person","url":"https://hartvaat.nl/mensen/craig-r-smith/","name":"Craig R Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cramariuc","type":"person","url":"https://hartvaat.nl/mensen/cramariuc/","name":"Cramariuc","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/29/geisoleerde-secundaire-tricuspidalisinsufficientie-na-linkszijdige-klepchirurgie/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/01/16/nt-probnp-voorspelt-sterfte-na-een-stemi-onafhankelijk-van-de-ejectiefractie/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cristiana-vitale","type":"person","url":"https://hartvaat.nl/mensen/cristiana-vitale/","name":"Cristiana Vitale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/27/frailte-versnelt-hartfalenprogressie-en-vermindert-therapietolerantie/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cristiano-ciaccio","type":"person","url":"https://hartvaat.nl/mensen/cristiano-ciaccio/","name":"Cristiano Ciaccio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cristina-balla","type":"person","url":"https://hartvaat.nl/mensen/cristina-balla/","name":"Cristina Balla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cristina-giannini","type":"person","url":"https://hartvaat.nl/mensen/cristina-giannini/","name":"Cristina Giannini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2018/12/01/mitraclip-plus-medicamenteus-versus-medicamenteus-alleen-bij-hf-met-mr-meta-anal/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cristina-hobeanu","type":"person","url":"https://hartvaat.nl/mensen/cristina-hobeanu/","name":"Cristina Hobeanu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cristina-pederiva","type":"person","url":"https://hartvaat.nl/mensen/cristina-pederiva/","name":"Cristina Pederiva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"crystal-a-gadegbeku","type":"person","url":"https://hartvaat.nl/mensen/crystal-a-gadegbeku/","name":"Crystal A Gadegbeku","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2016/08/01/apol1-nierrisicovarianten-en-cerebrale-wittestoflaesies/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"crystal-c-spencer","type":"person","url":"https://hartvaat.nl/mensen/crystal-c-spencer/","name":"Crystal C Spencer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"csaba-foldesi","type":"person","url":"https://hartvaat.nl/mensen/csaba-foldesi/","name":"Csaba Földesi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"curt-j-daniels","type":"person","url":"https://hartvaat.nl/mensen/curt-j-daniels/","name":"Curt J. Daniels","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/nieuwe-acc-aha-richtlijn-2025-voor-volwassenen-met-aangeboren-hartafwijkingen/","published":"2026-03-11"},{"url":"https://hartvaat.nl/2025/01/01/de-toekomst-van-zorg-voor-volwassenen-met-aangeboren-hartafwijkingen-in-de-vs/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"curtis-ginder","type":"person","url":"https://hartvaat.nl/mensen/curtis-ginder/","name":"Curtis Ginder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/bestaande-cv-data-benutten-voor-hypertensiedetectie-en-behandeling-vital-trial/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2023/03/14/real-time-remote-monitoring-voorspelt-maligne-ventriculaire-aritmieen/","published":"2023-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"curzen","type":"person","url":"https://hartvaat.nl/mensen/curzen/","name":"Curzen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/promise-minimal-risk-score-identificeert-veilig-laagrisicopatienten-met-stabiele/","published":"2026-03-06"},{"url":"https://hartvaat.nl/2026/01/23/multidisciplinair-cardiogene-shockteam-verbetert-de-1-jaarsoverleving-bij-infarc/","published":"2026-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cyndya-a-shibao","type":"person","url":"https://hartvaat.nl/mensen/cyndya-a-shibao/","name":"Cyndya A Shibao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/dpp-4-remming-en-catecholamines-tijdens-ace-remming/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/02/01/mineralocorticoidreceptoractivatie-draagt-bij-aan-supiene-hypertensie-bij-autono/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cynthia-m-tracy","type":"person","url":"https://hartvaat.nl/mensen/cynthia-m-tracy/","name":"Cynthia M Tracy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cynthia-papendick","type":"person","url":"https://hartvaat.nl/mensen/cynthia-papendick/","name":"Cynthia Papendick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cyrus-desouza","type":"person","url":"https://hartvaat.nl/mensen/cyrus-desouza/","name":"Cyrus Desouza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cyrus-r-mehta","type":"person","url":"https://hartvaat.nl/mensen/cyrus-r-mehta/","name":"Cyrus R Mehta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"d-christopher-metzger","type":"person","url":"https://hartvaat.nl/mensen/d-christopher-metzger/","name":"D Christopher Metzger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"d-a","type":"person","url":"https://hartvaat.nl/mensen/d-a/","name":"D. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/20/virtuele-afdeling-met-thuismonitoring-is-veilig-voor-patienten-die-wachten-op-sp/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2026/02/12/ct-coronairangiografie-bij-nstemi-uitstekende-diagnostische-nauwkeurigheid-maar-/","published":"2026-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"d-b","type":"person","url":"https://hartvaat.nl/mensen/d-b/","name":"D. B.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/sekseverschillen-in-secundaire-preventie-na-acs-vrouwen-halen-minder-vaak-hun-ld/","published":"2026-07-23"},{"url":"https://hartvaat.nl/2026/05/04/noorse-nationale-validatie-myocarditis-na-mrna-covid-vaccinatie-4-5-per-100-000-/","published":"2026-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"d-p","type":"person","url":"https://hartvaat.nl/mensen/d-p/","name":"D. P.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/21/chirurgie-voor-aortaklependocarditis-blijft-hoogrisico-spoed-en-inotropie-sterks/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/03/10/machine-learning-voorspelt-30-daagse-sterfte-na-een-dotterbehandeling-australisc/","published":"2026-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daan-j-touw","type":"person","url":"https://hartvaat.nl/mensen/daan-j-touw/","name":"Daan J Touw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/dapagliflozine-bij-cv-risico-met-zonder-diabetes-cardiorenale-effecten/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2020/01/01/renale-hemodynamische-effecten-van-dapagliflozine-postglomerulaire-vasodilatatie/","published":"2020-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daan-kromhout","type":"person","url":"https://hartvaat.nl/mensen/daan-kromhout/","name":"Daan Kromhout","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dae-young-hyun","type":"person","url":"https://hartvaat.nl/mensen/dae-young-hyun/","name":"Dae Young Hyun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dagfinn-aune","type":"person","url":"https://hartvaat.nl/mensen/dagfinn-aune/","name":"Dagfinn Aune","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2016/02/16/bmi-abdominale-adipositas-en-hartfalen-systematische-review-en-dosis-responsmeta/","published":"2016-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daiana-ibarretxe","type":"person","url":"https://hartvaat.nl/mensen/daiana-ibarretxe/","name":"Daiana Ibarretxe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/23/vldl-en-hdl-tg-verhoogd-bij-overgewicht-bij-kinderen-geavanceerd-lipoproteinepro/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daisuke-shishikura","type":"person","url":"https://hartvaat.nl/mensen/daisuke-shishikura/","name":"Daisuke Shishikura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/hemodynamische-en-bloedviscositeitsprofielen-van-culprit-versus-non-culprit-coro/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dale-presser","type":"person","url":"https://hartvaat.nl/mensen/dale-presser/","name":"Dale Presser","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"damian-j-kelly","type":"person","url":"https://hartvaat.nl/mensen/damian-j-kelly/","name":"Damian J Kelly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/24/langetermijnfollow-up-van-complete-versus-laesie-only-revascularisatie-bij-stemi/","published":"2019-12-24"},{"url":"https://hartvaat.nl/2016/06/07/ischemie-en-infarct-bij-stemi-met-multivatenlijden-cvlprit-nucleaire-substudie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"damiano-fedele","type":"person","url":"https://hartvaat.nl/mensen/damiano-fedele/","name":"Damiano Fedele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2025/03/13/minoca-pathologische-bevindingen-bij-invasieve-beoordeling-meta-analyse/","published":"2025-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"damiano-regazzoli","type":"person","url":"https://hartvaat.nl/mensen/damiano-regazzoli/","name":"Damiano Regazzoli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"damien-collison","type":"person","url":"https://hartvaat.nl/mensen/damien-collison/","name":"Damien Collison","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"damien-mandry","type":"person","url":"https://hartvaat.nl/mensen/damien-mandry/","name":"Damien Mandry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2016/08/02/omega-3-vetzuren-en-linkerkamerremodellering-na-acuut-mi-omega-remodel-trial/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"damini-dey","type":"person","url":"https://hartvaat.nl/mensen/damini-dey/","name":"Damini Dey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/30/leaf-liraglutide-voor-ablatie-verbetert-af-vrije-overleving/","published":"2026-03-30"},{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-dobreanu","type":"person","url":"https://hartvaat.nl/mensen/dan-dobreanu/","name":"Dan Dobreanu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/01/deliver-dapagliflozine-verbetert-individuele-kccq-componenten-bij-hfpef/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-li","type":"person","url":"https://hartvaat.nl/mensen/dan-li/","name":"Dan Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dan-m-roden","type":"person","url":"https://hartvaat.nl/mensen/dan-m-roden/","name":"Dan M Roden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dana-dawson","type":"person","url":"https://hartvaat.nl/mensen/dana-dawson/","name":"Dana Dawson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/metabool-cardiovasculair-risico-nieuwe-mechanismen-en-therapiekansen/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-a-gipe","type":"person","url":"https://hartvaat.nl/mensen/daniel-a-gipe/","name":"Daniel A Gipe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-bloomfield","type":"person","url":"https://hartvaat.nl/mensen/daniel-bloomfield/","name":"Daniel Bloomfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/17/azalea-timi-71-langwerkende-factor-xi-remmer-en-periprocedurale-bloedingen/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2025/01/23/abelacimab-versus-rivaroxaban-bij-af-nejm/","published":"2025-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-brodie","type":"person","url":"https://hartvaat.nl/mensen/daniel-brodie/","name":"Daniel Brodie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-c-andersson","type":"person","url":"https://hartvaat.nl/mensen/daniel-c-andersson/","name":"Daniel C Andersson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/06/09/acyl-ghreline-verbetert-hartfunctie-bij-hartfalen/","published":"2023-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-camillo-spona","type":"person","url":"https://hartvaat.nl/mensen/daniel-camillo-spona/","name":"Daniel Camillo Spona","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/15/hypokaliemie-en-af-gedetecteerd-door-implanteerbare-loop-recorders/","published":"2025-12-15"},{"url":"https://hartvaat.nl/2025/12/15/circadiaanse-patronen-van-af-en-ziekteprogressie-via-implanted-loop-recorders/","published":"2025-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-d-matlock","type":"person","url":"https://hartvaat.nl/mensen/daniel-d-matlock/","name":"Daniel D Matlock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/02/gezamenlijke-besluitvorming-bij-percutane-linker-atriumoorsluiting/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2019/10/01/verbetering-van-communicatie-bij-hartfalenpatientenzorg/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-goldstein","type":"person","url":"https://hartvaat.nl/mensen/daniel-goldstein/","name":"Daniel Goldstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-herpin","type":"person","url":"https://hartvaat.nl/mensen/daniel-herpin/","name":"Daniel Herpin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-i-chasman","type":"person","url":"https://hartvaat.nl/mensen/daniel-i-chasman/","name":"Daniel I Chasman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/21/lilrb5-variant-geassocieerd-met-statine-intolerantie-en-myalgie/","published":"2017-12-21"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-i-swerdlow","type":"person","url":"https://hartvaat.nl/mensen/daniel-i-swerdlow/","name":"Daniel I Swerdlow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/korte-interfererende-rna-tegen-lp-a-jama-fase-1-dosisstudie/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-j-blackman","type":"person","url":"https://hartvaat.nl/mensen/daniel-j-blackman/","name":"Daniel J Blackman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2016/06/21/strategieen-om-microvasculaire-obstructie-te-verminderen-bij-primaire-pci-relief/","published":"2016-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-j-scherer","type":"person","url":"https://hartvaat.nl/mensen/daniel-j-scherer/","name":"Daniel J Scherer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-m-f-claassens","type":"person","url":"https://hartvaat.nl/mensen/daniel-m-f-claassens/","name":"Daniel M F Claassens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-musikantow","type":"person","url":"https://hartvaat.nl/mensen/daniel-musikantow/","name":"Daniel Musikantow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/katheterablatie-of-antiaritmica-als-eerstelijnstherapie-bij-af-jama-cardiology-m/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/11/17/transcatheter-bariatrische-embolotherapie-voor-gewichtsreductie-bij-obesitas/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-p-judge","type":"person","url":"https://hartvaat.nl/mensen/daniel-p-judge/","name":"Daniel P Judge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-pella","type":"person","url":"https://hartvaat.nl/mensen/daniel-pella/","name":"Daniel Pella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/07/prevalentie-van-statine-intolerantie-meta-analyse-nuanceert-het-probleem/","published":"2022-09-07"},{"url":"https://hartvaat.nl/2017/09/21/anti-inflammatoire-therapie-met-canakinumab-bij-atherosclerose-nejm-cantos/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-soffer","type":"person","url":"https://hartvaat.nl/mensen/daniel-soffer/","name":"Daniel Soffer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-strbian","type":"person","url":"https://hartvaat.nl/mensen/daniel-strbian/","name":"Daniel Strbian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-viveros","type":"person","url":"https://hartvaat.nl/mensen/daniel-viveros/","name":"Daniel Viveros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniela-pedicino","type":"person","url":"https://hartvaat.nl/mensen/daniela-pedicino/","name":"Daniela Pedicino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/weer-een-stap-vooruit-in-de-verlaging-van-ernstige-hypertriglyceridemie/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2024/08/16/impella-cp-bij-door-mi-gecompliceerde-cardiogene-shock-journal-scan/","published":"2024-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniela-pini","type":"person","url":"https://hartvaat.nl/mensen/daniela-pini/","name":"Daniela Pini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2022/10/01/mitraclip-bij-secundaire-mitralisklepinsufficientie-meta-analyse-ischemisch-vs-n/","published":"2022-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniela-porta","type":"person","url":"https://hartvaat.nl/mensen/daniela-porta/","name":"Daniela Porta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniele-forlani","type":"person","url":"https://hartvaat.nl/mensen/daniele-forlani/","name":"Daniele Forlani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/01/sglt2-remmers-geassocieerd-met-lagere-sterfte-bij-attr-cardiomyopathie-meta-anal/","published":"2026-08-21"},{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"danielle-menosi-gualandro","type":"person","url":"https://hartvaat.nl/mensen/danielle-menosi-gualandro/","name":"Danielle Menosi Gualandro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"danila-azzolina","type":"person","url":"https://hartvaat.nl/mensen/danila-azzolina/","name":"Danila Azzolina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/09/coronaire-plaquefenotypeveranderingen-bij-lipidenverlagende-therapie-en-cardiova/","published":"2025-07-09"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daniel-v-mller","type":"person","url":"https://hartvaat.nl/mensen/daniel-v-mller/","name":"Daniél V Møller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"danqi-wang","type":"person","url":"https://hartvaat.nl/mensen/danqi-wang/","name":"Danqi Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dany-anglicheau","type":"person","url":"https://hartvaat.nl/mensen/dany-anglicheau/","name":"Dany Anglicheau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/onverklaarde-transplantaatdisfunctie-bij-een-zeldzame-metabole-stoornis/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/13/bcma-gerichte-t-cel-engagertherapie-bij-refractaire-hla-sensitisatie/","published":"2026-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"daoyan-liu","type":"person","url":"https://hartvaat.nl/mensen/daoyan-liu/","name":"Daoyan Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/01/voorkeur-voor-pikant-eten-versterkt-zoutwaarneming-en-vermindert-zoutinname-en-b/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/03/01/taurinesuppletie-verlaagt-bloeddruk-en-verbetert-vaatfunctie-bij-prehypertensie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darae-kim","type":"person","url":"https://hartvaat.nl/mensen/darae-kim/","name":"Darae Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/harttransplantatie-bij-hoogste-urgentie-meer-vroege-infecties-en-sterfte-mede-do/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/05/18/helios-b-post-hoc-vutrisiran-effectief-bij-oost-aziatische-attr-cm-patienten-hr-/","published":"2026-06-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dario-bruzzese","type":"person","url":"https://hartvaat.nl/mensen/dario-bruzzese/","name":"Dario Bruzzese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/semaglutide-verlaagt-mortaliteit-cv-events-en-nierschade-in-alle-stadia-van-ckm-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/09/14/glp-1-agonisten-bij-diabetes-type-2-met-en-zonder-cvd-meta-analyse/","published":"2020-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dario-turturiello","type":"person","url":"https://hartvaat.nl/mensen/dario-turturiello/","name":"Dario Turturiello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dariush-mozaffarian","type":"person","url":"https://hartvaat.nl/mensen/dariush-mozaffarian/","name":"Dariush Mozaffarian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darragh-j-twomey","type":"person","url":"https://hartvaat.nl/mensen/darragh-j-twomey/","name":"Darragh J Twomey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darren-a-dewalt","type":"person","url":"https://hartvaat.nl/mensen/darren-a-dewalt/","name":"Darren A DeWalt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2016/03/22/zelfmanagementinterventies-bij-hartfalen-individuele-patientdata-meta-analyse/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darren-walters","type":"person","url":"https://hartvaat.nl/mensen/darren-walters/","name":"Darren Walters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darrin-harris","type":"person","url":"https://hartvaat.nl/mensen/darrin-harris/","name":"Darrin Harris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"darryl-leong","type":"person","url":"https://hartvaat.nl/mensen/darryl-leong/","name":"Darryl Leong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/05/13/wereldwijde-hf-registry-fev1-is-een-onafhankelijke-prognostische-factor-pleidooi/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-a-asch","type":"person","url":"https://hartvaat.nl/mensen/david-a-asch/","name":"David A Asch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-a-bushinsky","type":"person","url":"https://hartvaat.nl/mensen/david-a-bushinsky/","name":"David A Bushinsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/06/01/geindividualiseerd-patiromer-doseringsregime-bij-hf-met-ckd-en-hyperkaliemie/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-adlam","type":"person","url":"https://hartvaat.nl/mensen/david-adlam/","name":"David Adlam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2018/05/08/spontane-coronaire-arterie-dissectie-aha-scientific-statement/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-b-badesch","type":"person","url":"https://hartvaat.nl/mensen/david-b-badesch/","name":"David B Badesch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-baanstra","type":"person","url":"https://hartvaat.nl/mensen/david-baanstra/","name":"David Baanstra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-burgner","type":"person","url":"https://hartvaat.nl/mensen/david-burgner/","name":"David Burgner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-c-goff","type":"person","url":"https://hartvaat.nl/mensen/david-c-goff/","name":"David C Goff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/01/01/intensieve-versus-standaard-bloeddrukcontrole-op-ambulante-bloeddruk-sprint-resu/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-calvo","type":"person","url":"https://hartvaat.nl/mensen/david-calvo/","name":"David Calvo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2022/04/19/substraatablatie-versus-antiaritmica-bij-symptomatische-vt/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-corcoran","type":"person","url":"https://hartvaat.nl/mensen/david-corcoran/","name":"David Corcoran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-d-rsted","type":"person","url":"https://hartvaat.nl/mensen/david-d-rsted/","name":"David D Ørsted","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/01/eerste-en-recidiverende-cv-events-met-liraglutide-bij-diabetes-type-2-leader/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-demicco","type":"person","url":"https://hartvaat.nl/mensen/david-demicco/","name":"David DeMicco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/05/atorvastatine-vermindert-eerste-en-volgende-vasculaire-events-sparcl/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2017/01/17/geoxideerde-fosfolipiden-op-apob-100-en-recidiverende-ischemische-events-na-cva/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-dean","type":"person","url":"https://hartvaat.nl/mensen/david-dean/","name":"David Dean","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-duncker","type":"person","url":"https://hartvaat.nl/mensen/david-duncker/","name":"David Duncker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2025/06/01/rv-disfunctie-voorspelt-langetermijnherstel-bij-de-novo-hfref-prolong-ii/","published":"2025-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-e-haines","type":"person","url":"https://hartvaat.nl/mensen/david-e-haines/","name":"David E Haines","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-h-v-vogel","type":"person","url":"https://hartvaat.nl/mensen/david-h-v-vogel/","name":"David H V Vogel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-horak","type":"person","url":"https://hartvaat.nl/mensen/david-horak/","name":"David Horak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/30/ffr-geleide-multivaten-pci-bij-myocardinfarct-nejm-compare-acute/","published":"2017-03-30"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-a-jenkins","type":"person","url":"https://hartvaat.nl/mensen/david-j-a-jenkins/","name":"David J A Jenkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/peulvruchten-in-de-voeding-verlagen-ldl-en-non-hdl-dose-response-meta-analyse-va/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2017/03/07/dieetaanbevelingen-en-gewichtsverlies-en-cardiovasculaire-risicofactoren/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-carey","type":"person","url":"https://hartvaat.nl/mensen/david-j-carey/","name":"David J Carey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-kurz","type":"person","url":"https://hartvaat.nl/mensen/david-j-kurz/","name":"David J Kurz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-magid","type":"person","url":"https://hartvaat.nl/mensen/david-j-magid/","name":"David J Magid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/17/million-hearts-betaald-cv-risicomanagement-vermindert-mi-en-cva-jama-rct/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/09/01/million-hearts-cv-risicoreductiemodel-en-medicatie-initiatie-jama-cardiology/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-t-campbell","type":"person","url":"https://hartvaat.nl/mensen/david-j-t-campbell/","name":"David J T Campbell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-j-werring","type":"person","url":"https://hartvaat.nl/mensen/david-j-werring/","name":"David J Werring","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-l-brown","type":"person","url":"https://hartvaat.nl/mensen/david-l-brown/","name":"David L Brown","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/01/random-uitstel-van-pci-bij-diabetes-met-stabiel-coronairlijden/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-ballonexpandeerbare-klep-bij-laagrisicopatienten-nejm-partner-3/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-l-hare","type":"person","url":"https://hartvaat.nl/mensen/david-l-hare/","name":"David L Hare","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-herrington","type":"person","url":"https://hartvaat.nl/mensen/david-m-herrington/","name":"David M Herrington","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-kent","type":"person","url":"https://hartvaat.nl/mensen/david-m-kent/","name":"David M Kent","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-m-shavelle","type":"person","url":"https://hartvaat.nl/mensen/david-m-shavelle/","name":"David M Shavelle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/empagliflozine-en-pulmonalisdruk-bij-hf-embrace-hf/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2017/09/01/provisional-versus-twee-stentstrategie-bij-bifurcatielaesies-meta-analyse/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-mortsell","type":"person","url":"https://hartvaat.nl/mensen/david-mortsell/","name":"David Mörtsell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/19/katheterablatie-versus-antiaritmica-en-kwaliteit-van-leven-bij-af-jama-captaf/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/10/01/enkele-versus-dubbele-cryoballon-applicatie-bij-af-effectiviteit-en-veiligheid/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-o-arnar","type":"person","url":"https://hartvaat.nl/mensen/david-o-arnar/","name":"David O Arnar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-p-ripley","type":"person","url":"https://hartvaat.nl/mensen/david-p-ripley/","name":"David P Ripley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-rodman","type":"person","url":"https://hartvaat.nl/mensen/david-rodman/","name":"David Rodman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/05/lorundrostat-bij-ongecontroleerde-en-therapieresistente-hypertensie-fase-3-resul/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-schaack","type":"person","url":"https://hartvaat.nl/mensen/david-schaack/","name":"David Schaack","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2024/12/17/ablatiestrategie-bij-af-recidief-na-duurzame-pvi/","published":"2024-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-schade","type":"person","url":"https://hartvaat.nl/mensen/david-schade/","name":"David Schade","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-simpson","type":"person","url":"https://hartvaat.nl/mensen/david-simpson/","name":"David Simpson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-smyth","type":"person","url":"https://hartvaat.nl/mensen/david-smyth/","name":"David Smyth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-soto-iglesias","type":"person","url":"https://hartvaat.nl/mensen/david-soto-iglesias/","name":"David Soto-Iglesias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-tanne","type":"person","url":"https://hartvaat.nl/mensen/david-tanne/","name":"David Tanne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-thaler","type":"person","url":"https://hartvaat.nl/mensen/david-thaler/","name":"David Thaler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-tuller","type":"person","url":"https://hartvaat.nl/mensen/david-tuller/","name":"David Tüller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-w-dunstan","type":"person","url":"https://hartvaat.nl/mensen/david-w-dunstan/","name":"David W Dunstan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/26/minder-zitten-of-meer-staan-effect-op-bloeddruk-en-glucose/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2019/04/01/ochtendbeweging-met-of-zonder-zitonderbrekingen-en-bloeddruk-bij-ouderen/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-wohns","type":"person","url":"https://hartvaat.nl/mensen/david-wohns/","name":"David Wohns","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"david-zemanek","type":"person","url":"https://hartvaat.nl/mensen/david-zemanek/","name":"David Zemanek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davide-ausili","type":"person","url":"https://hartvaat.nl/mensen/davide-ausili/","name":"Davide Ausili","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/motivational-interviewing-en-zorggebruik-en-mortaliteit-bij-hf-motivate-hf/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/06/01/motivational-interviewing-bij-hartfalen-voor-zelfzorg-motivate-hf-gerandomiseerd/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davide-bolignano","type":"person","url":"https://hartvaat.nl/mensen/davide-bolignano/","name":"Davide Bolignano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/28/kdigo-2026-richtlijn-anemie-bij-chronische-nierziekte-europees-commentaar/","published":"2026-01-28"},{"url":"https://hartvaat.nl/2018/08/01/sympathische-zenuwactivatie-bij-essentiele-hypertensie-meta-analyse/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davide-margonato","type":"person","url":"https://hartvaat.nl/mensen/davide-margonato/","name":"Davide Margonato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"davide-soranna","type":"person","url":"https://hartvaat.nl/mensen/davide-soranna/","name":"Davide Soranna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/inspanningshemodynamiek-bij-hfpef-systematische-review-en-meta-analyse/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dayana-flores","type":"person","url":"https://hartvaat.nl/mensen/dayana-flores/","name":"Dayana Flores","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dean-palmer","type":"person","url":"https://hartvaat.nl/mensen/dean-palmer/","name":"Dean Palmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/19/synchronisatie-van-voetstap-en-hartfase-bij-crt-patienten/","published":"2023-12-19"},{"url":"https://hartvaat.nl/2021/09/21/1-jaar-inspanningstraining-keert-lv-stijfheid-om-bij-stadium-b-hf/","published":"2021-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dean-r-p-p-chan-pin-yin","type":"person","url":"https://hartvaat.nl/mensen/dean-r-p-p-chan-pin-yin/","name":"Dean R P P Chan Pin Yin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2016/09/13/ganglionplexusablatie-bij-gevorderd-atriumfibrilleren-de-afact-studie/","published":"2016-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dean-s-picone","type":"person","url":"https://hartvaat.nl/mensen/dean-s-picone/","name":"Dean S Picone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-a-lawlor","type":"person","url":"https://hartvaat.nl/mensen/deborah-a-lawlor/","name":"Deborah A Lawlor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-cosmi","type":"person","url":"https://hartvaat.nl/mensen/deborah-cosmi/","name":"Deborah Cosmi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-d-stocken","type":"person","url":"https://hartvaat.nl/mensen/deborah-d-stocken/","name":"Deborah D Stocken","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/21/levothyroxine-bij-subklinische-hypothyreoidie-na-acuut-mi-jama/","published":"2020-07-21"},{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-davey","type":"person","url":"https://hartvaat.nl/mensen/deborah-davey/","name":"Deborah Davey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/13/traverse-testosteronsubstitutie-cardiovasculair-veilig-bij-hypogonadisme/","published":"2023-07-13"},{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-j-wexler","type":"person","url":"https://hartvaat.nl/mensen/deborah-j-wexler/","name":"Deborah J Wexler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/04/drive-remote-management-verbetert-richtlijnmedicatie-bij-hartfalen/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-l-williams","type":"person","url":"https://hartvaat.nl/mensen/deborah-l-williams/","name":"Deborah L Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-m-siegal","type":"person","url":"https://hartvaat.nl/mensen/deborah-m-siegal/","name":"Deborah M Siegal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-robins","type":"person","url":"https://hartvaat.nl/mensen/deborah-robins/","name":"Deborah Robins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/07/orforglipron-dagelijkse-orale-glp-1-agonist-bij-obesitas-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2018/11/17/ly3298176-duale-gip-glp-1-agonist-bij-diabetes-type-2-lancet-tirzepatide-fase-2/","published":"2018-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-wright","type":"person","url":"https://hartvaat.nl/mensen/deborah-wright/","name":"Deborah Wright","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"debra-carter","type":"person","url":"https://hartvaat.nl/mensen/debra-carter/","name":"Debra Carter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/laroprovstat-eerste-orale-pcsk9-remmer-haalt-80-ldl-reductie-in-combinatie-met-r/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/06/03/pursuit-orale-pcsk9-remmer-voor-hypercholesterolemie-gerandomiseerde-trial/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"debra-miller","type":"person","url":"https://hartvaat.nl/mensen/debra-miller/","name":"Debra Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2019/03/05/timing-van-prasugrel-start-en-coronairangiografie-bij-nstemi/","published":"2019-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deep-chandh-raja","type":"person","url":"https://hartvaat.nl/mensen/deep-chandh-raja/","name":"Deep Chandh Raja","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2022/12/01/langetermijnmortaliteit-bij-hfmref-systematische-review-en-meta-analyse/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dehghani","type":"person","url":"https://hartvaat.nl/mensen/dehghani/","name":"Dehghani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-myocardinfarct-winratio-analyse-uit-de-cle/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deidra-c-crews","type":"person","url":"https://hartvaat.nl/mensen/deidra-c-crews/","name":"Deidra C Crews","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/gofresh-dash-boodschappen-en-bloeddrukeffect-rct/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/07/16/rich-life-gelijkwaardige-hypertensiezorg-voor-achtergestelde-populaties/","published":"2024-07-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dejana-popovic","type":"person","url":"https://hartvaat.nl/mensen/dejana-popovic/","name":"Dejana Popovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/dapagliflozine-en-rv-pulmonale-interactie-bij-hfpef/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/09/05/cameo-dapa-cardiale-en-metabole-effecten-van-dapagliflozine-bij-hfpef/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dellborg","type":"person","url":"https://hartvaat.nl/mensen/dellborg/","name":"Dellborg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2026/03/31/volwassenen-met-een-ventrikelseptumdefect-hebben-drie-keer-hogere-sterfte-zweeds/","published":"2026-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"delphine-brugier","type":"person","url":"https://hartvaat.nl/mensen/delphine-brugier/","name":"Delphine Brugier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"demetre-labadarios","type":"person","url":"https://hartvaat.nl/mensen/demetre-labadarios/","name":"Demetre Labadarios","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"denis-j-wakeham","type":"person","url":"https://hartvaat.nl/mensen/denis-j-wakeham/","name":"Denis J Wakeham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/19/synchronisatie-van-voetstap-en-hartfase-bij-crt-patienten/","published":"2023-12-19"},{"url":"https://hartvaat.nl/2023/01/31/hfpef-inspanningsbeperking-niet-alleen-door-hemodynamiek/","published":"2023-01-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"denis-losik","type":"person","url":"https://hartvaat.nl/mensen/denis-losik/","name":"Denis Losik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/21/renale-denervatie-plus-katheterablatie-versus-ablatie-alleen-bij-af-met-hyperten/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"denise-e-jones","type":"person","url":"https://hartvaat.nl/mensen/denise-e-jones/","name":"Denise E Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"denise-m-paisani","type":"person","url":"https://hartvaat.nl/mensen/denise-m-paisani/","name":"Denise M Paisani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"denise-yates","type":"person","url":"https://hartvaat.nl/mensen/denise-yates/","name":"Denise Yates","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/21/sacubitril-valsartan-versus-olmesartan-en-cardiovasculaire-remodellering-bij-hyp/","published":"2017-11-21"},{"url":"https://hartvaat.nl/2016/10/18/canakinumab-en-arteriele-effecten-bij-atherosclerose-met-diabetes-of-glucosetole/","published":"2016-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dennis-sandeman","type":"person","url":"https://hartvaat.nl/mensen/dennis-sandeman/","name":"Dennis Sandeman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dennis-zavalloni","type":"person","url":"https://hartvaat.nl/mensen/dennis-zavalloni/","name":"Dennis Zavalloni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dennis-van-veghel","type":"person","url":"https://hartvaat.nl/mensen/dennis-van-veghel/","name":"Dennis van Veghel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/gepersonaliseerde-leefstijlinterventie-verbetert-af-ablatie-uitkomsten/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2024/08/03/anticoagulatie-bij-postoperatief-af-na-geisoleerde-cabg-meta-analyse/","published":"2024-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derek-d-cyr","type":"person","url":"https://hartvaat.nl/mensen/derek-d-cyr/","name":"Derek D Cyr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2016/01/21/neoplasiedetectie-bij-langdurige-dapt-met-prasugrel-versus-clopidogrel-triton-ti/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derek-so","type":"person","url":"https://hartvaat.nl/mensen/derek-so/","name":"Derek So","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"derek-yung","type":"person","url":"https://hartvaat.nl/mensen/derek-yung/","name":"Derek Yung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"desiree-wussler","type":"person","url":"https://hartvaat.nl/mensen/desiree-wussler/","name":"Desiree Wussler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"devi-g-nair","type":"person","url":"https://hartvaat.nl/mensen/devi-g-nair/","name":"Devi G Nair","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/gecombineerde-pulsed-field-ablatie-en-linker-atriumoorsluiting-haalbaarheid-en-u/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dhaval-kolte","type":"person","url":"https://hartvaat.nl/mensen/dhaval-kolte/","name":"Dhaval Kolte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2019/11/26/2019-aha-acc-prestatie-en-kwaliteitsmaten-voor-hoge-bloeddruk/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diana-menya","type":"person","url":"https://hartvaat.nl/mensen/diana-menya/","name":"Diana Menya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dianjianyi-sun","type":"person","url":"https://hartvaat.nl/mensen/dianjianyi-sun/","name":"Dianjianyi Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/12/01/genetische-gevoeligheid-eiwitinname-en-bloeddrukverandering-pounds-lost/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dianne-gallup","type":"person","url":"https://hartvaat.nl/mensen/dianne-gallup/","name":"Dianne Gallup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/19/screening-op-niet-gediagnosticeerd-af-voor-cva-preventie-gerandomiseerde-trial/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"didier-blanchard","type":"person","url":"https://hartvaat.nl/mensen/didier-blanchard/","name":"Didier Blanchard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"didier-collard","type":"person","url":"https://hartvaat.nl/mensen/didier-collard/","name":"Didier Collard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/oraal-butyraat-verlaagt-bloeddruk-bij-hypertensie-rct/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2018/12/01/creatininestijging-tijdens-bloeddrukbehandeling-en-uitkomsten-bij-diabetes-type-/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"didier-locca","type":"person","url":"https://hartvaat.nl/mensen/didier-locca/","name":"Didier Locca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diego-albrecht","type":"person","url":"https://hartvaat.nl/mensen/diego-albrecht/","name":"Diego Albrecht","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/sacubitril-valsartan-en-inspanningsgemedieerd-lipidenmetabolisme-bij-obesitas-me/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/11/21/sacubitril-valsartan-versus-olmesartan-en-cardiovasculaire-remodellering-bij-hyp/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diego-della-riva","type":"person","url":"https://hartvaat.nl/mensen/diego-della-riva/","name":"Diego Della Riva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diego-medvedofsky","type":"person","url":"https://hartvaat.nl/mensen/diego-medvedofsky/","name":"Diego Medvedofsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dieter-fischer","type":"person","url":"https://hartvaat.nl/mensen/dieter-fischer/","name":"Dieter Fischer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dieter-nuyens","type":"person","url":"https://hartvaat.nl/mensen/dieter-nuyens/","name":"Dieter Nuyens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2025/02/05/smartphone-ppg-voor-af-detectie-en-management-verbeterde-screening/","published":"2025-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dilan-aydin","type":"person","url":"https://hartvaat.nl/mensen/dilan-aydin/","name":"Dilan Aydin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/14/telemonitoring-bij-hartfalen-meta-analyse-van-alle-strategieen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"diller","type":"person","url":"https://hartvaat.nl/mensen/diller/","name":"Diller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/22/een-op-de-tien-volwassenen-met-een-aangeboren-hartafwijking-heeft-een-syndroom-e/","published":"2026-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimas-ikeoka","type":"person","url":"https://hartvaat.nl/mensen/dimas-ikeoka/","name":"Dimas Ikeoka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-charitos","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-charitos/","name":"Dimitrios Charitos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/06/circulerend-mir-10b-5p-voorspelt-af-recidief-na-ablatie/","published":"2026-05-06"},{"url":"https://hartvaat.nl/2026/03/30/linear-trial-lattice-tip-katheter-verslaat-standaard-irrigatie-bij-cti-ablatie-v/","published":"2026-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-s-goumenos","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-s-goumenos/","name":"Dimitrios S Goumenos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-tousoulis","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-tousoulis/","name":"Dimitrios Tousoulis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-6-maandsresultat/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitrios-tsiachris","type":"person","url":"https://hartvaat.nl/mensen/dimitrios-tsiachris/","name":"Dimitrios Tsiachris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/03/af-ablatie-timing-naar-af-duur-impact-op-aritmierecidief/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitris-mavridis","type":"person","url":"https://hartvaat.nl/mensen/dimitris-mavridis/","name":"Dimitris Mavridis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/04/07/statines-en-niet-statine-ldl-verlagers-en-cardiovasculaire-uitkomsten-meta-analy/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/07/19/glucoseverlagende-medicatie-en-cardiovasculaire-events-bij-diabetes-type-2-jama-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimitris-tousoulis","type":"person","url":"https://hartvaat.nl/mensen/dimitris-tousoulis/","name":"Dimitris Tousoulis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/05/06/circulerend-mir-10b-5p-voorspelt-af-recidief-na-ablatie/","published":"2026-05-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dimple-kondal","type":"person","url":"https://hartvaat.nl/mensen/dimple-kondal/","name":"Dimple Kondal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/07/yoga-gebaseerde-hartrevalidatie-na-acuut-mi-gerandomiseerde-trial/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2018/02/13/kwaliteitsverbeteringsinterventie-bij-acuut-mi-in-india-jama-acs-quik/","published":"2018-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dirk-j-lok","type":"person","url":"https://hartvaat.nl/mensen/dirk-j-lok/","name":"Dirk J Lok","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dirk-muller-wieland","type":"person","url":"https://hartvaat.nl/mensen/dirk-muller-wieland/","name":"Dirk Müller-Wieland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/12/lipidenmanagement-bij-type-2-diabetes-richt-je-op-alle-atherogene-lipoproteinen-/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2016/10/14/geen-effect-van-pcsk9-remmer-alirocumab-op-diabetes-incidentie-odyssey-analyse/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"djawid-hashemi","type":"person","url":"https://hartvaat.nl/mensen/djawid-hashemi/","name":"Djawid Hashemi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/baseline-parameters-en-1-jaars-qol-bij-hf-na-crt-d-esc-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/06/01/economische-impact-van-hfpef-aldo-dhf-inzichten/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"djordje-g-jakovljevic","type":"person","url":"https://hartvaat.nl/mensen/djordje-g-jakovljevic/","name":"Djordje G Jakovljevic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/10/01/revalidatie-bij-chronisch-hf-systematische-review-van-inspanningsinterventies/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dmitriy-n-feldman","type":"person","url":"https://hartvaat.nl/mensen/dmitriy-n-feldman/","name":"Dmitriy N Feldman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dmitry-elesin","type":"person","url":"https://hartvaat.nl/mensen/dmitry-elesin/","name":"Dmitry Elesin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dobromir-dobrev","type":"person","url":"https://hartvaat.nl/mensen/dobromir-dobrev/","name":"Dobromir Dobrev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"domenica-rubino","type":"person","url":"https://hartvaat.nl/mensen/domenica-rubino/","name":"Domenica Rubino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/cagrisema-verlaagt-bloeddruk-bij-overgewicht-obesitas-redefine-1/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/14/cagrisema-gecombineerd-cagrilintide-en-semaglutide-bij-overgewicht-nejm/","published":"2025-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"domenico-g-della-rocca","type":"person","url":"https://hartvaat.nl/mensen/domenico-g-della-rocca/","name":"Domenico G Della Rocca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2025/10/07/laa-occlusie-bij-terminale-nierziekte-ipd-meta-analyse/","published":"2025-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"domenico-giovanni-della-rocca","type":"person","url":"https://hartvaat.nl/mensen/domenico-giovanni-della-rocca/","name":"Domenico Giovanni Della Rocca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dominic-luc-webb","type":"person","url":"https://hartvaat.nl/mensen/dominic-luc-webb/","name":"Dominic-Luc Webb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/06/09/acyl-ghreline-verbetert-hartfunctie-bij-hartfalen/","published":"2023-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dominik-berliner","type":"person","url":"https://hartvaat.nl/mensen/dominik-berliner/","name":"Dominik Berliner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/verhoogd-activine-a-bij-peripartum-cardiomyopathie-en-tijdens-lv-herstel/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dominik-wiedemann","type":"person","url":"https://hartvaat.nl/mensen/dominik-wiedemann/","name":"Dominik Wiedemann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2021/04/01/cardio-microstroomdevice-bij-chronisch-hf-eerste-klinische-studie/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dominika-szalewska","type":"person","url":"https://hartvaat.nl/mensen/dominika-szalewska/","name":"Dominika Szalewska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donato-antonio-paglianiti","type":"person","url":"https://hartvaat.nl/mensen/donato-antonio-paglianiti/","name":"Donato Antonio Paglianiti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/vroeg-starten-met-mra-na-acuut-hartfalen-of-myocardinfarct-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/08/01/coronaire-microvasculaire-disfunctie-bij-hfpef-meta-analyse/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-joon-kim","type":"person","url":"https://hartvaat.nl/mensen/dong-joon-kim/","name":"Dong Joon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/vertraagde-intracraniele-bloeding-na-trombectomie-geassocieerd-met-slechtere-fun/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-oh-kang","type":"person","url":"https://hartvaat.nl/mensen/dong-oh-kang/","name":"Dong Oh Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/21/bij-coronaire-vasospasmen-zonder-significante-stenose-voorspelt-verhoogd-lp-a-ge/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-woon-jeon","type":"person","url":"https://hartvaat.nl/mensen/dong-woon-jeon/","name":"Dong Woon Jeon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-zhao","type":"person","url":"https://hartvaat.nl/mensen/dong-zhao/","name":"Dong Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/hart-en-vaatziekten-in-china-epidemiologische-evolutie-19902021/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-kie-kim","type":"person","url":"https://hartvaat.nl/mensen/dong-kie-kim/","name":"Dong-Kie Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dong-yun-kim","type":"person","url":"https://hartvaat.nl/mensen/dong-yun-kim/","name":"Dong-Yun Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dongfeng-li","type":"person","url":"https://hartvaat.nl/mensen/dongfeng-li/","name":"Dongfeng Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2023/12/01/step-trial-diastolische-bloeddruk-beinvloedt-effect-van-intensieve-behandeling/","published":"2023-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dongying-zhang","type":"person","url":"https://hartvaat.nl/mensen/dongying-zhang/","name":"Dongying Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/urinezuur-als-biomarker-maar-niet-therapeutisch-doel-bij-hartfalen-meta-analyse/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2019/10/01/sekseverschillen-bij-katheterablatie-van-af-meta-analyse/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"donna-m-mancini","type":"person","url":"https://hartvaat.nl/mensen/donna-m-mancini/","name":"Donna M Mancini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"doo-soo-jeon","type":"person","url":"https://hartvaat.nl/mensen/doo-soo-jeon/","name":"Doo-Soo Jeon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"doosup-shin","type":"person","url":"https://hartvaat.nl/mensen/doosup-shin/","name":"Doosup Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"doug-brugge","type":"person","url":"https://hartvaat.nl/mensen/doug-brugge/","name":"Doug Brugge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/26/hepa-luchtzuivering-en-bloeddruk-pragmatische-cross-over-trial/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2021/03/03/verminderde-verkeersgerelateerde-luchtvervuiling-en-bloeddruk-gerandomiseerde-cr/","published":"2021-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-m-gewehr","type":"person","url":"https://hartvaat.nl/mensen/douglas-m-gewehr/","name":"Douglas M Gewehr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/10/31/antitrombotische-therapie-na-laa-occlusie-netwerk-meta-analyse/","published":"2023-10-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"douglas-s-jacoby","type":"person","url":"https://hartvaat.nl/mensen/douglas-s-jacoby/","name":"Douglas S Jacoby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dragan-topic","type":"person","url":"https://hartvaat.nl/mensen/dragan-topic/","name":"Dragan Topic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"drahomir-aujesky","type":"person","url":"https://hartvaat.nl/mensen/drahomir-aujesky/","name":"Drahomir Aujesky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/11/geindividualiseerde-voedingsondersteuning-bij-gehospitaliseerd-chronisch-hf/","published":"2021-05-11"},{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dregoesc","type":"person","url":"https://hartvaat.nl/mensen/dregoesc/","name":"Dregoesc","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/29/geisoleerde-secundaire-tricuspidalisinsufficientie-na-linkszijdige-klepchirurgie/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/01/16/nt-probnp-voorspelt-sterfte-na-een-stemi-onafhankelijk-van-de-ejectiefractie/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dries-s-martens","type":"person","url":"https://hartvaat.nl/mensen/dries-s-martens/","name":"Dries S Martens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"duk-hyun-kang","type":"person","url":"https://hartvaat.nl/mensen/duk-hyun-kang/","name":"Duk-Hyun Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/11/effort-ertugliflozine-bij-functionele-mitralisinsufficientie-en-hartfalen/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2019/03/12/arni-bij-functionele-mitralisklepinsufficientie/","published":"2019-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"duminda-n-wijeysundera","type":"person","url":"https://hartvaat.nl/mensen/duminda-n-wijeysundera/","name":"Duminda N Wijeysundera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/08/15/overleving-na-geisoleerde-postoperatieve-troponine-elevatie/","published":"2017-08-15"},{"url":"https://hartvaat.nl/2016/09/06/duur-van-dapt-systematische-review-voor-de-acc-aha-gerichte-update-2016/","published":"2016-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dwayne-conway","type":"person","url":"https://hartvaat.nl/mensen/dwayne-conway/","name":"Dwayne Conway","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dylan-s-small","type":"person","url":"https://hartvaat.nl/mensen/dylan-s-small/","name":"Dylan S Small","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"e-kevin-heist","type":"person","url":"https://hartvaat.nl/mensen/e-kevin-heist/","name":"E Kevin Heist","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edda-bahlmann","type":"person","url":"https://hartvaat.nl/mensen/edda-bahlmann/","name":"Edda Bahlmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/lage-arteriele-compliance-en-cv-morbiditeit-bij-aortaklepstenose/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2017/09/01/slagvolume-en-cardiovasculair-risico-bij-progressie-van-aortaklepstenose/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edgar-j-daeter","type":"person","url":"https://hartvaat.nl/mensen/edgar-j-daeter/","name":"Edgar J Daeter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/03/anticoagulatie-bij-postoperatief-af-na-geisoleerde-cabg-meta-analyse/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edgar-zitron","type":"person","url":"https://hartvaat.nl/mensen/edgar-zitron/","name":"Edgar Zitron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/02/remote-monitoring-en-klinische-uitkomsten-bij-europese-hf-met-icd-langetermijn/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2019/09/01/remote-monitoring-en-patientgerapporteerde-uitkomsten-bij-europese-hf-patienten-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edgardo-sandoya","type":"person","url":"https://hartvaat.nl/mensen/edgardo-sandoya/","name":"Edgardo Sandoya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edmond-m-cronin","type":"person","url":"https://hartvaat.nl/mensen/edmond-m-cronin/","name":"Edmond M Cronin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edoardo-camenzind","type":"person","url":"https://hartvaat.nl/mensen/edoardo-camenzind/","name":"Edoardo Camenzind","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2016/04/26/predictieregel-voor-voordeel-en-schade-van-dapt-na-1-jaar-pci-jama-validatiestud/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edouard-l-fu","type":"person","url":"https://hartvaat.nl/mensen/edouard-l-fu/","name":"Edouard L Fu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/30/kfre-aangepast-voor-multimorbiditeit-verbetert-schatting-nierfalenrisico/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eduard-guasch","type":"person","url":"https://hartvaat.nl/mensen/eduard-guasch/","name":"Eduard Guasch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/autonoom-remodelling-vormt-onafhankelijk-domein-binnen-atriale-cardiomyopathie/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eduardo-alegria-barrero","type":"person","url":"https://hartvaat.nl/mensen/eduardo-alegria-barrero/","name":"Eduardo Alegria-Barrero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eduardo-b-saad","type":"person","url":"https://hartvaat.nl/mensen/eduardo-b-saad/","name":"Eduardo B Saad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eduardo-pinar","type":"person","url":"https://hartvaat.nl/mensen/eduardo-pinar/","name":"Eduardo Pinar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edward-d-nicol","type":"person","url":"https://hartvaat.nl/mensen/edward-d-nicol/","name":"Edward D Nicol","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"edward-g-soltesz","type":"person","url":"https://hartvaat.nl/mensen/edward-g-soltesz/","name":"Edward G Soltesz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eero-jokinen","type":"person","url":"https://hartvaat.nl/mensen/eero-jokinen/","name":"Eero Jokinen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2017/09/05/ivabradine-bij-kinderen-met-dilaterende-cardiomyopathie-en-symptomatisch-hartfal/","published":"2017-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"efstratios-k-theofilogiannakos","type":"person","url":"https://hartvaat.nl/mensen/efstratios-k-theofilogiannakos/","name":"Efstratios K Theofilogiannakos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"efstratios-karagiannidis","type":"person","url":"https://hartvaat.nl/mensen/efstratios-karagiannidis/","name":"Efstratios Karagiannidis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"efstratios-koutroumpakis","type":"person","url":"https://hartvaat.nl/mensen/efstratios-koutroumpakis/","name":"Efstratios Koutroumpakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/vroege-harttoxiciteit-na-doxorubicine-bij-jongvolwassenen-met-sarcoom/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/05/27/multimodaal-ai-model-verhoogt-accuratesse-van-echo-diagnose-cardiale-amyloidose/","published":"2026-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"egidio-imbalzano","type":"person","url":"https://hartvaat.nl/mensen/egidio-imbalzano/","name":"Egidio Imbalzano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ehab-bakbak","type":"person","url":"https://hartvaat.nl/mensen/ehab-bakbak/","name":"Ehab Bakbak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ehrin-armstrong","type":"person","url":"https://hartvaat.nl/mensen/ehrin-armstrong/","name":"Ehrin Armstrong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eike-tigges","type":"person","url":"https://hartvaat.nl/mensen/eike-tigges/","name":"Eike Tigges","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eileen-fonseca","type":"person","url":"https://hartvaat.nl/mensen/eileen-fonseca/","name":"Eileen Fonseca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/01/zelfgerapporteerde-versus-apotheekgeregistreerde-medicatietrouw-compass-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2020/01/01/p2y12-copay-reductie-en-therapietrouw-aan-andere-secundaire-preventiemiddelen/","published":"2020-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eileen-m-handberg","type":"person","url":"https://hartvaat.nl/mensen/eileen-m-handberg/","name":"Eileen M Handberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2016/11/01/langetermijnmortaliteit-bij-hypertensie-met-coronairlijden-invest-us-cohort/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eivind-berge","type":"person","url":"https://hartvaat.nl/mensen/eivind-berge/","name":"Eivind Berge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/arb-versus-calciumantagonist-bloeddrukprofiel-en-klinische-effecten-vergelijking/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/05/01/voortzetten-of-tijdelijk-stoppen-van-antihypertensiva-bij-acuut-cva-ipd-meta-ana/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ekaterini-lambrinou","type":"person","url":"https://hartvaat.nl/mensen/ekaterini-lambrinou/","name":"Ekaterini Lambrinou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/27/frailte-versnelt-hartfalenprogressie-en-vermindert-therapietolerantie/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2021/04/07/2020-esc-richtlijn-voor-nste-acs-management/","published":"2021-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elaine-ku","type":"person","url":"https://hartvaat.nl/mensen/elaine-ku/","name":"Elaine Ku","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/02/staken-van-ras-remmers-na-acute-egfr-daling-hangt-samen-met-meer-nierfalen-en-st/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2019/11/01/acute-egfr-daling-door-enalapril-en-mortaliteit-bij-hf-met-ckd/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elazer-r-edelman","type":"person","url":"https://hartvaat.nl/mensen/elazer-r-edelman/","name":"Elazer R Edelman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/renale-denervatie-bij-hypertensie-uitgebreide-meta-analyse-van-alle-trials/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elena-corrada","type":"person","url":"https://hartvaat.nl/mensen/elena-corrada/","name":"Elena Corrada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elena-meseguer","type":"person","url":"https://hartvaat.nl/mensen/elena-meseguer/","name":"Elena Meseguer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elias-koppen","type":"person","url":"https://hartvaat.nl/mensen/elias-koppen/","name":"Elias Koppen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/01/inspanningstraining-en-hoog-sensitief-troponine-i-bij-hfref/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elias-sanidas","type":"person","url":"https://hartvaat.nl/mensen/elias-sanidas/","name":"Elias Sanidas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/sympathische-overactiviteit-bij-resistente-hypertensie-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/07/14/hartfrequentieverlagende-middelen-en-uitkomsten-bij-hypertensie-cvd-meta-analyse/","published":"2025-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elijah-ogola","type":"person","url":"https://hartvaat.nl/mensen/elijah-ogola/","name":"Elijah Ogola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eline-h-groenland","type":"person","url":"https://hartvaat.nl/mensen/eline-h-groenland/","name":"Eline H Groenland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/smartphone-app-thuisbloeddrukmeting-versus-kantoor-en-ambulante-meting/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/01/01/plasmatrogconcentraties-van-antihypertensiva-voor-therapietrouwbeoordeling-meta-/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elisa-maietti","type":"person","url":"https://hartvaat.nl/mensen/elisa-maietti/","name":"Elisa Maietti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elisabeth-kleivhaug-vesterbekkmo","type":"person","url":"https://hartvaat.nl/mensen/elisabeth-kleivhaug-vesterbekkmo/","name":"Elisabeth Kleivhaug Vesterbekkmo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/19/fh-vrouwen-verliezen-mediaan-2-9-jaar-lipidenverlagende-behandeling-rond-elke-ki/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2022/06/01/vijf-jaar-inspanningstraining-verbetert-cardiovasculair-risicoprofiel-bij-oudere/","published":"2022-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elisabeth-stahle","type":"person","url":"https://hartvaat.nl/mensen/elisabeth-stahle/","name":"Elisabeth Ståhle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elisabeth-thiering","type":"person","url":"https://hartvaat.nl/mensen/elisabeth-thiering/","name":"Elisabeth Thiering","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elisabetta-tonet","type":"person","url":"https://hartvaat.nl/mensen/elisabetta-tonet/","name":"Elisabetta Tonet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-barrett-connor","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-barrett-connor/","name":"Elizabeth Barrett-Connor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-clark","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-clark/","name":"Elizabeth Clark","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elizabeth-m-webber","type":"person","url":"https://hartvaat.nl/mensen/elizabeth-m-webber/","name":"Elizabeth M Webber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-evidence-review-screening-op-hypertensieve-zwangerschapsstoornissen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-evidence-update-2021/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elke-hoendermis","type":"person","url":"https://hartvaat.nl/mensen/elke-hoendermis/","name":"Elke Hoendermis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ellen-a-nohr","type":"person","url":"https://hartvaat.nl/mensen/ellen-a-nohr/","name":"Ellen A Nohr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ellen-hettwer-magedanz","type":"person","url":"https://hartvaat.nl/mensen/ellen-hettwer-magedanz/","name":"Ellen Hettwer Magedanz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eloy-dominguez","type":"person","url":"https://hartvaat.nl/mensen/eloy-dominguez/","name":"Eloy Domínguez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"elzbieta-florczak","type":"person","url":"https://hartvaat.nl/mensen/elzbieta-florczak/","name":"Elzbieta Florczak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emileigh-walsh","type":"person","url":"https://hartvaat.nl/mensen/emileigh-walsh/","name":"Emileigh Walsh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/vesalius-cv-subgroep-jama-evolocumab-beschermt-ook-diabeten-zonder-vastgestelde-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/01/08/evolocumab-bij-patienten-zonder-eerder-mi-of-cva-fourier-subanalyse/","published":"2026-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emilio-di-lorenzo","type":"person","url":"https://hartvaat.nl/mensen/emilio-di-lorenzo/","name":"Emilio Di Lorenzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/26/werkzaamheid-en-veiligheid-van-stents-bij-stemi-jacc-analyse/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emma-sandgren","type":"person","url":"https://hartvaat.nl/mensen/emma-sandgren/","name":"Emma Sandgren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/smartphone-app-voor-symptoomregistratie-na-ablatie-bij-atriumfibrilleren-isolati/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/09/01/systematische-af-screening-met-gedetailleerde-fenotypering-en-risicopredictie/","published":"2025-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emma-waters","type":"person","url":"https://hartvaat.nl/mensen/emma-waters/","name":"Emma Waters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emmanouil-vavouris","type":"person","url":"https://hartvaat.nl/mensen/emmanouil-vavouris/","name":"Emmanouil Vavouris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/06/circulerend-mir-10b-5p-voorspelt-af-recidief-na-ablatie/","published":"2026-05-06"},{"url":"https://hartvaat.nl/2026/03/30/linear-trial-lattice-tip-katheter-verslaat-standaard-irrigatie-bij-cti-ablatie-v/","published":"2026-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emmanuel-oger","type":"person","url":"https://hartvaat.nl/mensen/emmanuel-oger/","name":"Emmanuel Oger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/m-teer-werkt-over-het-volledige-lvef-spectrum-vergroot-linkeratrium-volume-voors/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emmanuel-simantirakis","type":"person","url":"https://hartvaat.nl/mensen/emmanuel-simantirakis/","name":"Emmanuel Simantirakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emmanuelle-duceppe","type":"person","url":"https://hartvaat.nl/mensen/emmanuelle-duceppe/","name":"Emmanuelle Duceppe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emre-aldinc","type":"person","url":"https://hartvaat.nl/mensen/emre-aldinc/","name":"Emre Aldinc","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/27/vutrisiran-bij-attr-cm-impact-van-hartfalenernst-op-effectiviteit/","published":"2025-05-27"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hartfalenverslechtering-bij-attr-cardiomyopathie-attr-act-analyse/","published":"2025-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enayet-k-chowdhury","type":"person","url":"https://hartvaat.nl/mensen/enayet-k-chowdhury/","name":"Enayet K Chowdhury","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/21/lp-a-bepaling-sterk-onderbenut-bij-patienten-met-atherosclerotische-hart-en-vaat/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"endre-zima","type":"person","url":"https://hartvaat.nl/mensen/endre-zima/","name":"Endre Zima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"endrit-cekaj","type":"person","url":"https://hartvaat.nl/mensen/endrit-cekaj/","name":"Endrit Cekaj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eneida-rejane-rabelo-silva","type":"person","url":"https://hartvaat.nl/mensen/eneida-rejane-rabelo-silva/","name":"Eneida Rejane Rabelo-Silva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"engvall","type":"person","url":"https://hartvaat.nl/mensen/engvall/","name":"Engvall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/scapis-cohort-diastolische-dysfunctie-even-vaak-bij-prediabetes-als-diabetes-ple/","published":"2026-07-07"},{"url":"https://hartvaat.nl/2026/05/20/diffuse-myocardfibrose-bij-ernstige-aortastenose-is-ongelijk-verdeeld-vooral-aan/","published":"2026-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrica-mariano","type":"person","url":"https://hartvaat.nl/mensen/enrica-mariano/","name":"Enrica Mariano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2024/03/19/nierschade-na-minimale-contrasttoediening-bij-acs/","published":"2024-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrique-f-schisterman","type":"person","url":"https://hartvaat.nl/mensen/enrique-f-schisterman/","name":"Enrique F Schisterman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/01/preconceptiebloeddruk-en-verandering-naar-vroege-zwangerschap-risicofactor-voor-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddruk-voor-conceptie-en-reproductieve-uitkomsten/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"enrique-sanchez-munoz","type":"person","url":"https://hartvaat.nl/mensen/enrique-sanchez-munoz/","name":"Enrique Sánchez-Muñóz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eoin-donnellan","type":"person","url":"https://hartvaat.nl/mensen/eoin-donnellan/","name":"Eoin Donnellan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/decaaf-ii-af-last-en-symptoomreductie-na-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/08/02/decaaf-ii-fibroselocatie-beinvloedt-af-recidief-na-ablatie/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eoin-o-brien","type":"person","url":"https://hartvaat.nl/mensen/eoin-o-brien/","name":"Eoin O'Brien","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"},{"url":"https://hartvaat.nl/2016/04/01/prognostisch-effect-van-nachtelijke-bloeddrukdaling-bij-hypertensie-de-abc-h-stu/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eran-kalmanovich","type":"person","url":"https://hartvaat.nl/mensen/eran-kalmanovich/","name":"Eran Kalmanovich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eran-leitersdorf","type":"person","url":"https://hartvaat.nl/mensen/eran-leitersdorf/","name":"Eran Leitersdorf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erasmus-bachus","type":"person","url":"https://hartvaat.nl/mensen/erasmus-bachus/","name":"Erasmus Bachus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/18/deliver-dapagliflozine-effectief-ongeacht-frailteit-bij-hfpef/","published":"2022-10-18"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-a-dubois","type":"person","url":"https://hartvaat.nl/mensen/eric-a-dubois/","name":"Eric A Dubois","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-a-whitsel","type":"person","url":"https://hartvaat.nl/mensen/eric-a-whitsel/","name":"Eric A Whitsel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2018/06/01/gwas-van-pr-interval-bij-hispanic-latino-s-nieuw-locus-bij-id2/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-d-adler","type":"person","url":"https://hartvaat.nl/mensen/eric-d-adler/","name":"Eric D Adler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/07/mesenchymale-precursorcellen-bij-hfref-gerandomiseerde-trial/","published":"2023-03-07"},{"url":"https://hartvaat.nl/2016/05/01/intracoronaire-adenylylcyclase-6-gentherapie-bij-hartfalen-gerandomiseerde-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-e-smith","type":"person","url":"https://hartvaat.nl/mensen/eric-e-smith/","name":"Eric E Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2021/06/01/implanteerbare-versus-verlengde-externe-ecg-monitoring-voor-af-na-ischemisch-cva/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-j-maclaughlin","type":"person","url":"https://hartvaat.nl/mensen/eric-j-maclaughlin/","name":"Eric J MacLaughlin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-olinger","type":"person","url":"https://hartvaat.nl/mensen/eric-olinger/","name":"Eric Olinger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/tsc2-pkd1-contigue-gendeletiesyndroom/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/12/fenotype-eerst-een-datagestuurde-benadering-van-genetische-penetrantie/","published":"2026-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-r-bates","type":"person","url":"https://hartvaat.nl/mensen/eric-r-bates/","name":"Eric R Bates","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eric-r-skipper","type":"person","url":"https://hartvaat.nl/mensen/eric-r-skipper/","name":"Eric R Skipper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erica-l-dueger","type":"person","url":"https://hartvaat.nl/mensen/erica-l-dueger/","name":"Erica L Dueger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erica-s-w-jones","type":"person","url":"https://hartvaat.nl/mensen/erica-s-w-jones/","name":"Erica S W Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erik-berg-schmidt","type":"person","url":"https://hartvaat.nl/mensen/erik-berg-schmidt/","name":"Erik Berg Schmidt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/enkelvoudige-onverzadigde-vetzuren-in-vetweefsel-en-het-risico-op-perifeer-vaatl/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2021/02/09/omega-3-vetzuren-bij-oudere-mi-patienten-omemi-gerandomiseerde-trial/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erik-riessen","type":"person","url":"https://hartvaat.nl/mensen/erik-riessen/","name":"Erik Riessen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2017/10/01/visit-to-visit-bloeddrukvariabiliteit-en-cv-uitkomsten-in-sprint/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erik-thunstrom","type":"person","url":"https://hartvaat.nl/mensen/erik-thunstrom/","name":"Erik Thunström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2023/10/03/cpap-therapietrouw-en-recidief-cv-events-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erik-van-widenfelt","type":"person","url":"https://hartvaat.nl/mensen/erik-van-widenfelt/","name":"Erik van Widenfelt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erika-jones","type":"person","url":"https://hartvaat.nl/mensen/erika-jones/","name":"Erika Jones","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erin-iturriaga","type":"person","url":"https://hartvaat.nl/mensen/erin-iturriaga/","name":"Erin Iturriaga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erin-l-coppola","type":"person","url":"https://hartvaat.nl/mensen/erin-l-coppola/","name":"Erin L Coppola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/uspstf-evidence-review-lipidescreening-bij-kinderen-geactualiseerd/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-evidence-update-2021/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erland-erdmann","type":"person","url":"https://hartvaat.nl/mensen/erland-erdmann/","name":"Erland Erdmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"erlinge","type":"person","url":"https://hartvaat.nl/mensen/erlinge/","name":"Erlinge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/01/29/verminderde-pompfunctie-na-een-hartinfarct-hoge-symptoomlast-en-slechtere-secund/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"espen-holte","type":"person","url":"https://hartvaat.nl/mensen/espen-holte/","name":"Espen Holte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"esteban-escolar","type":"person","url":"https://hartvaat.nl/mensen/esteban-escolar/","name":"Esteban Escolar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"esteban-jodar","type":"person","url":"https://hartvaat.nl/mensen/esteban-jodar/","name":"Esteban Jódar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/14/tirzepatide-versus-insuline-degludec-bij-diabetes-type-2-lancet-surpass-3/","published":"2021-08-14"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"estefania-oliveros","type":"person","url":"https://hartvaat.nl/mensen/estefania-oliveros/","name":"Estefania Oliveros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"esther-i-schwarz","type":"person","url":"https://hartvaat.nl/mensen/esther-i-schwarz/","name":"Esther I Schwarz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/11/pulmonale-hemodynamiek-op-hoogte-bij-hfpef/","published":"2025-12-11"},{"url":"https://hartvaat.nl/2016/01/01/gesimuleerde-obstructieve-slaapapneu-bevordert-ritmestoornissen-bij-paroxysmaal-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"etienne-pruvot","type":"person","url":"https://hartvaat.nl/mensen/etienne-pruvot/","name":"Etienne Pruvot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eugenio-picano","type":"person","url":"https://hartvaat.nl/mensen/eugenio-picano/","name":"Eugenio Picano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/05/01/klinische-score-verbetert-risicostratificatie-bij-stressechocardiografie/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eugenio-stabile","type":"person","url":"https://hartvaat.nl/mensen/eugenio-stabile/","name":"Eugenio Stabile","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/09/gepersonaliseerde-versus-standaard-dapt-duur-na-pci-gerandomiseerde-trial/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2017/01/01/ontwikkeling-van-linkerventrikelhypertrofie-bij-behandelde-hypertensie-campania-/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eung-ju-kim","type":"person","url":"https://hartvaat.nl/mensen/eung-ju-kim/","name":"Eung Ju Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/thuis-bio-impedantie-voor-hartfalen-haalbaar-en-acceptabel-klinische-winst-nog-n/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eunjung-kim","type":"person","url":"https://hartvaat.nl/mensen/eunjung-kim/","name":"Eunjung Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eustachio-agricola","type":"person","url":"https://hartvaat.nl/mensen/eustachio-agricola/","name":"Eustachio Agricola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2020/12/01/longechogeleide-therapie-vermindert-acute-decompensatie-bij-chronisch-hf/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-corpeleijn","type":"person","url":"https://hartvaat.nl/mensen/eva-corpeleijn/","name":"Eva Corpeleijn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-kirchhof","type":"person","url":"https://hartvaat.nl/mensen/eva-kirchhof/","name":"Eva Kirchhof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"eva-swahn","type":"person","url":"https://hartvaat.nl/mensen/eva-swahn/","name":"Eva Swahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evan-lockwood","type":"person","url":"https://hartvaat.nl/mensen/evan-lockwood/","name":"Evan Lockwood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evangelos-evangelou","type":"person","url":"https://hartvaat.nl/mensen/evangelos-evangelou/","name":"Evangelos Evangelou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2019/11/01/causaal-verband-periodontitis-en-hypertensie-mendeliaanse-randomisatie-en-rct/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evangelos-giannitsis","type":"person","url":"https://hartvaat.nl/mensen/evangelos-giannitsis/","name":"Evangelos Giannitsis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/esc-0-1-uur-troponine-algoritme-voor-mi-veiligheid-en-werkzaamheid-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evelio-rodriguez","type":"person","url":"https://hartvaat.nl/mensen/evelio-rodriguez/","name":"Evelio Rodriguez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evelyn-p-whitlock","type":"person","url":"https://hartvaat.nl/mensen/evelyn-p-whitlock/","name":"Evelyn P Whitlock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-familiaire-hypercholesterolemie-uspstf-evidenc/","published":"2016-08-09"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-multifactoriele-dyslipidemie-uspstf-evidence-r/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evelyn-santiago-vacas","type":"person","url":"https://hartvaat.nl/mensen/evelyn-santiago-vacas/","name":"Evelyn Santiago-Vacas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"evelyne-rey","type":"person","url":"https://hartvaat.nl/mensen/evelyne-rey/","name":"Evelyne Rey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ewa-piotrowicz","type":"person","url":"https://hartvaat.nl/mensen/ewa-piotrowicz/","name":"Ewa Piotrowicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ewa-warchol-celinska","type":"person","url":"https://hartvaat.nl/mensen/ewa-warchol-celinska/","name":"Ewa Warchol-Celinska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ewan-r-pearson","type":"person","url":"https://hartvaat.nl/mensen/ewan-r-pearson/","name":"Ewan R Pearson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/12/genetisch-risico-op-coronairlijden-en-ontwikkeling-van-hfref-versus-hfpef/","published":"2019-02-12"},{"url":"https://hartvaat.nl/2017/12/21/lilrb5-variant-geassocieerd-met-statine-intolerantie-en-myalgie/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ewout-w-steyerberg","type":"person","url":"https://hartvaat.nl/mensen/ewout-w-steyerberg/","name":"Ewout W Steyerberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/19/externe-validatie-van-de-freedom-score-voor-pci-versus-cabg/","published":"2022-04-19"},{"url":"https://hartvaat.nl/2020/10/31/syntax-score-ii-herontwikkeling-voor-gepersonaliseerde-revascularisatiebeslissin/","published":"2020-10-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"expedito-e-ribeiro","type":"person","url":"https://hartvaat.nl/mensen/expedito-e-ribeiro/","name":"Expedito E Ribeiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"f-h","type":"person","url":"https://hartvaat.nl/mensen/f-h/","name":"F. H.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/21/delphi-consensus-over-uitgestelde-en-gemiste-diagnose-van-coronairlijden/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabian-hammer","type":"person","url":"https://hartvaat.nl/mensen/fabian-hammer/","name":"Fabian Hammer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2019/04/01/spironolacton-en-lv-massa-bij-hemodialysepatienten-gerandomiseerde-trial/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabien-huet","type":"person","url":"https://hartvaat.nl/mensen/fabien-huet/","name":"Fabien Huet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-angeli","type":"person","url":"https://hartvaat.nl/mensen/fabio-angeli/","name":"Fabio Angeli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/dabigatran-versus-warfarine-bij-af-met-linkerventrikelhypertrofie-re-ly/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/09/01/intensievere-versus-minder-intensieve-bloeddrukverlaging-cumulatief-bewijs-en-tr/","published":"2016-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-dorigotti","type":"person","url":"https://hartvaat.nl/mensen/fabio-dorigotti/","name":"Fabio Dorigotti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-fernandes","type":"person","url":"https://hartvaat.nl/mensen/fabio-fernandes/","name":"Fabio Fernandes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/answer-hf-sacubitril-valsartan-versus-enalapril-bij-chagas-hf-primaire-resultate/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-quartieri","type":"person","url":"https://hartvaat.nl/mensen/fabio-quartieri/","name":"Fabio Quartieri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2018/12/01/av-junctieablatie-plus-crt-bij-permanent-af-gerandomiseerde-trial/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabrizio-ricci","type":"person","url":"https://hartvaat.nl/mensen/fabrizio-ricci/","name":"Fabrizio Ricci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/14/langetermijnuitkomsten-bij-angina-zonder-obstructief-coronairlijden-systematisch/","published":"2018-06-14"},{"url":"https://hartvaat.nl/2017/03/21/doac-s-bij-af-met-kleplijden-jacc-review/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fahad-alnouri","type":"person","url":"https://hartvaat.nl/mensen/fahad-alnouri/","name":"Fahad Alnouri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"faisal-rahman","type":"person","url":"https://hartvaat.nl/mensen/faisal-rahman/","name":"Faisal Rahman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/ffr-geleide-versus-angiografie-geleide-revascularisatie-meta-analyse-van-rct-s/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"faizan-ahmed","type":"person","url":"https://hartvaat.nl/mensen/faizan-ahmed/","name":"Faizan Ahmed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/30/vutrisiran-remt-ttr-en-vermindert-valrisico-bij-attr-cardiomyopathie-meta-analys/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/02/03/intraveneus-ijzer-bij-hartfalen-met-ijzertekort-meta-analyse-met-trial-sequentie/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fan-liu","type":"person","url":"https://hartvaat.nl/mensen/fan-liu/","name":"Fan Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fan-ouyang","type":"person","url":"https://hartvaat.nl/mensen/fan-ouyang/","name":"Fan Ouyang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fan-zhang","type":"person","url":"https://hartvaat.nl/mensen/fan-zhang/","name":"Fan Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/31/steilere-egfr-daling-voorspelt-nierfalen-en-cardiovasculaire-mortaliteit-narrati/","published":"2026-08-14"},{"url":"https://hartvaat.nl/2026/12/01/cardiometabole-index-en-sarcopenie-voorspellen-sterfte-bij-chronische-nierziekte/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fang-sun","type":"person","url":"https://hartvaat.nl/mensen/fang-sun/","name":"Fang Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/01/voorkeur-voor-pikant-eten-versterkt-zoutwaarneming-en-vermindert-zoutinname-en-b/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/03/01/taurinesuppletie-verlaagt-bloeddruk-en-verbetert-vaatfunctie-bij-prehypertensie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fangchao-liu","type":"person","url":"https://hartvaat.nl/mensen/fangchao-liu/","name":"Fangchao Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/13/nt-probnp-en-af-risico-systematische-review-en-meta-analyse/","published":"2025-01-13"},{"url":"https://hartvaat.nl/2019/09/01/interactieve-mobiele-gezondheidsinterventie-en-bloeddrukmanagement/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"farhad-bakhtiary","type":"person","url":"https://hartvaat.nl/mensen/farhad-bakhtiary/","name":"Farhad Bakhtiary","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"farid-foroutan","type":"person","url":"https://hartvaat.nl/mensen/farid-foroutan/","name":"Farid Foroutan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2021/12/01/predictieve-modellen-voor-cv-en-renale-uitkomsten-bij-diabetes-type-2-meta-analy/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"farid-khasiyev","type":"person","url":"https://hartvaat.nl/mensen/farid-khasiyev/","name":"Farid Khasiyev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/stop-cad-1-op-6-cervicale-arteriedissecties-wordt-aanvankelijk-verkeerd-gediagno/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/01/01/lp-a-geoxideerde-fosfolipiden-en-apob100-bij-acuut-ischemisch-herseninfarct/","published":"2026-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"faridi-s-van-etten-jamaludin","type":"person","url":"https://hartvaat.nl/mensen/faridi-s-van-etten-jamaludin/","name":"Faridi S van Etten-Jamaludin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/01/frequente-premature-atriale-contracties-en-af-hersenischemie-en-mortaliteit-meta/","published":"2019-05-01"},{"url":"https://hartvaat.nl/2018/09/01/last-van-atriale-high-rate-episodes-en-cva-risico-systematische-review/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"farrel-hellig","type":"person","url":"https://hartvaat.nl/mensen/farrel-hellig/","name":"Farrel Hellig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"farrell-o-mendelsohn","type":"person","url":"https://hartvaat.nl/mensen/farrell-o-mendelsohn/","name":"Farrell O Mendelsohn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/11/target-bp-i-alcohol-gemedieerde-renale-denervatie-bij-hypertensie/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2023/03/07/mesenchymale-precursorcellen-bij-hfref-gerandomiseerde-trial/","published":"2023-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"farshad-farzadfar","type":"person","url":"https://hartvaat.nl/mensen/farshad-farzadfar/","name":"Farshad Farzadfar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/27/langetermijneffect-van-antihypertensiva-op-bloeddruk-meta-analyse-op-individueel/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fassil-ketema","type":"person","url":"https://hartvaat.nl/mensen/fassil-ketema/","name":"Fassil Ketema","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fatima-rodriguez","type":"person","url":"https://hartvaat.nl/mensen/fatima-rodriguez/","name":"Fatima Rodriguez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/28/incidenteel-coronair-calcium-op-ct-thorax-ai-gestuurde-screening-verbetert-stati/","published":"2023-02-28"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fatima-zaraket","type":"person","url":"https://hartvaat.nl/mensen/fatima-zaraket/","name":"Fatima Zaraket","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fazila-malik","type":"person","url":"https://hartvaat.nl/mensen/fazila-malik/","name":"Fazila Malik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/17/abluminus-des-versus-ees-bij-diabetes-en-coronairlijden/","published":"2026-01-17"},{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-carbone","type":"person","url":"https://hartvaat.nl/mensen/federico-carbone/","name":"Federico Carbone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/26/reverse-cardio-oncologie-obesitas-en-veroudering-als-aanjagers-van-borstkanker/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2020/12/22/fentanyl-versus-morfine-op-ticagrelor-plaatjesremming-bij-stemi/","published":"2020-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-guerra","type":"person","url":"https://hartvaat.nl/mensen/federico-guerra/","name":"Federico Guerra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/vaste-versus-responsieve-pacingfrequentie-bij-permanent-af-met-pacemakerindicati/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/01/flecainide-metoprolol-combinatie-vermindert-af-recidieven-1-jaarsresultaten/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-piscione","type":"person","url":"https://hartvaat.nl/mensen/federico-piscione/","name":"Federico Piscione","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"},{"url":"https://hartvaat.nl/2016/08/16/intracoronair-abciximab-bij-diabetespatienten-met-primaire-pci-1-jaarsresultaten/","published":"2016-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-silva","type":"person","url":"https://hartvaat.nl/mensen/federico-silva/","name":"Federico Silva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"federico-torres","type":"person","url":"https://hartvaat.nl/mensen/federico-torres/","name":"Federico Torres","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fei-li","type":"person","url":"https://hartvaat.nl/mensen/fei-li/","name":"Fei Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fei-xu","type":"person","url":"https://hartvaat.nl/mensen/fei-xu/","name":"Fei Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/eheart-trial-real-time-hartteam-verbetert-besluitvorming-bij-complexe-coronaire-/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2025/01/01/gedeeltelijke-cardiale-denervatie-voorkomt-af-na-cabg-rct/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fekadu","type":"person","url":"https://hartvaat.nl/mensen/fekadu/","name":"Fekadu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/05/25/patientspecifieke-3d-hartmodellen-bij-congenitale-hartchirurgie-18-minuten-korte/","published":"2026-07-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felekos","type":"person","url":"https://hartvaat.nl/mensen/felekos/","name":"Felekos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/invasieve-coronaire-functietest-bij-anoca-verandert-de-behandeling-bij-driekwart/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/23/multidisciplinair-cardiogene-shockteam-verbetert-de-1-jaarsoverleving-bij-infarc/","published":"2026-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felix-ayala-paredes","type":"person","url":"https://hartvaat.nl/mensen/felix-ayala-paredes/","name":"Felix Ayala-Paredes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2018/11/21/voortzetten-versus-onderbreken-doac-bij-device-chirurgie-bruise-control-2/","published":"2018-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felix-barasa","type":"person","url":"https://hartvaat.nl/mensen/felix-barasa/","name":"Felix Barasa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felix-j-woitek","type":"person","url":"https://hartvaat.nl/mensen/felix-j-woitek/","name":"Felix J Woitek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/17/danger-shock-sekseverschillen-in-impella-gebruik-bij-cardiogene-shock/","published":"2026-02-17"},{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felix-ramires","type":"person","url":"https://hartvaat.nl/mensen/felix-ramires/","name":"Felix Ramires","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/sacubitril-valsartan-versus-enalapril-bij-chagas-hartfalen/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felix-rudolph","type":"person","url":"https://hartvaat.nl/mensen/felix-rudolph/","name":"Felix Rudolph","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"felix-zijlstra","type":"person","url":"https://hartvaat.nl/mensen/felix-zijlstra/","name":"Felix Zijlstra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2017/01/10/trombusaspiratie-bij-stemi-individuele-patientdata-meta-analyse/","published":"2017-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feng-chen","type":"person","url":"https://hartvaat.nl/mensen/feng-chen/","name":"Feng Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feng-ding","type":"person","url":"https://hartvaat.nl/mensen/feng-ding/","name":"Feng Ding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/20/milt-norepinefrine-2-adrenerge-as-verergert-sepsis-geassocieerd-acuut-nierletsel/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2026/02/18/telomeerherstel-via-gentherapie-bij-cardiorenaal-syndroom-type-4/","published":"2026-02-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feng-li","type":"person","url":"https://hartvaat.nl/mensen/feng-li/","name":"Feng Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feng-lin","type":"person","url":"https://hartvaat.nl/mensen/feng-lin/","name":"Feng Lin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2016/03/15/voorspelling-van-persisterende-lv-disfunctie-na-myocardinfarct-de-predicts-studi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feng-wang","type":"person","url":"https://hartvaat.nl/mensen/feng-wang/","name":"Feng Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/nucleair-ago2-verergert-hfpef-via-myocardiale-ketogenese/","published":"2026-04-03"},{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"feng-yang","type":"person","url":"https://hartvaat.nl/mensen/feng-yang/","name":"Feng Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ferdinando-loiacono","type":"person","url":"https://hartvaat.nl/mensen/ferdinando-loiacono/","name":"Ferdinando Loiacono","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2020/12/01/longechogeleide-therapie-vermindert-acute-decompensatie-bij-chronisch-hf/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fernando-aros","type":"person","url":"https://hartvaat.nl/mensen/fernando-aros/","name":"Fernando Arós","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fernando-chernomordik","type":"person","url":"https://hartvaat.nl/mensen/fernando-chernomordik/","name":"Fernando Chernomordik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/routinematige-urine-natriummeting-drijft-agressievere-diurese-bij-acuut-hartfale/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2017/12/01/kauwen-versus-slikken-van-ticagrelor-en-plaatjesremming-bij-stemi/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fernando-civeira","type":"person","url":"https://hartvaat.nl/mensen/fernando-civeira/","name":"Fernando Civeira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/08/volanesorsen-en-triglyceriden-bij-familiair-chylomicronemiesyndroom-nejm/","published":"2019-08-08"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fernando-rivero","type":"person","url":"https://hartvaat.nl/mensen/fernando-rivero/","name":"Fernando Rivero","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fieke-terstappen","type":"person","url":"https://hartvaat.nl/mensen/fieke-terstappen/","name":"Fieke Terstappen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/foetale-groeirestrictie-en-bloeddruk-tegenstrijdige-effecten-bij-mens-en-rat-met/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/11/01/sildenafil-tijdens-de-zwangerschap-preklinische-meta-analyse-over-foetale-groei-/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"filip-birve","type":"person","url":"https://hartvaat.nl/mensen/filip-birve/","name":"Filip Birve","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fiona-c-warren","type":"person","url":"https://hartvaat.nl/mensen/fiona-c-warren/","name":"Fiona C Warren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fiona-ecarnot","type":"person","url":"https://hartvaat.nl/mensen/fiona-ecarnot/","name":"Fiona Ecarnot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"},{"url":"https://hartvaat.nl/2016/09/27/oct-geleide-pci-optimalisatie-bij-nste-acs-gerandomiseerde-trial/","published":"2016-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fiona-ryan","type":"person","url":"https://hartvaat.nl/mensen/fiona-ryan/","name":"Fiona Ryan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/01/parable-sacubitril-valsartan-vermindert-linkeratriumvolume-bij-pre-hfpef/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2019/06/01/klinische-predictieregels-voor-diagnostiek-van-chronisch-hartfalen-systematische/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"firat-duru","type":"person","url":"https://hartvaat.nl/mensen/firat-duru/","name":"Firat Duru","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2016/01/01/gesimuleerde-obstructieve-slaapapneu-bevordert-ritmestoornissen-bij-paroxysmaal-/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fizzah-choudry","type":"person","url":"https://hartvaat.nl/mensen/fizzah-choudry/","name":"Fizzah Choudry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flavio-giuseppe-biccire","type":"person","url":"https://hartvaat.nl/mensen/flavio-giuseppe-biccire/","name":"Flavio Giuseppe Biccirè","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flavo-ribichini","type":"person","url":"https://hartvaat.nl/mensen/flavo-ribichini/","name":"Flavo Ribichini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flora-au","type":"person","url":"https://hartvaat.nl/mensen/flora-au/","name":"Flora Au","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flora-babongo-bosombo","type":"person","url":"https://hartvaat.nl/mensen/flora-babongo-bosombo/","name":"Flora Babongo Bosombo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flora-s-siami","type":"person","url":"https://hartvaat.nl/mensen/flora-s-siami/","name":"Flora S Siami","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/19/langetermijnoverleving-na-multivatenrevascularisatie-bij-diabetes-freedom-follow/","published":"2019-02-19"},{"url":"https://hartvaat.nl/2018/12/11/syntax-score-bij-diabetes-met-coronaire-revascularisatie-freedom/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florence-sens","type":"person","url":"https://hartvaat.nl/mensen/florence-sens/","name":"Florence Sens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/09/uf-care-trial-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-geen-significante-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/09/uf-care-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-mist-primair-eindpunt-in/","published":"2026-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"florence-y-lai","type":"person","url":"https://hartvaat.nl/mensen/florence-y-lai/","name":"Florence Y Lai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/12/01/dagelijkse-remote-ischemische-conditionering-na-acuut-mi-gerandomiseerde-trial/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2016/06/07/ischemie-en-infarct-bij-stemi-met-multivatenlijden-cvlprit-nucleaire-substudie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"flavia-c-s-kojima","type":"person","url":"https://hartvaat.nl/mensen/flavia-c-s-kojima/","name":"Flávia C S Kojima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fouzia-sadiq","type":"person","url":"https://hartvaat.nl/mensen/fouzia-sadiq/","name":"Fouzia Sadiq","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frances-a-wood","type":"person","url":"https://hartvaat.nl/mensen/frances-a-wood/","name":"Frances A Wood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesc-formiga","type":"person","url":"https://hartvaat.nl/mensen/francesc-formiga/","name":"Francesc Formiga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/clorotic-subanalyse-acute-egfr-daling-door-thiaziden-bij-acuut-hf-is-geen-progno/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2023/02/01/clorotic-thiazide-toevoegen-aan-lisdiureticum-bij-acuut-hartfalen/","published":"2023-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-angeli","type":"person","url":"https://hartvaat.nl/mensen/francesco-angeli/","name":"Francesco Angeli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2025/03/13/minoca-pathologische-bevindingen-bij-invasieve-beoordeling-meta-analyse/","published":"2025-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-bandera","type":"person","url":"https://hartvaat.nl/mensen/francesco-bandera/","name":"Francesco Bandera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/atriale-mechanische-contractie-voorspelt-cerebrovasculair-risico-bij-transthyret/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2017/05/01/epicardiaal-vet-en-atriumfibrilleren-systematische-review-en-meta-analyse/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-bruno","type":"person","url":"https://hartvaat.nl/mensen/francesco-bruno/","name":"Francesco Bruno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-cipollone","type":"person","url":"https://hartvaat.nl/mensen/francesco-cipollone/","name":"Francesco Cipollone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/24/s100a8-a9-versnelt-cox-1-herstel-in-bloedplaatjes-en-beperkt-aspirinerespons/","published":"2026-02-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-fedele","type":"person","url":"https://hartvaat.nl/mensen/francesco-fedele/","name":"Francesco Fedele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/sacubitril-valsartan-na-acuut-mi-meta-analyse-van-in-hospital-initiatie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2019/02/01/herhaalde-levosimendan-infusies-bij-gevorderd-chronisch-hf-in-de-kwetsbare-postd/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-saia","type":"person","url":"https://hartvaat.nl/mensen/francesco-saia/","name":"Francesco Saia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-sbrana","type":"person","url":"https://hartvaat.nl/mensen/francesco-sbrana/","name":"Francesco Sbrana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/lipoproteine-aferese-blijft-relevant-in-het-tijdperk-van-pcsk9-remmers-en-sirna/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francesco-solimene","type":"person","url":"https://hartvaat.nl/mensen/francesco-solimene/","name":"Francesco Solimene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francis-bessiere","type":"person","url":"https://hartvaat.nl/mensen/francis-bessiere/","name":"Francis Bessière","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/varipure-studie-pulsed-field-ablatie-in-de-dagelijkse-af-praktijk/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2025/10/31/vrouwen-met-persisterend-af-pvi-alleen-is-onvoldoende/","published":"2025-10-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-a-fonseca","type":"person","url":"https://hartvaat.nl/mensen/francisco-a-fonseca/","name":"Francisco A Fonseca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-a-r-garcia","type":"person","url":"https://hartvaat.nl/mensen/francisco-a-r-garcia/","name":"Francisco A R García","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-bosa-ojeda","type":"person","url":"https://hartvaat.nl/mensen/francisco-bosa-ojeda/","name":"Francisco Bosa Ojeda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-fernandez-aviles","type":"person","url":"https://hartvaat.nl/mensen/francisco-fernandez-aviles/","name":"Francisco Fernández-Avilés","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/04/14/sildenafil-bij-persisterende-pulmonale-hypertensie-na-klepchirurgie/","published":"2018-04-14"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-h-fonseca","type":"person","url":"https://hartvaat.nl/mensen/francisco-h-fonseca/","name":"Francisco H Fonseca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/26/rivaroxaban-bij-af-met-bioprothese-mitralisklep-nejm-river/","published":"2020-11-26"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-en-evidence-based-prescriptie-bij-hoog-cv-risico-jama-card/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-marin","type":"person","url":"https://hartvaat.nl/mensen/francisco-marin/","name":"Francisco Marín","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-purroy","type":"person","url":"https://hartvaat.nl/mensen/francisco-purroy/","name":"Francisco Purroy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/24/systemische-inflammatie-en-recidief-na-een-af-gerelateerd-herseninfarct/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francisco-vasques-novoa","type":"person","url":"https://hartvaat.nl/mensen/francisco-vasques-novoa/","name":"Francisco Vasques-Nóvoa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/05/sglt2-remmer-met-en-zonder-mra-bij-hartfalen-gecombineerde-analyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"franco-rabbia","type":"person","url":"https://hartvaat.nl/mensen/franco-rabbia/","name":"Franco Rabbia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/geautomatiseerde-praktijkmeting-versus-andere-bloeddrukmeetmethoden/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/01/farmacologische-behandeling-van-hypertensie-bij-kinderen-netwerkmeta-analyse/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"franco-veglio","type":"person","url":"https://hartvaat.nl/mensen/franco-veglio/","name":"Franco Veglio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/geautomatiseerde-praktijkmeting-versus-andere-bloeddrukmeetmethoden/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/01/farmacologische-behandeling-van-hypertensie-bij-kinderen-netwerkmeta-analyse/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-a-cuoco","type":"person","url":"https://hartvaat.nl/mensen/frank-a-cuoco/","name":"Frank A Cuoco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-e-silvestry","type":"person","url":"https://hartvaat.nl/mensen/frank-e-silvestry/","name":"Frank E Silvestry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frank-den-hartog","type":"person","url":"https://hartvaat.nl/mensen/frank-den-hartog/","name":"Frank den Hartog","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2020/04/25/clopidogrel-versus-ticagrelor-of-prasugrel-bij-70-plussers-met-nste-acs-lancet-p/","published":"2020-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frantisek-tousek","type":"person","url":"https://hartvaat.nl/mensen/frantisek-tousek/","name":"Frantisek Tousek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francois-dagenais","type":"person","url":"https://hartvaat.nl/mensen/francois-dagenais/","name":"François Dagenais","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francois-lellouche","type":"person","url":"https://hartvaat.nl/mensen/francois-lellouche/","name":"François Lellouche","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"francois-m-carrier","type":"person","url":"https://hartvaat.nl/mensen/francois-m-carrier/","name":"François M Carrier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"freddy-del-carpio-munoz","type":"person","url":"https://hartvaat.nl/mensen/freddy-del-carpio-munoz/","name":"Freddy Del-Carpio Munoz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/02/af-ablatie-bij-hypertrofische-cardiomyopathie-meta-analyse/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2019/08/20/fysiologische-versus-rechterkamerpacing-bij-lvef-35/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"freddy-g-eliaschewitz","type":"person","url":"https://hartvaat.nl/mensen/freddy-g-eliaschewitz/","name":"Freddy G Eliaschewitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/29/orale-semaglutide-en-cv-uitkomsten-bij-diabetes-type-2-nejm-pioneer-6/","published":"2019-08-29"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederic-de-roeck","type":"person","url":"https://hartvaat.nl/mensen/frederic-de-roeck/","name":"Frederic De Roeck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederick-j-raal","type":"person","url":"https://hartvaat.nl/mensen/frederick-j-raal/","name":"Frederick J. Raal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2025/12/22/evinacumab-bij-kinderen-van-5-17-jaar-met-homozygote-familiaire-hypercholesterol/","published":"2025-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederico-l-j-monteiro","type":"person","url":"https://hartvaat.nl/mensen/frederico-l-j-monteiro/","name":"Frederico L J Monteiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederico-toledo-campo-dall-orto","type":"person","url":"https://hartvaat.nl/mensen/frederico-toledo-campo-dall-orto/","name":"Frederico Toledo Campo Dall Orto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederik-dalgaard","type":"person","url":"https://hartvaat.nl/mensen/frederik-dalgaard/","name":"Frederik Dalgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/01/vroegtijdig-permanent-staken-van-apixaban-of-warfarine-bij-af/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2020/01/07/nsaid-s-en-oac-bij-af-aristotle-analyse/","published":"2020-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederik-sand","type":"person","url":"https://hartvaat.nl/mensen/frederik-sand/","name":"Frederik Sand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederikus-a-klok","type":"person","url":"https://hartvaat.nl/mensen/frederikus-a-klok/","name":"Frederikus A Klok","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/05/25/longembolie-epidemiologie-stijgende-last-bij-vergrijzing-preventiestrategieen-bl/","published":"2026-06-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fredrick-larbi-kwapong","type":"person","url":"https://hartvaat.nl/mensen/fredrick-larbi-kwapong/","name":"Fredrick Larbi Kwapong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/factoren-bij-discordante-bloeddrukmeting-bij-zeer-oude-volwassenen-aric-studie/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2026/01/06/gofresh-dash-boodschappen-en-bloeddrukeffect-rct/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"freny-vaghaiwalla-mody","type":"person","url":"https://hartvaat.nl/mensen/freny-vaghaiwalla-mody/","name":"Freny Vaghaiwalla Mody","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/11/sacubitril-valsartan-bij-acuut-mi-nejm-paradise-mi/","published":"2021-11-11"},{"url":"https://hartvaat.nl/2017/03/21/kortetermijneffecten-van-tolvaptan-bij-acuut-hartfalen-met-volume-overbelasting/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"friedhelm-hildebrandt","type":"person","url":"https://hartvaat.nl/mensen/friedhelm-hildebrandt/","name":"Friedhelm Hildebrandt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/19/genotype-fenotypekenmerken-bij-fan1-gerelateerde-karyomegale-tubulointerstitiele/","published":"2026-01-19"},{"url":"https://hartvaat.nl/2025/12/24/genomische-ontdekking-bij-nefrotisch-syndroom-mefv-varianten-als-risicofactor-vo/","published":"2025-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"friedo-w-dekker","type":"person","url":"https://hartvaat.nl/mensen/friedo-w-dekker/","name":"Friedo W Dekker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/22/cva-risicoscores-bij-af-vergeleken-cha2ds2-vasc-blijft-de-beste/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"frederic-rouleau","type":"person","url":"https://hartvaat.nl/mensen/frederic-rouleau/","name":"Frédéric Rouleau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"furio-colivicchi","type":"person","url":"https://hartvaat.nl/mensen/furio-colivicchi/","name":"Furio Colivicchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2022/09/15/polypill-voor-secundaire-cardiovasculaire-preventie-secure-trial-in-nejm/","published":"2022-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fusco","type":"person","url":"https://hartvaat.nl/mensen/fusco/","name":"Fusco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fuyou-liang","type":"person","url":"https://hartvaat.nl/mensen/fuyou-liang/","name":"Fuyou Liang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-a-de-luca","type":"person","url":"https://hartvaat.nl/mensen/fabio-a-de-luca/","name":"Fábio A De Luca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/19/stoppen-versus-doorgaan-met-ace-remmers-arb-s-bij-gehospitaliseerde-patienten-ja/","published":"2021-01-19"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-akio-nishijuka","type":"person","url":"https://hartvaat.nl/mensen/fabio-akio-nishijuka/","name":"Fábio Akio Nishijuka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabio-m-de-castilho","type":"person","url":"https://hartvaat.nl/mensen/fabio-m-de-castilho/","name":"Fábio M de Castilho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"g-greg-peterson","type":"person","url":"https://hartvaat.nl/mensen/g-greg-peterson/","name":"G Greg Peterson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/17/million-hearts-betaald-cv-risicomanagement-vermindert-mi-en-cva-jama-rct/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/09/01/million-hearts-cv-risicoreductiemodel-en-medicatie-initiatie-jama-cardiology/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"g-michael-deeb","type":"person","url":"https://hartvaat.nl/mensen/g-michael-deeb/","name":"G Michael Deeb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"g-y-h","type":"person","url":"https://hartvaat.nl/mensen/g-y-h/","name":"G. Y. H.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/recidief-linkerventrikel-trombus-12-recidief-actieve-eerdere-maligniteit-verzesv/","published":"2026-07-03"},{"url":"https://hartvaat.nl/2026/02/23/luchtvervuiling-en-multimorbiditeit-verhogen-het-risico-op-atriumfibrilleren/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabe-b-bleeker","type":"person","url":"https://hartvaat.nl/mensen/gabe-b-bleeker/","name":"Gabe B Bleeker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabor-kunszt","type":"person","url":"https://hartvaat.nl/mensen/gabor-kunszt/","name":"Gabor Kunszt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriel-arefalk","type":"person","url":"https://hartvaat.nl/mensen/gabriel-arefalk/","name":"Gabriel Arefalk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriel-steg","type":"person","url":"https://hartvaat.nl/mensen/gabriel-steg/","name":"Gabriel Steg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/01/antiplaatjestherapie-bij-mi-zonder-obstructief-coronairlijden-minoca/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2016/01/21/ticagrelor-bij-nierfunctiestoornissen-langetermijnpreventie-na-myocardinfarct-pe/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriele-caggianelli","type":"person","url":"https://hartvaat.nl/mensen/gabriele-caggianelli/","name":"Gabriele Caggianelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/motivational-interviewing-en-zorggebruik-en-mortaliteit-bij-hf-motivate-hf/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/06/01/motivational-interviewing-bij-hartfalen-voor-zelfzorg-motivate-hf-gerandomiseerd/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriele-crimi","type":"person","url":"https://hartvaat.nl/mensen/gabriele-crimi/","name":"Gabriele Crimi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriele-negro","type":"person","url":"https://hartvaat.nl/mensen/gabriele-negro/","name":"Gabriele Negro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gabriele-riccardi","type":"person","url":"https://hartvaat.nl/mensen/gabriele-riccardi/","name":"Gabriele Riccardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/24/meer-kip-dan-rundvlees-of-vis-bij-avondmaaltijd-gekoppeld-aan-grotere-bloeddrukd/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gaelle-saint-hilary","type":"person","url":"https://hartvaat.nl/mensen/gaelle-saint-hilary/","name":"Gaelle Saint-Hilary","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/farmacologische-behandeling-van-hypertensie-bij-kinderen-netwerkmeta-analyse/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gaetano-ruocco","type":"person","url":"https://hartvaat.nl/mensen/gaetano-ruocco/","name":"Gaetano Ruocco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/het-spectrum-van-congestie-bij-hartfalen-pathofysiologie-en-diagnostische-strate/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2017/11/01/iv-lisdiuretica-bij-acuut-hartfalen-diur-ahf-studieontwerp/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gagan-singh","type":"person","url":"https://hartvaat.nl/mensen/gagan-singh/","name":"Gagan Singh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gail-p-jarvik","type":"person","url":"https://hartvaat.nl/mensen/gail-p-jarvik/","name":"Gail P Jarvik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gajen-kanaganayagam","type":"person","url":"https://hartvaat.nl/mensen/gajen-kanaganayagam/","name":"Gajen Kanaganayagam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gale","type":"person","url":"https://hartvaat.nl/mensen/gale/","name":"Gale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/05/20/klinisch-en-genetisch-risico-op-atriumfibrilleren-versterken-elkaar-additief-13-/","published":"2026-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gang-zhao","type":"person","url":"https://hartvaat.nl/mensen/gang-zhao/","name":"Gang Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/09/remote-ischemische-preconditionering-en-nierschade-na-coronairangiografie/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"garima-sharma","type":"person","url":"https://hartvaat.nl/mensen/garima-sharma/","name":"Garima Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"},{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gary-mintz","type":"person","url":"https://hartvaat.nl/mensen/gary-mintz/","name":"Gary Mintz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gary-n-asher","type":"person","url":"https://hartvaat.nl/mensen/gary-n-asher/","name":"Gary N Asher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-geactualiseerde-evidence-report-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-evidence-report-en-systematische-review/","published":"2018-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gary-tse","type":"person","url":"https://hartvaat.nl/mensen/gary-tse/","name":"Gary Tse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2022/01/04/sglt2-remmers-en-plotse-hartdood-ventriculaire-aritmie-meta-analyse/","published":"2022-01-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gaurav-a-upadhyay","type":"person","url":"https://hartvaat.nl/mensen/gaurav-a-upadhyay/","name":"Gaurav A Upadhyay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/14/real-time-remote-monitoring-voorspelt-maligne-ventriculaire-aritmieen/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2019/07/09/his-correctieve-pacing-versus-biventriculaire-pacing-voor-crt-bij-hartfalen/","published":"2019-07-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gayle-passmore","type":"person","url":"https://hartvaat.nl/mensen/gayle-passmore/","name":"Gayle Passmore","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geert-h-d-voordes","type":"person","url":"https://hartvaat.nl/mensen/geert-h-d-voordes/","name":"Geert H D Voordes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/10/decision-onttrekkingssubstudie-stoppen-van-digoxine-na-lange-behandeling-leidt-t/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geir-hirlekar","type":"person","url":"https://hartvaat.nl/mensen/geir-hirlekar/","name":"Geir Hirlekar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geir-andersen","type":"person","url":"https://hartvaat.nl/mensen/geir-andersen/","name":"Geir Ø Andersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/07/10/il-8-en-infarctgrootte-en-klinische-uitkomsten-bij-stemi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2018/06/01/complementactivatie-bij-acuut-hartfalen-na-mi-correlatie-met-ernst/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gene-kim","type":"person","url":"https://hartvaat.nl/mensen/gene-kim/","name":"Gene Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/ai-echotool-voor-hfpef-hoge-specificiteit-lage-sensitiviteit-bij-invasieve-valid/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gengru-jiang","type":"person","url":"https://hartvaat.nl/mensen/gengru-jiang/","name":"Gengru Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/innovatieve-wereldwijde-modellen-voor-ckd-zorg-casestudies-en-strategieen/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geoff-gill","type":"person","url":"https://hartvaat.nl/mensen/geoff-gill/","name":"Geoff Gill","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"geoffrey-a-donnan","type":"person","url":"https://hartvaat.nl/mensen/geoffrey-a-donnan/","name":"Geoffrey A Donnan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georg-ertl","type":"person","url":"https://hartvaat.nl/mensen/georg-ertl/","name":"Georg Ertl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/22/anemie-beinvloedt-ijzerhomeostase-en-empagliflozine-respons-bij-hf/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-capuano","type":"person","url":"https://hartvaat.nl/mensen/george-capuano/","name":"George Capuano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-davey-smith","type":"person","url":"https://hartvaat.nl/mensen/george-davey-smith/","name":"George Davey Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/13/bloeddrukverlaging-en-risico-op-diabetes-type-2-lancet-bplttc-ipd-meta-analyse/","published":"2021-11-13"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-howard","type":"person","url":"https://hartvaat.nl/mensen/george-howard/","name":"George Howard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/22/aspirine-voor-primaire-preventie-bij-matig-cv-risico-lancet-arrive/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2016/03/17/langetermijnresultaten-van-stenting-versus-endarteriectomie-bij-carotisstenose/","published":"2016-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-hripcsak","type":"person","url":"https://hartvaat.nl/mensen/george-hripcsak/","name":"George Hripcsak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/16/vergelijking-van-eerstelijns-antihypertensiva-lancet-systematische-multinational/","published":"2019-11-16"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-johnson","type":"person","url":"https://hartvaat.nl/mensen/george-johnson/","name":"George Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/28/langetermijn-icd-uitkomsten-scd-heft/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2020/06/30/af-recidief-na-ablatie-versus-antiaritmica-in-cabana/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-kassimis","type":"person","url":"https://hartvaat.nl/mensen/george-kassimis/","name":"George Kassimis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/symptomatisch-versus-asymptomatisch-af-en-klinische-uitkomsten-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/01/14/residuele-lekkage-na-laa-occlusie-en-uitkomsten-meta-analyse/","published":"2024-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-moschonis","type":"person","url":"https://hartvaat.nl/mensen/george-moschonis/","name":"George Moschonis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-sopko","type":"person","url":"https://hartvaat.nl/mensen/george-sopko/","name":"George Sopko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"george-thanassoulis","type":"person","url":"https://hartvaat.nl/mensen/george-thanassoulis/","name":"George Thanassoulis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georgia-salanti","type":"person","url":"https://hartvaat.nl/mensen/georgia-salanti/","name":"Georgia Salanti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georgios-georgiopoulos","type":"person","url":"https://hartvaat.nl/mensen/georgios-georgiopoulos/","name":"Georgios Georgiopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/15/fib-4-en-fni-duiden-op-cardiorenale-en-metabole-belasting-bij-t2dm-en-masld/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2026/06/24/sglt2-remmers-en-bloeddrukdoelen-bij-hypertensief-hfpef-een-overzicht-van-richtl/","published":"2026-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"georgios-v-gkoutos","type":"person","url":"https://hartvaat.nl/mensen/georgios-v-gkoutos/","name":"Georgios V Gkoutos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/26/smartphone-detectie-van-af-via-fotoplethysmografie-meta-analyse/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerald-mutungi","type":"person","url":"https://hartvaat.nl/mensen/gerald-mutungi/","name":"Gerald Mutungi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerard-london","type":"person","url":"https://hartvaat.nl/mensen/gerard-london/","name":"Gerard London","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2019/06/01/longechogeleide-drooggewichtreductie-en-ambulante-bloeddruk-bij-hemodialyse/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerard-pasterkamp","type":"person","url":"https://hartvaat.nl/mensen/gerard-pasterkamp/","name":"Gerard Pasterkamp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/macrofaagbelasting-in-carotisplaque-voorspelt-cardiovasculaire-events-na-endarte/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2026/02/13/genetisch-bepaalde-afkomst-en-morfologische-en-moleculaire-kenmerken-van-carotis/","published":"2026-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerhard-schuler","type":"person","url":"https://hartvaat.nl/mensen/gerhard-schuler/","name":"Gerhard Schuler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerhard-wikstrom","type":"person","url":"https://hartvaat.nl/mensen/gerhard-wikstrom/","name":"Gerhard Wikström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2019/02/01/herhaalde-levosimendan-infusies-bij-gevorderd-chronisch-hf-in-de-kwetsbare-postd/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerin-r-stevens","type":"person","url":"https://hartvaat.nl/mensen/gerin-r-stevens/","name":"Gerin R Stevens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gerlando-pilato","type":"person","url":"https://hartvaat.nl/mensen/gerlando-pilato/","name":"Gerlando Pilato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"german-malaga","type":"person","url":"https://hartvaat.nl/mensen/german-malaga/","name":"Germán Malaga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/05/01/ticagrelor-versus-clopidogrel-na-fibrinolyse-bij-stemi-jama-cardiology-gerandomi/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ghassan-s-kiwan","type":"person","url":"https://hartvaat.nl/mensen/ghassan-s-kiwan/","name":"Ghassan S Kiwan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/07/colchicine-timing-en-cv-uitkomsten-na-mi-colcot-analyse/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/12/26/laaggedoseerd-colchicine-na-myocardinfarct-nejm-colcot/","published":"2019-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ghazaleh-mehdipoor","type":"person","url":"https://hartvaat.nl/mensen/ghazaleh-mehdipoor/","name":"Ghazaleh Mehdipoor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/15/bright-4-bevestiging-bivalirudine-superieur-aan-heparine-bij-stemi/","published":"2024-10-15"},{"url":"https://hartvaat.nl/2023/10/17/bivalirudine-versus-heparine-bij-nstemi-ipd-meta-analyse/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ghiath-mikdadi","type":"person","url":"https://hartvaat.nl/mensen/ghiath-mikdadi/","name":"Ghiath Mikdadi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/22/implanteerbare-monitor-voor-snellere-behandeling-bij-acs/","published":"2019-10-22"},{"url":"https://hartvaat.nl/2019/04/23/implanteerbaar-cardiaal-alertsysteem-voor-vroege-herkenning-van-stemi/","published":"2019-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ghionul-ibram","type":"person","url":"https://hartvaat.nl/mensen/ghionul-ibram/","name":"Ghionul Ibram","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2021/11/16/sacubitril-valsartan-versus-standaardtherapie-op-nt-probnp-en-inspanningscapacit/","published":"2021-11-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gholamreza-roshandel","type":"person","url":"https://hartvaat.nl/mensen/gholamreza-roshandel/","name":"Gholamreza Roshandel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/24/vaste-dosiscombinatietherapie-voor-primaire-cv-preventie-ipd-meta-analyse/","published":"2023-08-24"},{"url":"https://hartvaat.nl/2019/08/24/polypil-voor-primaire-en-secundaire-cv-preventie-lancet-polyiran/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gian-paolo-rossi","type":"person","url":"https://hartvaat.nl/mensen/gian-paolo-rossi/","name":"Gian Paolo Rossi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2022/09/01/primair-aldosteronisme-in-de-zwangerschap-systematische-review/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gian-piero-perna","type":"person","url":"https://hartvaat.nl/mensen/gian-piero-perna/","name":"Gian Piero Perna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianfranco-sinagra","type":"person","url":"https://hartvaat.nl/mensen/gianfranco-sinagra/","name":"Gianfranco Sinagra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianluigi-condorelli","type":"person","url":"https://hartvaat.nl/mensen/gianluigi-condorelli/","name":"Gianluigi Condorelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"},{"url":"https://hartvaat.nl/2018/03/01/doac-plus-antiplaatjestherapie-voor-secundaire-preventie-na-acs-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianluigi-pironti","type":"person","url":"https://hartvaat.nl/mensen/gianluigi-pironti/","name":"Gianluigi Pironti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/06/09/acyl-ghreline-verbetert-hartfunctie-bij-hartfalen/","published":"2023-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianni-d-angelini","type":"person","url":"https://hartvaat.nl/mensen/gianni-d-angelini/","name":"Gianni D Angelini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/off-pump-versus-on-pump-cabg-bij-hoofdstamcoronairlijden/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianni-mazzoni","type":"person","url":"https://hartvaat.nl/mensen/gianni-mazzoni/","name":"Gianni Mazzoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianni-tognoni","type":"person","url":"https://hartvaat.nl/mensen/gianni-tognoni/","name":"Gianni Tognoni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/22/aspirine-voor-primaire-preventie-bij-matig-cv-risico-lancet-arrive/","published":"2018-09-22"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianpaolo-palmieri","type":"person","url":"https://hartvaat.nl/mensen/gianpaolo-palmieri/","name":"Gianpaolo Palmieri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2025/01/01/serum-transthyretine-voor-en-na-tafamidisstart-als-uitkomstvoorspeller-bij-attr-/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gianpiero-d-amico","type":"person","url":"https://hartvaat.nl/mensen/gianpiero-d-amico/","name":"Gianpiero D'Amico","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gijo-thomas","type":"person","url":"https://hartvaat.nl/mensen/gijo-thomas/","name":"Gijo Thomas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2021/10/09/klinische-risicofactoren-voor-cva-bij-anticoagulantie-naieve-af-meta-analyse/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gil-chernin","type":"person","url":"https://hartvaat.nl/mensen/gil-chernin/","name":"Gil Chernin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/semaglutide-vermindert-infectierisico-bij-diabetes-en-chronische-nierziekte/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/24/flow-semaglutide-cv-voordelen-naar-ckd-ernst-bij-diabetes/","published":"2025-03-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gill-louise-buchanan","type":"person","url":"https://hartvaat.nl/mensen/gill-louise-buchanan/","name":"Gill Louise Buchanan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2020/05/14/eapci-positiedocument-invasief-acs-management-tijdens-covid-19/","published":"2020-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giorgia-grutter","type":"person","url":"https://hartvaat.nl/mensen/giorgia-grutter/","name":"Giorgia Grutter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giorgia-panichella","type":"person","url":"https://hartvaat.nl/mensen/giorgia-panichella/","name":"Giorgia Panichella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/22/cardiale-amyloidose-komt-frequent-voor-bij-hfpef-aortastenose-en-lvh-meta-analys/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/05/05/sterftecijfers-in-controle-armen-van-hartfalen-rcts-dalen-niet-ondanks-betere-ac/","published":"2026-07-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giorgio-caretta","type":"person","url":"https://hartvaat.nl/mensen/giorgio-caretta/","name":"Giorgio Caretta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giorgio-chiaranda","type":"person","url":"https://hartvaat.nl/mensen/giorgio-chiaranda/","name":"Giorgio Chiaranda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-grazzi","type":"person","url":"https://hartvaat.nl/mensen/giovanni-grazzi/","name":"Giovanni Grazzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-occhipinti","type":"person","url":"https://hartvaat.nl/mensen/giovanni-occhipinti/","name":"Giovanni Occhipinti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2024/04/02/ivus-versus-oct-versus-angiografie-voor-pci-begeleiding-meta-analyse/","published":"2024-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-peretto","type":"person","url":"https://hartvaat.nl/mensen/giovanni-peretto/","name":"Giovanni Peretto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-tortorella","type":"person","url":"https://hartvaat.nl/mensen/giovanni-tortorella/","name":"Giovanni Tortorella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giovanni-veronesi","type":"person","url":"https://hartvaat.nl/mensen/giovanni-veronesi/","name":"Giovanni Veronesi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2018/07/01/sport-versus-beroepsmatige-lichamelijke-activiteit-en-cardiovasculair-risico/","published":"2018-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"girish-m-nair","type":"person","url":"https://hartvaat.nl/mensen/girish-m-nair/","name":"Girish M Nair","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gisela-meyer","type":"person","url":"https://hartvaat.nl/mensen/gisela-meyer/","name":"Gisela Meyer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gitte-g-fornitz","type":"person","url":"https://hartvaat.nl/mensen/gitte-g-fornitz/","name":"Gitte G Fornitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulietta-grigis","type":"person","url":"https://hartvaat.nl/mensen/giulietta-grigis/","name":"Giulietta Grigis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulio-falasconi","type":"person","url":"https://hartvaat.nl/mensen/giulio-falasconi/","name":"Giulio Falasconi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giulio-pompilio","type":"person","url":"https://hartvaat.nl/mensen/giulio-pompilio/","name":"Giulio Pompilio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/28/g-csf-voor-stamcelmobilisatie-na-acuut-mi-meta-analyse/","published":"2024-10-28"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-arena","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-arena/","name":"Giuseppe Arena","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-calligaris","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-calligaris/","name":"Giuseppe Calligaris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/21/oct-versus-angiografie-bij-pci-van-verkalkte-laesies-driejaarsdata/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/11/14/ilumien-iv-oct-predictoren-van-klinische-uitkomsten-na-stentimplantatie/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-di-gioia","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-di-gioia/","name":"Giuseppe Di Gioia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/20/ticagrelor-versus-prasugrel-en-coronaire-microcirculatie-bij-pci/","published":"2023-12-20"},{"url":"https://hartvaat.nl/2016/07/12/prasugrel-versus-clopidogrel-en-coronaire-microvasculaire-functie-bij-electieve-/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-grandaliano","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-grandaliano/","name":"Giuseppe Grandaliano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-massimo-sangiorgi","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-massimo-sangiorgi/","name":"Giuseppe Massimo Sangiorgi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/24/vexus-scoring-biedt-completer-beeld-van-congestie-bij-hartfalen/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2024/03/19/nierschade-na-minimale-contrasttoediening-bij-acs/","published":"2024-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"giuseppe-vergaro","type":"person","url":"https://hartvaat.nl/mensen/giuseppe-vergaro/","name":"Giuseppe Vergaro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/22/cardiale-amyloidose-komt-frequent-voor-bij-hfpef-aortastenose-en-lvh-meta-analys/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gladwell-gathecha","type":"person","url":"https://hartvaat.nl/mensen/gladwell-gathecha/","name":"Gladwell Gathecha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gladys-e-maestre","type":"person","url":"https://hartvaat.nl/mensen/gladys-e-maestre/","name":"Gladys E Maestre","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"glenn-carlson","type":"person","url":"https://hartvaat.nl/mensen/glenn-carlson/","name":"Glenn Carlson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/25/zenith-ckd-zibotentan-plus-dapagliflozine-bij-ckd-lancet/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2016/02/16/ticagrelor-versus-clopidogrel-bij-troponine-negatieve-laagrisico-acs-met-ad-hoc-/","published":"2016-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gonzalo-calvo","type":"person","url":"https://hartvaat.nl/mensen/gonzalo-calvo/","name":"Gonzalo Calvo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gopi-dandamudi","type":"person","url":"https://hartvaat.nl/mensen/gopi-dandamudi/","name":"Gopi Dandamudi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/28/cryoballonablatie-als-initiele-therapie-voor-af-nejm-early-af/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2019/07/09/his-correctieve-pacing-versus-biventriculaire-pacing-voor-crt-bij-hartfalen/","published":"2019-07-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"goran-milasinovic","type":"person","url":"https://hartvaat.nl/mensen/goran-milasinovic/","name":"Goran Milasinovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/05/biventriculair-versus-rv-pacing-bij-patienten-met-verwachte-frequente-pacing/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2016/07/12/nervus-vagus-stimulatie-bij-hartfalen-de-inovate-hf-trial/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gorav-batra","type":"person","url":"https://hartvaat.nl/mensen/gorav-batra/","name":"Gorav Batra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gordon","type":"person","url":"https://hartvaat.nl/mensen/gordon/","name":"Gordon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/proteomics-onthult-vier-subgroepen-van-acuut-hfpef-met-eigen-biologische-routes-/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gordon-chelune","type":"person","url":"https://hartvaat.nl/mensen/gordon-chelune/","name":"Gordon Chelune","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gordon-f-tomaselli","type":"person","url":"https://hartvaat.nl/mensen/gordon-f-tomaselli/","name":"Gordon F Tomaselli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gordon-ho","type":"person","url":"https://hartvaat.nl/mensen/gordon-ho/","name":"Gordon Ho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ai-gestuurde-ecg-lokalisatie-verbetert-ablatie-bij-instabiele-ventriculaire-tach/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2020/04/01/p2y12-remmers-met-oac-bij-af-na-pci-meta-analyse/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gordon-mcgregor","type":"person","url":"https://hartvaat.nl/mensen/gordon-mcgregor/","name":"Gordon McGregor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/revalidatie-bij-chronisch-hf-systematische-review-van-inspanningsinterventies/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2018/08/01/laagfrequente-elektrische-spierstimulatie-en-endotheelfunctie-bij-gevorderd-hart/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"grace-shedul","type":"person","url":"https://hartvaat.nl/mensen/grace-shedul/","name":"Grace Shedul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"graham-a-macgregor","type":"person","url":"https://hartvaat.nl/mensen/graham-a-macgregor/","name":"Graham A MacGregor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/01/bloeddrukverlagende-medicatie-en-natriumbeperking-gecombineerd-effect/","published":"2024-11-01"},{"url":"https://hartvaat.nl/2016/06/01/matige-zoutreductie-verlaagt-bloeddruk-en-albuminurie-bij-gestoorde-glucosetoler/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"grant-d-huang","type":"person","url":"https://hartvaat.nl/mensen/grant-d-huang/","name":"Grant D Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/29/chloortalidon-versus-hydrochloorthiazide-geen-verschil-in-cv-events/","published":"2022-12-29"},{"url":"https://hartvaat.nl/2019/01/10/endoscopische-versus-open-veneoogst-bij-cabg-nejm-regroup/","published":"2019-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gray","type":"person","url":"https://hartvaat.nl/mensen/gray/","name":"Gray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/02/12/ct-coronairangiografie-bij-nstemi-uitstekende-diagnostische-nauwkeurigheid-maar-/","published":"2026-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"grazia-canciello","type":"person","url":"https://hartvaat.nl/mensen/grazia-canciello/","name":"Grazia Canciello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/langetermijnwaarde-van-inspanningstesten-bij-hypertrofische-cardiomyopathie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2017/01/01/ontwikkeling-van-linkerventrikelhypertrofie-bij-behandelde-hypertensie-campania-/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregor-thalmann","type":"person","url":"https://hartvaat.nl/mensen/gregor-thalmann/","name":"Gregor Thalmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregorio-romero-gonzalez","type":"person","url":"https://hartvaat.nl/mensen/gregorio-romero-gonzalez/","name":"Gregorio Romero-González","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/tijd-voor-een-vijfde-pijler-bij-lichamelijk-onderzoek-van-kinderen-aan-dialyse/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/03/01/bij-niervervanging-bescherm-het-hart/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregorio-t-obrador","type":"person","url":"https://hartvaat.nl/mensen/gregorio-t-obrador/","name":"Gregorio T Obrador","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregorio-de-lara","type":"person","url":"https://hartvaat.nl/mensen/gregorio-de-lara/","name":"Gregorio de Lara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/13/verisec-register-vericiguat-halveert-hartfalen-decompensaties-bij-hfref-in-dagel/","published":"2026-06-21"},{"url":"https://hartvaat.nl/2026/05/13/verisec-vericiguat-in-de-praktijk-halveert-hartfalen-decompensaties-bij-hfref-sp/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-a-harshfield","type":"person","url":"https://hartvaat.nl/mensen/gregory-a-harshfield/","name":"Gregory A Harshfield","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/natriumreductie-verhoogt-korte-keten-vetzuren-bij-onbehandelde-hypertensie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/07/01/natriumreductie-metaboloom-en-cv-risico-bij-onbehandelde-zwarte-hypertensie/","published":"2019-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gregory-chlouverakis","type":"person","url":"https://hartvaat.nl/mensen/gregory-chlouverakis/","name":"Gregory Chlouverakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"greig-dougall","type":"person","url":"https://hartvaat.nl/mensen/greig-dougall/","name":"Greig Dougall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"grigorios-papageorgiou","type":"person","url":"https://hartvaat.nl/mensen/grigorios-papageorgiou/","name":"Grigorios Papageorgiou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"grzegorz-kopec","type":"person","url":"https://hartvaat.nl/mensen/grzegorz-kopec/","name":"Grzegorz Kopeć","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guang-hao","type":"person","url":"https://hartvaat.nl/mensen/guang-hao/","name":"Guang Hao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2020/05/01/werkplek-multicomponentinterventie-voor-hypertensie-jama-cardiology/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gudaye-tasissa","type":"person","url":"https://hartvaat.nl/mensen/gudaye-tasissa/","name":"Gudaye Tasissa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/07/07/orbusneich-combo-stent-japan-usa-harmonee-gerandomiseerde-multicenter-trial/","published":"2018-07-07"},{"url":"https://hartvaat.nl/2017/03/28/adaptieve-servoventilatie-bij-hartfalen-de-cat-hf-trial/","published":"2017-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gudmundur-thorgeirsson","type":"person","url":"https://hartvaat.nl/mensen/gudmundur-thorgeirsson/","name":"Gudmundur Thorgeirsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guichu-li","type":"person","url":"https://hartvaat.nl/mensen/guichu-li/","name":"Guichu Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guidong-shen","type":"person","url":"https://hartvaat.nl/mensen/guidong-shen/","name":"Guidong Shen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guilherme-fenelon","type":"person","url":"https://hartvaat.nl/mensen/guilherme-fenelon/","name":"Guilherme Fenelon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guillaume-turc","type":"person","url":"https://hartvaat.nl/mensen/guillaume-turc/","name":"Guillaume Turc","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-bij-basilarisocclusie-tot-24-uur-veelbelovende-lancet-data/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gunnar-jensen","type":"person","url":"https://hartvaat.nl/mensen/gunnar-jensen/","name":"Gunnar Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/01/icd-implantatie-en-gezondheidsgerelateerde-kwaliteit-van-leven-danish/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2016/09/29/icd-implantatie-bij-niet-ischemisch-systolisch-hartfalen-nejm-danish-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guobin-su","type":"person","url":"https://hartvaat.nl/mensen/guobin-su/","name":"Guobin Su","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/30/combinatietherapie-met-vier-pilaren-verlaagt-nierfalenrisico-bij-ckd/","published":"2026-08-02"},{"url":"https://hartvaat.nl/2026/05/29/lichaamsrondheidsindex-bri-voorspelt-sterfte-bij-nierpatienten-beter-dan-bmi/","published":"2026-07-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guocheng-ren","type":"person","url":"https://hartvaat.nl/mensen/guocheng-ren/","name":"Guocheng Ren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guohai-su","type":"person","url":"https://hartvaat.nl/mensen/guohai-su/","name":"Guohai Su","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guotao-fu","type":"person","url":"https://hartvaat.nl/mensen/guotao-fu/","name":"Guotao Fu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guray-erus","type":"person","url":"https://hartvaat.nl/mensen/guray-erus/","name":"Guray Erus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gurusher-panjrath","type":"person","url":"https://hartvaat.nl/mensen/gurusher-panjrath/","name":"Gurusher Panjrath","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2021/10/26/vroege-impedantie-geleide-interventie-verbetert-langetermijn-hf-uitkomsten/","published":"2021-10-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gustavo-morales","type":"person","url":"https://hartvaat.nl/mensen/gustavo-morales/","name":"Gustavo Morales","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/31/vrouwen-met-persisterend-af-pvi-alleen-is-onvoldoende/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2021/01/28/cryoballonablatie-als-initiele-therapie-voor-af-nejm-early-af/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guus-a-de-waard","type":"person","url":"https://hartvaat.nl/mensen/guus-a-de-waard/","name":"Guus A de Waard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"guy-piegari","type":"person","url":"https://hartvaat.nl/mensen/guy-piegari/","name":"Guy Piegari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gyorgy-paragh","type":"person","url":"https://hartvaat.nl/mensen/gyorgy-paragh/","name":"György Paragh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"goran-bergstrom","type":"person","url":"https://hartvaat.nl/mensen/goran-bergstrom/","name":"Göran Bergström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/20/darmmicrobiota-en-geschatte-glomerulaire-filtratiesnelheid-in-twee-zweedse-cohor/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2025/10/22/lagere-cardiorespiratoire-fitheid-en-atherosclerose-ondanks-cac-score-nul-scapis/","published":"2025-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"gotz-gelbrich","type":"person","url":"https://hartvaat.nl/mensen/gotz-gelbrich/","name":"Götz Gelbrich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/06/28/escitalopram-bij-hartfalen-en-depressie-de-mood-hf-trial/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"h-ardeschir-ghofrani","type":"person","url":"https://hartvaat.nl/mensen/h-ardeschir-ghofrani/","name":"H Ardeschir Ghofrani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"h-bart-van-der-worp","type":"person","url":"https://hartvaat.nl/mensen/h-bart-van-der-worp/","name":"H Bart van der Worp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"h-bryan-brewer","type":"person","url":"https://hartvaat.nl/mensen/h-bryan-brewer/","name":"H Bryan Brewer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/18/evacetrapib-en-cardiovasculaire-uitkomsten-bij-hoog-vasculair-risico-nejm-accele/","published":"2017-05-18"},{"url":"https://hartvaat.nl/2016/02/07/impact-van-pcsk9-remmers-op-lipidenniveaus-en-uitkomsten-netwerkmeta-analyse/","published":"2016-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"h-m","type":"person","url":"https://hartvaat.nl/mensen/h-m/","name":"H. M.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/04/angina-toevoegen-aan-de-h2fpef-score-verbetert-hfpef-diagnose-bij-vrouwen-geen-w/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/05/20/hypochloremie-bij-opname-voor-acuut-hartfalen-voorspelt-onafhankelijk-30-daagse-/","published":"2026-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"h-n","type":"person","url":"https://hartvaat.nl/mensen/h-n/","name":"H. N.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/02/is-depressie-een-onafhankelijke-risicofactor-voor-sterfte-bij-hart-en-vaatziekte/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2026/01/09/hartfalendiagnostiek-na-corona-bijna-niemand-kreeg-de-echo-binnen-de-aanbevolen-/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"h-o","type":"person","url":"https://hartvaat.nl/mensen/h-o/","name":"H. O.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/21/genetische-test-bij-cardiomyopathie-huidige-britse-criteria-missen-een-op-de-zev/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2026/01/09/endocarditis-van-de-natieve-klep-verschuift-naar-ouderen-chirurgie-blijft-levens/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"habib-khan","type":"person","url":"https://hartvaat.nl/mensen/habib-khan/","name":"Habib Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2016/12/07/linker-hartoorsluiting-uitkomsten-en-kosten-van-trial-en-real-world-versus-orale/","published":"2016-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hadi-younes","type":"person","url":"https://hartvaat.nl/mensen/hadi-younes/","name":"Hadi Younes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/decaaf-ii-af-last-en-symptoomreductie-na-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/08/02/decaaf-ii-fibroselocatie-beinvloedt-af-recidief-na-ablatie/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hageman","type":"person","url":"https://hartvaat.nl/mensen/hageman/","name":"Hageman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/16/smart2-risicomodel-onderschat-het-recidiefrisico-bij-kwetsbare-groepen-leids-haa/","published":"2026-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"haidong-kan","type":"person","url":"https://hartvaat.nl/mensen/haidong-kan/","name":"Haidong Kan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/luchtvervuiling-verhoogt-sterfte-door-hypertensie-case-crossover-studie-bij-2-1-/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2017/08/15/fijnstofblootstelling-en-stresshormoonspiegels-gerandomiseerde-luchtzuiveringstr/","published":"2017-08-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hailei-liu","type":"person","url":"https://hartvaat.nl/mensen/hailei-liu/","name":"Hailei Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/05/07/aanvullende-substraatmodificatie-bij-persisterend-af-met-low-voltage-gebieden/","published":"2025-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hailun-qin","type":"person","url":"https://hartvaat.nl/mensen/hailun-qin/","name":"Hailun Qin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/28/atriumfibrilleren-en-hartfalen-versterken-elkaar-en-verhogen-sterfte-aanzienlijk/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2024/08/01/candesartan-dosering-bij-mannen-versus-vrouwen-met-chronisch-hartfalen/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"haitao-zhang","type":"person","url":"https://hartvaat.nl/mensen/haitao-zhang/","name":"Haitao Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hamayak-sisakian","type":"person","url":"https://hartvaat.nl/mensen/hamayak-sisakian/","name":"Hamayak Sisakian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2020/12/01/longechogeleide-therapie-vermindert-acute-decompensatie-bij-chronisch-hf/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hamid-sharif-khan","type":"person","url":"https://hartvaat.nl/mensen/hamid-sharif-khan/","name":"Hamid Sharif Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/11/ivus-acs-ivus-geleide-pci-bij-acs-superieur-lancet/","published":"2024-05-11"},{"url":"https://hartvaat.nl/2024/05/11/ticagrelor-monotherapie-versus-dapt-na-1-maand-bij-acs-lancet-rct/","published":"2024-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hamilton","type":"person","url":"https://hartvaat.nl/mensen/hamilton/","name":"Hamilton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/01/29/verminderde-pompfunctie-na-een-hartinfarct-hoge-symptoomlast-en-slechtere-secund/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"han-cheol-lee","type":"person","url":"https://hartvaat.nl/mensen/han-cheol-lee/","name":"Han Cheol Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"han-feng","type":"person","url":"https://hartvaat.nl/mensen/han-feng/","name":"Han Feng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/decaaf-ii-af-last-en-symptoomreductie-na-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/08/02/decaaf-ii-fibroselocatie-beinvloedt-af-recidief-na-ablatie/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"han-ya-ling","type":"person","url":"https://hartvaat.nl/mensen/han-ya-ling/","name":"Han Ya-Ling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hang-guo","type":"person","url":"https://hartvaat.nl/mensen/hang-guo/","name":"Hang Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hani-salehi-had","type":"person","url":"https://hartvaat.nl/mensen/hani-salehi-had/","name":"Hani Salehi-Had","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/23/photon-aflibercept-8-mg-bij-diabetisch-macula-oedeem-verlengd-doseerinterval/","published":"2024-03-23"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hanne-berg-ravn","type":"person","url":"https://hartvaat.nl/mensen/hanne-berg-ravn/","name":"Hanne Berg Ravn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2018/04/24/hoge-versus-lage-bloeddrukstreefwaarden-tijdens-cardiopulmonale-bypass-en-cerebr/","published":"2018-04-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hanney-gonna","type":"person","url":"https://hartvaat.nl/mensen/hanney-gonna/","name":"Hanney Gonna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2021/02/05/slokdarmbescherming-met-temperatuurcontroleren-bij-af-ablatie-impact/","published":"2021-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hanno-l-tan","type":"person","url":"https://hartvaat.nl/mensen/hanno-l-tan/","name":"Hanno L Tan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2019/05/01/frequente-premature-atriale-contracties-en-af-hersenischemie-en-mortaliteit-meta/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hanno-ulmer","type":"person","url":"https://hartvaat.nl/mensen/hanno-ulmer/","name":"Hanno Ulmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/03/cardiale-shockwave-therapie-bij-cabg-verbetert-myocardfunctie/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2019/02/01/herhaalde-levosimendan-infusies-bij-gevorderd-chronisch-hf-in-de-kwetsbare-postd/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-a-bosker","type":"person","url":"https://hartvaat.nl/mensen/hans-a-bosker/","name":"Hans A Bosker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-gustav-hrsted-thyregod","type":"person","url":"https://hartvaat.nl/mensen/hans-gustav-hrsted-thyregod/","name":"Hans Gustav Hørsted Thyregod","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2024/04/01/notion-10-jaar-tavr-versus-chirurgie-bij-laagrisico-aortastenose/","published":"2024-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-kottkamp","type":"person","url":"https://hartvaat.nl/mensen/hans-kottkamp/","name":"Hans Kottkamp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-kragten","type":"person","url":"https://hartvaat.nl/mensen/hans-kragten/","name":"Hans Kragten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-olsson","type":"person","url":"https://hartvaat.nl/mensen/hans-olsson/","name":"Hans Olsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-rickli","type":"person","url":"https://hartvaat.nl/mensen/hans-rickli/","name":"Hans Rickli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hans-van-der-hoeven","type":"person","url":"https://hartvaat.nl/mensen/hans-van-der-hoeven/","name":"Hans van der Hoeven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hao-chen","type":"person","url":"https://hartvaat.nl/mensen/hao-chen/","name":"Hao Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/causaal-verband-tussen-mitochondriale-genen-en-carotisplaques-multi-omics-mr-stu/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hao-li","type":"person","url":"https://hartvaat.nl/mensen/hao-li/","name":"Hao Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hao-wang","type":"person","url":"https://hartvaat.nl/mensen/hao-wang/","name":"Hao Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hao-yu","type":"person","url":"https://hartvaat.nl/mensen/hao-yu/","name":"Hao Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/09/vertraagde-afgifteformulering-van-ivabradine-bij-systolisch-hartfalen/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2017/12/01/voorkeur-voor-pikant-eten-versterkt-zoutwaarneming-en-vermindert-zoutinname-en-b/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hao-zhang","type":"person","url":"https://hartvaat.nl/mensen/hao-zhang/","name":"Hao Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2022/12/22/orthostatische-bloeddruk-en-intensieve-behandeling-sprint-inzichten/","published":"2022-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hao-min-cheng","type":"person","url":"https://hartvaat.nl/mensen/hao-min-cheng/","name":"Hao-Min Cheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"haoyu-weng","type":"person","url":"https://hartvaat.nl/mensen/haoyu-weng/","name":"Haoyu Weng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2022/06/01/interatriale-shuntdevices-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2022-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harald-arnesen","type":"person","url":"https://hartvaat.nl/mensen/harald-arnesen/","name":"Harald Arnesen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/11/p2y12-monotherapie-versus-aspirine-voor-langetermijnsecundaire-preventie-meta-an/","published":"2023-07-11"},{"url":"https://hartvaat.nl/2021/02/09/omega-3-vetzuren-bij-oudere-mi-patienten-omemi-gerandomiseerde-trial/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harald-herkner","type":"person","url":"https://hartvaat.nl/mensen/harald-herkner/","name":"Harald Herkner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/prehospitale-hypothermie-bij-stemi-gerandomiseerde-trial/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2017/02/01/vernakalant-versus-ibutilide-voor-sinusritme-bij-recent-onset-af-gerandomiseerde/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harald-lapp","type":"person","url":"https://hartvaat.nl/mensen/harald-lapp/","name":"Harald Lapp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"haris-haqqani","type":"person","url":"https://hartvaat.nl/mensen/haris-haqqani/","name":"Haris Haqqani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2021/07/18/procedurevolume-en-complicaties-bij-af-ablatie-meta-analyse/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harold-e-bays","type":"person","url":"https://hartvaat.nl/mensen/harold-e-bays/","name":"Harold E Bays","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2019/03/14/bempedoinezuur-voor-ldl-verlaging-nejm-veiligheid-en-werkzaamheid/","published":"2019-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"harshil-dhutia","type":"person","url":"https://hartvaat.nl/mensen/harshil-dhutia/","name":"Harshil Dhutia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/cardiale-screening-bij-104-369-jongeren-opbrengst-interventies-en-incidentie-van/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/07/01/geleidingssysteempacing-versus-biventriculaire-pacing-bij-av-blok-vergelijkende-/","published":"2025-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hasan-k-siddiqi","type":"person","url":"https://hartvaat.nl/mensen/hasan-k-siddiqi/","name":"Hasan K Siddiqi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hasnain-m-dalal","type":"person","url":"https://hartvaat.nl/mensen/hasnain-m-dalal/","name":"Hasnain M Dalal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/09/01/hartrevalidatie-en-lichamelijke-activiteit-systematische-review-en-meta-analyse/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heather-baker","type":"person","url":"https://hartvaat.nl/mensen/heather-baker/","name":"Heather Baker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heather-j-ross","type":"person","url":"https://hartvaat.nl/mensen/heather-j-ross/","name":"Heather J Ross","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hector-m-garcia-garcia","type":"person","url":"https://hartvaat.nl/mensen/hector-m-garcia-garcia/","name":"Hector M Garcia-Garcia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2017/10/21/ultradunne-bioresorbeerbare-versus-dunne-duurzame-polymer-stents-lancet-bioscien/","published":"2017-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heidi-krause-steinrauf","type":"person","url":"https://hartvaat.nl/mensen/heidi-krause-steinrauf/","name":"Heidi Krause-Steinrauf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heidrun-bosch-traberg","type":"person","url":"https://hartvaat.nl/mensen/heidrun-bosch-traberg/","name":"Heidrun Bosch-Traberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/semaglutide-vermindert-infectierisico-bij-diabetes-en-chronische-nierziekte/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","published":"2024-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heiko-bugger","type":"person","url":"https://hartvaat.nl/mensen/heiko-bugger/","name":"Heiko Bugger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heiko-rauer","type":"person","url":"https://hartvaat.nl/mensen/heiko-rauer/","name":"Heiko Rauer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/27/periprocedurele-antistolling-bij-eliminate-af-ononderbroken-edoxaban-versus-vka/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2019/09/21/ononderbroken-edoxaban-versus-vka-bij-af-ablatie-eliminate-af/","published":"2019-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heinz-drexel","type":"person","url":"https://hartvaat.nl/mensen/heinz-drexel/","name":"Heinz Drexel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heinz-peter-schultheiss","type":"person","url":"https://hartvaat.nl/mensen/heinz-peter-schultheiss/","name":"Heinz-Peter Schultheiss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heleen-m-oudemans-van-straaten","type":"person","url":"https://hartvaat.nl/mensen/heleen-m-oudemans-van-straaten/","name":"Heleen M Oudemans-van Straaten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helen-campbell","type":"person","url":"https://hartvaat.nl/mensen/helen-campbell/","name":"Helen Campbell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helen-mayo","type":"person","url":"https://hartvaat.nl/mensen/helen-mayo/","name":"Helen Mayo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/21/vroegtijdig-staken-van-ticagrelor-bij-secundaire-cv-preventie-jacc-review/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2016/08/01/sedentair-gedrag-en-cardiovasculair-risico-continue-dosis-responsrelatie-in-meta/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helen-williams","type":"person","url":"https://hartvaat.nl/mensen/helen-williams/","name":"Helen Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/26/systematische-identificatie-van-familiaire-hypercholesterolemie-geactualiseerde-/","published":"2025-12-26"},{"url":"https://hartvaat.nl/2023/01/11/inadequate-noac-dosering-bij-af-uitkomsten-en-oorzaken-meta-analyse/","published":"2023-01-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helena-malmborg","type":"person","url":"https://hartvaat.nl/mensen/helena-malmborg/","name":"Helena Malmborg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/19/katheterablatie-versus-antiaritmica-en-kwaliteit-van-leven-bij-af-jama-captaf/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/10/01/enkele-versus-dubbele-cryoballon-applicatie-bij-af-effectiviteit-en-veiligheid/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helge-servatius","type":"person","url":"https://hartvaat.nl/mensen/helge-servatius/","name":"Helge Servatius","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helmut-klein","type":"person","url":"https://hartvaat.nl/mensen/helmut-klein/","name":"Helmut Klein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2017/09/01/budapest-crt-upgrade-study-studieontwerp-voor-crt-upgrade/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helmut-puererfellner","type":"person","url":"https://hartvaat.nl/mensen/helmut-puererfellner/","name":"Helmut Puererfellner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hemant-chumun","type":"person","url":"https://hartvaat.nl/mensen/hemant-chumun/","name":"Hemant Chumun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hendrik-gremmels","type":"person","url":"https://hartvaat.nl/mensen/hendrik-gremmels/","name":"Hendrik Gremmels","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/foetale-groeirestrictie-en-bloeddruk-tegenstrijdige-effecten-bij-mens-en-rat-met/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/11/01/sildenafil-tijdens-de-zwangerschap-preklinische-meta-analyse-over-foetale-groei-/","published":"2017-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hendrik-johannes-harms","type":"person","url":"https://hartvaat.nl/mensen/hendrik-johannes-harms/","name":"Hendrik Johannes Harms","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/metformine-remt-proliferatie-van-fibro-adipogene-stamcellen-uit-falende-harten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henk-everaars","type":"person","url":"https://hartvaat.nl/mensen/henk-everaars/","name":"Henk Everaars","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/temporele-veranderingen-in-coronaire-hemodynamiek-bij-niet-culprit-vaten-na-stem/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/microvasculaire-schade-bij-gerevasculariseerde-stemi-met-ticagrelor-versus-prasu/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henneke-versteeg","type":"person","url":"https://hartvaat.nl/mensen/henneke-versteeg/","name":"Henneke Versteeg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/02/remote-monitoring-en-klinische-uitkomsten-bij-europese-hf-met-icd-langetermijn/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2019/09/01/remote-monitoring-en-patientgerapporteerde-uitkomsten-bij-europese-hf-patienten-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henri-gruwez","type":"person","url":"https://hartvaat.nl/mensen/henri-gruwez/","name":"Henri Gruwez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/02/05/smartphone-ppg-voor-af-detectie-en-management-verbeterde-screening/","published":"2025-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henrik-schirmer","type":"person","url":"https://hartvaat.nl/mensen/henrik-schirmer/","name":"Henrik Schirmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henrique-barros","type":"person","url":"https://hartvaat.nl/mensen/henrique-barros/","name":"Henrique Barros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henry-j-dargie","type":"person","url":"https://hartvaat.nl/mensen/henry-j-dargie/","name":"Henry J Dargie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"henry-volzke","type":"person","url":"https://hartvaat.nl/mensen/henry-volzke/","name":"Henry Völzke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"herbert-d-aronow","type":"person","url":"https://hartvaat.nl/mensen/herbert-d-aronow/","name":"Herbert D Aronow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2019/04/09/sham-gecontroleerde-rct-s-van-renale-denervatie-meta-analyse/","published":"2019-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"herbert-haught","type":"person","url":"https://hartvaat.nl/mensen/herbert-haught/","name":"Herbert Haught","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2016/01/05/varenicline-voor-stoppen-met-roken-bij-patienten-opgenomen-met-acuut-coronair-sy/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"herbert-noack","type":"person","url":"https://hartvaat.nl/mensen/herbert-noack/","name":"Herbert Noack","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/23/dabigatran-versus-warfarine-bij-af-met-kleplijden-re-ly-analyse/","published":"2016-08-23"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hermann-haller","type":"person","url":"https://hartvaat.nl/mensen/hermann-haller/","name":"Hermann Haller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/23/sglt2-remming-verbetert-leeftijdsafhankelijke-microvasculaire-rarefactie-van-de-/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2017/05/01/aanhoudende-bloeddrukreductie-met-baroreceptoractivatietherapie-6-jaarsfollow-up/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hermann-reichenspurner","type":"person","url":"https://hartvaat.nl/mensen/hermann-reichenspurner/","name":"Hermann Reichenspurner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hernan-mejia-renteria","type":"person","url":"https://hartvaat.nl/mensen/hernan-mejia-renteria/","name":"Hernán Mejía-Rentería","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hester-m-den-ruijter","type":"person","url":"https://hartvaat.nl/mensen/hester-m-den-ruijter/","name":"Hester M den Ruijter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/28/geen-sekseverschillen-in-werkzaamheid-van-hartfalenmedicatie-meta-analyse-van-13/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2019/03/19/aanbevolen-hf-medicatie-en-bijwerkingen-bij-vrouwen/","published":"2019-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hideaki-jinnouchi","type":"person","url":"https://hartvaat.nl/mensen/hideaki-jinnouchi/","name":"Hideaki Jinnouchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/07/febuxostat-voor-cerebraal-en-cardiorenovasculaire-eventpreventie-freed/","published":"2019-06-07"},{"url":"https://hartvaat.nl/2017/02/14/laaggedoseerde-aspirine-voor-primaire-cardiovasculaire-preventie-bij-diabetes-ty/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hideki-okayama","type":"person","url":"https://hartvaat.nl/mensen/hideki-okayama/","name":"Hideki Okayama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hidemi-sorimachi","type":"person","url":"https://hartvaat.nl/mensen/hidemi-sorimachi/","name":"Hidemi Sorimachi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/dapagliflozine-en-rv-pulmonale-interactie-bij-hfpef/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/09/05/cameo-dapa-cardiale-en-metabole-effecten-van-dapagliflozine-bij-hfpef/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hidenori-komiyama","type":"person","url":"https://hartvaat.nl/mensen/hidenori-komiyama/","name":"Hidenori Komiyama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2019/08/14/langetermijn-ticagrelor-monotherapie-na-1-maand-dapt-bij-complexe-pci-global-lea/","published":"2019-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hideo-matama","type":"person","url":"https://hartvaat.nl/mensen/hideo-matama/","name":"Hideo Matama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hilary-p-grocott","type":"person","url":"https://hartvaat.nl/mensen/hilary-p-grocott/","name":"Hilary P Grocott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hildegard-tanner","type":"person","url":"https://hartvaat.nl/mensen/hildegard-tanner/","name":"Hildegard Tanner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hillary-bracken","type":"person","url":"https://hartvaat.nl/mensen/hillary-bracken/","name":"Hillary Bracken","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/21/orale-antihypertensiva-bij-ernstige-hypertensie-in-de-zwangerschap-lancet-vergel/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2017/08/12/foley-katheter-versus-misoprostol-voor-inleiden-bij-hypertensieve-zwangeren-in-i/","published":"2017-08-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hirofumi-tomiyama","type":"person","url":"https://hartvaat.nl/mensen/hirofumi-tomiyama/","name":"Hirofumi Tomiyama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/01/canagliflozine-bij-diabetes-type-2-met-chronisch-hf-candle-gerandomiseerde-trial/","published":"2020-08-01"},{"url":"https://hartvaat.nl/2018/06/01/interarmbloeddrukverschil-en-beroerte-ipd-meta-analyse/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroki-a-ueyama","type":"person","url":"https://hartvaat.nl/mensen/hiroki-a-ueyama/","name":"Hiroki A Ueyama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiromi-rakugi","type":"person","url":"https://hartvaat.nl/mensen/hiromi-rakugi/","name":"Hiromi Rakugi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/01/esaxerenon-versus-eplerenon-bij-essentiele-hypertensie-esax-htn-fase-3/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/02/01/bereikte-bloeddruk-en-cardiovasculaire-uitkomsten-bij-oudere-patienten-met-geiso/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroo-takayama","type":"person","url":"https://hartvaat.nl/mensen/hiroo-takayama/","name":"Hiroo Takayama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2019/02/19/lv-unloading-tijdens-ecmo-bij-cardiogene-shock/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroshi-iwata","type":"person","url":"https://hartvaat.nl/mensen/hiroshi-iwata/","name":"Hiroshi Iwata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroshi-nakagawa","type":"person","url":"https://hartvaat.nl/mensen/hiroshi-nakagawa/","name":"Hiroshi Nakagawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hirotsugu-ueshima","type":"person","url":"https://hartvaat.nl/mensen/hirotsugu-ueshima/","name":"Hirotsugu Ueshima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/30/visinname-en-visgerelateerde-metabolieten-geassocieerd-met-lagere-triglyceriden-/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2019/01/01/levenslangrisico-op-cva-en-coronairlijden-naar-bloeddrukniveau-epoch-japan/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroyuki-daida","type":"person","url":"https://hartvaat.nl/mensen/hiroyuki-daida/","name":"Hiroyuki Daida","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hiroyuki-takenaka","type":"person","url":"https://hartvaat.nl/mensen/hiroyuki-takenaka/","name":"Hiroyuki Takenaka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hirsch","type":"person","url":"https://hartvaat.nl/mensen/hirsch/","name":"Hirsch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/sekseverschillen-bij-infectieuze-endocarditis-vrouwen-vaker-conservatief-behande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/02/23/objectief-gemeten-lichaamsbeweging-en-levenskwaliteit-bij-hypertrofische-cardiom/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hitoshi-minamiguchi","type":"person","url":"https://hartvaat.nl/mensen/hitoshi-minamiguchi/","name":"Hitoshi Minamiguchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hlebowicz","type":"person","url":"https://hartvaat.nl/mensen/hlebowicz/","name":"Hlebowicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/langetermijnuitkomsten-na-de-ross-operatie-een-op-de-vier-krijgt-een-heroperatie/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hocine-tighiouart","type":"person","url":"https://hartvaat.nl/mensen/hocine-tighiouart/","name":"Hocine Tighiouart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/clorotic-subanalyse-acute-egfr-daling-door-thiaziden-bij-acuut-hf-is-geen-progno/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2019/11/01/acute-egfr-daling-door-enalapril-en-mortaliteit-bij-hf-met-ckd/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"holger-woehrle","type":"person","url":"https://hartvaat.nl/mensen/holger-woehrle/","name":"Holger Woehrle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/01/biomarkers-bij-hf-met-centrale-slaapapneu-serve-hf/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2017/03/28/adaptieve-servoventilatie-bij-hartfalen-de-cat-hf-trial/","published":"2017-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"holly-p-morgan","type":"person","url":"https://hartvaat.nl/mensen/holly-p-morgan/","name":"Holly P Morgan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hong-wang","type":"person","url":"https://hartvaat.nl/mensen/hong-wang/","name":"Hong Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/01/biomarker-gestuurde-farmacotherapie-biedt-raamwerk-voor-precisiebehandeling-bij-/","published":"2026-08-15"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hongjian-li","type":"person","url":"https://hartvaat.nl/mensen/hongjian-li/","name":"Hongjian Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/07/baxdrostat-verlaagt-bloeddruk-significant-bij-resistente-hypertensie/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/03/07/bax24-baxdrostat-en-ambulante-bloeddruk-bij-resistente-hypertensie/","published":"2026-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hongli-lin","type":"person","url":"https://hartvaat.nl/mensen/hongli-lin/","name":"Hongli Lin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hongqiu-yang","type":"person","url":"https://hartvaat.nl/mensen/hongqiu-yang/","name":"Hongqiu Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"},{"url":"https://hartvaat.nl/2017/07/18/palliatieve-zorg-bij-hartfalen-de-pal-hf-gerandomiseerde-trial/","published":"2017-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hongtao-yu","type":"person","url":"https://hartvaat.nl/mensen/hongtao-yu/","name":"Hongtao Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/laroprovstat-eerste-orale-pcsk9-remmer-haalt-80-ldl-reductie-in-combinatie-met-r/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/06/03/pursuit-orale-pcsk9-remmer-voor-hypercholesterolemie-gerandomiseerde-trial/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hongwei-pan","type":"person","url":"https://hartvaat.nl/mensen/hongwei-pan/","name":"Hongwei Pan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hossein-poustchi","type":"person","url":"https://hartvaat.nl/mensen/hossein-poustchi/","name":"Hossein Poustchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/08/24/polypil-voor-primaire-en-secundaire-cv-preventie-lancet-polyiran/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hsiaowei-deng","type":"person","url":"https://hartvaat.nl/mensen/hsiaowei-deng/","name":"Hsiaowei Deng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/21/rivaroxaban-en-cva-tia-bij-hf-met-coronairlijden-en-sinusritme-commander-hf/","published":"2019-11-21"},{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hsuan-ming-tsao","type":"person","url":"https://hartvaat.nl/mensen/hsuan-ming-tsao/","name":"Hsuan-Ming Tsao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hu-wang","type":"person","url":"https://hartvaat.nl/mensen/hu-wang/","name":"Hu Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/05/grsf1-beschermt-tegen-hartfalen-door-bcaa-homeostase-te-handhaven/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2026/01/01/insulineresistentie-en-bloeddrukcontrole-op-cognitieve-uitkomsten/","published":"2026-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hua-wang","type":"person","url":"https://hartvaat.nl/mensen/hua-wang/","name":"Hua Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hualing-liu","type":"person","url":"https://hartvaat.nl/mensen/hualing-liu/","name":"Hualing Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"huang","type":"person","url":"https://hartvaat.nl/mensen/huang/","name":"Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/hiv-infectie-hangt-onafhankelijk-samen-met-meer-en-kwetsbaardere-halsslagaderpla/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2026/02/23/biologische-versus-mechanische-prothesen-bij-aortaklepvervanging-op-middelbare-l/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"huanyi-zhang","type":"person","url":"https://hartvaat.nl/mensen/huanyi-zhang/","name":"Huanyi Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/17/option-indobufen-als-aspirine-alternatief-in-dapt-na-pci/","published":"2023-01-17"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hugo-charles","type":"person","url":"https://hartvaat.nl/mensen/hugo-charles/","name":"Hugo Charles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hugo-vinhas","type":"person","url":"https://hartvaat.nl/mensen/hugo-vinhas/","name":"Hugo Vinhas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hui-cao","type":"person","url":"https://hartvaat.nl/mensen/hui-cao/","name":"Hui Cao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/21/pelacarsen-vermindert-de-behoefte-aan-lipoproteine-a-aferese-lp-a-frontiers-aphe/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2025/07/22/victorion-initiate-inclisiran-monotherapie-bij-patienten-zonder-ascvd/","published":"2025-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hui-chen","type":"person","url":"https://hartvaat.nl/mensen/hui-chen/","name":"Hui Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hui-jiang","type":"person","url":"https://hartvaat.nl/mensen/hui-jiang/","name":"Hui Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/05/calcium-geinduceerde-autonome-denervatie-bij-postoperatief-af/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2017/03/01/bloedmarkers-voor-ablatie-en-af-recidief-meta-analyse/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hui-lin","type":"person","url":"https://hartvaat.nl/mensen/hui-lin/","name":"Hui Lin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/cryoablatie-versus-radiofrequentieablatie-bij-paroxysmaal-af-systematische-revie/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/04/01/rol-van-adenosine-geleide-pvi-bij-katheterablatie-voor-af-meta-analyse/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hui-wang","type":"person","url":"https://hartvaat.nl/mensen/hui-wang/","name":"Hui Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/22/maternale-auto-immuunziekte-verhoogt-cardiovasculair-risico-bij-nakomelingen/","published":"2026-05-06"},{"url":"https://hartvaat.nl/2026/01/01/overgewicht-en-de-tyg-index-als-voorspellers-van-sterfte-bij-diabetes-type-2/","published":"2026-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"huijin-lee","type":"person","url":"https://hartvaat.nl/mensen/huijin-lee/","name":"Huijin Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/01/10/host-exam-extended-clopidogrel-superieur-aan-aspirine-als-monotherapie-na-pci/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"huijuan-li","type":"person","url":"https://hartvaat.nl/mensen/huijuan-li/","name":"Huijuan Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/20/zoutvervanger-voorkomt-hypertensie-bij-normotensieve-volwassenen/","published":"2024-02-20"},{"url":"https://hartvaat.nl/2022/07/26/chinees-hartgezond-dieet-verlaagt-bloeddruk-effectief-gerandomiseerde-trial/","published":"2022-07-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hun-jun-park","type":"person","url":"https://hartvaat.nl/mensen/hun-jun-park/","name":"Hun-Jun Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hung","type":"person","url":"https://hartvaat.nl/mensen/hung/","name":"Hung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/29/geisoleerde-secundaire-tricuspidalisinsufficientie-na-linkszijdige-klepchirurgie/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/01/16/nt-probnp-voorspelt-sterfte-na-een-stemi-onafhankelijk-van-de-ejectiefractie/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hunter","type":"person","url":"https://hartvaat.nl/mensen/hunter/","name":"Hunter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/direct-naar-ct-coronairangiografie-bij-verdenking-angina-snellere-diagnose-en-mi/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/01/06/machine-learning-algoritme-mi3-helpt-een-infarct-uitsluiten-bij-een-onduidelijke/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hursh-naik","type":"person","url":"https://hartvaat.nl/mensen/hursh-naik/","name":"Hursh Naik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hussain-contractor","type":"person","url":"https://hartvaat.nl/mensen/hussain-contractor/","name":"Hussain Contractor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyeon-woo-yim","type":"person","url":"https://hartvaat.nl/mensen/hyeon-woo-yim/","name":"Hyeon Woo Yim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyo-suk-nam","type":"person","url":"https://hartvaat.nl/mensen/hyo-suk-nam/","name":"Hyo Suk Nam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/vertraagde-intracraniele-bloeding-na-trombectomie-geassocieerd-met-slechtere-fun/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyuck-moon-kwon","type":"person","url":"https://hartvaat.nl/mensen/hyuck-moon-kwon/","name":"Hyuck Moon Kwon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyun-jai-cho","type":"person","url":"https://hartvaat.nl/mensen/hyun-jai-cho/","name":"Hyun-Jai Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/harttransplantatie-bij-hoogste-urgentie-meer-vroege-infecties-en-sterfte-mede-do/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyun-jong-lee","type":"person","url":"https://hartvaat.nl/mensen/hyun-jong-lee/","name":"Hyun-Jong Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2023/02/07/ffr-geleide-versus-angiografie-geleide-pci-bij-acuut-mi-met-meervatslijden/","published":"2023-02-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyung-oh-choi","type":"person","url":"https://hartvaat.nl/mensen/hyung-oh-choi/","name":"Hyung Oh Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hyungwoo-lee","type":"person","url":"https://hartvaat.nl/mensen/hyungwoo-lee/","name":"Hyungwoo Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/vertraagde-intracraniele-bloeding-na-trombectomie-geassocieerd-met-slechtere-fun/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hakan-walfridsson","type":"person","url":"https://hartvaat.nl/mensen/hakan-walfridsson/","name":"Håkan Walfridsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/supraventriculaire-ectopie-na-af-ablatie-voorspelt-recidief/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/03/01/katheterablatie-als-eerstelijnsbehandeling-bij-paroxysmaal-af-5-jaarsresultaten/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"helene-rousseau","type":"person","url":"https://hartvaat.nl/mensen/helene-rousseau/","name":"Hélène Rousseau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"huseyin-ince","type":"person","url":"https://hartvaat.nl/mensen/huseyin-ince/","name":"Hüseyin Ince","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ia-topuria","type":"person","url":"https://hartvaat.nl/mensen/ia-topuria/","name":"Ia Topuria","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-b-wilkinson","type":"person","url":"https://hartvaat.nl/mensen/ian-b-wilkinson/","name":"Ian B Wilkinson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/01/zoutbuffering-in-de-huid-bij-mensen-een-nieuw-mechanisme/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/11/01/rol-van-het-autonome-zenuwstelsel-bij-regulatie-van-aortastijfheid/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-blazina","type":"person","url":"https://hartvaat.nl/mensen/ian-blazina/","name":"Ian Blazina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/25/gedragsinterventies-voor-gezond-gewicht-in-de-zwangerschap-jama-uspstf-evidence-/","published":"2021-05-25"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-evidence-report/","published":"2016-11-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-c-k-wong","type":"person","url":"https://hartvaat.nl/mensen/ian-c-k-wong/","name":"Ian C K Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/27/doac-s-en-fractuurrisico-systematische-review-en-meta-analyse/","published":"2021-01-27"},{"url":"https://hartvaat.nl/2017/06/01/impact-van-ischemisch-cva-op-af-gerelateerde-zorgkosten-systematische-review/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-h-de-boer","type":"person","url":"https://hartvaat.nl/mensen/ian-h-de-boer/","name":"Ian H de Boer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/19/vrouwen-met-ckd-krijgen-minder-vaak-ras-remmers-en-sglt2-remmers-dan-mannen/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/05/25/kdigo-overzicht-de-nier-centraal-in-het-cardiovasculair-renaal-metabool-ckm-synd/","published":"2026-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ian-kemp","type":"person","url":"https://hartvaat.nl/mensen/ian-kemp/","name":"Ian Kemp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"idris-harding","type":"person","url":"https://hartvaat.nl/mensen/idris-harding/","name":"Idris Harding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2021/02/05/slokdarmbescherming-met-temperatuurcontroleren-bij-af-ablatie-impact/","published":"2021-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"igal-moarof","type":"person","url":"https://hartvaat.nl/mensen/igal-moarof/","name":"Igal Moarof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"},{"url":"https://hartvaat.nl/2018/09/01/ultradunne-biodegradeerbare-versus-dunne-duurzame-stents-lancet-gerandomiseerde-/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ignacio-j-amat-santos","type":"person","url":"https://hartvaat.nl/mensen/ignacio-j-amat-santos/","name":"Ignacio J Amat-Santos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ignatios-ikonomidis","type":"person","url":"https://hartvaat.nl/mensen/ignatios-ikonomidis/","name":"Ignatios Ikonomidis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2017/01/01/bloeddrukverlaging-en-secundaire-cva-preventie-meta-regressieanalyse/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"igor-mikheenko","type":"person","url":"https://hartvaat.nl/mensen/igor-mikheenko/","name":"Igor Mikheenko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/22/temporaire-ruggenmergstimulatie-ter-preventie-van-postoperatief-af/","published":"2022-02-22"},{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"igor-ribeiro-de-castro-bienert","type":"person","url":"https://hartvaat.nl/mensen/igor-ribeiro-de-castro-bienert/","name":"Igor Ribeiro de Castro Bienert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"igor-rudez","type":"person","url":"https://hartvaat.nl/mensen/igor-rudez/","name":"Igor Rudez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ijeoma-isiadinso","type":"person","url":"https://hartvaat.nl/mensen/ijeoma-isiadinso/","name":"Ijeoma Isiadinso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"il-woo-suh","type":"person","url":"https://hartvaat.nl/mensen/il-woo-suh/","name":"Il-Woo Suh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/17/antiplaatjesmonotherapie-na-pci-clopidogrel-versus-aspirine-naar-risicoprofiel/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"il-young-oh","type":"person","url":"https://hartvaat.nl/mensen/il-young-oh/","name":"Il-Young Oh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilan-e-raymond","type":"person","url":"https://hartvaat.nl/mensen/ilan-e-raymond/","name":"Ilan E Raymond","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilaria-meynet","type":"person","url":"https://hartvaat.nl/mensen/ilaria-meynet/","name":"Ilaria Meynet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2026/02/26/fluoroscopieminimalisatie-bij-svt-ablatie-door-vrouwelijke-elektrofysiologen/","published":"2026-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilenia-minicocci","type":"person","url":"https://hartvaat.nl/mensen/ilenia-minicocci/","name":"Ilenia Minicocci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/02/01/de-verborgen-nierschade-bij-chylomicronemiesyndromen/","published":"2026-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilias-ninios","type":"person","url":"https://hartvaat.nl/mensen/ilias-ninios/","name":"Ilias Ninios","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilija-srdanovic","type":"person","url":"https://hartvaat.nl/mensen/ilija-srdanovic/","name":"Ilija Srdanovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/05/complete-versus-culprit-only-bij-ouderen-met-stemi-gerandomiseerde-trial/","published":"2024-11-05"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilkka-tikkanen","type":"person","url":"https://hartvaat.nl/mensen/ilkka-tikkanen/","name":"Ilkka Tikkanen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/01/baroreflexactivatietherapie-bij-resistente-hypertensie-sham-gecontroleerde-pilot/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2016/12/01/empagliflozine-en-bloeddruk-bij-diabetes-type-2-met-hypertensie-naar-achtergrond/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ilse-luirink","type":"person","url":"https://hartvaat.nl/mensen/ilse-luirink/","name":"Ilse Luirink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2017/08/29/rosuvastatine-bij-kinderen-met-homozygote-familiaire-hypercholesterolemie/","published":"2017-08-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"imazio","type":"person","url":"https://hartvaat.nl/mensen/imazio/","name":"Imazio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/geleidelijk-afbouwen-van-rilonacept-bij-recidiverende-pericarditis-voorkomt-vake/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/03/18/st-elevatie-bij-acute-pericarditis-wijst-op-myocardiale-betrokkenheid/","published":"2026-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"imre-janszky","type":"person","url":"https://hartvaat.nl/mensen/imre-janszky/","name":"Imre Janszky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/22/maternale-auto-immuunziekte-verhoogt-cardiovasculair-risico-bij-nakomelingen/","published":"2026-05-06"},{"url":"https://hartvaat.nl/2016/02/16/bmi-abdominale-adipositas-en-hartfalen-systematische-review-en-dosis-responsmeta/","published":"2016-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"imre-pavo","type":"person","url":"https://hartvaat.nl/mensen/imre-pavo/","name":"Imre Pavo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2021/11/13/tirzepatide-versus-insuline-glargine-bij-diabetes-type-2-met-hoog-cv-risico-lanc/","published":"2021-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"indulis-kumsars","type":"person","url":"https://hartvaat.nl/mensen/indulis-kumsars/","name":"Indulis Kumsars","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"inga-iamandii","type":"person","url":"https://hartvaat.nl/mensen/inga-iamandii/","name":"Inga Iamandii","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/01/alcohol-en-hypertensierisico-dosis-respons-meta-analyse-van-niet-experimentele-s/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/10/01/alcoholconsumptie-en-bloeddruk-dosis-respons-meta-analyse/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"inger-njlstad","type":"person","url":"https://hartvaat.nl/mensen/inger-njlstad/","name":"Inger Njølstad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"inger-lise-aamot-aksety","type":"person","url":"https://hartvaat.nl/mensen/inger-lise-aamot-aksety/","name":"Inger-Lise Aamot Aksetøy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/telerevalidatie-haalbaar-voor-hartfalenpatienten-zonder-toegang-tot-poliklinisch/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/08/01/cardiorenaal-syndroom-en-fitheid-bij-hartfalen-telerevalidatie-trial/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ingibjorg-j-gudmundsdottir","type":"person","url":"https://hartvaat.nl/mensen/ingibjorg-j-gudmundsdottir/","name":"Ingibjörg J Gudmundsdottir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"inki-moon","type":"person","url":"https://hartvaat.nl/mensen/inki-moon/","name":"Inki Moon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/thuis-bio-impedantie-voor-hartfalen-haalbaar-en-acceptabel-klinische-winst-nog-n/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2024/02/23/ar-brillen-voor-ef-schatting-bij-hartfalen-haalbaarheidstudie/","published":"2024-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ioana-r-preston","type":"person","url":"https://hartvaat.nl/mensen/ioana-r-preston/","name":"Ioana R Preston","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ioanna-xanthopoulou","type":"person","url":"https://hartvaat.nl/mensen/ioanna-xanthopoulou/","name":"Ioanna Xanthopoulou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/02/cangrelor-bij-ticagrelor-geladen-stemi-patienten-tijdens-primaire-pci/","published":"2018-10-02"},{"url":"https://hartvaat.nl/2017/10/17/laaggedoseerd-ticagrelor-versus-clopidogrel-na-eerder-mi/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ioannis-doundoulakis","type":"person","url":"https://hartvaat.nl/mensen/ioannis-doundoulakis/","name":"Ioannis Doundoulakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/09/13/prognostische-modellen-voor-hartfalen-bij-type-2-diabetes-systematische-review/","published":"2023-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ioannis-kapos","type":"person","url":"https://hartvaat.nl/mensen/ioannis-kapos/","name":"Ioannis Kapos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ionut-bebu","type":"person","url":"https://hartvaat.nl/mensen/ionut-bebu/","name":"Ionut Bebu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"},{"url":"https://hartvaat.nl/2017/04/20/frequentie-van-evidence-based-retinopathiescreening-bij-diabetes-type-1-nejm/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iqwal-mangat","type":"person","url":"https://hartvaat.nl/mensen/iqwal-mangat/","name":"Iqwal Mangat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irene-karungi","type":"person","url":"https://hartvaat.nl/mensen/irene-karungi/","name":"Irene Karungi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/01/16/non-hdl-c-doelen-halen-in-de-eerste-en-tweede-lijn-een-da-vinci-deelanalyse/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irfan-khan","type":"person","url":"https://hartvaat.nl/mensen/irfan-khan/","name":"Irfan Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pcsk9-remmers-verlagen-events-bij-ascvd-zonder-eerder-infarct-of-beroerte-real-w/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2017/09/26/sams-ci-score-toegepast-op-gerandomiseerde-trial-over-statine-myopathie/","published":"2017-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irina-savelieva","type":"person","url":"https://hartvaat.nl/mensen/irina-savelieva/","name":"Irina Savelieva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"irving-l-kron","type":"person","url":"https://hartvaat.nl/mensen/irving-l-kron/","name":"Irving L Kron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabel-wustrow","type":"person","url":"https://hartvaat.nl/mensen/isabel-wustrow/","name":"Isabel Wustrow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2020/11/24/ticagrelor-of-prasugrel-bij-nste-acs-isar-react-5-subanalyse/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabela-landsteiner","type":"person","url":"https://hartvaat.nl/mensen/isabela-landsteiner/","name":"Isabela Landsteiner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/07/multi-orgaan-inspanningstekorten-kenmerken-de-aanleg-voor-hfpef/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabella-alviz","type":"person","url":"https://hartvaat.nl/mensen/isabella-alviz/","name":"Isabella Alviz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/05/laa-isolatie-tijdens-af-ablatie-geactualiseerde-meta-analyse/","published":"2021-02-05"},{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabella-bonilha","type":"person","url":"https://hartvaat.nl/mensen/isabella-bonilha/","name":"Isabella Bonilha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/evolocumab-naast-empagliflozine-verandert-ldl-subdeeltjes-bij-type-2-diabetes/","published":"2026-04-08"},{"url":"https://hartvaat.nl/2023/04/01/aspirine-in-primaire-preventie-en-hartfalenrisico-meta-analyse/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabella-de-andrade-jesuino","type":"person","url":"https://hartvaat.nl/mensen/isabella-de-andrade-jesuino/","name":"Isabella de Andrade Jesuíno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabelle-durand-zaleski","type":"person","url":"https://hartvaat.nl/mensen/isabelle-durand-zaleski/","name":"Isabelle Durand-Zaleski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"isabelle-ruel","type":"person","url":"https://hartvaat.nl/mensen/isabelle-ruel/","name":"Isabelle Ruel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/14/sekseverschillen-in-fh-behandeling-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/09/07/aortastenose-bij-homozygote-familiaire-hypercholesterolemie-paradigmaverschuivin/","published":"2022-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"israel-gotsman","type":"person","url":"https://hartvaat.nl/mensen/israel-gotsman/","name":"Israel Gotsman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/uitkomsten-van-hartfalen-naar-ejectiefractie-het-esc-hf-iii-register/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivan-namakoola","type":"person","url":"https://hartvaat.nl/mensen/ivan-namakoola/","name":"Ivan Namakoola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivo-roca","type":"person","url":"https://hartvaat.nl/mensen/ivo-roca/","name":"Ivo Roca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/02/pam-vt-2-littekenverloop-na-vt-ablatie-beoordeeld-met-seriele-cardiale-mri/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivo-strebel","type":"person","url":"https://hartvaat.nl/mensen/ivo-strebel/","name":"Ivo Strebel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivo-varvarovsky","type":"person","url":"https://hartvaat.nl/mensen/ivo-varvarovsky/","name":"Ivo Varvarovsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ivy-timmermans","type":"person","url":"https://hartvaat.nl/mensen/ivy-timmermans/","name":"Ivy Timmermans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/02/remote-monitoring-en-klinische-uitkomsten-bij-europese-hf-met-icd-langetermijn/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2019/09/01/remote-monitoring-en-patientgerapporteerde-uitkomsten-bij-europese-hf-patienten-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iwan-c-c-van-der-horst","type":"person","url":"https://hartvaat.nl/mensen/iwan-c-c-van-der-horst/","name":"Iwan C C van der Horst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"izabella-uchmanowicz","type":"person","url":"https://hartvaat.nl/mensen/izabella-uchmanowicz/","name":"Izabella Uchmanowicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/27/frailte-versnelt-hartfalenprogressie-en-vermindert-therapietolerantie/","published":"2026-08-04"},{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-andrew-black","type":"person","url":"https://hartvaat.nl/mensen/j-andrew-black/","name":"J Andrew Black","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-d-schwalm","type":"person","url":"https://hartvaat.nl/mensen/j-d-schwalm/","name":"J D Schwalm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/intracoronair-lage-dosis-rtpa-bij-primaire-pci-voor-stemi-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-david-burkhardt","type":"person","url":"https://hartvaat.nl/mensen/j-david-burkhardt/","name":"J David Burkhardt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-david-spence","type":"person","url":"https://hartvaat.nl/mensen/j-david-spence/","name":"J David Spence","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antiplaatjestherapie-bij-cryptogeen-cva-nejm-close/","published":"2017-09-14"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-donald-easton","type":"person","url":"https://hartvaat.nl/mensen/j-donald-easton/","name":"J Donald Easton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/30/voorspellers-van-af-ontwikkeling-bij-embolic-stroke-of-undetermined-source-re-sp/","published":"2021-11-30"},{"url":"https://hartvaat.nl/2018/07/19/clopidogrel-plus-aspirine-bij-acuut-ischemisch-cva-en-hoogrisico-tia-nejm-point/","published":"2018-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-eduardo-rame","type":"person","url":"https://hartvaat.nl/mensen/j-eduardo-rame/","name":"J Eduardo Rame","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-j-coughlan","type":"person","url":"https://hartvaat.nl/mensen/j-j-coughlan/","name":"J J Coughlan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-kennedy-cruickshank","type":"person","url":"https://hartvaat.nl/mensen/j-kennedy-cruickshank/","name":"J Kennedy Cruickshank","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/01/labetalol-versus-nifedipine-bij-chronische-hypertensie-in-de-zwangerschap-gerand/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2017/09/26/verlaging-van-arteriele-stijfheid-onafhankelijk-van-bloeddruk-de-vasera-trial/","published":"2017-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-l-morales-rull","type":"person","url":"https://hartvaat.nl/mensen/j-l-morales-rull/","name":"J L Morales-Rull","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/01/intra-abdominale-druk-en-pocus-voor-decongestiebegeleiding-bij-hf/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2025/08/01/vroege-diuretische-respons-en-uitkomstvoorspelling-bij-ambulant-verslechterend-h/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-martijn-bos","type":"person","url":"https://hartvaat.nl/mensen/j-martijn-bos/","name":"J Martijn Bos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-parameters-voorspellen-nieuwe-hartklachten-bij-hypertrofische-cardiomyopathi/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/02/03/ryr2-mutaties-als-oorzaak-van-onverklaarde-plotse-hartdood-bij-jongeren/","published":"2026-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-michael-dimaio","type":"person","url":"https://hartvaat.nl/mensen/j-michael-dimaio/","name":"J Michael DiMaio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-michael-mangrum","type":"person","url":"https://hartvaat.nl/mensen/j-michael-mangrum/","name":"J Michael Mangrum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/terminatie-van-persisterend-af-tijdens-pvi-inzichten-uit-magic-af/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/05/21/stapsgewijze-ablatie-gestuurd-door-laaggedoseerd-ibutilide-bij-chronisch-af-magi/","published":"2016-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-simon-r-gibbs","type":"person","url":"https://hartvaat.nl/mensen/j-simon-r-gibbs/","name":"J Simon R Gibbs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/sotatercept-bij-pah-binnen-het-eerste-jaar-na-diagnose-stellar-subanalyse/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2023/04/20/stellar-sotatercept-bij-pulmonale-arteriele-hypertensie-nejm-fase-3/","published":"2023-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"j-g","type":"person","url":"https://hartvaat.nl/mensen/j-g/","name":"J. G.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/21/delphi-consensus-over-uitgestelde-en-gemiste-diagnose-van-coronairlijden/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/02/10/welke-hartfalenpatienten-ontwikkelen-ernstige-mitralisinsufficientie-voorspellen/","published":"2026-02-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacek-kadziela","type":"person","url":"https://hartvaat.nl/mensen/jacek-kadziela/","name":"Jacek Kadziela","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacek-legutko","type":"person","url":"https://hartvaat.nl/mensen/jacek-legutko/","name":"Jacek Legutko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2022/06/10/echogeleide-lvad-snelheidsoptimalisatie-voor-betere-inspanningstolerantie/","published":"2022-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jack-h-boyd","type":"person","url":"https://hartvaat.nl/mensen/jack-h-boyd/","name":"Jack H Boyd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/chirurgisch-unroofing-van-myocardiale-brug-verbetert-angina-klachten-langdurig-m/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2020/03/24/screening-en-profylactisch-amiodaron-vermindert-postoperatief-af/","published":"2020-03-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jack-w-c-tan","type":"person","url":"https://hartvaat.nl/mensen/jack-w-c-tan/","name":"Jack W C Tan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/09/cangrelor-en-infarctgrootte-bij-stemi-gerandomiseerde-trial/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2021/07/01/remote-post-ontslag-behandeling-na-mi-door-paramedici-versus-standaardzorg-jama-/","published":"2021-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jackson","type":"person","url":"https://hartvaat.nl/mensen/jackson/","name":"Jackson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/09/hartfalendiagnostiek-na-corona-bijna-niemand-kreeg-de-echo-binnen-de-aanbevolen-/","published":"2026-01-09"},{"url":"https://hartvaat.nl/2026/01/06/machine-learning-algoritme-mi3-helpt-een-infarct-uitsluiten-bij-een-onduidelijke/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacob-george","type":"person","url":"https://hartvaat.nl/mensen/jacob-george/","name":"Jacob George","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/01/metformine-en-linkerventrikelhypertrofie-bij-coronairlijden-zonder-diabetes-gera/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2017/12/21/lilrb5-variant-geassocieerd-met-statine-intolerantie-en-myalgie/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacopo-burrello","type":"person","url":"https://hartvaat.nl/mensen/jacopo-burrello/","name":"Jacopo Burrello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/geautomatiseerde-praktijkmeting-versus-andere-bloeddrukmeetmethoden/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/01/farmacologische-behandeling-van-hypertensie-bij-kinderen-netwerkmeta-analyse/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jacques-machecourt","type":"person","url":"https://hartvaat.nl/mensen/jacques-machecourt/","name":"Jacques Machecourt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jae-wook-jung","type":"person","url":"https://hartvaat.nl/mensen/jae-wook-jung/","name":"Jae Wook Jung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/vertraagde-intracraniele-bloeding-na-trombectomie-geassocieerd-met-slechtere-fun/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaewook-chung","type":"person","url":"https://hartvaat.nl/mensen/jaewook-chung/","name":"Jaewook Chung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/04/17/dapt-de-escalatie-na-acs-ipd-meta-analyse/","published":"2023-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jakob-ledwoch","type":"person","url":"https://hartvaat.nl/mensen/jakob-ledwoch/","name":"Jakob Ledwoch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jakub-podolec","type":"person","url":"https://hartvaat.nl/mensen/jakub-podolec/","name":"Jakub Podolec","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-a-hill","type":"person","url":"https://hartvaat.nl/mensen/james-a-hill/","name":"James A Hill","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/tienjaarsuitkomsten-na-cabg-naar-leeftijd-bij-hartfalen-met-lv-systolische-disfu/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/21/coronaire-bypasschirurgie-bij-ischemische-cardiomyopathie-nejm-stich-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-a-reiffel","type":"person","url":"https://hartvaat.nl/mensen/james-a-reiffel/","name":"James A Reiffel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-brian-byrd","type":"person","url":"https://hartvaat.nl/mensen/james-brian-byrd/","name":"James Brian Byrd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/11/angiotensine-ii-meten-bij-screening-op-primair-hyperaldosteronisme/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-c-blankenship","type":"person","url":"https://hartvaat.nl/mensen/james-c-blankenship/","name":"James C Blankenship","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/04/07/cangrelor-en-toegangsplaats-effect-op-ischemische-en-bloedingsevents-champion-ph/","published":"2016-04-07"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-d-neaton","type":"person","url":"https://hartvaat.nl/mensen/james-d-neaton/","name":"James D Neaton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/01/rivaroxaban-en-trombo-embolische-events-bij-hf-met-coronairlijden-en-sinusritme-/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/10/04/rivaroxaban-bij-hartfalen-met-sinusritme-en-coronairlijden-nejm-commander-hf/","published":"2018-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-e-tisdale","type":"person","url":"https://hartvaat.nl/mensen/james-e-tisdale/","name":"James E Tisdale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-f-meschia","type":"person","url":"https://hartvaat.nl/mensen/james-f-meschia/","name":"James F Meschia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/intensieve-versus-standaard-bloeddruk-op-cva-subtypes-sprint/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2016/03/17/langetermijnresultaten-van-stenting-versus-endarteriectomie-bij-carotisstenose/","published":"2016-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-johnston","type":"person","url":"https://hartvaat.nl/mensen/james-johnston/","name":"James Johnston","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/21/laaggedoseerd-methotrexaat-voor-preventie-van-atherosclerotische-events-nejm-cir/","published":"2019-02-21"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-m-eudicone","type":"person","url":"https://hartvaat.nl/mensen/james-m-eudicone/","name":"James M Eudicone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2025/01/01/dialysaat-kalium-3-0-mmol-l-met-natriumzirconiumcyclosilicaat-bij-dialyse/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-mancuso","type":"person","url":"https://hartvaat.nl/mensen/james-mancuso/","name":"James Mancuso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-mccready","type":"person","url":"https://hartvaat.nl/mensen/james-mccready/","name":"James McCready","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-mcdermott","type":"person","url":"https://hartvaat.nl/mensen/james-mcdermott/","name":"James McDermott","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-revkin","type":"person","url":"https://hartvaat.nl/mensen/james-revkin/","name":"James Revkin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-s-floyd","type":"person","url":"https://hartvaat.nl/mensen/james-s-floyd/","name":"James S Floyd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/01/immuuncelsubsets-voorspellen-incident-hartfalen-in-populatiestudies/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-sapontis","type":"person","url":"https://hartvaat.nl/mensen/james-sapontis/","name":"James Sapontis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-signorovitch","type":"person","url":"https://hartvaat.nl/mensen/james-signorovitch/","name":"James Signorovitch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/icd-bij-diabetes-met-niet-ischemisch-systolisch-hf-danish-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-w-dear","type":"person","url":"https://hartvaat.nl/mensen/james-w-dear/","name":"James W Dear","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/arteriele-stijfheid-en-endotheeldysfunctie-bij-anca-geassocieerde-vasculitis/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/08/01/endothelinereceptorantagonisme-verbetert-lipidenprofielen-en-verlaagt-pcsk9-bij-/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"james-white","type":"person","url":"https://hartvaat.nl/mensen/james-white/","name":"James White","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jamie-j-edwards","type":"person","url":"https://hartvaat.nl/mensen/jamie-j-edwards/","name":"Jamie J Edwards","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/cardiale-structuur-en-functie-bij-hypertensieve-zwangerschapsstoornissen-systema/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2022/02/01/myocardiale-mechanica-bij-hypertensieve-zwangerschapsaandoeningen-meta-analyse/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jamie-m-o-driscoll","type":"person","url":"https://hartvaat.nl/mensen/jamie-m-o-driscoll/","name":"Jamie M O'Driscoll","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/cardiale-structuur-en-functie-bij-hypertensieve-zwangerschapsstoornissen-systema/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2022/02/01/myocardiale-mechanica-bij-hypertensieve-zwangerschapsaandoeningen-meta-analyse/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jamil-mayet","type":"person","url":"https://hartvaat.nl/mensen/jamil-mayet/","name":"Jamil Mayet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-albert-kuivenhoven","type":"person","url":"https://hartvaat.nl/mensen/jan-albert-kuivenhoven/","name":"Jan Albert Kuivenhoven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/mendeliaanse-randomisatie-hmgcr-remming-verhoogt-diabetesrisico-andere-lipidendo/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2018/02/20/genetica-leefstijl-en-ldl-cholesterol-bij-jonge-gezonde-vrouwen/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-baan","type":"person","url":"https://hartvaat.nl/mensen/jan-baan/","name":"Jan Baan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-bech","type":"person","url":"https://hartvaat.nl/mensen/jan-bech/","name":"Jan Bech","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-bogaert","type":"person","url":"https://hartvaat.nl/mensen/jan-bogaert/","name":"Jan Bogaert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-elders","type":"person","url":"https://hartvaat.nl/mensen/jan-elders/","name":"Jan Elders","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-erik-otterstad","type":"person","url":"https://hartvaat.nl/mensen/jan-erik-otterstad/","name":"Jan Erik Otterstad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-heeringa","type":"person","url":"https://hartvaat.nl/mensen/jan-heeringa/","name":"Jan Heeringa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2017/02/21/genetische-obesitas-en-risico-op-atriumfibrilleren-mendeliaanse-randomisatie/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-mrozek","type":"person","url":"https://hartvaat.nl/mensen/jan-mrozek/","name":"Jan Mrozek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-paul-ottervanger","type":"person","url":"https://hartvaat.nl/mensen/jan-paul-ottervanger/","name":"Jan Paul Ottervanger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-torzewski","type":"person","url":"https://hartvaat.nl/mensen/jan-torzewski/","name":"Jan Torzewski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-vaclavik","type":"person","url":"https://hartvaat.nl/mensen/jan-vaclavik/","name":"Jan Václavík","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"},{"url":"https://hartvaat.nl/2016/02/01/spironolacton-versus-renale-denervatie-bij-therapieresistente-hypertensie-prague/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jan-van-der-heyden","type":"person","url":"https://hartvaat.nl/mensen/jan-van-der-heyden/","name":"Jan van der Heyden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jane-fletcher","type":"person","url":"https://hartvaat.nl/mensen/jane-fletcher/","name":"Jane Fletcher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jane-j-lee","type":"person","url":"https://hartvaat.nl/mensen/jane-j-lee/","name":"Jane J Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2021/05/18/diabetes-factoren-en-ticagrelor-plus-aspirine-themis-en-themis-pci/","published":"2021-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jane-warwick","type":"person","url":"https://hartvaat.nl/mensen/jane-warwick/","name":"Jane Warwick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2018/09/01/orthostatische-hypotensie-verhoogt-risico-op-cognitieve-stoornissen/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janelle-m-guirguis-blake","type":"person","url":"https://hartvaat.nl/mensen/janelle-m-guirguis-blake/","name":"Janelle M Guirguis-Blake","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/uspstf-evidence-review-lipidescreening-bij-kinderen-geactualiseerd/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-evidence-update-2021/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janet-b-mcgill","type":"person","url":"https://hartvaat.nl/mensen/janet-b-mcgill/","name":"Janet B McGill","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janet-t-powell","type":"person","url":"https://hartvaat.nl/mensen/janet-t-powell/","name":"Janet T Powell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2016/11/07/ace-remmer-en-groeisnelheid-van-kleine-abdominale-aorta-aneurysmata-gerandomisee/","published":"2016-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jang-ho-bae","type":"person","url":"https://hartvaat.nl/mensen/jang-ho-bae/","name":"Jang Ho Bae","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2022/11/22/ees-versus-cabg-bij-meervatslijden-langetermijn-follow-up-van-rct-s/","published":"2022-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janice-lea","type":"person","url":"https://hartvaat.nl/mensen/janice-lea/","name":"Janice Lea","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janice-y-chyou","type":"person","url":"https://hartvaat.nl/mensen/janice-y-chyou/","name":"Janice Y Chyou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janine-f-felix","type":"person","url":"https://hartvaat.nl/mensen/janine-f-felix/","name":"Janine F Felix","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janine-poess","type":"person","url":"https://hartvaat.nl/mensen/janine-poess/","name":"Janine Poess","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/28/culprit-interventie-bij-cardiogene-shock-met-hartstilstand/","published":"2023-03-28"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janis-m-nolde","type":"person","url":"https://hartvaat.nl/mensen/janis-m-nolde/","name":"Janis M Nolde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/renale-denervatie-langetermijn-bloeddrukeffect-bevestigd-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janusz-kaczorowski","type":"person","url":"https://hartvaat.nl/mensen/janusz-kaczorowski/","name":"Janusz Kaczorowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/12/01/lacunes-in-hypertensierichtlijnen-in-lage-en-middeninkomenslanden-systematische-/","published":"2016-12-01"},{"url":"https://hartvaat.nl/2016/10/01/cardiovasculair-risico-bij-hypertensie-in-relatie-tot-bereikte-bloeddruk-met-gea/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janusz-prokopczuk","type":"person","url":"https://hartvaat.nl/mensen/janusz-prokopczuk/","name":"Janusz Prokopczuk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/05/ticagrelor-monotherapie-versus-dapt-vanaf-1-maand-na-des-tico-trial/","published":"2019-11-05"},{"url":"https://hartvaat.nl/2019/03/09/ultradunne-sirolimus-eluting-stent-lancet-talent-trial/","published":"2019-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jarle-jortveit","type":"person","url":"https://hartvaat.nl/mensen/jarle-jortveit/","name":"Jarle Jortveit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaroslav-dusek","type":"person","url":"https://hartvaat.nl/mensen/jaroslav-dusek/","name":"Jaroslav Dusek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jarosaw-d-kasprzak","type":"person","url":"https://hartvaat.nl/mensen/jarosaw-d-kasprzak/","name":"Jarosław D Kasprzak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/02/03/levosimendan-infusies-en-klinisch-beloop-bij-hartfalen-levo-d-resultaten/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jasmine-choi","type":"person","url":"https://hartvaat.nl/mensen/jasmine-choi/","name":"Jasmine Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jason-chung","type":"person","url":"https://hartvaat.nl/mensen/jason-chung/","name":"Jason Chung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/gemaskeerde-hypertensie-bij-kinderen-prevalentie-en-cv-risico-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/06/01/eindorgaanschade-bij-kinderen-met-primaire-hypertensie-meta-analyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jason-e-bloom","type":"person","url":"https://hartvaat.nl/mensen/jason-e-bloom/","name":"Jason E Bloom","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jason-p-stopyra","type":"person","url":"https://hartvaat.nl/mensen/jason-p-stopyra/","name":"Jason P Stopyra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jasper-boeddinghaus","type":"person","url":"https://hartvaat.nl/mensen/jasper-boeddinghaus/","name":"Jasper Boeddinghaus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/esc-0-1-uur-versus-0-2-of-0-3-uur-hoog-sensitief-troponine-algoritmen-bij-verden/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jasvindar-singh","type":"person","url":"https://hartvaat.nl/mensen/jasvindar-singh/","name":"Jasvindar Singh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javier-bermejo","type":"person","url":"https://hartvaat.nl/mensen/javier-bermejo/","name":"Javier Bermejo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2018/04/14/sildenafil-bij-persisterende-pulmonale-hypertensie-na-klepchirurgie/","published":"2018-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javier-cuesta","type":"person","url":"https://hartvaat.nl/mensen/javier-cuesta/","name":"Javier Cuesta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/03/magnesium-resorbeerbare-scaffold-versus-metallic-stent-bij-stemi-biosolve-iii/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javier-san-martin","type":"person","url":"https://hartvaat.nl/mensen/javier-san-martin/","name":"Javier San Martin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/07/01/plozasiran-sirna-tegen-apoc3-bij-ernstige-hypertriglyceridemie-shasta-2/","published":"2024-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"javier-sanz","type":"person","url":"https://hartvaat.nl/mensen/javier-sanz/","name":"Javier Sanz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/22/anemie-beinvloedt-ijzerhomeostase-en-empagliflozine-respons-bij-hf/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jay-h-traverse","type":"person","url":"https://hartvaat.nl/mensen/jay-h-traverse/","name":"Jay H Traverse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/16/bio-absorbeerbare-intracoronaire-matrix-ter-preventie-van-ventriculaire-remodell/","published":"2016-08-16"},{"url":"https://hartvaat.nl/2016/05/01/intracoronaire-adenylylcyclase-6-gentherapie-bij-hartfalen-gerandomiseerde-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jay-p-mohr","type":"person","url":"https://hartvaat.nl/mensen/jay-p-mohr/","name":"Jay P Mohr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jay-thakkar","type":"person","url":"https://hartvaat.nl/mensen/jay-thakkar/","name":"Jay Thakkar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jaya-b-rosenmeier","type":"person","url":"https://hartvaat.nl/mensen/jaya-b-rosenmeier/","name":"Jaya B Rosenmeier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/laroprovstat-eerste-orale-pcsk9-remmer-haalt-80-ldl-reductie-in-combinatie-met-r/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/06/03/pursuit-orale-pcsk9-remmer-voor-hypercholesterolemie-gerandomiseerde-trial/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-claude-tardif","type":"person","url":"https://hartvaat.nl/mensen/jean-claude-tardif/","name":"Jean Claude Tardif","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/01/icosapent-ethyl-na-acs-reduce-it-subanalyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2022/10/14/dal-gene-farmacogenetica-geleide-dalcetrapib-na-acs/","published":"2022-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-michel-halimi","type":"person","url":"https://hartvaat.nl/mensen/jean-michel-halimi/","name":"Jean Michel Halimi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-ribstein","type":"person","url":"https://hartvaat.nl/mensen/jean-ribstein/","name":"Jean Ribstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-christophe-eicher","type":"person","url":"https://hartvaat.nl/mensen/jean-christophe-eicher/","name":"Jean-Christophe Eicher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-christophe-macia","type":"person","url":"https://hartvaat.nl/mensen/jean-christophe-macia/","name":"Jean-Christophe Macia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-francois-obadia","type":"person","url":"https://hartvaat.nl/mensen/jean-francois-obadia/","name":"Jean-François Obadia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-luc-fellahi","type":"person","url":"https://hartvaat.nl/mensen/jean-luc-fellahi/","name":"Jean-Luc Fellahi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/levoecmo-levosimendan-bij-ecmo-weaning-bij-cardiogene-shock/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-marc-raymond","type":"person","url":"https://hartvaat.nl/mensen/jean-marc-raymond/","name":"Jean-Marc Raymond","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-marie-moutquin","type":"person","url":"https://hartvaat.nl/mensen/jean-marie-moutquin/","name":"Jean-Marie Moutquin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-noel-labeque","type":"person","url":"https://hartvaat.nl/mensen/jean-noel-labeque/","name":"Jean-Noël Labeque","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"},{"url":"https://hartvaat.nl/2020/11/28/ticagrelor-versus-clopidogrel-bij-electieve-pci-lancet-alpheus/","published":"2020-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jean-paul-cristol","type":"person","url":"https://hartvaat.nl/mensen/jean-paul-cristol/","name":"Jean-Paul Cristol","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeane-m-tsutsui","type":"person","url":"https://hartvaat.nl/mensen/jeane-m-tsutsui/","name":"Jeane M Tsutsui","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jef-van-den-eynde","type":"person","url":"https://hartvaat.nl/mensen/jef-van-den-eynde/","name":"Jef Van den Eynde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/beeldvorming-bij-atriale-cardiomyopathie-esc-scientific-statement/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2023/01/31/tromboseprofylaxe-bij-fontan-circulatie-aspirine-warfarine-of-noac/","published":"2023-01-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-brettler","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-brettler/","name":"Jeffrey Brettler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/04/05/bloeddrukverlaging-bij-kappersbezoek-nejm-clustergerandomiseerde-trial/","published":"2018-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-cavendish","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-cavendish/","name":"Jeffrey Cavendish","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-d-alexis","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-d-alexis/","name":"Jeffrey D Alexis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2017/02/28/myocardiaal-herstel-bij-systolisch-hartfalen-met-auto-antilichamen-tegen-1-adren/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-l-anderson","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-l-anderson/","name":"Jeffrey L Anderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/victorion-inception-vroege-inclisiran-na-acuut-coronair-syndroom-verviervoudigt-/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-t-kuvin","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-t-kuvin/","name":"Jeffrey T Kuvin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/25/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn-jacc/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-w-christle","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-w-christle/","name":"Jeffrey W Christle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeffrey-w-moses","type":"person","url":"https://hartvaat.nl/mensen/jeffrey-w-moses/","name":"Jeffrey W Moses","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"},{"url":"https://hartvaat.nl/2019/01/15/lv-unloading-voor-reperfusie-bij-anterieure-stemi-dtu-stemi-pilot/","published":"2019-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jelle-c-l-himmelreich","type":"person","url":"https://hartvaat.nl/mensen/jelle-c-l-himmelreich/","name":"Jelle C L Himmelreich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/01/predictiemodellen-voor-af-in-de-community-meta-analyse/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/05/01/frequente-premature-atriale-contracties-en-af-hersenischemie-en-mortaliteit-meta/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jelmer-westra","type":"person","url":"https://hartvaat.nl/mensen/jelmer-westra/","name":"Jelmer Westra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2023/11/01/ifr-versus-ffr-en-vijfjaarsmortaliteit-swedeheart-en-define-flair/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jemima-h-kamano","type":"person","url":"https://hartvaat.nl/mensen/jemima-h-kamano/","name":"Jemima H Kamano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jemma-c-hopewell","type":"person","url":"https://hartvaat.nl/mensen/jemma-c-hopewell/","name":"Jemma C Hopewell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/differentiele-effecten-van-pcsk9-varianten-op-coronairlijden-versus-ischemisch-c/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/09/28/anacetrapib-bij-atherosclerotisch-vaatlijden-nejm-hps3-timi55-reveal/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-a-brody","type":"person","url":"https://hartvaat.nl/mensen/jennifer-a-brody/","name":"Jennifer A Brody","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-a-cowger","type":"person","url":"https://hartvaat.nl/mensen/jennifer-a-cowger/","name":"Jennifer A Cowger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/27/momentum-3-vijfjaarsresultaten-heartmate-3-versus-axiale-lvad/","published":"2022-09-27"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-a-tremmel","type":"person","url":"https://hartvaat.nl/mensen/jennifer-a-tremmel/","name":"Jennifer A Tremmel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/chirurgisch-unroofing-van-myocardiale-brug-verbetert-angina-klachten-langdurig-m/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-conway","type":"person","url":"https://hartvaat.nl/mensen/jennifer-conway/","name":"Jennifer Conway","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-e-ho","type":"person","url":"https://hartvaat.nl/mensen/jennifer-e-ho/","name":"Jennifer E Ho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-l-cluett","type":"person","url":"https://hartvaat.nl/mensen/jennifer-l-cluett/","name":"Jennifer L Cluett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/gofresh-dash-boodschappen-en-bloeddrukeffect-rct/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2023/10/17/orthostatische-hypotensie-en-intensieve-bloeddrukbehandeling-ipd-meta-analyse-in/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-lewey","type":"person","url":"https://hartvaat.nl/mensen/jennifer-lewey/","name":"Jennifer Lewey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/01/digitale-gamificatie-interventie-verhoogt-lichaamsbeweging-na-hypertensieve-zwan/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/05/05/furosemide-voor-versneld-bloeddrukherstel-postpartum-bij-hypertensieve-zwangersc/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-manne-goehler","type":"person","url":"https://hartvaat.nl/mensen/jennifer-manne-goehler/","name":"Jennifer Manne-Goehler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-martindale-adams","type":"person","url":"https://hartvaat.nl/mensen/jennifer-martindale-adams/","name":"Jennifer Martindale-Adams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-menzies","type":"person","url":"https://hartvaat.nl/mensen/jennifer-menzies/","name":"Jennifer Menzies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-s-lawton","type":"person","url":"https://hartvaat.nl/mensen/jennifer-s-lawton/","name":"Jennifer S Lawton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-t-thibodeau","type":"person","url":"https://hartvaat.nl/mensen/jennifer-t-thibodeau/","name":"Jennifer T Thibodeau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/glp-1-receptoragonisten-geassocieerd-met-lagere-mortaliteit-bij-hfref/","published":"2026-05-26"},{"url":"https://hartvaat.nl/2020/11/24/2020-acc-aha-prestatie-en-kwaliteitsmaten-voor-hartfalen/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jennifer-walker","type":"person","url":"https://hartvaat.nl/mensen/jennifer-walker/","name":"Jennifer Walker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jenny-hu","type":"person","url":"https://hartvaat.nl/mensen/jenny-hu/","name":"Jenny Hu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-aberle","type":"person","url":"https://hartvaat.nl/mensen/jens-aberle/","name":"Jens Aberle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/20/orforglipron-bij-obesitas-nejm-definitieve-fase-3-resultaten/","published":"2025-12-20"},{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-maurhofer","type":"person","url":"https://hartvaat.nl/mensen/jens-maurhofer/","name":"Jens Maurhofer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jens-refsgaard","type":"person","url":"https://hartvaat.nl/mensen/jens-refsgaard/","name":"Jens Refsgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/28/viborg-screeningsprogramma-verlaagt-5-jaarssterfte-bij-67-jarigen/","published":"2026-05-03"},{"url":"https://hartvaat.nl/2021/06/01/klinische-uitkomsten-en-respons-op-vericiguat-naar-index-hf-event-victoria/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jensen","type":"person","url":"https://hartvaat.nl/mensen/jensen/","name":"Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/klinisch-en-genetisch-risico-op-atriumfibrilleren-versterken-elkaar-additief-13-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/01/28/risicocommunicatie-instrument-in-de-huisartsenpraktijk-verlaagt-bloeddruk-en-cho/","published":"2026-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeong-cheon-ahn","type":"person","url":"https://hartvaat.nl/mensen/jeong-cheon-ahn/","name":"Jeong Cheon Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/20/lage-dosis-drievoudige-combinatiepil-versus-standaard-telmisartan-bij-hypertensi/","published":"2026-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeremy-dwight","type":"person","url":"https://hartvaat.nl/mensen/jeremy-dwight/","name":"Jeremy Dwight","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jernej-stublar","type":"person","url":"https://hartvaat.nl/mensen/jernej-stublar/","name":"Jernej Štublar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/csp-sync-geleidingssysteempacing-versus-biventriculaire-pacing-voor-crt-rct/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/05/02/preventieve-substraatablatie-vermindert-icd-interventies-bij-ischemische-cmp/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeroen-m-hendriks","type":"person","url":"https://hartvaat.nl/mensen/jeroen-m-hendriks/","name":"Jeroen M Hendriks","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/smartphone-app-voor-symptoomregistratie-na-ablatie-bij-atriumfibrilleren-isolati/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeroen-sonck","type":"person","url":"https://hartvaat.nl/mensen/jeroen-sonck/","name":"Jeroen Sonck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jerrold-h-levy","type":"person","url":"https://hartvaat.nl/mensen/jerrold-h-levy/","name":"Jerrold H Levy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/24/inhalatief-epoprostenol-versus-no-bij-rechterventrikel-falen-na-hartchirurgie/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jerry-d-estep","type":"person","url":"https://hartvaat.nl/mensen/jerry-d-estep/","name":"Jerry D Estep","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jersey-chen","type":"person","url":"https://hartvaat.nl/mensen/jersey-chen/","name":"Jersey Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/30/ticagrelor-plus-aspirine-en-ledematenuitkomsten-bij-diabetes-met-atherosclerose/","published":"2024-04-30"},{"url":"https://hartvaat.nl/2019/09/28/ticagrelor-bij-diabetes-met-stabiel-coronairlijden-en-eerder-pci-lancet-themis-p/","published":"2019-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jerzy-sacha","type":"person","url":"https://hartvaat.nl/mensen/jerzy-sacha/","name":"Jerzy Sacha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jes-sanddal-lindholt","type":"person","url":"https://hartvaat.nl/mensen/jes-sanddal-lindholt/","name":"Jes Sanddal Lindholt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/28/viborg-screeningsprogramma-verlaagt-5-jaarssterfte-bij-67-jarigen/","published":"2026-05-03"},{"url":"https://hartvaat.nl/2021/10/01/aortaklepcalcificatie-en-cv-risicofactoren-bij-oudere-deense-mannen/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jessry-veerapen","type":"person","url":"https://hartvaat.nl/mensen/jessry-veerapen/","name":"Jessry Veerapen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jesus-casado","type":"person","url":"https://hartvaat.nl/mensen/jesus-casado/","name":"Jesús Casado","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/clorotic-subanalyse-acute-egfr-daling-door-thiaziden-bij-acuut-hf-is-geen-progno/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2023/02/01/clorotic-thiazide-toevoegen-aan-lisdiureticum-bij-acuut-hartfalen/","published":"2023-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jet-milders","type":"person","url":"https://hartvaat.nl/mensen/jet-milders/","name":"Jet Milders","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/21/patientgerapporteerde-uitkomsten-verbeteren-voorspelling-van-mortaliteit-bij-dia/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2022/11/22/cva-risicoscores-bij-af-vergeleken-cha2ds2-vasc-blijft-de-beste/","published":"2022-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jeyaraj-d-pandian","type":"person","url":"https://hartvaat.nl/mensen/jeyaraj-d-pandian/","name":"Jeyaraj D Pandian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ji-hyun-lee","type":"person","url":"https://hartvaat.nl/mensen/ji-hyun-lee/","name":"Ji Hyun Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jia-feng","type":"person","url":"https://hartvaat.nl/mensen/jia-feng/","name":"Jia Feng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/04/microbioom-vriendelijk-dieet-di-gm-geassocieerd-met-27-minder-hartfalen-bij-pred/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jia-li","type":"person","url":"https://hartvaat.nl/mensen/jia-li/","name":"Jia Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2019/04/18/antitrombotische-therapie-na-acs-of-pci-bij-af-nejm-augustus/","published":"2019-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jia-pu","type":"person","url":"https://hartvaat.nl/mensen/jia-pu/","name":"Jia Pu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/17/million-hearts-betaald-cv-risicomanagement-vermindert-mi-en-cva-jama-rct/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/09/01/million-hearts-cv-risicoreductiemodel-en-medicatie-initiatie-jama-cardiology/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jialin-xu","type":"person","url":"https://hartvaat.nl/mensen/jialin-xu/","name":"Jialin Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jian-xu","type":"person","url":"https://hartvaat.nl/mensen/jian-xu/","name":"Jian Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/30/retractie-proteasoom-afhankelijke-degradatie-van-gtp-cyclohydrolase-i-bij-diabet/","published":"2026-01-30"},{"url":"https://hartvaat.nl/2021/04/01/sarcopenie-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jian-wen-hou","type":"person","url":"https://hartvaat.nl/mensen/jian-wen-hou/","name":"Jian-Wen Hou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/cryoablatie-versus-radiofrequentieablatie-bij-paroxysmaal-af-systematische-revie/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/04/01/rol-van-adenosine-geleide-pvi-bij-katheterablatie-voor-af-meta-analyse/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiangang-zou","type":"person","url":"https://hartvaat.nl/mensen/jiangang-zou/","name":"Jiangang Zou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2022/09/27/linkerbundeltakpacing-versus-biventriculaire-pacing-voor-crt-gerandomiseerde-tri/","published":"2022-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiangui-he","type":"person","url":"https://hartvaat.nl/mensen/jiangui-he/","name":"Jiangui He","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/01/hypertensie-wijzigt-de-relatie-tussen-lp-a-en-mortaliteit-bij-acuut-gedecompense/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianguo-zhang","type":"person","url":"https://hartvaat.nl/mensen/jianguo-zhang/","name":"Jianguo Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianjun-mu","type":"person","url":"https://hartvaat.nl/mensen/jianjun-mu/","name":"Jianjun Mu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jianxin-zhang","type":"person","url":"https://hartvaat.nl/mensen/jianxin-zhang/","name":"Jianxin Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiapeng-lu","type":"person","url":"https://hartvaat.nl/mensen/jiapeng-lu/","name":"Jiapeng Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"},{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jie-du","type":"person","url":"https://hartvaat.nl/mensen/jie-du/","name":"Jie Du","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/esprit-bescheiden-effecten-van-intensieve-bloeddrukverlaging-op-kwaliteit-van-le/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jie-jiang","type":"person","url":"https://hartvaat.nl/mensen/jie-jiang/","name":"Jie Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jie-ren","type":"person","url":"https://hartvaat.nl/mensen/jie-ren/","name":"Jie Ren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jie-wang","type":"person","url":"https://hartvaat.nl/mensen/jie-wang/","name":"Jie Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/12/31/annexine-a1-verergert-activatie-van-eilandjessterrecellen-via-triglyceridenafbra/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/01/effect-van-sglt2-remmers-op-atriumfibrilleren-bij-diabetes-met-gedilateerde-card/","published":"2026-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jill-barton","type":"person","url":"https://hartvaat.nl/mensen/jill-barton/","name":"Jill Barton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jill-mollison","type":"person","url":"https://hartvaat.nl/mensen/jill-mollison/","name":"Jill Mollison","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/antihypertensieve-medicatiereductie-versus-standaardzorg-bij-ouderen-jama-optimi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2018/08/01/zelfmanagement-van-postnatale-hypertensie-de-snap-ht-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jill-p-crandall","type":"person","url":"https://hartvaat.nl/mensen/jill-p-crandall/","name":"Jill P Crandall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jim-g-thornton","type":"person","url":"https://hartvaat.nl/mensen/jim-g-thornton/","name":"Jim G Thornton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-li","type":"person","url":"https://hartvaat.nl/mensen/jin-li/","name":"Jin Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/01/sglt2-remmers-raas-remmers-en-arni-vergeleken-bij-hartfalen-meta-analyse/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2023/03/14/real-time-remote-monitoring-voorspelt-maligne-ventriculaire-aritmieen/","published":"2023-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-liu","type":"person","url":"https://hartvaat.nl/mensen/jin-liu/","name":"Jin Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/verhoogd-lp-a-en-diabetes-verergeren-samen-de-prognose-bij-coronairlijden/","published":"2026-02-27"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-sin-koh","type":"person","url":"https://hartvaat.nl/mensen/jin-sin-koh/","name":"Jin Sin Koh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/09/occupi-oct-geleide-stentoptimalisatie-bij-complexe-coronairlaesies/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-bae-kim","type":"person","url":"https://hartvaat.nl/mensen/jin-bae-kim/","name":"Jin-Bae Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-bae-lee","type":"person","url":"https://hartvaat.nl/mensen/jin-bae-lee/","name":"Jin-Bae Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/12/clopidogrel-versus-aspirine-monotherapie-bij-hoog-risico-op-recidief-cva/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-ho-choi","type":"person","url":"https://hartvaat.nl/mensen/jin-ho-choi/","name":"Jin-Ho Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-man-cho","type":"person","url":"https://hartvaat.nl/mensen/jin-man-cho/","name":"Jin-Man Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jin-yong-hwang","type":"person","url":"https://hartvaat.nl/mensen/jin-yong-hwang/","name":"Jin-Yong Hwang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2018/04/01/valsartan-en-linkerkamerremodellering-na-mi/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jincheng-guo","type":"person","url":"https://hartvaat.nl/mensen/jincheng-guo/","name":"Jincheng Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/16/postprocedurale-anticoagulatie-na-primaire-pci-voor-stemi-multicenter-studie/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jinfeng-yang","type":"person","url":"https://hartvaat.nl/mensen/jinfeng-yang/","name":"Jinfeng Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jing-kang","type":"person","url":"https://hartvaat.nl/mensen/jing-kang/","name":"Jing Kang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/31/ontstekingsrijke-voeding-verhoogt-sterfterisico-bij-ckm-syndroom-nhanes-cohort/","published":"2026-08-14"},{"url":"https://hartvaat.nl/2026/03/25/meta-analyse-glp-1-agonisten-voorkomen-hartfalen-in-type-2-diabetes-sterkste-eff/","published":"2026-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jing-liu","type":"person","url":"https://hartvaat.nl/mensen/jing-liu/","name":"Jing Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/hart-en-vaatziekten-in-china-epidemiologische-evolutie-19902021/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jingjing-bai","type":"person","url":"https://hartvaat.nl/mensen/jingjing-bai/","name":"Jingjing Bai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/09/01/hypertensieduur-en-effect-van-intensieve-bloeddrukbehandeling/","published":"2024-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jingjing-zhao","type":"person","url":"https://hartvaat.nl/mensen/jingjing-zhao/","name":"Jingjing Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/01/hypertensie-wijzigt-de-relatie-tussen-lp-a-en-mortaliteit-bij-acuut-gedecompense/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jingkuo-li","type":"person","url":"https://hartvaat.nl/mensen/jingkuo-li/","name":"Jingkuo Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jingyu-zhou","type":"person","url":"https://hartvaat.nl/mensen/jingyu-zhou/","name":"Jingyu Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jingyuan-yang","type":"person","url":"https://hartvaat.nl/mensen/jingyuan-yang/","name":"Jingyuan Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jingzhou-jiang","type":"person","url":"https://hartvaat.nl/mensen/jingzhou-jiang/","name":"Jingzhou Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/14/depressietrajecten-bij-hfpef-impact-op-uitkomsten/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jinho-shin","type":"person","url":"https://hartvaat.nl/mensen/jinho-shin/","name":"Jinho Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jinkwon-kim","type":"person","url":"https://hartvaat.nl/mensen/jinkwon-kim/","name":"Jinkwon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/22/ldl-c-reductie-50-verlaagt-risico-op-secundaire-cardiovasculaire-gebeurtenissen-/","published":"2026-08-27"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiri-holy","type":"person","url":"https://hartvaat.nl/mensen/jiri-holy/","name":"Jiri Holy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiri-knot","type":"person","url":"https://hartvaat.nl/mensen/jiri-knot/","name":"Jiri Knot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jiri-ostransky","type":"person","url":"https://hartvaat.nl/mensen/jiri-ostransky/","name":"Jiri Ostransky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jisoo-lee","type":"person","url":"https://hartvaat.nl/mensen/jisoo-lee/","name":"Jisoo Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/30/empagliflozine-en-cardiale-energiestofwisseling-bij-hartfalen-empa-vision/","published":"2023-05-30"},{"url":"https://hartvaat.nl/2019/04/30/empagliflozine-antihyperglycemische-en-bloeddrukeffecten-bij-zwarte-diabetespati/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jixin-sun","type":"person","url":"https://hartvaat.nl/mensen/jixin-sun/","name":"Jixin Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jo-dens","type":"person","url":"https://hartvaat.nl/mensen/jo-dens/","name":"Jo Dens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joann-sperl-hillen","type":"person","url":"https://hartvaat.nl/mensen/joann-sperl-hillen/","name":"JoAnn Sperl-Hillen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/01/apotheker-geleide-telezorg-versus-poliklinische-zorg-bij-ongecontroleerde-hypert/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joachim-hoyer","type":"person","url":"https://hartvaat.nl/mensen/joachim-hoyer/","name":"Joachim Hoyer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/24/axadia-afnet-8-apixaban-versus-vka-bij-af-op-hemodialyse/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joachim-schofer","type":"person","url":"https://hartvaat.nl/mensen/joachim-schofer/","name":"Joachim Schofer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joachim-thiery","type":"person","url":"https://hartvaat.nl/mensen/joachim-thiery/","name":"Joachim Thiery","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2018/03/13/leefstijlinterventies-en-mobilisatie-van-vetstapeling-central-mri-gerandomiseerd/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joan-albert-arnaiz","type":"person","url":"https://hartvaat.nl/mensen/joan-albert-arnaiz/","name":"Joan Albert Arnaiz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/08/1-jaars-cv-events-bij-restrictieve-versus-liberale-transfusie-na-acuut-mi-realit/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2021/02/09/restrictieve-versus-liberale-transfusie-bij-acuut-mi-jama-reality/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joan-montaner","type":"person","url":"https://hartvaat.nl/mensen/joan-montaner/","name":"Joan Montaner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/24/systemische-inflammatie-en-recidief-na-een-af-gerelateerd-herseninfarct/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joanna-chikwe","type":"person","url":"https://hartvaat.nl/mensen/joanna-chikwe/","name":"Joanna Chikwe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joanna-huang","type":"person","url":"https://hartvaat.nl/mensen/joanna-huang/","name":"Joanna Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joanna-kelly","type":"person","url":"https://hartvaat.nl/mensen/joanna-kelly/","name":"Joanna Kelly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2017/06/03/intravitreaal-aflibercept-versus-panretinale-fotocoagulatie-bij-proliferatieve-d/","published":"2017-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joanne-lord","type":"person","url":"https://hartvaat.nl/mensen/joanne-lord/","name":"Joanne Lord","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2016/12/07/linker-hartoorsluiting-uitkomsten-en-kosten-van-trial-en-real-world-versus-orale/","published":"2016-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joanne-ryan","type":"person","url":"https://hartvaat.nl/mensen/joanne-ryan/","name":"Joanne Ryan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joao-a-c-lima","type":"person","url":"https://hartvaat.nl/mensen/joao-a-c-lima/","name":"Joao A C Lima","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joaquim-barreto","type":"person","url":"https://hartvaat.nl/mensen/joaquim-barreto/","name":"Joaquim Barreto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/14/dapagliflozin-verlaagt-serum-klotho-bij-dialysepatienten-zonder-effect-op-botbio/","published":"2026-08-22"},{"url":"https://hartvaat.nl/2023/04/01/aspirine-in-primaire-preventie-en-hartfalenrisico-meta-analyse/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joaquin-fernandez-concha","type":"person","url":"https://hartvaat.nl/mensen/joaquin-fernandez-concha/","name":"Joaquin Fernandez Concha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/more-crt-mpp-multipoint-pacing-bij-crt-non-responders/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/09/14/crt-non-responder-naar-responder-conversie-more-crt-mpp/","published":"2019-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"job-a-j-verdonschot","type":"person","url":"https://hartvaat.nl/mensen/job-a-j-verdonschot/","name":"Job A J Verdonschot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/hartfrequentiereactiviteit-en-inspanningstolerantie-bij-hartfalen/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2021/02/11/spironolacton-en-cardiovasculaire-functie-bij-risico-op-hf-ehj/","published":"2021-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"job-van-der-palen","type":"person","url":"https://hartvaat.nl/mensen/job-van-der-palen/","name":"Job van der Palen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jochen-borgermann","type":"person","url":"https://hartvaat.nl/mensen/jochen-borgermann/","name":"Jochen Börgermann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2017/08/01/vitamine-d-en-mortaliteit-bij-hartfalen-de-evita-3-jaars-gerandomiseerde-trial/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jochen-proff","type":"person","url":"https://hartvaat.nl/mensen/jochen-proff/","name":"Jochen Proff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/katheterablatie-bij-af-met-hartfalen-nejm-castle-af/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/06/07/dagelijkse-telemonitoring-van-icd-s-gepoolde-analyse-van-drie-gerandomiseerde-tr/","published":"2017-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joe-elie-salem","type":"person","url":"https://hartvaat.nl/mensen/joe-elie-salem/","name":"Joe-Elie Salem","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joel-d-schwartz","type":"person","url":"https://hartvaat.nl/mensen/joel-d-schwartz/","name":"Joel D Schwartz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/pm2-5-blootstelling-versnelt-daling-van-egfr-bij-volwassenen/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joel-handler","type":"person","url":"https://hartvaat.nl/mensen/joel-handler/","name":"Joel Handler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/04/05/bloeddrukverlaging-bij-kappersbezoek-nejm-clustergerandomiseerde-trial/","published":"2018-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joel-tsevat","type":"person","url":"https://hartvaat.nl/mensen/joel-tsevat/","name":"Joel Tsevat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joern-tongers","type":"person","url":"https://hartvaat.nl/mensen/joern-tongers/","name":"Joern Tongers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-brugemann","type":"person","url":"https://hartvaat.nl/mensen/johan-brugemann/","name":"Johan Brügemann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/08/21/behandeling-van-onderliggende-aandoeningen-verbetert-sinusritme-na-af-arrest-af/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johan-g-eriksson","type":"person","url":"https://hartvaat.nl/mensen/johan-g-eriksson/","name":"Johan G Eriksson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johannes-grand","type":"person","url":"https://hartvaat.nl/mensen/johannes-grand/","name":"Johannes Grand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johansson","type":"person","url":"https://hartvaat.nl/mensen/johansson/","name":"Johansson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/langetermijnuitkomsten-na-de-ross-operatie-een-op-de-vier-krijgt-een-heroperatie/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/19/welke-ijzermarker-voorspelt-de-prognose-bij-nieuw-hartfalen-lage-transferrinesat/","published":"2026-03-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-a-kern","type":"person","url":"https://hartvaat.nl/mensen/john-a-kern/","name":"John A Kern","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/26/intramyocardiale-mesenchymale-precursorcellen-en-lvad-weaning-jama/","published":"2019-03-26"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-a-wells","type":"person","url":"https://hartvaat.nl/mensen/john-a-wells/","name":"John A Wells","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/19/faricimab-bij-diabetisch-maculaoedeem-met-verlengde-dosering-lancet/","published":"2022-02-19"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-a-williams","type":"person","url":"https://hartvaat.nl/mensen/john-a-williams/","name":"John A Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/26/smartphone-detectie-van-af-via-fotoplethysmografie-meta-analyse/","published":"2022-09-26"},{"url":"https://hartvaat.nl/2021/10/16/betablokker-respons-bij-hf-met-sinusritme-en-af-machine-learning-clusteranalyse/","published":"2021-10-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-a-sayer","type":"person","url":"https://hartvaat.nl/mensen/john-a-sayer/","name":"John A. Sayer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/19/genotype-fenotypekenmerken-bij-fan1-gerelateerde-karyomegale-tubulointerstitiele/","published":"2026-01-19"},{"url":"https://hartvaat.nl/2025/12/24/genomische-ontdekking-bij-nefrotisch-syndroom-mefv-varianten-als-risicofactor-vo/","published":"2025-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-b-chambers","type":"person","url":"https://hartvaat.nl/mensen/john-b-chambers/","name":"John B Chambers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/lage-arteriele-compliance-en-cv-morbiditeit-bij-aortaklepstenose/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-c-larosa","type":"person","url":"https://hartvaat.nl/mensen/john-c-larosa/","name":"John C LaRosa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/geschat-individueel-levensvoordeel-van-pcsk9-remming-bij-statinebehandelde-cad-p/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-d-day","type":"person","url":"https://hartvaat.nl/mensen/john-d-day/","name":"John D Day","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-d-harding","type":"person","url":"https://hartvaat.nl/mensen/john-d-harding/","name":"John D Harding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-d-horowitz","type":"person","url":"https://hartvaat.nl/mensen/john-d-horowitz/","name":"John D Horowitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/09/05/n-acetylcysteine-met-nitraat-bij-primaire-pci-voor-stemi/","published":"2017-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-d-neary","type":"person","url":"https://hartvaat.nl/mensen/john-d-neary/","name":"John D Neary","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"},{"url":"https://hartvaat.nl/2018/04/28/liberale-versus-conservatieve-zuurstoftherapie-bij-acuut-zieke-volwassenen-lance/","published":"2018-04-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-d-overton","type":"person","url":"https://hartvaat.nl/mensen/john-d-overton/","name":"John D Overton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-danesh","type":"person","url":"https://hartvaat.nl/mensen/john-danesh/","name":"John Danesh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-dunn","type":"person","url":"https://hartvaat.nl/mensen/john-dunn/","name":"John Dunn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-familiaire-hypercholesterolemie-uspstf-evidenc/","published":"2016-08-09"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-multifactoriele-dyslipidemie-uspstf-evidence-r/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-e-blair","type":"person","url":"https://hartvaat.nl/mensen/john-e-blair/","name":"John E Blair","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/ai-echotool-voor-hfpef-hoge-specificiteit-lage-sensitiviteit-bij-invasieve-valid/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-e-hall","type":"person","url":"https://hartvaat.nl/mensen/john-e-hall/","name":"John E Hall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/20/ouderlijke-obesitas-verhoogt-cardiorenale-risico-s-bij-nakomelingen-review/","published":"2026-08-28"},{"url":"https://hartvaat.nl/2020/03/01/natriumreductie-en-energie-metabolisme-gewicht-en-dorst-dash-resultaten/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-gierula","type":"person","url":"https://hartvaat.nl/mensen/john-gierula/","name":"John Gierula","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-graeme-houston","type":"person","url":"https://hartvaat.nl/mensen/john-graeme-houston/","name":"John Graeme Houston","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/21/dapagliflozine-op-lv-hypertrofie-bij-diabetes-type-2-dapa-lvh-gerandomiseerde-tr/","published":"2020-09-21"},{"url":"https://hartvaat.nl/2019/11/01/metformine-en-linkerventrikelhypertrofie-bij-coronairlijden-zonder-diabetes-gera/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-hung","type":"person","url":"https://hartvaat.nl/mensen/john-hung/","name":"John Hung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/08/grace-2-0-score-bij-type-1-en-type-2-mi/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2018/09/15/hoog-sensitief-troponine-bij-verdenking-acs-lancet-stepped-wedge-clustergerandom/","published":"2018-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-kittelson","type":"person","url":"https://hartvaat.nl/mensen/john-kittelson/","name":"John Kittelson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-l-fitzgerald","type":"person","url":"https://hartvaat.nl/mensen/john-l-fitzgerald/","name":"John L Fitzgerald","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/10/09/klinische-risicofactoren-voor-cva-bij-anticoagulantie-naieve-af-meta-analyse/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-martin","type":"person","url":"https://hartvaat.nl/mensen/john-martin/","name":"John Martin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-mcclure","type":"person","url":"https://hartvaat.nl/mensen/john-mcclure/","name":"John McClure","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2016/12/15/infarctgrootte-en-linkerkamerremodellering-na-preventieve-pci/","published":"2016-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-ormiston","type":"person","url":"https://hartvaat.nl/mensen/john-ormiston/","name":"John Ormiston","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/12/implantatiechniek-en-uitkomsten-van-bioresorbeerbare-scaffolds-absorb-analyses/","published":"2017-12-12"},{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-p-foran","type":"person","url":"https://hartvaat.nl/mensen/john-p-foran/","name":"John P Foran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/12/07/linker-hartoorsluiting-uitkomsten-en-kosten-van-trial-en-real-world-versus-orale/","published":"2016-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-p-forman","type":"person","url":"https://hartvaat.nl/mensen/john-p-forman/","name":"John P Forman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/melatoninesecretie-en-myocardinfarctrisico-geneste-case-controlstudie/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/02/01/urinezuurverlagende-middelen-en-endotheelfunctie-gerandomiseerde-trial/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-p-middleton","type":"person","url":"https://hartvaat.nl/mensen/john-p-middleton/","name":"John P Middleton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/dialysaat-kalium-3-0-mmol-l-met-natriumzirconiumcyclosilicaat-bij-dialyse/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-pernow","type":"person","url":"https://hartvaat.nl/mensen/john-pernow/","name":"John Pernow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-r-cockcroft","type":"person","url":"https://hartvaat.nl/mensen/john-r-cockcroft/","name":"John R Cockcroft","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/03/01/sacubitril-valsartan-versus-olmesartan-op-centrale-hemodynamiek-bij-ouderen-para/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-r-giudicessi","type":"person","url":"https://hartvaat.nl/mensen/john-r-giudicessi/","name":"John R Giudicessi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-parameters-voorspellen-nieuwe-hartklachten-bij-hypertrofische-cardiomyopathi/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/02/03/ryr2-mutaties-als-oorzaak-van-onverklaarde-plotse-hartdood-bij-jongeren/","published":"2026-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-ransom","type":"person","url":"https://hartvaat.nl/mensen/john-ransom/","name":"John Ransom","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/01/lvad-gebruik-als-bridge-to-transplant-versus-destination-therapy-momentum-3/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-s-gottdiener","type":"person","url":"https://hartvaat.nl/mensen/john-s-gottdiener/","name":"John S Gottdiener","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2017/02/21/diabetesstatus-en-cardiovasculaire-uitkomsten-bij-hfpef-klinische-en-echocardiog/","published":"2017-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"john-w-lehmann","type":"person","url":"https://hartvaat.nl/mensen/john-w-lehmann/","name":"John W Lehmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"johnny-kahlert","type":"person","url":"https://hartvaat.nl/mensen/johnny-kahlert/","name":"Johnny Kahlert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jolanta-m-siller-matula","type":"person","url":"https://hartvaat.nl/mensen/jolanta-m-siller-matula/","name":"Jolanta M Siller-Matula","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/21/antitrombotische-middelen-bij-acs-bij-vrouwen-seksegecorrigeerde-behandeling/","published":"2025-07-21"},{"url":"https://hartvaat.nl/2022/11/01/emmy-empagliflozine-na-acuut-myocardinfarct-verbetert-nt-probnp-en-remodelling/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jolita-badariene","type":"person","url":"https://hartvaat.nl/mensen/jolita-badariene/","name":"Jolita Badariene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/kardia-2-zilebesiran-als-toevoeging-bij-ongecontroleerde-hypertensie-rct/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jolyon-cox","type":"person","url":"https://hartvaat.nl/mensen/jolyon-cox/","name":"Jolyon Cox","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jon-suh","type":"person","url":"https://hartvaat.nl/mensen/jon-suh/","name":"Jon Suh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/thuis-bio-impedantie-voor-hartfalen-haalbaar-en-acceptabel-klinische-winst-nog-n/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2018/10/16/hoge-coronaire-shear-stress-voorspelt-myocardinfarct/","published":"2018-10-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jon-david-schwalm","type":"person","url":"https://hartvaat.nl/mensen/jon-david-schwalm/","name":"Jon-David Schwalm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/10/05/uitgebreide-community-interventie-bij-hypertensie-lancet-hope-4/","published":"2019-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonas-persson","type":"person","url":"https://hartvaat.nl/mensen/jonas-persson/","name":"Jonas Persson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/02/griepvaccinatie-na-mi-iami-dubbelblinde-gerandomiseerde-multicenter-trial/","published":"2021-11-02"},{"url":"https://hartvaat.nl/2020/11/17/pci-voor-kwetsbare-coronaire-plaque/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-bodansky","type":"person","url":"https://hartvaat.nl/mensen/jonathan-bodansky/","name":"Jonathan Bodansky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-c-craig","type":"person","url":"https://hartvaat.nl/mensen/jonathan-c-craig/","name":"Jonathan C Craig","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2016/07/19/glucoseverlagende-medicatie-en-cardiovasculaire-events-bij-diabetes-type-2-jama-/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-d-mosley","type":"person","url":"https://hartvaat.nl/mensen/jonathan-d-mosley/","name":"Jonathan D Mosley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/10/23/lpa-varianten-en-residueel-cv-risico-bij-statinebehandelde-patienten/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-g-schwartz","type":"person","url":"https://hartvaat.nl/mensen/jonathan-g-schwartz/","name":"Jonathan G Schwartz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-g-zaroff","type":"person","url":"https://hartvaat.nl/mensen/jonathan-g-zaroff/","name":"Jonathan G Zaroff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/30/kp-chemo-cumulatieve-incidentie-cancer-therapy-related-cardiac-dysfunction-8-4-h/","published":"2026-07-02"},{"url":"https://hartvaat.nl/2019/12/17/echo-uitkomsten-na-mitraclip-bij-secundaire-mr-coapt-echocardiografisch/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-grinstein","type":"person","url":"https://hartvaat.nl/mensen/jonathan-grinstein/","name":"Jonathan Grinstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/ai-echotool-voor-hfpef-hoge-specificiteit-lage-sensitiviteit-bij-invasieve-valid/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-hyde","type":"person","url":"https://hartvaat.nl/mensen/jonathan-hyde/","name":"Jonathan Hyde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2018/11/01/nmarq-pvac-en-thoracoscopische-ablatie-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-k-ehrman","type":"person","url":"https://hartvaat.nl/mensen/jonathan-k-ehrman/","name":"Jonathan K Ehrman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/10/tact-2-chelatietherapie-na-mi-bij-diabetes-negatieve-trial/","published":"2024-09-10"},{"url":"https://hartvaat.nl/2016/02/23/inspanningstestvariabelen-als-mortaliteitsvoorspellers-bij-chronisch-systolisch-/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-karnon","type":"person","url":"https://hartvaat.nl/mensen/jonathan-karnon/","name":"Jonathan Karnon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-myers","type":"person","url":"https://hartvaat.nl/mensen/jonathan-myers/","name":"Jonathan Myers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-n-townend","type":"person","url":"https://hartvaat.nl/mensen/jonathan-n-townend/","name":"Jonathan N Townend","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-p-ariyaratnam","type":"person","url":"https://hartvaat.nl/mensen/jonathan-p-ariyaratnam/","name":"Jonathan P Ariyaratnam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/caan-af-av-knoopablatie-verbetert-crt-uitkomsten-bij-permanent-atriumfibrilleren/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2025/12/01/arrest-af-agressieve-risicofactorreductie-en-ablatie-uitkomsten/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-p-blatchford","type":"person","url":"https://hartvaat.nl/mensen/jonathan-p-blatchford/","name":"Jonathan P Blatchford","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/01/empulse-empagliflozine-verbetert-decongestie-bij-acuut-hartfalen/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2022/07/26/empulse-empagliflozine-verbetert-symptomen-en-kwaliteit-van-leven-bij-acuut-hart/","published":"2022-07-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-pak","type":"person","url":"https://hartvaat.nl/mensen/jonathan-pak/","name":"Jonathan Pak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonathan-r-clague","type":"person","url":"https://hartvaat.nl/mensen/jonathan-r-clague/","name":"Jonathan R Clague","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2016/12/07/linker-hartoorsluiting-uitkomsten-en-kosten-van-trial-en-real-world-versus-orale/","published":"2016-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jong-s-kim","type":"person","url":"https://hartvaat.nl/mensen/jong-s-kim/","name":"Jong S Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jong-kwan-park","type":"person","url":"https://hartvaat.nl/mensen/jong-kwan-park/","name":"Jong-Kwan Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jong-min-song","type":"person","url":"https://hartvaat.nl/mensen/jong-min-song/","name":"Jong-Min Song","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/11/effort-ertugliflozine-bij-functionele-mitralisinsufficientie-en-hartfalen/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2019/03/12/arni-bij-functionele-mitralisklepinsufficientie/","published":"2019-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jong-youn-kim","type":"person","url":"https://hartvaat.nl/mensen/jong-youn-kim/","name":"Jong-Youn Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jongmin-hwang","type":"person","url":"https://hartvaat.nl/mensen/jongmin-hwang/","name":"Jongmin Hwang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joon-ho-ahn","type":"person","url":"https://hartvaat.nl/mensen/joon-ho-ahn/","name":"Joon Ho Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joonnyung-heo","type":"person","url":"https://hartvaat.nl/mensen/joonnyung-heo/","name":"JoonNyung Heo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/vertraagde-intracraniele-bloeding-na-trombectomie-geassocieerd-met-slechtere-fun/","published":"2026-06-14"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joonsang-yoo","type":"person","url":"https://hartvaat.nl/mensen/joonsang-yoo/","name":"Joonsang Yoo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/22/ldl-c-reductie-50-verlaagt-risico-op-secundaire-cardiovasculaire-gebeurtenissen-/","published":"2026-08-27"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jordan-b-king","type":"person","url":"https://hartvaat.nl/mensen/jordan-b-king/","name":"Jordan B King","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/combinatietabletten-voor-intensieve-bloeddrukbehandeling-sprint-analyse/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/03/01/antihypertensieve-regimes-in-sprint-gedetailleerd-beschreven/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jordan-bernick","type":"person","url":"https://hartvaat.nl/mensen/jordan-bernick/","name":"Jordan Bernick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/01/aware-uitgebreide-ablatie-vermindert-af-recidief-niet-boven-standaard-pvi/","published":"2023-05-01"},{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jordan-fulcher","type":"person","url":"https://hartvaat.nl/mensen/jordan-fulcher/","name":"Jordan Fulcher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/tricuspidalisinsufficientie-en-mortaliteit-onafhankelijk-van-ph-en-rechterventri/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/03/01/voorspellers-van-succesvolle-cto-pci-systematische-review-en-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jordan-g-bauman","type":"person","url":"https://hartvaat.nl/mensen/jordan-g-bauman/","name":"Jordan G Bauman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/10/pulmonalisdrukgeleide-therapie-bij-hfref/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2016/01/30/hemodynamische-telemonitoring-bij-chronisch-hartfalen-volledige-champion-resulta/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jordi-riera","type":"person","url":"https://hartvaat.nl/mensen/jordi-riera/","name":"Jordi Riera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorge-mena-madrazo","type":"person","url":"https://hartvaat.nl/mensen/jorge-mena-madrazo/","name":"Jorge Mena-Madrazo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/26/inclisiran-als-monotherapie-verlaagt-ldl-c-met-47-5-in-chinese-volwassenen-victo/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2025/07/22/victorion-initiate-inclisiran-monotherapie-bij-patienten-zonder-ascvd/","published":"2025-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorge-polonia","type":"person","url":"https://hartvaat.nl/mensen/jorge-polonia/","name":"Jorge Polonia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/01/inspanningstraining-en-ambulante-bloeddruk-bij-resistente-hypertensie-jama-cardi/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2016/04/01/prognostisch-effect-van-nachtelijke-bloeddrukdaling-bij-hypertensie-de-abc-h-stu/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorge-r-kizer","type":"person","url":"https://hartvaat.nl/mensen/jorge-r-kizer/","name":"Jorge R Kizer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/01/immuuncelsubsets-voorspellen-incident-hartfalen-in-populatiestudies/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorge-thierer","type":"person","url":"https://hartvaat.nl/mensen/jorge-thierer/","name":"Jorge Thierer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/deliver-dapagliflozine-effectief-bij-hfpef-ongeacht-atriumfibrilleren/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joris-j-van-der-heijden","type":"person","url":"https://hartvaat.nl/mensen/joris-j-van-der-heijden/","name":"Joris J van der Heijden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorma-s-a-viikari","type":"person","url":"https://hartvaat.nl/mensen/jorma-s-a-viikari/","name":"Jorma S A Viikari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/01/20-jaars-dieetinterventie-vanaf-zuigelingenleeftijd-en-bloeddruk-strip-studie/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2017/08/01/cardiometabole-determinanten-van-carotis-en-aortadistensibiliteit-van-kindertijd/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jos-g-maessen","type":"person","url":"https://hartvaat.nl/mensen/jos-g-maessen/","name":"Jos G Maessen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2021/11/08/preoperatieve-tte-voor-voorspelling-van-postoperatief-af-meta-analyse/","published":"2021-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jos-widdershoven","type":"person","url":"https://hartvaat.nl/mensen/jos-widdershoven/","name":"Jos Widdershoven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/remote-monitoring-en-patientgerapporteerde-uitkomsten-bij-europese-hf-patienten-/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-alderete","type":"person","url":"https://hartvaat.nl/mensen/jose-alderete/","name":"Jose Alderete","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-jalife","type":"person","url":"https://hartvaat.nl/mensen/jose-jalife/","name":"Jose Jalife","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-l-zamorano","type":"person","url":"https://hartvaat.nl/mensen/jose-l-zamorano/","name":"Jose L Zamorano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/expanded-bij-73-verbetert-tricuspidalisinsufficientie-binnen-30-dagen-na-m-teer-/","published":"2026-06-26"},{"url":"https://hartvaat.nl/2026/03/16/vroege-linkerventrikel-reverse-remodellering-na-mitralisklep-edge-to-edge-repara/","published":"2026-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-lopez-miranda","type":"person","url":"https://hartvaat.nl/mensen/jose-lopez-miranda/","name":"Jose Lopez-Miranda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2017/10/28/zeer-lage-ldl-concentraties-met-evolocumab-lancet-fourier-subanalyse/","published":"2017-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-m-de-la-torre-hernandez","type":"person","url":"https://hartvaat.nl/mensen/jose-m-de-la-torre-hernandez/","name":"Jose M de la Torre Hernandez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-nativi-nicolau","type":"person","url":"https://hartvaat.nl/mensen/jose-nativi-nicolau/","name":"Jose Nativi-Nicolau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/10/2025-acc-attr-cm-evaluatie-en-management-beknopte-klinische-richtlijn/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-osorio","type":"person","url":"https://hartvaat.nl/mensen/jose-osorio/","name":"Jose Osorio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-silva-cardoso","type":"person","url":"https://hartvaat.nl/mensen/jose-silva-cardoso/","name":"Jose Silva-Cardoso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josef-niebauer","type":"person","url":"https://hartvaat.nl/mensen/josef-niebauer/","name":"Josef Niebauer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/cardiale-screening-van-jonge-sporters-eerste-eapc-aepc-consensus-voor-kinderen/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josef-stasek","type":"person","url":"https://hartvaat.nl/mensen/josef-stasek/","name":"Josef Stasek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josep-lupon","type":"person","url":"https://hartvaat.nl/mensen/josep-lupon/","name":"Josep Lupón","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josep-masip","type":"person","url":"https://hartvaat.nl/mensen/josep-masip/","name":"Josep Masip","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2019/02/01/herhaalde-levosimendan-infusies-bij-gevorderd-chronisch-hf-in-de-kwetsbare-postd/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-b-muhlestein","type":"person","url":"https://hartvaat.nl/mensen/joseph-b-muhlestein/","name":"Joseph B Muhlestein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/victorion-inception-vroege-inclisiran-na-acuut-coronair-syndroom-verviervoudigt-/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2020/10/21/icosapent-ethyl-en-coronaire-atheroscleroseprogressie-bij-verhoogde-triglyceride/","published":"2020-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-beyene","type":"person","url":"https://hartvaat.nl/mensen/joseph-beyene/","name":"Joseph Beyene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/peulvruchten-in-de-voeding-verlagen-ldl-en-non-hdl-dose-response-meta-analyse-va/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2016/08/01/digitale-gezondheidsinterventie-voor-cardiovasculaire-risicoverlaging-gerandomis/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-cheriyan","type":"person","url":"https://hartvaat.nl/mensen/joseph-cheriyan/","name":"Joseph Cheriyan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/cardiale-structuur-en-functie-bij-hypertensieve-zwangerschapsstoornissen-systema/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2016/11/01/rol-van-het-autonome-zenuwstelsel-bij-regulatie-van-aortastijfheid/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-j-derose","type":"person","url":"https://hartvaat.nl/mensen/joseph-j-derose/","name":"Joseph J DeRose","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/21/pacemakerimplantatie-na-mitralisklepchirurgie-met-af-ablatie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2016/05/19/chirurgische-behandeling-van-matige-ischemische-mitralisklepinsufficientie-2-jaa/","published":"2016-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-l-blackshear","type":"person","url":"https://hartvaat.nl/mensen/joseph-l-blackshear/","name":"Joseph L Blackshear","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/06/01/intensieve-versus-standaard-bloeddruk-naar-tertielen-in-sprint/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-l-izzo","type":"person","url":"https://hartvaat.nl/mensen/joseph-l-izzo/","name":"Joseph L Izzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/18/dapa-act-hf-timi-68-dapagliflozine-bij-gehospitaliseerd-hartfalen-nejm/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2019/04/30/empagliflozine-antihyperglycemische-en-bloeddrukeffecten-bij-zwarte-diabetespati/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-m-dimaria","type":"person","url":"https://hartvaat.nl/mensen/joseph-m-dimaria/","name":"Joseph M DiMaria","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/09/summit-tirzepatide-effect-bij-hfpef-met-en-zonder-diabetes/","published":"2025-09-09"},{"url":"https://hartvaat.nl/2025/02/25/summit-tirzepatide-vermindert-lv-massa-en-paracardiaal-vetweefsel-bij-hfpef/","published":"2025-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-m-sweeny","type":"person","url":"https://hartvaat.nl/mensen/joseph-m-sweeny/","name":"Joseph M Sweeny","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2016/02/16/ticagrelor-versus-clopidogrel-bij-troponine-negatieve-laagrisico-acs-met-ad-hoc-/","published":"2016-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-p-broderick","type":"person","url":"https://hartvaat.nl/mensen/joseph-p-broderick/","name":"Joseph P Broderick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-paul-de-bono","type":"person","url":"https://hartvaat.nl/mensen/joseph-paul-de-bono/","name":"Joseph Paul de Bono","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/25/jbs-richtlijn-management-van-hartstilstand-in-het-cathlab/","published":"2022-05-25"},{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-rossano","type":"person","url":"https://hartvaat.nl/mensen/joseph-rossano/","name":"Joseph Rossano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joseph-w-hogan","type":"person","url":"https://hartvaat.nl/mensen/joseph-w-hogan/","name":"Joseph W Hogan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josephine-birungi","type":"person","url":"https://hartvaat.nl/mensen/josephine-birungi/","name":"Josephine Birungi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josephine-mansell","type":"person","url":"https://hartvaat.nl/mensen/josephine-mansell/","name":"Josephine Mansell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/atriale-mechanische-contractie-voorspelt-cerebrovasculair-risico-bij-transthyret/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/14/tricorder-ai-stethoscoop-voor-triple-cv-ziektedetectie/","published":"2026-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"josephine-tse","type":"person","url":"https://hartvaat.nl/mensen/josephine-tse/","name":"Josephine Tse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/dapagliflozine-bij-cv-risico-met-zonder-diabetes-cardiorenale-effecten/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2022/08/09/renale-en-vasculaire-effecten-van-gecombineerde-sglt2-en-ace-remming/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joshi","type":"person","url":"https://hartvaat.nl/mensen/joshi/","name":"Joshi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/niet-invasieve-endotypering-met-stress-mri-verbetert-de-behandeling-van-angina-z/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/01/23/multidisciplinair-cardiogene-shockteam-verbetert-de-1-jaarsoverleving-bij-infarc/","published":"2026-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joshua-barzilay","type":"person","url":"https://hartvaat.nl/mensen/joshua-barzilay/","name":"Joshua Barzilay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joshua-j-neumiller","type":"person","url":"https://hartvaat.nl/mensen/joshua-j-neumiller/","name":"Joshua J Neumiller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/sglt2-remmers-head-to-head-empagliflozin-licht-beter-dan-canagliflozin-bij-matig/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2020/09/01/2020-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","published":"2020-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joshua-w-knowles","type":"person","url":"https://hartvaat.nl/mensen/joshua-w-knowles/","name":"Joshua W Knowles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/06/caviar-alirocumab-bij-cardiale-allograft-vasculopathie-na-harttransplantatie/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-a-barrabes","type":"person","url":"https://hartvaat.nl/mensen/jose-a-barrabes/","name":"José A Barrabés","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-a-de-figueiredo-neto","type":"person","url":"https://hartvaat.nl/mensen/jose-a-de-figueiredo-neto/","name":"José A de Figueiredo Neto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-luis-ferreiro","type":"person","url":"https://hartvaat.nl/mensen/jose-luis-ferreiro/","name":"José Luis Ferreiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2022/10/18/asundexian-factor-xia-remmer-na-acs-fase-2-dosisfindingsstudie/","published":"2022-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-rozado","type":"person","url":"https://hartvaat.nl/mensen/jose-rozado/","name":"José Rozado","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2026/01/20/es-bempedacs-triple-versus-duale-lipidenbehandeling-na-acs/","published":"2026-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jose-tomas-ortiz-perez","type":"person","url":"https://hartvaat.nl/mensen/jose-tomas-ortiz-perez/","name":"José-Tomás Ortiz-Pérez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jouke-dijkstra","type":"person","url":"https://hartvaat.nl/mensen/jouke-dijkstra/","name":"Jouke Dijkstra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/04/ivus-segmentatiemethoden-vergeleken-in-de-pacman-ami-trial/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2026/02/25/hemodynamische-en-bloedviscositeitsprofielen-van-culprit-versus-non-culprit-coro/","published":"2026-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joyce-kingsbury","type":"person","url":"https://hartvaat.nl/mensen/joyce-kingsbury/","name":"Joyce Kingsbury","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"joao-sergio-neves","type":"person","url":"https://hartvaat.nl/mensen/joao-sergio-neves/","name":"João Sérgio Neves","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/12/matige-koffiedrinken-waarschijnlijk-veilig-en-mogelijk-gunstig-bij-chronische-ni/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2023/08/08/glp-1-agonisten-met-en-zonder-sglt2-remmers-bij-type-2-diabetes-jacc-analyse/","published":"2023-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ju-hee-lee","type":"person","url":"https://hartvaat.nl/mensen/ju-hee-lee/","name":"Ju-Hee Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ju-hyeon-oh","type":"person","url":"https://hartvaat.nl/mensen/ju-hyeon-oh/","name":"Ju-Hyeon Oh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2018/03/31/6-versus-12-maanden-dapt-na-pci-bij-acs-lancet-netwerkmeta-analyse/","published":"2018-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-antonio-requena-ibanez","type":"person","url":"https://hartvaat.nl/mensen/juan-antonio-requena-ibanez/","name":"Juan Antonio Requena-Ibanez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/22/anemie-beinvloedt-ijzerhomeostase-en-empagliflozine-respons-bij-hf/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-c-villar","type":"person","url":"https://hartvaat.nl/mensen/juan-c-villar/","name":"Juan C Villar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-j-russo","type":"person","url":"https://hartvaat.nl/mensen/juan-j-russo/","name":"Juan J Russo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"},{"url":"https://hartvaat.nl/2019/02/19/lv-unloading-tijdens-ecmo-bij-cardiogene-shock/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juan-liu","type":"person","url":"https://hartvaat.nl/mensen/juan-liu/","name":"Juan Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/20/milt-norepinefrine-2-adrenerge-as-verergert-sepsis-geassocieerd-acuut-nierletsel/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"judith-e-lowry","type":"person","url":"https://hartvaat.nl/mensen/judith-e-lowry/","name":"Judith E Lowry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"judith-hall","type":"person","url":"https://hartvaat.nl/mensen/judith-hall/","name":"Judith Hall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"judith-mackay","type":"person","url":"https://hartvaat.nl/mensen/judith-mackay/","name":"Judith Mackay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/28/ascot-legacy-atorvastatine-verlaagt-cv-events-over-20-jaar/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2018/09/29/langetermijnmortaliteit-na-bloeddruk-en-lipidenverlaging-bij-hypertensie-ascot-l/","published":"2018-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"judith-spahr","type":"person","url":"https://hartvaat.nl/mensen/judith-spahr/","name":"Judith Spahr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/21/apixaban-versus-heparine-vka-bij-cardioversie-voor-af-emanate-trial/","published":"2018-08-21"},{"url":"https://hartvaat.nl/2016/07/01/langetermijnevaluatie-van-dabigatran-150-versus-110-mg-bij-niet-valvulair-af/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juhani-knuuti","type":"person","url":"https://hartvaat.nl/mensen/juhani-knuuti/","name":"Juhani Knuuti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/03/klinische-risicopredictie-ct-coronairangiografie-en-cv-events-bij-nieuwe-angina/","published":"2025-02-03"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-aulin","type":"person","url":"https://hartvaat.nl/mensen/julia-aulin/","name":"Julia Aulin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/neurofilament-light-chain-en-cva-risico-bij-af/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2016/04/01/biomarkers-van-inflammatie-en-cardiovasculair-risico-bij-patienten-met-atriumfib/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-h-indik","type":"person","url":"https://hartvaat.nl/mensen/julia-h-indik/","name":"Julia H Indik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-miranda","type":"person","url":"https://hartvaat.nl/mensen/julia-miranda/","name":"Julia Miranda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/pyelonefritis-verlaagt-serumcholesterol-en-remt-atherosclerose-ondanks-systemisc/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/01/19/sglt2-remming-behoudt-antibacteriele-respons-van-de-nier-door-complement-c1q-ver/","published":"2026-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-piasnik","type":"person","url":"https://hartvaat.nl/mensen/julia-piasnik/","name":"Julia Piaśnik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/mortaliteit-en-hospitalisaties-bij-hfpef-versus-hfref-vergelijkende-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/01/piek-vo2-en-prognose-bij-hartfalen-meta-analyse/","published":"2025-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-stehli","type":"person","url":"https://hartvaat.nl/mensen/julia-stehli/","name":"Julia Stehli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julia-weinland","type":"person","url":"https://hartvaat.nl/mensen/julia-weinland/","name":"Julia Weinland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/29/olezarsen-bij-ernstige-hypertriglyceridemie-en-pancreatitisrisico/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2025/10/02/olezarsen-bij-matige-hypertriglyceridemie-cv-uitkomstpotentieel/","published":"2025-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juliana-d-oliveira","type":"person","url":"https://hartvaat.nl/mensen/juliana-d-oliveira/","name":"Juliana D Oliveira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-a-johnson","type":"person","url":"https://hartvaat.nl/mensen/julie-a-johnson/","name":"Julie A Johnson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-a-lovshin","type":"person","url":"https://hartvaat.nl/mensen/julie-a-lovshin/","name":"Julie A Lovshin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/combinatietherapie-bij-t2dm-en-chronische-nierziekte-evidence-naar-praktijk/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/02/01/dapagliflozine-bij-cv-risico-met-zonder-diabetes-cardiorenale-effecten/","published":"2026-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-butters","type":"person","url":"https://hartvaat.nl/mensen/julie-butters/","name":"Julie Butters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/03/obicetrapib-bij-hoog-cv-risico-veiligheid-en-effectiviteit-fase-3/","published":"2025-07-03"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-e-westover","type":"person","url":"https://hartvaat.nl/mensen/julie-e-westover/","name":"Julie E Westover","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"},{"url":"https://hartvaat.nl/2021/01/01/passive-choice-en-active-choice-interventies-voor-statinevoorschrijving-jama-car/","published":"2021-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-haesebaert","type":"person","url":"https://hartvaat.nl/mensen/julie-haesebaert/","name":"Julie Haesebaert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/09/uf-care-trial-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-geen-significante-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/09/uf-care-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-mist-primair-eindpunt-in/","published":"2026-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-kolwelter","type":"person","url":"https://hartvaat.nl/mensen/julie-kolwelter/","name":"Julie Kolwelter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/12/01/empagliflozine-en-vaatfunctie-bij-chronisch-hf/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-m-miller","type":"person","url":"https://hartvaat.nl/mensen/julie-m-miller/","name":"Julie M Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2018/01/16/intraveneus-fentanyl-en-ticagrelorabsorptie-bij-pci/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julie-redfern","type":"person","url":"https://hartvaat.nl/mensen/julie-redfern/","name":"Julie Redfern","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julien-adjedj","type":"person","url":"https://hartvaat.nl/mensen/julien-adjedj/","name":"Julien Adjedj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/calcified-oct-versus-angiografie-bij-pci-van-verkalkte-laesies/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julien-dreyfus","type":"person","url":"https://hartvaat.nl/mensen/julien-dreyfus/","name":"Julien Dreyfus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julien-labreuche","type":"person","url":"https://hartvaat.nl/mensen/julien-labreuche/","name":"Julien Labreuche","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julien-mazieres","type":"person","url":"https://hartvaat.nl/mensen/julien-mazieres/","name":"Julien Mazieres","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/19/lorlatinib-versus-crizotinib-bij-alk-positief-longkanker-nejm/","published":"2020-11-19"},{"url":"https://hartvaat.nl/2016/04/02/bevacizumab-bij-pleuramesothelioom-de-maps-trial/","published":"2016-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julien-ternacle","type":"person","url":"https://hartvaat.nl/mensen/julien-ternacle/","name":"Julien Ternacle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juliette-leon","type":"person","url":"https://hartvaat.nl/mensen/juliette-leon/","name":"Juliette Leon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/onverklaarde-transplantaatdisfunctie-bij-een-zeldzame-metabole-stoornis/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/13/bcma-gerichte-t-cel-engagertherapie-bij-refractaire-hla-sensitisatie/","published":"2026-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julio-a-chirinos","type":"person","url":"https://hartvaat.nl/mensen/julio-a-chirinos/","name":"Julio A Chirinos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/01/kaliumnitraat-bij-hfpef-gerandomiseerde-trial/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"julio-marti-almor","type":"person","url":"https://hartvaat.nl/mensen/julio-marti-almor/","name":"Julio Martí-Almor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-guo","type":"person","url":"https://hartvaat.nl/mensen/jun-guo/","name":"Jun Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/gezond-eetpatroon-verlaagt-cv-risico-bij-kankeroverlevenden-los-van-genetisch-ri/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-qian","type":"person","url":"https://hartvaat.nl/mensen/jun-qian/","name":"Jun Qian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-na-acuut-mi-meta-analyse/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-takahashi","type":"person","url":"https://hartvaat.nl/mensen/jun-takahashi/","name":"Jun Takahashi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/01/gestoorde-glucosetolerantie-en-albuminurie-bij-chronisch-hf-support-trial/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-tao","type":"person","url":"https://hartvaat.nl/mensen/jun-tao/","name":"Jun Tao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/aerobe-training-bevordert-angiogenese-en-verlaagt-bloeddruk-bij-hypertensie-exca/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2016/07/01/luchtvervuiling-en-hypertensie-systematische-review-en-meta-analyse/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jun-wang","type":"person","url":"https://hartvaat.nl/mensen/jun-wang/","name":"Jun Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"junbeom-park","type":"person","url":"https://hartvaat.nl/mensen/junbeom-park/","name":"Junbeom Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jung","type":"person","url":"https://hartvaat.nl/mensen/jung/","name":"Jung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/betere-cardiovasculaire-gezondheid-life-s-simple-7-hangt-samen-met-minder-leverv/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/01/09/endocarditis-van-de-natieve-klep-verschuift-naar-ouderen-chirurgie-blijft-levens/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jung-hoon-sung","type":"person","url":"https://hartvaat.nl/mensen/jung-hoon-sung/","name":"Jung-Hoon Sung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/01/lage-dosis-tel-aml-chtd-combinatietablet-versus-standaard-tel-fase-iii/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/14/alone-af-langetermijn-anticoagulatieonthouding-na-af-ablatie-rct/","published":"2025-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"junghan-yoon","type":"person","url":"https://hartvaat.nl/mensen/junghan-yoon/","name":"Junghan Yoon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/04/lodestar-treat-to-target-versus-hoge-dosis-statine-bij-coronairlijden/","published":"2023-04-04"},{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"junjie-zhang","type":"person","url":"https://hartvaat.nl/mensen/junjie-zhang/","name":"Junjie Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"junkui-wang","type":"person","url":"https://hartvaat.nl/mensen/junkui-wang/","name":"Junkui Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"junqing-yang","type":"person","url":"https://hartvaat.nl/mensen/junqing-yang/","name":"Junqing Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"junyu-pei","type":"person","url":"https://hartvaat.nl/mensen/junyu-pei/","name":"Junyu Pei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/22/orthostatische-bloeddruk-en-intensieve-behandeling-sprint-inzichten/","published":"2022-12-22"},{"url":"https://hartvaat.nl/2021/02/01/revascularisatie-bij-ernstig-verminderde-lvef-korte-en-langetermijnuitkomsten/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jussi-sia","type":"person","url":"https://hartvaat.nl/mensen/jussi-sia/","name":"Jussi Sia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2023/07/01/tino-gecoate-versus-everolimus-eluting-stents-bij-acs-tides-acs-vijfjaarsdata/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"justin-cooke","type":"person","url":"https://hartvaat.nl/mensen/justin-cooke/","name":"Justin Cooke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"},{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"justine-i-davies","type":"person","url":"https://hartvaat.nl/mensen/justine-i-davies/","name":"Justine I Davies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jutta-franz","type":"person","url":"https://hartvaat.nl/mensen/jutta-franz/","name":"Jutta Franz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jutta-heinrich","type":"person","url":"https://hartvaat.nl/mensen/jutta-heinrich/","name":"Jutta Heinrich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juxiang-li","type":"person","url":"https://hartvaat.nl/mensen/juxiang-li/","name":"Juxiang Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juyan-zhang","type":"person","url":"https://hartvaat.nl/mensen/juyan-zhang/","name":"Juyan Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2023/09/01/step-substudie-intensieve-bloeddrukverlaging-verbetert-lvh-bij-ouderen/","published":"2023-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"juying-qian","type":"person","url":"https://hartvaat.nl/mensen/juying-qian/","name":"Juying Qian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/vroege-evolocumab-na-hartinfarct-verlaagt-mace-bij-uitgestelde-randstenosen/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2023/01/17/option-indobufen-als-aspirine-alternatief-in-dapt-na-pci/","published":"2023-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jwan-a-naser","type":"person","url":"https://hartvaat.nl/mensen/jwan-a-naser/","name":"Jwan A Naser","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/nierfunctiestoornis-verergert-pulmonale-vaatziekte-bij-hfpef/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jyotsna-garg","type":"person","url":"https://hartvaat.nl/mensen/jyotsna-garg/","name":"Jyotsna Garg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"},{"url":"https://hartvaat.nl/2016/05/01/sitagliptine-en-hartfalenrisico-bij-diabetes-type-2-secundaire-analyse-tecos-tri/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janos-tomcsanyi","type":"person","url":"https://hartvaat.nl/mensen/janos-tomcsanyi/","name":"János Tomcsányi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/01/omecamtiv-mecarbil-bij-ernstig-hf-galactic-hf-post-hoc-analyse/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2016/12/10/omecamtiv-mecarbil-bij-chronisch-hartfalen-lancet-cosmic-hf-fase-2-trial/","published":"2016-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jorg-carlsson","type":"person","url":"https://hartvaat.nl/mensen/jorg-carlsson/","name":"Jörg Carlsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jrgen-frkir","type":"person","url":"https://hartvaat.nl/mensen/jrgen-frkir/","name":"Jørgen Frøkiær","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/metformine-remt-proliferatie-van-fibro-adipogene-stamcellen-uit-falende-harten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"k-gert-van-houwelingen","type":"person","url":"https://hartvaat.nl/mensen/k-gert-van-houwelingen/","name":"K Gert van Houwelingen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"k-m-venkat-narayan","type":"person","url":"https://hartvaat.nl/mensen/k-m-venkat-narayan/","name":"K M Venkat Narayan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/pm2-5-blootstelling-versnelt-daling-van-egfr-bij-volwassenen/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2020/08/18/collaboratieve-zorg-voor-depressie-hba1c-bloeddruk-en-cholesterol-bij-diabetes-j/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"k-a","type":"person","url":"https://hartvaat.nl/mensen/k-a/","name":"K. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/29/obesitasparadox-bij-het-takotsubosyndroom-ondergewicht-geeft-de-hoogste-sterfte-/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2026/01/09/endocarditis-van-de-natieve-klep-verschuift-naar-ouderen-chirurgie-blijft-levens/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"k-e","type":"person","url":"https://hartvaat.nl/mensen/k-e/","name":"K. E.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/niet-invasieve-endotypering-met-stress-mri-verbetert-de-behandeling-van-angina-z/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/03/31/titine-cardiomyopathie-meestal-dcm-of-linksdominante-acm-met-blijvend-ritmestoor/","published":"2026-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"k-h","type":"person","url":"https://hartvaat.nl/mensen/k-h/","name":"K. H.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/verhoogd-crp-voorspelt-hartfalen-bij-kankeroverlevenden-uk-biobank/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/05/04/noorse-nationale-validatie-myocarditis-na-mrna-covid-vaccinatie-4-5-per-100-000-/","published":"2026-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaarin-j-anstey","type":"person","url":"https://hartvaat.nl/mensen/kaarin-j-anstey/","name":"Kaarin J Anstey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/01/bloeddrukvariabiliteit-en-dementie-cognitieve-stoornis-meta-analyse/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2018/09/01/orthostatische-hypotensie-verhoogt-risico-op-cognitieve-stoornissen/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaijun-wang","type":"person","url":"https://hartvaat.nl/mensen/kaijun-wang/","name":"Kaijun Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/08/01/kosteneffectiviteit-van-langdurig-ticagrelor-na-mi-pegasus-timi-54/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/25/kwaliteit-van-leven-na-chirurgie-of-des-bij-drienvaten-of-hoofdstamlijden/","published":"2017-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaisa-m-maki-petaja","type":"person","url":"https://hartvaat.nl/mensen/kaisa-m-maki-petaja/","name":"Kaisa M Mäki-Petäjä","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/01/zoutbuffering-in-de-huid-bij-mensen-een-nieuw-mechanisme/","published":"2017-11-01"},{"url":"https://hartvaat.nl/2016/11/01/rol-van-het-autonome-zenuwstelsel-bij-regulatie-van-aortastijfheid/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaiyuan-hua","type":"person","url":"https://hartvaat.nl/mensen/kaiyuan-hua/","name":"Kaiyuan Hua","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/06/combine-af-doac-s-versus-warfarine-over-het-nierfunctiespectrum-ipd-meta-analyse/","published":"2023-06-06"},{"url":"https://hartvaat.nl/2022/01/25/doac-s-versus-warfarine-bij-af-patient-niveau-netwerkmeta-analyse-van-gerandomis/","published":"2022-01-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaleab-asrress","type":"person","url":"https://hartvaat.nl/mensen/kaleab-asrress/","name":"Kaleab Asrress","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kamakshi-lakshminarayan","type":"person","url":"https://hartvaat.nl/mensen/kamakshi-lakshminarayan/","name":"Kamakshi Lakshminarayan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/01/mhealth-interventie-verbetert-hypertensiezorg-bij-hoogrisicopatienten/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/20/mhealth-interventie-verbetert-hypertensiezorg-bij-hoogrisicopatienten/","published":"2026-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kamran-khan","type":"person","url":"https://hartvaat.nl/mensen/kamran-khan/","name":"Kamran Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/09/tweemaal-daags-clopidogrel-versus-ticagrelor-voor-korttermijn-mace-na-pci/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kanika-i-dharmayat","type":"person","url":"https://hartvaat.nl/mensen/kanika-i-dharmayat/","name":"Kanika I Dharmayat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/06/02/prevalentie-van-fh-bij-atherosclerotische-cv-ziekte-meta-analyse/","published":"2020-06-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kanitha-phalakornkule","type":"person","url":"https://hartvaat.nl/mensen/kanitha-phalakornkule/","name":"Kanitha Phalakornkule","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/15/oct-gebaseerde-post-pci-fysiologiebeoordeling-voorspelt-klinische-uitkomsten/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/07/23/ilumien-iv-oct-geleide-pci-bij-complexe-laesies-subanalyse/","published":"2024-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kapildeo-lotun","type":"person","url":"https://hartvaat.nl/mensen/kapildeo-lotun/","name":"Kapildeo Lotun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/24/vroege-coronairangiografie-versus-uitstel-na-hartstilstand-zonder-st-elevatie-pi/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2019/01/15/lv-unloading-voor-reperfusie-bij-anterieure-stemi-dtu-stemi-pilot/","published":"2019-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kara-k-hoppe","type":"person","url":"https://hartvaat.nl/mensen/kara-k-hoppe/","name":"Kara K Hoppe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2022/05/12/behandeling-van-milde-chronische-hypertensie-in-de-zwangerschap-nejm-chap/","published":"2022-05-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-f-miller","type":"person","url":"https://hartvaat.nl/mensen/karen-f-miller/","name":"Karen F Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/09/dapagliflozine-bij-acuut-hartfalen-effectiviteit-en-veiligheid/","published":"2024-04-09"},{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-kimura","type":"person","url":"https://hartvaat.nl/mensen/karen-kimura/","name":"Karen Kimura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/09/renale-en-vasculaire-effecten-van-gecombineerde-sglt2-en-ace-remming/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-s-pieper","type":"person","url":"https://hartvaat.nl/mensen/karen-s-pieper/","name":"Karen S Pieper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2017/09/26/secundaire-cardiovasculaire-preventie-bij-diabetes-type-2-tecos-internationale-i/","published":"2017-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karen-smith","type":"person","url":"https://hartvaat.nl/mensen/karen-smith/","name":"Karen Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/14/lignocaine-versus-opioiden-op-antiplaatjeseffect-van-ticagrelor-local-trial/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2016/03/01/effect-van-aanvullende-zuurstoftoediening-op-myocardschade-bij-stemi/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kari-e-north","type":"person","url":"https://hartvaat.nl/mensen/kari-e-north/","name":"Kari E North","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/mendeliaanse-randomisatie-lp-a-verhoogt-coronarialijden-onafhankelijk-van-ldl-c-/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kari-margrethe-lundgren","type":"person","url":"https://hartvaat.nl/mensen/kari-margrethe-lundgren/","name":"Kari Margrethe Lundgren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/telerevalidatie-haalbaar-voor-hartfalenpatienten-zonder-toegang-tot-poliklinisch/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/08/01/cardiorenaal-syndroom-en-fitheid-bij-hartfalen-telerevalidatie-trial/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kari-niemela","type":"person","url":"https://hartvaat.nl/mensen/kari-niemela/","name":"Kari Niemela","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/03/timing-van-non-culprit-revascularisatie-bij-stemi-complete-trial/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karim-aacha","type":"person","url":"https://hartvaat.nl/mensen/karim-aacha/","name":"Karim Aacha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karim-benali","type":"person","url":"https://hartvaat.nl/mensen/karim-benali/","name":"Karim Benali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2023/05/30/complicaties-van-af-ablatie-actueel-overzicht/","published":"2023-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karin-klingel","type":"person","url":"https://hartvaat.nl/mensen/karin-klingel/","name":"Karin Klingel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karin-radholm","type":"person","url":"https://hartvaat.nl/mensen/karin-radholm/","name":"Karin Rådholm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-j-lackner","type":"person","url":"https://hartvaat.nl/mensen/karl-j-lackner/","name":"Karl J Lackner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2020/09/01/clopidogrel-versus-prasugrel-versus-ticagrelor-op-endotheelfunctie-en-inflammati/","published":"2020-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karl-werdan","type":"person","url":"https://hartvaat.nl/mensen/karl-werdan/","name":"Karl Werdan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2017/08/01/des-versus-bms-bij-acuut-mi-met-cardiogene-shock/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karol-curila","type":"person","url":"https://hartvaat.nl/mensen/karol-curila/","name":"Karol Čurila","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2016/02/01/spironolacton-versus-renale-denervatie-bij-therapieresistente-hypertensie-prague/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"karsten-lenk","type":"person","url":"https://hartvaat.nl/mensen/karsten-lenk/","name":"Karsten Lenk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2021/12/30/angiografie-na-buitenziekenhuis-hartstilstand-zonder-st-elevatie-nejm-tomahawk/","published":"2021-12-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kartik-s-sundareswaran","type":"person","url":"https://hartvaat.nl/mensen/kartik-s-sundareswaran/","name":"Kartik S Sundareswaran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/ero-lvedv-ratio-en-respons-op-mitraclip-jama-cardiology/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2017/05/23/hemocompatibiliteitsuitkomsten-van-heartmate-3-na-6-maanden-momentum-3/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kashif-b-khokhar","type":"person","url":"https://hartvaat.nl/mensen/kashif-b-khokhar/","name":"Kashif B Khokhar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/01/obesitas-opzettelijk-gewichtsverlies-en-hartfalen-meta-analyse/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kasper-pryds","type":"person","url":"https://hartvaat.nl/mensen/kasper-pryds/","name":"Kasper Pryds","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"},{"url":"https://hartvaat.nl/2016/07/01/remote-ischemische-conditionering-en-vertraging-van-het-zorgsysteem-bij-stemi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kate-caldwell","type":"person","url":"https://hartvaat.nl/mensen/kate-caldwell/","name":"Kate Caldwell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/lerodalcibep-bij-ascvd-of-hoog-risico-fase-3-resultaten/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/10/21/lerodalcibep-bij-familiaire-hypercholesterolemie-liberate-hefh-langetermijndata/","published":"2023-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katherine-connolly","type":"person","url":"https://hartvaat.nl/mensen/katherine-connolly/","name":"Katherine Connolly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kathleen-dracup","type":"person","url":"https://hartvaat.nl/mensen/kathleen-dracup/","name":"Kathleen Dracup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2019/02/01/snelle-gewichtstoename-van-2-3-kg-is-niet-geassocieerd-met-heropname-bij-hf/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kathleen-lynch","type":"person","url":"https://hartvaat.nl/mensen/kathleen-lynch/","name":"Kathleen Lynch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/04/05/bloeddrukverlaging-bij-kappersbezoek-nejm-clustergerandomiseerde-trial/","published":"2018-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kathleen-nolte","type":"person","url":"https://hartvaat.nl/mensen/kathleen-nolte/","name":"Kathleen Nolte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/baseline-parameters-en-1-jaars-qol-bij-hf-na-crt-d-esc-hf/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/02/01/hoeveelheid-of-intensiteit-van-inspanning-bij-hfpef/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kathleen-t-linta","type":"person","url":"https://hartvaat.nl/mensen/kathleen-t-linta/","name":"Kathleen T Linta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kathrin-eller","type":"person","url":"https://hartvaat.nl/mensen/kathrin-eller/","name":"Kathrin Eller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kathryn-s-taylor","type":"person","url":"https://hartvaat.nl/mensen/kathryn-s-taylor/","name":"Kathryn S Taylor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/01/gewichtsverandering-en-risico-op-af-systematische-review-en-meta-analyse/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katja-gabrysch","type":"person","url":"https://hartvaat.nl/mensen/katja-gabrysch/","name":"Katja Gabrysch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/12/01/multipele-biomarkers-en-mortaliteitsrisico-na-acs-jama-cardiology/","published":"2018-12-01"},{"url":"https://hartvaat.nl/2018/04/01/fibrinestoleigenschappen-en-klinische-uitkomsten-na-acs-plato-substudie/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katleen-vandenberghe","type":"person","url":"https://hartvaat.nl/mensen/katleen-vandenberghe/","name":"Katleen Vandenberghe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/29/stream-2-halve-dosis-tenecteplase-bij-ouderen-met-stemi/","published":"2023-08-29"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katri-raikkonen","type":"person","url":"https://hartvaat.nl/mensen/katri-raikkonen/","name":"Katri Räikkönen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katriona-j-m-brooksbank","type":"person","url":"https://hartvaat.nl/mensen/katriona-j-m-brooksbank/","name":"Katriona J M Brooksbank","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/14/dapagliflozine-versus-metolazone-bij-diureticaresistent-hartfalen/","published":"2023-08-14"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"katsuyuki-miura","type":"person","url":"https://hartvaat.nl/mensen/katsuyuki-miura/","name":"Katsuyuki Miura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/30/visinname-en-visgerelateerde-metabolieten-geassocieerd-met-lagere-triglyceriden-/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2019/01/01/levenslangrisico-op-cva-en-coronairlijden-naar-bloeddrukniveau-epoch-japan/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kauling","type":"person","url":"https://hartvaat.nl/mensen/kauling/","name":"Kauling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/29/erasmus-mc-linkeratrium-strain-voorspelt-aritmieen-na-chirurgische-correctie-van/","published":"2026-07-11"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaushik-ramaiya","type":"person","url":"https://hartvaat.nl/mensen/kaushik-ramaiya/","name":"Kaushik Ramaiya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kaveh-hosseini","type":"person","url":"https://hartvaat.nl/mensen/kaveh-hosseini/","name":"Kaveh Hosseini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/14/vereenvoudigd-crt-systeem-zonder-atriale-pacing-niet-slechter-dan-conventioneel-/","published":"2026-08-21"},{"url":"https://hartvaat.nl/2024/04/01/veiligheid-van-sglt2-remmers-bij-hartfalen-meta-analyse/","published":"2024-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kayla-clark","type":"person","url":"https://hartvaat.nl/mensen/kayla-clark/","name":"Kayla Clark","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/01/apothekerverwijzingen-voor-statine-start-twee-cluster-rct-s/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/01/01/nudging-verhoogt-statinevoorschrijving-bij-zowel-arts-als-patient/","published":"2023-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuhiko-kido","type":"person","url":"https://hartvaat.nl/mensen/kazuhiko-kido/","name":"Kazuhiko Kido","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuhiko-tsuruya","type":"person","url":"https://hartvaat.nl/mensen/kazuhiko-tsuruya/","name":"Kazuhiko Tsuruya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/lagere-kaliuminname-hangt-samen-met-meer-hart-en-vaatziekte-bij-ckd-vooral-bij-v/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuhiro-nakao","type":"person","url":"https://hartvaat.nl/mensen/kazuhiro-nakao/","name":"Kazuhiro Nakao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuhiro-satomi","type":"person","url":"https://hartvaat.nl/mensen/kazuhiro-satomi/","name":"Kazuhiro Satomi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazunori-toyoda","type":"person","url":"https://hartvaat.nl/mensen/kazunori-toyoda/","name":"Kazunori Toyoda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"},{"url":"https://hartvaat.nl/2016/09/15/intensieve-bloeddrukverlaging-bij-acute-hersenbloeding-nejm-atach-2-trial/","published":"2016-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kazuyuki-yahagi","type":"person","url":"https://hartvaat.nl/mensen/kazuyuki-yahagi/","name":"Kazuyuki Yahagi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keewan-kim","type":"person","url":"https://hartvaat.nl/mensen/keewan-kim/","name":"Keewan Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/01/preconceptiebloeddruk-en-verandering-naar-vroege-zwangerschap-risicofactor-voor-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddruk-voor-conceptie-en-reproductieve-uitkomsten/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kei-fukami","type":"person","url":"https://hartvaat.nl/mensen/kei-fukami/","name":"Kei Fukami","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2025/12/30/overgang-van-aki-naar-ckd-rol-van-niermacrofagen-en-neutrofielen/","published":"2025-12-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keiichi-sumida","type":"person","url":"https://hartvaat.nl/mensen/keiichi-sumida/","name":"Keiichi Sumida","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keisuke-narita","type":"person","url":"https://hartvaat.nl/mensen/keisuke-narita/","name":"Keisuke Narita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/postprandiale-hypotensie-en-valrisico-bij-oudere-hypertensieve-patienten-ambrosi/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keisuke-yonezu","type":"person","url":"https://hartvaat.nl/mensen/keisuke-yonezu/","name":"Keisuke Yonezu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/voedingsstatus-voorspelt-ventriculaire-ritmestoornissen-bij-gevorderd-hartfalen/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keith-d-aaronson","type":"person","url":"https://hartvaat.nl/mensen/keith-d-aaronson/","name":"Keith D Aaronson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/02/02/intrapericardiale-lvad-bij-gevorderd-hartfalen-nejm/","published":"2017-02-02"},{"url":"https://hartvaat.nl/2017/02/02/volledig-magnetisch-zwevende-circulatoire-pomp-bij-gevorderd-hartfalen-nejm-mome/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keith-d-dawkins","type":"person","url":"https://hartvaat.nl/mensen/keith-d-dawkins/","name":"Keith D Dawkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/12/pci-versus-cabg-bij-drievaten-of-hoofdstamlijden-lancet-syntax-extended-10-jaars/","published":"2019-10-12"},{"url":"https://hartvaat.nl/2016/01/05/doodsoorzaken-na-pci-versus-cabg-bij-complex-coronairlijden-5-jaarsfollow-up-van/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keith-kranker","type":"person","url":"https://hartvaat.nl/mensen/keith-kranker/","name":"Keith Kranker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/17/million-hearts-betaald-cv-risicomanagement-vermindert-mi-en-cva-jama-rct/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/09/01/million-hearts-cv-risicoreductiemodel-en-medicatie-initiatie-jama-cardiology/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keith-robertson","type":"person","url":"https://hartvaat.nl/mensen/keith-robertson/","name":"Keith Robertson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kelley-r-branch","type":"person","url":"https://hartvaat.nl/mensen/kelley-r-branch/","name":"Kelley R Branch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2019/08/13/rivaroxaban-met-of-zonder-aspirine-bij-hf-met-coronair-of-perifeer-vaatlijden/","published":"2019-08-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kellie-e-murphy","type":"person","url":"https://hartvaat.nl/mensen/kellie-e-murphy/","name":"Kellie E Murphy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kelly-byrne","type":"person","url":"https://hartvaat.nl/mensen/kelly-byrne/","name":"Kelly Byrne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kelly-cho","type":"person","url":"https://hartvaat.nl/mensen/kelly-cho/","name":"Kelly Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/glp-1-agonisten-en-gezonde-leefstijl-samen-sterker-tegen-hart-en-vaatziekten/","published":"2026-03-08"},{"url":"https://hartvaat.nl/2024/04/01/polygene-risicoscore-voor-aortastenose-naast-klinische-risicofactoren/","published":"2024-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kendrick-shunk","type":"person","url":"https://hartvaat.nl/mensen/kendrick-shunk/","name":"Kendrick Shunk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenichi-tsujita","type":"person","url":"https://hartvaat.nl/mensen/kenichi-tsujita/","name":"Kenichi Tsujita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/18/helios-b-post-hoc-vutrisiran-effectief-bij-oost-aziatische-attr-cm-patienten-hr-/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenichiro-sawada","type":"person","url":"https://hartvaat.nl/mensen/kenichiro-sawada/","name":"Kenichiro Sawada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenji-yodogawa","type":"person","url":"https://hartvaat.nl/mensen/kenji-yodogawa/","name":"Kenji Yodogawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2021/10/01/empagliflozine-en-nierprotectie-bij-acuut-mi-met-diabetes-pilot/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kennedy-r-lees","type":"person","url":"https://hartvaat.nl/mensen/kennedy-r-lees/","name":"Kennedy R Lees","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/voortzetten-of-tijdelijk-stoppen-van-antihypertensiva-bij-acuut-cva-ipd-meta-ana/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/03/07/cva-risico-bij-chronisch-hartfalen-met-behouden-ef-zonder-af-charm-analyse/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kenneth-rockwood","type":"person","url":"https://hartvaat.nl/mensen/kenneth-rockwood/","name":"Kenneth Rockwood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2018/09/01/orthostatische-hypotensie-verhoogt-risico-op-cognitieve-stoornissen/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kensey-l-gosch","type":"person","url":"https://hartvaat.nl/mensen/kensey-l-gosch/","name":"Kensey L Gosch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/vroege-versus-late-gestageerde-pci-na-subintimale-re-entry-bij-cto/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kentaro-nakai","type":"person","url":"https://hartvaat.nl/mensen/kentaro-nakai/","name":"Kentaro Nakai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kerstin-bode","type":"person","url":"https://hartvaat.nl/mensen/kerstin-bode/","name":"Kerstin Bode","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2018/03/13/doac-s-bij-af-met-ckd-systematische-review-werkzaamheid-en-veiligheid/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keun-ho-park","type":"person","url":"https://hartvaat.nl/mensen/keun-ho-park/","name":"Keun-Ho Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/11/matige-statine-plus-ezetimibe-bij-ouderen-met-atherosclerose-jacc-studie/","published":"2023-04-11"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevan-r-polkinghorne","type":"person","url":"https://hartvaat.nl/mensen/kevan-r-polkinghorne/","name":"Kevan R Polkinghorne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2020/05/01/bloeddruk-en-volumemanagement-bij-dialyse-kdigo-controverseconferentie/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-carroll","type":"person","url":"https://hartvaat.nl/mensen/kevin-carroll/","name":"Kevin Carroll","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-kris-warnakula-olesen","type":"person","url":"https://hartvaat.nl/mensen/kevin-kris-warnakula-olesen/","name":"Kevin Kris Warnakula Olesen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/02/14/sekseverschillen-in-tienjaarsuitkomsten-na-pci-decade-samenwerking/","published":"2023-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-murphy","type":"person","url":"https://hartvaat.nl/mensen/kevin-murphy/","name":"Kevin Murphy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kevin-r-an","type":"person","url":"https://hartvaat.nl/mensen/kevin-r-an/","name":"Kevin R An","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/24/graftfalen-na-cabg-individuele-patientdata-meta-analyse/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2018/09/01/chirurgische-af-ablatie-systematische-review-en-meta-analyse-van-rct-s/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"keyang-zheng","type":"person","url":"https://hartvaat.nl/mensen/keyang-zheng/","name":"Keyang Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/22/orthostatische-bloeddruk-en-intensieve-behandeling-sprint-inzichten/","published":"2022-12-22"},{"url":"https://hartvaat.nl/2021/02/01/revascularisatie-bij-ernstig-verminderde-lvef-korte-en-langetermijnuitkomsten/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khaled-abouelmagd","type":"person","url":"https://hartvaat.nl/mensen/khaled-abouelmagd/","name":"Khaled Abouelmagd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/sacubitril-valsartan-bij-secundaire-mitralisinsufficientie-en-reverse-remodeling/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/07/01/geleidingssysteempacing-versus-biventriculaire-pacing-bij-av-blok-vergelijkende-/","published":"2025-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khalid-al-rasadi","type":"person","url":"https://hartvaat.nl/mensen/khalid-al-rasadi/","name":"Khalid Al-Rasadi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khalid-f-alhabib","type":"person","url":"https://hartvaat.nl/mensen/khalid-f-alhabib/","name":"Khalid F Alhabib","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/20/secundaire-preventie-na-myocardinfarct-in-saudi-arabie-het-4s-register/","published":"2026-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khan","type":"person","url":"https://hartvaat.nl/mensen/khan/","name":"Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/relatieve-apicale-sparing-op-strain-echo-voor-cardiale-amyloidose-meta-analyse-v/","published":"2026-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khaula-n-baloch","type":"person","url":"https://hartvaat.nl/mensen/khaula-n-baloch/","name":"Khaula N Baloch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"khurram-nasir","type":"person","url":"https://hartvaat.nl/mensen/khurram-nasir/","name":"Khurram Nasir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2021/06/01/geisoleerde-diastolische-hypertensie-cohort-en-meta-analyse-voor-behandeldrempel/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ki-won-hwang","type":"person","url":"https://hartvaat.nl/mensen/ki-won-hwang/","name":"Ki Won Hwang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ki-bae-seung","type":"person","url":"https://hartvaat.nl/mensen/ki-bae-seung/","name":"Ki-Bae Seung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2016/09/20/cva-preventie-met-ticagrelor-na-myocardinfarct-pegasus-timi-54-inzichten/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ki-hun-kim","type":"person","url":"https://hartvaat.nl/mensen/ki-hun-kim/","name":"Ki-Hun Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kieren-j-mather","type":"person","url":"https://hartvaat.nl/mensen/kieren-j-mather/","name":"Kieren J Mather","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/07/orforglipron-dagelijkse-orale-glp-1-agonist-bij-obesitas-nejm/","published":"2023-09-07"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kim-a-williams","type":"person","url":"https://hartvaat.nl/mensen/kim-a-williams/","name":"Kim A Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-executive-summary/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/10/23/2017-acc-aha-hypertensierichtlijn-circulation-editie/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kin-hung-p-yu","type":"person","url":"https://hartvaat.nl/mensen/kin-hung-p-yu/","name":"Kin-Hung P Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kiril-ahtarovski","type":"person","url":"https://hartvaat.nl/mensen/kiril-ahtarovski/","name":"Kiril Ahtarovski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/ischemische-postconditionering-bij-primaire-pci-voor-stemi-jama-cardiology/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2016/05/28/uitgestelde-versus-conventionele-stentimplantatie-bij-stemi-danami-3-defer-trial/","published":"2016-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kirsten-l-johansen","type":"person","url":"https://hartvaat.nl/mensen/kirsten-l-johansen/","name":"Kirsten L Johansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kirsty-mcdowell","type":"person","url":"https://hartvaat.nl/mensen/kirsty-mcdowell/","name":"Kirsty McDowell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/cellulaire-adhesiemoleculen-en-uitkomsten-bij-chronisch-hf-dapa-hf-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/06/01/finearts-hf-finerenon-en-predict-hfpef-risicoscore/","published":"2025-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kirsty-wetherall","type":"person","url":"https://hartvaat.nl/mensen/kirsty-wetherall/","name":"Kirsty Wetherall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kit-c-roes","type":"person","url":"https://hartvaat.nl/mensen/kit-c-roes/","name":"Kit C Roes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/23/switchen-van-vka-naar-noac-bij-fragiele-ouderen-met-af-veilig/","published":"2024-01-23"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kitty-j-jager","type":"person","url":"https://hartvaat.nl/mensen/kitty-j-jager/","name":"Kitty J Jager","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kiyomi-sakata","type":"person","url":"https://hartvaat.nl/mensen/kiyomi-sakata/","name":"Kiyomi Sakata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/30/visinname-en-visgerelateerde-metabolieten-geassocieerd-met-lagere-triglyceriden-/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2019/01/01/levenslangrisico-op-cva-en-coronairlijden-naar-bloeddrukniveau-epoch-japan/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kiyonori-nanto","type":"person","url":"https://hartvaat.nl/mensen/kiyonori-nanto/","name":"Kiyonori Nanto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2018/09/01/pace-capture-geleide-ablatie-na-contact-force-pvi-dragon-gerandomiseerde-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kjetil-retterstl","type":"person","url":"https://hartvaat.nl/mensen/kjetil-retterstl/","name":"Kjetil Retterstøl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/19/fh-vrouwen-verliezen-mediaan-2-9-jaar-lipidenverlagende-behandeling-rond-elke-ki/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2026/01/16/statinegebruik-in-de-zwangerschap-en-congenitale-afwijkingen-noors-cohort/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"klaus-g-parhofer","type":"person","url":"https://hartvaat.nl/mensen/klaus-g-parhofer/","name":"Klaus G Parhofer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/21/pelacarsen-vermindert-de-behoefte-aan-lipoproteine-a-aferese-lp-a-frontiers-aphe/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"knud-nrregaard-hansen","type":"person","url":"https://hartvaat.nl/mensen/knud-nrregaard-hansen/","name":"Knud Nørregaard Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"},{"url":"https://hartvaat.nl/2016/02/23/everolimus-versus-sirolimus-eluting-stents-5-jaarsresultaten-sort-out-iv/","published":"2016-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"knut-asbjrn-rise-langlo","type":"person","url":"https://hartvaat.nl/mensen/knut-asbjrn-rise-langlo/","name":"Knut Asbjørn Rise Langlo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/telerevalidatie-haalbaar-voor-hartfalenpatienten-zonder-toegang-tot-poliklinisch/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/08/01/cardiorenaal-syndroom-en-fitheid-bij-hartfalen-telerevalidatie-trial/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koen-m-marques","type":"person","url":"https://hartvaat.nl/mensen/koen-m-marques/","name":"Koen M Marques","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koichi-node","type":"person","url":"https://hartvaat.nl/mensen/koichi-node/","name":"Koichi Node","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2020/08/01/canagliflozine-bij-diabetes-type-2-met-chronisch-hf-candle-gerandomiseerde-trial/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koji-miyamoto","type":"person","url":"https://hartvaat.nl/mensen/koji-miyamoto/","name":"Koji Miyamoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koji-takeda","type":"person","url":"https://hartvaat.nl/mensen/koji-takeda/","name":"Koji Takeda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2019/02/19/lv-unloading-tijdens-ecmo-bij-cardiogene-shock/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koki-nakanishi","type":"person","url":"https://hartvaat.nl/mensen/koki-nakanishi/","name":"Koki Nakanishi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/02/jamac-studie-slechte-5-jaarsprognose-bij-mitralisstenose-door-mitralisringverkal/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konrad-e-bloch","type":"person","url":"https://hartvaat.nl/mensen/konrad-e-bloch/","name":"Konrad E Bloch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/11/pulmonale-hemodynamiek-op-hoogte-bij-hfpef/","published":"2025-12-11"},{"url":"https://hartvaat.nl/2017/04/14/zuurstofverrijkte-lucht-en-inspanningsprestatie-bij-precapillaire-pulmonale-hype/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konsta-teppo","type":"person","url":"https://hartvaat.nl/mensen/konsta-teppo/","name":"Konsta Teppo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/12/01/positieve-levensorientatie-en-bloeddruk-bij-ouderen-nauwelijks-klinisch-relevant/","published":"2026-08-17"},{"url":"https://hartvaat.nl/2026/05/19/finacaf-n-229-565-hartfalen-verhoogt-cva-risico-bij-af-vooral-bij-jongere-patien/","published":"2026-06-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-aznaouridis","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-aznaouridis/","name":"Konstantinos Aznaouridis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/24/sglt2-remmers-en-bloeddrukdoelen-bij-hypertensief-hfpef-een-overzicht-van-richtl/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2026/02/26/lp-a-geassocieerd-met-microvasculaire-disfunctie-bij-niet-obstructief-coronairli/","published":"2026-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-koulogiannis","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-koulogiannis/","name":"Konstantinos Koulogiannis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-p-letsas","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-p-letsas/","name":"Konstantinos P Letsas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/sglt2-remmers-en-plotse-hartdood-ventriculaire-aritmie-meta-analyse/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2016/05/01/mineralocorticoidreceptorantagonisten-en-atriumfibrilleren-meta-analyse/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-papadopoulos","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-papadopoulos/","name":"Konstantinos Papadopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-spargias","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-spargias/","name":"Konstantinos Spargias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"konstantinos-vlachos","type":"person","url":"https://hartvaat.nl/mensen/konstantinos-vlachos/","name":"Konstantinos Vlachos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/30/linear-trial-lattice-tip-katheter-verslaat-standaard-irrigatie-bij-cti-ablatie-v/","published":"2026-04-19"},{"url":"https://hartvaat.nl/2026/02/03/ice-bij-af-ablatie-veiligheid-en-effectiviteit-meta-analyse/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koos-plomp","type":"person","url":"https://hartvaat.nl/mensen/koos-plomp/","name":"Koos Plomp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kota-murai","type":"person","url":"https://hartvaat.nl/mensen/kota-murai/","name":"Kota Murai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kotaro-nochioka","type":"person","url":"https://hartvaat.nl/mensen/kotaro-nochioka/","name":"Kotaro Nochioka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/01/polsdruk-prognose-en-sacubitril-valsartan-bij-hfpef-paragon-hf/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2019/12/01/gestoorde-glucosetolerantie-en-albuminurie-bij-chronisch-hf-support-trial/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kousick-biswas","type":"person","url":"https://hartvaat.nl/mensen/kousick-biswas/","name":"Kousick Biswas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/23/top-liberaal-versus-restrictief-transfusiebeleid-bij-hoogrisico-hartchirurgie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2019/01/10/endoscopische-versus-open-veneoogst-bij-cabg-nejm-regroup/","published":"2019-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"koutaro-yokote","type":"person","url":"https://hartvaat.nl/mensen/koutaro-yokote/","name":"Koutaro Yokote","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/06/orforglipron-voor-obesitasbehandeling-nejm-fase-3/","published":"2025-11-06"},{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kraaijeveld","type":"person","url":"https://hartvaat.nl/mensen/kraaijeveld/","name":"Kraaijeveld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/risicostratificatie-bij-longembolie-hoe-bruikbaar-zijn-de-huidige-instrumenten/","published":"2026-07-24"},{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kramer-wahlberg","type":"person","url":"https://hartvaat.nl/mensen/kramer-wahlberg/","name":"Kramer Wahlberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-klinische-uitkomsten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2023/03/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-met-pacemaker/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krassen-nedeltchev","type":"person","url":"https://hartvaat.nl/mensen/krassen-nedeltchev/","name":"Krassen Nedeltchev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kris-rogers","type":"person","url":"https://hartvaat.nl/mensen/kris-rogers/","name":"Kris Rogers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/18/kwartdosis-viervoudige-combinatiepil-versus-standaardzorg-bij-hypertensie-lancet/","published":"2021-09-18"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krishna-rocha-singh","type":"person","url":"https://hartvaat.nl/mensen/krishna-rocha-singh/","name":"Krishna Rocha-Singh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/10/22/symplicity-htn-3-langetermijn-follow-up-renale-denervatie-bij-resistente-hyperte/","published":"2022-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krishnaraj-s-rathod","type":"person","url":"https://hartvaat.nl/mensen/krishnaraj-s-rathod/","name":"Krishnaraj S Rathod","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"},{"url":"https://hartvaat.nl/2017/04/01/intracoronair-nitriet-onderdrukt-de-inflammatoire-respons-na-primaire-pci/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krista-ingle","type":"person","url":"https://hartvaat.nl/mensen/krista-ingle/","name":"Krista Ingle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/12/leefstijlmodificatie-bij-resistente-hypertensie-triumph-gerandomiseerde-trial/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2016/04/05/hartrevalidatie-versterkt-met-stressmanagementtraining-gerandomiseerde-trial/","published":"2016-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristi-prather","type":"person","url":"https://hartvaat.nl/mensen/kristi-prather/","name":"Kristi Prather","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/09/ranolazine-na-incomplete-pci-bij-diabetes-versus-zonder-diabetes-river-pci/","published":"2017-05-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristian-b-filion","type":"person","url":"https://hartvaat.nl/mensen/kristian-b-filion/","name":"Kristian B Filion","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/01/doac-s-cox-2-selectieve-nsaid-s-geven-37-minder-gi-bloedingen-dan-doac-s-niet-se/","published":"2026-07-01"},{"url":"https://hartvaat.nl/2017/09/05/cardiovasculair-risico-na-fertiliteitstherapie-systematische-review-en-meta-anal/","published":"2017-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristian-hylleberg-christensen","type":"person","url":"https://hartvaat.nl/mensen/kristian-hylleberg-christensen/","name":"Kristian Hylleberg Christensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristina-lambrakis","type":"person","url":"https://hartvaat.nl/mensen/kristina-lambrakis/","name":"Kristina Lambrakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristina-striepe","type":"person","url":"https://hartvaat.nl/mensen/kristina-striepe/","name":"Kristina Striepe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2017/09/19/empagliflozine-en-vasculaire-functie-en-centrale-hemodynamiek-bij-diabetes-type-/","published":"2017-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kristoffer-berg-hansen","type":"person","url":"https://hartvaat.nl/mensen/kristoffer-berg-hansen/","name":"Kristoffer Berg-Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krystian-wita","type":"person","url":"https://hartvaat.nl/mensen/krystian-wita/","name":"Krystian Wita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/02/26/cardiogene-shock-bij-myocardinfarct-resultaten-van-het-shock-pol-register/","published":"2026-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krzysztof-kiryluk","type":"person","url":"https://hartvaat.nl/mensen/krzysztof-kiryluk/","name":"Krzysztof Kiryluk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/polygene-risicoscores-en-hla-klasse-ii-als-biomarkers-voor-corticosteroidrespons/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/12/08/bijdrage-van-genetische-varianten-aan-nefrolithiase/","published":"2025-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krzysztof-kowalik","type":"person","url":"https://hartvaat.nl/mensen/krzysztof-kowalik/","name":"Krzysztof Kowalik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/af-ablatie-bij-hfref-versus-hfpef-meta-analyse/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2024/03/07/mra-s-verminderen-af-risico-meta-analyse-van-klinische-trials/","published":"2024-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krzysztof-macierzanka","type":"person","url":"https://hartvaat.nl/mensen/krzysztof-macierzanka/","name":"Krzysztof Macierzanka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2025/01/21/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerd-pci-effect/","published":"2025-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"krzysztof-zmudka","type":"person","url":"https://hartvaat.nl/mensen/krzysztof-zmudka/","name":"Krzysztof Zmudka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/10/echogeleide-lvad-snelheidsoptimalisatie-voor-betere-inspanningstolerantie/","published":"2022-06-10"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kumar-narayanan","type":"person","url":"https://hartvaat.nl/mensen/kumar-narayanan/","name":"Kumar Narayanan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/03/01/doodsoorzaken-bij-crt-met-en-zonder-defibrillator-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kunihiro-yamagata","type":"person","url":"https://hartvaat.nl/mensen/kunihiro-yamagata/","name":"Kunihiro Yamagata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kunitoshi-iseki","type":"person","url":"https://hartvaat.nl/mensen/kunitoshi-iseki/","name":"Kunitoshi Iseki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kunjan-bhatt","type":"person","url":"https://hartvaat.nl/mensen/kunjan-bhatt/","name":"Kunjan Bhatt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"},{"url":"https://hartvaat.nl/2021/04/27/empagliflozine-en-pulmonalisdruk-bij-hf-embrace-hf/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kuo-chen-chan","type":"person","url":"https://hartvaat.nl/mensen/kuo-chen-chan/","name":"Kuo-Chen Chan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kurt-boman","type":"person","url":"https://hartvaat.nl/mensen/kurt-boman/","name":"Kurt Boman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2017/09/01/slagvolume-en-cardiovasculair-risico-bij-progressie-van-aortaklepstenose/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kurt-hoffmayer","type":"person","url":"https://hartvaat.nl/mensen/kurt-hoffmayer/","name":"Kurt Hoffmayer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ai-gestuurde-ecg-lokalisatie-verbetert-ablatie-bij-instabiele-ventriculaire-tach/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2020/04/01/p2y12-remmers-met-oac-bij-af-na-pci-meta-analyse/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyoung-ha-park","type":"person","url":"https://hartvaat.nl/mensen/kyoung-ha-park/","name":"Kyoung-Ha Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyung-hoon-cho","type":"person","url":"https://hartvaat.nl/mensen/kyung-hoon-cho/","name":"Kyung Hoon Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kyungmann-kim","type":"person","url":"https://hartvaat.nl/mensen/kyungmann-kim/","name":"KyungMann Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ladouceur","type":"person","url":"https://hartvaat.nl/mensen/ladouceur/","name":"Ladouceur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/25/aortacoarctatie-voorspelt-langetermijnmorbiditeit-na-de-arteriele-switchoperatie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lai-seong-hooi","type":"person","url":"https://hartvaat.nl/mensen/lai-seong-hooi/","name":"Lai Seong Hooi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/20/voorspelling-van-individuele-corticosteroidrespons-bij-iga-nefropathie-testing-t/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laijing-du","type":"person","url":"https://hartvaat.nl/mensen/laijing-du/","name":"Laijing Du","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laimin-luo","type":"person","url":"https://hartvaat.nl/mensen/laimin-luo/","name":"Laimin Luo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lak-n-kotinkaduwa","type":"person","url":"https://hartvaat.nl/mensen/lak-n-kotinkaduwa/","name":"Lak N Kotinkaduwa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/01/nierdisfunctie-en-uitkomsten-bij-hf-met-mr-coapt/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/09/01/voorspellers-van-klinische-respons-op-transcatheter-mr-reductie-coapt/","published":"2020-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lan-mu","type":"person","url":"https://hartvaat.nl/mensen/lan-mu/","name":"Lan Mu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/21/find-af-biomarker-stratificeert-prognose-bij-hfref-met-atriale-cardiomyopathie-z/","published":"2026-06-08"},{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lana-dixon","type":"person","url":"https://hartvaat.nl/mensen/lana-dixon/","name":"Lana Dixon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/12/01/sglt2-remming-en-cardiale-reverse-remodelling-bij-hartfalen-systematische-review/","published":"2024-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lara-m-simpson","type":"person","url":"https://hartvaat.nl/mensen/lara-m-simpson/","name":"Lara M Simpson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/antihypertensivaklasse-en-vallen-syncope-en-orthostatische-hypotensie-bij-oudere/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2016/07/01/medicatie-non-adherentie-en-visit-to-visit-bloeddrukvariabiliteit-target-bp-stud/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"larry-r-jackson","type":"person","url":"https://hartvaat.nl/mensen/larry-r-jackson/","name":"Larry R Jackson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/07/zorgpaden-na-nieuw-vastgesteld-atriumfibrilleren-rol-van-de-elektrofysioloog-en-/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-aaberge","type":"person","url":"https://hartvaat.nl/mensen/lars-aaberge/","name":"Lars Aaberge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"},{"url":"https://hartvaat.nl/2016/03/12/invasieve-versus-conservatieve-strategie-bij-80-plussers-met-nstemi-gerandomisee/","published":"2016-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-lindhagen","type":"person","url":"https://hartvaat.nl/mensen/lars-lindhagen/","name":"Lars Lindhagen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-poulsen-tolbod","type":"person","url":"https://hartvaat.nl/mensen/lars-poulsen-tolbod/","name":"Lars Poulsen Tolbod","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/metformine-remt-proliferatie-van-fibro-adipogene-stamcellen-uit-falende-harten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lars-ake-levin","type":"person","url":"https://hartvaat.nl/mensen/lars-ake-levin/","name":"Lars-Åke Levin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/14/strokestop-af-screening-is-kosteneffectief-bij-75-76-jarigen/","published":"2023-01-14"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lata-kler","type":"person","url":"https://hartvaat.nl/mensen/lata-kler/","name":"Lata Kler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-azzolini","type":"person","url":"https://hartvaat.nl/mensen/laura-azzolini/","name":"Laura Azzolini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-blue","type":"person","url":"https://hartvaat.nl/mensen/laura-blue/","name":"Laura Blue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/17/million-hearts-betaald-cv-risicomanagement-vermindert-mi-en-cva-jama-rct/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/09/01/million-hearts-cv-risicoreductiemodel-en-medicatie-initiatie-jama-cardiology/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-cetran","type":"person","url":"https://hartvaat.nl/mensen/laura-cetran/","name":"Laura Cetran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-f-michael","type":"person","url":"https://hartvaat.nl/mensen/laura-f-michael/","name":"Laura F Michael","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/solbinsiran-angptl3-remming-van-preklinisch-tot-eerste-humane-studies/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/01/21/muvalaplin-orale-lp-a-verlaging-nejm-gerandomiseerde-trial/","published":"2025-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-gonzalez-martin","type":"person","url":"https://hartvaat.nl/mensen/laura-gonzalez-martin/","name":"Laura González-Martín","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-h-coker","type":"person","url":"https://hartvaat.nl/mensen/laura-h-coker/","name":"Laura H Coker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-morf","type":"person","url":"https://hartvaat.nl/mensen/laura-morf/","name":"Laura Morf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/12/01/ldl-verlaging-en-lesie-niveau-effecten-na-acuut-mi/","published":"2024-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-p-cohen","type":"person","url":"https://hartvaat.nl/mensen/laura-p-cohen/","name":"Laura P Cohen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/team-based-care-bij-hypertensie-meta-analyse-bevestigt-effectiviteit-en-kostenef/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2020/10/01/intensieve-versus-standaard-bloeddrukbehandeling-op-white-coat-effect-en-gemaske/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-rottner","type":"person","url":"https://hartvaat.nl/mensen/laura-rottner/","name":"Laura Rottner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/14/ulysses-echogeleide-venapunctie-halveert-toegangscomplicaties-bij-af-ablatie/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2024/06/03/east-afnet-4-natriumkanaalblokkers-veilig-en-effectief-voor-langetermijn-ritmeco/","published":"2024-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-scelsi","type":"person","url":"https://hartvaat.nl/mensen/laura-scelsi/","name":"Laura Scelsi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-t-grip","type":"person","url":"https://hartvaat.nl/mensen/laura-t-grip/","name":"Laura T Grip","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2018/09/25/edoxaban-versus-warfarine-bij-latijns-amerikaanse-af-patienten-engage-af-timi-48/","published":"2018-09-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laura-webb","type":"person","url":"https://hartvaat.nl/mensen/laura-webb/","name":"Laura Webb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lauren-b-cooper","type":"person","url":"https://hartvaat.nl/mensen/lauren-b-cooper/","name":"Lauren B Cooper","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2018/12/01/liraglutide-en-gewicht-bij-gevorderd-hfref-fight-trial-inzichten/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lauren-heath","type":"person","url":"https://hartvaat.nl/mensen/lauren-heath/","name":"Lauren Heath","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"},{"url":"https://hartvaat.nl/2024/11/26/glp-1-agonisten-alleen-en-met-sglt2-remmers-cv-renale-en-veiligheidsuitkomsten/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurence-guedon-moreau","type":"person","url":"https://hartvaat.nl/mensen/laurence-guedon-moreau/","name":"Laurence Guédon-Moreau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/03/uitgebreide-versus-standaard-remote-monitoring-bij-crt-en-hartfalen/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2017/06/07/dagelijkse-telemonitoring-van-icd-s-gepoolde-analyse-van-drie-gerandomiseerde-tr/","published":"2017-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-delorme","type":"person","url":"https://hartvaat.nl/mensen/laurent-delorme/","name":"Laurent Delorme","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/19/master-dapt-recurrente-events-analyse-van-verkorte-versus-standaard-dapt/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2022/08/23/impact-van-therapieontrouw-op-duale-antiplaatjestherapie-in-klinische-trial/","published":"2022-08-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-feldman","type":"person","url":"https://hartvaat.nl/mensen/laurent-feldman/","name":"Laurent Feldman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/15/non-culprit-laesie-ernst-en-uitkomsten-bij-stemi-met-multivatenlijden/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2019/10/10/complete-revascularisatie-met-multivaten-pci-bij-mi-nejm-complete/","published":"2019-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-leborgne","type":"person","url":"https://hartvaat.nl/mensen/laurent-leborgne/","name":"Laurent Leborgne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/ffr-voor-behandeling-van-multivatencoronairlijden-jacc/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-magaud","type":"person","url":"https://hartvaat.nl/mensen/laurent-magaud/","name":"Laurent Magaud","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/09/uf-care-trial-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-geen-significante-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/09/uf-care-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-mist-primair-eindpunt-in/","published":"2026-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-payot","type":"person","url":"https://hartvaat.nl/mensen/laurent-payot/","name":"Laurent Payot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-pison","type":"person","url":"https://hartvaat.nl/mensen/laurent-pison/","name":"Laurent Pison","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2025/02/05/smartphone-ppg-voor-af-detectie-en-management-verbeterde-screening/","published":"2025-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurent-roten","type":"person","url":"https://hartvaat.nl/mensen/laurent-roten/","name":"Laurent Roten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurie-howes","type":"person","url":"https://hartvaat.nl/mensen/laurie-howes/","name":"Laurie Howes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"laurien-e-zijlstra","type":"person","url":"https://hartvaat.nl/mensen/laurien-e-zijlstra/","name":"Laurien E Zijlstra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/17/alirocumab-en-cva-reductie-odyssey-outcomes/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lavanya-bellumkonda","type":"person","url":"https://hartvaat.nl/mensen/lavanya-bellumkonda/","name":"Lavanya Bellumkonda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/coronairverkalkingen-en-myocardiale-flowreserve-na-harttransplantatie/","published":"2026-04-03"},{"url":"https://hartvaat.nl/2020/09/15/empagliflozine-bij-hartfalen-diuretische-en-cardiorenale-effecten/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lawrence-h-young","type":"person","url":"https://hartvaat.nl/mensen/lawrence-h-young/","name":"Lawrence H Young","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lawrence-j-beilin","type":"person","url":"https://hartvaat.nl/mensen/lawrence-j-beilin/","name":"Lawrence J Beilin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"layla-lavallee","type":"person","url":"https://hartvaat.nl/mensen/layla-lavallee/","name":"Layla Lavallee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lazarina-engonidou","type":"person","url":"https://hartvaat.nl/mensen/lazarina-engonidou/","name":"Lazarina Engonidou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leah-e-cahill","type":"person","url":"https://hartvaat.nl/mensen/leah-e-cahill/","name":"Leah E Cahill","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/haptoglobinefenotype-en-cv-risico-accord-bloeddruk-rct/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2020/02/11/haptoglobinefenotype-wijzigt-het-effect-van-intensieve-glycemische-controle-op-c/","published":"2020-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leandro-slipczuk","type":"person","url":"https://hartvaat.nl/mensen/leandro-slipczuk/","name":"Leandro Slipczuk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/lp-a-en-hscrp-voorspellen-ascvd-bij-mensen-zonder-klassieke-risicofactoren/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leda-chatzi","type":"person","url":"https://hartvaat.nl/mensen/leda-chatzi/","name":"Leda Chatzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lee-h-schwamm","type":"person","url":"https://hartvaat.nl/mensen/lee-h-schwamm/","name":"Lee H Schwamm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2021/06/01/continue-cardiale-monitoring-versus-standaardzorg-bij-cryptogeen-cva-jama/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lee-l-eckhardt","type":"person","url":"https://hartvaat.nl/mensen/lee-l-eckhardt/","name":"Lee L Eckhardt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lee-twaddle","type":"person","url":"https://hartvaat.nl/mensen/lee-twaddle/","name":"Lee Twaddle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/laroprovstat-eerste-orale-pcsk9-remmer-haalt-80-ldl-reductie-in-combinatie-met-r/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/06/03/pursuit-orale-pcsk9-remmer-voor-hypercholesterolemie-gerandomiseerde-trial/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lee-ling-lim","type":"person","url":"https://hartvaat.nl/mensen/lee-ling-lim/","name":"Lee-Ling Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/07/relatie-tussen-obesitas-en-ckd-conclusies-van-een-kdigo-conferentie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2023/04/01/multicomponent-geintegreerde-zorg-bij-chronisch-hartfalen-meta-analyse/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lei-qin","type":"person","url":"https://hartvaat.nl/mensen/lei-qin/","name":"Lei Qin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/26/bivalirudine-versus-heparine-bij-primaire-pci-voor-stemi-lancet-trial/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lei-si","type":"person","url":"https://hartvaat.nl/mensen/lei-si/","name":"Lei Si","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lei-yan","type":"person","url":"https://hartvaat.nl/mensen/lei-yan/","name":"Lei Yan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/02/senescente-p16-cellen-verergeren-hartremodellering-na-ischemie-via-cytotoxische-/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2025/01/01/effect-van-baduanjin-op-bloeddruk-bij-hoog-normaal-bloeddruk-gerandomiseerde-tri/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lei-zhang","type":"person","url":"https://hartvaat.nl/mensen/lei-zhang/","name":"Lei Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/20/hypertensie-bij-45-plussers-in-china-prevalentie-bewustzijn-en-behandeling/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leibo-liu","type":"person","url":"https://hartvaat.nl/mensen/leibo-liu/","name":"Leibo Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leif-e-peterson","type":"person","url":"https://hartvaat.nl/mensen/leif-e-peterson/","name":"Leif E Peterson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/27/af-ablatie-met-vena-van-marshall-ethanol-versus-ablatie-alleen-jama-venus/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2018/04/17/cardiovasculair-risico-en-relatief-voordeel-van-intensieve-hypertensiebehandelin/","published":"2018-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leif-spange-mortensen","type":"person","url":"https://hartvaat.nl/mensen/leif-spange-mortensen/","name":"Leif Spange Mortensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/01/enkelvoudige-versus-tweekamer-pacing-bij-sick-sinus-syndroom-danpace-langetermij/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2017/03/01/katheterablatie-als-eerstelijnsbehandeling-bij-paroxysmaal-af-5-jaarsresultaten/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leif-svensson","type":"person","url":"https://hartvaat.nl/mensen/leif-svensson/","name":"Leif Svensson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/zuurstoftherapie-bij-stemi-overzichtsartikel/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leila-c-kahwati","type":"person","url":"https://hartvaat.nl/mensen/leila-c-kahwati/","name":"Leila C Kahwati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/25/screening-op-af-uspstf-geactualiseerde-evidence-report-2022/","published":"2022-01-25"},{"url":"https://hartvaat.nl/2018/08/07/ecg-screening-op-af-uspstf-evidence-report-en-systematische-review/","published":"2018-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leila-h-borowsky","type":"person","url":"https://hartvaat.nl/mensen/leila-h-borowsky/","name":"Leila H Borowsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2022/03/29/af-screening-bij-ouderen-in-de-huisartsenpraktijk-vital-af-gerandomiseerde-trial/","published":"2022-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leisheng-ru","type":"person","url":"https://hartvaat.nl/mensen/leisheng-ru/","name":"Leisheng Ru","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leng-han","type":"person","url":"https://hartvaat.nl/mensen/leng-han/","name":"Leng Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lennart-sandhall","type":"person","url":"https://hartvaat.nl/mensen/lennart-sandhall/","name":"Lennart Sandhall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leo-e-akioyamen","type":"person","url":"https://hartvaat.nl/mensen/leo-e-akioyamen/","name":"Leo E Akioyamen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/14/sekseverschillen-in-fh-behandeling-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/09/07/aortastenose-bij-homozygote-familiaire-hypercholesterolemie-paradigmaverschuivin/","published":"2022-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leo-f-buckley","type":"person","url":"https://hartvaat.nl/mensen/leo-f-buckley/","name":"Leo F Buckley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/01/arts-apotheker-samenwerkingsmodel-en-time-in-target-bloeddruk-post-hoc-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2021/03/16/systolische-bloeddruk-time-in-target-en-cv-uitkomsten-bij-hypertensie/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leo-veenstra","type":"person","url":"https://hartvaat.nl/mensen/leo-veenstra/","name":"Leo Veenstra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leon-a-simons","type":"person","url":"https://hartvaat.nl/mensen/leon-a-simons/","name":"Leon A Simons","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leonardo-de-luca","type":"person","url":"https://hartvaat.nl/mensen/leonardo-de-luca/","name":"Leonardo De Luca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/rivaroxaban-discontinueringspercentages-bij-niet-valvulair-af-in-de-italiaanse-p/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2018/06/05/verlaagde-dosis-prasugrel-versus-standaard-clopidogrel-bij-oudere-acs-patienten/","published":"2018-06-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leong-l-ng","type":"person","url":"https://hartvaat.nl/mensen/leong-l-ng/","name":"Leong L Ng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2018/12/01/dagelijkse-remote-ischemische-conditionering-na-acuut-mi-gerandomiseerde-trial/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lesca-holdt","type":"person","url":"https://hartvaat.nl/mensen/lesca-holdt/","name":"Lesca Holdt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lesley-a-inker","type":"person","url":"https://hartvaat.nl/mensen/lesley-a-inker/","name":"Lesley A Inker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lesley-h-curtis","type":"person","url":"https://hartvaat.nl/mensen/lesley-h-curtis/","name":"Lesley H Curtis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/adaptable-bijdrage-van-klinische-trial-data-naar-databron/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leslie-a-mcclure","type":"person","url":"https://hartvaat.nl/mensen/leslie-a-mcclure/","name":"Leslie A McClure","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/02/09/intensieve-versus-standaard-bloeddrukcontrole-en-nierfunctie-na-lacunair-herseni/","published":"2016-02-09"},{"url":"https://hartvaat.nl/2016/01/01/bereikte-bloeddruk-en-uitkomsten-in-de-sps3-trial-bij-lacunaire-herseninfarcten/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leslie-a-perdue","type":"person","url":"https://hartvaat.nl/mensen/leslie-a-perdue/","name":"Leslie A Perdue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/uspstf-evidence-review-lipidescreening-bij-kinderen-geactualiseerd/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2021/04/27/screening-op-hypertensie-bij-volwassenen-uspstf-evidence-update-2021/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"leslie-coleman","type":"person","url":"https://hartvaat.nl/mensen/leslie-coleman/","name":"Leslie Coleman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/26/echografie-renale-denervatie-bij-triple-pilresistente-hypertensie-lancet-radianc/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"letizia-bacchi-reggiani","type":"person","url":"https://hartvaat.nl/mensen/letizia-bacchi-reggiani/","name":"Letizia Bacchi Reggiani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/25/bloedingsgerelateerde-sterfte-naar-dapt-duur-na-coronaire-stenting/","published":"2017-04-25"},{"url":"https://hartvaat.nl/2017/04/07/drie-zes-of-twaalf-maanden-dapt-na-des-met-of-zonder-acs-meta-analyse/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lewis-d-ritchie","type":"person","url":"https://hartvaat.nl/mensen/lewis-d-ritchie/","name":"Lewis D Ritchie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lewis-j-rubin","type":"person","url":"https://hartvaat.nl/mensen/lewis-j-rubin/","name":"Lewis J Rubin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-hao","type":"person","url":"https://hartvaat.nl/mensen/li-hao/","name":"Li Hao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-luo","type":"person","url":"https://hartvaat.nl/mensen/li-luo/","name":"Li Luo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/mendeliaanse-randomisatie-hmgcr-remming-verhoogt-diabetesrisico-andere-lipidendo/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-wei","type":"person","url":"https://hartvaat.nl/mensen/li-wei/","name":"Li Wei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/08/all-heart-allopurinol-verbetert-cv-uitkomsten-niet-bij-ischemische-hartziekte/","published":"2022-10-08"},{"url":"https://hartvaat.nl/2017/06/14/overschakelen-van-niet-selectieve-nsaid-s-naar-celecoxib-de-scot-trial/","published":"2017-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-xu","type":"person","url":"https://hartvaat.nl/mensen/li-xu/","name":"Li Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/ai-clustering-identificeert-functionele-risicofenotypen-bij-hartfalen/","published":"2026-04-06"},{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"li-zhou","type":"person","url":"https://hartvaat.nl/mensen/li-zhou/","name":"Li Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lia-crotti","type":"person","url":"https://hartvaat.nl/mensen/lia-crotti/","name":"Lia Crotti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/05/13/mtmr4-modifier-heeft-tegenovergestelde-invloed-op-aritmierisico-bij-lqt1-en-lqt2/","published":"2026-06-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liang","type":"person","url":"https://hartvaat.nl/mensen/liang/","name":"Liang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/transapicale-tavi-met-de-j-valve-bij-ernstige-aortaklepinsufficientie-vergelijkb/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/01/30/off-label-lage-dosis-bloedplaatjesremmers-bij-coronairlijden-minder-infarcten-en/","published":"2026-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lida-feyz","type":"person","url":"https://hartvaat.nl/mensen/lida-feyz/","name":"Lida Feyz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/14/hartfalen-mondiale-economische-ziektelast/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2018/06/09/endovasculaire-echografie-renale-denervatie-lancet-radiance-htn-solo/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lidia-staszewsky","type":"person","url":"https://hartvaat.nl/mensen/lidia-staszewsky/","name":"Lidia Staszewsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ligia-nasi-laranjeira","type":"person","url":"https://hartvaat.nl/mensen/ligia-nasi-laranjeira/","name":"Ligia Nasi Laranjeira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/timing-van-atorvastatine-oplaaddosis-voor-pci-bij-acs-jama-cardiology/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/03/oplaaddosis-atorvastatine-voor-pci-jama-gerandomiseerde-trial/","published":"2018-04-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lihua-leng","type":"person","url":"https://hartvaat.nl/mensen/lihua-leng/","name":"Lihua Leng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lili-zhang","type":"person","url":"https://hartvaat.nl/mensen/lili-zhang/","name":"Lili Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/09/coronaire-atherosclerose-bij-kankerpatienten-en-overlevenden-aha-statement/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lin-feng","type":"person","url":"https://hartvaat.nl/mensen/lin-feng/","name":"Lin Feng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/26/chinees-hartgezond-dieet-verlaagt-bloeddruk-effectief-gerandomiseerde-trial/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lin-y-chen","type":"person","url":"https://hartvaat.nl/mensen/lin-y-chen/","name":"Lin Y Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/09/2019-aha-acc-hrs-gerichte-update-van-de-af-richtlijn/","published":"2019-07-09"},{"url":"https://hartvaat.nl/2016/08/01/vitamine-d-en-incidentie-van-atriumfibrilleren-de-aric-studie/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"linda-o-nichols","type":"person","url":"https://hartvaat.nl/mensen/linda-o-nichols/","name":"Linda O Nichols","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"linda-shavit","type":"person","url":"https://hartvaat.nl/mensen/linda-shavit/","name":"Linda Shavit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/bruine-tumor-van-de-patella-bij-een-langdurig-hemodialysepatient/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"linda-van-horn","type":"person","url":"https://hartvaat.nl/mensen/linda-van-horn/","name":"Linda Van Horn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/30/visinname-en-visgerelateerde-metabolieten-geassocieerd-met-lagere-triglyceriden-/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2020/01/21/voedingscholesterol-en-cv-risico-aha-science-advisory/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lindsay-hales","type":"person","url":"https://hartvaat.nl/mensen/lindsay-hales/","name":"Lindsay Hales","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/14/sekseverschillen-in-fh-behandeling-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2022/09/07/aortastenose-bij-homozygote-familiaire-hypercholesterolemie-paradigmaverschuivin/","published":"2022-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lindsey-sjaarda","type":"person","url":"https://hartvaat.nl/mensen/lindsey-sjaarda/","name":"Lindsey Sjaarda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/01/preconceptiebloeddruk-en-verandering-naar-vroege-zwangerschap-risicofactor-voor-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddruk-voor-conceptie-en-reproductieve-uitkomsten/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liping-liu","type":"person","url":"https://hartvaat.nl/mensen/liping-liu/","name":"Liping Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/02/01/antihypertensieve-behandeling-na-acuut-ischemisch-cva-continueren-of-niet/","published":"2026-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liping-yu","type":"person","url":"https://hartvaat.nl/mensen/liping-yu/","name":"Liping Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/09/podocyt-endotheline-1-en-endotheelcel-eta-receptoren-essentieel-bij-fsgs/","published":"2026-02-09"},{"url":"https://hartvaat.nl/2019/02/05/glycemische-controle-en-cardiale-auto-immuniteit-bij-diabetes-type-1-en-langeter/","published":"2019-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-d-levine","type":"person","url":"https://hartvaat.nl/mensen/lisa-d-levine/","name":"Lisa D Levine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/01/digitale-gamificatie-interventie-verhoogt-lichaamsbeweging-na-hypertensieve-zwan/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/05/05/furosemide-voor-versneld-bloeddrukherstel-postpartum-bij-hypertensieve-zwangersc/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-desiderio","type":"person","url":"https://hartvaat.nl/mensen/lisa-desiderio/","name":"Lisa Desiderio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-hinton","type":"person","url":"https://hartvaat.nl/mensen/lisa-hinton/","name":"Lisa Hinton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-meng","type":"person","url":"https://hartvaat.nl/mensen/lisa-meng/","name":"Lisa Meng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-w-m-leung","type":"person","url":"https://hartvaat.nl/mensen/lisa-w-m-leung/","name":"Lisa W M Leung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2021/02/05/slokdarmbescherming-met-temperatuurcontroleren-bij-af-ablatie-impact/","published":"2021-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisa-w-martin","type":"person","url":"https://hartvaat.nl/mensen/lisa-w-martin/","name":"Lisa W Martin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lisbeth-drozd-hjgaard","type":"person","url":"https://hartvaat.nl/mensen/lisbeth-drozd-hjgaard/","name":"Lisbeth Drozd Højgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/science-ii-mesenchymale-stamcellen-bij-niet-ischemisch-hartfalen-negatieve-trial/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"litten-bertelsen","type":"person","url":"https://hartvaat.nl/mensen/litten-bertelsen/","name":"Litten Bertelsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/danegaptide-bij-primaire-pci-voor-acuut-mi-fase-2-gerandomiseerde-trial/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/06/13/myocardschade-bij-uitgestelde-stenting-na-stemi-danami-3-defer-substudie/","published":"2017-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liwen-li","type":"person","url":"https://hartvaat.nl/mensen/liwen-li/","name":"Liwen Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/explorer-cn-week-78-langetermijneffect-en-veiligheid-van-mavacamten-bij-chinese-/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lixia-qiao","type":"person","url":"https://hartvaat.nl/mensen/lixia-qiao/","name":"Lixia Qiao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"liying-xing","type":"person","url":"https://hartvaat.nl/mensen/liying-xing/","name":"Liying Xing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lloyd-p-haskell","type":"person","url":"https://hartvaat.nl/mensen/lloyd-p-haskell/","name":"Lloyd P Haskell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/12/voyager-pad-rivaroxaban-plus-aspirine-na-endovasculaire-revascularisatie-voor-pa/","published":"2023-12-12"},{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"loes-p-hoebers","type":"person","url":"https://hartvaat.nl/mensen/loes-p-hoebers/","name":"Loes P Hoebers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"loghman-henareh","type":"person","url":"https://hartvaat.nl/mensen/loghman-henareh/","name":"Loghman Henareh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"loic-belle","type":"person","url":"https://hartvaat.nl/mensen/loic-belle/","name":"Loic Belle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lone-juul-hune-mogensen","type":"person","url":"https://hartvaat.nl/mensen/lone-juul-hune-mogensen/","name":"Lone Juul Hune Mogensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"},{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"loren-laine","type":"person","url":"https://hartvaat.nl/mensen/loren-laine/","name":"Loren Laine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/30/ozanimod-bij-colitis-ulcerosa-nejm/","published":"2021-09-30"},{"url":"https://hartvaat.nl/2016/04/12/protonpompremmers-verminderen-gastro-intestinale-events-ongeacht-aspirinedosis-b/","published":"2016-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lorenz-bott-flugel","type":"person","url":"https://hartvaat.nl/mensen/lorenz-bott-flugel/","name":"Lorenz Bott-Flügel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lorenzo-marcon","type":"person","url":"https://hartvaat.nl/mensen/lorenzo-marcon/","name":"Lorenzo Marcon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/kortste-af-cycluslengte-in-de-longvenen-identificeert-pvi-responders/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lorraine-c-kearney","type":"person","url":"https://hartvaat.nl/mensen/lorraine-c-kearney/","name":"Lorraine C Kearney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lothar-wiese","type":"person","url":"https://hartvaat.nl/mensen/lothar-wiese/","name":"Lothar Wiese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lotte-kaasenbrood","type":"person","url":"https://hartvaat.nl/mensen/lotte-kaasenbrood/","name":"Lotte Kaasenbrood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/geschat-individueel-levensvoordeel-van-pcsk9-remming-bij-statinebehandelde-cad-p/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/11/08/residueel-vasculair-risico-bij-secundaire-preventie-verdeling-van-10-jaarsrisico/","published":"2016-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"louis-j-aronne","type":"person","url":"https://hartvaat.nl/mensen/louis-j-aronne/","name":"Louis J Aronne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/06/orforglipron-voor-obesitasbehandeling-nejm-fase-3/","published":"2025-11-06"},{"url":"https://hartvaat.nl/2020/11/03/online-gewichtsmanagementprogramma-geintegreerd-met-populatiegezondheidsbeheer-j/","published":"2020-11-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"louise-a-cullen","type":"person","url":"https://hartvaat.nl/mensen/louise-a-cullen/","name":"Louise A Cullen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"loic-perchenet","type":"person","url":"https://hartvaat.nl/mensen/loic-perchenet/","name":"Loïc Perchenet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lu-mao","type":"person","url":"https://hartvaat.nl/mensen/lu-mao/","name":"Lu Mao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lu-qi","type":"person","url":"https://hartvaat.nl/mensen/lu-qi/","name":"Lu Qi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/12/01/optimale-cardiometabole-gezondheid-tijdens-zwangerschap-verlaagt-risico-op-compl/","published":"2026-08-17"},{"url":"https://hartvaat.nl/2019/12/01/genetische-gevoeligheid-eiwitinname-en-bloeddrukverandering-pounds-lost/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lubi-lei","type":"person","url":"https://hartvaat.nl/mensen/lubi-lei/","name":"Lubi Lei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukcontrole-en-cva-preventie/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lubna-choudhury","type":"person","url":"https://hartvaat.nl/mensen/lubna-choudhury/","name":"Lubna Choudhury","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/aficamten-veilig-en-effectief-bij-langdurige-behandeling-van-obstructieve-hcm/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luc-djousse","type":"person","url":"https://hartvaat.nl/mensen/luc-djousse/","name":"Luc Djoussé","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/03/vitamine-d-en-omega-3-en-hartfalen-hospitalisatie-vital-heart-failure/","published":"2020-03-03"},{"url":"https://hartvaat.nl/2018/04/10/geen-verband-tussen-hartfalen-en-kankerincidentie/","published":"2018-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-a-lotta","type":"person","url":"https://hartvaat.nl/mensen/luca-a-lotta/","name":"Luca A Lotta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/25/polygene-risicoscore-en-voordeel-van-alirocumab-bij-coronairlijden-odyssey-outco/","published":"2020-02-25"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-aerts","type":"person","url":"https://hartvaat.nl/mensen/luca-aerts/","name":"Luca Aerts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-antonelli","type":"person","url":"https://hartvaat.nl/mensen/luca-antonelli/","name":"Luca Antonelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-bergamaschi","type":"person","url":"https://hartvaat.nl/mensen/luca-bergamaschi/","name":"Luca Bergamaschi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2025/03/13/minoca-pathologische-bevindingen-bij-invasieve-beoordeling-meta-analyse/","published":"2025-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-biasiolli","type":"person","url":"https://hartvaat.nl/mensen/luca-biasiolli/","name":"Luca Biasiolli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2016/10/18/canakinumab-en-arteriele-effecten-bij-atherosclerose-met-diabetes-of-glucosetole/","published":"2016-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-bontempi","type":"person","url":"https://hartvaat.nl/mensen/luca-bontempi/","name":"Luca Bontempi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-faconti","type":"person","url":"https://hartvaat.nl/mensen/luca-faconti/","name":"Luca Faconti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/01/bloeddrukverlaging-en-polsgolfsnelheid-meta-analyse/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2017/09/26/verlaging-van-arteriele-stijfheid-onafhankelijk-van-bloeddruk-de-vasera-trial/","published":"2017-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-fileti","type":"person","url":"https://hartvaat.nl/mensen/luca-fileti/","name":"Luca Fileti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-koechlin","type":"person","url":"https://hartvaat.nl/mensen/luca-koechlin/","name":"Luca Koechlin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/de-troponine-i-t-ratio-bij-myocardschade-een-multicohort-synthese/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2025/01/01/esc-0-1-uur-versus-0-2-of-0-3-uur-hoog-sensitief-troponine-algoritmen-bij-verden/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-kuthi","type":"person","url":"https://hartvaat.nl/mensen/luca-kuthi/","name":"Luca Kuthi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-liberale","type":"person","url":"https://hartvaat.nl/mensen/luca-liberale/","name":"Luca Liberale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/26/reverse-cardio-oncologie-obesitas-en-veroudering-als-aanjagers-van-borstkanker/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2026/02/01/praktische-overwegingen-bij-vericiguat-voor-oudere-patienten-met-hartfalen/","published":"2026-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luca-nai-fovino","type":"person","url":"https://hartvaat.nl/mensen/luca-nai-fovino/","name":"Luca Nai Fovino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/21/korte-dapt-gevolgd-door-p2y12-mono-versus-verlengde-dapt-meta-analyse/","published":"2021-01-21"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucas-boersma","type":"person","url":"https://hartvaat.nl/mensen/lucas-boersma/","name":"Lucas Boersma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2018/02/01/katheterablatie-bij-af-met-hartfalen-nejm-castle-af/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucas-m-barbosa","type":"person","url":"https://hartvaat.nl/mensen/lucas-m-barbosa/","name":"Lucas M Barbosa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/colchicine-bij-acs-meta-analyse-van-alle-rct-s/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/09/01/sedatie-versus-narcose-bij-af-catheterablatie-meta-analyse/","published":"2025-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucas-s-aparicio","type":"person","url":"https://hartvaat.nl/mensen/lucas-s-aparicio/","name":"Lucas S Aparicio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucia-s-d-jewbali","type":"person","url":"https://hartvaat.nl/mensen/lucia-s-d-jewbali/","name":"Lucia S D Jewbali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucia-venneri","type":"person","url":"https://hartvaat.nl/mensen/lucia-venneri/","name":"Lucia Venneri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/atriale-mechanische-contractie-voorspelt-cerebrovasculair-risico-bij-transthyret/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luciano-potena","type":"person","url":"https://hartvaat.nl/mensen/luciano-potena/","name":"Luciano Potena","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/04/29/vroege-iabp-bij-hartfalen-gerelateerde-cardiogene-shock-gerandomiseerde-trial/","published":"2025-04-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lucy-yardley","type":"person","url":"https://hartvaat.nl/mensen/lucy-yardley/","name":"Lucy Yardley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ludek-haman","type":"person","url":"https://hartvaat.nl/mensen/ludek-haman/","name":"Ludek Haman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-anastasia","type":"person","url":"https://hartvaat.nl/mensen/luigi-anastasia/","name":"Luigi Anastasia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-ferrucci","type":"person","url":"https://hartvaat.nl/mensen/luigi-ferrucci/","name":"Luigi Ferrucci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-giannelli","type":"person","url":"https://hartvaat.nl/mensen/luigi-giannelli/","name":"Luigi Giannelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-palmieri","type":"person","url":"https://hartvaat.nl/mensen/luigi-palmieri/","name":"Luigi Palmieri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luigi-spadafora","type":"person","url":"https://hartvaat.nl/mensen/luigi-spadafora/","name":"Luigi Spadafora","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/27/cardiotoxiciteit-van-her2-remmers-en-multikinaseremmers-mechanismen-en-klinisch-/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-a-guzman","type":"person","url":"https://hartvaat.nl/mensen/luis-a-guzman/","name":"Luis A Guzman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-aguinaga","type":"person","url":"https://hartvaat.nl/mensen/luis-aguinaga/","name":"Luis Aguinaga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-beck-da-silva","type":"person","url":"https://hartvaat.nl/mensen/luis-beck-da-silva/","name":"Luis Beck-da-Silva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2019/11/21/diureticastaken-bij-stabiel-mild-hf-zonder-vochtretentie/","published":"2019-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-cerna","type":"person","url":"https://hartvaat.nl/mensen/luis-cerna/","name":"Luis Cerna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/factor-xi-xia-remmers-bij-atriumfibrilleren-dosisrespons-werkzaamheid-en-veiligh/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luis-e-echeverria","type":"person","url":"https://hartvaat.nl/mensen/luis-e-echeverria/","name":"Luis E Echeverria","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/20/sacubitril-valsartan-en-frailteit-bij-hfpef-paragon-hf-analyse/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luiz-a-bortolotto","type":"person","url":"https://hartvaat.nl/mensen/luiz-a-bortolotto/","name":"Luiz A Bortolotto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luiz-c-s-passos","type":"person","url":"https://hartvaat.nl/mensen/luiz-c-s-passos/","name":"Luiz C S Passos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luiz-e-f-ritt","type":"person","url":"https://hartvaat.nl/mensen/luiz-e-f-ritt/","name":"Luiz E F Ritt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lukasz-szumowski","type":"person","url":"https://hartvaat.nl/mensen/lukasz-szumowski/","name":"Lukasz Szumowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/05/antistolling-comorbiditeitsbehandeling-en-vroege-ritmecontrole-east-afnet-4-patr/","published":"2022-04-05"},{"url":"https://hartvaat.nl/2022/03/21/vroege-ritmecontrole-bij-af-met-of-zonder-symptomen-east-afnet-4/","published":"2022-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luke-j-laffin","type":"person","url":"https://hartvaat.nl/mensen/luke-j-laffin/","name":"Luke J Laffin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/08/lorundrostat-bij-ongecontroleerde-hypertensie-fase-3-nejm/","published":"2025-05-08"},{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"luke-roberts","type":"person","url":"https://hartvaat.nl/mensen/luke-roberts/","name":"Luke Roberts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/01/finerenon-en-lvh-bij-ckd-en-diabetes/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2021/07/13/finerenon-vermindert-nieuw-onset-af-bij-ckd-met-diabetes-fidelio-dkd/","published":"2021-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lupei-cai","type":"person","url":"https://hartvaat.nl/mensen/lupei-cai/","name":"Lupei Cai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/sprint-accord-gepoold-bloeddrukvariabiliteit-is-even-prognostisch-als-gemiddelde/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2026/05/14/bloeddrukvariabiliteit-sprint-accord-ipd-meta-even-prognostisch-als-gemiddelde-b/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lydia-a-bazzano","type":"person","url":"https://hartvaat.nl/mensen/lydia-a-bazzano/","name":"Lydia A Bazzano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2017/09/19/community-health-worker-interventie-voor-bloeddrukcontrole-in-argentina-jama-tri/","published":"2017-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lykke-larsen","type":"person","url":"https://hartvaat.nl/mensen/lykke-larsen/","name":"Lykke Larsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lynda-szczech","type":"person","url":"https://hartvaat.nl/mensen/lynda-szczech/","name":"Lynda Szczech","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lynn-ang","type":"person","url":"https://hartvaat.nl/mensen/lynn-ang/","name":"Lynn Ang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/cardiorenale-bescherming-door-sglt2-remmers-glp-1-agonisten-en-mra-s-bij-type-1-/","published":"2026-08-07"},{"url":"https://hartvaat.nl/2026/09/01/cardiorenale-risicos-bij-type-1-diabetes-een-overzicht-van-de-huidige-stand-van-/","published":"2026-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-hassan-murad","type":"person","url":"https://hartvaat.nl/mensen/m-hassan-murad/","name":"M Hassan Murad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/01/farmacologische-hypertensiebehandeling-bij-volwassenen-who-richtlijn-samenvattin/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2021/09/01/zorginterventies-voor-hypertensie-bij-achtergestelde-populaties-in-de-vs-meta-an/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-l-bouvy","type":"person","url":"https://hartvaat.nl/mensen/m-l-bouvy/","name":"M L Bouvy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/10/decision-trial-digoxine-staken-bij-hartfalen-leidt-tot-zevenvoudige-stijging-in-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/10/decision-onttrekkingssubstudie-stoppen-van-digoxine-na-lange-behandeling-leidt-t/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-louis-handoko","type":"person","url":"https://hartvaat.nl/mensen/m-louis-handoko/","name":"M Louis Handoko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/10/01/trimetazidine-bij-hfpef-gerandomiseerde-cross-over-trial/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-marije-vis","type":"person","url":"https://hartvaat.nl/mensen/m-marije-vis/","name":"M Marije Vis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/06/15/bioresorbeerbare-scaffolds-versus-metallic-stents-bij-routine-pci-nejm-aida/","published":"2017-06-15"},{"url":"https://hartvaat.nl/2017/01/24/percutane-mechanische-circulatoire-ondersteuning-versus-iabp-bij-cardiogene-shoc/","published":"2017-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-urooj-zafar","type":"person","url":"https://hartvaat.nl/mensen/m-urooj-zafar/","name":"M Urooj Zafar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"},{"url":"https://hartvaat.nl/2020/02/18/ticagrelor-met-of-zonder-aspirine-na-pci-twilight-plaatjessubstudie/","published":"2020-02-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-vinayaga-moorthy","type":"person","url":"https://hartvaat.nl/mensen/m-vinayaga-moorthy/","name":"M Vinayaga Moorthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/05/inflammatie-cholesterol-lp-a-en-30-jaars-cv-uitkomsten-bij-vrouwen/","published":"2024-12-05"},{"url":"https://hartvaat.nl/2021/03/16/omega-3-en-vitamine-d-en-incident-af-jama-vital-af/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-p","type":"person","url":"https://hartvaat.nl/mensen/m-p/","name":"M. P.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/04/noorse-nationale-validatie-myocarditis-na-mrna-covid-vaccinatie-4-5-per-100-000-/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/03/31/titine-cardiomyopathie-meestal-dcm-of-linksdominante-acm-met-blijvend-ritmestoor/","published":"2026-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ma-an-muhsin","type":"person","url":"https://hartvaat.nl/mensen/ma-an-muhsin/","name":"Ma'an Muhsin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/09/plozasiran-bij-persisterende-chylomicronemie-en-pancreatitisrisico-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maciej-tomaszewski","type":"person","url":"https://hartvaat.nl/mensen/maciej-tomaszewski/","name":"Maciej Tomaszewski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2019/11/01/causaal-verband-periodontitis-en-hypertensie-mendeliaanse-randomisatie-en-rct/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"madelyn-curto","type":"person","url":"https://hartvaat.nl/mensen/madelyn-curto/","name":"Madelyn Curto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mads-d-m-engelmann","type":"person","url":"https://hartvaat.nl/mensen/mads-d-m-engelmann/","name":"Mads D M Engelmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/soul-oraal-semaglutide-cv-voordeel-naar-sglt2i-gebruik/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/05/29/soul-oraal-semaglutide-en-cv-uitkomsten-bij-hoogrisico-type-2-diabetes-nejm/","published":"2025-05-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mads-jnsson-andersen","type":"person","url":"https://hartvaat.nl/mensen/mads-jnsson-andersen/","name":"Mads Jønsson Andersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mafalda-bourbon","type":"person","url":"https://hartvaat.nl/mensen/mafalda-bourbon/","name":"Mafalda Bourbon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"magdalena-januszewicz","type":"person","url":"https://hartvaat.nl/mensen/magdalena-januszewicz/","name":"Magdalena Januszewicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"magdi-el-omar","type":"person","url":"https://hartvaat.nl/mensen/magdi-el-omar/","name":"Magdi El-Omar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"magdy-abdelhamid","type":"person","url":"https://hartvaat.nl/mensen/magdy-abdelhamid/","name":"Magdy Abdelhamid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"magnus-back","type":"person","url":"https://hartvaat.nl/mensen/magnus-back/","name":"Magnus Bäck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/metabool-cardiovasculair-risico-nieuwe-mechanismen-en-therapiekansen/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2025/10/07/help-mi-helicobacter-pylori-screening-na-acuut-mi-cluster-rct/","published":"2025-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"magnus-janzon","type":"person","url":"https://hartvaat.nl/mensen/magnus-janzon/","name":"Magnus Janzon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/abc-af-risicoscores-voor-gepersonaliseerde-af-behandeling/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2016/10/15/vroeg-invasief-versus-conservatief-bij-nste-acs-15-jaarsfollow-up-frisc-ii/","published":"2016-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mahdi-nalini","type":"person","url":"https://hartvaat.nl/mensen/mahdi-nalini/","name":"Mahdi Nalini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/08/24/polypil-voor-primaire-en-secundaire-cv-preventie-lancet-polyiran/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mahesh-parmar","type":"person","url":"https://hartvaat.nl/mensen/mahesh-parmar/","name":"Mahesh Parmar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/13/transdermaal-oestradiol-bij-prostaatkanker-langetermijn-cv-uitkomsten-lancet/","published":"2021-02-13"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mai-tone-lnnebakken","type":"person","url":"https://hartvaat.nl/mensen/mai-tone-lnnebakken/","name":"Mai Tone Lønnebakken","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/lage-arteriele-compliance-en-cv-morbiditeit-bij-aortaklepstenose/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2017/09/01/slagvolume-en-cardiovasculair-risico-bij-progressie-van-aortaklepstenose/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maja-ivanovski","type":"person","url":"https://hartvaat.nl/mensen/maja-ivanovski/","name":"Maja Ivanovski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/csp-sync-geleidingssysteempacing-versus-biventriculaire-pacing-voor-crt-rct/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/05/02/preventieve-substraatablatie-vermindert-icd-interventies-bij-ischemische-cmp/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"malek-kass","type":"person","url":"https://hartvaat.nl/mensen/malek-kass/","name":"Malek Kass","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"malha-sadoune","type":"person","url":"https://hartvaat.nl/mensen/malha-sadoune/","name":"Malha Sadoune","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/16/natrium-hf-subanalyse-natriuretische-peptiden-lopen-achter-op-de-klinische-ontst/","published":"2026-03-16"},{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"malte-kuniss","type":"person","url":"https://hartvaat.nl/mensen/malte-kuniss/","name":"Malte Kuniss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manasi-tannu","type":"person","url":"https://hartvaat.nl/mensen/manasi-tannu/","name":"Manasi Tannu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/25/antitrombotische-therapie-bij-af-na-acs-pci-augustus-gecombineerde-inzichten/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mandalenakis","type":"person","url":"https://hartvaat.nl/mensen/mandalenakis/","name":"Mandalenakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/langetermijnuitkomsten-na-de-ross-operatie-een-op-de-vier-krijgt-een-heroperatie/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/31/volwassenen-met-een-ventrikelseptumdefect-hebben-drie-keer-hogere-sterfte-zweeds/","published":"2026-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mandana-haack-srensen","type":"person","url":"https://hartvaat.nl/mensen/mandana-haack-srensen/","name":"Mandana Haack-Sørensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/science-ii-mesenchymale-stamcellen-bij-niet-ischemisch-hartfalen-negatieve-trial/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manfred-d-seeberger","type":"person","url":"https://hartvaat.nl/mensen/manfred-d-seeberger/","name":"Manfred D Seeberger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manfred-hecking","type":"person","url":"https://hartvaat.nl/mensen/manfred-hecking/","name":"Manfred Hecking","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/dapa-hd-eerste-gerandomiseerde-studie-naar-dapagliflozin-bij-hemodialyse-patient/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2026/01/27/aldosteronsynthase-remmers-bij-ongecontroleerde-en-resistente-hypertensie-bij-ck/","published":"2026-01-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manfred-rauh","type":"person","url":"https://hartvaat.nl/mensen/manfred-rauh/","name":"Manfred Rauh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/16/sglt2-remming-waterconservatie-domineert-over-osmotische-diurese-bij-hf/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mangalath-n-krishnan","type":"person","url":"https://hartvaat.nl/mensen/mangalath-n-krishnan/","name":"Mangalath N Krishnan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"},{"url":"https://hartvaat.nl/2018/02/13/kwaliteitsverbeteringsinterventie-bij-acuut-mi-in-india-jama-acs-quik/","published":"2018-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manhua-chen","type":"person","url":"https://hartvaat.nl/mensen/manhua-chen/","name":"Manhua Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2023/01/17/option-indobufen-als-aspirine-alternatief-in-dapt-na-pci/","published":"2023-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manickavasagar-vinayagamoorthy","type":"person","url":"https://hartvaat.nl/mensen/manickavasagar-vinayagamoorthy/","name":"Manickavasagar Vinayagamoorthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2022/10/01/sekseverschillen-in-af-risico-vital-rhythm-studie/","published":"2022-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manish-d-sinha","type":"person","url":"https://hartvaat.nl/mensen/manish-d-sinha/","name":"Manish D Sinha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/gemaskeerde-hypertensie-bij-kinderen-prevalentie-en-cv-risico-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manjula-kurella-tamura","type":"person","url":"https://hartvaat.nl/mensen/manjula-kurella-tamura/","name":"Manjula Kurella Tamura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manuel-castella","type":"person","url":"https://hartvaat.nl/mensen/manuel-castella/","name":"Manuel Castella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manuela-licka","type":"person","url":"https://hartvaat.nl/mensen/manuela-licka/","name":"Manuela Licka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/kenmerken-van-asymptomatische-patienten-met-hartfalen-en-verminderde-ejectiefrac/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"manuja-premaratne","type":"person","url":"https://hartvaat.nl/mensen/manuja-premaratne/","name":"Manuja Premaratne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mar-alameda","type":"person","url":"https://hartvaat.nl/mensen/mar-alameda/","name":"Mar Alameda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maral-saadati","type":"person","url":"https://hartvaat.nl/mensen/maral-saadati/","name":"Maral Saadati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2022/12/21/empagliflozine-en-het-circulerend-proteoom-bij-hartfalen-emperor-mechanismen/","published":"2022-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-bellet","type":"person","url":"https://hartvaat.nl/mensen/marc-bellet/","name":"Marc Bellet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/03/precision-aprocitentan-bij-resistente-hypertensie-eerste-endothelineantagonist/","published":"2022-12-03"},{"url":"https://hartvaat.nl/2020/04/01/aprocitentan-bij-hypertensie-gerandomiseerde-dosis-responsstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-d-samsky","type":"person","url":"https://hartvaat.nl/mensen/marc-d-samsky/","name":"Marc D Samsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/01/veiligheid-van-sglt2-remmers-bij-hartfalen-meta-analyse/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2016/01/26/langketen-acylcarnitines-bij-hartfalen-prognostische-waarde-en-reversibiliteit-m/","published":"2016-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-gillinov","type":"person","url":"https://hartvaat.nl/mensen/marc-gillinov/","name":"Marc Gillinov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"},{"url":"https://hartvaat.nl/2020/07/18/dexmedetomidine-voor-af-en-delier-na-hartchirurgie-lancet-decade/","published":"2020-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-hartmann","type":"person","url":"https://hartvaat.nl/mensen/marc-hartmann/","name":"Marc Hartmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-j-claeys","type":"person","url":"https://hartvaat.nl/mensen/marc-j-claeys/","name":"Marc J Claeys","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2017/05/06/bloedingen-met-laaggedoseerd-rivaroxaban-versus-aspirine-naast-p2y12-atlas-acs-2/","published":"2017-05-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-leone","type":"person","url":"https://hartvaat.nl/mensen/marc-leone/","name":"Marc Leone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/07/10/epinefrine-versus-norepinefrine-bij-cardiogene-shock-na-acuut-mi/","published":"2018-07-10"},{"url":"https://hartvaat.nl/2017/10/10/geindividualiseerd-versus-standaard-bloeddrukbeleid-bij-hoog-risico-chirurgiepat/","published":"2017-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-silvestri","type":"person","url":"https://hartvaat.nl/mensen/marc-silvestri/","name":"Marc Silvestri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marc-alexander-ohlow","type":"person","url":"https://hartvaat.nl/mensen/marc-alexander-ohlow/","name":"Marc-Alexander Ohlow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcel-ballin","type":"person","url":"https://hartvaat.nl/mensen/marcel-ballin/","name":"Marcel Ballin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/21/hoge-jeugdige-conditie-en-af-risico-trade-off-verdwijnt-na-correctie-voor-famili/","published":"2026-07-05"},{"url":"https://hartvaat.nl/2023/01/10/dagelijkse-stappen-en-cardiovasculaire-ziekte-geharmoniseerde-meta-analyse/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcel-g-m-olde-rikkert","type":"person","url":"https://hartvaat.nl/mensen/marcel-g-m-olde-rikkert/","name":"Marcel G M Olde Rikkert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/01/bloeddrukvariabiliteit-en-progressie-van-klinische-alzheimer/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2019/08/01/nilvadipine-en-cerebrale-bloedflow-bij-alzheimer-gerandomiseerde-trial/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcel-l-geleijnse","type":"person","url":"https://hartvaat.nl/mensen/marcel-l-geleijnse/","name":"Marcel L Geleijnse","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/echocardiografie-overschatte-drukgradienten-na-tav-in-tav-met-ballon-expandable-/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2018/03/01/twee-geavanceerde-en-verlengde-hartrevalidatieprogramma-s-gerandomiseerde-trial/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcel-t-m-gosselink","type":"person","url":"https://hartvaat.nl/mensen/marcel-t-m-gosselink/","name":"Marcel T M Gosselink","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcelo-sanmartin-fernandez","type":"person","url":"https://hartvaat.nl/mensen/marcelo-sanmartin-fernandez/","name":"Marcelo Sanmartin Fernandez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/28/routine-invasieve-strategie-en-herinfarctrisico-bij-fragiele-ouderen-met-nste-ac/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2023/01/11/inadequate-noac-dosering-bij-af-uitkomsten-en-oorzaken-meta-analyse/","published":"2023-01-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcin-demkow","type":"person","url":"https://hartvaat.nl/mensen/marcin-demkow/","name":"Marcin Demkow","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/23/myocardinfarct-in-de-ischemia-trial-impact-van-verschillende-mi-definities/","published":"2021-02-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-antonio-alcocer-gamba","type":"person","url":"https://hartvaat.nl/mensen/marco-antonio-alcocer-gamba/","name":"Marco Antonio Alcocer-Gamba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/24/finearts-hf-finerenon-bij-hfmref-hfpef-nejm/","published":"2024-10-24"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-ballarotto","type":"person","url":"https://hartvaat.nl/mensen/marco-ballarotto/","name":"Marco Ballarotto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-bergonti","type":"person","url":"https://hartvaat.nl/mensen/marco-bergonti/","name":"Marco Bergonti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/02/03/kortste-af-cycluslengte-in-de-longvenen-identificeert-pvi-responders/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-c-post","type":"person","url":"https://hartvaat.nl/mensen/marco-c-post/","name":"Marco C Post","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-merlo","type":"person","url":"https://hartvaat.nl/mensen/marco-merlo/","name":"Marco Merlo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/03/geslachtsverschillen-bij-patienten-met-gevorderd-hartfalen/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-nazzaro","type":"person","url":"https://hartvaat.nl/mensen/marco-nazzaro/","name":"Marco Nazzaro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2017/04/07/radiale-versus-femorale-toegang-bij-acs-met-en-zonder-st-elevatie/","published":"2017-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-pappaccogli","type":"person","url":"https://hartvaat.nl/mensen/marco-pappaccogli/","name":"Marco Pappaccogli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/02/01/geautomatiseerde-praktijkmeting-versus-andere-bloeddrukmeetmethoden/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-ruozzi","type":"person","url":"https://hartvaat.nl/mensen/marco-ruozzi/","name":"Marco Ruozzi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/fysiologisch-geleide-complete-revascularisatie-bij-ouderen-met-mi-driejaarsdata/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2023/09/07/fire-complete-revascularisatie-bij-ouderen-75-jaar-met-mi-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-schiavone","type":"person","url":"https://hartvaat.nl/mensen/marco-schiavone/","name":"Marco Schiavone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-v-perez","type":"person","url":"https://hartvaat.nl/mensen/marco-v-perez/","name":"Marco V Perez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-vito-rossi","type":"person","url":"https://hartvaat.nl/mensen/marco-vito-rossi/","name":"Marco Vito Rossi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-vitolo","type":"person","url":"https://hartvaat.nl/mensen/marco-vitolo/","name":"Marco Vitolo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/03/device-algoritmen-voor-rv-pacingminimalisatie-meta-analyse-van-uitkomsten/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2021/09/14/copd-bij-af-prevalentie-management-en-impact-meta-analyse/","published":"2021-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marco-w-f-van-gent","type":"person","url":"https://hartvaat.nl/mensen/marco-w-f-van-gent/","name":"Marco W F van Gent","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-green","type":"person","url":"https://hartvaat.nl/mensen/marcus-green/","name":"Marcus Green","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-hennersdorf","type":"person","url":"https://hartvaat.nl/mensen/marcus-hennersdorf/","name":"Marcus Hennersdorf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-ohlsson","type":"person","url":"https://hartvaat.nl/mensen/marcus-ohlsson/","name":"Marcus Ohlsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marcus-stahlberg","type":"person","url":"https://hartvaat.nl/mensen/marcus-stahlberg/","name":"Marcus Ståhlberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/06/09/acyl-ghreline-verbetert-hartfunctie-bij-hartfalen/","published":"2023-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marek-gierlotka","type":"person","url":"https://hartvaat.nl/mensen/marek-gierlotka/","name":"Marek Gierlotka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/nationaal-cardiologisch-netwerk-als-nieuwe-zorgstandaard-in-polen/","published":"2026-04-12"},{"url":"https://hartvaat.nl/2026/02/03/levosimendan-infusies-en-klinisch-beloop-bij-hartfalen-levo-d-resultaten/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marek-hozman","type":"person","url":"https://hartvaat.nl/mensen/marek-hozman/","name":"Marek Hozman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/22/cooperative-pfa-driearmige-gerandomiseerde-trial-van-pfa-versus-rf-versus-cryo/","published":"2025-07-22"},{"url":"https://hartvaat.nl/2025/07/08/catheterablatie-versus-leefstijlmodificatie-plus-antiaritmica-bij-af-gerandomise/","published":"2025-07-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marek-kabat","type":"person","url":"https://hartvaat.nl/mensen/marek-kabat/","name":"Marek Kabat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marek-rajzer","type":"person","url":"https://hartvaat.nl/mensen/marek-rajzer/","name":"Marek Rajzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/ambulante-arteriele-stijfheidsindex-eindpuntgebaseerde-drempelwaarde/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/08/08/abpm-esc-streefwaarden-en-cv-uitkomsten-ipd-meta-analyse/","published":"2025-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margaret-arstall","type":"person","url":"https://hartvaat.nl/mensen/margaret-arstall/","name":"Margaret Arstall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/01/af-voorspelt-cognitieve-achteruitgang-meta-analyse-van-2-8-miljoen-personen/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2017/09/05/n-acetylcysteine-met-nitraat-bij-primaire-pci-voor-stemi/","published":"2017-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margaret-infeld","type":"person","url":"https://hartvaat.nl/mensen/margaret-infeld/","name":"Margaret Infeld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-klinische-uitkomsten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2023/03/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-met-pacemaker/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margaret-sunitha-selvaraj","type":"person","url":"https://hartvaat.nl/mensen/margaret-sunitha-selvaraj/","name":"Margaret Sunitha Selvaraj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/04/genetisch-bevestigde-familiaire-hypercholesterolemie-in-de-vs-prevalentie-en-ond/","published":"2026-03-22"},{"url":"https://hartvaat.nl/2026/02/22/genetische-voorspelling-van-lp-a-spiegels-in-diverse-populaties/","published":"2026-02-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margo-b-minissian","type":"person","url":"https://hartvaat.nl/mensen/margo-b-minissian/","name":"Margo B Minissian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/04/2022-acc-expert-consensus-niet-statine-therapieen-voor-ldl-verlaging-bij-ascvd/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2017/10/03/2017-acc-gerichte-update-niet-statinetherapie-voor-ldl-verlaging/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"margot-morris","type":"person","url":"https://hartvaat.nl/mensen/margot-morris/","name":"Margot Morris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/19/synchronisatie-van-voetstap-en-hartfase-bij-crt-patienten/","published":"2023-12-19"},{"url":"https://hartvaat.nl/2021/09/21/1-jaar-inspanningstraining-keert-lv-stijfheid-om-bij-stadium-b-hf/","published":"2021-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marguerite-r-irvin","type":"person","url":"https://hartvaat.nl/mensen/marguerite-r-irvin/","name":"Marguerite R Irvin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/polygene-risicoscore-en-chloortalidone-respons/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-c-magnus","type":"person","url":"https://hartvaat.nl/mensen/maria-c-magnus/","name":"Maria C Magnus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-f-paton","type":"person","url":"https://hartvaat.nl/mensen/maria-f-paton/","name":"Maria F Paton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-grazia-bongiorni","type":"person","url":"https://hartvaat.nl/mensen/maria-grazia-bongiorni/","name":"Maria Grazia Bongiorni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/upgrade-van-draadloze-pacemaker-van-enkelvoudig-naar-tweekamersysteem/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2021/03/08/katheterablatie-om-af-progressie-te-vertragen-attest-gerandomiseerde-trial/","published":"2021-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-guarino","type":"person","url":"https://hartvaat.nl/mensen/maria-guarino/","name":"Maria Guarino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-h-mehlum","type":"person","url":"https://hartvaat.nl/mensen/maria-h-mehlum/","name":"Maria H Mehlum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/01/value-trial-cv-uitkomsten-bij-hypertensie-met-perifeer-vaatlijden/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2020/06/01/arb-versus-calciumantagonist-bloeddrukprofiel-en-klinische-effecten-vergelijking/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-hee-jung-park-frausing","type":"person","url":"https://hartvaat.nl/mensen/maria-hee-jung-park-frausing/","name":"Maria Hee Jung Park Frausing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/minimalisatie-van-atriale-pacing-bij-sinusknoopziekte-vermindert-af/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-lucia-narducci","type":"person","url":"https://hartvaat.nl/mensen/maria-lucia-narducci/","name":"Maria Lucia Narducci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-luisa-pena-pena","type":"person","url":"https://hartvaat.nl/mensen/maria-luisa-pena-pena/","name":"Maria Luisa Peña-Peña","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-sara-mauro","type":"person","url":"https://hartvaat.nl/mensen/maria-sara-mauro/","name":"Maria Sara Mauro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/glp-1-agonisten-verlagen-cardiovasculaire-risicos-bij-diabetes-en-obesitas-overz/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2024/04/02/ivus-versus-oct-versus-angiografie-voor-pci-begeleiding-meta-analyse/","published":"2024-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-tafelmeier","type":"person","url":"https://hartvaat.nl/mensen/maria-tafelmeier/","name":"Maria Tafelmeier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/12/01/adaptieve-servoventilatie-en-hypoxemische-belasting-bij-hartfalen/","published":"2023-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-teresa-abola","type":"person","url":"https://hartvaat.nl/mensen/maria-teresa-abola/","name":"Maria Teresa Abola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/01/rivaroxaban-plus-aspirine-bij-symptomatisch-pav-compass-subanalyse/","published":"2021-01-01"},{"url":"https://hartvaat.nl/2020/05/01/langdurig-ticagrelor-na-mi-zonder-stent-voorgeschiedenis-pegasus-timi-54-inzicht/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-angela-losi","type":"person","url":"https://hartvaat.nl/mensen/maria-angela-losi/","name":"Maria-Angela Losi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/langetermijnwaarde-van-inspanningstesten-bij-hypertrofische-cardiomyopathie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2017/01/01/ontwikkeling-van-linkerventrikelhypertrofie-bij-behandelde-hypertensie-campania-/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariachiara-ciarlantini","type":"person","url":"https://hartvaat.nl/mensen/mariachiara-ciarlantini/","name":"Mariachiara Ciarlantini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2025/03/13/minoca-pathologische-bevindingen-bij-invasieve-beoordeling-meta-analyse/","published":"2025-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariana-blacher","type":"person","url":"https://hartvaat.nl/mensen/mariana-blacher/","name":"Mariana Blacher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marianne-b-treppendahl","type":"person","url":"https://hartvaat.nl/mensen/marianne-b-treppendahl/","name":"Marianne B Treppendahl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/18/step-hfpef-dm-semaglutide-bij-hfpef-met-obesitas-en-type-2-diabetes-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2023/09/21/step-hfpef-semaglutide-bij-hfpef-en-obesitas-nejm/","published":"2023-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marianne-becker","type":"person","url":"https://hartvaat.nl/mensen/marianne-becker/","name":"Marianne Becker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariano-badra-verdu","type":"person","url":"https://hartvaat.nl/mensen/mariano-badra-verdu/","name":"Mariano Badra-Verdu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/01/af-last-en-qol-na-af-ablatie-cabana-substudie/","published":"2021-11-01"},{"url":"https://hartvaat.nl/2019/11/26/cryoballon-versus-rf-ablatie-bij-af-beoordeeld-met-continue-monitoring-cryo-firs/","published":"2019-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariano-pellicano","type":"person","url":"https://hartvaat.nl/mensen/mariano-pellicano/","name":"Mariano Pellicano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/20/ticagrelor-versus-prasugrel-en-coronaire-microcirculatie-bij-pci/","published":"2023-12-20"},{"url":"https://hartvaat.nl/2016/07/12/prasugrel-versus-clopidogrel-en-coronaire-microvasculaire-functie-bij-electieve-/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariathas","type":"person","url":"https://hartvaat.nl/mensen/mariathas/","name":"Mariathas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/invasieve-coronaire-functietest-bij-anoca-verandert-de-behandeling-bij-driekwart/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/23/multidisciplinair-cardiogene-shockteam-verbetert-de-1-jaarsoverleving-bij-infarc/","published":"2026-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-bayer-elming","type":"person","url":"https://hartvaat.nl/mensen/marie-bayer-elming/","name":"Marie Bayer Elming","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/icd-bij-niet-ischemisch-systolisch-hf-met-coronaire-atherosclerose-danish/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2017/11/07/leeftijd-en-uitkomsten-van-primaire-preventie-icd-bij-niet-ischemisch-hartfalen-/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-dahl","type":"person","url":"https://hartvaat.nl/mensen/marie-dahl/","name":"Marie Dahl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/28/viborg-screeningsprogramma-verlaagt-5-jaarssterfte-bij-67-jarigen/","published":"2026-05-03"},{"url":"https://hartvaat.nl/2022/10/01/bloeddruk-in-hogere-versus-lagere-arm-en-cv-uitkomsten-interpress-ipd-meta-analy/","published":"2022-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-m-michelsen","type":"person","url":"https://hartvaat.nl/mensen/marie-m-michelsen/","name":"Marie M Michelsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/14/select-semaglutide-vermindert-cv-events-bij-obesitas-zonder-diabetes-nejm/","published":"2023-12-14"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-standl","type":"person","url":"https://hartvaat.nl/mensen/marie-standl/","name":"Marie Standl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-angele-morel","type":"person","url":"https://hartvaat.nl/mensen/marie-angele-morel/","name":"Marie-Angele Morel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/28/10-jaars-mortaliteit-na-pci-of-cabg-bij-diabetes-met-complex-coronairlijden/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-france-seronde","type":"person","url":"https://hartvaat.nl/mensen/marie-france-seronde/","name":"Marie-France Seronde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/09/telesat-prior-hf-telemonitoring-na-hartfalenopname-verbonden-met-46-lagere-morta/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marie-therese-cooney","type":"person","url":"https://hartvaat.nl/mensen/marie-therese-cooney/","name":"Marie-Therese Cooney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marielle-scherrer-crosbie","type":"person","url":"https://hartvaat.nl/mensen/marielle-scherrer-crosbie/","name":"Marielle Scherrer-Crosbie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/27/multimodaal-ai-model-verhoogt-accuratesse-van-echo-diagnose-cardiale-amyloidose/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2023/08/08/stop-ca-atorvastatine-beschermt-tegen-antracycline-cardiotoxiciteit/","published":"2023-08-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marije-m-lowik","type":"person","url":"https://hartvaat.nl/mensen/marije-m-lowik/","name":"Marije M Löwik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/5-jaarsuitkomsten-van-zotarolimus-en-everolimus-eluting-stents-trial-en-real-wor/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marina-cuchel","type":"person","url":"https://hartvaat.nl/mensen/marina-cuchel/","name":"Marina Cuchel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/18/global-hicc-register-950-hofh-patienten-uit-45-landen-slechts-4-haalt-ldl-doelen/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marina-huguet","type":"person","url":"https://hartvaat.nl/mensen/marina-huguet/","name":"Marina Huguet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marina-panova-noeva","type":"person","url":"https://hartvaat.nl/mensen/marina-panova-noeva/","name":"Marina Panova-Noeva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/13/empagliflozine-erytropoese-en-ijzermobilisatie-bij-hartfalen/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2024/11/12/sglt2-remming-en-proteomische-handtekeningen-bij-hartfalen-bevestiging/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marinella-temprosa","type":"person","url":"https://hartvaat.nl/mensen/marinella-temprosa/","name":"Marinella Temprosa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","published":"2022-05-31"},{"url":"https://hartvaat.nl/2017/07/04/langetermijn-metformine-en-leefstijl-en-coronair-calcium-diabetes-prevention-pro/","published":"2017-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mario-d-souza","type":"person","url":"https://hartvaat.nl/mensen/mario-d-souza/","name":"Mario D'Souza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/01/objectieve-risicobeoordeling-versus-standaardzorg-bij-acs-jama-cardiology/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2017/12/01/revascularisatie-versus-medicamenteus-beleid-bij-nste-acs-bij-ouderen-meta-analy/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mario-marzilli","type":"person","url":"https://hartvaat.nl/mensen/mario-marzilli/","name":"Mario Marzilli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/debat-preventieve-pci-bij-kwetsbare-plaques-als-standaardbehandeling/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2018/06/14/langetermijnuitkomsten-bij-angina-zonder-obstructief-coronairlijden-systematisch/","published":"2018-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mario-mekhael","type":"person","url":"https://hartvaat.nl/mensen/mario-mekhael/","name":"Mario Mekhael","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/decaaf-ii-af-last-en-symptoomreductie-na-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/08/02/decaaf-ii-fibroselocatie-beinvloedt-af-recidief-na-ablatie/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mario-talajic","type":"person","url":"https://hartvaat.nl/mensen/mario-talajic/","name":"Mario Talajic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/18/raft-langetermijn-crt-d-bij-hartfalen-nejm-14-jaarsresultaten/","published":"2024-01-18"},{"url":"https://hartvaat.nl/2022/06/07/raft-af-ablatie-versus-rate-control-bij-hartfalen-en-atriumfibrilleren/","published":"2022-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mario-volpicelli","type":"person","url":"https://hartvaat.nl/mensen/mario-volpicelli/","name":"Mario Volpicelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2025/08/04/lbbap-versus-rv-pacing-tweejaarsresultaten-bij-pacemakergeindiceerde-patienten/","published":"2025-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marion-janisch","type":"person","url":"https://hartvaat.nl/mensen/marion-janisch/","name":"Marion Janisch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marion-rabant","type":"person","url":"https://hartvaat.nl/mensen/marion-rabant/","name":"Marion Rabant","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/onverklaarde-transplantaatdisfunctie-bij-een-zeldzame-metabole-stoornis/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/13/bcma-gerichte-t-cel-engagertherapie-bij-refractaire-hla-sensitisatie/","published":"2026-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marios-k-georgakis","type":"person","url":"https://hartvaat.nl/mensen/marios-k-georgakis/","name":"Marios K Georgakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/roken-en-hartfalen-mendeliaanse-randomisatie-en-mediatie-analyse/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marisa-okano","type":"person","url":"https://hartvaat.nl/mensen/marisa-okano/","name":"Marisa Okano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/05/cardiovasculair-risico-na-fertiliteitstherapie-systematische-review-en-meta-anal/","published":"2017-09-05"},{"url":"https://hartvaat.nl/2016/12/01/vasculaire-disfunctiemarkers-na-hypertensieve-zwangerschapsaandoeningen-meta-ana/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariusz-k-szymanski","type":"person","url":"https://hartvaat.nl/mensen/mariusz-k-szymanski/","name":"Mariusz K Szymanski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariusz-pytkowski","type":"person","url":"https://hartvaat.nl/mensen/mariusz-pytkowski/","name":"Mariusz Pytkowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/enkele-freeze-cryoballonablatie-bij-af-ehra-systematische-review/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2017/10/01/antazoline-voor-snelle-cardioversie-van-paroxysmaal-af-de-anpaf-studie/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mariya-tokmakova","type":"person","url":"https://hartvaat.nl/mensen/mariya-tokmakova/","name":"Mariya Tokmakova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2026/03/03/beeldvorming-bij-atriale-cardiomyopathie-esc-scientific-statement/","published":"2026-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marjaana-tiainen","type":"person","url":"https://hartvaat.nl/mensen/marjaana-tiainen/","name":"Marjaana Tiainen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"},{"url":"https://hartvaat.nl/2020/08/18/optimale-bloeddruk-bij-shock-na-mi-en-hartstilstand/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marju-orho-melander","type":"person","url":"https://hartvaat.nl/mensen/marju-orho-melander/","name":"Marju Orho-Melander","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/20/darmmicrobiota-en-geschatte-glomerulaire-filtratiesnelheid-in-twee-zweedse-cohor/","published":"2026-02-20"},{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-a-menegus","type":"person","url":"https://hartvaat.nl/mensen/mark-a-menegus/","name":"Mark A Menegus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-hickey","type":"person","url":"https://hartvaat.nl/mensen/mark-hickey/","name":"Mark Hickey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/07/5-jaarsuitkomsten-na-pci-of-cabg-bij-hoofdstamlijden-nejm-excel/","published":"2019-11-07"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-j-graham","type":"person","url":"https://hartvaat.nl/mensen/mark-j-graham/","name":"Mark J Graham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/29/insuline-voorkomt-hypercholesterolemie-via-12-gehydroxyleerde-galzuren/","published":"2022-03-29"},{"url":"https://hartvaat.nl/2017/07/20/angptl3-antisense-oligonucleotiden-cardiovasculaire-en-metabole-effecten-nejm/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-j-haykowsky","type":"person","url":"https://hartvaat.nl/mensen/mark-j-haykowsky/","name":"Mark J Haykowsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/perifere-zuurstofextractie-bepaalt-belasting-bij-arrhythmogene-cardiomyopathie-f/","published":"2026-07-31"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-j-jaros","type":"person","url":"https://hartvaat.nl/mensen/mark-j-jaros/","name":"Mark J Jaros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/21/orion-11-inclisiran-verlaagt-ldl-effectief-bij-primaire-preventie/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2020/04/16/inclisiran-bij-heterozygote-familiaire-hypercholesterolemie-nejm-orion-9/","published":"2020-04-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-j-russo","type":"person","url":"https://hartvaat.nl/mensen/mark-j-russo/","name":"Mark J Russo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/partner-3-tavr-versus-chirurgie-bij-laagrisico-zevenjaarsresultaten-nejm/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/11/23/partner-3-vijfjaarsresultaten-tavr-vergelijkbaar-met-chirurgie-bij-laagrisico-ne/","published":"2023-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-l-warren","type":"person","url":"https://hartvaat.nl/mensen/mark-l-warren/","name":"Mark L Warren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/29/orale-semaglutide-en-cv-uitkomsten-bij-diabetes-type-2-nejm-pioneer-6/","published":"2019-08-29"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-la-meir","type":"person","url":"https://hartvaat.nl/mensen/mark-la-meir/","name":"Mark La Meir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-lakshmanan","type":"person","url":"https://hartvaat.nl/mensen/mark-lakshmanan/","name":"Mark Lakshmanan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-m-gallagher","type":"person","url":"https://hartvaat.nl/mensen/mark-m-gallagher/","name":"Mark M Gallagher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2021/02/05/slokdarmbescherming-met-temperatuurcontroleren-bij-af-ablatie-impact/","published":"2021-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-mitsnefes","type":"person","url":"https://hartvaat.nl/mensen/mark-mitsnefes/","name":"Mark Mitsnefes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/gemaskeerde-hypertensie-bij-kinderen-prevalentie-en-cv-risico-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/06/01/eindorgaanschade-bij-kinderen-met-primaire-hypertensie-meta-analyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-monahan","type":"person","url":"https://hartvaat.nl/mensen/mark-monahan/","name":"Mark Monahan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-norman","type":"person","url":"https://hartvaat.nl/mensen/mark-norman/","name":"Mark Norman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2021/02/05/slokdarmbescherming-met-temperatuurcontroleren-bij-af-ablatie-impact/","published":"2021-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-s-slaughter","type":"person","url":"https://hartvaat.nl/mensen/mark-s-slaughter/","name":"Mark S Slaughter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"},{"url":"https://hartvaat.nl/2017/02/02/intrapericardiale-lvad-bij-gevorderd-hartfalen-nejm/","published":"2017-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-t-kearney","type":"person","url":"https://hartvaat.nl/mensen/mark-t-kearney/","name":"Mark T Kearney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-tanner","type":"person","url":"https://hartvaat.nl/mensen/mark-tanner/","name":"Mark Tanner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/30/ablatie-versus-antiaritmica-voor-vermindering-van-ziekenhuisbezoeken-bij-af/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2017/07/01/crt-werkingsmechanismen-en-mogelijkheden-voor-verdere-verbetering/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-w-kennedy","type":"person","url":"https://hartvaat.nl/mensen/mark-w-kennedy/","name":"Mark W Kennedy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-westwood","type":"person","url":"https://hartvaat.nl/mensen/mark-westwood/","name":"Mark Westwood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/competenties-na-certificering-en-cardiovasculaire-zorgverlening/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mark-de-belder","type":"person","url":"https://hartvaat.nl/mensen/mark-de-belder/","name":"Mark de Belder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marko-poglitsch","type":"person","url":"https://hartvaat.nl/mensen/marko-poglitsch/","name":"Marko Poglitsch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/angiotensinepathways-onder-empagliflozine-bij-chronisch-hartfalen/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2020/06/01/il-1-receptorantagonist-verhoogt-ang-1-7-en-verlaagt-bloeddruk-bij-obesitas/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-kneihsl","type":"person","url":"https://hartvaat.nl/mensen/markus-kneihsl/","name":"Markus Kneihsl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-otto","type":"person","url":"https://hartvaat.nl/mensen/markus-otto/","name":"Markus Otto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-p-schneider","type":"person","url":"https://hartvaat.nl/mensen/markus-p-schneider/","name":"Markus P Schneider","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/spironolacton-en-lv-massa-bij-hemodialysepatienten-gerandomiseerde-trial/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2017/09/19/empagliflozine-en-vasculaire-functie-en-centrale-hemodynamiek-bij-diabetes-type-/","published":"2017-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"markus-perola","type":"person","url":"https://hartvaat.nl/mensen/markus-perola/","name":"Markus Perola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marla-b-sultan","type":"person","url":"https://hartvaat.nl/mensen/marla-b-sultan/","name":"Marla B Sultan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/01/tafamidis-en-cardiale-functie-bij-attr-cm-post-hoc-attr-act-analyse/","published":"2024-01-01"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marnie-bertolet","type":"person","url":"https://hartvaat.nl/mensen/marnie-bertolet/","name":"Marnie Bertolet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maros-ferencik","type":"person","url":"https://hartvaat.nl/mensen/maros-ferencik/","name":"Maros Ferencik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/23/uspstf-evidence-review-statines-voor-primaire-cv-preventie-geactualiseerd/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2017/11/21/coronair-calcium-en-prognostische-waarde-bij-pijn-op-de-borst-promise-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marshall-b-elam","type":"person","url":"https://hartvaat.nl/mensen/marshall-b-elam/","name":"Marshall B Elam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/24/prominent-pemafibrate-verlaagt-triglyceriden-maar-vermindert-cv-events-niet/","published":"2022-11-24"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marta-cecchini","type":"person","url":"https://hartvaat.nl/mensen/marta-cecchini/","name":"Marta Cecchini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/01/alcohol-en-hypertensierisico-dosis-respons-meta-analyse-van-niet-experimentele-s/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/10/01/alcoholconsumptie-en-bloeddruk-dosis-respons-meta-analyse/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marta-cocco","type":"person","url":"https://hartvaat.nl/mensen/marta-cocco/","name":"Marta Cocco","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/11/12/complete-versus-culprit-only-revascularisatie-bij-ouderen-met-mi-met-zonder-card/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marta-czesnikiewicz-guzik","type":"person","url":"https://hartvaat.nl/mensen/marta-czesnikiewicz-guzik/","name":"Marta Czesnikiewicz-Guzik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/parodontale-behandeling-remt-progressie-van-atherosclerose/","published":"2026-04-01"},{"url":"https://hartvaat.nl/2019/11/01/causaal-verband-periodontitis-en-hypertensie-mendeliaanse-randomisatie-en-rct/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marta-focardi","type":"person","url":"https://hartvaat.nl/mensen/marta-focardi/","name":"Marta Focardi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2025/08/01/linkeratriale-strain-en-prognose-bij-acuut-en-chronisch-hartfalen-meta-analyse/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marta-leite","type":"person","url":"https://hartvaat.nl/mensen/marta-leite/","name":"Marta Leite","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/05/sglt2-remmer-met-en-zonder-mra-bij-hartfalen-gecombineerde-analyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2023/06/01/hartfalentherapie-bij-hfmref-netwerk-meta-analyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marte-bratlie","type":"person","url":"https://hartvaat.nl/mensen/marte-bratlie/","name":"Marte Bratlie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/il-6-remming-en-coronaire-microvasculaire-en-endotheelfunctie-bij-myocardinfarct/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2016/08/07/il-6-receptorantagonist-tocilizumab-bij-nstemi-effect-op-inflammatie-en-troponin/","published":"2016-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martijin-meuwissen","type":"person","url":"https://hartvaat.nl/mensen/martijin-meuwissen/","name":"Martijin Meuwissen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martijn-gilbers","type":"person","url":"https://hartvaat.nl/mensen/martijn-gilbers/","name":"Martijn Gilbers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/08/preoperatieve-tte-voor-voorspelling-van-postoperatief-af-meta-analyse/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2021/04/01/va-ecls-bij-harttransplantatie-en-vad-centra-meta-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martijn-scholte","type":"person","url":"https://hartvaat.nl/mensen/martijn-scholte/","name":"Martijn Scholte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2016/11/26/ultradunne-biodegradeerbare-versus-duurzame-polymer-des-lancet-gerandomiseerde-t/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-borggrefe","type":"person","url":"https://hartvaat.nl/mensen/martin-borggrefe/","name":"Martin Borggrefe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/draagbare-cardioverter-defibrillator-na-myocardinfarct-nejm-vest/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2016/07/12/nervus-vagus-stimulatie-bij-hartfalen-de-inovate-hf-trial/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-e-w-hemels","type":"person","url":"https://hartvaat.nl/mensen/martin-e-w-hemels/","name":"Martin E W Hemels","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/23/switchen-van-vka-naar-noac-bij-fragiele-ouderen-met-af-veilig/","published":"2024-01-23"},{"url":"https://hartvaat.nl/2022/07/15/race-3-langetermijnresultaten-gerichte-behandeling-bij-vroeg-persisterend-af-en-/","published":"2022-07-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-flamant","type":"person","url":"https://hartvaat.nl/mensen/martin-flamant/","name":"Martin Flamant","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/creatinine-cystatine-c-of-beide-voor-gfr-schatting-bij-niertransplantatiepatient/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/12/26/pth-suppressieprofielen-na-orale-calciumbelasting-bij-niertransplantatiepatiente/","published":"2025-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-g-larson","type":"person","url":"https://hartvaat.nl/mensen/martin-g-larson/","name":"Martin G Larson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/10/dagelijkse-stappen-en-cardiovasculaire-ziekte-geharmoniseerde-meta-analyse/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-g-myers","type":"person","url":"https://hartvaat.nl/mensen/martin-g-myers/","name":"Martin G Myers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/aobp-na-nul-versus-vijf-minuten-rust-gerandomiseerde-trial/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2016/10/01/cardiovasculair-risico-bij-hypertensie-in-relatie-tot-bereikte-bloeddruk-met-gea/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-g-schultz","type":"person","url":"https://hartvaat.nl/mensen/martin-g-schultz/","name":"Martin G Schultz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-gallagher","type":"person","url":"https://hartvaat.nl/mensen/martin-gallagher/","name":"Martin Gallagher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/24/risicovoorspellingsmodellen-voor-ouderen-met-chronische-nierziekte/","published":"2025-12-24"},{"url":"https://hartvaat.nl/2025/08/16/achieve-spironolacton-bij-dialysepatienten-internationale-rct/","published":"2025-08-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-gardner","type":"person","url":"https://hartvaat.nl/mensen/martin-gardner/","name":"Martin Gardner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/haptoglobinefenotype-wijzigt-het-effect-van-intensieve-glycemische-controle-op-c/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/05/09/agressieve-bloeddrukcontrole-en-recidief-van-af-na-ablatie-gerandomiseerde-trial/","published":"2017-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-geyer","type":"person","url":"https://hartvaat.nl/mensen/martin-geyer/","name":"Martin Geyer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-hudec","type":"person","url":"https://hartvaat.nl/mensen/martin-hudec/","name":"Martin Hudec","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-j-schalij","type":"person","url":"https://hartvaat.nl/mensen/martin-j-schalij/","name":"Martin J Schalij","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/04/profylactische-icd-bij-dialysepatienten-ter-preventie-van-plotse-hartdood/","published":"2019-06-04"},{"url":"https://hartvaat.nl/2017/04/01/beperkte-chirurgische-linkeratriumablatie-bij-af-effectief-maar-vermindert-la-fu/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-kirk-christensen","type":"person","url":"https://hartvaat.nl/mensen/martin-kirk-christensen/","name":"Martin Kirk Christensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2020/06/23/polymeervrije-biolimus-stent-versus-ultradunne-biodegradeerbare-sirolimus-stent/","published":"2020-06-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-m-lewinter","type":"person","url":"https://hartvaat.nl/mensen/martin-m-lewinter/","name":"Martin M LeWinter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-met-pacemaker/","published":"2023-03-01"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-martinek","type":"person","url":"https://hartvaat.nl/mensen/martin-martinek/","name":"Martin Martinek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/aanbesteding-van-cardiale-implanteerbare-devices-in-europa-waarde-of-kosten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-orban","type":"person","url":"https://hartvaat.nl/mensen/martin-orban/","name":"Martin Orban","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/14/ecls-bij-cardiogene-shock-na-acuut-mi/","published":"2019-05-14"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-penicka","type":"person","url":"https://hartvaat.nl/mensen/martin-penicka/","name":"Martin Penicka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-poloczek","type":"person","url":"https://hartvaat.nl/mensen/martin-poloczek/","name":"Martin Poloczek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-snoer","type":"person","url":"https://hartvaat.nl/mensen/martin-snoer/","name":"Martin Snoer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-unverdorben","type":"person","url":"https://hartvaat.nl/mensen/martin-unverdorben/","name":"Martin Unverdorben","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/eldercare-af-subanalyse-dosisreductie-edoxaban-bij-80-jarigen-met-af/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-w-bergmann","type":"person","url":"https://hartvaat.nl/mensen/martin-w-bergmann/","name":"Martin W Bergmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/atrial-flow-regulator-en-overleving-bij-hartfalen-voorspelde-impact/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martin-van-eickels","type":"person","url":"https://hartvaat.nl/mensen/martin-van-eickels/","name":"Martin van Eickels","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martina-nesti","type":"person","url":"https://hartvaat.nl/mensen/martina-nesti/","name":"Martina Nesti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/fluoroscopieminimalisatie-bij-svt-ablatie-door-vrouwelijke-elektrofysiologen/","published":"2026-04-06"},{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martina-novackova","type":"person","url":"https://hartvaat.nl/mensen/martina-novackova/","name":"Martina Novackova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martine-clozel","type":"person","url":"https://hartvaat.nl/mensen/martine-clozel/","name":"Martine Clozel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/aprocitentan-bij-ckd-en-resistente-hypertensie/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/04/01/aprocitentan-bij-zwarte-patienten-met-hypertensie/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"martine-vrijheid","type":"person","url":"https://hartvaat.nl/mensen/martine-vrijheid/","name":"Martine Vrijheid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marwan-saad","type":"person","url":"https://hartvaat.nl/mensen/marwan-saad/","name":"Marwan Saad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/01/provisional-versus-twee-stentstrategie-bij-bifurcatielaesies-meta-analyse/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/07/01/bioresorbeerbare-scaffold-versus-des-2-jaars-meta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mary-birmingham","type":"person","url":"https://hartvaat.nl/mensen/mary-birmingham/","name":"Mary Birmingham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/sglt2-remmers-verbeteren-kwaliteit-van-leven-gelijk-bij-zwarte-en-witte-hartfale/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mary-e-putt","type":"person","url":"https://hartvaat.nl/mensen/mary-e-putt/","name":"Mary E Putt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/01/apothekerverwijzingen-voor-statine-start-twee-cluster-rct-s/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2022/06/01/digitale-gamificatie-interventie-verhoogt-lichaamsbeweging-na-hypertensieve-zwan/","published":"2022-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mary-ellen-sweeney","type":"person","url":"https://hartvaat.nl/mensen/mary-ellen-sweeney/","name":"Mary Ellen Sweeney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/01/bloeddrukcontrole-en-diabetes-incidentie-sprint-resultaten/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mary-elliott-davey","type":"person","url":"https://hartvaat.nl/mensen/mary-elliott-davey/","name":"Mary Elliott-Davey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/18/optimaal-bereikt-ldl-cholesterol-en-langetermijn-cv-uitkomsten-fourier-analyse/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2022/10/11/langetermijn-evolocumab-bij-atherosclerotisch-vaatlijden-open-label-extensie-fou/","published":"2022-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maryjo-l-cleveland","type":"person","url":"https://hartvaat.nl/mensen/maryjo-l-cleveland/","name":"Maryjo L Cleveland","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maryuri-briceno","type":"person","url":"https://hartvaat.nl/mensen/maryuri-briceno/","name":"Maryuri Briceno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maria-lopez-benito","type":"person","url":"https://hartvaat.nl/mensen/maria-lopez-benito/","name":"María López-Benito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masafumi-nakayama","type":"person","url":"https://hartvaat.nl/mensen/masafumi-nakayama/","name":"Masafumi Nakayama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2017/02/14/laaggedoseerde-aspirine-voor-primaire-cardiovasculaire-preventie-bij-diabetes-ty/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masafumi-watanabe","type":"person","url":"https://hartvaat.nl/mensen/masafumi-watanabe/","name":"Masafumi Watanabe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2022/03/01/bloeddruk-hypertensie-en-risico-op-aortadissectie-j-sch-en-uk-biobank/","published":"2022-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masahiro-yagi","type":"person","url":"https://hartvaat.nl/mensen/masahiro-yagi/","name":"Masahiro Yagi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masako-waki","type":"person","url":"https://hartvaat.nl/mensen/masako-waki/","name":"Masako Waki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/07/febuxostat-voor-cerebraal-en-cardiorenovasculaire-eventpreventie-freed/","published":"2019-06-07"},{"url":"https://hartvaat.nl/2017/02/14/laaggedoseerde-aspirine-voor-primaire-cardiovasculaire-preventie-bij-diabetes-ty/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masami-nishino","type":"person","url":"https://hartvaat.nl/mensen/masami-nishino/","name":"Masami Nishino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/01/dapagliflozine-bij-acuut-gedecompenseerd-hartfalen-en-nierfunctie-rct/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2021/12/01/egfr-variabiliteit-en-uitkomsten-bij-real-world-hf/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masami-sakurada","type":"person","url":"https://hartvaat.nl/mensen/masami-sakurada/","name":"Masami Sakurada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masanobu-ohya","type":"person","url":"https://hartvaat.nl/mensen/masanobu-ohya/","name":"Masanobu Ohya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masanori-yamamoto","type":"person","url":"https://hartvaat.nl/mensen/masanori-yamamoto/","name":"Masanori Yamamoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masaomi-nangaku","type":"person","url":"https://hartvaat.nl/mensen/masaomi-nangaku/","name":"Masaomi Nangaku","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masaru-obokata","type":"person","url":"https://hartvaat.nl/mensen/masaru-obokata/","name":"Masaru Obokata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/26/interatriale-shunt-en-pulmonale-vaatfunctie-bij-hfpef/","published":"2019-11-26"},{"url":"https://hartvaat.nl/2017/07/11/arteriele-verstijving-bij-inspanning-bij-hfpef/","published":"2017-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masashi-fujino","type":"person","url":"https://hartvaat.nl/mensen/masashi-fujino/","name":"Masashi Fujino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masatake-kobayashi","type":"person","url":"https://hartvaat.nl/mensen/masatake-kobayashi/","name":"Masatake Kobayashi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/het-spectrum-van-congestie-bij-hartfalen-pathofysiologie-en-diagnostische-strate/","published":"2026-05-31"},{"url":"https://hartvaat.nl/2025/11/14/nierfunctietrajecten-voor-en-na-hospitalisatie-voor-hfref/","published":"2025-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masato-nakamura","type":"person","url":"https://hartvaat.nl/mensen/masato-nakamura/","name":"Masato Nakamura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/rivaroxaban-monotherapie-versus-combinatie-met-plaatjesremmers-bij-af-en-coronai/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/09/19/antitrombotische-therapie-bij-af-met-stabiel-coronairlijden-nejm-afire/","published":"2019-09-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masato-okada","type":"person","url":"https://hartvaat.nl/mensen/masato-okada/","name":"Masato Okada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masayuki-doi","type":"person","url":"https://hartvaat.nl/mensen/masayuki-doi/","name":"Masayuki Doi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masliza-mahmod","type":"person","url":"https://hartvaat.nl/mensen/masliza-mahmod/","name":"Masliza Mahmod","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/05/30/empagliflozine-en-cardiale-energiestofwisseling-bij-hartfalen-empa-vision/","published":"2023-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mason-w-freeman","type":"person","url":"https://hartvaat.nl/mensen/mason-w-freeman/","name":"Mason W Freeman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/02/baxdrostat-aldosteronsynthaseremmer-bij-resistente-hypertensie-nejm-fase-2/","published":"2023-02-02"},{"url":"https://hartvaat.nl/2018/08/01/langetermijn-patiromer-bij-hyperkaliemie-met-mild-hf-en-diabetische-nefropathie/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masoor-kamalesh","type":"person","url":"https://hartvaat.nl/mensen/masoor-kamalesh/","name":"Masoor Kamalesh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/07/24/cva-incidentie-na-cabg-versus-pci/","published":"2018-07-24"},{"url":"https://hartvaat.nl/2018/03/10/cabg-versus-pci-met-stenting-bij-coronairlijden-lancet-10-jaarsfollow-up-systema/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"masoud-isanejad","type":"person","url":"https://hartvaat.nl/mensen/masoud-isanejad/","name":"Masoud Isanejad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/opnameduur-en-eerdere-hf-opnames-bij-frailteit-en-hartfalen-systematische-review/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/01/natriuretische-peptiden-en-crp-bij-hartfalen-en-ondervoeding-systematische-revie/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massimiliano-camilli","type":"person","url":"https://hartvaat.nl/mensen/massimiliano-camilli/","name":"Massimiliano Camilli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/10/hartfalen-en-infarct-verdrievoudigen-het-risico-op-kanker-vooral-hematologisch/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/03/03/beeldvorming-bij-atriale-cardiomyopathie-esc-scientific-statement/","published":"2026-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massimiliano-mule","type":"person","url":"https://hartvaat.nl/mensen/massimiliano-mule/","name":"Massimiliano Mulè","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/inotropica-bij-low-output-hartfalen-vergelijkbare-hemodynamische-effecten-in-met/","published":"2026-05-24"},{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massimo-federici","type":"person","url":"https://hartvaat.nl/mensen/massimo-federici/","name":"Massimo Federici","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/12/lipidenmanagement-bij-type-2-diabetes-richt-je-op-alle-atherogene-lipoproteinen-/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"massimo-iacoviello","type":"person","url":"https://hartvaat.nl/mensen/massimo-iacoviello/","name":"Massimo Iacoviello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/geschiktheid-van-poliklinische-chronische-hf-patienten-voor-sglt2-remmers/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2017/11/28/schildklierfunctie-en-risico-op-af-subclinische-hypothyreoidie/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mate-vamos","type":"person","url":"https://hartvaat.nl/mensen/mate-vamos/","name":"Mate Vamos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/quadripolaire-versus-bipolaire-lv-leads-bij-crt-klinische-uitkomsten/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2016/12/01/rivaroxaban-versus-vka-bij-periprocedurele-antistolling-rond-af-ablatie/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mateusz-siedlinski","type":"person","url":"https://hartvaat.nl/mensen/mateusz-siedlinski/","name":"Mateusz Siedlinski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/menopauzale-status-en-docetaxel-geinduceerde-vasculaire-disfunctie-bij-borstkank/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2019/11/01/causaal-verband-periodontitis-en-hypertensie-mendeliaanse-randomisatie-en-rct/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matevz-jan","type":"person","url":"https://hartvaat.nl/mensen/matevz-jan/","name":"Matevž Jan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/13/intracardiale-echocardiografie-in-de-elektrofysiologie-gezamenlijk-ehra-eapci-st/","published":"2026-05-23"},{"url":"https://hartvaat.nl/2024/05/02/preventieve-substraatablatie-vermindert-icd-interventies-bij-ischemische-cmp/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mathias-meine","type":"person","url":"https://hartvaat.nl/mensen/mathias-meine/","name":"Mathias Meine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/02/remote-monitoring-en-klinische-uitkomsten-bij-europese-hf-met-icd-langetermijn/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2019/09/01/remote-monitoring-en-patientgerapporteerde-uitkomsten-bij-europese-hf-patienten-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mathieu-kerneis","type":"person","url":"https://hartvaat.nl/mensen/mathieu-kerneis/","name":"Mathieu Kerneis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/23/aspirine-bij-chronisch-coronairsyndroom-plus-oac-wel-of-niet/","published":"2025-10-23"},{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mathijs-c-bunck","type":"person","url":"https://hartvaat.nl/mensen/mathijs-c-bunck/","name":"Mathijs C Bunck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/30/summit-tirzepatide-bij-hfpef-met-obesitas-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2024/09/16/tirzepatide-en-bloeddrukverlaging-surmount-1-gestratificeerde-analyse/","published":"2024-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matilde-winther-jensen","type":"person","url":"https://hartvaat.nl/mensen/matilde-winther-jensen/","name":"Matilde Winther-Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matt-nguyen","type":"person","url":"https://hartvaat.nl/mensen/matt-nguyen/","name":"Matt Nguyen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-familiaire-hypercholesterolemie-uspstf-evidenc/","published":"2016-08-09"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-multifactoriele-dyslipidemie-uspstf-evidence-r/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-armillotta","type":"person","url":"https://hartvaat.nl/mensen/matteo-armillotta/","name":"Matteo Armillotta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2025/03/13/minoca-pathologische-bevindingen-bij-invasieve-beoordeling-meta-analyse/","published":"2025-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-sturla","type":"person","url":"https://hartvaat.nl/mensen/matteo-sturla/","name":"Matteo Sturla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2020/05/09/p2y12-monotherapie-of-aspirine-voor-secundaire-preventie-lancet-meta-analyse/","published":"2020-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matteo-toma","type":"person","url":"https://hartvaat.nl/mensen/matteo-toma/","name":"Matteo Toma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/pah-met-renaal-diabetische-overlap-komt-vaak-voor-en-geeft-tweemaal-zo-hoog-mort/","published":"2026-06-01"},{"url":"https://hartvaat.nl/2021/10/01/sacubitril-valsartan-in-real-life-europese-hfref-meta-analyse/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-a-allison","type":"person","url":"https://hartvaat.nl/mensen/matthew-a-allison/","name":"Matthew A Allison","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-c-tattersall","type":"person","url":"https://hartvaat.nl/mensen/matthew-c-tattersall/","name":"Matthew C Tattersall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-denniff","type":"person","url":"https://hartvaat.nl/mensen/matthew-denniff/","name":"Matthew Denniff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/transcriptomische-onderdrukking-van-immuun-en-ecm-stabiliteit-in-skeletspier-bij/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2022/01/01/telomeerlengte-en-mortaliteit-bij-chronisch-hartfalen/","published":"2022-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-erickson","type":"person","url":"https://hartvaat.nl/mensen/matthew-erickson/","name":"Matthew Erickson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2018/10/27/absorb-iv-bioresorbeerbare-scaffold-30-daags-en-1-jaarsresultaten/","published":"2018-10-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-f-muldoon","type":"person","url":"https://hartvaat.nl/mensen/matthew-f-muldoon/","name":"Matthew F Muldoon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/postpartum-diureticabehandeling-bij-hypertensieve-zwangerschapsstoornissen/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2024/10/29/reset-bp-minder-sedentair-gedrag-verlaagt-bloeddruk-bij-kantoorwerkers/","published":"2024-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-g-d-bates","type":"person","url":"https://hartvaat.nl/mensen/matthew-g-d-bates/","name":"Matthew G D Bates","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2022/06/10/voorspelling-van-atriumfibrilleren-in-elektronische-gezondheidsdossiers-systemat/","published":"2022-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-j-bown","type":"person","url":"https://hartvaat.nl/mensen/matthew-j-bown/","name":"Matthew J Bown","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/metformin-verlaagt-risico-op-buikaorta-aneurysma-mr-en-cohortanalyse/","published":"2026-08-20"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-kelham","type":"person","url":"https://hartvaat.nl/mensen/matthew-kelham/","name":"Matthew Kelham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-m-loiacono","type":"person","url":"https://hartvaat.nl/mensen/matthew-m-loiacono/","name":"Matthew M Loiacono","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-r-reynolds","type":"person","url":"https://hartvaat.nl/mensen/matthew-r-reynolds/","name":"Matthew R Reynolds","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthew-w-gillman","type":"person","url":"https://hartvaat.nl/mensen/matthew-w-gillman/","name":"Matthew W Gillman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-antz","type":"person","url":"https://hartvaat.nl/mensen/matthias-antz/","name":"Matthias Antz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-hochadel","type":"person","url":"https://hartvaat.nl/mensen/matthias-hochadel/","name":"Matthias Hochadel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/14/temporaire-mechanische-circulatie-bij-cardiogene-shock-ipd-meta-analyse/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-kretzler","type":"person","url":"https://hartvaat.nl/mensen/matthias-kretzler/","name":"Matthias Kretzler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/deep-endotypering-onthult-heterogeniteit-van-nierschade-bij-diabetes-type-2/","published":"2026-03-27"},{"url":"https://hartvaat.nl/2026/02/24/polygene-risicoscores-en-hla-klasse-ii-als-biomarkers-voor-corticosteroidrespons/","published":"2026-02-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-paul","type":"person","url":"https://hartvaat.nl/mensen/matthias-paul/","name":"Matthias Paul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/grote-variatie-in-diureticabeleid-en-zeldzame-natriummeting-bij-acuut-hartfalen/","published":"2026-07-31"},{"url":"https://hartvaat.nl/2026/05/21/1-op-10-patienten-heroptname-binnen-30-dagen-na-tavi-sterfterisico-na-1-jaar-ver/","published":"2026-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-siepe","type":"person","url":"https://hartvaat.nl/mensen/matthias-siepe/","name":"Matthias Siepe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthias-thielmann","type":"person","url":"https://hartvaat.nl/mensen/matthias-thielmann/","name":"Matthias Thielmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthieu-godin","type":"person","url":"https://hartvaat.nl/mensen/matthieu-godin/","name":"Matthieu Godin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-laagrisico-acuut-mi/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthieu-monge","type":"person","url":"https://hartvaat.nl/mensen/matthieu-monge/","name":"Matthieu Monge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matthijs-bax","type":"person","url":"https://hartvaat.nl/mensen/matthijs-bax/","name":"Matthijs Bax","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/01/langetermijnimpact-van-cto-rekanalisatie-bij-stemi-patienten/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/10/11/pci-van-chronische-totale-occlusie-bij-stemi-met-multivatenlijden-explore-trial/","published":"2016-10-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matti-marklund","type":"person","url":"https://hartvaat.nl/mensen/matti-marklund/","name":"Matti Marklund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2022/09/26/zoutvervangers-verminderen-cardiovasculaire-events-systematische-review/","published":"2022-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mattias-ekstrom","type":"person","url":"https://hartvaat.nl/mensen/mattias-ekstrom/","name":"Mattias Ekström","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/prefers-stockholm-nieuw-ontstaan-hfpef-heeft-slechtere-langetermijnuitkomsten-da/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mattie-lenzen","type":"person","url":"https://hartvaat.nl/mensen/mattie-lenzen/","name":"Mattie Lenzen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/08/biovasc-directe-versus-gestageerde-complete-revascularisatie-bij-acs-met-meervat/","published":"2023-04-08"},{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maura-m-zylla","type":"person","url":"https://hartvaat.nl/mensen/maura-m-zylla/","name":"Maura M Zylla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2024/08/03/dagontslag-versus-overnachting-na-af-ablatie-uitgebreide-meta-analyse/","published":"2024-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maureen-g-maguire","type":"person","url":"https://hartvaat.nl/mensen/maureen-g-maguire/","name":"Maureen G Maguire","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/25/aflibercept-versus-bevacizumab-eerst-bij-diabetisch-macula-oedeem/","published":"2022-08-25"},{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurice-beghetti","type":"person","url":"https://hartvaat.nl/mensen/maurice-beghetti/","name":"Maurice Beghetti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/02/macitentan-bij-eisenmenger-syndroom/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurice-giroud","type":"person","url":"https://hartvaat.nl/mensen/maurice-giroud/","name":"Maurice Giroud","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mauricio-scanavacca","type":"person","url":"https://hartvaat.nl/mensen/mauricio-scanavacca/","name":"Mauricio Scanavacca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurizio-averna","type":"person","url":"https://hartvaat.nl/mensen/maurizio-averna/","name":"Maurizio Averna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurizio-landolina","type":"person","url":"https://hartvaat.nl/mensen/maurizio-landolina/","name":"Maurizio Landolina","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2019/04/01/pr-interval-en-pacingmodus-en-af-incidentie-bij-tweekamer-pacemaker/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurizio-paciaroni","type":"person","url":"https://hartvaat.nl/mensen/maurizio-paciaroni/","name":"Maurizio Paciaroni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maurizio-tespili","type":"person","url":"https://hartvaat.nl/mensen/maurizio-tespili/","name":"Maurizio Tespili","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/10-jaarsfollow-up-ees-versus-bms-bij-stemi-examination/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2016/01/23/everolimus-eluting-stent-versus-bare-metal-stent-bij-stemi-5-jaarsresultaten-exa/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mauro-gasparini","type":"person","url":"https://hartvaat.nl/mensen/mauro-gasparini/","name":"Mauro Gasparini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"max-bachmann","type":"person","url":"https://hartvaat.nl/mensen/max-bachmann/","name":"Max Bachmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/02/thuisgebaseerde-hypertensiezorg-in-ruraal-zuid-afrika-gerandomiseerde-trial/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"max-nieuwdorp","type":"person","url":"https://hartvaat.nl/mensen/max-nieuwdorp/","name":"Max Nieuwdorp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/oraal-butyraat-verlaagt-bloeddruk-bij-hypertensie-rct/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2020/01/01/renale-hemodynamische-effecten-van-dapagliflozine-postglomerulaire-vasodilatatie/","published":"2020-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maxime-schleef","type":"person","url":"https://hartvaat.nl/mensen/maxime-schleef/","name":"Maxime Schleef","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/09/uf-care-trial-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-geen-significante-/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/05/09/uf-care-ultrafiltratie-bij-type-2-cardiorenaal-syndroom-mist-primair-eindpunt-in/","published":"2026-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maxime-tapponnier","type":"person","url":"https://hartvaat.nl/mensen/maxime-tapponnier/","name":"Maxime Tapponnier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/25/biodegradeerbare-versus-duurzame-polymeer-des-bij-stemi-langetermijndata/","published":"2023-11-25"},{"url":"https://hartvaat.nl/2019/10/05/biodegradeerbare-versus-duurzame-polymer-des-bij-stemi-gerandomiseerde-trial/","published":"2019-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mayank-goyal","type":"person","url":"https://hartvaat.nl/mensen/mayank-goyal/","name":"Mayank Goyal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2020/03/01/bloeddruk-en-uitkomsten-bij-acute-beroerte-trombectomie/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mazen-hanna","type":"person","url":"https://hartvaat.nl/mensen/mazen-hanna/","name":"Mazen Hanna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meechai-tessalee","type":"person","url":"https://hartvaat.nl/mensen/meechai-tessalee/","name":"Meechai Tessalee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/03/restrictief-versus-liberaal-transfusiebeleid-bij-type-1-versus-type-2-mi-reality/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meena-p-rao","type":"person","url":"https://hartvaat.nl/mensen/meena-p-rao/","name":"Meena P Rao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/14/multifacet-interventie-voor-oac-gebruik-bij-af-lancet-impact-af/","published":"2017-10-14"},{"url":"https://hartvaat.nl/2017/03/21/plotse-hartdood-bij-ischemisch-hartfalen-na-cabg-stich-resultaten/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meena-verma","type":"person","url":"https://hartvaat.nl/mensen/meena-verma/","name":"Meena Verma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meg-jardine","type":"person","url":"https://hartvaat.nl/mensen/meg-jardine/","name":"Meg Jardine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/19/vrouwen-met-ckd-krijgen-minder-vaak-ras-remmers-en-sglt2-remmers-dan-mannen/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"megan-coylewright","type":"person","url":"https://hartvaat.nl/mensen/megan-coylewright/","name":"Megan Coylewright","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"megan-m-streur","type":"person","url":"https://hartvaat.nl/mensen/megan-m-streur/","name":"Megan M Streur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"megha-kureti","type":"person","url":"https://hartvaat.nl/mensen/megha-kureti/","name":"Megha Kureti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"megha-prasad","type":"person","url":"https://hartvaat.nl/mensen/megha-prasad/","name":"Megha Prasad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/15/ultradunne-versus-conventionele-2e-generatie-des-langetermijn-meta-analyse/","published":"2021-07-15"},{"url":"https://hartvaat.nl/2020/09/07/des-versus-cabg-bij-hoofdstamlijden-mortaliteits-meta-analyse/","published":"2020-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meinrad-p-gawaz","type":"person","url":"https://hartvaat.nl/mensen/meinrad-p-gawaz/","name":"Meinrad P Gawaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2017/10/14/intracoronaire-beenmergceltransfer-na-mi-de-boost-2-gerandomiseerde-trial/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meir-j-stampfer","type":"person","url":"https://hartvaat.nl/mensen/meir-j-stampfer/","name":"Meir J Stampfer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/09/rood-vlees-en-cardiovasculaire-risicofactoren-meta-analyse-van-gerandomiseerde-t/","published":"2019-04-09"},{"url":"https://hartvaat.nl/2018/03/13/leefstijlinterventies-en-mobilisatie-van-vetstapeling-central-mri-gerandomiseerd/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melanie-freeman","type":"person","url":"https://hartvaat.nl/mensen/melanie-freeman/","name":"Melanie Freeman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melek-ozgu-ozan","type":"person","url":"https://hartvaat.nl/mensen/melek-ozgu-ozan/","name":"Melek Ozgu Ozan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melissa-burroughs","type":"person","url":"https://hartvaat.nl/mensen/melissa-burroughs/","name":"Melissa Burroughs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"melissa-k-thomas","type":"person","url":"https://hartvaat.nl/mensen/melissa-k-thomas/","name":"Melissa K Thomas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","published":"2023-08-12"},{"url":"https://hartvaat.nl/2022/11/26/triple-gip-glp-1-glucagonreceptoragonist-bij-type-2-diabetes-fase-1b/","published":"2022-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meng-zhang","type":"person","url":"https://hartvaat.nl/mensen/meng-zhang/","name":"Meng Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/apolipoproteine-e-genpolymorfismen-en-het-risico-op-coronairlijden/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2018/10/02/periprocedurele-uitkomsten-van-doac-versus-warfarine-bij-niet-valvulair-af/","published":"2018-10-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mengdan-liu","type":"person","url":"https://hartvaat.nl/mensen/mengdan-liu/","name":"Mengdan Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"menglu-ouyang","type":"person","url":"https://hartvaat.nl/mensen/menglu-ouyang/","name":"Menglu Ouyang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mengqiu-zhang","type":"person","url":"https://hartvaat.nl/mensen/mengqiu-zhang/","name":"Mengqiu Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/29/monocyt-hdl-ratio-en-risico-op-beroerte-myocardinfarct-en-mortaliteit/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2025/12/23/kwetsbaarheid-genetische-gevoeligheid-en-risico-op-abdominaal-aorta-aneurysma/","published":"2025-12-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mengyue-yu","type":"person","url":"https://hartvaat.nl/mensen/mengyue-yu/","name":"Mengyue Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"menno-v-huisman","type":"person","url":"https://hartvaat.nl/mensen/menno-v-huisman/","name":"Menno V Huisman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/23/switchen-van-vka-naar-noac-bij-fragiele-ouderen-met-af-veilig/","published":"2024-01-23"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mera-stein","type":"person","url":"https://hartvaat.nl/mensen/mera-stein/","name":"Mera Stein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meral-kayikcioglu","type":"person","url":"https://hartvaat.nl/mensen/meral-kayikcioglu/","name":"Meral Kayikcioglu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2023/10/21/lerodalcibep-bij-familiaire-hypercholesterolemie-liberate-hefh-langetermijndata/","published":"2023-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mercedes-cruz-ruiz","type":"person","url":"https://hartvaat.nl/mensen/mercedes-cruz-ruiz/","name":"Mercedes Cruz-Ruiz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"merel-van-diepen","type":"person","url":"https://hartvaat.nl/mensen/merel-van-diepen/","name":"Merel van Diepen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/21/patientgerapporteerde-uitkomsten-verbeteren-voorspelling-van-mortaliteit-bij-dia/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2022/11/22/cva-risicoscores-bij-af-vergeleken-cha2ds2-vasc-blijft-de-beste/","published":"2022-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"merete-heitmann","type":"person","url":"https://hartvaat.nl/mensen/merete-heitmann/","name":"Merete Heitmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mervyn-andiapen","type":"person","url":"https://hartvaat.nl/mensen/mervyn-andiapen/","name":"Mervyn Andiapen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"},{"url":"https://hartvaat.nl/2017/04/01/intracoronair-nitriet-onderdrukt-de-inflammatoire-respons-na-primaire-pci/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"meyer-elbaz","type":"person","url":"https://hartvaat.nl/mensen/meyer-elbaz/","name":"Meyer Elbaz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/29/cannabis-en-cardiovasculair-risico-systematische-review-en-meta-analyse/","published":"2025-10-29"},{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"micha-t-maeder","type":"person","url":"https://hartvaat.nl/mensen/micha-t-maeder/","name":"Micha T Maeder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-a-borger","type":"person","url":"https://hartvaat.nl/mensen/michael-a-borger/","name":"Michael A. Borger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/vroege-heropnames-na-chirurgische-aortaklepvervanging-beinvloeden-trial-eindpunt/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/01/01/mitralisklepherstel-bij-degeneratief-mr-met-matige-tricuspidalisinsufficientie-2/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-aschermann","type":"person","url":"https://hartvaat.nl/mensen/michael-aschermann/","name":"Michael Aschermann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-burch","type":"person","url":"https://hartvaat.nl/mensen/michael-burch/","name":"Michael Burch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-c-honigberg","type":"person","url":"https://hartvaat.nl/mensen/michael-c-honigberg/","name":"Michael C Honigberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/lp-a-verhoogt-risico-op-veneuze-trombo-embolie-bij-premenopauzale-vrouwen-en-hor/","published":"2026-04-18"},{"url":"https://hartvaat.nl/2026/02/22/genetische-voorspelling-van-lp-a-spiegels-in-diverse-populaties/","published":"2026-02-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-c-mccarthy","type":"person","url":"https://hartvaat.nl/mensen/michael-c-mccarthy/","name":"Michael C McCarthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/laroprovstat-eerste-orale-pcsk9-remmer-haalt-80-ldl-reductie-in-combinatie-met-r/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/06/03/pursuit-orale-pcsk9-remmer-voor-hypercholesterolemie-gerandomiseerde-trial/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-chou","type":"person","url":"https://hartvaat.nl/mensen/michael-chou/","name":"Michael Chou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-chrissoheris","type":"person","url":"https://hartvaat.nl/mensen/michael-chrissoheris/","name":"Michael Chrissoheris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-christ","type":"person","url":"https://hartvaat.nl/mensen/michael-christ/","name":"Michael Christ","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/grote-variatie-in-diureticabeleid-en-zeldzame-natriummeting-bij-acuut-hartfalen/","published":"2026-07-31"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-d-miedema","type":"person","url":"https://hartvaat.nl/mensen/michael-d-miedema/","name":"Michael D Miedema","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/25/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn-jacc/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2019/06/18/systematische-review-voor-de-2018-aha-acc-cholesterolrichtlijn/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-dalager-pedersen","type":"person","url":"https://hartvaat.nl/mensen/michael-dalager-pedersen/","name":"Michael Dalager-Pedersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/rsv-vaccin-vermindert-cv-hospitalisaties-bij-ouderen/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-e-bowdish","type":"person","url":"https://hartvaat.nl/mensen/michael-e-bowdish/","name":"Michael E Bowdish","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2016/05/19/frequentiecontrole-versus-ritmecontrole-bij-af-na-hartchirurgie-nejm-trial/","published":"2016-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-e-ernst","type":"person","url":"https://hartvaat.nl/mensen/michael-e-ernst/","name":"Michael E Ernst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","published":"2020-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-froeschl","type":"person","url":"https://hartvaat.nl/mensen/michael-froeschl/","name":"Michael Froeschl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"},{"url":"https://hartvaat.nl/2020/02/01/femorale-versus-radiale-toegang-bij-stemi-jama-cardiology-safari-stemi/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-furian","type":"person","url":"https://hartvaat.nl/mensen/michael-furian/","name":"Michael Furian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/11/pulmonale-hemodynamiek-op-hoogte-bij-hfpef/","published":"2025-12-11"},{"url":"https://hartvaat.nl/2017/04/14/zuurstofverrijkte-lucht-en-inspanningsprestatie-bij-precapillaire-pulmonale-hype/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-g-crowe","type":"person","url":"https://hartvaat.nl/mensen/michael-g-crowe/","name":"Michael G Crowe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-grimm","type":"person","url":"https://hartvaat.nl/mensen/michael-grimm/","name":"Michael Grimm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/ehj-overzicht-mechanische-complicaties-na-hartinfarct-zeldzaam-1-maar-acuut-leve/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2024/08/03/cardiale-shockwave-therapie-bij-cabg-verbetert-myocardfunctie/","published":"2024-08-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-gross","type":"person","url":"https://hartvaat.nl/mensen/michael-gross/","name":"Michael Gross","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-h-picard","type":"person","url":"https://hartvaat.nl/mensen/michael-h-picard/","name":"Michael H Picard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-halank","type":"person","url":"https://hartvaat.nl/mensen/michael-halank/","name":"Michael Halank","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/20/tadalafil-bij-gecombineerde-post-en-precapillaire-ph-en-hfpef/","published":"2024-08-20"},{"url":"https://hartvaat.nl/2016/01/01/inspanningstraining-verbetert-zuurstofopname-en-hemodynamiek-bij-ernstige-pulmon/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-hecht-olsen","type":"person","url":"https://hartvaat.nl/mensen/michael-hecht-olsen/","name":"Michael Hecht Olsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-helewa","type":"person","url":"https://hartvaat.nl/mensen/michael-helewa/","name":"Michael Helewa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-ackerman","type":"person","url":"https://hartvaat.nl/mensen/michael-j-ackerman/","name":"Michael J Ackerman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-parameters-voorspellen-nieuwe-hartklachten-bij-hypertrofische-cardiomyopathi/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/02/03/ryr2-mutaties-als-oorzaak-van-onverklaarde-plotse-hartdood-bij-jongeren/","published":"2026-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-louie","type":"person","url":"https://hartvaat.nl/mensen/michael-j-louie/","name":"Michael J Louie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/13/clear-outcomes-bempedoinezuur-vermindert-cv-events-bij-statine-intolerantie/","published":"2023-04-13"},{"url":"https://hartvaat.nl/2019/11/05/risicoclassificatie-volgens-de-nieuwe-acc-aha-cholesterolrichtlijn-en-stenting-u/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-r-edmonds","type":"person","url":"https://hartvaat.nl/mensen/michael-j-r-edmonds/","name":"Michael J R Edmonds","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/late-rapid-tnt-uitkomsten-0-1-uur-hs-troponine-t-bij-verdenking-acs/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2019/11/05/1-uur-troponine-t-protocol-bij-verdenking-acs-gerandomiseerde-rapid-tnt-trial/","published":"2019-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-j-rokoss","type":"person","url":"https://hartvaat.nl/mensen/michael-j-rokoss/","name":"Michael J Rokoss","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-jerosch-herold","type":"person","url":"https://hartvaat.nl/mensen/michael-jerosch-herold/","name":"Michael Jerosch-Herold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/08/stop-ca-atorvastatine-beschermt-tegen-antracycline-cardiotoxiciteit/","published":"2023-08-08"},{"url":"https://hartvaat.nl/2016/08/02/omega-3-vetzuren-en-linkerkamerremodellering-na-acuut-mi-omega-remodel-trial/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-k-hansen","type":"person","url":"https://hartvaat.nl/mensen/michael-k-hansen/","name":"Michael K Hansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2020/11/03/canagliflozine-en-nt-probnp-implicaties-voor-cv-risicoreductie/","published":"2020-11-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-lay","type":"person","url":"https://hartvaat.nl/mensen/michael-lay/","name":"Michael Lay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-lehrke","type":"person","url":"https://hartvaat.nl/mensen/michael-lehrke/","name":"Michael Lehrke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2022/08/01/empagliflozine-vermindert-nierletselmarkers-bij-acuut-hartfalen/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-lewis","type":"person","url":"https://hartvaat.nl/mensen/michael-lewis/","name":"Michael Lewis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2018/11/01/nmarq-pvac-en-thoracoscopische-ablatie-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-melino","type":"person","url":"https://hartvaat.nl/mensen/michael-melino/","name":"Michael Melino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/01/determinanten-van-linkeratriumtrombi-bij-geplande-cardioversie-ensure-af/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2016/10/22/edoxaban-versus-enoxaparine-warfarine-bij-cardioversie-van-af-ensure-af-trial/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-motro","type":"person","url":"https://hartvaat.nl/mensen/michael-motro/","name":"Michael Motro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/17/iv-ijzercarboxymaltose-en-qol-bij-ijzerdeficient-acuut-hf-affirm-ahf/","published":"2021-08-17"},{"url":"https://hartvaat.nl/2020/12/12/ijzercarboxymaltose-bij-ijzerdeficientie-na-ontslag-voor-acuut-hf-lancet-affirm-/","published":"2020-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-p-fischbein","type":"person","url":"https://hartvaat.nl/mensen/michael-p-fischbein/","name":"Michael P Fischbein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/chirurgisch-unroofing-van-myocardiale-brug-verbetert-angina-klachten-langdurig-m/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2020/03/24/screening-en-profylactisch-amiodaron-vermindert-postoperatief-af/","published":"2020-03-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-p-pignone","type":"person","url":"https://hartvaat.nl/mensen/michael-p-pignone/","name":"Michael P Pignone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-ragosta","type":"person","url":"https://hartvaat.nl/mensen/michael-ragosta/","name":"Michael Ragosta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/ernstige-bloeding-en-mortaliteit-na-revascularisatie-van-linker-hoofdstam/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2018/08/14/hoofdstamrevascularisatie-bij-ckd-pci-versus-cabg-in-de-excel-trial/","published":"2018-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-s-kiernan","type":"person","url":"https://hartvaat.nl/mensen/michael-s-kiernan/","name":"Michael S Kiernan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/01/sacubitril-valsartan-bij-gevorderd-hfref-jama-cardiology-life-gerandomiseerde-tr/","published":"2022-01-01"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-stumvoll","type":"person","url":"https://hartvaat.nl/mensen/michael-stumvoll/","name":"Michael Stumvoll","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/30/glp-1-glucagon-duale-agonist-bij-obesitas-met-diabetes-type-2-lancet-fase-2/","published":"2018-06-30"},{"url":"https://hartvaat.nl/2018/03/13/leefstijlinterventies-en-mobilisatie-van-vetstapeling-central-mri-gerandomiseerd/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-v-holmes","type":"person","url":"https://hartvaat.nl/mensen/michael-v-holmes/","name":"Michael V Holmes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2018/01/01/genetische-associatie-van-lipiden-en-lipide-doelwitten-met-abdominaal-aorta-aneu/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-y-tsai","type":"person","url":"https://hartvaat.nl/mensen/michael-y-tsai/","name":"Michael Y Tsai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2018/03/27/hdl-subspecies-met-apoliproteine-c-iii-en-coronairlijden-vier-cohorten/","published":"2018-03-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michal-a-elovitz","type":"person","url":"https://hartvaat.nl/mensen/michal-a-elovitz/","name":"Michal A Elovitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/01/digitale-gamificatie-interventie-verhoogt-lichaamsbeweging-na-hypertensieve-zwan/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/05/05/furosemide-voor-versneld-bloeddrukherstel-postpartum-bij-hypertensieve-zwangersc/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michal-m-farkowski","type":"person","url":"https://hartvaat.nl/mensen/michal-m-farkowski/","name":"Michal M Farkowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/atriumfibrilleren-bij-kankerpatienten-de-esc-richtlijn-2025-in-de-praktijk/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2017/10/01/antazoline-voor-snelle-cardioversie-van-paroxysmaal-af-de-anpaf-studie/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michal-mokry","type":"person","url":"https://hartvaat.nl/mensen/michal-mokry/","name":"Michal Mokry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/macrofaagbelasting-in-carotisplaque-voorspelt-cardiovasculaire-events-na-endarte/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2026/02/13/genetisch-bepaalde-afkomst-en-morfologische-en-moleculaire-kenmerken-van-carotis/","published":"2026-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michal-siranec","type":"person","url":"https://hartvaat.nl/mensen/michal-siranec/","name":"Michal Siranec","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/16/watchful-leefstijl-wandelinterventie-bij-hfref/","published":"2024-01-16"},{"url":"https://hartvaat.nl/2020/10/01/accelerometrie-bij-cv-patienten-systematische-review-met-praktische-aanbevelinge/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"micha-tkaczyszyn","type":"person","url":"https://hartvaat.nl/mensen/micha-tkaczyszyn/","name":"Michał Tkaczyszyn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/cardiogene-shock-bij-myocardinfarct-resultaten-van-het-shock-pol-register/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2025/12/01/gelijktijdige-griep-en-rsv-vaccinatie-bij-hoogrisico-hartfalenpatienten/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michel-noutsias","type":"person","url":"https://hartvaat.nl/mensen/michel-noutsias/","name":"Michel Noutsias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-brignole","type":"person","url":"https://hartvaat.nl/mensen/michele-brignole/","name":"Michele Brignole","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/07/av-junctieablatie-plus-crt-bij-permanent-af-met-smal-qrs-apaf-crt-mortaliteitsan/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2018/12/01/av-junctieablatie-plus-crt-bij-permanent-af-gerandomiseerde-trial/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-correale","type":"person","url":"https://hartvaat.nl/mensen/michele-correale/","name":"Michele Correale","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/langetermijneffecten-van-sacubitril-valsartan-bij-hfref-italiaanse-real-world-st/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-magnocavallo","type":"person","url":"https://hartvaat.nl/mensen/michele-magnocavallo/","name":"Michele Magnocavallo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-morosato","type":"person","url":"https://hartvaat.nl/mensen/michele-morosato/","name":"Michele Morosato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/pandora-register-supra-versus-intra-annulaire-kleppen-bij-tavr-in-tavr/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michele-rossi","type":"person","url":"https://hartvaat.nl/mensen/michele-rossi/","name":"Michele Rossi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/prognose-takotsubo-syndroom-versus-hartfalen-op-de-lange-termijn/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-a-hladunewich","type":"person","url":"https://hartvaat.nl/mensen/michelle-a-hladunewich/","name":"Michelle A. Hladunewich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/13/nierbeschermende-medicatie-tijdens-borstvoeding/","published":"2026-02-13"},{"url":"https://hartvaat.nl/2025/12/22/sefaxersen-bij-iga-nefropathie-fase-2-trial-van-complementfactor-b-remming/","published":"2025-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-c-odden","type":"person","url":"https://hartvaat.nl/mensen/michelle-c-odden/","name":"Michelle C Odden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/02/09/intensieve-versus-standaard-bloeddrukcontrole-en-nierfunctie-na-lacunair-herseni/","published":"2016-02-09"},{"url":"https://hartvaat.nl/2016/01/01/bereikte-bloeddruk-en-uitkomsten-in-de-sps3-trial-bij-lacunaire-herseninfarcten/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-garcia","type":"person","url":"https://hartvaat.nl/mensen/michelle-garcia/","name":"Michelle Garcia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/03/rosuvastatine-versus-voedingssupplementen-voor-lipidenmanagement/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/12/08/hoog-dosis-omega-3-versus-maisolie-bij-hoog-cv-risico-jama-strength/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-gurvitz","type":"person","url":"https://hartvaat.nl/mensen/michelle-gurvitz/","name":"Michelle Gurvitz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/nieuwe-acc-aha-richtlijn-2025-voor-volwassenen-met-aangeboren-hartafwijkingen/","published":"2026-03-11"},{"url":"https://hartvaat.nl/2025/12/18/2025-acc-aha-richtlijn-voor-behandeling-van-volwassenen-met-aangeboren-hartafwij/","published":"2025-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-kittleson","type":"person","url":"https://hartvaat.nl/mensen/michelle-kittleson/","name":"Michelle Kittleson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","published":"2026-08-03"},{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-m-estrella","type":"person","url":"https://hartvaat.nl/mensen/michelle-m-estrella/","name":"Michelle M Estrella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/13/tubulaire-nierschade-hangt-samen-met-natriumretentie-en-diureticarespons-bij-acu/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michelle-michels","type":"person","url":"https://hartvaat.nl/mensen/michelle-michels/","name":"Michelle Michels","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/epicardiaal-vetweefsel-voorspelt-aritmieen-en-hartfalen-events-bij-genotype-posi/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2022/10/01/bloedbiomerkers-voor-prognose-bij-hypertrofische-cardiomyopathie-meta-analyse/","published":"2022-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michiel-j-blans","type":"person","url":"https://hartvaat.nl/mensen/michiel-j-blans/","name":"Michiel J Blans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michihiro-satoh","type":"person","url":"https://hartvaat.nl/mensen/michihiro-satoh/","name":"Michihiro Satoh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2019/01/01/levenslangrisico-op-cva-en-coronairlijden-naar-bloeddrukniveau-epoch-japan/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michinari-hieda","type":"person","url":"https://hartvaat.nl/mensen/michinari-hieda/","name":"Michinari Hieda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/19/synchronisatie-van-voetstap-en-hartfase-bij-crt-patienten/","published":"2023-12-19"},{"url":"https://hartvaat.nl/2021/09/21/1-jaar-inspanningstraining-keert-lv-stijfheid-om-bij-stadium-b-hf/","published":"2021-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miguel-lorenzo","type":"person","url":"https://hartvaat.nl/mensen/miguel-lorenzo/","name":"Miguel Lorenzo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/bio-impedantie-voor-vochtstatusbepaling-en-prognose-bij-chronisch-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miguel-m-fernandes-silva","type":"person","url":"https://hartvaat.nl/mensen/miguel-m-fernandes-silva/","name":"Miguel M Fernandes-Silva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miguel-o-d-aguiar","type":"person","url":"https://hartvaat.nl/mensen/miguel-o-d-aguiar/","name":"Miguel O D Aguiar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miguel-viscusi","type":"person","url":"https://hartvaat.nl/mensen/miguel-viscusi/","name":"Miguel Viscusi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miha-mrak","type":"person","url":"https://hartvaat.nl/mensen/miha-mrak/","name":"Miha Mrak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/csp-sync-geleidingssysteempacing-versus-biventriculaire-pacing-voor-crt-rct/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/05/02/preventieve-substraatablatie-vermindert-icd-interventies-bij-ischemische-cmp/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mika-kahonen","type":"person","url":"https://hartvaat.nl/mensen/mika-kahonen/","name":"Mika Kähönen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikael-kjr-poulsen","type":"person","url":"https://hartvaat.nl/mensen/mikael-kjr-poulsen/","name":"Mikael Kjær Poulsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikkel-hougaard","type":"person","url":"https://hartvaat.nl/mensen/mikkel-hougaard/","name":"Mikkel Hougaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/15/sort-out-xi-biomatrix-versus-duale-therapie-sirolimus-eluting-stent-bij-pci/","published":"2025-07-15"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mikko-minkkinen","type":"person","url":"https://hartvaat.nl/mensen/mikko-minkkinen/","name":"Mikko Minkkinen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2024/10/01/pulse-mi-prehospitale-puls-dosis-glucocorticoid-bij-stemi/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milensu-shanyinde","type":"person","url":"https://hartvaat.nl/mensen/milensu-shanyinde/","name":"Milensu Shanyinde","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/28/pop-ht-zelfmanagement-van-bloeddruk-na-hypertensieve-zwangerschap-jama-rct/","published":"2023-11-28"},{"url":"https://hartvaat.nl/2016/02/09/sms-berichten-ter-ondersteuning-van-therapietrouw-bij-hoge-bloeddruk-de-star-tri/","published":"2016-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miles-d-witham","type":"person","url":"https://hartvaat.nl/mensen/miles-d-witham/","name":"Miles D Witham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/04/02/inspanningsrevalidatie-bij-hf-ipd-meta-analyse-van-inspanningscapaciteit-en-qol/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"milosz-j-jaguszewski","type":"person","url":"https://hartvaat.nl/mensen/milosz-j-jaguszewski/","name":"Milosz J Jaguszewski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/01/milrinone-versus-dobutamine-bij-hartfalen-meta-analyse/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miloud-cherbi","type":"person","url":"https://hartvaat.nl/mensen/miloud-cherbi/","name":"Miloud Cherbi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/effect-van-mavacamten-op-risicoscores-voor-plotse-hartdood-bij-hypertrofische-ca/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/07/01/ventriculaire-aritmieen-na-lvad-implantatie-meta-analyse/","published":"2025-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-gao","type":"person","url":"https://hartvaat.nl/mensen/min-gao/","name":"Min Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/14/depressietrajecten-bij-hfpef-impact-op-uitkomsten/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2017/12/19/chirurgische-versus-percutane-revascularisatie-bij-diabetes-met-acs/","published":"2017-12-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-liang","type":"person","url":"https://hartvaat.nl/mensen/min-liang/","name":"Min Liang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/21/body-roundness-index-en-mortaliteit-bij-hemodialysepatienten/","published":"2026-01-21"},{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-liu","type":"person","url":"https://hartvaat.nl/mensen/min-liu/","name":"Min Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/22/bloeddrukcontrole-bij-hypertensie-in-gezondheidscentra-in-shenzhen/","published":"2026-02-22"},{"url":"https://hartvaat.nl/2026/02/13/mydgf-beschermt-de-endotheelfunctie-bij-hypertensie/","published":"2026-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-soo-cho","type":"person","url":"https://hartvaat.nl/mensen/min-soo-cho/","name":"Min Soo Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"min-seok-kim","type":"person","url":"https://hartvaat.nl/mensen/min-seok-kim/","name":"Min-Seok Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/11/effort-ertugliflozine-bij-functionele-mitralisinsufficientie-en-hartfalen/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2019/03/12/arni-bij-functionele-mitralisklepinsufficientie/","published":"2019-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mina-madan","type":"person","url":"https://hartvaat.nl/mensen/mina-madan/","name":"Mina Madan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/complete-revascularisatie-bij-stemi-verbetert-angina-gerelateerde-kwaliteit-van-/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2016/01/05/varenicline-voor-stoppen-met-roken-bij-patienten-opgenomen-met-acuut-coronair-sy/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mina-nakawuka-ssali","type":"person","url":"https://hartvaat.nl/mensen/mina-nakawuka-ssali/","name":"Mina Nakawuka Ssali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mingfang-li","type":"person","url":"https://hartvaat.nl/mensen/mingfang-li/","name":"Mingfang Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/07/aanvullende-substraatmodificatie-bij-persisterend-af-met-low-voltage-gebieden/","published":"2025-05-07"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"minggao-shi","type":"person","url":"https://hartvaat.nl/mensen/minggao-shi/","name":"Minggao Shi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/05/14/bmi-en-uitkomsten-bij-af-behandeld-met-edoxaban-of-warfarine-engage-af-timi-48/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mingyuan-shao","type":"person","url":"https://hartvaat.nl/mensen/mingyuan-shao/","name":"Mingyuan Shao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/28/cryoballonablatie-als-initiele-therapie-voor-af-nejm-early-af/","published":"2021-01-28"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"minyoul-baik","type":"person","url":"https://hartvaat.nl/mensen/minyoul-baik/","name":"Minyoul Baik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/22/ldl-c-reductie-50-verlaagt-risico-op-secundaire-cardiovasculaire-gebeurtenissen-/","published":"2026-08-27"},{"url":"https://hartvaat.nl/2023/09/05/optimal-bp-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-jama/","published":"2023-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"minzhou-zhang","type":"person","url":"https://hartvaat.nl/mensen/minzhou-zhang/","name":"Minzhou Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"miodrag-ostojic","type":"person","url":"https://hartvaat.nl/mensen/miodrag-ostojic/","name":"Miodrag Ostojic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/21/comfortable-ami-5-jaarsuitkomsten-biolimus-versus-bare-metal-stent/","published":"2019-06-21"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mira-katan","type":"person","url":"https://hartvaat.nl/mensen/mira-katan/","name":"Mira Katan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/24/systemische-inflammatie-en-recidief-na-een-af-gerelateerd-herseninfarct/","published":"2026-03-24"},{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mirela-hendel","type":"person","url":"https://hartvaat.nl/mensen/mirela-hendel/","name":"Mirela Hendel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/mortaliteit-en-hospitalisaties-bij-hfpef-versus-hfref-vergelijkende-analyse/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/10/01/piek-vo2-en-prognose-bij-hartfalen-meta-analyse/","published":"2025-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"misa-fister","type":"person","url":"https://hartvaat.nl/mensen/misa-fister/","name":"Misa Fister","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/30/heparin-stemi-prehospitale-heparine-vergroot-vroege-doorstroming-bij-stemi-zonde/","published":"2026-04-22"},{"url":"https://hartvaat.nl/2016/12/20/ticagrelor-versus-clopidogrel-bij-comateuze-overlevenden-van-reanimatie-met-pci/","published":"2016-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"misato-chimura","type":"person","url":"https://hartvaat.nl/mensen/misato-chimura/","name":"Misato Chimura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2025/01/01/finearts-hf-finerenon-gelijk-effectief-bij-vrouwen-en-mannen-met-hfpef/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"misha-eliasziw","type":"person","url":"https://hartvaat.nl/mensen/misha-eliasziw/","name":"Misha Eliasziw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/26/hepa-luchtzuivering-en-bloeddruk-pragmatische-cross-over-trial/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2021/03/03/verminderde-verkeersgerelateerde-luchtvervuiling-en-bloeddruk-gerandomiseerde-cr/","published":"2021-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"moffat-j-nyirenda","type":"person","url":"https://hartvaat.nl/mensen/moffat-j-nyirenda/","name":"Moffat J Nyirenda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohamad-rashid","type":"person","url":"https://hartvaat.nl/mensen/mohamad-rashid/","name":"Mohamad Rashid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/04/05/bloeddrukverlaging-bij-kappersbezoek-nejm-clustergerandomiseerde-trial/","published":"2018-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohamed-rahouma","type":"person","url":"https://hartvaat.nl/mensen/mohamed-rahouma/","name":"Mohamed Rahouma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohammed-al-omran","type":"person","url":"https://hartvaat.nl/mensen/mohammed-al-omran/","name":"Mohammed Al-Omran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"},{"url":"https://hartvaat.nl/2018/01/23/empagliflozine-bij-diabetes-type-2-met-perifeer-vaatlijden-empa-reg-outcome/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohammed-nejjari","type":"person","url":"https://hartvaat.nl/mensen/mohammed-nejjari/","name":"Mohammed Nejjari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohammed-qintar","type":"person","url":"https://hartvaat.nl/mensen/mohammed-qintar/","name":"Mohammed Qintar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/empagliflozine-en-pulmonalisdruk-bij-hf-embrace-hf/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/22/individualisering-van-revascularisatiestrategie-bij-diabetes-met-multivatenlijde/","published":"2019-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohammed-shurrab","type":"person","url":"https://hartvaat.nl/mensen/mohammed-shurrab/","name":"Mohammed Shurrab","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/13/palliatieve-zorginterventies-bij-hartfalen-jama-associatie-met-qol-en-symptoomla/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2017/02/01/reductie-van-onnodige-ventriculaire-pacing-en-klinische-uitkomsten-bij-behouden-/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohit-k-turagam","type":"person","url":"https://hartvaat.nl/mensen/mohit-k-turagam/","name":"Mohit K Turagam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/katheterablatie-of-antiaritmica-als-eerstelijnstherapie-bij-af-jama-cardiology-m/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2020/12/08/laa-sluiting-versus-oac-bij-af-meta-analyse-van-gerandomiseerde-trials/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mohsen-mohandes","type":"person","url":"https://hartvaat.nl/mensen/mohsen-mohandes/","name":"Mohsen Mohandes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"moloy-das","type":"person","url":"https://hartvaat.nl/mensen/moloy-das/","name":"Moloy Das","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2017/05/01/ablatie-index-als-marker-voor-ablatielaesiekwaliteit-voorspelling-van-pv-reconne/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mona-albanna","type":"person","url":"https://hartvaat.nl/mensen/mona-albanna/","name":"Mona AlBanna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mona-lichtblau","type":"person","url":"https://hartvaat.nl/mensen/mona-lichtblau/","name":"Mona Lichtblau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/11/pulmonale-hemodynamiek-op-hoogte-bij-hfpef/","published":"2025-12-11"},{"url":"https://hartvaat.nl/2016/01/01/inspanningstraining-verbetert-zuurstofopname-en-hemodynamiek-bij-ernstige-pulmon/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monica-fontana","type":"person","url":"https://hartvaat.nl/mensen/monica-fontana/","name":"Monica Fontana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monica-leyva","type":"person","url":"https://hartvaat.nl/mensen/monica-leyva/","name":"Monica Leyva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monica-r-shah","type":"person","url":"https://hartvaat.nl/mensen/monica-r-shah/","name":"Monica R Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monica-taljaard","type":"person","url":"https://hartvaat.nl/mensen/monica-taljaard/","name":"Monica Taljaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"},{"url":"https://hartvaat.nl/2020/02/01/elektrische-versus-farmacologische-cardioversie-bij-acuut-af-op-de-seh-lancet-ra/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monica-tiberi","type":"person","url":"https://hartvaat.nl/mensen/monica-tiberi/","name":"Monica Tiberi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/cardiale-screening-van-jonge-sporters-eerste-eapc-aepc-consensus-voor-kinderen/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2016/08/01/2016-europese-richtlijnen-voor-cardiovasculaire-preventie-in-de-klinische-prakti/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monika-kellerer","type":"person","url":"https://hartvaat.nl/mensen/monika-kellerer/","name":"Monika Kellerer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"monika-przewlocka-kosmala","type":"person","url":"https://hartvaat.nl/mensen/monika-przewlocka-kosmala/","name":"Monika Przewlocka-Kosmala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/lv-longitudinale-systolische-functieparameters-als-voorspellers-bij-hfpef/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2016/10/25/aldosteronantagonisme-en-inspanningstolerantie-bij-hfpef/","published":"2016-10-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"moo-hyun-kim","type":"person","url":"https://hartvaat.nl/mensen/moo-hyun-kim/","name":"Moo Hyun Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"moody-makar","type":"person","url":"https://hartvaat.nl/mensen/moody-makar/","name":"Moody Makar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"moon-hyoung-lee","type":"person","url":"https://hartvaat.nl/mensen/moon-hyoung-lee/","name":"Moon-Hyoung Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/03/ct-gestuurde-atriale-wanddiktemapping-bij-cryoballon-pvi/","published":"2024-12-03"},{"url":"https://hartvaat.nl/2019/05/14/wanneer-doac-stoppen-voor-af-ablatie-multicenter-analyse/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morio-shoda","type":"person","url":"https://hartvaat.nl/mensen/morio-shoda/","name":"Morio Shoda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/upgrade-van-draadloze-pacemaker-van-enkelvoudig-naar-tweekamersysteem/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2016/12/27/hotballoon-pulmonaalvene-ablatie-bij-paroxysmaal-af-japanse-multicenter-trial/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morten-bottcher","type":"person","url":"https://hartvaat.nl/mensen/morten-bottcher/","name":"Morten Böttcher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/cagrisema-verlaagt-bloeddruk-bij-overgewicht-obesitas-redefine-1/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morten-juhl","type":"person","url":"https://hartvaat.nl/mensen/morten-juhl/","name":"Morten Juhl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/science-ii-mesenchymale-stamcellen-bij-niet-ischemisch-hartfalen-negatieve-trial/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/04/01/mesenchymale-stamcellen-bij-ischemisch-hartfalen-deense-fase-ii-trial/","published":"2023-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mouin-s-abdallah","type":"person","url":"https://hartvaat.nl/mensen/mouin-s-abdallah/","name":"Mouin S Abdallah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/25/2022-acc-aha-datadefinities-voor-pijn-op-de-borst-en-acuut-myocardinfarct/","published":"2022-10-25"},{"url":"https://hartvaat.nl/2017/04/25/kwaliteit-van-leven-na-chirurgie-of-des-bij-drienvaten-of-hoofdstamlijden/","published":"2017-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mpiko-ntsekhe","type":"person","url":"https://hartvaat.nl/mensen/mpiko-ntsekhe/","name":"Mpiko Ntsekhe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/05/paradise-mi-sacubitril-valsartan-bij-stemi-versus-nstemi/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2022/09/15/invictus-rivaroxaban-versus-warfarine-bij-reumatische-hartziekte-en-af/","published":"2022-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mucio-t-oliveira","type":"person","url":"https://hartvaat.nl/mensen/mucio-t-oliveira/","name":"Mucio T Oliveira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mucio-tavares-de-oliveira-junior","type":"person","url":"https://hartvaat.nl/mensen/mucio-tavares-de-oliveira-junior/","name":"Mucio Tavares de Oliveira Junior","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"muhammad-jaffar","type":"person","url":"https://hartvaat.nl/mensen/muhammad-jaffar/","name":"Muhammad Jaffar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"muhammad-mohsin","type":"person","url":"https://hartvaat.nl/mensen/muhammad-mohsin/","name":"Muhammad Mohsin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/n-of-1-trial-voor-anginaverificatie-voor-pci/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"muhammad-munawar","type":"person","url":"https://hartvaat.nl/mensen/muhammad-munawar/","name":"Muhammad Munawar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/07/dcb-voor-zijtak-bij-provisionale-stenting-gerandomiseerde-trial/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"muhammed-gercek","type":"person","url":"https://hartvaat.nl/mensen/muhammed-gercek/","name":"Muhammed Gerçek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/gecombineerde-mitraal-en-tricuspidalis-teer-verbetert-overleving-bij-multivalvul/","published":"2026-05-07"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mulham-ali","type":"person","url":"https://hartvaat.nl/mensen/mulham-ali/","name":"Mulham Ali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"murat-sezer","type":"person","url":"https://hartvaat.nl/mensen/murat-sezer/","name":"Murat Sezer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"murillo-o-antunes","type":"person","url":"https://hartvaat.nl/mensen/murillo-o-antunes/","name":"Murillo O Antunes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"},{"url":"https://hartvaat.nl/2025/03/18/natriumzirconiumcyclosilicaat-voor-spironolacton-optitratie-na-hf-gerandomiseerd/","published":"2025-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mushood-ahmed","type":"person","url":"https://hartvaat.nl/mensen/mushood-ahmed/","name":"Mushood Ahmed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/intraveneus-ijzer-bij-hartfalen-met-ijzertekort-meta-analyse-met-trial-sequentie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/01/iv-ijzer-bij-hartfalen-en-ijzerdeficientie-geactualiseerde-meta-analyse-van-rct-/","published":"2025-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mustafa-i-ahmed","type":"person","url":"https://hartvaat.nl/mensen/mustafa-i-ahmed/","name":"Mustafa I Ahmed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mustafa-ilhan","type":"person","url":"https://hartvaat.nl/mensen/mustafa-ilhan/","name":"Mustafa Ilhan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mustafa-toma","type":"person","url":"https://hartvaat.nl/mensen/mustafa-toma/","name":"Mustafa Toma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/off-label-dosering-van-sacubitril-valsartan-wijdverspreid-in-de-praktijk/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2022/04/09/natriumreductie-100-mmol-bij-hartfalen-lancet-sodium-hf/","published":"2022-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mustafa-wali","type":"person","url":"https://hartvaat.nl/mensen/mustafa-wali/","name":"Mustafa Wali","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/13/laaggedoseerd-ticagrelor-versus-standaard-clopidogrel-bij-diabetes-farmacodynami/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/02/cangrelor-en-gemalen-ticagrelor-bij-stemi-met-primaire-pci/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mylinh-duong","type":"person","url":"https://hartvaat.nl/mensen/mylinh-duong/","name":"MyLinh Duong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/05/13/wereldwijde-hf-registry-fev1-is-een-onafhankelijke-prognostische-factor-pleidooi/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"myra-tilney","type":"person","url":"https://hartvaat.nl/mensen/myra-tilney/","name":"Myra Tilney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"matyas-szigeti","type":"person","url":"https://hartvaat.nl/mensen/matyas-szigeti/","name":"Mátyás Szigeti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"n-bryce-robinson","type":"person","url":"https://hartvaat.nl/mensen/n-bryce-robinson/","name":"N Bryce Robinson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/28/sekseverschillen-na-cabg-gepoolde-ipd-analyse/","published":"2021-12-28"},{"url":"https://hartvaat.nl/2021/12/04/posterieure-pericardiotomie-ter-preventie-van-af-na-hartchirurgie-lancet-palacs/","published":"2021-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"n-s","type":"person","url":"https://hartvaat.nl/mensen/n-s/","name":"N. S.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/20/virtuele-afdeling-met-thuismonitoring-is-veilig-voor-patienten-die-wachten-op-sp/","published":"2026-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadarajah-kangaharan","type":"person","url":"https://hartvaat.nl/mensen/nadarajah-kangaharan/","name":"Nadarajah Kangaharan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadia-a-khan","type":"person","url":"https://hartvaat.nl/mensen/nadia-a-khan/","name":"Nadia A Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/2020-ish-mondiale-hypertensie-praktijkrichtlijnen/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/05/01/verlaging-van-diastolische-druk-bij-patienten-met-en-zonder-cardiovasculaire-zie/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadia-n-ahmad","type":"person","url":"https://hartvaat.nl/mensen/nadia-n-ahmad/","name":"Nadia N Ahmad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/06/orforglipron-voor-obesitasbehandeling-nejm-fase-3/","published":"2025-11-06"},{"url":"https://hartvaat.nl/2024/09/16/tirzepatide-en-bloeddrukverlaging-surmount-1-gestratificeerde-analyse/","published":"2024-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadia-redmond","type":"person","url":"https://hartvaat.nl/mensen/nadia-redmond/","name":"Nadia Redmond","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/18/uspstf-evidence-review-lipidescreening-bij-kinderen-geactualiseerd/","published":"2023-07-18"},{"url":"https://hartvaat.nl/2020/11/24/gedragscounseling-voor-gezond-dieet-en-beweging-bij-cv-risico-jama-uspstf/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadira-hamid","type":"person","url":"https://hartvaat.nl/mensen/nadira-hamid/","name":"Nadira Hamid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nadjib-hammoudi","type":"person","url":"https://hartvaat.nl/mensen/nadjib-hammoudi/","name":"Nadjib Hammoudi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2016/01/21/stoppen-of-doorgaan-met-clopidogrel-12-maanden-na-drug-eluting-stent-optidual-tr/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nagaraja-moorthy","type":"person","url":"https://hartvaat.nl/mensen/nagaraja-moorthy/","name":"Nagaraja Moorthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/19/ischemia-impact-van-complete-revascularisatie-op-uitkomsten/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naji-younes","type":"person","url":"https://hartvaat.nl/mensen/naji-younes/","name":"Naji Younes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/26/grade-cv-uitkomsten-van-glucoseverlagende-middelen-bij-type-2-diabetes/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2022/09/22/grade-vergelijking-glucoseverlagende-middelen-op-microvasculaire-en-cv-uitkomste/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"namsik-chung","type":"person","url":"https://hartvaat.nl/mensen/namsik-chung/","name":"Namsik Chung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/edoxaban-versus-warfarine-naar-gemiddelde-bloeddruk-bij-af-met-hypertensie/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nan-chen","type":"person","url":"https://hartvaat.nl/mensen/nan-chen/","name":"Nan Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nan-zhang","type":"person","url":"https://hartvaat.nl/mensen/nan-zhang/","name":"Nan Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/15/3d-ct-fluoroscopie-fusie-maakt-laac-efficienter-minder-contrast-minder-straling-/","published":"2026-07-01"},{"url":"https://hartvaat.nl/2022/01/04/sglt2-remmers-en-plotse-hartdood-ventriculaire-aritmie-meta-analyse/","published":"2022-01-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nancy-houston-miller","type":"person","url":"https://hartvaat.nl/mensen/nancy-houston-miller/","name":"Nancy Houston-Miller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/03/natriuretisch-peptiderespons-en-uitkomsten-bij-chronisch-hfref/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2017/08/22/natriuretisch-peptide-geleide-therapie-bij-hoogrisico-hartfalen-jama-guide-it/","published":"2017-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nancy-l-geller","type":"person","url":"https://hartvaat.nl/mensen/nancy-l-geller/","name":"Nancy L Geller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/12/behandeling-van-milde-chronische-hypertensie-in-de-zwangerschap-nejm-chap/","published":"2022-05-12"},{"url":"https://hartvaat.nl/2016/01/28/mitralisklepchirurgie-bij-ernstige-ischemische-mitralisklepinsufficientie-2-jaar/","published":"2016-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nancy-mccall","type":"person","url":"https://hartvaat.nl/mensen/nancy-mccall/","name":"Nancy McCall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/17/million-hearts-betaald-cv-risicomanagement-vermindert-mi-en-cva-jama-rct/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/09/01/million-hearts-cv-risicoreductiemodel-en-medicatie-initiatie-jama-cardiology/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nancy-woolard","type":"person","url":"https://hartvaat.nl/mensen/nancy-woolard/","name":"Nancy Woolard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nandita-kaza","type":"person","url":"https://hartvaat.nl/mensen/nandita-kaza/","name":"Nandita Kaza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/30/upgrade-van-rv-pacemaker-naar-crt-of-geleidingssysteempacing-meta-analyse/","published":"2023-03-30"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naohiko-takahashi","type":"person","url":"https://hartvaat.nl/mensen/naohiko-takahashi/","name":"Naohiko Takahashi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/voedingsstatus-voorspelt-ventriculaire-ritmestoornissen-bij-gevorderd-hartfalen/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naoki-watanabe","type":"person","url":"https://hartvaat.nl/mensen/naoki-watanabe/","name":"Naoki Watanabe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naotake-yanagisawa","type":"person","url":"https://hartvaat.nl/mensen/naotake-yanagisawa/","name":"Naotake Yanagisawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2022/12/01/daprodustat-bij-anemie-en-hartfalen-met-ckd-gerandomiseerde-studie/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"narayana-prasad","type":"person","url":"https://hartvaat.nl/mensen/narayana-prasad/","name":"Narayana Prasad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/04/paradise-mi-sacubitril-valsartan-versus-ramipril-na-acuut-mi-echocardiografie/","published":"2022-10-04"},{"url":"https://hartvaat.nl/2019/12/10/echocardiografische-kenmerken-bij-hfpef/","published":"2019-12-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"narendra-d-lalwani","type":"person","url":"https://hartvaat.nl/mensen/narendra-d-lalwani/","name":"Narendra D Lalwani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/12/bempedoinezuur-toegevoegd-aan-statines-bij-hoog-cv-risico-jama-clear-harmony/","published":"2019-11-12"},{"url":"https://hartvaat.nl/2019/03/14/bempedoinezuur-voor-ldl-verlaging-nejm-veiligheid-en-werkzaamheid/","published":"2019-03-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nariman-sepehrvand","type":"person","url":"https://hartvaat.nl/mensen/nariman-sepehrvand/","name":"Nariman Sepehrvand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/hoog-versus-laag-zuurstof-bij-acuut-hartfalen-hilo-hf-pilot/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/10/01/zuurstof-bij-verdenking-acuut-mi-meta-analyse-van-gerandomiseerde-trials/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natale-daniele-brunetti","type":"person","url":"https://hartvaat.nl/mensen/natale-daniele-brunetti/","name":"Natale Daniele Brunetti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2021/08/01/geschiktheid-van-poliklinische-chronische-hf-patienten-voor-sglt2-remmers/","published":"2021-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natalia-alencar-de-pinho","type":"person","url":"https://hartvaat.nl/mensen/natalia-alencar-de-pinho/","name":"Natalia Alencar de Pinho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/02/discordantie-creatinine-versus-cystatine-c-egfr-en-klinische-uitkomsten-meta-ana/","published":"2025-12-02"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natalia-zaozerska","type":"person","url":"https://hartvaat.nl/mensen/natalia-zaozerska/","name":"Natalia Zaozerska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/25/dapagliflozine-en-perifeer-arterieel-vaatlijden-bij-hartfalen-dapa-hf-deliver-me/","published":"2023-06-25"},{"url":"https://hartvaat.nl/2022/09/22/deliver-dapagliflozine-effectief-bij-hfmref-en-hfpef/","published":"2022-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natalie-dayan","type":"person","url":"https://hartvaat.nl/mensen/natalie-dayan/","name":"Natalie Dayan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/05/cardiovasculair-risico-na-fertiliteitstherapie-systematische-review-en-meta-anal/","published":"2017-09-05"},{"url":"https://hartvaat.nl/2016/12/01/vasculaire-disfunctiemarkers-na-hypertensieve-zwangerschapsaandoeningen-meta-ana/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natan-m-bornstein","type":"person","url":"https://hartvaat.nl/mensen/natan-m-bornstein/","name":"Natan M Bornstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natasza-gilis-malinowska","type":"person","url":"https://hartvaat.nl/mensen/natasza-gilis-malinowska/","name":"Natasza Gilis-Malinowska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nathalie-demoulin","type":"person","url":"https://hartvaat.nl/mensen/nathalie-demoulin/","name":"Nathalie Demoulin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/adpkd-samen-met-primaire-hyperoxalurie-type-3/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/03/01/tsc2-pkd1-contigue-gendeletiesyndroom/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nathaniel-m-hawkins","type":"person","url":"https://hartvaat.nl/mensen/nathaniel-m-hawkins/","name":"Nathaniel M Hawkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/routinematige-urine-natriummeting-drijft-agressievere-diurese-bij-acuut-hartfale/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2021/12/01/hartfalen-en-atriumflutter-systematische-review/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nathorn-chaiyakunapruk","type":"person","url":"https://hartvaat.nl/mensen/nathorn-chaiyakunapruk/","name":"Nathorn Chaiyakunapruk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/door-to-balloon-tijd-en-uitkomsten-bij-stemi-meta-analyse/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/08/19/vergelijking-van-fibrinolytica-bij-stemi-lancet-netwerkmeta-analyse/","published":"2017-08-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"naveen-l-pereira","type":"person","url":"https://hartvaat.nl/mensen/naveen-l-pereira/","name":"Naveen L Pereira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/07/geleide-versus-potente-p2y12-therapie-bij-acs-netwerkmeta-analyse-van-61-898-pat/","published":"2022-03-07"},{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"navin-k-kapur","type":"person","url":"https://hartvaat.nl/mensen/navin-k-kapur/","name":"Navin K Kapur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/29/vroege-iabp-bij-hartfalen-gerelateerde-cardiogene-shock-gerandomiseerde-trial/","published":"2025-04-29"},{"url":"https://hartvaat.nl/2019/01/15/lv-unloading-voor-reperfusie-bij-anterieure-stemi-dtu-stemi-pilot/","published":"2019-01-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nay-m-htun","type":"person","url":"https://hartvaat.nl/mensen/nay-m-htun/","name":"Nay M Htun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nayyar-iqbal","type":"person","url":"https://hartvaat.nl/mensen/nayyar-iqbal/","name":"Nayyar Iqbal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nduka-c-okwose","type":"person","url":"https://hartvaat.nl/mensen/nduka-c-okwose/","name":"Nduka C Okwose","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/10/01/revalidatie-bij-chronisch-hf-systematische-review-van-inspanningsinterventies/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neal-k-lakdawala","type":"person","url":"https://hartvaat.nl/mensen/neal-k-lakdawala/","name":"Neal K Lakdawala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2023/01/03/aficamten-bij-obstructieve-hypertrofische-cardiomyopathie-fase-2-resultaten/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neal-s-kleiman","type":"person","url":"https://hartvaat.nl/mensen/neal-s-kleiman/","name":"Neal S Kleiman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/27/af-ablatie-met-vena-van-marshall-ethanol-versus-ablatie-alleen-jama-venus/","published":"2020-10-27"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-chapman","type":"person","url":"https://hartvaat.nl/mensen/neil-chapman/","name":"Neil Chapman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/ochtend-versus-avonddosering-van-antihypertensiva-gerandomiseerde-crossover-tria/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-fam","type":"person","url":"https://hartvaat.nl/mensen/neil-fam/","name":"Neil Fam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neil-j-perkins","type":"person","url":"https://hartvaat.nl/mensen/neil-j-perkins/","name":"Neil J Perkins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/01/preconceptiebloeddruk-en-verandering-naar-vroege-zwangerschap-risicofactor-voor-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddruk-voor-conceptie-en-reproductieve-uitkomsten/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nejc-piko","type":"person","url":"https://hartvaat.nl/mensen/nejc-piko/","name":"Nejc Piko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/29/cardiovasculaire-ziekte-blijft-leidend-na-niertransplantatie-overzicht-van-uitda/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nelson-k-sewankambo","type":"person","url":"https://hartvaat.nl/mensen/nelson-k-sewankambo/","name":"Nelson K Sewankambo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nermir-granov","type":"person","url":"https://hartvaat.nl/mensen/nermir-granov/","name":"Nermir Granov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"neus-salvatella","type":"person","url":"https://hartvaat.nl/mensen/neus-salvatella/","name":"Neus Salvatella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ngozi-erondu","type":"person","url":"https://hartvaat.nl/mensen/ngozi-erondu/","name":"Ngozi Erondu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"},{"url":"https://hartvaat.nl/2017/08/17/canagliflozine-en-cardiovasculaire-en-renale-events-bij-diabetes-type-2-nejm-can/","published":"2017-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nguyen","type":"person","url":"https://hartvaat.nl/mensen/nguyen/","name":"Nguyen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/hypochloremie-bij-opname-voor-acuut-hartfalen-voorspelt-onafhankelijk-30-daagse-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/03/02/is-depressie-een-onafhankelijke-risicofactor-voor-sterfte-bij-hart-en-vaatziekte/","published":"2026-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nguyen-h-thang","type":"person","url":"https://hartvaat.nl/mensen/nguyen-h-thang/","name":"Nguyen H Thang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nia-roberts","type":"person","url":"https://hartvaat.nl/mensen/nia-roberts/","name":"Nia Roberts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/01/thuis-versus-praktijkbloeddrukmeting-in-de-zwangerschap/","published":"2018-09-01"},{"url":"https://hartvaat.nl/2016/07/01/bewegingsadvies-als-behandeling-van-prehypertensie-en-hypertensie-bij-jongvolwas/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niall-g-campbell","type":"person","url":"https://hartvaat.nl/mensen/niall-g-campbell/","name":"Niall G Campbell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/24/tight-k-kaliumsuppletie-voorkomt-af-na-hartchirurgie-rct/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2016/03/01/intrathoracale-impedantiemonitoring-bij-chronisch-hartfalen-de-limit-chf-studie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niall-g-keenan","type":"person","url":"https://hartvaat.nl/mensen/niall-g-keenan/","name":"Niall G Keenan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"},{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-dirckx","type":"person","url":"https://hartvaat.nl/mensen/nicholas-dirckx/","name":"Nicholas Dirckx","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/aspirinestop-bij-lvad-met-vka-veiligheidsanalyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/03/01/aspirine-en-hemocompatibiliteit-na-lvad-bij-atherosclerotisch-vaatlijden/","published":"2025-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-j-cowans","type":"person","url":"https://hartvaat.nl/mensen/nicholas-j-cowans/","name":"Nicholas J Cowans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/04/troponine-i-en-cardiovasculair-risico-bij-copd/","published":"2018-09-04"},{"url":"https://hartvaat.nl/2018/09/01/bloeddruk-hartfrequentie-en-mortaliteit-bij-copd-summit-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-j-wareham","type":"person","url":"https://hartvaat.nl/mensen/nicholas-j-wareham/","name":"Nicholas J Wareham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicholas-w-s-chew","type":"person","url":"https://hartvaat.nl/mensen/nicholas-w-s-chew/","name":"Nicholas W S Chew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/brede-inzet-van-oraal-semaglutide-in-de-vs-zou-jaarlijks-tot-60-000-cardiovascul/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2022/04/01/glucoseverlagende-middelen-bij-niet-diabetisch-hf-bayesiaanse-netwerkmeta-analys/","published":"2022-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nick-e-j-west","type":"person","url":"https://hartvaat.nl/mensen/nick-e-j-west/","name":"Nick E J West","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/19/ilumien-iv-oct-geleide-versus-angiografie-geleide-pci-nejm/","published":"2023-10-19"},{"url":"https://hartvaat.nl/2023/07/18/bioresorbeerbare-coronaire-scaffolds-vijfjaarsuitkomsten-met-verbeterde-techniek/","published":"2023-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niclas-eriksson","type":"person","url":"https://hartvaat.nl/mensen/niclas-eriksson/","name":"Niclas Eriksson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/dapagliflozine-na-mi-naar-ef-cardiometabole-uitkomsten/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2020/11/01/ace2-niveaus-en-covid-19-risicofactoren-bij-af-patienten/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicola-ammirabile","type":"person","url":"https://hartvaat.nl/mensen/nicola-ammirabile/","name":"Nicola Ammirabile","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/glp-1-agonisten-verlagen-cardiovasculaire-risicos-bij-diabetes-en-obesitas-overz/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2024/04/02/ivus-versus-oct-versus-angiografie-voor-pci-begeleiding-meta-analyse/","published":"2024-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolai-tegn","type":"person","url":"https://hartvaat.nl/mensen/nicolai-tegn/","name":"Nicolai Tegn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/14/invasief-versus-conservatief-bij-ouderen-met-nste-acs-ipd-meta-analyse/","published":"2024-06-14"},{"url":"https://hartvaat.nl/2016/03/12/invasieve-versus-conservatieve-strategie-bij-80-plussers-met-nstemi-gerandomisee/","published":"2016-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-dumonteil","type":"person","url":"https://hartvaat.nl/mensen/nicolas-dumonteil/","name":"Nicolas Dumonteil","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2026/03/23/fate-register-mislukte-transkatheter-tricuspidalisreparatie-t-teer/","published":"2026-03-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicolas-nesseler","type":"person","url":"https://hartvaat.nl/mensen/nicolas-nesseler/","name":"Nicolas Nesseler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/levoecmo-levosimendan-bij-ecmo-weaning-bij-cardiogene-shock/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicole-blackman","type":"person","url":"https://hartvaat.nl/mensen/nicole-blackman/","name":"Nicole Blackman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/21/iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-ipd-meta-analyse/","published":"2023-12-21"},{"url":"https://hartvaat.nl/2023/09/14/heart-fid-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-nejm/","published":"2023-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicole-d-armstrong","type":"person","url":"https://hartvaat.nl/mensen/nicole-d-armstrong/","name":"Nicole D Armstrong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/polygene-risicoscore-en-chloortalidone-respons/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicole-gilgen","type":"person","url":"https://hartvaat.nl/mensen/nicole-gilgen/","name":"Nicole Gilgen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicole-habel","type":"person","url":"https://hartvaat.nl/mensen/nicole-habel/","name":"Nicole Habel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-klinische-uitkomsten/","published":"2025-10-01"},{"url":"https://hartvaat.nl/2023/03/01/gepersonaliseerde-versnelde-pacing-bij-hfpef-met-pacemaker/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nicole-li","type":"person","url":"https://hartvaat.nl/mensen/nicole-li/","name":"Nicole Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-jongs","type":"person","url":"https://hartvaat.nl/mensen/niels-jongs/","name":"Niels Jongs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2021/03/31/dapagliflozine-en-mortaliteit-bij-ckd-dapa-ckd-pre-gespecificeerde-analyse/","published":"2021-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-ramsing-holm","type":"person","url":"https://hartvaat.nl/mensen/niels-ramsing-holm/","name":"Niels Ramsing Holm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/eapci-ebc-consensus-intracoronaire-beeldvorming-als-standaard-bij-pci-van-hoofds/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2024/11/09/favor-iv-qvas-qfr-versus-ffr-bij-coronaire-revascularisatiedecisies-lancet/","published":"2024-11-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-risum","type":"person","url":"https://hartvaat.nl/mensen/niels-risum/","name":"Niels Risum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/20/kaliumverhoging-bij-hoogrisicopatienten-voor-ventriculaire-aritmieen-rct/","published":"2025-11-20"},{"url":"https://hartvaat.nl/2018/03/27/crt-bij-hartfalen-met-smal-qrs-complex/","published":"2018-03-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niels-t-b-scholte","type":"person","url":"https://hartvaat.nl/mensen/niels-t-b-scholte/","name":"Niels T B Scholte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/28/geen-sekseverschillen-in-werkzaamheid-van-hartfalenmedicatie-meta-analyse-van-13/","published":"2026-05-05"},{"url":"https://hartvaat.nl/2023/08/14/telemonitoring-bij-hartfalen-meta-analyse-van-alle-strategieen/","published":"2023-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nigel-beckett","type":"person","url":"https://hartvaat.nl/mensen/nigel-beckett/","name":"Nigel Beckett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/21/bloeddrukverlaging-en-dementiepreventie-ipd-meta-analyse/","published":"2022-12-21"},{"url":"https://hartvaat.nl/2018/09/01/orthostatische-hypotensie-verhoogt-risico-op-cognitieve-stoornissen/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nigel-gupta","type":"person","url":"https://hartvaat.nl/mensen/nigel-gupta/","name":"Nigel Gupta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/25/amulet-ide-vijfjaarsresultaten-laa-occlusie-met-amulet/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nigel-rowell","type":"person","url":"https://hartvaat.nl/mensen/nigel-rowell/","name":"Nigel Rowell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nigopan-gopalasingam","type":"person","url":"https://hartvaat.nl/mensen/nigopan-gopalasingam/","name":"Nigopan Gopalasingam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/ketonester-bij-type-2-diabetes-en-hartfalen-cross-over-trial/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/05/07/orale-ketonester-bij-hfref-gerandomiseerde-trial/","published":"2024-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niki-procopi","type":"person","url":"https://hartvaat.nl/mensen/niki-procopi/","name":"Niki Procopi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niklas-hammar","type":"person","url":"https://hartvaat.nl/mensen/niklas-hammar/","name":"Niklas Hammar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/12/sglt2-remmers-en-cardiovasculaire-events-de-cvd-real-2-real-world-studie/","published":"2018-06-12"},{"url":"https://hartvaat.nl/2017/07/18/sglt2-remmers-en-lager-risico-op-hartfalen-en-sterfte-versus-andere-glucoseverla/","published":"2017-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolaos-mezilis","type":"person","url":"https://hartvaat.nl/mensen/nikolaos-mezilis/","name":"Nikolaos Mezilis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolaos-papageorgiou","type":"person","url":"https://hartvaat.nl/mensen/nikolaos-papageorgiou/","name":"Nikolaos Papageorgiou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/01/ablatie-index-geleide-af-ablatie-geactualiseerde-meta-analyse/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2016/10/01/katheterablatie-bij-af-met-hypertrofische-cardiomyopathie-systematische-review-e/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolaos-pyrpyris","type":"person","url":"https://hartvaat.nl/mensen/nikolaos-pyrpyris/","name":"Nikolaos Pyrpyris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/lp-a-geassocieerd-met-microvasculaire-disfunctie-bij-niet-obstructief-coronairli/","published":"2026-03-10"},{"url":"https://hartvaat.nl/2023/07/04/colchicine-voorkomt-postoperatief-af-na-hartchirurgie-meta-analyse/","published":"2023-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolaus-sarafoff","type":"person","url":"https://hartvaat.nl/mensen/nikolaus-sarafoff/","name":"Nikolaus Sarafoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/01/optimaal-antitrombotisch-regime-bij-af-na-pci-jama-cardiology-netwerkmeta-analys/","published":"2020-05-01"},{"url":"https://hartvaat.nl/2019/08/01/antitrombotische-strategieen-bij-af-na-pci-jama-cardiology-veiligheids-en-werkza/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nikolay-sappler","type":"person","url":"https://hartvaat.nl/mensen/nikolay-sappler/","name":"Nikolay Sappler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/03/cardiale-shockwave-therapie-bij-cabg-verbetert-myocardfunctie/","published":"2024-08-03"},{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nilo-b-cater","type":"person","url":"https://hartvaat.nl/mensen/nilo-b-cater/","name":"Nilo B Cater","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-versus-heparine-vka-bij-cardioversie-voor-af-emanate-trial/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nils-henrik-hansson","type":"person","url":"https://hartvaat.nl/mensen/nils-henrik-hansson/","name":"Nils Henrik Hansson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/metformine-remt-proliferatie-van-fibro-adipogene-stamcellen-uit-falende-harten/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2019/04/30/ketonlichaam-3-hydroxybutyraat-bij-chronisch-hartfalen-cardiovasculaire-effecten/","published":"2019-04-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nils-einar-klw","type":"person","url":"https://hartvaat.nl/mensen/nils-einar-klw/","name":"Nils-Einar Kløw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/20/il-6-receptorremming-bij-acuut-stemi-gerandomiseerde-trial/","published":"2021-04-20"},{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nimesh-patel","type":"person","url":"https://hartvaat.nl/mensen/nimesh-patel/","name":"Nimesh Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nina-ajmone-marsan","type":"person","url":"https://hartvaat.nl/mensen/nina-ajmone-marsan/","name":"Nina Ajmone Marsan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","published":"2026-07-29"},{"url":"https://hartvaat.nl/2026/03/28/gestandaardiseerd-stappenplan-voor-tricuspidalisinsufficientie-van-verwijzing-to/","published":"2026-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nina-bual","type":"person","url":"https://hartvaat.nl/mensen/nina-bual/","name":"Nina Bual","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/13/orbita-2-dobutamine-stress-echo-voorspelt-pci-effectiviteit/","published":"2025-05-13"},{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ning-li","type":"person","url":"https://hartvaat.nl/mensen/ning-li/","name":"Ning Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/04/05/bloeddrukverlaging-bij-kappersbezoek-nejm-clustergerandomiseerde-trial/","published":"2018-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ning-ye","type":"person","url":"https://hartvaat.nl/mensen/ning-ye/","name":"Ning Ye","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/06/voordeel-nadeel-afwegingen-van-intensieve-bloeddrukcontrole/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ning-zhou","type":"person","url":"https://hartvaat.nl/mensen/ning-zhou/","name":"Ning Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ningling-sun","type":"person","url":"https://hartvaat.nl/mensen/ningling-sun/","name":"Ningling Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nirav-patel","type":"person","url":"https://hartvaat.nl/mensen/nirav-patel/","name":"Nirav Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/incidentie-en-implicaties-van-af-bij-hypertensie-sprint-inzichten/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/12/01/lvad-implantatie-verbetert-glycemische-controle-meta-analyse/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nishan-abeysuriya","type":"person","url":"https://hartvaat.nl/mensen/nishan-abeysuriya/","name":"Nishan Abeysuriya","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/tricuspidalisinsufficientie-en-mortaliteit-onafhankelijk-van-ph-en-rechterventri/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/03/01/voorspellers-van-succesvolle-cto-pci-systematische-review-en-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nishant-k-sekaran","type":"person","url":"https://hartvaat.nl/mensen/nishant-k-sekaran/","name":"Nishant K Sekaran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2019/03/05/inspanningstest-versus-ccta-bij-diabetes-met-verdenking-coronairlijden/","published":"2019-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nita-g-forouhi","type":"person","url":"https://hartvaat.nl/mensen/nita-g-forouhi/","name":"Nita G Forouhi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"niti-aggarwal","type":"person","url":"https://hartvaat.nl/mensen/niti-aggarwal/","name":"Niti Aggarwal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/09/13/prasugrel-versus-ticagrelor-bij-diabetes-type-2-met-coronairlijden-optimus-4-stu/","published":"2016-09-13"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nitish-k-dhingra","type":"person","url":"https://hartvaat.nl/mensen/nitish-k-dhingra/","name":"Nitish K Dhingra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/sglt2-remmers-bij-hfref-of-hfpef-meta-analyse/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/12/01/sglt2-remmers-en-cardiale-remodellering-meta-analyse-van-mri-trials/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"noah-ivers","type":"person","url":"https://hartvaat.nl/mensen/noah-ivers/","name":"Noah Ivers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2021/05/01/screening-op-af-bij-ouderen-jama-cardiology-gerandomiseerde-trial/","published":"2021-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuaki-suzuki","type":"person","url":"https://hartvaat.nl/mensen/nobuaki-suzuki/","name":"Nobuaki Suzuki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuaki-tanaka","type":"person","url":"https://hartvaat.nl/mensen/nobuaki-tanaka/","name":"Nobuaki Tanaka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuhiro-ikemura","type":"person","url":"https://hartvaat.nl/mensen/nobuhiro-ikemura/","name":"Nobuhiro Ikemura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/16/ischemia-anginatrajecten-na-invasieve-versus-conservatieve-strategie/","published":"2025-09-16"},{"url":"https://hartvaat.nl/2025/01/01/kccq-interpretatie-bij-hartfalen-patient-ankering/","published":"2025-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuhiro-suematsu","type":"person","url":"https://hartvaat.nl/mensen/nobuhiro-suematsu/","name":"Nobuhiro Suematsu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuhiro-tanaka","type":"person","url":"https://hartvaat.nl/mensen/nobuhiro-tanaka/","name":"Nobuhiro Tanaka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuyuki-horita","type":"person","url":"https://hartvaat.nl/mensen/nobuyuki-horita/","name":"Nobuyuki Horita","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/af-ablatie-verbetert-uitkomsten-bij-hartfalen-geactualiseerde-meta-analyse/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/11/01/checkpoint-remmers-verhogen-korttermijnrisico-op-hypertensie-niet-meta-analyse/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuyuki-kagiyama","type":"person","url":"https://hartvaat.nl/mensen/nobuyuki-kagiyama/","name":"Nobuyuki Kagiyama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/02/jamac-studie-slechte-5-jaarsprognose-bij-mitralisstenose-door-mitralisringverkal/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2020/08/25/machine-learning-voor-lv-diastolische-functie-op-ecg/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nobuyuki-ohte","type":"person","url":"https://hartvaat.nl/mensen/nobuyuki-ohte/","name":"Nobuyuki Ohte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/bnp-prognostische-waarde-bij-hartfalen-met-lvef-35/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"noemi-escalera","type":"person","url":"https://hartvaat.nl/mensen/noemi-escalera/","name":"Noemí Escalera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nona-sotoodehnia","type":"person","url":"https://hartvaat.nl/mensen/nona-sotoodehnia/","name":"Nona Sotoodehnia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2018/06/01/gwas-van-pr-interval-bij-hispanic-latino-s-nieuw-locus-bij-id2/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nora-b-henrikson","type":"person","url":"https://hartvaat.nl/mensen/nora-b-henrikson/","name":"Nora B Henrikson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-familiaire-hypercholesterolemie-uspstf-evidenc/","published":"2016-08-09"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-multifactoriele-dyslipidemie-uspstf-evidence-r/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"norman-e-lepor","type":"person","url":"https://hartvaat.nl/mensen/norman-e-lepor/","name":"Norman E Lepor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/orale-pcsk9-remmer-enlicitide-verlaagt-ldl-met-57-placebogecontroleerde-trial/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2022/11/17/olpasiran-sirna-verlaagt-lipoproteine-a-spectaculair-in-fase-2-trial/","published":"2022-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"norman-rosenthal","type":"person","url":"https://hartvaat.nl/mensen/norman-rosenthal/","name":"Norman Rosenthal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/08/stress-cardiale-biomarkers-en-cv-renale-uitkomsten-bij-canagliflozine/","published":"2022-02-08"},{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nour-chouman","type":"person","url":"https://hartvaat.nl/mensen/nour-chouman/","name":"Nour Chouman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/decaaf-ii-af-last-en-symptoomreductie-na-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/08/02/decaaf-ii-fibroselocatie-beinvloedt-af-recidief-na-ablatie/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nourhan-mohamed-soliman","type":"person","url":"https://hartvaat.nl/mensen/nourhan-mohamed-soliman/","name":"Nourhan Mohamed Soliman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nuno-lunet","type":"person","url":"https://hartvaat.nl/mensen/nuno-lunet/","name":"Nuno Lunet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nyda-fourie","type":"person","url":"https://hartvaat.nl/mensen/nyda-fourie/","name":"Nyda Fourie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/lerodalcibep-bij-ascvd-of-hoog-risico-fase-3-resultaten/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/10/21/lerodalcibep-bij-familiaire-hypercholesterolemie-liberate-hefh-langetermijndata/","published":"2023-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ola-vedin","type":"person","url":"https://hartvaat.nl/mensen/ola-vedin/","name":"Ola Vedin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/28/nt-probnp-prognose-en-empagliflozine-effect-bij-emperor-reduced/","published":"2021-09-28"},{"url":"https://hartvaat.nl/2020/01/07/hypoglykemie-cv-uitkomsten-en-empagliflozine-empa-reg-outcome/","published":"2020-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olaf-going","type":"person","url":"https://hartvaat.nl/mensen/olaf-going/","name":"Olaf Going","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olaf-oldenburg","type":"person","url":"https://hartvaat.nl/mensen/olaf-oldenburg/","name":"Olaf Oldenburg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/01/transveneuze-frenische-zenuwstimulatie-bij-centraal-slaapapneu-en-hartfalen/","published":"2025-02-01"},{"url":"https://hartvaat.nl/2017/03/28/adaptieve-servoventilatie-bij-hartfalen-de-cat-hf-trial/","published":"2017-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ole-rossvoll","type":"person","url":"https://hartvaat.nl/mensen/ole-rossvoll/","name":"Ole Rossvoll","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/02/cryoballon-versus-rf-bij-persisterend-af-noorse-no-pers-af-gerandomiseerde-trial/","published":"2022-02-02"},{"url":"https://hartvaat.nl/2016/02/02/aerobe-intervaltraining-vermindert-de-last-van-atriumfibrilleren-gerandomiseerde/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olena-mitchenko","type":"person","url":"https://hartvaat.nl/mensen/olena-mitchenko/","name":"Olena Mitchenko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"oliver-rivero-arias","type":"person","url":"https://hartvaat.nl/mensen/oliver-rivero-arias/","name":"Oliver Rivero-Arias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivia-manfrini","type":"person","url":"https://hartvaat.nl/mensen/olivia-manfrini/","name":"Olivia Manfrini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensusverklaring-over-microvasculaire-obstructie-en-no-reflow-na-stemi/","published":"2026-05-29"},{"url":"https://hartvaat.nl/2026/03/05/ongelijke-toegang-tot-cardiovasculaire-zorg-in-europa/","published":"2026-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-c-manintveld","type":"person","url":"https://hartvaat.nl/mensen/olivier-c-manintveld/","name":"Olivier C Manintveld","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/08/14/telemonitoring-bij-hartfalen-meta-analyse-van-alle-strategieen/","published":"2023-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-darremont","type":"person","url":"https://hartvaat.nl/mensen/olivier-darremont/","name":"Olivier Darremont","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/04/stapsgewijze-provisionale-versus-systematische-dualstent-bij-ware-linker-hoofdst/","published":"2025-03-04"},{"url":"https://hartvaat.nl/2021/10/01/ebc-hoofdstam-stentstudie-provisional-versus-systematisch-dubbel-stenten/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-devuyst","type":"person","url":"https://hartvaat.nl/mensen/olivier-devuyst/","name":"Olivier Devuyst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/18/gentherapie-voor-nefropathische-cystinose/","published":"2026-02-18"},{"url":"https://hartvaat.nl/2026/02/11/drosophila-model-voor-de-ziekte-van-dent-type-1-onthult-pathogeen-mechanisme/","published":"2026-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-lairez","type":"person","url":"https://hartvaat.nl/mensen/olivier-lairez/","name":"Olivier Lairez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/effect-van-mavacamten-op-risicoscores-voor-plotse-hartdood-bij-hypertrofische-ca/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2023/07/20/ni006-antilichaam-voor-afbraak-van-cardiale-transthyretine-amyloid-nejm-fase-1/","published":"2023-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-ormezzano","type":"person","url":"https://hartvaat.nl/mensen/olivier-ormezzano/","name":"Olivier Ormezzano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-s-descamps","type":"person","url":"https://hartvaat.nl/mensen/olivier-s-descamps/","name":"Olivier S Descamps","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/10/01/evolocumab-bij-pediatrische-heterozygoot-fh-nejm-hauser-rct/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-sitbon","type":"person","url":"https://hartvaat.nl/mensen/olivier-sitbon/","name":"Olivier Sitbon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olivier-van-leuven","type":"person","url":"https://hartvaat.nl/mensen/olivier-van-leuven/","name":"Olivier Van Leuven","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2026/02/03/kortste-af-cycluslengte-in-de-longvenen-identificeert-pvi-responders/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olov-wiklund","type":"person","url":"https://hartvaat.nl/mensen/olov-wiklund/","name":"Olov Wiklund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2016/10/14/2016-esc-eas-richtlijn-voor-het-management-van-dyslipidemieen/","published":"2016-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"olsen","type":"person","url":"https://hartvaat.nl/mensen/olsen/","name":"Olsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/04/noorse-nationale-validatie-myocarditis-na-mrna-covid-vaccinatie-4-5-per-100-000-/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/05/20/klinisch-en-genetisch-risico-op-atriumfibrilleren-versterken-elkaar-additief-13-/","published":"2026-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"oluseun-alli","type":"person","url":"https://hartvaat.nl/mensen/oluseun-alli/","name":"Oluseun Alli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/champion-af-watchman-flx-non-inferieur-aan-noac-s-en-superieur-in-bloedingsreduc/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"omar-abdel-razek","type":"person","url":"https://hartvaat.nl/mensen/omar-abdel-razek/","name":"Omar Abdel-Razek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"omar-ibrahim","type":"person","url":"https://hartvaat.nl/mensen/omar-ibrahim/","name":"Omar Ibrahim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"omary-said-ubuguyu","type":"person","url":"https://hartvaat.nl/mensen/omary-said-ubuguyu/","name":"Omary Said Ubuguyu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"omerovic","type":"person","url":"https://hartvaat.nl/mensen/omerovic/","name":"Omerovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/04/stami-linkerventrikel-trombus-komt-na-voorwand-stemi-voor-8-bij-takotsubo-nooit-/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/01/29/verminderde-pompfunctie-na-een-hartinfarct-hoge-symptoomlast-en-slechtere-secund/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ophelia-q-p-yin","type":"person","url":"https://hartvaat.nl/mensen/ophelia-q-p-yin/","name":"Ophelia Q P Yin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2018/10/30/endogene-factor-xa-activiteit-en-edoxaban-farmacodynamische-marker-en-klinische-/","published":"2018-10-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"orvar-jonsson","type":"person","url":"https://hartvaat.nl/mensen/orvar-jonsson/","name":"Orvar Jonsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/14/guide-hf-en-de-impact-van-covid-19-op-hartfalenuitkomsten/","published":"2022-07-14"},{"url":"https://hartvaat.nl/2021/04/27/empagliflozine-en-pulmonalisdruk-bij-hf-embrace-hf/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"oscar-prada-delgado","type":"person","url":"https://hartvaat.nl/mensen/oscar-prada-delgado/","name":"Oscar Prada-Delgado","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"otakar-jiravsky","type":"person","url":"https://hartvaat.nl/mensen/otakar-jiravsky/","name":"Otakar Jiravsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/20/stopstorm-stereotactische-bestraling-reduceert-refractaire-vt-met-80/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2025/07/08/catheterablatie-versus-leefstijlmodificatie-plus-antiaritmica-bij-af-gerandomise/","published":"2025-07-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ottavio-alfieri","type":"person","url":"https://hartvaat.nl/mensen/ottavio-alfieri/","name":"Ottavio Alfieri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"oussama-m-wazni","type":"person","url":"https://hartvaat.nl/mensen/oussama-m-wazni/","name":"Oussama M Wazni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2021/01/28/cryoballonablatie-als-initiele-therapie-voor-af-nejm-early-af/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ovidio-de-filippo","type":"person","url":"https://hartvaat.nl/mensen/ovidio-de-filippo/","name":"Ovidio De Filippo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2025/04/01/sacubitril-valsartan-na-acuut-mi-meta-analyse-van-in-hospital-initiatie/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ozlem-bilen","type":"person","url":"https://hartvaat.nl/mensen/ozlem-bilen/","name":"Ozlem Bilen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/aficamten-bij-obstructieve-hcm-multidomeinanalyse-van-maple-hcm/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2025/01/01/aficamten-versus-metoprolol-betere-levenskwaliteit-bij-obstructieve-hcm/","published":"2026-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"p-n-sylaja","type":"person","url":"https://hartvaat.nl/mensen/p-n-sylaja/","name":"P N Sylaja","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"p-s","type":"person","url":"https://hartvaat.nl/mensen/p-s/","name":"P. S.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/01/30/lager-opleidingsniveau-hangt-samen-met-meer-halsslagaderplaques-los-van-risicofa/","published":"2026-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"p-p","type":"person","url":"https://hartvaat.nl/mensen/p-p/","name":"P.-P.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/objectief-gemeten-lichaamsbeweging-en-levenskwaliteit-bij-hypertrofische-cardiom/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2026/01/29/lineaire-ablatie-van-de-voorwand-van-het-linkeratrium-vermindert-af-recidieven-b/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paari-dominic","type":"person","url":"https://hartvaat.nl/mensen/paari-dominic/","name":"Paari Dominic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/13/leadless-pacemaker-implantatie-ter-hoogte-van-de-bundel-van-bachmann/","published":"2026-04-11"},{"url":"https://hartvaat.nl/2018/01/01/linkeratriumvolume-voorspelt-af-recidief-na-radiofrequentieablatie-meta-analyse/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-a-mendoza","type":"person","url":"https://hartvaat.nl/mensen/pablo-a-mendoza/","name":"Pablo A Mendoza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-corral","type":"person","url":"https://hartvaat.nl/mensen/pablo-corral/","name":"Pablo Corral","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pablo-m-lavados","type":"person","url":"https://hartvaat.nl/mensen/pablo-m-lavados/","name":"Pablo M Lavados","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pamela-f-schwartz","type":"person","url":"https://hartvaat.nl/mensen/pamela-f-schwartz/","name":"Pamela F Schwartz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"},{"url":"https://hartvaat.nl/2017/04/20/ldl-reductievariabiliteit-en-antilichaamvorming-bij-bococizumab-nejm/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pamela-l-lutsey","type":"person","url":"https://hartvaat.nl/mensen/pamela-l-lutsey/","name":"Pamela L Lutsey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"},{"url":"https://hartvaat.nl/2016/08/01/vitamine-d-en-incidentie-van-atriumfibrilleren-de-aric-studie/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pamela-mckenna","type":"person","url":"https://hartvaat.nl/mensen/pamela-mckenna/","name":"Pamela McKenna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"panagiota-kourkoveli","type":"person","url":"https://hartvaat.nl/mensen/panagiota-kourkoveli/","name":"Panagiota Kourkoveli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"panagiotis-korantzopoulos","type":"person","url":"https://hartvaat.nl/mensen/panagiotis-korantzopoulos/","name":"Panagiotis Korantzopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/sglt2-remmers-en-plotse-hartdood-ventriculaire-aritmie-meta-analyse/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2016/05/01/mineralocorticoidreceptorantagonisten-en-atriumfibrilleren-meta-analyse/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"panagiotis-vardas","type":"person","url":"https://hartvaat.nl/mensen/panagiotis-vardas/","name":"Panagiotis Vardas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/07/2016-esc-richtlijn-voor-atriumfibrilleren-in-samenwerking-met-eacts/","published":"2016-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pankaj-arora","type":"person","url":"https://hartvaat.nl/mensen/pankaj-arora/","name":"Pankaj Arora","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/polygene-risicoscore-en-chloortalidone-respons/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2020/06/01/incidentie-en-implicaties-van-af-bij-hypertensie-sprint-inzichten/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"panos-e-vardas","type":"person","url":"https://hartvaat.nl/mensen/panos-e-vardas/","name":"Panos E Vardas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2026/02/24/kwaliteitscriteria-voor-ai-implementatie-in-de-cardiologie-bijgewerkt/","published":"2026-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pao-hwa-lin","type":"person","url":"https://hartvaat.nl/mensen/pao-hwa-lin/","name":"Pao-Hwa Lin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/26/chinees-hartgezond-dieet-verlaagt-bloeddruk-effectief-gerandomiseerde-trial/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2021/10/12/leefstijlmodificatie-bij-resistente-hypertensie-triumph-gerandomiseerde-trial/","published":"2021-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paola-gargiulo","type":"person","url":"https://hartvaat.nl/mensen/paola-gargiulo/","name":"Paola Gargiulo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/semaglutide-verlaagt-mortaliteit-cv-events-en-nierschade-in-alle-stadia-van-ckm-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/09/14/glp-1-agonisten-bij-diabetes-type-2-met-en-zonder-cvd-meta-analyse/","published":"2020-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paola-rebora","type":"person","url":"https://hartvaat.nl/mensen/paola-rebora/","name":"Paola Rebora","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/motivational-interviewing-en-zorggebruik-en-mortaliteit-bij-hf-motivate-hf/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/06/01/motivational-interviewing-bij-hartfalen-voor-zelfzorg-motivate-hf-gerandomiseerd/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-raggi","type":"person","url":"https://hartvaat.nl/mensen/paolo-raggi/","name":"Paolo Raggi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/cardiale-mortaliteit-bij-electieve-revascularisatie-plus-medicamenteus-versus-me/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/04/17/uitgangs-ldl-en-mortaliteitsreductie-na-ldl-verlaging-jama-meta-analyse/","published":"2018-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-rubartelli","type":"person","url":"https://hartvaat.nl/mensen/paolo-rubartelli/","name":"Paolo Rubartelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-rubba","type":"person","url":"https://hartvaat.nl/mensen/paolo-rubba/","name":"Paolo Rubba","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/20/evinacumab-bij-homozygoot-familiaire-hypercholesterolemie-nejm/","published":"2020-08-20"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-sbraccia","type":"person","url":"https://hartvaat.nl/mensen/paolo-sbraccia/","name":"Paolo Sbraccia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/cagrisema-verlaagt-bloeddruk-bij-overgewicht-obesitas-redefine-1/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/14/cagrisema-gecombineerd-cagrilintide-en-semaglutide-bij-overgewicht-nejm/","published":"2025-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paolo-zanaboni","type":"person","url":"https://hartvaat.nl/mensen/paolo-zanaboni/","name":"Paolo Zanaboni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/telerevalidatie-haalbaar-voor-hartfalenpatienten-zonder-toegang-tot-poliklinisch/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/08/01/cardiorenaal-syndroom-en-fitheid-bij-hartfalen-telerevalidatie-trial/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"parag-chevli","type":"person","url":"https://hartvaat.nl/mensen/parag-chevli/","name":"Parag Chevli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/lp-a-en-hscrp-voorspellen-ascvd-bij-mensen-zonder-klassieke-risicofactoren/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/05/22/il-6-sterker-met-hart-en-vaatziekte-geassocieerd-dan-ldl-lp-a-en-crp/","published":"2026-05-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"parag-goyal","type":"person","url":"https://hartvaat.nl/mensen/parag-goyal/","name":"Parag Goyal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/20/biomarkers-voorspellen-coronairlijden-bij-atriumfibrilleren-regards/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"parag-h-joshi","type":"person","url":"https://hartvaat.nl/mensen/parag-h-joshi/","name":"Parag H Joshi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/hs-troponine-en-natriuretische-peptiden-na-intensieve-bp-verlaging-sprint-biomar/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/12/17/biomarkers-in-risicobeoordeling-voor-antihypertensieve-therapie-acc-aha-2017/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"parasar-pal","type":"person","url":"https://hartvaat.nl/mensen/parasar-pal/","name":"Parasar Pal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/sacubitril-valsartan-en-inspanningsgemedieerd-lipidenmetabolisme-bij-obesitas-me/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/01/01/sacubitril-valsartan-en-natriurese-diurese-en-bloeddruk-bij-zoutgevoelige-hypert/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"parikshit-s-sharma","type":"person","url":"https://hartvaat.nl/mensen/parikshit-s-sharma/","name":"Parikshit S Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/21/high-power-short-duration-versus-conventionele-rf-ablatie-bij-af-meta-analyse/","published":"2021-05-21"},{"url":"https://hartvaat.nl/2019/07/09/his-correctieve-pacing-versus-biventriculaire-pacing-voor-crt-bij-hartfalen/","published":"2019-07-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"parminder-k-judge","type":"person","url":"https://hartvaat.nl/mensen/parminder-k-judge/","name":"Parminder K Judge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/09/sacubitril-valsartan-versus-irbesartan-bij-chronische-nierziekte/","published":"2018-10-09"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pascal-battistella","type":"person","url":"https://hartvaat.nl/mensen/pascal-battistella/","name":"Pascal Battistella","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/01/crp-sst2-en-gdf-15-multimarker-voor-prognostische-stratificatie-bij-stabiel-hf/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2020/04/01/sst2-voor-hartfalenmanagement-stade-hf-pilotstudie/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pasi-karjalainen","type":"person","url":"https://hartvaat.nl/mensen/pasi-karjalainen/","name":"Pasi Karjalainen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pasquale-santangeli","type":"person","url":"https://hartvaat.nl/mensen/pasquale-santangeli/","name":"Pasquale Santangeli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrice-guerin","type":"person","url":"https://hartvaat.nl/mensen/patrice-guerin/","name":"Patrice Guerin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/14/tri-fr-transcatheter-edge-to-edge-repair-bij-geisoleerde-ernstige-tr-rct/","published":"2025-01-14"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patricia-m-noujaim","type":"person","url":"https://hartvaat.nl/mensen/patricia-m-noujaim/","name":"Patricia M Noujaim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patricia-markovich","type":"person","url":"https://hartvaat.nl/mensen/patricia-markovich/","name":"Patricia Markovich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/17/million-hearts-betaald-cv-risicomanagement-vermindert-mi-en-cva-jama-rct/","published":"2023-10-17"},{"url":"https://hartvaat.nl/2021/09/01/million-hearts-cv-risicoreductiemodel-en-medicatie-initiatie-jama-cardiology/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patricia-palau","type":"person","url":"https://hartvaat.nl/mensen/patricia-palau/","name":"Patricia Palau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-bronzwaer","type":"person","url":"https://hartvaat.nl/mensen/patrick-bronzwaer/","name":"Patrick Bronzwaer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2020/02/01/verpleegkundig-geleide-versus-standaard-af-zorg/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-ecollan","type":"person","url":"https://hartvaat.nl/mensen/patrick-ecollan/","name":"Patrick Ecollan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/aldosteronblokkade-bij-myocardinfarct-ipd-analyse-van-twee-trials/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-feiereisen","type":"person","url":"https://hartvaat.nl/mensen/patrick-feiereisen/","name":"Patrick Feiereisen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/inspanningstraining-en-hs-troponine-t-bij-hfref/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-j-o-connor","type":"person","url":"https://hartvaat.nl/mensen/patrick-j-o-connor/","name":"Patrick J O'Connor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/01/apotheker-geleide-telezorg-versus-poliklinische-zorg-bij-ongecontroleerde-hypert/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-m-mccarthy","type":"person","url":"https://hartvaat.nl/mensen/patrick-m-mccarthy/","name":"Patrick M McCarthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-m-pullicino","type":"person","url":"https://hartvaat.nl/mensen/patrick-m-pullicino/","name":"Patrick M Pullicino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrick-y-jay","type":"person","url":"https://hartvaat.nl/mensen/patrick-y-jay/","name":"Patrick Y Jay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/25/ambulante-hf-verslechtering-bij-attr-cm-attr-act-subanalyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hartfalenverslechtering-bij-attr-cardiomyopathie-attr-act-analyse/","published":"2025-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrizia-pedrotti","type":"person","url":"https://hartvaat.nl/mensen/patrizia-pedrotti/","name":"Patrizia Pedrotti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2026/02/24/colchicine-bij-chronische-inflammatoire-cardiomyopathie-de-cmp-mythic-trial/","published":"2026-02-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrizia-torremante","type":"person","url":"https://hartvaat.nl/mensen/patrizia-torremante/","name":"Patrizia Torremante","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrizio-lancellotti","type":"person","url":"https://hartvaat.nl/mensen/patrizio-lancellotti/","name":"Patrizio Lancellotti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/01/14/2015-esc-richtlijn-voor-acute-coronaire-syndromen-zonder-persisterende-st-elevat/","published":"2016-01-14"},{"url":"https://hartvaat.nl/2016/01/01/2015-esc-ers-richtlijn-voor-diagnostiek-en-behandeling-van-pulmonale-hypertensie/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"patrizio-mazzone","type":"person","url":"https://hartvaat.nl/mensen/patrizio-mazzone/","name":"Patrizio Mazzone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","published":"2026-08-11"},{"url":"https://hartvaat.nl/2023/10/31/antitrombotische-therapie-na-laa-occlusie-netwerk-meta-analyse/","published":"2023-10-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pau-llacer","type":"person","url":"https://hartvaat.nl/mensen/pau-llacer/","name":"Pau Llácer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/01/clorotic-thiazide-toevoegen-aan-lisdiureticum-bij-acuut-hartfalen/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-a-sobotka","type":"person","url":"https://hartvaat.nl/mensen/paul-a-sobotka/","name":"Paul A Sobotka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/12/01/centrale-iliacale-av-anastomose-bij-ongecontroleerde-hypertensie-rox-control-htn/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-burton","type":"person","url":"https://hartvaat.nl/mensen/paul-burton/","name":"Paul Burton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/22/preventie-van-bloedingen-bij-af-patienten-die-pci-ondergaan-nejm-pioneer-af-pci/","published":"2016-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-clift","type":"person","url":"https://hartvaat.nl/mensen/paul-clift/","name":"Paul Clift","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/palliatieve-zorg-bij-ph-met-congenitaal-hartlijden-expertopinie/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2018/12/04/echocardiografische-screening-op-ph-bij-aangeboren-hartafwijkingen-jacc-review/","published":"2018-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-erne","type":"person","url":"https://hartvaat.nl/mensen/paul-erne/","name":"Paul Erne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-gordon","type":"person","url":"https://hartvaat.nl/mensen/paul-gordon/","name":"Paul Gordon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/genotype-geleide-p2y12-selectie-versus-clopidogrel-na-pci-jama-tailor-pci/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2017/03/21/kortetermijneffecten-van-tolvaptan-bij-acuut-hartfalen-met-volume-overbelasting/","published":"2017-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-j-nestel","type":"person","url":"https://hartvaat.nl/mensen/paul-j-nestel/","name":"Paul J Nestel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/13/lp-a-baseline-en-on-statin-voor-cv-eventvoorspelling-lancet-ipd-meta-analyse/","published":"2018-10-13"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-kolm","type":"person","url":"https://hartvaat.nl/mensen/paul-kolm/","name":"Paul Kolm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/hcmr-nhlbi-multidimensionele-risicovoorspelling-beter-dan-scd-gefocuste-richtlij/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-rocchiccioli","type":"person","url":"https://hartvaat.nl/mensen/paul-rocchiccioli/","name":"Paul Rocchiccioli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-s-myles","type":"person","url":"https://hartvaat.nl/mensen/paul-s-myles/","name":"Paul S Myles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/14/lignocaine-versus-opioiden-op-antiplaatjeseffect-van-ticagrelor-local-trial/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2017/08/15/overleving-na-geisoleerde-postoperatieve-troponine-elevatie/","published":"2017-08-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-s-teirstein","type":"person","url":"https://hartvaat.nl/mensen/paul-s-teirstein/","name":"Paul S Teirstein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"},{"url":"https://hartvaat.nl/2017/12/12/3-jaarsresultaten-van-bioresorbeerbare-scaffolds-absorb-iii-trial/","published":"2017-12-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paul-w-g-elbers","type":"person","url":"https://hartvaat.nl/mensen/paul-w-g-elbers/","name":"Paul W G Elbers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paula-franco-ocana","type":"person","url":"https://hartvaat.nl/mensen/paula-franco-ocana/","name":"Paula Franco-Ocaña","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paula-k-ogrocki","type":"person","url":"https://hartvaat.nl/mensen/paula-k-ogrocki/","name":"Paula K Ogrocki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paula-lozano","type":"person","url":"https://hartvaat.nl/mensen/paula-lozano/","name":"Paula Lozano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-familiaire-hypercholesterolemie-uspstf-evidenc/","published":"2016-08-09"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-multifactoriele-dyslipidemie-uspstf-evidence-r/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"paula-r-blasi","type":"person","url":"https://hartvaat.nl/mensen/paula-r-blasi/","name":"Paula R Blasi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-familiaire-hypercholesterolemie-uspstf-evidenc/","published":"2016-08-09"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-voor-multifactoriele-dyslipidemie-uspstf-evidence-r/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pauline-mendola","type":"person","url":"https://hartvaat.nl/mensen/pauline-mendola/","name":"Pauline Mendola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/01/preconceptiebloeddruk-en-verandering-naar-vroege-zwangerschap-risicofactor-voor-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddruk-voor-conceptie-en-reproductieve-uitkomsten/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pavel-hala","type":"person","url":"https://hartvaat.nl/mensen/pavel-hala/","name":"Pavel Hala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pavel-hamet","type":"person","url":"https://hartvaat.nl/mensen/pavel-hamet/","name":"Pavel Hamet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/01/bloeddrukverlaging-naar-uitgangsdruk-en-cv-risico-bij-diabetes-type-2/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2019/01/01/acute-creatininestijging-bij-start-ace-remmer-en-effecten-van-voortzetting-analy/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pawel-buszman","type":"person","url":"https://hartvaat.nl/mensen/pawel-buszman/","name":"Pawel Buszman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/03/sirolimus-eluting-bioabsorbeerbare-stent-versus-everolimus-eluting-stent-na-mi-l/","published":"2018-02-03"},{"url":"https://hartvaat.nl/2016/12/08/everolimus-eluting-stents-of-bypasschirurgie-bij-hoofdstamcoronairlijden-nejm-ex/","published":"2016-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-canas-silva","type":"person","url":"https://hartvaat.nl/mensen/pedro-canas-silva/","name":"Pedro Canas Silva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-e-p-carvalho","type":"person","url":"https://hartvaat.nl/mensen/pedro-e-p-carvalho/","name":"Pedro E P Carvalho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/korte-dapt-na-des-bij-acs-ipd-meta-analyse-bevestigt-veiligheid/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2023/10/31/antitrombotische-therapie-na-laa-occlusie-netwerk-meta-analyse/","published":"2023-10-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-l-sanchez","type":"person","url":"https://hartvaat.nl/mensen/pedro-l-sanchez/","name":"Pedro L Sánchez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-lopez-ayala","type":"person","url":"https://hartvaat.nl/mensen/pedro-lopez-ayala/","name":"Pedro Lopez-Ayala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/esc-0-1-uur-versus-0-2-of-0-3-uur-hoog-sensitief-troponine-algoritmen-bij-verden/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-marques","type":"person","url":"https://hartvaat.nl/mensen/pedro-marques/","name":"Pedro Marques","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/22/kosteneffectiviteit-van-sglt2-remmers-en-glp-1-agonisten-bij-hoog-cardiovasculai/","published":"2026-02-22"},{"url":"https://hartvaat.nl/2025/08/05/sglt2-remmer-met-en-zonder-mra-bij-hartfalen-gecombineerde-analyse/","published":"2025-08-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-martin","type":"person","url":"https://hartvaat.nl/mensen/pedro-martin/","name":"Pedro Martín","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-mata","type":"person","url":"https://hartvaat.nl/mensen/pedro-mata/","name":"Pedro Mata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/04/01/risicofactoren-voor-cardiovasculaire-events-bij-heterozygote-familiaire-hypercho/","published":"2026-05-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-r-moreno","type":"person","url":"https://hartvaat.nl/mensen/pedro-r-moreno/","name":"Pedro R Moreno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2021/01/26/empagliflozine-bij-niet-diabetische-hfref-emperor-reduced-subanalyse/","published":"2021-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pedro-s-farsky","type":"person","url":"https://hartvaat.nl/mensen/pedro-s-farsky/","name":"Pedro S Farsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2018/02/20/sekseverschillen-bij-ischemisch-hartfalen-na-cabg-stich-trial/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peeradon-vibhatavata","type":"person","url":"https://hartvaat.nl/mensen/peeradon-vibhatavata/","name":"Peeradon Vibhatavata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/13/nieuwe-medicamenteuze-therapieen-bij-primair-aldosteronisme/","published":"2026-02-13"},{"url":"https://hartvaat.nl/2025/12/18/gedeeltelijk-succesvolle-bijniervenesampling-bij-subtypering-van-primair-aldoste/","published":"2025-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peng","type":"person","url":"https://hartvaat.nl/mensen/peng/","name":"Peng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/voorspelmodellen-voor-hartfalen-bij-patienten-met-instabiele-angina-pectoris/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/02/machine-learning-nomogram-voorspelt-vroeg-transplantaatfalen-na-harttransplantat/","published":"2026-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peng-qu","type":"person","url":"https://hartvaat.nl/mensen/peng-qu/","name":"Peng Qu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peng-sheng-chen","type":"person","url":"https://hartvaat.nl/mensen/peng-sheng-chen/","name":"Peng-Sheng Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"per-grimfjard","type":"person","url":"https://hartvaat.nl/mensen/per-grimfjard/","name":"Per Grimfjärd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"per-olav-vandvik","type":"person","url":"https://hartvaat.nl/mensen/per-olav-vandvik/","name":"Per Olav Vandvik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/27/veiligheid-van-pcsk9-remmers-systematische-review-en-meta-analyse/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/12/01/predictieve-modellen-voor-cv-en-renale-uitkomsten-bij-diabetes-type-2-meta-analy/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"per-henrik-groop","type":"person","url":"https://hartvaat.nl/mensen/per-henrik-groop/","name":"Per-Henrik Groop","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/08/01/baroreflexactivatietherapie-bij-resistente-hypertensie-sham-gecontroleerde-pilot/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"perwaiz-m-meraj","type":"person","url":"https://hartvaat.nl/mensen/perwaiz-m-meraj/","name":"Perwaiz M Meraj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/15/lv-unloading-voor-reperfusie-bij-anterieure-stemi-dtu-stemi-pilot/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-a-noseworthy","type":"person","url":"https://hartvaat.nl/mensen/peter-a-noseworthy/","name":"Peter A Noseworthy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2017/02/14/doac-s-bij-af-met-kleplijden-excl-significante-mitralisstenose-meta-analyse/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-barlis","type":"person","url":"https://hartvaat.nl/mensen/peter-barlis/","name":"Peter Barlis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/hemodynamische-en-bloedviscositeitsprofielen-van-culprit-versus-non-culprit-coro/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2020/01/01/sekseverschillen-bij-pci-global-leaders-subanalyse/","published":"2020-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-c-austin","type":"person","url":"https://hartvaat.nl/mensen/peter-c-austin/","name":"Peter C Austin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/mondiale-vergelijking-van-heropnamepercentages-bij-hartfalen/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-collins","type":"person","url":"https://hartvaat.nl/mensen/peter-collins/","name":"Peter Collins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/sekseverschillen-in-effect-van-sglt2-remmers-en-glp-1-agonisten-meta-analyse/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2020/07/14/radiale-arterie-versus-vena-saphena-graft-bij-cabg-jama-langetermijn-meta-analys/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-cram","type":"person","url":"https://hartvaat.nl/mensen/peter-cram/","name":"Peter Cram","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/05/nejm-interventie-voor-snelle-ambulante-follow-up-na-acuut-hartfalen/","published":"2023-01-05"},{"url":"https://hartvaat.nl/2020/10/13/palliatieve-zorginterventies-bij-hartfalen-jama-associatie-met-qol-en-symptoomla/","published":"2020-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-damman","type":"person","url":"https://hartvaat.nl/mensen/peter-damman/","name":"Peter Damman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/14/prehospitale-troponine-voor-uitsluiting-nste-acs-gerandomiseerde-trial/","published":"2023-05-14"},{"url":"https://hartvaat.nl/2017/04/18/vroeg-invasief-versus-selectieve-strategie-bij-nste-acs-ictus-trial-langetermijn/","published":"2017-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-e-weeke","type":"person","url":"https://hartvaat.nl/mensen/peter-e-weeke/","name":"Peter E Weeke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/07/semaglutide-bij-hfmref-hfpef-gerandomiseerde-trial/","published":"2024-09-07"},{"url":"https://hartvaat.nl/2024/08/24/select-subanalyse-semaglutide-verbetert-cv-uitkomsten-bij-obesitas-met-hartfalen/","published":"2024-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-faris","type":"person","url":"https://hartvaat.nl/mensen/peter-faris/","name":"Peter Faris","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/16/afschaffen-eigen-bijdrage-medicatie-vermindert-cardiovasculair-risico-bij-oudere/","published":"2023-05-16"},{"url":"https://hartvaat.nl/2023/05/16/zelfmanagement-via-reclameprincipes-bij-ouderen-met-hoog-cv-risico/","published":"2023-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-fenici","type":"person","url":"https://hartvaat.nl/mensen/peter-fenici/","name":"Peter Fenici","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/12/sglt2-remmers-en-cardiovasculaire-events-de-cvd-real-2-real-world-studie/","published":"2018-06-12"},{"url":"https://hartvaat.nl/2017/07/18/sglt2-remmers-en-lager-risico-op-hartfalen-en-sterfte-versus-andere-glucoseverla/","published":"2017-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-g-smith","type":"person","url":"https://hartvaat.nl/mensen/peter-g-smith/","name":"Peter G Smith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-h-frederiksen","type":"person","url":"https://hartvaat.nl/mensen/peter-h-frederiksen/","name":"Peter H Frederiksen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-h-whincup","type":"person","url":"https://hartvaat.nl/mensen/peter-h-whincup/","name":"Peter H Whincup","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/10/dagelijkse-stappen-en-cardiovasculaire-ziekte-geharmoniseerde-meta-analyse/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-haemers","type":"person","url":"https://hartvaat.nl/mensen/peter-haemers/","name":"Peter Haemers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/05/smartphone-ppg-voor-af-detectie-en-management-verbeterde-screening/","published":"2025-02-05"},{"url":"https://hartvaat.nl/2024/12/26/gerichte-patienteneducatie-vermindert-ongeplande-cv-events-bij-af/","published":"2024-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-henriksson","type":"person","url":"https://hartvaat.nl/mensen/peter-henriksson/","name":"Peter Henriksson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/12/ivf-gebruik-niet-geassocieerd-met-hart-en-vaatziekten-behalve-herseninfarct/","published":"2026-08-20"},{"url":"https://hartvaat.nl/2017/08/01/nt-probnp-bij-systematische-screening-op-atriumfibrilleren/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-blankestijn","type":"person","url":"https://hartvaat.nl/mensen/peter-j-blankestijn/","name":"Peter J Blankestijn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2017/04/01/medicatietrouw-en-het-effect-van-renale-denervatie-de-sympathy-trial/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-cowburn","type":"person","url":"https://hartvaat.nl/mensen/peter-j-cowburn/","name":"Peter J Cowburn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/21/ironman-ijzerdeficientiedefinities-en-klinische-respons-op-iv-ijzer-bij-hf/","published":"2024-04-21"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-gallacher","type":"person","url":"https://hartvaat.nl/mensen/peter-j-gallacher/","name":"Peter J Gallacher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/01/hoog-sensitief-troponine-en-myocardinfarct-bij-nierfunctiestoornissen/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2019/08/01/endothelinereceptorantagonisme-verbetert-lipidenprofielen-en-verlaagt-pcsk9-bij-/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-mccartney","type":"person","url":"https://hartvaat.nl/mensen/peter-j-mccartney/","name":"Peter J McCartney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/31/laaggedoseerde-alteplase-bij-primaire-pci-naar-ischemietijd/","published":"2020-03-31"},{"url":"https://hartvaat.nl/2019/01/01/laaggedoseerd-intracoronair-alteplase-bij-primaire-pci-jama-t-time/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-meikle","type":"person","url":"https://hartvaat.nl/mensen/peter-j-meikle/","name":"Peter J Meikle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/14/lignocaine-versus-opioiden-op-antiplaatjeseffect-van-ticagrelor-local-trial/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2016/11/22/plasma-lipidomiek-verbetert-cardiovasculaire-risicovoorspelling-bij-diabetes-typ/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-j-van-der-most","type":"person","url":"https://hartvaat.nl/mensen/peter-j-van-der-most/","name":"Peter J van der Most","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-m-farrehi","type":"person","url":"https://hartvaat.nl/mensen/peter-m-farrehi/","name":"Peter M Farrehi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/aspirinedosering-voor-secundaire-preventie-bij-mannen-versus-vrouwen/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-m-spieth","type":"person","url":"https://hartvaat.nl/mensen/peter-m-spieth/","name":"Peter M Spieth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-p-toth","type":"person","url":"https://hartvaat.nl/mensen/peter-p-toth/","name":"Peter P Toth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/07/prevalentie-van-statine-intolerantie-meta-analyse-nuanceert-het-probleem/","published":"2022-09-07"},{"url":"https://hartvaat.nl/2020/04/28/apabetalone-en-cv-events-bij-acs-met-diabetes-type-2-jama-betonmace/","published":"2020-04-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-rickenbacher","type":"person","url":"https://hartvaat.nl/mensen/peter-rickenbacher/","name":"Peter Rickenbacher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/07/drug-coated-balloons-versus-des-bij-kleine-coronairarterien-lancet-basket-small-/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2018/09/08/drug-coated-balloons-bij-kleine-coronairarterien-lancet-basket-small-2/","published":"2018-09-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-ringleb","type":"person","url":"https://hartvaat.nl/mensen/peter-ringleb/","name":"Peter Ringleb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-s-fail","type":"person","url":"https://hartvaat.nl/mensen/peter-s-fail/","name":"Peter S Fail","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-s-lacy","type":"person","url":"https://hartvaat.nl/mensen/peter-s-lacy/","name":"Peter S Lacy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/polsgolfcalibratie-en-implicaties-voor-bloeddrukmeting-meta-analyse/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-schuster","type":"person","url":"https://hartvaat.nl/mensen/peter-schuster/","name":"Peter Schuster","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/07/vroege-substraatablatie-versus-antiaritmica-bij-vt-gerandomiseerde-trial/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2022/02/02/cryoballon-versus-rf-bij-persisterend-af-noorse-no-pers-af-gerandomiseerde-trial/","published":"2022-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-skov-olsen","type":"person","url":"https://hartvaat.nl/mensen/peter-skov-olsen/","name":"Peter Skov Olsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/01/notion-10-jaar-tavr-versus-chirurgie-bij-laagrisico-aortastenose/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2018/04/24/hoge-versus-lage-bloeddrukstreefwaarden-tijdens-cardiopulmonale-bypass-en-cerebr/","published":"2018-04-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-szecsody","type":"person","url":"https://hartvaat.nl/mensen/peter-szecsody/","name":"Peter Szecsödy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/diamond-patiromer-maakt-raas-remmer-optitratie-bij-hfref-met-hyperkaliemie-mogel/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-tadros","type":"person","url":"https://hartvaat.nl/mensen/peter-tadros/","name":"Peter Tadros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-u-heuschmann","type":"person","url":"https://hartvaat.nl/mensen/peter-u-heuschmann/","name":"Peter U Heuschmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2022/03/22/mri-hersenlaesies-en-cognitie-bij-af-na-laa-ablatie/","published":"2022-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-van-buren","type":"person","url":"https://hartvaat.nl/mensen/peter-van-buren/","name":"Peter Van Buren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/01/bloeddrukinterventie-en-controle-in-sprint-nader-geanalyseerd/","published":"2022-09-01"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-vasko","type":"person","url":"https://hartvaat.nl/mensen/peter-vasko/","name":"Peter Vasko","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/07/euroheart-definities-van-klinische-studie-eindpunten-voor-cvd/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2022/06/14/euroheart-datastandaarden-voor-hartfalenregistraties/","published":"2022-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peter-ohman","type":"person","url":"https://hartvaat.nl/mensen/peter-ohman/","name":"Peter Öhman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peteris-stradins","type":"person","url":"https://hartvaat.nl/mensen/peteris-stradins/","name":"Peteris Stradins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"peters","type":"person","url":"https://hartvaat.nl/mensen/peters/","name":"Peters","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/subklinische-atherosclerose-bij-vrouwen-na-pre-eclampsie-systematische-review-en/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/02/20/virtuele-afdeling-met-thuismonitoring-is-veilig-voor-patienten-die-wachten-op-sp/","published":"2026-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-budera","type":"person","url":"https://hartvaat.nl/mensen/petr-budera/","name":"Petr Budera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/sequentiele-hybride-ablatie-versus-chirurgische-cryomaze-bij-af-met-structurele-/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/06/03/linker-hartoorsluiting-tijdens-hartchirurgie-ter-preventie-van-cva-nejm-laaos-ii/","published":"2021-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-tousek","type":"person","url":"https://hartvaat.nl/mensen/petr-tousek/","name":"Petr Tousek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petr-waldauf","type":"person","url":"https://hartvaat.nl/mensen/petr-waldauf/","name":"Petr Waldauf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/22/cooperative-pfa-driearmige-gerandomiseerde-trial-van-pfa-versus-rf-versus-cryo/","published":"2025-07-22"},{"url":"https://hartvaat.nl/2016/02/01/spironolacton-versus-renale-denervatie-bij-therapieresistente-hypertensie-prague/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petra-barthel","type":"person","url":"https://hartvaat.nl/mensen/petra-barthel/","name":"Petra Barthel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2017/03/01/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-geactualiseerde-meta/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petra-buttner","type":"person","url":"https://hartvaat.nl/mensen/petra-buttner/","name":"Petra Büttner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/4-eiwitmodel-voor-cardiogene-shock-prognose-danger-substudie/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2024/10/01/galectine-3-en-langetermijnuitkomsten-bij-hartfalen-meta-analyse/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petra-kramarikova","type":"person","url":"https://hartvaat.nl/mensen/petra-kramarikova/","name":"Petra Kramarikova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petter-c-endresen","type":"person","url":"https://hartvaat.nl/mensen/petter-c-endresen/","name":"Petter C Endresen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/18/pci-versus-cabg-bij-onbeschermde-hoofdstam-lancet-noble-5-jaars-update/","published":"2020-01-18"},{"url":"https://hartvaat.nl/2016/12/03/pci-versus-cabg-bij-onbeschermde-hoofdstamstenose-lancet-noble-trial/","published":"2016-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-gentlesk","type":"person","url":"https://hartvaat.nl/mensen/philip-gentlesk/","name":"Philip Gentlesk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/qol-cognitie-en-functionele-status-na-af-ablatie/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2018/08/21/apixaban-bij-af-ablatie-veiligheid-bij-patienten-met-cva-risico/","published":"2018-08-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philip-s-tsao","type":"person","url":"https://hartvaat.nl/mensen/philip-s-tsao/","name":"Philip S Tsao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philipp-hartung","type":"person","url":"https://hartvaat.nl/mensen/philipp-hartung/","name":"Philipp Hartung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philipp-schuetz","type":"person","url":"https://hartvaat.nl/mensen/philipp-schuetz/","name":"Philipp Schuetz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/11/geindividualiseerde-voedingsondersteuning-bij-gehospitaliseerd-chronisch-hf/","published":"2021-05-11"},{"url":"https://hartvaat.nl/2020/06/01/il-1-receptorantagonist-verhoogt-ang-1-7-en-verlaagt-bloeddruk-bij-obesitas/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippa-c-lavallee","type":"person","url":"https://hartvaat.nl/mensen/philippa-c-lavallee/","name":"Philippa C Lavallée","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-amouyel","type":"person","url":"https://hartvaat.nl/mensen/philippe-amouyel/","name":"Philippe Amouyel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-b-bertrand","type":"person","url":"https://hartvaat.nl/mensen/philippe-b-bertrand/","name":"Philippe B Bertrand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/16/progressie-van-tricuspidalisinsufficientie-na-chirurgie-voor-ischemische-mr/","published":"2021-02-16"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-desfontaines","type":"person","url":"https://hartvaat.nl/mensen/philippe-desfontaines/","name":"Philippe Desfontaines","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"philippe-maury","type":"person","url":"https://hartvaat.nl/mensen/philippe-maury/","name":"Philippe Maury","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2025/07/01/ventriculaire-aritmieen-na-lvad-implantatie-meta-analyse/","published":"2025-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"phillip-freeman","type":"person","url":"https://hartvaat.nl/mensen/phillip-freeman/","name":"Phillip Freeman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2021/06/01/cd34-antilichaam-sirolimus-eluting-combo-stent-versus-orsiro-gerandomiseerde-tri/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"phillip-m-trusty","type":"person","url":"https://hartvaat.nl/mensen/phillip-m-trusty/","name":"Phillip M Trusty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"phyllis-august","type":"person","url":"https://hartvaat.nl/mensen/phyllis-august/","name":"Phyllis August","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/12/behandeling-van-milde-chronische-hypertensie-in-de-zwangerschap-nejm-chap/","published":"2022-05-12"},{"url":"https://hartvaat.nl/2018/08/01/raas-profielen-bij-zwangeren-met-chronische-hypertensie/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pier-d-lambiase","type":"person","url":"https://hartvaat.nl/mensen/pier-d-lambiase/","name":"Pier D Lambiase","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/triventriculaire-pacing-bij-hf-strive-hf-gerandomiseerde-trial/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2016/10/01/katheterablatie-bij-af-met-hypertrofische-cardiomyopathie-systematische-review-e/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierluigi-omede","type":"person","url":"https://hartvaat.nl/mensen/pierluigi-omede/","name":"Pierluigi Omedè","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/07/stentontwerp-en-dapt-duur-effect-op-ischemie-en-bloedingen-netwerkmeta-analyse/","published":"2017-11-07"},{"url":"https://hartvaat.nl/2016/12/21/statines-voor-primaire-preventie-bij-hiv-positieve-patienten-systematische-revie/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-albaladejo","type":"person","url":"https://hartvaat.nl/mensen/pierre-albaladejo/","name":"Pierre Albaladejo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-boutouyrie","type":"person","url":"https://hartvaat.nl/mensen/pierre-boutouyrie/","name":"Pierre Boutouyrie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2020/10/01/sequentiele-nefronblokkade-met-gecombineerde-diuretica-bij-resistente-hypertensi/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-delanaye","type":"person","url":"https://hartvaat.nl/mensen/pierre-delanaye/","name":"Pierre Delanaye","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/gepersonaliseerde-gfr-percentielen-een-nieuw-instrument-voor-ckd-detectie/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/02/19/creatinine-cystatine-c-of-beide-voor-gfr-schatting-bij-niertransplantatiepatient/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-verweij","type":"person","url":"https://hartvaat.nl/mensen/pierre-verweij/","name":"Pierre Verweij","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/01/aprocitentan-bij-hypertensie-gerandomiseerde-dosis-responsstudie/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-jean-touboul","type":"person","url":"https://hartvaat.nl/mensen/pierre-jean-touboul/","name":"Pierre-Jean Touboul","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/carotisatherosclerose-evolutie-bij-ldl-streefwaarde-70-na-ischemisch-cva-tst-sub/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pierre-yves-courand","type":"person","url":"https://hartvaat.nl/mensen/pierre-yves-courand/","name":"Pierre-Yves Courand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pieter-a-doevendans","type":"person","url":"https://hartvaat.nl/mensen/pieter-a-doevendans/","name":"Pieter A Doevendans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/bloeddruk-na-stenting-bij-aortacoarctatie-systematische-review-en-meta-analyse/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pieter-koopman","type":"person","url":"https://hartvaat.nl/mensen/pieter-koopman/","name":"Pieter Koopman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/22/antitrombotische-therapie-na-succesvolle-af-ablatie-gerandomiseerde-trial/","published":"2026-01-22"},{"url":"https://hartvaat.nl/2018/04/21/telemonitoring-verbetert-doac-therapietrouw-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pieter-vandervoort","type":"person","url":"https://hartvaat.nl/mensen/pieter-vandervoort/","name":"Pieter Vandervoort","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/05/smartphone-ppg-voor-af-detectie-en-management-verbeterde-screening/","published":"2025-02-05"},{"url":"https://hartvaat.nl/2021/12/21/iv-ijzercarboxymaltose-en-cardiale-reverse-remodellering-na-crt-iron-crt/","published":"2021-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pietro-di-santo","type":"person","url":"https://hartvaat.nl/mensen/pietro-di-santo/","name":"Pietro Di Santo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"},{"url":"https://hartvaat.nl/2019/02/19/lv-unloading-tijdens-ecmo-bij-cardiogene-shock/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pietro-francia","type":"person","url":"https://hartvaat.nl/mensen/pietro-francia/","name":"Pietro Francia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pil-sang-song","type":"person","url":"https://hartvaat.nl/mensen/pil-sang-song/","name":"Pil Sang Song","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/01/renovate-complex-pci-beeldvorming-geleide-pci-bij-vrouwen-versus-mannen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/05/04/renovate-complex-pci-intravasculaire-beeldvorming-versus-angiografie-bij-complex/","published":"2023-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pilar-escribano-subias","type":"person","url":"https://hartvaat.nl/mensen/pilar-escribano-subias/","name":"Pilar Escribano-Subías","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/inspanningsvoordelen-bij-pulmonale-hypertensie-jacc-review/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2018/04/14/sildenafil-bij-persisterende-pulmonale-hypertensie-na-klepchirurgie/","published":"2018-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pilar-galan","type":"person","url":"https://hartvaat.nl/mensen/pilar-galan/","name":"Pilar Galan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/nutrinet-sante-voedselconserveermiddelen-geassocieerd-met-meer-hypertensie-en-ca/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ping-wang","type":"person","url":"https://hartvaat.nl/mensen/ping-wang/","name":"Ping Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ping-ye","type":"person","url":"https://hartvaat.nl/mensen/ping-ye/","name":"Ping Ye","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piotr-adamski","type":"person","url":"https://hartvaat.nl/mensen/piotr-adamski/","name":"Piotr Adamski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/24/pcsk9-remming-bij-covid-19-anti-inflammatoir-potentieel-onderzocht/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2016/01/14/morfine-vertraagt-en-vermindert-de-werking-van-ticagrelor-bij-myocardinfarct-de-/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piotr-dobrowolski","type":"person","url":"https://hartvaat.nl/mensen/piotr-dobrowolski/","name":"Piotr Dobrowolski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2018/08/01/renale-denervatie-bij-resistente-hypertensie-met-obstructieve-slaapapneu-proof-o/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piotr-gajewski","type":"person","url":"https://hartvaat.nl/mensen/piotr-gajewski/","name":"Piotr Gajewski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/adipokineprofiel-bij-acuut-hartfalen-voorspelt-natriuretische-respons-en-mortali/","published":"2026-05-30"},{"url":"https://hartvaat.nl/2025/12/01/istaroxime-bij-hf-gerelateerde-cardiogene-shock-hemodynamische-effecten/","published":"2025-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piotr-niezgoda","type":"person","url":"https://hartvaat.nl/mensen/piotr-niezgoda/","name":"Piotr Niezgoda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2023/01/24/pcsk9-remming-bij-covid-19-anti-inflammatoir-potentieel-onderzocht/","published":"2023-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piotr-orzechowski","type":"person","url":"https://hartvaat.nl/mensen/piotr-orzechowski/","name":"Piotr Orzechowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pipin-kojodjojo","type":"person","url":"https://hartvaat.nl/mensen/pipin-kojodjojo/","name":"Pipin Kojodjojo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/07/mandibulaire-advancementsplint-versus-cpap-voor-bloeddrukverlaging-bij-osa/","published":"2024-05-07"},{"url":"https://hartvaat.nl/2024/03/01/svc-isolatie-bij-paroxysmaal-af-zonder-geinduceerde-svc-aritmieen/","published":"2024-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"piyamitr-sritara","type":"person","url":"https://hartvaat.nl/mensen/piyamitr-sritara/","name":"Piyamitr Sritara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/07/alirocumab-en-mace-naar-nierfunctie-na-acs-odyssey-outcomes/","published":"2020-11-07"},{"url":"https://hartvaat.nl/2019/09/01/alirocumab-en-mi-types-odyssey-outcomes-inzichten/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"placido-maria-mazzone","type":"person","url":"https://hartvaat.nl/mensen/placido-maria-mazzone/","name":"Placido Maria Mazzone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/glp-1-agonisten-verlagen-cardiovasculaire-risicos-bij-diabetes-en-obesitas-overz/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2024/04/02/ivus-versus-oct-versus-angiografie-voor-pci-begeleiding-meta-analyse/","published":"2024-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pompilio-faggiano","type":"person","url":"https://hartvaat.nl/mensen/pompilio-faggiano/","name":"Pompilio Faggiano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/afstand-tot-ldl-doelwaarde-stuurt-keuze-lipiddalende-therapie/","published":"2026-07-26"},{"url":"https://hartvaat.nl/2017/02/01/ehra-eacpr-positiedocument-beheer-van-patienten-met-af-en-acute-coronaire-events/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pooja-khatri","type":"person","url":"https://hartvaat.nl/mensen/pooja-khatri/","name":"Pooja Khatri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/05/best-ii-bloeddrukmanagement-na-trombectomie-bij-cva-jama/","published":"2023-09-05"},{"url":"https://hartvaat.nl/2020/03/01/bloeddruk-en-uitkomsten-bij-acute-beroerte-trombectomie/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pradeesh-sivapalan","type":"person","url":"https://hartvaat.nl/mensen/pradeesh-sivapalan/","name":"Pradeesh Sivapalan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/nudge-flu-subanalyse-griepvaccinatie-nudges-bij-mi-langetermijn/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/05/27/nudge-flu-elektronische-nudges-verhogen-griepvaccinatie-na-mi/","published":"2024-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prakash-deedwania","type":"person","url":"https://hartvaat.nl/mensen/prakash-deedwania/","name":"Prakash Deedwania","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/01/evolocumab-bij-metabool-syndroom-na-acs-fourier/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2019/06/18/evolocumab-bij-ckd-werkzaamheid-en-veiligheid-in-de-fourier-trial/","published":"2019-06-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pranobe-v-oemrawsingh","type":"person","url":"https://hartvaat.nl/mensen/pranobe-v-oemrawsingh/","name":"Pranobe V Oemrawsingh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prasant-mohanty","type":"person","url":"https://hartvaat.nl/mensen/prasant-mohanty/","name":"Prasant Mohanty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pratap-shetty","type":"person","url":"https://hartvaat.nl/mensen/pratap-shetty/","name":"Pratap Shetty","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pravin-manga","type":"person","url":"https://hartvaat.nl/mensen/pravin-manga/","name":"Pravin Manga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"prediman-k-shah","type":"person","url":"https://hartvaat.nl/mensen/prediman-k-shah/","name":"Prediman K Shah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/lipoproteine-a-en-recidiverende-ischemische-events-na-acs-dal-outcomes-analyse/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/12/06/dalcetrapib-wijzigt-de-relatie-tussen-hdl-cholesterol-en-crp/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"preethi-mani","type":"person","url":"https://hartvaat.nl/mensen/preethi-mani/","name":"Preethi Mani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/13/dapt-na-pci-met-des-netwerkmeta-analyse-van-duur-en-intensiteit/","published":"2020-10-13"},{"url":"https://hartvaat.nl/2019/04/01/initieel-en-serieel-crp-en-cv-events-en-dood-na-acs-jama-cardiology/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"priscila-torres-bueno","type":"person","url":"https://hartvaat.nl/mensen/priscila-torres-bueno/","name":"Priscila Torres Bueno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"},{"url":"https://hartvaat.nl/2018/03/13/bariatrische-chirurgie-bij-obese-patienten-met-hypertensie-gateway-gerandomiseer/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pruthvi-c-revaiah","type":"person","url":"https://hartvaat.nl/mensen/pruthvi-c-revaiah/","name":"Pruthvi C Revaiah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/yellow-iii-intracoronaire-beeldvorming-en-genexpressie-na-maximale-lipideverlagi/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"przemysaw-leszek","type":"person","url":"https://hartvaat.nl/mensen/przemysaw-leszek/","name":"Przemysław Leszek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/20/evolution-hf-cee-ba-real-world-dapagliflozin-bij-hfref-in-centraal-en-oost-europ/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2026/02/03/levosimendan-infusies-en-klinisch-beloop-bij-hartfalen-levo-d-resultaten/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"punag-h-divanji","type":"person","url":"https://hartvaat.nl/mensen/punag-h-divanji/","name":"Punag H Divanji","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"},{"url":"https://hartvaat.nl/2022/07/19/meteoric-hf-omecamtiv-mecarbil-verbetert-inspanningscapaciteit-niet-bij-hfref/","published":"2022-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"purnima-rao-melacini","type":"person","url":"https://hartvaat.nl/mensen/purnima-rao-melacini/","name":"Purnima Rao-Melacini","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/13/dulaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-lancet-rewind/","published":"2019-07-13"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"purva-jain","type":"person","url":"https://hartvaat.nl/mensen/purva-jain/","name":"Purva Jain","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/24/heropnames-bij-af-patienten-na-stenting-twee-antitromboticastrategieen-vergeleke/","published":"2017-01-24"},{"url":"https://hartvaat.nl/2016/12/13/csl112-gereconstitueerd-apoliproteine-a-i-na-acuut-mi-veiligheid-en-verdraagbaar/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qi-gao","type":"person","url":"https://hartvaat.nl/mensen/qi-gao/","name":"Qi Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2017/05/16/serieel-hoog-sensitief-troponine-i-en-cv-uitkomsten-bij-diabetes-type-2-examine/","published":"2017-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qi-li","type":"person","url":"https://hartvaat.nl/mensen/qi-li/","name":"Qi Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/29/monocyt-hdl-ratio-en-risico-op-beroerte-myocardinfarct-en-mortaliteit/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2016/05/05/perioperatief-rosuvastatine-bij-hartchirurgie-nejm-trial/","published":"2016-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qi-wu","type":"person","url":"https://hartvaat.nl/mensen/qi-wu/","name":"Qi Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/15/tirzepatide-verlaagt-hypertensierisico-maar-verhoogt-hypotensie-meta-analyse/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2026/12/01/optimale-cardiometabole-gezondheid-tijdens-zwangerschap-verlaagt-risico-op-compl/","published":"2026-08-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qian","type":"person","url":"https://hartvaat.nl/mensen/qian/","name":"Qian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/astma-geassocieerd-met-verhoogd-risico-op-degeneratieve-hartklepziekte-uk-bioban/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/02/20/kosteneffectiviteit-van-mavacamten-bij-obstructieve-hcm-gezondheidswinst-maar-ee/","published":"2026-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qian-wang","type":"person","url":"https://hartvaat.nl/mensen/qian-wang/","name":"Qian Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/cryoablatie-versus-radiofrequentieablatie-bij-paroxysmaal-af-systematische-revie/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/03/01/sacubitril-valsartan-versus-olmesartan-op-centrale-hemodynamiek-bij-ouderen-para/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiang-dong","type":"person","url":"https://hartvaat.nl/mensen/qiang-dong/","name":"Qiang Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/bloeddruk-en-cognitieve-stoornis-en-dementie-meta-analyse-van-209-studies/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qianqian-yang","type":"person","url":"https://hartvaat.nl/mensen/qianqian-yang/","name":"Qianqian Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/25/bloeddrukverlaging-beschermt-over-het-hele-spectrum-van-chronische-nierschade-la/","published":"2026-07-13"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiao-han","type":"person","url":"https://hartvaat.nl/mensen/qiao-han/","name":"Qiao Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qihua-li","type":"person","url":"https://hartvaat.nl/mensen/qihua-li/","name":"Qihua Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qin-wang","type":"person","url":"https://hartvaat.nl/mensen/qin-wang/","name":"Qin Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/15/fgf21-sirtuin-3-hoe-inspanning-beschermt-tegen-diabetische-cardiomyopathie/","published":"2022-11-15"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qinghua-lu","type":"person","url":"https://hartvaat.nl/mensen/qinghua-lu/","name":"Qinghua Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiukui-hao","type":"person","url":"https://hartvaat.nl/mensen/qiukui-hao/","name":"Qiukui Hao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/27/veiligheid-van-pcsk9-remmers-systematische-review-en-meta-analyse/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/12/01/predictieve-modellen-voor-cv-en-renale-uitkomsten-bij-diabetes-type-2-meta-analy/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiuqing-wang","type":"person","url":"https://hartvaat.nl/mensen/qiuqing-wang/","name":"Qiuqing Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/05/gelijktijdige-laa-occlusie-en-tavr-bij-af-haalbaarheid/","published":"2024-03-05"},{"url":"https://hartvaat.nl/2023/07/13/traverse-testosteronsubstitutie-cardiovasculair-veilig-bij-hypogonadisme/","published":"2023-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qiushi-chen","type":"person","url":"https://hartvaat.nl/mensen/qiushi-chen/","name":"Qiushi Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/04/pvi-met-versus-zonder-lineaire-ablatie-bij-persisterend-af-gerandomiseerde-trial/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2024/03/01/svc-isolatie-bij-paroxysmaal-af-zonder-geinduceerde-svc-aritmieen/","published":"2024-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"quentin-r-youmans","type":"person","url":"https://hartvaat.nl/mensen/quentin-r-youmans/","name":"Quentin R Youmans","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"quinn-s-wells","type":"person","url":"https://hartvaat.nl/mensen/quinn-s-wells/","name":"Quinn S Wells","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"qurrat-ul-ain-abid","type":"person","url":"https://hartvaat.nl/mensen/qurrat-ul-ain-abid/","name":"Qurrat-Ul-Ain Abid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/02/duurzaamheid-van-pvi-bij-af-meta-analyse/","published":"2023-11-02"},{"url":"https://hartvaat.nl/2021/05/21/high-power-short-duration-versus-conventionele-rf-ablatie-bij-af-meta-analyse/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"r-preston-mason","type":"person","url":"https://hartvaat.nl/mensen/r-preston-mason/","name":"R Preston Mason","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/23/lp-a-en-cv-risicoreductie-met-icosapent-ethyl-reduce-it-analyse/","published":"2024-04-23"},{"url":"https://hartvaat.nl/2022/08/02/reduce-it-icosapent-ethyl-vermindert-inflammatiemarkers/","published":"2022-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"r-thomas-lumbers","type":"person","url":"https://hartvaat.nl/mensen/r-thomas-lumbers/","name":"R Thomas Lumbers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2022/04/19/therapeutische-doelen-voor-hf-via-proteomics-en-mendeliaanse-randomisatie/","published":"2022-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"r-m","type":"person","url":"https://hartvaat.nl/mensen/r-m/","name":"R. M.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/29/erasmus-mc-linkeratrium-strain-voorspelt-aritmieen-na-chirurgische-correctie-van/","published":"2026-07-11"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"r-t","type":"person","url":"https://hartvaat.nl/mensen/r-t/","name":"R. T.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/direct-naar-ct-coronairangiografie-bij-verdenking-angina-snellere-diagnose-en-mi/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/01/09/hartfalendiagnostiek-na-corona-bijna-niemand-kreeg-de-echo-binnen-de-aanbevolen-/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rachel-h-pathimagaraj","type":"person","url":"https://hartvaat.nl/mensen/rachel-h-pathimagaraj/","name":"Rachel H Pathimagaraj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rachel-schunder","type":"person","url":"https://hartvaat.nl/mensen/rachel-schunder/","name":"Rachel Schunder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"radoslaw-parma","type":"person","url":"https://hartvaat.nl/mensen/radoslaw-parma/","name":"Radoslaw Parma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/leeftijd-en-geleide-de-escalatie-van-antiplaatjestherapie-na-acs-tropical-acs/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/14/geleide-de-escalatie-van-antiplaatjestherapie-na-acs-met-pci-lancet-tropical-acs/","published":"2017-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raffi-kaprielian","type":"person","url":"https://hartvaat.nl/mensen/raffi-kaprielian/","name":"Raffi Kaprielian","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ragnhild-helseth","type":"person","url":"https://hartvaat.nl/mensen/ragnhild-helseth/","name":"Ragnhild Helseth","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/finearts-hf-subanalyse-virale-luchtweginfecties-triggeren-hartfalen-verslechteri/","published":"2026-05-12"},{"url":"https://hartvaat.nl/2026/05/09/meta-analyse-decision-digit-hf-dig-digitalisglycosiden-reduceren-verslechterende/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raheel-ahmed","type":"person","url":"https://hartvaat.nl/mensen/raheel-ahmed/","name":"Raheel Ahmed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/intraveneus-ijzer-bij-hartfalen-met-ijzertekort-meta-analyse-met-trial-sequentie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/01/iv-ijzer-bij-hartfalen-en-ijzerdeficientie-geactualiseerde-meta-analyse-van-rct-/","published":"2025-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rahel-kesterke","type":"person","url":"https://hartvaat.nl/mensen/rahel-kesterke/","name":"Rahel Kesterke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/12/multistars-ami-timing-van-complete-revascularisatie-bij-stemi-nejm/","published":"2023-10-12"},{"url":"https://hartvaat.nl/2022/11/08/mtor-remming-bij-stemi-sirolimus-vermindert-infarctgrootte-niet/","published":"2022-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rahul-aggarwal","type":"person","url":"https://hartvaat.nl/mensen/rahul-aggarwal/","name":"Rahul Aggarwal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/sacubitril-valsartan-uitgebreide-fda-labeling-jama-cardiology-implicaties/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/06/01/mortaliteitsuitkomsten-bij-intensieve-bloeddrukstreefwaarden-bij-ckd/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rahul-chanchlani","type":"person","url":"https://hartvaat.nl/mensen/rahul-chanchlani/","name":"Rahul Chanchlani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/gemaskeerde-hypertensie-bij-kinderen-prevalentie-en-cv-risico-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/06/01/eindorgaanschade-bij-kinderen-met-primaire-hypertensie-meta-analyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rainer-malik","type":"person","url":"https://hartvaat.nl/mensen/rainer-malik/","name":"Rainer Malik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/01/mcp-1-en-cardiovasculaire-mortaliteit-populatie-gebaseerde-meta-analyse/","published":"2021-05-01"},{"url":"https://hartvaat.nl/2018/02/01/differentiele-effecten-van-pcsk9-varianten-op-coronairlijden-versus-ischemisch-c/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rainer-okrojek","type":"person","url":"https://hartvaat.nl/mensen/rainer-okrojek/","name":"Rainer Okrojek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/revacept-gpvi-antagonist-bij-pci-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajeev-malhotra","type":"person","url":"https://hartvaat.nl/mensen/rajeev-malhotra/","name":"Rajeev Malhotra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/07/nieuwe-inspanningsherstelpatronen-als-maat-voor-cardiale-prestatie/","published":"2025-10-07"},{"url":"https://hartvaat.nl/2017/05/16/oraal-ijzer-bij-hfref-met-ijzerdeficientie-jama-ironout-hf/","published":"2017-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raji-devarajan","type":"person","url":"https://hartvaat.nl/mensen/raji-devarajan/","name":"Raji Devarajan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/07/yoga-gebaseerde-hartrevalidatie-na-acuut-mi-gerandomiseerde-trial/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2018/02/13/kwaliteitsverbeteringsinterventie-bij-acuut-mi-in-india-jama-acs-quik/","published":"2018-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajiv-jauhar","type":"person","url":"https://hartvaat.nl/mensen/rajiv-jauhar/","name":"Rajiv Jauhar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/15/ami-management-tijdens-covid-19-scai-positiedocument/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rajiv-sankaranarayanan","type":"person","url":"https://hartvaat.nl/mensen/rajiv-sankaranarayanan/","name":"Rajiv Sankaranarayanan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ambulante-behandeling-van-gedecompenseerd-hartfalen-meta-analyse/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/10/01/natriuretische-peptiden-en-crp-bij-hartfalen-en-ondervoeding-systematische-revie/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralf-lehmann","type":"person","url":"https://hartvaat.nl/mensen/ralf-lehmann/","name":"Ralf Lehmann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralph-a-l-j-theunissen","type":"person","url":"https://hartvaat.nl/mensen/ralph-a-l-j-theunissen/","name":"Ralph A L J Theunissen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2019/11/19/beeldvorming-geleide-versus-routinezorg-bij-nstemi-jacc/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralph-g-brindis","type":"person","url":"https://hartvaat.nl/mensen/ralph-g-brindis/","name":"Ralph G Brindis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralph-j-riello","type":"person","url":"https://hartvaat.nl/mensen/ralph-j-riello/","name":"Ralph J Riello","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ralph-tolg","type":"person","url":"https://hartvaat.nl/mensen/ralph-tolg/","name":"Ralph Tölg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/26/biodegradeerbare-versus-duurzame-polymeer-stents-bij-hoog-bloedingsrisico/","published":"2023-09-26"},{"url":"https://hartvaat.nl/2019/10/17/ticagrelor-of-prasugrel-bij-acuut-coronair-syndroom-nejm-isar-react-5/","published":"2019-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raluca-i-mincu","type":"person","url":"https://hartvaat.nl/mensen/raluca-i-mincu/","name":"Raluca I Mincu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/empathy-hartfalentherapie-bij-patienten-met-gevorderde-kanker-en-palliatieve-zor/","published":"2026-03-05"},{"url":"https://hartvaat.nl/2019/08/01/hartfalen-door-kankerbehandeling-kunnen-we-het-voorkomen/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramez-nairooz","type":"person","url":"https://hartvaat.nl/mensen/ramez-nairooz/","name":"Ramez Nairooz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/01/provisional-versus-twee-stentstrategie-bij-bifurcatielaesies-meta-analyse/","published":"2017-09-01"},{"url":"https://hartvaat.nl/2017/07/01/bioresorbeerbare-scaffold-versus-des-2-jaars-meta-analyse/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rami-el-mahmoud","type":"person","url":"https://hartvaat.nl/mensen/rami-el-mahmoud/","name":"Rami El Mahmoud","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/06/drug-eluting-stents-bij-oudere-patienten-met-coronairlijden-lancet-senior-trial/","published":"2018-01-06"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rami-kahwash","type":"person","url":"https://hartvaat.nl/mensen/rami-kahwash/","name":"Rami Kahwash","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ramin-farzaneh-far","type":"person","url":"https://hartvaat.nl/mensen/ramin-farzaneh-far/","name":"Ramin Farzaneh-Far","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/01/09/ranolazine-bij-incomplete-revascularisatie-na-pci-de-river-pci-trial/","published":"2016-01-09"},{"url":"https://hartvaat.nl/2016/01/05/ranolazine-bij-angina-en-kwaliteit-van-leven-na-pci-met-incomplete-revascularisa/","published":"2016-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"randall-j-lee","type":"person","url":"https://hartvaat.nl/mensen/randall-j-lee/","name":"Randall J Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/decaf-cafeinehoudende-koffie-en-af-gerandomiseerde-trial/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/04/02/amaze-pvi-met-of-zonder-laa-ligatie-bij-af-jama-rct/","published":"2024-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"randi-elituv","type":"person","url":"https://hartvaat.nl/mensen/randi-elituv/","name":"Randi Elituv","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/evolocumab-en-doorgankelijkheid-van-veneuze-bypasses-na-cabg-newton-cabg-cardiol/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2025/09/20/newton-cabg-evolocumab-en-veneuze-graftpatency-na-cabg/","published":"2025-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ranjit-more","type":"person","url":"https://hartvaat.nl/mensen/ranjit-more/","name":"Ranjit More","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2019/10/19/remote-ischemische-conditionering-en-mi-uitkomsten-lancet-condi-2-eric-ppci/","published":"2019-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raphael-rosso","type":"person","url":"https://hartvaat.nl/mensen/raphael-rosso/","name":"Raphael Rosso","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/12/ehra-statement-pulsed-field-ablatie-als-nieuwe-standaard-voor-ablatie-bij-atrium/","published":"2026-05-27"},{"url":"https://hartvaat.nl/2022/05/03/radiale-strain-geleide-leadplaatsing-voor-crt-bij-ischemisch-hf/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raphaelle-dumaine","type":"person","url":"https://hartvaat.nl/mensen/raphaelle-dumaine/","name":"Raphaelle Dumaine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/reduce-ami-betablokker-interruptie-en-bloeddruk-hartfrequentie-effecten-na-mi/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/10/10/reduce-ami-betablokkers-na-mi-met-behouden-ef-niet-nodig-bevestiging/","published":"2024-10-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rasheed-gbadegesin","type":"person","url":"https://hartvaat.nl/mensen/rasheed-gbadegesin/","name":"Rasheed Gbadegesin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/polygene-risicoscores-en-hla-klasse-ii-als-biomarkers-voor-corticosteroidrespons/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/12/24/genomische-ontdekking-bij-nefrotisch-syndroom-mefv-varianten-als-risicofactor-vo/","published":"2025-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rashid","type":"person","url":"https://hartvaat.nl/mensen/rashid/","name":"Rashid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/zuinig-machine-learningmodel-voorspelt-1-jaarssterfte-en-zinloosheid-na-tavi/","published":"2026-07-23"},{"url":"https://hartvaat.nl/2026/03/25/waarom-de-sterfte-na-een-hartinfarct-daalde-15-jaar-nationale-data-uit-engeland-/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rashmi-pant","type":"person","url":"https://hartvaat.nl/mensen/rashmi-pant/","name":"Rashmi Pant","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ravi-assomull","type":"person","url":"https://hartvaat.nl/mensen/ravi-assomull/","name":"Ravi Assomull","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/ffr-en-ifr-als-voorspellers-van-placebo-gecontroleerde-pci-respons-orbita/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2018/01/06/pci-bij-stabiele-angina-lancet-orbita-dubbelblinde-gerandomiseerde-trial/","published":"2018-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ravi-dhar","type":"person","url":"https://hartvaat.nl/mensen/ravi-dhar/","name":"Ravi Dhar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raymond-benza","type":"person","url":"https://hartvaat.nl/mensen/raymond-benza/","name":"Raymond Benza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/triluminate-tweejaarsresultaten-transcatheter-tr-repair-duurzaam-effectief/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2023/05/18/triluminate-transcatheter-tricuspidaliskleprepair-bij-ernstige-tr-nejm/","published":"2023-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"raymond-c-m-leung","type":"person","url":"https://hartvaat.nl/mensen/raymond-c-m-leung/","name":"Raymond C M Leung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebecca-band","type":"person","url":"https://hartvaat.nl/mensen/rebecca-band/","name":"Rebecca Band","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-hypertensie-diagnose-bij-risicozwangerschap-jama-bump-1/","published":"2022-05-03"},{"url":"https://hartvaat.nl/2022/05/03/zelfmeting-bloeddruk-en-bloeddrukcontrole-bij-risicozwangerschap-jama-bump-2/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebecca-lane","type":"person","url":"https://hartvaat.nl/mensen/rebecca-lane/","name":"Rebecca Lane","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebecca-mathew","type":"person","url":"https://hartvaat.nl/mensen/rebecca-mathew/","name":"Rebecca Mathew","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"},{"url":"https://hartvaat.nl/2019/02/19/lv-unloading-tijdens-ecmo-bij-cardiogene-shock/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebecca-mills","type":"person","url":"https://hartvaat.nl/mensen/rebecca-mills/","name":"Rebecca Mills","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rebekah-schiff","type":"person","url":"https://hartvaat.nl/mensen/rebekah-schiff/","name":"Rebekah Schiff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reid","type":"person","url":"https://hartvaat.nl/mensen/reid/","name":"Reid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/verminderde-nierfunctie-verhoogt-hartfalenrisico-bij-ouderen-aspree-cohort/","published":"2026-05-08"},{"url":"https://hartvaat.nl/2026/03/10/machine-learning-voorspelt-30-daagse-sterfte-na-een-dotterbehandeling-australisc/","published":"2026-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"reinhard-vonthein","type":"person","url":"https://hartvaat.nl/mensen/reinhard-vonthein/","name":"Reinhard Vonthein","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/22/milde-hypothermie-bij-cardiogene-shock-complicerend-mi/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2017/08/19/optimale-timing-van-invasieve-strategie-bij-nste-acs-lancet-meta-analyse/","published":"2017-08-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"renato-pietro-ricci","type":"person","url":"https://hartvaat.nl/mensen/renato-pietro-ricci/","name":"Renato Pietro Ricci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/05/01/risicostratificatie-met-geintegreerde-devicediagnostiek-bij-hartfalen/","published":"2018-05-01"},{"url":"https://hartvaat.nl/2017/03/01/vaste-versus-responsieve-pacingfrequentie-bij-permanent-af-met-pacemakerindicati/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"renjie-chen","type":"person","url":"https://hartvaat.nl/mensen/renjie-chen/","name":"Renjie Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/luchtvervuiling-verhoogt-sterfte-door-hypertensie-case-crossover-studie-bij-2-1-/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2017/08/15/fijnstofblootstelling-en-stresshormoonspiegels-gerandomiseerde-luchtzuiveringstr/","published":"2017-08-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rhian-m-touyz","type":"person","url":"https://hartvaat.nl/mensen/rhian-m-touyz/","name":"Rhian M Touyz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/magnesiumsuppletie-en-bloeddruk-meta-analyse-van-rct-s/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/10/07/2024-esc-richtlijn-voor-management-van-hypertensie/","published":"2024-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rhondalyn-forde-mclean","type":"person","url":"https://hartvaat.nl/mensen/rhondalyn-forde-mclean/","name":"Rhondalyn Forde-McLean","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ricardo-avendano","type":"person","url":"https://hartvaat.nl/mensen/ricardo-avendano/","name":"Ricardo Avendano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/ononderbroken-doac-versus-vka-bij-af-ablatie-meta-analyse/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ricardo-fontes-carvalho","type":"person","url":"https://hartvaat.nl/mensen/ricardo-fontes-carvalho/","name":"Ricardo Fontes-Carvalho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/05/sglt2-remmer-met-en-zonder-mra-bij-hartfalen-gecombineerde-analyse/","published":"2025-08-05"},{"url":"https://hartvaat.nl/2023/06/01/hartfalentherapie-bij-hfmref-netwerk-meta-analyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ricardo-mourilhe-rocha","type":"person","url":"https://hartvaat.nl/mensen/ricardo-mourilhe-rocha/","name":"Ricardo Mourilhe-Rocha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ricardo-v-cohen","type":"person","url":"https://hartvaat.nl/mensen/ricardo-v-cohen/","name":"Ricardo V Cohen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/13/bariatrische-chirurgie-en-bloeddruk-na-5-jaar-gerandomiseerde-trial/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"riccardo-proietti","type":"person","url":"https://hartvaat.nl/mensen/riccardo-proietti/","name":"Riccardo Proietti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/linker-hartoorisolatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2017/10/01/korte-dabigatran-onderbreking-voor-device-implantatie-re-ly-multicenterervaring/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rich-davies","type":"person","url":"https://hartvaat.nl/mensen/rich-davies/","name":"Rich Davies","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-anderson","type":"person","url":"https://hartvaat.nl/mensen/richard-anderson/","name":"Richard Anderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/07/renale-denervatie-veilig-en-effectief-bij-patienten-op-antihypertensiva/","published":"2023-11-07"},{"url":"https://hartvaat.nl/2021/12/02/edoxaban-versus-vka-bij-af-na-tavr-nejm-envisage-tavi-af/","published":"2021-12-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-d-souza","type":"person","url":"https://hartvaat.nl/mensen/richard-d-souza/","name":"Richard D'Souza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/09/renale-denervatie-met-antihypertensiva-lancet-spyral-htn-on-med-langetermijn/","published":"2022-04-09"},{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-grimm","type":"person","url":"https://hartvaat.nl/mensen/richard-grimm/","name":"Richard Grimm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/01/fenofibraat-en-langetermijn-cardiovasculair-risico-bij-statinebehandelde-diabete/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/10/01/orthostatische-hypotensie-in-de-accord-bloeddruk-trial-prevalentie-en-klinische-/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-holcomb","type":"person","url":"https://hartvaat.nl/mensen/richard-holcomb/","name":"Richard Holcomb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-j-edwards","type":"person","url":"https://hartvaat.nl/mensen/richard-j-edwards/","name":"Richard J Edwards","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2016/12/15/infarctgrootte-en-linkerkamerremodellering-na-preventieve-pci/","published":"2016-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-kazibwe","type":"person","url":"https://hartvaat.nl/mensen/richard-kazibwe/","name":"Richard Kazibwe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/lp-a-en-hscrp-voorspellen-ascvd-bij-mensen-zonder-klassieke-risicofactoren/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2024/08/01/sarcopenie-en-intensieve-bloeddrukbehandeling-sprint-subanalyse/","published":"2024-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-kobza","type":"person","url":"https://hartvaat.nl/mensen/richard-kobza/","name":"Richard Kobza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-l-dunbar","type":"person","url":"https://hartvaat.nl/mensen/richard-l-dunbar/","name":"Richard L Dunbar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-m-bergenstal","type":"person","url":"https://hartvaat.nl/mensen/richard-m-bergenstal/","name":"Richard M Bergenstal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/09/01/ace-remmers-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-met-dpp-4-remmers/","published":"2016-09-01"},{"url":"https://hartvaat.nl/2016/07/28/liraglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-leader-trial/","published":"2016-07-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-m-cubbon","type":"person","url":"https://hartvaat.nl/mensen/richard-m-cubbon/","name":"Richard M Cubbon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/gepersonaliseerde-rate-response-programmering-verbetert-inspanningstolerantie-bi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2016/06/07/vitamine-d-bij-chronisch-hartfalen-de-vindicate-studie/","published":"2016-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-n-channick","type":"person","url":"https://hartvaat.nl/mensen/richard-n-channick/","name":"Richard N Channick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-n-re","type":"person","url":"https://hartvaat.nl/mensen/richard-n-re/","name":"Richard N Re","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/enterisch-gecoat-versus-ongecoat-aspirine-geen-verschil-in-gi-bloedingen-adaptab/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-p-steeds","type":"person","url":"https://hartvaat.nl/mensen/richard-p-steeds/","name":"Richard P Steeds","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"},{"url":"https://hartvaat.nl/2017/09/01/validiteit-en-reproduceerbaarheid-van-echocardiografie-bij-af-systematische-revi/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-peto","type":"person","url":"https://hartvaat.nl/mensen/richard-peto/","name":"Richard Peto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-t-george","type":"person","url":"https://hartvaat.nl/mensen/richard-t-george/","name":"Richard T George","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/12/evinacumab-bij-homozygote-fh-langetermijn-veiligheid-en-effectiviteit/","published":"2024-07-12"},{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"richard-xu","type":"person","url":"https://hartvaat.nl/mensen/richard-xu/","name":"Richard Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rick-b-vega","type":"person","url":"https://hartvaat.nl/mensen/rick-b-vega/","name":"Rick B Vega","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/15/laroprovstat-eerste-orale-pcsk9-remmer-haalt-80-ldl-reductie-in-combinatie-met-r/","published":"2026-06-19"},{"url":"https://hartvaat.nl/2025/06/03/pursuit-orale-pcsk9-remmer-voor-hypercholesterolemie-gerandomiseerde-trial/","published":"2025-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rickard-linder","type":"person","url":"https://hartvaat.nl/mensen/rickard-linder/","name":"Rickard Linder","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/12/pci-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2024-12-12"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rickey-e-carter","type":"person","url":"https://hartvaat.nl/mensen/rickey-e-carter/","name":"Rickey E Carter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/24/dapagliflozine-verbetert-arteriele-en-veneuze-compliantie-bij-hfpef/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2024/09/01/dapagliflozine-en-rv-pulmonale-interactie-bij-hfpef/","published":"2024-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rifat-atun","type":"person","url":"https://hartvaat.nl/mensen/rifat-atun/","name":"Rifat Atun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"riina-kandolin","type":"person","url":"https://hartvaat.nl/mensen/riina-kandolin/","name":"Riina Kandolin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/lvad-versus-harttransplantatie-bij-hartfalen-finse-kosten-en-uitkomsten/","published":"2026-03-02"},{"url":"https://hartvaat.nl/2020/03/10/routine-versus-selectieve-cardiale-mri-bij-niet-ischemisch-hf-outsmart-hf/","published":"2020-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"riitta-antikainen","type":"person","url":"https://hartvaat.nl/mensen/riitta-antikainen/","name":"Riitta Antikainen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/01/finger-trial-multidomein-leefstijlinterventie-verlaagt-cardiovasculair-risico-bi/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2018/09/01/orthostatische-hypotensie-verhoogt-risico-op-cognitieve-stoornissen/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rik-willems","type":"person","url":"https://hartvaat.nl/mensen/rik-willems/","name":"Rik Willems","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/plotse-hartdood-na-mi-ipd-analyse-van-gepoolde-cohorten/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2020/03/31/staken-van-neurohumorale-blokkade-na-crt/","published":"2020-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rikke-louise-jacobsen","type":"person","url":"https://hartvaat.nl/mensen/rikke-louise-jacobsen/","name":"Rikke Louise Jacobsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rishi-chandiramani","type":"person","url":"https://hartvaat.nl/mensen/rishi-chandiramani/","name":"Rishi Chandiramani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-na-complexe-pci-twilight-complex-pci/","published":"2020-05-19"},{"url":"https://hartvaat.nl/2020/05/19/ticagrelor-met-of-zonder-aspirine-bij-diabetes-na-pci-twilight-diabetes/","published":"2020-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"riyaz-s-patel","type":"person","url":"https://hartvaat.nl/mensen/riyaz-s-patel/","name":"Riyaz S Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-c-bourge","type":"person","url":"https://hartvaat.nl/mensen/robert-c-bourge/","name":"Robert C Bourge","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/10/pulmonalisdrukgeleide-therapie-bij-hfref/","published":"2017-10-10"},{"url":"https://hartvaat.nl/2016/01/30/hemodynamische-telemonitoring-bij-chronisch-hartfalen-volledige-champion-resulta/","published":"2016-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-ekart","type":"person","url":"https://hartvaat.nl/mensen/robert-ekart/","name":"Robert Ekart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2019/06/01/longechogeleide-drooggewichtreductie-en-ambulante-bloeddruk-bij-hemodialyse/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-frederich","type":"person","url":"https://hartvaat.nl/mensen/robert-frederich/","name":"Robert Frederich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/08/ertugliflozine-en-hf-events-bij-diabetes-met-atherosclerotische-cvd-vertis-cv/","published":"2020-12-08"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-h-helm","type":"person","url":"https://hartvaat.nl/mensen/robert-h-helm/","name":"Robert H Helm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-hatala","type":"person","url":"https://hartvaat.nl/mensen/robert-hatala/","name":"Robert Hatala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/upgrade-rv-naar-crt-pacing-bij-hartfalen-met-af-voordelen-bevestigd/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/10/21/upgrade-van-rv-pacing-naar-crt-bij-hartfalen-gerandomiseerde-trial/","published":"2023-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-hollriegel","type":"person","url":"https://hartvaat.nl/mensen/robert-hollriegel/","name":"Robert Höllriegel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-j-sanchez","type":"person","url":"https://hartvaat.nl/mensen/robert-j-sanchez/","name":"Robert J Sanchez","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/12/kosteneffectiviteit-van-alirocumab-na-acs-odyssey-outcomes/","published":"2020-05-12"},{"url":"https://hartvaat.nl/2017/09/26/sams-ci-score-toegepast-op-gerandomiseerde-trial-over-statine-myopathie/","published":"2017-09-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-leong","type":"person","url":"https://hartvaat.nl/mensen/robert-leong/","name":"Robert Leong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-m-califf","type":"person","url":"https://hartvaat.nl/mensen/robert-m-califf/","name":"Robert M Califf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/simvastatine-ezetimibe-versus-simvastatine-na-acs-bij-75-plussers-jama-cardiolog/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2016/07/01/natief-kleplijden-bij-af-patienten-op-warfarine-of-rivaroxaban/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-m-elashoff","type":"person","url":"https://hartvaat.nl/mensen/robert-m-elashoff/","name":"Robert M Elashoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/04/05/bloeddrukverlaging-bij-kappersbezoek-nejm-clustergerandomiseerde-trial/","published":"2018-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-m-silver","type":"person","url":"https://hartvaat.nl/mensen/robert-m-silver/","name":"Robert M Silver","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/01/preconceptiebloeddruk-en-verandering-naar-vroege-zwangerschap-risicofactor-voor-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddruk-voor-conceptie-en-reproductieve-uitkomsten/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-m-stoekenbroek","type":"person","url":"https://hartvaat.nl/mensen/robert-m-stoekenbroek/","name":"Robert M Stoekenbroek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/11/01/inclisiran-1-of-2-dosis-en-ldl-cholesterol-orion-1-1-jaarsfollow-up/","published":"2019-11-01"},{"url":"https://hartvaat.nl/2018/09/25/sirna-tegen-pcsk9-en-atherogene-lipoproteinen-orion-1-secundaire-eindpunten/","published":"2018-09-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-mikulik","type":"person","url":"https://hartvaat.nl/mensen/robert-mikulik/","name":"Robert Mikulik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/13/convince-langetermijn-colchicine-voor-preventie-van-recidief-niet-cardioembolisc/","published":"2024-07-13"},{"url":"https://hartvaat.nl/2024/05/16/annexa-i-andexanet-alfa-bij-factor-xa-remmer-geassocieerde-intracerebrale-bloedi/","published":"2024-05-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-nechwatal","type":"person","url":"https://hartvaat.nl/mensen/robert-nechwatal/","name":"Robert Nechwatal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/14/gestandaardiseerde-inspanningstraining-bij-pah-en-cteph-haalbaarheid-en-veilighe/","published":"2021-06-14"},{"url":"https://hartvaat.nl/2016/01/01/inspanningstraining-verbetert-zuurstofopname-en-hemodynamiek-bij-ernstige-pulmon/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-przybylski","type":"person","url":"https://hartvaat.nl/mensen/robert-przybylski/","name":"Robert Przybylski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/massieve-linkerventrikelhypertrofie-bij-kinderen-met-hypertrofische-cardiomyopat/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2026/05/12/massieve-lvh-bij-pediatrische-hcm-vroeger-diagnose-vaker-sarcomere-variant-driev/","published":"2026-05-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-scragg","type":"person","url":"https://hartvaat.nl/mensen/robert-scragg/","name":"Robert Scragg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/arteriele-golfvormclusters-en-langetermijn-klinisch-nut/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2017/06/01/maandelijks-hooggedoseerd-vitamine-d-en-cardiovasculaire-ziekte-gerandomiseerde-/","published":"2017-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-shaddy","type":"person","url":"https://hartvaat.nl/mensen/robert-shaddy/","name":"Robert Shaddy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-w-harrison","type":"person","url":"https://hartvaat.nl/mensen/robert-w-harrison/","name":"Robert W Harrison","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/27/ziekenhuis-en-post-ontslagkwaliteitsinterventie-bij-hf-jama-connect-hf/","published":"2021-07-27"},{"url":"https://hartvaat.nl/2017/05/25/levosimendan-bij-lv-disfunctie-voor-hartchirurgie-nejm-levo-cts/","published":"2017-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-whitbourn","type":"person","url":"https://hartvaat.nl/mensen/robert-whitbourn/","name":"Robert Whitbourn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robert-wilensky","type":"person","url":"https://hartvaat.nl/mensen/robert-wilensky/","name":"Robert Wilensky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/02/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med-pivotal/","published":"2020-05-02"},{"url":"https://hartvaat.nl/2017/11/11/renale-denervatie-zonder-antihypertensiva-lancet-spyral-htn-off-med/","published":"2017-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberta-campana","type":"person","url":"https://hartvaat.nl/mensen/roberta-campana/","name":"Roberta Campana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-badagliacca","type":"person","url":"https://hartvaat.nl/mensen/roberto-badagliacca/","name":"Roberto Badagliacca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/04/01/sacubitril-valsartan-na-acuut-mi-meta-analyse-van-in-hospital-initiatie/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-elosua","type":"person","url":"https://hartvaat.nl/mensen/roberto-elosua/","name":"Roberto Elosua","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/disfunctioneel-hdl-en-incidentie-van-acs-bij-hoog-cardiovasculair-risico/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2017/02/14/mediterraan-dieet-verbetert-hdl-functie-bij-hoog-cardiovasculair-risico-gerandom/","published":"2017-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-martin-reyes","type":"person","url":"https://hartvaat.nl/mensen/roberto-martin-reyes/","name":"Roberto Martín-Reyes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2025/04/10/dapagliflozine-bij-patienten-die-tavi-ondergaan-gerandomiseerde-trial-nejm/","published":"2025-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-minutolo","type":"person","url":"https://hartvaat.nl/mensen/roberto-minutolo/","name":"Roberto Minutolo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-rondine","type":"person","url":"https://hartvaat.nl/mensen/roberto-rondine/","name":"Roberto Rondine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roberto-rordorf","type":"person","url":"https://hartvaat.nl/mensen/roberto-rordorf/","name":"Roberto Rordorf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2018/03/13/digoxine-en-mortaliteit-bij-patienten-met-atriumfibrilleren/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robin-condliffe","type":"person","url":"https://hartvaat.nl/mensen/robin-condliffe/","name":"Robin Condliffe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/01/palliatieve-zorg-bij-ph-met-congenitaal-hartlijden-expertopinie/","published":"2021-06-01"},{"url":"https://hartvaat.nl/2018/12/04/echocardiografische-screening-op-ph-bij-aangeboren-hartafwijkingen-jacc-review/","published":"2018-12-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robin-conwit","type":"person","url":"https://hartvaat.nl/mensen/robin-conwit/","name":"Robin Conwit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robin-p-f-dullaart","type":"person","url":"https://hartvaat.nl/mensen/robin-p-f-dullaart/","name":"Robin P F Dullaart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/mendeliaanse-randomisatie-hmgcr-remming-verhoogt-diabetesrisico-andere-lipidendo/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2021/10/05/ketonlichamen-en-functionele-uitkomsten-na-stemi/","published":"2021-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"robin-ray","type":"person","url":"https://hartvaat.nl/mensen/robin-ray/","name":"Robin Ray","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/13/ironman-leeftijdgestratificeerde-effecten-van-iv-ijzer-bij-hf/","published":"2025-06-13"},{"url":"https://hartvaat.nl/2022/12/17/ironman-intraveneus-ijzer-bij-hartfalen-met-ijzerdeficientie-lancet-rct/","published":"2022-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rocco-a-montone","type":"person","url":"https://hartvaat.nl/mensen/rocco-a-montone/","name":"Rocco A Montone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/cardiologen-onderschatten-omgevingsrisicofactoren/","published":"2026-04-09"},{"url":"https://hartvaat.nl/2017/05/30/tijdstrends-in-complicaties-van-bioresorbeerbare-versus-metallic-stents/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roderick-tung","type":"person","url":"https://hartvaat.nl/mensen/roderick-tung/","name":"Roderick Tung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"},{"url":"https://hartvaat.nl/2019/07/09/his-correctieve-pacing-versus-biventriculaire-pacing-voor-crt-bij-hartfalen/","published":"2019-07-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rodrigo-bagur","type":"person","url":"https://hartvaat.nl/mensen/rodrigo-bagur/","name":"Rodrigo Bagur","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/brede-inzet-van-oraal-semaglutide-in-de-vs-zou-jaarlijks-tot-60-000-cardiovascul/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2017/10/03/ridaforolimus-versus-zotarolimus-eluting-stents-gerandomiseerde-primaire-resulta/","published":"2017-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rodrigo-m-joaquim","type":"person","url":"https://hartvaat.nl/mensen/rodrigo-m-joaquim/","name":"Rodrigo M Joaquim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rodrigue-garcia","type":"person","url":"https://hartvaat.nl/mensen/rodrigue-garcia/","name":"Rodrigue Garcia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/31/uit-het-hospitaal-hartstilstand-komt-12-keer-vaker-voor-bij-niet-ischemische-car/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roger-mcpherson","type":"person","url":"https://hartvaat.nl/mensen/roger-mcpherson/","name":"Roger McPherson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rohan-poulter","type":"person","url":"https://hartvaat.nl/mensen/rohan-poulter/","name":"Rohan Poulter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/02/determinanten-van-medicatietrouw-na-acs-secundaire-analyse/","published":"2025-05-02"},{"url":"https://hartvaat.nl/2022/05/10/sms-voor-medicatietrouw-en-secundaire-preventie-na-acs-textmeds/","published":"2022-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rohin-k-reddy","type":"person","url":"https://hartvaat.nl/mensen/rohin-k-reddy/","name":"Rohin K Reddy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/16/revascularisatiestrategieen-na-mi-systematische-review-en-meta-analyse/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/02/16/catheterablatie-verbetert-cv-uitkomsten-bij-af-en-hartfalen-meta-analyse-van-rct/","published":"2023-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roland-r-j-van-kimmenade","type":"person","url":"https://hartvaat.nl/mensen/roland-r-j-van-kimmenade/","name":"Roland R J van Kimmenade","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/05/14/prehospitale-troponine-voor-uitsluiting-nste-acs-gerandomiseerde-trial/","published":"2023-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rolf-doerr","type":"person","url":"https://hartvaat.nl/mensen/rolf-doerr/","name":"Rolf Doerr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rolf-h-h-groenwold","type":"person","url":"https://hartvaat.nl/mensen/rolf-h-h-groenwold/","name":"Rolf H H Groenwold","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/22/cva-risicoscores-bij-af-vergeleken-cha2ds2-vasc-blijft-de-beste/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2016/03/22/zelfmanagementinterventies-bij-hartfalen-individuele-patientdata-meta-analyse/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rolf-steffensen","type":"person","url":"https://hartvaat.nl/mensen/rolf-steffensen/","name":"Rolf Steffensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"romain-sonneville","type":"person","url":"https://hartvaat.nl/mensen/romain-sonneville/","name":"Romain Sonneville","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/06/levoecmo-levosimendan-bij-ecmo-weaning-bij-cardiogene-shock/","published":"2026-01-06"},{"url":"https://hartvaat.nl/2022/02/01/matige-hypothermie-versus-normothermie-bij-cardiogene-shock-met-va-ecmo-jama-hyp/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roman-miklik","type":"person","url":"https://hartvaat.nl/mensen/roman-miklik/","name":"Roman Miklik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"romy-gaillard","type":"person","url":"https://hartvaat.nl/mensen/romy-gaillard/","name":"Romy Gaillard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronald-g-victor","type":"person","url":"https://hartvaat.nl/mensen/ronald-g-victor/","name":"Ronald G Victor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/02/duurzaamheid-van-bloeddrukeffect-van-kapper-interventie/","published":"2019-01-02"},{"url":"https://hartvaat.nl/2018/04/05/bloeddrukverlaging-bij-kappersbezoek-nejm-clustergerandomiseerde-trial/","published":"2018-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronald-m-witteles","type":"person","url":"https://hartvaat.nl/mensen/ronald-m-witteles/","name":"Ronald M Witteles","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/27/vutrisiran-bij-attr-cm-impact-van-hartfalenernst-op-effectiviteit/","published":"2025-05-27"},{"url":"https://hartvaat.nl/2019/07/23/ag10-transthyretinestabilisator-bij-symptomatische-attr-cardiomyopathie/","published":"2019-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronald-s-freudenberger","type":"person","url":"https://hartvaat.nl/mensen/ronald-s-freudenberger/","name":"Ronald S Freudenberger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rong-jiang","type":"person","url":"https://hartvaat.nl/mensen/rong-jiang/","name":"Rong Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/06/dronedaron-na-af-ablatie-gelijke-werkzaamheid-minder-bijwerkingen-dan-amiodaron/","published":"2026-05-03"},{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rongwei-fu","type":"person","url":"https://hartvaat.nl/mensen/rongwei-fu/","name":"Rongwei Fu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/23/uspstf-evidence-review-statines-voor-primaire-cv-preventie-geactualiseerd/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2021/05/25/gedragsinterventies-voor-gezond-gewicht-in-de-zwangerschap-jama-uspstf-evidence-/","published":"2021-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ronit-katz","type":"person","url":"https://hartvaat.nl/mensen/ronit-katz/","name":"Ronit Katz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/20/aangetaste-tubulaire-secretiecapaciteit-verhoogt-cardiovasculaire-sterfte-hunt-s/","published":"2026-08-28"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rory-wolfe","type":"person","url":"https://hartvaat.nl/mensen/rory-wolfe/","name":"Rory Wolfe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/langetermijn-bloeddrukvariabiliteit-en-cv-risico-bij-ouderen-in-de-community/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","published":"2020-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rosa-sicari","type":"person","url":"https://hartvaat.nl/mensen/rosa-sicari/","name":"Rosa Sicari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/longechogeleide-behandeling-bij-hemodialysepatienten-met-hoog-cv-risico-gerandom/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2018/05/01/klinische-score-verbetert-risicostratificatie-bij-stressechocardiografie/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rosa-maria-bruno","type":"person","url":"https://hartvaat.nl/mensen/rosa-maria-bruno/","name":"Rosa-Maria Bruno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/01/bloeddrukverlaging-en-polsgolfsnelheid-meta-analyse/","published":"2024-07-01"},{"url":"https://hartvaat.nl/2021/09/01/normalisatie-van-arteriele-stijfheid-en-cv-events-sparte-studie/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rosalinda-madonna","type":"person","url":"https://hartvaat.nl/mensen/rosalinda-madonna/","name":"Rosalinda Madonna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/metabool-cardiovasculair-risico-nieuwe-mechanismen-en-therapiekansen/","published":"2026-03-26"},{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rosaly-a-buiten","type":"person","url":"https://hartvaat.nl/mensen/rosaly-a-buiten/","name":"Rosaly A Buiten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/01/uitkomsten-van-des-in-kleine-coronairen-naar-strutdikte-jama-cardiology-meta-ana/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2018/10/06/resolute-onyx-versus-orsiro-stent-lancet-gerandomiseerde-non-inferioriteitstrial/","published":"2018-10-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rosanne-m-crooke","type":"person","url":"https://hartvaat.nl/mensen/rosanne-m-crooke/","name":"Rosanne M Crooke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/29/insuline-voorkomt-hypercholesterolemie-via-12-gehydroxyleerde-galzuren/","published":"2022-03-29"},{"url":"https://hartvaat.nl/2017/07/20/angptl3-antisense-oligonucleotiden-cardiovasculaire-en-metabole-effecten-nejm/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rosaria-alvaro","type":"person","url":"https://hartvaat.nl/mensen/rosaria-alvaro/","name":"Rosaria Alvaro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/motivational-interviewing-en-zorggebruik-en-mortaliteit-bij-hf-motivate-hf/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/06/01/motivational-interviewing-bij-hartfalen-voor-zelfzorg-motivate-hf-gerandomiseerd/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rosario-tumino","type":"person","url":"https://hartvaat.nl/mensen/rosario-tumino/","name":"Rosario Tumino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roshan-weerackody","type":"person","url":"https://hartvaat.nl/mensen/roshan-weerackody/","name":"Roshan Weerackody","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/23/anatomische-versus-viabiliteitsgerichte-completeness-van-revascularisatie/","published":"2024-07-23"},{"url":"https://hartvaat.nl/2022/10/13/revived-bcis2-pci-verbetert-overleving-niet-bij-ischemische-lv-disfunctie/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ross-j-hunter","type":"person","url":"https://hartvaat.nl/mensen/ross-j-hunter/","name":"Ross J Hunter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/01/ablatie-index-geleide-af-ablatie-geactualiseerde-meta-analyse/","published":"2020-11-01"},{"url":"https://hartvaat.nl/2016/03/01/intrathoracale-impedantiemonitoring-bij-chronisch-hartfalen-de-limit-chf-studie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ross-welch","type":"person","url":"https://hartvaat.nl/mensen/ross-welch/","name":"Ross Welch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roxy-senior","type":"person","url":"https://hartvaat.nl/mensen/roxy-senior/","name":"Roxy Senior","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roy-beigel","type":"person","url":"https://hartvaat.nl/mensen/roy-beigel/","name":"Roy Beigel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/routinematige-urine-natriummeting-drijft-agressievere-diurese-bij-acuut-hartfale/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2017/12/01/kauwen-versus-slikken-van-ticagrelor-en-plaatjesremming-bij-stemi/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roy-beinart","type":"person","url":"https://hartvaat.nl/mensen/roy-beinart/","name":"Roy Beinart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/02/gerichte-lv-leadplaatsing-bij-crt-meta-analyse-van-beeldvorming-en-elektrisch-ge/","published":"2023-08-02"},{"url":"https://hartvaat.nl/2022/05/03/radiale-strain-geleide-leadplaatsing-voor-crt-bij-ischemisch-hf/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roy-s-gardner","type":"person","url":"https://hartvaat.nl/mensen/roy-s-gardner/","name":"Roy S Gardner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/15/implanteerbare-hemodynamische-monitoring-bij-hartfalen-meta-analyse-over-ef-spec/","published":"2023-05-15"},{"url":"https://hartvaat.nl/2019/09/01/antistolling-bij-hf-met-sinusritme-systematische-review-en-meta-analyse/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"roza-saraei","type":"person","url":"https://hartvaat.nl/mensen/roza-saraei/","name":"Roza Saraei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2022/07/15/geindividualiseerde-versus-standaard-cryoballonablatie-bij-paroxysmaal-af/","published":"2022-07-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruben-r-de-with","type":"person","url":"https://hartvaat.nl/mensen/ruben-r-de-with/","name":"Ruben R De With","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/08/antiaritmica-bij-vroeg-persisterend-af-met-hf-race-3/","published":"2021-09-08"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruben-w-de-winter","type":"person","url":"https://hartvaat.nl/mensen/ruben-w-de-winter/","name":"Ruben W de Winter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/pci-van-natief-coronairvat-versus-veneuze-graft-na-eerdere-cabg-rct/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/07/12/nste-acs-na-cabg-meta-analyse-van-behandelstrategieen/","published":"2024-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rudolf-duehmke","type":"person","url":"https://hartvaat.nl/mensen/rudolf-duehmke/","name":"Rudolf Duehmke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/03/01/doodsoorzaken-bij-crt-met-en-zonder-defibrillator-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rufus-akinyemi","type":"person","url":"https://hartvaat.nl/mensen/rufus-akinyemi/","name":"Rufus Akinyemi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2016/12/01/lacunes-in-hypertensierichtlijnen-in-lage-en-middeninkomenslanden-systematische-/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruhong-jiang","type":"person","url":"https://hartvaat.nl/mensen/ruhong-jiang/","name":"Ruhong Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruihai-yang","type":"person","url":"https://hartvaat.nl/mensen/ruihai-yang/","name":"Ruihai Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"},{"url":"https://hartvaat.nl/2022/05/21/dorpsarts-geleide-multifacet-interventie-voor-bloeddrukcontrole-in-ruraal-china-/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruining-zhang","type":"person","url":"https://hartvaat.nl/mensen/ruining-zhang/","name":"Ruining Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruixue-yang","type":"person","url":"https://hartvaat.nl/mensen/ruixue-yang/","name":"Ruixue Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2023/12/01/step-trial-diastolische-bloeddruk-beinvloedt-effect-van-intensieve-behandeling/","published":"2023-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruizhi-zheng","type":"person","url":"https://hartvaat.nl/mensen/ruizhi-zheng/","name":"Ruizhi Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/27/intensieve-bloeddrukcontrole-bij-type-2-diabetes-nejm/","published":"2025-03-27"},{"url":"https://hartvaat.nl/2023/08/01/bloeddrukstreefwaarden-bij-type-2-diabetes-netwerk-meta-analyse/","published":"2023-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruken-oezge-akbulak","type":"person","url":"https://hartvaat.nl/mensen/ruken-oezge-akbulak/","name":"Ruken Oezge Akbulak","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/09/gewichtsverlies-voor-af-ablatie-sort-af-gerandomiseerde-trial/","published":"2021-10-09"},{"url":"https://hartvaat.nl/2018/01/01/energiebron-en-vroeg-af-recidief-cryoballon-versus-radiofrequentie/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rulan-s-parekh","type":"person","url":"https://hartvaat.nl/mensen/rulan-s-parekh/","name":"Rulan S Parekh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/gemaskeerde-hypertensie-bij-kinderen-prevalentie-en-cv-risico-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/06/01/eindorgaanschade-bij-kinderen-met-primaire-hypertensie-meta-analyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rumes-sriamareswaran","type":"person","url":"https://hartvaat.nl/mensen/rumes-sriamareswaran/","name":"Rumes Sriamareswaran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rune-boas","type":"person","url":"https://hartvaat.nl/mensen/rune-boas/","name":"Rune Boas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/08/periodieke-repolarisatiedynamiek-identificeert-icd-responders-bij-nicm-danish/","published":"2022-03-08"},{"url":"https://hartvaat.nl/2021/04/06/ventriculaire-aritmie-bij-niet-ischemisch-hf-prevalentie-en-prognose-danish/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rune-mo","type":"person","url":"https://hartvaat.nl/mensen/rune-mo/","name":"Rune Mo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/01/telerevalidatie-haalbaar-voor-hartfalenpatienten-zonder-toegang-tot-poliklinisch/","published":"2023-08-01"},{"url":"https://hartvaat.nl/2022/08/01/cardiorenaal-syndroom-en-fitheid-bij-hartfalen-telerevalidatie-trial/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rupasvi-dhurjati","type":"person","url":"https://hartvaat.nl/mensen/rupasvi-dhurjati/","name":"Rupasvi Dhurjati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/30/bloeddrukverlagende-effectiviteit-van-antihypertensiva-en-combinaties-uitgebreid/","published":"2025-08-30"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-drievoudige-pil-versus-standaardzorg-bij-hypertensie-in-nigeria/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruschitzka","type":"person","url":"https://hartvaat.nl/mensen/ruschitzka/","name":"Ruschitzka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/31/titine-cardiomyopathie-meestal-dcm-of-linksdominante-acm-met-blijvend-ritmestoor/","published":"2026-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"russell-j-wiese","type":"person","url":"https://hartvaat.nl/mensen/russell-j-wiese/","name":"Russell J Wiese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","published":"2025-12-18"},{"url":"https://hartvaat.nl/2021/11/13/tirzepatide-versus-insuline-glargine-bij-diabetes-type-2-met-hoog-cv-risico-lanc/","published":"2021-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"russell-j-de-souza","type":"person","url":"https://hartvaat.nl/mensen/russell-j-de-souza/","name":"Russell J de Souza","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/peulvruchten-in-de-voeding-verlagen-ldl-en-non-hdl-dose-response-meta-analyse-va/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2017/03/07/dieetaanbevelingen-en-gewichtsverlies-en-cardiovasculaire-risicofactoren/","published":"2017-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"russell-p-tracy","type":"person","url":"https://hartvaat.nl/mensen/russell-p-tracy/","name":"Russell P Tracy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/01/immuuncelsubsets-voorspellen-incident-hartfalen-in-populatiestudies/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rutger-jan-nuis","type":"person","url":"https://hartvaat.nl/mensen/rutger-jan-nuis/","name":"Rutger-Jan Nuis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/echocardiografie-overschatte-drukgradienten-na-tav-in-tav-met-ballon-expandable-/","published":"2026-08-26"},{"url":"https://hartvaat.nl/2020/12/15/prehospitaal-gemalen-prasugrel-bij-stemi-gerandomiseerde-trial/","published":"2020-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruth-c-campbell","type":"person","url":"https://hartvaat.nl/mensen/ruth-c-campbell/","name":"Ruth C Campbell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/09/diastolische-bloeddruk-en-intensieve-bloeddrukcontrole-sprint-analyse/","published":"2018-01-09"},{"url":"https://hartvaat.nl/2016/06/28/intensieve-versus-standaard-bloeddrukcontrole-bij-75-plussers-sprint-subanalyse/","published":"2016-06-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ruth-kirby","type":"person","url":"https://hartvaat.nl/mensen/ruth-kirby/","name":"Ruth Kirby","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rutten","type":"person","url":"https://hartvaat.nl/mensen/rutten/","name":"Rutten","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/21/delphi-consensus-over-uitgestelde-en-gemiste-diagnose-van-coronairlijden/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/05/04/angina-toevoegen-aan-de-h2fpef-score-verbetert-hfpef-diagnose-bij-vrouwen-geen-w/","published":"2026-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ryan-gage","type":"person","url":"https://hartvaat.nl/mensen/ryan-gage/","name":"Ryan Gage","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/emerge-laa-amulet-occluder-in-12-180-patienten-96-succes-1-jaars-beroerte-1-6-re/","published":"2026-06-25"},{"url":"https://hartvaat.nl/2023/08/02/peri-device-lekkage-bij-laa-occluders-mechanismen-en-voorspellers/","published":"2023-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ryohei-ono","type":"person","url":"https://hartvaat.nl/mensen/ryohei-ono/","name":"Ryohei Ono","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/09/meta-analyse-decision-digit-hf-dig-digitalisglycosiden-reduceren-verslechterende/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2026/01/05/magnesium-en-uitkomsten-bij-hfref-galactic-hf-subanalyse/","published":"2026-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ryszard-piotrowicz","type":"person","url":"https://hartvaat.nl/mensen/ryszard-piotrowicz/","name":"Ryszard Piotrowicz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/01/telereh-hf-etiologie-subanalyse-van-telerevalidatie-bij-hartfalen/","published":"2021-04-01"},{"url":"https://hartvaat.nl/2020/03/01/hybride-telerevalidatie-bij-hartfalen-jama-cardiology-tele-hf-trial/","published":"2020-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"s-lale-tokgozoglu","type":"person","url":"https://hartvaat.nl/mensen/s-lale-tokgozoglu/","name":"S Lale Tokgozoglu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/pcsk9-remming-en-aortastenose-fourier-exploratieve-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/12/01/evolocumab-bij-hoogrisicopatienten-met-laag-ldl-op-statine-fourier-subanalyse/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"s-a","type":"person","url":"https://hartvaat.nl/mensen/s-a/","name":"S. A.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/waarom-de-sterfte-na-een-hartinfarct-daalde-15-jaar-nationale-data-uit-engeland-/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/01/06/machine-learning-algoritme-mi3-helpt-een-infarct-uitsluiten-bij-een-onduidelijke/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"s-h-j","type":"person","url":"https://hartvaat.nl/mensen/s-h-j/","name":"S. H. J.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/16/smart2-risicomodel-onderschat-het-recidiefrisico-bij-kwetsbare-groepen-leids-haa/","published":"2026-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"s-r","type":"person","url":"https://hartvaat.nl/mensen/s-r/","name":"S. R.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/sekseverschillen-in-secundaire-preventie-na-acs-vrouwen-halen-minder-vaak-hun-ld/","published":"2026-07-23"},{"url":"https://hartvaat.nl/2026/04/10/zuinig-machine-learningmodel-voorspelt-1-jaarssterfte-en-zinloosheid-na-tavi/","published":"2026-07-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"s-v","type":"person","url":"https://hartvaat.nl/mensen/s-v/","name":"S. V.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/04/noorse-nationale-validatie-myocarditis-na-mrna-covid-vaccinatie-4-5-per-100-000-/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/05/26/asymptomatische-matige-ernstige-aortaklepinsufficientie-niet-benigne-meta-analys/","published":"2026-07-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sabine-ernst","type":"person","url":"https://hartvaat.nl/mensen/sabine-ernst/","name":"Sabine Ernst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sabine-fenzl","type":"person","url":"https://hartvaat.nl/mensen/sabine-fenzl/","name":"Sabine Fenzl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sabrina-grant","type":"person","url":"https://hartvaat.nl/mensen/sabrina-grant/","name":"Sabrina Grant","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/01/kosteneffectiviteit-van-telemonitoring-en-zelfmeting-van-bloeddruk-tasminh4/","published":"2019-06-01"},{"url":"https://hartvaat.nl/2018/03/10/zelfgemeten-bloeddruk-met-of-zonder-telemonitoring-voor-medicatietitratie-lancet/","published":"2018-03-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sabrina-times","type":"person","url":"https://hartvaat.nl/mensen/sabrina-times/","name":"Sabrina Times","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-af-richtlijn-jacc-editie/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2024/01/02/2023-acc-aha-accp-hrs-af-richtlijn-nieuwe-classificatie-en-behandelaanpak/","published":"2024-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saeed","type":"person","url":"https://hartvaat.nl/mensen/saeed/","name":"Saeed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/infectieuze-endocarditis-na-tavi-diabetes-belangrijkste-risicofactor-e-faecalis-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/03/31/gespecialiseerde-hartklepklinieken-leiden-tot-betere-richtlijnconforme-zorg/","published":"2026-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sahrai-saeed","type":"person","url":"https://hartvaat.nl/mensen/sahrai-saeed/","name":"Sahrai Saeed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/10/01/lage-arteriele-compliance-en-cv-morbiditeit-bij-aortaklepstenose/","published":"2019-10-01"},{"url":"https://hartvaat.nl/2017/09/01/slagvolume-en-cardiovasculair-risico-bij-progressie-van-aortaklepstenose/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saima-mushtaq","type":"person","url":"https://hartvaat.nl/mensen/saima-mushtaq/","name":"Saima Mushtaq","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-laci-21-identificeert-hoogrisicopatienten-met-hfref-onafhankelijk-van-lvef-e/","published":"2026-06-30"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saleem-kassam","type":"person","url":"https://hartvaat.nl/mensen/saleem-kassam/","name":"Saleem Kassam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/06/21/myocardiale-blush-en-microvasculaire-reperfusie-na-handmatige-trombectomie-bij-s/","published":"2016-06-21"},{"url":"https://hartvaat.nl/2016/01/09/trombusaspiratie-bij-stemi-1-jaarsfollow-up-van-de-total-trial/","published":"2016-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salim-virani","type":"person","url":"https://hartvaat.nl/mensen/salim-virani/","name":"Salim Virani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/07/kosteneffectiviteit-van-stapsgewijze-lipidenverlaging-na-coronaire-bypasschirurg/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2016/11/22/management-van-klinisch-significante-geneesmiddelinteracties-met-statines-aha-aa/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sallie-anne-pearson","type":"person","url":"https://hartvaat.nl/mensen/sallie-anne-pearson/","name":"Sallie-Anne Pearson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/01/ssass-secundaire-analyse-kaliumverrijkt-zout-en-cardiale-uitkomsten/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salma-ayis","type":"person","url":"https://hartvaat.nl/mensen/salma-ayis/","name":"Salma Ayis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/21/ijzerisomaltosides-en-skeletspierdenergie-bij-chronisch-hf-met-ijzerdeficientie/","published":"2019-05-21"},{"url":"https://hartvaat.nl/2018/03/01/medicamenteuze-behandeling-en-uitkomsten-bij-hfpef-systematische-review-en-meta-/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salvatore-ierna","type":"person","url":"https://hartvaat.nl/mensen/salvatore-ierna/","name":"Salvatore Ierna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/08/radiale-versus-femorale-toegang-en-bivalirudine-versus-ufh-bij-acs-lancet-matrix/","published":"2018-09-08"},{"url":"https://hartvaat.nl/2018/03/20/bivalirudine-of-heparine-bij-invasief-acs-management/","published":"2018-03-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salvatore-panico","type":"person","url":"https://hartvaat.nl/mensen/salvatore-panico/","name":"Salvatore Panico","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salwa-beheiry","type":"person","url":"https://hartvaat.nl/mensen/salwa-beheiry/","name":"Salwa Beheiry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/linker-hartoorisolatie-bij-langdurig-persisterend-af-de-belief-trial/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/04/26/ablatie-versus-amiodaron-bij-persisterend-af-met-hartfalen-en-icd-gerandomiseerd/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samantha-greene","type":"person","url":"https://hartvaat.nl/mensen/samantha-greene/","name":"Samantha Greene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/01/polymeervrije-biolimus-stent-bij-hoog-bloedingsrisico-met-acs-leaders-free-subst/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sami-i-somo","type":"person","url":"https://hartvaat.nl/mensen/sami-i-somo/","name":"Sami I Somo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2019/01/08/cva-analyse-in-momentum-3-langetermijncohort/","published":"2019-01-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samiha-sarwat","type":"person","url":"https://hartvaat.nl/mensen/samiha-sarwat/","name":"Samiha Sarwat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/victorion-inception-vroege-inclisiran-na-acuut-coronair-syndroom-verviervoudigt-/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samir-agrawal","type":"person","url":"https://hartvaat.nl/mensen/samir-agrawal/","name":"Samir Agrawal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samir-mehta","type":"person","url":"https://hartvaat.nl/mensen/samir-mehta/","name":"Samir Mehta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/26/rate-af-kosteneffectiviteit-van-digoxine-versus-betablokkers-bij-permanent-af/","published":"2025-03-26"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samira-garonzik","type":"person","url":"https://hartvaat.nl/mensen/samira-garonzik/","name":"Samira Garonzik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/06/apixaban-bij-af-op-hemodialyse-eerste-gerandomiseerde-trial/","published":"2022-12-06"},{"url":"https://hartvaat.nl/2020/04/28/apixaban-versus-warfarine-bij-af-met-gevorderde-ckd/","published":"2020-04-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sammy-elmariah","type":"person","url":"https://hartvaat.nl/mensen/sammy-elmariah/","name":"Sammy Elmariah","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2016/01/21/doodsoorzaken-bij-langdurige-dapt-na-coronaire-stents/","published":"2016-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sammy-zwackman","type":"person","url":"https://hartvaat.nl/mensen/sammy-zwackman/","name":"Sammy Zwackman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/02/bioadaptor-implantaat-versus-drug-eluting-stent-bij-stabiel-coronairlijden/","published":"2024-11-02"},{"url":"https://hartvaat.nl/2024/04/25/frame-ami-ffr-geleide-versus-complete-pci-bij-mi-nejm/","published":"2024-04-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samuel-broderick","type":"person","url":"https://hartvaat.nl/mensen/samuel-broderick/","name":"Samuel Broderick","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samuel-dagogo-jack","type":"person","url":"https://hartvaat.nl/mensen/samuel-dagogo-jack/","name":"Samuel Dagogo-Jack","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samuel-heuts","type":"person","url":"https://hartvaat.nl/mensen/samuel-heuts/","name":"Samuel Heuts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/thoracoscopische-af-ablatie-met-bipolaire-clamp-5-jaars-ritmevrijheid-52-met-ant/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samuel-krasner","type":"person","url":"https://hartvaat.nl/mensen/samuel-krasner/","name":"Samuel Krasner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/01/bloeddrukzelfmanagement-en-vasculaire-remodelling-na-hypertensieve-zwangerschap/","published":"2025-11-01"},{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"samyut-shrestha","type":"person","url":"https://hartvaat.nl/mensen/samyut-shrestha/","name":"Samyut Shrestha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandberg","type":"person","url":"https://hartvaat.nl/mensen/sandberg/","name":"Sandberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/langetermijnuitkomsten-na-de-ross-operatie-een-op-de-vier-krijgt-een-heroperatie/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/05/21/swedeheart-na-een-eerste-hartinfarct-is-fysieke-fitheid-bij-start-cardiale-reval/","published":"2026-07-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sander-m-j-van-kuijk","type":"person","url":"https://hartvaat.nl/mensen/sander-m-j-van-kuijk/","name":"Sander M J van Kuijk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"},{"url":"https://hartvaat.nl/2019/11/19/beeldvorming-geleide-versus-routinezorg-bij-nstemi-jacc/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandosh-padmanabhan","type":"person","url":"https://hartvaat.nl/mensen/sandosh-padmanabhan/","name":"Sandosh Padmanabhan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"},{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandra-gomez-talavera","type":"person","url":"https://hartvaat.nl/mensen/sandra-gomez-talavera/","name":"Sandra Gómez-Talavera","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/reboot-betablokkers-na-mi-sekseverschillen/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-zonder-gereduceerde-ef-definitieve-meta-analyse/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandra-haynes","type":"person","url":"https://hartvaat.nl/mensen/sandra-haynes/","name":"Sandra Haynes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/26/rate-af-kosteneffectiviteit-van-digoxine-versus-betablokkers-bij-permanent-af/","published":"2025-03-26"},{"url":"https://hartvaat.nl/2020/12/22/digoxine-versus-bisoprolol-voor-frequentiecontrole-bij-af-en-qol-jama-rate-af/","published":"2020-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandra-lauck","type":"person","url":"https://hartvaat.nl/mensen/sandra-lauck/","name":"Sandra Lauck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sandra-millon-underwood","type":"person","url":"https://hartvaat.nl/mensen/sandra-millon-underwood/","name":"Sandra Millon Underwood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","published":"2023-09-19"},{"url":"https://hartvaat.nl/2023/07/18/uspstf-screening-op-lipidestoornissen-bij-kinderen-en-adolescenten/","published":"2023-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-wook-lim","type":"person","url":"https://hartvaat.nl/mensen/sang-wook-lim/","name":"Sang Wook Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-hyun-ihm","type":"person","url":"https://hartvaat.nl/mensen/sang-hyun-ihm/","name":"Sang-Hyun Ihm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2017/01/01/sacubitril-valsartan-en-natriurese-diurese-en-bloeddruk-bij-zoutgevoelige-hypert/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-jin-han","type":"person","url":"https://hartvaat.nl/mensen/sang-jin-han/","name":"Sang-Jin Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/19/fluoroscopievrije-cryoballonablatie-met-ice-begeleiding-bij-af/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2020/10/01/high-power-short-duration-ablatie-bij-af-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-rok-lee","type":"person","url":"https://hartvaat.nl/mensen/sang-rok-lee/","name":"Sang-Rok Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-wook-kim","type":"person","url":"https://hartvaat.nl/mensen/sang-wook-kim/","name":"Sang-Wook Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sang-yong-yoo","type":"person","url":"https://hartvaat.nl/mensen/sang-yong-yoo/","name":"Sang-Yong Yoo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2020/06/16/ticagrelor-monotherapie-versus-dapt-op-bloedingen-en-cv-events-bij-acs-jama-tico/","published":"2020-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sangyong-jo","type":"person","url":"https://hartvaat.nl/mensen/sangyong-jo/","name":"Sangyong Jo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/ivus-geleide-pci-versus-cabg-langetermijnuitkomsten/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjay-dixit","type":"person","url":"https://hartvaat.nl/mensen/sanjay-dixit/","name":"Sanjay Dixit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/01/langetermijnmortaliteit-bij-hfmref-systematische-review-en-meta-analyse/","published":"2022-12-01"},{"url":"https://hartvaat.nl/2021/02/13/transdermaal-oestradiol-bij-prostaatkanker-langetermijn-cv-uitkomsten-lancet/","published":"2021-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjay-mehta","type":"person","url":"https://hartvaat.nl/mensen/sanjay-mehta/","name":"Sanjay Mehta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/20/morbiditeit-bij-pulmonaal-arteriele-hypertensie-als-prognostische-marker-voor-mo/","published":"2018-02-20"},{"url":"https://hartvaat.nl/2017/04/14/macitentan-en-hemodynamiek-bij-pah-seraphin-hemodynamische-substudie/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjay-rajagopalan","type":"person","url":"https://hartvaat.nl/mensen/sanjay-rajagopalan/","name":"Sanjay Rajagopalan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/07/kosteneffectiviteit-van-stapsgewijze-lipidenverlaging-na-coronaire-bypasschirurg/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2017/10/01/inhalatiecorticosteroid-beta-2-agonist-en-cardiovasculaire-uitkomsten-bij-copd/","published":"2017-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjay-sharma","type":"person","url":"https://hartvaat.nl/mensen/sanjay-sharma/","name":"Sanjay Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/cardiale-screening-van-jonge-sporters-eerste-eapc-aepc-consensus-voor-kinderen/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjeev-gulati","type":"person","url":"https://hartvaat.nl/mensen/sanjeev-gulati/","name":"Sanjeev Gulati","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjib-kumar-sharma","type":"person","url":"https://hartvaat.nl/mensen/sanjib-kumar-sharma/","name":"Sanjib Kumar Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/wereldwijde-hf-registry-28-landen-fev1-is-een-onafhankelijke-prognostische-facto/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanjiv-m-narayan","type":"person","url":"https://hartvaat.nl/mensen/sanjiv-m-narayan/","name":"Sanjiv M Narayan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/31/pfa-versus-thermale-ablatie-periprocedurale-en-middellangetermijneffecten/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2016/05/01/intracoronaire-adenylylcyclase-6-gentherapie-bij-hartfalen-gerandomiseerde-trial/","published":"2016-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sankar-d-navaneethan","type":"person","url":"https://hartvaat.nl/mensen/sankar-d-navaneethan/","name":"Sankar D Navaneethan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/29/confidence-analyse-acute-egfr-daling-bij-empagliflozin-finerenone-is-reversibel-/","published":"2026-04-17"},{"url":"https://hartvaat.nl/2017/02/16/bariatrische-chirurgie-versus-intensieve-medicamenteuze-therapie-bij-diabetes-5-/","published":"2017-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sanket-s-dhruva","type":"person","url":"https://hartvaat.nl/mensen/sanket-s-dhruva/","name":"Sanket S Dhruva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/02/gezamenlijke-besluitvorming-bij-percutane-linker-atriumoorsluiting/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2017/07/01/heterogeniteit-in-vroege-respons-op-antihypertensiva-allhat/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sante-d-pierdomenico","type":"person","url":"https://hartvaat.nl/mensen/sante-d-pierdomenico/","name":"Sante D Pierdomenico","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/prognostische-waarde-van-gemaskeerd-ongecontroleerde-hypertensie/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2016/04/01/prognostisch-effect-van-nachtelijke-bloeddrukdaling-bij-hypertensie-de-abc-h-stu/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"santiago-garcia","type":"person","url":"https://hartvaat.nl/mensen/santiago-garcia/","name":"Santiago Garcia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sara-hamon","type":"person","url":"https://hartvaat.nl/mensen/sara-hamon/","name":"Sara Hamon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"},{"url":"https://hartvaat.nl/2017/07/20/genetische-en-farmacologische-inactivatie-van-angptl3-en-cardiovasculaire-ziekte/","published":"2017-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarah-hilmer","type":"person","url":"https://hartvaat.nl/mensen/sarah-hilmer/","name":"Sarah Hilmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/07/01/kwartdosis-antihypertensiva-systematische-review-en-meta-analyse/","published":"2017-07-01"},{"url":"https://hartvaat.nl/2017/03/11/kwartdosis-viervoudige-combinatietherapie-als-initiele-hypertensiebehandeling-la/","published":"2017-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarah-j-charman","type":"person","url":"https://hartvaat.nl/mensen/sarah-j-charman/","name":"Sarah J Charman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/economische-ziektelast-van-hartfalen-in-europa-systematische-review/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/08/24/fysieke-activiteitsniveaus-bij-hartfalen-meta-analyse/","published":"2023-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarah-lewington","type":"person","url":"https://hartvaat.nl/mensen/sarah-lewington/","name":"Sarah Lewington","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/03/01/omega-3-vetzuursupplementen-en-cv-risico-jama-cardiology-meta-analyse-van-10-tri/","published":"2018-03-01"},{"url":"https://hartvaat.nl/2017/02/01/reverse-causality-in-de-associatie-bloeddruk-cardiovasculair-risico-bij-ckd/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarah-parish","type":"person","url":"https://hartvaat.nl/mensen/sarah-parish/","name":"Sarah Parish","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/18/omega-3-vetzuursupplementen-bij-diabetes-nejm-ascend-omega-3/","published":"2018-10-18"},{"url":"https://hartvaat.nl/2018/10/18/aspirine-voor-primaire-preventie-bij-diabetes-nejm-ascend/","published":"2018-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarah-tawadros","type":"person","url":"https://hartvaat.nl/mensen/sarah-tawadros/","name":"Sarah Tawadros","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/13/clear-synergy-colchicine-bij-acuut-mi-nejm/","published":"2025-02-13"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sarubbi","type":"person","url":"https://hartvaat.nl/mensen/sarubbi/","name":"Sarubbi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sasko-jovev","type":"person","url":"https://hartvaat.nl/mensen/sasko-jovev/","name":"Sasko Jovev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satish-a-eraly","type":"person","url":"https://hartvaat.nl/mensen/satish-a-eraly/","name":"Satish A Eraly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/27/vutrisiran-bij-attr-cm-impact-van-hartfalenernst-op-effectiviteit/","published":"2025-05-27"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hartfalenverslechtering-bij-attr-cardiomyopathie-attr-act-analyse/","published":"2025-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satish-r-raj","type":"person","url":"https://hartvaat.nl/mensen/satish-r-raj/","name":"Satish R Raj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/18/letselrisico-bij-vasovagale-syncope-systematische-review-en-meta-analyse/","published":"2021-07-18"},{"url":"https://hartvaat.nl/2016/02/01/mineralocorticoidreceptoractivatie-draagt-bij-aan-supiene-hypertensie-bij-autono/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"satoshi-koyama","type":"person","url":"https://hartvaat.nl/mensen/satoshi-koyama/","name":"Satoshi Koyama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/24/genomische-ontdekking-bij-nefrotisch-syndroom-mefv-varianten-als-risicofactor-vo/","published":"2025-12-24"},{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saul-blecker","type":"person","url":"https://hartvaat.nl/mensen/saul-blecker/","name":"Saul Blecker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/medicatietrouw-bij-hypertensie-cluster-gerandomiseerde-trial/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2023/04/11/ambulante-beslisondersteuning-verbetert-mra-voorschrijving-bij-hfref/","published":"2023-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"saverio-iacopino","type":"person","url":"https://hartvaat.nl/mensen/saverio-iacopino/","name":"Saverio Iacopino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2021/07/18/cryoballonablatie-versus-antiaritmica-als-eerstelijns-paf-therapie/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sayoki-mfinanga","type":"person","url":"https://hartvaat.nl/mensen/sayoki-mfinanga/","name":"Sayoki Mfinanga","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scognamiglio","type":"person","url":"https://hartvaat.nl/mensen/scognamiglio/","name":"Scognamiglio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/crt-bij-volwassenen-met-systemische-rechterventrikel-gemengde-uitkomsten-in-inte/","published":"2026-05-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-a-hubers","type":"person","url":"https://hartvaat.nl/mensen/scott-a-hubers/","name":"Scott A Hubers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/dpp-4-remming-en-catecholamines-tijdens-ace-remming/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2021/03/01/bnp-en-cardiale-remodellering-na-mi-gerandomiseerde-trial/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-bull","type":"person","url":"https://hartvaat.nl/mensen/scott-bull/","name":"Scott Bull","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-chadderdon","type":"person","url":"https://hartvaat.nl/mensen/scott-chadderdon/","name":"Scott Chadderdon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-lilly","type":"person","url":"https://hartvaat.nl/mensen/scott-lilly/","name":"Scott Lilly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-lim","type":"person","url":"https://hartvaat.nl/mensen/scott-lim/","name":"Scott Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/pulmonale-hypertensie-bij-mitraclip-coapt-analyse/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2020/09/15/tricuspidalisinsufficientie-en-uitkomsten-na-mitraclip-coapt/","published":"2020-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-m-damrauer","type":"person","url":"https://hartvaat.nl/mensen/scott-m-damrauer/","name":"Scott M Damrauer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-mckenzie","type":"person","url":"https://hartvaat.nl/mensen/scott-mckenzie/","name":"Scott McKenzie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/reduce-lap-hf-ii-atriaal-shuntdevice-bij-hfpef-cardiale-effecten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scott-mclean","type":"person","url":"https://hartvaat.nl/mensen/scott-mclean/","name":"Scott McLean","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/02/01/ct-coronairangiografie-volgens-2016-nice-richtlijn-diagnostisch-en-prognostisch-/","published":"2018-02-01"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seamus-p-whelton","type":"person","url":"https://hartvaat.nl/mensen/seamus-p-whelton/","name":"Seamus P Whelton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/21/aspirine-lipoproteine-a-en-aortaklepstenose-de-mesa-studie/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2021/06/01/geisoleerde-diastolische-hypertensie-cohort-en-meta-analyse-voor-behandeldrempel/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-j-barbour","type":"person","url":"https://hartvaat.nl/mensen/sean-j-barbour/","name":"Sean J. Barbour","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/20/voorspelling-van-individuele-corticosteroidrespons-bij-iga-nefropathie-testing-t/","published":"2026-01-20"},{"url":"https://hartvaat.nl/2025/12/22/sefaxersen-bij-iga-nefropathie-fase-2-trial-van-complementfactor-b-remming/","published":"2025-12-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-l-zheng","type":"person","url":"https://hartvaat.nl/mensen/sean-l-zheng/","name":"Sean L Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/22/aspirine-voor-primaire-preventie-jama-meta-analyse-van-cv-events-en-bloedingen/","published":"2019-01-22"},{"url":"https://hartvaat.nl/2018/04/17/sglt2-remmers-glp-1-agonisten-en-dpp-4-remmers-vergelijkende-cardiovasculaire-me/","published":"2018-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-lal","type":"person","url":"https://hartvaat.nl/mensen/sean-lal/","name":"Sean Lal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/tricuspidalisinsufficientie-en-mortaliteit-onafhankelijk-van-ph-en-rechterventri/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/03/01/voorspellers-van-succesvolle-cto-pci-systematische-review-en-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-m-bagshaw","type":"person","url":"https://hartvaat.nl/mensen/sean-m-bagshaw/","name":"Sean M Bagshaw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-tan","type":"person","url":"https://hartvaat.nl/mensen/sean-tan/","name":"Sean Tan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-06-29"},{"url":"https://hartvaat.nl/2026/05/13/uk-biobank-na-ischemisch-cva-of-tia-is-het-risico-op-hartfalen-groter-dan-dat-op/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sean-wharton","type":"person","url":"https://hartvaat.nl/mensen/sean-wharton/","name":"Sean Wharton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/06/orforglipron-voor-obesitasbehandeling-nejm-fase-3/","published":"2025-11-06"},{"url":"https://hartvaat.nl/2023/09/07/orforglipron-dagelijkse-orale-glp-1-agonist-bij-obesitas-nejm/","published":"2023-09-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastian-reith","type":"person","url":"https://hartvaat.nl/mensen/sebastian-reith/","name":"Sebastian Reith","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2021/12/01/thin-cap-fibroatheroom-voorspelt-events-bij-diabetes-met-normale-ffr-combine-oct/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastian-thomas","type":"person","url":"https://hartvaat.nl/mensen/sebastian-thomas/","name":"Sebastian Thomas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/semaglutide-bij-perifeer-arterieel-vaatlijden-en-diabetes-stride-trial/","published":"2026-03-20"},{"url":"https://hartvaat.nl/2025/11/18/sekseverschillen-in-semaglutide-effect-bij-pad-stride-subanalyse/","published":"2025-11-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastian-vollmer","type":"person","url":"https://hartvaat.nl/mensen/sebastian-vollmer/","name":"Sebastian Vollmer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastian-winkler","type":"person","url":"https://hartvaat.nl/mensen/sebastian-winkler/","name":"Sebastian Winkler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2018/09/22/telemedische-interventie-bij-hartfalen-lancet-tim-hf2/","published":"2018-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastiano-sciarretta","type":"person","url":"https://hartvaat.nl/mensen/sebastiano-sciarretta/","name":"Sebastiano Sciarretta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/clopidogrel-versus-aspirine-bij-chronisch-coronair-syndroom-meta-analyse-toont-w/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2025/11/18/cv-effecten-en-verdraagbaarheid-van-glp-1-agonisten-meta-analyse/","published":"2025-11-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sebastien-knecht","type":"person","url":"https://hartvaat.nl/mensen/sebastien-knecht/","name":"Sebastien Knecht","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/ventriculaire-aritmieen-na-lvad-implantatie-meta-analyse/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2018/04/21/pvi-met-versus-zonder-antiaritmica-bij-recidiverend-af-powder-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seiko-n-doi","type":"person","url":"https://hartvaat.nl/mensen/seiko-n-doi/","name":"Seiko N Doi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/16/danish-langetermijn-icd-bij-niet-ischemische-hfref-uitgebreide-follow-up/","published":"2025-12-16"},{"url":"https://hartvaat.nl/2025/09/01/af-en-icd-bij-niet-ischemische-hfref-impliciaties-voor-devicetherapie/","published":"2025-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sekar-kathiresan","type":"person","url":"https://hartvaat.nl/mensen/sekar-kathiresan/","name":"Sekar Kathiresan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/verve-102-eenmalige-base-editing-schakelt-pcsk9-blijvend-uit-fase-1/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2017/05/30/polygene-risicoscore-en-relatief-voordeel-van-statinetherapie-primaire-preventie/","published":"2017-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"selim-r-krim","type":"person","url":"https://hartvaat.nl/mensen/selim-r-krim/","name":"Selim R Krim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/transform-hf-torsemide-versus-furosemide-bij-nieuw-vs-chronisch-hartfalen/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/09/11/hemodynamisch-geleid-hf-management-lancet-guide-hf/","published":"2021-09-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seng-chan-you","type":"person","url":"https://hartvaat.nl/mensen/seng-chan-you/","name":"Seng Chan You","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2019/11/16/vergelijking-van-eerstelijns-antihypertensiva-lancet-systematische-multinational/","published":"2019-11-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seok-kyu-oh","type":"person","url":"https://hartvaat.nl/mensen/seok-kyu-oh/","name":"Seok Kyu Oh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seong-mi-park","type":"person","url":"https://hartvaat.nl/mensen/seong-mi-park/","name":"Seong-Mi Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/thuis-bio-impedantie-voor-hartfalen-haalbaar-en-acceptabel-klinische-winst-nog-n/","published":"2026-06-28"},{"url":"https://hartvaat.nl/2026/03/25/bmi-en-prognose-bij-acuut-hartfalen-verschillen-per-fenotype-en-geslacht/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seonghoon-choi","type":"person","url":"https://hartvaat.nl/mensen/seonghoon-choi/","name":"Seonghoon Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/17/spironolacton-versus-amiloride-bij-resistente-hypertensie-gerandomiseerde-trial/","published":"2025-06-17"},{"url":"https://hartvaat.nl/2023/09/01/matige-statine-plus-ezetimibe-bij-zeer-hoog-ascvd-risico-non-inferioriteitstudie/","published":"2023-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seonok-kim","type":"person","url":"https://hartvaat.nl/mensen/seonok-kim/","name":"Seonok Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/post-pci-subanalyse-routine-stresstesten-niet-zinvol-bij-acs-noch-stabiel/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/03/01/post-pci-routine-stresstesten-bij-diabetespatienten-na-pci-niet-zinvol/","published":"2024-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serafina-valente","type":"person","url":"https://hartvaat.nl/mensen/serafina-valente/","name":"Serafina Valente","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/linkeratriale-strain-en-prognose-bij-acuut-en-chronisch-hartfalen-meta-analyse/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2025/04/29/vroege-iabp-bij-hartfalen-gerelateerde-cardiogene-shock-gerandomiseerde-trial/","published":"2025-04-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serge-a-trines","type":"person","url":"https://hartvaat.nl/mensen/serge-a-trines/","name":"Serge A Trines","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/22/cva-risicoscores-bij-af-vergeleken-cha2ds2-vasc-blijft-de-beste/","published":"2022-11-22"},{"url":"https://hartvaat.nl/2017/04/01/beperkte-chirurgische-linkeratriumablatie-bij-af-effectief-maar-vermindert-la-fu/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serge-c-harb","type":"person","url":"https://hartvaat.nl/mensen/serge-c-harb/","name":"Serge C Harb","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/anemie-verergert-mortaliteit-en-hartfalenheropnames-na-tavr-bij-patienten-boven-/","published":"2026-08-18"},{"url":"https://hartvaat.nl/2025/01/09/transcatheter-klepvervanging-bij-ernstige-tricuspidalisinsufficientie-nejm/","published":"2025-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serge-lepage","type":"person","url":"https://hartvaat.nl/mensen/serge-lepage/","name":"Serge Lepage","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/26/sacubitril-valsartan-bij-gedecompenseerd-hartfalen-tijdens-opname/","published":"2024-03-26"},{"url":"https://hartvaat.nl/2023/07/04/sacubitril-valsartan-bij-hfmref-hfpef-met-verslechterend-hartfalen/","published":"2023-07-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"serge-masson","type":"person","url":"https://hartvaat.nl/mensen/serge-masson/","name":"Serge Masson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"},{"url":"https://hartvaat.nl/2016/02/02/ciclosporine-a-bij-gereperfuseerd-myocardinfarct-de-multicenter-cycle-trial/","published":"2016-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-berti","type":"person","url":"https://hartvaat.nl/mensen/sergio-berti/","name":"Sergio Berti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/10/15/ice-gestuurde-laac-toont-lage-stroke-en-bloedingsrisicos-op-lange-termijn/","published":"2026-08-07"},{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-buccheri","type":"person","url":"https://hartvaat.nl/mensen/sergio-buccheri/","name":"Sergio Buccheri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/02/ivus-versus-oct-versus-angiografie-voor-pci-begeleiding-meta-analyse/","published":"2024-04-02"},{"url":"https://hartvaat.nl/2020/07/14/vergelijking-van-orale-p2y12-remmers-bij-acs-netwerkmeta-analyse-van-52-816-pati/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-garcia-blas","type":"person","url":"https://hartvaat.nl/mensen/sergio-garcia-blas/","name":"Sergio García-Blas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/25/amphilimus-versus-zotarolimus-eluting-stent-bij-diabetes-en-coronairlijden/","published":"2025-11-25"},{"url":"https://hartvaat.nl/2022/03/31/amphilimus-versus-zotarolimus-stents-bij-diabetes-sugar-gerandomiseerde-trial/","published":"2022-03-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-richter","type":"person","url":"https://hartvaat.nl/mensen/sergio-richter/","name":"Sergio Richter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-v-perrone","type":"person","url":"https://hartvaat.nl/mensen/sergio-v-perrone/","name":"Sergio V Perrone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2020/01/28/eerdere-hf-hospitalisatie-en-sacubitril-valsartan-versus-valsartan-bij-hfpef-par/","published":"2020-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"seung-uk-lee","type":"person","url":"https://hartvaat.nl/mensen/seung-uk-lee/","name":"Seung Uk Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"},{"url":"https://hartvaat.nl/2019/06/25/p2y12-remmer-monotherapie-versus-dapt-na-pci-jama-smart-choice/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sevasti-maria-chaldoupi","type":"person","url":"https://hartvaat.nl/mensen/sevasti-maria-chaldoupi/","name":"Sevasti-Maria Chaldoupi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/smartphone-app-voor-symptoomregistratie-na-ablatie-bij-atriumfibrilleren-isolati/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2024/10/03/geisoleerde-versus-hybride-thoracoscopische-ablatie-bij-af-korte-en-langetermijn/","published":"2024-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"severine-bompoint","type":"person","url":"https://hartvaat.nl/mensen/severine-bompoint/","name":"Severine Bompoint","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaan-khurshid","type":"person","url":"https://hartvaat.nl/mensen/shaan-khurshid/","name":"Shaan Khurshid","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/10/stressor-geassocieerd-af-incidentie-risicofactoren-en-uitkomsten/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2022/03/29/af-screening-bij-ouderen-in-de-huisartsenpraktijk-vital-af-gerandomiseerde-trial/","published":"2022-03-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shabbar-jaffar","type":"person","url":"https://hartvaat.nl/mensen/shabbar-jaffar/","name":"Shabbar Jaffar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shady-abohashem","type":"person","url":"https://hartvaat.nl/mensen/shady-abohashem/","name":"Shady Abohashem","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/21/glp-1-agonisten-kosten-geen-spiermassa-tijdens-intensieve-hartrevalidatie/","published":"2026-06-09"},{"url":"https://hartvaat.nl/2026/02/28/epic-hiv-trial-pcsk9-remming-ter-cardiovasculaire-preventie-bij-hiv-patienten/","published":"2026-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shah-ebrahim","type":"person","url":"https://hartvaat.nl/mensen/shah-ebrahim/","name":"Shah Ebrahim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/07/yoga-gebaseerde-hartrevalidatie-na-acuut-mi-gerandomiseerde-trial/","published":"2020-04-07"},{"url":"https://hartvaat.nl/2020/02/20/community-interventie-voor-hypertensie-in-ruraal-zuid-azie-nejm/","published":"2020-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shahab-ghafghazi","type":"person","url":"https://hartvaat.nl/mensen/shahab-ghafghazi/","name":"Shahab Ghafghazi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/24/reality-subanalyse-restrictief-transfusiebeleid-bij-mi-en-anemie-langere-follow-/","published":"2024-09-24"},{"url":"https://hartvaat.nl/2023/12/28/reality-restrictief-versus-liberaal-transfusiebeleid-bij-mi-en-anemie-nejm/","published":"2023-12-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shane-nanayakkara","type":"person","url":"https://hartvaat.nl/mensen/shane-nanayakkara/","name":"Shane Nanayakkara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/07/hartfalentherapie-staken-na-ef-herstel-door-af-ritmecontrole/","published":"2026-01-07"},{"url":"https://hartvaat.nl/2020/01/02/alcoholonthouding-bij-drinkers-met-af-nejm-gerandomiseerde-trial/","published":"2020-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shanmugakumar-chinnappa","type":"person","url":"https://hartvaat.nl/mensen/shanmugakumar-chinnappa/","name":"Shanmugakumar Chinnappa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/29/cardiovasculaire-ziekte-blijft-leidend-na-niertransplantatie-overzicht-van-uitda/","published":"2026-07-28"},{"url":"https://hartvaat.nl/2026/02/09/communicatie-tussen-nier-en-hart-via-extracellulaire-vesikels/","published":"2026-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shao-wei-chen","type":"person","url":"https://hartvaat.nl/mensen/shao-wei-chen/","name":"Shao-Wei Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/cardiovasculair-renaal-metabool-samenspel-bij-patienten-met-atriumfibrilleren/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/10/05/rivaroxaban-dosering-bij-af-on-label-versus-off-label-in-azie-en-niet-azie/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaobin-jia","type":"person","url":"https://hartvaat.nl/mensen/shaobin-jia/","name":"Shaobin Jia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaohui-wu","type":"person","url":"https://hartvaat.nl/mensen/shaohui-wu/","name":"Shaohui Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2021/05/21/extrapulmonale-vein-driver-mapping-bij-persisterend-af-bij-obese-patienten/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaoyong-su","type":"person","url":"https://hartvaat.nl/mensen/shaoyong-su/","name":"Shaoyong Su","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sharad-agarwal","type":"person","url":"https://hartvaat.nl/mensen/sharad-agarwal/","name":"Sharad Agarwal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/03/01/doodsoorzaken-bij-crt-met-en-zonder-defibrillator-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sharath-kumar","type":"person","url":"https://hartvaat.nl/mensen/sharath-kumar/","name":"Sharath Kumar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/uitkomsten-van-ablatie-bij-persisterend-en-langdurig-persisterend-af-meta-analys/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2018/04/21/subklinisch-device-gedetecteerd-af-en-cva-risico-meta-analyse/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaul-atar","type":"person","url":"https://hartvaat.nl/mensen/shaul-atar/","name":"Shaul Atar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/26/subcutaan-selatogrel-remt-plaatjesaggregatie-bij-acuut-mi/","published":"2020-05-26"},{"url":"https://hartvaat.nl/2017/03/01/cardiopoietische-celtherapie-bij-gevorderd-ischemisch-hartfalen-c-cure-39-weeksr/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaun-bender","type":"person","url":"https://hartvaat.nl/mensen/shaun-bender/","name":"Shaun Bender","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/25/ambulante-hf-verslechtering-bij-attr-cm-attr-act-subanalyse/","published":"2025-02-25"},{"url":"https://hartvaat.nl/2025/02/25/ambulante-hartfalenverslechtering-bij-attr-cardiomyopathie-attr-act-analyse/","published":"2025-02-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shaun-khanna","type":"person","url":"https://hartvaat.nl/mensen/shaun-khanna/","name":"Shaun Khanna","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/22/clopidogrel-superieur-aan-aspirine-na-pci-10-jaar-host-exam/","published":"2026-08-27"},{"url":"https://hartvaat.nl/2026/05/27/sglt2-remmers-verminderen-epicardiaal-vetweefsel-meta-analyse-van-11-studies/","published":"2026-05-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shelagh-b-coutts","type":"person","url":"https://hartvaat.nl/mensen/shelagh-b-coutts/","name":"Shelagh B Coutts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/11/artesia-apixaban-bij-subclinisch-af-nejm/","published":"2024-01-11"},{"url":"https://hartvaat.nl/2021/06/01/implanteerbare-versus-verlengde-externe-ecg-monitoring-voor-af-na-ischemisch-cva/","published":"2021-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheldon-w-tobe","type":"person","url":"https://hartvaat.nl/mensen/sheldon-w-tobe/","name":"Sheldon W Tobe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/aobp-na-nul-versus-vijf-minuten-rust-gerandomiseerde-trial/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2021/03/01/kdigo-2021-bloeddruk-bij-ckd-executive-summary/","published":"2021-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheng-liu","type":"person","url":"https://hartvaat.nl/mensen/sheng-liu/","name":"Sheng Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/eheart-trial-real-time-hartteam-verbetert-besluitvorming-bij-complexe-coronaire-/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shengxu-li","type":"person","url":"https://hartvaat.nl/mensen/shengxu-li/","name":"Shengxu Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheryl-l-rifas-shiman","type":"person","url":"https://hartvaat.nl/mensen/sheryl-l-rifas-shiman/","name":"Sheryl L Rifas-Shiman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheryl-l-windsor","type":"person","url":"https://hartvaat.nl/mensen/sheryl-l-windsor/","name":"Sheryl L Windsor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/01/nierfunctie-en-dapagliflozine-effect-op-gezondheidsstatus-define-hf/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2021/04/27/empagliflozine-en-pulmonalisdruk-bij-hf-embrace-hf/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sheyu-li","type":"person","url":"https://hartvaat.nl/mensen/sheyu-li/","name":"Sheyu Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/27/veiligheid-van-pcsk9-remmers-systematische-review-en-meta-analyse/","published":"2022-07-27"},{"url":"https://hartvaat.nl/2021/12/01/predictieve-modellen-voor-cv-en-renale-uitkomsten-bij-diabetes-type-2-meta-analy/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shi-yi-wang","type":"person","url":"https://hartvaat.nl/mensen/shi-yi-wang/","name":"Shi-Yi Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/31/herhaalde-in-situ-ablatie-versus-uitgebreide-ablatie-bij-recidief-persisterend-a/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2025/08/12/catheterablatie-versus-rate-control-bij-persisterend-af-en-ouder-hartfalen/","published":"2025-08-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shigeru-tanaka","type":"person","url":"https://hartvaat.nl/mensen/shigeru-tanaka/","name":"Shigeru Tanaka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/lagere-kaliuminname-hangt-samen-met-meer-hart-en-vaatziekte-bij-ckd-vooral-bij-v/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/02/27/albuminurie-geassocieerd-met-verhoogd-risico-op-abdominaal-aorta-aneurysma/","published":"2026-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shigeru-toyoda","type":"person","url":"https://hartvaat.nl/mensen/shigeru-toyoda/","name":"Shigeru Toyoda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"},{"url":"https://hartvaat.nl/2020/08/01/canagliflozine-bij-diabetes-type-2-met-chronisch-hf-candle-gerandomiseerde-trial/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shigeto-naito","type":"person","url":"https://hartvaat.nl/mensen/shigeto-naito/","name":"Shigeto Naito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/ononderbroken-versus-onderbroken-doac-bij-af-ablatie-prospectieve-trial/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2016/12/27/hotballoon-pulmonaalvene-ablatie-bij-paroxysmaal-af-japanse-multicenter-trial/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shigeyuki-saitoh","type":"person","url":"https://hartvaat.nl/mensen/shigeyuki-saitoh/","name":"Shigeyuki Saitoh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/30/visinname-en-visgerelateerde-metabolieten-geassocieerd-met-lagere-triglyceriden-/","published":"2026-08-16"},{"url":"https://hartvaat.nl/2019/01/01/levenslangrisico-op-cva-en-coronairlijden-naar-bloeddrukniveau-epoch-japan/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shijun-xia","type":"person","url":"https://hartvaat.nl/mensen/shijun-xia/","name":"Shijun Xia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2025/02/04/pvi-met-geoptimaliseerde-lineaire-ablatie-versus-pvi-alleen-bij-persisterend-af/","published":"2025-02-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shin-okamoto","type":"person","url":"https://hartvaat.nl/mensen/shin-okamoto/","name":"Shin Okamoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2018/09/01/pace-capture-geleide-ablatie-na-contact-force-pvi-dragon-gerandomiseerde-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shin-ichi-momomura","type":"person","url":"https://hartvaat.nl/mensen/shin-ichi-momomura/","name":"Shin-Ichi Momomura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/13/ef-en-uitkomsten-bij-omecamtiv-mecarbil-galactic-hf/","published":"2021-07-13"},{"url":"https://hartvaat.nl/2021/01/14/omecamtiv-mecarbil-bij-systolisch-hartfalen-nejm-galactic-hf/","published":"2021-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shintaro-minegishi","type":"person","url":"https://hartvaat.nl/mensen/shintaro-minegishi/","name":"Shintaro Minegishi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/16/sglt2-remming-waterconservatie-domineert-over-osmotische-diurese-bij-hf/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2022/11/01/checkpoint-remmers-verhogen-korttermijnrisico-op-hypertensie-niet-meta-analyse/","published":"2022-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shiqun-chen","type":"person","url":"https://hartvaat.nl/mensen/shiqun-chen/","name":"Shiqun Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/verhoogd-lp-a-en-diabetes-verergeren-samen-de-prognose-bij-coronairlijden/","published":"2026-02-27"},{"url":"https://hartvaat.nl/2022/05/25/hydratie-ter-preventie-van-nierschade-na-primaire-pci-gerandomiseerde-trial/","published":"2022-05-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shirjel-alam","type":"person","url":"https://hartvaat.nl/mensen/shirjel-alam/","name":"Shirjel Alam","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shirley-jansen","type":"person","url":"https://hartvaat.nl/mensen/shirley-jansen/","name":"Shirley Jansen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/07/colchicine-voor-secundaire-cv-preventie-meta-analyse-van-alle-trials/","published":"2025-07-07"},{"url":"https://hartvaat.nl/2024/05/01/quartet-therapeutische-inertie-bij-lage-dosis-viervoudige-combinatietherapie/","published":"2024-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shirley-pettit","type":"person","url":"https://hartvaat.nl/mensen/shirley-pettit/","name":"Shirley Pettit","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"},{"url":"https://hartvaat.nl/2016/12/15/off-pump-versus-on-pump-cabg-5-jaarsresultaten-nejm-coronary-trial/","published":"2016-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shitian-li","type":"person","url":"https://hartvaat.nl/mensen/shitian-li/","name":"Shitian Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/06/esprit-intensieve-bloeddrukcontrole-bij-fragiele-patienten-post-hoc-analyse/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shlomi-matetzky","type":"person","url":"https://hartvaat.nl/mensen/shlomi-matetzky/","name":"Shlomi Matetzky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/routinematige-urine-natriummeting-drijft-agressievere-diurese-bij-acuut-hartfale/","published":"2026-05-04"},{"url":"https://hartvaat.nl/2017/12/01/kauwen-versus-slikken-van-ticagrelor-en-plaatjesremming-bij-stemi/","published":"2017-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shobha-dhadda","type":"person","url":"https://hartvaat.nl/mensen/shobha-dhadda/","name":"Shobha Dhadda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shohei-kikuchi","type":"person","url":"https://hartvaat.nl/mensen/shohei-kikuchi/","name":"Shohei Kikuchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/02/jamac-studie-slechte-5-jaarsprognose-bij-mitralisstenose-door-mitralisringverkal/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2018/02/01/bnp-prognostische-waarde-bij-hartfalen-met-lvef-35/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shoo-k-lee","type":"person","url":"https://hartvaat.nl/mensen/shoo-k-lee/","name":"Shoo K Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shouvik-haldar","type":"person","url":"https://hartvaat.nl/mensen/shouvik-haldar/","name":"Shouvik Haldar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2016/12/07/linker-hartoorsluiting-uitkomsten-en-kosten-van-trial-en-real-world-versus-orale/","published":"2016-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shqipdona-lahu","type":"person","url":"https://hartvaat.nl/mensen/shqipdona-lahu/","name":"Shqipdona Lahu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/ticagrelor-of-prasugrel-na-pci-voor-acs-isar-react-5-pre-gespecificeerde-analyse/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2020/12/15/ticagrelor-of-prasugrel-bij-stemi-met-primaire-pci-isar-react-5-stemi/","published":"2020-12-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shu-lu","type":"person","url":"https://hartvaat.nl/mensen/shu-lu/","name":"Shu Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shuai-guo","type":"person","url":"https://hartvaat.nl/mensen/shuai-guo/","name":"Shuai Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/30/dapk2-reguleert-pkm2-fosforylering-bij-verstoorde-stroming-geinduceerde-atherosc/","published":"2026-01-30"},{"url":"https://hartvaat.nl/2024/02/01/maggic-score-voor-mortaliteitsvoorspelling-bij-klepziekte/","published":"2024-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shuaiwei-zhou","type":"person","url":"https://hartvaat.nl/mensen/shuaiwei-zhou/","name":"Shuaiwei Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/01/parable-sacubitril-valsartan-vermindert-linkeratriumvolume-bij-pre-hfpef/","published":"2023-04-01"},{"url":"https://hartvaat.nl/2019/06/01/klinische-predictieregels-voor-diagnostiek-van-chronisch-hartfalen-systematische/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shubin-sheng","type":"person","url":"https://hartvaat.nl/mensen/shubin-sheng/","name":"Shubin Sheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-medicamenteus-bij-af-en-kwaliteit-van-leven-jama-cabana-q/","published":"2019-04-02"},{"url":"https://hartvaat.nl/2018/11/27/economische-en-qol-uitkomsten-van-nt-probnp-geleide-hf-therapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shuchi-anand","type":"person","url":"https://hartvaat.nl/mensen/shuchi-anand/","name":"Shuchi Anand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/pm2-5-blootstelling-versnelt-daling-van-egfr-bij-volwassenen/","published":"2026-08-24"},{"url":"https://hartvaat.nl/2026/01/20/het-onbekende-uit-ckdu-halen-optimale-benaderingen-voor-epidemische-nierziekte/","published":"2026-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shuchita-mundle","type":"person","url":"https://hartvaat.nl/mensen/shuchita-mundle/","name":"Shuchita Mundle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/21/orale-antihypertensiva-bij-ernstige-hypertensie-in-de-zwangerschap-lancet-vergel/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2017/08/12/foley-katheter-versus-misoprostol-voor-inleiden-bij-hypertensieve-zwangeren-in-i/","published":"2017-08-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shuichi-yoneda","type":"person","url":"https://hartvaat.nl/mensen/shuichi-yoneda/","name":"Shuichi Yoneda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shukri-david","type":"person","url":"https://hartvaat.nl/mensen/shukri-david/","name":"Shukri David","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/01/spyral-htn-on-med-renale-denervatie-en-medicatiewijzigingen/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2021/06/15/plasma-renine-activiteit-na-renale-sympathische-denervatie/","published":"2021-06-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shulin-wu","type":"person","url":"https://hartvaat.nl/mensen/shulin-wu/","name":"Shulin Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/09/vertraagde-afgifteformulering-van-ivabradine-bij-systolisch-hartfalen/","published":"2022-08-09"},{"url":"https://hartvaat.nl/2016/01/01/katheterablatie-herstelt-verlaagde-plasma-mir-409-3p-en-mir-432-bij-atriumfibril/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shweta-r-motiwala","type":"person","url":"https://hartvaat.nl/mensen/shweta-r-motiwala/","name":"Shweta R Motiwala","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/16/2024-acc-expert-consensus-behandeling-van-hfref-beslispad-geactualiseerd/","published":"2024-04-16"},{"url":"https://hartvaat.nl/2021/02/16/2021-acc-hf-behandeloptimalisatie-update-antwoorden-op-10-cruciale-vragen/","published":"2021-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"shweta-urva","type":"person","url":"https://hartvaat.nl/mensen/shweta-urva/","name":"Shweta Urva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/26/triple-gip-glp-1-glucagonreceptoragonist-bij-type-2-diabetes-fase-1b/","published":"2022-11-26"},{"url":"https://hartvaat.nl/2018/11/17/ly3298176-duale-gip-glp-1-agonist-bij-diabetes-type-2-lancet-tirzepatide-fase-2/","published":"2018-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sibylle-j-hauske","type":"person","url":"https://hartvaat.nl/mensen/sibylle-j-hauske/","name":"Sibylle J Hauske","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/07/emperial-empagliflozine-bij-resistente-hypertensie-en-hfpef/","published":"2025-04-07"},{"url":"https://hartvaat.nl/2023/01/12/empa-kidney-empagliflozine-beschermt-nieren-bij-brede-ckd-populatie/","published":"2023-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sibylle-von-vietinghoff","type":"person","url":"https://hartvaat.nl/mensen/sibylle-von-vietinghoff/","name":"Sibylle von Vietinghoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/pyelonefritis-verlaagt-serumcholesterol-en-remt-atherosclerose-ondanks-systemisc/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/01/19/sglt2-remming-behoudt-antibacteriele-respons-van-de-nier-door-complement-c1q-ver/","published":"2026-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"siegfried-wassertheurer","type":"person","url":"https://hartvaat.nl/mensen/siegfried-wassertheurer/","name":"Siegfried Wassertheurer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/01/pulsatiele-hemodynamiek-voorspelt-bloeddrukrespons-op-renale-denervatie/","published":"2022-07-01"},{"url":"https://hartvaat.nl/2019/10/01/arteriele-golfvormclusters-en-langetermijn-klinisch-nut/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sigmund-a-anderssen","type":"person","url":"https://hartvaat.nl/mensen/sigmund-a-anderssen/","name":"Sigmund A Anderssen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/01/vijf-jaar-inspanningstraining-verbetert-cardiovasculair-risicoprofiel-bij-oudere/","published":"2022-06-01"},{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"signild-asberg","type":"person","url":"https://hartvaat.nl/mensen/signild-asberg/","name":"Signild Åsberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"},{"url":"https://hartvaat.nl/2022/10/04/timing-vroege-versus-late-noac-start-na-ischemisch-cva-bij-af/","published":"2022-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sijia-zhang","type":"person","url":"https://hartvaat.nl/mensen/sijia-zhang/","name":"Sijia Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sijie-zheng","type":"person","url":"https://hartvaat.nl/mensen/sijie-zheng/","name":"Sijie Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/01/monoklonaal-versus-monotypisch-bewustwording-van-terminologie-bij-mgrs/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/19/genotype-fenotypekenmerken-bij-fan1-gerelateerde-karyomegale-tubulointerstitiele/","published":"2026-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"silver-k-bahendeka","type":"person","url":"https://hartvaat.nl/mensen/silver-k-bahendeka/","name":"Silver K Bahendeka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"silvia-di-federico","type":"person","url":"https://hartvaat.nl/mensen/silvia-di-federico/","name":"Silvia Di Federico","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/01/alcohol-en-hypertensierisico-dosis-respons-meta-analyse-van-niet-experimentele-s/","published":"2024-08-01"},{"url":"https://hartvaat.nl/2023/10/01/alcoholconsumptie-en-bloeddruk-dosis-respons-meta-analyse/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"silvia-m-martins","type":"person","url":"https://hartvaat.nl/mensen/silvia-m-martins/","name":"Silvia M Martins","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/message-hf-geautomatiseerde-sms-na-hartfalenopname-verbetert-uitkomsten-niet/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/12/01/sms-strategie-bij-patienten-na-recente-hf-opname-studieontwerp/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"silvia-monticone","type":"person","url":"https://hartvaat.nl/mensen/silvia-monticone/","name":"Silvia Monticone","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/01/geautomatiseerde-praktijkmeting-versus-andere-bloeddrukmeetmethoden/","published":"2019-02-01"},{"url":"https://hartvaat.nl/2018/08/01/farmacologische-behandeling-van-hypertensie-bij-kinderen-netwerkmeta-analyse/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"silvia-r-l-assis","type":"person","url":"https://hartvaat.nl/mensen/silvia-r-l-assis/","name":"Silvia R L Assis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/neo-minor-potente-p2y12-monotherapie-versus-dapt-na-pci-bij-stemi/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/11/27/vroege-aspirinestop-na-pci-bij-acs-gerandomiseerde-trial/","published":"2025-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"silvio-nunes-augusto","type":"person","url":"https://hartvaat.nl/mensen/silvio-nunes-augusto/","name":"Silvio Nunes Augusto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/09/advor-bicarbonaatwaarden-en-decongestie-effect-van-acetazolamide/","published":"2023-06-09"},{"url":"https://hartvaat.nl/2023/01/17/advor-acetazolamide-effectief-over-het-hele-ef-spectrum-bij-acuut-hartfalen/","published":"2023-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simerjot-k-jassal","type":"person","url":"https://hartvaat.nl/mensen/simerjot-k-jassal/","name":"Simerjot K Jassal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"},{"url":"https://hartvaat.nl/2021/09/01/albuminurietesting-bij-hypertensie-en-diabetes-ipd-meta-analyse/","published":"2021-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-elhadad","type":"person","url":"https://hartvaat.nl/mensen/simon-elhadad/","name":"Simon Elhadad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2016/10/22/plaatjesfunctiemonitoring-voor-antiplaatjesaanpassing-bij-oudere-acs-patienten-a/","published":"2016-10-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-g-thompson","type":"person","url":"https://hartvaat.nl/mensen/simon-g-thompson/","name":"Simon G Thompson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-g-williams","type":"person","url":"https://hartvaat.nl/mensen/simon-g-williams/","name":"Simon G Williams","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/ijzertekort-bij-chronische-nierziekte-en-hartfalen-expertperspectieven/","published":"2026-03-04"},{"url":"https://hartvaat.nl/2017/08/07/remote-management-van-hartfalen-met-implanteerbare-devices-overzicht/","published":"2017-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-kircher","type":"person","url":"https://hartvaat.nl/mensen/simon-kircher/","name":"Simon Kircher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/10/01/slokdarmsonde-bij-rf-ablatie-voor-af-opera-prospectieve-gerandomiseerde-trial/","published":"2020-10-01"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-lee-hetherington","type":"person","url":"https://hartvaat.nl/mensen/simon-lee-hetherington/","name":"Simon Lee Hetherington","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2018/12/01/dagelijkse-remote-ischemische-conditionering-na-acuut-mi-gerandomiseerde-trial/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-mlstrm","type":"person","url":"https://hartvaat.nl/mensen/simon-mlstrm/","name":"Simon Mølstrøm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/05/bloeddruk-en-zuurstofstreefwaarden-en-nierschade-na-hartstilstand/","published":"2023-12-05"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-redwood","type":"person","url":"https://hartvaat.nl/mensen/simon-redwood/","name":"Simon Redwood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2017/01/17/2-jaarsuitkomsten-van-drug-coated-stents-zonder-polymeer-bij-hoog-bloedingsrisic/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-sawhney","type":"person","url":"https://hartvaat.nl/mensen/simon-sawhney/","name":"Simon Sawhney","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/16/landelijk-aki-alarmsysteem-effecten-op-zorg-en-patientuitkomsten/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2023/10/03/egfr-en-albuminurie-voorspellen-cv-events-ipd-mega-meta-analyse/","published":"2023-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-schalla","type":"person","url":"https://hartvaat.nl/mensen/simon-schalla/","name":"Simon Schalla","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/08/preoperatieve-tte-voor-voorspelling-van-postoperatief-af-meta-analyse/","published":"2021-11-08"},{"url":"https://hartvaat.nl/2019/11/19/beeldvorming-geleide-versus-routinezorg-bij-nstemi-jacc/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simon-schneider","type":"person","url":"https://hartvaat.nl/mensen/simon-schneider/","name":"Simon Schneider","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/07/bioresorbeerbare-scaffold-versus-ees-bij-stabiel-coronairlijden-prospectieve-tri/","published":"2019-01-07"},{"url":"https://hartvaat.nl/2017/03/01/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-geactualiseerde-meta/","published":"2017-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simone-sanna-cherchi","type":"person","url":"https://hartvaat.nl/mensen/simone-sanna-cherchi/","name":"Simone Sanna-Cherchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/polygene-risicoscores-en-hla-klasse-ii-als-biomarkers-voor-corticosteroidrespons/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2025/12/24/genomische-ontdekking-bij-nefrotisch-syndroom-mefv-varianten-als-risicofactor-vo/","published":"2025-12-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"simonetta-genovesi","type":"person","url":"https://hartvaat.nl/mensen/simonetta-genovesi/","name":"Simonetta Genovesi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/behandeling-van-familiaire-hypercholesterolemie-bij-kinderen-3-jaar-lipigen-regi/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2025/10/07/laa-occlusie-bij-terminale-nierziekte-ipd-meta-analyse/","published":"2025-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sin-gon-kim","type":"person","url":"https://hartvaat.nl/mensen/sin-gon-kim/","name":"Sin Gon Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/31/verhoogde-serumketonen-verlagen-niercomplicaties-bij-type-2-diabetes-prospectief/","published":"2026-08-14"},{"url":"https://hartvaat.nl/2025/12/20/orforglipron-bij-obesitas-nejm-definitieve-fase-3-resultaten/","published":"2025-12-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sinem-kilic","type":"person","url":"https://hartvaat.nl/mensen/sinem-kilic/","name":"Sinem Kilic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/10/01/langetermijnmortaliteit-en-prehospitale-tirofibanbehandeling-bij-stemi/","published":"2017-10-01"},{"url":"https://hartvaat.nl/2017/07/01/1-jaarsmortaliteit-bivalirudine-versus-heparine-in-de-ambulance-bij-stemi-matrix/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sining-xie","type":"person","url":"https://hartvaat.nl/mensen/sining-xie/","name":"Sining Xie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/orale-pcsk9-remmers-meta-analyse-bevestigt-krachtige-ldl-daling/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2026/04/22/angptl3-remmers-verlagen-breed-lipidenspectrum-vooral-remnant-en-triglyceriden/","published":"2026-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sion-k-roy","type":"person","url":"https://hartvaat.nl/mensen/sion-k-roy/","name":"Sion K Roy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/27/stop-semaglutide-vermindert-epicardiaal-vetweefsel-bij-type-2-diabetes/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2020/10/21/icosapent-ethyl-en-coronaire-atheroscleroseprogressie-bij-verhoogde-triglyceride/","published":"2020-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sirel-gurbuz","type":"person","url":"https://hartvaat.nl/mensen/sirel-gurbuz/","name":"Sirel Gurbuz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","published":"2023-08-12"},{"url":"https://hartvaat.nl/2022/11/26/triple-gip-glp-1-glucagonreceptoragonist-bij-type-2-diabetes-fase-1b/","published":"2022-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"siren-sezer","type":"person","url":"https://hartvaat.nl/mensen/siren-sezer/","name":"Siren Sezer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"siri-e-haberg","type":"person","url":"https://hartvaat.nl/mensen/siri-e-haberg/","name":"Siri E Håberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sisse-r-ostrowski","type":"person","url":"https://hartvaat.nl/mensen/sisse-r-ostrowski/","name":"Sisse R Ostrowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sivadasanpillai-harikrishnan","type":"person","url":"https://hartvaat.nl/mensen/sivadasanpillai-harikrishnan/","name":"Sivadasanpillai Harikrishnan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/15/opleidingsniveau-verandert-het-effect-van-diabetes-op-de-sterfte-bij-hartfalen-i/","published":"2026-07-19"},{"url":"https://hartvaat.nl/2019/03/01/ziekenhuisgebaseerde-kwaliteitsinterventies-bij-hartfalen-systematische-review/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"so-mi-jemma-cho","type":"person","url":"https://hartvaat.nl/mensen/so-mi-jemma-cho/","name":"So Mi Jemma Cho","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/polygeen-risico-gestuurde-detectie-en-behandeling-van-subklinische-coronaire-ath/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2026/01/14/polygene-risicoscore-voorspelt-langetermijn-bloeddrukcontrole-en-therapieresiste/","published":"2026-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"so-x0308-rensson","type":"person","url":"https://hartvaat.nl/mensen/so-x0308-rensson/","name":"Sörensson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/langetermijnuitkomsten-na-de-ross-operatie-een-op-de-vier-krijgt-een-heroperatie/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"so-ryoung-lee","type":"person","url":"https://hartvaat.nl/mensen/so-ryoung-lee/","name":"So-Ryoung Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/07/lancet-seminar-atriumfibrilleren-in-2026/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2026/02/27/van-vitamine-k-antagonist-naar-doac-bij-kwetsbare-ouderen-met-af/","published":"2026-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sobha-sivaprasad","type":"person","url":"https://hartvaat.nl/mensen/sobha-sivaprasad/","name":"Sobha Sivaprasad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/23/photon-aflibercept-8-mg-bij-diabetisch-macula-oedeem-verlengd-doseerinterval/","published":"2024-03-23"},{"url":"https://hartvaat.nl/2017/06/03/intravitreaal-aflibercept-versus-panretinale-fotocoagulatie-bij-proliferatieve-d/","published":"2017-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sofia-dias","type":"person","url":"https://hartvaat.nl/mensen/sofia-dias/","name":"Sofia Dias","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/25/leeftijds-en-sekseverschillen-in-effectiviteit-van-diabetesbehandeling-netwerk-m/","published":"2025-03-25"},{"url":"https://hartvaat.nl/2018/04/01/sekseverschillen-in-effectiviteit-van-orale-p2y12-remmers-meta-analyse/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sohaib-virk","type":"person","url":"https://hartvaat.nl/mensen/sohaib-virk/","name":"Sohaib Virk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/27/sglt2-remmers-verminderen-epicardiaal-vetweefsel-meta-analyse-van-11-studies/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2024/07/10/intracoronaire-trombolyse-bij-stemi-meta-analyse/","published":"2024-07-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sohail-q-khan","type":"person","url":"https://hartvaat.nl/mensen/sohail-q-khan/","name":"Sohail Q Khan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sojaita-jenny-mears","type":"person","url":"https://hartvaat.nl/mensen/sojaita-jenny-mears/","name":"Sojaita Jenny Mears","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/04/apoa-i-infusie-na-mi-geen-effect-op-recidief-ischemische-events/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2024/05/02/aegis-ii-apoa1-infusie-na-acuut-mi-verbetert-uitkomsten-niet-nejm/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sokoine-kivuyo","type":"person","url":"https://hartvaat.nl/mensen/sokoine-kivuyo/","name":"Sokoine Kivuyo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"solenn-toupin","type":"person","url":"https://hartvaat.nl/mensen/solenn-toupin/","name":"Solenn Toupin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/lge-granulariteit-op-cmr-voorspelt-sterfte-bij-eindstadium-hypertrofische-cardio/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"soma-banerjee","type":"person","url":"https://hartvaat.nl/mensen/soma-banerjee/","name":"Soma Banerjee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/07/vrouwen-hebben-slechtere-uitkomsten-na-een-herseninfarct-ondanks-antistolling-bi/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/04/01/doorgaan-met-dezelfde-doac-na-breakthrough-beroerte-even-goed-als-wisselen/","published":"2026-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"song-ding","type":"person","url":"https://hartvaat.nl/mensen/song-ding/","name":"Song Ding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/12/06/gemodificeerde-transseptale-punctie-bij-laa-occlusie-rct/","published":"2023-12-06"},{"url":"https://hartvaat.nl/2017/10/17/farmaco-invasieve-strategie-met-halve-dosis-alteplase-versus-primaire-pci-bij-st/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"song-yi-kim","type":"person","url":"https://hartvaat.nl/mensen/song-yi-kim/","name":"Song-Yi Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/12/af-therapie-bij-patienten-met-drug-eluting-stents/","published":"2026-02-12"},{"url":"https://hartvaat.nl/2025/05/01/aspirine-versus-clopidogrel-na-coronaire-stenting-naar-bloedingsrisico-en-comple/","published":"2025-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sonja-mckinlay","type":"person","url":"https://hartvaat.nl/mensen/sonja-mckinlay/","name":"Sonja McKinlay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/spironolacton-bij-hfpef-met-verslechterende-nierfunctie-topcat/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2016/02/01/invloed-van-ejectiefractie-op-uitkomsten-van-spironolacton-bij-hfpef/","published":"2016-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sonja-postma","type":"person","url":"https://hartvaat.nl/mensen/sonja-postma/","name":"Sonja Postma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"soo-joong-kim","type":"person","url":"https://hartvaat.nl/mensen/soo-joong-kim/","name":"Soo-Joong Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/14/oct-geleide-versus-angiografie-geleide-pci-bij-acs-gerandomiseerde-trial/","published":"2024-09-14"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sorin-stefan-popescu","type":"person","url":"https://hartvaat.nl/mensen/sorin-stefan-popescu/","name":"Sorin Stefan Popescu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2022/07/15/geindividualiseerde-versus-standaard-cryoballonablatie-bij-paroxysmaal-af/","published":"2022-07-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sotiris-antoniou","type":"person","url":"https://hartvaat.nl/mensen/sotiris-antoniou/","name":"Sotiris Antoniou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/13/nitrate-cin-nitraat-beschermt-tegen-contrastnefropathie-na-acs/","published":"2024-05-13"},{"url":"https://hartvaat.nl/2023/01/11/inadequate-noac-dosering-bij-af-uitkomsten-en-oorzaken-meta-analyse/","published":"2023-01-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"spencer-h-kubo","type":"person","url":"https://hartvaat.nl/mensen/spencer-h-kubo/","name":"Spencer H Kubo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2016/07/12/nervus-vagus-stimulatie-bij-hartfalen-de-inovate-hf-trial/","published":"2016-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sradha-kotwal","type":"person","url":"https://hartvaat.nl/mensen/sradha-kotwal/","name":"Sradha Kotwal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/19/vrouwen-met-ckd-krijgen-minder-vaak-ras-remmers-en-sglt2-remmers-dan-mannen/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2026/02/27/sglt2-remmers-bij-ernstig-verminderde-nierfunctie-data-uit-credence/","published":"2026-03-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sreekanth-vemulapalli","type":"person","url":"https://hartvaat.nl/mensen/sreekanth-vemulapalli/","name":"Sreekanth Vemulapalli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/30/adapt-cec-adaptief-ai-algoritme-voor-cardiovasculaire-event-adjudicatie-in-klini/","published":"2026-04-28"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"srikanth-yandrapalli","type":"person","url":"https://hartvaat.nl/mensen/srikanth-yandrapalli/","name":"Srikanth Yandrapalli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/gewicht-en-werkzaamheid-veiligheid-van-doac-s-bij-niet-valvulair-af-meta-analyse/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2019/09/01/oac-bij-af-met-kleplijden-en-bioprothese-overzicht/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stacey-melquist","type":"person","url":"https://hartvaat.nl/mensen/stacey-melquist/","name":"Stacey Melquist","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/plozasiran-en-lipoproteine-deeltjesgrootte-bij-hypertriglyceridemie/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/09/12/plozasiran-sirna-tegen-apoc3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stanislav-simek","type":"person","url":"https://hartvaat.nl/mensen/stanislav-simek/","name":"Stanislav Simek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/30/prasugrel-versus-ticagrelor-bij-primaire-pci-voor-mi-1-jaarsuitkomsten/","published":"2018-01-30"},{"url":"https://hartvaat.nl/2016/11/22/prasugrel-versus-ticagrelor-bij-acuut-mi-met-primaire-pci-multicenter-trial/","published":"2016-11-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stanley-j-chetcuti","type":"person","url":"https://hartvaat.nl/mensen/stanley-j-chetcuti/","name":"Stanley J Chetcuti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/splanchnische-zenuwablatie-bij-hfpef-endovasculaire-benadering/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stanley-nattel","type":"person","url":"https://hartvaat.nl/mensen/stanley-nattel/","name":"Stanley Nattel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stavros-e-mountantonakis","type":"person","url":"https://hartvaat.nl/mensen/stavros-e-mountantonakis/","name":"Stavros E Mountantonakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/pulmonaalvenenstenose-na-pfa-versus-thermale-ablatie-vergelijking/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/11/02/advent-pulsed-field-ablatie-non-inferieur-aan-thermale-ablatie-bij-af-nejm/","published":"2023-11-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stavroula-a-chrysanthopoulou","type":"person","url":"https://hartvaat.nl/mensen/stavroula-a-chrysanthopoulou/","name":"Stavroula A Chrysanthopoulou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stavroula-mavromichalis","type":"person","url":"https://hartvaat.nl/mensen/stavroula-mavromichalis/","name":"Stavroula Mavromichalis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"},{"url":"https://hartvaat.nl/2020/04/09/initieel-invasief-of-conservatief-bij-stabiel-coronairlijden-nejm-ischemia/","published":"2020-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steen-m-jensen","type":"person","url":"https://hartvaat.nl/mensen/steen-m-jensen/","name":"Steen M Jensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/19/katheterablatie-versus-antiaritmica-en-kwaliteit-van-leven-bij-af-jama-captaf/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/11/01/kwaliteit-van-leven-na-mitralisklepchirurgie-met-en-zonder-epicardiale-cryoablat/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-brunner","type":"person","url":"https://hartvaat.nl/mensen/stefan-brunner/","name":"Stefan Brunner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/14/va-ecmo-bij-cardiogene-shock-ipd-meta-analyse-lancet/","published":"2023-10-14"},{"url":"https://hartvaat.nl/2019/05/14/ecls-bij-cardiogene-shock-na-acuut-mi/","published":"2019-05-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-g-spitzer","type":"person","url":"https://hartvaat.nl/mensen/stefan-g-spitzer/","name":"Stefan G Spitzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/08/redo-firm-firm-geleide-ablatie-verbetert-uitkomst-niet-bij-recidief-af/","published":"2023-02-08"},{"url":"https://hartvaat.nl/2021/12/07/gold-force-multi-elektrode-rf-versus-irrigated-rf-bij-af-gerandomiseerde-trial/","published":"2021-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-hantel","type":"person","url":"https://hartvaat.nl/mensen/stefan-hantel/","name":"Stefan Hantel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/empagliflozine-voorkomt-progressie-van-ckd-empa-reg-outcome-renale-analyse/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/02/01/empagliflozine-en-cv-dood-en-hf-hospitalisatie-over-het-hf-spectrum-empa-reg-out/","published":"2018-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-john","type":"person","url":"https://hartvaat.nl/mensen/stefan-john/","name":"Stefan John","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-kiechl","type":"person","url":"https://hartvaat.nl/mensen/stefan-kiechl/","name":"Stefan Kiechl","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/18/carotis-intima-media-dikte-als-surrogaatmarker-meta-analyse-van-119-trials/","published":"2020-08-18"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-koudstaal","type":"person","url":"https://hartvaat.nl/mensen/stefan-koudstaal/","name":"Stefan Koudstaal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/27/nt-probnp-afkapwaarden-voor-hartfalentrials-optimaliseren-swedehf/","published":"2026-03-27"},{"url":"https://hartvaat.nl/2019/01/02/permanente-versus-polymeervrije-des-all-comers-gerandomiseerde-trial/","published":"2019-01-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-lonnerholm","type":"person","url":"https://hartvaat.nl/mensen/stefan-lonnerholm/","name":"Stefan Lönnerholm","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/19/katheterablatie-versus-antiaritmica-en-kwaliteit-van-leven-bij-af-jama-captaf/","published":"2019-03-19"},{"url":"https://hartvaat.nl/2018/10/01/enkele-versus-dubbele-cryoballon-applicatie-bij-af-effectiviteit-en-veiligheid/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-m-nidorf","type":"person","url":"https://hartvaat.nl/mensen/stefan-m-nidorf/","name":"Stefan M Nidorf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-neubauer","type":"person","url":"https://hartvaat.nl/mensen/stefan-neubauer/","name":"Stefan Neubauer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/05/30/empagliflozine-en-cardiale-energiestofwisseling-bij-hartfalen-empa-vision/","published":"2023-05-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-piechnik","type":"person","url":"https://hartvaat.nl/mensen/stefan-piechnik/","name":"Stefan Piechnik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-soderberg","type":"person","url":"https://hartvaat.nl/mensen/stefan-soderberg/","name":"Stefan Söderberg","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefan-t-engelter","type":"person","url":"https://hartvaat.nl/mensen/stefan-t-engelter/","name":"Stefan T Engelter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/stop-cad-1-op-6-cervicale-arteriedissecties-wordt-aanvankelijk-verkeerd-gediagno/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2025/07/05/optimale-timing-van-anticoagulatie-na-ischemisch-cva-en-af-collaboratief-project/","published":"2025-07-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefania-basili","type":"person","url":"https://hartvaat.nl/mensen/stefania-basili/","name":"Stefania Basili","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/cerebrale-microbloedingen-en-risico-bij-af-systematische-review/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2021/09/14/copd-bij-af-prevalentie-management-en-impact-meta-analyse/","published":"2021-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefania-paolillo","type":"person","url":"https://hartvaat.nl/mensen/stefania-paolillo/","name":"Stefania Paolillo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/semaglutide-verlaagt-mortaliteit-cv-events-en-nierschade-in-alle-stadia-van-ckm-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2020/09/14/glp-1-agonisten-bij-diabetes-type-2-met-en-zonder-cvd-meta-analyse/","published":"2020-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-bianchi","type":"person","url":"https://hartvaat.nl/mensen/stefano-bianchi/","name":"Stefano Bianchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/athena-register-pulsed-field-ablatie-voor-atriumfibrilleren-ook-effectief-bij-ha/","published":"2026-04-20"},{"url":"https://hartvaat.nl/2024/12/03/pfa-versus-cryoballon-voor-af-ablatie-multielectrode-vergelijking/","published":"2024-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-elia","type":"person","url":"https://hartvaat.nl/mensen/stefano-elia/","name":"Stefano Elia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/24/myocardiale-brug-praktische-gids-voor-diagnose-en-behandeling-in-het-ccta-tijdpe/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2026/02/03/vroeg-starten-met-mra-na-acuut-hartfalen-of-myocardinfarct-meta-analyse/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-f-rimoldi","type":"person","url":"https://hartvaat.nl/mensen/stefano-f-rimoldi/","name":"Stefano F Rimoldi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/03/20/effecten-van-ticagrelor-prasugrel-of-clopidogrel-op-endotheelfunctie/","published":"2018-03-20"},{"url":"https://hartvaat.nl/2016/06/01/selectieve-hartfrequentieverlaging-met-ivabradine-verhoogt-centrale-bloeddruk-bi/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-ghio","type":"person","url":"https://hartvaat.nl/mensen/stefano-ghio/","name":"Stefano Ghio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/rechterhart-hemodynamiek-voor-risicostratificatie-bij-pulmonale-arteriele-hypert/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2021/06/14/gestandaardiseerde-inspanningstraining-bij-pah-en-cteph-haalbaarheid-en-veilighe/","published":"2021-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-ricci","type":"person","url":"https://hartvaat.nl/mensen/stefano-ricci/","name":"Stefano Ricci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-rigattieri","type":"person","url":"https://hartvaat.nl/mensen/stefano-rigattieri/","name":"Stefano Rigattieri","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/24/timing-van-orale-p2y12-remmer-bij-nste-acs/","published":"2020-11-24"},{"url":"https://hartvaat.nl/2017/05/23/stralingsblootstelling-en-vasculaire-toegang-bij-acs-rad-matrix-trial/","published":"2017-05-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-romeo","type":"person","url":"https://hartvaat.nl/mensen/stefano-romeo/","name":"Stefano Romeo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/25/eas-consensus-familiaire-hypercholesterolemie-bij-kinderen-en-adolescenten/","published":"2026-06-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-taddei","type":"person","url":"https://hartvaat.nl/mensen/stefano-taddei/","name":"Stefano Taddei","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/14/empagliflozine-bij-hfpef-nejm-emperor-preserved/","published":"2021-10-14"},{"url":"https://hartvaat.nl/2020/10/08/empagliflozine-bij-hartfalen-cardiovasculaire-en-renale-uitkomsten-nejm-emperor-/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefano-volpato","type":"person","url":"https://hartvaat.nl/mensen/stefano-volpato/","name":"Stefano Volpato","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/11/multidomein-revalidatie-bij-ouderen-na-mi-gerandomiseerde-trial-nejm/","published":"2025-09-11"},{"url":"https://hartvaat.nl/2020/11/01/inspanningsinterventie-verbetert-qol-na-mi-bij-ouderen-gerandomiseerde-trial/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steff-lewis","type":"person","url":"https://hartvaat.nl/mensen/steff-lewis/","name":"Steff Lewis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/25/scot-heart-ct-coronairangiografie-bij-stabiele-thoracale-pijn-tienjaarsresultate/","published":"2025-01-25"},{"url":"https://hartvaat.nl/2025/01/21/evolved-vroege-interventie-bij-asymptomatische-ernstige-aortastenose-met-myocard/","published":"2025-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steffen-e-petersen","type":"person","url":"https://hartvaat.nl/mensen/steffen-e-petersen/","name":"Steffen E Petersen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/esc-atlas-2025-3-miljoen-cvd-doden-per-jaar-in-europa-middeninkomenlanden-hebben/","published":"2026-06-13"},{"url":"https://hartvaat.nl/2026/03/05/directe-versus-uitgestelde-non-culprit-pci-bij-mi-gerandomiseerde-trial/","published":"2026-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stella-trompet","type":"person","url":"https://hartvaat.nl/mensen/stella-trompet/","name":"Stella Trompet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2016/07/19/visit-to-visit-ldl-cholesterolvariabiliteit-en-cognitieve-functie/","published":"2016-07-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-blazek","type":"person","url":"https://hartvaat.nl/mensen/stephan-blazek/","name":"Stephan Blazek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/renale-denervatie-bij-geisoleerde-systolische-hypertensie-vergelijking-van-kathe/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/01/29/drie-armen-vergelijkende-renale-denervatie-radiosound-htn/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-dobner","type":"person","url":"https://hartvaat.nl/mensen/stephan-dobner/","name":"Stephan Dobner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/07/semaglutide-en-bloeddruk-ipd-meta-analyse/","published":"2024-10-07"},{"url":"https://hartvaat.nl/2021/10/01/paroxetine-grk2-remming-versus-placebo-bij-anterieur-mi-jama-cardiology/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-gielen","type":"person","url":"https://hartvaat.nl/mensen/stephan-gielen/","name":"Stephan Gielen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/04/07/2017-esc-eas-praktische-gids-voor-pcsk9-remming/","published":"2018-04-07"},{"url":"https://hartvaat.nl/2017/02/28/hoog-intensieve-intervaltraining-bij-hartfalen-met-verminderde-ejectiefractie/","published":"2017-02-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-j-l-bakker","type":"person","url":"https://hartvaat.nl/mensen/stephan-j-l-bakker/","name":"Stephan J L Bakker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/creatinine-cystatine-c-of-beide-voor-gfr-schatting-bij-niertransplantatiepatient/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2020/09/22/sekse-specifieke-cv-risicofactoren-en-biomarkers-bij-incident-hartfalen/","published":"2020-09-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-kische","type":"person","url":"https://hartvaat.nl/mensen/stephan-kische/","name":"Stephan Kische","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2023/10/19/october-oct-geleide-pci-bij-complexe-bifurcatielaesies-nejm/","published":"2023-10-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-mueller","type":"person","url":"https://hartvaat.nl/mensen/stephan-mueller/","name":"Stephan Mueller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/01/trainingseffect-op-diastolische-functie-bij-hfpef/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2021/02/09/hiit-matig-continu-of-richtlijnadvies-en-piek-vo2-bij-hfref-jama-smartex-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephan-wardell","type":"person","url":"https://hartvaat.nl/mensen/stephan-wardell/","name":"Stephan Wardell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephanie-lewis","type":"person","url":"https://hartvaat.nl/mensen/stephanie-lewis/","name":"Stephanie Lewis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/06/ct-coronairangiografie-en-5-jaars-mi-risico-nejm-scot-heart/","published":"2018-09-06"},{"url":"https://hartvaat.nl/2016/04/19/ct-coronairangiografie-voor-het-sturen-van-beleid-bij-coronairlijden/","published":"2016-04-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephanie-m-gustavson","type":"person","url":"https://hartvaat.nl/mensen/stephanie-m-gustavson/","name":"Stephanie M Gustavson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"},{"url":"https://hartvaat.nl/2017/09/28/exenatide-eenmaal-per-week-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-ne/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephanie-mabe","type":"person","url":"https://hartvaat.nl/mensen/stephanie-mabe/","name":"Stephanie Mabe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/12/leefstijlmodificatie-bij-resistente-hypertensie-triumph-gerandomiseerde-trial/","published":"2021-10-12"},{"url":"https://hartvaat.nl/2016/04/05/hartrevalidatie-versterkt-met-stressmanagementtraining-gerandomiseerde-trial/","published":"2016-04-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephanie-sanger","type":"person","url":"https://hartvaat.nl/mensen/stephanie-sanger/","name":"Stephanie Sanger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/gemaskeerde-hypertensie-bij-kinderen-prevalentie-en-cv-risico-meta-analyse/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/06/01/eindorgaanschade-bij-kinderen-met-primaire-hypertensie-meta-analyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephanie-t-nguyen","type":"person","url":"https://hartvaat.nl/mensen/stephanie-t-nguyen/","name":"Stephanie T Nguyen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/16/technieken-om-cardioversiesucces-bij-af-te-verbeteren-meta-analyse/","published":"2023-02-16"},{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-a-joseph","type":"person","url":"https://hartvaat.nl/mensen/stephen-a-joseph/","name":"Stephen A Joseph","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/07/14/vroege-versus-late-af-ablatie-impact-op-aritmierecidief/","published":"2023-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-b-wheatcroft","type":"person","url":"https://hartvaat.nl/mensen/stephen-b-wheatcroft/","name":"Stephen B Wheatcroft","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/09/20/recombinant-lcat-bij-acuut-stemi-fase-2b-trial/","published":"2022-09-20"},{"url":"https://hartvaat.nl/2022/08/30/ripcord-2-routinematige-ffr-meting-versus-conventionele-angiografie/","published":"2022-08-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-g-worthley","type":"person","url":"https://hartvaat.nl/mensen/stephen-g-worthley/","name":"Stephen G Worthley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/26/polymer-versus-polymeervrije-stents-bij-hoog-bloedingsrisico-nejm-leaders-free-2/","published":"2020-03-26"},{"url":"https://hartvaat.nl/2018/09/01/cer-001-hdl-mimeticum-en-coronaire-atherosclerose-na-acs-jama-cardiology/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-hamshere","type":"person","url":"https://hartvaat.nl/mensen/stephen-hamshere/","name":"Stephen Hamshere","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-helmke","type":"person","url":"https://hartvaat.nl/mensen/stephen-helmke/","name":"Stephen Helmke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/27/multimodaal-ai-model-verhoogt-accuratesse-van-echo-diagnose-cardiale-amyloidose/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2025/01/01/stijging-van-serum-transthyretine-na-tafamidis-voorspelt-betere-overleving-bij-a/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-j-nicholls","type":"person","url":"https://hartvaat.nl/mensen/stephen-j-nicholls/","name":"Stephen J. Nicholls","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-r-rapp","type":"person","url":"https://hartvaat.nl/mensen/stephen-r-rapp/","name":"Stephen R Rapp","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-t-turner","type":"person","url":"https://hartvaat.nl/mensen/stephen-t-turner/","name":"Stephen T Turner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephen-watiti","type":"person","url":"https://hartvaat.nl/mensen/stephen-watiti/","name":"Stephen Watiti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/14/inte-africa-2-community-based-versus-facilitair-beheer-hiv-dm-htn/","published":"2026-03-14"},{"url":"https://hartvaat.nl/2023/10/07/inte-africa-geintegreerd-management-van-hiv-diabetes-en-hypertensie-lancet/","published":"2023-10-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-elkin","type":"person","url":"https://hartvaat.nl/mensen/steven-elkin/","name":"Steven Elkin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/02/01/cangrelor-versus-gpiib-iiia-remmers-ischemie-en-bloedingsrisico-s-vergeleken/","published":"2017-02-01"},{"url":"https://hartvaat.nl/2017/01/17/cangrelor-met-en-zonder-gpiib-iiia-remmers-bij-pci/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-j-podd","type":"person","url":"https://hartvaat.nl/mensen/steven-j-podd/","name":"Steven J Podd","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/07/01/implanteerbare-monitors-als-goudstandaard-voor-af-detectie-gerandomiseerde-verge/","published":"2016-07-01"},{"url":"https://hartvaat.nl/2016/03/01/eerste-trial-met-specifieke-ikach-blokker-toont-geen-reductie-in-af-last-bij-par/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-j-yakubov","type":"person","url":"https://hartvaat.nl/mensen/steven-j-yakubov/","name":"Steven J Yakubov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/02/amaze-pvi-met-of-zonder-laa-ligatie-bij-af-jama-rct/","published":"2024-04-02"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-lindsay","type":"person","url":"https://hartvaat.nl/mensen/steven-lindsay/","name":"Steven Lindsay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/11/07/invasieve-strategie-bij-ouderen-met-mi-gerandomiseerde-trial-nejm/","published":"2024-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-m-bradley","type":"person","url":"https://hartvaat.nl/mensen/steven-m-bradley/","name":"Steven M Bradley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/05/27/vergelijkende-effectiviteit-van-aspirinedoseringen-bij-cvd-nejm-adaptable/","published":"2021-05-27"},{"url":"https://hartvaat.nl/2016/09/06/duur-van-dapt-systematische-review-voor-de-acc-aha-gerichte-update-2016/","published":"2016-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-p-schulman","type":"person","url":"https://hartvaat.nl/mensen/steven-p-schulman/","name":"Steven P Schulman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/28/evolocumab-op-atherogene-lipoproteinen-in-de-peri-infarctperiode-gerandomiseerde/","published":"2020-07-28"},{"url":"https://hartvaat.nl/2018/01/16/intraveneus-fentanyl-en-ticagrelorabsorptie-bij-pci/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"steven-r-bailey","type":"person","url":"https://hartvaat.nl/mensen/steven-r-bailey/","name":"Steven R Bailey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/05/17/institutionele-en-operateurvereisten-voor-linker-hartoorocclusie-scai-acc-hrs-st/","published":"2016-05-17"},{"url":"https://hartvaat.nl/2016/03/15/2015-acc-aha-scai-gerichte-update-primaire-pci-bij-stemi/","published":"2016-03-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stig-lyngbk","type":"person","url":"https://hartvaat.nl/mensen/stig-lyngbk/","name":"Stig Lyngbæk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stuart-d-rosen","type":"person","url":"https://hartvaat.nl/mensen/stuart-d-rosen/","name":"Stuart D Rosen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/13/transdermaal-oestradiol-bij-prostaatkanker-langetermijn-cv-uitkomsten-lancet/","published":"2021-02-13"},{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stuart-hood","type":"person","url":"https://hartvaat.nl/mensen/stuart-hood/","name":"Stuart Hood","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/01/post-stenting-ffr-versus-angiografie-voor-pci-optimalisatie-target-ffr/","published":"2021-12-01"},{"url":"https://hartvaat.nl/2020/05/01/pci-versus-medicamenteus-bij-angina-met-ffr-in-de-grijze-zone/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stuti-fernandes","type":"person","url":"https://hartvaat.nl/mensen/stuti-fernandes/","name":"Stuti Fernandes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/09/01/cardiorenale-bescherming-door-sglt2-remmers-glp-1-agonisten-en-mra-s-bij-type-1-/","published":"2026-08-07"},{"url":"https://hartvaat.nl/2026/09/01/cardiorenale-risicos-bij-type-1-diabetes-een-overzicht-van-de-huidige-stand-van-/","published":"2026-08-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stefanie-parisien","type":"person","url":"https://hartvaat.nl/mensen/stefanie-parisien/","name":"Stéfanie Parisien","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/17/veel-vrouwen-met-hypertensie-en-een-doorgemaakte-zwangerschapshypertensie-blijke/","published":"2026-03-17"},{"url":"https://hartvaat.nl/2026/03/11/behandeling-van-primair-aldosteronisme-chirurgie-of-mra-met-zoutbeperking-als-ho/","published":"2026-03-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephanie-rouanet","type":"person","url":"https://hartvaat.nl/mensen/stephanie-rouanet/","name":"Stéphanie Rouanet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2021/01/19/residuele-syntax-score-bij-cardiogene-shock/","published":"2021-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"stephanie-saxer","type":"person","url":"https://hartvaat.nl/mensen/stephanie-saxer/","name":"Stéphanie Saxer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/14/gestandaardiseerde-inspanningstraining-bij-pah-en-cteph-haalbaarheid-en-veilighe/","published":"2021-06-14"},{"url":"https://hartvaat.nl/2017/04/14/zuurstofverrijkte-lucht-en-inspanningsprestatie-bij-precapillaire-pulmonale-hype/","published":"2017-04-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sue-finch","type":"person","url":"https://hartvaat.nl/mensen/sue-finch/","name":"Sue Finch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/12/af-ablatie-vermindert-psychologische-distress-jama-rct/","published":"2023-09-12"},{"url":"https://hartvaat.nl/2023/01/10/capla-posterior-wand-isolatie-verbetert-uitkomst-niet-bij-persisterend-af/","published":"2023-01-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suhail-dohad","type":"person","url":"https://hartvaat.nl/mensen/suhail-dohad/","name":"Suhail Dohad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"},{"url":"https://hartvaat.nl/2025/04/12/orbitale-atherectomie-versus-ballonangioplastie-voor-des-bij-ernstig-verkalkte-l/","published":"2025-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sumant-p-radhoe","type":"person","url":"https://hartvaat.nl/mensen/sumant-p-radhoe/","name":"Sumant P Radhoe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/01/pa-drukmonitoring-bij-chronisch-hartfalen-meta-analyse-van-drie-rct-s/","published":"2023-10-01"},{"url":"https://hartvaat.nl/2023/06/24/monitor-hf-pa-drukmonitoring-bij-hartfalen-effectief-in-europa-lancet-rct/","published":"2023-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"summer-syed","type":"person","url":"https://hartvaat.nl/mensen/summer-syed/","name":"Summer Syed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sung-woo-kwon","type":"person","url":"https://hartvaat.nl/mensen/sung-woo-kwon/","name":"Sung Woo Kwon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/ticagrelor-monotherapie-na-acs-ipd-meta-analyse-van-vier-trials/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2024/02/20/t-pass-ticagrelor-monotherapie-binnen-1-maand-na-stenting-bij-acs/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sung-yun-lee","type":"person","url":"https://hartvaat.nl/mensen/sung-yun-lee/","name":"Sung Yun Lee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/prasugrel-dosis-de-escalatie-na-complexe-pci-bij-acs-jama-cardiology/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/12/03/klinisch-significante-bloedingen-met-ticagrelor-versus-clopidogrel-bij-koreaanse/","published":"2019-12-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sung-ji-park","type":"person","url":"https://hartvaat.nl/mensen/sung-ji-park/","name":"Sung-Ji Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/11/effort-ertugliflozine-bij-functionele-mitralisinsufficientie-en-hartfalen/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2019/03/12/arni-bij-functionele-mitralisklepinsufficientie/","published":"2019-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sunni-l-mumford","type":"person","url":"https://hartvaat.nl/mensen/sunni-l-mumford/","name":"Sunni L Mumford","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/01/preconceptiebloeddruk-en-verandering-naar-vroege-zwangerschap-risicofactor-voor-/","published":"2020-09-01"},{"url":"https://hartvaat.nl/2018/05/01/bloeddruk-voor-conceptie-en-reproductieve-uitkomsten/","published":"2018-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sunny-s-po","type":"person","url":"https://hartvaat.nl/mensen/sunny-s-po/","name":"Sunny S Po","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/01/05/calcium-geinduceerde-autonome-denervatie-bij-postoperatief-af/","published":"2021-01-05"},{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-b-promes","type":"person","url":"https://hartvaat.nl/mensen/susan-b-promes/","name":"Susan B Promes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-connolly","type":"person","url":"https://hartvaat.nl/mensen/susan-connolly/","name":"Susan Connolly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/21/bijwerkingspatronen-in-crossover-trial-statine-placebo-geen-behandeling-statinwi/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2020/11/26/n-of-1-trial-van-statine-placebo-of-geen-behandeling-voor-bijwerkingen-nejm-stat/","published":"2020-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-graham","type":"person","url":"https://hartvaat.nl/mensen/susan-graham/","name":"Susan Graham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/icd-mortaliteit-naar-hartfalenetiologie-propensity-matched-analyse/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2018/10/01/linkeratriumvolume-en-cv-uitkomsten-bij-systolisch-hf-antitromboticaeffect/","published":"2018-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-huyck","type":"person","url":"https://hartvaat.nl/mensen/susan-huyck/","name":"Susan Huyck","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/01/sglt2-remmers-en-cv-renale-uitkomsten-bij-diabetes-type-2-jama-cardiology-meta-a/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2020/10/08/ertugliflozine-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-vertis-cv/","published":"2020-10-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-redline","type":"person","url":"https://hartvaat.nl/mensen/susan-redline/","name":"Susan Redline","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/hypotensieve-episodes-op-24-uurs-abpm-en-cognitieve-functie-sprint-inzichten/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-ross","type":"person","url":"https://hartvaat.nl/mensen/susan-ross/","name":"Susan Ross","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/01/chips-trial-is-ernstige-hypertensie-in-de-zwangerschap-meer-dan-alleen-verhoogde/","published":"2016-11-01"},{"url":"https://hartvaat.nl/2016/10/01/kostenimplicaties-van-minder-strikte-versus-strikte-bloeddrukcontrole-bij-zwange/","published":"2016-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susan-solar-yohay","type":"person","url":"https://hartvaat.nl/mensen/susan-solar-yohay/","name":"Susan Solar-Yohay","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"susanna-r-stevens","type":"person","url":"https://hartvaat.nl/mensen/susanna-r-stevens/","name":"Susanna R Stevens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/03/invasief-versus-conservatief-bij-stabiel-coronairlijden-met-hf-of-lage-ef-ischem/","published":"2020-11-03"},{"url":"https://hartvaat.nl/2020/04/28/open-label-drop-in-van-glucoseverlagende-medicatie-en-exscel-uitkomsten/","published":"2020-04-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sushrut-s-waikar","type":"person","url":"https://hartvaat.nl/mensen/sushrut-s-waikar/","name":"Sushrut S Waikar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-niet-dialysepatienten-nejm/","published":"2021-12-16"},{"url":"https://hartvaat.nl/2021/12/16/daprodustat-bij-anemie-bij-dialysepatienten-nejm/","published":"2021-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suvasini-lakshmanan","type":"person","url":"https://hartvaat.nl/mensen/suvasini-lakshmanan/","name":"Suvasini Lakshmanan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/27/stop-semaglutide-vermindert-epicardiaal-vetweefsel-bij-type-2-diabetes/","published":"2024-08-27"},{"url":"https://hartvaat.nl/2020/10/21/icosapent-ethyl-en-coronaire-atheroscleroseprogressie-bij-verhoogde-triglyceride/","published":"2020-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"suzanne-j-baron","type":"person","url":"https://hartvaat.nl/mensen/suzanne-j-baron/","name":"Suzanne J Baron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/07/gezondheidsstatus-na-mitraclip-bij-hf-met-secundaire-mr-coapt/","published":"2019-05-07"},{"url":"https://hartvaat.nl/2017/12/26/kwaliteit-van-leven-na-ees-of-cabg-bij-hoofdstamlijden-excel-qol/","published":"2017-12-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sven-trelle","type":"person","url":"https://hartvaat.nl/mensen/sven-trelle/","name":"Sven Trelle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sven-erik-olsson","type":"person","url":"https://hartvaat.nl/mensen/sven-erik-olsson/","name":"Sven-Erik Olsson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/15/5-jaars-ifr-versus-ffr-geleide-pci-define-flair-ifr-swedeheart/","published":"2022-03-15"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"svenja-seide","type":"person","url":"https://hartvaat.nl/mensen/svenja-seide/","name":"Svenja Seide","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/11/empact-mi-lv-functie-congestie-en-empagliflozine-effect-na-mi/","published":"2024-06-11"},{"url":"https://hartvaat.nl/2024/05/21/empact-mi-empagliflozine-en-hartfalenuitkomsten-na-mi/","published":"2024-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"svetozar-putnik","type":"person","url":"https://hartvaat.nl/mensen/svetozar-putnik/","name":"Svetozar Putnik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/01/ffr-geleide-pci-versus-cabg-bij-diffuus-coronairlijden/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2021/04/01/cardio-microstroomdevice-bij-chronisch-hf-eerste-klinische-studie/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"syed-saqib-imran","type":"person","url":"https://hartvaat.nl/mensen/syed-saqib-imran/","name":"Syed Saqib Imran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/09/cangrelor-en-infarctgrootte-bij-stemi-gerandomiseerde-trial/","published":"2024-07-09"},{"url":"https://hartvaat.nl/2024/01/01/verkorte-dapt-bij-hoog-bloedingsrisico-geen-sekseverschillen/","published":"2024-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sylvain-sebert","type":"person","url":"https://hartvaat.nl/mensen/sylvain-sebert/","name":"Sylvain Sebert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-b-baptista","type":"person","url":"https://hartvaat.nl/mensen/sergio-b-baptista/","name":"Sérgio B Baptista","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sergio-barra","type":"person","url":"https://hartvaat.nl/mensen/sergio-barra/","name":"Sérgio Barra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/trends-in-plotse-hartdood-bij-hf-met-crt-systematische-review/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2018/03/01/doodsoorzaken-bij-crt-met-en-zonder-defibrillator-meta-analyse/","published":"2018-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"soren-moller","type":"person","url":"https://hartvaat.nl/mensen/soren-moller/","name":"Sören Möller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/empagliflozine-en-lv-volumes-en-functie-bij-hfref-jama-cardiology/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/12/08/empagliflozine-en-hemodynamiek-bij-hfref/","published":"2020-12-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sren-boesgaard","type":"person","url":"https://hartvaat.nl/mensen/sren-boesgaard/","name":"Søren Boesgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/18/danger-shock-impella-versus-standaardzorg-bij-cardiogene-shock-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2022/10/20/box-bloeddrukdoelen-bij-comateuze-overlevenden-van-hartstilstand/","published":"2022-10-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sren-galatius","type":"person","url":"https://hartvaat.nl/mensen/sren-galatius/","name":"Søren Galatius","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sren-toubro","type":"person","url":"https://hartvaat.nl/mensen/sren-toubro/","name":"Søren Toubro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/12/amycretine-fase-2-subcutaan-toegediend-bij-obesitas/","published":"2025-07-12"},{"url":"https://hartvaat.nl/2025/07/12/amycretine-eerste-glp-1-amyline-agonist-fase-1-veiligheid-en-farmacologie/","published":"2025-07-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"t-jared-bunch","type":"person","url":"https://hartvaat.nl/mensen/t-jared-bunch/","name":"T Jared Bunch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/07/zorgpaden-na-nieuw-vastgesteld-atriumfibrilleren-rol-van-de-elektrofysioloog-en-/","published":"2026-07-18"},{"url":"https://hartvaat.nl/2019/04/02/katheterablatie-versus-antiaritmica-bij-af-mortaliteit-en-cva-jama-cabana/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"t-c","type":"person","url":"https://hartvaat.nl/mensen/t-c/","name":"T. C.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/hypochloremie-bij-opname-voor-acuut-hartfalen-voorspelt-onafhankelijk-30-daagse-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/05/20/klinisch-en-genetisch-risico-op-atriumfibrilleren-versterken-elkaar-additief-13-/","published":"2026-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"t-f","type":"person","url":"https://hartvaat.nl/mensen/t-f/","name":"T. F.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/04/noorse-nationale-validatie-myocarditis-na-mrna-covid-vaccinatie-4-5-per-100-000-/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/01/29/obesitasparadox-bij-het-takotsubosyndroom-ondergewicht-geeft-de-hoogste-sterfte-/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"t-k-m","type":"person","url":"https://hartvaat.nl/mensen/t-k-m/","name":"T. K. M.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/cardiovasculaire-ziekte-bij-sikkelcelziekte-ondergediagnosticeerde-drijver-van-m/","published":"2026-05-11"},{"url":"https://hartvaat.nl/2026/03/25/geleidelijk-afbouwen-van-rilonacept-bij-recidiverende-pericarditis-voorkomt-vake/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"t-w","type":"person","url":"https://hartvaat.nl/mensen/t-w/","name":"T. W.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/24/sekseverschillen-bij-infectieuze-endocarditis-vrouwen-vaker-conservatief-behande/","published":"2026-07-20"},{"url":"https://hartvaat.nl/2026/01/23/multidisciplinair-cardiogene-shockteam-verbetert-de-1-jaarsoverleving-bij-infarc/","published":"2026-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"t-c","type":"person","url":"https://hartvaat.nl/mensen/t-c/","name":"T.-C.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/22/een-op-de-tien-volwassenen-met-een-aangeboren-hartafwijking-heeft-een-syndroom-e/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/05/26/recidief-linkerventrikel-trombus-12-recidief-actieve-eerdere-maligniteit-verzesv/","published":"2026-07-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tadej-battelino","type":"person","url":"https://hartvaat.nl/mensen/tadej-battelino/","name":"Tadej Battelino","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/lp-a-spiegels-bij-kinderen-met-hypercholesterolemie-impact-op-ldl-c-interpretati/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tadej-zlahtic","type":"person","url":"https://hartvaat.nl/mensen/tadej-zlahtic/","name":"Tadej Žlahtič","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/csp-sync-geleidingssysteempacing-versus-biventriculaire-pacing-voor-crt-rct/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2024/05/02/preventieve-substraatablatie-vermindert-icd-interventies-bij-ischemische-cmp/","published":"2024-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tae-hoon-ahn","type":"person","url":"https://hartvaat.nl/mensen/tae-hoon-ahn/","name":"Tae Hoon Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/21/prevent-langetermijn-follow-up-van-preventieve-pci-bij-kwetsbare-plaques/","published":"2025-08-21"},{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tae-ho-park","type":"person","url":"https://hartvaat.nl/mensen/tae-ho-park/","name":"Tae-Ho Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/06/26/aspirine-versus-clopidogrel-voor-chronische-monotherapie-na-pci-lancet-host-exam/","published":"2021-06-26"},{"url":"https://hartvaat.nl/2018/04/01/valsartan-en-linkerkamerremodellering-na-mi/","published":"2018-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tahar-chouihed","type":"person","url":"https://hartvaat.nl/mensen/tahar-chouihed/","name":"Tahar Chouihed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/23/paradise-cohort-hartfalen-en-copd-samen-verhogen-de-langetermijnmortaliteit-met-/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2020/11/17/seh-zorgbundel-en-30-daags-ontslag-en-overleving-bij-oudere-hf-patienten-jama/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"taiji-sakamoto","type":"person","url":"https://hartvaat.nl/mensen/taiji-sakamoto/","name":"Taiji Sakamoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/23/photon-aflibercept-8-mg-bij-diabetisch-macula-oedeem-verlengd-doseerinterval/","published":"2024-03-23"},{"url":"https://hartvaat.nl/2022/02/19/faricimab-bij-diabetisch-maculaoedeem-met-verlengde-dosering-lancet/","published":"2022-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takafumi-oka","type":"person","url":"https://hartvaat.nl/mensen/takafumi-oka/","name":"Takafumi Oka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takafumi-yokomatsu","type":"person","url":"https://hartvaat.nl/mensen/takafumi-yokomatsu/","name":"Takafumi Yokomatsu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takahiro-okumura","type":"person","url":"https://hartvaat.nl/mensen/takahiro-okumura/","name":"Takahiro Okumura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/18/helios-b-post-hoc-vutrisiran-effectief-bij-oost-aziatische-attr-cm-patienten-hr-/","published":"2026-06-17"},{"url":"https://hartvaat.nl/2019/10/01/neuromusculaire-elektrische-stimulatie-bij-acuut-hartfalen-haalbaarheid/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takamasa-iwai","type":"person","url":"https://hartvaat.nl/mensen/takamasa-iwai/","name":"Takamasa Iwai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takanori-kusuyama","type":"person","url":"https://hartvaat.nl/mensen/takanori-kusuyama/","name":"Takanori Kusuyama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takashi-yamamoto","type":"person","url":"https://hartvaat.nl/mensen/takashi-yamamoto/","name":"Takashi Yamamoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takayuki-ishihara","type":"person","url":"https://hartvaat.nl/mensen/takayuki-ishihara/","name":"Takayuki Ishihara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2018/09/01/pace-capture-geleide-ablatie-na-contact-force-pvi-dragon-gerandomiseerde-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takehiro-sugiyama","type":"person","url":"https://hartvaat.nl/mensen/takehiro-sugiyama/","name":"Takehiro Sugiyama","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/28/orale-antistolling-bij-af-op-langdurige-hemodialyse/","published":"2020-01-28"},{"url":"https://hartvaat.nl/2017/07/01/cardiovasculair-risico-bij-diabetes-op-betablokkers/","published":"2017-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"takuya-tsujimura","type":"person","url":"https://hartvaat.nl/mensen/takuya-tsujimura/","name":"Takuya Tsujimura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2018/09/01/pace-capture-geleide-ablatie-na-contact-force-pvi-dragon-gerandomiseerde-trial/","published":"2018-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamara-horwich","type":"person","url":"https://hartvaat.nl/mensen/tamara-horwich/","name":"Tamara Horwich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2016/12/06/comorbiditeiten-bij-hartfalen-hypertensie-obesitas-diabetes-hyperlipidemie-en-me/","published":"2016-12-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamas-alexy","type":"person","url":"https://hartvaat.nl/mensen/tamas-alexy/","name":"Tamas Alexy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/clip-hfpef-cilostazol-bij-hfpef-gerandomiseerde-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/07/11/transform-hf-torsemide-versus-furosemide-geen-verschil-in-symptomen/","published":"2023-07-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamer-coskun","type":"person","url":"https://hartvaat.nl/mensen/tamer-coskun/","name":"Tamer Coskun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","published":"2023-08-12"},{"url":"https://hartvaat.nl/2022/11/26/triple-gip-glp-1-glucagonreceptoragonist-bij-type-2-diabetes-fase-1b/","published":"2022-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamila-heresztyn","type":"person","url":"https://hartvaat.nl/mensen/tamila-heresztyn/","name":"Tamila Heresztyn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/14/adma-en-sdma-voorspellen-uitkomsten-bij-af-aristotle-substudie/","published":"2018-08-14"},{"url":"https://hartvaat.nl/2017/09/05/n-acetylcysteine-met-nitraat-bij-primaire-pci-voor-stemi/","published":"2017-09-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamim-m-nazif","type":"person","url":"https://hartvaat.nl/mensen/tamim-m-nazif/","name":"Tamim M Nazif","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2016/11/26/oct-versus-ivus-versus-angiografie-bij-coronaire-stentimplantatie-lancet-ilumien/","published":"2016-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamique-mason","type":"person","url":"https://hartvaat.nl/mensen/tamique-mason/","name":"Tamique Mason","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/24/empa-heart-2-empagliflozine-vermindert-lv-massa-niet-bij-patienten-zonder-diabet/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2019/11/19/empagliflozine-en-lv-massa-bij-diabetes-type-2-met-coronairlijden-empa-heart/","published":"2019-11-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamiris-a-miranda","type":"person","url":"https://hartvaat.nl/mensen/tamiris-a-miranda/","name":"Tamiris A Miranda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/ticagrelor-versus-clopidogrel-bij-stemi-na-fibrinolyse-treat-trial/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2019/03/01/bariatrische-chirurgie-versus-medicamenteus-beleid-op-24-uurs-ambulante-bloeddru/","published":"2019-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tammy-m-brady","type":"person","url":"https://hartvaat.nl/mensen/tammy-m-brady/","name":"Tammy M Brady","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/12/nhlbi-workshop-bloeddrukmeting-verfijnen-door-de-hele-levensloop-heen-knelpunten/","published":"2026-06-23"},{"url":"https://hartvaat.nl/2021/11/01/rustduur-voor-bloeddrukmeting-best-rest-trial/","published":"2021-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tang","type":"person","url":"https://hartvaat.nl/mensen/tang/","name":"Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/hiv-infectie-hangt-onafhankelijk-samen-met-meer-en-kwetsbaardere-halsslagaderpla/","published":"2026-02-26"},{"url":"https://hartvaat.nl/2026/01/09/littekenweefsel-voorspelt-plotse-hartdood-na-een-infarct-grotendeels-buiten-de-e/","published":"2026-01-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tania-garito","type":"person","url":"https://hartvaat.nl/mensen/tania-garito/","name":"Tania Garito","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tania-pawade","type":"person","url":"https://hartvaat.nl/mensen/tania-pawade/","name":"Tania Pawade","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/05/05/laag-attenuatie-plaque-op-ccta-voorspelt-mi-scot-heart-resultaten/","published":"2020-05-05"},{"url":"https://hartvaat.nl/2019/01/29/coronaire-plaquekenmerken-en-adverse-uitkomsten-scot-heart/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tanja-popov","type":"person","url":"https://hartvaat.nl/mensen/tanja-popov/","name":"Tanja Popov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","published":"2026-08-25"},{"url":"https://hartvaat.nl/2026/03/03/c-mic-ii-hartfunctie-inspanningscapaciteit-en-kwaliteit-van-leven-zijn-verwante-/","published":"2026-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tanja-zeller","type":"person","url":"https://hartvaat.nl/mensen/tanja-zeller/","name":"Tanja Zeller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/22/anemie-beinvloedt-ijzerhomeostase-en-empagliflozine-respons-bij-hf/","published":"2025-04-22"},{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tanveer-rab","type":"person","url":"https://hartvaat.nl/mensen/tanveer-rab/","name":"Tanveer Rab","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/2025-acc-aha-acs-richtlijn-jacc-editie/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2025/04/01/2025-acc-aha-acs-richtlijn-management-van-acuut-coronair-syndroom/","published":"2025-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tanvir-bajwa","type":"person","url":"https://hartvaat.nl/mensen/tanvir-bajwa/","name":"Tanvir Bajwa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/zesjaarsuitkomsten-van-transkatheter-versus-chirurgische-aortaklepvervanging-bij/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tanya-gaynor","type":"person","url":"https://hartvaat.nl/mensen/tanya-gaynor/","name":"Tanya Gaynor","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/16/interventie-voor-evidence-based-zorg-bij-diabetes-en-cv-risico/","published":"2024-07-16"},{"url":"https://hartvaat.nl/2023/04/18/gecoordineerde-zorg-optimaliseert-cv-preventie-bij-type-2-diabetes-jama-rct/","published":"2023-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tanya-r-gure","type":"person","url":"https://hartvaat.nl/mensen/tanya-r-gure/","name":"Tanya R Gure","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/01/orthostatische-hypotensie-cv-uitkomsten-en-adverse-events-sprint-resultaten/","published":"2020-03-01"},{"url":"https://hartvaat.nl/2017/08/24/intensieve-bloeddrukbehandeling-en-patientgerapporteerde-uitkomsten-nejm-sprint-/","published":"2017-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tao-liu","type":"person","url":"https://hartvaat.nl/mensen/tao-liu/","name":"Tao Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/01/frailteit-en-antihypertensieve-behandeling-bij-ouderen-meta-analyse/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2016/07/01/luchtvervuiling-en-hypertensie-systematische-review-en-meta-analyse/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tao-sun","type":"person","url":"https://hartvaat.nl/mensen/tao-sun/","name":"Tao Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2018/01/23/canagliflozine-voor-primaire-en-secundaire-cardiovasculaire-preventie-canvas/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tao-wu","type":"person","url":"https://hartvaat.nl/mensen/tao-wu/","name":"Tao Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"},{"url":"https://hartvaat.nl/2019/05/01/kwaliteitsverbetering-bij-acs-in-resource-beperkte-ziekenhuizen-jama-cardiology-/","published":"2019-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tao-yu","type":"person","url":"https://hartvaat.nl/mensen/tao-yu/","name":"Tao Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tao-zhou","type":"person","url":"https://hartvaat.nl/mensen/tao-zhou/","name":"Tao Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/13/nt-probnp-en-af-risico-systematische-review-en-meta-analyse/","published":"2025-01-13"},{"url":"https://hartvaat.nl/2019/12/01/genetische-gevoeligheid-eiwitinname-en-bloeddrukverandering-pounds-lost/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tara-landry","type":"person","url":"https://hartvaat.nl/mensen/tara-landry/","name":"Tara Landry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/05/cardiovasculair-risico-na-fertiliteitstherapie-systematische-review-en-meta-anal/","published":"2017-09-05"},{"url":"https://hartvaat.nl/2016/12/01/vasculaire-disfunctiemarkers-na-hypertensieve-zwangerschapsaandoeningen-meta-ana/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tatsufumi-oka","type":"person","url":"https://hartvaat.nl/mensen/tatsufumi-oka/","name":"Tatsufumi Oka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/clorotic-subanalyse-acute-egfr-daling-door-thiaziden-bij-acuut-hf-is-geen-progno/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2021/12/01/egfr-variabiliteit-en-uitkomsten-bij-real-world-hf/","published":"2021-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"taya-v-glotzer","type":"person","url":"https://hartvaat.nl/mensen/taya-v-glotzer/","name":"Taya V Glotzer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/05/af-last-in-klinische-praktijk-onderzoek-en-technologie-consensus-document/","published":"2025-03-05"},{"url":"https://hartvaat.nl/2024/11/26/artesia-subanalyse-cva-risico-naar-frequentie-en-duur-van-subclinisch-af/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tea-monk-fries","type":"person","url":"https://hartvaat.nl/mensen/tea-monk-fries/","name":"Tea Monk Fries","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/12/18/liraglutide-cv-uitkomsten-met-of-zonder-eerder-mi-leader/","published":"2018-12-18"},{"url":"https://hartvaat.nl/2018/05/15/liraglutide-bij-diabetes-type-2-met-polyvasculaire-ziekte-leader-analyse/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ted-feldman","type":"person","url":"https://hartvaat.nl/mensen/ted-feldman/","name":"Ted Feldman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/01/transcatheter-interatriale-shunt-bij-hfpef-1-jaarsresultaten/","published":"2018-10-01"},{"url":"https://hartvaat.nl/2018/01/23/transcatheter-interatriale-shunt-bij-hfpef-reduce-lap-hf-i/","published":"2018-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"teemu-j-niiranen","type":"person","url":"https://hartvaat.nl/mensen/teemu-j-niiranen/","name":"Teemu J Niiranen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"teiichi-yamane","type":"person","url":"https://hartvaat.nl/mensen/teiichi-yamane/","name":"Teiichi Yamane","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tem-jrgensen","type":"person","url":"https://hartvaat.nl/mensen/tem-jrgensen/","name":"Tem Jørgensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/11/ct-coronairangiografie-bij-nste-acs-verdict-cta-substudie/","published":"2020-02-11"},{"url":"https://hartvaat.nl/2018/12/11/vroeg-versus-standaard-invasief-onderzoek-bij-nste-acs-verdict-gerandomiseerde-t/","published":"2018-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"temitope-olufade","type":"person","url":"https://hartvaat.nl/mensen/temitope-olufade/","name":"Temitope Olufade","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"terence-j-quinn","type":"person","url":"https://hartvaat.nl/mensen/terence-j-quinn/","name":"Terence J Quinn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/01/antihypertensieve-behandeling-en-cerebrale-bloedflow-meta-analyse/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2021/02/01/urinezuur-bloeddruk-en-cv-ziekte-mendeliaanse-randomisatie-en-meta-analyse/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"teresa-strisciuglio","type":"person","url":"https://hartvaat.nl/mensen/teresa-strisciuglio/","name":"Teresa Strisciuglio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/26/fluoroscopieminimalisatie-bij-svt-ablatie-door-vrouwelijke-elektrofysiologen/","published":"2026-04-06"},{"url":"https://hartvaat.nl/2019/08/01/eenvoudige-techniek-voor-pvi-van-linker-longvenen-gerandomiseerde-studie/","published":"2019-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"terho-lehtimaki","type":"person","url":"https://hartvaat.nl/mensen/terho-lehtimaki/","name":"Terho Lehtimäki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"terrance-d-barrett","type":"person","url":"https://hartvaat.nl/mensen/terrance-d-barrett/","name":"Terrance D Barrett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/05/28/canagliflozine-en-hf-uitkomsten-bij-behouden-versus-verminderde-ef-canvas/","published":"2019-05-28"},{"url":"https://hartvaat.nl/2018/07/31/canagliflozine-en-hartfalen-bij-diabetes-type-2-canvas-programma/","published":"2018-07-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"teruo-inoue","type":"person","url":"https://hartvaat.nl/mensen/teruo-inoue/","name":"Teruo Inoue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/06/racing-subanalyse-matige-statine-plus-ezetimibe-voor-secundaire-preventie/","published":"2024-08-06"},{"url":"https://hartvaat.nl/2018/05/08/hoog-versus-laaggedoseerd-pitavastatine-bij-stabiel-coronairlijden-real-cad/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tetsuo-shoji","type":"person","url":"https://hartvaat.nl/mensen/tetsuo-shoji/","name":"Tetsuo Shoji","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/cardiovasculaire-mortaliteit-bij-chronische-nierziekte-en-dialyse-een-tweestappe/","published":"2026-04-08"},{"url":"https://hartvaat.nl/2018/06/01/interarmbloeddrukverschil-en-beroerte-ipd-meta-analyse/","published":"2018-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tetsuro-yoshida","type":"person","url":"https://hartvaat.nl/mensen/tetsuro-yoshida/","name":"Tetsuro Yoshida","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/03/01/edoxaban-15-mg-naar-nierfunctie-bij-zeer-oude-af-eldercare-subanalyse/","published":"2022-03-01"},{"url":"https://hartvaat.nl/2020/10/29/laaggedoseerd-edoxaban-bij-zeer-oude-af-patienten-nejm-eldercare-af/","published":"2020-10-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tetsuya-ishikawa","type":"person","url":"https://hartvaat.nl/mensen/tetsuya-ishikawa/","name":"Tetsuya Ishikawa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/aspirine-versus-clopidogrel-na-pci-eenjaars-follow-up-van-rct/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2024/02/20/stopdapt-3-aspirinevrij-versus-standaard-dapt-na-coronaire-stenting/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thabo-mahendiran","type":"person","url":"https://hartvaat.nl/mensen/thabo-mahendiran/","name":"Thabo Mahendiran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/28/coronaire-autoregulatie-samenspel-van-epicardiale-en-microvasculaire-weerstand/","published":"2026-03-28"},{"url":"https://hartvaat.nl/2025/06/09/tino-stents-versus-des-bij-acs-ipd-meta-analyse/","published":"2025-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tharusan-thevathasan","type":"person","url":"https://hartvaat.nl/mensen/tharusan-thevathasan/","name":"Tharusan Thevathasan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/scai-shockklassen-en-prognose-bij-ami-cardiogene-shock-danger-substudie/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"theis-lange","type":"person","url":"https://hartvaat.nl/mensen/theis-lange/","name":"Theis Lange","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"},{"url":"https://hartvaat.nl/2018/04/24/hoge-versus-lage-bloeddrukstreefwaarden-tijdens-cardiopulmonale-bypass-en-cerebr/","published":"2018-04-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"themistocles-l-assimes","type":"person","url":"https://hartvaat.nl/mensen/themistocles-l-assimes/","name":"Themistocles L Assimes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/08/20/dna-methylering-in-leukocyten-voorspelt-mi-en-coronairlijden/","published":"2019-08-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"therese-holmager","type":"person","url":"https://hartvaat.nl/mensen/therese-holmager/","name":"Therese Holmager","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/betami-danblock-is-representatief-betablokker-effect-ook-geldig-in-echte-noorse-/","published":"2026-06-02"},{"url":"https://hartvaat.nl/2025/11/13/betablokkers-na-mi-bij-patienten-zonder-hartfalen-definitieve-trial/","published":"2025-11-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thibaud-damy","type":"person","url":"https://hartvaat.nl/mensen/thibaud-damy/","name":"Thibaud Damy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/20/ni006-antilichaam-voor-afbraak-van-cardiale-transthyretine-amyloid-nejm-fase-1/","published":"2023-07-20"},{"url":"https://hartvaat.nl/2018/09/13/tafamidis-bij-transthyretine-amyloid-cardiomyopathie-nejm-attr-act/","published":"2018-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thierry-denolle","type":"person","url":"https://hartvaat.nl/mensen/thierry-denolle/","name":"Thierry Denolle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/03/01/24-uurs-bloeddrukmonitoring-bij-renale-denervatie-denerhtn-studie/","published":"2017-03-01"},{"url":"https://hartvaat.nl/2016/09/20/medicatietrouw-en-bloeddrukeffecten-van-renale-denervatie-rsd-pathway-2-analyse/","published":"2016-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thijs-s-r-delnoij","type":"person","url":"https://hartvaat.nl/mensen/thijs-s-r-delnoij/","name":"Thijs S R Delnoij","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thilo-burkard","type":"person","url":"https://hartvaat.nl/mensen/thilo-burkard/","name":"Thilo Burkard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/behandelstrategieen-voor-bloeddrukcontrole-in-tanzania-en-lesotho-rct/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2020/06/01/il-1-receptorantagonist-verhoogt-ang-1-7-en-verlaagt-bloeddruk-bij-obesitas/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-a-gaziano","type":"person","url":"https://hartvaat.nl/mensen/thomas-a-gaziano/","name":"Thomas A Gaziano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/02/thuisgebaseerde-hypertensiezorg-in-ruraal-zuid-afrika-gerandomiseerde-trial/","published":"2025-10-02"},{"url":"https://hartvaat.nl/2024/06/04/drive-remote-management-verbetert-richtlijnmedicatie-bij-hartfalen/","published":"2024-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-a-kite","type":"person","url":"https://hartvaat.nl/mensen/thomas-a-kite/","name":"Thomas A Kite","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/03/12/rapid-nstemi-zeer-vroege-invasieve-strategie-bij-hoger-risico-nstemi/","published":"2024-03-12"},{"url":"https://hartvaat.nl/2022/09/01/timing-van-invasieve-strategie-bij-nste-acs-meta-analyse-van-rct-s/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-arentz","type":"person","url":"https://hartvaat.nl/mensen/thomas-arentz/","name":"Thomas Arentz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/10/07/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-af-herinterventierate-e/","published":"2016-10-07"},{"url":"https://hartvaat.nl/2016/06/09/cryoballon-versus-radiofrequentieablatie-bij-paroxysmaal-atriumfibrilleren-nejm-/","published":"2016-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-c-havighurst","type":"person","url":"https://hartvaat.nl/mensen/thomas-c-havighurst/","name":"Thomas C Havighurst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/01/invested-griepvaccin-immuunrespons-bij-hoog-risico-cv-patienten/","published":"2024-06-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-deneke","type":"person","url":"https://hartvaat.nl/mensen/thomas-deneke/","name":"Thomas Deneke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/21/mri-geleide-fibroseablatie-versus-conventionele-ablatie-bij-persisterend-af/","published":"2022-06-21"},{"url":"https://hartvaat.nl/2022/06/21/timing-van-vt-ablatie-bij-icd-patienten-partita-trial/","published":"2022-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-easterling","type":"person","url":"https://hartvaat.nl/mensen/thomas-easterling/","name":"Thomas Easterling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/21/orale-antihypertensiva-bij-ernstige-hypertensie-in-de-zwangerschap-lancet-vergel/","published":"2019-09-21"},{"url":"https://hartvaat.nl/2017/08/12/foley-katheter-versus-misoprostol-voor-inleiden-bij-hypertensieve-zwangeren-in-i/","published":"2017-08-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-gaspar","type":"person","url":"https://hartvaat.nl/mensen/thomas-gaspar/","name":"Thomas Gaspar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/25/digitoxine-bij-hfref-gerandomiseerde-trial-nejm/","published":"2025-09-25"},{"url":"https://hartvaat.nl/2018/11/01/individueel-aangepaste-versus-gestandaardiseerde-substraatmodificatie-bij-rf-abl/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-h-langenickel","type":"person","url":"https://hartvaat.nl/mensen/thomas-h-langenickel/","name":"Thomas H Langenickel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/sacubitril-valsartan-en-inspanningsgemedieerd-lipidenmetabolisme-bij-obesitas-me/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2017/01/01/sacubitril-valsartan-en-natriurese-diurese-en-bloeddruk-bij-zoutgevoelige-hypert/","published":"2017-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-horvath","type":"person","url":"https://hartvaat.nl/mensen/thomas-horvath/","name":"Thomas Horvath","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-kueffer","type":"person","url":"https://hartvaat.nl/mensen/thomas-kueffer/","name":"Thomas Kueffer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","published":"2026-08-12"},{"url":"https://hartvaat.nl/2025/04/17/pfa-versus-cryoballon-bij-paroxysmaal-af-gerandomiseerde-trial/","published":"2025-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-kurz","type":"person","url":"https://hartvaat.nl/mensen/thomas-kurz/","name":"Thomas Kurz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-m-gorter","type":"person","url":"https://hartvaat.nl/mensen/thomas-m-gorter/","name":"Thomas M Gorter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/24/latent-pulmonaal-vaatlijden-en-respons-op-atriale-shunt-bij-hf/","published":"2022-05-24"},{"url":"https://hartvaat.nl/2022/05/21/bariatrische-chirurgie-en-cardiovasculaire-ziekte-meta-analyse/","published":"2022-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-mayrhofer","type":"person","url":"https://hartvaat.nl/mensen/thomas-mayrhofer/","name":"Thomas Mayrhofer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/19/sglt2-remming-behoudt-antibacteriele-respons-van-de-nier-door-complement-c1q-ver/","published":"2026-01-19"},{"url":"https://hartvaat.nl/2017/11/21/coronair-calcium-en-prognostische-waarde-bij-pijn-op-de-borst-promise-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-meinicke","type":"person","url":"https://hartvaat.nl/mensen/thomas-meinicke/","name":"Thomas Meinicke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/15/linagliptine-en-hartfalenuitkomsten-bij-diabetes-type-2-carmelina/","published":"2019-01-15"},{"url":"https://hartvaat.nl/2019/01/01/linagliptine-versus-placebo-bij-diabetes-type-2-met-hoog-cv-en-renaal-risico-jam/","published":"2019-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-modine","type":"person","url":"https://hartvaat.nl/mensen/thomas-modine/","name":"Thomas Modine","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-neff","type":"person","url":"https://hartvaat.nl/mensen/thomas-neff/","name":"Thomas Neff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-p-cappola","type":"person","url":"https://hartvaat.nl/mensen/thomas-p-cappola/","name":"Thomas P Cappola","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/01/kaliumnitraat-bij-hfpef-gerandomiseerde-trial/","published":"2025-03-01"},{"url":"https://hartvaat.nl/2016/08/02/liraglutide-en-klinische-stabiliteit-bij-gevorderd-hartfalen-met-verminderde-ef-/","published":"2016-08-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-phlips","type":"person","url":"https://hartvaat.nl/mensen/thomas-phlips/","name":"Thomas Phlips","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/26/gerichte-patienteneducatie-vermindert-ongeplande-cv-events-bij-af/","published":"2024-12-26"},{"url":"https://hartvaat.nl/2018/04/21/pvi-met-versus-zonder-antiaritmica-bij-recidiverend-af-powder-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-r-pieber","type":"person","url":"https://hartvaat.nl/mensen/thomas-r-pieber/","name":"Thomas R Pieber","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/emmy-empagliflozine-na-acuut-myocardinfarct-verbetert-nt-probnp-en-remodelling/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2017/08/24/degludec-versus-glargine-bij-diabetes-type-2-nejm-devote-werkzaamheid-en-veiligh/","published":"2017-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-r-porter","type":"person","url":"https://hartvaat.nl/mensen/thomas-r-porter/","name":"Thomas R Porter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/11/sonotrombolyse-bij-stemi-behandeld-met-primaire-pci/","published":"2019-06-11"},{"url":"https://hartvaat.nl/2016/05/31/diagnostische-ultrageluidspulsen-verbeteren-microvasculaire-flow-bij-stemi-met-m/","published":"2016-05-31"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-rauwolf","type":"person","url":"https://hartvaat.nl/mensen/thomas-rauwolf/","name":"Thomas Rauwolf","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/11/invasieve-drukvolumelussen-onthullen-mechanisme-van-tricuspidalisinsufficientie-/","published":"2026-06-24"},{"url":"https://hartvaat.nl/2019/09/01/remote-monitoring-en-patientgerapporteerde-uitkomsten-bij-europese-hf-patienten-/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-s-metkus","type":"person","url":"https://hartvaat.nl/mensen/thomas-s-metkus/","name":"Thomas S Metkus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/18/2021-acc-aha-scai-richtlijn-voor-coronaire-revascularisatie-executive-summary/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-severin","type":"person","url":"https://hartvaat.nl/mensen/thomas-severin/","name":"Thomas Severin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/01/hepatorenale-disfunctie-identificeert-hoogrisico-acuut-hf-relax-ahf/","published":"2019-12-01"},{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-stiermaier","type":"person","url":"https://hartvaat.nl/mensen/thomas-stiermaier/","name":"Thomas Stiermaier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/gp-iib-iiia-remmers-bij-acuut-mi-en-microvasculaire-obstructie-meta-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2020/04/21/morfine-met-metoclopramide-en-ticagrelor-plaatjesremming-bij-acuut-mi/","published":"2020-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-suter","type":"person","url":"https://hartvaat.nl/mensen/thomas-suter/","name":"Thomas Suter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/06/14/omecamtiv-mecarbil-bij-hartfalen-met-en-zonder-atriumfibrilleren-galactic-hf/","published":"2022-06-14"},{"url":"https://hartvaat.nl/2017/07/13/adjuvant-pertuzumab-en-trastuzumab-bij-vroege-her2-positieve-borstkanker-nejm-ap/","published":"2017-07-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-thum","type":"person","url":"https://hartvaat.nl/mensen/thomas-thum/","name":"Thomas Thum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/10/hf-revert-antisense-mirna-remmer-cdr132l-mist-primair-eindpunt-na-infarct-met-ve/","published":"2026-05-10"},{"url":"https://hartvaat.nl/2021/01/07/antisense-tegen-microrna-132-bij-hartfalen-fase-1b-resultaten/","published":"2021-01-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-vanassche","type":"person","url":"https://hartvaat.nl/mensen/thomas-vanassche/","name":"Thomas Vanassche","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/artesia-majeure-bloedingen-met-apixaban-versus-aspirine-subanalyse/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2018/01/20/rivaroxaban-met-of-zonder-aspirine-bij-stabiel-perifeer-vaatlijden-lancet-compas/","published":"2018-01-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-w-painter","type":"person","url":"https://hartvaat.nl/mensen/thomas-w-painter/","name":"Thomas W Painter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-wadden","type":"person","url":"https://hartvaat.nl/mensen/thomas-wadden/","name":"Thomas Wadden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/14/cagrisema-gecombineerd-cagrilintide-en-semaglutide-bij-overgewicht-nejm/","published":"2025-08-14"},{"url":"https://hartvaat.nl/2016/03/08/naltrexon-bupropion-en-cardiovasculaire-events-bij-obesitas-gerandomiseerde-tria/","published":"2016-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thomas-zanchin","type":"person","url":"https://hartvaat.nl/mensen/thomas-zanchin/","name":"Thomas Zanchin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/01/lokale-hemodynamische-krachten-en-fenotype-van-coronaire-plaques/","published":"2019-07-01"},{"url":"https://hartvaat.nl/2016/12/01/tienjaarsuitkomsten-van-eerste-generatie-drug-eluting-stents-ses-versus-pes/","published":"2016-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thompson","type":"person","url":"https://hartvaat.nl/mensen/thompson/","name":"Thompson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/sekseverschillen-in-secundaire-preventie-na-acs-vrouwen-halen-minder-vaak-hun-ld/","published":"2026-07-23"},{"url":"https://hartvaat.nl/2026/02/23/invasieve-coronaire-functietest-bij-anoca-verandert-de-behandeling-bij-driekwart/","published":"2026-02-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thorald-stolte","type":"person","url":"https://hartvaat.nl/mensen/thorald-stolte/","name":"Thorald Stolte","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/13/transkatheter-tricuspidalisreparatie-bij-hoogrisicopatienten-real-world-toets-va/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","published":"2026-06-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thorkild-i-a-srensen","type":"person","url":"https://hartvaat.nl/mensen/thorkild-i-a-srensen/","name":"Thorkild I A Sørensen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/hypertensieve-zwangerschapsaandoeningen-en-dna-methylering-bij-pasgeborenen/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"thorsten-wahlers","type":"person","url":"https://hartvaat.nl/mensen/thorsten-wahlers/","name":"Thorsten Wahlers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/14/matterhorn-transcatheter-repair-versus-chirurgie-bij-secundaire-mr-nejm/","published":"2024-11-14"},{"url":"https://hartvaat.nl/2023/07/01/statinoplaaddosis-voor-cabg-gerandomiseerde-trial/","published":"2023-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"theo-pezel","type":"person","url":"https://hartvaat.nl/mensen/theo-pezel/","name":"Théo Pezel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/lge-granulariteit-op-cmr-voorspelt-sterfte-bij-eindstadium-hypertrofische-cardio/","published":"2026-06-06"},{"url":"https://hartvaat.nl/2026/02/11/andaman-aspirinedosering-na-acs-met-verdenking-aspirineresistentie/","published":"2026-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tiantian-zhang","type":"person","url":"https://hartvaat.nl/mensen/tiantian-zhang/","name":"Tiantian Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/16/sluiting-van-het-linker-hartoor-versus-doac-s-na-longembolie/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tieci-yi","type":"person","url":"https://hartvaat.nl/mensen/tieci-yi/","name":"Tieci Yi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/11/ffr-geleide-nierslagaderstenting-bij-atherosclerotische-renovasculaire-hypertens/","published":"2026-02-11"},{"url":"https://hartvaat.nl/2022/06/01/interatriale-shuntdevices-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2022-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"till-barnighausen","type":"person","url":"https://hartvaat.nl/mensen/till-barnighausen/","name":"Till Bärnighausen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-collier","type":"person","url":"https://hartvaat.nl/mensen/tim-collier/","name":"Tim Collier","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/29/langetermijnmortaliteit-na-bloeddruk-en-lipidenverlaging-bij-hypertensie-ascot-l/","published":"2018-09-29"},{"url":"https://hartvaat.nl/2017/06/24/bijwerkingen-bij-niet-geblindeerde-versus-geblindeerde-statinetherapie-lancet-as/","published":"2017-06-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-koldenhof","type":"person","url":"https://hartvaat.nl/mensen/tim-koldenhof/","name":"Tim Koldenhof","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/10/rate-control-bij-af-calciumantagonisten-versus-betablokkers/","published":"2023-11-10"},{"url":"https://hartvaat.nl/2022/03/02/frequentiecontrolemiddelen-verschillen-in-preventie-van-af-progressie/","published":"2022-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-seidler","type":"person","url":"https://hartvaat.nl/mensen/tim-seidler/","name":"Tim Seidler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/14/ecls-shock-eenjaarsresultaten-ecmo-bij-cardiogene-shock-blijft-negatief/","published":"2024-10-14"},{"url":"https://hartvaat.nl/2023/10/05/ecls-shock-ecmo-bij-infarctgerelateerde-cardiogene-shock-nejm/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tim-todt","type":"person","url":"https://hartvaat.nl/mensen/tim-todt/","name":"Tim Tödt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/09/21/bivalirudine-versus-heparine-monotherapie-bij-myocardinfarct-nejm-validate-swede/","published":"2017-09-21"},{"url":"https://hartvaat.nl/2017/05/11/instantaneous-wave-free-ratio-versus-ffr-voor-pci-indicatie-nejm-ifr-swedeheart/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"timothy-byrne","type":"person","url":"https://hartvaat.nl/mensen/timothy-byrne/","name":"Timothy Byrne","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/triplace-register-paravalvulaire-lekkage-na-transkatheter-tricuspidalisklepverva/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2025/01/01/zesjaarsuitkomsten-van-transkatheter-versus-chirurgische-aortaklepvervanging-bij/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tina-vilsbll","type":"person","url":"https://hartvaat.nl/mensen/tina-vilsbll/","name":"Tina Vilsbøll","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/29/orale-semaglutide-en-cv-uitkomsten-bij-diabetes-type-2-nejm-pioneer-6/","published":"2019-08-29"},{"url":"https://hartvaat.nl/2016/11/10/semaglutide-en-cardiovasculaire-uitkomsten-bij-diabetes-type-2-nejm-sustain-6/","published":"2016-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ting-chang","type":"person","url":"https://hartvaat.nl/mensen/ting-chang/","name":"Ting Chang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/12/zodasiran-sirna-tegen-angptl3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"},{"url":"https://hartvaat.nl/2024/09/12/plozasiran-sirna-tegen-apoc3-bij-gemengde-hyperlipidemie-nejm/","published":"2024-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tingting-zhang","type":"person","url":"https://hartvaat.nl/mensen/tingting-zhang/","name":"Tingting Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tiny-jaarsma","type":"person","url":"https://hartvaat.nl/mensen/tiny-jaarsma/","name":"Tiny Jaarsma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/29/2024-esc-richtlijn-voor-management-van-atriumfibrilleren/","published":"2024-09-29"},{"url":"https://hartvaat.nl/2016/03/22/zelfmanagementinterventies-bij-hartfalen-individuele-patientdata-meta-analyse/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tjerk-s-j-opstal","type":"person","url":"https://hartvaat.nl/mensen/tjerk-s-j-opstal/","name":"Tjerk S J Opstal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/31/colchicine-bij-chronisch-coronairlijden-met-versus-zonder-eerder-acs/","published":"2021-08-31"},{"url":"https://hartvaat.nl/2021/07/21/laaggedoseerd-colchicine-bij-coronairlijden-meta-analyse-van-gerandomiseerde-tri/","published":"2021-07-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobias-breidthardt","type":"person","url":"https://hartvaat.nl/mensen/tobias-breidthardt/","name":"Tobias Breidthardt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/10/01/uitgebreide-vasodilatatie-en-qol-bij-acuut-hf-substudie/","published":"2021-10-01"},{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobias-harle","type":"person","url":"https://hartvaat.nl/mensen/tobias-harle/","name":"Tobias Härle","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobias-toennis","type":"person","url":"https://hartvaat.nl/mensen/tobias-toennis/","name":"Tobias Toennis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/07/anticoagulatie-bij-device-gedetecteerd-af-met-zonder-vaatlijden-noah-artesia-gec/","published":"2024-12-07"},{"url":"https://hartvaat.nl/2023/09/28/noah-afnet-6-edoxaban-bij-atriaal-high-rate-episodes-nejm/","published":"2023-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tobler","type":"person","url":"https://hartvaat.nl/mensen/tobler/","name":"Tobler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/25/aortacoarctatie-voorspelt-langetermijnmorbiditeit-na-de-arteriele-switchoperatie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"todd-anderson","type":"person","url":"https://hartvaat.nl/mensen/todd-anderson/","name":"Todd Anderson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/10/23/evolocumab-en-coronaire-plaquesamenstelling-glagov-beeldvorming/","published":"2018-10-23"},{"url":"https://hartvaat.nl/2016/12/13/evolocumab-en-progressie-van-coronairlijden-bij-statinebehandelde-patienten-jama/","published":"2016-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"todd-l-edwards","type":"person","url":"https://hartvaat.nl/mensen/todd-l-edwards/","name":"Todd L Edwards","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2019/02/01/genetische-schildklierfunctievoorspellers-en-af-jama-cardiology-mendeliaanse-ran/","published":"2019-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-adriaenssens","type":"person","url":"https://hartvaat.nl/mensen/tom-adriaenssens/","name":"Tom Adriaenssens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/30/oac-continueren-versus-onderbreken-tijdens-tavi-gerandomiseerde-trial-nejm/","published":"2025-01-30"},{"url":"https://hartvaat.nl/2018/08/01/inhalatie-stikstofoxide-bij-stemi-nomi-gerandomiseerde-trial/","published":"2018-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-crake","type":"person","url":"https://hartvaat.nl/mensen/tom-crake/","name":"Tom Crake","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/5-jaarsfollow-up-van-intracoronaire-celtherapie-na-mi-regenerate-ami/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2016/01/14/intracoronaire-beenmergcelinfusie-bij-acuut-myocardinfarct-de-regenerate-ami-tri/","published":"2016-01-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-r-keeble","type":"person","url":"https://hartvaat.nl/mensen/tom-r-keeble/","name":"Tom R Keeble","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/orbita-2-subanalyse-symptomen-voorspellen-pci-effect-bij-stabiel-coronairlijden/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2024/04/20/orbita-cosmic-coronaire-sinusreducer-bij-refractaire-angina-sham-gecontroleerd/","published":"2024-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-verbelen","type":"person","url":"https://hartvaat.nl/mensen/tom-verbelen/","name":"Tom Verbelen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/palliatieve-zorg-in-de-cardiologie-een-state-of-the-art-overzicht/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/02/19/delirium-in-de-cardiovasculaire-geneeskunde/","published":"2026-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-wilsgaard","type":"person","url":"https://hartvaat.nl/mensen/tom-wilsgaard/","name":"Tom Wilsgaard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2016/09/29/drug-eluting-of-bare-metal-stents-bij-coronairlijden-nejm-norstent-trial/","published":"2016-09-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tom-wong","type":"person","url":"https://hartvaat.nl/mensen/tom-wong/","name":"Tom Wong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2016/12/07/linker-hartoorsluiting-uitkomsten-en-kosten-van-trial-en-real-world-versus-orale/","published":"2016-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomas-kovarnik","type":"person","url":"https://hartvaat.nl/mensen/tomas-kovarnik/","name":"Tomas Kovarnik","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomas-vetrovsky","type":"person","url":"https://hartvaat.nl/mensen/tomas-vetrovsky/","name":"Tomas Vetrovsky","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/16/watchful-leefstijl-wandelinterventie-bij-hfref/","published":"2024-01-16"},{"url":"https://hartvaat.nl/2020/10/01/accelerometrie-bij-cv-patienten-systematische-review-met-praktische-aanbevelinge/","published":"2020-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomasz-mazurek","type":"person","url":"https://hartvaat.nl/mensen/tomasz-mazurek/","name":"Tomasz Mazurek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2020/04/23/management-van-coronairlijden-bij-gevorderde-nierziekte-nejm-ischemia-ckd/","published":"2020-04-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomaz-goslar","type":"person","url":"https://hartvaat.nl/mensen/tomaz-goslar/","name":"Tomaž Goslar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/1-jaarsuitkomsten-na-pci-strategieen-bij-cardiogene-shock-nejm-culprit-shock/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/12/21/pci-strategieen-bij-acuut-mi-met-cardiogene-shock-nejm-culprit-shock/","published":"2017-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tommaso-bucci","type":"person","url":"https://hartvaat.nl/mensen/tommaso-bucci/","name":"Tommaso Bucci","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/prognose-takotsubo-syndroom-versus-hartfalen-op-de-lange-termijn/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2026/02/03/lichamelijke-activiteit-en-risico-op-complicaties-bij-atriumfibrilleren/","published":"2026-03-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomoharu-dohi","type":"person","url":"https://hartvaat.nl/mensen/tomoharu-dohi/","name":"Tomoharu Dohi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2021/04/06/pvi-alleen-versus-uitgebreide-ablatie-bij-persisterend-af-meta-analyse/","published":"2021-04-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tomohisa-tada","type":"person","url":"https://hartvaat.nl/mensen/tomohisa-tada/","name":"Tomohisa Tada","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/01/clopidogrel-monotherapie-na-1-2-maanden-dapt-versus-12-maanden-dapt-jama-cardiol/","published":"2022-04-01"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tonje-thorvaldsen","type":"person","url":"https://hartvaat.nl/mensen/tonje-thorvaldsen/","name":"Tonje Thorvaldsen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/acyl-ghreline-verbetert-cardiac-output-met-behoud-van-rv-pa-koppeling-bij-hf/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2023/06/09/acyl-ghreline-verbetert-hartfunctie-bij-hartfalen/","published":"2023-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toomas-marandi","type":"person","url":"https://hartvaat.nl/mensen/toomas-marandi/","name":"Toomas Marandi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/18/abyss-betablokkers-na-mi-met-behouden-ef-niet-nodig-nejm/","published":"2024-04-18"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toshiaki-mano","type":"person","url":"https://hartvaat.nl/mensen/toshiaki-mano/","name":"Toshiaki Mano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/nierfunctie-en-effectiviteit-van-lva-ablatie-na-pvi-bij-af/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toshiaki-nakano","type":"person","url":"https://hartvaat.nl/mensen/toshiaki-nakano/","name":"Toshiaki Nakano","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/lagere-kaliuminname-hangt-samen-met-meer-hart-en-vaatziekte-bij-ckd-vooral-bij-v/","published":"2026-07-17"},{"url":"https://hartvaat.nl/2026/02/27/albuminurie-geassocieerd-met-verhoogd-risico-op-abdominaal-aorta-aneurysma/","published":"2026-03-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toshiaki-toyota","type":"person","url":"https://hartvaat.nl/mensen/toshiaki-toyota/","name":"Toshiaki Toyota","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"},{"url":"https://hartvaat.nl/2016/02/14/kortdurend-antiaritmica-na-katheterablatie-voor-atriumfibrilleren-east-af-trial/","published":"2016-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toshiro-shinke","type":"person","url":"https://hartvaat.nl/mensen/toshiro-shinke/","name":"Toshiro Shinke","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/29/functionele-en-morfologische-karakterisering-van-coronaire-atherosclerose/","published":"2025-12-29"},{"url":"https://hartvaat.nl/2017/11/07/optische-frequentiedomeinbeeldvorming-versus-ivus-bij-pci-opinion-trial/","published":"2017-11-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"toshiyuki-noda","type":"person","url":"https://hartvaat.nl/mensen/toshiyuki-noda/","name":"Toshiyuki Noda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/02/clopidogrel-versus-aspirine-als-langetermijnmonotherapie-na-pci-bevestiging/","published":"2024-01-02"},{"url":"https://hartvaat.nl/2019/06/25/1-maand-dapt-gevolgd-door-clopidogrel-versus-12-maanden-dapt-jama-stopdapt-2/","published":"2019-06-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tove-fredriksson","type":"person","url":"https://hartvaat.nl/mensen/tove-fredriksson/","name":"Tove Fredriksson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/01/stapsgewijze-af-screening-met-nt-probnp-strokestop-ii-resultaten/","published":"2020-01-01"},{"url":"https://hartvaat.nl/2017/02/01/stapsgewijze-massascreening-op-af-met-nt-probnp-strokestop-ii-studieontwerp/","published":"2017-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tracy-dana","type":"person","url":"https://hartvaat.nl/mensen/tracy-dana/","name":"Tracy Dana","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/23/uspstf-evidence-review-statines-voor-primaire-cv-preventie-geactualiseerd/","published":"2022-08-23"},{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-evidence-report/","published":"2016-11-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tran","type":"person","url":"https://hartvaat.nl/mensen/tran/","name":"Tran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/20/hypochloremie-bij-opname-voor-acuut-hartfalen-voorspelt-onafhankelijk-30-daagse-/","published":"2026-07-06"},{"url":"https://hartvaat.nl/2026/03/02/is-depressie-een-onafhankelijke-risicofactor-voor-sterfte-bij-hart-en-vaatziekte/","published":"2026-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"trevor-simard","type":"person","url":"https://hartvaat.nl/mensen/trevor-simard/","name":"Trevor Simard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/05/milrinone-versus-dobutamine-bij-cardiogene-shock-nejm-doremi/","published":"2021-08-05"},{"url":"https://hartvaat.nl/2019/02/19/lv-unloading-tijdens-ecmo-bij-cardiogene-shock/","published":"2019-02-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"troy-hounshell","type":"person","url":"https://hartvaat.nl/mensen/troy-hounshell/","name":"Troy Hounshell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/03/laa-sluiting-na-af-ablatie-gerandomiseerde-trial-nejm/","published":"2025-04-03"},{"url":"https://hartvaat.nl/2024/04/02/amaze-pvi-met-of-zonder-laa-ligatie-bij-af-jama-rct/","published":"2024-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tsung-ying-tsai","type":"person","url":"https://hartvaat.nl/mensen/tsung-ying-tsai/","name":"Tsung-Ying Tsai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/invloed-van-coronaire-ziekte-patronen-op-klinische-uitkomsten-pullback-pressure-/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/16/aanvullende-farmacologische-strategieen-voor-restrisicoreductie-na-revascularisa/","published":"2026-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tsushung-a-hua","type":"person","url":"https://hartvaat.nl/mensen/tsushung-a-hua/","name":"Tsushung A Hua","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/22/serelaxine-bij-acuut-hartfalen-nejm-relax-ahf-2/","published":"2019-08-22"},{"url":"https://hartvaat.nl/2016/03/21/cardiovasculaire-uitkomsten-bij-verschillende-bereiktestreefdrukken-in-de-value-/","published":"2016-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tsveta-rahneva","type":"person","url":"https://hartvaat.nl/mensen/tsveta-rahneva/","name":"Tsveta Rahneva","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/01/05/staken-van-hf-medicatie-bij-herstelde-dilaterende-cardiomyopathie-lancet-tred-hf/","published":"2019-01-05"},{"url":"https://hartvaat.nl/2016/03/01/intrathoracale-impedantiemonitoring-bij-chronisch-hartfalen-de-limit-chf-studie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tuomas-t-rissanen","type":"person","url":"https://hartvaat.nl/mensen/tuomas-t-rissanen/","name":"Tuomas T Rissanen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/10/overleving-na-revascularisatie-met-paclitaxel-gecoate-ballonnen/","published":"2020-03-10"},{"url":"https://hartvaat.nl/2019/07/20/drug-coated-balloon-bij-de-novo-coronairlaesies-met-hoog-bloedingsrisico-lancet-/","published":"2019-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tushar-patel","type":"person","url":"https://hartvaat.nl/mensen/tushar-patel/","name":"Tushar Patel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tuvia-ben-gal","type":"person","url":"https://hartvaat.nl/mensen/tuvia-ben-gal/","name":"Tuvia Ben Gal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/hfa-consensus-gestructureerde-aanpak-van-recent-ontstane-cardiomyopathie/","published":"2026-05-01"},{"url":"https://hartvaat.nl/2022/12/01/hartfalen-tijdens-de-covid-19-pandemie-klinische-en-organisatorische-dilemma-s/","published":"2022-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ty-j-gluckman","type":"person","url":"https://hartvaat.nl/mensen/ty-j-gluckman/","name":"Ty J Gluckman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","published":"2021-02-09"},{"url":"https://hartvaat.nl/2020/08/04/2020-acc-bloedingsmanagement-bij-oac-expert-consensus-decision-pathway/","published":"2020-08-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tyson-rogers","type":"person","url":"https://hartvaat.nl/mensen/tyson-rogers/","name":"Tyson Rogers","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/draadloos-ultrasound-gebaseerd-crt-systeem-bij-hartfalen/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2020/07/07/baroreflexactivatietherapie-bij-hfref-beat-hf/","published":"2020-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"udaya-tantry","type":"person","url":"https://hartvaat.nl/mensen/udaya-tantry/","name":"Udaya Tantry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/24/pcsk9-remming-bij-covid-19-anti-inflammatoir-potentieel-onderzocht/","published":"2023-01-24"},{"url":"https://hartvaat.nl/2018/04/17/uitgangs-ldl-en-mortaliteitsreductie-na-ldl-verlaging-jama-meta-analyse/","published":"2018-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ueda","type":"person","url":"https://hartvaat.nl/mensen/ueda/","name":"Ueda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"},{"url":"https://hartvaat.nl/2026/03/06/cardiale-sarcoidose-een-onderhoudsdosis-corticosteroiden-van-5-10-mg-dag-geeft-d/","published":"2026-03-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulf-ekelund","type":"person","url":"https://hartvaat.nl/mensen/ulf-ekelund/","name":"Ulf Ekelund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/10/dagelijkse-stappen-en-cardiovasculaire-ziekte-geharmoniseerde-meta-analyse/","published":"2023-01-10"},{"url":"https://hartvaat.nl/2017/09/28/zuurstoftherapie-bij-vermoedelijk-acuut-myocardinfarct-nejm-deto2x-ami/","published":"2017-09-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulf-naslund","type":"person","url":"https://hartvaat.nl/mensen/ulf-naslund/","name":"Ulf Näslund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2019/01/12/visualisatie-van-asymptomatische-atherosclerose-voor-cv-preventie-lancet-vipviza/","published":"2019-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulf-riserus","type":"person","url":"https://hartvaat.nl/mensen/ulf-riserus/","name":"Ulf Risérus","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2023/07/25/omega-3-biomarkers-en-incident-af-ipd-analyse/","published":"2023-07-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrich-broeckel","type":"person","url":"https://hartvaat.nl/mensen/ulrich-broeckel/","name":"Ulrich Broeckel","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/polygene-risicoscore-en-chloortalidone-respons/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2016/03/22/genetische-risicoscore-en-ldl-cholesterolbehandeling-bij-coronairlijden/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrich-julius","type":"person","url":"https://hartvaat.nl/mensen/ulrich-julius/","name":"Ulrich Julius","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/lipoproteine-aferese-blijft-relevant-in-het-tijdperk-van-pcsk9-remmers-en-sirna/","published":"2026-06-12"},{"url":"https://hartvaat.nl/2026/02/21/pelacarsen-vermindert-de-behoefte-aan-lipoproteine-a-aferese-lp-a-frontiers-aphe/","published":"2026-02-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ulrika-birgersdotter-green","type":"person","url":"https://hartvaat.nl/mensen/ulrika-birgersdotter-green/","name":"Ulrika Birgersdotter-Green","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/30/leadless-atriaal-pacen-geeft-minder-complicaties-dan-transveneus-1-jaars-medicar/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2020/04/01/p2y12-remmers-met-oac-bij-af-na-pci-meta-analyse/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"unnur-thorsteinsdottir","type":"person","url":"https://hartvaat.nl/mensen/unnur-thorsteinsdottir/","name":"Unnur Thorsteinsdottir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/genetische-bijdrage-aan-aortastenose-dyslipidemie-inflammatie-en-verkalking/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2023/03/21/genetische-varianten-geassocieerd-met-syncope-neurale-en-autonome-processen/","published":"2023-03-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"uri-goldbourt","type":"person","url":"https://hartvaat.nl/mensen/uri-goldbourt/","name":"Uri Goldbourt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ursula-rauch-krohnert","type":"person","url":"https://hartvaat.nl/mensen/ursula-rauch-krohnert/","name":"Ursula Rauch-Kröhnert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/10/fair-hf2-iv-ferricarboxymaltose-bij-hartfalen-met-ijzerdeficientie-definitieve-r/","published":"2025-06-10"},{"url":"https://hartvaat.nl/2022/10/04/empagliflozine-bij-hfpef-gelijk-effect-bij-vrouwen-en-mannen/","published":"2022-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"uta-ceglarek","type":"person","url":"https://hartvaat.nl/mensen/uta-ceglarek/","name":"Uta Ceglarek","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/02/10/propionaat-vermindert-atherosclerose-via-immuunregulatie-van-intestinaal-cholest/","published":"2022-02-10"},{"url":"https://hartvaat.nl/2018/03/13/leefstijlinterventies-en-mobilisatie-van-vetstapeling-central-mri-gerandomiseerd/","published":"2018-03-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"uta-scheidt","type":"person","url":"https://hartvaat.nl/mensen/uta-scheidt/","name":"Uta Scheidt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/25/pyelonefritis-verlaagt-serumcholesterol-en-remt-atherosclerose-ondanks-systemisc/","published":"2026-02-25"},{"url":"https://hartvaat.nl/2026/01/19/sglt2-remming-behoudt-antibacteriele-respons-van-de-nier-door-complement-c1q-ver/","published":"2026-01-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"utibe-r-essien","type":"person","url":"https://hartvaat.nl/mensen/utibe-r-essien/","name":"Utibe R Essien","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/02/medische-kosten-en-productiviteitsverlies-door-atriumfibrilleren-in-de-vs/","published":"2026-02-02"},{"url":"https://hartvaat.nl/2018/12/01/ras-etniciteit-en-oac-gebruik-bij-af-orbit-af/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"uwe-malzahn","type":"person","url":"https://hartvaat.nl/mensen/uwe-malzahn/","name":"Uwe Malzahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/15/doac-s-versus-geen-anticoagulatie-na-intracraniele-bloeding-bij-af-meta-analyse/","published":"2025-03-15"},{"url":"https://hartvaat.nl/2019/04/01/spironolacton-en-lv-massa-bij-hemodialysepatienten-gerandomiseerde-trial/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"v-s","type":"person","url":"https://hartvaat.nl/mensen/v-s/","name":"V. S.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/04/noorse-nationale-validatie-myocarditis-na-mrna-covid-vaccinatie-4-5-per-100-000-/","published":"2026-07-10"},{"url":"https://hartvaat.nl/2026/01/16/nt-probnp-voorspelt-sterfte-na-een-stemi-onafhankelijk-van-de-ejectiefractie/","published":"2026-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valentina-zeffiro","type":"person","url":"https://hartvaat.nl/mensen/valentina-zeffiro/","name":"Valentina Zeffiro","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/08/01/motivational-interviewing-en-zorggebruik-en-mortaliteit-bij-hf-motivate-hf/","published":"2021-08-01"},{"url":"https://hartvaat.nl/2020/06/01/motivational-interviewing-bij-hartfalen-voor-zelfzorg-motivate-hf-gerandomiseerd/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valeria-calvi","type":"person","url":"https://hartvaat.nl/mensen/valeria-calvi/","name":"Valeria Calvi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2022/02/02/thuismonitoring-temporele-trends-en-baseline-risico-voor-hf-voorspelling-bij-icd/","published":"2022-02-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valerie-m-wilson","type":"person","url":"https://hartvaat.nl/mensen/valerie-m-wilson/","name":"Valerie M Wilson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/13/intensieve-versus-standaard-bloeddruk-en-cerebrale-wittestoflaesies-jama-sprint-/","published":"2019-08-13"},{"url":"https://hartvaat.nl/2019/02/12/intensieve-versus-standaard-bloeddrukcontrole-en-waarschijnlijke-dementie-jama-s/","published":"2019-02-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valon-asani","type":"person","url":"https://hartvaat.nl/mensen/valon-asani/","name":"Valon Asani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/colchicine-en-spironolacton-bij-acuut-mi-voordeel-risico-analyse/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2025/02/13/routine-spironolacton-na-acuut-mi-gerandomiseerde-trial-nejm/","published":"2025-02-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"valerie-tikhonoff","type":"person","url":"https://hartvaat.nl/mensen/valerie-tikhonoff/","name":"Valérie Tikhonoff","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanasa-nageswaran","type":"person","url":"https://hartvaat.nl/mensen/vanasa-nageswaran/","name":"Vanasa Nageswaran","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/01/oraal-butyraat-verlaagt-bloeddruk-bij-hypertensie-rct/","published":"2024-10-01"},{"url":"https://hartvaat.nl/2022/02/10/propionaat-vermindert-atherosclerose-via-immuunregulatie-van-intestinaal-cholest/","published":"2022-02-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vandana-sachdev","type":"person","url":"https://hartvaat.nl/mensen/vandana-sachdev/","name":"Vandana Sachdev","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/18/aha-scientific-statement-gestructureerde-inspanningstraining-bij-hfpef/","published":"2023-04-18"},{"url":"https://hartvaat.nl/2023/01/17/transform-hf-torsemide-biedt-geen-overlevingsvoordeel-boven-furosemide/","published":"2023-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanessa-blumer","type":"person","url":"https://hartvaat.nl/mensen/vanessa-blumer/","name":"Vanessa Blumer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/18/2025-acc-scientific-statement-obesitasmanagement-bij-hartfalen/","published":"2025-11-18"},{"url":"https://hartvaat.nl/2024/09/17/2024-acc-aha-kwaliteitsmaatstaven-voor-hartfalen-geactualiseerd/","published":"2024-09-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanessa-ferreira","type":"person","url":"https://hartvaat.nl/mensen/vanessa-ferreira/","name":"Vanessa Ferreira","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/13/pop-ht-bloeddrukzelfmanagement-verbetert-cardiale-remodelling-na-hypertensieve-z/","published":"2024-02-13"},{"url":"https://hartvaat.nl/2023/11/01/beta3-lvh-mirabegron-bij-linkerventrikel-hypertrofie-fase-2b-rct/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanessa-karlinski-vizentin","type":"person","url":"https://hartvaat.nl/mensen/vanessa-karlinski-vizentin/","name":"Vanessa Karlinski Vizentin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/05/cmr-parameters-voorspellen-nieuwe-hartklachten-bij-hypertrofische-cardiomyopathi/","published":"2026-07-30"},{"url":"https://hartvaat.nl/2026/02/03/ryr2-mutaties-als-oorzaak-van-onverklaarde-plotse-hartdood-bij-jongeren/","published":"2026-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanessa-roldan-schilling","type":"person","url":"https://hartvaat.nl/mensen/vanessa-roldan-schilling/","name":"Vanessa Roldan-Schilling","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/08/01/2018-ehra-praktische-gids-doac-s-bij-af-europace-editie/","published":"2018-08-01"},{"url":"https://hartvaat.nl/2018/04/21/2018-ehra-praktische-gids-voor-doac-gebruik-bij-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vanessa-sciacca","type":"person","url":"https://hartvaat.nl/mensen/vanessa-sciacca/","name":"Vanessa Sciacca","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/02/style-af-veneuze-closure-device-versus-figuur-van-acht-hechting-na-af-ablatie/","published":"2024-05-02"},{"url":"https://hartvaat.nl/2023/10/12/castle-htx-af-ablatie-bij-eindstadium-hartfalen-nejm/","published":"2023-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vasiliki-patsiou","type":"person","url":"https://hartvaat.nl/mensen/vasiliki-patsiou/","name":"Vasiliki Patsiou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/01/14/residuele-lekkage-na-laa-occlusie-en-uitkomsten-meta-analyse/","published":"2024-01-14"},{"url":"https://hartvaat.nl/2023/11/10/transcatheter-asd-sluiting-bij-ouderen-systematische-review-en-meta-analyse/","published":"2023-11-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vassilios-liakopoulos","type":"person","url":"https://hartvaat.nl/mensen/vassilios-liakopoulos/","name":"Vassilios Liakopoulos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/31/era-s-abcde-raamwerk-voor-preventie-van-nierziekten/","published":"2026-03-31"},{"url":"https://hartvaat.nl/2026/01/24/oproep-tot-actie-europese-trials-nodig-tegen-tsunami-van-nierfalen/","published":"2026-01-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veena-s-rao","type":"person","url":"https://hartvaat.nl/mensen/veena-s-rao/","name":"Veena S Rao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/09/15/empagliflozine-bij-hartfalen-diuretische-en-cardiorenale-effecten/","published":"2020-09-15"},{"url":"https://hartvaat.nl/2018/05/08/nierfunctieverslechtering-bij-acuut-hartfalen-met-agressieve-diurese-geen-tubula/","published":"2018-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"venkatesh-mani","type":"person","url":"https://hartvaat.nl/mensen/venkatesh-mani/","name":"Venkatesh Mani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/persisterende-arteriele-wandinflammatie-bij-verhoogd-lp-a-ondanks-lage-ldl/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2016/10/18/canakinumab-en-arteriele-effecten-bij-atherosclerose-met-diabetes-of-glucosetole/","published":"2016-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vera-h-m-deneer","type":"person","url":"https://hartvaat.nl/mensen/vera-h-m-deneer/","name":"Vera H M Deneer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/11/10/ticagrelor-plus-aspirine-en-safeneuze-graft-patency-na-cabg/","published":"2020-11-10"},{"url":"https://hartvaat.nl/2019/10/24/genotype-geleide-p2y12-remmerkeuze-bij-primaire-pci-nejm-popular-genetics/","published":"2019-10-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vera-krane","type":"person","url":"https://hartvaat.nl/mensen/vera-krane/","name":"Vera Krane","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/01/spironolacton-en-lv-massa-bij-hemodialysepatienten-gerandomiseerde-trial/","published":"2019-04-01"},{"url":"https://hartvaat.nl/2016/06/01/langetermijneffecten-van-atorvastatine-bij-diabetes-type-2-op-hemodialyse-4d-tri/","published":"2016-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veronica-francis","type":"person","url":"https://hartvaat.nl/mensen/veronica-francis/","name":"Veronica Francis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veronica-giorgione","type":"person","url":"https://hartvaat.nl/mensen/veronica-giorgione/","name":"Veronica Giorgione","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/01/cardiale-structuur-en-functie-bij-hypertensieve-zwangerschapsstoornissen-systema/","published":"2025-07-01"},{"url":"https://hartvaat.nl/2022/02/01/myocardiale-mechanica-bij-hypertensieve-zwangerschapsaandoeningen-meta-analyse/","published":"2022-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"veronika-lekesova","type":"person","url":"https://hartvaat.nl/mensen/veronika-lekesova/","name":"Veronika Lekesova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vias-markides","type":"person","url":"https://hartvaat.nl/mensen/vias-markides/","name":"Vias Markides","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2016/12/07/linker-hartoorsluiting-uitkomsten-en-kosten-van-trial-en-real-world-versus-orale/","published":"2016-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vibhu-parcha","type":"person","url":"https://hartvaat.nl/mensen/vibhu-parcha/","name":"Vibhu Parcha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/polygene-risicoscore-en-chloortalidone-respons/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2020/06/01/incidentie-en-implicaties-van-af-bij-hypertensie-sprint-inzichten/","published":"2020-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vicent-bodi","type":"person","url":"https://hartvaat.nl/mensen/vicent-bodi/","name":"Vicent Bodí","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/04/01/betablokkerstaken-verbetert-inspanningscapaciteit-bij-hfpef/","published":"2024-04-01"},{"url":"https://hartvaat.nl/2021/11/23/betablokkerstaken-en-functionele-capaciteit-bij-hfpef/","published":"2021-11-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-a-chu","type":"person","url":"https://hartvaat.nl/mensen/victor-a-chu/","name":"Victor A Chu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/voorbehandeling-met-antiaritmica-voor-cardioversie-bij-af-netwerk-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/06/01/amiodaron-voor-en-na-electrische-cardioversie-van-af-meta-analyse/","published":"2019-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-chong","type":"person","url":"https://hartvaat.nl/mensen/victor-chong/","name":"Victor Chong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/29/ironman-adjudicatie-van-hospitalisaties-en-sterfgevallen-heranalyse/","published":"2024-10-29"},{"url":"https://hartvaat.nl/2021/02/09/empagliflozine-en-lv-volumes-bij-diabetes-prediabetes-met-hfref-sugar-dm-hf/","published":"2021-02-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-g-davila-roman","type":"person","url":"https://hartvaat.nl/mensen/victor-g-davila-roman/","name":"Victor G Davila-Roman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/08/01/schone-kookbrandstof-en-bloeddruk-tijdens-zwangerschap-hapin-trial/","published":"2022-08-01"},{"url":"https://hartvaat.nl/2018/11/06/anorganisch-nitriet-versus-placebo-bij-inspanningscapaciteit-bij-hfpef-jama-indi/","published":"2018-11-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-m-montori","type":"person","url":"https://hartvaat.nl/mensen/victor-m-montori/","name":"Victor M Montori","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/sglt2-remmers-head-to-head-empagliflozin-licht-beter-dan-canagliflozin-bij-matig/","published":"2026-06-15"},{"url":"https://hartvaat.nl/2016/03/22/genetische-risicoscore-en-ldl-cholesterolbehandeling-bij-coronairlijden/","published":"2016-03-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victor-w-zwartkruis","type":"person","url":"https://hartvaat.nl/mensen/victor-w-zwartkruis/","name":"Victor W Zwartkruis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2019/04/01/upstream-therapie-verbetert-qol-bij-persisterend-af-arrest-af/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victoria-cornelius","type":"person","url":"https://hartvaat.nl/mensen/victoria-cornelius/","name":"Victoria Cornelius","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victoria-j-bartlett","type":"person","url":"https://hartvaat.nl/mensen/victoria-j-bartlett/","name":"Victoria J Bartlett","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/04/06/apoc-iii-reductie-bij-matige-hypertriglyceridemie-met-hoog-cv-risico/","published":"2022-04-06"},{"url":"https://hartvaat.nl/2020/10/21/vupanorsen-angptl3-antisense-en-triglyceriden-ehj/","published":"2020-10-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"victorien-monguillon","type":"person","url":"https://hartvaat.nl/mensen/victorien-monguillon/","name":"Victorien Monguillon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/vesalius-cv-lp-a-voorspelt-risico-evolocumab-werkt-ongeacht-uitgangswaarde/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2026/01/13/effectiviteit-en-veiligheid-van-zeer-laag-bereikt-ldl-na-ischemisch-cva/","published":"2026-01-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vijay-k-sharma","type":"person","url":"https://hartvaat.nl/mensen/vijay-k-sharma/","name":"Vijay K Sharma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vikas-tandon","type":"person","url":"https://hartvaat.nl/mensen/vikas-tandon/","name":"Vikas Tandon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2018/06/09/dabigatran-bij-myocardschade-na-niet-cardiale-chirurgie-lancet-manage-trial/","published":"2018-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"viliam-fridrich","type":"person","url":"https://hartvaat.nl/mensen/viliam-fridrich/","name":"Viliam Fridrich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/03/antitrombotische-therapie-bij-af-met-acs-medicamenteus-of-met-pci/","published":"2019-12-03"},{"url":"https://hartvaat.nl/2016/01/23/reg1-anticoagulatiesysteem-versus-bivalirudine-bij-pci-de-regulate-pci-trial/","published":"2016-01-23"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ville-langen","type":"person","url":"https://hartvaat.nl/mensen/ville-langen/","name":"Ville Langén","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/12/01/positieve-levensorientatie-en-bloeddruk-bij-ouderen-nauwelijks-klinisch-relevant/","published":"2026-08-17"},{"url":"https://hartvaat.nl/2026/05/19/finacaf-n-229-565-hartfalen-verhoogt-cva-risico-bij-af-vooral-bij-jongere-patien/","published":"2026-06-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vin-cent-wu","type":"person","url":"https://hartvaat.nl/mensen/vin-cent-wu/","name":"Vin-Cent Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/10/risico-op-nier-en-urotheelkanker-bij-sglt2-remmers-versus-glp-1-receptoragoniste/","published":"2026-02-10"},{"url":"https://hartvaat.nl/2020/11/01/raas-remmers-en-covid-19-risico-systematische-review-en-meta-analyse/","published":"2020-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vinay-badhwar","type":"person","url":"https://hartvaat.nl/mensen/vinay-badhwar/","name":"Vinay Badhwar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/01/01/2017-af-ablatieconsensus-samenvatting/","published":"2018-01-01"},{"url":"https://hartvaat.nl/2018/01/01/2017-hrs-ehra-ecas-aphrs-solaece-expertconsensus-katheter-en-chirurgische-af-abl/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vinay-thohan","type":"person","url":"https://hartvaat.nl/mensen/vinay-thohan/","name":"Vinay Thohan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/relieve-hf-interatriale-shunt-bij-hartfalen-negatieve-gerandomiseerde-trial/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2018/10/30/zorggebruik-en-kosten-in-momentum-3-langetermijnstudie/","published":"2018-10-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincent-f-van-dijk","type":"person","url":"https://hartvaat.nl/mensen/vincent-f-van-dijk/","name":"Vincent F Van Dijk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/12/07/gold-force-multi-elektrode-rf-versus-irrigated-rf-bij-af-gerandomiseerde-trial/","published":"2021-12-07"},{"url":"https://hartvaat.nl/2019/04/18/vroege-of-uitgestelde-cardioversie-bij-recent-onset-af-nejm-race-7-acwas/","published":"2019-04-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincent-roule","type":"person","url":"https://hartvaat.nl/mensen/vincent-roule/","name":"Vincent Roule","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/22/multivaten-pci-geleid-door-ffr-of-angiografie-bij-mi-nejm-flower-mi/","published":"2021-07-22"},{"url":"https://hartvaat.nl/2016/04/26/vroege-aldosteronblokkade-bij-acuut-myocardinfarct-de-albatross-trial/","published":"2016-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincenzo-castiglione","type":"person","url":"https://hartvaat.nl/mensen/vincenzo-castiglione/","name":"Vincenzo Castiglione","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/22/cardiale-amyloidose-komt-frequent-voor-bij-hfpef-aortastenose-en-lvh-meta-analys/","published":"2026-08-10"},{"url":"https://hartvaat.nl/2025/01/01/serum-transthyretine-voor-en-na-tafamidisstart-als-uitkomstvoorspeller-bij-attr-/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vincenzo-maiolo","type":"person","url":"https://hartvaat.nl/mensen/vincenzo-maiolo/","name":"Vincenzo Maiolo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vinodh-srinivasasainagendra","type":"person","url":"https://hartvaat.nl/mensen/vinodh-srinivasasainagendra/","name":"Vinodh Srinivasasainagendra","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/01/polygene-risicoscore-en-chloortalidone-respons/","published":"2024-12-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"violet-naanyu","type":"person","url":"https://hartvaat.nl/mensen/violet-naanyu/","name":"Violet Naanyu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"virginia-j-howard","type":"person","url":"https://hartvaat.nl/mensen/virginia-j-howard/","name":"Virginia J Howard","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/20/biomarkers-voorspellen-coronairlijden-bij-atriumfibrilleren-regards/","published":"2026-07-16"},{"url":"https://hartvaat.nl/2016/03/17/langetermijnresultaten-van-stenting-versus-endarteriectomie-bij-carotisstenose/","published":"2016-03-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vitalis-orango","type":"person","url":"https://hartvaat.nl/mensen/vitalis-orango/","name":"Vitalis Orango","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/groepsmedisch-consult-en-microfinanciering-bij-diabetes-hypertensie-in-kenia/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2019/10/15/community-health-workers-verbeteren-koppeling-met-hypertensiezorg-in-kenia/","published":"2019-10-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vitaliy-shabanov","type":"person","url":"https://hartvaat.nl/mensen/vitaliy-shabanov/","name":"Vitaliy Shabanov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/08/25/pulmonale-arterie-denervatie-bij-residuele-ph-na-endarterectomie/","published":"2020-08-25"},{"url":"https://hartvaat.nl/2020/01/21/renale-denervatie-plus-katheterablatie-versus-ablatie-alleen-bij-af-met-hyperten/","published":"2020-01-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vlasis-ninios","type":"person","url":"https://hartvaat.nl/mensen/vlasis-ninios/","name":"Vlasis Ninios","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"vlastimil-vancura","type":"person","url":"https://hartvaat.nl/mensen/vlastimil-vancura/","name":"Vlastimil Vancura","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/04/4-jaars-laa-sluiting-versus-niet-warfarine-oac-bij-af/","published":"2022-01-04"},{"url":"https://hartvaat.nl/2020/06/30/laa-sluiting-versus-doac-bij-hoogrisico-af-vergelijkende-analyse/","published":"2020-06-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"volker-schettler","type":"person","url":"https://hartvaat.nl/mensen/volker-schettler/","name":"Volker Schettler","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/21/pelacarsen-vermindert-de-behoefte-aan-lipoproteine-a-aferese-lp-a-frontiers-aphe/","published":"2026-02-21"},{"url":"https://hartvaat.nl/2016/12/21/alirocumab-bij-heterozygoot-fh-met-lipoproteine-aferese-odyssey-escape/","published":"2016-12-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"volkmar-falk","type":"person","url":"https://hartvaat.nl/mensen/volkmar-falk/","name":"Volkmar Falk","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/vroege-heropnames-na-chirurgische-aortaklepvervanging-beinvloeden-trial-eindpunt/","published":"2026-03-23"},{"url":"https://hartvaat.nl/2016/07/14/2016-esc-richtlijn-voor-diagnostiek-en-behandeling-van-acuut-en-chronisch-hartfa/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"w-douglas-weaver","type":"person","url":"https://hartvaat.nl/mensen/w-douglas-weaver/","name":"W Douglas Weaver","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/05/03/diabetes-en-preventie-van-laat-myocardinfarct-na-stenting-dapt-studie/","published":"2016-05-03"},{"url":"https://hartvaat.nl/2016/04/21/mtp-131-bij-reperfusieschade-na-stemi-de-embrace-stemi-fase-2a-trial/","published":"2016-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"w-frank-peacock","type":"person","url":"https://hartvaat.nl/mensen/w-frank-peacock/","name":"W Frank Peacock","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/02/01/zelfzorginterventie-en-90-daags-uitkomsten-bij-acuut-hf-na-seh-ontslag-jama-card/","published":"2021-02-01"},{"url":"https://hartvaat.nl/2017/05/18/ularitide-en-cardiovasculaire-mortaliteit-bij-acuut-hartfalen-nejm-true-ahf/","published":"2017-05-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"w-timothy-garvey","type":"person","url":"https://hartvaat.nl/mensen/w-timothy-garvey/","name":"W Timothy Garvey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/cagrisema-verlaagt-bloeddruk-bij-overgewicht-obesitas-redefine-1/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/14/cagrisema-gecombineerd-cagrilintide-en-semaglutide-bij-overgewicht-nejm/","published":"2025-08-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wael-almahmeed","type":"person","url":"https://hartvaat.nl/mensen/wael-almahmeed/","name":"Wael Almahmeed","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/02/24/lipide-aferese-verlaagt-lp-a-met-60-75-systematische-review-en-meta-analyse/","published":"2026-02-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wagner","type":"person","url":"https://hartvaat.nl/mensen/wagner/","name":"Wagner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/03/25/vrouwen-krijgen-een-type-a-aortadissectie-bij-een-kleinere-aortadiameter-door-hu/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wajid-hussain","type":"person","url":"https://hartvaat.nl/mensen/wajid-hussain/","name":"Wajid Hussain","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2016/12/07/linker-hartoorsluiting-uitkomsten-en-kosten-van-trial-en-real-world-versus-orale/","published":"2016-12-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"waldemar-bojara","type":"person","url":"https://hartvaat.nl/mensen/waldemar-bojara/","name":"Waldemar Bojara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"walter-n-kernan","type":"person","url":"https://hartvaat.nl/mensen/walter-n-kernan/","name":"Walter N Kernan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/18/hartfalen-na-cva-tia-bij-insulineresistente-patienten-behandeld-met-pioglitazon/","published":"2018-09-18"},{"url":"https://hartvaat.nl/2016/04/07/pioglitazon-na-ischemisch-cva-of-tia-gerandomiseerde-nejm-trial/","published":"2016-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wan-chung-law","type":"person","url":"https://hartvaat.nl/mensen/wan-chung-law/","name":"Wan Chung Law","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/23/triple-pill-verlaagt-risico-op-terugkerende-beroerte-na-hersenbloeding/","published":"2026-04-30"},{"url":"https://hartvaat.nl/2021/07/18/smartphone-ecg-voor-af-detectie-na-cerebrovasculair-event-multicenter-rct/","published":"2021-07-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wayne-huey-herng-sheu","type":"person","url":"https://hartvaat.nl/mensen/wayne-huey-herng-sheu/","name":"Wayne Huey-Herng Sheu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/23/van-internationale-richtlijnen-naar-nationale-implementatie-bij-cardio-renaal-me/","published":"2026-02-23"},{"url":"https://hartvaat.nl/2021/07/08/cv-uitkomsten-bij-diabetes-met-vastgesteld-of-hoog-risico-coronairlijden-dulaglu/","published":"2021-07-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wayne-w-campbell","type":"person","url":"https://hartvaat.nl/mensen/wayne-w-campbell/","name":"Wayne W Campbell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/24/meer-kip-dan-rundvlees-of-vis-bij-avondmaaltijd-gekoppeld-aan-grotere-bloeddrukd/","published":"2026-08-08"},{"url":"https://hartvaat.nl/2019/04/09/rood-vlees-en-cardiovasculaire-risicofactoren-meta-analyse-van-gerandomiseerde-t/","published":"2019-04-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-chen","type":"person","url":"https://hartvaat.nl/mensen/wei-chen/","name":"Wei Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-feng","type":"person","url":"https://hartvaat.nl/mensen/wei-feng/","name":"Wei Feng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/gedeeltelijke-cardiale-denervatie-voorkomt-af-na-cabg-rct/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-gao","type":"person","url":"https://hartvaat.nl/mensen/wei-gao/","name":"Wei Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/vroege-evolocumab-na-hartinfarct-verlaagt-mace-bij-uitgestelde-randstenosen/","published":"2026-05-25"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-liu","type":"person","url":"https://hartvaat.nl/mensen/wei-liu/","name":"Wei Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/01/step-substudie-intensieve-bloeddrukverlaging-verbetert-lvh-bij-ouderen/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-ma","type":"person","url":"https://hartvaat.nl/mensen/wei-ma/","name":"Wei Ma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/25/explorer-cn-week-78-langetermijneffect-en-veiligheid-van-mavacamten-bij-chinese-/","published":"2026-06-03"},{"url":"https://hartvaat.nl/2022/06/01/interatriale-shuntdevices-bij-hartfalen-systematische-review-en-meta-analyse/","published":"2022-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-miao","type":"person","url":"https://hartvaat.nl/mensen/wei-miao/","name":"Wei Miao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/multifactorieel-intensief-bloeddrukmodel-bij-ouderen-en-jongeren/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wei-zhang","type":"person","url":"https://hartvaat.nl/mensen/wei-zhang/","name":"Wei Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/31/draagbare-sensoren-voor-comorbiditeit-osa-en-hypertensie-huidige-stand-van-zaken/","published":"2026-08-14"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weihao-liang","type":"person","url":"https://hartvaat.nl/mensen/weihao-liang/","name":"Weihao Liang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/14/depressietrajecten-bij-hfpef-impact-op-uitkomsten/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weihong-jiang","type":"person","url":"https://hartvaat.nl/mensen/weihong-jiang/","name":"Weihong Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/26/inclisiran-als-monotherapie-verlaagt-ldl-c-met-47-5-in-chinese-volwassenen-victo/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2024/06/01/opt-birisk-clopidogrel-monotherapie-bij-acs-met-hoog-ischemisch-en-bloedingsrisi/","published":"2024-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weili-zhang","type":"person","url":"https://hartvaat.nl/mensen/weili-zhang/","name":"Weili Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weixian-yang","type":"person","url":"https://hartvaat.nl/mensen/weixian-yang/","name":"Weixian Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weizhu-ju","type":"person","url":"https://hartvaat.nl/mensen/weizhu-ju/","name":"Weizhu Ju","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/07/aanvullende-substraatmodificatie-bij-persisterend-af-met-low-voltage-gebieden/","published":"2025-05-07"},{"url":"https://hartvaat.nl/2020/04/01/intraprocedurele-eindpunten-voor-duurzame-pvi-gerandomiseerde-trial-van-vier-tec/","published":"2020-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wen-chih-wu","type":"person","url":"https://hartvaat.nl/mensen/wen-chih-wu/","name":"Wen-Chih Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/01/cv-risicomodellen-bij-hiv-patienten-systematische-review/","published":"2023-02-01"},{"url":"https://hartvaat.nl/2022/12/13/micronutrientensuppletie-en-cardiovasculair-risico-jacc-systematische-review/","published":"2022-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenbing-jiang","type":"person","url":"https://hartvaat.nl/mensen/wenbing-jiang/","name":"Wenbing Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wendy-mccallum","type":"person","url":"https://hartvaat.nl/mensen/wendy-mccallum/","name":"Wendy McCallum","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/23/clorotic-subanalyse-acute-egfr-daling-door-thiaziden-bij-acuut-hf-is-geen-progno/","published":"2026-04-21"},{"url":"https://hartvaat.nl/2019/11/01/acute-egfr-daling-door-enalapril-en-mortaliteit-bij-hf-met-ckd/","published":"2019-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenfeng-miao","type":"person","url":"https://hartvaat.nl/mensen/wenfeng-miao/","name":"Wenfeng Miao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/24/lorcaserine-en-preventie-remissie-van-diabetes-type-2-bij-obesitas-camellia-timi/","published":"2018-11-24"},{"url":"https://hartvaat.nl/2018/09/20/cardiovasculaire-veiligheid-van-lorcaserine-bij-obesitas-nejm-camellia/","published":"2018-09-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenhao-xia","type":"person","url":"https://hartvaat.nl/mensen/wenhao-xia/","name":"Wenhao Xia","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/luchtvervuiling-en-hypertensierisico-ernst-van-de-ziekte-doet-ertoe/","published":"2026-03-29"},{"url":"https://hartvaat.nl/2021/04/01/aerobe-training-bevordert-angiogenese-en-verlaagt-bloeddruk-bij-hypertensie-exca/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenjuan-zhang","type":"person","url":"https://hartvaat.nl/mensen/wenjuan-zhang/","name":"Wenjuan Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/orale-pcsk9-remmer-enlicitide-verlaagt-ldl-met-57-placebogecontroleerde-trial/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenli-dai","type":"person","url":"https://hartvaat.nl/mensen/wenli-dai/","name":"Wenli Dai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2022/10/13/intensieve-bloeddrukcontrole-bij-af-inzichten-uit-sprint/","published":"2022-10-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenwen-chen","type":"person","url":"https://hartvaat.nl/mensen/wenwen-chen/","name":"Wenwen Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/mettl3-interventie-onderdrukt-pathogene-th17-differentiatie-en-herstelt-nierscha/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2021/10/01/sacubitril-valsartan-verbetert-hartfunctie-bij-chinese-hf-patienten-real-world/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wenxin-zhang","type":"person","url":"https://hartvaat.nl/mensen/wenxin-zhang/","name":"Wenxin Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/hypotensieve-episodes-op-24-uurs-abpm-en-cognitieve-functie-sprint-inzichten/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2024/09/01/troponine-nt-probnp-en-cognitieve-uitkomsten-in-sprint/","published":"2024-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wern-yew-ding","type":"person","url":"https://hartvaat.nl/mensen/wern-yew-ding/","name":"Wern Yew Ding","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2021/10/01/katheterablatie-als-eerstelijns-paf-therapie-meta-analyse/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"werner-budts","type":"person","url":"https://hartvaat.nl/mensen/werner-budts/","name":"Werner Budts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/09/cardiale-screening-van-jonge-sporters-eerste-eapc-aepc-consensus-voor-kinderen/","published":"2026-07-15"},{"url":"https://hartvaat.nl/2016/11/01/2016-esc-af-richtlijn-europace-editie/","published":"2016-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wesley-t-beaulieu","type":"person","url":"https://hartvaat.nl/mensen/wesley-t-beaulieu/","name":"Wesley T Beaulieu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/15/aflibercept-versus-vitrectomie-bij-diabetische-glasvochtbloeding-jama-drcr-net-p/","published":"2020-12-15"},{"url":"https://hartvaat.nl/2019/05/21/aflibercept-versus-fotocoagulatie-versus-observatie-bij-diabetisch-maculaoedeem-/","published":"2019-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"whitney-huey","type":"person","url":"https://hartvaat.nl/mensen/whitney-huey/","name":"Whitney Huey","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/13/risicofactoren-en-plaquevolume-op-coronaire-ct-angiografie-lessen-uit-het-advanc/","published":"2026-01-13"},{"url":"https://hartvaat.nl/2023/10/01/precise-uitgesteld-testen-bij-stabiel-coronairlijden-is-veilig/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wietze-lindeboom","type":"person","url":"https://hartvaat.nl/mensen/wietze-lindeboom/","name":"Wietze Lindeboom","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/03/11/tavr-bij-systolisch-hartfalen-en-matige-aortastenose-nejm/","published":"2025-03-11"},{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wig-zamore","type":"person","url":"https://hartvaat.nl/mensen/wig-zamore/","name":"Wig Zamore","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/26/hepa-luchtzuivering-en-bloeddruk-pragmatische-cross-over-trial/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2021/03/03/verminderde-verkeersgerelateerde-luchtvervuiling-en-bloeddruk-gerandomiseerde-cr/","published":"2021-03-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wiktor-kuliczkowski","type":"person","url":"https://hartvaat.nl/mensen/wiktor-kuliczkowski/","name":"Wiktor Kuliczkowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2026/02/26/cardiogene-shock-bij-myocardinfarct-resultaten-van-het-shock-pol-register/","published":"2026-03-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wiktoria-wojciechowska","type":"person","url":"https://hartvaat.nl/mensen/wiktoria-wojciechowska/","name":"Wiktoria Wojciechowska","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/01/drempelwaarde-voor-aortale-polsgolfsnelheid-en-cv-events-ipd-meta-analyse/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"willem-j-bos","type":"person","url":"https://hartvaat.nl/mensen/willem-j-bos/","name":"Willem J Bos","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/01/03/traditionele-cv-risicofactoren-en-veneuze-trombo-embolie-individuele-patientdata/","published":"2017-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-cornwell","type":"person","url":"https://hartvaat.nl/mensen/william-cornwell/","name":"William Cornwell","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/03/17/2020-acc-hfsa-ishlt-verklaring-voor-gevorderd-hf-en-transplantatiespecialisten/","published":"2020-03-17"},{"url":"https://hartvaat.nl/2018/04/10/sedentaire-veroudering-omkeren-op-middelbare-leeftijd-gerandomiseerde-trial-voor/","published":"2018-04-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-g-cotts","type":"person","url":"https://hartvaat.nl/mensen/william-g-cotts/","name":"William G Cotts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/04/25/heartmate-3-lvad-definitief-rapport-nejm-momentum-3-final/","published":"2019-04-25"},{"url":"https://hartvaat.nl/2018/04/12/heartmate-3-2-jaarsresultaten-bij-gevorderd-hartfalen-nejm-momentum-3/","published":"2018-04-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-g-stevenson","type":"person","url":"https://hartvaat.nl/mensen/william-g-stevenson/","name":"William G Stevenson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/02/20/vanish2-catheterablatie-versus-antiaritmica-bij-ventriculaire-tachycardie-nejm/","published":"2025-02-20"},{"url":"https://hartvaat.nl/2016/07/14/ablatie-versus-escalatie-van-antiaritmica-bij-ventriculaire-tachycardie-nejm-van/","published":"2016-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-l-baker","type":"person","url":"https://hartvaat.nl/mensen/william-l-baker/","name":"William L Baker","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/01/arts-apotheker-samenwerkingsmodel-en-time-in-target-bloeddruk-post-hoc-analyse/","published":"2021-09-01"},{"url":"https://hartvaat.nl/2018/12/01/lvad-implantatie-verbetert-glycemische-controle-meta-analyse/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-merhi","type":"person","url":"https://hartvaat.nl/mensen/william-merhi/","name":"William Merhi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/06/smart-zelf-expanderend-versus-ballonexpandeerbaar-tavr-bij-kleine-annulus-nejm/","published":"2024-06-06"},{"url":"https://hartvaat.nl/2019/05/02/tavr-met-zelfexpanderende-klep-bij-laagrisicopatienten-nejm-evolut-low-risk/","published":"2019-05-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-nicholson","type":"person","url":"https://hartvaat.nl/mensen/william-nicholson/","name":"William Nicholson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/vroege-versus-late-gestageerde-pci-na-subintimale-re-entry-bij-cto/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/08/19/paclitaxel-gecoate-ballon-bij-multilayer-in-stent-restenose-agent-ide-subgroep/","published":"2025-08-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-r-phillips","type":"person","url":"https://hartvaat.nl/mensen/william-r-phillips/","name":"William R Phillips","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2016/11/15/statines-voor-primaire-cardiovasculaire-preventie-uspstf-aanbeveling/","published":"2016-11-15"},{"url":"https://hartvaat.nl/2016/08/09/lipidescreening-bij-kinderen-en-adolescenten-uspstf-aanbeveling/","published":"2016-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-whiteley","type":"person","url":"https://hartvaat.nl/mensen/william-whiteley/","name":"William Whiteley","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/28/ascot-legacy-atorvastatine-verlaagt-cv-events-over-20-jaar/","published":"2025-07-28"},{"url":"https://hartvaat.nl/2020/05/19/bloeddrukverlaging-en-dementie-of-cognitieve-stoornis-jama-meta-analyse/","published":"2020-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-wilson","type":"person","url":"https://hartvaat.nl/mensen/william-wilson/","name":"William Wilson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"william-van-gaal","type":"person","url":"https://hartvaat.nl/mensen/william-van-gaal/","name":"William van Gaal","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","published":"2021-11-09"},{"url":"https://hartvaat.nl/2020/11/17/colchicine-bij-acs-australische-cops-gerandomiseerde-trial/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wim-huybrechts","type":"person","url":"https://hartvaat.nl/mensen/wim-huybrechts/","name":"Wim Huybrechts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/kortste-af-cycluslengte-in-de-longvenen-identificeert-pvi-responders/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2023/05/19/geleidingssysteempacing-in-europa-inzichten-uit-klinische-praktijk/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"winnie-chua","type":"person","url":"https://hartvaat.nl/mensen/winnie-chua/","name":"Winnie Chua","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/16/biomarkervoorspelling-van-sinusritme-bij-af-east-afnet-4-biomoleculaire-analyse/","published":"2024-12-16"},{"url":"https://hartvaat.nl/2020/05/01/predictie-van-af-recidief-na-ablatie-systematische-review-van-prognostische-mode/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wissam-khalife","type":"person","url":"https://hartvaat.nl/mensen/wissam-khalife/","name":"Wissam Khalife","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/05/19/slokdarmkoeling-voorkomt-oesofagale-schade-bij-af-ablatie-meta-analyse/","published":"2023-05-19"},{"url":"https://hartvaat.nl/2018/12/01/prognose-van-hfmref-systematische-review-en-meta-analyse/","published":"2018-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wojciech-drygas","type":"person","url":"https://hartvaat.nl/mensen/wojciech-drygas/","name":"Wojciech Drygas","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/05/vijf-modificeerbare-risicofactoren-en-mondiale-cv-sterfte-nejm-pure-analyse/","published":"2023-10-05"},{"url":"https://hartvaat.nl/2020/07/01/phactr1-en-fibromusculaire-dysplasie-arcadia-pol-meta-analyse/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wojciech-wanha","type":"person","url":"https://hartvaat.nl/mensen/wojciech-wanha/","name":"Wojciech Wańha","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/salamander-register-95-5-technisch-succes-bij-stand-alone-linker-hartoor-occlusi/","published":"2026-06-10"},{"url":"https://hartvaat.nl/2025/11/11/ct-angiografie-of-standaardzorg-na-pci-van-de-linker-hoofdstam/","published":"2025-11-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wojtek-wojakowski","type":"person","url":"https://hartvaat.nl/mensen/wojtek-wojakowski/","name":"Wojtek Wojakowski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/21/tavi-plus-ffr-geleide-pci-gecombineerde-benadering-onderzocht/","published":"2025-12-21"},{"url":"https://hartvaat.nl/2022/05/03/vupanorsen-en-non-hdl-cholesterol-bij-statinebehandelde-patienten-translate-timi/","published":"2022-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wolfgang-schillinger","type":"person","url":"https://hartvaat.nl/mensen/wolfgang-schillinger/","name":"Wolfgang Schillinger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wolfgang-zierhut","type":"person","url":"https://hartvaat.nl/mensen/wolfgang-zierhut/","name":"Wolfgang Zierhut","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/14/edoxaban-bij-af-met-pci-naar-acute-versus-chronische-coronaire-presentatie-entru/","published":"2020-12-14"},{"url":"https://hartvaat.nl/2019/10/12/edoxaban-versus-vka-gebaseerd-antitrombotisch-regime-na-stenting-bij-af-lancet-e/","published":"2019-10-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"won-yong-shin","type":"person","url":"https://hartvaat.nl/mensen/won-yong-shin/","name":"Won-Yong Shin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2021/03/16/duurzame-versus-biodegradeerbare-polymer-des-bij-acs-meta-analyse/","published":"2021-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"woods","type":"person","url":"https://hartvaat.nl/mensen/woods/","name":"Woods","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"},{"url":"https://hartvaat.nl/2026/04/24/verminderde-nierfunctie-verhoogt-hartfalenrisico-bij-ouderen-aspree-cohort/","published":"2026-05-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wouter-e-m-kok","type":"person","url":"https://hartvaat.nl/mensen/wouter-e-m-kok/","name":"Wouter E M Kok","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/21/pa-drukmonitoring-bij-chronisch-hartfalen-effecten-over-klinische-subgroepen/","published":"2024-08-21"},{"url":"https://hartvaat.nl/2023/10/01/trimetazidine-bij-hfpef-gerandomiseerde-cross-over-trial/","published":"2023-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wouter-r-berger","type":"person","url":"https://hartvaat.nl/mensen/wouter-r-berger/","name":"Wouter R Berger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/05/j-curve-bij-gerandomiseerde-bloeddrukstreefwaarden-sprint-experimentele-analyse/","published":"2017-12-05"},{"url":"https://hartvaat.nl/2016/09/13/ganglionplexusablatie-bij-gevorderd-atriumfibrilleren-de-afact-studie/","published":"2016-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wouter-remkes","type":"person","url":"https://hartvaat.nl/mensen/wouter-remkes/","name":"Wouter Remkes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/06/22/des-versus-bms-lancet-ipd-systematische-review-en-meta-analyse/","published":"2019-06-22"},{"url":"https://hartvaat.nl/2016/06/14/vroege-intraveneuze-betablokkade-voor-primaire-pci-bij-stemi/","published":"2016-06-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wouter-de-ruijter","type":"person","url":"https://hartvaat.nl/mensen/wouter-de-ruijter/","name":"Wouter de Ruijter","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/01/coronairangiografie-na-hartstilstand-zonder-st-elevatie-coact-1-jaarsuitkomsten/","published":"2020-12-01"},{"url":"https://hartvaat.nl/2019/04/11/coronairangiografie-na-hartstilstand-zonder-st-elevatie-nejm-coact/","published":"2019-04-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wynand-smythe","type":"person","url":"https://hartvaat.nl/mensen/wynand-smythe/","name":"Wynand Smythe","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/01/antihypertensieve-combinaties-bij-afrikaanse-patienten-creole-secundaire-analyse/","published":"2022-11-01"},{"url":"https://hartvaat.nl/2019/06/20/vergelijking-van-duale-therapieen-voor-bloeddrukverlaging-bij-afrikaanse-afrikan/","published":"2019-06-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xavier-armoiry","type":"person","url":"https://hartvaat.nl/mensen/xavier-armoiry/","name":"Xavier Armoiry","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/13/evoque-transcatheter-tricuspidalisklep-mogelijk-kosteneffectief-bij-ernstige-tr-/","published":"2026-06-22"},{"url":"https://hartvaat.nl/2018/12/13/percutaan-herstel-of-medicamenteuze-therapie-bij-secundaire-mr-nejm-mitra-fr/","published":"2018-12-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xavier-freixa","type":"person","url":"https://hartvaat.nl/mensen/xavier-freixa/","name":"Xavier Freixa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/23/korte-anticoagulatie-versus-dapt-na-laa-occlusie-devicetrombosepreventie/","published":"2025-12-23"},{"url":"https://hartvaat.nl/2024/10/01/lage-dosis-doac-versus-dapt-na-laa-occlusie-gerandomiseerde-trial/","published":"2024-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xavier-iriart","type":"person","url":"https://hartvaat.nl/mensen/xavier-iriart/","name":"Xavier Iriart","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/19/afloat-flecainide-voorkomt-af-na-pfo-sluiting-rct/","published":"2024-11-19"},{"url":"https://hartvaat.nl/2022/03/08/amulet-versus-watchman-voor-laa-sluiting-swiss-apero-gerandomiseerde-trial/","published":"2022-03-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xi-su","type":"person","url":"https://hartvaat.nl/mensen/xi-su/","name":"Xi Su","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/closed-loop-stimulatie-vermindert-ahre-s-versus-conventionele-rate-adaptieve-pac/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2017/10/17/farmaco-invasieve-strategie-met-halve-dosis-alteplase-versus-primaire-pci-bij-st/","published":"2017-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xi-zhang","type":"person","url":"https://hartvaat.nl/mensen/xi-zhang/","name":"Xi Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/05/trem-1-remming-vermindert-in-stent-neoatherosclerose-in-diermodel/","published":"2026-04-12"},{"url":"https://hartvaat.nl/2016/08/01/magnesiumsuppletie-en-bloeddruk-meta-analyse-van-dubbelblinde-placebogecontrolee/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiang-wang","type":"person","url":"https://hartvaat.nl/mensen/xiang-wang/","name":"Xiang Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/12/01/kort-slapen-6-uur-verhoogt-kans-op-hypertensie-bij-ouderen-clhls/","published":"2026-08-23"},{"url":"https://hartvaat.nl/2022/09/27/linkerbundeltakpacing-versus-biventriculaire-pacing-voor-crt-gerandomiseerde-tri/","published":"2022-09-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiangfeng-lu","type":"person","url":"https://hartvaat.nl/mensen/xiangfeng-lu/","name":"Xiangfeng Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/13/nt-probnp-en-af-risico-systematische-review-en-meta-analyse/","published":"2025-01-13"},{"url":"https://hartvaat.nl/2019/09/01/interactieve-mobiele-gezondheidsinterventie-en-bloeddrukmanagement/","published":"2019-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiangting-li","type":"person","url":"https://hartvaat.nl/mensen/xiangting-li/","name":"Xiangting Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiangyi-kong","type":"person","url":"https://hartvaat.nl/mensen/xiangyi-kong/","name":"Xiangyi Kong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xianxian-zhao","type":"person","url":"https://hartvaat.nl/mensen/xianxian-zhao/","name":"Xianxian Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/driejaarsuitkomsten-van-linker-hartoorsluiting-met-of-zonder-ablatie-record-stud/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiao-sun","type":"person","url":"https://hartvaat.nl/mensen/xiao-sun/","name":"Xiao Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaocheng-cheng","type":"person","url":"https://hartvaat.nl/mensen/xiaocheng-cheng/","name":"Xiaocheng Cheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/urinezuur-als-biomarker-maar-niet-therapeutisch-doel-bij-hartfalen-meta-analyse/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2019/10/01/sekseverschillen-bij-katheterablatie-van-af-meta-analyse/","published":"2019-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaofeng-hu","type":"person","url":"https://hartvaat.nl/mensen/xiaofeng-hu/","name":"Xiaofeng Hu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2021/05/21/extrapulmonale-vein-driver-mapping-bij-persisterend-af-bij-obese-patienten/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaogang-guo","type":"person","url":"https://hartvaat.nl/mensen/xiaogang-guo/","name":"Xiaogang Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/06/dronedaron-na-af-ablatie-gelijke-werkzaamheid-minder-bijwerkingen-dan-amiodaron/","published":"2026-05-03"},{"url":"https://hartvaat.nl/2025/01/01/varenicline-vermindert-ventriculaire-ectopie-na-myocardinfarct/","published":"2026-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaohong-gao","type":"person","url":"https://hartvaat.nl/mensen/xiaohong-gao/","name":"Xiaohong Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaohong-yang","type":"person","url":"https://hartvaat.nl/mensen/xiaohong-yang/","name":"Xiaohong Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/21/pcsk9-remming-en-geoxideerde-fosfolipiden/","published":"2021-09-21"},{"url":"https://hartvaat.nl/2017/01/17/geoxideerde-fosfolipiden-op-apob-100-en-recidiverende-ischemische-events-na-cva/","published":"2017-01-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaohui-zhao","type":"person","url":"https://hartvaat.nl/mensen/xiaohui-zhao/","name":"Xiaohui Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaojie-xie","type":"person","url":"https://hartvaat.nl/mensen/xiaojie-xie/","name":"Xiaojie Xie","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2022/08/09/vertraagde-afgifteformulering-van-ivabradine-bij-systolisch-hartfalen/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoling-wang","type":"person","url":"https://hartvaat.nl/mensen/xiaoling-wang/","name":"Xiaoling Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaolong-li","type":"person","url":"https://hartvaat.nl/mensen/xiaolong-li/","name":"Xiaolong Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/smoothened-signalering-bevordert-nierfibrose-via-autofagieremming/","published":"2026-04-10"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaomin-chen","type":"person","url":"https://hartvaat.nl/mensen/xiaomin-chen/","name":"Xiaomin Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoping-chen","type":"person","url":"https://hartvaat.nl/mensen/xiaoping-chen/","name":"Xiaoping Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/rf-renale-denervatie-bij-ongecontroleerde-hypertensie-in-china-gerandomiseerde-t/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoping-peng","type":"person","url":"https://hartvaat.nl/mensen/xiaoping-peng/","name":"Xiaoping Peng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2025/04/26/angiografie-afgeleide-ffr-versus-ivus-bij-pci-gerandomiseerde-trial/","published":"2025-04-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaopu-wang","type":"person","url":"https://hartvaat.nl/mensen/xiaopu-wang/","name":"Xiaopu Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/22/orthostatische-bloeddruk-en-intensieve-behandeling-sprint-inzichten/","published":"2022-12-22"},{"url":"https://hartvaat.nl/2021/02/01/revascularisatie-bij-ernstig-verminderde-lvef-korte-en-langetermijnuitkomsten/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoqing-peng","type":"person","url":"https://hartvaat.nl/mensen/xiaoqing-peng/","name":"Xiaoqing Peng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/01/systolische-bloeddrukamplificatie-ipd-meta-analyse/","published":"2025-09-01"},{"url":"https://hartvaat.nl/2017/08/01/nauwkeurigheid-van-manchetbloeddrukmeting-systematische-review-en-meta-analyse/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoyang-zhou","type":"person","url":"https://hartvaat.nl/mensen/xiaoyang-zhou/","name":"Xiaoyang Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/step-6-jaarsresultaten-intensieve-bloeddrukcontrole-bij-ouderen-langetermijn/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiaoyu-zhang","type":"person","url":"https://hartvaat.nl/mensen/xiaoyu-zhang/","name":"Xiaoyu Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/overgewicht-en-de-tyg-index-als-voorspellers-van-sterfte-bij-diabetes-type-2/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2021/04/01/aerobe-training-bevordert-angiogenese-en-verlaagt-bloeddruk-bij-hypertensie-exca/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ximena-reyes","type":"person","url":"https://hartvaat.nl/mensen/ximena-reyes/","name":"Ximena Reyes","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xin-li","type":"person","url":"https://hartvaat.nl/mensen/xin-li/","name":"Xin Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/06/trpm7-deficientie-beschermt-tegen-myocardiale-ischemie-reperfusieschade/","published":"2026-02-06"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xin-wan","type":"person","url":"https://hartvaat.nl/mensen/xin-wan/","name":"Xin Wan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/18/telomeerherstel-via-gentherapie-bij-cardiorenaal-syndroom-type-4/","published":"2026-02-18"},{"url":"https://hartvaat.nl/2025/06/09/remote-ischemische-preconditionering-en-nierschade-na-coronairangiografie/","published":"2025-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xin-wang","type":"person","url":"https://hartvaat.nl/mensen/xin-wang/","name":"Xin Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2020/05/01/werkplek-multicomponentinterventie-voor-hypertensie-jama-cardiology/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xin-zheng","type":"person","url":"https://hartvaat.nl/mensen/xin-zheng/","name":"Xin Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/effect-van-baduanjin-op-bloeddruk-bij-hoog-normaal-bloeddruk-gerandomiseerde-tri/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinchun-yang","type":"person","url":"https://hartvaat.nl/mensen/xinchun-yang/","name":"Xinchun Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/01/step-substudie-intensieve-bloeddrukverlaging-verbetert-lvh-bij-ouderen/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xingqiang-he","type":"person","url":"https://hartvaat.nl/mensen/xingqiang-he/","name":"Xingqiang He","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinling-liang","type":"person","url":"https://hartvaat.nl/mensen/xinling-liang/","name":"Xinling Liang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinqun-hu","type":"person","url":"https://hartvaat.nl/mensen/xinqun-hu/","name":"Xinqun Hu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/12/22/orthostatische-bloeddruk-en-intensieve-behandeling-sprint-inzichten/","published":"2022-12-22"},{"url":"https://hartvaat.nl/2021/02/01/revascularisatie-bij-ernstig-verminderde-lvef-korte-en-langetermijnuitkomsten/","published":"2021-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinru-liu","type":"person","url":"https://hartvaat.nl/mensen/xinru-liu/","name":"Xinru Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukverlaging-bij-ongediagnosticeerde-hfpef-met-hoog-risico/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xinwen-ren","type":"person","url":"https://hartvaat.nl/mensen/xinwen-ren/","name":"Xinwen Ren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/30/right-2-ambulancebloeddrukverlaging-bij-hyperacuut-cva-nejm-vervolgresultaten/","published":"2024-05-30"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xiping-xu","type":"person","url":"https://hartvaat.nl/mensen/xiping-xu/","name":"Xiping Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xuebin-cao","type":"person","url":"https://hartvaat.nl/mensen/xuebin-cao/","name":"Xuebin Cao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/nieuwe-therapeutische-mogelijkheden-voor-cholesterolverlaging-een-expertreview/","published":"2025-01-01"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xuebo-liu","type":"person","url":"https://hartvaat.nl/mensen/xuebo-liu/","name":"Xuebo Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/11/29/favor-iii-qfr-geleide-pci-verbetert-tweejaarsuitkomsten/","published":"2022-11-29"},{"url":"https://hartvaat.nl/2021/12/11/qfr-geleide-coronaire-interventie-lancet-favor-iii-china-sham-gecontroleerd/","published":"2021-12-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xueling-lu","type":"person","url":"https://hartvaat.nl/mensen/xueling-lu/","name":"Xueling Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/27/genen-voor-bloeddruk-in-de-kindertijd-voorspellen-cardiometabool-risico-op-later/","published":"2026-05-09"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xueming-wu","type":"person","url":"https://hartvaat.nl/mensen/xueming-wu/","name":"Xueming Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"},{"url":"https://hartvaat.nl/2018/12/18/ivus-versus-angiografie-geleide-des-implantatie-de-ultimate-trial/","published":"2018-12-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xuewei-cui","type":"person","url":"https://hartvaat.nl/mensen/xuewei-cui/","name":"Xuewei Cui","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/10/tirzepatide-bij-diabetes-type-2-lancet-surpass-1-fase-3/","published":"2021-07-10"},{"url":"https://hartvaat.nl/2018/11/17/ly3298176-duale-gip-glp-1-agonist-bij-diabetes-type-2-lancet-tirzepatide-fase-2/","published":"2018-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xunmei-zhou","type":"person","url":"https://hartvaat.nl/mensen/xunmei-zhou/","name":"Xunmei Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/01/voorkeur-voor-pikant-eten-versterkt-zoutwaarneming-en-vermindert-zoutinname-en-b/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/03/01/taurinesuppletie-verlaagt-bloeddruk-en-verbetert-vaatfunctie-bij-prehypertensie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"xunming-ji","type":"person","url":"https://hartvaat.nl/mensen/xunming-ji/","name":"Xunming Ji","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/sprint-accord-gepoold-bloeddrukvariabiliteit-is-even-prognostisch-als-gemiddelde/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2023/06/01/remote-ischemische-conditionering-bij-milde-hypertensie-zonder-medicatie-rct/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"y-fred-yang","type":"person","url":"https://hartvaat.nl/mensen/y-fred-yang/","name":"Y Fred Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/07/01/kbp-5074-en-bloeddruk-bij-gevorderde-ckd-block-ckd/","published":"2021-07-01"},{"url":"https://hartvaat.nl/2020/07/01/mra-bij-hypertensie-met-gevorderde-ckd-block-ckd-trial/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ya-gao","type":"person","url":"https://hartvaat.nl/mensen/ya-gao/","name":"Ya Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/luchtvervuiling-verhoogt-sterfte-door-hypertensie-case-crossover-studie-bij-2-1-/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2023/01/11/metamfetamine-geassocieerd-hartfalen-systematische-review/","published":"2023-01-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yaariv-khaykin","type":"person","url":"https://hartvaat.nl/mensen/yaariv-khaykin/","name":"Yaariv Khaykin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/01/12/early-af-2-jaar-cryoablatie-vertraagt-af-progressie-beter-dan-antiaritmica/","published":"2023-01-12"},{"url":"https://hartvaat.nl/2021/01/28/cryoablatie-of-medicatie-als-initiele-af-behandeling-nejm-stop-af-first/","published":"2021-01-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yajun-han","type":"person","url":"https://hartvaat.nl/mensen/yajun-han/","name":"Yajun Han","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-dong","type":"person","url":"https://hartvaat.nl/mensen/yan-dong/","name":"Yan Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/04/pvi-met-versus-zonder-lineaire-ablatie-bij-persisterend-af-gerandomiseerde-trial/","published":"2025-08-04"},{"url":"https://hartvaat.nl/2024/03/01/svc-isolatie-bij-paroxysmaal-af-zonder-geinduceerde-svc-aritmieen/","published":"2024-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-gao","type":"person","url":"https://hartvaat.nl/mensen/yan-gao/","name":"Yan Gao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/20/sbp-120-versus-140-mmhg-bij-hoog-cv-risico-meta-analyse-van-intensieve-behandeli/","published":"2024-07-20"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-v-sun","type":"person","url":"https://hartvaat.nl/mensen/yan-v-sun/","name":"Yan V Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/01/genoomwijde-analyse-identificeert-nieuwe-mi-gevoeligheidsloci/","published":"2021-03-01"},{"url":"https://hartvaat.nl/2020/07/01/nieuwe-dna-methyleringsloci-voor-bloeddruk-erfelijkheid-en-genexpressie/","published":"2020-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yan-yu","type":"person","url":"https://hartvaat.nl/mensen/yan-yu/","name":"Yan Yu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yanfang-zhao","type":"person","url":"https://hartvaat.nl/mensen/yanfang-zhao/","name":"Yanfang Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/07/26/chinees-hartgezond-dieet-verlaagt-bloeddruk-effectief-gerandomiseerde-trial/","published":"2022-07-26"},{"url":"https://hartvaat.nl/2020/07/14/twee-stent-versus-provisional-stenting-bij-complexe-bifurcatielaesies-multicente/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-li","type":"person","url":"https://hartvaat.nl/mensen/yang-li/","name":"Yang Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/06/09/remote-ischemische-preconditionering-en-nierschade-na-coronairangiografie/","published":"2025-06-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-pan","type":"person","url":"https://hartvaat.nl/mensen/yang-pan/","name":"Yang Pan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-shen","type":"person","url":"https://hartvaat.nl/mensen/yang-shen/","name":"Yang Shen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/kanttekeningen-bij-statistische-analyse-van-nhanes-data-en-orale-microbioomstudi/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2020/05/01/werkplek-multicomponentinterventie-voor-hypertensie-jama-cardiology/","published":"2020-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-xu","type":"person","url":"https://hartvaat.nl/mensen/yang-xu/","name":"Yang Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/24/glp-1-agonisten-versus-dpp-4-remmers-en-sglt2-remmers-bij-hartfalenrisico/","published":"2026-02-24"},{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yang-zhao","type":"person","url":"https://hartvaat.nl/mensen/yang-zhao/","name":"Yang Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2017/05/01/lichamelijke-activiteit-en-incidentie-van-hypertensie-dosis-responsemeta-analyse/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yangyang-tang","type":"person","url":"https://hartvaat.nl/mensen/yangyang-tang/","name":"Yangyang Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/intensieve-bloeddrukverlaging-bij-ongediagnosticeerde-hfpef-met-hoog-risico/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2025/06/13/frailteit-en-intensieve-bloeddrukcontrole-bij-diabetes/","published":"2025-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yanhong-tang","type":"person","url":"https://hartvaat.nl/mensen/yanhong-tang/","name":"Yanhong Tang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/10/21/shensong-yangxin-voorkomt-af-recidief-na-ablatie-bij-persisterend-af/","published":"2024-10-21"},{"url":"https://hartvaat.nl/2021/05/21/katheterablatie-versus-medicatie-bij-persisterend-en-langdurig-persisterend-af-l/","published":"2021-05-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yannick-bejot","type":"person","url":"https://hartvaat.nl/mensen/yannick-bejot/","name":"Yannick Béjot","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/01/02/vergelijking-van-twee-ldl-streefwaarden-na-ischemisch-cva-nejm-tst/","published":"2020-01-02"},{"url":"https://hartvaat.nl/2017/09/14/pfo-sluiting-of-antistolling-versus-antiplaatjestherapie-na-cva-nejm-reduce/","published":"2017-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yannis-manios","type":"person","url":"https://hartvaat.nl/mensen/yannis-manios/","name":"Yannis Manios","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","published":"2023-04-21"},{"url":"https://hartvaat.nl/2019/05/07/zwangerschapsgewichtstoename-en-maternale-en-neonatale-uitkomsten-jama-meta-anal/","published":"2019-05-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yanzhe-wang","type":"person","url":"https://hartvaat.nl/mensen/yanzhe-wang/","name":"Yanzhe Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yaping-zeng","type":"person","url":"https://hartvaat.nl/mensen/yaping-zeng/","name":"Yaping Zeng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/07/04/arteriele-remodellering-na-bioresorbeerbare-scaffolds-versus-metallic-stents/","published":"2017-07-04"},{"url":"https://hartvaat.nl/2016/09/06/pci-versus-cabg-bij-onbeschermde-hoofdstamziekte-uitkomsten/","published":"2016-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yaqin-liu","type":"person","url":"https://hartvaat.nl/mensen/yaqin-liu/","name":"Yaqin Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/01/intensieve-bloeddrukcontrole-en-cognitieve-functie-gerandomiseerde-trial/","published":"2026-03-01"},{"url":"https://hartvaat.nl/2025/10/28/esprit-intensieve-bloeddrukverlaging-en-retinale-microvasculatuur/","published":"2025-10-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasuchika-takeishi","type":"person","url":"https://hartvaat.nl/mensen/yasuchika-takeishi/","name":"Yasuchika Takeishi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/16/winteropname-voor-acuut-hartfalen-gaat-gepaard-met-hogere-sterfte/","published":"2026-07-14"},{"url":"https://hartvaat.nl/2018/01/16/hoog-sensitief-troponine-t-bij-chronisch-hartfalen-individuele-patientdata-meta-/","published":"2018-01-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasuhide-asaumi","type":"person","url":"https://hartvaat.nl/mensen/yasuhide-asaumi/","name":"Yasuhide Asaumi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasuhiro-honda","type":"person","url":"https://hartvaat.nl/mensen/yasuhiro-honda/","name":"Yasuhiro Honda","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/22/chirurgisch-unroofing-van-myocardiale-brug-verbetert-angina-klachten-langdurig-m/","published":"2026-06-07"},{"url":"https://hartvaat.nl/2026/01/06/caviar-alirocumab-bij-cardiale-allograft-vasculopathie-na-harttransplantatie/","published":"2026-01-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasuhiro-sasaki","type":"person","url":"https://hartvaat.nl/mensen/yasuhiro-sasaki/","name":"Yasuhiro Sasaki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2019/01/29/oac-met-of-zonder-antiplaatjes-bij-af-na-pci-1-jaar-gerandomiseerde-trial/","published":"2019-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yasuteru-yamauchi","type":"person","url":"https://hartvaat.nl/mensen/yasuteru-yamauchi/","name":"Yasuteru Yamauchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2016/12/27/hotballoon-pulmonaalvene-ablatie-bij-paroxysmaal-af-japanse-multicenter-trial/","published":"2016-12-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yaver-bashir","type":"person","url":"https://hartvaat.nl/mensen/yaver-bashir/","name":"Yaver Bashir","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/dagopname-na-af-ablatie-even-veilig-als-overnachting-meta-analyse/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2018/01/01/endocardiale-linkerkamer-pacing-voor-crt-systematische-review-en-meta-analyse/","published":"2018-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yawei-xu","type":"person","url":"https://hartvaat.nl/mensen/yawei-xu/","name":"Yawei Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/16/sluiting-van-het-linker-hartoor-versus-doac-s-na-longembolie/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-chen","type":"person","url":"https://hartvaat.nl/mensen/yi-chen/","name":"Yi Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/sophocarpine-beschermt-tegen-pulmonale-hypertensie-in-preklinische-modellen/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2021/01/05/hoog-dosis-versus-standaarddosis-griepvaccin-en-mortaliteit-bij-ouderen-jama/","published":"2021-01-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-pan","type":"person","url":"https://hartvaat.nl/mensen/yi-pan/","name":"Yi Pan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/09/semaglutide-stimuleert-anti-inflammatoire-stamcelflux-vanuit-beenmerg/","published":"2026-03-09"},{"url":"https://hartvaat.nl/2023/06/01/igfbp7-en-lv-massaregressie-met-empagliflozine-empa-heart-subanalyse/","published":"2023-06-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-wang","type":"person","url":"https://hartvaat.nl/mensen/yi-wang/","name":"Yi Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/01/kosteneffectiviteit-van-cascadescreening-voor-familiaire-hypercholesterolemie-ti/","published":"2026-04-01"},{"url":"https://hartvaat.nl/2026/01/26/isolinderalacton-remt-nlrp3-inflammasoomactivatie-bij-atherosclerose/","published":"2026-01-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-zhao","type":"person","url":"https://hartvaat.nl/mensen/yi-zhao/","name":"Yi Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-gang-li","type":"person","url":"https://hartvaat.nl/mensen/yi-gang-li/","name":"Yi-Gang Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/cryoablatie-versus-radiofrequentieablatie-bij-paroxysmaal-af-systematische-revie/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/04/01/rol-van-adenosine-geleide-pvi-bij-katheterablatie-voor-af-meta-analyse/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-he-chen","type":"person","url":"https://hartvaat.nl/mensen/yi-he-chen/","name":"Yi-He Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/05/01/cryoablatie-versus-radiofrequentieablatie-bij-paroxysmaal-af-systematische-revie/","published":"2017-05-01"},{"url":"https://hartvaat.nl/2017/04/01/rol-van-adenosine-geleide-pvi-bij-katheterablatie-voor-af-meta-analyse/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yi-hsin-chan","type":"person","url":"https://hartvaat.nl/mensen/yi-hsin-chan/","name":"Yi-Hsin Chan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/19/cardiovasculair-renaal-metabool-samenspel-bij-patienten-met-atriumfibrilleren/","published":"2026-02-19"},{"url":"https://hartvaat.nl/2023/10/05/rivaroxaban-dosering-bij-af-on-label-versus-off-label-in-azie-en-niet-azie/","published":"2023-10-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yifan-xu","type":"person","url":"https://hartvaat.nl/mensen/yifan-xu/","name":"Yifan Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/ischemia-invasief-versus-conservatief-bij-chronische-totale-occlusie/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2023/01/03/ischemia-langetermijn-geen-overlevingsverschil-invasief-versus-conservatief-bij-/","published":"2023-01-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yifang-yuan","type":"person","url":"https://hartvaat.nl/mensen/yifang-yuan/","name":"Yifang Yuan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/01/consistentie-van-bloeddrukrespons-op-kaliumverrijkt-zout-ssass-subanalyse/","published":"2026-01-01"},{"url":"https://hartvaat.nl/2024/02/20/zoutvervanger-voorkomt-hypertensie-bij-normotensieve-volwassenen/","published":"2024-02-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yifei-zhong","type":"person","url":"https://hartvaat.nl/mensen/yifei-zhong/","name":"Yifei Zhong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/31/steilere-egfr-daling-voorspelt-nierfalen-en-cardiovasculaire-mortaliteit-narrati/","published":"2026-08-14"},{"url":"https://hartvaat.nl/2026/12/01/cardiometabole-index-en-sarcopenie-voorspellen-sterfte-bij-chronische-nierziekte/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yigal-m-pinto","type":"person","url":"https://hartvaat.nl/mensen/yigal-m-pinto/","name":"Yigal M Pinto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/06/laminopathieen-natuurlijk-beloop-en-voorspelmodel-voor-hartfalen/","published":"2026-03-21"},{"url":"https://hartvaat.nl/2018/04/17/nt-probnp-geleide-therapie-bij-acuut-gedecompenseerd-hartfalen-prima-ii/","published":"2018-04-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yilong-wang","type":"person","url":"https://hartvaat.nl/mensen/yilong-wang/","name":"Yilong Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/02/01/antihypertensieve-behandeling-na-acuut-ischemisch-cva-continueren-of-niet/","published":"2026-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yimin-cui","type":"person","url":"https://hartvaat.nl/mensen/yimin-cui/","name":"Yimin Cui","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"},{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ying-huang","type":"person","url":"https://hartvaat.nl/mensen/ying-huang/","name":"Ying Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/07/01/natriumreductie-verhoogt-korte-keten-vetzuren-bij-onbehandelde-hypertensie/","published":"2020-07-01"},{"url":"https://hartvaat.nl/2019/07/01/natriumreductie-metaboloom-en-cv-risico-bij-onbehandelde-zwarte-hypertensie/","published":"2019-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ying-lu","type":"person","url":"https://hartvaat.nl/mensen/ying-lu/","name":"Ying Lu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/04/01/gdmt-en-uitkomsten-in-ischemia-trial/","published":"2025-04-01"},{"url":"https://hartvaat.nl/2018/05/19/des-versus-bms-in-veneuze-bypass-grafts-lancet-dubbelblinde-trial/","published":"2018-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yinggan-zheng","type":"person","url":"https://hartvaat.nl/mensen/yinggan-zheng/","name":"Yinggan Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/01/remote-ischemische-conditionering-bij-stemi-registergebaseerde-gerandomiseerde-t/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2016/04/01/ischemisch-risicogebied-en-reperfusiemethode-bij-stemi-klinische-implicaties/","published":"2016-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yingqing-feng","type":"person","url":"https://hartvaat.nl/mensen/yingqing-feng/","name":"Yingqing Feng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yingsha-li","type":"person","url":"https://hartvaat.nl/mensen/yingsha-li/","name":"Yingsha Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/12/01/voorkeur-voor-pikant-eten-versterkt-zoutwaarneming-en-vermindert-zoutinname-en-b/","published":"2017-12-01"},{"url":"https://hartvaat.nl/2016/03/01/taurinesuppletie-verlaagt-bloeddruk-en-verbetert-vaatfunctie-bij-prehypertensie/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yining-huang","type":"person","url":"https://hartvaat.nl/mensen/yining-huang/","name":"Yining Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/03/02/intensieve-bloeddrukverlaging-bij-iv-trombolyse-voor-acuut-cva-lancet-enchanted/","published":"2019-03-02"},{"url":"https://hartvaat.nl/2016/06/16/lage-versus-standaarddosis-alteplase-bij-acuut-ischemisch-cva-nejm-enchanted-tri/","published":"2016-06-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yishu-liu","type":"person","url":"https://hartvaat.nl/mensen/yishu-liu/","name":"Yishu Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yitong-ma","type":"person","url":"https://hartvaat.nl/mensen/yitong-ma/","name":"Yitong Ma","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/01/18/magnetisch-gecontroleerde-capsule-endoscopie-voor-antiplaatjestherapie-gi-schade/","published":"2022-01-18"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yizhe-xu","type":"person","url":"https://hartvaat.nl/mensen/yizhe-xu/","name":"Yizhe Xu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/28/prevent-vergelijkingen-voor-intensieve-versus-standaard-bloeddrukcontrole/","published":"2025-10-28"},{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yohei-ohno","type":"person","url":"https://hartvaat.nl/mensen/yohei-ohno/","name":"Yohei Ohno","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yolande-appelman","type":"person","url":"https://hartvaat.nl/mensen/yolande-appelman/","name":"Yolande Appelman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/26/esc-consensus-vrouwenhartcentra-whc-als-nieuw-zorgmodel-in-europa/","published":"2026-05-28"},{"url":"https://hartvaat.nl/2026/04/28/geen-sekseverschillen-in-werkzaamheid-van-hartfalenmedicatie-meta-analyse-van-13/","published":"2026-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yonathan-freund","type":"person","url":"https://hartvaat.nl/mensen/yonathan-freund/","name":"Yonathan Freund","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/01/steroidstoot-bij-acuut-hartfalen-kwaliteit-van-leven-cortahf-inzichten/","published":"2025-06-01"},{"url":"https://hartvaat.nl/2020/11/17/seh-zorgbundel-en-30-daags-ontslag-en-overleving-bij-oudere-hf-patienten-jama/","published":"2020-11-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yong-seog-oh","type":"person","url":"https://hartvaat.nl/mensen/yong-seog-oh/","name":"Yong-Seog Oh","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/12/off-label-onderdosering-edoxaban-bij-af-en-systemische-embolieen/","published":"2026-03-12"},{"url":"https://hartvaat.nl/2024/12/05/edoxaban-bij-af-en-stabiel-coronairlijden-antitrombotische-monotherapie/","published":"2024-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yongwhan-lim","type":"person","url":"https://hartvaat.nl/mensen/yongwhan-lim/","name":"Yongwhan Lim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/09/06/directe-versus-gestageerde-complete-revascularisatie-tijdens-index-opname-bij-st/","published":"2025-09-06"},{"url":"https://hartvaat.nl/2023/11/14/early-unload-vroege-lv-ontlading-bij-va-ecmo-gerandomiseerde-trial/","published":"2023-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yongwhi-park","type":"person","url":"https://hartvaat.nl/mensen/yongwhi-park/","name":"Yongwhi Park","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/03/14/matige-statine-plus-ezetimibe-versus-hoge-dosis-statine-bij-diabetes-en-ascvd/","published":"2023-03-14"},{"url":"https://hartvaat.nl/2016/05/03/gemalen-prasugrel-bij-stemi-met-primaire-pci-de-crush-studie/","published":"2016-05-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yoshiharu-higuchi","type":"person","url":"https://hartvaat.nl/mensen/yoshiharu-higuchi/","name":"Yoshiharu Higuchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/ldl-cholesterol-en-neoatherosclerose-na-stemi-secundaire-analyse/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2025/08/01/biodegradeerbare-versus-duurzame-polymeer-ees-langetermijn-neoatherosclerose/","published":"2025-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yosuke-miyazaki","type":"person","url":"https://hartvaat.nl/mensen/yosuke-miyazaki/","name":"Yosuke Miyazaki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/01/ct-coronairangiografie-voor-heart-team-besluitvorming-bij-multivatenlijden/","published":"2018-11-01"},{"url":"https://hartvaat.nl/2017/09/01/late-trombotische-events-na-bioresorbeerbare-scaffold-meta-analyse-van-gerandomi/","published":"2017-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"you-jeong-ki","type":"person","url":"https://hartvaat.nl/mensen/you-jeong-ki/","name":"You-Jeong Ki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/26/flavour-langetermijn-ffr-versus-ivus-voor-pci-begeleiding/","published":"2025-08-26"},{"url":"https://hartvaat.nl/2022/09/01/flavour-ffr-versus-ivus-voor-pci-beslissingen-bij-coronairlijden/","published":"2022-09-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"youbao-li","type":"person","url":"https://hartvaat.nl/mensen/youbao-li/","name":"Youbao Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/08/01/foliumzuurtherapie-en-nieuwe-proteinurie-bij-chinese-hypertensieve-patienten-csp/","published":"2017-08-01"},{"url":"https://hartvaat.nl/2017/04/01/optimale-systolische-bloeddruk-voor-primaire-cva-preventie-bij-hypertensie-csppt/","published":"2017-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"youhua-liu","type":"person","url":"https://hartvaat.nl/mensen/youhua-liu/","name":"Youhua Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/27/smoothened-signalering-bevordert-nierfibrose-via-autofagieremming/","published":"2026-04-10"},{"url":"https://hartvaat.nl/2026/02/16/fibrilline-1-is-een-nieuw-ligand-van-de-egf-receptor-dat-mesangiumcellen-activee/","published":"2026-02-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-won-yoon","type":"person","url":"https://hartvaat.nl/mensen/young-won-yoon/","name":"Young Won Yoon","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/01/angiografie-versus-ivus-voor-des-implantatie-gerandomiseerde-trial/","published":"2024-05-01"},{"url":"https://hartvaat.nl/2023/10/17/octivus-oct-geleide-versus-ivus-geleide-pci-non-inferioriteit-bevestigd/","published":"2023-10-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"young-keun-ahn","type":"person","url":"https://hartvaat.nl/mensen/young-keun-ahn/","name":"Young-Keun Ahn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/05/04/prevent-preventieve-pci-versus-medicatie-bij-kwetsbare-coronaire-plaques-lancet/","published":"2024-05-04"},{"url":"https://hartvaat.nl/2019/04/02/pci-bij-chronische-totale-occlusie-gerandomiseerde-decision-cto-trial/","published":"2019-04-02"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"youngsook-choi","type":"person","url":"https://hartvaat.nl/mensen/youngsook-choi/","name":"Youngsook Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/07/16/edoxaban-versus-warfarine-bij-af-met-leverziekte-engage-af-timi-48/","published":"2019-07-16"},{"url":"https://hartvaat.nl/2016/09/13/edoxaban-versus-warfarine-bij-af-patienten-met-valrisico-engage-af-timi-48-analy/","published":"2016-09-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"youren-chen","type":"person","url":"https://hartvaat.nl/mensen/youren-chen/","name":"Youren Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/cumulatieve-blootstelling-aan-cardiometabole-index-en-risico-op-hartfalen/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yshai-yavin","type":"person","url":"https://hartvaat.nl/mensen/yshai-yavin/","name":"Yshai Yavin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/27/canagliflozine-bij-diabetes-type-2-met-ckd-primaire-en-secundaire-preventie/","published":"2019-08-27"},{"url":"https://hartvaat.nl/2019/06/13/canagliflozine-en-renale-uitkomsten-bij-diabetes-type-2-met-nefropathie-nejm-cre/","published":"2019-06-13"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-bai","type":"person","url":"https://hartvaat.nl/mensen/yu-bai/","name":"Yu Bai","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"},{"url":"https://hartvaat.nl/2023/03/01/diastolische-bloeddruk-en-cognitie-bij-intensieve-behandeling-sprint-mind/","published":"2023-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-cao","type":"person","url":"https://hartvaat.nl/mensen/yu-cao/","name":"Yu Cao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/06/01/remote-ischemische-conditionering-bij-milde-hypertensie-zonder-medicatie-rct/","published":"2023-06-01"},{"url":"https://hartvaat.nl/2020/08/01/antidiabetica-en-cardiovasculaire-geneeskunde-meta-analyse-en-perspectief/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-du","type":"person","url":"https://hartvaat.nl/mensen/yu-du/","name":"Yu Du","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","published":"2023-08-12"},{"url":"https://hartvaat.nl/2022/11/26/triple-gip-glp-1-glucagonreceptoragonist-bij-type-2-diabetes-fase-1b/","published":"2022-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-horiuchi","type":"person","url":"https://hartvaat.nl/mensen/yu-horiuchi/","name":"Yu Horiuchi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/13/tubulaire-nierschade-hangt-samen-met-natriumretentie-en-diureticarespons-bij-acu/","published":"2026-03-13"},{"url":"https://hartvaat.nl/2024/11/08/premier-in-hospital-start-van-sacubitril-valsartan-bij-acuut-hartfalen/","published":"2024-11-08"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-kataoka","type":"person","url":"https://hartvaat.nl/mensen/yu-kataoka/","name":"Yu Kataoka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/24/lp-a-japan-verhoogd-lp-a-blijft-risicovol-ondanks-ldl-onder-55-mg-dl/","published":"2026-06-05"},{"url":"https://hartvaat.nl/2026/01/12/lipide-inhoud-in-verkalkte-plaques-kenmerken-en-respons-op-lage-ldl-c/","published":"2026-01-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-yamamoto","type":"person","url":"https://hartvaat.nl/mensen/yu-yamamoto/","name":"Yu Yamamoto","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/21/prompt-ahf-epd-alerts-verbeteren-hartfalenmedicatie-bij-ontslag/","published":"2023-10-21"},{"url":"https://hartvaat.nl/2022/06/07/elektronische-alerts-verbeteren-hartfalenbehandeling-in-de-polikliniek/","published":"2022-06-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yu-ki-iwasaki","type":"person","url":"https://hartvaat.nl/mensen/yu-ki-iwasaki/","name":"Yu-Ki Iwasaki","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/07/crrf-peaf-cryoballon-versus-rf-ablatie-bij-persisterend-af/","published":"2025-11-07"},{"url":"https://hartvaat.nl/2021/10/01/empagliflozine-en-nierprotectie-bij-acuut-mi-met-diabetes-pilot/","published":"2021-10-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuan-fang","type":"person","url":"https://hartvaat.nl/mensen/yuan-fang/","name":"Yuan Fang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/16/apolipoproteine-c3-verergert-vaatverkalking-via-ferroptose-bij-chronisch-nierfal/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2026/02/11/bloeddruk-voor-zwangerschap-en-ivf-uitkomsten/","published":"2026-02-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuanyuan-shi","type":"person","url":"https://hartvaat.nl/mensen/yuanyuan-shi/","name":"Yuanyuan Shi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/12/31/inter-enkel-bloeddrukverschil-correleert-met-microalbuminurie-bij-hypertensiepat/","published":"2026-08-17"},{"url":"https://hartvaat.nl/2017/05/01/lichamelijke-activiteit-en-incidentie-van-hypertensie-dosis-responsemeta-analyse/","published":"2017-05-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yue-qiao","type":"person","url":"https://hartvaat.nl/mensen/yue-qiao/","name":"Yue Qiao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/sprint-accord-gepoold-bloeddrukvariabiliteit-is-even-prognostisch-als-gemiddelde/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2026/05/14/bloeddrukvariabiliteit-sprint-accord-ipd-meta-even-prognostisch-als-gemiddelde-b/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yue-xing","type":"person","url":"https://hartvaat.nl/mensen/yue-xing/","name":"Yue Xing","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/07/31/steilere-egfr-daling-voorspelt-nierfalen-en-cardiovasculaire-mortaliteit-narrati/","published":"2026-08-14"},{"url":"https://hartvaat.nl/2026/12/01/cardiometabole-index-en-sarcopenie-voorspellen-sterfte-bij-chronische-nierziekte/","published":"2026-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuejin-yang","type":"person","url":"https://hartvaat.nl/mensen/yuejin-yang/","name":"Yuejin Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/10/24/cts-ami-tongxinluo-bij-acuut-mi-jama-mega-trial/","published":"2023-10-24"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuesong-pan","type":"person","url":"https://hartvaat.nl/mensen/yuesong-pan/","name":"Yuesong Pan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/antihypertensieve-behandeling-na-acuut-ischemisch-cva-continueren-of-niet/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2026/01/01/insulineresistentie-en-bloeddrukcontrole-op-cognitieve-uitkomsten/","published":"2026-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuetsu-kikuta","type":"person","url":"https://hartvaat.nl/mensen/yuetsu-kikuta/","name":"Yuetsu Kikuta","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/ifr-versus-ffr-bij-diabetespatienten-jama-cardiology/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2017/05/11/ifr-of-ffr-bij-pci-nejm-define-flair/","published":"2017-05-11"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yufeng-li","type":"person","url":"https://hartvaat.nl/mensen/yufeng-li/","name":"Yufeng Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"},{"url":"https://hartvaat.nl/2016/08/01/magnesiumsuppletie-en-bloeddruk-meta-analyse-van-dubbelblinde-placebogecontrolee/","published":"2016-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuhong-zhang","type":"person","url":"https://hartvaat.nl/mensen/yuhong-zhang/","name":"Yuhong Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yujie-zhao","type":"person","url":"https://hartvaat.nl/mensen/yujie-zhao/","name":"Yujie Zhao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/06/04/sglt2-remmers-en-mace-smart-c-collaboratieve-mega-meta-analyse/","published":"2024-06-04"},{"url":"https://hartvaat.nl/2020/04/07/mobiele-gezondheidstechnologie-voor-af-zorg/","published":"2020-04-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuk-law","type":"person","url":"https://hartvaat.nl/mensen/yuk-law/","name":"Yuk Law","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/08/01/nt-probnp-veranderingen-en-klinische-uitkomsten-bij-pediatrisch-hartfalen/","published":"2025-08-01"},{"url":"https://hartvaat.nl/2024/11/26/panorama-hf-sacubitril-valsartan-bij-pediatrisch-hartfalen-nejm/","published":"2024-11-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuko-kiyohara","type":"person","url":"https://hartvaat.nl/mensen/yuko-kiyohara/","name":"Yuko Kiyohara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/01/07/optimale-strategie-voor-complete-revascularisatie-bij-stemi-met-meervatslijden-m/","published":"2025-01-07"},{"url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","published":"2023-12-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuko-y-palesch","type":"person","url":"https://hartvaat.nl/mensen/yuko-y-palesch/","name":"Yuko Y Palesch","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/07/19/clopidogrel-plus-aspirine-bij-acuut-ischemisch-cva-en-hoogrisico-tia-nejm-point/","published":"2018-07-19"},{"url":"https://hartvaat.nl/2016/09/15/intensieve-bloeddrukverlaging-bij-acute-hersenbloeding-nejm-atach-2-trial/","published":"2016-09-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuli-huang","type":"person","url":"https://hartvaat.nl/mensen/yuli-huang/","name":"Yuli Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/06/09/remote-ischemische-preconditionering-en-nierschade-na-coronairangiografie/","published":"2025-06-09"},{"url":"https://hartvaat.nl/2021/04/01/canagliflozine-naar-diureticagebruik-canvas-post-hoc-analyse/","published":"2021-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuliya-lytvyn","type":"person","url":"https://hartvaat.nl/mensen/yuliya-lytvyn/","name":"Yuliya Lytvyn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/01/dapagliflozine-bij-cv-risico-met-zonder-diabetes-cardiorenale-effecten/","published":"2026-02-01"},{"url":"https://hartvaat.nl/2022/08/09/renale-en-vasculaire-effecten-van-gecombineerde-sglt2-en-ace-remming/","published":"2022-08-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yumei-xue","type":"person","url":"https://hartvaat.nl/mensen/yumei-xue/","name":"Yumei Xue","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/09/nieuw-bifasisch-pfa-systeem-versus-thermale-ablatie-bij-paroxysmaal-af/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2016/01/01/katheterablatie-herstelt-verlaagde-plasma-mir-409-3p-en-mir-432-bij-atriumfibril/","published":"2016-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yumin-zhang","type":"person","url":"https://hartvaat.nl/mensen/yumin-zhang/","name":"Yumin Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/11/12/recaticimab-als-toevoeging-aan-statines-fase-3-remain-2/","published":"2024-11-12"},{"url":"https://hartvaat.nl/2024/11/12/recaticimab-monotherapie-bij-niet-familiaire-hypercholesterolemie-fase-3-remain-/","published":"2024-11-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yun-gi-kim","type":"person","url":"https://hartvaat.nl/mensen/yun-gi-kim/","name":"Yun Gi Kim","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/10/13/gecombineerde-epicardiale-en-endocardiale-redo-ablatie-bij-persisterend-af/","published":"2022-10-13"},{"url":"https://hartvaat.nl/2019/04/01/lineaire-versus-focale-cfae-ablatie-bij-niet-paroxysmaal-af/","published":"2019-04-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yun-seok-choi","type":"person","url":"https://hartvaat.nl/mensen/yun-seok-choi/","name":"Yun Seok Choi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/02/01/talos-ami-dapt-de-escalatie-veilig-bij-mi-met-hoog-ischemisch-risico/","published":"2024-02-01"},{"url":"https://hartvaat.nl/2021/10/09/ongeleide-de-escalatie-van-ticagrelor-naar-clopidogrel-na-mi-met-pci-lancet-talo/","published":"2021-10-09"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yun-song","type":"person","url":"https://hartvaat.nl/mensen/yun-song/","name":"Yun Song","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/05/15/trombocytenaantal-beinvloedt-werkzaamheid-van-foliumzuur-bij-cva-preventie/","published":"2018-05-15"},{"url":"https://hartvaat.nl/2016/07/01/polsgolfsnelheid-en-bloeddrukcontrole-als-onafhankelijke-voorspellers-van-cva-bi/","published":"2016-07-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yunke-li","type":"person","url":"https://hartvaat.nl/mensen/yunke-li/","name":"Yunke Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/07/01/interact3-bundeled-care-bij-acute-intracerebrale-bloeding-lancet/","published":"2023-07-01"},{"url":"https://hartvaat.nl/2022/11/05/enchanted2-mt-intensieve-bloeddrukverlaging-na-trombectomie-bij-cva-is-schadelij/","published":"2022-11-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yunli-shen","type":"person","url":"https://hartvaat.nl/mensen/yunli-shen/","name":"Yunli Shen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/19/memantine-remt-premature-atriumcontracties-in-fase-2-trial-nieuw-aangrijpingspun/","published":"2026-04-22"},{"url":"https://hartvaat.nl/2025/01/01/varenicline-vermindert-ventriculaire-ectopie-na-myocardinfarct/","published":"2026-03-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuping-dong","type":"person","url":"https://hartvaat.nl/mensen/yuping-dong/","name":"Yuping Dong","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/12/10/evinacumab-bij-refractaire-hypercholesterolemie-nejm/","published":"2020-12-10"},{"url":"https://hartvaat.nl/2020/07/14/alirocumab-bij-homozygoot-fh-odyssey-hofh/","published":"2020-07-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuquan-he","type":"person","url":"https://hartvaat.nl/mensen/yuquan-he/","name":"Yuquan He","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2025/05/20/angptl3-antilichaam-bij-suboptimaal-gecontroleerde-hyperlipidemie-fase-2/","published":"2025-05-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuri-karpov","type":"person","url":"https://hartvaat.nl/mensen/yuri-karpov/","name":"Yuri Karpov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/03/alirocumab-bij-polyvasculaire-ziekte-na-acs-odyssey-outcomes/","published":"2019-09-03"},{"url":"https://hartvaat.nl/2017/04/20/cardiovasculaire-werkzaamheid-en-veiligheid-van-bococizumab-bij-hoogrisicopatien/","published":"2017-04-20"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yusuke-yakushiji","type":"person","url":"https://hartvaat.nl/mensen/yusuke-yakushiji/","name":"Yusuke Yakushiji","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/03/03/prasugrel-vs-clopidogrel-invloed-van-patientkenmerken-op-trombocytenremming-bij-/","published":"2026-04-12"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yuzhong-wu","type":"person","url":"https://hartvaat.nl/mensen/yuzhong-wu/","name":"Yuzhong Wu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/07/14/depressietrajecten-bij-hfpef-impact-op-uitkomsten/","published":"2025-07-14"},{"url":"https://hartvaat.nl/2021/05/05/bloeddrukvariabiliteit-en-uitkomsten-bij-hfpef/","published":"2021-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yves-guyomar","type":"person","url":"https://hartvaat.nl/mensen/yves-guyomar/","name":"Yves Guyomar","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/10/31/vrouwen-met-persisterend-af-pvi-alleen-is-onvoldoende/","published":"2025-10-31"},{"url":"https://hartvaat.nl/2024/10/03/uitgebreide-versus-standaard-remote-monitoring-bij-crt-en-hartfalen/","published":"2024-10-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yves-vandekerckhove","type":"person","url":"https://hartvaat.nl/mensen/yves-vandekerckhove/","name":"Yves Vandekerckhove","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/08/01/eenvoudige-techniek-voor-pvi-van-linker-longvenen-gerandomiseerde-studie/","published":"2019-08-01"},{"url":"https://hartvaat.nl/2018/04/21/pvi-met-versus-zonder-antiaritmica-bij-recidiverend-af-powder-af/","published":"2018-04-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yvonne-doring","type":"person","url":"https://hartvaat.nl/mensen/yvonne-doring/","name":"Yvonne Döring","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/03/galectine-1-herprogrammeert-macrofagen-en-moduleert-t-celimmuniteit-bij-atherosc/","published":"2025-12-03"},{"url":"https://hartvaat.nl/2022/02/10/propionaat-vermindert-atherosclerose-via-immuunregulatie-van-intestinaal-cholest/","published":"2022-02-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"yvonne-t-van-der-schouw","type":"person","url":"https://hartvaat.nl/mensen/yvonne-t-van-der-schouw/","name":"Yvonne T van der Schouw","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/02/14/gelijkstelling-van-vier-cv-risicoalgoritmen-na-hercalibratie-ipd-meta-analyse/","published":"2019-02-14"},{"url":"https://hartvaat.nl/2016/10/04/ldl-cholesterolverlagende-genetische-varianten-en-risico-op-diabetes-type-2-jama/","published":"2016-10-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zahi-a-fayad","type":"person","url":"https://hartvaat.nl/mensen/zahi-a-fayad/","name":"Zahi A Fayad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/01/persisterende-arteriele-wandinflammatie-bij-verhoogd-lp-a-ondanks-lage-ldl/","published":"2019-09-01"},{"url":"https://hartvaat.nl/2016/10/18/canakinumab-en-arteriele-effecten-bij-atherosclerose-met-diabetes-of-glucosetole/","published":"2016-10-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zahid-ahmad","type":"person","url":"https://hartvaat.nl/mensen/zahid-ahmad/","name":"Zahid Ahmad","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/29/nla-consensusupdate-familiaire-hypercholesterolemie-screening-diagnostiek-en-beh/","published":"2026-01-29"},{"url":"https://hartvaat.nl/2019/08/06/angptl3-remming-met-monoklonaal-antilichaam-verlaagt-triglyceriden/","published":"2019-08-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zaid-sabti","type":"person","url":"https://hartvaat.nl/mensen/zaid-sabti/","name":"Zaid Sabti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"},{"url":"https://hartvaat.nl/2017/11/21/hoog-sensitief-troponine-i-en-uitkomsten-bij-verdenking-acs-jama-studie/","published":"2017-11-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zaneta-petrulioniene","type":"person","url":"https://hartvaat.nl/mensen/zaneta-petrulioniene/","name":"Zaneta Petrulioniene","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/eas-fhsc-wereldwijd-onderzoek-toont-grote-variatie-in-genetische-fh-diagnostiek-/","published":"2026-06-04"},{"url":"https://hartvaat.nl/2026/05/24/eas-consensus-wereldwijde-harmonisatie-van-lipidenklinieken/","published":"2026-06-04"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zarko-calovic","type":"person","url":"https://hartvaat.nl/mensen/zarko-calovic/","name":"Zarko Calovic","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/linkerbundeltakpacing-versus-rechterventrikel-pacing-na-tavi/","published":"2026-03-03"},{"url":"https://hartvaat.nl/2026/02/03/semaglutide-als-aanvulling-op-katheterablatie-bij-obesitas-gerelateerd-atriumfib/","published":"2026-02-03"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zejun-yang","type":"person","url":"https://hartvaat.nl/mensen/zejun-yang/","name":"Zejun Yang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/03/dare-af-dapagliflozine-vermindert-vroeg-af-recidief-na-ablatie/","published":"2026-02-03"},{"url":"https://hartvaat.nl/2023/11/01/tijd-in-streefwaarde-van-bloeddruk-en-af-sprint-inzichten/","published":"2023-11-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zeng","type":"person","url":"https://hartvaat.nl/mensen/zeng/","name":"Zeng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/29/geisoleerde-secundaire-tricuspidalisinsufficientie-na-linkszijdige-klepchirurgie/","published":"2026-07-12"},{"url":"https://hartvaat.nl/2026/02/26/hiv-infectie-hangt-onafhankelijk-samen-met-meer-en-kwetsbaardere-halsslagaderpla/","published":"2026-02-26"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zenghui-zhang","type":"person","url":"https://hartvaat.nl/mensen/zenghui-zhang/","name":"Zenghui Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/19/gezond-eetpatroon-verlaagt-cv-risico-bij-kankeroverlevenden-los-van-genetisch-ri/","published":"2026-06-16"},{"url":"https://hartvaat.nl/2024/12/01/nt-probnp-voorspelt-nieuw-ontstaan-af-bij-hfpef/","published":"2024-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zengtang-zhang","type":"person","url":"https://hartvaat.nl/mensen/zengtang-zhang/","name":"Zengtang Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/ice-versus-tee-bij-af-ablatie-gerandomiseerde-trial/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2023/05/19/drie-substraatstrategieen-voor-persisterend-af-vergeleken-multicenter-rct/","published":"2023-05-19"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhanquan-li","type":"person","url":"https://hartvaat.nl/mensen/zhanquan-li/","name":"Zhanquan Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/11/28/double-kissing-crush-versus-provisional-stenting-bij-hoofdstambifurcatie-dkcrush/","published":"2017-11-28"},{"url":"https://hartvaat.nl/2016/05/17/biodegradeerbare-sirolimus-eluting-stents-de-panda-iii-trial/","published":"2016-05-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhaoxia-liang","type":"person","url":"https://hartvaat.nl/mensen/zhaoxia-liang/","name":"Zhaoxia Liang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/12/01/optimale-cardiometabole-gezondheid-tijdens-zwangerschap-verlaagt-risico-op-compl/","published":"2026-08-17"},{"url":"https://hartvaat.nl/2019/12/01/genetische-gevoeligheid-eiwitinname-en-bloeddrukverandering-pounds-lost/","published":"2019-12-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhaxybay-zhumadilov","type":"person","url":"https://hartvaat.nl/mensen/zhaxybay-zhumadilov/","name":"Zhaxybay Zhumadilov","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/09/bloeddrukverlagende-medicatie-naar-hypertensierichtlijn-in-lage-middeninkomensla/","published":"2021-03-09"},{"url":"https://hartvaat.nl/2019/08/24/hypertensiezorg-in-44-lage-en-middeninkomenslanden-lancet/","published":"2019-08-24"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhe-zheng","type":"person","url":"https://hartvaat.nl/mensen/zhe-zheng/","name":"Zhe Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/08/30/simultane-hybride-ablatie-versus-thoracoscopische-chirurgische-ablatie-bij-persi/","published":"2024-08-30"},{"url":"https://hartvaat.nl/2016/05/05/perioperatief-rosuvastatine-bij-hartchirurgie-nejm-trial/","published":"2016-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhen-zhou","type":"person","url":"https://hartvaat.nl/mensen/zhen-zhou/","name":"Zhen Zhou","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/09/aspree-cardiale-stress-en-bloeddrukmanagement-bij-ouderen/","published":"2025-12-09"},{"url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","published":"2020-07-07"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhen-yu-zhang","type":"person","url":"https://hartvaat.nl/mensen/zhen-yu-zhang/","name":"Zhen-Yu Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/01/risicostratificatie-door-kruisclassificatie-van-centrale-en-brachiale-systolisch/","published":"2022-05-01"},{"url":"https://hartvaat.nl/2020/08/01/antidiabetica-en-cardiovasculaire-geneeskunde-meta-analyse-en-perspectief/","published":"2020-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhenfei-fang","type":"person","url":"https://hartvaat.nl/mensen/zhenfei-fang/","name":"Zhenfei Fang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zheng","type":"person","url":"https://hartvaat.nl/mensen/zheng/","name":"Zheng","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/04/17/verhoogd-crp-voorspelt-hartfalen-bij-kankeroverlevenden-uk-biobank/","published":"2026-07-21"},{"url":"https://hartvaat.nl/2026/01/30/off-label-lage-dosis-bloedplaatjesremmers-bij-coronairlijden-minder-infarcten-en/","published":"2026-01-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhengming-chen","type":"person","url":"https://hartvaat.nl/mensen/zhengming-chen/","name":"Zhengming Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/11/27/metabolome-consequenties-van-pcsk9-remming-versus-statinetherapie/","published":"2018-11-27"},{"url":"https://hartvaat.nl/2016/05/05/perioperatief-rosuvastatine-bij-hartchirurgie-nejm-trial/","published":"2016-05-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhengrong-liu","type":"person","url":"https://hartvaat.nl/mensen/zhengrong-liu/","name":"Zhengrong Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-langdurige-dialysepatienten-nejm/","published":"2019-09-12"},{"url":"https://hartvaat.nl/2019/09/12/roxadustat-bij-anemie-bij-nierziekte-zonder-dialyse-nejm/","published":"2019-09-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhi-tan","type":"person","url":"https://hartvaat.nl/mensen/zhi-tan/","name":"Zhi Tan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/16/landelijk-aki-alarmsysteem-effecten-op-zorg-en-patientuitkomsten/","published":"2026-02-16"},{"url":"https://hartvaat.nl/2022/09/06/klinisch-beslisondersteuning-vermindert-acute-nierschade-bij-coronairangiografie/","published":"2022-09-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhifang-li","type":"person","url":"https://hartvaat.nl/mensen/zhifang-li/","name":"Zhifang Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhihui-zhang","type":"person","url":"https://hartvaat.nl/mensen/zhihui-zhang/","name":"Zhihui Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhijie-huang","type":"person","url":"https://hartvaat.nl/mensen/zhijie-huang/","name":"Zhijie Huang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/09/01/nieuwe-metabolieten-geassocieerd-met-bloeddrukrespons-op-dieetinterventies/","published":"2024-09-01"},{"url":"https://hartvaat.nl/2022/08/01/hele-genoomsequencing-onthult-nieuwe-bloeddruk-loci/","published":"2022-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhiwei-jiang","type":"person","url":"https://hartvaat.nl/mensen/zhiwei-jiang/","name":"Zhiwei Jiang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/01/27/rec-cagefree-dcb-versus-stenting-bij-de-novo-cad-driejaarsdata/","published":"2026-01-27"},{"url":"https://hartvaat.nl/2024/09/14/drug-coated-balloon-versus-intended-stenting-bij-de-novo-coronairlaesies/","published":"2024-09-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhixin-hao","type":"person","url":"https://hartvaat.nl/mensen/zhixin-hao/","name":"Zhixin Hao","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2022/05/17/kosteneffectiviteit-van-zoutsubstitutie-ssass-analyse/","published":"2022-05-17"},{"url":"https://hartvaat.nl/2021/09/16/zoutsubstitutie-en-cv-events-en-sterfte-nejm-ssass/","published":"2021-09-16"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhiying-wang","type":"person","url":"https://hartvaat.nl/mensen/zhiying-wang/","name":"Zhiying Wang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2017/01/01/genoomwijde-meta-analyse-van-bloeddrukrespons-op-hydrochloorthiazide/","published":"2017-01-01"},{"url":"https://hartvaat.nl/2016/03/01/farmacogenomische-meta-analyse-van-bloeddrukrespons-op-betablokkers-bij-afro-ame/","published":"2016-03-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhong-chen","type":"person","url":"https://hartvaat.nl/mensen/zhong-chen/","name":"Zhong Chen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/02/14/cryoballon-pvi-als-eerstelijnsbehandeling-voor-typisch-atriumflutter/","published":"2023-02-14"},{"url":"https://hartvaat.nl/2020/12/14/katheterablatie-versus-thoracoscopische-ablatie-bij-langdurig-persisterend-af-ca/","published":"2020-12-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhu-ming-zhang","type":"person","url":"https://hartvaat.nl/mensen/zhu-ming-zhang/","name":"Zhu-Ming Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2020/06/01/intensieve-bloeddrukverlaging-en-risico-op-af-sprint-analyse/","published":"2020-06-01"},{"url":"https://hartvaat.nl/2017/08/01/intensieve-bloeddrukverlaging-en-linkerventrikelhypertrofie-sprint-echocardiogra/","published":"2017-08-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zhuoru-li","type":"person","url":"https://hartvaat.nl/mensen/zhuoru-li/","name":"Zhuoru Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/11/04/colchicine-vermindert-perioperatief-af-na-thoraxchirurgie-lancet-rct/","published":"2023-11-04"},{"url":"https://hartvaat.nl/2023/03/28/amplitude-o-dosisrespons-van-efpeglenatide-op-cv-uitkomsten-bij-diabetes/","published":"2023-03-28"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zia-zuberi","type":"person","url":"https://hartvaat.nl/mensen/zia-zuberi/","name":"Zia Zuberi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/03/08/multi-katheter-cryotherapie-versus-rf-ablatie-bij-langdurig-persisterend-af-gera/","published":"2021-03-08"},{"url":"https://hartvaat.nl/2021/02/05/slokdarmbescherming-met-temperatuurcontroleren-bij-af-ablatie-impact/","published":"2021-02-05"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zihan-sun","type":"person","url":"https://hartvaat.nl/mensen/zihan-sun/","name":"Zihan Sun","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/05/14/sprint-accord-gepoold-bloeddrukvariabiliteit-is-even-prognostisch-als-gemiddelde/","published":"2026-06-20"},{"url":"https://hartvaat.nl/2026/05/14/bloeddrukvariabiliteit-sprint-accord-ipd-meta-even-prognostisch-als-gemiddelde-b/","published":"2026-05-15"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zihong-guo","type":"person","url":"https://hartvaat.nl/mensen/zihong-guo/","name":"Zihong Guo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2023/09/01/step-substudie-intensieve-bloeddrukverlaging-verbetert-lvh-bij-ouderen/","published":"2023-09-01"},{"url":"https://hartvaat.nl/2021/09/30/intensieve-bloeddrukcontrole-bij-oudere-patienten-met-hypertensie-nejm-step/","published":"2021-09-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zixiao-li","type":"person","url":"https://hartvaat.nl/mensen/zixiao-li/","name":"Zixiao Li","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/02/05/tenecteplase-versus-standaardbehandeling-bij-basilaris-occlusie-in-the-lancet/","published":"2026-02-05"},{"url":"https://hartvaat.nl/2026/01/01/insulineresistentie-en-bloeddrukcontrole-op-cognitieve-uitkomsten/","published":"2026-01-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zoltan-ruzsa","type":"person","url":"https://hartvaat.nl/mensen/zoltan-ruzsa/","name":"Zoltán Ruzsa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/11/11/ffr-geleide-complete-versus-culprit-only-revascularisatie-bij-nstemi/","published":"2025-11-11"},{"url":"https://hartvaat.nl/2019/06/21/plaatjesreactiviteit-en-uitkomsten-bij-acs-met-prasugrel-versus-clopidogrel/","published":"2019-06-21"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zugui-zhang","type":"person","url":"https://hartvaat.nl/mensen/zugui-zhang/","name":"Zugui Zhang","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2021/04/27/patientselectie-voor-intensieve-bloeddrukbehandeling-naar-voordeel-en-bijwerking/","published":"2021-04-27"},{"url":"https://hartvaat.nl/2020/02/01/geschatte-cva-vrije-overleving-van-foliumzuurtherapie-bij-hypertensie-csppt/","published":"2020-02-01"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zuyi-yuan","type":"person","url":"https://hartvaat.nl/mensen/zuyi-yuan/","name":"Zuyi Yuan","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2026/06/26/inclisiran-als-monotherapie-verlaagt-ldl-c-met-47-5-in-chinese-volwassenen-victo/","published":"2026-08-09"},{"url":"https://hartvaat.nl/2023/03/18/intensieve-bloeddrukinterventie-door-niet-artsen-in-lage-inkomenslanden-lancet-r/","published":"2023-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zuzana-gdovinova","type":"person","url":"https://hartvaat.nl/mensen/zuzana-gdovinova/","name":"Zuzana Gdovinova","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/07/02/vroege-versus-late-doac-na-cva-met-hemorrhagische-transformatie-bij-af/","published":"2024-07-02"},{"url":"https://hartvaat.nl/2023/06/29/elan-vroege-versus-late-anticoagulatie-na-cva-bij-af-nejm/","published":"2023-06-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"etienne-de-medicis","type":"person","url":"https://hartvaat.nl/mensen/etienne-de-medicis/","name":"Étienne de Médicis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2018/09/27/6-maandsuitkomsten-van-restrictieve-versus-liberale-transfusie-bij-hartchirurgie/","published":"2018-09-27"},{"url":"https://hartvaat.nl/2017/11/30/restrictieve-versus-liberale-bloedtransfusie-bij-hartchirurgie-nejm-trics-iii/","published":"2017-11-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"oscar-camara","type":"person","url":"https://hartvaat.nl/mensen/oscar-camara/","name":"Óscar Cámara","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2025/12/01/lawt-geleide-pvi-bij-persisterend-af-gepersonaliseerde-benadering/","published":"2025-12-01"},{"url":"https://hartvaat.nl/2024/03/30/qdot-by-lawt-gepersonaliseerde-pvi-gestuurd-door-linkeratriale-wanddikte/","published":"2024-03-30"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ukasz-wiewiorka","type":"person","url":"https://hartvaat.nl/mensen/ukasz-wiewiorka/","name":"Łukasz Wiewiórka","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":2,"articles":[{"url":"https://hartvaat.nl/2024/12/10/hospitalisatie-bij-symptomatische-hf-met-matige-tot-ernstige-functionele-mr/","published":"2024-12-10"},{"url":"https://hartvaat.nl/2024/11/14/reshape-hf2-transcatheter-kleprepair-bij-hf-met-matige-tot-ernstige-mr-nejm/","published":"2024-11-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"alejo","type":"person","url":"https://hartvaat.nl/mensen/alejo/","name":"Alejo","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"anselmi","type":"person","url":"https://hartvaat.nl/mensen/anselmi/","name":"Anselmi","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/bayesiaanse-netwerkmeta-analyse-vergelijkt-revascularisatie-bij-stabiele-ischemi/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"beat-muller","type":"person","url":"https://hartvaat.nl/mensen/beat-muller/","name":"Beat Müller","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bettina-glatz","type":"person","url":"https://hartvaat.nl/mensen/bettina-glatz/","name":"Bettina Glatz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"bo-liu","type":"person","url":"https://hartvaat.nl/mensen/bo-liu/","name":"Bo Liu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2025/10/14/heparine-bij-eerste-medisch-contact-versus-voor-primaire-pci-bij-stemi/","published":"2025-10-14"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"boden","type":"person","url":"https://hartvaat.nl/mensen/boden/","name":"Boden","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/bayesiaanse-netwerkmeta-analyse-vergelijkt-revascularisatie-bij-stabiele-ischemi/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brand","type":"person","url":"https://hartvaat.nl/mensen/brand/","name":"Brand","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brigitte-fitze","type":"person","url":"https://hartvaat.nl/mensen/brigitte-fitze/","name":"Brigitte Fitze","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"brophy","type":"person","url":"https://hartvaat.nl/mensen/brophy/","name":"Brophy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/bayesiaanse-netwerkmeta-analyse-vergelijkt-revascularisatie-bij-stabiele-ischemi/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"budaj","type":"person","url":"https://hartvaat.nl/mensen/budaj/","name":"Budaj","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"budts","type":"person","url":"https://hartvaat.nl/mensen/budts/","name":"Budts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"cameron","type":"person","url":"https://hartvaat.nl/mensen/cameron/","name":"Cameron","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"canpolat","type":"person","url":"https://hartvaat.nl/mensen/canpolat/","name":"Canpolat","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"carmela-schumacher","type":"person","url":"https://hartvaat.nl/mensen/carmela-schumacher/","name":"Carmela Schumacher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ceriani","type":"person","url":"https://hartvaat.nl/mensen/ceriani/","name":"Ceriani","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/03/18/st-elevatie-bij-acute-pericarditis-wijst-op-myocardiale-betrokkenheid/","published":"2026-03-18"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"christian-puelacher","type":"person","url":"https://hartvaat.nl/mensen/christian-puelacher/","name":"Christian Puelacher","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"danchin","type":"person","url":"https://hartvaat.nl/mensen/danchin/","name":"Danchin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"deborah-schneider","type":"person","url":"https://hartvaat.nl/mensen/deborah-schneider/","name":"Deborah Schneider","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dorresteijn","type":"person","url":"https://hartvaat.nl/mensen/dorresteijn/","name":"Dorresteijn","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"dronkert","type":"person","url":"https://hartvaat.nl/mensen/dronkert/","name":"Dronkert","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"emberson","type":"person","url":"https://hartvaat.nl/mensen/emberson/","name":"Emberson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"fabian-vogt","type":"person","url":"https://hartvaat.nl/mensen/fabian-vogt/","name":"Fabian Vogt","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"furena-x0308-s","type":"person","url":"https://hartvaat.nl/mensen/furena-x0308-s/","name":"Furenäs","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"glikson","type":"person","url":"https://hartvaat.nl/mensen/glikson/","name":"Glikson","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"hall","type":"person","url":"https://hartvaat.nl/mensen/hall/","name":"Hall","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"heuts","type":"person","url":"https://hartvaat.nl/mensen/heuts/","name":"Heuts","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/bayesiaanse-netwerkmeta-analyse-vergelijkt-revascularisatie-bij-stabiele-ischemi/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"iung","type":"person","url":"https://hartvaat.nl/mensen/iung/","name":"Iung","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"janine-vogele","type":"person","url":"https://hartvaat.nl/mensen/janine-vogele/","name":"Janine Vögele","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jasmin-martin","type":"person","url":"https://hartvaat.nl/mensen/jasmin-martin/","name":"Jasmin Martin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonas-hilti","type":"person","url":"https://hartvaat.nl/mensen/jonas-hilti/","name":"Jonas Hilti","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jonas-schwarz","type":"person","url":"https://hartvaat.nl/mensen/jonas-schwarz/","name":"Jonas Schwarz","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"jondeau","type":"person","url":"https://hartvaat.nl/mensen/jondeau/","name":"Jondeau","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kathrin-meissner","type":"person","url":"https://hartvaat.nl/mensen/kathrin-meissner/","name":"Kathrin Meissner","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kawczynski","type":"person","url":"https://hartvaat.nl/mensen/kawczynski/","name":"Kawczynski","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/bayesiaanse-netwerkmeta-analyse-vergelijkt-revascularisatie-bij-stabiele-ischemi/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"kayikcioglu","type":"person","url":"https://hartvaat.nl/mensen/kayikcioglu/","name":"Kayikcioglu","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"lawton","type":"person","url":"https://hartvaat.nl/mensen/lawton/","name":"Lawton","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"m-k","type":"person","url":"https://hartvaat.nl/mensen/m-k/","name":"M. K.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/05/20/klinisch-en-genetisch-risico-op-atriumfibrilleren-versterken-elkaar-additief-13-/","published":"2026-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maggioni","type":"person","url":"https://hartvaat.nl/mensen/maggioni/","name":"Maggioni","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"maniadakis","type":"person","url":"https://hartvaat.nl/mensen/maniadakis/","name":"Maniadakis","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"marelli","type":"person","url":"https://hartvaat.nl/mensen/marelli/","name":"Marelli","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"mekonnen","type":"person","url":"https://hartvaat.nl/mensen/mekonnen/","name":"Mekonnen","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"michael-freese","type":"person","url":"https://hartvaat.nl/mensen/michael-freese/","name":"Michael Freese","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"morissens","type":"person","url":"https://hartvaat.nl/mensen/morissens/","name":"Morissens","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nagy","type":"person","url":"https://hartvaat.nl/mensen/nagy/","name":"Nagy","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"natascha-herr","type":"person","url":"https://hartvaat.nl/mensen/natascha-herr/","name":"Natascha Herr","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nedoshivin","type":"person","url":"https://hartvaat.nl/mensen/nedoshivin/","name":"Nedoshivin","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"nisha-arenja","type":"person","url":"https://hartvaat.nl/mensen/nisha-arenja/","name":"Nisha Arenja","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"parolari","type":"person","url":"https://hartvaat.nl/mensen/parolari/","name":"Parolari","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/bayesiaanse-netwerkmeta-analyse-vergelijkt-revascularisatie-bij-stabiele-ischemi/","published":"2026-05-10"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pasquet","type":"person","url":"https://hartvaat.nl/mensen/pasquet/","name":"Pasquet","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"petronio","type":"person","url":"https://hartvaat.nl/mensen/petronio/","name":"Petronio","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"pham","type":"person","url":"https://hartvaat.nl/mensen/pham/","name":"Pham","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/05/20/hypochloremie-bij-opname-voor-acuut-hartfalen-voorspelt-onafhankelijk-30-daagse-/","published":"2026-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"ropac-executive-committee","type":"person","url":"https://hartvaat.nl/mensen/ropac-executive-committee/","name":"ROPAC Executive Committee","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"rahel-isenrich","type":"person","url":"https://hartvaat.nl/mensen/rahel-isenrich/","name":"Rahel Isenrich","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sabine-hartwiger","type":"person","url":"https://hartvaat.nl/mensen/sabine-hartwiger/","name":"Sabine Hartwiger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"salenger","type":"person","url":"https://hartvaat.nl/mensen/salenger/","name":"Salenger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sara-barata","type":"person","url":"https://hartvaat.nl/mensen/sara-barata/","name":"Sara Barata","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"scho-x0308-nberger","type":"person","url":"https://hartvaat.nl/mensen/scho-x0308-nberger/","name":"Schönberger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/01/29/obesitasparadox-bij-het-takotsubosyndroom-ondergewicht-geeft-de-hoogste-sterfte-/","published":"2026-01-29"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"sliwa","type":"person","url":"https://hartvaat.nl/mensen/sliwa/","name":"Sliwa","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"t-p","type":"person","url":"https://hartvaat.nl/mensen/t-p/","name":"T. P.","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/05/20/hypochloremie-bij-opname-voor-acuut-hartfalen-voorspelt-onafhankelijk-30-daagse-/","published":"2026-07-06"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"tamina-mosimann","type":"person","url":"https://hartvaat.nl/mensen/tamina-mosimann/","name":"Tamina Mosimann","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2019/12/17/uitgebreide-vasodilatatie-versus-standaardzorg-bij-acuut-hf-jama-galactic-hf-pil/","published":"2019-12-17"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"visseren","type":"person","url":"https://hartvaat.nl/mensen/visseren/","name":"Visseren","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"weidinger","type":"person","url":"https://hartvaat.nl/mensen/weidinger/","name":"Weidinger","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"wernly","type":"person","url":"https://hartvaat.nl/mensen/wernly/","name":"Wernly","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/03/12/betere-cardiovasculaire-gezondheid-life-s-simple-7-hangt-samen-met-minder-leverv/","published":"2026-03-12"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"whitman","type":"person","url":"https://hartvaat.nl/mensen/whitman/","name":"Whitman","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/24/ita-bypass-veilig-bij-patienten-met-eerdere-mediastinale-bestraling-maryland-coh/","published":"2026-05-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"zeymer","type":"person","url":"https://hartvaat.nl/mensen/zeymer/","name":"Zeymer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/04/10/tweelingzwangerschap-bij-vrouwen-met-een-hartaandoening-geeft-een-hoog-risico-op/","published":"2026-07-22"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"van-der-harst","type":"person","url":"https://hartvaat.nl/mensen/van-der-harst/","name":"van der Harst","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."},{"id":"van-der-meer","type":"person","url":"https://hartvaat.nl/mensen/van-der-meer/","name":"van der Meer","title":"","dutch_institution":false,"orcid":"","scholar":"","website":"","article_count":1,"articles":[{"url":"https://hartvaat.nl/2026/03/25/vier-klinische-fenotypes-bij-coronairlijden-met-sterk-verschillend-risico-op-nie/","published":"2026-03-25"}],"videos":[],"licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies."}]}